PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Karakikes, I; Morrison, IEG; O'Toole, P; Metodieva, G; Navarrete, CV; Gomez, J; Miranda-Sayago, JM; Cherry, RJ; Metodiev, M; Fernandez, N				Karakikes, Ioannis; Morrison, Ian E. G.; O'Toole, Peter; Metodieva, Gergana; Navarrete, Cristina V.; Gomez, Jesus; Miranda-Sayago, Jose M.; Cherry, Richard J.; Metodiev, Metodi; Fernandez, Nelson			Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis	FASEB JOURNAL			English	Article						dendritic cells; monocytes; phycobiliprotein	MHC CLASS-II; INVARIANT CHAIN CD74; DENDRITIC CELLS; LIVING CELLS; RAPID INTERNALIZATION; CYTOPLASMIC TAIL; EARLY ENDOSOMES; MOLECULES; BINDING; ENDOCYTOSIS	Major histocompatibility complex (MHC) class II-associated antigen presentation involves an array of interacting molecules. CD74, the cell surface isoform of the MHC class II-associated invariant chain, is one such molecule; its role remains poorly defined. To address this, we have employed a high-resolution single-particle imaging method for quantifying the colocalization of CD74 with human leukocyte antigen (HLA)-DR molecules on human fibroblast cells known for their capacity to function as antigen-presenting cells. We have also examined whether the colocalization induces internalization of HLA-DR using HA(307-319), a "universal" peptide that binds specifically to the peptide-binding groove of all HLA-DR molecules, irrespective of their alleles. We have determined that 25 +/- 1.3% of CD74 and 17 +/- 0.3% of HLA-DR are colocalized, and the association of CD74 with HLA-DR and the internalization of HLA-DR are both inhibited by HA(307-319). A similar inhibition of HLA-DR internalization was observed in freshly isolated monocyte-derived dendritic cells. A key role of CD74 is to translocate HLA-DR molecules to early endosomes for reloading with peptides prior to recycling to the cell surface. We conclude that CD74 regulates the balance of peptide-occupied and peptide-free forms of MHC class II at the cell surface.-Karakikes, I., Morrison, I. E. G., O'Toole, P., Metodieva, G., Navarrete, C. V., Gomez, J., Miranda-Sayago, J. M., Cherry, R. J., Metodiev, M., Fernandez, N. Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single-particle image analysis. FASEB J. 26, 4886-4896 (2012). www.fasebj.org	[Karakikes, Ioannis; Morrison, Ian E. G.; Metodieva, Gergana; Miranda-Sayago, Jose M.; Cherry, Richard J.; Metodiev, Metodi; Fernandez, Nelson] Univ Essex, Sch Biol Sci, Colchester C04 3SQ, Essex, England; [O'Toole, Peter] Univ York, Dept Biol, Imaging & Cytometry Lab, Technol Facil, York YO10 5DD, N Yorkshire, England; [Navarrete, Cristina V.; Gomez, Jesus] Natl Blood Ctr, Histocompatibil & Immunogenet Res Dept, London, England	University of Essex; University of York - UK	Fernandez, N (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester C04 3SQ, Essex, England.	nelson@essex.ac.uk	Miranda-Sayago, Jose/F-9620-2014	O'Toole, Peter John/0000-0001-5295-2001; Metodiev, Metodi V/0000-0001-6810-0719; Karakikes, Ioannis/0000-0002-4348-600X	UK Biotechnology and Biological Sciences Research Council; Wellcome Trust	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Prof. R. Lechler (King's College, London, UK) for providing the M1DR1 transfectant cell line series. The authors also thank Prof. I. McLennan (University of Birmingham, Birmingham, UK) for the monoclonal antibody BU45 and Dr. K. Guy (University of Strathclyde, Glasgow, UK) for the antibody DA6.231. The authors thank the UK Biotechnology and Biological Sciences Research Council and Wellcome Trust for support.	Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BREMNES B, 1994, J CELL SCI, V107, P2021; BUSCH R, 1990, INT IMMUNOL, V2, P443, DOI 10.1093/intimm/2.5.443; Castellino F, 2001, EUR J IMMUNOL, V31, P841, DOI 10.1002/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D; Cefai D, 1998, J IMMUNOL, V160, P2223; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cherry RJ, 1998, J CELL BIOL, V140, P71, DOI 10.1083/jcb.140.1.71; DAVIS JE, 1990, J IMMUNOL, V144, P990; DODI AI, 1994, EUR J IMMUNOL, V24, P1632, DOI 10.1002/eji.1830240727; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; FERNANDEZ N, 1991, ELECTROPHORESIS, V12, P523, DOI 10.1002/elps.1150120711; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Greenwood C, 2012, J PROTEOMICS, V75, P3031, DOI 10.1016/j.jprot.2011.11.033; Griffin JP, 1997, J IMMUNOL, V158, P1523; HARDING CV, 1989, J IMMUNOL, V142, P12; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Illingworth JJ, 2012, IMMUNOLOGY, V135, P198, DOI 10.1111/j.1365-2567.2011.03537.x; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lightstone L, 1997, P NATL ACAD SCI USA, V94, P5772, DOI 10.1073/pnas.94.11.5772; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Moldenhauer G, 1999, IMMUNOLOGY, V96, P473; Moller F, 2000, J BIOL REG HOMEOS AG, V14, P299; Monji T, 1997, J IMMUNOL, V158, P3155; MORRISON IEG, 1994, BIOPHYS J, V67, P1280, DOI 10.1016/S0006-3495(94)80600-9; Morrison IEG, 2003, BIOPHYS J, V85, P4110, DOI 10.1016/S0006-3495(03)74823-1; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Newcomb JR, 1996, J BIOL CHEM, V271, P24249, DOI 10.1074/jbc.271.39.24249; NYGARD NR, 1994, J IMMUNOL, V152, P1082; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; PIETERS J, 1993, J CELL SCI, V106, P831; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Pinet VM, 1998, EUR J IMMUNOL, V28, P799, DOI 10.1002/(SICI)1521-4141(199803)28:03<799::AID-IMMU799>3.0.CO;2-5; REID PA, 1992, IMMUNOLOGY, V77, P539; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; Roucard C, 1996, J BIOL CHEM, V271, P13993, DOI 10.1074/jbc.271.24.13993; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Siebenkotten IM, 1998, J IMMUNOL, V160, P3355; Smith P. R., 1998, MHC, P133; Smith PR, 1999, BIOPHYS J, V76, P3331, DOI 10.1016/S0006-3495(99)77486-2; Stumptner P, 1997, EMBO J, V16, P5807, DOI 10.1038/sj.emboj.7590555; Thayer WP, 1999, J IMMUNOL, V162, P1502; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Trabesinger W, 2001, ANAL CHEM, V73, P1100, DOI 10.1021/ac000810t; Warmerdam PAM, 1996, J CELL BIOL, V133, P281, DOI 10.1083/jcb.133.2.281; Wilson KM, 1996, J CELL SCI, V109, P2101; WILSON KM, 1993, IMMUNOLOGY, V79, P331	54	17	20	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4886	4896		10.1096/fj.12-211466	http://dx.doi.org/10.1096/fj.12-211466			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22889831				2022-12-25	WOS:000311838300012
J	Moon, SM; Kim, SA; Yoon, JH; Ahn, SG				Moon, Sung-Min; Kim, Soo-A; Yoon, Jung-Hoon; Ahn, Sang-Gun			HOXC6 Is Deregulated in Human Head and Neck Squamous Cell Carcinoma and Modulates Bcl-2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENES; CANCER; APOPTOSIS; PROSTATE; FAMILY; GROWTH; DEATH; MORPHOGENESIS; EPIDEMIOLOGY; METHYLATION	Homeobox C6 (HOXC6) genes belong to the homeoprotein family of transcription factors, which play an important role in morphogenesis and cellular differentiation during embryonic development. The aim of this study was to explore the role of HOXC6 in the regulation of Bcl-2 in human head and neck squamous cell carcinoma (HNSCC). The HOXC6 and Bcl-2 gene were identified as being overexpressed in HNSCC tissue and cell lines. Transfection assays demonstrated that HOXC6 increased the levels of Bcl-2 mRNA and protein. A luciferase reporter assay suggested that HOXC6 induced activity of the Bcl-2 promoter. A series of Bcl-2 promoter deletion mutants were examined and the minimal HOXC6-responsive region was identified to be in the TAAT motif (-420 bp) of the Bcl-2 promoter. Interestingly, the inhibition of HOXC6 using siRNA led to the repression of Bcl-2 expression and induced caspase-3-dependent apoptosis; overexpression of HOXC6 in HNSCC cells increased the resistance to paclitaxel-induced apoptosis. Together, our findings suggest that HOXC6 is an important mechanism of the anti-apoptotic pathway via regulation of Bcl-2 expression.	[Ahn, Sang-Gun] Chosun Univ, Sch Dent, Dept Pathol, Coll Dent, Kwangju 501759, South Korea; [Kim, Soo-A] Dongguk Univ, Dept Biochem, Gyeongju 780714, South Korea; [Yoon, Jung-Hoon] Wonkwang Univ, Daejeon Dent Hosp, Dept Oral Pathol, Taejon 302120, South Korea	Chosun University; Dongguk University; Wonkwang University	Ahn, SG (corresponding author), Chosun Univ, Sch Dent, Dept Pathol, Coll Dent, 375 Seosuk Dong, Kwangju 501759, South Korea.	ahnsg@chosun.ac.kr		Kim, Soo-A/0000-0001-6777-739X	National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [R13-2008-010-00000-0, 2012-0002140]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (No. R13-2008-010-00000-0; No. 2012-0002140).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Argiris A, 2003, CANC TREAT, V114, P15; Babidge WJ, 2001, ANTICANCER RES, V21, P2809; Bijl J, 1996, BLOOD, V87, P1737, DOI 10.1182/blood.V87.5.1737.bloodjournal8751737; Bodey B, 2000, ANTICANCER RES, V20, P3281; Bodey B, 2000, ANTICANCER RES, V20, P2717; CASTRONOVO V, 1994, BIOCHEM PHARMACOL, V47, P137, DOI 10.1016/0006-2952(94)90447-2; Cazal C, 2006, ORAL DIS, V12, P424, DOI 10.1111/j.1601-0825.2005.01218.x; Chen KN, 2005, CLIN CANCER RES, V11, P1044; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Drenning SD, 1998, CLIN CANCER RES, V4, P2913; FRIEDMANN Y, 1994, CANCER RES, V54, P5981; Fujiki K, 2008, GASTROENTEROLOGY, V135, P907, DOI 10.1053/j.gastro.2008.06.034; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; Grishina IB, 2005, DEV BIOL, V288, P334, DOI 10.1016/j.ydbio.2005.08.018; Hassan NMM, 2006, ONCOL RES, V16, P217, DOI 10.3727/000000006783981080; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JONES FS, 1993, P NATL ACAD SCI USA, V90, P6557, DOI 10.1073/pnas.90.14.6557; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Li RX, 2007, NEOPLASIA, V9, P801, DOI 10.1593/neo.07394; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; McCabe CD, 2008, CANCER RES, V68, P1988, DOI 10.1158/0008-5472.CAN-07-5843; Miller GJ, 2003, CANCER RES, V63, P5879; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Park S, 2007, BIOCHEM BIOPH RES CO, V357, P1011, DOI 10.1016/j.bbrc.2007.04.051; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Ricort JM, 2002, J BIOL CHEM, V277, P19448, DOI 10.1074/jbc.M200439200; Sharma H, 2005, CANCER BIOL THER, V4, P720, DOI 10.4161/cbt.4.7.1783; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Trask DK, 2002, LARYNGOSCOPE, V112, P638, DOI 10.1097/00005537-200204000-00009; Tucci R, 2011, J APPL ORAL SCI, V19, P125, DOI 10.1590/S1678-77572011000200008; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Warnakulasuriya Saman, 2009, Evid Based Dent, V10, P4, DOI 10.1038/sj.ebd.6400623; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wolter KG, 2006, NEOPLASIA, V8, P163, DOI 10.1593/neo.05691; Yahagi Naohisa, 2004, Congenital Anomalies, V44, P18, DOI 10.1111/j.1741-4520.2003.00004.x; Zhu QH, 2011, SCAND J GASTROENTERO, V46, P436, DOI 10.3109/00365521.2010.537682; Zhu X, 2007, AM J PATHOL, V170, P1618, DOI 10.2353/ajpath.2007.061111	45	35	36	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35678	35688		10.1074/jbc.M112.361675	http://dx.doi.org/10.1074/jbc.M112.361675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896703	Green Published, hybrid			2022-12-25	WOS:000309968000079
J	Bozdagi, O; Sakurai, T; Dorr, N; Pilorge, M; Takahashi, N; Buxbaum, JD				Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.			Haploinsufficiency of Cyfip1 Produces Fragile X-Like Phenotypes in Mice	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; PRADER-WILLI-SYNDROME; COPY NUMBER VARIATION; SYNAPTIC PLASTICITY; MOUSE MODEL; SOCIAL APPROACH; CRITICAL REGION; 4 GENES; SCHIZOPHRENIA	Background: Copy number variation (CNV) at the 15q11.2 region, which includes a gene that codes for CYFIP1 (cytoplasmic FMR1 interacting protein 1), has been implicated in autism, intellectual disability and additional neuropsychiatric phenotypes. In the current study we studied the function of Cyfip1 in synaptic physiology and behavior, using mice with a disruption of the Cyfip1 gene. Methodology/Principal Findings: We observed that in Cyfip1 heterozygous mice metabotropic glutamate receptor (mGluR)-dependent long-term depression (LTD) induced by paired-pulse low frequency stimulation (PP-LFS) was significantly increased in comparison to wildtype mice. In addition, mGluR-LTD was not affected in the presence of protein synthesis inhibitor in the Cyfip1 heterozygous mice, while the same treatment inhibited LTD in wildtype littermate controls. mGluR-agonist (RS)-3,5-dihydroxyphenylglycine (DHPG)-induced LTD was also significantly increased in hippocampal slices from Cyfip1 heterozygous mice and again showed independence from protein synthesis only in the heterozygous animals. Furthermore, we observed that the mammalian Target of Rapamycin (mTOR) inhibitor rapamycin was only effective at reducing mGluR-LTD in wildtype animals. Behaviorally, Cyfip1 heterozygous mice showed enhanced extinction of inhibitory avoidance. Application of both mGluR5 and mGluR1 antagonist to slices from Cyfip1 heterozygous mice reversed the increase in DHPG-induced LTD in these mice. Conclusions/Significance: These results demonstrate that haploinsufficiency of Cyfip1 mimics key aspects of the phenotype of Fmr1 knockout mice and are consistent with the hypothesis that these effects are mediated by interaction of Cyfip1 and Fmrp in regulating activity-dependent translation. The data provide support for a model where CYFIP1 haploinsufficiency in patients results in intermediate phenotypes increasing risk for neuropsychiatric disorders.	[Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Bozdagi, Ozlem; Sakurai, Takeshi; Dorr, Nathan; Pilorge, Marion; Takahashi, Nagahide; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bozdagi, O (corresponding author), Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.	joseph.buxbaum@mssm.edu	Takahashi, Nagahide/AAR-6268-2020; Buxbaum, Joseph D/G-6001-2010	Takahashi, Nagahide/0000-0002-7711-0297; Buxbaum, Joseph/0000-0001-8898-8313	Seaver Foundation	Seaver Foundation	This work was supported by the Seaver Foundation. OB and TS are Seaver Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bittel DC, 2006, PEDIATRICS, V118, pE1276, DOI 10.1542/peds.2006-0424; Botzolakis EJ, 2011, MOL CELL NEUROSCI, V46, P122, DOI 10.1016/j.mcn.2010.08.012; Bozdagi O, 2010, J NEUROSCI, V30, P9984, DOI 10.1523/JNEUROSCI.1223-10.2010; Burnside R, 2011, HUM GENET, V130, P517, DOI 10.1007/s00439-011-0970-4; Butler MG, 2004, PEDIATRICS, V113, P565, DOI 10.1542/peds.113.3.565; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Doornbos M, 2009, EUR J MED GENET, V52, P108, DOI 10.1016/j.ejmg.2009.03.010; Elder GA, 2008, BEHAV BRAIN RES, V191, P256, DOI 10.1016/j.bbr.2008.03.036; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Garber KB, 2008, EUR J HUM GENET, V16, P666, DOI 10.1038/ejhg.2008.61; Godfraind JM, 1996, AM J MED GENET, V64, P246; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Heyser Charles J, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0818s25; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; James AP, 2006, BIOCHIM BIOPHYS ACTA, V1762, p[11, 986]; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murthy SK, 2007, CYTOGENET GENOME RES, V116, P135, DOI 10.1159/000097433; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Peters SU, 2011, J CHILD PSYCHOL PSYC; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sahoo T, 2006, J MED GENET, V43, P512, DOI 10.1136/jmg.2005.036913; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; von der Lippe C, 2011, EUR J MED GENET, V54, P357, DOI 10.1016/j.ejmg.2010.12.008; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101	48	73	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42422	10.1371/journal.pone.0042422	http://dx.doi.org/10.1371/journal.pone.0042422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900020	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900037
J	Coombs, GW; Goering, RV; Chua, KYL; Monecke, S; Howden, BP; Stinear, TP; Ehricht, R; O'Brien, FG; Christiansen, KJ				Coombs, Geoffrey W.; Goering, Richard V.; Chua, Kyra Y. L.; Monecke, Stefan; Howden, Benjamin P.; Stinear, Timothy P.; Ehricht, Ralf; O'Brien, Frances G.; Christiansen, Keryn J.			The Molecular Epidemiology of the Highly Virulent ST93 Australian Community Staphylococcus aureus Strain	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; UNITED-STATES; WESTERN-AUSTRALIA; GENES; ELECTROPHORESIS; HOSPITALS; LINEAGES; DATABASE; CLONES	In Australia the PVL - positive ST93-IV [2B], colloquially known as "Queensland CA-MRSA" has become the dominant CA-MRSA clone. First described in the early 2000s, ST93-IV [2B] is associated with skin and severe invasive infections including necrotizing pneumonia. A singleton by multilocus sequence typing (MLST) eBURST analysis ST93 is distinct from other S aureus clones. To determine if the increased prevalence of ST93-IV [2B] is due to the widespread transmission of a single strain of ST93-IV [2B] the genetic relatedness of 58 S. aureus ST93 isolated throughout Australia over an extended period were studied in detail using a variety of molecular methods including pulsed-field gel electrophoresis, spa typing, MLST, microarray DNA, SCCmec typing and dru typing. Identification of the phage harbouring the lukS-PV/lukF-PV Panton Valentine leucocidin genes, detection of allelic variations in lukS-PV/lukF-PV, and quantification of LukF-PV expression was also performed. Although ST93-IV [2B] is known to have an apparent enhanced clinical virulence, the isolates harboured few known virulence determinants. All PVL-positive isolates carried the PVL-encoding phage Phi Sa2USA and the lukS-PV/lukF-PV genes had the same R variant SNP profile. The isolates produced similar expression levels of LukF-PV. Although multiple rearrangements of the spa sequence have occurred, the core genome in ST93 is very stable. The emergence of ST93-MRSA is due to independent acquisitions of different dru-defined type IV and type V SCCmec elements in several spa-defined ST93-MSSA backgrounds. Rearrangement of the spa sequence in ST93-MRSA has subsequently occurred in some of these strains. Although multiple ST93-MRSA strains were characterised, little genetic diversity was identified for most isolates, with PVL-positive ST93-IVa [2B]-t202-dt10 predominant across Australia. Whether ST93-IVa [2B] t202-dt10 arose from one PVL-positive ST93-MSSA-t202, or by independent acquisitions of SCCmec-IVa [2B]-dt10 into multiple PVL-positive ST93-MSSA-t202 strains is not known.	[Coombs, Geoffrey W.; Christiansen, Keryn J.] Royal Perth Hosp, PathWest Lab Med Western Australia, Australian Collaborating Ctr Enterococcus & Staph, Western Australia, Australia; [Coombs, Geoffrey W.; O'Brien, Frances G.; Christiansen, Keryn J.] Curtin Univ, Sch Biomed Sci, Western Australia, Australia; [Goering, Richard V.] Creighton Univ, Dept Med Microbiol, Omaha, NE 68178 USA; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.] Austin Hlth, Dept Infect Dis, ACIR, Heidelberg, Vic, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Austin Hlth, Dept Microbiol, Heidelberg, Vic, Australia; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany	Royal Perth Hospital; Curtin University; Creighton University; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Alere; Technische Universitat Dresden	Coombs, GW (corresponding author), Royal Perth Hosp, PathWest Lab Med Western Australia, Australian Collaborating Ctr Enterococcus & Staph, Western Australia, Australia.	Geoffrey.coombs@health.wa.gov.au		Goering, Richard/0000-0001-7502-7185; Stinear, Timothy/0000-0003-0150-123X; Chua, Kyra Yu Lin/0000-0001-8826-7137; Howden, Benjamin/0000-0003-0237-1473; Coombs, Geoffrey/0000-0003-1635-6506	PathWest Laboratory Medicine - WA; Curtin University; Western Australian Department of Health; National Health and Medical Research Council of Australia [1008656]	PathWest Laboratory Medicine - WA; Curtin University; Western Australian Department of Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by PathWest Laboratory Medicine - WA, Curtin University, the Western Australian Department of Health and the National Health and Medical Research Council of Australia Project Grant 1008656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Benson G, 1997, J COMPUT BIOL, V4, P351, DOI 10.1089/cmb.1997.4.351; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; CA-SFM, 1996, CLIN MICROBIOL INFEC, V2; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Chua KYL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025887; CLSI, 2009, M100S18 CLSI; Collignon P, 1998, LANCET, V352, P145, DOI 10.1016/S0140-6736(98)85051-4; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Munckhof WJ, 2008, EUR J CLIN MICROBIOL, V27, P355, DOI 10.1007/s10096-007-0449-3; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; O'Brien FG, 2009, J ANTIMICROB CHEMOTH, V64, P684, DOI 10.1093/jac/dkp285; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Peleg AY, 2005, EUR J CLIN MICROBIOL, V24, P384, DOI 10.1007/s10096-005-1329-3; Riley D, 1998, NEW ZEAL MED J, V111, P59; Risson DC, 2007, MED J AUSTRALIA, V186, P479, DOI 10.5694/j.1326-5377.2007.tb01002.x; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P1324, DOI 10.1128/AAC.05804-11; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wolter DJ, 2007, CLIN MICROBIOL INFEC, V13, P827, DOI 10.1111/j.1469-0691.2007.01763.x	44	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43037	10.1371/journal.pone.0043037	http://dx.doi.org/10.1371/journal.pone.0043037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900085	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900103
J	Herrera-Aguilar, JL; Larralde, H; Aldana, M				Herrera-Aguilar, Jose L.; Larralde, Hernan; Aldana, Maximino			Pattern Recognition in Neural Networks with Competing Dynamics: Coexistence of Fixed-Point and Cyclic Attractors	PLOS ONE			English	Article							STATE-DEPENDENT SYNAPSES; LONG-TERM-MEMORY; STORAGE CAPACITY; MODEL	We study the properties of the dynamical phase transition occurring in neural network models in which a competition between associative memory and sequential pattern recognition exists. This competition occurs through a weighted mixture of the symmetric and asymmetric parts of the synaptic matrix. Through a generating functional formalism, we determine the structure of the parameter space at non-zero temperature and near saturation (i.e., when the number of stored patterns scales with the size of the network), identifying the regions of high and weak pattern correlations, the spin-glass solutions, and the order-disorder transition between these regions. This analysis reveals that, when associative memory is dominant, smooth transitions appear between high correlated regions and spurious states. In contrast when sequential pattern recognition is stronger than associative memory, the transitions are always discontinuous. Additionally, when the symmetric and asymmetric parts of the synaptic matrix are defined in terms of the same set of patterns, there is a discontinuous transition between associative memory and sequential pattern recognition. In contrast, when the symmetric and asymmetric parts of the synaptic matrix are defined in terms of independent sets of patterns, the network is able to perform both associative memory and sequential pattern recognition for a wide range of parameter values.	[Herrera-Aguilar, Jose L.; Larralde, Hernan; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Herrera-Aguilar, Jose L.] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico; [Aldana, Maximino] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Aldana, Maximino] Harvard Univ, David Rockefeller Ctr Latin Amer Studies, Cambridge, MA 02138 USA	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Harvard University; Harvard University	Herrera-Aguilar, JL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	jlherrera@uach.mx	Aldana, Maximino/D-9372-2017	Aldana, Maximino/0000-0002-3419-6641; Larralde, Hernan/0000-0002-6037-2629	PAPIIT-UNAM [IN109111]; SEP-CONACyT [129471]; David Rockefeller Center at Harvard University; CONACyT [177241]; Fundacion BBVA Bancomer-UAEM	PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); David Rockefeller Center at Harvard University; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion BBVA Bancomer-UAEM	This work was partially supported by PAPIIT-UNAM grant IN109111 and the SEP-CONACyT grant no. 129471. MA acknowledges David Rockefeller Center at Harvard University for the Madero/ Fundacion Mexico Fellowship. JLHA also thanks CONACyT for a Ph.D. grant under contract No. 177241 and Fundacion BBVA Bancomer-UAEM for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; COOLEN ACC, 1992, J PHYS A-MATH GEN, V25, P5493, DOI 10.1088/0305-4470/25/21/011; During A, 1998, J PHYS A-MATH GEN, V31, P8607, DOI 10.1088/0305-4470/31/43/005; Fukai T, 1999, J PHYS A-MATH GEN, V32, P5551, DOI 10.1088/0305-4470/32/30/303; GRINIASTY M, 1993, NEURAL COMPUT, V5, P1, DOI 10.1162/neco.1993.5.1.1; Hebb Donald O., 1949, ORG BEHAV; Hertz J, 1991, SANTA FE I SCI COMPL, VI; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kawamura M, 2002, J PHYS A-MATH GEN, V35, P253, DOI 10.1088/0305-4470/35/2/306; LAUGHTON SN, 1994, J PHYS A-MATH GEN, V27, P8011, DOI 10.1088/0305-4470/27/24/013; LITTLE W A, 1974, Mathematical Biosciences, V19, P101, DOI 10.1016/0025-5564(74)90031-5; LITTLE WA, 1975, BEHAV BIOL, V14, P115, DOI 10.1016/S0091-6773(75)90122-4; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Metz FL, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/38/385001; Metz FL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041907; Metz FL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021908; Mimura K, 2004, J PHYS A-MATH GEN, V37, P6437, DOI 10.1088/0305-4470/37/25/002; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; WHYTE W, 1995, J PHYS A-MATH GEN, V28, P3421, DOI 10.1088/0305-4470/28/12/016; ZERTUCHE F, 1994, J PHYS A-MATH GEN, V27, P5879, DOI 10.1088/0305-4470/27/17/020; ZERTUCHE F, 1994, J PHYS A-MATH GEN, V27, P1575, DOI 10.1088/0305-4470/27/5/021	24	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42348	10.1371/journal.pone.0042348	http://dx.doi.org/10.1371/journal.pone.0042348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900014	Green Published, gold			2022-12-25	WOS:000307380900031
J	Howard, J; Battaglini, M; Babb, JS; Arienzo, D; Holst, B; Omari, M; De Stefano, N; Herbert, J; Inglese, M				Howard, Jonathan; Battaglini, Marco; Babb, James Scott; Arienzo, Donatello; Holst, Brigitte; Omari, Mirza; De Stefano, Nicola; Herbert, Joseph; Inglese, Matilde			MRI Correlates of Disability in African-Americans with Multiple Sclerosis	PLOS ONE			English	Article								Objectives: Multiple sclerosis (MS) in African-Americans (AAs) is characterized by more rapid disease progression and poorer response to treatment than in Caucasian-Americans (CAs). MRI provides useful and non-invasive tools to investigate the pathological substrate of clinical progression. The aim of our study was to compare MRI measures of brain damage between AAs and CAs with MS. Methods: Retrospective analysis of 97 AAs and 97 CAs with MS matched for age, gender, disease duration and age at MRI examination. Results: AA patients had significantly greater T2- (p = 0.001) and T1-weighted (p = 0.0003) lesion volumes compared to CA patients. In contrast, measurements of global and regional brain volume did not significantly differ between the two ethnic groups (p>0.1). Conclusions: By studying a quite large sample of well demographically and clinically matched CA and AA patients with a homogeneous MRI protocol we showed that higher lesion accumulation, rather than pronounced brain volume decrease might explain the early progress to ambulatory assistance of AAs with MS.	[Howard, Jonathan; Omari, Mirza; Herbert, Joseph; Inglese, Matilde] Langone Med Ctr, Dept Neurol, New York, NY USA; [Babb, James Scott; Arienzo, Donatello; Holst, Brigitte; Inglese, Matilde] Langone Med Ctr, Dept Radiol, New York, NY USA; [Battaglini, Marco; De Stefano, Nicola] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy; [Holst, Brigitte] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany; [Inglese, Matilde] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	NYU Langone Medical Center; NYU Langone Medical Center; University of Siena; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai	Howard, J (corresponding author), Langone Med Ctr, Dept Neurol, New York, NY USA.	matilde.inglese@mssm.edu	De Stefano, Nicola/AHE-3052-2022; Inglese, Matilde/AAH-3189-2020	De Stefano, Nicola/0000-0003-4930-7639; Inglese, Matilde/0000-0002-9610-0297; Howard, Jonathan/0000-0003-2658-3219	National institute of health (NIH) [R01 NS051623]; Merck Serono; Novartis; Teva Pharmaceutical Industries ltd.; Biogen; Teva; Bayer; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051623] Funding Source: NIH RePORTER	National institute of health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Serono(Merck & Company); Novartis(Novartis); Teva Pharmaceutical Industries ltd.(Teva Pharmaceutical Industries); Biogen(Biogen); Teva(Teva Pharmaceutical Industries); Bayer(Bayer AG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded in part by National institute of health (NIH) [grant R01 NS051623 to Mirza Omari]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nicola De Stefano serves on the scientific advisory boards for Merck Serono and Novartis; he has received funding for travel from Merck Serono, Novartis and Teva Pharmaceutical Industries ltd.; he has received speaker honoraria from Novartis, Teva Pharmaceutical Industries ltd., Biogen-Dompe, Schering-Bayer, Sanofi-Aventis, and Merck Serono. Joseph Herbert has received grants from Biogen, Teva, Merk Serono and Bayer. Mirza Omari is funded by NIH grant R01 NS051623. Mirza Omari serves on the scientific advisory board of Celgene and she has served as consultant for Vaccinex and Biogen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Battaglini M., 2011, HUM BRAIN MAPP; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Isamah N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013642; Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Naismith RT, 2006, MULT SCLER J, V12, P775, DOI 10.1177/1352458506070923; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rinker JR, 2007, NEUROLOGY, V69, P68, DOI 10.1212/01.wnl.0000265057.79843.d9; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Weinstock-Guttman B, 2010, NEUROLOGY, V74, P538, DOI 10.1212/WNL.0b013e3181cff6fb	12	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43061	10.1371/journal.pone.0043061	http://dx.doi.org/10.1371/journal.pone.0043061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900088	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900106
J	Kuhn, PC; Horimoto, ARVR; Sanches, JM; Vieira, JPB; Franco, L; Dal Fabbro, A; Franco, LJ; Pereira, AC; Moises, RS				Kuhn, Patricia C.; Russo Horimoto, Andrea R. V.; Sanches, Jose Mauricio; Vieira Filho, Joao Paulo B.; Franco, Luciana; Dal Fabbro, Amaury; Franco, Laercio Joel; Pereira, Alexandre C.; Moises, Regina S.			Genome-Wide Analysis in Brazilian Xavante Indians Reveals Low Degree of Admixture	PLOS ONE			English	Article							GENETIC-STRUCTURE; PATTERNS; POPULATIONS; HISTORY; ORIGIN	Characterization of population genetic variation and structure can be used as tools for research in human genetics and population isolates are of great interest. The aim of the present study was to characterize the genetic structure of Xavante Indians and compare it with other populations. The Xavante, an indigenous population living in Brazilian Central Plateau, is one of the largest native groups in Brazil. A subset of 53 unrelated subjects was selected from the initial sample of 300 Xavante Indians. Using 86,197 markers, Xavante were compared with all populations of HapMap Phase III and HGDP-CEPH projects and with a Southeast Brazilian population sample to establish its population structure. Principal Components Analysis showed that the Xavante Indians are concentrated in the Amerindian axis near other populations of known Amerindian ancestry such as Karitiana, Pima, Surui and Maya and a low degree of genetic admixture was observed. This is consistent with the historical records of bottlenecks experience and cultural isolation. By calculating pair-wise F-st statistics we characterized the genetic differentiation between Xavante Indians and representative populations of the HapMap and from HGDP-CEPH project. We found that the genetic differentiation between Xavante Indians and populations of Ameridian, Asian, European, and African ancestry increased progressively. Our results indicate that the Xavante is a population that remained genetically isolated over the past decades and can offer advantages for genome-wide mapping studies of inherited disorders.	[Kuhn, Patricia C.; Vieira Filho, Joao Paulo B.; Franco, Luciana; Moises, Regina S.] Univ Fed Sao Paulo, Disciplina Endocrinol, Escola Paulista Med, Sao Paulo, Brazil; [Russo Horimoto, Andrea R. V.; Sanches, Jose Mauricio; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Lab Genet & Mol Cardiol, Inst Heart, Sao Paulo, Brazil; [Dal Fabbro, Amaury; Franco, Laercio Joel] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Social Med, Ribeirao Preto, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Kuhn, PC (corresponding author), Univ Fed Sao Paulo, Disciplina Endocrinol, Escola Paulista Med, Sao Paulo, Brazil.	rmoises@unifesp.br	Pereira, Alexandre/HHN-1038-2022; Dal-Fabbro, Amaury/H-7307-2012; Moises, Regina/AAP-8918-2021	Dal-Fabbro, Amaury/0000-0002-0824-4603; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); INCT- Obesidade e Diabetes	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT- Obesidade e Diabetes	This study was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and INCT- Obesidade e Diabetes. The funders have no rule in study design, data coletion and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Coimbra Jr CEA, 2002, XAVANT TRANSITION HL; Friedrich DC, 2012, AM J PHYS ANTHROPOL, V147, P427, DOI 10.1002/ajpa.22010; Garfield Seth, 2001, INDIGENOUS STRUGGLE; Giolo SR, 2012, EUR J HUM GENET, V20, P111, DOI 10.1038/ejhg.2011.144; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kolman CJ, 1996, GENETICS, V142, P1321; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pereira NDM, 2009, HUM ORGAN, V68, P166; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; NEEL JV, 1964, AM J HUM GENET, V16, P52; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Salzano FM, 1997, AM J PHYS ANTHROPOL, V104, P23, DOI 10.1002/(SICI)1096-8644(199709)104:1<23::AID-AJPA2>3.0.CO;2-E; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	27	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42702	10.1371/journal.pone.0042702	http://dx.doi.org/10.1371/journal.pone.0042702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900041	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900058
J	Lee, DN; Papes, M; Van Den Bussche, RA				Lee, Dana N.; Papes, Monica; Van Den Bussche, Ronald A.			Present and Potential Future Distribution of Common Vampire Bats in the Americas and the Associated Risk to Cattle	PLOS ONE			English	Article							CLIMATE-CHANGE; GEOGRAPHIC DISTRIBUTIONS; DESMODUS-ROTUNDUS; SPECIES DISTRIBUTIONS; TRANSMITTED RABIES; SPATIAL-PATTERNS; LIVESTOCK; DISEASE; MODELS; PREDICTION	Success of the cattle industry in Latin America is impeded by the common vampire bat, Desmodus rotundus, through decreases in milk production and mass gain and increased risk of secondary infection and rabies. We used ecological niche modeling to predict the current potential distribution of D. rotundus and the future distribution of the species for the years 2030, 2050, and 2080 based on the A2, A1B, and B1 climate scenarios from the Intergovernmental Panel on Climate Change. We then combined the present day potential distribution with cattle density estimates to identify areas where cattle are at higher risk for the negative impacts due to D. rotundus. We evaluated our risk prediction by plotting 17 documented outbreaks of cattle rabies. Our results indicated highly suitable habitat for D. rotundus occurs throughout most of Mexico and Central America as well as portions of Venezuela, Guyana, the Brazilian highlands, western Ecuador, northern Argentina, and east of the Andes in Peru, Bolivia, and Paraguay. With future climate projections suitable habitat for D. rotundus is predicted in these same areas and additional areas in French Guyana, Suriname, Venezuela and Columbia; however D. rotundus are not likely to expand into the U.S. because of inadequate 'temperature seasonality.' Areas with large portions of cattle at risk include Mexico, Central America, Paraguay, and Brazil. Twelve of 17 documented cattle rabies outbreaks were represented in regions predicted at risk. Our present day and future predictions can help authorities focus rabies prevention efforts and inform cattle ranchers which areas are at an increased risk of cattle rabies because it has suitable habitat for D. rotundus.	[Lee, Dana N.; Papes, Monica; Van Den Bussche, Ronald A.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Lee, DN (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	dana.lee10@okstate.edu		Van Den Bussche, Ronald/0000-0002-6481-3209				Acha P. N., 1988, Natural history of vampire bats., P207; Aguiar LMS, 2010, ACTA CHIROPTEROL, V12, P275, DOI 10.3161/150811010X537855; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS615; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS707; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Coen CE, 2002, THESIS CORNELL U ITH, P11; DELPIETRO HA, 1992, PREV VET MED, V14, P13, DOI 10.1016/0167-5877(92)90080-Y; ELIAS DJ, 1978, B ENVIRON CONTAM TOX, V20, P71, DOI 10.1007/BF01683488; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; ESRI, 2011, ARCGIS DESKT REL 10; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flores-Crespo R., 1991, P461; Gibbons RV, 2002, ANN EMERG MED, V39, P528, DOI 10.1067/mem.2002.121521; Gomes MN, 2010, PREV VET MED, V93, P139, DOI 10.1016/j.prevetmed.2009.10.006; GONZALEZ R, 1976, Proceedings of the Vertebrate Pest Conference, V7, P254; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; GREENHALL A M, 1971, Biotropica, V3, P136, DOI 10.2307/2989817; GREENHALL AM, 1972, J ZOOL, V168, P451; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Jones P.G., 2009, GENERATING CHARACTER; Kobayashi Y, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-44; KUZMIN IV, 2007, RABIES, P259; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Leedom JM, 2006, CLIN INFECT DIS, V43, P610, DOI 10.1086/507035; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lord R.D., 1980, Proceedings of the Vertebrate Pest Conference, V9, P170; Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011; MartinezBurnes J, 1997, CAN VET J, V38, P175; Massad E, 2001, THEOR POPUL BIOL, V60, P265, DOI 10.1006/tpbi.2000.1494; Mayen F, 2003, J VET MED B, V50, P469, DOI 10.1046/j.1439-0450.2003.00713.x; MCNAB BK, 1973, J MAMMAL, V54, P131, DOI 10.2307/1378876; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P481, DOI 10.2165/00019053-199814050-00003; Mistry S, 2008, BATS, V26, P8; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Neerinckx SB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-54; Nel L., 2009, MICROBE, V4, P61; [Pan American Health Organization Veterinary Public Health Program], 1993, EP SURV RAB AM; Pan American Health Organization Veterinary Public Health Program, 2007, EP SURV RAB AM; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson A Townsend, 2007, Vet Ital, V43, P393; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; ProMED-mail, RAB VIR COWS MEX CEN; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Rios NE, 2010, GEOLOCATE VERSION 3; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731; SCHMIDT K M, 1979, Proceedings of the Oklahoma Academy of Science, V59, P112; SIKES RK, 1970, AM J PUBLIC HEALTH N, V60, P1133, DOI 10.2105/AJPH.60.6.1133; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sterner RT, 2004, P VERTEBR PEST C, V390, P185; THOMPSON RD, 1977, J WILDLIFE MANAGE, V41, P736, DOI 10.2307/3799998; THOMPSON RD, 1972, SCIENCE, V177, P806, DOI 10.1126/science.177.4051.806; Turner DC, 1995, VAMPIRE BAT FIELD ST; Voigt CC, 2006, J MAMMAL, V87, P1, DOI 10.1644/05-MAMM-F-276R1.1; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Zijpp J. van der, 2003, Archivos Latinoamericanos de Produccion Animal, V11, P50	73	80	83	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42466	10.1371/journal.pone.0042466	http://dx.doi.org/10.1371/journal.pone.0042466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900023	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900039
J	Yeo, J; Hong, S; Lee, D; Hotz, N; Lee, MT; Grigoropoulos, CP; Ko, SH				Yeo, Junyeob; Hong, Sukjoon; Lee, Daehoo; Hotz, Nico; Lee, Ming-Tsang; Grigoropoulos, Costas P.; Ko, Seung Hwan			Next Generation Non-Vacuum, Maskless, Low Temperature Nanoparticle Ink Laser Digital Direct Metal Patterning for a Large Area Flexible Electronics	PLOS ONE			English	Article							STRETCHABLE ELECTRONICS; ELASTIC CONDUCTORS; ARRAYS; GOLD; TRANSISTORS; SUBSTRATE; DISPLAYS	Flexible electronics opened a new class of future electronics. The foldable, light and durable nature of flexible electronics allows vast flexibility in applications such as display, energy devices and mobile electronics. Even though conventional electronics fabrication methods are well developed for rigid substrates, direct application or slight modification of conventional processes for flexible electronics fabrication cannot work. The future flexible electronics fabrication requires totally new low-temperature process development optimized for flexible substrate and it should be based on new material too. Here we present a simple approach to developing a flexible electronics fabrication without using conventional vacuum deposition and photolithography. We found that direct metal patterning based on laser-induced local melting of metal nanoparticle ink is a promising low-temperature alternative to vacuum deposition- and photolithography-based conventional metal patterning processes. The "digital" nature of the proposed direct metal patterning process removes the need for expensive photomask and allows easy design modification and short turnaround time. This new process can be extremely useful for current small-volume, large-variety manufacturing paradigms. Besides, simple, scalable, fast and low-temperature processes can lead to cost-effective fabrication methods on a large-area polymer substrate. The developed process was successfully applied to demonstrate high-quality Ag patterning (2.1 mu Omega.cm) and high-performance flexible organic field effect transistor arrays.	[Yeo, Junyeob; Hong, Sukjoon; Ko, Seung Hwan] Korea Adv Inst Sci & Technol, Appl Nano Technol & Sci Lab, Dept Mech Engn, Taejon 305701, South Korea; [Lee, Daehoo; Grigoropoulos, Costas P.] Univ Calif Berkeley, Laser Thermal Lab, Berkeley, CA 94720 USA; [Hotz, Nico] Duke Univ, Dept Mech Engn & Mat Sci, Thermodynam & Sustainable Energy Lab, Durham, NC 27706 USA; [Lee, Ming-Tsang] Natl Chung Hsing Univ, Dept Mech Engn, Taichung 40227, Taiwan	Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Berkeley; Duke University; National Chung Hsing University	Yeo, J (corresponding author), Korea Adv Inst Sci & Technol, Appl Nano Technol & Sci Lab, Dept Mech Engn, Taejon 305701, South Korea.	cgrigoro@me.berkeley.edu; maxko@kaist.ac.kr	Ko, Seung Hwan/B-5448-2008; Hotz, Nico/A-5624-2013; Yeo, Junyeob/I-1287-2013; Lee, Daeho/M-2734-2017; Ko, Seung Hwan/B-5448-2008	Ko, Seung Hwan/0000-0002-7477-0820; Yeo, Junyeob/0000-0001-7422-3467; Lee, Daeho/0000-0002-8119-9677; Lee, Ming-Tsang/0000-0002-5715-6044; Ko, Seung Hwan/0000-0001-5614-4773; Grigoropoulos, Costas/0000-0002-8505-4037	National Research Foundation of Korea [2011-0005321, 2011-0028662]; Ministry of Education Science of Korea; King Abdullah University of Science and Technology; U.S. National Science Foundation Small Business Technology Transfer Program through AppliFlex LLC [0930594]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education Science of Korea; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); U.S. National Science Foundation Small Business Technology Transfer Program through AppliFlex LLC	This study was partially supported by Basic Science Research Program (2011-0005321, 2011-0028662) from the National Research Foundation of Korea funded by the Ministry of Education Science of Korea to Korea Advanced Institute of Science and Technology, and by a grant from King Abdullah University of Science and Technology to UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests to declare. This study was partially supported by the U.S. National Science Foundation Small Business Technology Transfer Program (0930594) through AppliFlex LLC. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Ding L, 2010, EUR J INORG CHEM, P4357, DOI 10.1002/ejic.201000563; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Hu LB, 2009, P NATL ACAD SCI USA, V106, P21490, DOI 10.1073/pnas.0908858106; Khairy M, 2010, ELECTROANAL, V22, P2496, DOI 10.1002/elan.201000226; Ko SH, 2008, APPL PHYS A-MATER, V92, P579, DOI 10.1007/s00339-008-4597-9; Ko SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345202; Ko SH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2802302; Ko SH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/12/125010; Ko SH, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.05EC03; Korgel BA, 1998, ADV MATER, V10, P661, DOI 10.1002/(SICI)1521-4095(199806)10:9<661::AID-ADMA661>3.0.CO;2-L; Lacour SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201874; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Lipomi DJ, 2011, ADV MATER, V23, P1771, DOI 10.1002/adma.201004426; Murphy AR, 2005, CHEM MATER, V17, P4892, DOI 10.1021/cm050911d; Pan H, 2008, APPL PHYS A-MATER, V90, P247, DOI 10.1007/s00339-007-4320-2; Pan H, 2010, SMALL, V6, P1812, DOI 10.1002/smll.201000345; Pan H, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2943303; Pan H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3082095; Pan H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3043583; Park I, 2008, ADV MATER, V20, P489, DOI 10.1002/adma.200702326; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Santhanam V, 2004, NANO LETT, V4, P41, DOI 10.1021/nl034851r; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/NMAT2459, 10.1038/nmat2459]; Sirringhaus H, 2003, MRS BULL, V28, P802, DOI 10.1557/mrs2003.228; Son Y, 2012, THERMOCHIM ACTA, V542, P52, DOI 10.1016/j.tca.2012.03.004; Son Y, 2011, ADV MATER, V23, P3176, DOI 10.1002/adma.201100717; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/NNANO.2011.36, 10.1038/nnano.2011.36]; Yin WW, 2008, KOREAN J CHEM ENG, V25, P1358, DOI 10.1007/s11814-008-0223-y	34	91	93	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42315	10.1371/journal.pone.0042315	http://dx.doi.org/10.1371/journal.pone.0042315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900011	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900028
J	Collins, D; Luxton, T; Kumar, N; Shah, S; Walker, VK; Shah, V				Collins, Daniel; Luxton, Todd; Kumar, Niraj; Shah, Shreya; Walker, Virginia K.; Shah, Vishal			Assessing the Impact of Copper and Zinc Oxide Nanoparticles on Soil: A Field Study	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL DIVERSITY; SPECIATION; SILVER; AGGREGATION; COMMUNITY; FECES; XAFS; ZN; PH	It is not known if the annual production of tonnes of industrial nanoparticles (NPs) has the potential to impact terrestrial microbial communities, which are so necessary for ecosystem functioning. Here, we have examined the consequences of adding zero valent copper and zinc oxide NPs to soil in pots that were then maintained under field conditions. The fate of these NPs, as well as changes in the microbial communities, was monitored over 162 days. Both NP types traveled through the soil matrix, albeit at differential rates, with Cu NPs retained in the soil matrix at a higher rate compared to ZnO NPs. Leaching of Cu and Zn ions from the parent NPs was also observed as a function of time. Analysis of microbial communities using culture-dependent and independent methods clearly indicated that Cu and ZnO NPs altered the microbial community structure. In particular, two orders of organisms found in rhizosphere, Flavobacteriales and Sphingomonadales, appeared to be particularly susceptible to the presence of NPs. Together, the migration of NPs through soil matrix and the ability of these potential pollutants to influence the composition of microbial community in this field study, cannot help but raise some environmental concerns.	[Collins, Daniel; Shah, Shreya; Shah, Vishal] Dowling Coll, Dept Biol, Oakdale, NY USA; [Luxton, Todd] US EPA, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Kumar, Niraj; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kumar, Niraj; Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	United States Environmental Protection Agency; Queens University - Canada; Queens University - Canada	Collins, D (corresponding author), Dowling Coll, Dept Biol, Oakdale, NY USA.	ShahV@dowling.edu	luxton, todd/AAA-7671-2020; Shah, Shreya/HDN-1499-2022		National Science Foundation grant [966741]; NSERC (Canada) grant; Queen's Research Chair award; Div Of Chem, Bioeng, Env, & Transp Sys [0966741] Funding Source: National Science Foundation	National Science Foundation grant(National Science Foundation (NSF)); NSERC (Canada) grant; Queen's Research Chair award; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work was funded by National Science Foundation grant # 966741, NSERC (Canada) grant, and a Queen's Research Chair award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Ben-Moshe T, 2010, CHEMOSPHERE, V81, P387, DOI 10.1016/j.chemosphere.2010.07.007; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Bystrzejewska-Piotrowska G, 2009, WASTE MANAGE, V29, P2587, DOI 10.1016/j.wasman.2009.04.001; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Colwell RR, 1997, J IND MICROBIOL BIOT, V18, P302, DOI 10.1038/sj.jim.2900390; Cullen LG, 2011, CHEMOSPHERE, V82, P1675, DOI 10.1016/j.chemosphere.2010.11.009; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Feare CJ, 1999, J R SOC PROMO HEALTH, V119, P146, DOI 10.1177/146642409911900303; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; GLUNDER G, 1981, AVIAN DIS, V25, P195, DOI 10.2307/1589841; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Haggstrom JA, 2010, NANOSCALE, V2, P399, DOI 10.1039/b9nr00245f; Hansch M, 2010, J PLANT NUTR SOIL SC, V173, P554, DOI 10.1002/jpln.200900358; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P5554, DOI 10.1016/j.gca.2009.05.069; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P5256, DOI 10.1016/j.gca.2009.05.066; Jacquat O, 2009, GEOCHIM COSMOCHIM AC, V73, P348, DOI 10.1016/j.gca.2008.10.026; Jeong SW, 2009, J ENVIRON MONITOR, V11, P1595, DOI 10.1039/b907658a; Kanel SR, 2011, J NANOPART RES, V13, P4035, DOI 10.1007/s11051-011-0345-8; Kato S, 2010, ENVIRON MICROBIOL, V12, P3114, DOI 10.1111/j.1462-2920.2010.02284.x; Kosmulski M, 2009, ADV COLLOID INTERFAC, V152, P14, DOI 10.1016/j.cis.2009.08.003; Kumar N, 2012, ENVIRON TOXICOL CHEM, V31, P131, DOI 10.1002/etc.721; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Nishimura S, 2010, LANGMUIR, V26, P4473, DOI 10.1021/la904248z; Pampulha ME, 2007, J BASIC MICROB, V47, P325, DOI 10.1002/jobm.200610274; Peterson SB, 2008, THESIS U WISCONSIN M; Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h; Pisz JM, 2007, J MICROBIOL METH, V71, P312, DOI 10.1016/j.mimet.2007.09.015; Ramyadevi J, 2012, MATER LETT, V71, P114, DOI 10.1016/j.matlet.2011.12.055; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rispoli F, 2010, J HAZARD MATER, V180, P212, DOI 10.1016/j.jhazmat.2010.04.016; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; Simonet BM, 2009, ANAL BIOANAL CHEM, V393, P17, DOI 10.1007/s00216-008-2484-z; Strawn DG, 2008, ENVIRON SCI TECHNOL, V42, P37, DOI 10.1021/es071605z; Strawn DG, 2009, ENVIRON POLLUT, V157, P2813, DOI 10.1016/j.envpol.2009.04.018; Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b; USEPA, 1986, AC DIG SED SLUDG SOI, V1; Voegelin A, 2011, ENVIRON SCI TECHNOL, V45, P255, DOI 10.1021/es101189d; Yan F, 2000, GEODERMA, V96, P321, DOI 10.1016/S0016-7061(00)00018-5; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Zelazny L.W., 1996, METHODS SOIL ANAL, P1231, DOI DOI 10.2136/SSSABOOKSER5.3.C41; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025	49	92	95	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42663	10.1371/journal.pone.0042663	http://dx.doi.org/10.1371/journal.pone.0042663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905159	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100055
J	Orshinsky, AM; Hu, JN; Opiyo, SO; Reddyvari-Channarayappa, V; Mitchell, TK; Boehm, MJ				Orshinsky, Angela M.; Hu, Jinnan; Opiyo, Stephen O.; Reddyvari-Channarayappa, Venu; Mitchell, Thomas K.; Boehm, Michael J.			RNA-Seq Analysis of the Sclerotinia homoeocarpa - Creeping Bentgrass Pathosystem	PLOS ONE			English	Article							ABC TRANSPORTER BCATRB; DOLLAR SPOT; BOTRYTIS-CINEREA; TRANSPOSABLE ELEMENTS; GENETIC-VARIATION; RESISTANCE; ACID; SENSITIVITY; EXPRESSION; TOOL	Sclerotinia homoeocarpa causes dollar spot disease, the predominate disease on highly-maintained turfgrass. Currently, there are major gaps in our understanding of the molecular interactions between S. homoeocarpa and creeping bentgrass. In this study, 454 sequencing technology was used in the de novo assembly of S. homoeocarpa and creeping bentgrass transcriptomes. Transcript sequence data obtained using Illumina's first generation sequencing-by-synthesis (SBS) were mapped to the transcriptome assemblies to estimate transcript representation in different SBS libraries. SBS libraries included a S. homoeocarpa culture control, a creeping bentgrass uninoculated control, and a library for creeping bentgrass inoculated with S. homoeocarpa and incubated for 96 h. A Fisher's exact test was performed to determine transcripts that were significantly different during creeping bentgrass infection with S. homoeocarpa. Fungal transcripts of interest included glycosyl hydrolases, proteases, and ABC transporters. Of particular interest were the large number of glycosyl hydrolase transcripts that target a wide range of plant cell wall compounds, corroborating the suggested wide host range and saprophytic abilities of S. homoeocarpa. Several of the multidrug resistance ABC transporters may be important for resistance to both fungicides and plant defense compounds. Creeping bentgrass transcripts of interest included germins, ubiquitin transcripts involved in proteasome degradation, and cinnamoyl reductase, which is involved in lignin production. This analysis provides an extensive overview of the S. homoeocarpa-turfgrass pathosystem and provides a starting point for the characterization of potential virulence factors and host defense responses. In particular, determination of important host defense responses may assist in the development of highly resistant creeping bentgrass varieties.	[Orshinsky, Angela M.; Hu, Jinnan; Mitchell, Thomas K.; Boehm, Michael J.] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Opiyo, Stephen O.] Ohio State Univ, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA; [Reddyvari-Channarayappa, Venu] Dale Bumpers Natl Rice Res Ctr, Stuttgart, AZ USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Orshinsky, AM (corresponding author), Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA.	aorshinsky@gmail.com	Opiyo, Stephen/A-9385-2013	Boehm, Michael/0000-0001-5592-1710	Ohio State University; Ohio Agricultural Research and Development Center	Ohio State University(Ohio State University); Ohio Agricultural Research and Development Center	This study was supported with state and federal dollars appropriated to The Ohio State University and the Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; BALL AM, 1991, PHYSIOL MOL PLANT P, V38, P147, DOI 10.1016/S0885-5765(05)80132-8; Birch P, 2000, NEW TECHNOLOGIES LIF, V0, P1471; Bonos SA, 2007, INTEGRATED APPROACH; Bonos SA, 2006, PHYTOPATHOLOGY, V96, P808, DOI 10.1094/PHYTO-96-0808; BURPEE LL, 1986, CAN J PLANT SCI, V66, P345, DOI 10.4141/cjps86-049; Chakraborty N, 2006, CROP SCI, V46, P1237, DOI 10.2135/cropsci2005.04-0031; Chipps TJ, 2005, PHYTOPATHOLOGY, V95, P292, DOI 10.1094/PHYTO-95-0292; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COUCH HB, 1960, PHYTOPATHOLOGY, V50, P761; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; DaRoche A.B., 2004, PHYTOPATHOLOGY, V94S, P157; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; DETWEILER AR, 1983, PLANT DIS, V67, P627, DOI 10.1094/PD-67-627; Dobinson KF, 1997, CAN J MICROBIOL, V43, P227, DOI 10.1139/m97-031; ENDO RM, 1963, PHYTOPATHOLOGY, V53, P857; ENDO RM, 1966, PHYTOPATHOLOGY, V56, P877; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GOLEMBIEWSKI RC, 1995, PLANT DIS, V79, P491, DOI 10.1094/PD-79-0491; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Guo ZF, 2003, MOL BREEDING, V11, P95, DOI 10.1023/A:1022458101221; HALL R, 1984, CAN J PLANT SCI, V64, P167, DOI 10.4141/cjps84-021; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Herath HMTB, 2009, J NAT PROD, V72, P2091, DOI 10.1021/np900334k; Hsiang T, 1999, PLANT PATHOL, V48, P83, DOI 10.1046/j.1365-3059.1999.00306.x; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kars I, 2007, EXTRACELLULAR ENZYME; Kejnovsky E, 2012, PLANT GENOME DIVERSI, P18; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Latin R, 2009, TURFGRASS DIS PROFIL; LEHTINEN U, 1993, PHYSIOL MOL PLANT P, V43, P121, DOI 10.1006/pmpp.1993.1045; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Lu Guihua, 2003, African Journal of Biotechnology, V2, P509; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MONTEITH J., 1932, Bull. U.S. Golf Ass. Green Sec., V12, P85; Orshinsky AM, 2011, CAN J MICROBIOL, V57, P398, DOI [10.1139/w11-019, 10.1139/W11-019]; Orshinsky AM, 2010, CHARACTERIZATION GRO; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pigati RL, 2010, PLANT DIS, V94, P596, DOI 10.1094/PDIS-94-5-0596; Rotter D, 2007, MOL GENET GENOMICS, V278, P197, DOI 10.1007/s00438-007-0240-2; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Sabot F, 2004, EUPHYTICA, V139, P227, DOI 10.1007/s10681-004-3179-y; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; StLeger RJ, 1997, MICROBIOL-UK, V143, P1983, DOI 10.1099/00221287-143-6-1983; Venu R.C., 2009, INT TURFGRASS SOC RE, V11, P263; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vermeulen T, 2001, PEST MANAG SCI, V57, P393, DOI 10.1002/ps.309; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; Walz A, 2008, PLANT PATHOLOGY, P57; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhou T, 1999, CAN J PLANT PATHOL, V21, P93, DOI 10.1080/07060661.1999.10600090	62	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41150	10.1371/journal.pone.0041150	http://dx.doi.org/10.1371/journal.pone.0041150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905098	Green Published, gold			2022-12-25	WOS:000307331100010
J	Saijo, T; Maeda, J; Okauchi, T; Maeda, JI; Morio, Y; Kuwahara, Y; Suzuki, M; Goto, N; Fukumura, T; Suhara, T; Higuchi, M				Saijo, Takeaki; Maeda, Jun; Okauchi, Takashi; Maeda, Jun-ichi; Morio, Yasunori; Kuwahara, Yasuhiro; Suzuki, Masayuki; Goto, Nobuharu; Fukumura, Toshimitsu; Suhara, Tetsuya; Higuchi, Makoto			Presynaptic Selectivity of a Ligand for Serotonin 1A Receptors Revealed by In Vivo PET Assays of Rat Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PLACEBO-CONTROLLED TRIAL; DORSAL RAPHE NUCLEUS; 5-HT1A RECEPTOR; REUPTAKE INHIBITORS; DOUBLE-BLIND; ANTIDEPRESSANT THERAPY; INTRINSIC ACTIVITY; MAJOR DEPRESSION; FRONTAL-CORTEX	A novel investigational antidepressant with high affinity for the serotonin transporter and the serotonin 1A (5-HT1A) receptor, called Wf-516 (structural formula: (2S)-1-[4-(3,4-dichlorophenyl) piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl) benzo[b]furan-4-yloxy]propan-2-ol monohydrochloride), has been found to exert a rapid therapeutic effect, although the mechanistic basis for this potential advantage remains undetermined. We comparatively investigated the pharmacokinetics and pharmacodynamics of Wf-516 and pindolol by positron emission tomographic (PET) and autoradiographic assays of rat brains in order to elucidate their molecular interactions with presynaptic and postsynaptic 5-HT1A receptors. In contrast to the full receptor occupancy by pindolol in PET measurements, the binding of Wf-516 to 5-HT1A receptors displayed limited capacity, with relatively high receptor occupancy being achieved in regions predominantly containing presynaptic receptors. This selectivity was further proven by PET scans of neurotoxicant-treated rats deficient in presynaptic 5-HT1A receptors. In addition, [S-35] guanosine 5'-O-[gamma-thio] triphosphate autoradiography indicated a partial agonistic ability of Wf-516 for 5-HT1A receptors. This finding has lent support to reports that diverse partial agonists for 5-HT1A receptors exert high sensitivity for presynaptic components. Thus, the present PET data suggest a relatively high capacity of presynaptic binding sites for partial agonists. Since our in vitro and ex vivo autoradiographies failed to illustrate these distinct features of Wf-516, in vivo PET imaging is considered to be, thus far, the sole method capable of pharmacokinetically demonstrating the unique actions of Wf-516 and similar new-generation antidepressants.	[Saijo, Takeaki; Maeda, Jun; Okauchi, Takashi; Fukumura, Toshimitsu; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Saijo, Takeaki; Suhara, Tetsuya; Higuchi, Makoto] Tohoku Univ, Sch Med, Dept Mol Neuroimaging, Sendai, Miyagi 980, Japan; [Saijo, Takeaki; Suzuki, Masayuki] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Kisarazu, Japan; [Maeda, Jun-ichi] Mitsubishi Tanabe Pharma Corp, Res Qual Assurance Dept, Yokohama, Kanagawa, Japan; [Kuwahara, Yasuhiro] Mitsubishi Tanabe Pharma Corp, Adv Med Res Lab, Yokohama, Kanagawa, Japan; [Morio, Yasunori] Mitsubishi Tanabe Pharma Corp, Dev Project Management Dept, Tokyo, Japan; [Goto, Nobuharu] Mitsubishi Tanabe Pharma Corp, Early Stage Clin Res Ctr, Tokyo, Japan	National Institutes for Quantum Science & Technology; Tohoku University; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation	Saijo, T (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	mhiguchi@nirs.go.jp	Fukumura, Toshimitsu/E-2847-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for the Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study.	ADELL A, 1991, N-S ARCH PHARMACOL, V343, P237; ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Andree B, 1999, PSYCHOPHARMACOLOGY, V144, P303, DOI 10.1007/s002130051009; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Assie MB, 1999, EUR J PHARMACOL, V386, P97, DOI 10.1016/S0014-2999(99)00738-4; Bantick RA, 2004, NEUROPSYCHOPHARMACOL, V29, P847, DOI 10.1038/sj.npp.1300390; Berman RM, 1997, AM J PSYCHIAT, V154, P37; Castro ME, 2000, J NEUROCHEM, V75, P755, DOI 10.1046/j.1471-4159.2000.0750755.x; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; CHAPUT Y, 1991, NEUROPSYCHOPHARMACOL, V5, P219; Corradetti R, 1998, BRIT J PHARMACOL, V123, P449, DOI 10.1038/sj.bjp.0701632; Dawson LA, 2009, CNS NEUROSCI THER, V15, P107, DOI 10.1111/j.1755-5949.2008.00067.x; Duman RS, 2001, J PHARMACOL EXP THER, V299, P401; El Mansari M, 2008, N-S ARCH PHARMACOL, V376, P351, DOI 10.1007/s00210-007-0210-6; Finnema SJ, 2010, CURR TOP MED CHEM, V10, P1477; Fitzgerald LW, 1999, J NEUROCHEM, V72, P2127, DOI 10.1046/j.1471-4159.1999.0722127.x; GUGLER R, 1974, EUR J CLIN PHARMACOL, V7, P17, DOI 10.1007/BF00614385; Hamed A, 2004, MED CARE, V42, P551, DOI 10.1097/01.mlr.0000128002.73998.87; Hansen DG, 2003, EUR J CLIN PHARMACOL, V59, P143, DOI 10.1007/s00228-003-0593-3; Herndon Jeffrey L., 1993, P167; Hirani E, 2000, SYNAPSE, V36, P330, DOI 10.1002/(SICI)1098-2396(20000615)36:4<330::AID-SYN10>3.0.CO;2-H; HJORTH S, 1994, EUR J PHARMACOL, V260, P251, DOI 10.1016/0014-2999(94)90346-8; Hughes ZA, 2005, EUR J PHARMACOL, V510, P49, DOI 10.1016/j.ejphar.2005.01.018; HYTTEL J, 1994, INT CLIN PSYCHOPHARM, V9, P19, DOI 10.1097/00004850-199403001-00004; INVERNIZZI R, 1992, BRAIN RES, V584, P322, DOI 10.1016/0006-8993(92)90914-U; KHAWAJA X, 1995, J NEUROCHEM, V64, P2716; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Komori T, 1998, BIOL PHARM BULL, V21, P1376; Laughren TP, 2011, J CLIN PSYCHIAT, V72, P1166, DOI 10.4088/JCP.11r06984; Lemoine L, 2010, EUR J NUCL MED MOL I, V37, P594, DOI 10.1007/s00259-009-1274-y; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; Maeda J, 2001, SYNAPSE, V40, P122, DOI 10.1002/syn.1033; MAEDA J, 2006, EUR NEUROPSYCHOPH S4, V16, pS333; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P209, DOI 10.1016/S0893-133X(00)00187-1; McAskill R, 1998, BRIT J PSYCHIAT, V173, P203, DOI 10.1192/bjp.173.3.203; McCarron JA, 1996, J LABELLED COMPD RAD, V38, P941, DOI 10.1002/(SICI)1099-1344(199610)38:10<941::AID-JLCR906>3.3.CO;2-P; MELLER E, 1990, MOL PHARMACOL, V37, P231; Milak MS, 2008, J NUCL MED, V49, P587, DOI 10.2967/jnumed.107.046540; Nakayama T, 2002, PSYCHOPHARMACOLOGY, V165, P37, DOI 10.1007/s00213-002-1234-8; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Papp M, 2006, EUR NEUROPSYCHOPHARM, V16, pS305, DOI 10.1016/S0924-977X(06)70322-4; Perez V, 1997, LANCET, V349, P1594, DOI 10.1016/S0140-6736(96)08007-5; Pike VW, 1996, EUR J PHARMACOL, V301, pR5, DOI 10.1016/0014-2999(96)00079-9; Rabiner EA, 2000, NEUROPSYCHOPHARMACOL, V23, P285, DOI 10.1016/S0893-133X(00)00109-3; Rabiner EA, 2000, NUCL MED BIOL, V27, P509, DOI 10.1016/S0969-8051(00)00120-7; Radley JJ, 2002, BRAIN RES, V955, P264, DOI 10.1016/S0006-8993(02)03477-7; Rickels K, 2009, J CLIN PSYCHIAT, V70, P326, DOI 10.4088/JCP.08m04637; Saijo T, 2009, INT J NEUROPSYCHOPH, V12, P1021, DOI 10.1017/S1461145709000042; Sanchez C, 1996, EUR J PHARMACOL, V315, P245, DOI 10.1016/S0014-2999(96)00621-8; Seeman P, 2012, SYNAPSE, V66, P88, DOI 10.1002/syn.20987; Serrats J, 2004, INT J NEUROPSYCHOPH, V7, P27, DOI 10.1017/S1461145703003924; Sprouse J, 2000, BIOL PSYCHIAT, V47, P1050, DOI 10.1016/S0006-3223(99)00322-4; Tai YC, 2005, J NUCL MED, V46, P455; Takano A, 2007, NUCL MED COMMUN, V28, P193, DOI 10.1097/MNM.0b013e328013ebec; Uchida N, 2007, PSYCHIAT CLIN NEUROS, V61, P522, DOI 10.1111/j.1440-1819.2007.01702.x; VANDENHOOFF P, 1992, BRIT J PHARMACOL, V106, P893; VANDENHOOFF P, 1991, EUR J PHARMACOL, V196, P291, DOI 10.1016/0014-2999(91)90442-S; YOCCA FD, 1992, MOL PHARMACOL, V41, P1066; Zanardi R, 1998, J CLIN PSYCHOPHARM, V18, P441, DOI 10.1097/00004714-199812000-00004; Zanardi R, 1997, J CLIN PSYCHOPHARM, V17, P446, DOI 10.1097/00004714-199712000-00002	60	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42589	10.1371/journal.pone.0042589	http://dx.doi.org/10.1371/journal.pone.0042589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880045	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900044
J	Higgins, M; Miller, M; Nighorn, A				Higgins, Mark; Miller, Michael; Nighorn, Alan			Nitric Oxide Has Differential Effects on Currents in Different Subsets of Manduca sexta Antennal Lobe Neurons	PLOS ONE			English	Article							PROJECTION NEURONS; RECOGNITION MEMORY; VOLUME TRANSMITTER; S-NITROSYLATION; IN-VITRO; SYNTHASE; MOTH; EXCITABILITY; CHANNELS; PROTEIN	Nitric oxide has been shown to regulate many biological systems including olfaction. In the moth olfactory system nitric oxide is produced in the antennal lobe in response to odor stimulation and has complex effects on the activity of both projection neurons and local interneurons. To examine the cell autonomous effects of nitric oxide on these cells, we used patch-clamp recording in conjunction with pharmacological manipulation of nitric oxide to test the hypothesis that nitric oxide differentially regulates the channel properties of these different antennal lobe neuron subsets. We found that nitric oxide caused increasing inward currents in a subset of projection neurons while the effects on local neurons were variable but consistent within identifiable morphological subtypes.	[Higgins, Mark; Miller, Michael; Nighorn, Alan] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA	University of Arizona	Higgins, M (corresponding author), Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA.	nighorn@email.arizona.edu			National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) [DC04292]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004292] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) grant number DC04292 awarded to Alan Nighorn. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustin-Pavon C, 2009, PHYSIOL BEHAV, V98, P608, DOI 10.1016/j.physbeh.2009.09.011; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Artinian L, 2010, J NEUROSCI, V30, P1699, DOI 10.1523/JNEUROSCI.4511-09.2010; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BREER H, 1993, TRENDS NEUROSCI, V16, P5, DOI 10.1016/0166-2236(93)90040-S; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Ding SY, 2011, J NEUROPHYSIOL, V106, P3019, DOI 10.1152/jn.00305.2011; EGBERONGBE YI, 1994, NEUROSCIENCE, V59, P561, DOI 10.1016/0306-4522(94)90177-5; Hanafy K A, 2001, Med Sci Monit, V7, P801; Hatcher NG, 2006, J NEUROPHYSIOL, V95, P3219, DOI 10.1152/jn.0815.2005; HAYASHI JH, 1990, J NEUROSCI, V10, P848; Jacklet JW, 2004, J NEUROPHYSIOL, V91, P656, DOI 10.1152/jn.00409.2003; Jetti SK, 2010, NITRIC OXIDE-BIOL CH, V22, P213, DOI 10.1016/j.niox.2009.12.006; Juch M, 2009, NEUROBIOL LEARN MEM, V92, P469, DOI 10.1016/j.nlm.2009.06.004; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; Kloppenburg P, 1999, J NEUROSCI, V19, P8172; KrippeitDrews P, 1996, BIOCHEM BIOPH RES CO, V224, P199, DOI 10.1006/bbrc.1996.1007; Lei H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023382; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2650, DOI 10.1152/jn.2002.87.6.2650; Molleman A., 2003, PATCH CLAMPING INTRO; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Mustafa AK., 2009, SCI SIGNAL, V2, P1; Nighorn A, 1998, J NEUROSCI, V18, P7244; Nunez L, 2006, CARDIOVASC RES, V72, P80, DOI 10.1016/j.cardiores.2006.06.021; Okere CO, 1996, NEUROSCIENCE, V71, P349, DOI 10.1016/0306-4522(95)00467-X; OLAND LA, 1987, J COMP NEUROL, V255, P196, DOI 10.1002/cne.902550204; OLAND LA, 1993, J NEUROBIOL, V24, P1170, DOI 10.1002/neu.480240905; Oland LA, 1996, J NEUROSCI METH, V69, P103, DOI 10.1016/S0165-0270(96)00025-8; Park JH, 1998, J NEUROSCI, V18, P5463, DOI 10.1523/JNEUROSCI.18-14-05463.1998; Reisenman CE, 2011, J COMP PHYSIOL A, V197, P653, DOI 10.1007/s00359-011-0625-x; Ryuman N, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/450317; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Secondo A, 2006, AM J PHYSIOL-CELL PH, V290, pC233, DOI 10.1152/ajpcell.00231.2005; Sokolovski S, 2004, PLANT PHYSIOL, V136, P4275, DOI 10.1104/pp.104.050344; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yang S, 2008, J PHYSIOL-LONDON, V586, P3617, DOI 10.1113/jphysiol.2008.153312; ZHAO HQ, 1994, NEUROREPORT, V6, P149, DOI 10.1097/00001756-199412300-00038	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42556	10.1371/journal.pone.0042556	http://dx.doi.org/10.1371/journal.pone.0042556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880032	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100128
J	Juneau, KJ; Tarasoff, CS				Juneau, Kevyn J.; Tarasoff, Catherine S.			Leaf Area and Water Content Changes after Permanent and Temporary Storage	PLOS ONE			English	Article							STOMATAL DENSITY; ATMOSPHERIC CO2; LIGNIN CONTENT; PINE NEEDLES; TEMPERATURE; PLANTS; SHAPE; DECOMPOSITION; NITROGEN; TRANSPIRATION	Accurate measurements of leaf morphology must be taken to develop models of ecosystem productivity and climate change projections. Once leaves are removed from a plant they begin to lose water and degrade. If specimens cannot be measured immediately after harvest, it is important to store the leaves in a manner that reduces morphological changes. If preserved specimens are used, estimates that closely match fresh measurements need to be calculated. This study examined the change in leaf area after storage treatments and developed models that can be used to more accurately estimate initial leaf area. Fresh leaf area was measured from ten plant species then stored in one of two common storage treatments. After storage, leaf area was re-measured and comparisons were made between species and growth forms. Leaf area decreased the most after permanent storage treatments and the least after temporary storage. Pressed leaves shrunk over 18% while cold storage leaves shrunk under 4%. The woody dicot growth form shrunk the least in all treatments. Shrinkage was positively correlated with initial water content and dissection index, a measure of leaf shape and complexity.	[Juneau, Kevyn J.; Tarasoff, Catherine S.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Juneau, KJ (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	kjjuneau@mtu.edu			Minnesota Department of Transportation [89258]; Ecosystem Science Center, Michigan Technological University, Houghton, MI	Minnesota Department of Transportation; Ecosystem Science Center, Michigan Technological University, Houghton, MI	This work was supported in part by the Minnesota Department of Transportation (grant #89258) and the Ecosystem Science Center, Michigan Technological University, Houghton, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bond-Lamberty B, 2002, TREE PHYSIOL, V22, P993, DOI 10.1093/treephys/22.14.993; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Brett CT, 1996, PHYSL BIOCH PLANT CE; Brodribb TJ, 2005, PLANT PHYSIOL, V137, P1139, DOI 10.1104/pp.104.058156; Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Cochard H, 2004, PLANT PHYSIOL, V134, P401, DOI 10.1104/pp.103.028357; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Evans GC., 1972, QUANTITATIVE ANAL PL; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Farrant JM, 2000, PLANT ECOL, V151, P29, DOI 10.1023/A:1026534305831; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; HARMON ME, 1990, FOREST ECOL MANAG, V31, P55, DOI 10.1016/0378-1127(90)90111-N; HICKS A J, 1978, Taxon, V27, P63, DOI 10.2307/1220483; Holbrook NM., 2005, VASCULAR TRANSPORT P, DOI [10.1016/B978-0-12-088457-5.X5000-X, DOI 10.1016/B978-0-12-088457-5.X5000-X]; Hultine KR, 2001, J EXP BOT, V52, P369, DOI 10.1093/jexbot/52.355.369; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; Kouwenberg LLR, 2003, AM J BOT, V90, P610, DOI 10.3732/ajb.90.4.610; Kramer P.J., 1995, WATER RELATIONS PLAN; Li YL, 2005, BOT BULL ACAD SINICA, V46, P127; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; MCLELLAN T, 1993, AM J BOT, V80, P796, DOI 10.2307/2445599; Miller-Rushing AJ, 2009, AM J BOT, V96, P1779, DOI 10.3732/ajb.0800410; MILTHORPE FL, 1957, J EXP BOT, V8, P413, DOI 10.1093/jxb/8.3.413; Nicotra AB, 2008, OECOLOGIA, V154, P625, DOI 10.1007/s00442-007-0865-1; NIKLAS KJ, 1986, AM J BOT, V73, P636; NIKLAS KJ, 1989, AM J BOT, V76, P929, DOI 10.2307/2444549; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; PENUELAS J, 1990, J EXP BOT, V41, P1119, DOI 10.1093/jxb/41.9.1119; Prado CHBA, 1997, PHOTOSYNTHETICA, V33, P103, DOI 10.1023/A:1022183423630; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Reich PB, 1998, FUNCT ECOL, V12, P948, DOI 10.1046/j.1365-2435.1998.00274.x; ROBINSON JM, 1990, GEOLOGY, V18, P607, DOI 10.1130/0091-7613(1990)015<0607:LLPAFB>2.3.CO;2; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Ryser P, 2008, J EXP BOT, V59, P2461, DOI 10.1093/jxb/ern120; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; SCHAEFER D, 1985, OECOLOGIA, V65, P382, DOI 10.1007/BF00378913; Siso S, 2001, TREES-STRUCT FUNCT, V15, P341, DOI 10.1007/s004680100110; USDA NRCS (US Department of Agriculture Natural Resources Conservation Service), 2011, PLANTS DAT; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Vicre M, 2004, PHYSIOL PLANTARUM, V120, P229, DOI 10.1111/j.0031-9317.2004.0234.x; Watanabe A, 2006, APPL SPECTROSC, V60, P611, DOI 10.1366/000370206777670549; WATSON DJ, 1947, ANN BOT-LONDON, V11, P41, DOI 10.1093/oxfordjournals.aob.a083148; Weatherley P E, 1965, Symp Soc Exp Biol, V19, P157; Wheeler DA, 2001, ENTOMOL EXP APPL, V98, P9, DOI 10.1023/A:1018755203570; WHITE RH, 1987, WOOD FIBER SCI, V19, P446; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0	52	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42604	10.1371/journal.pone.0042604	http://dx.doi.org/10.1371/journal.pone.0042604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880051	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100141
J	Savage, C; Thrush, SF; Lohrer, AM; Hewitt, JE				Savage, Candida; Thrush, Simon F.; Lohrer, Andrew M.; Hewitt, Judi E.			Ecosystem Services Transcend Boundaries: Estuaries Provide Resource Subsidies and Influence Functional Diversity in Coastal Benthic Communities	PLOS ONE			English	Article							STABLE-ISOTOPES; ORGANIC-MATTER; FOOD WEBS; CARBON; SEA; NITRIFICATION; DELTA-N-15; DELTA-C-13; SEDIMENTS; NITROGEN	Background: Estuaries are highly productive ecosystems that can export organic matter to coastal seas (the 'outwelling hypothesis'). However the role of this food resource subsidy on coastal ecosystem functioning has not been examined. Methodology/Principal Findings: We investigated the influence of estuarine primary production as a resource subsidy and the influence of estuaries on biodiversity and ecosystem functioning in coastal mollusk-dominated sediment communities. Stable isotope values (delta C-13, delta N-15) demonstrated that estuarine primary production was exported to the adjacent coast and contributed to secondary production up to 4 km from the estuary mouth. Further, isotope signatures of suspension feeding bivalves on the adjacent coast (Dosinia subrosea) closely mirrored the isotope values of the dominant bivalves inside the estuaries (Austrovenus stutchburyi), indicating utilization of similar organic matter sources. However, the food subsidies varied between estuaries; with estuarine suspended particulate organic matter (SPOM) dominant at Tairua estuary, while seagrass and fringing vegetation detritus was proportionately more important at Whangapoua estuary, with lesser contributions of estuarine SPOM. Distance from the estuary mouth and the size and density of large bivalves (Dosinia spp.) had a significant influence on the composition of biological traits in the coastal macrobenthic communities, signaling the potential influence of these spatial subsidies on ecosystem functioning. Conclusions/Significance: Our study demonstrated that the locations where ecosystem services like productivity are generated are not necessarily where the services are utilized. Further, we identified indirect positive effects of the nutrient subsidies on biodiversity (the estuarine subsidies influenced the bivalves, which in turn affected the diversity and functional trait composition of the coastal sediment macrofaunal communities). These findings highlight the importance of integrative ecosystem-based management that maintains the connectivity of estuarine and coastal ecosystems.	[Savage, Candida] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Thrush, Simon F.; Lohrer, Andrew M.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Savage, C (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	candida.savage@otago.ac.nz		Thrush, Simon/0000-0002-4005-3882	New Zealand Ministry of Fisheries Biodiversity Program [ZBD2008-07]	New Zealand Ministry of Fisheries Biodiversity Program	This work was funded by the New Zealand Ministry of Fisheries Biodiversity Program (project ZBD2008-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2004, ECOL APPL, V14, P1921, DOI 10.1890/03-5379; Antonio ES, 2010, ESTUAR COAST SHELF S, V86, P401, DOI 10.1016/j.ecss.2009.05.010; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bianchi M, 1999, AQUAT MICROB ECOL, V18, P301, DOI 10.3354/ame018301; Bianchi M, 1999, AQUAT MICROB ECOL, V17, P267, DOI 10.3354/ame017267; Caraco NF, 1998, MAR ECOL PROG SER, V167, P59, DOI 10.3354/meps167059; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cunha MA, 2003, AQUAT ECOL, V37, P45, DOI 10.1023/A:1022173730178; Dame R.F., 1993, BIVALVE FILTER FEEDE; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Hewitt JE, 2007, AM NAT, V169, P398, DOI 10.1086/510925; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hume TM, 2007, OCEAN COAST MANAGE, V50, P905, DOI 10.1016/j.ocecoaman.2007.05.009; JONES GA, 1983, J SEDIMENT PETROL, V53, P655, DOI 10.1306/212F825B-2B24-11D7-8648000102C1865D; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Lorrain A, 2002, J EXP MAR BIOL ECOL, V275, P47, DOI 10.1016/S0022-0981(02)00220-4; McCullagh P, 1989, GEN LINEAR MODELS; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; ODUM WE, 1979, ECOLOGICAL PROCESSES, P69; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Riera P, 2002, MAR ECOL PROG SER, V240, P291, DOI 10.3354/meps240291; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Schlacher TA, 2009, AQUAT ECOL, V43, P383, DOI 10.1007/s10452-008-9196-5; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turner S, 2006, ENV WIAKATO INTERNAL; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Vasconcelos RP, 2011, ECOL INDIC, V11, P1123, DOI 10.1016/j.ecolind.2010.12.012; Yokoyama H, 2007, MAR ECOL PROG SER, V346, P127, DOI 10.3354/meps07010	34	54	54	0	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42708	10.1371/journal.pone.0042708	http://dx.doi.org/10.1371/journal.pone.0042708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880089	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100162
J	Alam, MR; Groschner, LN; Parichatikanond, W; Kuo, L; Bondarenko, AI; Rost, R; Waldeck-Weiermair, M; Malli, R; Graier, WF				Alam, Muhammad Rizwan; Groschner, Lukas N.; Parichatikanond, Warisara; Kuo, Liang; Bondarenko, Alexander I.; Rost, Rene; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.			Mitochondrial Ca2+ Uptake 1 (MICU1) and Mitochondrial Ca2+ Uniporter (MCU) Contribute to Metabolism-Secretion Coupling in Clonal Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; ESSENTIAL COMPONENT; RYANODINE RECEPTOR; GLUCOSE; CALCIUM; MEMBRANE; PROTEINS; SIGNALS; ENTRY; LETM1	In pancreatic beta-cells, uptake of Ca2+ into mitochondria facilitates metabolism-secretion coupling by activation of various matrix enzymes, thus facilitating ATP generation by oxidative phosphorylation and, in turn, augmenting insulin release. We employed an siRNA-based approach to evaluate the individual contribution of four proteins that were recently described to be engaged in mitochondrial Ca2+ sequestration in clonal INS-1 832/13 pancreatic beta-cells: the mitochondrial Ca2+ uptake 1 (MICU1), mitochondrial Ca2+ uniporter (MCU), uncoupling protein 2 (UCP2), and leucine zipper EF-hand-containing transmembrane protein 1 (LETM1). Using a FRET-based genetically encoded Ca2+ sensor targeted to mitochondria, we show that a transient knockdown of MICU1 or MCU diminished mitochondrial Ca2+ uptake upon both intracellular Ca2+ release and Ca2+ entry via L-type channels. In contrast, knockdown of UCP2 and LETM1 exclusively reduced mitochondrial Ca2+ uptake in response to either intracellular Ca2+ release or Ca2+ entry, respectively. Therefore, we further investigated the role of MICU1 and MCU in metabolism-secretion coupling. Diminution of MICU1 or MCU reduced mitochondrial Ca2+ uptake in response to D-glucose, whereas D-glucose-triggered cytosolic Ca2+ oscillations remained unaffected. Moreover, D-glucose-evoked increases in cytosolic ATP and D-glucose-stimulated insulin secretion were diminished in MICU1- or MCU-silenced cells. Our data highlight the crucial role of MICU1 and MCU in mitochondrial Ca2+ uptake in pancreatic beta-cells and their involvement in the positive feedback required for sustained insulin secretion.	[Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Mol & Cellular Physiol Res Unit, A-8010 Graz, Austria; [Kuo, Liang] Capital Med Univ, Xuan Wu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China	Medical University of Graz; Capital Medical University	Graier, WF (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Mol & Cellular Physiol Res Unit, Harrachgasse 21-3, A-8010 Graz, Austria.	wolfgang.graier@medunigraz.at	Waldeck-Weiermair, Markus/AAV-5193-2020; Alam, Muhammad Rizwan/AAE-2266-2019; Graier, Wolfgang F./B-7052-2008; Groschner, Lukas/AHD-6319-2022; Groschner, Lukas/J-9398-2012; Bondarenko, Alexander I/B-3080-2013	Waldeck-Weiermair, Markus/0000-0002-5792-6766; Alam, Muhammad Rizwan/0000-0002-1578-5723; Graier, Wolfgang F./0000-0003-1871-3298; Groschner, Lukas/0000-0002-4325-0232; Groschner, Lukas/0000-0002-4325-0232; Parichatikanond, Warisara/0000-0001-7851-2477; Malli, Roland/0000-0001-6327-8729; Rost, Rene/0000-0002-5393-0370; Bondarenko, Oleksandr/0000-0003-2629-5962	Austrian Science Funds (FWF) [P21857-B18, P22553-B18]; FWF within the Doctoral College "Molecular Medicine" at the Medical University of Graz [P21857-B18]; Austrian Academic Exchange Service (AD); Austrian Science Fund (FWF) [P 21857, P 22553] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); FWF within the Doctoral College "Molecular Medicine" at the Medical University of Graz; Austrian Academic Exchange Service (AD); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF) (Grants P21857-B18 and P22553-B18).; Funded by the FWF (Grant P21857-B18) within the Doctoral College "Molecular Medicine" at the Medical University of Graz.; Supported by the Austrian Academic Exchange Service (AD).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Malli R, 2007, CELL CALCIUM, V41, P63, DOI 10.1016/j.ceca.2006.05.001; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Medvedev AV, 2002, J BIOL CHEM, V277, P42639, DOI 10.1074/jbc.M208645200; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V390, P16, DOI 10.1016/j.bbrc.2009.09.043; Olsson AH, 2011, EUR J ENDOCRINOL, V164, P765, DOI 10.1530/EJE-10-0995; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Ravier MA, 2010, DIABETOLOGIA, V53, P1947, DOI 10.1007/s00125-010-1775-z; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; RUTTER GA, 1989, ANN NY ACAD SCI, V573, P206, DOI 10.1111/j.1749-6632.1989.tb14998.x; Ryu SY, 2011, J BIOL CHEM, V286, P21324, DOI 10.1074/jbc.C111.245597; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	39	93	97	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34445	34454		10.1074/jbc.M112.392084	http://dx.doi.org/10.1074/jbc.M112.392084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904319	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000309654200046
J	Darmellah, A; Rayah, A; Auger, R; Cuif, MH; Prigent, M; Arpin, M; Alcover, A; Delarasse, C; Kanellopoulos, JM				Darmellah, Amaria; Rayah, Amel; Auger, Rodolphe; Cuif, Marie-Helene; Prigent, Magali; Arpin, Monique; Alcover, Andres; Delarasse, Cecile; Kanellopoulos, Jean M.			Ezrin/Radixin/Moesin Are Required for the Purinergic P2X7 Receptor (P2X7R)-dependent Processing of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERM PROTEINS; P2X(7) RECEPTOR; EXTRACELLULAR ATP; STRUCTURAL BASIS; NEUTRAL ENDOPEPTIDASE-24.11; MEMBRANE-PROTEINS; ADAPTER PROTEINS; CELL CORTEX; ACTIVATION; PHOSPHORYLATION	The amyloid precursor protein (APP) can be cleaved by alpha-secretases in neural cells to produce the soluble APP ectodomain (sAPP alpha), which is neuroprotective. We have shown previously that activation of the purinergic P2X7 receptor(P2X7R) triggers sAPP alpha shedding from neural cells. Here, we demonstrate that the activation of ezrin, radixin, and moesin(ERM) proteins is required for the P2X7R-dependent proteolytic processing of APP leading to sAPP alpha release. Indeed, the down-regulation of ERM by siRNA blocked the P2X7R-dependent shedding of sAPP alpha. We also show that P2X7R stimulation triggered the phosphorylation of ERM. Thus, ezrin translocates to the plasma membrane to interact with P2X7R. Using specific pharmacological inhibitors, we established the order in which several enzymes trigger the P2X7R-dependent release of sAPP alpha. Thus, a Rho kinase and the MAPK modules ERK1/2 and JNK act upstream of ERM, whereas a PI3K activity is triggered downstream. For the first time, this work identifies ERM as major partners in the regulated non-amyloidogenic processing of APP.	[Delarasse, Cecile] Univ Paris 06, INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,UMRS 975,UMR 7225,CRICM, F-75013 Paris, France; [Darmellah, Amaria; Rayah, Amel; Auger, Rodolphe; Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Cuif, Marie-Helene; Prigent, Magali] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Arpin, Monique] CNRS, Inst Curie, Ctr Rech, UMR 144, F-75248 Paris, France; [Alcover, Andres] CNRS, Dept Immunol, Lymphocyte Cell Biol Unit, Inst Pasteur,URA 1961, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Delarasse, C (corresponding author), Univ Paris 06, INSERM, Inst Cerveau & Moelle Epiniere, Ctr Rech,CNRS,UMRS 975,UMR 7225,CRICM, F-75013 Paris, France.	cecile.delarasse@upmc.fr; jean.kanellopoulos@u-psud.fr	Delarasse, Cecile/K-8234-2017	Delarasse, Cecile/0000-0001-9739-4306; Alcover, Andres/0000-0002-9507-3450	CNRS; Agence Nationale pour la Recherche [ANR-07-BLAN-0089-02]; Neuropple de Recherche Francilien; French government; Association France Alzheimer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Neuropple de Recherche Francilien; French government; Association France Alzheimer	This work was supported in part by the CNRS and Agence Nationale pour la Recherche Grant ANR-07-BLAN-0089-02.; Supported by a postdoctoral fellowship from Neuropple de Recherche Francilien.; Supported by a Ph.D. fellowship from the French government.; Supported by Association France Alzheimer. To whom correspondence may be addressed: CRICM, INSERM UMRS_975, Universite Pierre et Marie Curie (Paris 6), CNRS UMR 7225, 75013 Paris, France. E-mail: cecile.delarasse@upmc.fr.	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Darmellah A, 2009, CARDIOVASC RES, V81, P294, DOI 10.1093/cvr/cvn320; Delarasse C, 2011, J BIOL CHEM, V286, P2596, DOI 10.1074/jbc.M110.200618; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Feyt C, 2007, BIOCHEM BIOPH RES CO, V357, P1004, DOI 10.1016/j.bbrc.2007.04.036; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; PASTOR R, 1994, ONCOGENE, V9, P1081; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Roubinet C, 2011, J CELL BIOL, V195, P99, DOI 10.1083/jcb.201106048; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Schettini G, 2010, J NEUROCHEM, V115, P1299, DOI 10.1111/j.1471-4159.2010.07044.x; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takenouchi T, 2008, J IMMUNOL, V180, P7827, DOI 10.4049/jimmunol.180.12.7827; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	75	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34583	34595		10.1074/jbc.M112.400010	http://dx.doi.org/10.1074/jbc.M112.400010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891241	Green Published, hybrid			2022-12-25	WOS:000309654200061
J	Peterson, S; Liu, J				Peterson, Sherket; Liu, Jian			Deciphering Mode of Action of Heparanase Using Structurally Defined Oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SPECIFICITY; PROGRESSION; METASTASIS; MECHANISM; SEQUENCE; RELEASE; ROLES	Heparan sulfate (HS) is a highly sulfated polysaccharide that serves many biological functions, including regulating cell growth and inflammatory responses as well as the blood coagulation process. Heparanase is an enzyme that cleaves HS and is known to display a variety of pathophysiological effects in cancer, diabetes, and Alzheimer disease. The link between heparanase and diseases is a result of its selective cleavage of HS, which releases smaller HS fragments to enhance cell proliferation, migration, and invasion. Despite its importance in pathological diseases, the structural cues in HS that direct heparanase cleavage and the steps of HS depolymerization remain unknown. Here, we sought to probe the substrate specificity of heparanase using a series of structurally defined oligosaccharide substrates. The sites of heparanase cleavage on the oligosaccharide substrates were determined by mass spectrometry and gel permeation chromatography. We discovered that heparanase cleaves the linkage of glucuronic acid linked to glucosamine carrying 6-O-sulfo groups. Furthermore, our findings suggest that heparanase displays different cleavage modes by recognizing the structures of the nonreducing ends of the substrates. Our results deepen the understanding of the action mode of heparanase.	[Peterson, Sherket; Liu, Jian] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Beard Hall,Rm 303, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [HL094463]; Ruth L. Kirschstein National Research Service Award from the National Institutes of Health [F31GM090647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM090647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant HL094463.; Recipient of Ruth L. Kirschstein National Research Service Award F31GM090647 from the National Institutes of Health.	Bame KJ, 2001, GLYCOBIOLOGY, V11, p91R, DOI 10.1093/glycob/11.6.91R; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; BASHKIN P, 1992, J CELL PHYSIOL, V151, P126, DOI 10.1002/jcp.1041510117; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Steinkuhler C., 2007, U.S. Patent, Patent No. [2007/0009989, 20070009989]; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	24	45	45	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34836	34843		10.1074/jbc.M112.390161	http://dx.doi.org/10.1074/jbc.M112.390161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893710	Green Published, hybrid			2022-12-25	WOS:000309654200082
J	Sexton, AN; Youmans, DT; Collins, K				Sexton, Alec N.; Youmans, Daniel T.; Collins, Kathleen			Specificity Requirements for Human Telomere Protein Interaction with Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL BODIES; CATALYTIC SUBUNIT; LENGTH REGULATION; YEAST TELOMERASE; END-PROTECTION; EST3 PROTEIN; HUMAN CANCER; 10 DOMAIN; OB-FOLD; RECRUITMENT	Human telomeres are maintained by the enzyme telomerase, which uses a template within its integral RNA subunit (hTR) and telomerase reverse transcriptase protein (TERT) to accomplish the synthesis of single-stranded DNA repeats. Many questions remain unresolved about the cellular regulation of telomerase subunits and the fully assembled telomerase holoenzyme, including the basis for the specificity of binding and acting on telomeres. Previous studies have revealed that the telomere protein TPP1 is necessary for stable TERT and hTR association with telomeres in vivo. Here, we expand the biochemical characterization and understanding of TPP1 interaction with TERT and the catalytically active telomerase holoenzyme. Using extracts from human cells, we show that TPP1 interacts sequence-specifically with TERT when TERT is assembled into holoenzyme context. In holoenzyme context, the TERT N-terminal domain mediates a TPP1 interaction. Assays of stable subunit complexes purified after their cellular assembly suggest that other telomere proteins do not necessarily influence TPP1 association with telomerase holoenzyme or alter its impact on elongation processivity. We show that a domain of recombinant TPP1 comprised of an oligonucleotide/oligosaccharide binding fold recapitulates the full-length protein interaction specificity for the TERT N-terminal domain assembled into telomerase holoenzyme. By global analysis of TPP1 side chain requirements for holoenzyme association, we demonstrate a selective requirement for the amino acids in one surface-exposed protein loop. Our results reveal the biochemical determinants of a sequence-specific TPP1-TERT interaction in human cells, with implications for the mechanisms of TPP1 function in recruiting telomerase subunits to telomeres and in promoting telomere elongation.	[Sexton, Alec N.; Youmans, Daniel T.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu		Youmans, Daniel/0000-0003-2648-0797	National Institutes of Health [RO1 HL079585]; University of California Cancer Research Coordinating Committee predoctoral fellowship award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Cancer Research Coordinating Committee predoctoral fellowship award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant RO1 HL079585 and a University of California Cancer Research Coordinating Committee predoctoral fellowship award.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Egan E. D., 2012, RNA IN PRESS, V18; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Lee SR, 2003, J BIOL CHEM, V278, P52531, DOI 10.1074/jbc.M311359200; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yang D, 2011, J BIOL CHEM, V286, P23022, DOI 10.1074/jbc.M111.225870; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	35	80	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34455	34464		10.1074/jbc.M112.394767	http://dx.doi.org/10.1074/jbc.M112.394767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893708	hybrid, Green Published			2022-12-25	WOS:000309654200047
J	Traina, F; Visconte, V; Jankowska, AM; Makishima, H; O'Keefe, CL; Elson, P; Han, YC; Hsieh, FH; Sekeres, MA; Mali, RS; Kalaycio, M; Lichtin, AE; Advani, AS; Duong, HK; Copelan, E; Kapur, R; Saad, STO; Maciejewski, JP; Tiu, RV				Traina, Fabiola; Visconte, Valeria; Jankowska, Anna M.; Makishima, Hideki; O'Keefe, Christine L.; Elson, Paul; Han, Yingchun; Hsieh, Fred H.; Sekeres, Mikkael A.; Mali, Raghuveer Singh; Kalaycio, Matt; Lichtin, Alan E.; Advani, Anjali S.; Duong, Hien K.; Copelan, Edward; Kapur, Reuben; Olalla Saad, Sara T.; Maciejewski, Jaroslaw P.; Tiu, Ramon V.			Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; MAST-CELL NEOPLASMS; C-KIT; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE NEOPLASMS; MYELOID MALIGNANCIES; PROGENITOR-CELL; SPECTRUM; CRITERIA; IDENTIFICATION	We hypothesized that analysis of single nucleotide polymorphism arrays (SNP-A) and new molecular defects may provide new insight in the pathogenesis of systemic mastocytosis (SM). SNP-A karyotyping was applied to identify recurrent areas of loss of heterozygosity and bidirectional sequencing was performed to evaluate the mutational status of TET2, DNMT3A, ASXL1, EZH2, IDH1/IDH2 and the CBL gene family. Overall survival (OS) was analyzed using the Kaplan-Meier method. We studied a total of 26 patients with SM. In 67% of SM patients, SNP-A karyotyping showed new chromosomal abnormalities including uniparental disomy of 4q and 2p spanning TET2/KIT and DNMT3A. Mutations in TET2, DNMT3A, ASXL1 and CBL were found in 23%, 12%, 12%, and 4% of SM patients, respectively. No mutations were observed in EZH2 and IDH1/IDH2. Significant differences in OS were observed for SM mutated patients grouped based on the presence of combined TET2/DNMT3A/ASXL1 mutations independent of KIT (P = 0.04) and sole TET2 mutations (P<0.001). In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.	[Traina, Fabiola; Visconte, Valeria; Jankowska, Anna M.; Makishima, Hideki; O'Keefe, Christine L.; Sekeres, Mikkael A.; Maciejewski, Jaroslaw P.; Tiu, Ramon V.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA; [Traina, Fabiola; Olalla Saad, Sara T.] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, INCT Sangue, Sao Paulo, Brazil; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Han, Yingchun; Hsieh, Fred H.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Han, Yingchun; Hsieh, Fred H.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Sekeres, Mikkael A.; Kalaycio, Matt; Lichtin, Alan E.; Advani, Anjali S.; Duong, Hien K.; Copelan, Edward; Maciejewski, Jaroslaw P.; Tiu, Ramon V.] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA; [Mali, Raghuveer Singh; Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA	Cleveland Clinic Foundation; Universidade Estadual de Campinas; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Indiana University System; Indiana University Bloomington	Traina, F (corresponding author), Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA.	tiur@ccf.org	Traina, Fabiola/U-1451-2019; Traina, Fabiola/L-3809-2014	Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; Sekeres, Mikkael/0000-0003-2009-6524	Celgene Future Leaders of Hematology Award; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL077522, R01HL077177] Funding Source: NIH RePORTER	Celgene Future Leaders of Hematology Award(Bristol-Myers SquibbCelgene Corporation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from Celgene Future Leaders of Hematology Award and Cleveland Clinic Seed Support (RVT), Howard Hughes Medical Institute Career Grant (FHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, LEUKEMIA, V24, P1656, DOI 10.1038/leu.2010.144; Akin C, 2000, EXP HEMATOL, V28, P140, DOI 10.1016/S0301-472X(99)00145-9; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gelsi-Boyer V, 2010, BRIT J HAEMATOL, V151, P365, DOI 10.1111/j.1365-2141.2010.08381.x; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Huh J, 2010, GENE CHROMOSOME CANC, V49, P390, DOI 10.1002/gcc.20748; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Makishima H, 2010, LEUKEMIA, V24, P1799, DOI 10.1038/leu.2010.167; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Pardanani A, 2003, LEUKEMIA RES, V27, P739, DOI 10.1016/S0145-2126(02)00303-X; Sugimoto Y, 2010, BRIT J HAEMATOL, V150, P83, DOI 10.1111/j.1365-2141.2010.08196.x; Tefferi A, 2004, CURR OPIN HEMATOL, V11, P58, DOI 10.1097/00062752-200401000-00009; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tiu R, 2007, LEUKEMIA, V21, P1648, DOI 10.1038/sj.leu.2404757; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2004, EUR J CLIN INVEST, V34, P41, DOI 10.1111/j.0960-135X.2004.01369.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yavuz AS, 2002, BLOOD, V100, P661, DOI 10.1182/blood-2002-01-0203; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	34	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43090	10.1371/journal.pone.0043090	http://dx.doi.org/10.1371/journal.pone.0043090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905207	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600045
J	Huynh, TT; McDougald, D; Klebensberger, J; Al Qarni, B; Barraud, N; Rice, SA; Kjelleberg, S; Schleheck, D				Huynh, Tran T.; McDougald, Diane; Klebensberger, Janosch; Al Qarni, Budoor; Barraud, Nicolas; Rice, Scott A.; Kjelleberg, Staffan; Schleheck, David			Glucose Starvation-Induced Dispersal of Pseudomonas aeruginosa Biofilms Is cAMP and Energy Dependent	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; CELLULAR DETACHMENT; TWITCHING MOTILITY; PUTIDA; EXPRESSION; RESISTANCE; VIRULENCE	Carbon starvation has been shown to induce a massive dispersal event in biofilms of the opportunistic pathogen Pseudomonas aeruginosa; however, the molecular pathways controlling this dispersal response remain unknown. We quantified changes in the proteome of P. aeruginosa PAO1 biofilm and planktonic cells during glucose starvation by differential peptide-fingerprint mass-spectrometry (iTRAQ). In addition, we monitored dispersal photometrically, as a decrease in turbidity/opacity of biofilms pre-grown and starved in continuous flow-cells, in order to evaluate treatments (e. g. inhibitors CCCP, arsenate, chloramphenicol, L-serine hydroxamate) and key mutants altered in biofilm development and dispersal (e.g. nirS, vfr, bdlA, rpoS, lasRrhlR, Pf4-bacteriophage and cyaA). In wild-type biofilms, dispersal started within five minutes of glucose starvation, was maximal after 2 h, and up to 60% of the original biomass had dispersed after 24 h of starvation. The changes in protein synthesis were generally not more than two fold and indicated that more than 100 proteins belonging to various classes, including carbon and energy metabolism, stress adaptation, and motility, were differentially expressed. For the different treatments, only the proton-ionophore CCCP or arsenate, an inhibitor of ATP synthesis, prevented dispersal of the biofilms. For the different mutants tested, only cyaA, the synthase of the intracellular second messenger cAMP, failed to disperse; complementation of the cyaA mutation restored the wild-type phenotype. Hence, the pathway for carbon starvation-induced biofilm dispersal in P. aeruginosa PAO1 involves ATP production via direct ATP synthesis and proton-motive force dependent step(s) and is mediated through cAMP, which is likely to control the activity of proteins involved in remodeling biofilm cells in preparation for planktonic survival.	[Huynh, Tran T.; McDougald, Diane; Klebensberger, Janosch; Al Qarni, Budoor; Barraud, Nicolas; Rice, Scott A.; Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [McDougald, Diane] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore, Singapore; [Rice, Scott A.; Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Schleheck, David] Univ Konstanz, Dept Biol Sci, Constance, Germany; [Schleheck, David] Univ Konstanz, Res Sch Chem Biol, Constance, Germany	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Konstanz; University of Konstanz	Huynh, TT (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	d.mcdougald@unsw.edu.au	Kjelleberg, Staffan/AAB-4641-2020; McDougald, Diane/B-5564-2009; Rice, Scott/A-6084-2019; Barraud, Nicolas/D-1569-2010; McDougald, Diane/AAF-4799-2020; Kjelleberg, Staffan/C-9229-2015	Kjelleberg, Staffan/0000-0003-4271-6413; McDougald, Diane/0000-0001-5827-8441; Rice, Scott/0000-0002-9486-2343; Barraud, Nicolas/0000-0002-1807-7765; McDougald, Diane/0000-0001-5827-8441; Kjelleberg, Staffan/0000-0003-4271-6413; Klebensberger, Janosch/0000-0003-2740-3769	Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW); Australian Research Council (ARC) [DP110104525]; Environmental Biotechnology Cooperative Research Centre (EB-CRC); UNSW; University of Konstanz	Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW); Australian Research Council (ARC)(Australian Research Council); Environmental Biotechnology Cooperative Research Centre (EB-CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); UNSW; University of Konstanz	The project was funded by the Centre for Marine Bio-Innovation, the School of Biotechnology and Biomolecular Sciences, University of New South Wales (UNSW), and by the Australian Research Council (ARC Discovery Project DP110104525). The work of T. T. H. was supported by a postgraduate scholarship from the Environmental Biotechnology Cooperative Research Centre (EB-CRC). The work of D. S. was supported by a UNSW Vice-Chancellor's Postdoctoral Research Fellowship and by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BOOMINATHAN K, 1992, P NATL ACAD SCI USA, V89, P5586, DOI 10.1073/pnas.89.12.5586; BOYD A, 1994, APPL ENVIRON MICROB, V60, P2355, DOI 10.1128/AEM.60.7.2355-2359.1994; Buhmann M, 2012, ENV MICROBIOL REP, V4, P133, DOI 10.1111/j.1758-2229.2011.00315.x; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; DELAQUIS PJ, 1989, MICROBIAL ECOL, V18, P199, DOI 10.1007/BF02075808; Denkhaus E, 2007, MICROCHIM ACTA, V158, P1, DOI 10.1007/s00604-006-0688-5; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; Endoh T, 2009, J BACTERIOL, V191, P7193, DOI 10.1128/JB.00970-09; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; GHOUL M, 1989, APPL ENVIRON MICROB, V55, P1040, DOI 10.1128/AEM.55.4.1040-1043.1989; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; MAZON MJ, 1982, EUR J BIOCHEM, V127, P605; Merighi M, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P97, DOI 10.1007/978-90-481-3909-5_4; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Musk DJ, 2005, CHEM BIOL, V12, P789, DOI 10.1016/j.chembiol.2005.05.007; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; NG EYW, 1994, ANTIMICROB AGENTS CH, V38, P1345, DOI 10.1128/AAC.38.6.1345; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; STEFANOVICH V, 1979, NEUROCHEM RES, V4, P587, DOI 10.1007/BF00964436; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; WRANGSTADH M, 1989, CAN J MICROBIOL, V35, P309, DOI 10.1139/m89-046	54	49	51	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42874	10.1371/journal.pone.0042874	http://dx.doi.org/10.1371/journal.pone.0042874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905180	gold, Green Published			2022-12-25	WOS:000307500800025
J	Willing, EM; Dreyer, C; van Oosterhout, C				Willing, Eva-Maria; Dreyer, Christine; van Oosterhout, Cock			Estimates of Genetic Differentiation Measured by F-ST Do Not Necessarily Require Large Sample Sizes When Using Many SNP Markers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; STRUCTURED POPULATIONS; CONSERVATION; ECOLOGY; HISTORY; POWER; BIAS	Population genetic studies provide insights into the evolutionary processes that influence the distribution of sequence variants within and among wild populations. F-ST is among the most widely used measures for genetic differentiation and plays a central role in ecological and evolutionary genetic studies. It is commonly thought that large sample sizes are required in order to precisely infer F-ST and that small sample sizes lead to overestimation of genetic differentiation. Until recently, studies in ecological model organisms incorporated a limited number of genetic markers, but since the emergence of next generation sequencing, the panel size of genetic markers available even in non-reference organisms has rapidly increased. In this study we examine whether a large number of genetic markers can substitute for small sample sizes when estimating F-ST. We tested the behavior of three different estimators that infer F-ST and that are commonly used in population genetic studies. By simulating populations, we assessed the effects of sample size and the number of markers on the various estimates of genetic differentiation. Furthermore, we tested the effect of ascertainment bias on these estimates. We show that the population sample size can be significantly reduced (as small as n = 4-6) when using an appropriate estimator and a large number of bi-allelic genetic markers (k > 1,000). Therefore, conservation genetic studies can now obtain almost the same statistical power as studies performed on model organisms using markers developed with next-generation sequencing.	[Willing, Eva-Maria; Dreyer, Christine] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Max Planck Society; University of East Anglia	Willing, EM (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	willing@mpipz.mpg.de		van Oosterhout, Cock/0000-0002-5653-738X	Deutsche Forschungsgemeinschaft; Max Planck Society; ELSA, The Earth and Life Sciences Alliance	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); ELSA, The Earth and Life Sciences Alliance	Supported by a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft to Detlef Weigel at the Max Planck Institute for Developmental Biology, and the Max Planck Society. CvO was funded by ELSA, The Earth and Life Sciences Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Excoffier L, 2007, HDB STAT GENETICS; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; LEWONTIN RC, 1973, GENETICS, V74, P175; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Raufaste N, 2000, THEOR POPUL BIOL, V57, P285, DOI 10.1006/tpbi.2000.1457; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Seddon JM, 2005, MOL ECOL, V14, P503, DOI 10.1111/j.1365-294X.2005.02435.x; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x	19	265	265	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42649	10.1371/journal.pone.0042649	http://dx.doi.org/10.1371/journal.pone.0042649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905157	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000307500800019
J	Zhang, YF; Xie, QG; Robertson, JB; Johnson, CH				Zhang, Yunfei; Xie, Qiguang; Robertson, J. Brian; Johnson, Carl Hirschie			pHlash: A New Genetically Encoded and Ratiometric Luminescence Sensor of Intracellular pH	PLOS ONE			English	Article							ENERGY-TRANSFER BRET; PROTEIN INTERACTIONS; CA2+; PLANT; OSCILLATIONS; HOMEOSTASIS; DYNAMICS; CALCIUM; GLUCOSE; SYSTEM	We report the development of a genetically encodable and ratiometic pH probe named "pHlash'' that utilizes Bioluminescence Resonance Energy Transfer (BRET) rather than fluorescence excitation. The pHlash sensor-composed of a donor luciferase that is genetically fused to a Venus fluorophore-exhibits pH dependence of its spectral emission in vitro. When expressed in either yeast or mammalian cells, pHlash reports basal pH and cytosolic acidification in vivo. Its spectral ratio response is H+ specific; neither Ca++, Mg++, Na+, nor K+ changes the spectral form of its luminescence emission. Moreover, it can be used to image pH in single cells. This is the first BRET-based sensor of H+ ions, and it should allow the approximation of pH in cytosolic and organellar compartments in applications where current pH probes are inadequate.	[Zhang, Yunfei] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Zhang, YF (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA.	carl.h.johnson@vanderbilt.edu	Xu, Xiaodong/HGD-8082-2022; Johnson, Carl H/I-4655-2014		National Science Foundation (NSF SGER) [IOS-0854942]; National Institute of Mental Health [R21 MH 080035]; National Institute of General Medical Sciences [R01 GM 065467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH080035] Funding Source: NIH RePORTER	National Science Foundation (NSF SGER)(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Science Foundation (NSF SGER # IOS-0854942), the National Institute of Mental Health (R21 MH 080035), and the National Institute of General Medical Sciences (R01 GM 065467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS RJ, 1985, CELL, V43, P653, DOI 10.1016/0092-8674(85)90237-5; Agulhon C, 2007, J PHYSIOL-LONDON, V583, P945, DOI 10.1113/jphysiol.2007.135715; Audet M, 2010, FASEB J, V24, P2829, DOI 10.1096/fj.09-144816; Boonsirichai K, 2003, PLANT CELL, V15, P2612, DOI 10.1105/tpc.015560; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; BUSA WB, 1983, SCIENCE, V221, P366, DOI 10.1126/science.221.4608.366; Dreosti E, 2011, EXP PHYSIOL, V96, P4, DOI 10.1113/expphysiol.2009.051953; Eklund SE, 2004, ANAL CHEM, V76, P519, DOI 10.1021/ac034641z; Fernandez NA, 2011, AM J PHYSIOL-CELL PH, V300, pC1513, DOI 10.1152/ajpcell.00433.2010; Fricker MD., 1999, FLUORESCENT LUMINESC, P569; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; GRAINGER JL, 1979, DEV BIOL, V68, P396, DOI 10.1016/0012-1606(79)90213-6; Hoshino H, 2007, NAT METHODS, V4, P637, DOI 10.1038/NMETH1069; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; LEE HC, 1983, DEV BIOL, V95, P31, DOI 10.1016/0012-1606(83)90004-0; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Plieth C, 1999, PLANT J, V18, P643, DOI 10.1046/j.1365-313x.1999.00492.x; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SATROUTDINOV AD, 1992, FEMS MICROBIOL LETT, V98, P261, DOI 10.1016/0378-1097(92)90167-M; Schulte A, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Xie QG, 2011, METHODS MOL BIOL, V680, P3, DOI 10.1007/978-1-60761-901-7_1; Xu XD, 2007, P NATL ACAD SCI USA, V104, P10264, DOI 10.1073/pnas.0701987104; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	36	20	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43072	10.1371/journal.pone.0043072	http://dx.doi.org/10.1371/journal.pone.0043072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905204	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800043
J	Smeti, I; Assou, S; Savary, E; Masmoudi, S; Zine, A				Smeti, Ibtihel; Assou, Said; Savary, Etienne; Masmoudi, Saber; Zine, Azel			Transcriptomic Analysis of the Developing and Adult Mouse Cochlear Sensory Epithelia	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; NOTCH SIGNALING PATHWAY; AUDITORY HAIR-CELLS; INNER-EAR; ANDROGEN RECEPTOR; STEM-CELLS; POSTMITOTIC STATE; CDNA MICROARRAYS; ACOUSTIC TRAUMA; GROWTH-HORMONE	The adult mammalian cochlea lacks regenerative ability and the irreversible degeneration of cochlear sensory hair cells leads to permanent hearing loss. Previous data show that early postnatal cochlea harbors stem/progenitor-like cells and shows a limited regenerative/repair capacity. These properties are progressively lost later during the postnatal development. Little is known about the genes and pathways that are potentially involved in this difference of the regenerative/repair potentialities between early postnatal and adult mammalian cochlear sensory epithelia (CSE). The goal of our study is to investigate the transcriptomic profiles of these two stages. We used Mouse Genome 430 2.0 microarray to perform an extensive analysis of the genes expressed in mouse postnatal day-3 (P3) and adult CSE. Statistical analysis of microarray data was performed using SAM (Significance Analysis of Microarrays) software. We identified 5644 statistically significant differentially expressed transcripts with a fold change (FC) >2 and a False Discovery Rate (FDR) <= 0.05. The P3 CSE signature included 3,102 transcripts, among which were known genes in the cochlea, but also new transcripts such as, Hmga2 (high mobility group AT-hook 2) and Nrarp (Notch-regulated ankyrin repeat protein). The adult CSE overexpressed 2,542 transcripts including new transcripts, such as Prl (Prolactin) and Ar (Androgen receptor), that previously were not known to be expressed in the adult cochlea. Our comparative study revealed important genes and pathways differentially expressed between the developing and adult CSE. The identification of new candidate genes would be useful as potential markers of the maintenance or the loss of stem cells and regenerative/repair ability during mammalian cochlear development.	[Smeti, Ibtihel; Savary, Etienne; Zine, Azel] UMR 7260 Aix Marseille Univ, CNRS, Marseille, France; [Smeti, Ibtihel; Zine, Azel] Univ Montpellier I, Fac Pharm, Montpellier, France; [Assou, Said] Univ Montpellier I, CHU Montpellier, Inst Res Biotherapy, INSERM,U1040, Montpellier, France; [Smeti, Ibtihel; Masmoudi, Saber] Ctr Biotechnol, Lab Microorganismes & Biomol, Sfax, Tunisia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre de Biotechnologie de Borj Cedria; Centre de Biotechnologie de Sfax; Universite de Sfax	Smeti, I (corresponding author), UMR 7260 Aix Marseille Univ, CNRS, Marseille, France.	azel.zine@univ-montp1.fr	Masmoudi, Saber/W-1478-2019	assou, said/0000-0001-6448-7995; Saber, Masmoudi/0000-0002-1076-5256	ANR (Agence Nationale de Recherche) [ANR-2010-BLAN-1107-01-b]; Fondation de France Fonds; Averroes program/University Montpellier I	ANR (Agence Nationale de Recherche)(French National Research Agency (ANR)); Fondation de France Fonds; Averroes program/University Montpellier I	Funding was provided by the ANR (Agence Nationale de Recherche; ANR-2010-BLAN-1107-01-b to AZ), The Fondation de France Fonds, and the Averroes program/University Montpellier I (doctoral fellowship to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chen FQ, 2009, J NEUROCHEM, V108, P1226, DOI 10.1111/j.1471-4159.2009.05871.x; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; Cho YS, 2002, JARO, V3, P54, DOI 10.1007/s101620010042; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Drayton M, 2006, HEARING RES, V212, P128, DOI 10.1016/j.heares.2005.11.006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falkenius-Schmidt K, 2005, HEARING RES, V203, P154, DOI 10.1016/j.heares.2004.11.015; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hawkins RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000525; Hawkins RD, 2003, HUM MOL GENET, V12, P1261, DOI 10.1093/hmg/ddg150; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Horner KC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1224, DOI 10.1152/ajpendo.00279.2007; Horner KC, 2002, NEUROPSYCHOPHARMACOL, V26, P135, DOI 10.1016/S0893-133X(01)00356-6; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Lenoir M, 1997, INT J DEV NEUROSCI, V15, P487, DOI 10.1016/S0736-5748(96)00105-0; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Lin JH, 2003, HEARING RES, V175, P2, DOI 10.1016/S0378-5955(02)00704-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Nagashima R, 2005, J PHARMACOL SCI, V99, P301, DOI 10.1254/jphs.CPJ05004X; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; National Center for Biotechnology Information, GUID CAR US LAB AN; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ogita K, 2000, NEUROREPORT, V11, P859, DOI 10.1097/00001756-200003200-00040; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Paxton CN, 2010, GENE EXPR PATTERNS, V10, P31, DOI 10.1016/j.gep.2009.11.002; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Price K, 2009, HEARING RES, V252, P29, DOI 10.1016/j.heares.2009.02.010; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; REITER E, 1992, MOL CELL ENDOCRINOL, V88, P77, DOI 10.1016/0303-7207(92)90011-T; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sajan SA, 2007, GENETICS, V177, P631, DOI 10.1534/genetics.107.078584; Sato T, 2009, ACTA OTO-LARYNGOL, V129, P12, DOI 10.1080/00016480902926464; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Slattery EL, 2009, JARO-J ASSOC RES OTO, V10, P341, DOI 10.1007/s10162-009-0166-y; Smeti I, 2011, GENE EXPR PATTERNS, V11, P22, DOI 10.1016/j.gep.2010.08.008; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Staecker H, 1998, CURR OPIN NEUROBIOL, V8, P480, DOI 10.1016/S0959-4388(98)80035-4; Sun HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028372; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Zine A, 1998, NEUROREPORT, V9, P263, DOI 10.1097/00001756-199801260-00016	62	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42987	10.1371/journal.pone.0042987	http://dx.doi.org/10.1371/journal.pone.0042987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900075	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900093
J	Aliferis, KA; Jabaji, S				Aliferis, Konstantinos A.; Jabaji, Suha			FT-ICR/MS and GC-EI/MS Metabolomics Networking Unravels Global Potato Sprout's Responses to Rhizoctonia solani Infection	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; DISEASE RESISTANCE; PLANT DEFENSE; GLYCOALKALOIDS SOLASONINE; PHENYLPROPANOID PATHWAY; MAGNAPORTHE-GRISEA; MASS-SPECTROMETRY; FLUX ANALYSIS; TUBER TISSUE; ACID	The complexity of plant-pathogen interactions makes their dissection a challenging task for metabolomics studies. Here we are reporting on an integrated metabolomics networking approach combining gas chromatography/mass spectrometry (GC/MS) with Fourier transform ion cyclotron resonance/mass spectrometry (FT-ICR/MS) and bioinformatics analyses for the study of interactions in the potato sprout-Rhizoctonia solani pathosystem and the fluctuations in the global metabolome of sprouts. The developed bioanalytical and bioinformatics protocols provided a snapshot of the sprout's global metabolic network and its perturbations as a result of pathogen invasion. Mevalonic acid and deoxy-xylulose pathways were substantially up-regulated leading to the biosynthesis of sesquiterpene alkaloids such as the phytoalexins phytuberin, rishitin, and solavetivone, and steroidal alkaloids having solasodine and solanidine as their common aglycons. Additionally, the perturbation of the sprout's metabolism was depicted in fluctuations of the content of their amino acids pool and that of carboxylic and fatty acids. Components of the systemic acquired resistance (SAR) and hypersensitive reaction (HR) such as azelaic and oxalic acids were detected in increased levels in infected sprouts and strategies of the pathogen to overcome plant defense were proposed. Our metabolic approach has not only greatly expanded the multitude of metabolites previously reported in potato in response to pathogen invasion, but also enabled the identification of bioactive plant-derived metabolites providing valuable information that could be exploited in biotechnology, biomarker-assisted plant breeding, and crop protection for the development of new crop protection agents.	[Aliferis, Konstantinos A.; Jabaji, Suha] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Aliferis, KA (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	suha.jabaji@mcgill.ca	Jabaji, Suha/D-2479-2016	Jabaji, Suha/0000-0002-7232-9994	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work has been funded by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Farid IB, 2009, PLANT SCI, V176, P608, DOI 10.1016/j.plantsci.2009.01.017; Aliferis KA, 2010, METABOLOMICS, V6, P96, DOI 10.1007/s11306-009-0180-4; Aliferis KA, 2012, METABOLOMICS, DOI 101007/s11306-011-0340-1; Aliferis KA, 2011, PESTIC BIOCHEM PHYS, V100, P105, DOI 10.1016/j.pestbp.2011.03.004; Aliferis KA, 2011, METABOLOMICS, V7, P35, DOI 10.1007/s11306-010-0231-x; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; Allwood JW, 2010, PHYTOCHEMISTRY, V71, P590, DOI 10.1016/j.phytochem.2010.01.006; Allwood JW, 2006, PLANT J, V46, P351, DOI 10.1111/j.1365-313X.2006.02692.x; Andreu A, 2001, POTATO RES, V44, P1, DOI 10.1007/BF02360281; AOKI H, 1963, NATURE, V200, P575, DOI 10.1038/200575a0; AOKI M, 1991, AGR BIOL CHEM TOKYO, V55, P715, DOI 10.1080/00021369.1991.10870632; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Becker P, 1998, FEMS MICROBIOL LETT, V167, P197, DOI 10.1111/j.1574-6968.1998.tb13228.x; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; BOSTOCK RM, 1992, PLANT PHYSIOL, V100, P1448, DOI 10.1104/pp.100.3.1448; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Bown AW, 1997, PLANT PHYSIOL, V115, P1, DOI 10.1104/pp.115.1.1; CARLING DE, 1989, AM POTATO J, V66, P693, DOI 10.1007/BF02896825; Cowan D, 2009, NAT BIOTECHNOL, V27, P1132, DOI 10.1038/nbt1209-1132; Defernez M, 2004, J AGR FOOD CHEM, V52, P6075, DOI 10.1021/jf049522e; DESJARDINS AE, 1995, J AGR FOOD CHEM, V43, P2267, DOI 10.1021/jf00056a056; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dobson G, 2010, J AGR FOOD CHEM, V58, P1214, DOI 10.1021/jf903104b; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Engstrom K, 1999, POTATO RES, V42, P43, DOI 10.1007/BF02358390; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fammartino A, 2007, PLANT PHYSIOL, V143, P378, DOI 10.1104/pp.106.087304; FARMER EE, 1994, PLANT MOL BIOL, V26, P1423, DOI 10.1007/BF00016483; FEWELL AM, 1994, PHYTOCHEMISTRY, V37, P1007, DOI 10.1016/S0031-9422(00)89518-7; Fewell AM, 1997, MYCOL RES, V101, P597, DOI 10.1017/S0953756296002973; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t; Geigenberger P, 2004, PLANT CELL ENVIRON, V27, P655, DOI 10.1111/j.1365-3040.2004.01183.x; Geigenberger P, 2010, TRENDS PLANT SCI, V15, P98, DOI 10.1016/j.tplants.2009.11.004; Gvozdeva EL, 2006, APPL BIOCHEM MICRO+, V42, P502, DOI 10.1134/S0003683806050103; Halliwell B, 2007, CELLULAR RESPONSES O; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; HIDE GA, 1985, ANN APPL BIOL, V106, P423, DOI 10.1111/j.1744-7348.1985.tb03133.x; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Jourdan F, 2010, METABOLOMICS, V6, P312, DOI 10.1007/s11306-009-0196-9; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Keller H, 1996, PHYTOCHEMISTRY, V42, P389, DOI 10.1016/0031-9422(95)00866-7; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kolomiets MV, 2000, PLANT PHYSIOL, V124, P1121, DOI 10.1104/pp.124.3.1121; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Last RL, 2007, NAT REV MOL CELL BIO, V8, P167, DOI 10.1038/nrm2098; Lehtonen MJ, 2008, PHYTOPATHOLOGY, V98, P1190, DOI 10.1094/PHYTO-98-11-1190; Leiss KA, 2011, PHYTOCHEM REV, V10, P205, DOI 10.1007/s11101-010-9175-z; LI WX, 1991, AGR BIOL CHEM TOKYO, V55, P1041, DOI 10.1080/00021369.1991.10870743; Matsuda F, 2005, PLANT CELL PHYSIOL, V46, P454, DOI 10.1093/pcp/pci042; Matsuda F, 2003, PLANT CELL PHYSIOL, V44, P510, DOI 10.1093/pcp/pcg063; Moerschbacher BM, 1999, J EXP BOT, V50, P605, DOI 10.1093/jexbot/50.334.605; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; MORROW LS, 1983, AM POTATO J, V60, P403, DOI 10.1007/BF02877246; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; Negrel J, 1996, PHYTOCHEMISTRY, V43, P1195, DOI 10.1016/S0031-9422(96)00500-6; Oda Y, 2002, J BIOSCI BIOENG, V94, P321, DOI 10.1016/S1389-1723(02)80171-2; OHTA H, 1991, PLANT PHYSIOL, V97, P94, DOI 10.1104/pp.97.1.94; Osbourn A, 1996, TRENDS PLANT SCI, V1, P4, DOI 10.1016/S1360-1385(96)80016-1; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; RAYBURN JR, 1994, J AGR FOOD CHEM, V42, P1511, DOI 10.1021/jf00043a022; RODDICK JG, 1990, PHYTOCHEMISTRY, V29, P1513, DOI 10.1016/0031-9422(90)80111-S; Roessner U, 2001, PLANT PHYSIOL, V127, P749, DOI [10.1104/pp.010316, 10.1104/pp.127.3.749]; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Sarquis JI, 2000, AM J POTATO RES, V77, P295, DOI 10.1007/BF02853950; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Shepherd LVT, 2010, METABOLOMICS, V6, P274, DOI 10.1007/s11306-009-0183-1; Simons SA, 1997, PLANT PATHOL, V46, P642, DOI 10.1046/j.1365-3059.1997.d01-53.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Stumpe M, 2001, FEBS LETT, V507, P371, DOI 10.1016/S0014-5793(01)03019-8; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Urbanczyk-Wochniak E, 2005, PLANTA, V221, P891, DOI 10.1007/s00425-005-1483-y; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Weber H, 1999, PLANT CELL, V11, P485, DOI 10.1105/tpc.11.3.485; Wolski EA, 2006, PHYSIOL MOL PLANT P, V69, P93, DOI 10.1016/j.pmpp.2007.02.001; Yang WL, 2007, METABOLOMICS, V3, P147, DOI 10.1007/s11306-007-0053-7; Yao MK, 2003, MYCORRHIZA, V13, P333, DOI 10.1007/s00572-003-0267-0; Yara A, 2008, BIOCHEM BIOPH RES CO, V370, P344, DOI 10.1016/j.bbrc.2008.03.083	84	52	54	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42576	10.1371/journal.pone.0042576	http://dx.doi.org/10.1371/journal.pone.0042576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880040	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100135
J	Hatton, O; Lambert, SL; Krams, SM; Martinez, OM				Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.			Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV) plus B Cell Lymphomas	PLOS ONE			English	Article							NF-KAPPA-B; TYROSINE KINASES; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGEN RECEPTOR; EPITHELIAL-CELLS; ENCODED LMP1; FCR-GAMMA; PATHWAY; CBL; FAMILY	The B lymphotrophic gamma-herpesvirus EBV is associated with a variety of lymphoid-and epithelial-derived malignancies, including B cell lymphomas in immunocompromised and immunosuppressed individuals. The primary oncogene of EBV, latent membrane protein 1 (LMP1), activates the PI3K/Akt pathway to induce the autocrine growth factor, IL-10, in EBV-infected B cells, but the mechanisms underlying PI3K activation remain incompletely understood. Using small molecule inhibition and siRNA strategies in human B cell lines expressing a chimeric, signaling-inducible LMP1 protein, nerve growth factor receptor (NGFR)-LMP1, we show that NGFR-LMP1 utilizes Syk to activate PI3K/Akt signaling and induce IL-10 production. NGFR-LMP1 signaling induces phosphorylation of BLNK, a marker of Syk activation. Whereas Src kinases are often required for Syk activation, we show here that PI3K/Akt activation and autocrine IL-10 production by NGFR-LMP1 involves the Src family kinase Fyn. Finally, we demonstrate that NGFR-LMP1 induces phosphorylation of c-Cbl in a Syk- and Fyn-dependent fashion. Our results indicate that the EBV protein LMP1, which lacks the canonical ITAM required for Syk activation, can nevertheless activate Syk, and the Src kinase Fyn, resulting in downstream c-Cbl and PI3K/Akt activation. Fyn, Syk, and PI3K/Akt antagonists thus may present potential new therapeutic strategies that target the oncogene LMP1 for treatment of EBV+ B cell lymphomas.	[Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA; [Hatton, Olivia; Lambert, Stacie L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Dept Surg, Div Abdominal Transplantat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Hatton, O (corresponding author), Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA.	omm@stanford.edu		, Olivia/0000-0002-2798-0251; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [ROI AI41769]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041769] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by an National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant ROI AI41769 (OMM) (nih.gov). O.H. was supported by a Stanford Graduate Fellowship (sgf.stanford.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Beatty PR, 1997, J IMMUNOL, V158, P4045; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Dawson CW, 2001, VIROLOGY, V289, P192, DOI 10.1006/viro.2001.1142; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Eliopoulos AG, 1999, J VIROL, V73, P1023, DOI 10.1128/JVI.73.2.1023-1035.1999; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GHOSH D, 1990, J VIROL, V64, P1855, DOI 10.1128/JVI.64.4.1855-1858.1990; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Hatton O, 2011, J BIOL CHEM, V286, P37368, DOI 10.1074/jbc.M111.255125; HUEN DS, 1995, ONCOGENE, V10, P549; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Jakus Z, 2007, TRENDS CELL BIOL, V17, P493, DOI 10.1016/j.tcb.2007.09.001; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; LONGNECKER R, 1990, J VIROL, V64, P2319, DOI 10.1128/JVI.64.5.2319-2326.1990; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; MacGlashan D, 2004, J ALLERGY CLIN IMMUN, V114, P1317, DOI 10.1016/j.jaci.2004.08.037; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; MANN KP, 1985, J VIROL, V55, P710, DOI 10.1128/JVI.55.3.710-720.1985; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shao YA, 2004, J BIOL CHEM, V279, P43646, DOI 10.1074/jbc.M404082200; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Vaysberg M, 2008, J BIOL CHEM, V283, P36573, DOI 10.1074/jbc.M802968200; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Ying HY, 2011, IMMUNOBIOLOGY, V216, P566, DOI 10.1016/j.imbio.2010.09.016; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023	60	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42610	10.1371/journal.pone.0042610	http://dx.doi.org/10.1371/journal.pone.0042610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880054	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100143
J	Piao, SL; Liu, YL; Hu, J; Guo, FL; Ma, J; Sun, Y; Zhang, B				Piao, Songlin; Liu, Yanlong; Hu, Jing; Guo, Fulin; Ma, Jie; Sun, Yao; Zhang, Bin			USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							PROTEASE 22; CANCER; EXPRESSION; UBIQUITYLATION; METASTASIS; CHROMATIN; SURVIVAL; SUBUNIT	Background and Objective: The significance of ubiquitin-specific protease 22 (USP22) as a potential marker has been growing in the field of oncology. The aim of this study was to investigate the role of USP22 and the association with its potential targets in oral squamous cell carcinoma (OSCC). Methods: Immunohistochemistry was used to determine the expression of USP22 protein in 319 OSCC patients in comparison with 42 healthy controls. The clinical correlations and prognostic significance of the aberrantly expressed protein was evaluated to identify novel biomarker of OSCC. Results: The incidence of positive USP22 expression was 63.32% in 319 conventional OSCC tissues. The protein expression level of USP22 was concomitantly up-regulated from non-cancerous mucosa to primary carcinoma and from carcinomas to lymph node metastasis (P<0.001). Moreover, statistical analysis showed that positive USP22 expression was positively related to lymph node metastasis, Ki67, Cox-2 and recurrence. Furthermore, it was shown that patients with positive USP22 expression had significantly poorer outcome compared with patients with negative expression of USP22 for patients with positive lymph nodes. Multivariate Cox regression analysis revealed that USP22 expression level was an independent prognostic factor for both overall survival and disease-free survival (P<0.001 and P<0.001, respectively). Cancer cells with reduced USP22 expression exhibited reduced proliferation and colony formation evaluated by MTT and soft agar assays. Conclusion: To our knowledge, this is the first study that determines the relationship between USP22 expression and prognosis in OSCC. We found that increased expression of USP22 is associated with poor prognosis in OSCC. USP22 may represent a novel and useful prognostic marker for OSCC.	[Piao, Songlin; Guo, Fulin; Ma, Jie] Harbin Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China; [Liu, Yanlong] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin, Heilongjiang, Peoples R China; [Hu, Jing] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Med Oncol, Harbin, Heilongjiang, Peoples R China; [Sun, Yao; Zhang, Bin] Harbin Med Univ, Affiliated Hosp 2, Hard Tissue Lab, Harbin, Heilongjiang, Peoples R China; [Zhang, Bin] Harbin Med Univ, Affiliated Hosp 2, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Guo, FL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Harbin, Heilongjiang, Peoples R China.	guofulinhyd@126.com; zhangbinhyd@163.com	Liu, Yanlong/AAL-3503-2021		National Natural Science Foundation of China [81170960]; Ministry of Education College Doctoral Degree Special Fund [20102307110006]; Province Natural Science Foundation of Heilongjiang [D200848]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education College Doctoral Degree Special Fund; Province Natural Science Foundation of Heilongjiang	This work was supported by the National Natural Science Foundation of China [grant number 81170960], the Ministry of Education College Doctoral Degree Special Fund [grant number 20102307110006] and the Province Natural Science Foundation of Heilongjiang [grant number D200848]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Chipumuro E, 2012, FASEB J, V26, P842, DOI 10.1096/fj.11-189498; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Jiang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034283; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Liu YL, 2010, J GASTROEN HEPATOL, V25, P1800, DOI 10.1111/j.1440-1746.2010.06352.x; Liu YL, 2012, CELL BIOCHEM BIOPHYS, V62, P229, DOI 10.1007/s12013-011-9287-0; Liu YL, 2011, J SURG ONCOL, V103, P283, DOI 10.1002/jso.21802; Lv L, 2011, MOL CELL BIOCHEM, V346, P11, DOI 10.1007/s11010-010-0585-4; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Miller CS, 2003, ORAL SURG ORAL MED O, V95, P570, DOI 10.1067/moe.2003.108; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Pijnappel WWMP, 2008, MOL CELL, V29, P152, DOI 10.1016/j.molcel.2008.01.007; Wolff D, 2004, J CRANIO MAXILL SURG, V32, P318, DOI 10.1016/j.jcms.2004.05.005; Xu H, 2012, INT J COLORECTAL DIS, V27, P21, DOI 10.1007/s00384-011-1275-8; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang YX, 2011, J CANCER RES CLIN, V137, P1245, DOI 10.1007/s00432-011-0998-9; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	24	49	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42540	10.1371/journal.pone.0042540	http://dx.doi.org/10.1371/journal.pone.0042540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880026	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100125
J	Wu, QJ; Vogtmann, E; Zhang, W; Xie, L; Yang, WS; Tan, YT; Gao, J; Xiang, YB				Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing			Cancer Incidence among Adolescents and Young Adults in Urban Shanghai, 1973-2005	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER; UNITED-STATES; CHILDHOOD-CANCER; KIDNEY CANCER; HEPATITIS-B; TRENDS; CHILDREN; AGE; PATTERNS	Background: Lack of cancer incidence information for adolescents and young adults led us to describe incidence trends within the young population of 15 to 49 year-olds in urban Shanghai between 1973 and 2005. Methods: During 1973 to 2005, data on 43,009 (45.8%) male and 50,828 (54.2%) female cancer cases aged 15-49 years from the Shanghai Cancer Registry were analyzed. Five-year age-specific rates, world age-standardized rates, percent change (PC), and annual percent change (APC) were calculated using annual data on population size and its estimated age structure. Results: During the 33-year study period, overall cancer incidence of adolescents and young adults among males marginally decreased by 0.5% per year (P<0.05). However, overall cancer incidence for females slightly increased by 0.8% per year (P<0.05). The leading cancer for males in rank were liver, stomach, lung, colorectal, and nasopharyngeal cancers and for females were breast, stomach, colorectal, thyroid, and ovarian cancers. Among specific sites, incidence rates significantly decreased for cancers of the esophagus, stomach, and liver in both sexes. In contrast, incidence rates significantly increased for kidney cancers, non-Hodgkin lymphoma, and brain and nervous system tumors in both sexes and increased for breast and ovarian cancers among females. Conclusions: Overall cancer incidence rates of adolescents and young adults decreased in males whereas they increased in females. Our findings suggest the importance of further epidemiology and etiologic studies to further elucidate factors contributing to the cancer incidence trends of adolescents and young adults in China.	[Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Wu, Qi-Jun; Vogtmann, Emily; Zhang, Wei; Xie, Li; Yang, Wan-Shui; Tan, Yu-Ting; Gao, Jing; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, State Key Lab Oncogene & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China; [Vogtmann, Emily] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Alabama System; University of Alabama Birmingham	Wu, QJ (corresponding author), Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China.	ybxiang@shsci.org	Yang, Wanshui/S-9322-2019; Vogtmann, Emily/O-9125-2017	Yang, Wanshui/0000-0002-7365-2689; Vogtmann, Emily/0000-0003-1355-5593	State Key Project Specialized for Infectious Diseases of China [2008ZX10002-015, 2012ZX10002008-002]; Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health; Fogarty International Center, National Institutes of Health (NIH) [R24TW007988-5]; Cancer Prevention and Control Training Program at the University of Alabama at Birmingham; NIH [5R25 CA047888]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER	State Key Project Specialized for Infectious Diseases of China; Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health; Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Cancer Prevention and Control Training Program at the University of Alabama at Birmingham; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funds of State Key Project Specialized for Infectious Diseases of China (No. 2008ZX10002-015 and 2012ZX10002008-002). Emily Vogtmann was also supported by the Fogarty International Clinical Research Scholars and Fellows Support Center at the Vanderbilt Institute for Global Health, funded by the Fogarty International Center, National Institutes of Health (NIH), through an R24 Training Grant (Grant number: R24TW007988-5), and the Cancer Prevention and Control Training Program at the University of Alabama at Birmingham funded through the NIH (5R25 CA047888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao PP, 2010, PEDIATR BLOOD CANCER, V54, P1009, DOI 10.1002/pbc.22383; Barr RD, 1999, MED PEDIATR ONCOL, V32, P404, DOI 10.1002/(SICI)1096-911X(199906)32:6<404::AID-MPO2>3.0.CO;2-F; Barr RD, 2011, CANCER-AM CANCER SOC, V117, P2245, DOI 10.1002/cncr.26052; Bhatia S, 1999, MED PEDIATR ONCOL, V33, P470, DOI 10.1002/(SICI)1096-911X(199911)33:5<470::AID-MPO6>3.0.CO;2-A; Bleyer A, 2006, NIH PUB; Blot W, 2006, CANC EPIDEMIOLOGY PR; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; COPELAN EA, 1995, BLOOD, V85, P1151, DOI 10.1182/blood.V85.5.1151.bloodjournal8551151; Croucher C, 2009, CLIN ONCOL-UK, V21, P417, DOI 10.1016/j.clon.2009.02.006; de Camargo B, 2010, INT J CANCER, V126, P715, DOI 10.1002/ijc.24799; Desandes E, 2007, B CANCER, V94, P331; Gao S, 2012, EUR J EPIDEMIOL, V27, P39, DOI 10.1007/s10654-011-9636-8; Gao YT, 2007, CANC INCIDENCE MORT; Gatta G, 2003, EUR J CANCER, V39, P2600, DOI 10.1016/j.ejca.2003.09.004; Giovannucci E, 2006, CANC EPIDEMIOLOGY PR, P809; Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688; HERNANDEZ JA, 1995, CANCER, V75, P381, DOI 10.1002/1097-0142(19950101)75:1+<381::AID-CNCR2820751320>3.0.CO;2-B; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; HUNGER SP, 1992, J CLIN ONCOL, V10, P156, DOI 10.1200/JCO.1992.10.1.156; *IARC WORK GROUP E, 1994, SCHIST LIV FLUK HEL, P177; Jin F, 1999, INT J CANCER, V83, P435, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt;435::AID-IJC1&gt;3.0.CO;2-J; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lagergren J, 1998, CANCER EPIDEM BIOMAR, V7, P913; Lee SY, 2003, INT J CANCER, V105, P390, DOI 10.1002/ijc.11078; Leung AWH, 2008, CANCER DETECT PREV, V32, P156, DOI 10.1016/j.cdp.2008.05.004; Li WD, 2010, B CHINESE CANC, V12, P782; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; McNally RJQ, 1997, HEMATOL ONCOL, V15, P173, DOI 10.1002/(SICI)1099-1069(199711)15:4<173::AID-HON610>3.0.CO;2-K; METTLIN C, 1990, AM J EPIDEMIOL, V131, P973, DOI 10.1093/oxfordjournals.aje.a115617; MUIR C, 1987, CANC INCIDENCE 5 CON, V5; National Cancer Institute, 2006, NIH PUB, V06-6067; Nepple KG, 2012, J UROLOGY, V187, P32, DOI 10.1016/j.juro.2011.09.028; Nordenstedt H, 2011, SCAND J GASTROENTERO, V46, P597, DOI 10.3109/00365521.2011.551890; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Percy C., 1990, INT CLASSIFICATION D; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Robison L, 1995, CHESSELLS HANN BAILL, P639; ROSS JA, 2006, CANC EPIDEMIOLOGY PR, P1251; Sandler DP, 1997, SEMIN ONCOL, V24, P3; Semenza JC, 2001, AM J EPIDEMIOL, V153, P851, DOI 10.1093/aje/153.9.851; SMITH MA, 1994, MED PEDIATR ONCOL, V23, P86, DOI 10.1002/mpo.2950230205; Spix C, 2008, INT J CANCER, V122, P1859, DOI 10.1002/ijc.23281; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stuebe AM, 2009, ARCH INTERN MED, V169, P1364, DOI 10.1001/archinternmed.2009.231; SU D, 1979, CHINESE MED J-PEKING, V92, P748; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wu XC, 2005, CANCER CAUSE CONTROL, V16, P309, DOI 10.1007/s10552-004-4026-0; Wu XC, 2003, J ADOLESCENT HEALTH, V32, P405, DOI 10.1016/S1054-139X(03)00057-0; Zhang SW, 2009, B CHINESE CANC, V18, P256; [张薇 Zhang Wei], 2005, [中华老年医学杂志, Chinese Journal of Geriatrics], V24, P701; Zhou YH, 2009, CHINESE MED J-PEKING, V122, P98, DOI 10.3760/cma.j.issn.0366-6999.2009.01.018	59	38	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42607	10.1371/journal.pone.0042607	http://dx.doi.org/10.1371/journal.pone.0042607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880052	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100142
J	Zhong, WX; Wang, YB; Peng, L; Ge, XZ; Zhang, J; Liu, SS; Zhang, XN; Xu, ZH; Chen, Z; Luo, JH				Zhong, Wei-xia; Wang, Yu-bin; Peng, Lin; Ge, Xue-zhen; Zhang, Jie; Liu, Shuang-shuang; Zhang, Xiang-nan; Xu, Zheng-hao; Chen, Zhong; Luo, Jian-hong			Lanthionine Synthetase C-like Protein 1 Interacts with and Inhibits Cystathionine beta-Synthase A TARGET FOR NEURONAL ANTIOXIDANT DEFENSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; S-ADENOSYL-METHIONINE; TRANSSULFURATION PATHWAY; REDOX REGULATION; GLUTATHIONE; BRAIN; DISEASE; IDENTIFICATION; HOMEOSTASIS; METABOLISM	The finding that eukaryotic lanthionine synthetase C-like protein 1 (LanCL1) is a glutathione-binding protein prompted us to investigate the potential relationship between LanCL1 and cystathionine beta-synthase (CBS). CBS is a trans-sulfuration enzyme critical for the reduced glutathione (GSH) synthesis and GSH-dependent defense against oxidative stress. In this study we found that LanCL1 bound to CBS in mouse cortex and HEK293 cells. Mapping studies revealed that the binding region in LanCL1 spans amino acids 158-169, and that in CBS contains N-terminal and C-terminal regulatory domains. Recombinant His-LanCL1 directly bound endogenous CBS from mouse cortical lysates and inhibited its activity. Overexpression of LanCL1 inhibited CBS activity in HEK293 cells. CBS activity is reported to be regulated by oxidative stress. Here we found that oxidative stress induced by H2O2 or glutamate lowered the GSH/GSSG ratio, dissociated LanCL1 from CBS, and elevated CBS activity in primary rat cortical neurons. Decreasing the GSH/GSSG ratio by adding GSSG to cellular extracts also dissociated LanCL1 from CBS. Either lentiviral knockdown of LanCL1 or specific disruption of the LanCL1-CBS interaction using the peptide Tat-LanCL1(153-173) released CBS activity in neurons but occluded CBS activation in response to oxidative stress, indicating the major contribution of the LanCL1-CBS interaction to the regulation of CBS activity. Furthermore, LanCL1 knockdown or Tat-LanCL1(153-173) treatment reduced H2O2 or glutamate-induced neuronal damage. This study implies potential therapeutic value in targeting the LanCL1-CBS interaction for neuronal oxidative stress-related diseases.	[Luo, Jian-hong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xiang-nan; Xu, Zheng-hao; Chen, Zhong] Zhejiang Univ, Key Lab Med Neurobiol, Zhejiang Prov Key Lab Neurobiol, Dept Pharmacol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhong, Wei-xia] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Wang, Yu-bin] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA	Zhejiang University; Zhejiang University; Western University of Health Sciences; Western University of Health Sciences	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Zhang, xiangnan/C-9649-2010; Luo, jian/HGE-7331-2022; ZHANG, Jie/S-6936-2019	Zhang, xiangnan/0000-0002-7603-7403; ZHANG, Jie/0000-0002-5492-8088	National Basic Research Program of China [2010CB912002]; Natural Science Foundation of China [81221003]; Natural Science Foundation of Zhejiang, China [Y2100494]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the National Basic Research Program of China (2010CB912002), the Natural Science Foundation of China (81221003), and the Natural Science Foundation of Zhejiang, China (Y2100494).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adams James D. Jr., 2001, Current Topics in Medicinal Chemistry, V1, P473, DOI 10.2174/1568026013394778; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Gupta S, 2008, HUM MUTAT, V29, P1048, DOI 10.1002/humu.20773; Hensley K, 2010, MOLECULES, V15, P5581, DOI 10.3390/molecules15085581; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Hnizda A, 2010, BIOCHEMISTRY-US, V49, P10526, DOI 10.1021/bi101384m; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P3483, DOI 10.1073/pnas.95.7.3483; Kabil O, 2006, BIOCHEMISTRY-US, V45, P13528, DOI 10.1021/bi0615644; Kim EA, 2010, CELL MOL NEUROBIOL, V30, P807, DOI 10.1007/s10571-010-9508-x; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Lee ES, 2008, LIFE SCI, V83, P821, DOI 10.1016/j.lfs.2008.09.020; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Mayer H, 2001, GENE, V269, P73, DOI 10.1016/S0378-1119(01)00463-2; McBean GJ, 2012, AMINO ACIDS, V42, P199, DOI 10.1007/s00726-011-0864-8; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Regnier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029056; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shea TB, 2008, J ALZHEIMERS DIS, V13, P67; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Suchy J, 2010, NEUROMOL MED, V12, P86, DOI 10.1007/s12017-009-8089-7; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209; Zhao WQ, 2002, J NEUROSCI RES, V69, P519, DOI 10.1002/jnr.10314	39	37	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34189	34201		10.1074/jbc.M112.383646	http://dx.doi.org/10.1074/jbc.M112.383646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891245	hybrid, Green Published			2022-12-25	WOS:000309654200024
J	Bansal, H; Seifert, T; Bachier, C; Rao, M; Tomlinson, G; Iyer, SP; Bansal, S				Bansal, Hima; Seifert, Theresea; Bachier, Carlos; Rao, Manjeet; Tomlinson, Gail; Iyer, Swaminathan Padmanabhan; Bansal, Sanjay			The Transcription Factor Wilms Tumor 1 Confers Resistance in Myeloid Leukemia Cells against the Proapoptotic Therapeutic Agent TRAIL (Tumor Necrosis Factor alpha-related Apoptosis-inducing Ligand) by Regulating the Antiapoptotic Protein Bcl-xL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WT1 EXPRESSION; CYTOCHROME-C; CANCER-CELLS; MECHANISMS; GENE; ACTIVATION; DEATH; DIFFERENTIATION; MITOCHONDRIA; CHEMOTHERAPY	Tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL) is considered a promising cancer therapeutic agent due to its ability to induce apoptosis in a variety of cancer cells, while sparing normal cells. However, many human tumors including acute myeloid leukemia (AML) are partially or completely resistant to monotherapy with TRAIL, limiting its therapeutic utility. Therefore, identification of factors that contribute to TRAIL resistance may facilitate future development of more effective TRAIL-based cancer therapies. Here, we report a previously unknown role for WT1 in mediating TRAIL resistance in leukemia. Knockdown of WT1 with shRNA rendered TRAIL-resistant myeloid leukemia cells sensitive to TRAIL-induced cell death, and re-expression of shRNA-resistant WT1 restored TRAIL resistance. Notably, TRAIL-mediated apoptosis in WT1-silenced cells was largely due to down-regulation of the antiapoptotic protein Bcl-xL. Moreover, WT1 expression strongly correlated with overexpression of Bcl-xL in AML cell lines and blasts from AML patients. Furthermore, we found that WT1 transactivates Bcl-xL by directly binding to its promoter. We previously showed that WT1 is a novel client protein of heat shock protein 90 (Hsp90). Consistent with this, pharmacological inhibition of Hsp90 resulted in reduced WT1 and Bcl-xL expression leading to increased sensitivity of leukemia cells to TRAIL-mediated apoptosis. Collectively, our results suggest that WT1-dependent Bcl-xL overexpression contributes to TRAIL resistance in myeloid leukemias.	[Bansal, Sanjay] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Bachier, Carlos] Texas Transplant Inst, San Antonio, TX 78229 USA; [Iyer, Swaminathan Padmanabhan] Methodist Canc Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; The Methodist Hospital System; The Methodist Hospital - Houston	Bansal, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Greehey Childrens Canc Res Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	bansals@uthscsa.edu	Iyer, Swaminathan Padmanabhan/AAB-6709-2020; Iyer, Swaminathan/GRS-9668-2022; Bansal, Sanjay/F-5944-2012; Tomlinson, Gail/AAR-9776-2020	Iyer, Swaminathan Padmanabhan/0000-0002-1646-813X; 	National Institutes of Health [HD057118]; Castella Foundation; American Cancer Society through the Roswell Park Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Castella Foundation; American Cancer Society through the Roswell Park Cancer Institute(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057118 (to M. R.). This work was also supported by the Castella Foundation, institutional start-up funds (to S. B.), and an institutional grant from the American Cancer Society (to S. P. I.) through the Roswell Park Cancer Institute.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Ariyaratana Suzie, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000336; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bansal H, 2010, BLOOD, V116, P4591, DOI 10.1182/blood-2009-10-247239; Boublikova L, 2006, LEUKEMIA, V20, P254, DOI 10.1038/sj.leu.2404047; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Cheng JR, 2006, MOL CANCER THER, V5, P1844, DOI 10.1158/1535-7163.MCT-06-0050; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Elmaagacli AH, 2005, HAEMATOLOGICA, V90, P326; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Hasegawa H, 2006, BLOOD, V107, P679, DOI 10.1182/blood-2005-05-1982; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim KI, 2003, BRIT J CANCER, V88, P910, DOI 10.1038/sj.bjc.6600795; Lapillonne H, 2006, J CLIN ONCOL, V24, P1507, DOI 10.1200/JCO.2005.03.5303; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Medema JP, 1998, J BIOL CHEM, V273, P3388, DOI 10.1074/jbc.273.6.3388; Morrison DJ, 2005, CANCER RES, V65, P8174, DOI 10.1158/0008-5472.CAN-04-3657; Ogawa H, 2003, BLOOD, V101, P1698, DOI 10.1182/blood-2002-06-1831; Oka Y, 2006, CURR MED CHEM, V13, P2345, DOI 10.2174/092986706777935104; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Rosenfeld C, 2003, LEUKEMIA, V17, P1301, DOI 10.1038/sj.leu.2402988; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Simpson LA, 2006, BLOOD, V107, P4695, DOI 10.1182/blood-2005-10-4025; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Sugiyama Haruo, 2002, Methods Mol Med, V68, P223; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Tschan MP, 2008, LEUKEMIA, V22, P1087, DOI 10.1038/sj.leu.2405018; Wang XD, 2001, GENE DEV, V15, P2922; Weisser M, 2005, LEUKEMIA, V19, P1416, DOI 10.1038/sj.leu.2403809; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	42	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2012	287	39					32875	32880		10.1074/jbc.C112.366559	http://dx.doi.org/10.1074/jbc.C112.366559			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	011ME	22898820	hybrid, Green Published			2022-12-25	WOS:000309168300053
J	King, AV; Welter, BH; Koushik, AB; Gordon, LN; Temesvari, LA				King, Ada V.; Welter, Brenda H.; Koushik, Amrita B.; Gordon, Lindsay N.; Temesvari, Lesly A.			A Genome-Wide Over-Expression Screen Identifies Genes Involved in Phagocytosis in the Human Protozoan Parasite, Entamoeba histolytica	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; LARGE-SCALE ANALYSIS; OVEREXPRESSION SCREEN; PROTEOMIC ANALYSIS; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; IONIZING-RADIATION; RNA INTERFERENCE; LIM PROTEIN; DNA-DAMAGE	Functional genomics and forward genetics seek to assign function to all known genes in a genome. Entamoeba histolytica is a protozoan parasite for which forward genetics approaches have not been extensively applied. It is the causative agent of amoebic dysentery and liver abscess, and infection is prevalent in developing countries that cannot prevent its fecal-oral spread. It is responsible for considerable global morbidity and mortality. Given that the E. histolytica genome has been sequenced, it should be possible to apply genomic approaches to discover gene function. We used a genome-wide overexpression screen to uncover genes regulating an important virulence function of E. histolytica, namely phagocytosis. We developed an episomal E. histolytica cDNA over-expression library, transfected the collection of plasmids into trophozoites, and applied a high-throughput screen to identify phagocytosis mutants in the population of over-expressing cells. The screen was based on the phagocytic uptake of human red blood cells loaded with the metabolic toxin, tubercidin. Expression plasmids were isolated from trophozoites that survived exposure to tubercidin-charged erythrocytes (phagocytosis mutants), and the cDNAs were sequenced. We isolated the gene encoding profilin, a well-characterized cytoskeleton-regulating protein with a known role in phagocytosis. This supports the validity of our approach. Furthermore, we assigned a phagocytic role to several genes not previously known to function in this manner. To our knowledge, this is the first genome-wide forward genetics screen to be applied to this pathogen. The study demonstrates the power of forward genetics in revealing genes regulating virulence in E. histolytica. In addition, the study validates an E. histolytica cDNA over-expression library as a valuable tool for functional genomics.	[King, Ada V.; Welter, Brenda H.; Temesvari, Lesly A.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Koushik, Amrita B.; Gordon, Lindsay N.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Clemson University; Clemson University	King, AV (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ltemesv@clemson.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21 AI081100-01]; NIFA/USDA [SC-1700312]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081100] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIFA/USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by grant no. R21 AI081100-01 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health to L.A.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This material is based upon work supported by NIFA/USDA, under project number SC-1700312 (Technical Contribution No. 6026 of the Clemson University Experiment Station). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, or the USDA.	Abhyankar MM, 2009, PARASITOL INT, V58, P95, DOI 10.1016/j.parint.2008.08.004; ACS G, 1964, P NATL ACAD SCI USA, V52, P493, DOI 10.1073/pnas.52.2.493; Anderson JB, 2003, GENETICS, V163, P1287; Arlt H, 2011, TRAFFIC, V12, P1592, DOI 10.1111/j.1600-0854.2011.01252.x; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Biller L, 2009, PROTEOMICS, V9, P4107, DOI 10.1002/pmic.200900022; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Butcher RA, 2003, CHEM BIOL, V10, P521, DOI 10.1016/S1074-5521(03)00108-X; Byekova YA, 2010, INFECT IMMUN, V78, P125, DOI 10.1128/IAI.00719-09; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chavez-Rios R, 2003, MOL BIOCHEM PARASIT, V127, P151, DOI 10.1016/S0166-6851(02)00332-8; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Ehrenkaufer GM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-216; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hart CP, 2005, DRUG DISCOV TODAY, V10, P513, DOI 10.1016/S1359-6446(05)03415-X; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Khurana T, 2005, EMBO J, V24, P2254, DOI 10.1038/sj.emboj.7600716; KNIGHT R, 1980, J ANTIMICROB CHEMOTH, V6, P577, DOI 10.1093/jac/6.5.577; Laughlin Richard C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009622; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Luesch Hendrik, 2008, V477, P343, DOI 10.1007/978-1-60327-517-0_26; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marion S, 2006, INT J PARASITOL, V36, P131, DOI 10.1016/j.ijpara.2005.10.007; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; MUSCHEL RJ, 1977, J EXP MED, V145, P175, DOI 10.1084/jem.145.1.175; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2006, ARCH MED RES, V37, P244, DOI 10.1016/j.arcmed.2005.10.003; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Olivos-Garcia A, 2004, PARASITOLOGY, V129, P19, DOI 10.1017/S0031182004005116; Page N, 2003, GENETICS, V163, P875; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prassler J, 1998, MOL BIOL CELL, V9, P545, DOI 10.1091/mbc.9.3.545; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122; RODRIGUEZ MA, 1986, J INFECT DIS, V154, P27, DOI 10.1093/infdis/154.1.27; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Samarawickrema NA, 1997, J ANTIMICROB CHEMOTH, V40, P833, DOI 10.1093/jac/40.6.833; Sateriale Adam, 2011, Journal of Parasitology Research, P926706, DOI 10.1155/2011/926706; Schneider N, 2003, CELL MOTIL CYTOSKEL, V56, P130, DOI 10.1002/cm.10139; Seifert K, 2000, ARCH MED RES, V31, pS6, DOI 10.1016/S0188-4409(00)00139-9; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; SMITH CG, 1970, CANCER RES, V30, P69; Sokal R. R., 1981, BIOMETRY; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Tallada VA, 2002, YEAST, V19, P1139, DOI 10.1002/yea.902; Temesvari L, 2000, MOL BIOL CELL, V11, P2019, DOI 10.1091/mbc.11.6.2019; Tseng ASK, 2002, GENETICS, V162, P229; Voigt H, 1999, J CELL SCI, V112, P1191; Welter BH, 2006, EXP PARASITOL, V113, P91, DOI 10.1016/j.exppara.2005.12.012; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Wender N, 2007, EUKARYOT CELL, V6, P1646, DOI 10.1128/EC.00177-07; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43025	10.1371/journal.pone.0043025	http://dx.doi.org/10.1371/journal.pone.0043025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905196	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800038
J	Dovzhenok, A; Kuznetsov, AS				Dovzhenok, Andrey; Kuznetsov, Alexey S.			Exploring Neuronal Bistability at the Depolarization Block	PLOS ONE			English	Article							BISTABLE BEHAVIOR; MEMBRANE; MODEL; AXON	Many neurons display bistability-coexistence of two firing modes such as bursting and tonic spiking or tonic spiking and silence. Bistability has been proposed to endow neurons with richer forms of information processing in general and to be involved in short-term memory in particular by allowing a brief signal to elicit long-lasting changes in firing. In this paper, we focus on bistability that allows for a choice between tonic spiking and depolarization block in a wide range of the depolarization levels. We consider the spike-producing currents in two neurons, models of which differ by the parameter values. Our dopaminergic neuron model displays bistability in a wide range of applied currents at the depolarization block. The Hodgkin-Huxley model of the squid giant axon shows no bistability. We varied parameter values for the model to analyze transitions between the two parameter sets. We show that bistability primarily characterizes the inactivation of the Na+ current. Our study suggests a connection between the amount of the Na+ window current and the length of the bistability range. For the dopaminergic neuron we hypothesize that bistability can be linked to a prolonged action of antipsychotic drugs.	[Dovzhenok, Andrey] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; Indiana Univ Purdue Univ, Ctr Math Biosci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Dovzhenok, A (corresponding author), Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA.	adovzhen@iupui.edu	Kuznetsov, Alexey/L-1128-2017					Boye SM, 2000, J NEUROSCI, V20, P1229, DOI 10.1523/JNEUROSCI.20-03-01229.2000; Cymbalyuk G, 2005, J COMPUT NEUROSCI, V18, P255, DOI 10.1007/s10827-005-0354-7; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; GUTTMAN R, 1980, J PHYSIOL-LONDON, V305, P377, DOI 10.1113/jphysiol.1980.sp013370; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Kuznetsov AS, 2006, J NEUROPHYSIOL, V95, P932, DOI 10.1152/jn.00691.2004; Le T, 2006, J NEUROPHYSIOL, V95, P1356, DOI 10.1152/jn.00893.2005; Lechner HA, 1996, J NEUROPHYSIOL, V75, P957, DOI 10.1152/jn.1996.75.2.957; Lee RH, 1996, J NEUROPHYSIOL, V76, P2107, DOI 10.1152/jn.1996.76.3.2107; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; RINZEL J, 1978, FED PROC, V37, P2793; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011	19	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42811	10.1371/journal.pone.0042811	http://dx.doi.org/10.1371/journal.pone.0042811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900051	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900069
J	Kursu, O; Tuukkanen, T; Rahkonen, T; Vahasoyrinki, M				Kursu, Olli; Tuukkanen, Tuomas; Rahkonen, Timo; Vahasoyrinki, Mikko			3D Active Stabilization System with Sub-Micrometer Resolution	PLOS ONE			English	Article							SENSOR	Stable positioning between a measurement probe and its target from sub- to few micrometer scales has become a prerequisite in precision metrology and in cellular level measurements from biological tissues. Here we present a 3D stabilization system based on an optoelectronic displacement sensor and custom piezo-actuators driven by a feedback control loop that constantly aims to zero the relative movement between the sensor and the target. We used simulations and prototyping to characterize the developed system. Our results show that 95 % attenuation of movement artifacts is achieved at 1 Hz with stabilization performance declining to ca. 70 % attenuation at 10 Hz. Stabilization bandwidth is limited by mechanical resonances within the displacement sensor that occur at relatively low frequencies, and are attributable to the sensor's high force sensitivity. We successfully used brain derived micromotion trajectories as a demonstration of complex movement stabilization. The micromotion was reduced to a level of similar to 1 mu m with nearly 100 fold attenuation at the lower frequencies that are typically associated with physiological processes. These results, and possible improvements of the system, are discussed with a focus on possible ways to increase the sensor's force sensitivity without compromising overall system bandwidth.	[Kursu, Olli; Rahkonen, Timo] Univ Oulu, Dept Elect & Informat Engn, Oulu, Finland; [Kursu, Olli; Rahkonen, Timo] Univ Oulu, Infotech Oulu, Elect Lab, Oulu, Finland; [Tuukkanen, Tuomas; Vahasoyrinki, Mikko] Univ Oulu, Dept Phys, FIN-90570 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Kursu, O (corresponding author), Univ Oulu, Dept Elect & Informat Engn, Oulu, Finland.	mikko.vahasoyrinki@oulu.fi	Rahkonen, Timo E/H-9249-2012; Kursu, Olli/ABB-6597-2021	Kursu, Olli/0000-0002-8490-7069; Rahkonen, Timo/0000-0002-1343-1120	Academy of Finland [118480, 129762]; Sigrid Juselius Foundation; Infotech Oulu Graduate School; Tauno Tonning foundation; Emil Aaltonen foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Infotech Oulu Graduate School; Tauno Tonning foundation; Emil Aaltonen foundation	The work was supported by the Academy of Finland grants 118480 and 129762 (to MV), Sigrid Juselius Foundation (to MV and TT), Infotech Oulu Graduate School (to OK), Tauno Tonning foundation (to OK) and Emil Aaltonen foundation (to OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkelman PJ, 2003, IEEE T ROBOTIC AUTOM, V19, P917, DOI 10.1109/TRA.2003.817526; BRITT RH, 1982, J NEUROSCI METH, V6, P219, DOI 10.1016/0165-0270(82)90085-1; Cham JG, 2005, J NEUROPHYSIOL, V93, P570, DOI 10.1152/jn.00369.2004; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Fauver ME, 1998, IEEE T BIO-MED ENG, V45, P891, DOI 10.1109/10.686797; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Muntwyler S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/2/025011; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Saif MTA, 2003, ANN BIOMED ENG, V31, P950, DOI 10.1114/1.1591189; Stenlund L, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/7/075102; Strang W. G., 1973, ANAL FINITE ELEMENT; Vahasoyrinki M, 2009, J NEUROSCI METH, V180, P290, DOI 10.1016/j.jneumeth.2009.04.004	14	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42733	10.1371/journal.pone.0042733	http://dx.doi.org/10.1371/journal.pone.0042733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900045	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900062
J	Nakanishi, W; Imura, T; Inagaki, A; Nakamura, Y; Sekiguchi, S; Fujimori, K; Satomi, S; Goto, M				Nakanishi, Wataru; Imura, Takehiro; Inagaki, Akiko; Nakamura, Yasuhiro; Sekiguchi, Satoshi; Fujimori, Keisei; Satomi, Susumu; Goto, Masafumi			Ductal Injection Does Not Increase the Islet Yield or Function after Cold Storage in a Vascular Perfusion Model	PLOS ONE			English	Article							ISOLATED PANCREATIC-ISLETS; ISCHEMIC STRESS; TRANSPLANTATION; PRESERVATION; CULTURE; QUALITY; IMPACT	Several studies have reported that pancreatic ductal preservation greatly improved the islet yield and function after cold storage. However, these studies were devoid of appropriate controls, such as vascular perfusion, which is routinely performed to preserve organs in the clinical setting. In this study, we created a vascular perfusion model using inbred rats, and investigated the effect of ductal injection on the islet yield and function after cold storage. Rat pancreases after 10 h cold ischemia were classified as follows: without ductal/vascular perfusion; with ductal injection; with vascular perfusion; and with ductal/vascular perfusion. The islet yield, function, viability, release of inflammatory mediators, and pathological changes in the exocrine tissues were assessed in the Hanks' Balanced Salt Solution (HBSS) model. The islet yield was also assesed by introducing University of Wisconsin Solution (UWS) and Histidine-Tryptophan-Ketoglutarate solution (HTK), which are the standard clinical preservation solutions. In the HBSS model, ductal injection and vascular perfusion significantly improved the islet yield compared with the control group. However, ductal injection showed no additional effects on the islet yield, function, viability and suppressing the release of inflammatory mediators when vascular perfusion was performed. Although ductal injection significantly decreased the apoptosis of exocrine cells, no beneficial effect on vacuolation was observed. In contrast, vascular perfusion significantly suppressed vacuolation in the exocrine tissues. Likewise, in the UWS and HTK model, ductal injection and vascular perfusion improved the islet yield compared with the control group. Nevertheless, the combination group showed no additional effects. These data suggest that ductal injection has no additional effect on islet yield and function after cold storage in a vascular perfusion model. We propose that ductal injection can be an effective and simple alternative for vascular perfusion prior to pancreas harvest, but is not necessary in most cases, since vascular perfusion is routinely performed.	[Nakanishi, Wataru; Sekiguchi, Satoshi; Fujimori, Keisei; Satomi, Susumu; Goto, Masafumi] Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan; [Imura, Takehiro; Inagaki, Akiko; Goto, Masafumi] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan; [Nakamura, Yasuhiro] Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Nakanishi, W (corresponding author), Tohoku Univ, Div Adv Surg Sci & Technol, Sendai, Miyagi 980, Japan.	gotokichi@aol.com	Goto, Masafumi/GPF-7677-2022; Nakamura, Yasuhiro/AAR-7367-2020		Innovation Plaza Miyagi of Japan Science and Technology Agency (JST); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23791479] Funding Source: KAKEN	Innovation Plaza Miyagi of Japan Science and Technology Agency (JST); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Innovation Plaza Miyagi of Japan Science and Technology Agency (JST), the Japanese Grant-in-Aid for Scientific Research (B), the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Takeda Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne K, 1996, PHYSIOLOGIST, V39, P199; Goto M, 2005, TRANSPLANT P, V37, P1315, DOI 10.1016/j.transproceed.2004.11.042; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Goto M, 2010, TRANSPL P, V42, P2040, DOI 10.1016/j.transproceed.2010.05.101; Goto M, 2009, TRANSPL P, V41, P311, DOI 10.1016/j.transproceed.2008.10.075; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Matsumoto S, 2006, TRANSPLANTATION, V82, P460, DOI 10.1097/01.tp.0000231710.37981.64; Matsumoto S, 2010, CELL TRANSPLANT, V19, P291, DOI 10.3727/096368909X481773; Monbaliu D, 2005, TRANSPLANTATION, V79, P1226, DOI 10.1097/01.TP.0000153508.71684.99; Movahedi B, 2004, DIABETOLOGIA, V47, P998, DOI 10.1007/s00125-004-1426-3; Noguchi H, 2008, CELL TRANSPLANT, V17, P69, DOI 10.3727/000000008783907062; Pileggi A, 2009, TRANSPLANTATION, V87, P1442, DOI 10.1097/TP.0b013e3181a36b1e; Saito Y, 2010, CELL TRANSPLANT, V19, P775, DOI 10.3727/096368910X508889; Sawada T, 2003, TRANSPLANTATION, V75, P1965, DOI 10.1097/01.TP.0000068871.09469.E0; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Takita Morihito, 2010, Proc (Bayl Univ Med Cent), V23, P341; Toso C, 2002, TRANSPLANT P, V34, P826, DOI 10.1016/S0041-1345(01)02925-6; Wennberg L, 2001, TRANSPLANTATION, V71, P1024, DOI 10.1097/00007890-200104270-00002	18	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42319	10.1371/journal.pone.0042319	http://dx.doi.org/10.1371/journal.pone.0042319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900012	gold, Green Submitted, Green Published			2022-12-25	WOS:000307380900029
J	Baird, TA; Baird, TD; Shine, R				Baird, Troy A.; Baird, Teresa D.; Shine, Richard			Aggressive Transition between Alternative Male Social Tactics in a Long-Lived Australian Dragon (Physignathus lesueurii) Living at High Density	PLOS ONE			English	Article							MALE COLLARED LIZARDS; AMPHIBOLURUS-MURICATUS; TERRITORY ACQUISITION; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; CROTAPHYTUS-COLLARIS; FIGHTING ABILITY; VISUAL-DISPLAYS; MARINE IGUANAS; JACKY DRAGON	Theory predicts the evolution of alternative male social tactics when intense competition coupled with the superior competitive ability of some individuals limits access to reproductive opportunities by others. How selection has shaped alternative social tactics may be especially interesting in long-lived species where size among sexually mature males varies markedly. We conducted experimental studies on long-lived eastern Australian water dragons living where competition was intense to test the hypotheses that mature males adopt alternative social tactics that are plastic, and that large size and body condition determine resource-holding potential. Approximately one-half of mature males (N = 14) defended territories using high rates of patrol and advertisement display, whereas 16 smaller mature males having lower body condition indices utilized non-territorial social tactics. Although territorial males were larger in absolute size and head dimensions, their heads were not allometrically larger. Territorial males advertised very frequently using displays involving stereotypical movements of the head and dewlap. More aggressive displays were given infrequently during baseline social conditions, but increased during periods of social instability. Female home ranges overlapped those of several territorial and non-territorial males, but females interacted more frequently with territorial males. The extreme plasticity of social tactics in this species that are dependent on body size was confirmed by two instances when relatively large non-territorial males spontaneously evicted territory owners, and by marked shifts in tactics by non-territorial males in response to temporary experimental removals of territory owners, followed (usually) by their expulsion when original owners were reinstated. The high level of social plasticity in this population where same-sex competitors are densely concentrated in preferred habitat suggests that chronic high energetic costs of defense may select for males to cycle between territorial and non-territorial social tactics depending upon their changing energetic status and their current capacity for competition with rivals.	[Baird, Troy A.; Baird, Teresa D.] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Central Oklahoma; University of Sydney	Baird, TA (corresponding author), Univ Cent Oklahoma, Dept Biol, Edmond, OK USA.	tbaird@uco.edu			Australian Research Council Grant [FF056365]	Australian Research Council Grant(Australian Research Council)	Australian Research Council Grant FF056365 to Richard Shine. The funders had no role in sudy design, data collection and analysis, descision to publish, or preparation of the manuscript.	Alonzo SH, 2004, BEHAV ECOL, V15, P278, DOI 10.1093/beheco/arh007; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDERSON RA, 1990, OECOLOGIA, V84, P145, DOI 10.1007/BF00318265; Anibaldi C, 1998, AFR J ECOL, V36, P199, DOI 10.1046/j.1365-2028.1998.00119.x; Aragon P, 2004, ETHOLOGY, V110, P1001, DOI 10.1111/j.1439-0310.2004.01046.x; ARCESE P, 1989, ANIM BEHAV, V37, P45, DOI 10.1016/0003-3472(89)90005-5; Baird TA, 2003, LIZARD SOCIAL BEHAVIOR, P7; Baird TA, 2008, BEHAV ECOL, V19, P589, DOI 10.1093/beheco/arn014; Baird TA, 2007, BEHAV ECOL, V18, P1146, DOI 10.1093/beheco/arm092; Baird TA, 2010, BEHAV ECOL, V21, P753, DOI 10.1093/beheco/arq049; BAUGH JR, 1994, BEHAVIOUR, V131, P207, DOI 10.1163/156853994X00442; BERRY K H, 1974, University of California Publications in Zoology, V101, P1; Buston PM, 2004, P ROY SOC B-BIOL SCI, V271, pS252, DOI 10.1098/rsbl.2003.0156; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; CARPENTER CC, 1970, COPEIA, P497; CENSKY EJ, 1995, BEHAVIOUR, V132, P529, DOI 10.1163/156853995X00199; COGGER HG, 1978, AUST J ZOOL, V26, P653, DOI 10.1071/ZO9780653; COURTICE GP, 1981, COMP BIOCHEM PHYS A, V68, P429, DOI 10.1016/0300-9629(81)90072-4; Cuervo JJ, 2007, J ZOOL, V273, P298, DOI 10.1111/j.1469-7998.2007.00328.x; Earley RL, 2002, AMPHIBIA-REPTILIA, V23, P469, DOI 10.1163/15685380260462374; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOX SF, 1992, ANIM BEHAV, V44, P780, DOI 10.1016/S0003-3472(05)80306-9; Fretwell SD, 1985, ACTA BIOTHEOR, V19, P16; Gier PJ, 2003, LIZARD SOCIAL BEHAVIOR, P278; Hacklander K, 1999, BEHAV ECOL, V10, P592, DOI 10.1093/beheco/10.5.592; Harlow PS, 2001, THESIS MACQUARIE U; Heideman Neil J.L., 1993, Journal of the Herpetological Association of Africa, V42, P28; Hews DK, 2003, LIZARD SOCIAL BEHAVIOR, P253; Hews DK, 1997, BEHAV ECOL SOCIOBIOL, V41, P371, DOI 10.1007/s002650050398; Husak JF, 2003, ANIM BEHAV, V65, P391, DOI 10.1006/anbe.2003.2058; Hussein H.K., 2000, PAKISTAN J BIOL SCI, V3, P1700; Jenssen TA, 2005, ANIM BEHAV, V69, P1325, DOI 10.1016/j.anbehav.2004.07.023; Karsten KB, 2009, BEHAV ECOL, V20, P1079, DOI 10.1093/beheco/arp100; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; Lebas NR, 2001, MOL ECOL, V10, P193, DOI 10.1046/j.1365-294X.2001.01174.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; MILES DB, 1994, LIZARD ECOLOGY, P207; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; ONEILL KM, 1983, BEHAVIOUR, V86, P295, DOI 10.1163/156853983X00408; Ord TJ, 2003, BEHAVIOUR, V140, P1495, DOI 10.1163/156853903771980684; Pal Arttatrana, 2011, Taprobanica, V3, P31; Partecke J, 2002, BEHAV ECOL SOCIOBIOL, V51, P579, DOI 10.1007/s00265-002-0469-z; Paruk JD, 1999, WILSON BULL, V111, P116; Peters RA, 2003, AUSTRAL ECOL, V28, P499, DOI 10.1046/j.1442-9993.2003.01306.x; PICMAN J, 1987, AUK, V104, P405, DOI 10.2307/4087537; Piper WH, 2000, ANIM BEHAV, V59, P385, DOI 10.1006/anbe.1999.1295; PRATT NC, 1994, ANIM BEHAV, V47, P1101, DOI 10.1006/anbe.1994.1148; Radder RS, 2006, J ETHOL, V24, P275, DOI 10.1007/s10164-006-0192-8; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Schwartz AM, 2007, ETHOLOGY, V113, P9, DOI 10.1111/j.1439-0310.2006.01297.x; SHINE R, 1990, BIOL J LINN SOC, V40, P11, DOI 10.1111/j.1095-8312.1990.tb00531.x; SHUSTER SM, 1989, EVOLUTION, V43, P1683, DOI 10.1111/j.1558-5646.1989.tb02618.x; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH SM, 1978, AM NAT, V112, P571, DOI 10.1086/283298; Stone PA, 2002, J HERPETOL, V36, P427, DOI 10.1670/0022-1511(2002)036[0427:ELHRTR]2.0.CO;2; Stuart-Fox D, 2006, P ROY SOC B-BIOL SCI, V273, P1555, DOI 10.1098/rspb.2006.3468; Stuart-Fox DM, 2005, BEHAVIOUR, V142, P329, DOI 10.1163/1568539053778265; STUTCHBURY BJ, 1991, ANIM BEHAV, V42, P435, DOI 10.1016/S0003-3472(05)80042-9; Switzer PV, 2002, ANN ENTOMOL SOC AM, V95, P628, DOI 10.1603/0013-8746(2002)095[0628:IVITDO]2.0.CO;2; THOMPSON MB, 1993, WILDLIFE RES, V20, P613, DOI 10.1071/WR9930613; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; Turner F. B., 1971, Herpetological Review, V3, P77; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; VITT LJ, 1985, CAN J ZOOL, V63, P995, DOI 10.1139/z85-148; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; Watkins GG, 1996, ECOLOGY, V77, P1473, DOI 10.2307/2265544; Watt MJ, 2003, BRAIN BEHAV EVOLUT, V61, P172, DOI 10.1159/000070701; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47; Wikelski M, 2005, BEHAV ECOL, V16, P260, DOI 10.1093/beheco/arh160; ZACK S, 1992, BEHAVIOUR, V123, P194, DOI 10.1163/156853992X00020; Zamudio KR, 2003, LIZARD SOCIAL BEHAVIOR, P83	72	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41819	10.1371/journal.pone.0041819	http://dx.doi.org/10.1371/journal.pone.0041819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905109	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100019
J	Taranto, GH; Kvile, KO; Pitcher, TJ; Morato, T				Taranto, Gerald H.; Kvile, Kristina O.; Pitcher, Tony J.; Morato, Telmo			An Ecosystem Evaluation Framework for Global Seamount Conservation and Management	PLOS ONE			English	Article							SPECIES RICHNESS; DEEP; ENDEMISM; PATTERNS; CORALS; AREAS; FAUNA; VULNERABILITY; BIODIVERSITY; BIOGEOGRAPHY	In the last twenty years, several global targets for protection of marine biodiversity have been adopted but have failed. The Convention on Biological Diversity (CBD) aims at preserving 10% of all the marine biomes by 2020. For achieving this goal, ecologically or biologically significant areas (EBSA) have to be identified in all biogeographic regions. However, the methodologies for identifying the best suitable areas are still to be agreed. Here, we propose a framework for applying the CBD criteria to locate potential ecologically or biologically significant seamount areas based on the best information currently available. The framework combines the likelihood of a seamount constituting an EBSA and its level of human impact and can be used at global, regional and local scales. This methodology allows the classification of individual seamounts into four major portfolio conservation categories which can help optimize management efforts toward the protection of the most suitable areas. The framework was tested against 1000 dummy seamounts and satisfactorily assigned seamounts to proper EBSA and threats categories. Additionally, the framework was applied to eight case study seamounts that were included in three out of four portfolio categories: areas highly likely to be identified as EBSA with high degree of threat; areas highly likely to be EBSA with low degree of threat; and areas with a low likelihood of being EBSA with high degree of threat. This framework will allow managers to identify seamount EBSAs and to prioritize their policies in terms of protecting undisturbed areas, disturbed areas for recovery of habitats and species, or both based on their management objectives. It also identifies seamount EBSAs and threats considering different ecological groups in both pelagic and benthic communities. Therefore, this framework may represent an important tool to mitigate seamount biodiversity loss and to achieve the 2020 CBD goals.	[Taranto, Gerald H.; Kvile, Kristina O.; Morato, Telmo] Univ Acores, Dept Oceanografia & Pescas, IMAR, LARSYS, Horta, Portugal; [Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Universidade dos Acores; University of British Columbia	Taranto, GH (corresponding author), Univ Acores, Dept Oceanografia & Pescas, IMAR, LARSYS, Horta, Portugal.	telmo@uac.pt	Morato, Telmo/A-4548-2009; Kvile, Kristina/AAO-6084-2020	Morato, Telmo/0000-0003-2393-4773; Kvile, Kristina/0000-0003-2771-9077; Taranto, Gerald Hechter/0000-0002-7968-1982	European Community Seventh Framework Programme (FP7) under the CoralFISH project [213144]; Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology; POPH; QREN; European Social Fund; Portuguese Ministry for Science and Education; Natural Science and Engineering Research Council of Canada; HERMIONE project [226354]	European Community Seventh Framework Programme (FP7) under the CoralFISH project; Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology; POPH; QREN; European Social Fund(European Social Fund (ESF)); Portuguese Ministry for Science and Education(Portuguese Foundation for Science and Technology); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); HERMIONE project	This research has received funding from the European Community Seventh Framework Programme (FP7/2007-2013) under the CoralFISH project, grant agreement no 213144 and HERMIONE project, grant agreement no 226354. Additional funding was received from the Marine Conservation Institute through the Mia J. Tegner Memorial Research Grant Program in Marine Environmental History and Historical Marine Ecology. TM was funded by POPH, QREN, European Social Fund and the Portuguese Ministry for Science and Education. TJP was funded in part by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Ardron J, 2009, DEFINING ECOLOGICALL; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Auster PJ, 1998, AM FISH S S, V22, P150; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Baker KD, 2009, ENVIRON BIOL FISH, V85, P79, DOI 10.1007/s10641-009-9465-8; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; CBD, 2009, AZ SCI CRIT GUID ID; Charles A, 2009, ICES J MAR SCI, V66, P6, DOI 10.1093/icesjms/fsn182; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Collie JS, 2000, J ANIM ECOL, V69, P785, DOI 10.1046/j.1365-2656.2000.00434.x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Dunn DC, 2011, ECOLOGICALLY BIOL SI; Etnoyer PJ, 2010, OCEANOGRAPHY, V23, P206, DOI 10.5670/oceanog.2010.96; Ferreira Rogerio L., 2001, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V18A, P75; Food and Agriculture Organization, 2009, INT GUID MAN DEEP SE; Freese JL, 2001, MAR FISH REV, V63, P38; Freiwald A., 2004, COLD WATER CORAL REE, V22; Fuller S., 2008, WE FISH MATTERS ADDR; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Gilman E, 2011, BIODIVERS CONSERV, V20, P3363, DOI 10.1007/s10531-011-0116-y; Grantham HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016552; Gregr EJ, 2012, MAR POLICY, V36, P716, DOI 10.1016/j.marpol.2011.10.009; Halfar J, 2007, SCIENCE, V316, P987, DOI 10.1126/science.1138289; HALLSPENCER J, 2007, BULLMARSCI, P135; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Haury L, 2000, PROG OCEANOGR, V45, P69, DOI 10.1016/S0079-6611(99)00051-8; He GW, 2011, ACTA OCEANOL SIN, V30, P63, DOI 10.1007/s13131-011-0120-9; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hogg MM, 2010, DEEP SEA SPONGE GROU; ICES, 2008, REP ICES NAFO JOINT; Ince R, 2007, ESTUAR COAST SHELF S, V74, P77, DOI 10.1016/j.ecss.2007.03.029; IUCN, 2019, IUCN RED LIST THREAT; IUCN World Commission on Protected Areas, 2008, EST RES MAR PROT AR; Kaplan DM, 2010, TRENDS ECOL EVOL, V25, P62, DOI 10.1016/j.tree.2009.09.003; Kaschner Kristin, 2007, Fish and Aquatic Resources Series, V12, P230; Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832; Kim SS, 2011, GEOPHYS J INT, V186, P615, DOI 10.1111/j.1365-246X.2011.05076.x; KLIMLEY AP, 1984, BEHAV ECOL SOCIOBIOL, V15, P45, DOI 10.1007/BF00310214; KLITGAARD AB, 1995, SARSIA, V80, P1; Koslow JA, 1996, J FISH BIOL, V49, P54, DOI 10.1111/j.1095-8649.1996.tb06067.x; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; Kvile KO, 2011, SEAMOUNT ECOSYSTEM E; Litvinov Feodor, 2007, Fish and Aquatic Resources Series, V12, P202; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques da Silva Helder, 2007, Fish and Aquatic Resources Series, V12, P335; Maxwell SM, 2011, MARINE MAMM IN PRESS; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; McDonald MA, 2009, J ACOUST SOC AM, V125, P624, DOI 10.1121/1.3050317; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014453; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Morato T, 2009, DEEP-SEA RES PT II, V56, P2713, DOI 10.1016/j.dsr2.2008.12.029; Norse EA, 2006, MPA NEWS, V7, P4; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; OSPAR, 2008, 20086 OSPAR; Pitcher Tony J., 2007, Fish and Aquatic Resources Series, V12, P282; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P123, DOI 10.5670/oceanog.2010.90; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Roberts CM, 2003, ECOL APPL, V13, pS199; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; Rogers A.D., 2008, SCI GUIDELINES SCI G; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Rowden AA, 2010, MAR ECOL S, V31, P1226; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Santos Marco A., 2007, Fish and Aquatic Resources Series, V12, P239; Santos RS, 2009, DEEP-SEA RES PT II, V56, P2720, DOI 10.1016/j.dsr2.2008.12.031; Sautya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016162; Sedberry GR, 2001, MAR BIOL, V139, P355; Silva MA, 2011, AQUAT CONSERV, V21, P17, DOI 10.1002/aqc.1158; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Thomaz Sidinei Magela, 2010, Acta Limnol. Bras., V22, P218, DOI 10.4322/actalb.02202011; Thompson David R., 2007, Fish and Aquatic Resources Series, V12, P245; Toropova C., 2010, GLOBAL OCEAN PROTECT; UNESCO, 2009, IOC TECHN SER, V84; Van den Hove S, 2007, ECOSYSTEMS BIODIVERS; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Young JW, 2011, DEEP-SEA RES PT II, V58, P720, DOI 10.1016/j.dsr2.2010.10.005; Zezina ON, 1997, ADV MAR BIOL, V32, P389	114	29	30	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42950	10.1371/journal.pone.0042950	http://dx.doi.org/10.1371/journal.pone.0042950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905190	gold, Green Submitted, Green Published			2022-12-25	WOS:000307331100077
J	Huang, SS; Huang, PH; Wu, TC; Chen, JW; Lin, SJ				Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Association of Serum Bilirubin with Contrast-Induced Nephropathy and Future Cardiovascular Events in Patients Undergoing Coronary Intervention	PLOS ONE			English	Article							ALBUMIN-BOUND BILIRUBIN; LOW-DENSITY-LIPOPROTEIN; CHRONIC-RENAL-FAILURE; ACUTE KIDNEY INJURY; CLINICAL-OUTCOMES; RISK-FACTORS; ANTIOXIDANT; PLASMA; INSUFFICIENCY; MEDIA	Objectives: Enhanced reactive oxygen species formation within the kidney following the administration of contrast media may play a key role in the development of contrast-induced nephropathy (CIN). Bilirubin has emerged as an important endogenous antioxidant molecule. This study was undertaken to determine whether bilirubin is associated with CIN and future cardiovascular events in patients undergoing coronary intervention. Methods: Totally, 544 consecutive patients received coronary intervention were enrolled. All patients were followed up for at least 3 years or until the occurrence of a major event. The primary endpoint was CIN, defined as a rise in serum creatinine (SCr) of 0.5 mg/dl or a 25% increase from the baseline value within 48 hours after the procedure. The secondary endpoint was the combined occurrence of major adverse cardiovascular events (MACE), including death, nonfatal myocardial infarction, and ischemic stroke. Results: Overall, CIN occurred in 85 (15.6%) patients. All patients were stratified into 3 groups (low/normal/high) according to the serum bilirubin levels. In a multivariate logistic analysis, the odds ratio for CIN with low-bilirubin levels relative to high-bilirubin levels was 11.82 (95% CI, 3.25-43.03). By Cox regression analysis, serum bilirubin levels was an independent predictor of MACE in patients undergoing coronary intervention (low vs. high hazard ratio 2.26; 95% CI, 1.05-4.90). Conclusions: CIN is a serious complication of coronary intervention. Higher serum bilirubin concentrations were associated with lower risk of CIN and fewer cardiovascular events. The development of interventions that promote bilirubin levels may be a potential target to reduce CIN and future MACE in patients undergoing coronary intervention.	[Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Shao-Sung; Huang, Po-Hsun; Wu, Tao-Cheng; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Po-Hsun; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, SS (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw						Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; BREZIS M, 1989, NEW ENGL J MED, V320, P179, DOI 10.1056/NEJM198901193200309; Cox CD, 2004, J CLIN PHARMACOL, V44, P327, DOI 10.1177/0091270004263466; Cracowski JL, 2001, J VASC RES, V38, P93, DOI 10.1159/000051036; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Fiaccadori E, 2004, NEPHROL DIAL TRANSPL, V19, P865, DOI 10.1093/ndt/gfh039; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Goodman AI, 2007, KIDNEY INT, V72, P945, DOI 10.1038/sj.ki.5002447; Huang SS, 2010, HEART, V96, P1227, DOI 10.1136/hrt.2009.192393; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Martin-Mateo MC, 1999, RENAL FAILURE, V21, P155, DOI 10.3109/08860229909066980; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mimic-Oka J, 1999, CLIN NEPHROL, V51, P233; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Myers SI, 2006, J VASC SURG, V44, P383, DOI 10.1016/j.jvs.2006.04.036; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Yamaguchi T, 1996, BIOCHEM BIOPH RES CO, V223, P129, DOI 10.1006/bbrc.1996.0857; Yoshimura S, 1996, NEPHRON, V73, P207; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	32	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42594	10.1371/journal.pone.0042594	http://dx.doi.org/10.1371/journal.pone.0042594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880046	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000050
J	Kigozi, R; Baxi, SM; Gasasira, A; Sserwanga, A; Kakeeto, S; Nasr, S; Rubahika, D; Dissanayake, G; Kamya, MR; Filler, S; Dorsey, G				Kigozi, Ruth; Baxi, Sanjiv M.; Gasasira, Anne; Sserwanga, Asadu; Kakeeto, Stella; Nasr, Sussann; Rubahika, Denis; Dissanayake, Gunawardena; Kamya, Moses R.; Filler, Scott; Dorsey, Grant			Indoor Residual Spraying of Insecticide and Malaria Morbidity in a High Transmission Intensity Area of Uganda	PLOS ONE			English	Article							TOME-AND-PRINCIPE; ANOPHELES-GAMBIAE; TREATED NETS; RESISTANCE; MOZAMBIQUE; AFRICA; BENIN	Background: Recently the use of indoor residual spraying of insecticide (IRS) has greatly increased in Africa; however, limited data exist on the quantitative impacts of IRS on health outcomes in highly malaria endemic areas. Methodology/Principal Findings: Routine data were collected on more than 90,000 patient visits at a single health facility over a 56 month period covering five rounds of IRS using three different insecticides. Temporal associations between the timing of IRS and the probability of a patient referred for microscopy having laboratory confirmed malaria were estimated controlling for seasonality and age. Considering patients less than five years of age there was a modest decrease in the odds of malaria following the 1st round of IRS using DDT (OR = 0.76, p<0.001) and the 2nd round using alpha-cypermethrin (OR = 0.83, p = 0.002). Following rounds 3-5 using bendiocarb there was a much greater decrease in the odds of malaria (ORs 0.34, 0.16, 0.17 respectively, p<0.001 for all comparisons). Overall, the impact of IRS was less pronounced among patients 5 years or older. Conclusions/Significance: IRS was associated with a reduction in malaria morbidity in an area of high transmission intensity in Uganda and the benefits appeared to be greatest after switching to a carbamate class of insecticide.	[Kigozi, Ruth; Gasasira, Anne; Sserwanga, Asadu; Kakeeto, Stella] Uganda Malaria Surveillance Project, Kampala, Uganda; [Baxi, Sanjiv M.; Dorsey, Grant] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Nasr, Sussann; Filler, Scott] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Rubahika, Denis] Uganda Minist Hlth, Kampala, Uganda; [Dissanayake, Gunawardena] Presidents Malaria Initiat, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; Makerere University	Kigozi, R (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	gdorsey@medsfgh.ucsf.edu			U.S. President's Malaria Initiative; Centers for Disease Control and Prevention [1U51CK000117]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	U.S. President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. President's Malaria Initiative through a cooperative agreement with the Centers for Disease Control and Prevention (1U51CK000117) and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (U19AI089674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; [Anonymous], 2008, GLOB MAL ACT PLAN; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hunt RH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-107; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Kouznetsov R L, 1977, Trop Doct, V7, P81; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mnzava AEP, 2001, SAMJ S AFR MED J, V91, P978; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Sharp B, 2002, TROP MED INT HEALTH, V7, P732, DOI 10.1046/j.1365-3156.2002.00928.x; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; Tseng LF, 2008, AM J TROP MED HYG, V78, P248, DOI 10.4269/ajtmh.2008.78.248; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, US IND RES SPRAYING; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yeka A, 2012, ACTA TROP, V342, pd1617	28	62	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42857	10.1371/journal.pone.0042857	http://dx.doi.org/10.1371/journal.pone.0042857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880123	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000078
J	Kim, JH; Oh, MY; Paek, J; Lee, J				Kim, Jee Hwan; Oh, Min Young; Paek, Janghyun; Lee, Jaehoon			Association between FGFR1OP2/wit3.0 Polymorphisms and Residual Ridge Resorption of Mandible in Korean Population	PLOS ONE			English	Article							COMPLETE DENTURES; TOOTH EXTRACTION; ORAL-MUCOSA; COLLAGEN	Background: A previous study on the genetic association between single nucleotide polymorphisms in FGFR1OP2/wit3.0 and the long term atrophy of edentulous mandible hypothesized that the excessive jawbone atrophy after dental extraction may be associated with abnormal oral mucosa contraction induced by the FGFR1OP2/wit 3.0 gene. It was reported that the minor allele of rs840869 or rs859024 in FGFR1OP2/wit3.0 was associated with the excessive atrophy of edentulous mandible. The present study represents an attempt to replicate the results of this previous study and to examine the genetic association between polymorphisms in FGFR1OP2 and residual ridge resorption of mandible in a Korean population. Methodology/Principal Findings: 134 subjects (70.46 +/- 9.02 years) with partially or completely edentulous mandible were recruited. The mandibular bone height was measured following the protocol of the American College of Prosthodontists (ACP). From 24 subjects, seven variants in FGFR1OP2 were discovered and four of them were novel. Selected SNPs that are not in high LD at r2 threshold of 0.8 were genotyped for the remaining population. There was no frequency of the minor allele of SNP rs859024 in Korean population. SNP rs840869 was not associated with residual ridge resorption (p = 0.479). The bone height of the subject with the ss518063493 minor allele (8.52 mm) was shorter than that of those subjects with major alleles (18.96 +/- 5.33 mm, p = 0.053). Conclusions/Significance: The patient with minor allele of ss518063493 may be associated with excessive atrophy of edentulous mandible whereas the patients with that of rs840869 are not associated in Korean population. The result from this study may assist in developing a novel genetic diagnostic test and be useful in identifying Koreans susceptible to developing excessive jawbone atrophy after dental extraction.	[Kim, Jee Hwan; Oh, Min Young; Lee, Jaehoon] Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea; [Paek, Janghyun] Kyung Hee Univ, Dent Hosp, Dept Prosthodont, Seoul, South Korea	Yonsei University; Yonsei University Health System; Kyung Hee University	Kim, JH (corresponding author), Yonsei Univ, Coll Dent, Dept Prosthodont, Seoul 120749, South Korea.	jaehoon115@yuhs.ac	Kim, Jeehwan/R-7536-2019	Kim, Jeehwan/0000-0002-0872-4906; Lee, Jae Hoon/0000-0003-2281-8885	Yonsei University College of Dentistry [6-2010-0170]	Yonsei University College of Dentistry	This work was supported by intramural grants from Yonsei University College of Dentistry (Project No. 6-2010-0170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2008, INT J PERIODONT REST, V28, P123; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; ATWOOD DA, 1979, J PERIODONTOL, P11, DOI 10.1902/jop.1979.50.4s.11; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x; Carlsson G E, 1969, Sven Tandlak Tidskr, V62, P125; CECCONI BT, 1971, J PROSTHET DENT, V25, P44, DOI 10.1016/0022-3913(71)90148-X; JACOBSON TE, 1983, J PROSTHET DENT, V49, P5, DOI 10.1016/0022-3913(83)90228-7; JACOBSON TE, 1983, J PROSTHET DENT, V49, P165, DOI 10.1016/0022-3913(83)90494-8; JACOBSON TE, 1983, J PROSTHET DENT, V49, P306, DOI 10.1016/0022-3913(83)90267-6; Jahangiri L, 1998, J PROSTHET DENT, V80, P224, DOI 10.1016/S0022-3913(98)70116-7; Kalk W, 1993, Int Dent J, V43, P483; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1; SCHROEDER HE, 1986, CELL TISSUE RES, V243, P661; Simpson H E, 1969, Br Dent J, V126, P550; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Sukotjo C, 2002, J DENT RES, V81, P229, DOI 10.1177/154405910208100402; Suwanwela J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016204; Tallgren A, 2003, J PROSTHET DENT, V89, P427, DOI 10.1016/S0022-3913(03)00158-6; TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6; TURCK D, 1965, J PROSTHET DENT, V15, P419, DOI 10.1016/S0022-3913(65)80010-5; WATSON IB, 1982, J PROSTHET DENT, V47, P133, DOI 10.1016/0022-3913(82)90176-7	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42734	10.1371/journal.pone.0042734	http://dx.doi.org/10.1371/journal.pone.0042734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880093	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000064
J	Burgess, STG; Greer, A; Frew, D; Wells, B; Marr, EJ; Nisbet, AJ; Huntley, JF				Burgess, Stewart T. G.; Greer, Andrew; Frew, David; Wells, Beth; Marr, Edward J.; Nisbet, Alasdair J.; Huntley, John F.			Transcriptomic Analysis of Circulating Leukocytes Reveals Novel Aspects of the Host Systemic Inflammatory Response to Sheep Scab Mites	PLOS ONE			English	Article							ENDOTHELIAL CELL RECOGNITION; GENE-EXPRESSION PROFILES; PSOROPTES-OVIS; LYMPHOCYTE RECIRCULATION; COMPLEMENT-SYSTEM; TRAFFIC SIGNALS; INNATE IMMUNITY; S100 PROTEINS; DISEASE; BLOOD	Infestation of ovine skin with the ectoparasitic mite Psoroptes ovis results in the development of a rapid cutaneous inflammatory response, leading to the crusted skin lesions characteristic of sheep scab. To facilitate the identification of novel diagnostic and therapeutic targets, a better understanding of the host-parasite relationship in sheep scab is essential. Although our knowledge of the host's local cutaneous inflammatory response to sheep scab has increased in recent years, we still know relatively little about the mechanisms of this response at the systemic level. This study used a combined network and pathway analysis of the in vivo transcriptomic response of circulating leukocytes to infestation with P. ovis, during a 6 week period. Network graph analysis identified six temporally-associated gene clusters, which separated into two distinct sub-networks within the graph, representing those genes either up or down-regulated during the time course. Functional and pathway analysis of these clusters identified novel insights into the host systemic response to P. ovis infestation, including roles for the complement system, clotting cascade and fibrinolysis. These analyses also highlighted potential mechanisms by which the systemic immune response to sheep scab can influence local tissue responses via enhanced leukocyte activation and extravasation. By analysing the transcriptomic responses of circulating leukocytes in sheep following infestation with P. ovis, this study has provided key insights into the inflammatory response to infestation and has also demonstrated the utility of these cells as a proxy of events occurring at local tissue sites, providing insight into the mechanisms by which a local allergen-induced inflammatory response may be controlled.	[Burgess, Stewart T. G.; Frew, David; Wells, Beth; Marr, Edward J.; Nisbet, Alasdair J.; Huntley, John F.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Greer, Andrew] Lincoln Univ, Fac Agr & Life Sci, Canterbury, New Zealand	Moredun Research Institute; Lincoln University - New Zealand	Burgess, STG (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Edinburgh EH17 7JH, Midlothian, Scotland.	stewart.burgess@moredun.ac.uk	Greer, Andrew W/S-5846-2018	Greer, Andrew W/0000-0002-1479-3297; Nisbet, Alasdair/0000-0002-4965-5396; burgess, stewart/0000-0002-9268-7641	Department for Environment, Food and Rural Affairs, United Kingdom [OD0553]; Scottish Government's Rural and Environment Science and Analytical Services Division	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government's Rural and Environment Science and Analytical Services Division	This study was funded by the Department for Environment, Food and Rural Affairs, United Kingdom under project OD0553 and also supported by The Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Burgess STG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-624; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; COCHRANE CG, 1982, ADV IMMUNOL, V33, P241, DOI 10.1016/S0065-2776(08)60837-8; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Guyer DA, 1996, BLOOD, V88, P2415, DOI 10.1182/blood.V88.7.2415.bloodjournal8872415; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ji SQ, 1998, ANIM BIOTECHNOL, V9, P1, DOI 10.1080/10495399809525887; Kenyon F, 2002, VET PARASITOL, V105, P317, DOI 10.1016/S0304-4017(02)00015-8; Kijas JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/j.1365-2052.2005.01399.x; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; KIRKWOOD AC, 1986, PARASITOL TODAY, V2, P302, DOI 10.1016/0169-4758(86)90124-9; Kitayama J, 1998, J CLIN INVEST, V101, P2017, DOI 10.1172/JCI2688; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu WG, 2006, VET IMMUNOL IMMUNOP, V110, P11, DOI 10.1016/j.vetimm.2005.08.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; MARUO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P62, DOI 10.1016/0304-4165(91)90040-N; MARUO K, 1993, J BIOL CHEM, V268, P17711; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nisbet AJ, 2006, PARASITE IMMUNOL, V28, P165, DOI 10.1111/j.1365-3024.2006.00803.x; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROTH J, 1992, INT ARCH ALLERGY IMM, V98, P140, DOI 10.1159/000236177; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Samitas K, 2011, EUR RESPIR J, V37, P331, DOI 10.1183/09031936.00017810; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SEOW HF, 1994, IMMUNOL CELL BIOL, V72, P398, DOI 10.1038/icb.1994.59; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; STETLER G, 1986, NUCLEIC ACIDS RES, V14, P7883, DOI 10.1093/nar/14.20.7883; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; van den Broek AH, 2003, J COMP PATHOL, V128, P79, DOI 10.1053/jcpa.2002.0627; van den Broek AHM, 2004, J COMP PATHOL, V131, P318, DOI 10.1016/j.jcpa.2004.05.005; van den Broek AHM, 2000, PARASITE IMMUNOL, V22, P407, DOI 10.1046/j.1365-3024.2000.00318.x; VanDongen S., 2000, THESIS U UTRECHT UTR, P169; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu K., 2007, GLOBIN REDUCTION PRO; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	64	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42778	10.1371/journal.pone.0042778	http://dx.doi.org/10.1371/journal.pone.0042778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880105	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100169
J	Chaimowitz, NS; Kang, DJ; Dean, LM; Conrad, DH				Chaimowitz, Natalia S.; Kang, Dae-Joong; Dean, Lee M.; Conrad, Daniel H.			ADAM10 Regulates Transcription Factor Expression Required for Plasma Cell Function	PLOS ONE			English	Article							GERMINAL CENTER RESPONSE; MEMORY B-CELLS; DIFFERENTIATION; BLIMP-1; NOTCH; BCL6; MICE; CD40; INFLAMMATION; ACTIVATION	A disintegrin and metalloprotease 10 (ADAM10) is a key regulator of cellular processes by shedding extracellular domains of transmembrane proteins. We have previously demonstrated that deletion of B cell expressed ADAM10 results in changes in lymphoid tissue architecture and impaired germinal center (GC) formation. In this study, mice were generated in which ADAM10 is deleted in B cells following class switch recombination (ADAM10(Delta/Delta) IgG1-cre(+/-) mice). Despite normal GC formation, antibody responses were impaired in ADAM10(Delta/Delta)IgG1-cre(+/-) mice, implicating ADAM10 in post-GC and extrafollicular B cell terminal differentiation. Surprisingly, plasma cell (PC) numbers were normal in ADAM10(Delta/Delta) IgG1-cre(+/-) mice when compared to controls. However, PCs isolated from ADAM10(Delta/Delta)IgG1-cre(+/-) mice exhibited decreased expression of transcription factors important for PC function: Prdm1, Xbp1 and Irf4. Bcl6 is a GC transcriptional repressor that inhibits the PC transcriptional program and thus must be downregulated for PC differentiation to occur. Bcl6 expression was increased in PCs isolated from ADAM10(Delta/Delta) IgG1-cre(+/-) mice at both the mRNA and protein level. These results demonstrate that ADAM10 is required for proper transcription factor expression in PCs and thus, for normal PC function.	[Chaimowitz, Natalia S.; Kang, Dae-Joong; Dean, Lee M.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Chaimowitz, NS (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA.	dconrad@vcu.edu			National Heart Lung Blood Institute (NHLBI); National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH)	National Heart Lung Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH)	This work was funded by the National Heart Lung Blood Institute (NHLBI) and the National Institute of Allergy and Infections disease (NIAID) of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Alinikula J, 2011, EUR J IMMUNOL, V41, P2404, DOI 10.1002/eji.201141553; Arima T, 2007, CANCER SCI, V98, P1720, DOI 10.1111/j.1349-7006.2007.00601.x; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Casola S, 2006, P NATL ACAD SCI USA, V103, P7396, DOI 10.1073/pnas.0602353103; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Caven TH, 2005, CELL IMMUNOL, V238, P123, DOI 10.1016/j.cellimm.2006.03.001; Chaimowitz NS, 2011, J IMMUNOL, DOI [10.4049/jimmu-nol.1102172, DOI 10.4049/JIMMU-NOL.1102172]; Cozine CL, 2005, CURR OPIN IMMUNOL, V17, P298, DOI 10.1016/j.coi.2005.04.007; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Gibb DR, 2011, MOL IMMUNOL, V48, P1319, DOI 10.1016/j.molimm.2010.12.005; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Hampel F, 2011, BLOOD, V118, P6321, DOI 10.1182/blood-2010-12-325944; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sakurai N, 2011, J CLIN INVEST, V121, P2583, DOI 10.1172/JCI45682; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Soro PG, 1999, J IMMUNOL, V163, P611; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas M, 2007, BLOOD, V109, P3342, DOI 10.1182/blood-2006-09-046698; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Tsuyama N, 2005, BIOCHEM BIOPH RES CO, V337, P201, DOI 10.1016/j.bbrc.2005.09.036; Vu F, 2008, J IMMUNOL, V180, P2284, DOI 10.4049/jimmunol.180.4.2284; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42694	10.1371/journal.pone.0042694	http://dx.doi.org/10.1371/journal.pone.0042694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880085	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100159
J	Pirotta, E; Milor, R; Quick, N; Moretti, D; Di Marzio, N; Tyack, P; Boyd, I; Hastie, G				Pirotta, Enrico; Milor, Rachael; Quick, Nicola; Moretti, David; Di Marzio, Nancy; Tyack, Peter; Boyd, Ian; Hastie, Gordon			Vessel Noise Affects Beaked Whale Behavior: Results of a Dedicated Acoustic Response Study	PLOS ONE			English	Article							LONG	Some beaked whale species are susceptible to the detrimental effects of anthropogenic noise. Most studies have concentrated on the effects of military sonar, but other forms of acoustic disturbance (e. g. shipping noise) may disrupt behavior. An experiment involving the exposure of target whale groups to intense vessel-generated noise tested how these exposures influenced the foraging behavior of Blainville's beaked whales (Mesoplodon densirostris) in the Tongue of the Ocean (Bahamas). A military array of bottom-mounted hydrophones was used to measure the response based upon changes in the spatial and temporal pattern of vocalizations. The archived acoustic data were used to compute metrics of the echolocation-based foraging behavior for 16 targeted groups, 10 groups further away on the range, and 26 non-exposed groups. The duration of foraging bouts was not significantly affected by the exposure. Changes in the hydrophone over which the group was most frequently detected occurred as the animals moved around within a foraging bout, and their number was significantly less the closer the whales were to the sound source. Non-exposed groups also had significantly more changes in the primary hydrophone than exposed groups irrespective of distance. Our results suggested that broadband ship noise caused a significant change in beaked whale behavior up to at least 5.2 kilometers away from the vessel. The observed change could potentially correspond to a restriction in the movement of groups, a period of more directional travel, a reduction in the number of individuals clicking within the group, or a response to changes in prey movement.	[Pirotta, Enrico; Quick, Nicola; Hastie, Gordon] SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland; [Pirotta, Enrico; Boyd, Ian] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Milor, Rachael] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Quick, Nicola; Hastie, Gordon] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland; [Moretti, David; Di Marzio, Nancy] USN, Undersea Warfare Ctr Div, Newport, RI USA; [Tyack, Peter] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of St Andrews; Newcastle University - UK; University of St Andrews; United States Department of Defense; United States Navy; Woods Hole Oceanographic Institution	Pirotta, E (corresponding author), SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland.	gdh@smru.co.uk	Tyack, Peter/AAC-4513-2019; Tyack, Peter L/D-6209-2013	Tyack, Peter/0000-0002-8409-4790; Tyack, Peter L/0000-0002-8409-4790; Hastie, Gordon/0000-0002-9773-2755; Quick, Nicola/0000-0003-3840-6711	United States (U.S.) Office of Naval Research [N00014-07-10988, N00014-07-11023, N00014-08-10990]; U.S. Strategic Environmental Research and Development Program [SI-1539]; Environmental Readiness Division of the U.S. Navy; U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology); U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program; Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council [smru10001] Funding Source: researchfish	United States (U.S.) Office of Naval Research(Office of Naval Research); U.S. Strategic Environmental Research and Development Program; Environmental Readiness Division of the U.S. Navy; U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance); U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology)(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program; Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers; U.S. Navy; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research reported here was financially supported by the United States (U.S.) Office of Naval Research (www.onr.navy.mil) grants N00014-07-10988, N00014-07-11023, N00014-08-10990; the U.S. Strategic Environmental Research and Development Program (www.serdp.org) grant SI-1539, the Environmental Readiness Division of the U.S. Navy (http://www.navy.mil/local/n45/), the U.S. Chief of Naval Operations Submarine Warfare Division (Undersea Surveillance), the U.S. National Oceanic and Atmospheric Administration (National Marine Fisheries Service, Office of Science and Technology) (http://www.st.nmfs.noaa.gov/), U.S. National Oceanic and Atmospheric Administration Ocean Acoustics Program (http://www.nmfs.noaa.gov/pr/acoustics/), and the Joint Industry Program on Sound and Marine Life of the International Association of Oil and Gas Producers (www.soundandmarinelife.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; While the sponsors of this study come from an international mix of sound producers and a United States regulatory agency, the majority of funding for the research reported here comes from different divisions of the U.S. Navy, and all of the authors have had at least some of the research reported here partially funded by different divisions of the U.S. Navy. The following authors are employed by the U.S. Navy: David Moretti and Nancy DiMarzio. Their primary involvement was in designing, installing, and helping to operate the passive acoustic marine mammal monitoring system at the AUTEC range; providing the sound sources used in the experiments; and with analyzing and writing up the data. The following authors are employed by a commercial marine mammal consultancy (SMRU Ltd): Enrico Pirotta, Gordon Hastie and Nicola Quick. The following authors have been asked by the U.S. Department of Justice to act as expert witnesses in cases involving the effects of naval sonar on marine mammals: Peter Tyack. Peter Tyack is also a member of Natural Resources Defense Council, which is an advocacy organization that has sued the Navy concerning effects of sonar on marine mammals. None of the analysis nor write up of the paper involved or was influenced by the sponsors of the research. Furthermore, the declarations provided do not alter the authors' adherence to all the PloSONE policies on sharing data and materials.	[Anonymous], 2008, CANADIAN ACOUSTICS; Arveson PT, 2000, J ACOUST SOC AM, V107, P118, DOI 10.1121/1.428344; Balcomb Kenneth C. III, 2001, Bahamas Journal of Science, V8, P2; Boyd IL, 2008, BEHAV RESPONSE STUDY; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; DiMarzio N, 2008, MARINE MAMMAL MONITO; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Fox J., 2019, CAR COMPANION APPL R; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Moretti D, 2010, APPL ACOUST, V71, P1036, DOI 10.1016/j.apacoust.2010.04.011; National Research Council, 2003, OC NOIS MAR MAMM; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; Nowacek SM, 2001, MAR MAMMAL SCI, V17, P673, DOI 10.1111/j.1748-7692.2001.tb01292.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Perry C., 1998, SCI COMM 50 M INT WH; R Development Core Team, 2009, R FDN STAT COMP; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Sakamoto Y., 1986, AKAIKE INFORM CRITER; SIMMONDS MP, 1991, NATURE, V351, P448, DOI 10.1038/351448a0; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Southall B. L., 2005, 2004 INT S SHIPP NOI; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; Tyack P, 2009, MAR ECOL PROG SER, V395, P187, DOI 10.3354/meps08363; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; VINCENT HT, 2001, THESIS U RHODE ISLAN; Ward J, 2011, J ACOUST SOC AM, V129, P662, DOI 10.1121/1.3531844; Ward JP, 2008, POETRY WALES, V44, P60; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; [No title captured]	39	39	39	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42535	10.1371/journal.pone.0042535	http://dx.doi.org/10.1371/journal.pone.0042535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880022	Green Published, gold			2022-12-25	WOS:000307284100123
J	Schmidt, F; Levin, J; Kamp, F; Kretzschmar, H; Giese, A; Botzel, K				Schmidt, Felix; Levin, Johannes; Kamp, Frits; Kretzschmar, Hans; Giese, Armin; Boetzel, Kai			Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by alpha-Synuclein Oligomers in Lipid Membranes	PLOS ONE			English	Article							PROTEIN AGGREGATION; COMMON MECHANISM; DISSOCIATION; HEMOLYSIN; IMPLIES	Synucleinopathies such as Parkinson's disease, multiple system atrophy and dementia with Lewy bodies are characterized by deposition of aggregated alpha-synuclein. Recent findings indicate that pathological oligomers rather than fibrillar aggregates may represent the main toxic protein species. It has been shown that alpha-synuclein oligomers can increase the conductance of lipid bilayers and, in cell-culture, lead to calcium dyshomeostasis and cell death. In this study, employing a setup for single-channel electrophysiology, we found that addition of iron-induced alpha-synuclein oligomers resulted in quantized and stepwise increases in bilayer conductance indicating insertion of distinct transmembrane pores. These pores switched between open and closed states depending on clamped voltage revealing a single-pore conductance comparable to that of bacterial porins. Pore conductance was dependent on transmembrane potential and the available cation. The pores stably inserted into the bilayer and could not be removed by buffer exchange. Pore formation could be inhibited by co-incubation with the aggregation inhibitor baicalein. Our findings indicate that iron-induced alpha-synuclein oligomers can form a uniform and distinct pore species with characteristic electrophysiological properties. Pore formation could be a critical event in the pathogenesis of synucleinopathies and provide a novel structural target for disease-modifying therapy.	[Schmidt, Felix; Levin, Johannes; Kamp, Frits; Boetzel, Kai] Univ Munich, Klinikum Univ Munchen, Neurol Klin, Munich, Germany; [Schmidt, Felix; Kretzschmar, Hans; Giese, Armin] Univ Munich, Zentrum Neuropathol & Prionforsch, Munich, Germany; [Kamp, Frits] Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Kamp, Frits] Univ Munich, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Schmidt, F (corresponding author), Univ Munich, Klinikum Univ Munchen, Neurol Klin, Munich, Germany.	Armin.Giese@med.uni-muenchen.de	Levin, Johannes/E-4052-2010; Giese, Armin/F-3271-2010	Levin, Johannes/0000-0001-5092-4306; Giese, Armin/0000-0002-8238-4102	Luneburg fund for Parkinson's disease research; DFG [SFB596-B13]	Luneburg fund for Parkinson's disease research; DFG(German Research Foundation (DFG))	This work was supported by the Luneburg fund for Parkinson's disease research and by the DFG (Grant SFB596-B13 to AG and HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; BRUNEN M, 1993, EUR J BIOCHEM, V212, P129, DOI 10.1111/j.1432-1033.1993.tb17642.x; Caruana M, 2012, BIOCH BIOPHYS ACTA; Delcour AH, 1997, FEMS MICROBIOL LETT, V151, P115, DOI 10.1016/S0378-1097(97)00166-3; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hemmler R, 2005, BIOPHYS J, V88, P4000, DOI 10.1529/biophysj.104.058255; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Huls S, 2011, J NEUROCHEM, V117, P868, DOI 10.1111/j.1471-4159.2011.07254.x; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HY, 2008, ANGEW CHEM INT EDIT, V47, P5046, DOI 10.1002/anie.200800342; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; KRASILNIKOV OV, 1988, GEN PHYSIOL BIOPHYS, V7, P467; LAKEY JH, 1985, BIOCHIM BIOPHYS ACTA, V817, P208, DOI 10.1016/0005-2736(85)90022-7; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Levin J, 2011, MOVEMENT DISORD, V26, pS21; Levin J, 2011, J PARKINSON DIS, V1, P205, DOI 10.3233/JPD-2011-11040; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	31	54	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42545	10.1371/journal.pone.0042545	http://dx.doi.org/10.1371/journal.pone.0042545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880029	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100127
J	Aprelikova, O; Palla, J; Hibler, B; Yu, X; Greer, YE; Yi, M; Stephens, R; Maxwell, GL; Jazaeri, A; Risinger, JI; Rubin, JS; Niederhuber, J				Aprelikova, O.; Palla, J.; Hibler, B.; Yu, X.; Greer, Y. E.; Yi, M.; Stephens, R.; Maxwell, G. L.; Jazaeri, A.; Risinger, J. I.; Rubin, J. S.; Niederhuber, J.			Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility	ONCOGENE			English	Article						cancer-associated fibroblasts; endometrial cancer; microRNA; miR-148a; WNT10B	NUCLEAR BETA-CATENIN; STROMAL CELLS; HUMAN BREAST; GASTRIC-CANCER; ENDOMETRIAL; MICRORNAS; DNA; CARCINOMAS; EXPRESSION; ABNORMALITIES	The tumor microenvironment has an important role in cancer progression. Here we show that miR-148a is downregulated in 15 out of 16 samples (94%) of cancer-associated fibroblasts (CAFs) compared with matched normal tissue fibroblasts (NFs) established from patients with endometrial cancer. Laser-capture microdissection of stromal cells from normal tissue and endometrial cancer confirmed this observation. Treatment of cells with 5-aza-deoxycytidine stimulated the expression of miR-148a in the majority of CAFs implicating DNA methylation in the regulation of miR-148a expression. Investigation of miR-148a function in fibroblasts demonstrated that conditioned media (CM) from CAFs overexpressing miR-148a significantly impaired the migration of five endometrial cancer cell lines without affecting their growth rates in co-culture experiments. Among predicted miR-148a target genes are two WNT family members, WNT1 and WNT10B. Activation of the WNT/b-catenin pathway in CAFs was confirmed by microarray analysis of gene expression and increased activity of the SuperTOPFlash luciferase reporter. We found elevated levels of WNT10B protein in CAFs and its level decreased when miR-148a was re-introduced by lentiviral infection. The 3'-UTR of WNT10B, cloned downstream of luciferase cDNA, suppressed luciferase activity when co-expressed with miR-148a indicating that WNT10B is a direct target of miR-148a. In contrast to the effect of miR-148a, WNT10B stimulated migration of endometrial cancer cell lines. Our findings have defined a molecular mechanism in the tumor microenvironment that is a novel target for cancer therapy.	[Aprelikova, O.; Palla, J.; Hibler, B.; Yu, X.; Niederhuber, J.] Canc & Cell Biol Branch, Bethesda, MD USA; [Greer, Y. E.; Rubin, J. S.] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA; [Yi, M.; Stephens, R.] SAIC Inc, Frederick, MD USA; [Maxwell, G. L.] Walter Reed Army Med Ctr, US Mil Canc Inst, Washington, DC 20307 USA; [Jazaeri, A.] Univ Virginia, Charlottesville, VA USA; [Risinger, J. I.] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of Virginia; Michigan State University; Michigan State University College of Human Medicine	Aprelikova, O (corresponding author), NCI, Bldg 37,Rm 1042,9000 Rockville Pike, Bethesda, MD 20892 USA.	apreliko@mail.nih.gov; rubinj@mail.nih.gov	Jazaeri, Amir/I-3458-2015; Greer, Yoshimi/K-2155-2019	Jazaeri, Amir/0000-0003-4335-4151; Yi, Ming/0000-0001-9098-1364	Intramural Research Program of National Institutes of Health; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010251] Funding Source: NIH RePORTER	Intramural Research Program of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Julie Oliver, Tracy Litzi, and Shelley Hoover for help with laser capture microdissection, Dr Xin Wei Wang (NCI) for the WNT10B expression vector and Dr Randall Moon (University of Washington) for the SuperTOPFlash and SuperFOPFlash constructs. This work was supported by the Intramural Research Program of National Institutes of Health, National Cancer Institute, and Center for Cancer Research.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cardone A, 1997, PANMINERVA MED, V39, P174; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Konopka B, 2007, J CANCER RES CLIN, V133, P361, DOI 10.1007/s00432-006-0179-4; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Nagendra DC, MOL CARCINOG, DOI DOI 10.1002/MC.20850); Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Risinger JI, 2005, CANCER RES, V65, P5031, DOI 10.1158/0008-5472.CAN-04-0850; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Scholten AN, 2003, J PATHOL, V201, P460, DOI 10.1002/path.1402; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Yi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003288; Yoshikawa H, 2007, MOL BIOL CELL, V18, P4292, DOI 10.1091/mbc.E06-10-0889; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714	50	95	100	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2013	32	27					3246	3253		10.1038/onc.2012.351	http://dx.doi.org/10.1038/onc.2012.351			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22890324	Green Accepted			2022-12-25	WOS:000321301600004
J	Saouros, S; Dou, ZC; Henry, M; Marchant, J; Carruthers, VB; Matthews, S				Saouros, Savvas; Dou, Zhicheng; Henry, Maud; Marchant, Jan; Carruthers, Vern B.; Matthews, Stephen			Microneme Protein 5 Regulates the Activity of Toxoplasma Subtilisin 1 by Mimicking a Subtilisin Prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; SWISS-MODEL; GONDII; SPECIFICITY; PROTEOLYSIS; PROPEPTIDE; ADHESION; TGSUB1; RECOGNITION; ASSIGNMENT	Toxoplasma gondii is the model parasite of the phylum Apicomplexa, which contains obligate intracellular parasites of medical and veterinary importance. Apicomplexans invade host cells by a multistep process involving the secretion of adhesive microneme protein (MIC) complexes. The subtilisin protease TgSUB1 trims several MICs on the parasite surface to activate gliding motility and host invasion. Although a previous study showed that expression of the secretory protein TgMIC5 suppresses TgSUB1 activity, the mechanism was unknown. Here, we solve the three-dimensional structure of TgMIC5 by nuclear magnetic resonance (NMR), revealing that it mimics a subtilisin prodomain including a flexible C-terminal peptide that may insert into the subtilisin active site. We show that TgMIC5 is an almost 50-fold more potent inhibitor of TgSUB1 activity than the small molecule inhibitorN-[N-(N-acetyl-L-leucyl)-L-leucyl]-L-norleucine (ALLN). Moreover, we demonstrate that TgMIC5 is retained on the parasite plasma membrane via its physical interaction with the membrane-anchored TgSUB1.	[Dou, Zhicheng; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Saouros, Savvas; Henry, Maud; Marchant, Jan; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Carruthers, VB (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	vcarruth@umich.edu; s.j.matthews@imperial.ac.uk		Carruthers, Vern/0000-0001-6859-8895; Matthews, Steve/0000-0003-0676-0927	National Institutes of Health [AI063263]; Medical Research Council [G0800038]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046675, R01AI063263] Funding Source: NIH RePORTER; MRC [G0800038] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by Medical Research Council Grants G0800038 (to S. M.) and an American Heart Association postdoctoral fellowship (to Z. D.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brydges SD, 2000, MOL BIOCHEM PARASIT, V111, P51, DOI 10.1016/S0166-6851(00)00296-6; Brydges SD, 2006, EUKARYOT CELL, V5, P2174, DOI 10.1128/EC.00163-06; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; ENDO T, 1987, J PROTOZOOL, V34, P291, DOI 10.1111/j.1550-7408.1987.tb03177.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Friedrich N, 2010, INT J PARASITOL, V40, P1145, DOI 10.1016/j.ijpara.2010.04.007; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Garcia-Castellanos R, 2005, CELL MOL LIFE SCI, V62, P1996, DOI 10.1007/s00018-005-5174-4; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Helland R, 2006, FEBS J, V273, P61, DOI 10.1111/j.1742-4658.2005.05040.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Lai L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002296; Marchant J, 2012, J BIOL CHEM, V287, P16720, DOI 10.1074/jbc.M111.325928; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; RICHARDS FO, 1995, CLIN INFECT DIS, V21, pS49, DOI 10.1093/clinids/21.Supplement_1.S49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Ruan B, 2008, BIOCHEMISTRY-US, V47, P6628, DOI 10.1021/bi800089f; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sell M, 2005, CLIN NEUROPATHOL, V24, P106; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	45	19	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36029	36040		10.1074/jbc.M112.389825	http://dx.doi.org/10.1074/jbc.M112.389825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896704	Green Published, hybrid			2022-12-25	WOS:000310364000025
J	Vollmer, TR; Stockhausen, A; Zhang, JZ				Vollmer, Thomas R.; Stockhausen, Anthony; Zhang, Jin-Zhong			Anti-inflammatory Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, Is Partially Mediated by MAP Kinase Phosphatase-1 (MKP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; DUAL-SPECIFICITY PHOSPHATASES; INNATE IMMUNE-RESPONSES; INITIATION-FACTOR 4E; MESSENGER-RNA; LIPOPOLYSACCHARIDE STIMULATION; CONDITIONAL EXPRESSION; P38 MAPK; TNF	Mapracorat is a novel selective glucocorticoid receptor agonist (SEGRA), structurally distinct from corticosteroids. In preclinical studies, mapracorat potently inhibits the production of a variety of inflammatory mediators including cytokines and prostaglandin E2 (PGE(2)), with limited side effects associated with traditional corticosteroids. The objective of this study was to delineate the mechanisms underlying the anti-inflammatory properties of mapracorat. We found that mapracorat potently inhibited the production of GM-CSF and TNF-alpha in LPS-stimulated Raw 264.7 macrophages. Mapracorat also substantially attenuated the expression of COX-2 and the production of PGE(2). The inhibition of mapracorat on the inflammatory response was dose-dependent, and substantially inhibitory effects were observed at concentrations in the 10-100 nM range. Examination of the activation kinetics of p38 and its downstream target MAPK-activated protein kinase-2 (MK-2) revealed a shortened activation course after LPS stimulation in cells pretreated with mapracorat. Supporting the notion that mapracorat augments a feedback control mechanism restraining the p38 pathway, we found that mapracorat enhanced the expression of MAPK phosphatase-1 (MKP-1), a critical negative regulator of MAPKs that drive the production of cytokines and other inflammatory mediators. While mapracorat alone did not stimulate MKP-1 expression, it markedly enhanced the expression of MKP-1 in cells stimulated by LPS, in a similar manner and potency to the augmenting effect of dexamethasone. Blocking MKP-1 expression by triptolide also abolished the accelerating effects of mapracorat on p38 and MK-2 deactivation, further supporting a role of MKP-1 in the anti-inflammatory mechanism of mapracorat. Taken together, these results indicate that mapracorat exerts its anti-inflammatory effects, at least in part, by augmenting MKP-1 expression.	[Vollmer, Thomas R.; Stockhausen, Anthony; Zhang, Jin-Zhong] Bausch Lomb Inc, Global Pharmaceut R&D, Rochester, NY 14609 USA	Bausch Health; Bausch + Lomb	Zhang, JZ (corresponding author), Reata Pharmaceut Inc, 2801 Gateway Dr,Suite 150, Irving, TX 75063 USA.	jz168_us@hotmail.com						Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aeberli D, 2006, FEBS LETT, V580, P974, DOI 10.1016/j.febslet.2006.01.027; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Baiula M, 2011, MOL VIS, V17, P3208; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BEUTLER B, 1995, J INVEST MED, V43, P227; Beutler B, 1998, BLOOD CELL MOL DIS, V24, P216, DOI 10.1006/bcmd.1998.0187; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; Cavet ME, 2010, MOL VIS, V16, P1791; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joyce DA, 2001, INFLAMM RES, V50, P337, DOI 10.1007/PL00012387; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Maier JV, 2007, MOL ENDOCRINOL, V21, P2663, DOI 10.1210/me.2007-0067; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Morris DL, 2010, TOXICOL PATHOL, V38, P606, DOI 10.1177/0192623310367807; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pfeffer BA, 2010, INVEST OPHTH VIS SCI, V51, P437, DOI 10.1167/iovs.09-4202; Pratt PF, 2003, J BIOL CHEM, V278, P51928, DOI 10.1074/jbc.M309256200; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413; Saklatvala J, 2002, ARTHRITIS RES, V4, P146, DOI 10.1186/ar398; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schacke H, 2009, BRIT J PHARMACOL, V158, P1088, DOI 10.1111/j.1476-5381.2009.00238.x; Shafiee A, 2011, INVEST OPHTH VIS SCI, V52, P1422, DOI 10.1167/iovs.10-5598; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Sweeney SE, 2006, ANN RHEUM DIS, V65, P83, DOI 10.1136/ard.2006.058388; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Zhang JZ, 2009, MOL VIS, V15, P2606; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	71	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35212	35221		10.1074/jbc.M112.400671	http://dx.doi.org/10.1074/jbc.M112.400671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22898817	Green Published, hybrid			2022-12-25	WOS:000309968000031
J	Kroth, H; Ansaloni, A; Varisco, Y; Jan, A; Sreenivasachary, N; Rezaei-Ghaleh, N; Giriens, V; Lohmann, S; Lopez-Deber, MP; Adolfsson, O; Pihlgren, M; Paganetti, P; Froestl, W; Nagel-Steger, L; Willbold, D; Schrader, T; Zweckstetter, M; Pfeifer, A; Lashuel, HA; Muhs, A				Kroth, Heiko; Ansaloni, Annalisa; Varisco, Yvan; Jan, Asad; Sreenivasachary, Nampally; Rezaei-Ghaleh, Nasrollah; Giriens, Valerie; Lohmann, Sophie; Lopez-Deber, Maria Pilar; Adolfsson, Oskar; Pihlgren, Maria; Paganetti, Paolo; Froestl, Wolfgang; Nagel-Steger, Luitgard; Willbold, Dieter; Schrader, Thomas; Zweckstetter, Markus; Pfeifer, Andrea; Lashuel, Hilal A.; Muhs, Andreas			Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic beta-Amyloid-42 Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-AGGREGATION; A-BETA; ALZHEIMERS-DISEASE; PROTEIN; OLIGOMERS; SHEET; FIBRILLOGENESIS; PATHOLOGY; PEPTIDES; TAU	Increasing evidence implicates A beta peptides self-assembly and fibril formation as crucial events in the pathogenesis of Alzheimer disease. Thus, inhibiting A beta aggregation, among others, has emerged as a potential therapeutic intervention for this disorder. Herein, we employed 3-aminopyrazole as a key fragment in our design of non-dye compounds capable of interacting with A beta 42 via a donor-acceptor-donor hydrogen bond pattern complementary to that of the beta-sheet conformation of A beta 42. The initial design of the compounds was based on connecting two 3-aminopyrazole moieties via a linker to identify suitable scaffold molecules. Additional aryl substitutions on the two 3-aminopyrazole moieties were also explored to enhance pi-pi stacking/hydrophobic interactions with amino acids of A beta 42. The efficacy of these compounds on inhibiting A beta fibril formation and toxicity in vitro was assessed using a combination of biophysical techniques and viability assays. Using structure activity relationship data from the in vitro assays, we identified compounds capable of preventing pathological self-assembly of A beta 42 leading to decreased cell toxicity.	[Kroth, Heiko; Varisco, Yvan; Sreenivasachary, Nampally; Giriens, Valerie; Lohmann, Sophie; Lopez-Deber, Maria Pilar; Adolfsson, Oskar; Pihlgren, Maria; Paganetti, Paolo; Froestl, Wolfgang; Pfeifer, Andrea; Muhs, Andreas] Swiss Fed Inst Technol Lausanne EPFL, AC Immune SA, CH-1015 Lausanne, Switzerland; [Ansaloni, Annalisa; Jan, Asad; Lashuel, Hilal A.] Swiss Fed Inst Technol Lausanne EPFL, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, Struct Biochem, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Schrader, Thomas] Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis, DZNE, D-37077 Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Duisburg Essen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Muhs, A (corresponding author), Swiss Fed Inst Technol Lausanne EPFL, AC Immune SA, PSE Bldg B, CH-1015 Lausanne, Switzerland.	andreas.muhs@acimmune.com	Paganetti, Paolo/AAF-8039-2020; Nagel-Steger, Luitgard/H-6415-2013; Jan, Asad/AAZ-2920-2021; Jan, Asad/D-4389-2009; Willbold, Dieter/A-6280-2013; Rezaei-Ghaleh, Nasrollah/B-9443-2008; Lashuel, Hilal/M-3500-2017	Nagel-Steger, Luitgard/0000-0001-5232-2149; Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; Willbold, Dieter/0000-0002-0065-7366; Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Kroth, Heiko/0000-0002-6936-3921; Paganetti, Paolo/0000-0003-1896-6324; Zweckstetter, Markus/0000-0002-2536-6581	Heisenberg scholarship [ZW71/2-2, 3-2]	Heisenberg scholarship(German Research Foundation (DFG))	This work was supported by a Heisenberg scholarship (ZW71/2-2 and 3-2; to M. Z.). Heiko Kroth, Yvan Varisco, Nampally Sreenivasachary, Valerie Giriens, Sophie Lohmann, Mar a Pilar Lopez-Deber, Oskar Adolfsson, Maria Pihlgren, Paolo Paganetti, Wolfgang Froestl, Andrea Pfeifer, and Andreas Muhs are all full-time employees of AC Immune SA.	Adlard PA, 2009, DRUG TODAY, V45, P293, DOI [10.1358/dot.2009.045.004.1353853, 10.1358/dot.2009.45.4.1353853]; Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0; Bandiera T, 1997, CURR MED CHEM, V4, P159; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Clark CM, 2003, ANN INTERN MED, V138, P400, DOI 10.7326/0003-4819-138-5-200303040-00010; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Di Giovanni S, 2010, J BIOL CHEM, V285, P14941, DOI 10.1074/jbc.M109.080390; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Grundman M, 2000, NEUROL CLIN, V18, P807, DOI 10.1016/S0733-8619(05)70227-9; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JORGENSEN WL, 1990, J AM CHEM SOC, V112, P2008, DOI 10.1021/ja00161a061; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Klunk WE, 1998, LIFE SCI, V63, P1807, DOI 10.1016/S0024-3205(98)00454-8; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Nakagami Y, 2002, BRIT J PHARMACOL, V137, P676, DOI 10.1038/sj.bjp.0704911; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Oddo S, 2007, J NEUROCHEM, V102, P1053, DOI 10.1111/j.1471-4159.2007.04607.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Poduslo JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008813; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Rzepecki P, 2004, J BIOL CHEM, V279, P47497, DOI 10.1074/jbc.M405914200; Rzepecki P, 2003, SYNTHESIS-STUTTGART, P1815, DOI 10.1055/s-2003-41031; Samura E, 2006, BRAIN RES, V1094, P192, DOI 10.1016/j.brainres.2005.12.134; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smith MA, 1998, INT REV NEUROBIOL, V42, P1, DOI 10.1016/S0074-7742(08)60607-8; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Thapa A, 2011, BIOCHEMISTRY-US, V50, P2445, DOI 10.1021/bi101731d; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	70	47	47	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34786	34800		10.1074/jbc.M112.357665	http://dx.doi.org/10.1074/jbc.M112.357665			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891248	Green Published, hybrid			2022-12-25	WOS:000309654200078
J	Safavi-Hemami, H; Gorasia, DG; Steiner, AM; Williamson, NA; Karas, JA; Gajewiak, J; Olivera, BM; Bulaj, G; Purcell, AW				Safavi-Hemami, Helena; Gorasia, Dhana G.; Steiner, Andrew M.; Williamson, Nicholas A.; Karas, John A.; Gajewiak, Joanna; Olivera, Baldomero M.; Bulaj, Grzegorz; Purcell, Anthony W.			Modulation of Conotoxin Structure and Function Is Achieved through a Multienzyme Complex in the Venom Glands of Cone Snails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; IN-VITRO; ENDOPLASMIC-RETICULUM; BIOLOGICAL-ACTIVITY; ALPHA-CONOTOXINS; QUALITY-CONTROL; ISOMERIZATION; IDENTIFICATION; EXPRESSION; CHAPERONE	The oxidative folding of large polypeptides has been investigated in detail; however, comparatively little is known about the enzyme-assisted folding of small, disulfide-containing peptide substrates. To investigate the concerted effect of multiple enzymes on the folding of small disulfide-rich peptides, we sequenced and expressed protein-disulfide isomerase (PDI), peptidyl-prolyl cis-trans isomerase, and immunoglobulin-binding protein (BiP) from Conus venom glands. Conus PDI was shown to catalyze the oxidation and reduction of disulfide bonds in two conotoxins, alpha-GI and alpha-ImI. Oxidative folding rates were further increased in the presence of Conus PPI with the maximum effect observed in the presence of both enzymes. In contrast, Conus BiP was only observed to assist folding in the presence of microsomes, suggesting that additional co-factors were involved. The identification of a complex between BiP, PDI, and nascent conotoxins further suggests that the folding and assembly of conotoxins is a highly regulated multienzyme-assisted process. Unexpectedly, all three enzymes contributed to the folding of the ribbon isomer of alpha-ImI. Here, we identify this alternative disulfide-linked species in the venom of Conus imperialis, providing the first evidence for the existence of a "non-native" peptide isomer in the venom of cone snails. Thus, ER-resident enzymes act in concert to accelerate the oxidative folding of conotoxins and modulate their conformation and function by reconfiguring disulfide connectivities. This study has evaluated the role of a number of ER-resident enzymes in the folding of conotoxins, providing novel insights into the enzyme-guided assembly of these small, disulfide-rich peptides.	[Safavi-Hemami, Helena; Gorasia, Dhana G.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Safavi-Hemami, Helena; Gorasia, Dhana G.; Williamson, Nicholas A.; Karas, John A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Steiner, Andrew M.; Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Gajewiak, Joanna; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia	University of Melbourne; University of Melbourne; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Monash University	Purcell, AW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	anthony.purcell@monash.edu	Safavi-Hemami, Helena/E-7624-2015; Purcell, Anthony/AAH-1942-2019; Williamson, Nicholas A/O-9812-2016; Karas, John/AAE-9729-2019	Safavi-Hemami, Helena/0000-0002-1984-2721; Purcell, Anthony/0000-0003-0532-8331; Williamson, Nicholas A/0000-0002-2173-3452; Karas, John/0000-0002-3800-5152	National Institutes of Health, NIGMS [GM48677]; Australian Research Council [DP110101331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Program Project GM48677. This work was also supported by Australian Research Council Grant DP110101331.	Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FORTE LR, 1995, FASEB J, V9, P643, DOI 10.1096/fasebj.9.8.7768356; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kang TS, 2007, BIOCHEMISTRY-US, V46, P3338, DOI 10.1021/bi061969o; Kharrat R, 1997, FEBS LETT, V406, P284, DOI 10.1016/S0014-5793(97)00285-8; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Marcinkiewicz C, 2003, CANCER RES, V63, P2020; Maslennikov IV, 1999, FEBS LETT, V444, P275, DOI 10.1016/S0014-5793(99)00069-1; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MURRAY I, 1971, Journal of the History of Medicine and Allied Sciences, V26, P150; Nicke A, 2003, FEBS LETT, V554, P219, DOI 10.1016/S0014-5793(03)01161-X; Okudo H, 2005, J BIOCHEM, V138, P773, DOI 10.1093/jb/mvi166; Ostermeier M, 1996, J BIOL CHEM, V271, P10616, DOI 10.1074/jbc.271.18.10616; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rioux V, 1998, ELECTROPHORESIS, V19, P788, DOI 10.1002/elps.1150190531; Safavi-Hemami H, 2011, J PROTEOME RES, V10, P3904, DOI 10.1021/pr1012976; Safavi-Hemami H, 2011, J BIOL CHEM, V286, P22546, DOI 10.1074/jbc.M110.217703; Safavi-Hemami H, 2010, J BIOL CHEM, V285, P12735, DOI 10.1074/jbc.M109.078691; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wang XH, 1999, EUR J BIOCHEM, V264, P488, DOI 10.1046/j.1432-1327.1999.00646.x; Wang ZQ, 2007, FEBS J, V274, P4778, DOI 10.1111/j.1742-4658.2007.06003.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	62	33	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34288	34303		10.1074/jbc.M112.366781	http://dx.doi.org/10.1074/jbc.M112.366781			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891240	Green Published, hybrid			2022-12-25	WOS:000309654200033
J	Kobayashi, H; Hatada, Y; Tsubouchi, T; Nagahama, T; Takami, H				Kobayashi, Hideki; Hatada, Yuji; Tsubouchi, Taishi; Nagahama, Takahiko; Takami, Hideto			The Hadal Amphipod Hirondellea gigas Possessing a Unique Cellulase for Digesting Wooden Debris Buried in the Deepest Seafloor	PLOS ONE			English	Article							SCAVENGING AMPHIPODS; MARIANA TRENCH; BODY-SIZE; TERMITE; OCEAN; LYSIANASSOIDEA; METABOLISM; GASTROPODA; PATTERNS; ORIGIN	The Challenger Deep in the Mariana Trench is the deepest point in the ocean (10,994 m). Certain deep-sea animals can withstand the extreme pressure at this great depth. The amphipod Hirondellea gigas is a resident of the Challenger Deep. Amphipods are common inhabitants at great depths and serve as scavengers. However, there is relatively little information available regarding the physiology of H. gigas or this organism's ecological interactions in the hadopelagic zone. To understand the feeding behavior of this scavenger in the deepest oligotrophic hadal zone, we analyzed the digestive enzymes in whole-body extracts. We describe the detection of amylase, cellulase, mannanase, xylanase, and alpha-glycosidase activities that are capable of digesting plant-derived polysaccharides. Our identification of glucose, maltose, and cellobiose in the H. gigas extracts indicated that these enzymes function under great pressure in situ. In fact, the glucose content of H. gigas averaged 0.4% (w/dry-w). The purified H. gigas cellulase (HGcel) converted cellulose to glucose and cellobiose at an exceptional molar ratio of 2:1 and efficiently produced glucose from dried wood, a natural cellulosic biomass, at 35 degrees C. The enzyme activity increased under a high hydrostatic pressure of 100 MPa at 2 degrees C, conditions equivalent to those found in the Challenger Deep. An analysis of the amino acid sequence of HGcel supported its classification as a family 31 glycosyl hydrolase. However, none of the enzymes of this family had previously been shown to possess cellulase activity. These results strongly suggested that H. gigas adapted to its extreme oligotrophic hadal oceanic environment by evolving digestive enzymes capable of digesting sunken wooden debris.	[Kobayashi, Hideki; Hatada, Yuji; Tsubouchi, Taishi; Nagahama, Takahiko; Takami, Hideto] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Nagahama, Takahiko] Higashi Chikushi Jr Coll, Dept Food & Nutr, Fukuoka, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kobayashi, H (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa, Japan.	hidekik@jamstec.go.jp	Takami, Hideto/D-4200-2012	Takami, Hideto/0000-0003-3433-7018; Tsubouchi, Taishi/0000-0002-1635-2604	Japan Society for the Promotion of Science [24580153]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) 24580153 from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ISO82451999 AM NAT S; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Beliaev G. M., 1989, DEEP SEA OCEAN TRENC; Blankenship LE, 2006, DEEP-SEA RES PT I, V53, P48, DOI 10.1016/j.dsr.2005.09.006; Blankenship LE, 2007, LIMNOL OCEANOGR, V52, P1685, DOI 10.4319/lo.2007.52.4.1685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; FRANCE SC, 1993, MAR ECOL PROG SER, V92, P277, DOI 10.3354/meps092277; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; GEORGE RY, 1979, AMBIO SPECIAL REPORT, V6, P51; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Hargrave BT, 1995, DEEP-SEA RES PT 1, V42, P11; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henry AR, 2008, P NATL ACAD SCI USA, V105, P17006; HESSLER RR, 1978, DEEP-SEA RES, V25, P1029, DOI 10.1016/0146-6291(78)90585-4; Ise Y, 2008, DEEP SEA LIFE BIOL O; Jamieson AJ, 2010, TRENDS ECOL EVOL, V25, P190, DOI 10.1016/j.tree.2009.09.009; Kaariainen JI, 2006, J MAR BIOL ASSOC UK, V86, P1339, DOI 10.1017/S0025315406014366; Kobayashi H, 1998, EXTREMOPHILES, V2, P401, DOI 10.1007/s007920050085; Kobayashi Hideki, 2000, JAMSTEC Journal of Deep Sea Research, V17, P19; Labropoulos KC, 2002, CARBOHYD POLYM, V50, P393, DOI 10.1016/S0144-8617(02)00084-X; Leal JH, 1999, INVERTEBR BIOL, V118, P116, DOI 10.2307/3227054; Lemche H., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P263; Lorenz M. G., 1959, ANAL CHEM, V31, P426; MOORE DR, 1963, SCIENCE, V139, P1234; Nyssen F, 2002, POLAR BIOL, V25, P280, DOI 10.1007/s00300-001-0340-0; ODELSON DA, 1985, APPL ENVIRON MICROB, V49, P614, DOI 10.1128/AEM.49.3.614-621.1985; Perrone FM, 2002, J MAR BIOL ASSOC UK, V82, P419, DOI 10.1017/S0025315402005672; PICCARD J, 1960, NATL GEOGR, V118, P224; PRATT RM, 1962, SCIENCE, V138, P492, DOI 10.1126/science.138.3539.492; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Strong EE, 1999, INVERTEBR BIOL, V118, P137, DOI 10.2307/3227055; Takami H, 1999, EXTREMOPHILES, V3, P97, DOI 10.1007/s007920050104; THIEL H, 1975, HYDROBIOLOGY, V60, P576; Treude T, 2002, DEEP-SEA RES PT I, V49, P1281, DOI 10.1016/S0967-0637(02)00023-7; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; WOLFF T, 1976, Aquatic Botany, V2, P161, DOI 10.1016/0304-3770(76)90017-6; YAMIN MA, 1981, SCIENCE, V211, P58, DOI 10.1126/science.211.4477.58; YAYANOS AA, 1978, SCIENCE, V200, P1056, DOI 10.1126/science.200.4345.1056; YAYANOS AA, 1981, P NATL ACAD SCI-BIOL, V78, P5212, DOI 10.1073/pnas.78.8.5212; YOKOE Y, 1964, COMP BIOCHEM PHYSIOL, V13, P323, DOI 10.1016/0010-406X(64)90027-1; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	47	53	58	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42727	10.1371/journal.pone.0042727	http://dx.doi.org/10.1371/journal.pone.0042727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905166	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600026
J	Park, JE; Kim, MJ; Ha, SK; Hong, SG; Oh, HJ; Kim, GA; Park, J; Kang, T; Saadeldin, IM; Jang, G; Lee, BC				Park, Jung Eun; Kim, Min Jung; Ha, Seung Kwon; Hong, So Gun; Oh, Hyun Ju; Kim, Geon A.; Park, Jung; Kang, Taek; Saadeldin, Islam M.; Jang, Goo; Lee, Byeong Chun			Altered Cell Cycle Gene Expression and Apoptosis in Post-Implantation Dog Parthenotes	PLOS ONE			English	Article							CONTROL PRIMER SYSTEM; PARTHENOGENETIC MOUSE EMBRYOS; NUCLEAR TRANSFER; IMPRINTED GENES; IN-VITRO; STEM-CELLS; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION EMBRYOS; SOMATIC-CELLS; OOCYTES	Mature oocytes can be parthenogenetically activated by a variety of methods and the resulting embryos are valuable for studies of the respective roles of paternal and maternal genomes in early mammalian development. In the present study, we report the first successful development of parthenogenetic canine embryos to the post-implantation stage. Nine out of ten embryo transfer recipients became pregnant and successful in utero development of canine parthenotes was confirmed. For further evaluation of these parthenotes, their fetal development was compared with artificially inseminated controls and differentially expressed genes (DEGs) were compared using ACP RT-PCR, histological analysis and immunohistochemistry. We found formation of the limb-bud and no obvious differences in histological appearance of the canine parthenote recovered before degeneration occurred; however canine parthenotes were developmentally delayed with different cell cycle regulating-, mitochondria-related and apoptosis-related gene expression patterns compared with controls. In conclusion, our protocols were suitable for activating canine oocytes artificially and supported early fetal development. We demonstrated that the developmental abnormalities in canine parthenotes may result from defective regulation of apoptosis and aberrant gene expression patterns, and provided evidence that canine parthenotes can be a useful tool for screening and for comparative studies of imprinted genes.	[Park, Jung Eun; Kim, Min Jung; Hong, So Gun; Oh, Hyun Ju; Kim, Geon A.; Park, Jung; Kang, Taek; Saadeldin, Islam M.; Jang, Goo; Lee, Byeong Chun] Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea; [Ha, Seung Kwon] SK Chem, Life Sci R&D Ctr, Seoul, South Korea; [Saadeldin, Islam M.] Zagazig Univ, Dept Physiol, Fac Vet Med, Zagazig, Sharkia, Egypt	Seoul National University (SNU); SK Group; Egyptian Knowledge Bank (EKB); Zagazig University	Park, JE (corresponding author), Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea.	bclee@snu.ac.kr	Saadeldin, Islam M./J-6729-2013; Lee, Byeong Chun/C-5707-2014	Saadeldin, Islam M./0000-0002-7633-730X; Kang, Jung-Taek/0000-0001-9185-165X	National Research Foundation of Korea Grant; Korean Government [NRF 550-20110039]; Rural Development Administration [PJ0089752012]; RNL Bio [550-20120006]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries [311062-04-1-SB010]; Research Institute for Veterinary Science; Nestle Purina Korea; Nestle Purina PetCare	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); RNL Bio; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; Research Institute for Veterinary Science; Nestle Purina Korea(Nestle SA); Nestle Purina PetCare(Nestle SA)	This study was supported by National Research Foundation of Korea Grant funded by Korean Government (NRF 550-20110039), Rural Development Administration (#PJ0089752012), RNL Bio (#550-20120006), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (#311062-04-1-SB010), Research Institute for Veterinary Science and Nestle Purina Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nestle Purina PetCare provided financial support, and Seung Kwon Ha is an employee of ORIENT CRO. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alberio R, 2001, INT J DEV BIOL, V45, P797; Alexander B, 2006, MOL REPROD DEV, V73, P20, DOI 10.1002/mrd.20372; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Brevini TAL, 2012, THERIOGENOLOGY, V77, P766, DOI 10.1016/j.theriogenology.2011.11.010; Brill A, 1999, J ASSIST REPROD GEN, V16, P512, DOI 10.1023/A:1020541019347; Chen B, 2003, MOL ENDOCRINOL, V17, P1368, DOI 10.1210/me.2003-0036; Chen ZS, 2009, STEM CELLS, V27, P2136, DOI 10.1002/stem.158; Cheng WM, 2007, ANIM BIOTECHNOL, V18, P131, DOI 10.1080/10495390601096148; Cibelli JB, 2006, METHOD ENZYMOL, V418, P117, DOI 10.1016/S0076-6879(06)18008-8; Cui XS, 2007, MOL REPROD DEV, V74, P133, DOI 10.1002/mrd.20483; Cui XS, 2005, MOL REPROD DEV, V70, P278, DOI 10.1002/mrd.20210; Dobenecker B, 2006, J ANIM PHYSIOL AN N, V90, P394, DOI 10.1111/j.1439-0396.2006.00618.x; Gomez E, 2009, REPRODUCTION, V137, P285, DOI 10.1530/REP-08-0220; Hong SG, 2009, ANIM REPROD SCI, V115, P334, DOI 10.1016/j.anireprosci.2008.12.005; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Hossein MS, 2009, CLONING STEM CELLS, V11, P123, DOI 10.1089/clo.2008.0029; Hwang IT, 2003, BIOTECHNIQUES, V35, P1180, DOI 10.2144/03356st03; Hwang KC, 2004, MOL REPROD DEV, V69, P43, DOI 10.1002/mrd.20156; Jang G, 2008, THERIOGENOLOGY, V69, P146, DOI 10.1016/j.theriogenology.2007.08.022; Jang G, 2007, THERIOGENOLOGY, V67, P941, DOI 10.1016/j.theriogenology.2006.11.006; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Ka H, 2009, MOL REPROD DEV, V76, P75, DOI 10.1002/mrd.20935; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Kim HJ, 2007, J VET SCI, V8, P75, DOI 10.4142/jvs.2007.8.1.75; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Kobayashi S, 2000, GENES CELLS, V5, P1029, DOI 10.1046/j.1365-2443.2000.00390.x; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee JH, 2009, PATHOLOGY, V41, P229, DOI 10.1080/00313020902756279; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi P, 1998, BIOL REPROD, V58, P1177, DOI 10.1095/biolreprod58.5.1177; Luvoni GC, 2006, REPROD DOMEST ANIM, V41, P286, DOI 10.1111/j.1439-0531.2006.00704.x; Marshall VS, 1998, BIOL REPROD, V59, P1491, DOI 10.1095/biolreprod59.6.1491; McElroy SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010979; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; O'Sullivan FM, 2007, EVOL DEV, V9, P579, DOI 10.1111/j.1525-142X.2007.00198.x; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Oh HJ, 2008, THERIOGENOLOGY, V70, P638, DOI 10.1016/j.theriogenology.2008.04.032; Oh HJ, 2009, THERIOGENOLOGY, V72, P461, DOI 10.1016/j.theriogenology.2009.03.016; Oh HJ, 2011, THERIOGENOLOGY, V75, P1221, DOI 10.1016/j.theriogenology.2010.11.035; OZIL JP, 1990, DEVELOPMENT, V109, P117; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rodrigues BD, 2007, ZYGOTE, V15, P43, DOI 10.1017/S0967199406003960; Saikhun J, 2008, THERIOGENOLOGY, V69, P1104, DOI 10.1016/j.theriogenology.2008.01.024; Spanos S, 2002, REPRODUCTION, V124, P353, DOI 10.1530/reprod/124.3.353; Stelzer Y, 2011, NAT STRUCT MOL BIOL, V18, P735, DOI 10.1038/nsmb.2050; STURM KS, 1994, DEV DYNAM, V201, P11, DOI 10.1002/aja.1002010103; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; VARMUZA S, 1993, DEV GENET, V14, P239, DOI 10.1002/dvg.1020140310; WALSH C, 1994, MECH DEVELOP, V46, P55, DOI 10.1016/0925-4773(94)90037-X; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Wianny F, 1998, DEV DYNAM, V212, P49, DOI 10.1002/(SICI)1097-0177(199805)212:1<49::AID-AJA5>3.0.CO;2-2; Zeng FY, 2003, BIOL REPROD, V68, P31, DOI 10.1095/biolreprod.102.007674	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e41256	10.1371/journal.pone.0041256	http://dx.doi.org/10.1371/journal.pone.0041256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905100	gold, Green Published, Green Submitted			2022-12-25	WOS:000307823600004
J	Wu, P; Su, Y; Guan, XH; Liu, XW; Zhang, JK; Dong, XW; Huang, WH; Hu, YZ				Wu, Peng; Su, Yi; Guan, Xianghong; Liu, Xiaowen; Zhang, Jiankang; Dong, Xiaowu; Huang, Wenhai; Hu, Yongzhou			Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; CANCER; KINASE; PI3K-ALPHA; DISCOVERY; PATHWAY	Background: Development of small-molecule inhibitors targeting phosphoinositide 3-kinase (PI3K) has been an appealing strategy for the treatment of various types of cancers. Methodology/Principal Finding: Our approach was to perform structural modification and optimization based on previously identified morpholinoquinoxaline derivative WR1 and piperidinylquinoxaline derivative WR23 with a total of forty-five novel piperazinylquinoxaline derivatives synthesized. Most target compounds showed low micromolar to nanomolar antiproliferative potency against five human cancer cell lines using MTT method. Selected compounds showed potent PI3K alpha inhibitory activity in a competitive fluorescent polarization assay, such as compound 22 (IC50 40 nM) and 41 (IC50: 24 nM), which induced apoptosis in PC3 cells. Molecular docking analysis was performed to explore possible binding modes between target compounds and PI3K. Conclusions/Significance: The identified novel piperazinylquinoxaline derivatives that showed potent PI3K alpha inhibitory activity and cellular antiproliferative potency may be promising agents for potential applications in cancer treatment.	[Wu, Peng; Guan, Xianghong; Zhang, Jiankang; Dong, Xiaowu; Huang, Wenhai; Hu, Yongzhou] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Univ Ecole Normale Super Joint Lab Med C, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Yi; Liu, Xiaowen] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, P (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Univ Ecole Normale Super Joint Lab Med C, Hangzhou 310003, Zhejiang, Peoples R China.	huyz@zju.edu.cn	Wu, Peng/N-4377-2018	Wu, Peng/0000-0002-0186-1086; Guan, Xianghong/0000-0002-7874-8065	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	PW was supported by the European Commission Eramus Mundus LiSUM project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Denley A, 2008, ONCOGENE, V27, P2561, DOI 10.1038/sj.onc.1210918; DESAI M, 1976, ORG PREP PROCED INT, V8, P85, DOI 10.1080/00304947609355594; Drees BE, 2003, COMB CHEM HIGH T SCR, V6, P321; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; HALL HK, 1956, J AM CHEM SOC, V78, P2570, DOI 10.1021/ja01592a066; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hu Y, 2009, CN 2009/101560179, Patent No. 2009101560179; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wu P, 2012, MEDCHEMCOMM, V3, P1337, DOI 10.1039/c2md20044a; Wu P, 2012, MEDCHEMCOMM, V3, P659, DOI 10.1039/c2md00255h; Wu P, 2012, BIOORGAN MED CHEM, V20, P2837, DOI 10.1016/j.bmc.2012.03.026; Wu P, 2011, EUR J MED CHEM, V46, P5540, DOI 10.1016/j.ejmech.2011.09.015; Wu P, 2009, CURR MED CHEM, V16, P916, DOI 10.2174/092986709787581905	25	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43171	10.1371/journal.pone.0043171	http://dx.doi.org/10.1371/journal.pone.0043171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905224	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800056
J	Zeng, Y; Ebong, EE; Fu, BMM; Tarbell, JM				Zeng, Ye; Ebong, Eno E.; Fu, Bingmei M.; Tarbell, John M.			The Structural Stability of the Endothelial Glycocalyx after Enzymatic Removal of Glycosaminoglycans	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CHONDROITIN SULFATE; GLOMERULAR CHARGE; CELL GLYCOCALYX; SHEAR-STRESS; CAROTID-ARTERY; BARRIER; HYALURONAN; GLUCOSE; PERMEABILITY	Rationale: It is widely believed that glycosaminoglycans (GAGs) and bound plasma proteins form an interconnected gel-like structure on the surface of endothelial cells (the endothelial glycocalyx layer-EGL) that is stabilized by the interaction of its components. However, the structural organization of GAGs and proteins and the contribution of individual components to the stability of the EGL are largely unknown. Objective: To evaluate the hypothesis that the interconnected gel-like glycocalyx would collapse when individual GAG components were almost completely removed by a specific enzyme. Methods and Results: Using confocal microscopy, we observed that the coverage and thickness of heparan sulfate (HS), chondroitin sulfate (CS), hyaluronic acid (HA), and adsorbed albumin were similar, and that the thicknesses of individual GAGs were spatially nonuniform. The individual GAGs were degraded by specific enzymes in a dose-dependent manner, and decreased much more in coverage than in thickness. Removal of HS or HA did not result in cleavage or collapse of any of the remaining components. Simultaneous removal of CS and HA by chondroitinase did not affect HS, but did reduce adsorbed albumin, although the effect was not large. Conclusion: All GAGs and adsorbed proteins are well inter-mixed within the structure of the EGL, but the GAG components do not interact with one another. The GAG components do provide binding sites for albumin. Our results provide a new view of the organization of the endothelial glycocalyx layer and provide the first demonstration of the interaction between individual GAG components.	[Zeng, Ye; Fu, Bingmei M.; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA; [Ebong, Eno E.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); Yeshiva University	Zeng, Y (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu	Zeng, Ye/E-3010-2010; Fu, Bingmei M/I-3295-2013	Zeng, Ye/0000-0001-5440-6194; 	National Institutes of Health [HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 Grant HL 094889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; Barker AL, 2004, PHYS CHEM CHEM PHYS, V6, P1006, DOI 10.1039/b312189e; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Dancu MB, 2007, ATHEROSCLEROSIS, V192, P9, DOI 10.1016/j.atherosclerosis.2006.05.042; DELVOS U, 1985, THROMB HAEMOSTASIS, V53, P26; DERBY MA, 1978, HISTOCHEM J, V10, P529, DOI 10.1007/BF01003135; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; Duan WL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-16; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; EGGLI PS, 1995, J HISTOCHEM CYTOCHEM, V43, P689, DOI 10.1177/43.7.7608523; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Grondahl F, 2011, CARBOHYD RES, V346, P50, DOI 10.1016/j.carres.2010.10.025; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; Hamai A, 1997, J BIOL CHEM, V272, P9123; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Koshiishi I, 1998, ANAL BIOCHEM, V265, P49, DOI 10.1006/abio.1998.2883; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lipowsky Herbert H, 2011, Drug Discov Today Dis Models, V8, P57; Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; Marechal X, 2008, SHOCK, V29, P572, DOI 10.1097/SHK.0b013e318157e926; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nikmanesh M, 2012, BIOTECHNOL BIOENG, V109, P583, DOI 10.1002/bit.23302; Ohlson M, 2001, AM J PHYSIOL-RENAL, V280, pF396, DOI 10.1152/ajprenal.2001.280.3.F396; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, J VASC RES, V48, P297, DOI 10.1159/000322176; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Sorensson J, 1998, ACTA PHYSIOL SCAND, V163, P83, DOI 10.1046/j.1365-201x.1998.00315.x; Sorensson J, 2001, AM J PHYSIOL-RENAL, V280, pF646, DOI 10.1152/ajprenal.2001.280.4.F646; Stevens AP, 2007, AM J PHYSIOL-LUNG C, V293, pL328, DOI 10.1152/ajplung.00390.2006; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Tarbell JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.140pt8; TENNYSON VM, 1990, J COMP NEUROL, V291, P345, DOI 10.1002/cne.902910303; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Vogl-Willis CA, 2004, BBA-GEN SUBJECTS, V1672, P36, DOI 10.1016/j.bbagen.2004.02.005; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WITTE S, 1988, THROMB RES, V52, P111, DOI 10.1016/0049-3848(88)90089-8; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005	56	82	82	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43168	10.1371/journal.pone.0043168	http://dx.doi.org/10.1371/journal.pone.0043168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905223	gold, Green Published			2022-12-25	WOS:000307500800055
J	Briggs, AA; Young, HS; McCauley, DJ; Hathaway, SA; Dirzo, R; Fisher, RN				Briggs, Amy A.; Young, Hillary S.; McCauley, Douglas J.; Hathaway, Stacie A.; Dirzo, Rodolfo; Fisher, Robert N.			Effects of Spatial Subsidies and Habitat Structure on the Foraging Ecology and Size of Geckos	PLOS ONE			English	Article							FOOD-CHAIN LENGTH; HEMIDACTYLUS-FRENATUS; REPRODUCTIVE SUCCESS; MARINE SUBSIDIES; BODY CONDITION; HOUSE GECKOS; WEB; LIZARDS; ISLAND; COMPETITION	While it is well established that ecosystem subsidies-the addition of energy, nutrients, or materials across ecosystem boundaries-can affect consumer abundance, there is less information available on how subsidy levels may affect consumer diet, body condition, trophic position, and resource partitioning among consumer species. There is also little information on whether changes in vegetation structure commonly associated with spatial variation in subsidies may play an important role in driving consumer responses to subsidies. To address these knowledge gaps, we studied changes in abundance, diet, trophic position, size, and body condition of two congeneric gecko species (Lepidodactylus spp.) that coexist in palm dominated and native (hereafter dicot dominated) forests across the Central Pacific. These forests differ strongly both in the amount of marine subsidies that they receive from seabird guano and carcasses, and in the physical structure of the habitat. Contrary to other studies, we found that subsidy level had no impact on the abundance of either gecko species; it also did not have any apparent effects on resource partitioning between species. However, it did affect body size, dietary composition, and trophic position of both species. Geckos in subsidized, dicot forests were larger, had higher body condition and more diverse diets, and occupied a much higher trophic position than geckos found in palm dominated, low subsidy level forests. Both direct variation in subsidy levels and associated changes in habitat structure appear to play a role in driving these responses. These results suggest that variation in subsidy levels may drive important behavioral responses in predators, even when their numerical response is limited. Strong changes in trophic position of consumers also suggest that subsidies may drive increasingly complex food webs, with longer overall food chain length.	[Briggs, Amy A.; Young, Hillary S.; McCauley, Douglas J.; Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hathaway, Stacie A.; Fisher, Robert N.] US Geol Survey, Western Ecol Res Ctr, San Diego Field Stn, San Diego, CA USA	Stanford University; United States Department of the Interior; United States Geological Survey	Briggs, AA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hyoung@fas.harvard.edu	Fisher, Robert/AAA-7301-2022; Young, Hillary/S-1514-2017	Fisher, Robert/0000-0002-2956-3240; Briggs, Amy/0000-0002-5782-7928	National Science Foundation; National Geographic Society; Woods Institute for the Environment; Stanford University	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Woods Institute for the Environment; Stanford University(Stanford University)	This work was supported by funding from the National Science Foundation, the National Geographic Society, the Woods Institute for the Environment, and Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Arim M, 2007, AM NAT, V169, P62, DOI 10.1086/510210; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Barrett K, 2003, J BIOGEOGR, V30, P1575, DOI 10.1046/j.1365-2699.2003.00936.x; Brehme CS, 2009, J ARID ENVIRON, V73, P811, DOI 10.1016/j.jaridenv.2009.03.002; BUSTARD HR, 1970, COPEIA, P173; BUSTARD HR, 1970, ECOLOGY, V51, P724; CASE TJ, 1994, ECOLOGY, V75, P464, DOI 10.2307/1939550; CASE TJ, 1991, TRENDS ECOL EVOL, V6, P135, DOI 10.1016/0169-5347(91)90093-D; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Deenik JL, 2008, SOIL SCI, V173, P54, DOI 10.1097/ss.0b013e31815a668c; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Ellis JC, 2011, SEABIRD ISLANDS ECOL, P212; FRANKENBERG E, 1981, J HERPETOL, V15, P373, DOI 10.2307/1563445; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; HANLEY KA, 1994, EVOL ECOL, V8, P438, DOI 10.1007/BF01238194; HANLEY KA, 1995, EVOLUTION, V49, P418, DOI [10.2307/2410266, 10.1111/j.1558-5646.1995.tb02274.x]; Helfield JM, 2001, ECOLOGY, V82, P2403, DOI 10.1890/0012-9658(2001)082[2403:EOSDNO]2.0.CO;2; Hines J, 2006, ECOLOGY, V87, P1542, DOI 10.1890/0012-9658(2006)87[1542:NSTBMI]2.0.CO;2; HUEY RB, 1979, OECOLOGIA, V38, P249, DOI 10.1007/BF00345186; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Huxel GR, 2002, ECOL RES, V17, P419, DOI 10.1046/j.1440-1703.2002.00501.x; IASON GR, 1986, J ANIM ECOL, V55, P507, DOI 10.2307/4734; Ineich I., 1992, B COLL SCI U RYUKYUS, V53, P31; Kauzinger CMK, 1998, NATURE, V395, P495; Kolb G.S., 2011, P212; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; KUO S, 1996, METHODS SOIL ANAL 3, P898; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Markwell TJ, 2002, ECOSCIENCE, V9, P293, DOI 10.1080/11956860.2002.11682715; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1111/j.1095-8312.1993.tb00882.x; Petren K, 1998, P NATL ACAD SCI USA, V95, P11739, DOI 10.1073/pnas.95.20.11739; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POLIS GA, 1995, P NATL ACAD SCI USA, V92, P4382, DOI 10.1073/pnas.92.10.4382; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; RADTKEY RR, 1995, P ROY SOC B-BIOL SCI, V259, P145, DOI 10.1098/rspb.1995.0022; Rand TA, 2006, CONSERV BIOL, V20, P1720, DOI 10.1111/j.1523-1739.2006.00507.x; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Salvador A, 2008, BEHAV ECOL, V19, P169, DOI 10.1093/beheco/arm118; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; SCHOENER TW, 1980, J ANIM ECOL, V49, P19, DOI 10.2307/4276; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; VANBERKUM FH, 1989, FUNCT ECOL, V3, P97; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Werth M, 2010, SOIL BIOL BIOCHEM, V42, P1372, DOI 10.1016/j.soilbio.2010.04.009; Young HS, 2010, J VEG SCI, V21, P1058, DOI 10.1111/j.1654-1103.2010.01219.x; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107	62	21	24	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41364	10.1371/journal.pone.0041364	http://dx.doi.org/10.1371/journal.pone.0041364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899995	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900010
J	Castle, MD; Gilligan, CA				Castle, Matthew D.; Gilligan, Christopher A.			An Epidemiological Framework for Modelling Fungicide Dynamics and Control	PLOS ONE			English	Article							PLANT PATHOGEN POPULATIONS; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; CONTROL STRATEGIES; CHEMICAL CONTROL; DISEASE; INVASION; SCALE; PERSISTENCE; SIMULATION	Defining appropriate policies for controlling the spread of fungal disease in agricultural landscapes requires appropriate theoretical models. Most existing models for the fungicidal control of plant diseases do not explicitly include the dynamics of the fungicide itself, nor do they consider the impact of infection occurring during the host growth phase. We introduce a modelling framework for fungicide application that allows us to consider how "explicit" modelling of fungicide dynamics affects the invasion and persistence of plant pathogens. Specifically, we show that "explicit" models exhibit bistability zones for values of the basic reproductive number (R-0) less than one within which the invasion and persistence threshold depends on the initial infection levels. This is in contrast to classical models where invasion and persistence thresholds are solely dependent on R-0. In addition if initial infection occurs during the growth phase then an additional "invasion zone" can exist for even smaller values of R-0. Within this region the system will experience an epidemic that is not able to persist. We further show that ideal fungicides with high levels of effectiveness, low rates of application and low rates of decay lead to the existence of these bistability zones. The results are robust to the inclusion of demographic stochasticity.	[Castle, Matthew D.; Gilligan, Christopher A.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Cambridge	Castle, MD (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	mdc31@cam.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/B502379/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MDC acknowledges the support of a Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship. CAG acknowledges the support of a BBSRC Professorial Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham I.J., 2006, BARLEY GROWTH GUIDE, P3; Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Blake J, 2012, 20041068 USGS; Brauer F, 2004, J MATH ANAL APPL, V298, P418, DOI 10.1016/j.jmaa.2004.05.045; Brent KJ, 2007, 20041068 USGS; CHIN KM, 1987, PHYTOPATHOLOGY, V77, P666, DOI 10.1094/Phyto-77-666; Cunniffe NJ, 2010, J R SOC INTERFACE, V7, P439, DOI 10.1098/rsif.2009.0226; DEWAARD MA, 1993, ANNU REV PHYTOPATHOL, V31, P403, DOI 10.1146/annurev.py.31.090193.002155; Dybiec B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066145; Dybiec B, 2005, ACTA PHYS POL B, V36, P1509; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gilligan CA, 2002, ADV BOT RES, V38, P1, DOI 10.1016/S0065-2296(02)38027-3; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; HADELER KP, 1995, MATH BIOSCI, V128, P41, DOI 10.1016/0025-5564(94)00066-9; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; Holt J, 1999, PLANT PATHOL, V48, P453, DOI 10.1046/j.1365-3059.1999.00360.x; Kribs-Zaleta CM, 2000, MATH BIOSCI, V164, P183, DOI 10.1016/S0025-5564(00)00003-1; LEVY Y, 1983, PHYTOPATHOLOGY, V73, P1475, DOI 10.1094/Phyto-73-1475; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley N, 2012, 20041068 USGS; Reinink K, 1986, EUROPEAN J PLANT PAT, V92, P3; Russell PE, 2005, J AGR SCI-CAMBRIDGE, V143, P11, DOI 10.1017/S0021859605004971; Safan M, 2006, J MATH BIOL, V53, P703, DOI 10.1007/s00285-006-0028-8; SHAW MW, 1989, CROP PROT, V8, P405, DOI 10.1016/0261-2194(89)90065-3; Sylvester-Bradley R, 2008, 20041068 USGS; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; ZILBERMAN D, 1991, SCIENCE, V253, P518, DOI 10.1126/science.253.5019.518	33	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40941	10.1371/journal.pone.0040941	http://dx.doi.org/10.1371/journal.pone.0040941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899992	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900007
J	Charbaji, N; Schafer-Korting, M; Kuchler, S				Charbaji, Nada; Schaefer-Korting, Monika; Kuechler, Sarah			Morphine Stimulates Cell Migration of Oral Epithelial Cells by Delta-Opioid Receptor Activation	PLOS ONE			English	Article							MU-OPIATE RECEPTOR; TGF-BETA; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; MAP KINASES; PAIN; SKIN; PROLIFERATION; KERATINOCYTES; ANALGESIA	Oral mucositis is one of the most common side effects of chemoradiation regimens and manifestation can be dose-limiting for the therapy, can impair the patient's nutritional condition and quality of life due to severe pain. The therapeutic options are limited; often only an alleviation of the symptoms such as pain reduction by using systemic opioids is possible. Stimulating opioid receptors on peripheral neurons and dermal tissue, potent analgesic effects are induced e.g. in skin grafted patients. Advantageous effects on the cell migration and, thus, on the wound healing process are described, too. In this study, we investigated whether opioid receptors are also expressed on oral epithelial cells and if morphine can modulate their cell migration behavior. The expression of the opioid receptors MOR, DOR and KOR on primary human oral epithelial cells was verified. Furthermore, a significantly accelerated cell migration was observed following incubation with morphine. The effect even slightly exceeded the cell migration stimulating effect of TGF-beta: After 14 h of morphine treatment about 86% of the wound area was closed, whereas TGF-beta application resulted in a closed wound area of 80%. With respect to morphine stimulated cell migration we demonstrate that DOR plays a key role and we show the involvement of the MAPK members Erk 1/2 and p38 using Western blot analysis. Further studies in more complex systems in vitro and in vivo are required. Nevertheless, these findings might open up a new therapeutic option for the treatment of oral mucositis.	[Charbaji, Nada; Schaefer-Korting, Monika; Kuechler, Sarah] Free Univ Berlin, Inst Pharm, Berlin, Germany	Free University of Berlin	Charbaji, N (corresponding author), Free Univ Berlin, Inst Pharm, Berlin, Germany.	sarah.kuechler@cup.uni-muenchen.de		Hedtrich (nee Kuchler), Sarah/0000-0001-6770-3657	European Funding for Regional Development (EFRE)	European Funding for Regional Development (EFRE)	Nada Charbaji was funded partly by the European Funding for Regional Development (EFRE). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellm LA, 2000, SUPPORT CARE CANCER, V8, P33; Bigliardi PL, 2009, EXP DERMATOL, V18, P424, DOI 10.1111/j.1600-0625.2009.00844.x; Bigliardi PL, 1998, J INVEST DERMATOL, V111, P297, DOI 10.1046/j.1523-1747.1998.00259.x; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887; Cerchietti LCA, 2003, PAIN, V105, P265, DOI 10.1016/S0304-3959(03)00227-6; Cerchietti LCA, 2002, CANCER, V95, P2230, DOI 10.1002/cncr.10938; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Farooqui M, 2007, BRIT J CANCER, V97, P1523, DOI 10.1038/sj.bjc.6604057; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FERREIRA SH, 1979, PROSTAGLANDINS, V18, P191, DOI 10.1016/0090-6980(79)90104-7; Flock P, 2003, J PAIN SYMPTOM MANAG, V25, P547, DOI 10.1016/S0885-3924(03)00140-4; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gysler A, 1997, PHARMACEUT RES, V14, P793, DOI 10.1023/A:1012162708675; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ibrahim AS, DIABETES, V60, P1122; Kuchler S, 2010, J BIOTECHNOL, V148, P24, DOI 10.1016/j.jbiotec.2010.01.001; LeBon B, 2009, J PAIN SYMPTOM MANAG, V37, P913, DOI 10.1016/j.jpainsymman.2008.06.007; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203; Moon SE, 2002, BRIT J CANCER, V87, P457, DOI 10.1038/sj.bjc.6600478; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohshima M, 2002, EUR J ORAL SCI, V110, P130, DOI 10.1034/j.1600-0722.2002.11179.x; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; PASI A, 1991, GEN PHARMACOL, V22, P1077, DOI 10.1016/0306-3623(91)90580-Y; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Platzer M, 2005, SCHMERZ, V19, P296, DOI 10.1007/s00482-004-0372-9; Poonawala T, 2005, WOUND REPAIR REGEN, V13, P165, DOI 10.1111/j.1067-1927.2005.130207.x; PRATHER PL, 1994, J PHARMACOL EXP THER, V270, P177; Rachinger-Adam B, 2011, CURR OPIN ANESTHESIO, V24, P408, DOI 10.1097/ACO.0b013e32834873e5; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Salemi S, 2005, BIOCHEM BIOPH RES CO, V338, P1012, DOI 10.1016/j.bbrc.2005.10.072; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; Silverman Sol Jr, 2007, J Support Oncol, V5, P13; Sonis Stephen T, 2007, J Support Oncol, V5, P3; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; Stein C, 2003, ADV EXP MED BIOL, V521, P69; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stone Rebecca, 2005, Eur J Oncol Nurs, V9 Suppl 1, pS24, DOI 10.1016/j.ejon.2005.08.004; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wolf NB, 2009, EUR J PHARM BIOPHARM, V73, P34, DOI 10.1016/j.ejpb.2009.03.009; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; ZADINA JE, 1994, J PHARMACOL EXP THER, V270, P1086; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	51	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42616	10.1371/journal.pone.0042616	http://dx.doi.org/10.1371/journal.pone.0042616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900034	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900050
J	Jiang, Q; Thiffault, C; Kramer, BC; Ding, GL; Zhang, L; Nejad-Davarani, SP; Li, L; Arbab, AS; Lu, M; Navia, B; Victor, SJ; Hong, K; Li, QJ; Wang, SY; Li, Y; Chopp, M				Jiang, Quan; Thiffault, Christine; Kramer, Brian C.; Ding, Guang Liang; Zhang, Li; Nejad-Davarani, Siamak P.; Li, Lian; Arbab, Ali S.; Lu, Mei; Navia, Brad; Victor, Stephen J.; Hong, Klaudyne; Li, Qing Jiang; Wang, Shi Yang; Li, Yi; Chopp, Michael			MRI Detects Brain Reorganization after Human Umbilical Tissue-Derived Cells (hUTC) Treatment of Stroke in Rat	PLOS ONE			English	Article							MARROW STROMAL CELLS; ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; EMBOLIC STROKE; ENHANCES ANGIOGENESIS; THERAPEUTIC BENEFIT; CEREBRAL-ISCHEMIA; NEUROGENESIS; VEGF; PERMEABILITY	Human umbilical tissue-derived cells (hUTC) represent an attractive cell source and a potential technology for neurorestoration and improvement of functional outcomes following stroke. Male Wistar rats were subjected to a transient middle cerebral artery occlusion (tMCAo) and were intravenously administered hUTC (N = 11) or vehicle (N = 10) 48 hrs after stroke. White matter and vascular reorganization was monitored over a 12-week period using MRI and histopathology. MRI results were correlated with neurological functional and histology outcomes to demonstrate that MRI can be a useful tool to measure structural recovery after stroke. MRI revealed a significant reduction in the ventricular volume expansion and improvement in cerebral blood flow (CBF) in the hUTC treated group compared to vehicle treated group. Treatment with hUTC resulted in histological and functional improvements as evidenced by enhanced expression of vWF and synaptophysin, and improved outcomes on behavioral tests. Significant correlations were detected between MRI ventricular volumes and histological lesion volume as well as number of apoptotic cells. A positive correlation was also observed between MRI CBF or cerebral blood volume (CBV) and histological synaptic density. Neurological functional tests were also significantly correlated with MRI ventricular volume and CBV. Our data demonstrated that MRI measurements can detect the effect of hUTC therapy on the brain reorganization and exhibited positive correlation with histological measurements of brain structural changes and functional behavioral tests after stroke. MRI ventricular volumes provided the most sensitive index in monitoring brain remodeling and treatment effects and highly correlated with histological and functional measurements.	[Jiang, Quan; Ding, Guang Liang; Zhang, Li; Nejad-Davarani, Siamak P.; Li, Lian; Li, Qing Jiang; Wang, Shi Yang; Li, Yi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Lu, Mei] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Arbab, Ali S.] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA; [Thiffault, Christine; Kramer, Brian C.; Hong, Klaudyne] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Navia, Brad; Victor, Stephen J.] Johnson & Johnson Pharmaceut Res & Dev, Titusville, NJ USA; [Jiang, Quan; Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Johnson & Johnson; Johnson & Johnson USA; Oakland University	Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.	qjiang1@hfhs.org	Arbab, Ali/AAS-1933-2020; Wang, Shiyang/C-1729-2012; Nejad-Davarani, Siamak/AAH-8399-2021	Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184	Advanced Technologies and Regenerative Medicine, LLC. [08-0320-TR]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134, P50NS023393, R01NS048349] Funding Source: NIH RePORTER	Advanced Technologies and Regenerative Medicine, LLC.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research presented herein was funded by Advanced Technologies and Regenerative Medicine, LLC. 08-0320-TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; BRIX G, 1990, MAGN RESON IMAGING, V8, P351, DOI 10.1016/0730-725X(90)90041-Y; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; DERYCK M, 1992, BRAIN RES, V573, P44; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Institution S, 2004, SAS ATAT 9 1 SOFTW; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Jiang Q, 2005, J CEREBR BLOOD F MET, V25, P583, DOI 10.1038/sj.jcbfm.9600053; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jin KL, 2004, J CEREBR BLOOD F MET, V24, P399, DOI 10.1097/00004647-200404000-00005; Johansen-Berg H, 2007, INT J STROKE, V2, P7, DOI 10.1111/j.1747-4949.2007.00093.x; KNIGHT RA, 1991, STROKE, V22, P802, DOI 10.1161/01.STR.22.6.802; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MATSON GB, 1994, MAGN RESON IMAGING, V12, P1205, DOI 10.1016/0730-725X(94)90086-7; Mintzopoulos D, 2009, NEUROIMAGE, V47, pT90, DOI 10.1016/j.neuroimage.2009.03.007; Navaratna D, 2009, CELL ADHES MIGR, V3, P216, DOI 10.4161/cam.3.2.8396; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Pourabdollah-Nejad S, 2009, P 17 ANN M INT SOC M, P3206; Pourabdollah-Nejad S, 2008, P 16 ANN M INT SOC M, P3332; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Walters RJL, 2003, J NEUROL NEUROSUR PS, V74, P213, DOI 10.1136/jnnp.74.2.213; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; WEILLER C, 1993, ANN NEUROL, V33, P181; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2005, STROKE UNPUB; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2002, TRENDS CARDIOVAS MED, V12, P62, DOI 10.1016/S1050-1738(01)00149-9; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	59	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42845	10.1371/journal.pone.0042845	http://dx.doi.org/10.1371/journal.pone.0042845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900057	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900075
J	Kakimoto, Y; Tsuruyama, T; Yamamoto, T; Furuta, M; Kotani, H; Ozeki, M; Yoshizawa, A; Haga, H; Tamaki, K				Kakimoto, Yu; Tsuruyama, Tatsuaki; Yamamoto, Takushi; Furuta, Masaru; Kotani, Hirokazu; Ozeki, Munetaka; Yoshizawa, Akihiko; Haga, Hironori; Tamaki, Keiji			Novel In Situ Pretreatment Method for Significantly Enhancing the Signal In MALDI-TOF MS of Formalin-Fixed Paraffin-Embedded Tissue Sections	PLOS ONE			English	Article							ANTIGEN RETRIEVAL; MASS-SPECTROMETRY; PROTEIN EXTRACTION; PROTEOMIC ANALYSIS; CANCER; SURFACTANTS; EXPRESSION; DIGESTION	The application of matrix-assisted laser desorption/ionization (MALDI)-based mass spectrometry (MS) to the proteomic analysis of formalin-fixed paraffin-embedded (FFPE) tissue presents significant technical challenges. In situ enzymatic digestion is frequently used to unlock formalin-fixed tissues for analysis, but the results are often unsatisfactory. Here, we report a new, simplified in situ pretreatment method for preparing tissue sections for MS that involves heating with vapor containing acetonitrile in a small airtight pressurized space. The utility of the novel method is shown using FFPE tissue of human colon carcinoma. The number and intensity of MALDI peaks obtained from analysis of pretreated tissue was significantly higher than control tissue not subjected to pretreatment. A prominent peak (m/z 850) apparently specific to cancerous tissue was identified as a fragment of histone H2A in FFPE tissue pretreated using our method. This highly sensitive treatment may enable MALDI-MS analysis of archived pathological FFPE samples, thus leading to the identification of new biomarkers.	[Kakimoto, Yu; Tsuruyama, Tatsuaki; Kotani, Hirokazu; Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan; [Yamamoto, Takushi; Furuta, Masaru] Shimadzu Co Ltd, Kyoto Applicat Dev Ctr, Analyt & Measuring Instruments Div, Kyoto, Japan; [Yoshizawa, Akihiko] Shinshu Univ Hosp, Grad Sch Med, Dept Diagnost Pathol, Matsumoto, Nagano, Japan; [Haga, Hironori] Kyoto Univ Hosp, Grad Sch Med, Dept Diagnost Pathol, Kyoto 606, Japan	Kyoto University; Shimadzu Corporation; Shinshu University; Kyoto University	Kakimoto, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.	tsuruyama@kuhp.kyoto-u.ac.jp	Yoshizawa, Akihiko/AAM-9519-2020	Haga, Hironori/0000-0003-4322-9561	Ministry of Education, Culture, Science and Technology, Japan; Ministry of Health, Welfare, and Labor, Japan	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Science and Technology, Japan, and by a grant from the Ministry of Health, Welfare, and Labor, Japan. The funding agencies had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bornsen KO, 2000, METH MOL B, V146, P387, DOI 10.1385/1-59259-045-4:387; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gustafsson JOR, 2010, J PROTEOME RES, V9, P4315, DOI 10.1021/pr9011766; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Kahveci Z, 2003, BIOTECH HISTOCHEM, V78, P119, DOI 10.1080/10520290310001593775; LEE TD, 1990, METHOD ENZYMOL, V193, P361, DOI 10.1016/0076-6879(90)93427-M; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Mandal SM, 2010, EUR J MASS SPECTROM, V16, P567, DOI 10.1255/ejms.1097; Maneta-Peyret L, 1999, HISTOCHEM J, V31, P541, DOI 10.1023/A:1003844107756; Naldi M, 2006, J CHROMATOGR A, V1129, P73, DOI 10.1016/j.chroma.2006.06.100; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Ronci M, 2008, PROTEOMICS, V8, P3702, DOI 10.1002/pmic.200701143; SHANRONG S, 2000, ANTIGEN RETRIEVAL TE; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sugiura Y., 2006, J MASS SPECTROM SOC, V54, P45, DOI DOI 10.5702/MASSSPEC.54.45; SUTTON CW, 1995, ELECTROPHORESIS, V16, P308, DOI 10.1002/elps.1150160151; Werner M, 1996, HISTOCHEM CELL BIOL, V105, P253, DOI 10.1007/BF01463928; Zhang N, 2004, RAPID COMMUN MASS SP, V18, P889, DOI 10.1002/rcm.1423	22	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41607	10.1371/journal.pone.0041607	http://dx.doi.org/10.1371/journal.pone.0041607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899997	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900012
J	Kim, L; Hoe, KL; Yu, YM; Yeon, JH; Maeng, PJ				Kim, Lila; Hoe, Kwang-Lae; Yu, Yeong Man; Yeon, Ji-Hyun; Maeng, Pil Jae			The Fission Yeast GATA Factor, Gaf1, Modulates Sexual Development via Direct Down-Regulation of ste11(+) Expression in Response to Nitrogen Starvation	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; ZINC-FINGER PROTEIN; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; MAP KINASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ECTOPIC MEIOSIS; G(1) ARREST; PHEROMONE	Gaf1 is the first GATA family zinc-finger transcription factor identified in Schizosaccharomyces pombe. Here, we report that Gaf1 functions as a negatively acting transcription factor of ste11(+), delaying the entrance of cells exposed to transient nitrogen starvation into the meiotic cycle. gaf1 Delta strains exhibited accelerated G(1)-arrest upon nitrogen starvation. Moreover, gaf1 Delta mutation caused increased mating and sporulation frequency under both nitrogen-starved and unstarved conditions, while overexpression of gaf1(+) led to a significant impairment of sporulation. By microarray analysis, we found that approximately 63% (116 genes) of the 183 genes up-regulated in unstarved gaf1 Delta cells were nitrogen starvation-responsive genes, and furthermore that 25 genes among the genes up-regulated by gaf1 Delta mutation are Ste11 targets (e.g., gpa1(+), ste4(+), spk1(+), ste11(+), and mei2(+)). The phenotype caused by gaf1 Delta mutation was masked by ste11 Delta mutation, indicating that ste11(+) is epistatic to gaf1(+) with respect to sporulation efficiency, and accordingly that gaf1(+) functions upstream of ste11(+) in the signaling pathway governing sexual development. gaf1 Delta strains showed accelerated ste11(+) expression under nitrogen starvation and increased ste11(+) expression even under normal conditions. Electrophoretic mobility shift assay analysis demonstrated that Gaf1 specifically binds to the canonical GATA motif (5'-HGATAR-3') spanning from -371 to -366 in ste11(+) promoter. Consequently, Gaf1 provides the prime example for negative regulation of ste11(+) transcription through direct binding to a cis-acting motif of its promoter.	[Kim, Lila; Yu, Yeong Man; Yeon, Ji-Hyun; Maeng, Pil Jae] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon, South Korea; [Hoe, Kwang-Lae] Chungnam Natl Univ, Grad Sch New Drug Discovery & Dev, Taejon, South Korea	Chungnam National University; Chungnam National University	Kim, L (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon, South Korea.	pjmaeng@cnu.ac.kr		Hoe, Kwang Lae/0000-0002-3943-4549; Maeng, Pil Jae/0000-0002-7677-3208	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST) [313-2008-2-C00778]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 313-2008-2-C00778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Charron F, 1999, MOL CELL BIOL, V19, P4355; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DAVEY J, 1994, CURR GENET, V26, P105, DOI 10.1007/BF00313796; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; EGEL R, 1973, MOL GEN GENET, V122, P339, DOI 10.1007/BF00269434; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoe KL, 1998, GENE, V215, P319, DOI 10.1016/S0378-1119(98)00301-1; IMAI Y, 1994, GENE DEV, V8, P328, DOI 10.1101/gad.8.3.328; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; KUNITOMO H, 1995, CURR GENET, V28, P32, DOI 10.1007/BF00311879; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2006, CURR GENET, V49, P403, DOI 10.1007/s00294-006-0067-0; Ohmiya R, 2000, MOL GEN GENET, V264, P441, DOI 10.1007/s004380000305; Pearson BM, 1998, YEAST, V14, P391, DOI 10.1002/(SICI)1097-0061(19980315)14:4<391::AID-YEA235>3.0.CO;2-O; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Shieh JC, 1998, J CELL SCI, V111, P2799; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Wang LL, 2005, GENETICS, V171, P1523, DOI 10.1534/genetics.105.047233; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Won M, 1999, BIOCHEM CELL BIOL, V77, P127, DOI 10.1139/bcb-77-2-127; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada H, 1997, J GEN APPL MICROBIOL, V43, P209, DOI 10.2323/jgam.43.209; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; Yamamoto TG, 2004, J CELL SCI, V117, P3875, DOI 10.1242/jcs.01248	50	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42409	10.1371/journal.pone.0042409	http://dx.doi.org/10.1371/journal.pone.0042409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900017	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900034
J	Xu, XF; Zhou, YQ; Xie, CG; Wei, SM; Gan, HZ; He, SL; Wang, F; Xu, L; Lu, J; Dai, WQ; He, L; Chen, P; Wang, XP; Guo, CY				Xu, Xuanfu; Zhou, Yingqun; Xie, Chuangao; Wei, Shu-mei; Gan, Huizhong; He, Shengli; Wang, Fan; Xu, Ling; Lu, Jie; Dai, Weiqi; He, Lei; Chen, Ping; Wang, Xingpeng; Guo, Chuanyong			Genome-Wide Screening Reveals an EMT Molecular Network Mediated by Sonic Hedgehog-Gli1 Signaling in Pancreatic Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; REGULATORY NETWORKS; UP-REGULATION; TARGET GENES; METASTASIS; INVASION; INHIBITION; EXPRESSION; S100A4	Aims: The role of sonic hedgehog (SHH) in epithelial mesenchymal transition (EMT) of pancreatic cancer (PC) is known, however, its mechanism is unclear. Because SHH promotes tumor development predominantly through Gli1, we sought to understand its mechanism by identifying Gli1 targets in pancreatic cancer cells. Methods: First, we investigated invasion, migration, and EMT in PC cells transfected with lentiviral Gli1 interference vectors or SHH over-expression vectors in vitro and in vivo. Next, we determined the target gene profiles of Gli1 in PC cells using cDNA microarray assays. Finally, the primary regulatory networks downstream of SHH-Gli1 signaling in PC cells were studied through functional analyses of these targets. Results: Our results indicate there is decreased E-cadherin expression upon increased expression of SHH/Gli1. Migration of PC cells increased significantly in a dose-dependent manner within 24 hours of Gli1 expression (P<0.05). The ratio of liver metastasis and intrasplenic miniature metastasis increased markedly upon activation of SHH-Gli1 signals in nude mice. Using cDNA microarray, we identified 278 upregulated and 59 downregulated genes upon Gli1 expression in AsPC-1 cells. The data indicate that SHH-Gli1 signals promote EMT by mediating a complex signaling network including TGF beta, Ras, Wnt, growth factors, PI3K/AKT, integrins, transmembrane 4 superfamily (TM4SF), and S100A4. Conclusion: Our results suggest that targeting the molecular connections established between SHH-Gli1 signaling and EMT could provide effective therapies for PC.	[Xu, Xuanfu; Zhou, Yingqun; Wang, Fan; Xu, Ling; Lu, Jie; Dai, Weiqi; He, Lei; Chen, Ping; Wang, Xingpeng; Guo, Chuanyong] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China; [Xie, Chuangao; Wei, Shu-mei] Zhejiang Univ, Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Gan, Huizhong] Anhui Med Univ, Peoples Hosp Hefei 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China; [He, Shengli] Fudan Univ, Dept Integrat Oncol, Minhang Branch, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Tongji University; Zhejiang University; Anhui Medical University; Fudan University	Xu, XF (corresponding author), Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China.	guochuanyong@yahoo.com.cn		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81072005, 81172312]; Shanghai Science and Technology Committee [10ZR1423300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was funded by grants from the National Natural Science Foundation of China (81072005 and 81172312) and Shanghai Science and Technology Committee (10ZR1423300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Botta GP, 2012, MOL CANCER RES, V10, P183, DOI 10.1158/1541-7786.MCR-11-0399; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Chen L, 2009, WORLD J GASTROENTERO, V15, P2270, DOI 10.3748/wjg.15.2270; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Dai JT, 2011, PANCREAS, V40, P233, DOI 10.1097/MPA.0b013e3181f7e09f; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lin Kimberly, 2010, Genes Cancer, V1, P409; Luncsford PJ, 2010, J MOL BIOL, V403, P351, DOI 10.1016/j.jmb.2010.08.045; Mfopou JK, 2007, STEM CELLS, V25, P1156, DOI 10.1634/stemcells.2006-0720; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nishio R, 2002, CANCER SCI, V102, P622; Partecke IL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-40; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki T, 2011, DRUG METAB PHARMACOK, V26, P374, DOI 10.2133/dmpk.DMPK-10-RG-103; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Walker E, 2011, CELL CYCLE, V10, P45, DOI 10.4161/cc.10.1.14389; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1	34	41	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43119	10.1371/journal.pone.0043119	http://dx.doi.org/10.1371/journal.pone.0043119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900095	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900113
J	Sciorra, VA; Sanchez, MA; Kunibe, A; Wurmser, AE				Sciorra, Vicki A.; Sanchez, Michael A.; Kunibe, Akemi; Wurmser, Andrew E.			Suppression of Glioma Progression by Egln3	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; STEM-CELLS; TUMOR VASCULATURE; GENE-EXPRESSION; ANGIOGENESIS; GLIOBLASTOMA; TUMORIGENESIS; NORMALIZATION; PHD2; HYDROXYLASE	Grade IV astrocytoma or glioblastoma has a poor clinical outcome that can be linked to hypoxia, invasiveness and active vascular remodeling. It has recently been suggested that hypoxia-inducible factors, Hifs, increase glioma growth and aggressiveness [1,2,3]. Here, we tested the hypothesis that Egl 9 homolog 3 (Egln3), a prolyl-hydroxylase that promotes Hif degradation, suppresses tumor progression of human and rodent glioma models. Through intracranial tumorigenesis and in vitro assays, we demonstrate for the first time that Egln3 was sufficient to decrease the kinetics of tumor progression and increase survival. We also find that Klf5, a transcription factor important to vascular remodeling, was regulated by hypoxia in glioma. An analysis of the tumor vasculature revealed that elevated Egln3 normalized glioma capillary architecture, consistent with a role for Egln3 in eliciting decreases in the production of Hif-regulated, angiogenic factors. We also find that the hydroxylase-deficient mutant, Egln3(H196A) partially maintained tumor suppressive activity. These results highlight a bifurcation of Egln3 signaling and suggest that Egln3 has a non-hydroxylase-dependent function in glioma. We conclude that Egln3 is a critical determinant of glioma formation and tumor vascular functionality.	[Sciorra, Vicki A.; Sanchez, Michael A.; Kunibe, Akemi; Wurmser, Andrew E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sciorra, VA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	aewurmser@yahoo.com			Berkeley Chancellor's Fellowship; Ellison Medical Foundation [AG-NS-0340-06]; Hellman Family Faculty Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	Berkeley Chancellor's Fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); Hellman Family Faculty Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.A.S. is supported by a Berkeley Chancellor's Fellowship. The authors thank the Ellison Medical Foundation for its financial support (Grant # AG-NS-0340-06; http://www.ellisonfoundation.org/index.jsp) and the Hellman Family Faculty Fund (http://vpaafw.chance.berkeley.edu/hellman.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Erez N, 2003, CANCER RES, V63, P8777; Garcia JA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe70; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hatzimichael E, 2010, EUR J HAEMATOL, V84, P47, DOI 10.1111/j.1600-0609.2009.01344.x; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	52	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40053	10.1371/journal.pone.0040053	http://dx.doi.org/10.1371/journal.pone.0040053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905089	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100002
J	Cimino, M; Thomas, C; Namouchi, A; Dubrac, S; Gicquel, B; Gopaul, DN				Cimino, Mena; Thomas, Christophe; Namouchi, Amine; Dubrac, Sarah; Gicquel, Brigitte; Gopaul, Deshmukh N.			Identification of DNA Binding Motifs of the Mycobacterium tuberculosis PhoP/PhoR Two-Component Signal Transduction System	PLOS ONE			English	Article							DENDRITIC CELLS; REGULATOR PHOP; IN-VIVO; VIRULENCE; EXPRESSION; TRANSCRIPTION; RECOGNITION; STRAIN; GENES; PHOSPHORYLATION	Background: The Mycobacterium tuberculosis PhoP/PhoR two-component signal transduction system controls the expression of about 2% of the genome and plays a major role in pathogenicity. However, its regulon has not been well characterized. Methodology/Principal Findings: The binding site of PhoP transcription regulator was identified in the upstream regions of msl3, pks2, lipF and fadD21 genes, by using gene fusions, electrophoretic mobility shift assays and DNase I footprinting experiments. A consensus sequence for PhoP binding was deduced. It consists of two direct repeats, DR1/DR2, associated with a third repeat, DR3, important in some cases for PhoP binding to DR1/DR2 but located at a variable distance from these direct repeats. DR1/DR2 and DR3 consensus sequences were used to screen the whole-genome sequence for other putative binding sites potentially corresponding to genes directly regulated by PhoP. The identified 87 genes, encoding transcription regulators, and proteins involved in secondary metabolites biosynthesis, transport and catabolism are proposed to belong to the PhoP regulon. Conclusions/Significance: A consensus sequence derived from the analysis of PhoP binding to four gene promoter regions is proposed. We show for the first time the involvement of a third direct repeat motif in this binding reaction. The consensus sequence was instrumented to study the global regulation mediated by PhoP in M. tuberculosis. This analysis leads to the identification of several genes that are potentially regulated by this key player.	[Cimino, Mena; Namouchi, Amine; Gicquel, Brigitte] Inst Pasteur, Unit Genet Mycobacterienne, Paris, France; [Thomas, Christophe; Gopaul, Deshmukh N.] Inst Pasteur, CNRS UMR 3525, Unite Plasticite Genome Bacterien, Paris, France; [Dubrac, Sarah] Inst Pasteur, Unite Rech Biol Bacteries Pathogenes Gram Positif, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cimino, M (corresponding author), Inst Pasteur, Unit Genet Mycobacterienne, Paris, France.	brigitte.gicquel@pasteur.fr		GOPAUL, Deshmukh/0000-0003-1631-3303; Sarah, Dubrac/0000-0002-9810-5390	7th Framework Program NEWTBVAC contract [HEALTH-F3-2009-241745]; FP7-REGPOT EUMEDNET; TB project [ANR-09-MIEN-024-02]; Institut Pasteur Starter grant [CNRS URA 2185]	7th Framework Program NEWTBVAC contract; FP7-REGPOT EUMEDNET; TB project; Institut Pasteur Starter grant	This study received funding from the 7th Framework Program NEWTBVAC contract, HEALTH-F3-2009-241745, the FP7-REGPOT EUMEDNET vs TB project, the ANR-09-MIEN-024-02 project and the Institut Pasteur Starter grant/CNRS URA 2185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dove SL, 2003, MOL MICROBIOL, V48, P863, DOI 10.1046/j.1365-2958.2003.03467.x; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goyal R, 2011, J BIOL CHEM, V286, P45197, DOI 10.1074/jbc.M111.307447; Groisman EA, 2006, COLD SPRING HARB SYM, V71, P251, DOI 10.1101/sqb.2006.71.005; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MILLER SI, 1990, INFECT IMMUN, V58, P3706, DOI 10.1128/IAI.58.11.3706-3710.1990; MURRAY A, 1992, MOL MICROBIOL, V6, P3331, DOI 10.1111/j.1365-2958.1992.tb02201.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Saviola B, 2003, INFECT IMMUN, V71, P1379, DOI 10.1128/IAI.71.3.1379-1388.2003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	42	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42876	10.1371/journal.pone.0042876	http://dx.doi.org/10.1371/journal.pone.0042876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880126	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900057
J	Agosta, F; Valsasina, P; Riva, N; Copetti, M; Messina, MJ; Prelle, A; Comi, G; Filippi, M				Agosta, Federica; Valsasina, Paola; Riva, Nilo; Copetti, Massimiliano; Messina, Maria Jose; Prelle, Alessandro; Comi, Giancarlo; Filippi, Massimo			The Cortical Signature of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MILD AD DEMENTIA; BRAIN ATROPHY; MOTOR CORTEX; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; TRACT DAMAGE; WHOLE-BRAIN; ALS; THICKNESS	The aim of this study was to explore the pattern of regional cortical thickness in patients with non-familial amyotrophic lateral sclerosis (ALS) and to investigate whether cortical thinning is associated with disease progression rate. Cortical thickness analysis was performed in 44 ALS patients and 26 healthy controls. Group differences in cortical thickness and the age-by-group effects were assessed using vertex-by-vertex and multivariate linear models. The discriminatory ability of MRI variables in distinguishing patients from controls was estimated using the Concordance Statistics (C-statistic) within logistic regression analyses. Correlations between cortical thickness measures and disease progression rate were tested using the Pearson coefficient. Relative to controls, ALS patients showed a bilateral cortical thinning of the primary motor, prefrontal and ventral frontal cortices, cingulate gyrus, insula, superior and inferior temporal and parietal regions, and medial and lateral occipital areas. There was a significant age-by-group effect in the sensorimotor cortices bilaterally, suggesting a stronger association between age and cortical thinning in ALS patients compared to controls. The mean cortical thickness of the sensorimotor cortices distinguished patients with ALS from controls (C-statistic >= 0.74). Cortical thinning of the left sensorimotor cortices was related to a faster clinical progression (r = -0.33, p = 0.03). Cortical thickness measurements allowed the detection and quantification of motor and extramotor involvement in patients with ALS. Cortical thinning of the precentral gyrus might offer a marker of upper motor neuron involvement and disease progression.	[Agosta, Federica; Valsasina, Paola; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy; [Riva, Nilo; Messina, Maria Jose; Comi, Giancarlo; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Dept Neurol,Inst Expt Neurol, Milan, Italy; [Copetti, Massimiliano] IRCCS Osped Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [Prelle, Alessandro] Osped Maggiore Crema, Neurol Unit, Crema, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Casa Sollievo Della Sofferenza	Agosta, F (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy.	filippi.massimo@hsr.it	Riva, Nilo/J-7187-2012; Agosta, Federica/J-9908-2016; Valsasina, Paola/K-5820-2016; Filippi, Massimo/K-1755-2018; COPETTI, MASSIMILIANO/K-3186-2016	Riva, Nilo/0000-0002-0513-9517; prelle, alessandro/0000-0002-7019-5291; Agosta, Federica/0000-0003-3121-4979; Valsasina, Paola/0000-0001-5390-2655; Filippi, Massimo/0000-0002-5485-0479; COPETTI, MASSIMILIANO/0000-0002-7960-5947				Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2010, AM J NEURORADIOL, V31, P1769, DOI 10.3174/ajnr.A2043; Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gredal O, 2000, J NEUROSCI METH, V95, P171, DOI 10.1016/S0165-0270(99)00175-2; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Grosskreutz J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-17; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kassubek J, 2005, AMYOTROPH LATERAL SC, V6, P213, DOI 10.1080/14660820510038538; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; TSERMENTSELI S, 2011, CORTEX; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verstraete E, 2011, J NEUROL NEUROSURG P; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664	41	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42816	10.1371/journal.pone.0042816	http://dx.doi.org/10.1371/journal.pone.0042816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880116	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000075
J	Chua, JC; Douglass, JA; Gillman, A; O'Hehir, RE; Meeusen, EN				Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.; Meeusen, Els N.			Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation	PLOS ONE			English	Article							LEYDEN CRYSTAL PROTEIN; EXHALED NITRIC-OXIDE; ALLERGIC RHINITIS; INDUCED SPUTUM; ASTHMA; HYPERRESPONSIVENESS; EXACERBATIONS; SUBTYPES; DISEASE; COUNTS	Measurement of eosinophilic airway inflammation can assist in the diagnosis of allergic asthma and in the management of exacerbations, however its clinical implementation remains difficult. Galectin-10 has been associated with eosinophilic inflammation and has the potential to be used as a surrogate biomarker. This study aimed to assess the relationship between galectin-10 in sputum with sputum eosinophil counts, the current gold standard of eosinophil inflammation in the lung. Thirty-eight sputum samples were processed for both eosinophil counts by cytospins and semi-quantitative measurements of galectin-10 by western blots. A strong association was observed between galectin-10 levels in sputum and sputum eosinophil measurements, and they accurately determined sputum eosinophilia. The results support the potential for galectin-10 to be used as a surrogate biomarker of eosinophilic airway inflammation.	[Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Chua, Justin C.; Douglass, Jo A.; Gillman, Andrew; O'Hehir, Robyn E.] Monash Univ, Melbourne, Vic 3004, Australia; [Meeusen, Els N.] Monash Univ, Biotechnol Res Labs, Sch Biomed Sci, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Chua, JC (corresponding author), Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia.	mail@jodouglass.com	O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Douglass, Jo/0000-0002-1200-8048; Meeusen, Els/0000-0003-1239-6287; Chua, Justin/0000-0002-2399-9078	Australian Research Council	Australian Research Council(Australian Research Council)	Funding was provided by The Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Al-Samri M, 2010, J ALLERGY CLIN IMMUN; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Carlsson MC, BIOCH BIOPHYS ACTA; Chlumsky J, 2006, J INT MED RES, V34, P129, DOI 10.1177/147323000603400202; De Re V, 2009, ANN NY ACAD SCI, V1173, P357, DOI 10.1111/j.1749-6632.2009.04627.x; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DOR PJ, 1984, AM REV RESPIR DIS, V130, P1072; Dunphy JL, 2002, J BIOL CHEM, V277, P14916, DOI 10.1074/jbc.M200214200; Dvorak Ann M, 2005, Chem Immunol Allergy, V85, P89; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Leuppi JD, 2001, EUR RESPIR J, V18, P444, DOI 10.1183/09031936.01.00058601; Lovett CJ, 2007, CLIN EXP ALLERGY, V37, P1594, DOI 10.1111/j.1365-2222.2007.02839.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Patil SU, 2010, ALLERGY ASTHMA PROC, V31, P259, DOI 10.2500/aap.2010.31.3350; Pavord ID, 2008, J ASTHMA, V45, P523, DOI 10.1080/02770900801978557; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Petsky HL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005603.pub2; Porsbjerg C, 2009, J ASTHMA, V46, P606, DOI 10.1080/02770900903015654; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2010, RESPIRATION, V79, P147, DOI 10.1159/000245899; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Taylor DR, 2011, J ALLERGY CLIN IMMUN, V128, P927, DOI 10.1016/j.jaci.2011.03.051	31	43	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42549	10.1371/journal.pone.0042549	http://dx.doi.org/10.1371/journal.pone.0042549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880030	Green Published, gold			2022-12-25	WOS:000307810000045
J	Ding, SL; Walton, KLW; Blue, RE; MacNaughton, K; Magness, ST; Lund, PK				Ding, Shengli; Walton, Kristen L. W.; Blue, Randall Eric; MacNaughton, Kirk; Magness, Scott T.; Lund, Pauline Kay			Mucosal Healing and Fibrosis after Acute or Chronic Inflammation in Wild Type FVB-N Mice and C57BL6 Procollagen alpha 1(I)-Promoter-GFP Reporter Mice	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; INTESTINAL FIBROSIS; TRANSGENIC MICE; CROHNS-DISEASE; SUSCEPTIBILITY; EXPRESSION; ALPHA-1(I); CELLS; FIBROGENESIS; MODELS	Background: Injury and intestinal inflammation trigger wound healing responses that can restore mucosal architecture but if chronic, can promote intestinal fibrosis. Intestinal fibrosis is a major complication of Crohn's disease. The cellular and molecular basis of mucosal healing and intestinal fibrosis are not well defined and better understanding requires well characterized mouse models. Methods: FVB-N wild type mice and C57BL6 procollagen alpha 1(I)-GFP reporter mice were given one (DSS1) or two (DSS2) cycles of 3% DSS (5 days/cycle) followed by 7 days recovery. Histological scoring of inflammation and fibrosis were performed at DSS1, DSS1+3, DSS1+7, DSS2, DSS2+3, and DSS2+7. Procollagen alpha 1(I)-GFP activation was assessed in DSS and also TNBS models by whole colon GFP imaging and fluorescence microscopy. Colocalization of GFP with alpha-smooth muscle actin (alpha-SMA) or vimentin was examined. GFP mRNA levels were tested for correlation with endogenous collagen alpha 1(I) mRNA. Results: Males were more susceptible to DSS-induced disease and mortality than females. In FVB-N mice one DSS cycle induced transient mucosal inflammation and fibrosis that resolved by 7 days of recovery. Two DSS cycles induced transmural inflammation and fibrosis in a subset of FVB-N mice but overall, did not yield more consistent, severe or sustained fibrosis. In C57BL6 mice, procollagen alpha 1(I)-GFP reporter was activated at the end of DSS1 and through DSS+7 with more dramatic and transmural activation at DSS2 through DSS2+7, and in TNBS treated mice. In DSS and TNBS models GFP reporter expression localized to vimentin(+) cells and much fewer alpha-SMA(+) cells. GFP mRNA strongly correlated with collagen alpha 1(I) mRNA. Conclusions: One DSS cycle in FVB-N mice provides a model to study mucosal injury and subsequent mucosal healing. The procollagen alpha 1(I)-GFP transgenic provides a useful model to study activation of a gene encoding a major extracellular matrix protein during acute or chronic experimental intestinal inflammation and fibrosis.	[Ding, Shengli; MacNaughton, Kirk] Univ N Carolina, Dept Cell & Mol Physiol, Histol Core Facil, Chapel Hill, NC 27515 USA; [Walton, Kristen L. W.] Missouri Western State Univ, Dept Biol, St Joseph, MO USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ding, SL (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Histol Core Facil, Chapel Hill, NC 27515 USA.	shengli_ding@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Walton, Kristen/GMO-7132-2022	Magness, Scott/0000-0002-2746-1224	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK047769-12]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK047769-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOPER HS, 1993, LAB INVEST, V69, P238; Dave Maneesh, 2012, Gastroenterol Hepatol (N Y), V8, P29; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Klopcic B, 2008, DIGEST DIS SCI, V53, P1553, DOI 10.1007/s10620-007-0068-y; Koon HW, 2010, AM J PATHOL, V177, P2300, DOI 10.2353/ajpath.2010.100314; Krempen K, 1999, GENE EXPRESSION, V8, P151; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Luna J, 2011, AM J PHYSIOL-GASTR L, V300, pG703, DOI 10.1152/ajpgi.00504.2010; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mahavadi S, 2011, INFLAMM BOWEL DIS, V17, P711, DOI 10.1002/ibd.21437; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG1307, DOI 10.1152/ajpgi.2000.279.6.G1307; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Sasaoka T, 2011, AM J PHYSIOL-GASTR L, V300, pG568, DOI 10.1152/ajpgi.00329.2010; Strober W, 2009, CURR MOL MED, V9, P740, DOI 10.2174/156652409788970652; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; Szabo H, 2010, ALIMENT PHARM THER, V31, P189, DOI 10.1111/j.1365-2036.2009.04171.x; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Vermeire S, 2001, GASTROENTEROLOGY, V120, P834, DOI 10.1053/gast.2001.22453; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067	30	28	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42568	10.1371/journal.pone.0042568	http://dx.doi.org/10.1371/journal.pone.0042568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880035	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100131
J	Roberts, BJ; Catterall, CP; Eby, P; Kanowski, J				Roberts, Billie J.; Catterall, Carla P.; Eby, Peggy; Kanowski, John			Long-Distance and Frequent Movements of the Flying-Fox Pteropus poliocephalus: Implications for Management	PLOS ONE			English	Article							FRUIT-BATS; HENDRA VIRUS; PTEROPODIDAE; CHIROPTERA; LANDBIRDS	Flying-foxes (Pteropodidae) are large bats capable of long-distance flight. Many species are threatened; some are considered pests. Effective conservation and management of flying-foxes are constrained by lack of knowledge of their ecology, especially of movement patterns over large spatial scales. Using satellite telemetry, we quantified long-distance movements of the grey-headed flying-fox Pteropus poliocephalus among roost sites in eastern Australia. Fourteen adult males were tracked for 2-40 weeks (mean 25 weeks). Collectively, these individuals utilised 77 roost sites in an area spanning 1,075 km by 128 km. Movement patterns varied greatly between individuals, with some travelling long distances. Five individuals travelled cumulative distances >1,000 km over the study period. Five individuals showed net displacements >300 km during one month, including one movement of 500 km within 48 hours. Seasonal movements were consistent with facultative latitudinal migration in part of the population. Flying-foxes shifted roost sites frequently: 64% of roost visits lasted <5 consecutive days, although some individuals remained at one roost for several months. Modal 2-day distances between consecutive roosts were 21-50 km (mean 45 km, range 3-166 km). Of 13 individuals tracked for >12 weeks, 10 moved >100 km in one or more weeks. Median cumulative displacement distances over 1, 10 and 30 weeks were 0 km, 260 km and 821 km, respectively. On average, over increasing time-periods, one additional roost site was visited for each additional 100 km travelled. These findings explain why culling and relocation attempts have had limited success in resolving human-bat conflicts in Australia. Flying-foxes are highly mobile between camps and regularly travel long distances. Consequently, local control actions are likely to have only temporary effects on local flying-fox populations. Developing alternative methods to manage these conflicts remains an important challenge that should be informed by a better understanding of the species' movement patterns.	[Roberts, Billie J.; Catterall, Carla P.; Kanowski, John] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [Roberts, Billie J.; Catterall, Carla P.; Kanowski, John] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Eby, Peggy] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Kanowski, John] Australian Wildlife Conservancy, Malanda, Qld, Australia	Griffith University; Griffith University; University of New South Wales Sydney	Roberts, BJ (corresponding author), Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia.	billie.roberts@griffith.edu.au	Catterall, Carla P/K-7996-2017	Catterall, Carla P/0000-0002-1914-0455	Queensland Department of Environment and Resource Management; Griffith University	Queensland Department of Environment and Resource Management; Griffith University(Griffith University)	This study was part funded by the Queensland Department of Environment and Resource Management and by a PhD scholarship awarded by Griffith University to BR. New South Wales National Parks and Wildlife Service (Grafton) provided additional in-kind support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berthold P, 2001, AUK, V2nd; Birt P, 2005, THESIS U QUEENSLAND; Birtchnell M. J., 2008, FLOWERING ECOLOGY HO; Breed A, 2010, AUST VET J, V88, pN24; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Chan J, 2007, THESIS U NEW S WALES; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Churchill S, 2008, AUSTR BATS, V2nd; Dickman Chris, 2002, P20; Duncan AM, 1999, ACTION PLAN AUSTR BA; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Eby P, 2007, FLYING FOX ROOSTS GR; Eby P., 2002, MANAGING GREY HEADED; Eby P., 2008, RANKING FEEDING HABI; EBY P, 1996, THESIS U NEW ENGLAND; Eby Peggy, 2002, P273; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Fleming TH, 2003, BAT ECOLOGY, P156; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Hall L.S., 2000, FLYING FOXES FRUIT B; Hall Leslie S., 2002, P215; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hyne R, 2010, AUST VET J, V88, pN20; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Keith D.A., 2004, OCEAN SHORES DESERT; Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030; LUNNEY D, 2008, PTEROPUS POLIOCEPHAL; Lunney D., 1997, AUSTR EVER CHANGING, P247; Markus N, 2001, THESIS U QUEENSLAND; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; McWilliam A.N., 1986, Myotis, V23-24, P201; Mickleburgh S., 1992, OLD WORLD FRUIT BATS, DOI https://doi.org/10.2305/IUCN.CH.1992.SSC-AP.6.en; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; NELSON J. E., 1965, AUSTRALIAN J ZOOL, V13, P53, DOI 10.1071/ZO9650053; Palmer C, 1999, WILDLIFE RES, V26, P823, DOI 10.1071/WR97106; PARRYJONES KA, 1992, WILDLIFE RES, V19, P331, DOI 10.1071/WR9920331; Philbey AW, 2008, AUST VET J, V86, P449, DOI 10.1111/j.1751-0813.2008.00361.x; Pierson Elizabeth D., 1992, U S Fish and Wildlife Service Biological Report, V90, P1; Ratcliffe FN, 1931, COUNCIL SCI IND RES, V53; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Rogers John, 2002, P58; Sinclair EA, 1996, BIOL CONSERV, V76, P45, DOI 10.1016/0006-3207(95)00086-0; Singaravelan N, 2009, ORYX, V43, P608, DOI 10.1017/S0030605309990391; Smith CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014696; SPENCER HJ, 1991, WILDLIFE RES, V18, P463, DOI 10.1071/WR9910463; Thiriet D., 2010, AUSTRALASIAN J NATUR, V13, P161; Tidemann CR, 1999, ACTA CHIROPTEROL, V1, P151; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Tidemann CR, 1997, AUSTR BIOL, V10, P179; Waples Kelly, 2002, P39; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075; West Carole, 2002, P176; Wilson DE, 1992, P INT CONS C	56	66	75	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42532	10.1371/journal.pone.0042532	http://dx.doi.org/10.1371/journal.pone.0042532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880021	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100122
J	Sun, S; Ke, RQ; Hughes, D; Nilsson, M; Andersson, DI				Sun, Song; Ke, Rongqin; Hughes, Diarmaid; Nilsson, Mats; Andersson, Dan I.			Genome-Wide Detection of Spontaneous Chromosomal Rearrangements in Bacteria	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; ESCHERICHIA-COLI CHROMOSOME; PADLOCK PROBES; STRUCTURAL VARIATION; RECOMBINATION; SALMONELLA; DELETION; TRANSPOSASE; HOMOLOGIES; EVOLUTION	Genome rearrangements have important effects on bacterial phenotypes and influence the evolution of bacterial genomes. Conventional strategies for characterizing rearrangements in bacterial genomes rely on comparisons of sequenced genomes from related species. However, the spectra of spontaneous rearrangements in supposedly homogenous and clonal bacterial populations are still poorly characterized. Here we used 454 pyrosequencing technology and a 'split mapping' computational method to identify unique junction sequences caused by spontaneous genome rearrangements in chemostat cultures of Salmonella enterica Var. Typhimurium LT2. We confirmed 22 unique junction sequences with a junction microhomology more than 10 bp and this led to an estimation of 51 true junction sequences, of which 28, 12 and 11 were likely to be formed by deletion, duplication and inversion events, respectively. All experimentally confirmed rearrangements had short inverted (inversions) or direct (deletions and duplications) homologous repeat sequences at the endpoints. This study demonstrates the feasibility of genome wide characterization of spontaneous genome rearrangements in bacteria and the very high steady-state frequency (20-40%) of rearrangements in bacterial populations.	[Sun, Song; Hughes, Diarmaid; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ke, Rongqin; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Uppsala University	Sun, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	dan.andersson@imbim.uu.se	Ke, Rongqin/P-2701-2019; Hughes, Diarmaid/A-9487-2014	Ke, Rongqin/0000-0002-9868-3713; Hughes, Diarmaid/0000-0002-7456-9182; Andersson, Dan/0000-0001-6640-2174	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; ANDERSON P, 1981, P NATL ACAD SCI-BIOL, V78, P3113, DOI 10.1073/pnas.78.5.3113; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Bierne H, 1997, MOL MICROBIOL, V24, P1225, DOI 10.1046/j.1365-2958.1997.4381795.x; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Dahl F, 2004, P NATL ACAD SCI USA, V101, P4548, DOI 10.1073/pnas.0400834101; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; EGNER C, 1981, P NATL ACAD SCI-BIOL, V78, P459, DOI 10.1073/pnas.78.1.459; Henriksson S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-37; Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; LOVETT ST, 1993, GENETICS, V135, P631; MAHAN MJ, 1988, GENETICS, V120, P23; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Rappleye CA, 1997, J BACTERIOL, V179, P2047, DOI 10.1128/jb.179.6.2047-2052.1997; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; REBOLLO JE, 1988, P NATL ACAD SCI USA, V85, P9391, DOI 10.1073/pnas.85.24.9391; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; Saveson CJ, 1997, GENETICS, V146, P457; SEGALL A, 1988, SCIENCE, V241, P1314, DOI 10.1126/science.3045970; SEGALL AM, 1989, GENETICS, V122, P737; SHIMIZU H, 1995, GENETICS, V140, P889; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wamsley HL, 2008, J CLIN MICROBIOL, V46, P2314, DOI 10.1128/JCM.02197-07; ZIEG J, 1977, J BACTERIOL, V131, P123, DOI 10.1128/JB.131.1.123-132.1977	34	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42639	10.1371/journal.pone.0042639	http://dx.doi.org/10.1371/journal.pone.0042639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880062	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100146
J	Laurent-Matha, V; Huesgen, PF; Masson, O; Derocq, D; Prebois, C; Gary-Bobo, M; Lecaille, F; Rebiere, B; Meurice, G; Orear, C; Hollingsworth, RE; Abrahamson, M; Lalmanach, G; Overall, CM; Liaudet-Coopman, E				Laurent-Matha, Valerie; Huesgen, Pitter F.; Masson, Olivier; Derocq, Danielle; Prebois, Christine; Gary-Bobo, Magali; Lecaille, Fabien; Rebiere, Bertrand; Meurice, Guillaume; Orear, Cedric; Hollingsworth, Robert E.; Abrahamson, Magnus; Lalmanach, Gilles; Overall, Christopher M.; Liaudet-Coopman, Emmanuelle			Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment	FASEB JOURNAL			English	Article						cancer; protease web	PROTEASE CLEAVAGE PRODUCTS; CYSTEINE CATHEPSINS; LUNG METASTASIS; TUMOR-GROWTH; N-TERMINOME; D INTERACTS; CELLS; ACTIVATION; RECEPTOR; IDENTIFICATION	The aspartic protease cathepsin D, a poor prognostic indicator of breast cancer, is abundantly secreted as procathepsin D by human breast cancer cells and self-activates at low pH in vitro, giving rise to catalytically active cathepsin D. Due to a lower extracellular pH in tumor microenvironments compared to normal tissues, cathepsin D may cleave pathophysiological substrates contributing to cancer progression. Here, we show by yeast 2-hybrid and degradomics analyses that cystatin C, the most potent natural secreted inhibitor of cysteine cathepsins, both binds to and is a substrate of extracellular procathepsin D. The amount of cystatin C in the extracellular environment is reduced in the secretome of mouse embryonic fibroblasts stably transfected with human cathepsin D. Cathepsin D extensively cleaved cystatin C in vitro at low pH. Cathepsin D secreted by breast cancer cells also processed cystatin C at the pericellular pH of tumors and so enhancing extracellular proteolytic activity of cysteine cathepsins. Thus, tumor derived cathepsin D assists breast cancer progression by reducing cystatin C activity, which, in turn, enhances cysteine cathepsin proteolytic activity, revealing a new link between protease classes in the protease web.-Laurent-Matha, V., Huesgen, P. F., Masson, O., Derocq, D., Prebois, C., Gary-Bobo, M., Lecaille, F., Rebiere, B., Meurice, G., Orear, C., Hollingsworth, R. E., Abrahamson, M., Lalmanach, G., Overall, C. M., Liaudet-Coopman, E. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 26, 5172-5181 (2012). www.fasebj.org	[Laurent-Matha, Valerie; Masson, Olivier; Derocq, Danielle; Prebois, Christine; Gary-Bobo, Magali; Liaudet-Coopman, Emmanuelle] Univ Montpellier I, INSERM, U896, IRCM, F-34298 Montpellier, France; [Laurent-Matha, Valerie; Masson, Olivier; Derocq, Danielle; Prebois, Christine; Gary-Bobo, Magali; Liaudet-Coopman, Emmanuelle] Ctr Reg Lutte Canc CRLC, Montpellier, France; [Huesgen, Pitter F.; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Lecaille, Fabien; Lalmanach, Gilles] Univ Tours, INSERM, U1100, Fac Med, Tours, France; [Rebiere, Bertrand] CNRS, UMR 5237, CRBM, Montpellier, France; [Meurice, Guillaume; Orear, Cedric] Inst Gustave Roussy, Villejuif, France; [Hollingsworth, Robert E.] Medimmune Inc, Oncol Res, Gaithersburg, MD 20878 USA; [Abrahamson, Magnus] Lund Univ, Univ Hosp, Div Clin Chem, Dept Lab Med, Lund, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of British Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UNICANCER; Gustave Roussy; AstraZeneca; Medimmune; Lund University; Skane University Hospital	Liaudet-Coopman, E (corresponding author), Univ Montpellier I, INSERM, U896, IRCM, 208 Rue Apothicaires, F-34298 Montpellier, France.	emmanuelle.liaudet-coopman@inserm.fr	Abrahamson, Magnus/CAG-9507-2022; Bonnemaison, Marc/AAD-9243-2021; Huesgen, Pitter/E-9246-2019; Liaudet-Coopman, Emmanuelle/N-4744-2017; Lecaille, Fabien/GRY-5313-2022	Huesgen, Pitter/0000-0002-0335-2242; Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Lalmanach, Gilles/0000-0001-8562-4821; Lecaille, Fabien/0000-0003-1060-4222; Rebiere, Bertrand/0000-0002-1767-6547; Valerie, LAURENT-MATHA/0000-0002-3277-7397	INSERM, University of Montpellier I; Agence Nationale de la Recherche (ANR) Jeunes Chercheuses, Jeunes Chercheurs; HEMORES consortium (EU FP6) [LSHC-CT-2007-037665]; Canadian Institutes of Health Research; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research, Vancouver, BC, Canada); British Columbia Proteomics Network	INSERM, University of Montpellier I; Agence Nationale de la Recherche (ANR) Jeunes Chercheuses, Jeunes Chercheurs(French National Research Agency (ANR)); HEMORES consortium (EU FP6); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research, Vancouver, BC, Canada); British Columbia Proteomics Network	The authors thank Alix Joulin-Giet [Institut National de la Sante et de la Recherche Medicale (INSERM) U1100, Universite Francois Rabelais, Tours, France] for Western blot analysis of cysteine cathepsins. The authors thank Dr. Vladimir Lazar (head of genomic core facilities at Institut Gustave Roussy, Villejuif, France) and the CHEMORES consortium for transcriptomic experiments. The authors thank Simon Thezenas (Centre Regional de Lutte Contre le Cancer Val D'Aurelle Paul Lamarque, Montpellier, France) for statistical analysis, and Dr. Owen Parkes (Romagne, France) for checking the English text. This work was supported by INSERM, University of Montpellier I; Agence Nationale de la Recherche (ANR) Jeunes Chercheuses, Jeunes Chercheurs, which provided a fellowship for V. L. M.; the CHEMORES consortium (EU FP6; grant LSHC-CT-2007-037665); a Canadian Institutes of Health Research grant (C.M.O.); an infrastructure grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research, Vancouver, BC, Canada); and the British Columbia Proteomics Network. C.M.O. holds a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology. INSERM U896 and INSERM U1100 are affiliated with LabEx MabImprove (Tours and Montpellier, France).	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Brisson L, 2011, ONCOGENE, V30, P2070, DOI 10.1038/onc.2010.574; CAPONY F, 1989, CANCER RES, V49, P3904; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Derocq D, 2012, ONCOGENE, V31, P3202, DOI 10.1038/onc.2011.501; Dunn BM, 2000, BBA-PROTEIN STRUCT M, V1477, P231, DOI 10.1016/S0167-4838(99)00275-7; Ferrandina G, 1997, BRIT J CANCER, V76, P661, DOI 10.1038/bjc.1997.442; Foekens JA, 1999, BRIT J CANCER, V79, P300, DOI 10.1038/sj.bjc.6990048; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Griffiths J R, 2001, Novartis Found Symp, V240, P46; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; HASILIK A, 1982, EUR J BIOCHEM, V125, P317, DOI 10.1111/j.1432-1033.1982.tb06685.x; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Jelassi B, 2011, ONCOGENE, V30, P2108, DOI 10.1038/onc.2010.593; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; Laurent-Matha V, 2002, EXP CELL RES, V277, P210, DOI 10.1006/excr.2002.5556; LENARCIC B, 1991, FEBS LETT, V280, P211, DOI 10.1016/0014-5793(91)80295-E; LENARCIC B, 1988, BIOCHEM BIOPH RES CO, V154, P765, DOI 10.1016/0006-291X(88)90206-9; Martino S, 2011, INT J BIOCHEM CELL B, V43, P775, DOI 10.1016/j.biocel.2011.02.001; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Tholen S, 2011, BIOL CHEM, V392, P961, DOI [10.1515/BC-2011-162, 10.1515/BC.2011.162]; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; vanderStappen JWJ, 1996, INT J CANCER, V67, P547, DOI 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4; VIGNON F, 1986, ENDOCRINOLOGY, V118, P1537, DOI 10.1210/endo-118-4-1537; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; WATABE S, 1983, BIOCHEM BIOPH RES CO, V110, P934, DOI 10.1016/0006-291X(83)91052-5; Wegiel B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007953	44	45	46	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5172	5181		10.1096/fj.12-205229	http://dx.doi.org/10.1096/fj.12-205229			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22898924	Green Submitted			2022-12-25	WOS:000311838300037
J	Hasan, NM; Gupta, A; Polishchuk, E; Yu, CH; Polishchuk, R; Dmitriev, OY; Lutsenko, S				Hasan, Nesrin M.; Gupta, Arnab; Polishchuk, Elena; Yu, Corey H.; Polishchuk, Roman; Dmitriev, Oleg Y.; Lutsenko, Svetlana			Molecular Events Initiating Exit of a Copper-transporting ATPase ATP7B from the Trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; N-TERMINAL DOMAIN; MENKES DISEASE; FUNCTIONAL EXPRESSION; DEPENDENT INTERACTION; TRAFFICKING; BINDING; GENE; SIGNALS; PHOSPHORYLATION	The copper-transporting ATPase ATP7B has a dual intracellular localization: the trans-Golgi network (TGN) and cytosolic vesicles. Changes in copper levels, kinase-mediated phosphorylation, and mutations associated with Wilson disease alter the steady-state distribution of ATP7B between these compartments. To identify a primary molecular event that triggers ATP7B exit from the TGN, we characterized the folding, activity, and trafficking of the ATP7B variants with mutations within the regulatory N-terminal domain (N-ATP7B). We found that structural changes disrupting the inter-domain contacts facilitate ATP7B exit from the TGN. Mutating Ser-340/341 in the N-ATP7B individually or together to Ala, Gly, Thr, or Asp produced active protein and shifted the steady-state localization of ATP7B to vesicles, independently of copper levels. The Ser340/341G mutant had a lower kinase-mediated phosphorylation under basal conditions and no copper-dependent phosphorylation. Thus, negative charges introduced by copper-dependent phosphorylation are not obligatory for ATP7B trafficking from the TGN. The Ser340/341A mutation did not alter the overall fold of N-ATP7B, but significantly decreased interactions with the nucleotide-binding domain, mimicking consequences of copper binding to N-ATP7B. We propose that structural changes that specifically alter the inter-domain contacts initiate exit of ATP7B from the TGN, whereas increased phosphorylation may be needed to maintain an open interface between the domains.	[Polishchuk, Elena; Polishchuk, Roman] Telethon Inst Genet & Med, Naples, Italy; [Hasan, Nesrin M.; Gupta, Arnab; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Polishchuk, Elena] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Yu, Corey H.; Dmitriev, Oleg Y.] Univ Saskatchewan, Saskatoon, SK S7N 5E5, Canada	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Johns Hopkins University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Saskatchewan	Lutsenko, S (corresponding author), 725N Wolfe St, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Dmitriev, Oleg/AAB-7830-2019		National Institutes of Health [DK071865, P01GM067166]; Telethon [GTF08001, TRPCB4TELD]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071865 and P01GM067166 (to S. L.) and by Telethon Grants GTF08001 and TRPCB4TELD (to R. P.).	Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bartee MY, 2007, BIOMETALS, V20, P627, DOI 10.1007/s10534-006-9074-3; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braiterman L, 2009, AM J PHYSIOL-GASTR L, V296, pG433, DOI 10.1152/ajpgi.90489.2008; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Materia S, 2012, J BIOL CHEM, V287, P2485, DOI 10.1074/jbc.M111.302216; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	34	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36041	36050		10.1074/jbc.M112.370403	http://dx.doi.org/10.1074/jbc.M112.370403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898812	Green Published, hybrid			2022-12-25	WOS:000310364000026
J	Singh, NK; Kundumani-Sridharan, V; Kumar, S; Verma, SK; Kotla, S; Mukai, H; Heckle, MR; Rao, GN				Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Kumar, Sanjay; Verma, Shailendra K.; Kotla, Sivareddy; Mukai, Hideyuki; Heckle, Mark R.; Rao, Gadiparthi N.			Protein Kinase N1 Is a Novel Substrate of NFATc1-mediated Cyclin D1-CDK6 Activity and Modulates Vascular Smooth Muscle Cell Division and Migration Leading to Inward Blood Vessel Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ACTIVATED T-CELLS; GROWTH-FACTOR RECEPTOR; MONOCYTE CHEMOATTRACTANT; NUCLEAR FACTOR; NEOINTIMA FORMATION; TRANSCRIPTION; INJURY; RHO; PHOSPHORYLATION	Toward understanding the mechanisms of vascular wall remodeling, here we have studied the role of NFATc1 in MCP-1-induced human aortic smooth muscle cell (HASMC) growth and migration and injury-induced rat aortic wall remodeling. We have identified PKN1 as a novel downstream target of NFATc1-cyclin D1/CDK6 activity in mediating vascular wall remodeling following injury. MCP-1, a potent chemoattractant protein, besides enhancing HASMC motility, also induced its growth, and these effects require NFATc1-dependent cyclin D1 expression and CDK4/6 activity. In addition, MCP-1 induced PKN1 activation in a sustained and NFATc1-cyclin D1/CDK6-dependent manner. Furthermore, PKN1 activation is required for MCP-1-induced HASMC growth and migration. Balloon injury induced PKN1 activation in NFAT-dependent manner and pharmacological or dominant negative mutant-mediated blockade of PKN1 function or siRNA-mediated down-regulation of its levels substantially suppressed balloon injury-induced smooth muscle cell migration and proliferation resulting in reduced neointima formation. These novel findings suggest that PKN1 plays a critical role in vascular wall remodeling, and therefore, it could be a promising new target for the next generation of drugs for vascular diseases, particularly restenosis following angioplasty, stent implantation, or vein grafting.	[Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Kumar, Sanjay; Verma, Shailendra K.; Kotla, Sivareddy; Heckle, Mark R.; Rao, Gadiparthi N.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Mukai, Hideyuki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan	University of Tennessee System; University of Tennessee Health Science Center; Kobe University	Rao, GN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Verma, Shailendra Kumar/GYU-7804-2022; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016	Verma, Shailendra Kumar/0000-0001-9142-3022; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; kumar, sanjay/0000-0002-2678-3387; Singh, Nikhlesh/0000-0002-3665-6023; Mukai, Hideyuki/0000-0002-0167-8695; kotla, sivareddy/0000-0001-7516-7647	National Institutes of Health from the NHLBI [HL069908, HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103575, R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069908 and HL103575 from the NHLBI (to G. N. R.).	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chow W, 2008, EXP CELL RES, V314, P2919, DOI 10.1016/j.yexcr.2008.07.010; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; IKEDA U, 1995, AM J PHYSIOL-HEART C, V268, pH1021, DOI 10.1152/ajpheart.1995.268.3.H1021; Isagawa T, 2005, MOL CARCINOGEN, V43, P1, DOI 10.1002/mc.20087; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; Standaert M, 1998, J BIOL CHEM, V273, P7470, DOI 10.1074/jbc.273.13.7470; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Turner EC, 2011, J BIOL CHEM, V286, P15440, DOI 10.1074/jbc.M110.181180; Urso K, 2011, BLOOD, V118, P795, DOI 10.1182/blood-2010-12-322701; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	51	32	34	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36291	36304		10.1074/jbc.M112.361220	http://dx.doi.org/10.1074/jbc.M112.361220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22893700	Green Published, hybrid			2022-12-25	WOS:000310364000050
J	Christ, NA; Bochmann, S; Gottstein, D; Duchardt-Ferner, E; Hellmich, UA; Duterhus, S; Kotter, P; Guntert, P; Entian, KD; Wohnert, J				Christ, Nina A.; Bochmann, Sophie; Gottstein, Daniel; Duchardt-Ferner, Elke; Hellmich, Ute A.; Duesterhus, Stefanie; Koetter, Peter; Guentert, Peter; Entian, Karl-Dieter; Woehnert, Jens			The First Structure of a Lantibiotic Immunity Protein, SpaI from Bacillus subtilis, Reveals a Novel Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; LACTOCOCCUS-LACTIS 6F3; NISIN GENE-CLUSTER; LIPID-II; FUNCTIONAL-ANALYSIS; SYNTHETASE COMPLEX; BIOSYNTHESIS; EXPRESSION; PEPTIDES	Lantibiotics are peptide-derived antibiotics that inhibit the growth of Gram-positive bacteria via interactions with lipid II and lipid II-dependent pore formation in the bacterial membrane. Due to their general mode of action the Gram-positive producer strains need to express immunity proteins (LanI proteins) for protection against their own lantibiotics. Little is known about the immunity mechanism protecting the producer strain against its own lantibiotic on the molecular level. So far, no structures have been reported for any LanI protein. We solved the structure of SpaI, a LanI protein from the subtilin producing strain Bacillus subtilis ATCC 6633. SpaI is a 16.8-kDa lipoprotein that is attached to the outside of the cytoplasmic membrane via a covalent diacylglycerol anchor. SpaI together with the ABC transporter SpaFEG protects the B. subtilis membrane from subtilin insertion. The solution-NMR structure of a 15-kDa biologically active C-terminal fragment reveals a novel fold. We also demonstrate that the first 20 N-terminal amino acids not present in this C-terminal fragment are unstructured in solution and are required for interactions with lipid membranes. Additionally, growth tests reveal that these 20 N-terminal residues are important for the immunity mediated by SpaI but most likely are not part of a possible subtilin binding site. Our findings are the first step on the way of understanding the immunity mechanism of B. subtilis in particular and of other lantibiotic producing strains in general.	[Christ, Nina A.; Bochmann, Sophie; Duchardt-Ferner, Elke; Hellmich, Ute A.; Duesterhus, Stefanie; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Gottstein, Daniel; Hellmich, Ute A.; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Christ, Nina A.; Gottstein, Daniel; Duchardt-Ferner, Elke; Hellmich, Ute A.; Guentert, Peter; Woehnert, Jens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Entian, KD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	entian@bio.uni-frankfurt.de; woehnert@bio.uni-frankfurt.de	Güntert, Peter/L-5577-2013	Güntert, Peter/0000-0002-2911-7574; Hellmich, Ute/0000-0001-7162-285X	Aventis Foundation professorship; Lichtenberg professorship of the Volkswagen Foundation; Deutsche Forschungsgemeinschaft; Center of Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence "Macromolecular Complexes"; Forderfonds of the Goethe University Frankfurt am Main	Aventis Foundation professorship; Lichtenberg professorship of the Volkswagen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center of Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence "Macromolecular Complexes"; Forderfonds of the Goethe University Frankfurt am Main	This work was supported by an Aventis Foundation professorship (to J.W.), a Lichtenberg professorship of the Volkswagen Foundation (to P. G.), the Deutsche Forschungsgemeinschaft (to P. G.), the Center of Biomolecular Magnetic Resonance (BMRZ), the Cluster of Excellence "Macromolecular Complexes" (to K.-D.E. and J.W.), and the Forderfonds of the Goethe University Frankfurt am Main.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANERJEE S, 1988, J BIOL CHEM, V263, P9508; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; Burkard M, 2008, J MICROBIOL METH, V75, P70, DOI 10.1016/j.mimet.2008.05.002; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ NA, 2012, BIOMOL NMR ASSIGN, V6, P9, DOI 10.1007/s12104-011-9314-5; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Draper LA, 2008, CURR PROTEIN PEPT SC, V9, P39; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; Entian KD, 1996, ANTON LEEUW INT J G, V69, P109, DOI 10.1007/BF00399416; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fuchs SW, 2011, APPL ENVIRON MICROB, V77, P1698, DOI 10.1128/AEM.01962-10; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; GROSS E, 1971, J AM CHEM SOC, V93, P4634, DOI 10.1021/ja00747a073; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halami PM, 2010, MICROBIOL RES, V165, P183, DOI 10.1016/j.micres.2009.02.001; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hoffmann A, 2004, APPL ENVIRON MICROB, V70, P3263, DOI 10.1128/AEM.70.6.3263-3271.2004; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiesau P, 1997, J BACTERIOL, V179, P1475, DOI 10.1128/jb.179.5.1475-1481.1997; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; KLEIN C, 1992, APPL ENVIRON MICROB, V58, P132, DOI 10.1128/AEM.58.1.132-142.1992; KLEIN C, 1994, APPL ENVIRON MICROB, V60, P2793, DOI 10.1128/AEM.60.8.2793-2801.1994; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Oleary W.M., 1988, MICROBIAL LIPIDS, P117; Parisot JL, 2008, ANTIMICROB AGENTS CH, V52, P612, DOI 10.1128/AAC.00836-07; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SCHULLER F, 1989, EUR J BIOCHEM, V182, P181, DOI 10.1111/j.1432-1033.1989.tb14815.x; Seydlova G, 2008, FOLIA MICROBIOL, V53, P303, DOI 10.1007/s12223-008-0047-5; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Siegers K, 1996, J BIOL CHEM, V271, P12294, DOI 10.1074/jbc.271.21.12294; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stein T, 2005, J BACTERIOL, V187, P822, DOI 10.1128/JB.187.3.822-828.2005; Stein T, 2002, J BACTERIOL, V184, P1703, DOI 10.1128/JB.184.6.1703-1711.2002; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; Takala TM, 2004, FEMS MICROBIOL LETT, V237, P171, DOI 10.1111/j.1574-6968.2004.tb09693.x; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	73	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35286	35298		10.1074/jbc.M112.401620	http://dx.doi.org/10.1074/jbc.M112.401620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904324	Green Published, hybrid			2022-12-25	WOS:000309968000038
J	Morimatsu, K; Wu, Y; Kowalczykowski, SC				Morimatsu, Katsumi; Wu, Yun; Kowalczykowski, Stephen C.			RecFOR Proteins Target RecA Protein to a DNA Gap with Either DNA or RNA at the 5 ' Terminus IMPLICATION FOR REPAIR OF STALLED REPLICATION FORKS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECF; BINDING-PROTEIN; GENETIC-RECOMBINATION; HOMOLOGOUS RECOMBINATION; SOS RESPONSE; SSB PROTEIN; MUTANT; INDUCTION; TRIPHOSPHATE	The repair of single-stranded gaps in duplex DNA by homologous recombination requires the proteins of the RecF pathway. The assembly of RecA protein onto gapped DNA (gDNA) that is complexed with the single-stranded DNA-binding protein is accelerated by the RecF, RecO, and RecR (RecFOR) proteins. Here, we show the RecFOR proteins specifically target RecA protein to gDNA even in the presence of a thousand-fold excess of single-stranded DNA (ssDNA). The binding constant of RecF protein, in the presence of the RecOR proteins, to the junction of ssDNA and dsDNA within a gap is 1-2 nM, suggesting that a few RecF molecules in the cell are sufficient to recognize gDNA. We also found that the nucleation of a RecA filament on gDNA in the presence of the RecFOR proteins occurs at a faster rate than filament elongation, resulting in a RecA nucleoprotein filament on ssDNA for 1000-2000 nucleotides downstream (5' -> 3') of the junction with duplex DNA. Thus, RecA loading by RecFOR is localized to a region close to a junction. RecFOR proteins also recognize RNA at the 5'-end of an RNA-DNA junction within an ssDNA gap, which is compatible with their role in the repair of lagging strand gaps at stalled replication forks.	[Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Morimatsu, Katsumi/G-5029-2013		National Institutes of Health [GM62653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62653 (to S. C. K.).	Bianco P R, 1998, Front Biosci, V3, pD570; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; ENNIS DG, 1987, GENETICS, V115, P11; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GOLUB EI, 1983, P NATL ACAD SCI-BIOL, V80, P1401, DOI 10.1073/pnas.80.5.1401; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; Makharashvili N, 2009, J BIOL CHEM, V284, P1425, DOI 10.1074/jbc.M806378200; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; MORIMATSU K, 1995, EUR J BIOCHEM, V228, P779, DOI 10.1111/j.1432-1033.1995.0779m.x; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; SILVER MS, 1983, BIOCHEMISTRY-US, V22, P2860, DOI 10.1021/bi00281a014; THOMS B, 1987, J BACTERIOL, V169, P1731, DOI 10.1128/jb.169.4.1731-1736.1987; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; URBANKE C, 1990, BIOCHEMISTRY-US, V29, P1744, DOI 10.1021/bi00459a012; VOLKERT MR, 1987, MUTAT RES, V184, P181, DOI 10.1016/0167-8817(87)90015-0; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; WANG TCV, 1986, J BACTERIOL, V168, P940, DOI 10.1128/jb.168.2.940-946.1986; WANG TCV, 1984, J BACTERIOL, V158, P727, DOI 10.1128/JB.158.2.727-729.1984; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	45	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35621	35630		10.1074/jbc.M112.397034	http://dx.doi.org/10.1074/jbc.M112.397034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902627	hybrid, Green Published			2022-12-25	WOS:000309968000074
J	Schmidt, E; Nilsson, O; Koskela, A; Tuukkanen, J; Ohlsson, C; Rozell, B; Eriksson, M				Schmidt, Eva; Nilsson, Ola; Koskela, Antti; Tuukkanen, Juha; Ohlsson, Claes; Rozell, Bjorn; Eriksson, Maria			Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMIN-A; PRELAMIN-A; NUCLEAR-ENVELOPE; BONE-FORMATION; FEMORAL-NECK; MICE; DISEASE; DIFFERENTIATION; PHENOTYPE; DYSPLASIA	Hutchinson-Gilford progeria syndrome (HGPS) is a very rare genetic disorder that is characterized by multiple features of premature aging and largely affects tissues of mesenchymal origin. In this study, we describe the development of a tissue-specific mouse model that overexpresses the most common HGPS mutation (LMNA, c.1824C > T, p.G608G) in osteoblasts. Already at the age of 5 weeks, HGPS mutant mice show growth retardation, imbalanced gait and spontaneous fractures. Histopathological examination revealed an irregular bone structure, characterized by widespread loss of osteocytes, defects in mineralization, and a hypocellular red bone marrow. Computerized tomography analysis demonstrated impaired skeletal geometry and altered bone structure. The skeletal defects, which resemble the clinical features reported for bone disease in HGPS patients, was associated with an abnormal osteoblast differentiation. The osteoblast-specific expression of the HGPS mutation increased DNA damage and affected Wnt signaling. In the teeth, irregular dentin formation, as was previously demonstrated in human progeria cases, caused severe dental abnormalities affecting the incisors. The observed phenotype also shows similarities to reported bone abnormalities in aging mice and may therefore help to uncover general principles of the aging process.	[Schmidt, Eva; Eriksson, Maria] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Nilsson, Ola] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden; [Nilsson, Ola] Univ Hosp, SE-17177 Stockholm, Sweden; [Koskela, Antti; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, FI-90014 Oulu, Finland; [Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, SE-40530 Gothenburg, Sweden; [Rozell, Bjorn] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1165 Copenhagen, Denmark	Karolinska Institutet; Karolinska Institutet; University of Oulu; University of Gothenburg; University of Copenhagen	Eriksson, M (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	Maria.Eriksson.2@ki.se	Tuukkanen, Juha/R-3728-2018; Ohlsson, Claes/AGP-3544-2022	Tuukkanen, Juha/0000-0002-1723-6461; Ohlsson, Claes/0000-0002-9633-2805; Koskela, Antti/0000-0001-7371-2488; Nilsson, Ola/0000-0002-9986-8138	Karolinska Institutet; Swedish Research Council; Swedish Foundation for Strategic Research; Torsten and Ragnar Soderberg Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation; Hagelen Foundation; Loo and Hans Osterman Foundation	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderberg Foundation; Tore Nilsson Foundation; Ake Wiberg Foundation; Hagelen Foundation; Loo and Hans Osterman Foundation(Instituto de Salud Carlos III)	This work was supported by grants from the Karolinska Institutet, the Swedish Research Council, the Swedish Foundation for Strategic Research, the Torsten and Ragnar Soderberg Foundation, the Tore Nilsson Foundation, the Ake Wiberg Foundation, the Hagelen Foundation, and the Loo and Hans Osterman Foundation.	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Boskey AL, 2006, PRIMER METABOLIC BON, V6th, P12; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cunningham VJ, 2010, BONE, V47, P591, DOI 10.1016/j.bone.2010.06.004; de Carlos F, 2008, J ANAT, V213, P509, DOI 10.1111/j.1469-7580.2008.00970.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Domingo DL, 2009, ORAL DIS, V15, P187, DOI 10.1111/j.1601-0825.2009.01521.x; Duarte WR, 2003, J BONE MINER RES, V18, P493, DOI 10.1359/jbmr.2003.18.3.493; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; GARDNER DG, 1969, ORAL SURG ORAL MED O, V28, P877, DOI 10.1016/0030-4220(69)90343-0; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon CM, 2011, J BONE MINER RES, V26, P1670, DOI 10.1002/jbmr.392; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; HEINRICHS C, 1994, ENDOCRINOLOGY, V135, P1113, DOI 10.1210/en.135.3.1113; Jamsa T, 1998, J BIOMECH, V31, P723, DOI 10.1016/S0021-9290(98)00087-6; Jamsa T, 1999, J BONE MINER RES, V14, P1708, DOI 10.1359/jbmr.1999.14.10.1708; Kamoun-Goldrat AS, 2007, J BONE MINER METAB, V25, P211, DOI 10.1007/s00774-007-0750-3; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019313; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nagy A., 2003, MANIPULATING MOUSE E; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Rivas D, 2009, J GERONTOL A-BIOL, V64, P1015, DOI 10.1093/gerona/glp089; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt Eva, 2011, BMC Res Notes, V4, P282, DOI 10.1186/1756-0500-4-282; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHOZAWA T, 1984, ACTA PATHOL JAPON, V34, P797; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; SINENSKY M, 1994, J CELL SCI, V107, P61; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Zreiqat H, 2007, J MOL HISTOL, V38, P381, DOI 10.1007/s10735-007-9117-2	50	31	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33512	33522		10.1074/jbc.M112.366450	http://dx.doi.org/10.1074/jbc.M112.366450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22893709	Green Published, hybrid			2022-12-25	WOS:000309602100037
J	Benslimane, N; Hassan, GS; Yacoub, D; Mourad, W				Benslimane, Nadir; Hassan, Ghada S.; Yacoub, Daniel; Mourad, Walid			Requirement of Transmembrane Domain for CD154 Association to Lipid Rafts and Subsequent Biological Events	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; CD4(+) T-LYMPHOCYTES; CD40 LIGAND; SIGNALING PATHWAYS; ACTIVATION; CHOLESTEROL; TRIGGERS; PHOSPHORYLATION; INTEGRIN	Interaction of CD40 with CD154 leads to recruitment of both molecules into lipid rafts, resulting in bi-directional cell activation. The precise mechanism by which CD154 is translocated into lipid rafts and its impact on CD154 signaling remain largely unknown. Our aim is to identify the domain of CD154 facilitating its association to lipid rafts and the impact of such association on signaling events and cytokine production. Thus, we generated Jurkat cell lines expressing truncated CD154 lacking the cytoplasmic domain or chimeric CD154 in which the transmembrane domain was replaced by that of transferrin receptor I, known to be excluded from lipid rafts. Our results show that cell stimulation with soluble CD40 leads to the association of CD154 wild-type and CD154-truncated, but not CD154-chimera, with lipid rafts. This is correlated with failure of CD154-chimera to activate Akt and p38 MAP kinases, known effectors of CD154 signaling. We also found that CD154-chimera lost the ability to promote IL-2 production upon T cell stimulation with anti-CD3/CD28 and soluble CD40. These results demonstrate the implication of the transmembrane domain of CD154 in lipid raft association, and that this association is necessary for CD154-mediated Akt and p38 activation with consequent enhancement of IL-2 production.	[Benslimane, Nadir; Hassan, Ghada S.; Yacoub, Daniel; Mourad, Walid] CHU Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada	Universite de Montreal	Benslimane, N (corresponding author), CHU Montreal, Hop St Luc, Lab Immunol Cellulaire & Mol, Montreal, PQ, Canada.	mw.mourad@umontreal.ca		Mourad, Walid/0000-0002-1859-9387; Hassan, Ghada S./0000-0002-1391-5248	Canadian Institutes of Health Research; Canadian Arthritis Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported by the Canadian Institutes of Health Research (www.cihr.ca) and the Canadian Arthritis Network (www.arthritisnetwork.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Blair PJ, 2000, J EXP MED, V191, P651, DOI 10.1084/jem.191.4.651; Blotta MH, 1996, J IMMUNOL, V156, P3133; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Brenner B, 1997, BIOCHEM BIOPH RES CO, V239, P11, DOI 10.1006/bbrc.1997.7415; Brenner B, 1997, FEBS LETT, V417, P301, DOI 10.1016/S0014-5793(97)01306-9; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; CAYABYAB M, 1994, J IMMUNOL, V152, P1523; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Hassan Ghada S., 2009, Current Immunology Reviews, V5, P285; Hassan GS, 2009, TRENDS IMMUNOL, V30, P165, DOI 10.1016/j.it.2009.01.004; Hassan GS, 2011, IMMUNOBIOLOGY; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kiani-Alikhan S, 2011, J CLIN IMMUNOL; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mikolajczak SA, 2004, J EXP MED, V199, P1025, DOI 10.1084/jem.20031705; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yu TC, 2004, ACTA BIOCH BIOPH SIN, V36, P741, DOI 10.1093/abbs/36.11.741; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43070	10.1371/journal.pone.0043070	http://dx.doi.org/10.1371/journal.pone.0043070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905203	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800042
J	Liu, L; Zhang, Q; Hu, LL; Tang, JJ; Xu, LG; Yang, XT; Yong, JWH; Chen, X				Liu, Ling; Zhang, Qian; Hu, Liangliang; Tang, Jianjun; Xu, Ligen; Yang, Xiantian; Yong, Jean W. H.; Chen, Xin			Legumes Can Increase Cadmium Contamination in Neighboring Crops	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION; FOOD SECURITY; SOIL; PRODUCTIVITY; AVAILABILITY; RESTORATION; NITROGEN; PLANTS; MAIZE	Legumes are widely used in many cropping systems because they share their nitrogen fixation products and phosphorus mobilization activities with their neighbors. In the current study, however, we showed that co-cultivation with legumes increased cadmium (Cd) contamination in the adjacent crops. Both field and mesocosm experiments indicated that legumes increased Cd levels in edible parts and shoots of four neighboring crops and five maize varieties tested, regardless of the Cd levels in the soil. This enhanced Cd accumulation in crops was attributed to root interactions that alter the rhizosphere environment. Co-cultivation with legumes reduced soil pH, which somewhat increased the exchangeable forms of Cd. Our results have demonstrated the inevitable increases in Cd levels of crops as a direct result of co-cultivation with legumes even under situations when these levels are below the permissible threshold. With this new revelation, we need to consider carefully the current cropping systems involving legumes and perhaps to re-design the current and future cropping systems in view of avoiding food contamination by Cd.	[Liu, Ling; Zhang, Qian; Hu, Liangliang; Tang, Jianjun; Xu, Ligen; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yong, Jean W. H.] Singapore Univ Technol & Design, Singapore, Singapore; [Yang, Xiantian] Taizhou Acad Agr Sci, Taizhou, Peoples R China	Zhejiang University; Singapore University of Technology & Design; Jiangsu Academy of Agricultural Sciences	Liu, L (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Yong, Jean/B-9976-2019; Yong, Jean W. H./H-4671-2012	Yong, Jean/0000-0003-3325-8254; Yong, Jean W. H./0000-0003-3325-8254	Natural Science Foundation of China [30970477]; Natural Science Foundation of Zhejiang Province [Y307418]; Key Laboratory of Ministry of Agriculture of the People's Republic of China [KYJD09021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Key Laboratory of Ministry of Agriculture of the People's Republic of China	The work was supported by the Natural Science Foundation of China (no. 30970477), the Natural Science Foundation of Zhejiang Province (no. Y307418) and the Key Laboratory of Ministry of Agriculture of the People's Republic of China (no. 278 KYJD09021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada I, 1999, COMMUN SOIL SCI PLAN, V30, P1507, DOI 10.1080/00103629909370303; Bromley DW, 2010, SCIENCE, V328, P169, DOI 10.1126/science.328.5975.169-d; Chaer GM, 2011, TREE PHYSIOL, V31, P139, DOI 10.1093/treephys/tpq116; Ghosh PK, 2007, J SUSTAIN AGR, V30, P59, DOI 10.1300/J064v30n01_07; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V85, P141, DOI 10.1007/s10705-009-9254-y; Krishnamurti GSR, 1997, J ENVIRON QUAL, V26, P271, DOI 10.2134/jeq1997.00472425002600010038x; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li NY, 2009, WATER AIR SOIL POLL, V199, P45, DOI 10.1007/s11270-008-9858-x; Liu L, 2012, J ENVIRON MANAGE, V93, P22, DOI 10.1016/j.jenvman.2011.08.021; Liu L, 2011, J ENVIRON SCI, V23, P453, DOI 10.1016/S1001-0742(10)60430-5; Luo SM, 2010, PRINCIPLE TECHNOLOGY; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mench MJ, 1998, AGR ECOSYST ENVIRON, V67, P175, DOI 10.1016/S0167-8809(97)00117-5; Ministry of Health of the People's Republic of China, 2005, GB27622005 MIN HLTH; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Omondi EC, 2010, J SUSTAIN AGR, V34, P244, DOI 10.1080/10440041003613230; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Padilla FM, 2009, BASIC APPL ECOL, V10, P640, DOI 10.1016/j.baae.2009.03.003; Rao MR, 2000, AGR ECOSYST ENVIRON, V78, P123, DOI 10.1016/S0167-8809(99)00125-5; Sappin-Didier V, 2005, PLANT SOIL, V270, P189, DOI 10.1007/s11104-004-1494-7; Siddique I, 2008, BIOGEOCHEMISTRY, V88, P89, DOI 10.1007/s10533-008-9196-5; State Environmental Protection Administration of China, 1995, GB156181995 STAT ENV; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; [杨忠芳 Yang Zhongfang], 2005, [地学前缘, Earth science frontiers], V12, P252	27	24	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42944	10.1371/journal.pone.0042944	http://dx.doi.org/10.1371/journal.pone.0042944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905189	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800032
J	Bill, MA; Nicholas, C; Mace, TA; Etter, JP; Li, CL; Schwartz, EB; Fuchs, JR; Young, GS; Lin, L; Lin, JY; He, L; Phelps, M; Li, PK; Lesinski, GB				Bill, Matthew A.; Nicholas, Courtney; Mace, Thomas A.; Etter, Jonathan P.; Li, Chenglong; Schwartz, Eric B.; Fuchs, James R.; Young, Gregory S.; Lin, Li; Lin, Jiayuh; He, Lei; Phelps, Mitch; Li, Pui-Kai; Lesinski, Gregory B.			Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines	PLOS ONE			English	Article							FLUORESCENCE POLARIZATION ASSAY; TUMOR-SUPPRESSOR GENE; TARGETING STAT3; SIGNAL TRANSDUCER; INTERFERON-ALPHA; T-CELLS; IMMUNE CELLS; IFN-ALPHA; CANCER; EXPRESSION	The Janus kinase-2 (Jak2)-signal transducer and activator of transcription-3 (STAT3) pathway is critical for promoting an oncogenic and metastatic phenotype in several types of cancer including renal cell carcinoma (RCC) and melanoma. This study describes two small molecule inhibitors of the Jak2-STAT3 pathway, FLLL32 and its more soluble analog, FLLL62. These compounds are structurally distinct curcumin analogs that bind selectively to the SH2 domain of STAT3 to inhibit its phosphorylation and dimerization. We hypothesized that FLLL32 and FLLL62 would induce apoptosis in RCC and melanoma cells and display specificity for the Jak2-STAT3 pathway. FLLL32 and FLLL62 could inhibit STAT3 dimerization in vitro. These compounds reduced basal STAT3 phosphorylation (pSTAT3), and induced apoptosis in four separate human RCC cell lines and in human melanoma cell lines as determined by Annexin V/PI staining. Apoptosis was also confirmed by immunoblot analysis of caspase-3 processing and PARP cleavage. Pre-treatment of RCC and melanoma cell lines with FLLL32/62 did not inhibit IFN-gamma-induced pSTAT1. In contrast to FLLL32, curcumin and FLLL62 reduced downstream STAT1-mediated gene expression of IRF1 as determined by Real Time PCR. FLLL32 and FLLL62 significantly reduced secretion of VEGF from RCC cell lines in a dose-dependent manner as determined by ELISA. Finally, each of these compounds inhibited in vitro generation of myeloid-derived suppressor cells. These data support further investigation of FLLL32 and FLLL62 as lead compounds for STAT3 inhibition in RCC and melanoma.	[Bill, Matthew A.; Nicholas, Courtney; Mace, Thomas A.; Lesinski, Gregory B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Etter, Jonathan P.; Li, Chenglong; Schwartz, Eric B.; Fuchs, James R.; He, Lei; Phelps, Mitch; Li, Pui-Kai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Arthur G James Canc Hosp, Ctr Biostat, Columbus, OH 43210 USA; [Young, Gregory S.] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Lin, Li; Lin, Jiayuh] Nationwide Childrens Hosp, Coll Med, Dept Pediat, Ctr Childhood Canc,Res Inst, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Bill, MA (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	Gregory.Lesinski@osumc.edu	nicholas, courtney/AAU-3887-2021; Lin, Jiayuh/E-3515-2011; Phelps, Mitch A/H-3941-2013; Li, Chenglong/E-7182-2010	Phelps, Mitch A/0000-0002-1615-5280; Li, Chenglong/0000-0003-3174-8719; Nicholas, Courtney/0000-0001-8596-0200; Li, Pui Kai/0000-0002-4831-7213; Fuchs, James/0000-0002-8743-6389	National Institutes of Health (NIH) [CA84402, 1R21 CA141434, K22CA134551]; Valvano Foundation for Cancer Research; American Cancer Society [IRG 67 003-44]; National Center for Research Resources [UL1RR025755]; Office of the Director, NIH (OD); NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA016058, R21CA141434, R21CA084402, K22CA134551] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Valvano Foundation for Cancer Research; American Cancer Society(American Cancer Society); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director, NIH (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health (NIH) grants CA84402, 1R21 CA141434 (Lesinski), K22CA134551 (Lesinski) (http://www.nih.gov/); The Valvano Foundation for Cancer Research (Lesinski) (http://www.jimmyv.org/); and grant IRG 67 003-44 from the American Cancer Society (Fuchs) (http://www.cancer.org/). The project described was supported by award mumber UL1RR025755 from the National Center for Research Resources, funded by the Office of the Director, NIH (OD) and supported by the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Bill MA, 2009, MOL CANCER THER, V8, P2726, DOI 10.1158/1535-7163.MCT-09-0377; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Du YH, 2007, J BIOMOL SCREEN, V12, P915, DOI 10.1177/1087057107306067; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hao WS, 2008, BIOORG MED CHEM LETT, V18, P4988, DOI 10.1016/j.bmcl.2008.08.032; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herrmann A, 2010, CANCER RES, V70, P7455, DOI 10.1158/0008-5472.CAN-10-0736; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Horiguchi A, 2002, J UROLOGY, V168, P762, DOI 10.1016/S0022-5347(05)64741-6; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hutson TE, 2011, ONCOLOGIST, V16, P14, DOI 10.1634/theoncologist.2011-S2-14; Ito N, 2007, J CLIN ONCOL, V25, P2785, DOI 10.1200/JCO.2006.09.8897; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kong LY, 2010, CLIN CANCER RES, V16, P2550, DOI 10.1158/1078-0432.CCR-10-0279; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lee JW, 2010, KOREAN J UROL, V51, P870, DOI 10.4111/kju.2010.51.12.870; Lesinski GB, 2004, JNCI-J NATL CANCER I, V96, P1331, DOI 10.1093/jnci/djh252; Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Lin L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-217; Masuda A, 2009, BIOMED RES-TOKYO, V30, P171, DOI 10.2220/biomedres.30.171; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Mundy-Bosse BL, 2011, CANCER IMMUNOL IMMUN, V60, P1269, DOI 10.1007/s00262-011-1029-z; Nieto M, 2011, CLIN CANCER RES, V17, P6608, DOI 10.1158/1078-0432.CCR-11-1734; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Saradhi UVRV, 2010, J CHROMATOGR B, V878, P3045, DOI 10.1016/j.jchromb.2010.08.039; Sarkar FH, 2010, CURR PHARM DESIGN, V16, P1801, DOI 10.2174/138161210791208956; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zimmerer JM, 2007, J IMMUNOL, V178, P4832, DOI 10.4049/jimmunol.178.8.4832	55	68	71	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40724	10.1371/journal.pone.0040724	http://dx.doi.org/10.1371/journal.pone.0040724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899991	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900006
J	Kraneveld, EA; Buijs, MJ; Bonder, MJ; Visser, M; Keijser, BJF; Crielaard, W; Zaura, E				Kraneveld, Eefje A.; Buijs, Mark J.; Bonder, Marc J.; Visser, Marjolein; Keijser, Bart J. F.; Crielaard, Wim; Zaura, Egija			The Relation between Oral Candida Load and Bacterial Microbiome Profiles in Dutch Older Adults	PLOS ONE			English	Article							ALKALI PRODUCTION; ACID PRODUCTION; PCR ASSAYS; ALBICANS; DIVERSITY; EPIDEMIOLOGY; COMMUNITIES; SALIVARY; CARIES; STREPTOCOCCI	Currently there are no evidence-based ecological measures for prevention of overgrowth and subsequent infection by fungi in the oral cavity. The aim of this study was to increase our knowledge on fungal-bacterial ecological interactions. Salivary Candida abundance of 82 Dutch adults aged 58-80 years was established relative to the bacterial load by quantitative PCR analysis of the Internal Transcribed (ITS) region (Candida) and 16S rDNA gene (bacteria). The salivary microbiome was assessed using barcoded pyrosequencing of the bacterial hypervariable regions V5-V7 of 16S rDNA. Sequencing data was preprocessed by denoising and chimera removal, clustered in Operational Taxonomic Units (OTUs) and assigned to taxonomy. Both OTU-based (PCA, diversity statistics) and phylogeny-based analyses (UniFrac, PCoA) were performed. Saliva of Dutch older adults contained 0-4 x 10(8) CFU/mL Candida with a median Candida load of 0.06%. With increased Candida load the diversity of the salivary microbiome decreased significantly (p<0.001). Increase in the Candida load correlated positively with class Bacilli, and negatively with class Fusobacteria, Flavobacteria, and Bacteroidia. Microbiomes with high Candida load were less diverse and had a distinct microbial composition towards dominance by saccharolytic and acidogenic bacteria - streptococci. The control of the acidification of the oral environment may be a potential preventive measure for Candida outgrowth that should be evaluated in longitudinal clinical intervention trials.	[Kraneveld, Eefje A.; Buijs, Mark J.; Bonder, Marc J.; Crielaard, Wim; Zaura, Egija] Univ Amsterdam, Dept Prevent Dent, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Keijser, Bart J. F.] TNO Earth Environm & Life Sci, Zeist, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research	Kraneveld, EA (corresponding author), Univ Amsterdam, Dept Prevent Dent, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands.	e.zaura@acta.nl	Visser, Marjolein/AAP-3224-2020	Bonder, Marc Jan/0000-0002-8431-3180; Visser, Marjolein/0000-0002-5136-298X; Zaura, Egija/0000-0003-1432-6194	Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care	The Longitudinal Aging Study Amsterdam is largely supported by a grant from the Netherlands Ministry of Health Welfare and Sports, Directorate of Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeele AV, 2008, GERODONTOLOGY, V25, P222, DOI 10.1111/j.1741-2358.2007.00247.x; Acevedo Ana Maria, 2005, J Clin Dent, V16, P63; Bodineau Agnes, 2009, Curr Aging Sci, V2, P109; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Brandt BW, 2012, NUCLEIC ACIDS RES, V40, pW82, DOI 10.1093/nar/gks418; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Deeg DJH, 1994, AUTONOMY WELL BEING; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gordan VV, 2010, CARIES RES, V44, P547, DOI 10.1159/000321139; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holmes AR, 2006, ORAL SURG ORAL MED O, V102, P488, DOI 10.1016/j.tripleo.2005.10.052; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; Jenkinson HF, 2002, POLYMICROBIAL DIS; Klinke T, 2009, CARIES RES, V43, P83, DOI 10.1159/000204911; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Muenz R., 2007, AGING DEMOGRAPHIC CH; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nair RG, 2001, APMIS, V109, P147, DOI 10.1034/j.1600-0463.2001.d01-116.x; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; O'Sullivan JM, 2000, MICROBIOL-UK, V146, P41, DOI 10.1099/00221287-146-1-41; PERCIVAL RS, 1991, J MED MICROBIOL, V35, P5, DOI 10.1099/00222615-35-1-5; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pham LC, 2009, ARCH ORAL BIOL, V54, P132, DOI 10.1016/j.archoralbio.2008.09.007; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pybus V, 1998, FEMS IMMUNOL MED MIC, V22, P317, DOI 10.1016/S0928-8244(98)00103-5; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; RICHARDS S, 1987, J APPL BACTERIOL, V62, P421, DOI 10.1111/j.1365-2672.1987.tb02671.x; Gusmao JMR, 2011, GERODONTOLOGY, V28, P283, DOI 10.1111/j.1741-2358.2010.00390.x; Ryu M, 2010, J ORAL REHABIL, V37, P194, DOI 10.1111/j.1365-2842.2009.02042.x; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P251, DOI 10.1111/j.1600-0714.1986.tb00617.x; Schabereiter-Gurtner C, 2007, J CLIN MICROBIOL, V45, P906, DOI 10.1128/JCM.01344-06; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	54	78	80	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42770	10.1371/journal.pone.0042770	http://dx.doi.org/10.1371/journal.pone.0042770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900048	gold, Green Published			2022-12-25	WOS:000307380900066
J	Minot, S; Wu, GD; Lewis, JD; Bushman, FD				Minot, Samuel; Wu, Gary D.; Lewis, James D.; Bushman, Frederic D.			Conservation of Gene Cassettes among Diverse Viruses of the Human Gut	PLOS ONE			English	Article							DE-NOVO ASSEMBLER; MODULAR EVOLUTION; PHAGE; DNA; BACTERIOPHAGES; PROTEINS; GENOMICS; SEQUENCE; FEATURES; LAMBDA	Viruses are a crucial component of the human microbiome, but large population sizes, high sequence diversity, and high frequencies of novel genes have hindered genomic analysis by high-throughput sequencing. Here we investigate approaches to metagenomic assembly to probe genome structure in a sample of 5.6 Gb of gut viral DNA sequence from six individuals. Tests showed that a new pipeline based on DeBruijn graph assembly yielded longer contigs that were able to recruit more reads than the equivalent non-optimized, single-pass approach. To characterize gene content, the database of viral RefSeq proteins was compared to the assembled viral contigs, generating a bipartite graph with functional cassettes linking together viral contigs, which revealed a high degree of connectivity between diverse genomes involving multiple genes of the same functional class. In a second step, open reading frames were grouped by their co-occurrence on contigs in a database-independent manner, revealing conserved cassettes of co-oriented ORFs. These methods reveal that free-living bacteriophages, while usually dissimilar at the nucleotide level, often have significant similarity at the level of encoded amino acid motifs, gene order, and gene orientation. These findings thus connect contemporary metagenomic analysis with classical studies of bacteriophage genomic cassettes. Software is available at https://sourceforge.net/projects/optitdba/.	[Minot, Samuel; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lewis, James D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minot, S (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056; Minot, Samuel/0000-0003-1639-3905	Human Microbiome Roadmap Demonstration Project [UH2DK083981]; NIH [T32AI060516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981] Funding Source: NIH RePORTER	Human Microbiome Roadmap Demonstration Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Human Microbiome Roadmap Demonstration Project UH2DK083981 (Wu, Bushman, Lewis, Co-PIs). SM was supported by NIH Training Grant T32AI060516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; BOTSTEIN D, 1974, NATURE, V251, P584, DOI 10.1038/251584a0; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charuvaka A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S8; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Hendrix R. W, 1983, LAMBDA, VII; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Hoffmann KH, 2007, FEMS MICROBIOL LETT, V273, P224, DOI 10.1111/j.1574-6968.2007.00790.x; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lucchini S, 1999, J VIROL, V73, P8647, DOI 10.1128/JVI.73.10.8647-8656.1999; Luo C, 2011, ISME J; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minot S, 2012, P NATL ACAD SCI US; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; OHLENDORF DH, 1983, J MOL BIOL, V169, P757, DOI 10.1016/S0022-2836(83)80169-7; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Pruitt K, 2011, NCBI HDB; Ptashne M, 1986, GENETIC SWITCH; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rao Venigalla B., 2005, P40; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; WILGUS GS, 1973, VIROLOGY, V56, P46, DOI 10.1016/0042-6822(73)90286-9; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	49	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42342	10.1371/journal.pone.0042342	http://dx.doi.org/10.1371/journal.pone.0042342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900013	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900030
J	Richey, EA; Qin, HM				Richey, Elizabeth A.; Qin, Hongmin			Dissecting the Sequential Assembly and Localization of Intraflagellar Transport Particle Complex B in Chlamydomonas	PLOS ONE			English	Article							SENSORY CILIA; CAENORHABDITIS-ELEGANS; IFT PARTICLES; CELLS ANTENNA; DISEASE GENE; KINESIN-II; BASAL BODY; C-ELEGANS; PROTEIN; REINHARDTII	Intraflagellar transport (IFT), the key mechanism for ciliogenesis, involves large protein particles moving bi-directionally along the entire ciliary length. IFT particles contain two large protein complexes, A and B, which are constructed with proteins in a core and several peripheral proteins. Prior studies have shown that in Chlamydomonas reinhardtii, IFT46, IFT52, and IFT88 directly interact with each other and are in a subcomplex of the IFT B core. However, ift46, bld1, and ift88 mutants differ in phenotype as ift46 mutants are able to form short flagella, while the other two lack flagella completely. In this study, we investigated the functional differences of these individual IFT proteins contributing to complex B assembly, stability, and basal body localization. We found that complex B is completely disrupted in bld1 mutant, indicating an essential role of IFT52 for complex B core assembly. Ift46 mutant cells are capable of assembling a relatively intact complex B, but such complex is highly unstable and prone to degradation. In contrast, in ift88 mutant cells the complex B core still assembles and remains stable, but the peripheral proteins no longer attach to the B core. Moreover, in ift88 mutant cells, while complex A and the anterograde IFT motor FLA10 are localized normally to the transition fibers, complex B proteins instead are accumulated at the proximal ends of the basal bodies. In addition, in bld2 mutant, the IFT complex B proteins still localize to the proximal ends of defective centrioles which completely lack transition fibers. Taken together, these results revealed a step-wise assembly process for complex B, and showed that the complex first localizes to the proximal end of the centrioles and then translocates onto the transition fibers via an IFT88-dependent mechanism.	[Richey, Elizabeth A.; Qin, Hongmin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Richey, EA (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	hqin@bio.tamu.edu		Qin, Hongmin/0000-0002-0045-5780	National Science Foundation [MCB-0923835]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant MCB-0923835 to H. Qin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bell LR, 2006, GENETICS, V173, P1275, DOI 10.1534/genetics.106.056721; Bhogaraju S, 2011, EMBO J; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dave D, 2009, EUKARYOT CELL, V8, P1397, DOI 10.1128/EC.00378-08; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Dutcher SK, 2012, G3-GENES GENOM GENET, V2, P15, DOI 10.1534/g3.111.000919; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kobayashi T, 2007, GENES CELLS, V12, P593, DOI 10.1111/j.1365-2443.2007.01076.x; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; LUCKER BF, 2010, J BIOL CHEM; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2005, CURR BIOL, V15, P262, DOI 10.1016/j.cub.2005.01.037; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Silva DA, 2012, CYTOSKELETON, V69, P33, DOI 10.1002/cm.20546; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Taschner M, 2011, J BIOL CHEM, V286, P26344, DOI 10.1074/jbc.M111.254920; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Williamson SM, 2011, PROTOPLASMA	43	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43118	10.1371/journal.pone.0043118	http://dx.doi.org/10.1371/journal.pone.0043118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900094	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900112
J	Ruiz, XD; Mlakar, LR; Yamaguchi, Y; Su, YY; Larregina, AT; Pilewski, JM; Feghali-Bostwick, CA				Ruiz, Ximena D.; Mlakar, Logan R.; Yamaguchi, Yukie; Su, Yunyun; Larregina, Adriana T.; Pilewski, Joseph M.; Feghali-Bostwick, Carol A.			Syndecan-2 Is a Novel Target of Insulin-Like Growth Factor Binding Protein-3 and Is Over-Expressed in Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HEPARAN-SULFATE PROTEOGLYCANS; INITIATION-FACTOR 4E; BREAST-CANCER CELLS; FACTOR-BETA; CYTOKINE REGULATION; GENE-EXPRESSION; RETINOIC ACID; ADHESION; FIBROBLASTS	Extracellular matrix deposition and tissue scarring characterize the process of fibrosis. Transforming growth factor beta (TGF beta) and Insulin-like growth factor binding protein-3 (IGFBP-3) have been implicated in the pathogenesis of fibrosis in various tissues by inducing mesenchymal cell proliferation and extracellular matrix deposition. We identified Syndecan-2 (SDC2) as a gene induced by TGF beta in an IGFBP-3-dependent manner. TGF beta induction of SDC2 mRNA and protein required IGFBP-3. IGFBP-3 independently induced production of SDC2 in primary fibroblasts. Using an ex-vivo model of human skin in organ culture expressing IGFBP-3, we demonstrate that IGFBP-3 induces SDC2 ex vivo in human tissue. We also identified Mitogen-activated protein kinase-interacting kinase (Mknk2) as a gene induced by IGFBP-3. IGFBP-3 triggered Mknk2 phosphorylation resulting in its activation. Mknk2 independently induced SDC2 in human skin. Since IGFBP-3 is over-expressed in fibrotic tissues, we examined SDC2 levels in skin and lung tissues of patients with systemic sclerosis (SSc) and lung tissues of patients with idiopathic pulmonary fibrosis (IPF). SDC2 levels were increased in fibrotic dermal and lung tissues of patients with SSc and in lung tissues of patients with IPF. This is the first report describing elevated levels of SDC2 in fibrosis. Increased SDC2 expression is due, at least in part, to the activity of two pro-fibrotic factors, TGF beta and IGFBP-3.	[Ruiz, Ximena D.; Mlakar, Logan R.; Yamaguchi, Yukie; Su, Yunyun; Pilewski, Joseph M.; Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Larregina, Adriana T.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15261 USA; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ruiz, XD (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	feghalica@upmc.edu	Pilewski, Joseph/AAF-5149-2021	Yamaguchi, Yukie/0000-0002-0297-6627	National Institutes of Health [AR050840, P30 DK072506]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grant AR050840 (CFB) and grant P30 DK072506 (JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTON C, 1995, AM J RESP CRIT CARE, V151, P1597, DOI 10.1164/ajrccm.151.5.7537587; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cevikbas F, 2008, MATRIX BIOL, V27, P42, DOI 10.1016/j.matbio.2007.07.003; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2009, BIOCHEM BIOPH RES CO, V384, P231, DOI 10.1016/j.bbrc.2009.04.093; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Frangogiannis NG, 2010, HYPERTENSION, V55, P233, DOI 10.1161/HYPERTENSIONAHA.109.147256; Fujishima S, 2010, ARCH PATHOL LAB MED, V134, P1136, DOI 10.1043/2009-0144-OA.1; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; Gucev ZS, 1996, CANCER RES, V56, P1545; Huang CC, 2005, MODERN PATHOL, V18, P941, DOI 10.1038/modpathol.3800374; Hwa V, 1997, ENDOCRINE, V6, P235, DOI 10.1007/BF02820498; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Klass CM, 2000, J CELL SCI, V113, P493; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kuemmerle JF, 2004, AM J PHYSIOL-GASTR L, V287, pG795, DOI 10.1152/ajpgi.00009.2004; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Martin JL, 2006, ENDOCRINOLOGY, V147, P4400, DOI 10.1210/en.2006-0094; MARTIN JL, 1991, ENDOCRINOLOGY, V128, P1425, DOI 10.1210/endo-128-3-1425; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sadikot RT, 2004, CURR DRUG TARGETS, V5, P581, DOI 10.2174/1389450043345281; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Sebestyen A, 2000, CYTOKINE, V12, P1557, DOI 10.1006/cyto.2000.0754; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Venkatesan N, 2002, AM J PHYSIOL-LUNG C, V283, pL806, DOI 10.1152/ajplung.00061.2002; Villena J, 2003, CELL BIOL INT, V27, P1005, DOI 10.1016/j.cellbi.2003.09.004; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Worapamorn W, 2002, J PERIODONTAL RES, V37, P273, DOI 10.1034/j.1600-0765.2002.01610.x; Worapamorn W, 2001, J CELL PHYSIOL, V186, P448, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1047>3.0.CO;2-V; Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084; Yasuoka Hidekata, 2008, Open Rheumatol J, V2, P17, DOI 10.2174/1874312900802010017	44	27	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43049	10.1371/journal.pone.0043049	http://dx.doi.org/10.1371/journal.pone.0043049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900087	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000307380900105
J	Sengupta, A; Foster, SD; Patterson, TA; Bravington, M				Sengupta, Aritra; Foster, Scott D.; Patterson, Toby A.; Bravington, Mark			Accounting for Location Error in Kalman Filters: Integrating Animal Borne Sensor Data into Assimilation Schemes	PLOS ONE			English	Article							TRACKING; FISH	Data assimilation is a crucial aspect of modern oceanography. It allows the future forecasting and backward smoothing of ocean state from the noisy observations. Statistical methods are employed to perform these tasks and are often based on or related to the Kalman filter. Typically Kalman filters assumes that the locations associated with observations are known with certainty. This is reasonable for typical oceanographic measurement methods. Recently, however an alternative and abundant source of data comes from the deployment of ocean sensors on marine animals. This source of data has some attractive properties: unlike traditional oceanographic collection platforms, it is relatively cheap to collect, plentiful, has multiple scientific uses and users, and samples areas of the ocean that are often difficult of costly to sample. However, inherent uncertainty in the location of the observations is a barrier to full utilisation of animal-borne sensor data in data-assimilation schemes. In this article we examine this issue and suggest a simple approximation to explicitly incorporate the location uncertainty, while staying in the scope of Kalman-filter-like methods. The approximation stems from a Taylor-series approximation to elements of the updating equation.	[Sengupta, Aritra] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Foster, Scott D.; Bravington, Mark] CSIRO Math & Informat Sci, Hobart, Tas, Australia; [Patterson, Toby A.] CSIRO Wealth Oceans Res Flagship, Castray Esplanade, Hobart, Tas, Australia	University System of Ohio; Ohio State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sengupta, A (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	sengupta.11@osu.edu	Foster, Scott D/E-9311-2010; Sengupta, Aritra/AAV-4492-2021; Patterson, Toby/B-3836-2011	Foster, Scott D/0000-0002-6719-8002; Sengupta, Aritra/0000-0001-6268-010X; Patterson, Toby/0000-0002-7150-9205	CSIRO Centre for Mathematics, Informatics, and Statistics, Australia	CSIRO Centre for Mathematics, Informatics, and Statistics, Australia	This research was carried out as an internship project for the first author (Aritra Sengupta). The internship was supported by CSIRO Centre for Mathematics, Informatics, and Statistics, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B.D.O., 1979, OPTIMAL FILTERING; Boehme L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004647; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Costa DP, 2010, P OCEANOBS, V9, P21; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Ide K, 1997, J METEOROL SOC JPN, V75, P181, DOI 10.2151/jmsj1965.75.1B_181; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; MEINHOLD RJ, 1983, AM STAT, V37, P123, DOI 10.2307/2685871; Menard R, 1996, TELLUS A, V48, P221, DOI 10.1034/j.1600-0870.1996.t01-1-00003.x; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; NIILER PP, 1995, J PHYS OCEANOGR, V25, P2819, DOI 10.1175/1520-0485(1995)025<2819:WDMITN>2.0.CO;2; Oke PR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031549; Pedersen MW, 2007, THESIS DTU; Poulain PM, 1996, J GEOPHYS RES-OCEANS, V101, P18237, DOI 10.1029/96JC00506; Press W.H., 1988, NUMERICAL RECIPIES C; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Sibert JR, 2009, REV-METHODS TECHNOL, V9, P311, DOI 10.1007/978-1-4020-9640-2_19; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x	25	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42093	10.1371/journal.pone.0042093	http://dx.doi.org/10.1371/journal.pone.0042093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900005	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900020
J	Sun, LF; Wu, XJ; Peng, Y; Goh, JY; Liou, YC; Lin, DH; Zhao, YF				Sun, Lifang; Wu, Xueji; Peng, Yu; Goh, Jian Yuan; Liou, Yih-Cherng; Lin, Donghai; Zhao, Yufen			Solution Structural Analysis of the Single-Domain Parvulin TbPin1	PLOS ONE			English	Article							PROLYL CIS/TRANS-ISOMERASE; MITOTIC REGULATOR HPIN1; CIS-TRANS-ISOMERIZATION; N-15 NMR RELAXATION; ROTATIONAL DIFFUSION; CATALYTIC MECHANISM; ESSENTIAL ESS1; PIN1; PHOSPHORYLATION; RECOGNITION	Background: Pin1-type parvulins are phosphorylation-dependent peptidyl-prolyl cis-trans isomerases. Their functions have been widely reported to be involved in a variety of cellular responses or processes, such as cell division, transcription, and apoptosis, as well as in human diseases including Alzheimer's disease and cancers. TbPin1 was identified as a novel class of Pin1-type parvulins from Trypanosoma brucei, containing a unique PPIase domain, which can catalyze the isomerization of phosphorylated Ser/Thr-Pro peptide bond. Methodology/Principal Findings: We determined the solution structure of TbPin1 and performed N-15 relaxation measurements to analyze its backbone dynamics using multi-dimensional heteronuclear NMR spectroscopy. The average RMSD values of the 20 lowest energy structures are 0.50+/-0.05 angstrom for backbone heavy atoms and 0.85+/-0.08 angstrom for all heavy atoms. TbPin1 adopts the typical catalytic tertiary structure of Pin1-type parvulins, which comprises a globular fold with a four-stranded anti-parallel beta-sheet core surrounded by three alpha-helices and one 3(10)-helix. The global structure of TbPin1 is relatively rigid except the active site. The 2D EXSY spectra illustrate that TbPin1 possesses a phosphorylation-dependent PPIase activity. The binding sites of TbPin1 for a phosphorylated peptide substrate {SSYFSG[p]TPLEDDSD} were determined by the chemical shift perturbation approach. Residues Ser15, Arg18, Asn19, Val21, Ser22, Val32, Gly66, Ser67, Met83, Asp105 and Gly107 are involved in substantial contact with the substrate. Conclusions/Significance: The solution structure of TbPin1 and the binding sites of the phosphorylated peptide substrate on TbPin1 were determined. The work is helpful for further understanding the molecular basis of the substrate specificity for Pin1-type parvulin family and enzyme catalysis.	[Sun, Lifang; Wu, Xueji; Lin, Donghai; Zhao, Yufen] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China; [Peng, Yu] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China; [Goh, Jian Yuan; Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Xiamen University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National University of Singapore; National University of Singapore	Sun, LF (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China.	dhlin@xmu.edu.cn; yfzhao@xmu.edu.cn	Zhao, Yufen/G-3445-2010	Peng, Yu/0000-0003-2039-9015	Chinese National Science Foundation [20972130, 91129713, 31170717]; Major State Basic Research Development Program of China (973 Program) [2012CB821600]; Program of Shanghai Subject Chief Scientist [09XD1405100]; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore [06/1/21/19/473]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Biomedical Research Council, the Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Chinese National Science Foundation (Nos. 20972130, 91129713, 31170717), the Major State Basic Research Development Program of China (973 Program, No. 2012CB821600) and the Program of Shanghai Subject Chief Scientist (No. 09XD1405100). Y-CL was supported by a grant (06/1/21/19/473) from the Biomedical Research Council, the Agency for Science, Research and Technology, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey ML, 2008, BIOCHEMISTRY-US, V47, P11481, DOI 10.1021/bi800964q; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Behrsin CD, 2007, J MOL BIOL, V365, P1143, DOI 10.1016/j.jmb.2006.10.078; Bialik S, 2011, MOL CELL, V42, P139, DOI 10.1016/j.molcel.2011.04.002; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daum S, 2006, BIOCHEMISTRY-US, V45, P12125, DOI 10.1021/bi0608820; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Erben ED, 2007, MOL BIOCHEM PARASIT, V153, P186, DOI 10.1016/j.molbiopara.2007.03.004; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Goh JY, 2010, FEBS LETT, V584, P2901, DOI 10.1016/j.febslet.2010.04.077; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Heikkinen O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-17; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Ishima R, 2012, TOP CURR CHEM, V326, P99, DOI 10.1007/128_2011_212; Jaremko L, 2011, J BIOL CHEM, V286, P6554, DOI 10.1074/jbc.M110.160713; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouri ED, 2009, PLANT PHYSIOL, V150, P1160, DOI 10.1104/pp.108.132415; Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Landrieu I, 2002, J MOL BIOL, V320, P321, DOI 10.1016/S0022-2836(02)00429-1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; Lim JN, 2005, BBA-MOL BASIS DIS, V1739, P311, DOI 10.1016/j.bbadis.2004.10.003; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Metzner M, 2001, J BIOL CHEM, V276, P13524, DOI 10.1074/jbc.M007005200; Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195; Mueller JW, 2008, PERSPECT MED CHEM, V2, P11; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PARK ST, 1992, J BIOL CHEM, V267, P3316; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Terada T, 2001, J MOL BIOL, V305, P917, DOI 10.1006/jmbi.2000.4293; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Velazquez HA, 2011, BIOCHEMISTRY-US, V50, P9605, DOI 10.1021/bi2009954; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Y, 2010, MOL CELL, V37, P112, DOI 10.1016/j.molcel.2009.12.020; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang QY, 2009, J BIOL CHEM, V284, P23980, DOI 10.1074/jbc.M109.022814; Yao JL, 2001, J BIOL CHEM, V276, P13517, DOI 10.1074/jbc.M007006200; Zerbe O, 2003, BIONMR DRUG RES; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	65	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43017	10.1371/journal.pone.0043017	http://dx.doi.org/10.1371/journal.pone.0043017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900083	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900101
J	Bouso, JC; Gonzalez, D; Fondevila, S; Cutchet, M; Fernandez, X; Barbosa, PCR; Alcazar-Corcoles, MA; Araujo, WS; Barbanoj, MJ; Fabregas, JM; Riba, J				Carlos Bouso, Jose; Gonzalez, Debora; Fondevila, Sabela; Cutchet, Marta; Fernandez, Xavier; Ribeiro Barbosa, Paulo Cesar; Angel Alcazar-Corcoles, Miguel; Sena Araujo, Wladimyr; Barbanoj, Manel J.; Maria Fabregas, Josep; Riba, Jordi			Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study	PLOS ONE			English	Article							PSYCHOACTIVE BEVERAGE AYAHUASCA; DRUG-USE; ADDICTION SEVERITY; RECEPTOR; 5-HT2A; PHARMACOLOGY; SPIRITUALITY; ADOLESCENCE; IMPULSIVITY; MECHANISMS	Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT2A agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North America. Members of these groups typically ingest ayahuasca at least twice per month. Prior research has shown that acute ayahuasca increases blood flow in prefrontal and temporal brain regions and that it elicits intense modifications in thought processes, perception and emotion. However, regular ayahuasca use does not seem to induce the pattern of addiction-related problems that characterize drugs of abuse. To study the impact of repeated ayahuasca use on general psychological well-being, mental health and cognition, here we assessed personality, psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users (n = 127) and controls (n = 115) at baseline and 1 year later. Controls were actively participating in non-ayahuasca religions. Users showed higher Reward Dependence and Self-Transcendence and lower Harm Avoidance and Self-Directedness. They scored significantly lower on all psychopathology measures, showed better performance on the Stroop test, the Wisconsin Card Sorting Test and the Letter-Number Sequencing task from the WAIS-III, and better scores on the Frontal Systems Behavior Scale. Analysis of life attitudes showed higher scores on the Spiritual Orientation Inventory, the Purpose in Life Test and the Psychosocial Well-Being test. Despite the lower number of participants available at follow-up, overall differences with controls were maintained one year later. In conclusion, we found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment in the ayahuasca-using group.	[Carlos Bouso, Jose; Riba, Jordi] IIB St Pau, Barcelona, Spain; [Carlos Bouso, Jose; Barbanoj, Manel J.; Riba, Jordi] Univ Autonoma Barcelona, Ctr Invest Medicaments, Serv Farmacol Clin, Dept Farmacol & Terapeut, E-08193 Barcelona, Spain; [Carlos Bouso, Jose] ICEERS, Halsteren, Netherlands; [Gonzalez, Debora] Univ Autonoma Barcelona, Unidad Farmacol Humana & Neurociencias, Inst Invest Hosp Mar IMIM, E-08193 Barcelona, Spain; [Fondevila, Sabela] Ctr UCM ISCIII Human Evolut & Behav, Madrid, Spain; [Cutchet, Marta; Maria Fabregas, Josep] IDEAA, Barcelona, Spain; [Ribeiro Barbosa, Paulo Cesar] Univ Estadual Santa Cruz, Dept Filosofia & Ciencias Humanas, Ilheus, Bahia, Brazil; [Angel Alcazar-Corcoles, Miguel] Univ Autonoma Madrid, Dept Psicol Biol & Salud, Fac Psicol, Madrid, Spain; [Sena Araujo, Wladimyr] Conselho Estadual Educac Estado Acre, Prefeitura Municipal Rio Branco, Rio Branco, Acre, Brazil; [Riba, Jordi] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universidade Estadual de Santa Cruz; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona	Bouso, JC (corresponding author), IIB St Pau, Barcelona, Spain.	jbouso@santpau.cat	Alcázar-Córcoles, Miguel Ángel/AAE-5735-2020; Alcázar-Córcoles, Miguel Ángel/C-4012-2011	Alcázar-Córcoles, Miguel Ángel/0000-0003-1650-2606; Alcázar-Córcoles, Miguel Ángel/0000-0003-1650-2606; Riba, Jordi/0000-0002-9375-8421; Bouso, Jose Carlos/0000-0003-1115-9407	IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil); International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation)	IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil); International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation)	Funding for this study was provided by IDEAA, Instituto de Estopsicologia Amazonica Aplicada, Barcelona (Spain)/Prato Raso (Brazil). We also would like to thank the International Center for Ethnobotanical Education, Research & Service (ICEERS Foundation; www.iceers.org) for funding the edition costs of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INT NARC CONTR BOARD; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barbosa PCR, 2005, J PSYCHOACTIVE DRUGS, V37, P193, DOI 10.1080/02791072.2005.10399801; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Bouso JC, 2011, ETHNOPHARMACOLOGY AY, P55; Cami J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160; Casullo M. M, 2000, REV PSICOLOGIA LIMA, VXVIII, P35; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Colzato LS, 2009, PSYCHOPHARMACOLOGY, V207, P225, DOI 10.1007/s00213-009-1650-0; Crumbaugh JC, 1976, PURPOSE LIFE TEST; Da Silveira DX, 2005, J PSYCHOACTIVE DRUGS, V37, P129, DOI 10.1080/02791072.2005.10399792; de Araujo DB, 2012, HUM BRAIN MAPP, V33, P2550, DOI 10.1002/hbm.21381; Derogatis L. R., 1994, SCL 90 R SYMPT CHECK; Derogatis LR, 2001, CUESTIONARIO 90 SINT; Doering-Silveira E, 2005, J PSYCHOACTIVE DRUGS, V37, P123, DOI 10.1080/02791072.2005.10399791; dos Santos RG, 2012, PSYCHOPHARMACOLOGY, V219, P1039, DOI 10.1007/s00213-011-2434-x; dos Santos RG, 2011, J CLIN PSYCHOPHARM, V31, P717, DOI 10.1097/JCP.0b013e31823607f6; ELKINS DN, 1988, J HUMANIST PSYCHOL, V28, P5, DOI 10.1177/0022167888284002; Fantegrossi WE, 2008, BIOCHEM PHARMACOL, V75, P17, DOI 10.1016/j.bcp.2007.07.018; Francis L, 2001, RES SOCIAL SCI STUDY, V12, P53; Fuentes D., 2000, ESCALAS AVALIA O 150, P363; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Golden C.J., 1994, STROOP TEST COLORES; Grace J., 2001, FRSBE FRONTAL SYSTEM; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Halpern JH, 2005, BIOL PSYCHIAT, V58, P624, DOI 10.1016/j.biopsych.2005.06.038; Halpern JH, 2008, MED SCI MONITOR, V14, pSR15; Heaton RK, 2001, WCST TEST CLASIFICAC; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Fernandez-Serrano MJ, 2012, PSYCHOPHARMACOLOGY, V219, P673, DOI 10.1007/s00213-011-2485-z; Fernandez-Serrano MJ, 2010, J PSYCHOPHARMACOL, V24, P1317, DOI 10.1177/0269881109349841; Labate B.C., 2008, AYAHUASCA RELIG COMP; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; Le Berre AP, 2010, ALCOHOL CLIN EXP RES, V34, P1888, DOI 10.1111/j.1530-0277.2010.01277.x; Lima F, 2002, REV BRAS PSIQUIAT S2, V24; Macher RB, 2012, J CLIN EXP NEUROPSYC, V34, P405, DOI 10.1080/13803395.2011.646957; MacLean KA, 2011, J PSYCHOPHARMACOL, V25, P1453, DOI 10.1177/0269881111420188; MacRae E., 1992, GUIDED MOON SHAMANIS; Fabregas JM, 2010, DRUG ALCOHOL DEPEN, V111, P257, DOI 10.1016/j.drugalcdep.2010.03.024; McIlhenny EH, 2011, BIOMED CHROMATOGR, V25, P970, DOI 10.1002/bmc.1551; McKenna DJ, 2004, PHARMACOL THERAPEUT, V102, P111, DOI 10.1016/j.pharmathera.2004.03.002; McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316; Melcher T, 2008, BRAIN RES REV, V59, P96, DOI 10.1016/j.brainresrev.2008.06.003; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moreno JL, 2011, NEUROSCI LETT, V493, P76, DOI 10.1016/j.neulet.2011.01.046; Nestor LJ, 2011, PSYCHIAT RES-NEUROIM, V194, P287, DOI 10.1016/j.pscychresns.2011.04.010; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Oberauer K, 2005, PSYCHOL BULL, V131, P61, DOI 10.1037/0033-2909.131.1.61; Passetti F, 2003, PSYCHOPHARMACOLOGY, V165, P136, DOI 10.1007/s00213-002-1227-7; Passie T, 2008, CNS NEUROSCI THER, V14, P295, DOI 10.1111/j.1755-5949.2008.00059.x; Pedrero-Perez E. J., 2006, ADICCIONES, V18, P135; PIERCE PA, 1989, PSYCHOPHARMACOLOGY, V97, P118, DOI 10.1007/BF00443425; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Riba J, 2001, PSYCHOPHARMACOLOGY, V154, P85, DOI 10.1007/s002130000606; Riba J, 2003, J PHARMACOL EXP THER, V306, P73, DOI 10.1124/jpet.103.049882; Riba J, 2002, BRIT J CLIN PHARMACO, V53, P613, DOI 10.1046/j.1365-2125.2002.01609.x; Barbosa PCR, 2009, J PSYCHOACTIVE DRUGS, V41, P205, DOI 10.1080/02791072.2009.10400530; Santos RG, 2007, J ETHNOPHARMACOL, V112, P507, DOI 10.1016/j.jep.2007.04.012; Santos RG, 2008, BR J PSYCHIAT; Schultes R., 1979, PLANTS GODS ORIGINS; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909; Stenner K., 2005, AUTHORITARIAN DYNAMI; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tosello D, 2001, THESIS U CATOLICA CA; Trichter S, 2009, J PSYCHOACTIVE DRUGS, V41, P121, DOI 10.1080/02791072.2009.10399905; Tupper KW, 2008, INT J DRUG POLICY, V19, P297, DOI 10.1016/j.drugpo.2006.11.001; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444	77	158	160	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42421	10.1371/journal.pone.0042421	http://dx.doi.org/10.1371/journal.pone.0042421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905130	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100037
J	Park, JK; Askin, F; Giles, JT; Halushka, MK; Rosen, A; Levine, SM				Park, Jin Kyun; Askin, Frederic; Giles, Jon T.; Halushka, Marc K.; Rosen, Antony; Levine, Stuart M.			Increased Generation of TRAP Expressing Multinucleated Giant Cells in Patients with Granulomatosis with Polyangiitis	PLOS ONE			English	Article							WEGENERS-GRANULOMATOSIS; OSTEOCLAST PRECURSORS; PSORIATIC-ARTHRITIS; IDENTIFICATION; BONE; VASCULITIS; RELAPSE; BLOOD	Background: Tissue-infiltrating multinucleated giant cells (MNGs) within geographic necrosis are pathologic hallmarks of granulomatosis with polyangiitis (GPA). However, the origin, phenotype, and function of these cells in GPA remain undefined. Methodology/Principal Findings: MNG phenotype in GPA lung tissue was examined by immunohistochemistry using antibody directed against cathepsin K and calcitonin-receptor. Tartrate-resistant-acid-phosphatase (TRAP) expression was assessed using enzymatic color reaction. Peripheral blood mononuclear cells (PBMCs) from 13 GPA patients (5 with localized and 8 with systemic disease) and 11 healthy controls were cultured in the presence of RANKL and M-CSF for 9 days, and TRAP+ MNGs containing 3 or more nuclei were identified. GPA lung granulomata contained numerous MNGs that expressed osteoclastic TRAP and cathepsin K but not calcitonin receptors. In the presence of RANKL and M-CSF, PBMCs of GPA patients formed significantly more MNGs than healthy controls (114 +/- 29 MNG/well vs. 22 +/- 9 MNG/well, P=0.02). In a subgroup analysis, patients with systemic disease generated significantly more MNGs than patients with localized disease (161 +/- 35 MNG/well vs. 39 +/- 27 MNG/well, P<0.01) or healthy controls (P<0.01). MNG production did not differ between localized GPA and control subjects (P=0.96). Conclusions/Significance: MNGs in granulomata in the GPA lung express osteoclastic enzymes TRAP and cathepsin K. GPA patients have a higher propensity to form TRAP+ MNGs from peripheral blood than healthy controls. These data suggest that (i) the tendency to form MNGs is a component of the GPA phenotype itself, and (ii) that lesional MNGs might participate in the destructive process through their proteolytic enzymes.	[Park, Jin Kyun; Rosen, Antony; Levine, Stuart M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA; [Askin, Frederic; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Giles, Jon T.] Columbia Univ Coll Phys & Surg, Dept Med, Div Rheumatol, New York, NY 10032 USA	Johns Hopkins University; Johns Hopkins University; Columbia University	Park, JK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA.	jinkyunpark@gmail.com		Park, Jin Kyun/0000-0003-2167-9393; Halushka, Marc/0000-0002-7112-7389	Brian & Bettina Finn and Family; Trish and Edward Savides and Family; Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program; Brian Finn and Family; Trish and Ed Savides and family; Dr. Ira T. Fine Discovery fund; Johns Hopkins RDRCC Award [P30AR053503]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	Brian & Bettina Finn and Family; Trish and Edward Savides and Family; Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program; Brian Finn and Family; Trish and Ed Savides and family; Dr. Ira T. Fine Discovery fund; Johns Hopkins RDRCC Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Levine's work was supported by Brian & Bettina Finn and Family, and Trish and Edward Savides and Family, Johns Hopkins Center for Innovative Medicine and Lowe Family Scholar program, Brian Finn and Family, Trish and Ed Savides and family, Dr. Ira T. Fine Discovery fund, and the Johns Hopkins RDRCC Award # P30AR053503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; BURSTONE MS, 1959, J HISTOCHEM CYTOCHEM, V7, P39, DOI 10.1177/7.1.39; Cheadle C, 2010, ARTHRITIS RHEUM-US, V62, P1744, DOI 10.1002/art.27398; Chiu YG, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2915; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; DEVANEY KO, 1990, AM J SURG PATHOL, V14, P555, DOI 10.1097/00000478-199006000-00006; Falk RJ, 2011, ARTHRITIS RHEUM-US, V63, P863, DOI 10.1002/art.30286; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Muto A, 2011, J BONE MINER RES, V26, P2978, DOI 10.1002/jbmr.490; Popa ER, 2007, RHEUMATOLOGY, V46, P1029, DOI 10.1093/rheumatology/kem022; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Shen ZX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1938; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Sullivan EJ, 1998, CLIN CHEST MED, V19, P759, DOI 10.1016/S0272-5231(05)70115-5; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42659	10.1371/journal.pone.0042659	http://dx.doi.org/10.1371/journal.pone.0042659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905158	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100054
J	Paterson, KB; McGowan, VA; Jordan, TR				Paterson, Kevin B.; McGowan, Victoria A.; Jordan, Timothy R.			Eye Movements Reveal Effects of Visual Content on Eye Guidance and Lexical Access during Reading	PLOS ONE			English	Article							E-Z READER; FOVEAL PROCESSING DIFFICULTY; PARAFOVEAL WORD-LENGTH; CONTRAST SENSITIVITY; SPATIAL-FREQUENCY; INTEGRATING INFORMATION; FIXATION DURATIONS; MODEL; ATTENTION; IDENTIFICATION	Background: Normal reading requires eye guidance and activation of lexical representations so that words in text can be identified accurately. However, little is known about how the visual content of text supports eye guidance and lexical activation, and thereby enables normal reading to take place. Methods and Findings: To investigate this issue, we investigated eye movement performance when reading sentences displayed as normal and when the spatial frequency content of text was filtered to contain just one of 5 types of visual content: very coarse, coarse, medium, fine, and very fine. The effect of each type of visual content specifically on lexical activation was assessed using a target word of either high or low lexical frequency embedded in each sentence Results: No type of visual content produced normal eye movement performance but eye movement performance was closest to normal for medium and fine visual content. However, effects of lexical frequency emerged early in the eye movement record for coarse, medium, fine, and very fine visual content, and were observed in total reading times for target words for all types of visual content. Conclusion: These findings suggest that while the orchestration of multiple scales of visual content is required for normal eye-guidance during reading, a broad range of visual content can activate processes of word identification independently. Implications for understanding the role of visual content in reading are discussed.	[Paterson, Kevin B.; McGowan, Victoria A.; Jordan, Timothy R.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	Paterson, KB (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	kbp3@le.ac.uk; proftimjordan@gmail.com		McGowan, Victoria/0000-0003-1956-1599; Paterson, Kevin/0000-0002-8150-8628				ALLEN PA, 1990, J EXP PSYCHOL HUMAN, V16, P48, DOI 10.1037/0096-1523.16.1.48; Allen PA, 2009, ATTEN PERCEPT PSYCHO, V71, P281, DOI 10.3758/APP.71.2.281; Baayen R. H, 1995, CELEX LEXICAL DATABA; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; BECKMANN PJ, 1991, SID 91, P106; Blais C, 2005, J VIS, V5, p813a; Blakemore C, 1969, J PHYSL, V2000, P11; Boden C, 2009, BRAIN COGNITION, V69, P580, DOI 10.1016/j.bandc.2008.12.002; BRIIHL D, 1995, J EXP PSYCHOL LEARN, V21, P55, DOI 10.1037/0278-7393.21.1.55; Chung STL, 2009, J VISION, V9, DOI 10.1167/9.9.16; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Drieghe D, 2005, J EXP PSYCHOL HUMAN, V31, P954, DOI 10.1037/0096-1523.31.5.954; Drieghe D, 2004, EUR J COGN PSYCHOL, V16, P79, DOI 10.1080/09541440340000141; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fiset D, 2009, COGN NEUROPSYCHOL, V26, P23, DOI 10.1080/02643290802421160; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; Gollan TH, 2011, J EXP PSYCHOL GEN, V140, P186, DOI 10.1037/a0022256; GUZMAN O, 1985, VISION RES, V25, P137, DOI 10.1016/0042-6989(85)90087-2; HENDERSON JM, 1990, J EXP PSYCHOL LEARN, V16, P417, DOI 10.1037/0278-7393.16.3.417; INHOFF AW, 1986, PERCEPT PSYCHOPHYS, V40, P431, DOI 10.3758/BF03208203; Jordan TR, 2003, J EXP PSYCHOL LEARN, V29, P900, DOI 10.1037/0278-7393.29.5.900; JORDAN TR, 1990, J EXP PSYCHOL HUMAN, V16, P893, DOI 10.1037/0096-1523.16.4.893; JORDAN TR, 1995, J EXP PSYCHOL HUMAN, V21, P512, DOI 10.1037/0096-1523.21.3.512; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Juhasz BJ, 2003, J EXP PSYCHOL LEARN, V29, P1312, DOI 10.1037/0278-7393.29.6.1312; KENNISON SM, 1995, J EXP PSYCHOL LEARN, V21, P68, DOI 10.1037/0278-7393.21.1.68; Leat SJ, 1994, TECHNICAL DIGEST SER, V2, P250; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; Levy-Schoen A., 1981, EYE MOVEMENTS COGNIT, P299; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; MASON A, 1993, CLIN VISION SCI, V8, P345; Patching GR, 2005, MEM COGNITION, V33, P961, DOI 10.3758/BF03193205; Patching GR, 2005, INVEST OPHTH VIS SCI, V46, P2219, DOI 10.1167/iovs.03-1247; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Paterson KB, 2009, PSYCHON B REV, V16, P43, DOI 10.3758/PBR.16.1.43; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Plummer P, 2012, ATTEN PERCEPT PSYCHO, V74, P950, DOI 10.3758/s13414-012-0286-z; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; POLLATSEK A, 1982, J EXP PSYCHOL HUMAN, V8, P817, DOI 10.1037/0096-1523.8.6.817; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1996, J EXP PSYCHOL HUMAN, V22, P1188, DOI 10.1037/0096-1523.22.5.1188; Rayner K, 1998, VISION RES, V38, P1129, DOI 10.1016/S0042-6989(97)00274-5; RAYNER K, 1980, COGNITIVE PSYCHOL, V12, P206, DOI 10.1016/0010-0285(80)90009-2; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K., 1989, PSYCHOL READING; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reichle ED, 2011, PSYCHOPHYSIOLOGY, V48, P993, DOI 10.1111/j.1469-8986.2011.01169.x; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Reingold EM, 2010, J EXP PSYCHOL HUMAN, V36, P1677, DOI 10.1037/a0019959; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; Schroyens W, 1999, Q J EXP PSYCHOL-A, V52, P1021, DOI 10.1080/713755859; White Sarah J., 2007, P409, DOI 10.1016/B978-008044980-7/50020-3; White SJ, 2006, Q J EXP PSYCHOL, V59, P760, DOI 10.1080/02724980543000024; White SJ, 2006, VISION RES, V46, P426, DOI 10.1016/j.visres.2005.07.006; White SJ, 2005, PSYCHON B REV, V12, P466, DOI 10.3758/BF03193789; White SJ, 2004, EUR J COGN PSYCHOL, V16, P52, DOI 10.1080/09541440340000204; Young LK, 2011, J VISION, V11, DOI 10.1167/11.13.20	62	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41766	10.1371/journal.pone.0041766	http://dx.doi.org/10.1371/journal.pone.0041766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905106	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100017
J	von Wyl, V; Cambiano, V; Jordan, MR; Bertagnolio, S; Miners, A; Pillay, D; Lundgren, J; Phillips, AN				von Wyl, Viktor; Cambiano, Valentina; Jordan, Michael R.; Bertagnolio, Silvia; Miners, Alec; Pillay, Deenan; Lundgren, Jens; Phillips, Andrew N.			Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring	PLOS ONE			English	Article							HIV-1 DRUG-RESISTANCE; TREATMENT-NAIVE PATIENTS; DISOPROXIL FUMARATE; REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; K65R MUTATION; SOUTH-AFRICA; VIRAL LOAD; EFAVIRENZ; EMTRICITABINE	Background: The most recent World Health Organization (WHO) antiretroviral treatment guidelines recommend the inclusion of zidovudine (ZDV) or tenofovir (TDF) in first-line therapy. We conducted a cost-effectiveness analysis with emphasis on emerging patterns of drug resistance upon treatment failure and their impact on second-line therapy. Methods: We used a stochastic simulation of a generalized HIV-1 epidemic in sub-Saharan Africa to compare two strategies for first-line combination antiretroviral treatment including lamivudine, nevirapine and either ZDV or TDF. Model input parameters were derived from literature and, for the simulation of resistance pathways, estimated from drug resistance data obtained after first-line treatment failure in settings without virological monitoring. Treatment failure and cost effectiveness were determined based on WHO definitions. Two scenarios with optimistic (no emergence; base) and pessimistic (extensive emergence) assumptions regarding occurrence of multidrug resistance patterns were tested. Results: In the base scenario, cumulative proportions of treatment failure according to WHO criteria were higher among first-line ZDV users (median after six years 36% [95% simulation interval 32%; 39%]) compared with first-line TDF users (31% [29%; 33%]). Consequently, a higher proportion initiated second-line therapy (including lamivudine, boosted protease inhibitors and either ZDV or TDF) in the first-line ZDV user group 34% [31%; 37%] relative to first-line TDF users (30% [27%; 32%]). At the time of second-line initiation, a higher proportion (16%) of first-line ZDV users harboured TDF-resistant HIV compared with ZDV-resistant viruses among first-line TDF users (0% and 6% in base and pessimistic scenarios, respectively). In the base scenario, the incremental cost effectiveness ratio with respect to quality adjusted life years (QALY) was US$83 when TDF instead of ZDV was used in first-line therapy (pessimistic scenario: US$ 315), which was below the WHO threshold for high cost effectiveness (US$ 2154). Conclusions: Using TDF instead of ZDV in first-line treatment in resource-limited settings is very cost-effective and likely to better preserve future treatment options in absence of virological monitoring.	[von Wyl, Viktor; Cambiano, Valentina; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [von Wyl, Viktor] CSS Inst Empir Hlth Econ, Luzern, Switzerland; [Jordan, Michael R.; Bertagnolio, Silvia] World Hlth Org, Geneva, Switzerland; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Miners, Alec] London Sch Hyg & Trop Med, London WC1, England; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark	University of London; University College London; World Health Organization; Tufts University; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Rigshospitalet; University of Copenhagen	von Wyl, V (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	viktor.vonwyl@css-institut.ch	Phillips, Andrew N/B-4427-2008; Lundgren, Jens/AAE-6876-2019	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850; von Wyl, Viktor/0000-0002-8754-9797	European Community's Seventh Framework Programme under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)' [223131]; Swiss National Science Foundation (SNF) Grant for Prospective Researchers [PBEZP3-125726]; National Institutes of Health [NIH K23 AI074423-05]	European Community's Seventh Framework Programme under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)'; Swiss National Science Foundation (SNF) Grant for Prospective Researchers(Swiss National Science Foundation (SNSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research leading to these results has received partial funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project 'Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)' - grant agreement no 223131. VvW was supported by a Swiss National Science Foundation (SNF) Grant for Prospective Researchers (PBEZP3-125726), and MRJ has received a grant from the National Institutes of Health (NIH K23 AI074423-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; BENDAVID E, 2011, 17 INT AIDS C MEX CI, V25, P211, DOI DOI 10.1097/QAD.0B013E328340FDF8; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Boucher S, 2006, HIV MED, V7, P294, DOI 10.1111/j.1468-1293.2006.00379.x; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Bygrave H, 2011, JAIDS-J ACQ IMM DEF, V56, pE75, DOI 10.1097/QAI.0b013e3182097505; Chappell BJ, 2007, AIDS, V21, P761, DOI 10.1097/QAD.0b013e3280187533; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Clinton Health Access Initiative, 2010, ANT ARV PRIC LIST VE; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grant PM, 2010, ANTIMICROB AGENTS CH, V54, P1520, DOI 10.1128/AAC.01380-09; Hamers RL, 2011, LANCET INFECT DIS; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jouquet G., 2011, J ACQUIR IMMUNE DEFI; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; KEISER O, 2009, 17 INT AIDS C MEX CI, V23, P1867, DOI DOI 10.1097/QAD.0B013E32832E05B2; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Lyagoba F, 2010, JAIDS-J ACQ IMM DEF, V55, P277, DOI 10.1097/QAI.0b013e3181ea0df8; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Ndembi N, 2010, J INFECT DIS, V201, P106, DOI 10.1086/648590; PHILLIPS AN, 2011, 17 INT AIDS C MEX CI, V25, P843, DOI DOI 10.1097/QAD.0B013E328344037A; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Sanchez-de la Rosa R, 2008, CLIN THER, V30, P372, DOI 10.1016/j.clinthera.2008.02.009; Scherrer AU, 2012, JAIDS-J ACQ IMM DEF, V59, P105, DOI 10.1097/QAI.0b013e31823c8b69; Trotta MP, 2006, J MED VIROL, V78, P535, DOI 10.1002/jmv.20573; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42834	10.1371/journal.pone.0042834	http://dx.doi.org/10.1371/journal.pone.0042834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905175	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100067
J	Verma, M; Sharma, A; Naidu, S; Bhadra, AK; Kukreti, R; Taneja, V				Verma, Meenakshi; Sharma, Abhishek; Naidu, Swarna; Bhadra, Ankan Kumar; Kukreti, Ritushree; Taneja, Vibha			Curcumin Prevents Formation of Polyglutamine Aggregates by Inhibiting Vps36, a Component of the ESCRT-II Complex	PLOS ONE			English	Article							AMYLOID PATHOLOGY; ALPHA-SYNUCLEIN; SMALL MOLECULES; TOXICITY; YEAST; PROTEIN; PRION; FIBRILS; ENHANCE; PLAQUES	Small molecules with antioxidative properties have been implicated in amyloid disorders. Curcumin is the active ingredient present in turmeric and known for several biological and medicinal effects. Adequate evidence substantiates the importance of curcumin in Alzheimer's disease and recent evidence suggests its role in Prion and Parkinson's disease. However, contradictory effects have been suggested for Huntington's disease. This difference provided a compelling reason to investigate the effect of curcumin on glutamine-rich (Q-rich) and non-glutamine-rich (non Q-rich) amyloid aggregates in the well established yeast model system. Curcumin significantly inhibited the formation of htt72Q-GFP (a Q-rich) and Het-s-GFP (a non Q-rich) aggregates in yeast. We show that curcumin prevents htt72Q-GFP aggregation by down regulating Vps36, a component of the ESCRT-II (Endosomal sorting complex required for transport). Moreover, curcumin disrupted the htt72Q-GFP aggregates that were pre-formed in yeast and cured the yeast prion, [PSI+].	[Verma, Meenakshi; Kukreti, Ritushree] Inst Genom & Integrat Biol CSIR, Delhi, India; [Sharma, Abhishek] Ruhr Univ Bochum, Fac Chem & Biochem, Bochum, Germany; [Naidu, Swarna; Taneja, Vibha] Sir Ganga Ram Hosp, Dept Res, Delhi, India; [Bhadra, Ankan Kumar] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Sas Nagar, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Ruhr University Bochum; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Verma, M (corresponding author), Inst Genom & Integrat Biol CSIR, Mall Rd, Delhi, India.	vibha17@yahoo.com	Bhadra, Ankan/AAJ-6115-2021	Bhadra, Ankan/0000-0002-8679-0984; Sharma, Abhishek/0000-0003-3699-5460; BHADRA, ANKAN KUMAR/0000-0001-8729-9153	Department of Biotechnology, Government of India, India; Department of Biotechnology, India; Indian Council of Medical Research	Department of Biotechnology, Government of India, India(Department of Biotechnology (DBT) India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Innovative Young Biotechnology Award, Department of Biotechnology, Government of India, India. VT acknowledges fellowship from Innovative Young Biotechnologist Award, Department of Biotechnology, India. MV acknowledges senior research fellowship from Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Dikshit P, 2006, BIOCHEM BIOPH RES CO, V342, P1323, DOI 10.1016/j.bbrc.2006.02.104; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gong EJ, 2011, NEUROBIOL DIS, V44, P223, DOI 10.1016/j.nbd.2011.07.005; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Hickey MA, 2012, MOL NEURODEGENER, P7; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P1159; Jagota S, 2012, NEUROCHEM RES, V37, P40, DOI 10.1007/s11064-011-0580-5; Kaganovich D, 2006, BIOCH BIOPHYSICAL RE, V342, P1323; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Mathur V, 2010, MOL BIOL CELL, V21, P1449, DOI 10.1091/mbc.E09-11-0927; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yilmaz R, 2012, AFR J BIOTECHNOL, V11, P1046; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520; Zhang X, 2011, PHARMACOL REP, V63, P1101, DOI 10.1016/S1734-1140(11)70629-6; Zhang X, 2011, EUR J PHARM SCI, V42, P540, DOI 10.1016/j.ejps.2011.02.009	40	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42923	10.1371/journal.pone.0042923	http://dx.doi.org/10.1371/journal.pone.0042923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880132	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900062
J	Fan, L; Xiao, HP; Hu, ZY; Ernst, JD				Fan, Lin; Xiao, He-ping; Hu, Zhong-yi; Ernst, Joel D.			Variation of Mycobacterium tuberculosis Antigen-Specific IFN-gamma and IL-17 Responses in Healthy Tuberculin Skin Test (TST)-Positive Human Subjects	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSE; LUNG; VACCINATION; GRANULOMA; INFECTION; CAVITARY; SPECTRUM; IL-23	Objective: To determine the variation of IFN-gamma and IL-17 responses to M. tuberculosis antigens in healthy TST+ humans. Methods: We isolated peripheral blood mononuclear cells from 21 TST+ healthy adults, stimulated them with phytohemagglutinin (PHA), PPD, Ag85B, ESAT-6, and live M. bovis BCG, and assayed IFN-gamma and IL-17 secretion by ELISA in supernatants after 24 or 72 hours of incubation respectively. Results: As in other studies, we found a wide range of IFN-gamma responses to M. tuberculosis antigens; the variation significantly exceeded that observed in the same donors to the polyclonal T cell stimulus, phytohemagglutinin (PHA). In addition, we assayed IL-17 secretion in response to the same stimuli, and found less subject-to-subject variation. Analysis of the ratio of IFN-gamma to IL-17 secretion on a subject-to-subject basis also revealed a wide range, with the majority of results distributed in a narrow range, and a minority with extreme results all of which were greater than that in the majority of subjects. The data suggest that study of exceptional responses to M. tuberculosis antigens may reveal immunologic correlates with specific outcomes of M. tuberculosis infection. Conclusion: Variation of IFN gamma and IFN-gamma/IL-17 responses to mycobacterial antigens exceeds that of responses to the polyclonal stimulus, PHA, in TST positive healthy humans. This indicates a quantitative spectrum of human immune responses to infection with M. tuberculosis. Since the outcome of human infection with M. tuberculosis varies greatly, systematic study of multiple immune responses to multiple antigens is likely to reveal correlations between selected immune responses and the outcomes of infection.	[Fan, Lin; Ernst, Joel D.] NYU, Sch Med, Div Infect Dis, New York, NY 10003 USA; [Fan, Lin; Xiao, He-ping; Hu, Zhong-yi] Tongji Univ, Sch Med, TB Ctr Diag & Treatment, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China	New York University; Tongji University	Fan, L (corresponding author), NYU, Sch Med, Div Infect Dis, New York, NY 10003 USA.	shhuzy@163.com; joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NIH [R01 AI090928]; NIH/NCRR [1UL1RR029893-0109]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI090928 and NIH/NCRR 1UL1RR029893-0109. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Barry S, 2009, TUBERCULOSIS, V89, P48, DOI 10.1016/j.tube.2008.07.002; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Agostino RB., 2004, INTRO APPL BIOSTATIS; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42716	10.1371/journal.pone.0042716	http://dx.doi.org/10.1371/journal.pone.0042716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880090	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000063
J	Fricke, K; Koban, I; Tresp, H; Jablonowski, L; Schroder, K; Kramer, A; Weltmann, KD; von Woedtke, T; Kocher, T				Fricke, Katja; Koban, Ina; Tresp, Helena; Jablonowski, Lukasz; Schroeder, Karsten; Kramer, Axel; Weltmann, Klaus-Dieter; von Woedtke, Thomas; Kocher, Thomas			Atmospheric Pressure Plasma: A High-Performance Tool for the Efficient Removal of Biofilms	PLOS ONE			English	Article							CANDIDA-ALBICANS; NONTHERMAL PLASMA; IN-VITRO; EMISSION-SPECTROSCOPY; INACTIVATION; DECONTAMINATION	Introduction: The medical use of non-thermal physical plasmas is intensively investigated for sterilization and surface modification of biomedical materials. A further promising application is the removal or etching of organic substances, e. g., biofilms, from surfaces, because remnants of biofilms after conventional cleaning procedures are capable to entertain inflammatory processes in the adjacent tissues. In general, contamination of surfaces by micro-organisms is a major source of problems in health care. Especially biofilms are the most common type of microbial growth in the human body and therefore, the complete removal of pathogens is mandatory for the prevention of inflammatory infiltrate. Physical plasmas offer a huge potential to inactivate micro-organisms and to remove organic materials through plasma-generated highly reactive agents. Method: In this study a Candida albicans biofilm, formed on polystyrene (PS) wafers, as a prototypic biofilm was used to verify the etching capability of the atmospheric pressure plasma jet operating with two different process gases (argon and argon/oxygen mixture). The capability of plasma-assisted biofilm removal was assessed by microscopic imaging. Results: The Candida albicans biofilm, with a thickness of 10 to 20 mm, was removed within 300 s plasma treatment when oxygen was added to the argon gas discharge, whereas argon plasma alone was practically not sufficient in biofilm removal. The impact of plasma etching on biofilms is localized due to the limited presence of reactive plasma species validated by optical emission spectroscopy.	[Fricke, Katja; Tresp, Helena; Schroeder, Karsten; Weltmann, Klaus-Dieter; von Woedtke, Thomas] INP Greifswald, Leibniz Inst Plasma Sci & Technol eV, Greifswald, Germany; [Koban, Ina; Jablonowski, Lukasz; Kocher, Thomas] Ernst Moritz Arndt Univ Greifswald, Sch Dent, Unit Periodontol, Greifswald, Germany; [Tresp, Helena] Ctr Innovat Competence Plasmatis, Greifswald, Germany; [Kramer, Axel] Ernst Moritz Arndt Univ Greifswald, Inst Hyg & Environm Med, Greifswald, Germany	Leibniz Institut fur Plasmaforschung und Technologie; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Fricke, K (corresponding author), INP Greifswald, Leibniz Inst Plasma Sci & Technol eV, Greifswald, Germany.	k.fricke@inp-greifswald.de	von Woedtke, Thomas/U-3604-2018	von Woedtke, Thomas/0000-0002-1097-4832; Fricke, Katja/0000-0001-6050-7725	Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research [13N9779, 13N11188]	Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from Bundesministerium fur Bildung und Forschung (BMBF) - Federal Ministry of Education and Research, grant no. 13N9779 and 13N11188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Baxter HC, 2005, J GEN VIROL, V86, P2393, DOI 10.1099/vir.0.81016-0; Boudam MK, 2006, J PHYS D APPL PHYS, V39, P3494, DOI 10.1088/0022-3727/39/16/S07; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fricke K, 2011, PLASMA PROCESS POLYM, V8, P51, DOI 10.1002/ppap.201000093; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; He M, 2007, MYCOPATHOLOGIA, V163, P137, DOI 10.1007/s11046-007-0097-2; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Koban I, 2011, J CLIN PERIODONTOL, V38, P956, DOI 10.1111/j.1600-051X.2011.01740.x; Koban I, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073039; Kudrle V, 2010, J PHYS D, V43, P13; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Machala Z, 2007, J MOL SPECTROSC, V243, P194, DOI 10.1016/j.jms.2007.03.001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Melzer A., 2008, LOW TEMPERATURE PLAS, V2nd ed., P129; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Navratil Z, 2006, CZECH J PHYS, V56, pB944, DOI 10.1007/s10582-006-0308-y; Otto C, 2011, FOOD ENG REV, V3, P171, DOI 10.1007/s12393-011-9038-4; Pompl R, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115023; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; Rupf S, 2011, PLOS ONE, V6, P9; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y; Schulz-von der Gathen V, 2008, J PHYS D, V41, P6; Sureshkumar A, 2010, INT J PHARMACEUT, V396, P17, DOI 10.1016/j.ijpharm.2010.05.045; von Keudell A, 2010, PLASMA PROCESS POLYM, V7, P327, DOI 10.1002/ppap.200900121; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Weltmann KD, 2011, IEEE T PLASMA SCI, V39, P1015, DOI 10.1109/TPS.2011.2112674; Whittaker AG, 2004, J HOSP INFECT, V56, P37, DOI 10.1016/j.jhin.2003.09.019	38	126	130	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42539	10.1371/journal.pone.0042539	http://dx.doi.org/10.1371/journal.pone.0042539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880025	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000043
J	Gupta, GK; Agrawal, T; Del Core, MG; Hunter, WJ; Agrawal, DK				Gupta, Gaurav K.; Agrawal, Tanupriya; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.			Decreased Expression of Vitamin D Receptors in Neointimal Lesions following Coronary Artery Angioplasty in Atherosclerotic Swine	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BALLOON ANGIOPLASTY; D DEFICIENCY; CARDIOVASCULAR-DISEASE; BARE-METAL; RESTENOSIS; MODEL; 1,25-DIHYDROXYVITAMIN-D3; INFLAMMATION; ASSOCIATION	Background: Inflammatory cytokines, such as TNF-alpha, play a key role in the pathogenesis of occlusive vascular diseases. Activation of vitamin D receptors (VDR) elicits both growth-inhibitory and anti-inflammatory effects. Here, we investigated the expression of TNF-alpha and VDR in post-angioplasty coronary artery neointimal lesions of hypercholesterolemic swine and examined the effect of vitamin D deficiency on the development of coronary restenosis. We also examined the effect of calcitriol on cell proliferation and effect of TNF-alpha on VDR activity and expression in porcine coronary artery smooth muscle cells (PCASMCs) in-vitro. Methodology/Principal Findings: Expression of VDR and TNF-alpha and the effect of vitamin D deficiency in post-angioplasty coronary arteries were analyzed by immunohistochemistry and histomorphometry. Cell proliferation was examined by thymidine and BrdU incorporation assays in cultured PCASMCs. Effect of TNF-alpha-stimulation on the activity and expression of VDR was analyzed by luciferase assay, immunoblotting and immunocytochemistry. In-vivo, morphometric analysis of the tissues revealed typical lesions with significant neointimal proliferation. Histological evaluation showed expression of smooth muscle alpha-actin and significantly increased expression of TNF-alpha in neointimal lesions. Interestingly, there was significantly decreased expression of VDR in PCASMCs of neointimal region compared to normal media. Indeed, post-balloon angioplasty restenosis was significantly higher in vitamin D-deficient hypercholesterolemic swine compared to vitamin D-sufficient group. In-vitro, calcitriol inhibited both serum- and PDGF-BB-induced proliferation in PCASMCs and TNF-alpha-stimulation significantly decreased the expression and activity of VDR in PCASMCs. Conclusions/Significance:These data suggest that significant downregulation of VDR in proliferating smooth muscle cells in neointimal lesions could be due to atherogenic cytokines, including TNF-alpha. Vitamin D deficiency potentiates the development of coronary restenosis. Calcitriol has anti-proliferative properties in PCASMCs and these actions are mediated through VDR. This could be a potential mechanism for uncontrolled growth of neointimal cells in injured arteries leading to restenosis.	[Gupta, Gaurav K.; Agrawal, Tanupriya; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Gupta, Gaurav K.; Agrawal, Tanupriya; Agrawal, Devendra K.] Creighton Univ, Sch Med, Ctr Clin & Translat Sci, Omaha, NE 68178 USA; [Del Core, Michael G.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Internal Med, Omaha, NE 68178 USA; [Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Hunter, William J., III] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University; Creighton University; Creighton University	Gupta, GK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022; Stefanadis, Christodoulos/ABH-2232-2020	Agrawal, Devendra/0000-0001-5445-0013; Agrawal, Tanupriya/0000-0002-7649-2828; Stefanadis, Christodoulos/0000-0001-5974-6454	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL104516, R01HL116042]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104516, R01HL116042, R01HL112597, R01HL120659] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award numbers R01HL104516 and R01HL116042 to DKA. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Cardus A, 2003, NEFROLOGIA, V23, P117; Carlberg C, 2001, STEROIDS, V66, P213, DOI 10.1016/S0039-128X(00)00150-1; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; DOKOH S, 1984, CANCER RES, V44, P2103; Donners MMPC, 2003, ANN MED, V35, P523, DOI 10.1080/07853890310014876; Fernandez-Martin JL, 1998, MOL CELL ENDOCRINOL, V141, P65, DOI 10.1016/S0303-7207(98)00094-X; Garg P, 2008, J AM COLL CARDIOL, V51, P1844, DOI 10.1016/j.jacc.2008.01.042; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; HALLORAN BP, 1981, J BIOL CHEM, V256, P7338; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Jia GH, 2007, J SURG RES, V142, P137, DOI 10.1016/j.jss.2006.11.007; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Michos ED, 2008, CURR OPIN CLIN NUTR, V11, P7, DOI 10.1097/MCO.0b013e3282f2f4dd; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Pilz S, 2008, J CLIN ENDOCR METAB, V93, P3927, DOI 10.1210/jc.2008-0784; Rajasree S, 2002, LIFE SCI, V70, P1777, DOI 10.1016/S0024-3205(02)01473-X; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; Seol Sang-Hoon, 2009, Korean Circ J, V39, P439, DOI 10.4070/kcj.2009.39.10.439; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Williams S, 2009, ETHN DIS S5, V19; Wu-Wong JR, 2007, J CELL BIOCHEM, V100, P1395, DOI 10.1002/jcb.21133; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zhou ZM, 2002, ATHEROSCLEROSIS, V161, P153, DOI 10.1016/S0021-9150(01)00640-2	33	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42789	10.1371/journal.pone.0042789	http://dx.doi.org/10.1371/journal.pone.0042789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880111	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000071
J	Nolasco, S; Bellido, J; Goncalves, J; Tavares, A; Zabala, JC; Soares, H				Nolasco, Sofia; Bellido, Javier; Goncalves, Joao; Tavares, Alexandra; Carlos Zabala, Juan; Soares, Helena			The Expression of Tubulin Cofactor A (TBCA) Is Regulated by a Noncoding Antisense Tbca RNA during Testis Maturation	PLOS ONE			English	Article							MAMMALIAN-CELLS; BETA-TUBULIN; ENDOGENOUS SIRNAS; INTERFERING RNAS; GENE-EXPRESSION; MOUSE OOCYTES; TRANSCRIPTS; PSEUDOGENES; IDENTIFICATION; RETROPOSITION	Background: Recently, long noncoding RNAs have emerged as pivotal molecules for the regulation of coding genes' expression. These molecules might result from antisense transcription of functional genes originating natural antisense transcripts (NATs) or from transcriptional active pseudogenes. TBCA interacts with beta-tubulin and is involved in the folding and dimerization of new tubulin heterodimers, the building blocks of microtubules. Methodology/Principal Findings: We found that the mouse genome contains two structurally distinct Tbca genes located in chromosomes 13 (Tbca13) and 16 (Tbca16). Interestingly, the two Tbca genes albeit ubiquitously expressed, present differential expression during mouse testis maturation. In fact, as testis maturation progresses Tbca13 mRNA levels increase progressively, while Tbca16 mRNA levels decrease. This suggests a regulatory mechanism between the two genes and prompted us to investigate the presence of the two proteins. However, using tandem mass spectrometry we were unable to identify the TBCA16 protein in testis extracts even in those corresponding to the maturation step with the highest levels of Tbca16 transcripts. These puzzling results led us to re-analyze the expression of Tbca16. We then detected that Tbca16 transcription produces sense and natural antisense transcripts. Strikingly, the specific depletion by RNAi of these transcripts leads to an increase of Tbca13 transcript levels in a mouse spermatocyte cell line. Conclusions/Significance: Our results demonstrate that Tbca13 mRNA levels are post-transcriptionally regulated by the sense and natural antisense Tbca16 mRNA levels. We propose that this regulatory mechanism operates during spermatogenesis, a process that involves microtubule rearrangements, the assembly of specific microtubule structures and requires critical TBCA levels.	[Goncalves, Joao; Tavares, Alexandra; Soares, Helena] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Quim & Bioquim, Lisbon, Portugal; [Nolasco, Sofia; Bellido, Javier; Carlos Zabala, Juan] Univ Cantabria, IFIMAV, Fac Med, Dept Biol Mol, E-39005 Santander, Spain; [Nolasco, Sofia; Goncalves, Joao; Tavares, Alexandra; Soares, Helena] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Soares, Helena] Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade de Lisboa; Universidad de Cantabria; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Nolasco, S (corresponding author), Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Lisbon, Portugal.	mhsoares@fc.ul.pt	Nolasco, Sofia/J-3353-2013; Gonçalves, João/P-4778-2017; Soares, Helena/G-3065-2010; Zabala, Juan Carlos/K-5163-2014; Goncalves, Joao/B-2013-2008	Nolasco, Sofia/0000-0003-2168-0511; Gonçalves, João/0000-0001-5329-0986; Soares, Helena/0000-0001-6180-7041; Zabala, Juan Carlos/0000-0003-2679-5473; Tavares, Alexandra/0000-0002-5332-3386; Goncalves, Joao/0000-0002-1245-3715	Fundacao para a Ciencia e a Tecnologia (FCT) [QUI-LVT-612]; Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D [BFU2007-64882, BFU2010-18948]; Instituto de Formacion e Investigacion Marques de Valdecilla;  [POCTI/CTM/61622/2004];  [PTDC/CVT/105470/2008];  [FCT-SFRH/BPD/20681/2004];  [FCT-SFRH/BD/24532/2005]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D; Instituto de Formacion e Investigacion Marques de Valdecilla; ; ; ; 	This work was partly supported by POCTI/CTM/61622/2004, PTDC/CVT/105470/2008 and funds from unit key QUI-LVT-612 given by Fundacao para a Ciencia e a Tecnologia (FCT); by BFU2007-64882 and BFU2010-18948 and Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D and the Instituto de Formacion e Investigacion Marques de Valdecilla. Fellowships were given to S.N. (FCT-SFRH/BPD/20681/2004) and to J.G. (FCT-SFRH/BD/24532/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fanarraga ML, 1999, CELL MOTIL CYTOSKEL, V43, P243, DOI 10.1002/(SICI)1097-0169(1999)43:3<243::AID-CM7>3.0.CO;2-0; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Korneev SA, 2008, RNA, V14, P2030, DOI 10.1261/rna.1084308; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Llosa M, 1996, FEBS LETT, V397, P283, DOI 10.1016/S0014-5793(96)01198-2; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; Malecova B, 2010, CURR OPIN MOL THER, V12, P214; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Meadus W. J., 2003, Biological Procedures Online, V5, P20, DOI 10.1251/bpo43; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	55	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42536	10.1371/journal.pone.0042536	http://dx.doi.org/10.1371/journal.pone.0042536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880023	Green Published, gold			2022-12-25	WOS:000307810000042
J	Perina, D; Korolija, M; Mikoc, A; Roller, M; Plese, B; Imesek, M; Morrow, C; Batel, R; Cetkovic, H				Perina, Drago; Korolija, Marina; Mikoc, Andreja; Roller, Masa; Plese, Bruna; Imesek, Mirna; Morrow, Christine; Batel, Renato; Cetkovic, Helena			Structural and Functional Characterization of Ribosomal Protein Gene Introns in Sponges	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; EXTRARIBOSOMAL FUNCTIONS; SUBERITES-DOMUNCULA; ANGSTROM RESOLUTION; NONCODING RNAS; EVOLUTION; SNORNAS; GENOME; ASSOCIATION; CONGRUENCE	Ribosomal protein genes (RPGs) are a powerful tool for studying intron evolution. They exist in all three domains of life and are much conserved. Accumulating genomic data suggest that RPG introns in many organisms abound with non-protein-coding-RNAs (ncRNAs). These ancient ncRNAs are small nucleolar RNAs (snoRNAs) essential for ribosome assembly. They are also mobile genetic elements and therefore probably important in diversification and enrichment of transcriptomes through various mechanisms such as intron/exon gain/loss. snoRNAs in basal metazoans are poorly characterized. We examined 449 RPG introns, in total, from four demosponges: Amphimedon queenslandica, Suberites domuncula, Suberites ficus and Suberites pagurorum and showed that RPG introns from A. queenslandica share position conservancy and some structural similarity with "higher'' metazoans. Moreover, our study indicates that mobile element insertions play an important role in the evolution of their size. In four sponges 51 snoRNAs were identified. The analysis showed discrepancies between the snoRNA pools of orthologous RPG introns between S. domuncula and A. queenslandica. Furthermore, these two sponges show as much conservancy of RPG intron positions between each other as between themselves and human. Sponges from the Suberites genus show consistency in RPG intron position conservation. However, significant differences in some of the orthologous RPG introns of closely related sponges were observed. This indicates that RPG introns are dynamic even on these shorter evolutionary time scales.	[Perina, Drago; Mikoc, Andreja; Plese, Bruna; Imesek, Mirna; Cetkovic, Helena] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Korolija, Marina] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Roller, Masa] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Morrow, Christine] Queens Univ, Sch Biol Sci, Belfast, Antrim, North Ireland; [Batel, Renato] Rudjer Boskovic Inst, Ctr Marine Res, Rovinj, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Zagreb; Queens University Belfast; Rudjer Boskovic Institute	Perina, D (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	cetkovic@irb.hr	Roller, Maša/F-4532-2011; Plese, Bruna/L-8289-2016	Plese, Bruna/0000-0001-6690-3876; Halasz, Mirna/0000-0003-1715-1625; Morrow, Christine/0000-0001-5686-8747; Roller, Masa/0000-0001-5667-3317	Croatian Ministry of Science, Education and Sports [098-0982913-2874]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was funded by the Croatian Ministry of Science, Education and Sports grants 098-0982913-2874 (H. Cetkovic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gardner Paul P., 2010, Journal of Biology (London), V8, P4, DOI 10.1186/jbiol211; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gilbert D, 2009, BIOINFORMATICS, V25, P2171, DOI 10.1093/bioinformatics/btp389; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Harcet M, 2010, MOL BIOL EVOL, V27, P2747, DOI 10.1093/molbev/msq174; Hertel J, 2009, NUCLEIC ACIDS RES, V37, P1602, DOI 10.1093/nar/gkn1084; Hoeppner MP, 2009, GENOME BIOL EVOL, V1, P420, DOI 10.1093/gbe/evp045; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kressler D., 2009, BIOCHIM BIOPHYS ACTA, V1803, P673; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Luo YP, 2007, NUCLEIC ACIDS RES, V35, P559, DOI 10.1093/nar/gkl1086; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Perina D, 2006, GENE, V366, P275, DOI 10.1016/j.gene.2005.08.015; Perina D, 2011, NAUNYN SCHMIEDEBERGS; Perina D, 2011, GENOMICS, V98, P56, DOI 10.1016/j.ygeno.2011.03.009; Perina D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-87; Perina D, 2009, FOOD TECHNOL BIOTECH, V47, P269; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; QU LH, 1995, NUCLEIC ACIDS RES, V23, P2669, DOI 10.1093/nar/23.14.2669; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Scott MS, 2011, BIOCHIMIE; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Yoshihama M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000141; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025; Zemann A, 2006, NUCLEIC ACIDS RES, V34, P2676, DOI 10.1093/nar/gkl359	53	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42523	10.1371/journal.pone.0042523	http://dx.doi.org/10.1371/journal.pone.0042523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880015	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000039
J	Kang, DW; Hwang, WC; Park, MH; Ko, GH; Ha, WS; Kim, KS; Lee, YC; Choi, KY; Min, DS				Kang, D. W.; Hwang, W. C.; Park, M. H.; Ko, G-H; Ha, W-S; Kim, K-S; Lee, Y-C; Choi, K-Y; Min, D. S.			Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NF kappa B and suppresses invasion of gastric cancer cells	ONCOGENE			English	Article						phospholipase D1; Helicobacter pylori; CagA; gastric cancer; NF kappa B; rebamipide	TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; C-MET; ACTIVATION; PATHWAY; SECRETION; PROTEIN; MATRIX-METALLOPROTEINASE-9; PROLIFERATION; MECHANISMS	Infection with cagA-positive Helicobacter pylori is a risk factor for the development of severe gastritis and gastric cancer (GC). CagA protein is injected into gastric epithelial cells and deregulates a variety of cellular signaling molecules. Phospholipase D (PLD) is elevated in many different types of human cancers and has been implicated as a critical factor in inflammation and carcinogenesis. In this study, we show that infection with cagA-positive H. pylori in GC cells significantly induces PLD1 expression via CagA-dependent activation of nuclear factor kappa B (NF kappa B). Interestingly, the level of PLD1 protein and I kappa B alpha phosphorylation is aberrantly upregulated in H. pylori-infected human GC tissues. Infection with cagA-positive H. pylori and expression of CagA enhanced the binding of NF kappa B to the PLD1 promoter, and two functional NF kappa B-binding sites were identified within the PLD1 promoter. Rebamipide, a mucosal-protective antiulcer agent, abolished H. pylori cagA-induced PLD1 expression via inhibition of binding of NF kappa B to the PLD1 promoter, and also inhibited PLD activity. Moreover, rebamipide suppressed H. pylori-induced matrix metalloproteinase-9, interleukin-8 and activation-induced cytidine deaminase expression as well as invasion of GC cells through downregulation of PLD1. Our data suggest that H. pylori cagA targets PLD1 for invasion of GC cells, and rebamipide might contribute to the antitumorigenic effect of GC cells via inhibition of the H. pylori cagA-NF kappa B-PLD1 signaling pathway.	[Kang, D. W.; Hwang, W. C.; Park, M. H.; Min, D. S.] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Ko, G-H] Gyeongsang Natl Univ, Sch Med, Dept Pathol, Jinju, Gyeongnam, South Korea; [Ha, W-S] Gyeongsang Natl Univ, Sch Med, Dept Surg, Jinju, Gyeongnam, South Korea; [Kim, K-S; Lee, Y-C] Dong A Univ, Dept Biotechnol, Pusan, South Korea; [Choi, K-Y; Min, D. S.] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Choi, K-Y; Min, D. S.] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Pusan National University; Gyeongsang National University; Gyeongsang National University; Dong A University; Yonsei University; Yonsei University	Min, DS (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea.	minds@pusan.ac.kr	Park, Min Hi/AAL-9880-2020		Translational Research Center for Protein Function Control, NSF, South Korea [2009-0092960]; National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2012002009]; National R&D program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea grant [0920050]	Translational Research Center for Protein Function Control, NSF, South Korea; National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National R&D program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea grant	This work was supported by a grant from the Translational Research Center for Protein Function Control, NSF (2009-0092960), South Korea and a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST; no. 2012002009) and by the National R&D program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea grant 0920050. We are most grateful to Dr DaiHyun Yu (Otsuka Pharmaceutical Co. Ltd. Otsuka International Asia Arab Division, Korea) for his helpful suggestions and generous comments.	ARAKAWA T, 1995, DIGEST DIS SCI, V40, P2469, DOI 10.1007/BF02063257; Arakawa T, 2005, DIGEST DIS SCI, V50, pS3, DOI 10.1007/s10620-005-2800-9; Arakawa T, 1998, DIGEST DIS SCI, V43, p5S; BLASER MJ, 1995, CANCER RES, V55, P2111; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen G, 1997, BIOCHEM BIOPH RES CO, V239, P626, DOI 10.1006/bbrc.1997.7485; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; COVER TL, 1990, INFECT IMMUN, V58, P603, DOI 10.1128/IAI.58.3.603-610.1990; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Foryst-Ludwig A, 2000, J BIOL CHEM, V275, P39779, DOI 10.1074/jbc.M007617200; Gozgit JM, 2007, BRIT J CANCER, V97, P809, DOI 10.1038/sj.bjc.6603926; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Jones NL, 1999, INFECT IMMUN, V67, P4237, DOI 10.1128/IAI.67.8.4237-4242.1999; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kang DW, 2011, CANCER RES, V71, P293, DOI 10.1158/0008-5472.CAN-10-2463; Kang DW, 2011, INT J CANCER, V128, P805, DOI 10.1002/ijc.25402; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Kang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012109; Kang DW, 2010, CANCER LETT, V294, P125, DOI 10.1016/j.canlet.2010.01.031; Kang DW, 2010, CANCER RES, V70, P4233, DOI 10.1158/0008-5472.CAN-09-3470; Kishimoto S, 2000, DIGEST DIS SCI, V45, P1608, DOI 10.1023/A:1005525313856; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Mori N, 2003, GASTROENTEROLOGY, V124, P983, DOI 10.1053/gast.2003.50152; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek Jr RM, 2005, SCI STKE, V2005, P14, DOI [10.1126/stke.2772005pe14, DOI 10.1126/STKE.2772005PE14]; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 1999, CANCER RES, V59, P6124; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Rudi J, 1998, J CLIN INVEST, V102, P1506, DOI 10.1172/JCI2808; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Shibata W, 2006, J PATHOL, V210, P306, DOI 10.1002/path.2040; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Snider Jared L, 2009, J Carcinog, V8, P7, DOI 10.4103/1477-3163.50892; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tarnawski A, 2005, BIOCHEM BIOPH RES CO, V334, P207, DOI 10.1016/j.bbrc.2005.05.204; Wang HY, 2011, FEMS IMMUNOL MED MIC, V63, P82, DOI 10.1111/j.1574-695X.2011.00833.x; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Yamane T, 1998, DIGEST DIS SCI, V43, p207S; Yoshida N, 1996, DIGEST DIS SCI, V41, P1139, DOI 10.1007/BF02088229; Zhang XY, 2002, DIAGN MOL PATHOL, V11, P135, DOI 10.1097/00019606-200209000-00002	58	34	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3531	3542		10.1038/onc.2012.358	http://dx.doi.org/10.1038/onc.2012.358			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22890316				2022-12-25	WOS:000322220800006
J	Normoyle, KPM; Brieher, WM				Normoyle, Kieran P. M.; Brieher, William M.			Cyclase-associated Protein (CAP) Acts Directly on F-actin to Accelerate Cofilin-mediated Actin Severing across the Range of Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT TURNOVER; INTERACTING PROTEIN-1; IN-VIVO; LISTERIA-MONOCYTOGENES; DEPOLYMERIZING FACTOR; ADP-ACTIN; MOLECULAR-MECHANISMS; NONMUSCLE CELLS; COMET TAILS; BOUND ACTIN	Fast actin depolymerization is necessary for cells to rapidly reorganize actin filament networks. Utilizing a Listeria fluorescent actin comet tail assay to monitor actin disassembly rates, we observed that although a mixture of actin disassembly factors (cofilin, coronin, and actin-interacting protein 1 is sufficient to disassemble actin comet tails in the presence of physiological G-actin concentrations this mixture was insufficient to disassemble actin comet tails in the presence of physiological F-actin concentrations. Using biochemical complementation, we purified cyclase-associated protein (CAP) from thymus extracts as a factor that protects against the inhibition of excess F-actin. CAP has been shown to participate in actin dynamics but has been thought to act by liberating cofilin from ADP center dot G-actin monomers to restore cofilin activity. However, we found that CAP augments cofilin-mediated disassembly by accelerating the rate of cofilin-mediated severing. We also demonstrated that CAP acts directly on F-actin and severs actin filaments at acidic, but not neutral, pH. At the neutral pH characteristic of cytosol in most mammalian cells, we demonstrated that neither CAP nor cofilin are capable of severing actin filaments. However, the combination of CAP and cofilin rapidly severed actin at all pH values across the physiological range. Therefore, our results reveal a new function for CAP in accelerating cofilin-mediated actin filament severing and provide a mechanism through which cells can maintain high actin turnover rates without having to alkalinize cytosol, which would affect many biochemical reactions beyond actin depolymerization.	[Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Normoyle, Kieran P. M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Brieher, WM (corresponding author), Univ Illinois, Dept Cell & Dev Biol, 601 Goodwin Ave, Urbana, IL 61801 USA.	wbrieher@illinois.edu		Normoyle, Kieran/0000-0003-1375-5958; Brieher, William/0000-0002-3168-6688	National Institutes of Health, NIDDK [DK 091169]; Ruth L. Kirschstein National Research Service Award predoctoral fellowship; March of Dimes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091169] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Research Service Award predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 091169 from the NIDDK (to K.P.M.N.) and a Ruth L. Kirschstein National Research Service Award predoctoral fellowship (to K.P.M.N.). This work was also supported by a grant from the March of Dimes.	Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Blondin L, 2002, EUR J BIOCHEM, V269, P4194, DOI 10.1046/j.1432-1033.2002.03101.x; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kueh HY, 2010, BIOPHYS J, V99, P2153, DOI 10.1016/j.bpj.2010.07.038; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; MACIVER SK, 1994, FEBS LETT, V347, P251, DOI 10.1016/0014-5793(94)00552-4; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Moriyama K, 2002, J CELL SCI, V115, P1591; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Muhlrad A, 2006, FEBS J, V273, P1488, DOI 10.1111/j.1742-4658.2006.05169.x; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; ROTTENBERG DA, 1985, ANN NEUROL, V17, P70, DOI 10.1002/ana.410170116; Sultana H, 2005, TRAFFIC, V6, P930, DOI 10.1111/j.1600-0854.2005.00330.x; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; SWISTON J, 1995, GENE, V165, P273, DOI 10.1016/0378-1119(95)00522-8; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VAUPEL P, 1989, CANCER RES, V49, P6449; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410	56	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35722	35732		10.1074/jbc.M112.396051	http://dx.doi.org/10.1074/jbc.M112.396051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904322	Green Published, hybrid			2022-12-25	WOS:000309968000083
J	Shi, M; Pedchenko, V; Greer, BH; Van Horn, WD; Santoro, SA; Sanders, CR; Hudson, BG; Eichman, BF; Zent, R; Pozzi, A				Shi, Mingjian; Pedchenko, Vadim; Greer, Briana H.; Van Horn, Wade D.; Santoro, Samuel A.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.; Zent, Roy; Pozzi, Ambra			Enhancing Integrin alpha 1 Inserted (I) Domain Affinity to Ligand Potentiates Integrin alpha 1 beta 1-mediated Down-regulation of Collagen Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; BINDING-SITE; A-DOMAIN; FEEDBACK-REGULATION; CRYSTAL-STRUCTURE; ALPHA-2-BETA-1; RECOGNITION; ACTIVATION; SUBUNIT; GENE	Integrin alpha 1 beta 1 binding to collagen IV, which is mediated by the alpha 1-inserted (I) domain, down-regulates collagen synthesis. When unligated, a salt bridge between Arg(287) and Glu(317) is thought to keep this domain in a low affinity conformation. Ligand binding opens the salt bridge leading to a high-affinity conformation. How modulating integrin alpha 1 beta 1 affinity alters collagen homeostasis is unknown. To address this question, we utilized a thermolysin-derived product of the alpha 1 alpha 2 alpha 1 network of collagen IV (alpha 1 alpha 2 alpha 1(IV) truncated protomer) that selectively binds integrin alpha 1 beta 1. We show that an E317A substitution enhanced binding to the truncated protomer, consistent with a previous finding that this substitution eliminates the salt bridge. Surprisingly, we show that an R287A substitution did not alter binding, whereas R287E/E317R substitutions enhanced binding to the truncated protomer. NMR spectroscopy and molecular modeling suggested that eliminating the Glu(317) negative charge is sufficient to induce a conformational change toward the open state. Thus, the role played by Glu(317) is largely independent of the salt bridge. We further show that cells expressing E317A or R287E/E317R substitutions have enhanced down-regulation of collagen IV synthesis, which is mediated by the ERK/MAPK pathway. In conclusion, we have demonstrated that modulating the affinity of the extracellular alpha 1 I domain to collagen IV enhances outside-in signaling by potentiating ERK activation and enhancing the down-regulation of collagen synthesis.	[Shi, Mingjian; Pedchenko, Vadim; Hudson, Billy G.; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Med Nephrol, Nashville, TN 37232 USA; [Pedchenko, Vadim; Santoro, Samuel A.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Van Horn, Wade D.; Sanders, Charles R.; Hudson, Billy G.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Greer, Briana H.; Sanders, Charles R.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Greer, Briana H.; Van Horn, Wade D.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Santoro, Samuel A.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Zent, Roy; Pozzi, Ambra] Vet Affairs Med Ctr, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Pozzi, A (corresponding author), Vanderbilt Univ, Med Ctr N, Div Nephrol & Hypertens, Dept Med, B3115, Nashville, TN 37232 USA.	ambra.pozzi@vanderbilt.edu	Van Horn, Wade/GSN-2667-2022	Van Horn, Wade/0000-0002-2493-5578; Shi, Mingjian/0000-0003-1569-9822; Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [2P01DK065123, DK069221, DK075594, DK083187, P30DK79341]; Department of Veterans Affairs; American Heart Association (AHA) [10POST4210008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R01DK075594, R01DK083187, P30DK079341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported, in whole or in part, by National Institutes of Health Grants 2P01DK065123 (to A. P., B. F. E., R. Z., and B. G. H.), DK069221 and DK075594 (to R. Z.), DK083187 (to R. Z. and C. R. S.), and P30DK79341 (the O'Brien) (to A. P. and R. Z.). This work was also supported by a Department of Veterans Affairs Merit Review (to A. P. and R. Z.) and by an American Heart Association (AHA) Established Investigator Award (to R. Z.) and AHA Grant 10POST4210008 (to W. D. V.-H.).	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAHOU WF, 1994, BLOOD, V84, P3734, DOI 10.1182/blood.V84.11.3734.bloodjournal84113734; Borza CM, 2012, J AM SOC NEPHROL, V23, P1027, DOI 10.1681/ASN.2011040367; Borza CM, 2010, J BIOL CHEM, V285, P40114, DOI 10.1074/jbc.M110.156729; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Dickeson SK, 1999, J BIOL CHEM, V274, P32182, DOI 10.1074/jbc.274.45.32182; Dzobo K, 2012, IUBMB LIFE, V64, P87, DOI 10.1002/iub.568; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fleming FE, 2011, J BIOL CHEM, V286, P6165, DOI 10.1074/jbc.M110.142992; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; Gardner H, 1999, J CELL SCI, V112, P263; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; KAMATA T, 1994, J BIOL CHEM, V269, P26006; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; KERN A, 1994, J BIOL CHEM, V269, P22811; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Papakrivopoulou J, 2004, CARDIOVASC RES, V61, P736, DOI 10.1016/j.cardiores.2003.12.018; Pozzi A, 2009, CURR PHARM DESIGN, V15, P1318, DOI 10.2174/138161209787846748; Pozzi M, 1998, J CELL BIOL, V142, P587; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	40	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35139	35152		10.1074/jbc.M112.358648	http://dx.doi.org/10.1074/jbc.M112.358648			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22888006	hybrid, Green Published			2022-12-25	WOS:000309968000024
J	Miki, T; Holst, O; Hardt, WD				Miki, Tsuyoshi; Holst, Otto; Hardt, Wolf-Dietrich			The Bactericidal Activity of the C-type Lectin RegIII beta against Gram-negative Bacteria involves Binding to Lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION; VIRULENCE FACTORS; INNATE IMMUNITY; PANETH CELLS; EXPRESSION; MICROBIOTA; PROTEIN; GAMMA; SALMONELLA; HOST	RegIII beta is a member of the C-type lectin family called RegIII. It is known to bind peptidoglycan, and its bactericidal activity shapes the interactions with commensal and pathogenic gut bacteria. However, little is known about its carbohydrate recognition specificity and the bactericidal mechanism, particularly against Gram-negative bacteria. Here, we show that RegIII beta can bind directly to LPS by recognizing the carbohydrate moiety of lipid A via a novel motif that is indispensable for its bactericidal activity. This bactericidal activity of RegIII beta could be inhibited by preincubation with LPS, lipid A, or gentiobiose. The latter is a disaccharide composed of two units of beta-(1 -> 6)-linked D-glucose and resembles the carbohydrate moiety of lipid A. Therefore, this structural element may form a key target site recognized by RegIII beta. Using point-mutated RegIII beta proteins, we found that amino acid residues in two structural motifs termed "loop 1" and "loop 2," are important for peptidoglycan and lipid A binding (Arg-135, Asp-142) and for the bactericidal activity (Glu-134, Asn-136, Asp-142). Thus, the ERN motif and residue Asp-142 in the loop 2 are of critical importance for RegIII beta function. This provides novel insights into the carbohydrate recognition specificity of RegIII beta and explains its bactericidal activity against Gram-negative bacteria.	[Miki, Tsuyoshi; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Forschungszentrum Borstel	Hardt, WD (corresponding author), ETH, Inst Microbiol, Dept Biol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hardt@micro.biol.ethz.ch		Hardt, Wolf-Dietrich/0000-0002-9892-6420	ETH Zurich Research Foundation [ETH-08-08-3]; Naito Foundation	ETH Zurich Research Foundation(ETH Zurich); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant ETH-08-08-3 from the ETH Zurich Research Foundation (to W.-D. H.).; Supported by the Naito Foundation.	Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Christa L, 1996, AM J PHYSIOL-GASTR L, V271, pG993, DOI 10.1152/ajpgi.1996.271.6.G993; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Keilbaugh SA, 2005, GUT, V54, P623, DOI 10.1136/gut.2004.056028; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Narushima Y, 1997, GENE, V185, P159, DOI 10.1016/S0378-1119(96)00589-6; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	33	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34844	34855		10.1074/jbc.M112.399998	http://dx.doi.org/10.1074/jbc.M112.399998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896700	hybrid, Green Published			2022-12-25	WOS:000309654200083
J	Russell, CL; Semerdjieva, S; Empson, RM; Austen, BM; Beesley, PW; Alifragis, P				Russell, Claire L.; Semerdjieva, Sophia; Empson, Ruth M.; Austen, Brian M.; Beesley, Philip W.; Alifragis, Pavlos			Amyloid-beta Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; RAT HIPPOCAMPUS; VESICLE ENDOCYTOSIS; SOLUBLE OLIGOMERS; NATURAL OLIGOMERS; RECEPTOR	Background: It is becoming increasingly evident that deficits in the cortex and hippocampus at early stages of dementia in Alzheimer's disease (AD) are associated with synaptic damage caused by oligomers of the toxic amyloid-beta peptide (A beta 42). However, the underlying molecular and cellular mechanisms behind these deficits are not fully understood. Here we provide evidence of a mechanism by which A beta 42 affects synaptic transmission regulating neurotransmitter release. Methodology/Findings: We first showed that application of 50 nM A beta 42 in cultured neurones is followed by its internalisation and translocation to synaptic contacts. Interestingly, our results demonstrate that with time, A beta 42 can be detected at the presynaptic terminals where it interacts with Synaptophysin. Furthermore, data from dissociated hippocampal neurons as well as biochemical data provide evidence that A beta 42 disrupts the complex formed between Synaptophysin and VAMP2 increasing the amount of primed vesicles and exocytosis. Finally, electrophysiology recordings in brain slices confirmed that A beta 42 affects baseline transmission. Conclusions/Significance: Our observations provide a necessary and timely insight into cellular mechanisms that underlie the initial pathological events that lead to synaptic dysfunction in Alzheimer's disease. Our results demonstrate a new mechanism by which A beta 42 affects synaptic activity.	[Russell, Claire L.; Semerdjieva, Sophia; Empson, Ruth M.; Beesley, Philip W.; Alifragis, Pavlos] Royal Holloway Univ London, Sch Biol Sci, Surrey, England; [Empson, Ruth M.] Univ Otago, Sch Med Sci, Dept Physiol, Dunedin, New Zealand; [Austen, Brian M.] Univ London, Neurodegenerat Unit, London, England	University of London; Royal Holloway University London; University of Otago; University of London	Russell, CL (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Surrey, England.	pavlos.alifragis@rhul.ac.uk		Alifragis, Pavlos/0000-0003-0844-2316; Empson, Ruth/0000-0002-0415-6083	Southwest Academic Network (SWAN); Biotechnology and Biological Sciences Research Council (BBSRC)	Southwest Academic Network (SWAN); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C.L.R. was supported by the Southwest Academic Network (SWAN) and S. S. was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416; Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cuevas ME, 2011, J ALZHEIMERS DIS; Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HARRIS ME, 1995, NEUROREPORT, V6, P1875, DOI 10.1097/00001756-199510020-00013; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kabogo D, 2010, NEUROBIOL AGING, V31, P1164, DOI 10.1016/j.neurobiolaging.2008.08.009; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kim JH, 2001, J NEUROSCI, V21, P1327; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mezler M, 2011, BR J PHARM; Molnar Z, 2004, NEUROREPORT, V15, P1649, DOI 10.1097/01.wnr.0000134471.06244.d2; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Pellistri F, 2008, J BIOL CHEM; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puangthong U, 2009, NEUROPSYCH DIS TREAT, V5, P553; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Scholtzova H, 2008, J NEUROSCI RES; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Sian AK, 2000, BIOCHEM J, V349, P299, DOI 10.1042/0264-6021:3490299; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200	75	75	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43201	10.1371/journal.pone.0043201	http://dx.doi.org/10.1371/journal.pone.0043201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905234	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600058
J	Creanza, N; Fogarty, L; Feldman, MW				Creanza, Nicole; Fogarty, Laurel; Feldman, Marcus W.			Models of Cultural Niche Construction with Selection and Assortative Mating	PLOS ONE			English	Article							MARRIAGE FORM; SEX-RATIOS; EVOLUTION; TRANSMISSION; INHERITANCE; COEVOLUTION; WAR	Niche construction is a process through which organisms modify their environment and, as a result, alter the selection pressures on themselves and other species. In cultural niche construction, one or more cultural traits can influence the evolution of other cultural or biological traits by affecting the social environment in which the latter traits may evolve. Cultural niche construction may include either gene-culture or culture-culture interactions. Here we develop a model of this process and suggest some applications of this model. We examine the interactions between cultural transmission, selection, and assorting, paying particular attention to the complexities that arise when selection and assorting are both present, in which case stable polymorphisms of all cultural phenotypes are possible. We compare our model to a recent model for the joint evolution of religion and fertility and discuss other potential applications of cultural niche construction theory, including the evolution and maintenance of large-scale human conflict and the relationship between sex ratio bias and marriage customs. The evolutionary framework we introduce begins to address complexities that arise in the quantitative analysis of multiple interacting cultural traits.	[Creanza, Nicole; Feldman, Marcus W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Fogarty, Laurel] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	Stanford University; University of St Andrews	Creanza, N (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	creanza@stanford.edu		Creanza, Nicole/0000-0001-8821-7383	National Institutes of Health [GM28016]; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health grant GM28016 and a Biotechnology and Biological Sciences Research Council studentship to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1986, P NATL ACAD SCI USA, V83, P2929, DOI 10.1073/pnas.83.9.2929; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown MJ, 2009, P NATL ACAD SCI USA, V106, P22139, DOI 10.1073/pnas.0907520106; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; CAVALLIS.LL, 1973, AM J HUM GENET, V25, P618; CAVALLISFORZA LL, 1976, P NATL ACAD SCI USA, V73, P1689, DOI 10.1073/pnas.73.5.1689; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Durham WH., 1991, COEVOLUTION GENES CU; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Feldman M.W., 1989, MATH EVOLUTIONARY TH; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GUGLIELMINO CR, 1995, P NATL ACAD SCI USA, V92, P7585, DOI 10.1073/pnas.92.16.7585; Halperin E, 2011, SCIENCE, V333, P1767, DOI 10.1126/science.1202925; HEATON TB, 1990, SOCIOL ANAL, V51, P363, DOI 10.2307/3711077; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hinde R. A., 1987, INDIVIDUALS RELATION; Hinde RA, 1997, INTERDISCIPL SCI REV, V22, P229; Ihara Y, 2004, THEOR POPUL BIOL, V65, P105, DOI 10.1016/j.tpb.2003.07.003; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KUMM J, 1994, THEOR POPUL BIOL, V46, P249, DOI 10.1006/tpbi.1994.1027; Kumm J, 1997, THEOR POPUL BIOL, V52, P1, DOI 10.1006/tpbi.1997.1304; Laland Kevin., 2002, SENSE NONSENSE EVOLU; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lewontin R.C., 1983, P273; Lewontin R.C., 1982, LEARNING DEV CULTURE, P151; Li N., 2000, MATH POPUL STUD, V8, P91, DOI [DOI 10.1080/08898480009525475, 10.1080/08898480009525475]; Li SZ, 2001, SOC BIOL, V48, P125; Lipatov M, 2011, PHILOS T R SOC B, V366, P901, DOI 10.1098/rstb.2010.0303; Odling-Smee F. J., 2009, PREHISTORY LANGUAGE, P99, DOI DOI 10.1093/ACPROF:OSO/9780199545872.003.0006; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Odling-Smee John, 2010, P175; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Rowthorn R, 2011, P ROY SOC B-BIOL SCI, V278, P2519, DOI 10.1098/rspb.2010.2504; Saunders MA, 2002, GENETICS, V162, P1849; Sosis R, 2003, EVOL ANTHROPOL, V12, P264, DOI 10.1002/evan.10120; TULJAPURKAR S, 1995, SCIENCE, V267, P874, DOI 10.1126/science.7846529	39	30	31	1	240	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42744	10.1371/journal.pone.0042744	http://dx.doi.org/10.1371/journal.pone.0042744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905167	Green Published, gold			2022-12-25	WOS:000307500800020
J	Svensson, PA; Lehtonen, TK; Wong, BBM				Svensson, P. Andreas; Lehtonen, Topi K.; Wong, Bob B. M.			A High Aggression Strategy for Smaller Males	PLOS ONE			English	Article							ESCALATING FIGHTS; ROUND GOBIES; BODY-SIZE; FEMALE; INFORMATION; EVOLUTION; DOMINANCE; SELECTION; DURATION; SPIDER	Male-male conflict is common among animals, but questions remain as to when, how and by whom aggression should be initiated. Factors that affect agonistic strategies include residency, the value of the contested resource and the fighting ability of the two contestants. We quantified initiation of aggression in a fish, the desert goby, Chlamydogobius eremius, by exposing nest-holding males to a male intruder. The perceived value of the resource ( the nest) was manipulated by exposing half of the residents to sexually receptive females for two days before the trial. Resident male aggression, however, was unaffected by perceived mating opportunities. It was also unaffected by the absolute and relative size of the intruder. Instead resident aggression was negatively related to resident male size. In particular, smaller residents attacked sooner and with greater intensity compared to larger residents. These results suggest that resident desert goby males used set, rather than conditional, strategies for initiating aggression. If intruders are more likely to flee than retaliate, small males may benefit from attacking intruders before these have had an opportunity to assess the resident and/or the resource.	[Svensson, P. Andreas] Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden; [Svensson, P. Andreas; Lehtonen, Topi K.; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Lehtonen, Topi K.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	Linnaeus University; Monash University; University of Turku	Svensson, PA (corresponding author), Linnaeus Univ, Dept Nat Sci, Kalmar, Sweden.	andreas.svensson@lnu.se	Lehtonen, Topi/A-6679-2010; Svensson, P Andreas/D-2517-2015	Lehtonen, Topi/0000-0002-1372-9509; Svensson, P Andreas/0000-0002-1426-0036; Wong, Bob/0000-0001-9352-6500	Australian Research Council Discovery Project [DP0771070]; Deakin University; Academy of Finland; Department of Biology, University of Turku	Australian Research Council Discovery Project(Australian Research Council); Deakin University; Academy of Finland(Academy of Finland); Department of Biology, University of Turku	Funding was provided by the Australian Research Council Discovery Project, grant number DP0771070 (to BBMW), an Alfred Deakin Postdoctoral Research Fellowship from Deakin University (to PAS), and the Academy of Finland and Department of Biology, University of Turku (to TKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshine S, 2005, J GREAT LAKES RES, V31, P68, DOI 10.1016/S0380-1330(05)70238-0; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bergman M, 2010, P ROY SOC B-BIOL SCI, V277, P3027, DOI 10.1098/rspb.2010.0646; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Cooper William E. Jr., 1997, Amphibia-Reptilia, V18, P59, DOI 10.1163/156853897X00314; Crawley MJ., 2007, R BOOK; Dubs DOL, 1996, J GREAT LAKES RES, V22, P838, DOI 10.1016/S0380-1330(96)71005-5; DUGATKIN LA, 1990, ANIM BEHAV, V39, P802, DOI 10.1016/S0003-3472(05)80394-X; FRANCK D, 1989, BEHAV ECOL SOCIOBIOL, V24, P133, DOI 10.1007/BF00292096; Glover CJM, 1971, THESIS U ADELAIDE; Goldsmith SK, 1996, J INSECT BEHAV, V9, P719, DOI 10.1007/BF02213552; GROSSMAN GD, 1980, OECOLOGIA, V45, P261, DOI 10.1007/BF00346467; Hack MA, 1997, ETHOLOGY, V103, P488; Hsu YY, 2001, ANIM BEHAV, V61, P777, DOI 10.1006/anbe.2000.1650; JANSSEN J, 1990, COPEIA, P349, DOI 10.2307/1446340; Johnsson JI, 2002, BEHAV ECOL SOCIOBIOL, V51, P282, DOI 10.1007/S00265-001-0430-6; Just W, 2003, EVOL ECOL, V17, P509, DOI 10.1023/B:EVEC.0000005629.54152.83; Just W, 2000, IEEE C EVOL COMPUTAT, P851, DOI 10.1109/CEC.2000.870727; Just W, 2007, BEHAV PROCESS, V74, P342, DOI 10.1016/j.beproc.2006.12.005; Lehtonen TK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-233; Lindstrom K, 2001, AM NAT, V158, P64, DOI 10.1086/320867; Magnhagen C, 2006, ANIM BEHAV, V71, P879, DOI 10.1016/j.anbehav.2005.07.017; Maynard Smith J., 1982, pi; McPhee MV, 1998, ENVIRON BIOL FISH, V51, P369, DOI 10.1023/A:1007432928783; Mehlis M, 2010, P ROY SOC B-BIOL SCI, V277, P2627, DOI 10.1098/rspb.2010.0234; Morrell LJ, 2005, P ROY SOC B-BIOL SCI, V272, P1235, DOI 10.1098/rspb.2005.3085; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Nijman V, 2011, NEOTROP ICHTHYOL, V9, P543, DOI 10.1590/S1679-62252011005000031; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; R Development Core Team, 2009, R FDN STAT COMP; Raftery AE, 2010, BMA BAYESIAN MODEL A; RIBOWSKI A, 1993, ETHOLOGY, V93, P265; RIBOWSKI A, 1993, AGGRESSIVE BEHAV, V19, P223, DOI 10.1002/1098-2337(1993)19:3<223::AID-AB2480190307>3.0.CO;2-T; SIGURJONSDOTTIR H, 1981, BEHAV ECOL SOCIOBIOL, V8, P219, DOI 10.1007/BF00299834; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Svensson PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1967, DOI 10.1007/s00265-010-1007-z; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; TEMELES EJ, 1990, ANIM BEHAV, V40, P361, DOI 10.1016/S0003-3472(05)80931-5; Therneau T., 2009, SURVIVAL SURVIVAL AN; Thunken T, 2011, BEHAV ECOL, V22, P358, DOI 10.1093/beheco/arq217; Van Tassell JL, 2012, BIOLOGY OF GOBIES, P3; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Wong BBM, 2009, BEHAV ECOL SOCIOBIOL, V63, P543, DOI 10.1007/s00265-008-0689-y	45	21	21	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43121	10.1371/journal.pone.0043121	http://dx.doi.org/10.1371/journal.pone.0043121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905213	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800047
J	Bridges, D; Chang, L; Lodhi, IJ; Clark, NA; Saltiel, AR				Bridges, Dave; Chang, Louise; Lodhi, Irfan J.; Clark, Natalie A.; Saltiel, Alan R.			TC10 Is Regulated by Caveolin in 3T3-L1 Adipocytes	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; NUCLEOTIDE-EXCHANGE FACTORS; RHO-GTPASES; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; EXOCYST COMPLEX; G-PROTEINS; INSULIN; MEMBRANE	Background: TC10 is a small GTPase found in lipid raft microdomains of adipocytes. The protein undergoes activation in response to insulin, and plays a key role in the regulation of glucose uptake by the hormone. Methodology/Principal Findings: TC10 requires high concentrations of magnesium in order to stabilize guanine nucleotide binding. Kinetic analysis of this process revealed that magnesium acutely decreased the nucleotide release and exchange rates of TC10, suggesting that the G protein may behave as a rapidly exchanging, and therefore active protein in vivo. However, in adipocytes, the activity of TC10 is not constitutive, indicating that mechanisms must exist to maintain the G protein in a low activity state in untreated cells. Thus, we searched for proteins that might bind to and stabilize TC10 in the inactive state. We found that Caveolin interacts with TC10 only when GDP-bound and stabilizes GDP binding. Moreover, knockdown of Caveolin 1 in 3T3-L1 adipocytes increased the basal activity state of TC10. Conclusions/Significance: Together these data suggest that TC10 is intrinsically active in vivo, but is maintained in the inactive state by binding to Caveolin 1 in 3T3-L1 adipocytes under basal conditions, permitting its activation by insulin.	[Bridges, Dave; Chang, Louise; Lodhi, Irfan J.; Clark, Natalie A.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bridges, D (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019; Bridges, Dave/A-8825-2010	Bridges, Dave/0000-0002-5334-972X; Lodhi, Irfan/0000-0002-6246-9862; Chang, Louise/0000-0001-5501-4774; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health [DK01618]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (www.nih.gov) grant DK01618 and an American Diabetes Association (www.diabetes.org) Mentor Based Postdoctoral Fellowship (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kanzaki M, 2004, J CELL BIOL, V164, P279, DOI 10.1083/jcb.200306152; Kepner EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1072, DOI 10.1152/ajpendo.00312.2011; Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; Neudauer CL, 2000, METHOD ENZYMOL, V325, P3; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	36	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42451	10.1371/journal.pone.0042451	http://dx.doi.org/10.1371/journal.pone.0042451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900022	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900038
J	Ma, L; Ranganathan, R				Ma, Lan; Ranganathan, Rama			Quantifying the Rhythm of KaiB-C Interaction for In Vitro Cyanobacterial Circadian Clock	PLOS ONE			English	Article							SYNECHOCOCCUS-ELONGATUS; PROTEIN INTERACTIONS; FLUORESCENT PROTEIN; ATPASE ACTIVITY; PHOSPHORYLATION; DYNAMICS; OSCILLATION; MODEL; DETERMINES; FEEDBACK	An oscillator consisting of KaiA, KaiB, and KaiC proteins comprises the core of cyanobacterial circadian clock. While one key reaction in this process-KaiC phosphorylation-has been extensively investigated and modeled, other key processes, such as the interactions among Kai proteins, are not understood well. Specifically, different experimental techniques have yielded inconsistent views about Kai A, B, and C interactions. Here, we first propose a mathematical model of cyanobacterial circadian clock that explains the recently observed dynamics of the four phospho-states of KaiC as well as the interactions among the three Kai proteins. Simulations of the model show that the interaction between KaiB and KaiC oscillates with the same period as the phosphorylation of KaiC, but displays a phase delay of similar to 8 hr relative to the total phosphorylated KaiC. Secondly, this prediction on KaiB-C interaction are evaluated using a novel FRET (Fluorescence Resonance Energy Transfer)based assay by tagging fluorescent proteins Cerulean and Venus to KaiC and KaiB, respectively, and reconstituting fluorescent protein-labeled in vitro clock. The data show that the KaiB: KaiC interaction indeed oscillates with similar to 24 hr periodicity and similar to 8 hr phase delay relative to KaiC phosphorylation, consistent with model prediction. Moreover, it is noteworthy that our model indicates that the interlinked positive and negative feedback loops are the underlying mechanism for oscillation, with the serine phosphorylated-state (the "S-state") of KaiC being a hub for the feedback loops. Because the kinetics of the KaiB-C interaction faithfully follows that of the S-state, the FRET measurement may provide an important real-time probe in quantitative study of the cyanobacterial circadian clock.	[Ma, Lan] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Ma, Lan; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Ma, Lan; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ma, L (corresponding author), Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.	lan.ma@utdallas.edu						Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Dong GG, 2010, CURR OPIN GENET DEV, V20, P619, DOI 10.1016/j.gde.2010.09.002; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Goda K, 2012, J BIOL CHEM, V287, P3241, DOI 10.1074/jbc.M111.265777; Golden SS, 2003, NAT REV MICROBIOL, V1, P191, DOI 10.1038/nrmicro774; Golden SS, 2007, NAT STRUCT MOL BIOL, V14, P362, DOI 10.1038/nsmb0507-362; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kondo T, 2007, COLD SPRING HARB SYM, V72, P47, DOI 10.1101/sqb.2007.72.029; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kurosawa G, 2006, BIOPHYS J, V91, P2015, DOI 10.1529/biophysj.105.076554; Li CX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000568; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mehra A, 2006, PLOS COMPUT BIOL, V2, P816, DOI 10.1371/journal.pcbi.0020096; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Poon AC, 2007, SCIENCE, V318, P757, DOI 10.1126/science.1150740; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Yoda M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000408	42	8	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42581	10.1371/journal.pone.0042581	http://dx.doi.org/10.1371/journal.pone.0042581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900029	gold, Green Submitted, Green Published			2022-12-25	WOS:000307380900045
J	Liang, YJ; Luo, J; Lu, Q; Zhou, Y; Wu, HW; Zheng, D; Ren, YY; Sun, KY; Wang, Y; Zhang, ZS				Liang, Yue-jin; Luo, Jie; Lu, Qiao; Zhou, Ying; Wu, Hai-wei; Zheng, Dan; Ren, Yong-ya; Sun, Ke-yi; Wang, Yong; Zhang, Zhao-song			Gene Profile of Chemokines on Hepatic Stellate Cells of Schistosome-Infected Mice and Antifibrotic Roles of CXCL9/10 on Liver Non-Parenchymal Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; RECEPTOR CXCR3; FIBROSIS; INFLAMMATION; ACTIVATION; EXPRESSION; HUMANS; MODEL; IMMUNOPATHOLOGY; IDENTIFICATION	Hepatic stellate cells (HSCs) play a key role in the development of liver fibrosis caused by schistosomiasis. Chemokines were widely expressed and involved in cellular activation, proliferation and migration in inflammatory and infectious diseases. However, little is known about the expressions of chemokines on HSCs in the schistosoma infection. In addition, the roles of chemokines in pathogenesis of liver fibrosis are not totally clear. In our study, we used microarray to analyze the temporal gene expressions of primary HSCs isolated from mice with both acute and chronic schistosomiasis. Our microarray data showed that most of the chemokines expressed on HSCs were upregulated at 3 weeks post-infection (p.i) when the egg granulomatous response was not obviously evoked in the liver. However, some of them like CXCL9, CXCL10 and CXCL11 were subsequently decreased at 6 weeks p.i when the granulomatous response reached the peak. In the chronic stage, most of the differentially expressed chemokines maintained persistent high-abundances. Furthermore, several chemokines including CCR2, CCR5, CCR7, CXCR3, CXCR4, CCL2, CCL5, CCL21, CXCL9 and CXCL10 were expressed by HCSs and the abundances of them were changed following the praziquantel treatment in the chronic stage, indicating that chemokines were possibly necessary for the persistence of the chronic stage. In vitro experiments, hepatic non-parenchymal cells, primary HSCs and human HSCs line LX-2 were stimulated by chemokines. The results showed that CXCL9 and CXCL10, but not CXCL11 or CXCL4, significantly inhibited the gene expressions of Col1 alpha 1, Col3 alpha 1 and alpha-SMA, indicating the potential anti-fibrosis effect of CXCL9 and CXCL10 in schistosomiasis. More interestingly, soluble egg antigen (SEA) of Schistosoma japonicum was able to inhibit transcriptional expressions of some chemokines by LX-2 cells, suggesting that SEA was capable of regulating the expression pattern of chemokine family and modulating the hepatic immune microenvironment in schistosomiasis.	[Liang, Yue-jin; Luo, Jie; Lu, Qiao; Zhou, Ying; Zheng, Dan; Wang, Yong; Zhang, Zhao-song] Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Hai-wei] Brown Univ, Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI 02903 USA; [Ren, Yong-ya] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Sun, Ke-yi] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Nanjing Medical University; Nanjing Medical University	Liang, YJ (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yongwsh@njmu.edu.cn	Liang, Yuejin/X-5250-2019	Liang, Yuejin/0000-0002-9557-1847	National Basic Research Program of China (973 Program) [2007CB513102]; Basic Research Program of Jiangsu Higher Education Institutions [11KJA330003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Basic Research Program of Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program) (No. 2007CB513102). The Basic Research Program of Jiangsu Higher Education Institutions (No. 11KJA330003) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Bourd-Boittin K, 2009, J CELL MOL MED, V13, P1526, DOI 10.1111/j.1582-4934.2009.00787.x; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Campanella GSV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012700; Efsen E, 2002, J HEPATOL, V37, P39, DOI 10.1016/S0168-8278(02)00065-X; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; GRAVES DT, 1989, SCIENCE, V245, P1490, DOI 10.1126/science.2781291; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020247; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Morais CNL, 2006, MEM I OSWALDO CRUZ, V101, P353, DOI 10.1590/S0074-02762006000900057; Nakaya I, 2007, NEPHRON EXP NEPHROL, V107, pE12, DOI 10.1159/000106505; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perney P, 2009, CLIN IMMUNOL, V132, P55, DOI 10.1016/j.clim.2009.03.521; Peterson TC, 1998, BIOCHEM PHARMACOL, V55, P703, DOI 10.1016/S0006-2952(97)00593-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rutitzky LI, 2001, P NATL ACAD SCI USA, V98, P13243, DOI 10.1073/pnas.231258498; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tao FF, 2009, VACCINE, V27, P4110, DOI 10.1016/j.vaccine.2009.04.073; Wasmuth HE, 2010, Z GASTROENTEROL, V48, P38, DOI 10.1055/s-0028-1109933; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	42	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42490	10.1371/journal.pone.0042490	http://dx.doi.org/10.1371/journal.pone.0042490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905138	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100042
J	Link, A; Becker, V; Goel, A; Wex, T; Malfertheiner, P				Link, Alexander; Becker, Verena; Goel, Ajay; Wex, Thomas; Malfertheiner, Peter			Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; COLON-CANCER; EXPRESSION; ADENOCARCINOMA; TUMORS; STOOL; STRATEGIES; SIGNATURE; SURVIVAL; FEATURES	Introduction: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in PCA. As a proof-of-principle study, we aimed to evaluate the potential of fecal miRNAs as biomarkers for pancreatic cancer. Materials and Methods: Total RNA was extracted from feces using Qiagen's miRNA Mini Kit. For miRNA expression analyses we selected a subset of 7 miRNAs that are frequently dysregulated in PCA (miR-21, -143, -155, -196a, -210, -216a, -375). Subsequently, expression levels of these miRNAs were determined in fecal samples from controls (n = 15), chronic pancreatitis (n = 15) and PCA patients (n = 15) using quantitative TaqMan-PCR assays. Results: All selected miRNAs were detectable in fecal samples with high reproducibility. Four of seven miRNAs (miR-216a, -196a, -143 und -155) were detected at lower concentrations in feces of PCA patients when compared to controls (p < 0.05). Analysis of fecal miRNA expression in controls and patients with chronic pancreatitis and PCA revealed that the expression of miR-216a, -196a, -143 und -155 were highest in controls and lowest in PCA. The expression of the remaining three miRNAs (miR-21, -210 and -375) remained unchanged among controls and the patients with either chronic pancreatitis or PCA. Conclusion: Our data provide novel evidence for the differential expression of miRNAs in feces of patients with PCA. If successfully validated in large-scale prospective studies, the fecal miRNA biomarkers may offer novel tools for PCA screening research.	[Link, Alexander; Becker, Verena; Wex, Thomas; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA	Otto von Guericke University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Link, A (corresponding author), Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	alinkmail@gmail.com		Goel, Ajay/0000-0003-1396-6341; Link, Alexander/0000-0002-9514-4562				Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Ali S, 2011, AM J TRANSL RES, V3, P28; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Buchholz M, 2008, PANCREATOLOGY, V8, P551, DOI 10.1159/000159213; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Canto MI, 2007, SEMIN ONCOL, V34, P295, DOI 10.1053/j.seminoncol.2007.05.008; Chang Y, 2012, GASTROENTEROLOGY; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Furukawa H, 1996, CANCER, V78, P986, DOI 10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A; Ghaneh P, 2008, POSTGRAD MED J, V84, P478, DOI 10.1136/gut.2006.103333; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greenhalf W, 2009, PANCREATOLOGY, V9, P215, DOI 10.1159/000210262; Greenhalf W, 2006, NAT CLIN PRACT ONCOL, V3, P346, DOI 10.1038/ncponc0483; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Haug U, 2008, EXPERT REV MOL DIAGN, V8, P753, DOI 10.1586/14737159.8.6.753; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; LaConti JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020687; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Melnikov AA, 2009, J SURG ONCOL, V99, P119, DOI 10.1002/jso.21208; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sadakari Y, 2010, J PANCREAS, V11, P587; Stan SD, 2010, NAT REV GASTRO HEPAT, V7, P347, DOI 10.1038/nrgastro.2010.61; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489	49	65	71	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42933	10.1371/journal.pone.0042933	http://dx.doi.org/10.1371/journal.pone.0042933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905187	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100076
J	Treacy, O; Ryan, AE; Heinzl, T; O'Flynn, L; Cregg, M; Wilk, M; Odoardi, F; Lohan, P; O'Brien, T; Nosov, M; Ritter, T				Treacy, Oliver; Ryan, Aideen E.; Heinzl, Teresa; O'Flynn, Lisa; Cregg, Marese; Wilk, Mieszko; Odoardi, Francesca; Lohan, Paul; O'Brien, Timothy; Nosov, Mikhail; Ritter, Thomas			Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation	PLOS ONE			English	Article							FUNCTIONAL CHEMOKINE RECEPTORS; MEDIATED GENE-TRANSFER; STROMAL CELLS; DENDRITIC CELLS; ENGRAFTMENT; MIGRATION; THERAPY; VECTORS; MODULATION; EXPRESSION	Adult mesenchymal stem cells (MSCs) are non-hematopoietic cells with multi-lineage potential which makes them attractive targets for regenerative medicine applications. However, to date, therapeutic success of MSC-therapy is limited and the genetic modification of MSCs using viral vectors is one option to improve their therapeutic potential. Ex-vivo genetic modification of MSCs using recombinant adenovirus (Ad) could be promising to reduce undesired immune responses as Ad will be removed before cell/tissue transplantation. In this regard, we investigated whether Ad-modification of MSCs alters their immunological properties in vitro and in vivo. We found that Ad-transduction of MSCs does not lead to up-regulation of major histocompatibility complex class I and II and co-stimulatory molecules CD80 and CD86. Moreover, Ad-transduction caused no significant changes in terms of pro-inflammatory cytokine expression, chemokine and chemokine receptor and Toll-like receptor expression. In addition, Ad-modification of MSCs had no affect on their ability to suppress T cell proliferation in vitro. In vivo injection of Ad-transduced MSCs did not change the frequency of various immune cell populations (antigen presenting cells, T helper and cytotoxic T cells, natural killer and natural killer T cells) neither in the blood nor in tissues. Our results indicate that Ad-modification has no major influence on the immunological properties of MSCs and therefore can be considered as a suitable gene vector for therapeutic applications of MSCs.	[Treacy, Oliver; Ryan, Aideen E.; Heinzl, Teresa; O'Flynn, Lisa; Cregg, Marese; Wilk, Mieszko; Lohan, Paul; O'Brien, Timothy; Nosov, Mikhail; Ritter, Thomas] Natl Univ Ireland, Regenerat Med Inst, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Odoardi, Francesca] Univ Med, Dept Neuroimmunol, Inst Multiple Sclerosis Res, Gottingen, Germany	Ollscoil na Gaillimhe-University of Galway	Treacy, O (corresponding author), Natl Univ Ireland, Regenerat Med Inst, Sch Med, Coll Med Nursing & Hlth Sci, Galway, Ireland.	thomas.ritter@nuigalway.ie	O'Brien, Timothy/N-7112-2014; Treacy, Oliver/AAQ-3679-2020; Ryan, Aideen/H-3909-2019	O'Brien, Timothy/0000-0001-9028-5481; Ryan, Aideen/0000-0002-5831-6783; Wilk, Mieszko/0000-0002-7947-633X; Ritter, Thomas/0000-0001-7709-8489; Treacy, Oliver/0000-0003-3898-9806	Science Foundation Ireland [07/IN.1/B925, 09/SRC/B1794]; Health Research Board [RP/2007/60]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board	This material is based upon works supported by the Science Foundation Ireland (www.sfi.ie) under Grant No. [07/IN.1/B925 and 09/SRC/B1794] and by the Health Research Board (www.hrb.ie) under Grant No. [RP/2007/60]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Basner-Tschakarjan E, 2006, J GENE MED, V8, P1300, DOI 10.1002/jgm.964; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Chen DM, 2003, AM J TRANSPLANT, V3, P1216, DOI 10.1046/j.1600-6143.2003.00207.x; Chuang CK, 2009, MOL THER, V17, P889, DOI 10.1038/mt.2009.30; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duffy GP, 2010, TISSUE ENG PT A, V16, P2755, DOI 10.1089/ten.tea.2009.0623; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Griffin M, 2010, DISCOV MED, V9, P219; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Ritter T, 1999, EXP EYE RES, V69, P563, DOI 10.1006/exer.1999.0731; Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260; Schu S, 2011, J CELL MOL MED; Shujia J, 2008, CARDIOVASC RES, V77, P525, DOI 10.1093/cvr/cvm077; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tang JM, 2010, MOL CELL BIOCHEM, V339, P107, DOI 10.1007/s11010-009-0374-0; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x	38	30	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42662	10.1371/journal.pone.0042662	http://dx.doi.org/10.1371/journal.pone.0042662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880073	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000058
J	Wang, RX; Sun, XJ; Wang, CY; Hu, PZ; Chu, CY; Liu, SR; Zhau, HE; Chung, LWK				Wang, Ruoxiang; Sun, Xiaojuan; Wang, Christopher Y.; Hu, Peizhen; Chu, Chia-Yi; Liu, Shurong; Zhau, Haiyen E.; Chung, Leland W. K.			Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression	PLOS ONE			English	Article							MITOTIC CATASTROPHE; BONE FIBROBLASTS; SARCOMA-CELLS; GROWTH-INVIVO; METASTASIS; HYBRIDS; CHROMOSOME; DIFFERENTIATION; CHECKPOINT; ANEUPLOIDY	We have previously shown that human prostate cancer cells are capable of acquiring malignant attributes through interaction with stromal cells in the tumor microenvironment, while the interacting stromal cells can also become affected with both phenotypic and genotypic alterations. This study used a co-culture model to investigate the mechanism underlying the co-evolution of cancer and stromal cells. Red fluorescent androgen-dependent LNCaP prostate cancer cells were cultured with a matched pair of normal and cancer-associated prostate myofibroblast cells to simulate cancer-stromal interaction, and cellular changes in the co-culture were documented by tracking the red fluorescence. We found frequent spontaneous fusions between cancer and stromal cells throughout the co-culture. In colony formation assays assessing the fate of the hybrid cells, most of the cancer-stromal fusion hybrids remained growth-arrested and eventually perished. However, some of the hybrids survived to form colonies from the co-culture with cancer-associated stromal cells. These derivative clones showed genomic alterations together with androgen-independent phenotype. The results from this study reveal that prostate cancer cells are fusogenic, and cancer-stromal interaction can lead to spontaneous fusion between the two cell types. While a cancer-stromal fusion strategy may allow the stromal compartment to annihilate invading cancer cells, certain cancer-stromal hybrids with increased survival capability may escape annihilation to form a derivative cancer cell population with an altered genotype and increased malignancy. Cancer-stromal fusion thus lays a foundation for an incessant co-evolution between cancer and the cancer-associated stromal cells in the tumor microenvironment.	[Wang, Ruoxiang; Hu, Peizhen; Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Wang, Ruoxiang; Sun, Xiaojuan; Wang, Christopher Y.; Chu, Chia-Yi; Liu, Shurong] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA	Cedars Sinai Medical Center; Emory University	Wang, RX (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	ruoxiang.wang@cshs.org			NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.) [R21CA112330, CA132388]; DoD [PC040578]; NCI/NIH [CA98912-02]; NATIONAL CANCER INSTITUTE [P01CA098912, P20CA132388, R21CA112330] Funding Source: NIH RePORTER	NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.); DoD(United States Department of Defense); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by research grants R21CA112330 and CA132388 from NCI/NIH (National Cancer Institute of the National Institutes of Health of the United States.), and PC040578 from DoD to Ruoxiang Wang; and NCI/NIH grant CA98912-02 to Leland W. K. Chung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichel O., 1911, ZELLVERSCHMELZUNG QU; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; BARSKI G, 1961, J NATL CANCER I, V26, P1269; BARSKI G, 1962, J NATL CANCER I, V28, P801; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Busund LTR, 2002, INT J CANCER, V98, P573, DOI 10.1002/ijc.10249; Canman CE, 2001, CURR BIOL, V11, pR121, DOI 10.1016/S0960-9822(01)00057-4; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chaudhary KS, 1999, ENVIRON HEALTH PERSP, V107, P49, DOI 10.2307/3434471; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; CHUNG LWK, 1993, SEMIN CANCER BIOL, V4, P183; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; CHUNG LWK, 1991, CANCER SURV, V11, P91; ENG B, 1994, J FORENSIC SCI, V39, P1356; GLEAVE M, 1991, CANCER RES, V51, P3753; GLEAVE ME, 1992, J UROLOGY, V147, P1151, DOI 10.1016/S0022-5347(17)37506-7; Hasegawa T, 2000, J VET MED SCI, V62, P1109, DOI 10.1292/jvms.62.1109; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; Larsson LI, 2008, HISTOCHEM CELL BIOL, V129, P551, DOI 10.1007/s00418-008-0411-1; Larsson LI, 2007, THESCIENTIFICWORLDJO, V7, P1193, DOI 10.1100/tsw.2007.212; LIEBER MM, 1992, J CELL BIOCHEM, P44; Mortensen K, 2004, CELL MOL LIFE SCI, V61, P2125, DOI 10.1007/s00018-004-4200-2; Murillo H, 2006, GENE CHROMOSOME CANC, V45, P702, DOI 10.1002/gcc.20333; Navarro D, 2002, J STEROID BIOCHEM, V81, P191, DOI 10.1016/S0960-0760(02)00064-X; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; PETERS J M, 1989, Henry Ford Hospital Medical Journal, V37, P8; Podbilewicz Benjamin, 2006, WormBook, P1; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rhee HW, 2001, IN VITRO CELL DEV-AN, V37, P127; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; STONE JF, 1995, MUTAT RES-DNAGING G, V338, P107, DOI 10.1016/0921-8734(95)00016-Y; Sun XJ, 2010, IN VITRO CELL DEV-AN, V46, P538, DOI 10.1007/s11626-010-9309-z; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; THALMANN GN, 1994, CANCER RES, V54, P2577; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436; WAKELING WF, 1994, CELL BIOL INT, V18, P207, DOI 10.1006/cbir.1994.1063; Wang RX, 2004, CANCER RES, V64, P1589, DOI 10.1158/0008-5472.CAN-03-3331; WIENER F, 1974, P NATL ACAD SCI USA, V71, P148, DOI 10.1073/pnas.71.1.148; WIENER F, 1974, J NATL CANCER I, V52, P1779, DOI 10.1093/jnci/52.6.1779; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319	49	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42653	10.1371/journal.pone.0042653	http://dx.doi.org/10.1371/journal.pone.0042653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880071	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100152
J	Costa, C; Santos, M; Martinez-Fernandez, M; Duenas, M; Lorz, C; Garcia-Escudero, R; Paramio, JM				Costa, C.; Santos, M.; Martinez-Fernandez, M.; Duenas, M.; Lorz, C.; Garcia-Escudero, R.; Paramio, J. M.			E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis	ONCOGENE			English	Article						skin; pRb; E2F1; p53; hair follicle; Wnt signalling	HAIR FOLLICLE MORPHOGENESIS; MOUSE SKIN CARCINOGENESIS; BETA-CATENIN ACTIVATION; EPITHELIAL STEM-CELLS; BLADDER-CANCER; RETINOBLASTOMA FAMILY; EXPRESSION PROFILES; TRANSGENIC MODEL; S-PHASE; PROLIFERATION	The specific ablation of Rb1 gene in epidermis (Rb-F/F; K14cre) promotes proliferation and altered differentiation but does not produce spontaneous tumour development. These phenotypic changes are associated with increased expression of E2F members and E2F-dependent transcriptional activity. Here, we have focused on the possible dependence on E2F1 gene function. We have generated mice that lack Rb1 in epidermis in an inducible manner (RbF/F; K14creER(TM)). These mice are indistinguishable from those lacking pRb in this tissue in a constitutive manner (Rb-F/F; K14cre). In an E2F1-null background (Rb-F/F; K14creER(TM); and E2F1(-/-) mice), the phenotype due to acute Rb1 loss is not ameliorated by E2F1 loss, but rather exacerbated, indicating that pRb functions in epidermis do not rely solely on E2F1. On the other hand, Rb-F/F; K14creER(TM); E2F1(-/-) mice develop spontaneous epidermal tumours of hair follicle origin with high incidence. These tumours, which retain a functional p19(arf)/p53 axis, also show aberrant activation of beta-catenin/Wnt pathway. Gene expression studies revealed that these tumours display relevant similarities with specific human tumours. These data demonstrate that the Rb/E2F1 axis exerts essential functions not only in maintaining epidermal homoeostasis, but also in suppressing tumour development in epidermis, and that the disruption of this pathway may induce tumour progression through specific alteration of developmental programs.	[Costa, C.; Santos, M.; Martinez-Fernandez, M.; Duenas, M.; Lorz, C.; Garcia-Escudero, R.; Paramio, J. M.] CIEMAT, Mol Oncol Unit, Dept Basic Res, E-28040 Madrid, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Paramio, JM (corresponding author), CIEMAT, Mol Oncol Unit, Dept Basic Res, Ed 70A,Ave Complutense 40, E-28040 Madrid, Spain.	jesusm.paramio@ciemat.es	Costa, Clotilde/L-6850-2015; Lorz, Corina/E-3651-2016; Paramio, Jesus M/M-8482-2014; Santos, Mirentxu/AAA-1727-2020; Garcia-Escudero, Ramon/A-2735-2012	Lorz, Corina/0000-0001-8214-9076; Paramio, Jesus M/0000-0001-7520-3177; Garcia-Escudero, Ramon/0000-0001-5640-6542; Costa, Clotilde/0000-0001-7327-2259; Duenas, Marta/0000-0003-0857-9726	Ministerio de Ciencia e Innovacion (MICINN) [SAF2006-0121, SAF2011-26122C02-01, JCI-2010-06167]; Comunidad Autonoma de Madrid Oncocycle Program Grant [S2006/BIO-0232, CAM P2010/BMD-2470]; Ministerio de Sanidad y Consumo grant [SCIII-RETIC RD06/0020/0029]; Fundacion Sandra Ibarra	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid Oncocycle Program Grant; Ministerio de Sanidad y Consumo grant; Fundacion Sandra Ibarra	Ministerio de Ciencia e Innovacion (MICINN) grants SAF2006-0121, SAF2011-26122C02-01 and JCI-2010-06167, Comunidad Autonoma de Madrid Oncocycle Program Grant S2006/BIO-0232 and: CAM P2010/BMD-2470, Ministerio de Sanidad y Consumo grant ISCIII-RETIC RD06/0020/0029 and from Fundacion Sandra Ibarra to JMP. The excellent technical support by Pilar Hernandez in histology and the personnel of the CIEMAT Animal Facility are specially acknowledged.	Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Ahmad I, 2012, DIS MODEL MECH, V5, P323, DOI 10.1242/dmm.008888; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Brandt WD, 2009, CANCER METAST REV, V28, P291, DOI 10.1007/s10555-009-9187-6; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doglioni C, 2003, AM J PATHOL, V163, P2277, DOI 10.1016/S0002-9440(10)63585-7; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Lara MF, 2008, MOL CARCINOGEN, V47, P105, DOI 10.1002/mc.20367; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Lorz C, 2010, STEM CELL REV REP, V6, P162, DOI 10.1007/s12015-010-9139-0; Lorz C, 2010, METHODS MOL BIOL, V585, P1, DOI 10.1007/978-1-60761-380-0_1; Lorz C, 2009, CURR MOL MED, V9, P355, DOI 10.2174/156652409787847227; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Martinez-Cruz AB, 2008, CANCER RES, V68, P683, DOI 10.1158/0008-5472.CAN-07-3049; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; OGUIN WM, 1992, J INVEST DERMATOL, V98, P24, DOI 10.1111/1523-1747.ep12494172; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; Pierce AM, 1998, ONCOGENE, V16, P1267, DOI 10.1038/sj.onc.1201666; Pierce AM, 1999, MOL CELL BIOL, V19, P6408; Pierce AM, 1998, P NATL ACAD SCI USA, V95, P8858, DOI 10.1073/pnas.95.15.8858; Rabbani F, 1999, J NATL CANCER I, V91, P874, DOI 10.1093/jnci/91.10.874; Rabbani F, 2000, UROL CLIN N AM, V27, P83, DOI 10.1016/S0094-0143(05)70237-8; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rounbehler RJ, 2002, CANCER RES, V62, P3276; Ruiz S, 2005, CANCER RES, V65, P9678, DOI 10.1158/0008-5472.CAN-05-1853; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Ruiz S, 2004, DEV DYNAM, V230, P410, DOI 10.1002/dvdy.20065; Ruiz S, 2006, CELL CYCLE, V5, P625, DOI 10.4161/cc.5.6.2580; Russell JL, 2006, ONCOGENE, V25, P867, DOI 10.1038/sj.onc.1209120; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Santos M, 2008, MOL CARCINOGEN, V47, P815, DOI 10.1002/mc.20426; Segrelles C, 2008, MOL BIOL CELL, V19, P137, DOI 10.1091/mbc.E07-08-0764; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	67	17	17	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2937	2951		10.1038/onc.2012.316	http://dx.doi.org/10.1038/onc.2012.316			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22890321				2022-12-25	WOS:000320369700004
J	Philip, F; Guo, YJ; Aisiku, O; Scarlata, S				Philip, Finly; Guo, Yuanjian; Aisiku, Omoz; Scarlata, Suzanne			Phospholipase C beta 1 is linked to RNA interference of specific genes through translin-associated factor X	FASEB JOURNAL			English	Article						G protein signaling; RNA transcription; histone H2B	C BETA-1; EXPRESSION; BRAIN; TRAX; MICE; ACTIVATION; COMPLEX; ROLES; MODEL; C3PO	Phospholipase C beta 1 (PLC beta 1) is a G-protein-regulated enzyme whose activity results in proliferative and mitogenic changes in the cell. We have previously found that in solution PLC beta 1 binds to the RNA processing protein translin-associated factor X (TRAX) with nanomolar affinity and that this binding competes with G proteins. Here, we show that endogenous PLC beta 1 and TRAX interact in SK-N-SH cells and also in HEK293 cells induced to overexpress PLC beta 1. In HEK293 cells, TRAX overexpression ablates Ca2+ signals generated by G protein-PLC beta 1 activation. TRAX plays a key role in down-regulation of proteins by small, interfering RNA, and PLC beta 1 overexpression completely reverses the 2- to 4-fold down-regulation of GAPDH by siRNA in HEK293 and HeLa cells as seen by an similar to 4-fold recovery in both the transcript and protein levels. Also, down-regulation of endogenous PLC beta 1 in HEK293 and HeLa cells allows for an similar to 20% increase in siRNA(GAPDH) silencing. While PLC beta 1 overexpression results in a 50% reversal of cell death caused by siRNA(LDH), it does not affect cell survival or silencing of other genes (e. g., cyclophilin, Hsp90, translin). PLC beta 1 overexpression in HEK293 and HeLa cells causes a 30% reduction in the total amount of small RNAs. LDH and GAPDH are part of a complex that promotes H2B synthesis that allows cells to progress through the S phase. We find that PLC beta 1 reverses the cell death and completely rescues H2B levels caused by siRNA knockdown of LDH or GAPDH. Taken together, our study shows a novel role of PLC beta 1 in gene regulation through TRAX association.-Philip, F., Guo, Y., Aisiku, O., Scarlata, S. Phospholipase C beta 1 is linked to RNA interference of specific genes through translin-associated factor X. FASEB J. 26, 4903-4913 (2012). www.fasebj.org	[Philip, Finly; Guo, Yuanjian; Aisiku, Omoz; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Basic Sci Tower T6-146, Stony Brook, NY 11794 USA.	suzanne.scarlata@stonybrook.edu			U.S. National Institutes of Health [GM53132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Loren Runnels (University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA) for the HEK293-TAP-PLC beta 1 cells, to Catherine Berlot (Geisinger Research Center, Danville, PA, USA) for the G alpha<INF>q</INF>(RC) construct, to Izolda Mileva (Stony Brook University) for her assistance in the RT-PCR studies, and to Urszula Golebiewska and Mario Rebecchi (Stony Brook University) for critically reading this paper. This work was supported by U.S. National Institutes of Health grant GM53132.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Chennathukuzhi V, 2003, MOL CELL BIOL, V23, P6419, DOI 10.1128/MCB.23.18.6419-6434.2003; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Cocco L, 2002, ADV ENZYME REGUL, V42, P181, DOI 10.1016/S0065-2571(01)00030-9; Cocco L, 2001, BBA-MOL CELL BIOL L, V1530, P1, DOI 10.1016/S1388-1981(00)00169-4; Cocco L, 2006, BBA-MOL CELL BIOL L, V1761, P509, DOI 10.1016/j.bbalip.2006.03.001; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Faenza I, 2002, BBA-MOL CELL RES, V1589, P305, DOI 10.1016/S0167-4889(02)00192-1; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaendling A, 2010, BIOCHEM J, V429, P225, DOI 10.1042/BJ20100273; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LEE YM, 2000, LIFE SCI, V56, P67; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Siomi H, 2009, NAT CELL BIOL, V11, P1049, DOI 10.1038/ncb0909-1049; Stein JM, 2006, J NEUROSCI, V26, P2184, DOI 10.1523/JNEUROSCI.4437-05.2006; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tian Y, 2011, NAT STRUCT MOL BIOL, V18, P658, DOI 10.1038/nsmb.2069; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l; Xu AM, 2001, MOL CELL BIOL, V21, P2981, DOI 10.1128/MCB.21.9.2981-2990.2001; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	33	17	21	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4903	4913		10.1096/fj.12-213934	http://dx.doi.org/10.1096/fj.12-213934			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22889834	Green Published			2022-12-25	WOS:000311838300014
J	Zhou, P; Luo, Y; Liu, X; Fan, L; Lu, Y				Zhou, Peng; Luo, Yi; Liu, Xin; Fan, Lei; Lu, Yi			Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract	FASEB JOURNAL			English	Article						alpha A-crystallin; bisulfite genomic sequencing; zebularine	ALPHA-B-CRYSTALLIN; C-TERMINAL TRUNCATION; A-CRYSTALLIN; CELL; ZEBULARINE	Age-related cataract (ARC) is the leading cause of blindness among older adults, and the chaperone-like activity of alpha A-crystallin (CRYAA) is considered to be critical for the maintenance of eye lens transparency. To assess the potential contribution of epigenetic regulation of CRYAA genes relevant to ARC pathogenesis, we evaluated DNA methylation, a tissue-specific genetic modulation that affects gene expression. Reverse-transcription PCR and Western blot were used to analyze the expression of CRYAA. Methylation status was analyzed by bisulfite genomic sequencing of the CpG islands in 15 eyes with age-related nuclear cataracts and 15 control eyes. The demethylating agent zebularine was used to investigate the relationship between hypermethylation of the CpG islands and down-expression of CRYAA. The mRNA and protein levels of CRYAA were significantly reduced in the lens epithelia of age-related nuclear cataract cases vs. age-matched controls, which corresponded to hypermethylation of the CpG island of CRYAA promoter. Treatment with a DNA-demethylating agent was associated with restoration of CRYAA expression. Comparing DNA methylation and mRNA and protein levels revealed significant differences between age-related nuclear cataract and control lenses. The evidence presented suggests that CRYAA undergoes epigenetic repression in the lens epithelia in age-related nuclear cataract.-Zhou, P., Luo, Y., Liu, X., Fan, L., Lu, Y. Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract. FASEB J. 26, 4897-4902 (2012). www.fasebj.org	[Zhou, Peng; Luo, Yi; Liu, Xin; Lu, Yi] Fudan Univ, Eye & Ear Nose & Throat Hosp, Dept Ophthalmol, Shanghai 200031, Peoples R China; [Fan, Lei] Fudan Univ, Ctr Canc, Dept Breast Surg, Shanghai 200031, Peoples R China	Fudan University; Fudan University	Lu, Y (corresponding author), Fudan Univ, Eye & Ear Nose & Throat Hosp, Dept Ophthalmol, 83 Fenyang Rd, Shanghai 200031, Peoples R China.	luyi0705@yahoo.com.cn			National Natural Science Foundation of China [81200669, 81102003]; Program of Shanghai Subject Chief Scientist [11XD1401200]; Program of Shanghai 100 Medical Scientist [XBR2011056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Program of Shanghai 100 Medical Scientist	This study was supported by grants from the National Natural Science Foundation of China (81200669 and 81102003), Program of Shanghai Subject Chief Scientist (11XD1401200), and Program of Shanghai 100 Medical Scientist (XBR2011056).	Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; BOYLE D, 1993, BIOCHEM BIOPH RES CO, V192, P1147, DOI 10.1006/bbrc.1993.1536; Boyle Daniel L, 2003, BMC Ophthalmol, V3, P3, DOI 10.1186/1471-2415-3-3; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Chen Y, 2010, J INT MED RES, V38, P1016, DOI 10.1177/147323001003800328; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hunter A, 2012, INVEST OPHTH VIS SCI, V53, P2089, DOI 10.1167/iovs.11-8449; KUPFER C, 1987, INVEST OPHTH VIS SCI, V28, P1; McCarthy N, 2012, NAT REV CANCER, V12, DOI [10.1038/nrc3222, 10.1038/nrc3227]; Richter GM, 2009, OPHTHALMOLOGY, V116, P2327, DOI 10.1016/j.ophtha.2009.05.040; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Scott SA, 2007, EXP HEMATOL, V35, P263, DOI 10.1016/j.exphem.2006.10.005; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; Wiggs JL, 2012, INVEST OPHTH VIS SCI, V53, P2467, DOI 10.1167/iovs.12-9483e; You QS, 2011, OPHTHALMOLOGY, V118, P1069, DOI 10.1016/j.ophtha.2010.09.032; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhou P, 2007, CURR EYE RES, V32, P973, DOI 10.1080/02713680701658323; Zhou P, 2012, MOL VIS, V18, P22; Zhou P, 2011, MOL VIS, V17, P2717; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	24	49	56	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4897	4902		10.1096/fj.12-213702	http://dx.doi.org/10.1096/fj.12-213702			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22889833				2022-12-25	WOS:000311838300013
J	Zhou, YZ; Smith, D; Leong, BJ; Brannstrom, K; Almqvist, F; Chapman, MR				Zhou, Yizhou; Smith, Daniel; Leong, Bryan J.; Brannstrom, Kristoffer; Almqvist, Fredrik; Chapman, Matthew R.			Promiscuous Cross-seeding between Bacterial Amyloids Promotes Interspecies Biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN AGGREGATIVE FIMBRIAE; PRION SPECIES BARRIER; ESCHERICHIA-COLI K-12; X-RAY-DIFFRACTION; YEAST PRION; ALZHEIMERS-DISEASE; MOLECULAR-BASIS; SALMONELLA-TYPHIMURIUM; MULTICELLULAR BEHAVIOR; BETA-PROTEIN	Amyloids are highly aggregated proteinaceous fibers historically associated with neurodegenerative conditions including Alzheimers, Parkinsons, and prion-based encephalopathies. Polymerization of amyloidogenic proteins into ordered fibers can be accelerated by preformed amyloid aggregates derived from the same protein in a process called seeding. Seeding of disease-associated amyloids and prions is highly specific and cross-seeding is usually limited or prevented. Here we describe the first study on the cross-seeding potential of bacterial functional amyloids. Curli are produced on the surface of many Gram-negative bacteria where they facilitate surface attachment and biofilm development. Curli fibers are composed of the major subunit CsgA and the nucleator CsgB, which templates CsgA into fibers. Our results showed that curli subunit homologs from Escherichia coli, Salmonella typhimurium LT2, and Citrobacter koseri were able to cross-seed in vitro. The polymerization of Escherichia coli CsgA was also accelerated by fibers derived from a distant homolog in Shewanella oneidensis that shares less than 30% identity in primary sequence. Cross-seeding of curli proteins was also observed in mixed colony biofilms with E. coli and S. typhimurium. CsgA was secreted from E. coli csgB- mutants assembled into fibers on adjacent S. typhimurium that presented CsgB on its surfaces. Similarly, CsgA was secreted by S. typhimurium csgB- mutants formed curli on CsgB-presenting E. coli. This interspecies curli assembly enhanced bacterial attachment to agar surfaces and supported pellicle biofilm formation. Collectively, this work suggests that the seeding specificity among curli homologs is relaxed and that heterogeneous curli fibers can facilitate multispecies biofilm development.	[Zhou, Yizhou; Smith, Daniel; Leong, Bryan J.; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Almqvist, Fredrik] Umea Univ, Dept Chem, Chem Biol Ctr, S-90187 Umea, Sweden; [Almqvist, Fredrik; Chapman, Matthew R.] Umea Univ, Umea Ctr Microbial Res, S-90187 Umea, Sweden	University of Michigan System; University of Michigan; Umea University; Umea University	Chapman, MR (corresponding author), Univ Michigan LSA, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	chapmanm@umich.edu	Brännström, Kristoffer/D-3648-2009; Zhou, Yizhou/G-3680-2014; Brännström, Kristoffer/AAC-1204-2020; Leong, Bryan J/F-2817-2015	Leong, Bryan J/0000-0003-4042-1160; Chapman, Matthew/0000-0002-2645-1294; Almqvist, Fredrik/0000-0002-0504-4446	National Institutes of Health [AI073847]; Umea University Linnaeus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847, R56AI073847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Umea University Linnaeus Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI073847 and the Umea University Linnaeus Foundation.	Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jordal PB, 2009, APPL ENVIRON MICROB, V75, P4101, DOI 10.1128/AEM.02107-08; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kim SM, 2012, J MICROBIOL, V50, P175, DOI 10.1007/s12275-012-2044-2; Kobayashi H, 1996, BRIT J RHEUMATOL, V35, P44; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morten S., 2012, FUNCTIONAL IN PRESS; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2008, J MOL BIOL, V380, P570, DOI 10.1016/j.jmb.2008.05.019; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Weiss-Muszkat M, 2010, APPL ENVIRON MICROB, V76, P1545, DOI 10.1128/AEM.01395-09; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; White AP, 2001, J MOL BIOL, V311, P735, DOI 10.1006/jmbi.2001.4876; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	84	84	85	4	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35092	35103		10.1074/jbc.M112.383737	http://dx.doi.org/10.1074/jbc.M112.383737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22891247	Green Published, hybrid			2022-12-25	WOS:000309968000020
J	Enesa, K; Ordureau, A; Smith, H; Barford, D; Cheung, PCF; Patterson-Kane, J; Arthur, JSC; Cohen, P				Enesa, Karine; Ordureau, Alban; Smith, Hilary; Barford, David; Cheung, Peter C. F.; Patterson-Kane, Janet; Arthur, J. Simon C.; Cohen, Philip			Pellino1 Is Required for Interferon Production by Viral Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-KINASE; UBIQUITIN LIGASE PELLINO; TOLL-LIKE RECEPTOR-4; SIGNALING PATHWAY; GENE-EXPRESSION; IKK-EPSILON; TRANSCRIPTION FACTORS; REGULATORY FACTOR-3; PROTEIN-KINASES; DENDRITIC CELLS	Viral double-stranded RNA, a ligand for Toll-like Receptor 3 (TLR3) and the cytoplasmic RNA receptors RIG1 and MDA5, activate a signaling network in which the IKK-related protein kinase TBK1 phosphorylates the transcription factor Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquitin ligase Pellino1. IRF3 then translocates to the nucleus where it stimulates transcription of the interferon beta (IFN beta) gene, but the function of Pellino1 in this pathway is unknown. Here, we report that myeloid cells and embryonic fibroblasts from knock-in mice expressing an E3 ligase-deficient mutant of Pellino1 produce reduced levels of IFN beta mRNA and secrete much less IFN beta in response to viral double-stranded RNA because the interaction of IRF3 with the IFN beta promoter is impaired. These results identify Pellino1 as a novel component of the signal transduction network by which viral double-stranded RNA stimulates IFN beta gene transcription.	[Enesa, Karine; Ordureau, Alban; Smith, Hilary; Arthur, J. Simon C.; Cohen, Philip] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Cohen, Philip] Univ Dundee, Scottish Inst Cell Signaling, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Cheung, Peter C. F.] Nanyang Technol Univ, Singapore 637551, Singapore; [Barford, David] Inst Canc Res, London SW3 6JB, England; [Patterson-Kane, Janet] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G61 1QH, Lanark, Scotland	University of Dundee; University of Dundee; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Glasgow	Cohen, P (corresponding author), Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk	Arthur, J. Simon/B-8058-2010; Ordureau, Alban/C-7558-2012; Cheung, Peter/A-2213-2011	Arthur, J. Simon/0000-0002-8135-1958; Ordureau, Alban/0000-0002-4924-8520; Barford, David/0000-0001-8810-950X; Patterson-Kane, Janet/0000-0002-9094-1263	Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck KGaA; Janssen Pharmaceutica; Pfizer; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_U127084348, MC_U127081014] Funding Source: researchfish; MRC [MC_U127084348, MC_U127081014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck KGaA; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and the pharmaceutical companies supporting the Division of Signal Transduction Therapy (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KGaA, Janssen Pharmaceutica, and Pfizer).	Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Doyle SE, 2003, J IMMUNOL, V170, P3565, DOI 10.4049/jimmunol.170.7.3565; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Griffin BD, 2011, EUR J IMMUNOL, V41, P798, DOI 10.1002/eji.201040774; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Haghayeghi A, 2010, MECH DEVELOP, V127, P301, DOI 10.1016/j.mod.2010.01.004; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Ng SL, 2011, P NATL ACAD SCI USA, V108, P21170, DOI 10.1073/pnas.1119137109; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Smith H, 2009, P NATL ACAD SCI USA, V106, P4584, DOI 10.1073/pnas.0900774106; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	44	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34825	34835		10.1074/jbc.M112.367557	http://dx.doi.org/10.1074/jbc.M112.367557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902624	Green Published, hybrid			2022-12-25	WOS:000309654200081
J	Stehle, T; Sreeramulu, S; Lohr, F; Richter, C; Saxena, K; Jonker, HRA; Schwalbe, H				Stehle, Tanja; Sreeramulu, Sridhar; Loehr, Frank; Richter, Christian; Saxena, Krishna; Jonker, Hendrik R. A.; Schwalbe, Harald			The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; SEQUENCE-SPECIFIC ASSIGNMENT; CRYSTAL-STRUCTURE; PHOSPHOTYROSYL PHOSPHATASE; NMR-SPECTRA; BACKBONE DYNAMICS; PULSE SEQUENCES; CHEMICAL-SHIFT; KINASE; RELAXATION	Protein-tyrosine phosphatases (PTPs) and protein-tyrosine kinases co-regulate cellular processes. In pathogenic bacteria, they are frequently exploited to act as key virulence factors for human diseases. Mycobacterium tuberculosis, the causative organism of tuberculosis, secretes a low molecular weight PTP (LMW-PTP), MptpA, which is required for its survival upon infection of host macrophages. Although there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding loop (P-loop) CX5R and the loop containing a critical aspartic acid residue (D-loop), required for the catalytic activity, are well conserved. In most high molecular weight PTPs, ligand binding to the P-loop triggers a large conformational reorientation of the D-loop, in which it moves similar to 10 angstrom, from an "open" to a "closed" conformation. Until now, there have been no ligand-free structures of LMW-PTPs described, and hence the dynamics of the D-loop have remained largely unknown for these PTPs. Here, we present a high resolution solution NMR structure of the free form of the MptpA LMW-PTP. In the absence of ligand and phosphate ions, the D-loop adopts an open conformation. Furthermore, we characterized the binding site of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of both the P- and D-loop in phosphate binding. Notably, in LMW-PTPs, the phosphorylation status of two well conserved tyrosine residues, typically located in the D-loop, regulates the enzyme activity. PtkA, the kinase complementary to MptpA, phosphorylates these two tyrosine residues in MptpA. We characterized the MptpA-PtkA interaction by NMR spectroscopy to show that both the P-and D-loop form part of the binding interface.	[Stehle, Tanja; Sreeramulu, Sridhar; Richter, Christian; Saxena, Krishna; Jonker, Hendrik R. A.; Schwalbe, Harald] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Biophys Chem, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Jonker, HRA (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Organ Chem & Chem Biol, Max von Laue Str 7, D-60438 Frankfurt, Germany.	h.jonker@nmr.uni-frankfurt.de	Schwalbe, Harald J/F-9023-2010; Schwalbe, Harald/AAB-3143-2020	Schwalbe, Harald J/0000-0001-5693-7909; Schwalbe, Harald/0000-0001-5693-7909	European Union Commission; state of Hesse	European Union Commission(European Commission); state of Hesse	This work was supported by the European Union Commission in the program WeNMR (to H. J. and T. S.). The Center for Biomolecular Magnetic Resonance (BMRZ) is supported by the state of Hesse.	Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; [Anonymous], 2012, 2011 2012 TUB GLOB F; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cowley SC, 2002, RES MICROBIOL, V153, P233, DOI 10.1016/S0923-2508(02)01309-8; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Doreleijers JF, 2012, NUCLEIC ACIDS RES, V40, pD519, DOI 10.1093/nar/gkr1134; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GODDARD TD, 2002, SPARKY; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustafson CLT, 2005, PROTEIN SCI, V14, P2515, DOI 10.1110/ps.051618805; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Lohr F, 2005, J BIOMOL NMR, V32, P309, DOI 10.1007/s10858-005-1195-4; Lohr F, 2002, J BIOMOL NMR, V22, P153, DOI 10.1023/A:1014271204953; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Pervushin KV, 1999, P NATL ACAD SCI USA, V96, P9607, DOI 10.1073/pnas.96.17.9607; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sambrook J., 2006, MOL CLONING LAB MANU, P718; Saxena K, 2005, J BIOMOL NMR, V33, P136, DOI 10.1007/s10858-005-2718-8; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; Schwarzer D, 2006, J AM CHEM SOC, V128, P4192, DOI 10.1021/ja0585174; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva APG, 2010, FUTURE MED CHEM, V2, P1325, DOI 10.4155/fmc.10.214; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Tolkatchev D, 2006, PROTEIN SCI, V15, P2381, DOI 10.1110/ps.062279806; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; VUISTER GW, 1994, J BIOMOL NMR, V4, P193; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu HM, 2006, J BACTERIOL, V188, P1509, DOI 10.1128/JB.188.4.1509-1517.2006; Zabell APR, 2006, J BIOL CHEM, V281, P6520, DOI 10.1074/jbc.M506285200; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; Zhang ZY, 1997, CURR TOP CELL REGUL, V35, P21, DOI 10.1016/S0070-2137(97)80002-7; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161	77	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34569	34582		10.1074/jbc.M112.399261	http://dx.doi.org/10.1074/jbc.M112.399261			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888002	Green Published, hybrid			2022-12-25	WOS:000309654200060
J	Xu, B; Chelikani, P; Bhullar, RP				Xu, Bing; Chelikani, Prashen; Bhullar, Rajinder P.			Characterization and Functional Analysis of the Calmodulin-Binding Domain of Rac1 GTPase	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RHO-GTPASES; CDC42 ACTIVATION; H-RAS; K-RAS; CA2+/CALMODULIN; MEMBRANE; PROTEIN; PLATELET; ELEMENTS	Rac1, a member of the Rho family of small GTPases, has been shown to promote formation of lamellipodia at the leading edge of motile cells and affect cell migration. We previously demonstrated that calmodulin can bind to a region in the C-terminal of Rac1 and that this interaction is important in the activation of platelet Rac1. Now, we have analyzed amino acid residue(s) in the Rac1-calmodulin binding domain that are essential for the interaction and assessed their functional contribution in Rac1 activation. The results demonstrated that region 151-164 in Rac1 is essential for calmodulin binding. Within the 151-164 region, positively-charged amino acids K153 and R163 were mutated to alanine to study impact on calmodulin binding. Mutant form of Rac1 (K153A) demonstrated significantly reduced binding to calmodulin while the double mutant K153A/R163A demonstrated complete lack of binding to calmodulin. Thrombin or EGF resulted in activation of Rac1 in CHRF-288-11 or HeLa cells respectively and W7 inhibited this activation. Immunoprecipitation studies demonstrated that higher amount of CaM was associated with Rac1 during EGF dependent activation. In cells expressing mutant forms of Rac1 (K153A or K153A/R163A), activation induced by EGF was significantly decreased in comparison to wild type or the R163A forms of Rac1. The lack of Rac1 activation in mutant forms was not due to an inability of GDP-GTP exchange or a change in subcelllular distribution. Moreover, Rac1 activation was decreased in cells where endogenous level of calmodulin was reduced using shRNA knockdown and increased in cells where calmodulin was overexpressed. Docking analysis and modeling demonstrated that K153 in Rac1 interacts with Q41 in calmodulin. These results suggest an important role for calmodulin in the activation of Rac1 and thus, in cytoskeleton reorganization and cell migration.	[Xu, Bing; Chelikani, Prashen; Bhullar, Rajinder P.] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Bhullar, Rajinder P.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Xu, B (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	bhullar@cc.umanitoba.ca	Xu, Bing/AAB-6608-2019	Chelikani, Prashen/0000-0003-1129-7957	Heart & Stroke Foundation of Manitoba	Heart & Stroke Foundation of Manitoba	The work is supported by the Heart & Stroke Foundation of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; Elsaraj SM, 2008, BBA-MOL CELL RES, V1783, P770, DOI 10.1016/j.bbamcr.2008.01.022; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Guo F, 2008, J ELECTRON MATER, V37, P1, DOI 10.1007/s11664-007-0302-6; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lian JP, 2001, J IMMUNOL, V166, P2643, DOI 10.4049/jimmunol.166.4.2643; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; MacDougall DA, 2009, J BIOL CHEM, V284, P15573, DOI 10.1074/jbc.M809585200; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Rashid A, 2004, BIOCHEM BIOPH RES CO, V317, P363, DOI 10.1016/j.bbrc.2004.03.051; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Sehn X, 2005, P NATL ACAD SCI USA, V102, P5969; Sidhu RS, 2005, BIOCHEM BIOPH RES CO, V336, P105, DOI 10.1016/j.bbrc.2005.08.053; Sidhu RS, 2001, BIOCHEM BIOPH RES CO, V289, P1039, DOI 10.1006/bbrc.2001.6113; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Vidal-Quadras M, 2011, TRAFFIC, V12, P1879, DOI 10.1111/j.1600-0854.2011.01274.x; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xu B, 2011, MOL CELL BIOCHEM, V353, P73, DOI 10.1007/s11010-011-0776-7; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33	40	13	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42975	10.1371/journal.pone.0042975	http://dx.doi.org/10.1371/journal.pone.0042975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905193	Green Submitted, gold, Green Published			2022-12-25	WOS:000307823600037
J	Ishida, K; Nishizuka, SS; Chiba, T; Ikeda, M; Kume, K; Endo, F; Katagiri, H; Matsuo, T; Noda, H; Iwaya, T; Yamada, N; Fujiwara, H; Takahashi, M; Itabashi, T; Uesugi, N; Maesawa, C; Tamura, G; Sugai, T; Otsuka, K; Koeda, K; Wakabayashi, G				Ishida, Kazushige; Nishizuka, Satoshi S.; Chiba, Takehiro; Ikeda, Miyuki; Kume, Kohei; Endo, Fumitaka; Katagiri, Hirokatsu; Matsuo, Teppei; Noda, Hironobu; Iwaya, Takeshi; Yamada, Noriyuki; Fujiwara, Hisataka; Takahashi, Masanori; Itabashi, Tetsuya; Uesugi, Noriyuki; Maesawa, Chihaya; Tamura, Gen; Sugai, Tamotsu; Otsuka, Koki; Koeda, Keisuke; Wakabayashi, Go			Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers	PLOS ONE			English	Article							NF-KAPPA-B; LYSATE MICROARRAYS; GENE-EXPRESSION; JNK ACTIVATION; COLON-CANCER; CELL-LINES; CARCINOMA; INHIBITION; ALPHA; CHEMORESISTANCE	To confirm the clinical significance of NF-kappa B and JNK protein expression from experimentally identified candidates for predicting prognosis for patients with 5-FU treatment, we evaluated the protein expression of surgically removed specimens. A total of 79 specimens were obtained from 30 gastric and 49 colorectal cancer patients who underwent R0 resection followed by postoperative 5-FU based adjuvant chemotherapy. Immunohistochemical examinations of NF-kappa B and JNK on tissue microarrays (TMAs) revealed that significantly shorter time-to-relapse (TTR) in both NF-kappa B(+) and JNK(-) subgroups in both gastric (NF-kappa B(+), p = 0.0002, HR11.7. 95% CI3 3.2-43.4; JNK(-), p = 0.0302, HR4.4, 95% CI 1.2-16.6) and colon (NF-kappa B(+), p = 0.0038, HR36.9, 95% CI 3.2-426.0; JNK(-), p = 0.0098, HR3.2, 95% CI 1.3-7.7) cancers. These protein expression patterns also show strong discriminately power in gastric cancer patients for overall survival rate, suggesting a potential utility as prognostic or chemosensitivity markers. Baseline expression of these proteins using gastric cancer cell lines demonstrated the reciprocal patterns between NF-kappa B and JNK, while 5-FU exposure of these cell lines only induced NF-kappa B, suggesting that NF-kappa B plays a dominant role in the response to 5-FU. Subsequent siRNA experiments confirmed that gene knockdown of NF-kappa B increased 5-FU-specific sensitivity, whereas that of JNK did not affect the chemosensitivity. These results suggest that the expression of these proteins may aid in the decisions involved with adjuvant chemotherapy for gastrointestinal tract cancers.	[Ishida, Kazushige; Nishizuka, Satoshi S.; Chiba, Takehiro; Ikeda, Miyuki; Kume, Kohei; Endo, Fumitaka; Katagiri, Hirokatsu; Matsuo, Teppei; Noda, Hironobu; Iwaya, Takeshi; Fujiwara, Hisataka; Takahashi, Masanori; Itabashi, Tetsuya; Otsuka, Koki; Koeda, Keisuke; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 020, Japan; [Nishizuka, Satoshi S.; Kume, Kohei; Uesugi, Noriyuki; Maesawa, Chihaya; Wakabayashi, Go] Iwate Med Univ, MIAST, Morioka, Iwate 020, Japan; [Iwaya, Takeshi] Kyushu Univ, Med Inst Bioregulat, Dept Surg, Beppu, Oita, Japan; [Kume, Kohei; Maesawa, Chihaya] Iwate Med Univ, Ctr Adv Med Sci, Dept Tumor Biol, Yahaba, Iwate, Japan; [Yamada, Noriyuki; Uesugi, Noriyuki; Sugai, Tamotsu] Iwate Med Univ, Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Morioka, Iwate 020, Japan; [Tamura, Gen] Yamagata Prefectural Cent Hosp, Dept Pathol & Lab Med, Yamagata, Japan	Iwate Medical University; Iwate Medical University; Kyushu University; Iwate Medical University; Iwate Medical University; Yamagata Prefectural Central Hospital	Ishida, K (corresponding author), NCI, Chem Immunol Sect, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	snishizu@iwate-med.ac.jp			Keiryokai Research Foundation [101]; KAKENHI [21591676]; MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN; Grants-in-Aid for Scientific Research [24591917] Funding Source: KAKEN	Keiryokai Research Foundation(Keiryokai Research Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Keiryokai Research Foundation (101) by S.S.N.; KAKENHI (21591676); Grant-in-Aid for Scientific Research(C) by S.S.N; and MIAST (Medical Innovation by Advanced Science and Technology) project of the Ministry of Education, Culture, Sports, Science and Technology, JAPAN by S.S.N, K. K, N.U., C. M., T. S., and G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2011, GASTRIC CANC; Aoyama T, 2011, GASTRIC CANCER, V14, P150, DOI 10.1007/s10120-011-0020-x; Bednarski BK, 2008, MOL CANCER THER, V7, P1827, DOI 10.1158/1535-7163.MCT-08-0321; Bourgarel-Rey V, 2001, MOL PHARMACOL, V59, P1165, DOI 10.1124/mol.59.5.1165; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cunningham D, 2007, LANCET, V370, P1980, DOI 10.1016/S0140-6736(07)61841-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Grem JL, 2001, CLIN CANCER RES, V7, P999; Honda T, 2005, JPN J CLIN ONCOL, V35, P580, DOI 10.1093/jjco/hyi166; Ishida K, 2010, J IWATE MED ASS, V62, P363; Ito N, 1997, JPN J GASTROENTEROL, V30, P741; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kojima M, 2004, ANTICANCER RES, V24, P675; Krueger S, 2006, J BIOL CHEM, V281, P2868, DOI 10.1074/jbc.m511053200; Levidou G, 2007, VIRCHOWS ARCH, V450, P519, DOI 10.1007/s00428-007-0396-5; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matsuyama R, 2006, INT J CANCER, V119, P406, DOI 10.1002/ijc.21843; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Nishizuka S, 2003, CANCER RES, V63, P5243; Nishizuka S, 2008, CURR OPIN BIOTECH, V19, P41, DOI 10.1016/j.copbio.2007.11.007; Nishizuka S, 2008, J PROTEOME RES, V7, P803, DOI 10.1021/pr0702971; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Roxburgh C, 2011, INT J COLORECTAL DIS, V26, P483, DOI 10.1007/s00384-010-1120-5; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Scartozzi M, 2007, J CLIN ONCOL, V25, P3930, DOI 10.1200/JCO.2007.11.5022; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Uen YH, 2008, ANN SURG ONCOL, V15, P2120, DOI 10.1245/s10434-008-9961-7; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; Voboril R, 2007, NEOPLASMA, V54, P495; Voboril R, 2004, J SURG RES, V120, P178, DOI 10.1016/j.jss.2003.11.023; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yamanaka N, 2004, ANTICANCER RES, V24, P1071	52	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43236	10.1371/journal.pone.0043236	http://dx.doi.org/10.1371/journal.pone.0043236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905237	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800062
J	Kitab, B; El Feydi, AE; Afifi, R; Trepo, C; Benazzouz, M; Essamri, W; Zoulim, F; Chemin, I; Alj, HS; Ezzikouri, S; Benjelloun, S				Kitab, Bouchra; El Feydi, Abdellah Essaid; Afifi, Rajaa; Trepo, Christian; Benazzouz, Mustapha; Essamri, Wafaa; Zoulim, Fabien; Chemin, Isabelle; Alj, Hanane Salih; Ezzikouri, Sayeh; Benjelloun, Soumaya			Variability in the Precore and Core Promoter Regions of HBV Strains in Morocco: Characterization and Impact on Liver Disease Progression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; GENOTYPE-D; NATURAL-HISTORY; MUTATIONS; RISK; MUTANTS; INFECTION; INCREASE	Background: Hepatitis B virus (HBV) is one of the most common human pathogens that cause aggressive hepatitis and advanced liver disease (AdLD), including liver cirrhosis and Hepatocellular Carcinoma. The persistence of active HBV replication and liver damage after the loss of hepatitis B e antigen (HBeAg) has been frequently associated with mutations in the pre-core (pre-C) and core promoter (CP) regions of HBV genome that abolish or reduce HBeAg expression. The purpose of this study was to assess the prevalence of pre-C and CP mutations and their impact on the subsequent course of liver disease in Morocco. Methods/Principal Findings: A cohort of 186 patients with HBeAg-negative chronic HBV infection was studied (81 inactive carriers, 69 with active chronic hepatitis, 36 with AdLD). Pre-C and CP mutations were analyzed by PCR-direct sequencing method. The pre-C stop codon G1896A mutation was the most frequent (83.9%) and was associated with a lower risk of AdLD development (OR, 0.4; 95% CI, 0.15-1.04; p = 0.04). HBV-DNA levels in patients with G1896A were not significantly different from the other patients carrying wild-type strains (p = 0.84). CP mutations C1653T, T1753V, A1762T/G1764A, and C1766T/T1768A were associated with higher HBV-DNA level and increased liver disease severity. Multiple logistic regression analysis showed that older age (>= 40 years), male sex, high viral load (>4.3 log(10) IU/mL) and CP mutations C1653T, T1753V, A1762T/G1764A, and C1766T/T1768A were independent risk factors for AdLD development. Combination of these mutations was significantly associated with AdLD (OR, 7.52; 95% CI, 4.8-8; p<0.0001). Conclusions: This study shows for the first time the association of HBV viral load and CP mutations with the severity of liver disease in Moroccan HBV chronic carriers. The examination of CP mutations alone or in combination could be helpful for prediction of the clinical outcome.	[Kitab, Bouchra; Ezzikouri, Sayeh; Benjelloun, Soumaya] Inst Pasteur Maroc, Lab Hepatites Virales, Casablanca, Morocco; [El Feydi, Abdellah Essaid; Afifi, Rajaa; Benazzouz, Mustapha; Essamri, Wafaa] CHU Ibn Sina, Serv Med C, Rabat, Morocco; [Trepo, Christian; Zoulim, Fabien; Chemin, Isabelle] INSERM, U1052, F-69008 Lyon, France; [Kitab, Bouchra; Alj, Hanane Salih] Univ Hassan 2, CNRST, Lab Rech Lipoprot & Atherosclerose, Unite Associee,CNRST,URAC 34,Fac Sci Ben Msik, Casablanca, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique & Technologique (CNRST); Hassan II University of Casablanca	Kitab, B (corresponding author), Inst Pasteur Maroc, Lab Hepatites Virales, Casablanca, Morocco.	soumaya.benjelloun@pasteur.ma	Zoulim, Fabien/ABD-5594-2021; Ezzikouri, Sayeh/Q-8116-2019; Chemin, Isabelle/I-3032-2016	Zoulim, Fabien/0000-0002-2245-0083; Chemin, Isabelle/0000-0002-7188-5489; Ezzikouri, Sayeh/0000-0002-3982-6163; Benjelloun, Soumaya/0000-0001-5573-8684	Novartis Pharma Morocco; Pasteur Institute of Morocco	Novartis Pharma Morocco; Pasteur Institute of Morocco	This study was supported in part by a research grant from Novartis Pharma Morocco and the additional part was supported by Pasteur Institute of Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest. The study was supported by Novartis Pharma Morocco and Pasteur Institute of Morocco; there are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; Baha W, 2012, INFECT GENET EVOL, V12, P1157, DOI 10.1016/j.meegid.2012.04.026; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bai X, 2011, CARCINOGENESIS, V32, P63, DOI 10.1093/carcin/bgq195; Baumert TF, 1996, J CLIN INVEST, V98, P2268, DOI 10.1172/JCI119037; BENJELLOUN S, 1993, RES VIROLOGY, V144, P159, DOI 10.1016/S0923-2516(06)80024-5; Bozdayi AM, 2001, J CLIN VIROL, V21, P91, DOI 10.1016/S1386-6532(01)00148-2; Bozdayi AM, 1999, INFECTION, V27, P357, DOI 10.1007/s150100050043; CARMAN WF, 1989, LANCET, V2, P588; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Ducancelle A, 2011, PATHOL BIOL PARIS, V59, P21; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Ezzikouri S, 2008, INFECT GENET EVOL, V8, P306, DOI 10.1016/j.meegid.2008.01.010; Ezzikouri S, 2007, HEPATOL RES, V37, P748, DOI 10.1111/j.1872-034X.2007.00126.x; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Gandhe SS, 2003, J VIRAL HEPATITIS, V10, P367, DOI 10.1046/j.1365-2893.2003.00445.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guo X, 2008, J HEPATOL, V49, P718, DOI 10.1016/j.jhep.2008.06.026; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Jardi R, 2004, J HEPATOL, V40, P507, DOI 10.1016/j.jhep.2003.11.015; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Khelifa F, 2009, PATHOL BIOL, V57, P107, DOI 10.1016/j.patbio.2008.07.031; Kim TH, 2006, J KOREAN MED SCI, V21, P279, DOI 10.3346/jkms.2006.21.2.279; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Kramvis A, 1998, J VIRAL HEPATITIS, V5, P357, DOI 10.1046/j.1365-2893.1998.00124.x; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kurosaki M, 1996, J MED VIROL, V49, P115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARZUL D, 1990, J VIROL METHODS, V27, P49, DOI 10.1016/0166-0934(90)90145-6; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lindh M, 1996, HEPATOLOGY, V24, P494, DOI 10.1053/jhep.1996.v24.pm0008781313; Liu CJ, 2009, J INFECT DIS, V199, P742, DOI 10.1086/596655; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Mrani S, 2002, CAH MED, V4, P87; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Parekh S, 2003, J VIROL, V77, P6601, DOI 10.1128/JVI.77.12.6601-6612.2003; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sbai A, 2011, PATHOL BIOL PARIS; Sebti M F, 1984, IARC Sci Publ, P227; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Wang Y, 2004, ONCOGENE, V23, P142, DOI 10.1038/sj.onc.1206889; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yoo BC, 2003, J HEPATOL, V38, P98, DOI 10.1016/S0168-8278(02)00349-5; Yotsuyanagi H, 2002, J HEPATOL, V37, P355, DOI 10.1016/S0168-8278(02)00180-0	53	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42891	10.1371/journal.pone.0042891	http://dx.doi.org/10.1371/journal.pone.0042891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905181	Green Published, Green Submitted, gold			2022-12-25	WOS:000307500800027
J	Wong, FY; Silas, R; Hew, S; Samarasinghe, T; Walker, AM				Wong, Flora Y.; Silas, Reshma; Hew, Simon; Samarasinghe, Thilini; Walker, Adrian M.			Cerebral Oxygenation Is Highly Sensitive to Blood Pressure Variability in Sick Preterm Infants	PLOS ONE			English	Article							SPATIALLY-RESOLVED SPECTROSCOPY; BIRTH-WEIGHT INFANTS; PREMATURE-INFANTS; NEWBORN LAMBS; FLOW; AUTOREGULATION; CIRCULATION; PASSIVITY; FETAL	Objectives: The significance of blood pressure variability (BPV) for cerebral oxygenation in extremely preterm infants has not been explored, though BPV may well be associated with end organ injury. We hypothesized that increased BPV in sick preterm infants, by exceeding the cerebral autoregulatory capacity, is associated with cerebral oxygenation changes which closely follow the blood pressure fluctuations. We assessed the autoregulatory capacity in the early postnatal period, by determining the correlation between BPV (mmHg(2)) and coherence of mean arterial blood pressure (MABP mmHg) and cerebral oxygenation (tissue oxygenation index, TOI %). Study Design: Thirty-two preterm infants of mean gestational age of 26.3 (+/- 1.5) weeks were studied on the first 3 postnatal days. Spectral analysis (Coherence and transfer-function gain analysis) was used to calculate coherence of MABP and TOI; BPV was quantified using power spectral density of MABP. Results: Overall, maximum Coherence showed a trend for positive correlation with BPV (n = 32, p = 0.06). Infants identified as clinically unstable with documented brain injury (n = 7) had high Coherence values at low BPV. Separate analysis of stable infants (excluding the 7 critically ill infants) revealed a significant association between maximum Coherence and BPV (n = 25, p = 0.006). Conclusions: Fluctuation in cerebral oxygenation is closely associated with increased BPV in preterm infants undergoing intensive care. Moreover, in the critically sick preterm infant, blood pressure-dependent variations in cerebral oxygenation occur even with relatively lower BPV, suggesting they have severely impaired autoregulation, and placing them at greater vulnerability to cerebral injury arising from blood pressure fluctuations.	[Wong, Flora Y.; Silas, Reshma; Hew, Simon; Samarasinghe, Thilini; Walker, Adrian M.] Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Wong, Flora Y.; Silas, Reshma] Monash Med Ctr, Melbourne, Vic, Australia; [Wong, Flora Y.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Wong, FY (corresponding author), Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia.	Flora.Wong@monash.edu			Ritchie Centre, Monash University; Kathleen Tinsley Fellowship	Ritchie Centre, Monash University; Kathleen Tinsley Fellowship	Internal funding provided by the Ritchie Centre, Monash University. Dr. Wong was supported by the Kathleen Tinsley Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, GUIDELINES GOOD PRAC; Bassan H, 2006, PEDIATRICS, V117, P2111, DOI 10.1542/peds.2005-1570; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Boylan GB, 2000, PEDIATR RES, V48, P12, DOI 10.1203/00006450-200007000-00005; Grant DA, 1998, J CEREBR BLOOD F MET, V18, P639, DOI 10.1097/00004647-199806000-00006; Greisen G, 2005, EARLY HUM DEV, V81, P423, DOI 10.1016/j.earlhumdev.2005.03.005; Hahn GH, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3426323; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Liu JG, 2003, J HYPERTENS, V21, P1961, DOI 10.1097/00004872-200310000-00025; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Musini VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005673; O'Leary H, 2009, PEDIATRICS, V124, P302, DOI 10.1542/peds.2008-2004; Omboni S, 1996, CLIN AUTON RES, V6, P171, DOI 10.1007/BF02281905; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; Parati G, 2005, J HYPERTENS, V23, pS19, DOI 10.1097/01.hjh.0000165624.79933.d3; PRYDS O, 1989, J PEDIATR-US, V115, P638, DOI 10.1016/S0022-3476(89)80301-4; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Suzuki S, 1999, P SOC PHOTO-OPT INS, V3597, P582, DOI 10.1117/12.356862; SZYMONOWICZ W, 1988, AM J PHYSIOL, V254, pH52, DOI 10.1152/ajpheart.1988.254.1.H52; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Volpe JJ., 2001, NEUROLOGY NEWBORN, P428; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wong FY, 2009, INTENS CARE MED, V35, P1464, DOI 10.1007/s00134-009-1486-4; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	27	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43165	10.1371/journal.pone.0043165	http://dx.doi.org/10.1371/journal.pone.0043165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905222	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800054
J	Conrad, JL; Balcarcel, AM; Mehling, CM				Conrad, Jack L.; Balcarcel, Ana M.; Mehling, Carl M.			Earliest Example of a Giant Monitor Lizard (Varanus, Varanidae, Squamata)	PLOS ONE			English	Article							BODY-SIZE; EVOLUTION; REPTILIA; PHYLOGENY; MOSASAURS; ECOLOGY; AMPHISBAENIANS; SYSTEMATICS; VARANOIDEA; OLIGOCENE	Background: Varanidae is a clade of tiny (<20 mm pre-caudal length [PCL]) to giant (>600 mm PCL) lizards first appearing in the Cretaceous. True monitor lizards (Varanus) are known from diagnostic remains beginning in the early Miocene (Varanus rusingensis), although extremely fragmentary remains have been suggested as indicating earlier Varanus. The paleobiogeographic history of Varanus and timing for origin of its gigantism remain uncertain. Methodology/Principal Findings: A new Varanus from the Mytilini Formation (Turolian, Miocene) of Samos, Greece is described. The holotype consists of a partial skull roof, right side of a braincase, partial posterior mandible, fragment of clavicle, and parts of six vertebrae. A cladistic analysis including 83 taxa coded for 5733 molecular and 489 morphological characters (71 previously unincluded) demonstrates that the new fossil is a nested member of an otherwise exclusively East Asian Varanus clade. The new species is the earliest-known giant (>600 mm PCL) terrestrial lizard. Importantly, this species co-existed with a diverse continental mammalian fauna. Conclusions/Significance: The new monitor is larger (longer) than 99% of known fossil and living lizards. Varanus includes, by far, the largest limbed squamates today. The only extant non-snake squamates that approach monitors in maximum size are the glass-snake Pseudopus and the worm-lizard Amphisbaena. Mosasauroids were larger, but exclusively marine, and occurred only during the Late Cretaceous. Large, extant, non-Varanus, lizards are limbless and/or largely isolated from mammalian competitors. By contrast, our new Varanus achieved gigantism in a continental environment populated by diverse eutherian mammal competitors.	[Conrad, Jack L.] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY USA; [Conrad, Jack L.; Balcarcel, Ana M.; Mehling, Carl M.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA	New York Institute Technology; American Museum of Natural History (AMNH)	Conrad, JL (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY USA.	jack.conrad@gmail.com						Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Ast JC, 2002, THESIS U MICHIGAN AN; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Bakker RT., 1986, DINOSAUR HERESIES; Balsai M.J., 2001, THESIS U PENNSYLVANI; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bever G.S., 2005, PALAEONT ELECT, V8, P1, DOI DOI 10.1080/08912960600679570; Bever GS, 2005, SHINISAURUS CROCODIL; Burnell A, 2012, B SOC GEOL FR, V183, P151, DOI 10.2113/gssgfbull.183.2.151; Caldwell MW, 2000, J VERTEBR PALEONTOL, V20, P720, DOI 10.1671/0272-4634(2000)020[0720:OTASDL]2.0.CO;2; Case T.J., 1982, P184; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; Colli GR, 1999, COPEIA, P733, DOI 10.2307/1447606; Conrad J, 2004, J VERTEBR PALEONTOL, V24, p47A; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2006, HIST BIOL, V18, P405, DOI 10.1080/08912960600679570; Conrad JL, 2011, B AM MUS NAT HIST, P1; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/596.1; Conrad JL, 2008, AM MUS NOVIT, P1, DOI 10.1206/586.1; Conrad JL, 2004, ZOOL J LINN SOC-LOND, V141, P399, DOI 10.1111/j.1096-3642.2004.00128.x; de Fejervary GJ, 1918, ANN HIST NATURALES M, V16, P341; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Estes R, 1983, SAURIA TERRESTRIA AM; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Falconer H. P., 1868, PALEONTOLOGICAL MEMO; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Fuller S, 1998, MOL PHYLOGENET EVOL, V9, P294, DOI 10.1006/mpev.1997.0476; Gao K., 1996, B CARNEGIE MUSEUM NA, V33, P1; Gao KQ, 2000, B AM MUS NAT HIST, P1; Gilmore C. W., 1928, Mem Nat Acad Sci Washington, V22, P1; Goloboff P.A., 2003, T N T TREE ANAL USIN; Goloboff PA, 2010, T N T TREE ANAL USIN; Goloboff P, 2008, CLADISTICS, V24, P91; Haber A, 2005, NETH J GEOSCI, V84, P247, DOI 10.1017/S001677460002103X; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; HECHT M K, 1975, Proceedings of the Royal Society of Victoria, V87, P239; Hocknull SA, 2009, PLOS ONE, V4, p[e7241, 7241]; Holmes RB, 2010, PALAEONTOLOGY, V53, P1099, DOI 10.1111/j.1475-4983.2010.00994.x; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; King D, 1999, MERTENSIELLA ADV MON, P43; KING M, 1990, ADV LIF SCI, P153; KING M, 1975, AUST J BIOL SCI, V28, P89, DOI 10.1071/BI9750089; Koch Andre, 2010, Bonn Zoological Bulletin, V57, P127; Lee MSY, 2000, J PALEONTOL, V74, P915, DOI 10.1666/0022-3360(2000)074<0915:AATAOM>2.0.CO;2; LINGHAMSOLIAR T, 1995, PHILOS T ROY SOC B, V347, P155, DOI 10.1098/rstb.1995.0019; MADDISON WP, 2006, MESQUITE MODULAR SYS; Maisano JA, 2001, HERPETOL MONOGR, V15, P135, DOI 10.2307/1467041; Meiri S, 2010, J ZOOL, P1; Mertens R, 1942, ABHANDLUNGEN SENCKEN, V465, P117; MOLNAR R E, 1990, Memoirs of the Queensland Museum, V29, P437; Molnar RE, 2004, VARANOID LIZARDS OF THE WORLD, P10; Molnar RE, 2004, VARANOID LIZARDS OF THE WORLD, P68; Molnar RE., 2004, DRAGONS DUST PALEOBI; Murphy J. C., 1997, TALES GIANT SNAKES H; Norell Mark A., 1997, American Museum Novitates, V3211, P1; Norell MA, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3605[1:ANPLDS]2.0.CO;2; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Page R. D. M., 2001, NDE NEXUS DATA EDITO; Palci A, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:VFAAEI]2.0.CO;2; Pepin David J., 1999, Mertensiella, V11, P11; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; PIANKA ER, 1994, AUST J ECOL, V19, P395, DOI 10.1111/j.1442-9993.1994.tb00505.x; Pianka ER, 2004, VARANOID LIZARDS OF THE WORLD, P3; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Pianka ER, 2004, VARANOID LIZARDS WOR; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; Pregill GK, 2003, HERPETOLOGICA, V59, P57, DOI 10.1655/0018-0831(2003)059[0057:ANILSI]2.0.CO;2; Rieppel O, 2001, NEUES JAHRB GEOL P-A, V221, P111; RIEPPEL O, 1983, Z ZOOL SYST EVOL, V21, P142; Rieppel O, 2000, ZOOL J LINN SOC-LOND, V129, P489, DOI 10.1006/zjls.1999.0215; RIEPPEL O, 1980, PHYLOGENY ANGUINIMOR; Rieppel O, 2007, J PALEONTOL, V81, P643, DOI 10.1666/pleo0022-3360(2007)081[0643:TAOTFV]2.0.CO;2; SCHWARTZ A., 1991, AMPHIBIANS REPTILES; Smith KT, 2008, J VERTEBR PALEONTOL, V28, P909, DOI 10.1671/0272-4634(2008)28[909:EAROTV]2.0.CO;2; Solounias N., 1981, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V6, P1; SOLOUNIAS N, 1981, Annals of Carnegie Museum, V50, P231; Soulinias N, 2007, J VIRTUAL EXPLORER; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Weithoffer K., 1888, BEITRAGE PALAONTOLOG, V6, P225; Welton L. J., 2010, BIOL LETT, V6, P1; Wroe S, 2002, AUST J ZOOL, V50, P1, DOI 10.1071/ZO01053; Zug G. R., 2001, HERPETOLOGY, P57; [No title captured]	91	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41767	10.1371/journal.pone.0041767	http://dx.doi.org/10.1371/journal.pone.0041767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900001	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900016
J	Santamaria, ME; Martinez, ICM; Pozancos, C; Gonzalez-Melendi, P; Grbic, V; Castanera, P; Ortego, F; Diaz, I				Estrella Santamaria, Maria; Manuel Martinez, Ines Cambra; Pozancos, Clara; Gonzalez-Melendi, Pablo; Grbic, Vojislava; Castanera, Pedro; Ortego, Felix; Diaz, Isabel			Gene Pyramiding of Peptidase Inhibitors Enhances Plant Resistance to the Spider Mite Tetranychus urticae	PLOS ONE			English	Article							COLORADO POTATO BEETLE; PROTEINASE-INHIBITORS; INSECT RESISTANCE; BARLEY; CYSTEINE; EXPRESSION; ACARI; CME; PHYTOSEIIDAE; LEPIDOPTERA	The two-spotted spider mite Tetranychus urticae is a damaging pest worldwide with a wide range of host plants and an extreme record of pesticide resistance. Recently, the complete T. urticae genome has been published and showed a proliferation of gene families associated with digestion and detoxification of plant secondary compounds which supports its polyphagous behaviour. To overcome spider mite adaptability a gene pyramiding approach has been developed by co-expressing two barley proteases inhibitors, the cystatin Icy6 and the trypsin inhibitor Itr1 genes in Arabidopsis plants by Agrobacterium-mediated transformation. The presence and expression of both transgenes was studied by conventional and quantitative real time RT-PCR assays and by indirect ELISA assays. The inhibitory activity of cystatin and trypsin inhibitor was in vitro analysed using specific substrates. Single and double transformants were used to assess the effects of spider mite infestation. Double transformed lines showed the lowest damaged leaf area in comparison to single transformants and non-transformed controls and different accumulation of H2O2 as defence response in the leaf feeding site, detected by diaminobenzidine staining. Additionally, an impact on endogenous mite cathepsin B-and L-like activities was observed after feeding on Arabidopsis lines, which correlates with a significant increase in the mortality of mites fed on transformed plants. These effects were analysed in view of the expression levels of the target mite protease genes, C1A cysteine peptidase and S1 serine peptidase, identified in the four developmental mite stages (embryo, larvae, nymphs and adults) performed using the RNA-seq information available at the BOGAS T. urticae database. The potential of pyramiding different classes of plant protease inhibitors to prevent plant damage caused by mites as a new tool to prevent pest resistance and to improve pest control is discussed.	[Estrella Santamaria, Maria; Manuel Martinez, Ines Cambra; Pozancos, Clara; Gonzalez-Melendi, Pablo; Diaz, Isabel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPM INIA, Madrid, Spain; [Estrella Santamaria, Maria; Castanera, Pedro; Ortego, Felix] CSIC, Ctr Invest Biol, Dpto Biol Medioambiental, Madrid, Spain; [Estrella Santamaria, Maria; Grbic, Vojislava] Western Univ, Dept Biol, Ottawa, ON, Canada	Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Santamaria, ME (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas UPM INIA, Campus Montegancedo,Autopista M40,Km 38, Madrid, Spain.	i.diaz@upm.es	Diaz, Isabel/I-8840-2014; SANTAMARIA, M ESTRELLA/I-9337-2014; Martinez, Manuel/I-8743-2014; Ortego, Félix/F-9402-2011; de León, Pablo González-Melendi/K-1604-2014; , risueno/AAD-3993-2019; castanera, pedro/G-2165-2015	Diaz, Isabel/0000-0001-9865-902X; SANTAMARIA, M ESTRELLA/0000-0003-4999-6227; Martinez, Manuel/0000-0002-7826-5872; Ortego, Félix/0000-0002-7778-8508; de León, Pablo González-Melendi/0000-0003-4355-4495; 	Ministerio de Economia y Competitividad [AGL2011-23650]; CSIC [2010-40E049]; Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-046]; Ontario Research Fend-Global Leadership in Genomics and Life Sciences [GL2-01-035]	Ministerio de Economia y Competitividad(Spanish Government); CSIC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Research Fend-Global Leadership in Genomics and Life Sciences	Financial support from the Ministerio de Economia y Competitividad (project AGL2011-23650), from CSIC (project 2010-40E049) and the Government of Canada through Genome Canada and the Ontario Genomics Institute (project OGI-046) and Ontario Research Fend-Global Leadership in Genomics and Life Sciences (project GL2-01-035), are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2007, FEBS J, V274, P2800, DOI 10.1111/j.1472-4658.2007.05816.x; Alfonso-Rubi J, 2003, TRANSGENIC RES, V12, P23, DOI 10.1023/A:1022176207180; Altpeter F, 1999, MOL BREEDING, V5, P53, DOI 10.1023/A:1009659911798; Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrillo L, 2011, PLANT PHYSIOL BIOCH, V49, P1191, DOI 10.1016/j.plaphy.2011.03.012; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Castagnoli M, 2003, EXP APPL ACAROL, V31, P177, DOI 10.1023/B:APPA.0000010387.48323.ee; Charity JA, 2005, FUNCT PLANT BIOL, V32, P35, DOI 10.1071/FP04105; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui JJ, 2011, J ECON ENTOMOL, V104, P673, DOI 10.1603/EC09228; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; Down RE, 1999, PARASITOLOGY, V119, P157, DOI 10.1017/S0031182099004515; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Esteves AB, 2010, NEOTROP ENTOMOL, V39, P338, DOI 10.1590/S1519-566X2010000300005; Filimonova SA, 2009, ARTHROPOD STRUCT DEV, V38, P303, DOI 10.1016/j.asd.2009.01.002; Golmirzaie A., 1997, Hortscience, V32, P435; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Hnasko R, 2011, BIOCHEM BIOPH RES CO, V410, P726, DOI 10.1016/j.bbrc.2011.06.005; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; Li GY, 2005, PEST MANAG SCI, V61, P390, DOI 10.1002/ps.990; McCafferty HRK, 2008, PLANT SCI, V175, P385, DOI 10.1016/j.plantsci.2008.05.007; McCafferty HRK, 2006, TRANSGENIC RES, V15, P337, DOI 10.1007/s11248-006-0005-4; Michaud D, 1996, ELECTROPHORESIS, V17, P74, DOI 10.1002/elps.1150170113; Migeon A., 2011, SPIDER MITES WEB COM; Navarro M, 2011, ICAR 22 INT C AR RES; Nisbet AJ, 2000, INT J PARASITOL, V30, P19, DOI 10.1016/S0020-7519(99)00169-1; Novillo C, 1997, ARCH INSECT BIOCHEM, V36, P181, DOI 10.1002/(SICI)1520-6327(1997)36:3<181::AID-ARCH3>3.0.CO;2-X; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Ortego F, 2001, J INSECT PHYSIOL, V47, P1291, DOI 10.1016/S0022-1910(01)00118-4; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Rovenska GZ, 2005, BIOL CONTROL, V33, P293, DOI 10.1016/j.biocontrol.2005.03.017; Royo J, 1996, PLANT MOL BIOL, V31, P1051, DOI 10.1007/BF00040723; Sambrook J, 2001, MOL CLONING LAB MANU; Senthilkumar R, 2010, PLANT BIOTECHNOL J, V8, P65, DOI 10.1111/j.1467-7652.2009.00466.x; Van Leeuween T., 2012, P NATL ACAD SCI USA, V105, P598; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	44	59	59	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43011	10.1371/journal.pone.0043011	http://dx.doi.org/10.1371/journal.pone.0043011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900081	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900099
J	McCormick, MI; Weaver, CJ				McCormick, Mark I.; Weaver, Christine J.			It Pays to Be Pushy: Intracohort Interference Competition between Two Reef Fishes	PLOS ONE			English	Article							CORAL-DWELLING FISHES; GREAT-BARRIER-REEF; INTERSPECIFIC COMPETITION; SELECTIVE MORTALITY; INTRASPECIFIC COMPETITION; TERRITORIAL DAMSELFISHES; PREDATOR RECOGNITION; DENSITY-DEPENDENCE; HUMBUG DAMSELFISH; DASCYLLUS-ARUANUS	Competition is often most intense between similar sized organisms that have similar ecological requirements. Many coral reef fish species settle preferentially to live coral at the end of their larval phase where they interact with other species that recruited to the same habitat patch at a similar time. Mortality is high and usually selective and individuals must compete for low risk space. This study examined the competitive interactions between two species of juvenile damselfish and the extent to which interactions that occurred within a recruitment cohort established the disjunct distribution patterns that were displayed in later life stages. Censuses and field experiments with juveniles found that one species, the ambon damsel, was dominant immediately after settlement and pushed the subordinate species higher up the reef and further from shelter. Presence of a competitor resulted in reduced growth for both species. Juvenile size was the best predictor of competitive success and outweighed the effects of short term prior residency. Size at settlement also dramatically influenced survival, with slightly larger individuals displaying higher aggression, pushing the subordinate species into higher risk habitats. While subordinates had higher feeding rates, they also sustained higher mortality. The study highlights the importance of interaction dynamics between species within a recruitment cohort to patterns of growth and distribution of species within communities.	[McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	McCormick, MI (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	mark.mccormick@jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645	Australian Research Council	Australian Research Council(Australian Research Council)	Research was funded through the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; BENKE AC, 1978, J ANIM ECOL, V47, P335, DOI 10.2307/3787; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BUCHHEIM JR, 1992, J EXP MAR BIOL ECOL, V164, P45, DOI 10.1016/0022-0981(92)90135-W; CHAMBERS RC, 1987, CAN J FISH AQUAT SCI, V44, P1936, DOI 10.1139/f87-238; CLARKE RD, 1992, CORAL REEFS, V11, P199, DOI 10.1007/BF00301994; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; CROWLEY PH, 1987, OECOLOGIA, V71, P447, DOI 10.1007/BF00378720; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; DOHERTY PJ, 1988, OCEANOGR MAR BIOL, V26, P487; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; DOHERTY PJ, 1982, J EXP MAR BIOL ECOL, V65, P249, DOI 10.1016/0022-0981(82)90057-0; DOHERTY PJ, 1983, ECOLOGY, V64, P176, DOI 10.2307/1937339; EBERSOLE JP, 1985, ECOLOGY, V66, P14, DOI 10.2307/1941302; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; FIGLER MH, 1976, BEHAVIOUR, V58, P254, DOI 10.1163/156853976X00181; Figueira WF, 2008, OECOLOGIA, V156, P215, DOI 10.1007/s00442-008-0985-2; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Forrester GE, 2006, OECOLOGIA, V148, P632, DOI 10.1007/s00442-006-0397-0; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Geange SW, 2009, ECOLOGY, V90, P2868, DOI 10.1890/08-0630.1; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Hawkins LA, 2004, BEHAVIOUR, V141, P1249, DOI 10.1163/1568539042729694; Hobbs JPA, 2004, MAR ECOL PROG SER, V278, P253, DOI 10.3354/meps278253; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Jones G.P., 1991, P294; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Knight CM, 2009, BIOL INVASIONS, V11, P1033, DOI 10.1007/s10530-008-9314-2; LAWLER SP, 1993, ECOLOGY, V74, P174, DOI 10.2307/1939512; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Louette G, 2007, OIKOS, V116, P419, DOI 10.1111/j.2006.0030-1299.15381.x; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; Mathis A, 1996, ANIM BEHAV, V51, P185, DOI 10.1006/anbe.1996.0016; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; MCCORMICK MI, 1994, MAR ECOL PROG SER, V103, P1, DOI 10.3354/meps103001; McCormick MI, 2002, MAR BIOL, V141, P841, DOI 10.1007/s00227-002-0883-9; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Meekan MG, 2001, MAR BIOL, V139, P373; Metcalfe NB, 2003, J APPL ECOL, V40, P535, DOI 10.1046/j.1365-2664.2003.00815.x; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P121, DOI 10.3354/meps110121; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Munday PL, 2004, ECOLOGY, V85, P623, DOI 10.1890/03-3100; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Nilsson GE, 2007, P ROY SOC B-BIOL SCI, V274, P79, DOI 10.1098/rspb.2006.3706; PATTERSON JW, 1989, HYDROBIOLOGIA, V171, P121, DOI 10.1007/BF00008172; Perez-Dominguez R., 2010, EVOLUTION, V64, P2450, DOI DOI 10.1111/J.1558-5646.2010.00994.X; Rauch TJ, 2007, ENVIRON BIOL FISH, V78, P347, DOI 10.1007/s10641-006-9158-5; ROBERTSON DR, 1995, OECOLOGIA, V103, P180, DOI 10.1007/BF00329078; ROBERTSON DR, 1984, ECOLOGY, V65, P1121, DOI 10.2307/1938320; Robertson DR, 1996, ECOLOGY, V77, P885, DOI 10.2307/2265509; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; SALE PF, 1976, J EXP MAR BIOL ECOL, V24, P297, DOI 10.1016/0022-0981(76)90061-7; Samhouri JF, 2009, ECOLOGY, V90, P1009, DOI 10.1890/07-1161.1; Schmitt RJ, 1999, ECOLOGY, V80, P35, DOI 10.1890/0012-9658(1999)080[0035:MOJDIF]2.0.CO;2; Schmitt RJ, 1999, OECOLOGIA, V118, P76, DOI 10.1007/s004420050705; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Shand J, 1997, ENVIRON BIOL FISH, V49, P307, DOI 10.1023/A:1007353003066; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; THOMPSON P, 1993, OIKOS, V67, P264, DOI 10.2307/3545471; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; van Gremberghe I, 2009, ENVIRON MICROBIOL, V11, P2564, DOI 10.1111/j.1462-2920.2009.01981.x; WALDNER R. E., 1980, B MAR SCI, V30, P171; Webster MS, 2004, ECOLOGY, V85, P986, DOI 10.1890/02-0576; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; Whiteman EA, 2004, ANIM BEHAV, V67, P239, DOI 10.1016/j.anbehav.2003.04.006; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259; Wilson JA, 2005, J EXP MAR BIOL ECOL, V327, P144, DOI 10.1016/j.jembe.2005.06.013; [No title captured]	84	56	56	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42590	10.1371/journal.pone.0042590	http://dx.doi.org/10.1371/journal.pone.0042590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900030	Green Accepted, gold, Green Published			2022-12-25	WOS:000307380900046
J	Zahler, AM; Neeb, ZT; Lin, A; Katzman, S				Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena; Katzman, Sol			Mating of the Stichotrichous Ciliate Oxytricha trifallax Induces Production of a Class of 27 nt Small RNAs Derived from the Parental Macronucleus	PLOS ONE			English	Article							PROGRAMMED GENOME REARRANGEMENTS; DICER-LIKE PROTEIN; DNA ELIMINATION; STERKIELLA-HISTRIOMUSCORUM; TETRAHYMENA-THERMOPHILA; CODING PROPERTIES; GENE; NOVA; PIWI; MECHANISM	Ciliated protozoans possess two types of nuclei; a transcriptionally silent micronucleus, which serves as the germ line nucleus, and a transcriptionally active macronucleus, which serves as the somatic nucleus. The macronucleus is derived from a new diploid micronucleus after mating, with epigenetic information contributed by the parental macronucleus serving to guide the formation of the new macronucleus. In the stichotrichous ciliate Oxytricha trifallax, the macronuclear DNA is highly processed to yield gene-sized nanochromosomes with telomeres at each end. Here we report that soon after mating of Oxytricha trifallax, abundant 27 nt small RNAs are produced that are not present prior to mating. We performed next generation sequencing of Oxytricha small RNAs from vegetative and mating cells. Using sequence comparisons between macronuclear and micronuclear versions of genes, we found that the 27 nt RNA class derives from the parental macronucleus, not the developing macronucleus. These small RNAs are produced equally from both strands of macronuclear nanochromosomes, but in a highly non-uniform distribution along the length of the nanochromosome, and with a particular depletion in the 30 nt telomere-proximal positions. This production of small RNAs from the parental macronucleus during macronuclear development stands in contrast to the mechanism of epigenetic control in the distantly related ciliate Tetrahymena. In that species, 28-29 nt scanRNAs are produced from the micronucleus and these micronuclear-derived RNAs serve as epigenetic controllers of macronuclear development. Unlike the Tetrahymena scanRNAs, the Oxytricha macronuclear-derived 27 mers are not modified by 2'O-methylation at their 3' ends. We propose models for the role of these "27macRNAs" in macronuclear development.	[Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Zahler, Alan M.; Neeb, Zachary T.; Lin, Athena] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zahler@ucsc.edu		Neeb, Zachary T./0000-0001-8930-3574; Zahler, Alan/0000-0003-0027-1647	National Science Foundation [MCB-1121290]; University of California Institute for Quantitative Biology [QB3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of California Institute for Quantitative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Science Foundation (MCB-1121290) to AMZ. SK is supported in part by the University of California Institute for Quantitative Biology (QB3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cavalcanti ARO, 2004, CHROMOSOMA, V113, P69, DOI 10.1007/s00412-004-0295-3; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GRESLIN AF, 1989, P NATL ACAD SCI USA, V86, P6264, DOI 10.1073/pnas.86.16.6264; Heyse G, 2010, P NATL ACAD SCI USA, V107, P22134, DOI 10.1073/pnas.1009284107; Hoffman DC, 1996, NUCLEIC ACIDS RES, V24, P3337, DOI 10.1093/nar/24.17.3337; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Jung S, 2011, NUCLEIC ACIDS RES, V39, P7529, DOI 10.1093/nar/gkr501; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAUTH MR, 1976, CELL, V7, P67, DOI 10.1016/0092-8674(76)90256-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; MITCHAM JL, 1992, GENE DEV, V6, P788, DOI 10.1101/gad.6.5.788; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; Nowacki M, 2009, CURR OPIN MICROBIOL, V12, P638, DOI 10.1016/j.mib.2009.09.012; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Postberg J, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-3; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; SWANTON MT, 1980, CHROMOSOMA, V77, P217, DOI 10.1007/BF00329546; Swart EC, 2012, GENOME BIOL EVOL, V4, P136, DOI 10.1093/gbe/evr136; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; ZAHLER AM, 1989, NUCLEIC ACIDS RES, V17, P6299, DOI 10.1093/nar/17.15.6299; Zoller SD, 2012, PROTIST	46	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42371	10.1371/journal.pone.0042371	http://dx.doi.org/10.1371/journal.pone.0042371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900016	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900033
J	Fekete, A; Kenesi, E; Hunyadi-Gulyas, E; Durgo, H; Berko, B; Dunai, ZA; Bauer, PI				Fekete, Anna; Kenesi, Erzsebet; Hunyadi-Gulyas, Eva; Durgo, Hajnalka; Berko, Barbara; Dunai, Zsuzsanna A.; Bauer, Pal I.			The Guanine-Quadruplex Structure in the Human c-myc Gene's Promoter Is Converted into B-DNA Form by the Human Poly(ADP-Ribose)Polymerase-1	PLOS ONE			English	Article							TOPOISOMERASE-I; TRANSCRIPTIONAL CONTROL; POLYMERASE; IDENTIFICATION; BINDING; PROTEIN; NUCLEOLIN; PARP-1; POLY(ADP-RIBOSYL)ATION; ACTIVATION	The important regulatory role of the guanine-quadruplex (GQ) structure, present in the nuclease hypersensitive element (NHE) III1 region of the human c-myc (h c-myc) gene's promoter, in the regulation of the transcription of that gene has been documented. Here we present evidences, that the human nuclear poly(ADP-ribose)polymerase-1 (h PARP-1) protein participates in the regulation of the h c-myc gene expression through its interaction with this GQ structure, characterized by binding assays, fluorescence energy transfer (FRET) experiments and by affinity pull-down experiments in vitro, and by chromatin immunoprecipitation (ChIP)-qPCR analysis and h c-myc-promoter-luciferase reporter determinations in vivo. We surmise that h PARP-1 binds to the GQ structure and participates in the conversion of that structure into the transcriptionally more active B-DNA form. The first Zn-finger structure present in h PARP-1 participates in this interaction. PARP-1 might be a new member of the group of proteins participating in the regulation of transcription through their interactions with GQ structures present in the promoters of different genes.	[Fekete, Anna; Kenesi, Erzsebet; Berko, Barbara; Bauer, Pal I.] Semmelweis Univ, Dept Med Biochem, H-1085 Budapest, Hungary; [Hunyadi-Gulyas, Eva; Durgo, Hajnalka] Hungarian Acad Sci, Biol Res Ctr, Lab Prote, H-6701 Szeged, Hungary; [Dunai, Zsuzsanna A.] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Biological Research Center; National Institute of Oncology Hungary	Fekete, A (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	bauer.pal@med.semmelweis-univ.hu		Hunyadi-Gulyas, Eva/0000-0003-2089-1499	Hungarian Medical Research Council [ETT 071/07/2009]	Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant of Hungarian Medical Research Council, [ETT 071/07/2009] to PIB (http://www.ett.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Arora A, 2008, J PHYS CHEM B, V112, P8151, DOI 10.1021/jp711608y; Balakrishnan L, 2010, J BIOL CHEM, V285, P38861, DOI 10.1074/jbc.M110.165191; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bauer PI, 2000, INT J MOL MED, V5, P533; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; FERRO AM, 1984, J BIOL CHEM, V259, P547; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Halder K, 2005, BIOCHEM BIOPH RES CO, V327, P49, DOI 10.1016/j.bbrc.2004.11.137; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; IKAI K, 1983, J HISTOCHEM CYTOCHEM, V31, P1261, DOI 10.1177/31.11.6311893; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; IQBAL MA, 1987, NUCLEIC ACIDS RES, V15, P87, DOI 10.1093/nar/15.1.87; JI L, 1995, J BIOL CHEM, V270, P13392, DOI 10.1074/jbc.270.22.13392; Ju BG, 2006, CELL CYCLE, V5, P2557, DOI 10.4161/cc.5.22.3497; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; Kodym R, 2005, BIOCHEM BIOPH RES CO, V333, P411, DOI 10.1016/j.bbrc.2005.05.136; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kun E, 2006, INT J MOL MED, V17, P293; Kun E, 2008, FEBS LETT, V582, P2709, DOI 10.1016/j.febslet.2008.06.052; Kun E, 2008, BIOCHEM BIOPH RES CO, V366, P568, DOI 10.1016/j.bbrc.2007.12.004; Kun E, 2011, INT J MOL MED, V27, P181, DOI 10.3892/ijmm.2010.567; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lis JT, 2006, CELL, V125, P1225, DOI 10.1016/j.cell.2006.06.016; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogino H., 2007, BMC GENOMICS, V8; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; Saenz L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-171; SASTRY SS, 1990, BIOCHEM BIOPH RES CO, V167, P842, DOI 10.1016/0006-291X(90)92102-6; Sedoris KC, 2011, MOL CANCER THER, V11, P66; SHIMA H, 1989, P NATL ACAD SCI USA, V86, P7442, DOI 10.1073/pnas.86.19.7442; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Szego A, 2010, VIRUS GENES, V40, P267, DOI 10.1007/s11262-009-0432-4; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Yoon J, 2010, B KOREAN CHEM SOC, V31, P1025, DOI 10.5012/bkcs.2010.31.04.1025; Zhang HJ, 2009, SPECTROCHIM ACTA A, V74, P243, DOI 10.1016/j.saa.2009.06.018; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#; Zupan K, 2005, BIOCHEMISTRY-US, V44, P15000, DOI 10.1021/bi0510227	67	23	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42690	10.1371/journal.pone.0042690	http://dx.doi.org/10.1371/journal.pone.0042690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880082	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000061
J	Velazquez-Delgado, EM; Hardy, JA				Velazquez-Delgado, Elih M.; Hardy, Jeanne A.			Zinc-mediated Allosteric Inhibition of Caspase-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; IN-VITRO; COORDINATION ENVIRONMENTS; ACTIVATION; CLEAVAGE; PROTEIN; APOPTOSIS; DISTINCT; SITE; PROCASPASE-3	Zinc and caspase-6 have independently been implicated in several neurodegenerative disorders. Depletion of zinc intracellularly leads to apoptosis by an unknown mechanism. Zinc inhibits cysteine proteases, including the apoptotic caspases, leading to the hypothesis that zinc-mediated inhibition of caspase-6 might contribute to its regulation in a neurodegenerative context. Using inductively coupled plasma optical emission spectroscopy, we observed that caspase-6 binds one zinc per monomer, under the same conditions where the zinc leads to complete loss of enzymatic activity. To understand the molecular details of zinc binding and inhibition, we performed an anomalous diffraction experiment above the zinc edge. The anomalous difference maps showed strong 5 sigma peaks, indicating the presence of one zinc/monomer bound at an exosite distal from the active site. Zinc was not observed bound to the active site. The zinc in the exosite was liganded by Lys-36, Glu-244, and His-287 with a water molecule serving as the fourth ligand, forming a distorted tetrahedral ligation sphere. This exosite appears to be unique to caspase-6, as the residues involved in zinc binding were not conserved across the caspase family. Our data suggest that binding of zinc at the exosite is the primary route of inhibition, potentially locking caspase-6 into the inactive helical conformation.	[Velazquez-Delgado, Elih M.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 Lederle Grad Res Tower,710 N Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM80532, GM-0080]; National Science Foundation [S21000025700000, DGE-0504485]; National Synchrotron Light Source at Brookhaven National Laboratory; United States Department of Energy [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Synchrotron Light Source at Brookhaven National Laboratory; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80532.; Supported by the National Science Foundation Grants S21000025700000 and DGE-0504485.; We thank Kristen Huber for many helpful discussions; Michael Maroney, Nitai Giri, and Julius Campecino for assistance with ICP-OES analysis and insights on zinc coordination geometry; and Scott Garman for exceptional help in calculating the anomalous difference map. We thank Vivian Stojanoff for assistance with data collection and acknowledge NSLS X6A, which is funded by the National Institutes of Health Grant GM-0080, and the National Synchrotron Light Source at Brookhaven National Laboratory, which is supported by the United States Department of Energy Grant DE-AC02-98CH10886.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chimienti F, 2001, BIOCHEM PHARMACOL, V62, P51, DOI 10.1016/S0006-2952(01)00624-4; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Del Rio MJ, 2004, ARCH MED RES, V35, P185, DOI 10.1016/j.arcmed.2004.01.001; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hardy JA, 2009, J BIOL CHEM, V284, P26063, DOI 10.1074/jbc.M109.001826; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Huber KL, 2012, PROTEIN SCI, V21, P1056, DOI 10.1002/pro.2090; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kondoh M, 2005, BIOL PHARM BULL, V28, P757, DOI 10.1248/bpb.28.757; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lucas PW, 2011, INVEST NEW DRUG, V29, P901, DOI 10.1007/s10637-010-9445-z; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Peterson QP, 2009, J MED CHEM, V52, P5721, DOI 10.1021/jm900722z; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; ROGERS JM, 1995, TERATOLOGY, V52, P149, DOI 10.1002/tera.1420520307; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Rudolf E, 2010, BIOMETALS, V23, P339, DOI 10.1007/s10534-010-9302-8; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schrantz N, 2001, CELL DEATH DIFFER, V8, P152, DOI 10.1038/sj.cdd.4400772; Shu N., 2010, PROTEIN STRUCTURE PR, P47; Singh AB, 2002, KIDNEY INT, V62, P106, DOI 10.1046/j.1523-1755.2002.00427.x; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Sukumar N, 2011, J INORG BIOCHEM, V105, P1638, DOI 10.1016/j.jinorgbio.2011.08.002; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Truong-Tran AQ, 2003, BIOCHEM PHARMACOL, V66, P1459, DOI 10.1016/S0006-2952(03)00498-2; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; VALLEE BL, 1993, ACCOUNTS CHEM RES, V26, P543, DOI 10.1021/ar00034a005; VALLEE BL, 1993, BIOCHEMISTRY-US, V32, P6493, DOI 10.1021/bi00077a001; Velazquez-Delgado EM, 2012, STRUCTURE, V20, P742, DOI 10.1016/j.str.2012.02.003; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Yoo NJ, 2010, TUMORI J, V96, P138, DOI 10.1177/030089161009600122	71	63	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36000	36011		10.1074/jbc.M112.397752	http://dx.doi.org/10.1074/jbc.M112.397752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22891250	Green Published, hybrid			2022-12-25	WOS:000310364000022
J	Pfister, AS; Hadjihannas, MV; Rohrig, W; Schambony, A; Behrens, J				Pfister, Astrid S.; Hadjihannas, Michel V.; Roehrig, Waldemar; Schambony, Alexandra; Behrens, Juergen			Amer2 Protein Interacts with EB1 Protein and Adenomatous Polyposis Coli (APC) and Controls Microtubule Stability and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BETA-CATENIN; WILMS-TUMOR; PLUS ENDS; BINDING; PHOSPHORYLATION; GSK3-BETA; DYNAMICS; POLARITY; GROWTH	EB1 is key factor in the organization of the microtubule cytoskeleton by binding to the plus-ends of microtubules and serving as a platform for a number of interacting proteins (termed +TIPs) that control microtubule dynamics. Together with its direct binding partner adenomatous polyposis coli (APC), EB1 can stabilize microtubules. Here, we show that Amer2 (APC membrane recruitment 2), a previously identified membrane-associated APC-binding protein, is a direct interaction partner of EB1 and acts as regulator of microtubule stability together with EB1. Amer2 binds to EB1 via specific (S/T)xIP motifs and recruits it to the plasma membrane. Coexpression of Amer2 and EB1 generates stabilized microtubules at the plasma membrane, whereas knockdown of Amer2 leads to destabilization of microtubules. Knockdown of Amer2, APC, or EB1 reduces cell migration, and morpholino-mediated down-regulation of Xenopus Amer2 blocks convergent extension cell movements, suggesting that the Amer2-EB1-APC complex regulates cell migration by altering microtubule stability.	[Pfister, Astrid S.; Hadjihannas, Michel V.; Roehrig, Waldemar; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Schambony, Alexandra/0000-0001-8771-5487	Deutsche Forschungsgemeinschaft [Be 1550/6-1, SCHA965/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Be 1550/6-1 (to J.B.) and SCHA965/6-1 (to A.S.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Barth AIM, 2002, J CELL SCI, V115, P1583; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Polakis P, 2000, GENE DEV, V14, P1837; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SU LK, 1995, CANCER RES, V55, P2972; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Wen YD, 2004, KENYON REV, V26, P1; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	30	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35333	35340		10.1074/jbc.M112.385393	http://dx.doi.org/10.1074/jbc.M112.385393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22898821	hybrid, Green Published			2022-12-25	WOS:000309968000042
J	Wilson, SM; Schmutzler, BS; Brittain, JM; Dustrude, ET; Ripsch, MS; Pellman, JJ; Yeum, TS; Hurley, JH; Hingtgen, CM; White, FA; Khanna, R				Wilson, Sarah M.; Schmutzler, Brian S.; Brittain, Joel M.; Dustrude, Erik T.; Ripsch, Matthew S.; Pellman, Jessica J.; Yeum, Tae-Sung; Hurley, Joyce H.; Hingtgen, Cynthia M.; White, Fletcher A.; Khanna, Rajesh			Inhibition of Transmitter Release and Attenuation of Anti-retroviral-associated and Tibial Nerve Injury-related Painful Peripheral Neuropathy by Novel Synthetic Ca2+ Channel Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; GENE-RELATED PEPTIDE; N-TYPE; SYNAPTIC-TRANSMISSION; BETA-SUBUNIT; PROTEIN; BINDING; BLOCKADE; NEURONS; MICE	N-type Ca2+ channels (CaV2.2) are a nidus for neurotransmitter release and nociceptive transmission. However, the use of CaV2.2 blockers in pain therapeutics is limited by side effects resulting from inhibition of the physiological functions of CaV2.2 within the CNS. We identified an anti-nociceptive peptide (Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., Liu, N., Xiong, W., Ripsch, M. S., Wang, Y., Fehrenbacher, J. C., Fitz, S. D., Khanna, M., Park, C. K., Schmutzler, B. S., Cheon, B. M., Due, M. R., Brustovetsky, T., Ashpole, N. M., Hudmon, A., Meroueh, S. O., Hingtgen, C. M., Brustovetsky, N., Ji, R. R., Hurley, J. H., Jin, X., Shekhar, A., Xu, X. M., Oxford, G. S., Vasko, M. R., White, F. A., and Khanna, R. (2011) Suppression of inflammatory and neuropathic pain by uncoupling CRMP2 from the presynaptic Ca2+ channel complex. Nat. Med. 17, 822-829) derived from the axonal collapsin response mediator protein 2 (CRMP2), a protein known to bind and enhance CaV2.2 activity. Using a peptide tiling array, we identified novel peptides within the first intracellular loop (CaV2.2(388-402), "L1") and the distal C terminus (CaV1.2(2014-2028) "Ct-dis") that bound CRMP2. Microscale thermophoresis demonstrated micromolar and nanomolar binding affinities between recombinant CRMP2 and synthetic L1 and Ct-dis peptides, respectively. Co-immunoprecipitation experiments showed that CRMP2 association with CaV2.2 was inhibited by L1 and Ct-dis peptides. L1 and Ct-dis, rendered cell-penetrant by fusion with the protein transduction domain of the human immunodeficiency virus TAT protein, were tested in in vitro and in vivo experiments. Depolarization-induced calcium influx in dorsal root ganglion (DRG) neurons was inhibited by both peptides. Ct-dis, but not L1, peptide inhibited depolarization-stimulated release of the neuropeptide transmitter calcitonin gene-related peptide in mouse DRG neurons. Similar results were obtained in DRGs from mice with a heterozygous mutation of Nf1 linked to neurofibromatosis type 1. Ct-dis peptide, administered intraperitoneally, exhibited antinociception in a zalcitabine (2'-3'-dideoxycytidine) model of AIDS therapy-induced and tibial nerve injury-related peripheral neuropathy. This study suggests that CaV peptides, by perturbing interactions with the neuromodulator CRMP2, contribute to suppression of neuronal hypersensitivity and nociception.	[Schmutzler, Brian S.; Pellman, Jessica J.; Hingtgen, Cynthia M.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wilson, Sarah M.; Brittain, Joel M.; Dustrude, Erik T.; Hurley, Joyce H.; Hingtgen, Cynthia M.; White, Fletcher A.; Khanna, Rajesh] Indiana Univ Sch Med, Program Med Neurosci, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ripsch, Matthew S.; Yeum, Tae-Sung; White, Fletcher A.] Indiana Univ Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Hurley, Joyce H.; Khanna, Rajesh] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hingtgen, Cynthia M.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Khanna, Rajesh] Sophia Therapeut LLC, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Khanna, R (corresponding author), 950 W Walnut St,R2 Rm 478, Indianapolis, IN 46202 USA.	khanna5@iu.edu	White, Fletcher/F-3203-2015	White, Fletcher/0000-0002-8408-9262; Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health (NIH), NCRR of the Indiana Clinical and Translational Sciences Institute [RR025761]; NIH, NINDS [NS049136-06]; NIH, NIDA [DA026040-04]; Indiana State Department of Health [A70-9-079138]; American Heart Association [SDG5280023]; Department of Defense [NF1000099]; Ralph W. and Grace M. Showalter Foundation; Indiana University Biomedical Committee [2286501]; Indiana Clinical and Translational Sciences Institute; Elwert Award in Medicine; Paul and Carole Stark Fellowship; Children's Tumor Foundation; Larry Kays Medical Neuroscience Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026040] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCRR of the Indiana Clinical and Translational Sciences Institute; NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Indiana State Department of Health; American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Ralph W. and Grace M. Showalter Foundation; Indiana University Biomedical Committee; Indiana Clinical and Translational Sciences Institute; Elwert Award in Medicine; Paul and Carole Stark Fellowship; Children's Tumor Foundation; Larry Kays Medical Neuroscience Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCRR, Project Development Team Grant RR025761 in support of the Indiana Clinical and Translational Sciences Institute (to R. K); NIH, NINDS, Grant NS049136-06 (to F. A. W.); and NIH, NIDA, Grant DA026040-04 (to F. A. W.). This work was also supported by a Clinical and Translational Sciences Award from the Indiana State Department of Health Spinal Cord and Brain Injury Fund (A70-9-079138 to R. K.), American Heart Association National Scientist Development Grant SDG5280023 (to R. K.), Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award NF1000099 (to R. K.), a Ralph W. and Grace M. Showalter Foundation grant (to R. K.), Indiana University Biomedical Committee Research Support Funds Grant 2286501 (to R. K), a Research Inventions and Scientific Commercialization grant (to R. K.) from the Indiana Clinical and Translational Sciences Institute, and the Elwert Award in Medicine (to R. K.).; Supported in part by a Paul and Carole Stark Fellowship.; Supported by a Young Investigator's Award from the Children's Tumor Foundation.; Supported by a Larry Kays Medical Neuroscience Fellowship.	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; BOWERSOX SS, 1992, J CARDIOVASC PHARM, V20, P756, DOI 10.1097/00005344-199220050-00011; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brittain JM, 2012, CHANNELS, V6, P94, DOI 10.4161/chan.19415; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Bucci G, 2011, J PHYSIOL-LONDON, V589, P3085, DOI 10.1113/jphysiol.2010.204735; Chan AW, 2007, CHANNELS, V1, DOI 10.4161/chan.3694; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen JJ, 1996, PEPTIDES, V17, P31, DOI 10.1016/0196-9781(95)02091-8; Chen L, 2007, BIOCHEM SOC T, V35, P821, DOI 10.1042/BST0350821; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DODGE FA, 1967, J PHYSIOL-LONDON, V189, pP90; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Fossat P, 2010, J NEUROSCI, V30, P1073, DOI 10.1523/JNEUROSCI.3145-09.2010; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Hingtgen CM, 2006, NEUROSCIENCE, V137, P637, DOI 10.1016/j.neuroscience.2005.09.030; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Joseph EK, 2004, PAIN, V107, P147, DOI 10.1016/j.pain.2003.10.010; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Li B, 2004, MOL PHARMACOL, V66, P761; MALMBERG AB, 1994, J NEUROSCI, V14, P4882; Manceur AP, 2009, MOL THER, V17, P500, DOI 10.1038/mt.2008.271; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McGivern Joseph G, 2007, Neuropsychiatr Dis Treat, V3, P69, DOI 10.2147/nedt.2007.3.1.69; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Neugebauer V, 1996, NEUROSCIENCE, V71, P1095, DOI 10.1016/0306-4522(95)00473-4; Neugebauer V, 1996, J NEUROPHYSIOL, V76, P3740, DOI 10.1152/jn.1996.76.6.3740; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Piekarz AD, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-54; Polyakov V, 2000, BIOCONJUGATE CHEM, V11, P762, DOI 10.1021/bc000008y; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ripsch MS, 2012, TRANSL NEUROSCI, V3, P1, DOI 10.2478/s13380-012-0002-4; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sluka KA, 1997, PAIN, V71, P157, DOI 10.1016/S0304-3959(97)03354-X; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Tedford HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-6; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; Wang YY, 2010, TRANSL NEUROSCI, V1, P106, DOI 10.2478/v10134-010-0025-8; Wang YY, 2011, TRANSL NEUROSCI, V2, P13, DOI 10.2478/s13380-011-0002-9; Wang YY, 2011, ACS CHEM NEUROSCI, V2, P317, DOI 10.1021/cn200024z; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; White DM, 1998, BRAIN RES, V801, P50, DOI 10.1016/S0006-8993(98)00539-3; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wilson SM, 2011, CHANNELS, V5, P447, DOI 10.4161/chan.5.5.17363; Winquist RJ, 2005, BIOCHEM PHARMACOL, V70, P489, DOI 10.1016/j.bcp.2005.04.035; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	61	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35065	35077		10.1074/jbc.M112.378695	http://dx.doi.org/10.1074/jbc.M112.378695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22891239	Green Published, hybrid			2022-12-25	WOS:000309968000018
J	Andreasen, M; Nielsen, SB; Runager, K; Christianse, G; Nielse, NC; Enghild, JJ; Otzen, DE				Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Christianse, Gunna; Nielse, Niels Chr.; Enghild, Jan J.; Otzen, Daniel E.			Polymorphic Fibrillation of the Destabilized Fourth Fasciclin-1 Domain Mutant A546T of the Transforming Growth Factor-beta-induced Protein (TGFBIp) Occurs through Multiple Pathways with Different Oligomeric Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-FLOW FRACTIONATION; KERATO-EPITHELIN MUTATIONS; HEAT-INDUCED AGGREGATION; CORNEAL DYSTROPHIES; VESICLE PERMEABILIZATION; SEQUENCE-ANALYSIS; LACTOGLOBULIN AB; GENE-MUTATIONS; BETA-IG-H3; PH	Mutations in the transforming growth factor beta-induced protein (TGFBIp) are linked to the development of corneal dystrophies in which abnormal protein deposition in the cornea leads to a loss of corneal transparency and ultimately blindness. Different mutations give rise to phenotypically distinct corneal dystrophies. Most mutations are located in the fourth fasciclin-1 domain (FAS1-4). The amino acid substitution A546T in the FAS1-4 domain is linked to the development of lattice corneal dystrophy with amyloid deposits in the superficial and deep stroma, classifying it as an amyloid disease. Here we provide a detailed description of the fibrillation of the isolated FAS1-4 domain carrying the A546T substitution. The A546T substitution leads to a significant destabilization of FAS1-4 and induces a partially folded structure with increased surface exposure of hydrophobic patches. The mutation also leads to two distinct fibril morphologies. Long straight fibrils composed of pure beta-sheet structure are formed at lower concentrations, whereas short and curly fibrils containing a mixture of alpha-helical and beta-sheet structures are formed at higher concentrations. The formation of short and curly fibrils is preceded by the formation of a small number of oligomeric species with high membrane permeabilization potential and rapid fibril formation. The long straight fibrils are formed more slowly and through progressively bigger oligomers that lose their membrane permeabilization potential as fibrillation proceeds beyond the lag phase. These different fibril classes and associated biochemical differences may lead to different clinical symptoms associated with the mutation.	[Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Andreasen, Maria; Nielsen, Soren B.; Runager, Kasper; Enghild, Jan J.; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Christianse, Gunna] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Nielse, Niels Chr.] Aarhus Univ, inSPIN, iNANO, DK-8000 Aarhus, Denmark; [Nielse, Niels Chr.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.	dao@inano.au.dk	Nielsen, Søren B/D-5936-2011	Enghild, Jan Johannes/0000-0001-9292-9172; Andreasen, Maria/0000-0002-6096-2995; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish National Research Foundation.	Alizadeh-Pasdar N, 2000, J AGR FOOD CHEM, V48, P328, DOI 10.1021/jf990393p; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Andersen CB, 2007, BIOCHEMISTRY-US, V46, P7314, DOI 10.1021/bi6025374; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreasen M, 2012, BBA-PROTEINS PROTEOM, V1824, P274, DOI 10.1016/j.bbapap.2011.10.014; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Chakravarthi SVVK, 2005, INVEST OPHTH VIS SCI, V46, P121, DOI 10.1167/iovs.04-0440; Clout NJ, 2003, STRUCTURE, V11, P197, DOI 10.1016/S0969-2126(03)00002-9; CONRAD TJ, 1994, LAB INVEST, V70, P426; Dighiero P, 2000, AM J OPHTHALMOL, V129, P248, DOI 10.1016/S0002-9394(99)00324-4; ESCRIBANO J, 1994, J CELL PHYSIOL, V160, P511, DOI 10.1002/jcp.1041600314; Fraunhofer W, 2004, EUR J PHARM BIOPHARM, V58, P369, DOI 10.1016/j.ejpb.2004.03.034; Fujiki K, 2001, J HUM GENET, V46, P431, DOI 10.1007/s100380170041; Ghodke S, 2012, FEBS J, V279, P752, DOI 10.1111/j.1742-4658.2011.08465.x; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haris PI, 2010, BIOCHEM SOC T, V38, P940, DOI 10.1042/BST0380940; HARIS PI, 1992, BIOCHEMISTRY-US, V31, P6279, DOI 10.1021/bi00142a016; Hoppe C.C., 2008, J BIOL ENG, V2, P1; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Klintworth GK, 1998, AM J PATHOL, V152, P743; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Korvatska E, 1998, AM J HUM GENET, V62, P320, DOI 10.1086/301720; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Lorenzen N, 2012, BIOPHYS J, V102, P2167, DOI 10.1016/j.bpj.2012.03.047; Macchi F, 2011, LANGMUIR, V27, P12539, DOI 10.1021/la202125c; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Mashima Y, 1997, AM J HUM GENET, V61, P1448, DOI 10.1086/301649; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mogensen JE, 2004, BIOCHEMISTRY-US, V43, P3357, DOI 10.1021/bi0358622; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; Nesgaard L, 2009, BBA-PROTEINS PROTEOM, V1794, P84, DOI 10.1016/j.bbapap.2008.09.021; Nielsen SB, 2012, J MOL BIOL, V421, P601, DOI 10.1016/j.jmb.2012.01.050; Okada M, 1998, AM J OPHTHALMOL, V126, P169, DOI 10.1016/S0002-9394(98)00075-0; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rambaldi DC, 2009, ANAL BIOANAL CHEM, V394, P2145, DOI 10.1007/s00216-009-2899-1; Rosenberg ME, 2000, OPHTHALMOLOGY, V107, P565, DOI 10.1016/S0161-6420(99)00086-X; Runager K, 2011, J BIOL CHEM, V286, P4951, DOI 10.1074/jbc.M110.181099; Schokker EP, 1999, INT DAIRY J, V9, P791, DOI 10.1016/S0958-6946(99)00148-X; Schokker EP, 2000, INT DAIRY J, V10, P233, DOI 10.1016/S0958-6946(00)00047-9; Silveira JR, 2006, METHOD ENZYMOL, V412, P21, DOI 10.1016/S0076-6879(06)12002-9; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Streeten BW, 1999, ARCH OPHTHALMOL-CHIC, V117, P67; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; WAHLUND KG, 1987, ANAL CHEM, V59, P1332, DOI 10.1021/ac00136a016; Weiss JS, 2008, CORNEA, V27, pS1, DOI 10.1097/ICO.0b013e31817780fb; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	68	18	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34730	34742		10.1074/jbc.M112.379552	http://dx.doi.org/10.1074/jbc.M112.379552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893702	Green Published, hybrid			2022-12-25	WOS:000309654200073
J	Xiong, YN; Khanna, S; Grzenda, AL; Sarmento, OF; Svingen, PA; Lomberk, GA; Urrutia, RA; Faubion, WA				Xiong, Yuning; Khanna, Sahil; Grzenda, Adrienne L.; Sarmento, Olga F.; Svingen, Phyllis A.; Lomberk, Gwen A.; Urrutia, Raul A.; Faubion, William A., Jr.			Polycomb Antagonizes p300/CREB-binding Protein-associated Factor to Silence FOXP3 in a Kruppel-like Factor-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; RESPONSE ELEMENT; TRANSFORMING GROWTH-FACTOR-BETA-1; HISTONE ACETYLTRANSFERASE; INTESTINAL INFLAMMATION; BINDING PROTEIN; IN-VIVO; EXPRESSION; GENE	Inducible gene expression underlies the epigenetically inherited differentiation program of most immune cells. We report that the promoter of the FOXP3 gene possesses two distinct functional states: an "off state" mediated by the polycomb histone methyltransferase complex and a histone acetyltransferase-dependent "on state." Regulating these states is the presence of a Kruppel-like factor (KLF)-containing Polycomb response element. In the KLF10(-/-) mouse, the FOXP3 promoter is epigenetically silenced by EZH2 (Enhancer of Zeste 2)-mediated trimethylation of Histone 3 K27; thus, impaired FOXP3 induction and inappropriate adaptive T regulatory cell differentiation results in vitro and in vivo. The epigenetic transmittance of adaptive T regulatory cell deficiency is demonstrated throughout more than 40 generations of mice. These results provide insight into chromatin remodeling events key to phenotypic features of distinct T cell populations.	[Faubion, William A., Jr.] Mayo Clin, Dept Gastroenterol & Hepatol, Chromatin Dynam & Epigenet Lab, Rochester, MN 55905 USA; [Grzenda, Adrienne L.; Urrutia, Raul A.] Mayo Clin, Dept Mol Biol, Rochester, MN 55905 USA; [Faubion, William A., Jr.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Xiong, Yuning; Khanna, Sahil; Grzenda, Adrienne L.; Sarmento, Olga F.; Svingen, Phyllis A.; Lomberk, Gwen A.; Urrutia, Raul A.; Faubion, William A., Jr.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Faubion, WA (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Chromatin Dynam & Epigenet Lab, 200 1st St SW, Rochester, MN 55905 USA.	faubion.william@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Grzenda, Adrienne L/K-4421-2019	Lomberk, Gwen/0000-0001-5463-789X; Grzenda, Adrienne L/0000-0001-5952-6953	National Institutes of Health [AI89714-R01, NCI T32 CA148073]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089714, R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI89714-R01.; Supported by National Institutes of Health Grant NCI T32 CA148073.	Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; CASARES F, 1995, DEVELOPMENT, V121, P1855; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Drummond A., 2011, GENEIOUS V5 5; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Faubion WA, 2004, GASTROENTEROLOGY, V126, P1759, DOI 10.1053/j.gastro.2004.03.015; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lin WC, 2008, DEV GROWTH DIFFER, V50, P321, DOI [10.1111/j.1440-169x.2008.01041.x, 10.1111/j.1440-169X.2008.01041.x]; Liu ZJ, 2010, BIOCHEM BIOPH RES CO, V400, P409, DOI 10.1016/j.bbrc.2010.08.090; Mahmoudi T, 2003, NUCLEIC ACIDS RES, V31, P4147, DOI 10.1093/nar/gkg479; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; RILEY PD, 1987, GENE DEV, V1, P716, DOI 10.1101/gad.1.7.716; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Song A, 2002, J BIOL CHEM, V277, P30055, DOI 10.1074/jbc.M204278200; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496	54	44	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34372	34385		10.1074/jbc.M111.325332	http://dx.doi.org/10.1074/jbc.M111.325332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896699	Green Published, hybrid			2022-12-25	WOS:000309654200040
J	Frock, RL; Chen, SC; Da, DF; Frett, E; Lau, C; Brown, C; Pak, DN; Wang, YX; Muchir, A; Worman, HJ; Santana, LF; Ladiges, WC; Rabinovitch, PS; Kennedy, BK				Frock, Richard L.; Chen, Steven C.; Da, Dao-Fu; Frett, Ellie; Lau, Carmen; Brown, Christina; Pak, Diana N.; Wang, Yuexia; Muchir, Antoine; Worman, Howard J.; Santana, Luis F.; Ladiges, Warren C.; Rabinovitch, Peter S.; Kennedy, Brian K.			Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna(-/-) Mice	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; A-TYPE LAMINS; JUNCTIONAL INTERCELLULAR COMMUNICATION; CONDUCTION-SYSTEM DISEASE; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; GAP-JUNCTION; DILATED CARDIOMYOPATHY; A/C GENE; NUCLEAR-ENVELOPE	Lmna(-/-) mice display multiple tissue defects and die by 6-8 weeks of age reportedly from dilated cardiomyopathy with associated conduction defects. We sought to determine whether restoration of lamin A in cardiomyocytes improves cardiac function and extends the survival of Lmna(-/-) mice. We observed increased total desmin protein levels and disorganization of the cytoplasmic desmin network in,20% of Lmna(-/-) ventricular myocytes, rescued in a cell-autonomous manner in Lmna(-/-) mice expressing a cardiac-specific lamin A transgene (Lmna(-/-); Tg). Lmna(-/-); Tg mice displayed significantly increased contractility and preservation of myocardial performance compared to Lmna(-/-) mice. Lmna(-/-); Tg mice attenuated ERK1/2 phosphorylation relative to Lmna(-/-) mice, potentially underlying the improved localization of connexin43 to the intercalated disc. Electrocardiographic recordings from Lmna(-/-) mice revealed arrhythmic events and increased frequency of PR interval prolongation, which is partially rescued in Lmna(-/-); Tg mice. These findings support our observation that Lmna(-/-); Tg mice have a 12% median extension in lifespan compared to Lmna(-/-) mice. While significant, Lmna(-/-); Tg mice only have modest improvement in cardiac function and survival likely stemming from the observation that only 40% of Lmna(-/-); Tg cardiomyocytes have detectable lamin A expression. Cardiomyocyte-specific restoration of lamin A in Lmna(-/-) mice improves heart-specific pathology and extends lifespan, demonstrating that the cardiac pathology of Lmna(-/-) mice limits survival. The expression of lamin A is sufficient to rescue certain cellular defects associated with loss of A-type lamins in cardiomyocytes in a cell-autonomous fashion.	[Frock, Richard L.; Chen, Steven C.; Lau, Carmen; Brown, Christina; Pak, Diana N.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Da, Dao-Fu; Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Santana, Luis F.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Frett, Ellie] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY USA; [Kennedy, Brian K.] Buck Inst Age Res, Novato, CA USA; [Wang, Yuexia; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Wang, Yuexia; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; Buck Institute for Research on Aging; Columbia University; Columbia University	Frock, RL (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkennedy@buckinstitute.org	Dai, Dao-Fu/AAB-7547-2022; Frock, Richard/I-6934-2019; Dai, Dao-Fu/AAM-4396-2021; Pak, Diana/GWZ-8091-2022; Santana, Luis/AAF-9298-2019	Frock, Richard/0000-0001-6963-4931; Dai, Dao-Fu/0000-0001-7724-321X; Santana, Luis/0000-0002-4297-8029; Kennedy, Brian/0000-0002-5754-1874; Muchir, Antoine/0000-0002-4780-9275	NICHD; National Institute on Aging at the National Institutes of Health [R01 AG024287]; National Institutes of Health [T32 HL007312, HL085686]; National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [R01 AR048997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085686, T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024287] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Sara Mamman, Rubysue Mangalindan, Ashot Safarli and other members of the Ladiges lab in the Department of Comparative Medicine for handling and maintenance of mouse colonies. The MF20 myosin antibody (Fischman) was obtained from the Developmental Studies Hybridoma Bank under the auspices of the NICHD, maintained by University of Iowa (Biological Sciences, Iowa City, IA 52242).; Contract grant sponsor: National Institute on Aging at the National Institutes of Health; Contract grant number: R01 AG024287. Contract grant sponsor: National Institutes of Health; Contract grant number: T32 HL007312. Contract grant sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health; Contract grant number: R01 AR048997. Contract grant sponsor: National Institutes of Health; Contract grant number: HL085686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; Eckardt D, 2004, J MOL CELL CARDIOL, V36, P101, DOI 10.1016/j.yjmcc.2003.10.006; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Faureau C, 2008, EXP CELL RES, V314, P1392, DOI 10.1016/j.yexcr.2008.01.018; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gard JJ, 2005, CARDIOVASC RES, V67, P539, DOI 10.1016/j.cardiores.2005.04.004; Gary-Bobo G, 2008, EUR J HEART FAIL, V10, P635, DOI 10.1016/j.ejheart.2008.04.014; Gonzalez S, 2011, AUTOIMMUN REV, V10, P175, DOI 10.1016/j.autrev.2010.09.022; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Gutstein DE, 2005, AM J PHYSIOL-HEART C, V289, pH1091, DOI 10.1152/ajpheart.00095.2005; Gutstein DE, 2001, CELL COMMUN ADHES, V8, P345, DOI 10.3109/15419060109080751; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kodama H, 2000, AM J PHYSIOL-HEART C, V279, pH1635, DOI 10.1152/ajpheart.2000.279.4.H1635; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lee DC, 2009, EXP CELL RES, V315, P996, DOI 10.1016/j.yexcr.2009.01.003; Lu G, 2010, CARDIOVASC RES, V88, P277, DOI 10.1093/cvr/cvq293; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Polontchouk L, 2001, FASEB J, V15, P87, DOI 10.1096/fj.01-0381fje; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Rottlaender D, 2010, J CLIN INVEST, V120, P1441, DOI 10.1172/JCI40927; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673	45	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42918	10.1371/journal.pone.0042918	http://dx.doi.org/10.1371/journal.pone.0042918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905185	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600034
J	Christopherson, MR; Lambrecht, JA; Downs, D; Downs, DM				Christopherson, Melissa R.; Lambrecht, Jennifer A.; Downs, Deanna; Downs, Diana M.			Suppressor Analyses Identify Threonine as a Modulator of ridA Mutant Phenotypes in Salmonella enterica	PLOS ONE			English	Article							HOMOSERINE DEHYDROGENASE-I; ESCHERICHIA-COLI K-12; SACCHAROMYCES-CEREVISIAE; ISOLEUCINE BIOSYNTHESIS; PROTEIN; YJGF; TYPHIMURIUM; ENZYME; FAMILY; ACID	The RidA (YjgF/YER057c/UK114) family of proteins is broadly conserved in the three domains of life yet the functional understanding of these proteins is at an early stage. Physiological studies of ridA mutant strains of Salmonella enterica provided a framework to inform in vitro studies and led to the description of a conserved biochemical activity for this family. ridA mutant strains of S. enterica have characteristic phenotypes including new synthesis of thiamine biosynthetic intermediate phosphoribosylamine (PRA), inability to grow on pyruvate as a sole carbon and energy source or when serine is present in the minimal growth medium, and a decreased specific activity of transaminase B (IlvE). Secondary mutations restoring growth to a ridA mutant in the presence of serine were in dapA (encoding dihydrodipicolinate synthase) and thrA (encoding homoserine dehydrogenase). These mutations suppressed multiple ridA mutant phenotypes by increasing the synthesis of threonine. The ability of threonine to suppress the metabolic defects of a ridA mutant is discussed in the context of recent biochemical data and in vivo results presented here.	[Christopherson, Melissa R.; Lambrecht, Jennifer A.; Downs, Deanna; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Christopherson, MR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health (NIH) [GM47296, GM95837, T32 GM07215]; National Science Foundation; Department of Bacteriology; Hilldale Competition; Merck and Co.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM047296, R01GM095837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Bacteriology; Hilldale Competition; Merck and Co.(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by competitive grants GM47296 and GM95837 from the National Institutes of Health (NIH) to DMD and a National Science Foundation Graduate Research Fellowship to MRC. JAL was supported as a trainee on the Molecular Biosciences Training Grant from the NIH (T32 GM07215). DD was the recipient of undergraduate research fellowships from the Department of Bacteriology, the Hilldale Competition, and Merck and Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acord J, 2004, FEMS MICROBIOL LETT, V235, P131, DOI 10.1016/j.femsle.2004.04.022; ANGELES TS, 1989, BIOCHEMISTRY-US, V28, P8771, DOI 10.1021/bi00448a014; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; BURNS RO, 1979, J BIOL CHEM, V254, P1074; Burns RO, 1971, METHOD ENZYMOL, P555; CAETANOANOLLES G, 1993, PCR METH APPL, V3, P85; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; D'Inca R, 2010, J PROTEOMICS, V73, P1542, DOI 10.1016/j.jprot.2010.03.017; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; DUGGAN DE, 1973, ANAL BIOCHEM, V51, P67, DOI 10.1016/0003-2697(73)90453-3; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; HOFLER JG, 1978, J BIOL CHEM, V253, P1245; JAGUSZTYNKRYNICKA EK, 1982, J GEN MICROBIOL, V128, P1135; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Leitner-Dagan Y, 2006, PLANTA, V225, P89, DOI 10.1007/s00425-006-0332-y; Marchini A, 2002, YEAST, V19, P703, DOI 10.1002/yea.868; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; OMORI K, 1993, J BACTERIOL, V175, P785, DOI 10.1128/JB.175.3.785-794.1993; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SZCZESIUL M, 1976, BIOCHEMISTRY-US, V15, P2236, DOI 10.1021/bi00655a033; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; YUGARI YASUMI, 1965, J BIOL CHEM, V240, P4710	38	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43082	10.1371/journal.pone.0043082	http://dx.doi.org/10.1371/journal.pone.0043082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900093	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900111
J	Reininger, V; Sieber, TN				Reininger, Vanessa; Sieber, Thomas N.			Mycorrhiza Reduces Adverse Effects of Dark Septate Endophytes (DSE) on Growth of Conifers	PLOS ONE			English	Article							APPLANATA SPECIES COMPLEX; PHIALOCEPHALA-FORTINII; ECTOMYCORRHIZAL FUNGI; LACCARIA-BICOLOR; ARBUSCULAR MYCORRHIZAL; DOUGLAS-FIR; COMMUNITY STRUCTURE; SPRUCE SEEDLINGS; ROOT ENDOPHYTES; BLACK SPRUCE	Mycorrhizal roots are frequently colonized by fungi of the Phialocephala fortinii s.l. - Acephala applanata species complex (PAC). These ascomycetes are common and widespread colonizers of tree roots. Some PAC strains reduce growth increments of their hosts but are beneficial in protecting roots against pathogens. Nothing is known about the effects of PAC on mycorrhizal fungi and the PAC-mycorrhiza association on plant growth, even though these two fungal groups occur closely together in natural habitats. We expect reduced colonization rates and reduced negative effects of PAC on host plants if roots are co-colonized by an ectomycorrhizal fungus (ECM). Depending on the temperature regime interactions among the partners in this tripartite ECM-PAC-plant system might also change. To test our hypotheses, effects of four PAC genotypes (two pathogenic and two non-pathogenic on the Norway spruce), mycorrhization by Laccaria bicolor (strain S238N) and two temperature regimes (19 degrees C and 25 degrees C) on the biomass of the Douglas-fir (Pseudotsuga menziesii) and Norway spruce (Picea abies) seedlings were studied. Mycorrhization compensated the adverse effects of PAC on the growth of the Norway spruce at both temperatures. The growth of the Douglas-fir was not influenced either by PAC or mycorrhization at 19 degrees C, but at 25 degrees C mycorrhization had a similar protective effect as in the Norway spruce. The compensatory effects probably rely on the reduction of the PAC-colonization density by mycorrhizae. Temperature and the PAC strain only had a differential effect on the biomass of the Norway spruce but not on the Douglas-fir. Higher temperature reduced mycorrhization of both hosts. We conclude that ectomycorrhizae form physical and/or physiological barriers against PAC leading to reduced PAC-colonization of the roots. Additionally, our results indicate that global warming could cause a general decrease of mycorrhization making primary roots more accessible to other symbionts and pathogens.	[Reininger, Vanessa; Sieber, Thomas N.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Reininger, V (corresponding author), ETH, Dept Environm Syst Sci, Zurich, Switzerland.	Vanessa.Reininger@env.ethz.ch	Trilety, Roman/I-8225-2014; Reininger, Vanessa/F-7014-2011	Trilety, Roman/0000-0002-3778-0368; 	Competence Center Environment and Sustainability (CCES); Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain	Competence Center Environment and Sustainability (CCES); Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain	Funding came from Competence Center Environment and Sustainability (CCES), GEDIHAP Work Package 1B. http://www.cces.ethz.ch/projects/feh/gedihap. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study represents part of the research project GEDIHAP funded by the Competence Center Environment and Sustainability (CCES) of the Swiss Federal Institute of Technology (ETH) Domain. We wish to thank the Genetic Diversity Centre (GDC) of ETH Zurich for providing the necessary laboratory facilities to perform microsatellite analyses and Sophie Stroheker for taking care of the experiment, help with harvesting and measuring the plants' dry weight. We also would like to thank Sebastian Leuzinger for his help with the software R.	Ahlich K, 1996, NEW PHYTOL, V132, P259, DOI 10.1111/j.1469-8137.1996.tb01845.x; Alabouvette C, 2009, NEW PHYTOL, V184, P529, DOI 10.1111/j.1469-8137.2009.03014.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bonello P, 2001, FOREST PATHOL, V31, P99, DOI 10.1046/j.1439-0329.2001.00230.x; Branzanti MB, 1999, MYCORRHIZA, V9, P103, DOI 10.1007/s005720050007; Christophe C, 2010, PLANT SOIL, V328, P145, DOI 10.1007/s11104-009-0092-0; CHUCHOU M, 1992, SOIL BIOL BIOCHEM, V24, P633, DOI 10.1016/0038-0717(92)90041-U; Crawley M.J., 2007, R BOOK; CURRAH RS, 1993, CAN J BOT, V71, P1639, DOI 10.1139/b93-199; DiBattista C, 1996, MYCOL RES, V100, P1315, DOI 10.1016/S0953-7562(96)80058-X; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Girlanda M, 2002, NEW PHYTOL, V155, P481, DOI 10.1046/j.1469-8137.2002.00474.x; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Grunig CR, 2007, FUNGAL GENET BIOL, V44, P773, DOI 10.1016/j.fgb.2006.12.008; HOLDENRIEDER O, 1992, MYCOL RES, V96, P151, DOI 10.1016/S0953-7562(09)80932-5; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 1998, MYCORRHIZA, V7, P261, DOI 10.1007/s005720050190; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2007, J ECOL, V95, P1338, DOI 10.1111/j.1365-2745.2007.01306.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Larimer AL, 2010, SYMBIOSIS, V51, P139, DOI 10.1007/s13199-010-0083-1; Liu QH, 2011, FUNCT ECOL, V25, P910, DOI 10.1111/j.1365-2435.2011.01853.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Mahmood S, 2003, FEMS MICROBIOL LETT, V221, P81, DOI 10.1016/S0378-1097(03)00166-6; Mandyam K, 2008, MYCORRHIZA, V18, P145, DOI 10.1007/s00572-008-0165-6; Marler M, 1999, CAN J FOREST RES, V29, P1317, DOI 10.1139/cjfr-29-9-1317; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MELIN E., 1923, Mykologische Untersuchungen und Berichte, V2, P73; Menkis A, 2004, MYCOL RES, V108, P965, DOI 10.1017/S0953756204000668; Morin C, 1999, CAN J BOT, V77, P169, DOI 10.1139/cjb-77-1-169; Muller J, 2003, FUNCT PLANT BIOL, V30, P419, DOI 10.1071/FP02189; Oikawa, 2000, MICROBES ENVIRON, V15, P197; PARLADE J, 1993, MYCORRHIZA, V3, P93, DOI 10.1007/BF00210699; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Queloz V, 2010, MOL ECOL RESOUR, V10, P348, DOI 10.1111/j.1755-0998.2009.02757.x; Queloz V, 2008, MOL ECOL RESOUR, V8, P1322, DOI 10.1111/j.1755-0998.2008.02279.x; Reininger V, 2012, ENVIRON MICROBIOL, V14, P1064, DOI 10.1111/j.1462-2920.2011.02686.x; Reininger V, 2011, MICROB ECOL, V61, P676, DOI 10.1007/s00248-010-9798-z; Richard C, 1971, CAN J FOREST RES, V1, P246; Roger SO, 1994, PLANT MOL BIOL MAN D, P183, DOI [10.1007/978-94-011-0511-8_12, DOI 10.1007/978-94-011-0511-8_12]; ROGERS SO, 1989, CAN J BOT, V67, P1235, DOI 10.1139/b89-161; Rygiewicz PT, 2000, OECOLOGIA, V124, P299, DOI 10.1007/s004420000385; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Sieber T. N., 2002, Plant roots: the hidden half, P887; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; STOYKE G, 1992, CAN J BOT, V70, P2009, DOI 10.1139/b92-250; STROBEL NE, 1991, PHYTOPATHOLOGY, V81, P420, DOI 10.1094/Phyto-81-420; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Summerbell RC, 2005, STUD MYCOL, P121; Tellenbach C, 2011, THESIS ETH ZURICH, P104; Tellenbach C, 2011, ENVIRON MICROBIOL, V13, P2508, DOI 10.1111/j.1462-2920.2011.02523.x; Tucci M, 2011, MOL PLANT PATHOL, V12, P341, DOI 10.1111/j.1364-3703.2010.00674.x; Wagg C, 2008, MYCORRHIZA, V18, P103, DOI 10.1007/s00572-007-0157-y; Xu G, 2011, RUSS J PLANT PHYSL+, V58, P491, DOI 10.1134/S1021443711030216; ZAK BRATISLAV, 1964, ANN REV PHYTOPATHOL, V2, P377, DOI 10.1146/annurev.py.02.090164.002113; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	60	44	47	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42865	10.1371/journal.pone.0042865	http://dx.doi.org/10.1371/journal.pone.0042865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900058	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900076
J	Ricardi, MM; Guaimas, FF; Gonzalez, RM; Burrieza, HP; Lopez-Fernandez, MP; Jares-Erijman, EA; Estevez, JM; Iusem, ND				Ricardi, Martiniano M.; Guaimas, Francisco F.; Gonzalez, Rodrigo M.; Burrieza, Hernan P.; Lopez-Fernandez, Maria P.; Jares-Erijman, Elizabeth A.; Estevez, Jose M.; Iusem, Norberto D.			Nuclear Import and Dimerization of Tomato ASR1, a Water Stress-Inducible Protein Exclusive to Plants	PLOS ONE			English	Article							DNA-BINDING; LOCALIZATION SIGNAL; BINARY VECTORS; GENE; PORE; TRANSFORMATION; EXPRESSION; TRANSPORT; FAMILY; GRAPE	The ASR (for ABA/water stress/ripening) protein family, first described in tomato as nuclear and involved in adaptation to dry climates, is widespread in the plant kingdom, including crops of high agronomic relevance. We show both nuclear and cytosolic localization for ASR1 (the most studied member of the family) in histological plant samples by immunodetection, typically found in small proteins readily diffusing through nuclear pores. Indeed, a nuclear localization was expected based on sorting prediction software, which also highlight a monopartite nuclear localization signal (NLS) in the primary sequence. However, here we prove that such an "NLS" of ASR1 from tomato is dispensable and non-functional, being the transport of the protein to the nucleus due to simple diffusion across nuclear pores. We attribute such a targeting deficiency to the misplacing in that cryptic NLS of two conserved contiguous lysine residues. Based on previous in vitro experiments regarding quaternary structure, we also carried out live cell imaging assays through confocal microscopy to explore dimer formation in planta. We found homodimers in both the cytosol and the nucleus and demonstrated that assembly of both subunits together can occur in the cytosol, giving rise to translocation of preformed dimers. The presence of dimers was further corroborated by means of in vivo crosslinking of nuclei followed by SDS-PAGE.	[Ricardi, Martiniano M.; Gonzalez, Rodrigo M.; Estevez, Jose M.; Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, IFIByNE CONICET, Buenos Aires, DF, Argentina; [Guaimas, Francisco F.; Jares-Erijman, Elizabeth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Dept Quim Organ, Buenos Aires, DF, Argentina; [Guaimas, Francisco F.; Jares-Erijman, Elizabeth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, CIHIDECAR, Buenos Aires, DF, Argentina; [Burrieza, Hernan P.; Lopez-Fernandez, Maria P.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular FBMC, LFBM, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Ricardi, MM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias, IFIByNE CONICET, Buenos Aires, DF, Argentina.	norbius@fbmc.fcen.uba.ar	Estevez, Jose Manuel/AAZ-9261-2020; Estevez, Jose Manuel/C-2915-2018	Estevez, Jose Manuel/0000-0001-6332-7738; Estevez, Jose Manuel/0000-0001-6332-7738; Ricardi, Martiniano/0000-0002-7904-6305; Iusem, Norberto/0000-0002-3052-2489	Universidad de Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina	Universidad de Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBA), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova R, 2003, PLANT PHYSIOL, V131, P326, DOI 10.1104/pp.009522; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Frankel N, 2003, MOL BIOL EVOL, V20, P1955, DOI 10.1093/molbev/msg214; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HARRIS KF, 1995, MICROSC RES TECHNIQ, V32, P264, DOI 10.1002/jemt.1070320312; Hawkins J, 2007, J PROTEOME RES, V6, P1402, DOI 10.1021/pr060564n; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Maskin L, 2007, BIOCHEM BIOPH RES CO, V352, P831, DOI 10.1016/j.bbrc.2006.11.115; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ricardi MM, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-11; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Urtasun Nicolas, 2010, Open Biochem J, V4, P68, DOI 10.2174/1874091X01004010068; Vogt M, 2011, J CELL SCI, V124, P900, DOI 10.1242/jcs.072520; Wang HJ, 2005, PHYSIOL PLANTARUM, V123, P314, DOI 10.1111/j.1399-3054.2005.00454.x; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082	33	23	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41008	10.1371/journal.pone.0041008	http://dx.doi.org/10.1371/journal.pone.0041008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899993	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900008
J	Sarabdjitsingh, RA; Kofink, D; Karst, H; de Kloet, ER; Joels, M				Sarabdjitsingh, Ratna Angela; Kofink, Daniel; Karst, Henk; de Kloet, E. Ron; Joels, Marian			Stress-Induced Enhancement of Mouse Amygdalar Synaptic Plasticity Depends on Glucocorticoid and beta-Adrenergic Activity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CORTICOTROPIN-RELEASING-FACTOR; BASOLATERAL AMYGDALA; DENTATE GYRUS; EMOTIONAL MEMORY; NORADRENERGIC ACTIVATION; FREQUENCY STIMULATION; PREFRONTAL CORTEX; PRESYNAPTIC LTP; DIETHYL-ETHER	Background: Glucocorticoid hormones, in interaction with noradrenaline, enable the consolidation of emotionally arousing and stressful experiences in rodents and humans. Such interaction is thought to occur at least partly in the basolateral nucleus of the amygdala (BLA) which is crucially involved in emotional memory formation. Extensive evidence points to long-term synaptic potentiation (LTP) as a mechanism contributing to memory formation. Here we determined in adolescent C57/Bl6 mice the effects of stress on LTP in the LA-BLA pathway and the specific roles of corticosteroid and beta-adrenergic receptor activation in this process. Principal Findings: Exposure to 20 min of restraint stress (compared to control treatment) prior to slice preparation enhanced subsequent LTP induction in vitro, without affecting baseline fEPSP responses. The role of glucocorticoid receptors, mineralocorticoid receptors and beta 2-adrenoceptors in the effects of stress was studied by treating mice with the antagonists mifepristone, spironolactone or propranolol respectively (or the corresponding vehicles) prior to stress or control treatment. In undisturbed controls, mifepristone and propranolol administration in vivo did not influence LTP induced in vitro. By contrast, spironolactone caused a gradually attenuating form of LTP, both in unstressed and stressed mice. Mifepristone treatment prior to stress strongly reduced the ability to induce LTP in vitro. Propranolol normalized the stress-induced enhancement of LTP to control levels during the first 10 min after high frequency stimulation, after which synaptic responses further declined. Conclusions: Acute stress changes BLA electrical properties such that subsequent LTP induction is facilitated. Both beta-adrenergic and glucocorticoid receptors are involved in the development of these changes. Mineralocorticoid receptors are important for the maintenance of LTP in the BLA, irrespective of stress-induced changes in the circuit. The prolonged changes in BLA network function after stress may contribute to effective memory formation of emotional and stressful events.	[Sarabdjitsingh, Ratna Angela; Kofink, Daniel; Karst, Henk; Joels, Marian] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [de Kloet, E. Ron] Leiden Univ, Leiden Univ Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sarabdjitsingh, RA (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	r.a.sarabdjitsingh@gmail.com	Karst, Henk/AAD-9281-2021; Joëls, Marian/P-6415-2016	de Kloet, Ron/0000-0001-9176-1830; Joels, Marian/0000-0002-4826-6209	Royal Netherlands Academy of Arts and Sciences	Royal Netherlands Academy of Arts and Sciences	RAS was supported in part by the Royal Netherlands Academy of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Ahmed T, 2006, J NEUROSCI, V26, P3951, DOI 10.1523/JNEUROSCI.4901-05.2006; Akirav I, 2002, J NEUROSCI, V22, P9912; Akirav I, 1999, J NEUROSCI, V19, P10530; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Connor SA, 2011, LEARN MEMORY, V18, P207, DOI 10.1101/lm.2043811; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; de Haan M, 2002, LAB ANIM-UK, V36, P105, DOI 10.1258/0023677021912316; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Ferry B, 1999, J NEUROSCI, V19, P5119; Ferry B, 1997, EUR J NEUROSCI, V9, P1356, DOI 10.1111/j.1460-9568.1997.tb01490.x; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gelinas JN, 2008, LEARN MEMORY, V15, P281, DOI 10.1101/lm.829208; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Herman JP, 1998, J NEUROSCI, V18, P7462; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Huang CC, 1996, J NEUROSCI, V16, P1026; Huang CC, 1998, J NEUROSCI, V18, P2276; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; Huge V, 2009, EUR J PAIN, V13, P124, DOI 10.1016/j.ejpain.2008.03.010; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; IKEGAYA Y, 1995, NEUROSCI RES, V22, P203, DOI 10.1016/0168-0102(95)00894-7; Joels M, 2012, PHARM REV IN PRESS; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2002, EUR J NEUROSCI, V16, P1083, DOI 10.1046/j.1460-9568.2002.02172.x; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kavushansky A, 2006, HIPPOCAMPUS, V16, P35, DOI 10.1002/hipo.20130; Kavushansky A, 2006, J NEUROSCI RES, V84, P1580, DOI 10.1002/jnr.21058; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; Liebmann L, 2009, EUR J NEUROSCI, V30, P800, DOI 10.1111/j.1460-9568.2009.06882.x; Manzanares PAR, 2005, J NEUROSCI, V25, P8725, DOI 10.1523/JNEUROSCI.2260-05.2005; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McIntyre CK, 2002, EUR J NEUROSCI, V16, P1223, DOI 10.1046/j.1460-9568.2002.02188.x; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Nakao K, 2004, P NATL ACAD SCI USA, V101, P14270, DOI 10.1073/pnas.0405709101; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; PITKANEN A, 1995, J COMP NEUROL, V356, P288, DOI 10.1002/cne.903560211; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Pu Zhenwei, 2009, Learn Mem, V16, P155, DOI 10.1101/lm.1272409; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Richter-Levin G, 2004, NEUROSCIENTIST, V10, P31, DOI 10.1177/1073858403259955; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Roozendaal B, 2008, J NEUROSCI, V28, P6642, DOI 10.1523/JNEUROSCI.1336-08.2008; Roozendaal B, 2006, NEUROBIOL LEARN MEM, V86, P249, DOI 10.1016/j.nlm.2006.03.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; SHORS TJ, 1994, BRAIN RES, V666, P232, DOI 10.1016/0006-8993(94)90777-3; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; SPENCER RL, 1990, BRAIN RES, V514, P37, DOI 10.1016/0006-8993(90)90433-C; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Vouimba RM, 2005, CEREB CORTEX, V15, P1815, DOI 10.1093/cercor/bhi058; Vouimba RM, 2004, EUR J NEUROSCI, V19, P1887, DOI 10.1111/j.1460-9568.2004.03294.x; Vouimba RM, 2007, NEUROPHARMACOLOGY, V52, P244, DOI 10.1016/j.neuropharm.2006.07.007; Vouimba RM, 2006, STRESS, V9, P29, DOI 10.1080/10253890600610973; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005	80	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42143	10.1371/journal.pone.0042143	http://dx.doi.org/10.1371/journal.pone.0042143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900007	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900022
J	Schlitter, AM; Dorneburg, C; Barth, TFE; Wahl, J; Schulte, JH; Bruuderlein, S; Debatin, KM; Beltinger, C				Schlitter, Anne-Marie; Dorneburg, Carmen; Barth, Thomas F. E.; Wahl, Joachim; Schulte, Johannes H.; Bruederlein, Silke; Debatin, Klaus-Michael; Beltinger, Christian			CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients	PLOS ONE			English	Article							NEURAL CREST MIGRATION; CARBOHYDRATE; EXPRESSION; ADHESION; TUMORS; DIFFERENTIATION; PREDICTS; CRITERIA	Background: Neuroblastoma is thought to originate from neural crest-derived cells. CD57 defines migratory neural crest cells in normal development and is expressed in neuroblastoma. Methodology and Principal Findings: We investigated the role of CD57 expression in neuroblastoma cells ex situ and in situ. Compared to CD57(low) U-NB1 neuroblastoma cells, CD57(high) cells developed tumors with decreased latency after orthotopic transplantation into adrenal glands of mice. In addition, CD57(high) U-NB1 and SK-N-BE(2)-C neuroblastoma cells were also more clonogenic, induced more spheres and were less lineage-restricted. CD57(high) cells attached better to endothelial cells and showed enhanced invasiveness. While invasion of U-NB1 cells was inhibited by blocking antibodies against CD57, neither invasion of SK-N-BE(2)-C cells nor adhesion of U-NB1 and SK-N-BE(2)-C cells was attenuated. After tail vein injection only CD57(high) cells generated liver metastases, while overall metastatic rate was not increased as compared to CD57(low) cells. In stroma-poor neuroblastoma of patients CD57(high) cells were associated with undifferentiated tumor cells across all stages and tended to be more frequent after chemotherapy. Conclusion: Strong expression of CD57 correlates with aggressive attributes of U-NB1 and SK-N-BE(2)-C neuroblastoma cells and is linked with undifferentiated neuroblastoma cells in patients.	[Schlitter, Anne-Marie; Dorneburg, Carmen; Wahl, Joachim; Debatin, Klaus-Michael; Beltinger, Christian] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Barth, Thomas F. E.; Bruederlein, Silke] Univ Med Ctr Ulm, Inst Pathol, Ulm, Germany; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Essen, Germany	Ulm University; Ulm University; University of Duisburg Essen	Schlitter, AM (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany.	christian.beltinger@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Schulte, Johannes H./V-2474-2018; Schulte, Johannes H/G-3981-2010	Debatin, Klaus-Michael/0000-0002-8397-1886; Schulte, Johannes Hubertus/0000-0003-0671-1201	Wilhelm Sander-Stiftung; Deutsche Krebshilfe	Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported in part by grants from the Wilhelm Sander-Stiftung and the Deutsche Krebshilfe (to C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABO T, 1981, J IMMUNOL, V127, P1024; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; COOPER MJ, 1992, J CLIN INVEST, V90, P2402, DOI 10.1172/JCI116131; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; Hall H, 1997, EUR J BIOCHEM, V246, P233, DOI 10.1111/j.1432-1033.1997.t01-1-00233.x; Hall H, 1997, J NEUROCHEM, V68, P544; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; HARMS D, 1979, KLIN PADIATR, V191, P228; Hoehner JC, 1998, LAB INVEST, V78, P29; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Suzuki-Anekoji M, 2011, J BIOL CHEM, V286, P32824, DOI 10.1074/jbc.M111.245886; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; Tweddle DA, 2001, CANCER RES, V61, P8; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42025	10.1371/journal.pone.0042025	http://dx.doi.org/10.1371/journal.pone.0042025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900004	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900019
J	Shiga, A; Ishihara, T; Miyashita, A; Kuwabara, M; Kato, T; Watanabe, N; Yamahira, A; Kondo, C; Yokoseki, A; Takahashi, M; Kuwano, R; Kakita, A; Nishizawa, M; Takahashi, H; Onodera, O				Shiga, Atsushi; Ishihara, Tomohiko; Miyashita, Akinori; Kuwabara, Misaki; Kato, Taisuke; Watanabe, Norihiro; Yamahira, Akie; Kondo, Chigusa; Yokoseki, Akio; Takahashi, Masuhiro; Kuwano, Ryozo; Kakita, Akiyoshi; Nishizawa, Masatoyo; Takahashi, Hitoshi; Onodera, Osamu			Alteration of POLDIP3 Splicing Associated with Loss of Function of TDP-43 in Tissues Affected with ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; CELL-GROWTH; IN-VIVO; INCLUSIONS; MUTATIONS; DEPLETION; GENE; NEURODEGENERATION; HETEROGENEITY	Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease caused by selective loss of motor neurons. In the ALS motor neurons, TAR DNA-binding protein of 43 kDa (TDP-43) is dislocated from the nucleus to cytoplasm and forms inclusions, suggesting that loss of a nuclear function of TDP-43 may underlie the pathogenesis of ALS. TDP-43 functions in RNA metabolism include regulation of transcription, mRNA stability, and alternative splicing of pre-mRNA. However, a function of TDP-43 in tissue affected with ALS has not been elucidated. We sought to identify the molecular indicators reflecting on a TDP-43 function. Using exon array analysis, we observed a remarkable alteration of splicing in the polymerase delta interacting protein 3 (POLDIP3) as a result of the depletion of TDP-43 expression in two types of cultured cells. In the cells treated with TDP-43 siRNA, wild-type POLDIP3 (variant-1) decreased and POLDIP3 lacking exon 3 (variant-2) increased. The RNA binding ability of TDP-43 was necessary for inclusion of POLDIP3 exon 3. Moreover, we found an increment of POLDIP3 variant-2 mRNA in motor cortex, spinal cord and spinal motor neurons collected by laser capture microdissection with ALS. Our results suggest a loss of TDP-43 function in tissues affected with ALS, supporting the hypothesis that a loss of function of TDP-43 underlies the pathogenesis of ALS.	[Shiga, Atsushi; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Ishihara, Tomohiko; Kuwabara, Misaki; Kato, Taisuke; Kondo, Chigusa; Yokoseki, Akio; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Mol Genet,Genome Sci Branch, Niigata, Japan; [Watanabe, Norihiro; Yamahira, Akie; Takahashi, Masuhiro] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Niigata, Japan; [Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol Neurosci, Resource Branch Brain Dis Res, Niigata, Japan; [Onodera, Osamu] Niigata Univ, Brain Res Inst, Dept Mol Neurosci, Resource Branch Brain Dis Res, Niigata, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Niigata University; Niigata University	Shiga, A (corresponding author), Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013; Ishihara, Tomohiko/AAJ-8742-2020	Onodera, Osamu/0000-0003-3354-5472; Ishihara, Tomohiko/0000-0001-9915-8665; Kato, Taisuke/0000-0001-5696-7104; Kato, Taisuke/0000-0003-0738-4951	Japan Society for the Promotion of Science [23240049, 22249036, 22659169]; Ministry of Education, Culture, Sports, Sceience and Technology, Japan [22113506]; Ministry of Health, Labor and Welfare, Japan [201024015A]; Grants-in-Aid for Scientific Research [24510275] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Sceience and Technology, Japan; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-1 in-Aid for Scientific Research (A) (23240049, 22249036) and Grant-in-Aid for challenging Exploratory Research (22659169) from Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas (22113506) from Ministry of Education, Culture, Sports, Sceience and Technology, Japan, and Grant-in-Aid for the Research Committee of CNS Degenerative Diseases (201024015A) form Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mori F, 2010, NEUROPATH APPL NEURO, V36, P345, DOI 10.1111/j.1365-2990.2010.01081.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	33	53	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43120	10.1371/journal.pone.0043120	http://dx.doi.org/10.1371/journal.pone.0043120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900096	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900114
J	Stephenne, X; Nicastro, E; Eeckhoudt, S; Hermans, C; Nyabi, O; Lombard, C; Najimi, M; Sokal, E				Stephenne, Xavier; Nicastro, Emanuele; Eeckhoudt, Stephane; Hermans, Cedric; Nyabi, Omar; Lombard, Catherine; Najimi, Mustapha; Sokal, Etienne			Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR EXPRESSION; SMOOTH-MUSCLE-CELLS; RECOMBINANT HIRUDIN; VEIN THROMBOSIS; STEM-CELLS; FACTOR XA; TRANSPLANTATION; HEPATOCYTES; FIBROBLASTS	Islet and hepatocyte transplantation are associated with tissue factor-dependent activation of coagulation which elicits instant blood mediated inflammatory reaction, thereby contributing to a low rate of engraftment. The aim of this study was i) to evaluate the procoagulant activity of human adult liver-derived mesenchymal progenitor cells (hALPCs), ii) to compare it to other mesenchymal cells of extra-hepatic (bone marrow mesenchymal stem cells and skin fibroblasts) or liver origin (liver myofibroblasts), and iii) to determine the ways this activity could be modulated. Using a whole blood coagulation test (thromboelastometry), we demonstrated that all analyzed cell types exhibit procoagulant activity. The hALPCs pronounced procoagulant activity was associated with an increased tissue factor and a decreased tissue factor pathway inhibitor expression as compared with hepatocytes. At therapeutic doses, the procoagulant effect of hALPCs was inhibited by neither antithrombin activators nor direct factor Xa inhibitor or direct thrombin inhibitors individually. However, concomitant administration of an antithrombin activator or direct factor Xa inhibitor and direct thrombin inhibitor proved to be a particularly effective combination for controlling the procoagulant effects of hALPCs both in vitro and in vivo. The results suggest that this dual antithrombotic therapy should also improve the efficacy of cell transplantation in humans.	[Stephenne, Xavier; Nicastro, Emanuele; Nyabi, Omar; Lombard, Catherine; Najimi, Mustapha; Sokal, Etienne] Catholic Univ Louvain, Inst Rech Expt & Clin, Unite Rech PEDI, B-1200 Brussels, Belgium; [Stephenne, Xavier; Nicastro, Emanuele; Sokal, Etienne] Clin Univ St Luc, Serv Gastroenterol & Hepatol Pediat, B-1200 Brussels, Belgium; [Eeckhoudt, Stephane] Clin Univ St Luc, Lab Hematol Hemostase, B-1200 Brussels, Belgium; [Hermans, Cedric] Clin Univ St Luc, Serv Hematol, Unite Hemostase Thrombose, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Stephenne, X (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Unite Rech PEDI, B-1200 Brussels, Belgium.	xavier.stephenne@uclouvain.be	Nicastro, Emanuele/AAJ-2274-2020; Nicastro, Emanuele/K-1260-2018; Hermans, Cedric/AAK-9433-2020	Nicastro, Emanuele/0000-0002-4518-9375; Sokal, Etienne/0000-0001-5597-4708; Lombard, Catherine/0000-0002-5653-9545	Belgian National Fund for Medical Research (FRSM); Belgian National Fund for Scientific Research [FNRS-3.4521.09]	Belgian National Fund for Medical Research (FRSM)(Fonds de la Recherche Scientifique - FNRS); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	Research was supported by the Belgian National Fund for Medical Research (FRSM). X. Stephenne is recipient of a grant from the Belgian National Fund for Scientific Research (FNRS-3.4521.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban S, 2001, THROMB HAEMOSTASIS, V85, P824; Baccarani U, 2005, TRANSPLANT INT, V18, P750, DOI 10.1111/j.1432-2277.2005.00127.x; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1663; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Beuneu C, 2004, DIABETES, V53, P1407, DOI 10.2337/diabetes.53.6.1407; BIEMOND BJ, 1994, THROMB HAEMOSTASIS, V72, P377; Khuu DN, 2011, CELL TRANSPLANT, V20, P287, DOI 10.3727/096368910X516655; Feng LM, 2009, CLIN THER, V31, P1559, DOI 10.1016/j.clinthera.2009.07.017; Fisher RA, 2000, TRANSPLANTATION, V69, P303, DOI 10.1097/00007890-200001270-00018; Forbes TJ, 2011, CATHETER CARDIO INTE, V77, P671, DOI 10.1002/ccd.22817; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Garg HG, 2000, AM J PHYSIOL-LUNG C, V279, pL779, DOI 10.1152/ajplung.2000.279.5.L779; GAST A, 1994, BLOOD COAGUL FIBRIN, V5, P879, DOI 10.1097/00001721-199412000-00003; Gerotziafas GT, 2004, THROMB HAEMOSTASIS, V92, P1296, DOI 10.1160/TH03-11-0694; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; Koutouzis M, 2011, HEART, V97, P1484, DOI 10.1136/hrt.2011.224709; Lysy PA, 2008, CELL PROLIFERAT, V41, P36, DOI 10.1111/j.1365-2184.2007.00507.x; Lysy PA, 2008, WORLD J GASTROENTERO, V14, P864, DOI 10.3748/wjg.14.864; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Meddahi S, 2009, BLOOD COAGUL FIBRIN, V20, P207, DOI 10.1097/MBC.0b013e3283273529; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Mrabat H, 2009, J CELL PHYSIOL, V221, P603, DOI 10.1002/jcp.21891; Najimi M, 2005, Minerva Pediatr, V57, P243; Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154; PATTON WA, 1995, BIOCHEM J, V311, P461, DOI 10.1042/bj3110461; Pepke W, 2011, CARDIOVASC THER; POUPLARD C, 1995, THROMB RES, V80, P527, DOI 10.1016/0049-3848(95)00208-1; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076; Sokal EM, 2003, TRANSPLANTATION, V76, P735, DOI 10.1097/01.TP.0000077420.81365.53; Stephenne X, 2005, AM J TRANSPLANT, V5, P2058, DOI 10.1111/j.1600-6143.2005.00935.x; Stephenne X, 2006, GASTROENTEROLOGY, V130, P1317, DOI 10.1053/j.gastro.2006.01.008; Stephenne X, 2007, LIVER TRANSPLANT, V13, P599, DOI 10.1002/lt.21128; TAUBMAN MB, 1993, J CLIN INVEST, V91, P547, DOI 10.1172/JCI116234; Wang J, 2009, BBA-GEN SUBJECTS, V1790, P1689, DOI 10.1016/j.bbagen.2009.09.002; Xuereb JM, 1999, THROMB HAEMOSTASIS, V81, P151	39	46	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42819	10.1371/journal.pone.0042819	http://dx.doi.org/10.1371/journal.pone.0042819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900053	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900071
J	Drion, G; Franci, A; Seutin, V; Sepulchre, R				Drion, Guillaume; Franci, Alessio; Seutin, Vincent; Sepulchre, Rodolphe			A Novel Phase Portrait for Neuronal Excitability	PLOS ONE			English	Article							PIG THALAMIC NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; IONIC BASIS; BURST; MODEL; SPIKE; OSCILLATIONS; CHANNELS; CURRENTS; CELLS	Fifty years ago, FitzHugh introduced a phase portrait that became famous for a twofold reason: it captured in a physiological way the qualitative behavior of Hodgkin-Huxley model and it revealed the power of simple dynamical models to unfold complex firing patterns. To date, in spite of the enormous progresses in qualitative and quantitative neural modeling, this phase portrait has remained a core picture of neuronal excitability. Yet, a major difference between the neurophysiology of 1961 and of 2011 is the recognition of the prominent role of calcium channels in firing mechanisms. We show that including this extra current in Hodgkin-Huxley dynamics leads to a revision of FitzHugh-Nagumo phase portrait that affects in a fundamental way the reduced modeling of neural excitability. The revisited model considerably enlarges the modeling power of the original one. In particular, it captures essential electrophysiological signatures that otherwise require non-physiological alteration or considerable complexification of the classical model. As a basic illustration, the new model is shown to highlight a core dynamical mechanism by which calcium channels control the two distinct firing modes of thalamocortical neurons.	[Drion, Guillaume; Seutin, Vincent] Univ Liege, Neurophysiol Unit, Liege, Belgium; [Drion, Guillaume; Seutin, Vincent] Univ Liege, GIGA Neurosci, Liege, Belgium; [Drion, Guillaume; Sepulchre, Rodolphe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Drion, Guillaume; Sepulchre, Rodolphe] Univ Liege, GIGA Res, Liege, Belgium; [Franci, Alessio] Univ Paris 11, L2S, Gif Sur Yvette, France	University of Liege; University of Liege; University of Liege; University of Liege; UDICE-French Research Universities; Universite Paris Saclay	Drion, G (corresponding author), Univ Liege, Neurophysiol Unit, Liege, Belgium.	R.Sepulchre@ulg.ac.be		Drion, Guillaume/0000-0002-8076-9500	European Union Seventh Framework Programme [FP7] HYCON2 Network of excellence [n 257462]; F.R.S.-FNRS [9.4560.03]; Belgian Science Policy [IAP6/31, IAP6/4]; Fonds Leon Fredericq	European Union Seventh Framework Programme [FP7] HYCON2 Network of excellence; F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); Fonds Leon Fredericq	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement n 257462 HYCON2 Network of excellence, from grant 9.4560.03 from the F.R.S.-FNRS (VS), from two grants from the Belgian Science Policy (IAP6/31 (VS) and IAP6/4 (RS)), and from the Fonds Leon Fredericq (GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Canavier CC, 2006, J NEUROPHYSIOL, V96, P2549, DOI 10.1152/jn.00704.2006; Chen S, 2008, J PHYSIOL-LONDON, V586, P1351, DOI 10.1113/jphysiol.2007.148171; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Drion G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002050; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Ermentrout G.B., 2010, INTERDISCIPLINARY AP; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Franci A, 2011, ARXIV11122588V1; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; Halnes G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002160; Hille B., 1991, IONIC CHANNELS EXCIT; Hirsh M. V., 1977, LECT NOTES MATH; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huguenard J R, 1999, Adv Neurol, V79, P991; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2010, PHILOS T R SOC A, V368, P5061, DOI 10.1098/rsta.2010.0130; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; KOKOZ YM, 1973, BIOFIZIKA+, V18, P878; KRINSKII VI, 1973, BIOFIZIKA+, V18, P506; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Pospischil M, 2011, BIOL CYBERN, V105, P167, DOI 10.1007/s00422-011-0458-2; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; Richert M, 2011, FRONT NEUROINFORM, V5, P19, DOI [10.3389/fninf.2011.00019, DOI 10.3389/FNINF.2011.00019]; RINZEL J, 1985, FED PROC, V44, P2944; Rinzel J, 1989, ANAL NEURAL EXCITABI, P135; Seydel R., 2010, PRACTICAL BIFURCATIO, DOI [10.1007/978-1-4419-1740-9, DOI 10.1007/978-1-4419-1740-9]; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shin HS, 2006, CELL CALCIUM, V40, P191, DOI 10.1016/j.ceca.2006.04.023; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Touboul J, 2009, SIAM J APPL DYN SYST, V8, P1462, DOI 10.1137/080742762; WANG XJ, 1991, J NEUROPHYSIOL, V66, P839, DOI 10.1152/jn.1991.66.3.839; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Zaman T, 2011, NEURON, V70, P95, DOI 10.1016/j.neuron.2011.02.042; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360; Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816, DOI 10.1152/jn.1997.77.5.2816	51	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41806	10.1371/journal.pone.0041806	http://dx.doi.org/10.1371/journal.pone.0041806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905107	Green Published, gold			2022-12-25	WOS:000307331100018
J	Filippi-Chiela, EC; Oliveira, MM; Jurkovski, B; Callegari-Jacques, SM; da Silva, VD; Lenz, G				Filippi-Chiela, Eduardo C.; Oliveira, Manuel M.; Jurkovski, Bruno; Callegari-Jacques, Sidia Maria; da Silva, Vinicius Duval; Lenz, Guido			Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities	PLOS ONE			English	Article							CYTOTOXICITY; RESVERATROL; INHIBITORS; DEATH; CELLS	Several cellular mechanisms affect nuclear morphology which can therefore be used to assess certain processes. Here, we present an analytic tool to quantify the number of cells in a population that present characteristics of senescence, apoptosis or nuclear irregularities through nuclear morphometric analysis. The tool presented here is based on nuclear image analysis and evaluation of size and regularity of adhered cells in culture. From 46 measurements of nuclear morphometry, principal component analysis filtered four measurements that best separated regular from irregular nuclei. These measurements, namely aspect, area box, radius ratio and roundness were combined into a single nuclear irregularity index (NII). Normal nuclei are used to set the parameters for a given cell type, and different nuclear phenotypes are separated in an area versus NII plot. The tool was validated with beta-gal staining for senescence and annexin or caspases inhibitor for apoptosis as well as several treatments that induce different cellular phenotypes. This method provides a direct and objective way of screening normal, senescent, apoptotic and nuclear irregularities which may occur during failed mitosis or mitotic catastrophe, which may be very useful in basic and clinical research.	[Filippi-Chiela, Eduardo C.; Lenz, Guido] Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, RS, Brazil; [Lenz, Guido] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil; [Oliveira, Manuel M.; Jurkovski, Bruno] Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil; [Callegari-Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Grad Program Genet & Mol Biol, Dept Stat, Porto Alegre, RS, Brazil; [da Silva, Vinicius Duval] Pontificia Univ Catolica Rio Grande do Sul, Sao Lucas Hosp, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Filippi-Chiela, EC (corresponding author), Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, RS, Brazil.	lenz@ufrgs.br	Lenz, Guido/A-7618-2008; da Silva, Vinicius Duval/AAE-9220-2021; da Silva, Vinicius D/C-5289-2013; Oliveira, Manuel M/H-1508-2011; Filippi-Chiela, Eduardo/F-1959-2014; Callegari-Jacques, Sidia M/H-1774-2016	da Silva, Vinicius Duval/0000-0003-3515-0263; da Silva, Vinicius D/0000-0003-3515-0263; Oliveira, Manuel M/0000-0003-4957-9984; Filippi-Chiela, Eduardo/0000-0001-8192-3779; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [476491/2008-8, 472512/20110]; Pronex-Fapergs/CNPq [10/0044-3]; Pronem/FAPERGS [11/2072-2]; CNPq	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pronex-Fapergs/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Pronem/FAPERGS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant numbers 476491/2008-8 and 472512/20110, Pronex-Fapergs/CNPq no: 10/0044-3 and Pronem/FAPERGS 11/2072-2. ECFC, MMO, BJ, VDS and GL are recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2010, ONCOGENE; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Jung HJ, 2000, PLANTA MED, V66, P74, DOI 10.1055/s-0029-1243113; KONDO S, 1995, CANCER RES, V55, P6166; Rello-Varona S, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.6; Roninson IB, 2003, CANCER RES, V63, P2705; Saraste A, 1999, HERZ, V24, P189, DOI 10.1007/BF03044961; Sekhar KR, 2007, CANCER RES, V67, P695, DOI 10.1158/0008-5472.CAN-06-3212; Shao RG, 2004, ACTA PHARMACOL SIN, V25, P756; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Xia L, 2008, BRIT J PHARMACOL, V155, P387, DOI 10.1038/bjp.2008.272; Zamin LL, 2009, CANCER SCI, V100, P1655, DOI 10.1111/j.1349-7006.2009.01215.x	17	115	117	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42522	10.1371/journal.pone.0042522	http://dx.doi.org/10.1371/journal.pone.0042522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905142	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100045
J	Toriseva, M; Laato, M; Carpen, O; Ruohonen, ST; Savontaus, E; Inada, M; Krane, SM; Kahari, VM				Toriseva, Mervi; Laato, Matti; Carpen, Olli; Ruohonen, Suvi T.; Savontaus, Eriika; Inada, Masaki; Krane, Stephen M.; Kahari, Veli-Matti			MMP-13 Regulates Growth of Wound Granulation Tissue and Modulates Gene Expression Signatures Involved in Inflammation, Proteolysis, and Cell Viability	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; COLLAGENASE-3 MMP-13; NEUROPEPTIDE-Y; HUMAN SKIN; 3-DIMENSIONAL COLLAGEN; KERATINOCYTE MIGRATION; ENDOTHELIAL-CELLS; FACTOR-BETA; ANGIOGENESIS; REPAIR	Proteinases play a pivotal role in wound healing by regulating cell-matrix interactions and availability of bioactive molecules. The role of matrix metalloproteinase-13 (MMP-13) in granulation tissue growth was studied in subcutaneously implanted viscose cellulose sponge in MMP-13 knockout (Mmp13(-/-)) and wild type (WT) mice. The tissue samples were harvested at time points day 7, 14 and 21 and subjected to histological analysis and gene expression profiling. Granulation tissue growth was significantly reduced (42%) at day 21 in Mmp13(-/-) mice. Granulation tissue in Mmp13(-/-) mice showed delayed organization of myofibroblasts, increased microvascular density at day 14, and virtual absence of large vessels at day 21. Gene expression profiling identified differentially expressed genes in Mmp13(-/-) mouse granulation tissue involved in biological functions including inflammatory response, angiogenesis, cellular movement, cellular growth and proliferation and proteolysis. Among genes linked to angiogenesis, Adamts4 and Npy were significantly upregulated in early granulation tissue in Mmp13(-/-) mice, and a set of genes involved in leukocyte motility including Il6 were systematically downregulated at day 14. The expression of Pdgfd was downregulated in Mmp13(-/-) granulation tissue in all time points. The expression of matrix metalloproteinases Mmp2, Mmp3, Mmp9 was also significantly downregulated in granulation tissue of Mmp13(-/-) mice compared to WT mice. Mmp13(-/-) mouse skin fibroblasts displayed altered cell morphology and impaired ability to contract collagen gel and decreased production of MMP-2. These results provide evidence for an important role for MMP-13 in wound healing by coordinating cellular activities important in the growth and maturation of granulation tissue, including myofibroblast function, inflammation, angiogenesis, and proteolysis.	[Toriseva, Mervi; Kahari, Veli-Matti] Univ Turku, Dept Dermatol, Turku, Finland; [Toriseva, Mervi; Kahari, Veli-Matti] Univ Turku, MediCity Res Lab, Turku, Finland; [Laato, Matti] Turku Univ Hosp, Dept Surg, FIN-20520 Turku, Finland; [Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Ruohonen, Suvi T.; Savontaus, Eriika] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Inada, Masaki] Tokyo Univ Agr & Technol, Fac Engn, Dept Life Sci & Biotechnol, Tokyo, Japan; [Krane, Stephen M.] Harvard Univ, Sch Med, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Krane, Stephen M.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Tokyo University of Agriculture & Technology; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Toriseva, M (corresponding author), Univ Turku, Dept Dermatol, Turku, Finland.	veli-matti.kahari@utu.fi	inada, masaki/D-1581-2013; Kähäri, Veli-Matti/E-5144-2011; Kahari, Veli-Matti/T-4925-2019	inada, masaki/0000-0002-5066-8506; Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368; Savontaus, Eriika/0000-0003-3421-0367; Toriseva, Mervi/0000-0003-3024-6282	Academy of Finland [137687]; Turku University Hospital [13336]; Sigrid Juselius Foundation; Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila's Memory Foundation; Paulo Foundation; Finnish Cultural Foundation; U.S. National Institutes of Health; Cancer Foundation Finland sr [110087, 100104] Funding Source: researchfish	Academy of Finland(Academy of Finland); Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Research Foundation of Finland; Orion-Farmos Research Foundation; K. Albin Johansson's Foundation; Southwestern Finnish Cancer Foundation; Maud Kuistila's Memory Foundation; Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation Finland sr	The study has been supported by grants from the Academy of Finland (project 137687), Turku University Hospital (project 13336), the Sigrid Juselius Foundation, the Cancer Research Foundation of Finland, and by personal grants (to M. Toriseva) from Orion-Farmos Research Foundation, K. Albin Johansson's Foundation, Southwestern Finnish Cancer Foundation, Maud Kuistila's Memory Foundation, Paulo Foundation and Finnish Cultural Foundation. Generation of the Mmp13<SUP>-/-</SUP> mice and backcrossing into WT mice was supported by grants from the U.S. National Institutes of Health to S. M. Krane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN MS, 1994, BRIT J DERMATOL, V131, P634, DOI 10.1111/j.1365-2133.1994.tb04974.x; Ahokas K, 2005, J INVEST DERMATOL, V124, P849, DOI 10.1111/j.0022-202X.2005.23640.x; Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Farshchian M, 2011, AM J PATHOL, V179, P1110, DOI 10.1016/j.ajpath.2011.05.012; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GACK S, 1995, CELL GROWTH DIFFER, V6, P759; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hieta N, 2003, J INVEST DERMATOL, V121, P997, DOI 10.1046/j.1523-1747.2003.12533.x; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inkinen K, 2000, APMIS, V108, P318, DOI 10.1034/j.1600-0463.2000.d01-63.x; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Johansson N, 1997, AM J PATHOL, V151, P499; Kahn J, 2000, AM J PATHOL, V156, P1887, DOI 10.1016/S0002-9440(10)65062-6; Kato T, 2001, FEBS LETT, V508, P187, DOI 10.1016/S0014-5793(01)02897-6; Koulu M, 2004, ANN MED, V36, P232, DOI 10.1080/07853890410031236; LAATO M, 1987, BIOCHEM J, V247, P385, DOI 10.1042/bj2470385; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lohi J, 2001, J BIOL CHEM, V276, P10134, DOI 10.1074/jbc.M001599200; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mirastschijski U, 2002, HUM PATHOL, V33, P355, DOI 10.1053/hupa.2002.32221; Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Nikkola J, 2002, INT J CANCER, V97, P432, DOI 10.1002/ijc.1636; Nowacki S, 2008, ONCOGENE, V27, P3329, DOI 10.1038/sj.onc.1210996; Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Pins GD, 2000, J INVEST DERMATOL, V114, P647, DOI 10.1046/j.1523-1747.2000.00858.x; Ravanti L, 2001, FASEB J, V15, P1098, DOI 10.1096/fj.00-0588fje; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Roy S, 2008, PHYSIOL GENOMICS, V34, P162, DOI 10.1152/physiolgenomics.00045.2008; Salter RC, 2011, INT J BIOCHEM CELL B, V43, P805, DOI 10.1016/j.biocel.2011.02.005; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Stokes A, 2010, CLIN CANCER RES, V16, P2022, DOI 10.1158/1078-0432.CCR-09-2525; Tommila M, 2011, J MOL CELL BIOL, V3, P190, DOI 10.1093/jmcb/mjq036; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Toriseva MJ, 2007, J INVEST DERMATOL, V127, P49, DOI 10.1038/sj.jid.5700500; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Vaalamo M, 1997, J INVEST DERMATOL, V109, P96, DOI 10.1111/1523-1747.ep12276722; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; Veit G, 2011, J BIOL CHEM, V286, P27804, DOI 10.1074/jbc.M111.220046; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	65	65	66	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42596	10.1371/journal.pone.0042596	http://dx.doi.org/10.1371/journal.pone.0042596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880047	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900045
J	Holtta, M; Zetterberg, H; Mirgorodskaya, E; Mattsson, N; Blennow, K; Gobom, J				Holtta, Mikko; Zetterberg, Henrik; Mirgorodskaya, Ekaterina; Mattsson, Niklas; Blennow, Kaj; Gobom, Johan			Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS	PLOS ONE			English	Article							SCLEROSIS-RELATED PROTEINS; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; MULTIPLE-SCLEROSIS; SERUM PEPTIDOME; FRONTOTEMPORAL DEMENTIA; PROTEOMIC ANALYSIS; IDENTIFICATION; BIOMARKERS; WEIGHT	We report on the analysis of endogenous peptides in cerebrospinal fluid (CSF) by mass spectrometry. A method was developed for preparation of peptide extracts from CSF. Analysis of the extracts by offline LC-MALDI MS resulted in the detection of 3,000-4,000 peptide-like features. Out of these, 730 peptides were identified by MS/MS. The majority of these peptides have not been previously reported in CSF. The identified peptides were found to originate from 104 proteins, of which several have been reported to be involved in different disorders of the central nervous system. These results support the notion that CSF peptidomics may be viable complement to proteomics in the search of biomarkers of CNS disorders.	[Holtta, Mikko; Zetterberg, Henrik; Mattsson, Niklas; Blennow, Kaj; Gobom, Johan] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden; [Mirgorodskaya, Ekaterina] Univ Gothenburg, Dept Occupat & Environm Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Holtta, M (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Clin Neurochem Lab,Dept Psychiat & Neurochem, Gothenburg, Sweden.	johan.gobom@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Holtta, Mikko/0000-0001-6024-3686				Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Benarroch EE, 2009, NEUROLOGY, V72, P1016, DOI 10.1212/01.wnl.0000345258.18071.54; Berger T, 2000, ADV RES NEURODEGENER, V8, P351; Berven FS, 2007, PROTEOM CLIN APPL, V1, P699, DOI 10.1002/prca.200700126; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Flechsig E, 2004, CURR MOL MED, V4, P337, DOI 10.2174/1566524043360645; Gu CG, 1999, ANAL CHIM ACTA, V397, P247, DOI 10.1016/S0003-2670(99)00409-2; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Huang HL, 2005, ELECTROPHORESIS, V26, P2843, DOI 10.1002/elps.200500167; Huang JTJ, 2006, PLOS MED, V3, P2145, DOI 10.1371/journal.pmed.0030428; Huhmer AF, 2006, DIS MARKERS, V22, P3; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Jurado R., 1990, CEREBROSPINAL FLUID; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Liotta LA, 2006, J CLIN INVEST, V116, P26, DOI 10.1172/JCI27467; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; Maccarrone G, 2004, ELECTROPHORESIS, V25, P2402, DOI 10.1002/elps.200305909; Mattsson N, 2007, J NEUROCHEM, V103, P1932, DOI 10.1111/j.1471-4159.2007.04985.x; Mattsson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031084; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shores KS, 2007, J PROTEOME RES, V6, P3739, DOI 10.1021/pr070293w; Sickmann A, 2000, ELECTROPHORESIS, V21, P2721, DOI 10.1002/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Stark M, 2001, J CHROMATOGR B, V754, P357, DOI 10.1016/S0378-4347(00)00628-9; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Stoop MP, 2009, J PROTEOME RES, V8, P1404, DOI 10.1021/pr8010155; Takeda K, 2004, FASEB J, V18, P1755, DOI 10.1096/fj.03-1070fje; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wenner BR, 2004, J PROTEOME RES, V3, P97, DOI 10.1021/pr034070r; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; YU W, 1993, ANAL CHEM, V65, P3015, DOI 10.1021/ac00069a014; Yuan XL, 2005, J MASS SPECTROM, V40, P176, DOI 10.1002/jms.737; Yuan XL, 2005, PROTEOMICS, V5, P541, DOI 10.1002/pmic.200400934; Zhang J, 2005, J ALZHEIMERS DIS, V8, P377; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	53	51	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42555	10.1371/journal.pone.0042555	http://dx.doi.org/10.1371/journal.pone.0042555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880031	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000046
J	Vasileiadis, S; Puglisi, E; Arena, M; Cappa, F; Cocconcelli, PS; Trevisan, M				Vasileiadis, Sotirios; Puglisi, Edoardo; Arena, Maria; Cappa, Fabrizio; Cocconcelli, Pier S.; Trevisan, Marco			Soil Bacterial Diversity Screening Using Single 16S rRNA Gene V Regions Coupled with Multi-Million Read Generating Sequencing Technologies	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ECOSYSTEMS; POLYMERASE	The novel multi-million read generating sequencing technologies are very promising for resolving the immense soil 16S rRNA gene bacterial diversity. Yet they have a limited maximum sequence length screening ability, restricting studies in screening DNA stretches of single 16S rRNA gene hypervariable (V) regions. The aim of the present study was to assess the effects of properties of four consecutive V regions (V3-6) on commonly applied analytical methodologies in bacterial ecology studies. Using an in silico approach, the performance of each V region was compared with the complete 16S rRNA gene stretch. We assessed related properties of the soil derived bacterial sequence collection of the Ribosomal Database Project (RDP) database and concomitantly performed simulations based on published datasets. Results indicate that overall the most prominent V region for soil bacterial diversity studies was V3, even though it was outperformed in some of the tests. Despite its high performance during most tests, V4 was less conserved along flanking sites, thus reducing its ability for bacterial diversity coverage. V5 performed well in the non-redundant RDP database based analysis. However V5 did not resemble the full-length 16S rRNA gene sequence results as well as V3 and V4 did when the natural sequence frequency and occurrence approximation was considered in the virtual experiment. Although, the highly conserved flanking sequence regions of V6 provide the ability to amplify partial 16S rRNA gene sequences from very diverse owners, it was demonstrated that V6 was the least informative compared to the rest examined V regions. Our results indicate that environment specific database exploration and theoretical assessment of the experimental approach are strongly suggested in 16S rRNA gene based bacterial diversity studies.	[Vasileiadis, Sotirios; Arena, Maria; Trevisan, Marco] Univ Cattolica Sacro Cuore, Inst Agr & Environm Chem, Fac Agr Sci, Piacenza, Italy; [Puglisi, Edoardo; Cappa, Fabrizio; Cocconcelli, Pier S.] Inst Microbiol, Piacenza, Italy	Catholic University of the Sacred Heart	Vasileiadis, S (corresponding author), Univ Cattolica Sacro Cuore, Inst Agr & Environm Chem, Fac Agr Sci, Piacenza, Italy.	marco.trevisan@unicatt.it	Vasileiadis, Sotirios/G-4119-2014; COCCONCELLI, Pier Sandro/ABB-5485-2020; Puglisi, Edoardo/O-3876-2019; Puglisi, Edoardo/I-8720-2012	Vasileiadis, Sotirios/0000-0002-2048-8192; COCCONCELLI, Pier Sandro/0000-0003-2212-7611; Puglisi, Edoardo/0000-0001-5051-0971; Puglisi, Edoardo/0000-0001-5051-0971; Cappa, Fabrizio/0000-0003-3814-4766	Cariplo Foundation	Cariplo Foundation(Fondazione Cariplo)	The performance of this study was financially supported by the Cariplo Foundation (URL http://www.fondazionecariplo.it/portal/sv1.do;jsessionid = 91C459E9C6037A2A296CE7B629CC3A17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Degnan PH, 2011, ISME J; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Meyer M, 2010, ILLUMINA SEQUENCING; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roux S, 2011, FEMS MICROBIOL ECOL, V78, P617, DOI 10.1111/j.1574-6941.2011.01190.x; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255	34	83	94	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42671	10.1371/journal.pone.0042671	http://dx.doi.org/10.1371/journal.pone.0042671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880076	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000060
J	Wei, CY; Kumar, S; Kim, IK; Gupta, S				Wei, Chuanyu; Kumar, Sandeep; Kim, Il-Kwon; Gupta, Sudhiranjan			Thymosin Beta 4 Protects Cardiomyocytes from Oxidative Stress by Targeting Anti-Oxidative Enzymes and Anti-Apoptotic Genes	PLOS ONE			English	Article							NF-KAPPA-B; HEART-FAILURE; CARDIAC REPAIR; MITOCHONDRIAL DYSFUNCTION; EPITHELIAL-CELLS; COMPLEX-I; OXYGEN; ACTIVATION; DEATH; OVEREXPRESSION	Background: Thymosin beta-4 (T beta 4) is a ubiquitous protein with many properties relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory mediators. The mechanism by which T beta 4 modulates cardiac protection under oxidative stress is not known. The purpose of this study is to dissect the cardioprotective mechanism of T beta 4 on H2O2 induced cardiac damage. Methods: Rat neonatal cardiomyocytes with or without T beta 4 pretreatment were exposed to H2O2 and expression of antioxidant, apoptotic, and anti-inflammatory genes was evaluated by quantitative real-time PCR and western blotting. ROS levels were estimated by DCF-DA using fluorescent microscopy and fluorimetry. Selected antioxidant, anti-inflammatory and antiapoptotic genes were silenced by siRNA transfections in neonatal cardiomyocytes and effect of T beta 4 on H2O2-induced cardiac damage was evaluated. Results: Pre-treatment of T beta 4 resulted in reduction of the intracellular ROS levels induced by H2O2 in cardiomyocytes. T beta 4 pretreatment also resulted in an increase in the expression of antiapoptotic proteins and reduction of Bax/BCl2 ratio in the cardiomyocytes. Pretreatment with T beta 4 resulted in stimulating the expression of antioxidant enzymes copper/zinc SOD and catalase in cardiomyocytes at both transcription and translation levels. T beta 4 treatment resulted in the increased expression of anti-apoptotic and anti-inflammatory genes. Silencing of Cu/Zn SOD and catalase gene resulted in apoptotic cell death in the cardiomyocytes which was prevented by treatment with T beta 4. Conclusion: This is the first report that demonstrates the effect of T beta 4 on cardiomyocytes and its capability to selectively upregulate anti-oxidative enzymes, anti-inflammatory genes, and antiapoptotic enzymes in the neonatal cardiomyocytes thus preventing cell death thereby protecting the myocardium. T beta 4 treatment resulted in decreased oxidative stress and inflammation in the myocardium under oxidative stress.	[Wei, Chuanyu; Kumar, Sandeep; Kim, Il-Kwon; Gupta, Sudhiranjan] Texas A & M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wei, CY (corresponding author), Texas A & M Hlth Sci Ctr, Coll Med, Dept Med, Div Mol Cardiol,Cent Texas Vet Hlth Care Syst, Temple, TX USA.	sgupta@medicine.tamhsc.edu	Kumar, Sandeep/AAX-4612-2021; wei, chuanyu/H-3150-2016	Kumar, Sandeep/0000-0003-3440-3628; 	Texas A & M Health Science Center, College of Medicine; American Heart Association-National Scientist Development Grant [0835227N]	Texas A & M Health Science Center, College of Medicine; American Heart Association-National Scientist Development Grant(American Heart Association)	This study was partly supported by start-up funds from the Texas A & M Health Science Center, College of Medicine, by an American Heart Association-National Scientist Development Grant (0835227N) to S. Gupta. The authors acknowledge the Central Texas Veterans Affairs Health Care System for providing the research facility to complete this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afanas'ev I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/293769; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Crockford D, 2010, ANN NY ACAD SCI, V1194, P179, DOI 10.1111/j.1749-6632.2010.05492.x; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; DHALLA AK, 1994, AM J PHYSIOL, V266, pH1280, DOI 10.1152/ajpheart.1994.266.4.H1280; Dube KN, 2012, CURR PHARM DESIGN, V18, P799; Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Han H, 2004, AM J PHYSIOL-HEART C, V286, pH2169, DOI 10.1152/ajpheart.00199.2003; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Ho JHC, 2008, BRIT J OPHTHALMOL, V92, P992, DOI 10.1136/bjo.2007.136747; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Kratsios P, 2010, CIRC RES, V106, P133, DOI 10.1161/CIRCRESAHA.109.202200; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Kumar S, 2011, FREE RADICAL BIO MED, V50, P206, DOI 10.1016/j.freeradbiomed.2010.10.711; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murphy MP, 1998, GEN PHARMACOL, V31, P179, DOI 10.1016/S0306-3623(97)00418-7; Nelson M, 2007, INT J BIOCHEM CELL B, V39, P879, DOI 10.1016/j.biocel.2006.10.004; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Pendergrass KD, 2011, CIRC-HEART FAIL, V4, P98, DOI 10.1161/CIRCHEARTFAILURE.110.957712; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Sadoshima J, 2006, ANTIOXID REDOX SIGN, V8, P1621, DOI 10.1089/ars.2006.8.1621; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Shrivastava S, 2010, ANN NY ACAD SCI, V1194, P87, DOI 10.1111/j.1749-6632.2010.05468.x; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Stanley WC, 2000, CARDIOVASC RES, V45, P805, DOI 10.1016/S0008-6363(99)00419-8; Tsutsui H, 2001, INTERNAL MED, V40, P1177, DOI 10.2169/internalmedicine.40.1177; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Zhou SX, 2009, J CARDIOVASC PHARM, V54, P154, DOI 10.1097/FJC.0b013e3181af6d7f	47	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42586	10.1371/journal.pone.0042586	http://dx.doi.org/10.1371/journal.pone.0042586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880044	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100137
J	Ying, SW; Kanda, VA; Hu, ZY; Purtell, K; King, EC; Abbott, GW; Goldstein, PA				Ying, Shui-Wang; Kanda, Vikram A.; Hu, Zhaoyang; Purtell, Kerry; King, Elizabeth C.; Abbott, Geoffrey W.; Goldstein, Peter A.			Targeted Deletion of Kcne2 Impairs HCN Channel Function in Mouse Thalamocortical Circuits	PLOS ONE			English	Article							ACTIVATED CATION CHANNELS; RETICULAR THALAMIC NEURONS; MINK-RELATED PEPTIDE-1; POTASSIUM CHANNELS; I-H; PACEMAKER CHANNELS; RELAY NEURONS; ABSENCE EPILEPSY; PHYSIOLOGICAL-FUNCTION; PROPOFOL-BLOCK	Background: Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels generate the pacemaking current, I-h, which regulates neuronal excitability, burst firing activity, rhythmogenesis, and synaptic integration. The physiological consequence of HCN activation depends on regulation of channel gating by endogenous modulators and stabilization of the channel complex formed by principal and ancillary subunits. KCNE2 is a voltage-gated potassium channel ancillary subunit that also regulates heterologously expressed HCN channels; whether KCNE2 regulates neuronal HCN channel function is unknown. Methodology/Principal Findings: We investigated the effects of Kcne2 gene deletion on Ih properties and excitability in ventrobasal (VB) and cortical layer 6 pyramidal neurons using brain slices prepared from Kcne2(+/+) and Kcne2(-/-) mice. Kcne2 deletion shifted the voltage-dependence of Ih activation to more hyperpolarized potentials, slowed gating kinetics, and decreased Ih density. Kcne2 deletion was associated with a reduction in whole-brain expression of both HCN1 and HCN2 (but not HCN4), although co-immunoprecipitation from whole-brain lysates failed to detect interaction of KCNE2 with HCN1 or 2. Kcne2 deletion also increased input resistance and temporal summation of subthreshold voltage responses; this increased intrinsic excitability enhanced burst firing in response to 4-aminopyridine. Burst duration increased in corticothalamic, but not thalamocortical, neurons, suggesting enhanced cortical excitatory input to the thalamus; such augmented excitability did not result from changes in glutamate release machinery since miniature EPSC frequency was unaltered in Kcne2(-/-) neurons. Conclusions/Significance: Loss of KCNE2 leads to downregulation of HCN channel function associated with increased excitability in neurons in the cortico-thalamo-cortical loop. Such findings further our understanding of the normal physiology of brain circuitry critically involved in cognition and have implications for our understanding of various disorders of consciousness.	[Ying, Shui-Wang; Goldstein, Peter A.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA; [Kanda, Vikram A.; Purtell, Kerry; King, Elizabeth C.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	Cornell University; Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ying, SW (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, New York, NY USA.	pag2014@med.cornell.edu		Goldstein, Peter/0000-0002-5973-9104; Abbott, Geoffrey/0000-0003-4552-496X	Dept. of Anesthesiolgy; National Institutes of Health [R01 HL079275, R01HL101190]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL101190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	Dept. of Anesthesiolgy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Dept. of Anesthesiolgy and by the National Institutes of Health (R01 HL079275 and R01HL101190, both to GWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SY, 2006, NEUROSCIENCE, V141, P1811, DOI 10.1016/j.neuroscience.2006.05.034; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Brandt MC, 2009, AM J PHYSIOL-HEART C, V297, pH355, DOI 10.1152/ajpheart.00154.2009; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Faivre JF, 1999, CARDIOVASC RES, V41, P188, DOI 10.1016/S0008-6363(98)00215-6; Golshani P, 1999, J NEUROSCI, V19, P2865; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; HOFFMAN SN, 1995, DEV BRAIN RES, V85, P64, DOI 10.1016/0165-3806(94)00196-7; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lam YW, 2010, CEREB CORTEX, V20, P13, DOI 10.1093/cercor/bhp077; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Ledergerber D, 2010, J NEUROSCI, V30, P13031, DOI 10.1523/JNEUROSCI.2254-10.2010; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Salah A, 2011, EPILEPSY RES, V94, P163, DOI 10.1016/j.eplepsyres.2011.01.017; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tsaur ML, 1997, FEBS LETT, V400, P215, DOI 10.1016/S0014-5793(96)01388-9; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Whyment AD, 2011, NEUROSCIENCE, V178, P68, DOI 10.1016/j.neuroscience.2010.12.061; Wierschke S, 2010, EPILEPSIA, V51, P404, DOI 10.1111/j.1528-1167.2009.02275.x; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Ying SW, 2011, J NEUROSCI, V31, P10412, DOI 10.1523/JNEUROSCI.0021-11.2011; Ying SW, 2006, EUR J NEUROSCI, V23, P465, DOI 10.1111/j.1460-9568.2005.04587.x; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Ying SW, 2011, NEUROSCIENCE; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	76	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42756	10.1371/journal.pone.0042756	http://dx.doi.org/10.1371/journal.pone.0042756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880098	Green Published, gold			2022-12-25	WOS:000307284100164
J	Das, TK; Sangodkar, J; Negre, N; Narla, G; Cagan, RL				Das, T. K.; Sangodkar, J.; Negre, N.; Narla, G.; Cagan, R. L.			Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors	ONCOGENE			English	Article						Sin3a; Ret; Src; Rho; wingless; Drosophila	GENE-EXPRESSION PATTERNS; HISTONE DEACETYLASE; BETA-CATENIN; TRANSCRIPTIONAL REPRESSION; LUNG ADENOCARCINOMA; FUNCTIONAL-ROLE; CANCER; COMPLEX; GROWTH; PROGRESSION	Chromatin remodeling proteins regulate multiple aspects of cell homeostasis, making them ideal candidates for misregulation in transformed cells. Here, we explore Sin3A, a member of the Sin3 family of proteins linked to tumorigenesis that are thought to regulate gene expression through their role as histone deacetylases (HDACs). We identified Drosophila Sin3a as an important mediator of oncogenic Ret receptor in a fly model of Multiple Endocrine Neoplasia Type 2. Reducing Drosophila Sin3a activity led to metastasis-like behavior and, in the presence of Diap1, secondary tumors distant from the site of origin. Genetic and Chip-Seq analyses identified previously undescribed Sin3a targets including genes involved in cell motility and actin dynamics, as well as signaling pathways including Src, Jnk and Rho. A key Sin3a oncogenic target, PP1B, regulates stability of beta-Catenin/Armadillo: the outcome is to oppose T-cell factor (TCF) function and Wg/Wnt pathway signaling in both fly and mammalian cancer cells. Reducing Sin3A strongly increased the invasive behavior of A549 human lung adenocarcinoma cells. We show that Sin3A is downregulated in a variety of human tumors and that Src, JNK, RhoA and PP1B/beta-Catenin are regulated in a manner analogous to our Drosophila models. Our data suggest that Sin3A influences a specific step of tumorigenesis by regulating a module of genes involved in cell invasion. Tumor progression may commonly rely on such 'modules of invasion' under the control of broad transcriptional regulators.	[Das, T. K.; Cagan, R. L.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Sangodkar, J.; Narla, G.] Mt Sinai Sch Med, Dept Genet, New York, NY 10029 USA; [Negre, N.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Narla, G.] Mt Sinai Sch Med, Div Hematol Oncol, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Chicago; Icahn School of Medicine at Mount Sinai	Cagan, RL (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Box 1020,1 Gustave Levy Pl, New York, NY 10029 USA.	Ross.Cagan@mssm.edu	Narla, Goutham/AAZ-5710-2020; Cagan, Ross Leigh/AAV-9528-2021	Narla, Goutham/0000-0003-4098-4203; Cagan, Ross/0000-0001-5297-450X; Negre, Nicolas/0000-0001-9727-3416	NIH/NCI [R01-CA084309, R01-CA109730]; American Cancer Society [120886-PFM-11-137-01-DDC]; NATIONAL CANCER INSTITUTE [R01CA109730, R01CA170495, R01CA084309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082773] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Cagan Lab for sharing reagents, information, and helpful advice and Justin Graves for providing help mapping UAS-dRet<SUP>MEN2</SUP> transgenic flies. This work was supported by NIH/NCI grants R01-CA084309 and R01-CA109730 to RC and American Cancer Society Fellowship grant 120886-PFM-11-137-01-DDC to TD.	Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Brachmann CB, 2000, CURR BIOL, V10, P547, DOI 10.1016/S0960-9822(00)00474-7; Cadigan KM, 2012, CURR TOP DEV BIOL, V98, P1, DOI 10.1016/B978-0-12-386499-4.00001-X; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Duman-Scheel M, 2004, P NATL ACAD SCI USA, V101, P3857, DOI 10.1073/pnas.0400526101; Ellison-Zelski SJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-263; Farias EF, 2010, P NATL ACAD SCI USA, V107, P11811, DOI 10.1073/pnas.1006737107; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa T, 2008, ONCOGENE, V27, P5684, DOI 10.1038/onc.2008.182; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Iwashita T, 1996, ONCOGENE, V12, P481; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Rao G, 1996, ONCOGENE, V12, P1165; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Read RD, 2005, GENETICS, V171, P1057, DOI 10.1534/genetics.104.038018; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Suzuki H, 2008, LUNG CANCER, V59, P24, DOI 10.1016/j.lungcan.2007.08.002; Teng DHF, 1997, CANCER RES, V57, P4177; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903	67	45	45	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2013	32	26					3184	3197		10.1038/onc.2012.326	http://dx.doi.org/10.1038/onc.2012.326			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22890320	Green Accepted			2022-12-25	WOS:000321004600009
J	Godel, C; Kumar, S; Koutsovoulos, G; Ludin, P; Nilsson, D; Comandatore, F; Wrobel, N; Thompson, M; Schmid, CD; Goto, S; Bringaud, F; Wolstenholme, A; Bandi, C; Epe, C; Kaminsky, R; Blaxter, M; Maser, P				Godel, Christelle; Kumar, Sujai; Koutsovoulos, Georgios; Ludin, Philipp; Nilsson, Daniel; Comandatore, Francesco; Wrobel, Nicola; Thompson, Marian; Schmid, Christoph D.; Goto, Susumu; Bringaud, Frederic; Wolstenholme, Adrian; Bandi, Claudio; Epe, Christian; Kaminsky, Ronald; Blaxter, Mark; Maeser, Pascal			The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets	FASEB JOURNAL			English	Article						comparative genomics; filaria; transposon; Wolbachia	BACTERIAL ENDOSYMBIONTS; CANINE HEARTWORM; WEB SERVER; WOLBACHIA; GENES; RESISTANCE; PREDICTION; SEQUENCE; BIOSYNTHESIS; TETRACYCLINE	The heartworm Dirofilaria immitis is an important parasite of dogs. Transmitted by mosquitoes in warmer climatic zones, it is spreading across southern Europe and the Americas at an alarming pace. There is no vaccine, and chemotherapy is prone to complications. To learn more about this parasite, we have sequenced the genomes of D. immitis and its endosymbiont Wolbachia. We predict 10,179 protein coding genes in the 84.2 Mb of the nuclear genome, and 823 genes in the 0.9-Mb Wolbachia genome. The D. immitis genome harbors neither DNA transposons nor active retrotransposons, and there is very little genetic variation between two sequenced isolates from Europe and the United States. The differential presence of anabolic pathways such as heme and nucleotide biosynthesis hints at the intricate metabolic interrelationship between the heartworm and Wolbachia. Comparing the proteome of D. immitis with other nematodes and with mammalian hosts, we identify families of potential drug targets, immune modulators, and vaccine candidates. This genome sequence will support the development of new tools against dirofilariasis and aid efforts to combat related human pathogens, the causative agents of lymphatic filariasis and river blindness.-Godel, C., Kumar, S., Koutsovoulos, G., Ludin, P., Nilsson, D., Comandatore, F., Wrobel, N., Thompson, M., Schmid, C. D., Goto, S., Bringaud, F., Wolstenholme, A., Bandi, C., Epe, C., Kaminsky, R., Blaxter, M., Maser, P. The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets. FASEB J. 26, 4650-4661 (2012). www.fasebj.org	[Godel, Christelle; Ludin, Philipp; Schmid, Christoph D.; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Godel, Christelle; Ludin, Philipp; Schmid, Christoph D.; Maeser, Pascal] Univ Basel, Basel, Switzerland; [Godel, Christelle; Kaminsky, Ronald] Novartis Anim Hlth, Ctr Rech Sante Anim, St Aubin, Switzerland; [Kumar, Sujai; Koutsovoulos, Georgios; Blaxter, Mark] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Wrobel, Nicola; Thompson, Marian; Blaxter, Mark] Univ Edinburgh, Sch Biol Sci, GenePool Genom Facil, Edinburgh, Midlothian, Scotland; [Nilsson, Daniel] Karolinska Inst, Dept Mol Med & Surg Sci Life Lab, Solna, Sweden; [Comandatore, Francesco; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [Goto, Susumu] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol, Unite Mixte Rech 5536, Ctr Natl Rech Sci, Bordeaux, France; [Wolstenholme, Adrian] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Wolstenholme, Adrian] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Novartis; University of Edinburgh; University of Edinburgh; Karolinska Institutet; University of Milan; Kyoto University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Maser, P (corresponding author), Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland.	pascal.maeser@unibas.ch	GenePool, The/D-8812-2012; Blaxter, Mark/O-2535-2019; Wolstenholme, Adrian/AAY-1611-2020; Kumar, Sujai/D-1768-2011; Nilsson, Daniel/B-8365-2009; Blaxter, Mark L/B-4113-2010; Bandi, Claudio/J-7835-2018	Wolstenholme, Adrian/0000-0001-7989-3929; Kumar, Sujai/0000-0001-5902-6641; Nilsson, Daniel/0000-0001-5831-385X; Blaxter, Mark L/0000-0003-2861-949X; Bandi, Claudio/0000-0002-0181-4618; Koutsovoulos, Georgios/0000-0003-3406-3715; Maser, Pascal/0000-0003-3122-1941	Novartis; School of Biological Sciences, University of Edinburgh; UK Biotechnology and Biological Sciences Research Council; Swedish Research Council; UK Medical Research Council [G0900740]; UK Natural Environment Research Council [R8/H10/561]; Centre National de Recherche Scientifique; European collaboration Enhanced Protective Immunity Against Filariasis (EPIAF), a focused research project (Specific International Cooperative Action) of the EU [242131]; Swiss National Science Foundation; MRC [G0900740] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish	Novartis(Novartis); School of Biological Sciences, University of Edinburgh(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre National de Recherche Scientifique; European collaboration Enhanced Protective Immunity Against Filariasis (EPIAF), a focused research project (Specific International Cooperative Action) of the EU; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Claudio and Marco Genchi (University of Milan, Milan, Italy) for providing D. immitis from Pavia, Italy, and Andrew Moorhead (University of Georgia, Athens, GA, USA) for the D. immitis from Athens, GA, USA. D. immitis genomic and RNA sequencing was performed by Fasteris SA (Geneva, Switzerland), and The GenePool Genomics Facility (Edinburgh, UK). The authors are grateful for financial support from the Novartis Fellowship Program (C. G.), the School of Biological Sciences, University of Edinburgh (S. K. and G. K.), the UK Biotechnology and Biological Sciences Research Council (G. K.), the Swedish Research Council (D.N.), the UK Medical Research Council (G0900740; M. B., N.W., and M. T.), the UK Natural Environment Research Council (R8/H10/561; M. B.), the Centre National de Recherche Scientifique (F. B.), the European collaboration Enhanced Protective Immunity Against Filariasis (EPIAF), a focused research project (Specific International Cooperative Action) of the EU (award 242131; M. B.) and the Swiss National Science Foundation (P.M.).	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; American Heartworm Society, 2010, DIAGN PREV MAN HEART; American Pet Products Association, 2012, APPA NAT PET OWN SUR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Babayan SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000525; Baier M, 1997, P NATL ACAD SCI USA, V94, P5273, DOI 10.1073/pnas.94.10.5273; Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bazzocchi C, 2008, INT J PARASITOL, V38, P1401, DOI 10.1016/j.ijpara.2008.03.002; Belanger DH, 2011, J PARASITOL, V97, P602, DOI 10.1645/GE-2679.1; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Borrelli S, 2010, INT J ANTIMICROB AG, V36, P364, DOI 10.1016/j.ijantimicag.2010.06.030; Bourguinat C, 2011, VET PARASITOL, V181, P388, DOI 10.1016/j.vetpar.2011.04.012; Bowman DD, 2009, VET CLIN N AM-SMALL, V39, P1127, DOI 10.1016/j.cvsm.2009.06.003; CAMPBELL WC, 1982, VET RES COMMUN, V5, P251; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CARLISLE CH, 1984, AUST VET J, V61, P282, DOI 10.1111/j.1751-0813.1984.tb06010.x; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; EICKBUSH TH, 2002, MOBILE DNA, V2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenn K, 2006, TRENDS PARASITOL, V22, P60, DOI 10.1016/j.pt.2005.12.012; Fenn K, 2004, TRENDS ECOL EVOL, V19, P163, DOI 10.1016/j.tree.2004.01.002; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ganapathy K, 2011, ARCH BIOCHEM BIOPHYS, V505, P194, DOI 10.1016/j.abb.2010.10.008; Genchi C, 2009, VET PARASITOL, V163, P286, DOI 10.1016/j.vetpar.2009.03.026; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; GUERRERO J, 1983, AM J VET RES, V44, P2405; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hu M, 2003, PARASITOLOGY, V127, P37, DOI 10.1017/S0031182003003275; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Katz AH, 2003, CURR PHARM DESIGN, V9, P857, DOI 10.2174/1381612033455305; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lamprea-Burgunder E, 2011, DNA RES, V18, P117, DOI 10.1093/dnares/dsr004; Lee ACY, 2010, TRENDS PARASITOL, V26, P168, DOI 10.1016/j.pt.2010.01.003; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Ludin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017546; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; Ma S, 2012, CHEMMEDCHEM, V7, P1161, DOI 10.1002/cmdc.201200156; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Makepeace BL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000544; McCall JW, 2005, VET PARASITOL, V133, P197, DOI 10.1016/j.vetpar.2005.04.005; MCCALL JW, 1976, J PARASITOL, V62, P844, DOI 10.2307/3278982; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Mulder NJ, 2008, MOL BIOTECHNOL, V38, P165, DOI 10.1007/s12033-007-9003-x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oppenheimer M., 2011, ENZYME RES; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732; Sangster NC, 2005, PARASITOLOGY, V131, pS179, DOI 10.1017/S0031182005008656; Segers K, 2011, CHEM BIOL, V18, P685, DOI 10.1016/j.chembiol.2011.04.007; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-21; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Williamson Sally M., 2007, Invertebrate Neuroscience, V7, P219, DOI 10.1007/s10158-007-0056-0; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	77	93	101	0	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4650	4661		10.1096/fj.12-205096	http://dx.doi.org/10.1096/fj.12-205096			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22889830	Green Published, hybrid			2022-12-25	WOS:000310574200026
J	Rahman, SM; Janssen, RC; Choudhury, M; Baquero, KC; Aikens, RM; de la Houssaye, BA; Friedman, JE				Rahman, Shaikh M.; Janssen, Rachel C.; Choudhury, Mahua; Baquero, Karalee C.; Aikens, Rebecca M.; de la Houssaye, Becky A.; Friedman, Jacob E.			CCAAT/Enhancer-binding Protein beta (C/EBP beta) Expression Regulates Dietary-induced Inflammation in Macrophages and Adipose Tissue in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTORS; FATTY-ACIDS; ADIPOCYTE DIFFERENTIATION; NLRP3 INFLAMMASOME; NEGATIVE REGULATOR; IMMUNE-RESPONSE; DENDRITIC CELLS; INNATE IMMUNITY	Strong evidence exists for a link between chronic low level inflammation and dietary-induced insulin resistance; however, little is known about the transcriptional networks involved. Here we show that high fat diet (HFD) or saturated fatty acid exposure directly activates CCAAT/enhancer-binding protein beta(C/EBP beta) protein expression in liver, adipocytes, and macrophages. Global C/EBP beta deletion prevented HFD-induced inflammation and surprisingly increased mitochondrial gene expression in white adipose tissue along with brown adipose tissue markers PRDM16, CIDEa, and UCP1, consistent with a resistance to HFD-induced obesity. In isolated peritoneal macrophages from C/EBP beta(-/-) mice, the anti-inflammatory gene LXR alpha and its targets SCD1 and DGAT2 were strikingly up-regulated along with IL-10, while NLRP3, a gene important for activating the inflammasome, was suppressed in response to palmitate. Using RAW 264.7 macrophage cells or 3T3-L1 adipocytes, C/EBP beta knockdown prevented palmitate-induced inflammation and p65-NF kappa B DNA binding activity, while C/EBP beta overexpression induced NF kappa B binding, JNK activation, and pro-inflammatory cytokine gene expression directly. Finally, chimeric bone marrow mice transplanted with bone marrow lacking C/EBP beta(-/-) demonstrated reduced systemic and adipose tissue inflammatory markers, macrophage content, and maintained insulin sensitivity on HFD. Taken together, these results demonstrate that HFD or palmitate exposure triggers C/EBP beta expression that controls expression of distinct aspects of alternative macrophage activation. Reducing C/EBP beta in macrophages confers protection from HFD-induced systemic inflammation and insulin resistance, suggesting it may be an attractive therapeutic target for ameliorating obesity-induced inflammatory responses.	[Rahman, Shaikh M.; Janssen, Rachel C.; Choudhury, Mahua; Baquero, Karalee C.; Aikens, Rebecca M.; de la Houssaye, Becky A.; Friedman, Jacob E.] Univ Colorado Denver Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Friedman, Jacob E.] Univ Colorado Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Friedman, JE (corresponding author), 12801 E 17th Ave,Mail Stop 8106, Aurora, CO 80045 USA.	jed.friedman@ucdenver.edu	Rahman, Shaikh Mizanoor/GLN-7518-2022	Rahman, Shaikh Mizanoor/0000-0002-4879-2663	National Institutes of Health [R01-DK059767]; Colorado Nutrition and Obesity Research Center (NORC) [NIH-P30DK048520]; UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant [P30DK57516]; American Heart Association [09BGIA2060705]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, P30DK057516, R01DK059767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition and Obesity Research Center (NORC); UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant; American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK059767 (to J. E. F.) and the Colorado Nutrition and Obesity Research Center (NORC) NIH-P30DK048520.; Supported by a UCD Diabetes and Endocrinology Research Center Pilot and Feasibility Grant P30DK57516 and a Beginning Grant in Aid from the American Heart Association (09BGIA2060705; Southwest Affiliate).; Supported by an American Diabetes Association Mentored Post-Doctoral Fellowship.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Bennett CE, 2010, DIABETES VASC DIS RE, V7, P195, DOI 10.1177/1479164110366274; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cloutier A, 2009, J IMMUNOL, V182, P563, DOI 10.4049/jimmunol.182.1.563; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hui TY, 1998, J BIOL CHEM, V273, P27420, DOI 10.1074/jbc.273.42.27420; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rahman SM, 2009, J LIPID RES, V50, P2193, DOI 10.1194/jlr.M800633-JLR200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tsai VWW, 2011, J NEUROSCI, V31, P17612, DOI 10.1523/JNEUROSCI.3449-11.2011; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; Wang LQ, 2000, J BIOL CHEM, V275, P14173, DOI 10.1074/jbc.M000764200; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	61	77	79	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34349	34360		10.1074/jbc.M112.410613	http://dx.doi.org/10.1074/jbc.M112.410613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902781	Green Published, hybrid			2022-12-25	WOS:000309654200038
J	Zhang, WW; Huang, YL; Gunst, SJ				Zhang, Wenwu; Huang, Youliang; Gunst, Susan J.			The Small GTPase RhoA Regulates the Contraction of Smooth Muscle Tissues by Catalyzing the Assembly of Cytoskeletal Signaling Complexes at Membrane Adhesion Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; NONMUSCLE MYOSIN-II; ACTIN POLYMERIZATION; TYROSINE PHOSPHORYLATION; TENSION DEVELOPMENT; ARP2/3 COMPLEX; FOCAL ADHESIONS; CELL-ADHESION; N-WASP; PAXILLIN PHOSPHORYLATION	The activation of the small GTPase RhoA is necessary for ACh-induced actin polymerization and airway smooth muscle (ASM) contraction, but the mechanism by which it regulates these events is unknown. Actin polymerization in ASM is catalyzed by the actin filament nucleation activator, N-WASp and the polymerization catalyst, Arp2/3 complex. Activation of the small GTPase cdc42, a specific N-WASp activator, is also required for actin polymerization and tension generation. We assessed the mechanism by which RhoA regulates actin dynamics and smooth muscle contraction by expressing the dominant negative mutants RhoA T19N and cdc42 T17N, and non-phosphorylatable paxillin Y118/31F and paxillin Delta LD4 deletion mutants in SM tissues. Their effects were evaluated in muscle tissue extracts and freshly dissociated SM cells. Protein interactions and cellular localization were analyzed using proximity ligation assays (PLA), immunofluorescence, and GTPase and kinase assays. RhoA inhibition prevented ACh-induced cdc42 activation, N-WASp activation and the interaction of N-WASp with the Arp2/3 complex at the cell membrane. ACh induced paxillin phosphorylation and its association with the cdc42 GEFS, DOCK180 and alpha/beta PIX. Paxillin tyrosine phosphorylation and its association with beta PIX were RhoA-dependent, and were required for cdc42 activation. The ACh-induced recruitment of paxillin and FAK to the cell membrane was dependent on RhoA. We conclude that RhoA regulates the contraction of ASM by catalyzing the assembly and activation of cytoskeletal signaling modules at membrane adhesomes that initiate signaling cascades that regulate actin polymerization and tension development in response to contractile agonist stimulation. Our results suggest that the RhoA-mediated assembly of adhesome complexes is a fundamental step in the signal transduction process in response to agonist-induced smooth muscle contraction.	[Zhang, Wenwu; Huang, Youliang; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	NHLBI, National Institutes of Health (NIH) [HL-29289, HL074099]; American Lung Association; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029289, R01HL074099, R23HL029289, R01HL109629] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health (NIH) Grants HL-29289 and HL074099; and an American Lung Association and an NIH T32 postdoctoral fellowship (to W. Z.).	Allen WE, 1997, J CELL SCI, V110, P707; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Corteling RL, 2007, AM J PHYSIOL-HEART C, V293, pH440, DOI 10.1152/ajpheart.01374.2006; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenberger G, 2003, HUM MOL GENET, V12, P155, DOI 10.1093/hmg/ddg019; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Suzuki T, 2000, J EXP MED, V191, P1905, DOI 10.1084/jem.191.11.1905; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	68	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					33996	34008		10.1074/jbc.M112.369603	http://dx.doi.org/10.1074/jbc.M112.369603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893699	Green Published, hybrid			2022-12-25	WOS:000309654200007
J	Edwards, AM; Bowden, MG; Brown, EL; Laabei, M; Massey, RC				Edwards, Andrew M.; Bowden, Maria Gabriela; Brown, Eric L.; Laabei, Maisem; Massey, Ruth C.			Staphylococcus aureus Extracellular Adherence Protein Triggers TNF alpha Release, Promoting Attachment to Endothelial Cells via Protein A	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; NECROSIS-FACTOR-ALPHA; FIBRINOGEN RECEPTOR; SECRETED PROTEIN; CLUMPING FACTOR; EAP-PROTEIN; EXPRESSION; IDENTIFICATION; GC1QR/P33; INVASION	Staphylococcus aureus is a leading cause of bacteraemia, which frequently results in complications such as infective endocarditis, osteomyelitis and exit from the bloodstream to cause metastatic abscesses. Interaction with endothelial cells is critical to these complications and several bacterial proteins have been shown to be involved. The S. aureus extracellular adhesion protein (Eap) has many functions, it binds several host glyco-proteins and has both pro-and anti-inflammatory activity. Unfortunately its role in vivo has not been robustly tested to date, due to difficulties in complementing its activity in mutant strains. We previously found Eap to have pro-inflammatory activity, and here show that purified native Eap triggered TNF alpha release in whole human blood in a dose-dependent manner. This level of TNF alpha increased adhesion of S. aureus to endothelial cells 4-fold via a mechanism involving protein A on the bacterial surface and gC1qR/p33 on the endothelial cell surface. The contribution this and other Eap activities play in disease severity during bacteraemia was tested by constructing an isogenic set of strains in which the eap gene was inactivated and complemented by inserting an intact copy elsewhere on the bacterial chromosome. Using a murine bacteraemia model we found that Eap expressing strains cause a more severe infection, demonstrating its role in invasive disease.	[Edwards, Andrew M.; Laabei, Maisem; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Bowden, Maria Gabriela] Texas A&M Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Houston, TX USA; [Brown, Eric L.] Univ Texas Houston, Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA	University of Bath; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Edwards, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, London, England.	r.c.massey@bath.ac.uk	Laabei, Maisem/AAH-6383-2021; Massey, Ruth/AAT-6415-2021	Laabei, Maisem/0000-0002-8425-3704; Massey, Ruth/0000-0002-8154-4039; Edwards, Andrew/0000-0002-7173-7355	Medical Research Council (UK) [G0700836]; MRC [G0700836] Funding Source: UKRI; Medical Research Council [G0700836] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK) # G0700836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasopoulos AN, 2006, BLOOD, V107, P2720, DOI 10.1182/blood-2005-08-3140; BONE RC, 1994, ARCH INTERN MED, V154, P26, DOI 10.1001/archinte.154.1.26; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Carnicer-Pont D, 2006, EPIDEMIOL INFECT, V134, P1167, DOI 10.1017/S0950268806006327; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; CHEUNG AL, 1991, INFECT IMMUN, V59, P3827, DOI 10.1128/IAI.59.10.3827-3831.1991; Collins J, 2008, J CLIN MICROBIOL, V46, P2112, DOI 10.1128/JCM.00156-08; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Haggar A, 2004, INFECT IMMUN, V72, P6164, DOI 10.1128/IAI.72.10.6164-6167.2004; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; Haggar A, 2010, CLIN MICROBIOL INFEC, V16, P1155, DOI 10.1111/j.1469-0691.2009.03058.x; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Hartleib J, 2000, BLOOD, V96, P2149; Hussain M, 2001, CLIN DIAGN LAB IMMUN, V8, P1271, DOI 10.1128/CDLI.8.6.1271-1276.2001; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Hussain M, 2008, J CLIN MICROBIOL, V46, P470, DOI 10.1128/JCM.01425-07; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Joost I, 2011, FEMS IMMUNOL MED MIC, V62, P23, DOI 10.1111/j.1574-695X.2011.00783.x; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Kerdudou S, 2006, THROMB HAEMOSTASIS, V96, P183, DOI 10.1160/TH-06-02-0116; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Massey RC, 2007, INFECT IMMUN, V75, P5711, DOI 10.1128/IAI.00875-07; MCDEVITT D, 1992, INFECT IMMUN, V60, P1514, DOI 10.1128/IAI.60.4.1514-1523.1992; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Oviedo-Boyso J, 2008, SCAND J IMMUNOL, V67, P169, DOI 10.1111/j.1365-3083.2007.02056.x; Oviedo-Boyso J, 2008, FEMS IMMUNOL MED MIC, V54, P53, DOI 10.1111/j.1574-695X.2008.00447.x; Palma M, 1999, J BACTERIOL, V181, P2840, DOI 10.1128/JB.181.9.2840-2845.1999; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Peerschke EIB, 2006, INFECT IMMUN, V74, P4418, DOI 10.1128/IAI.01794-05; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Scriba TJ, 2008, INFECT IMMUN, V76, P2164, DOI 10.1128/IAI.01699-07; Sethi S, 2011, MICROVASC RES, V82, P66, DOI 10.1016/j.mvr.2011.04.007; Spentzas T, 2011, CELL IMMUNOL, V269, P46, DOI 10.1016/j.cellimm.2011.03.009; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Wang JE, 2000, INFECT IMMUN, V68, P3965, DOI 10.1128/IAI.68.7.3965-3970.2000; Xie CP, 2006, J EXP MED, V203, P985, DOI 10.1084/jem.20051681	54	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43046	10.1371/journal.pone.0043046	http://dx.doi.org/10.1371/journal.pone.0043046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905199	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600042
J	Alves-Guerra, MC; Aheng, C; Pecqueur, C; Masscheleyn, S; Tharaux, PL; Druilhe, A; Ricquier, D; Challet, E; Miroux, B				Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Masscheleyn, Sandrine; Tharaux, Pierre Louis; Druilhe, Anne; Ricquier, Daniel; Challet, Etienne; Miroux, Bruno			Analysis of Uncoupling Protein 2-Deficient Mice upon Anaesthesia and Sedation Revealed a Role for UCP2 in Locomotion	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; BROWN ADIPOCYTES; EXPRESSION; OBESITY; DYSFUNCTION; SECRETION; SURVIVAL; CELLS; MODEL	General anaesthesia is associated with hypothermia, oxidative stress, and immune depression. Uncoupling Protein (UCP2) is a member of the mitochondrial carrier family present in many organs including the spleen, the lung and the brain. A role of UCP2 in the activation of the inflammatory/immune cells, in the secretion of hormones, and in the excitability of neurons by regulating the production of reactive oxygen species has been discussed. Because of the side effects of anaesthesia listed above, we aimed to question the expression and the function of UCP2 during anaesthesia. Induction of anaesthesia with ketamine (20 mg/kg) or isoflurane (3.6%) and induction of sedation with the alpha 2 adrenergic receptor agonist medetomidine (0.2 mg/kg) stimulated infiltration of immune cells in the lung and increased UCP2 protein content in the lung, in both immune and non-immune cells. UCP2 content in the lung inversely correlated with body temperature decrease induced by medetomidine treatment. Challenge of the Ucp2(-/-) mice with isoflurane and medetomidine revealed an earlier behavioral recovery phenotype. Transponder analysis of body temperature and activity showed no difference between Ucp2(-/-) and control mice in basal conditions. However, upon an acute decrease of body temperature induced by medetomidine, Ucp2(-/-) mice exhibited increased locomotion activity. Together, these results show that UCP2 is rapidly mobilized during anaesthesia and sedation in immune cells, and suggest a role of UCP2 in locomotion.	[Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Ricquier, Daniel] Inst Cochin, CNRS, UMR8104, INSERM,U1016, Paris, France; [Alves-Guerra, Marie-Clotilde; Aheng, Caroline; Pecqueur, Claire; Tharaux, Pierre Louis; Druilhe, Anne; Ricquier, Daniel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Masscheleyn, Sandrine; Miroux, Bruno] IBPC, CNRS, UMR7099, Lab Biol Physicochim Prot Membranaires, Paris, France; [Masscheleyn, Sandrine; Miroux, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tharaux, Pierre Louis] Paris Ctr Rech Cardiovasc, INSERM, U970, Paris, France; [Druilhe, Anne] Ctr Rech Croissance & Signalisat, INSERM, U845, Paris, France; [Challet, Etienne] Inst Neurosci Cellulaires & Integrat, CNRS, UPR3212, Dept Neurobiol Rythmes, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Alves-Guerra, MC (corresponding author), Inst Cochin, CNRS, UMR8104, INSERM,U1016, Paris, France.	bruno.miroux@ibpc.fr	Pecqueur, Claire/L-3073-2015; Alves-Guerra, Marie-Clotilde/P-4356-2017; Druilhe, Anne/T-1296-2019; Challet, Etienne/ABF-7553-2020; Druilhe, Anne/O-8684-2016; Miroux, Bruno/E-9267-2017; Tharaux, Pierre-Louis/A-9155-2009	Pecqueur, Claire/0000-0002-7612-1672; Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Druilhe, Anne/0000-0003-0064-110X; Challet, Etienne/0000-0001-9416-9496; Druilhe, Anne/0000-0003-3024-5001; Tharaux, Pierre-Louis/0000-0002-6062-5905; Miroux, Bruno/0000-0002-3066-4700	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [05-JCJC-0092-01]; Institut de Recherche Servier; European Community [LSHM-CT-2003-503041]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut de Recherche Servier; European Community(European Commission)	This work was supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (grant #05-JCJC-0092-01 to BM), the Institut de Recherche Servier (to DR), and the European Community (grant FP6 No LSHM-CT-2003-503041 to DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaouchiche B, 2001, ANESTH ANALG, V93, P981, DOI 10.1097/00000539-200110000-00036; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Alves-Guerra MC, SIGNALLING CELL ADAP, P257; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Delogu G, 2001, ARCH SURG-CHICAGO, V136, P1190, DOI 10.1001/archsurg.136.10.1190; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gnanalingham MG, 2006, J ENDOCRINOL, V188, P375, DOI 10.1677/joe.1.06530; Grasshoff C, 2006, CURR PHARM DESIGN, V12, P3665, DOI 10.2174/138161206778522038; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Irifune M, 1997, ANESTHESIOLOGY, V86, P464, DOI 10.1097/00000542-199702000-00022; Juttler E, 2007, J NEUROIMMUNOL, V189, P41, DOI 10.1016/j.jneuroim.2007.06.020; KOTANI N, 1995, ANESTH ANALG, V81, P1255, DOI 10.1097/00000539-199512000-00023; Lahdesmaki J, 2003, NEUROPHARMACOLOGY, V44, P882, DOI 10.1016/S0028-3908(03)00080-7; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Ohlson KBE, 2004, BIOCHEM PHARMACOL, V68, P463, DOI 10.1016/j.bcp.2004.03.028; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Richard D, 1999, INT J OBESITY, V23, pS53, DOI 10.1038/sj.ijo.0800947; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Yamada S, 2003, J NEUROCHEM, V87, P461, DOI 10.1046/j.1471-4159.2003.02005.x; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41846	10.1371/journal.pone.0041846	http://dx.doi.org/10.1371/journal.pone.0041846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900002	Green Published, gold			2022-12-25	WOS:000307380900017
J	Herrmann, L; Ionescu, IA; Henes, K; Golub, Y; Wang, NXR; Buell, DR; Holsboer, F; Wotjak, CT; Schmidt, U				Herrmann, Leonie; Ionescu, Irina A.; Henes, Kathrin; Golub, Yulia; Wang, Nancy Xin Ru; Buell, Dominik R.; Holsboer, Florian; Wotjak, Carsten T.; Schmidt, Ulrike			Long-Lasting Hippocampal Synaptic Protein Loss in a Mouse Model of Posttraumatic Stress Disorder	PLOS ONE			English	Article							SYNAPSIN-I; PREFRONTAL CORTEX; RAT HIPPOCAMPUS; GENE-EXPRESSION; MESSENGER-RNA; DEPRESSION; BRAIN; MARKERS; VOLUME; SCHIZOPHRENIA	Despite intensive research efforts, the molecular pathogenesis of posttraumatic stress disorder (PTSD) and especially of the hippocampal volume loss found in the majority of patients suffering from this anxiety disease still remains elusive. We demonstrated before that trauma-induced hippocampal shrinkage can also be observed in mice exhibiting a PTSD-like syndrome. Aiming to decipher the molecular correlates of these trans-species posttraumatic hippocampal alterations, we compared the expression levels of a set of neurostructural marker proteins between traumatized and control mice at different time points after their subjection to either an electric footshock or mock treatment which was followed by stressful re-exposure in several experimental groups. To our knowledge, this is the first systematic in vivo study analyzing the long-term neuromolecular sequelae of acute traumatic stress combined with re-exposure. We show here that a PTSD-like syndrome in mice is accompanied by a long-lasting reduction of hippocampal synaptic proteins which interestingly correlates with the strength of the generalized and conditioned fear response but not with the intensity of hyperarousal symptoms. Furthermore, we demonstrate that treatment with the serotonin reuptake inhibitor (SSRI) fluoxetine is able to counteract both the PTSD-like syndrome and the posttraumatic synaptic protein loss. Taken together, this study demonstrates for the first time that a loss of hippocampal synaptic proteins is associated with a PTSD-like syndrome in mice. Further studies will have to reveal whether these findings are transferable to PTSD patients.	[Herrmann, Leonie; Ionescu, Irina A.; Henes, Kathrin; Golub, Yulia; Wang, Nancy Xin Ru; Buell, Dominik R.; Holsboer, Florian; Wotjak, Carsten T.; Schmidt, Ulrike] Max Planck Inst Psychiat, Munich, Germany; [Golub, Yulia] Univ Clin Erlangen, Dept Child & Adolescent Mental Hlth, Erlangen, Germany	Max Planck Society; University of Erlangen Nuremberg	Herrmann, L (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	uschmidt@mpipsykl.mpg.de	Wotjak, Carsten T./S-3200-2019; Golub, Yulia/AHC-3528-2022		private Horst Kubler foundation, Bad Ragaz	private Horst Kubler foundation, Bad Ragaz	Part of the study (consumables) was funded by the private Horst Kubler foundation, Bad Ragaz. The Horst Kubler foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Ary AW, 2007, SYNAPSE, V61, P938, DOI 10.1002/syn.20439; Beasley CL, 2005, BIPOLAR DISORD, V7, P449, DOI 10.1111/j.1399-5618.2005.00239.x; Bowirrat A, 2010, CURR NEUROPHARMACOL, V8, P335, DOI 10.2174/157015910793358123; Briones A, 2012, BRIT J PHARMACOL, V165, P897, DOI 10.1111/j.1476-5381.2011.01602.x; Chang YC, 2006, NEUROBIOL DIS, V24, P101, DOI 10.1016/j.nbd.2006.06.001; Chen Q, 2004, AM J HUM GENET, V75, P873, DOI 10.1086/425588; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; Dagyte G, 2011, J NEUROSCI RES, V89, P1646, DOI 10.1002/jnr.22697; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Fasani F, 2004, J CELL SCI, V117, P861, DOI 10.1242/jcs.00940; Felmingham K, 2009, NEUROREPORT, V20, P1402, DOI 10.1097/WNR.0b013e3283300fbc; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Gamo NJ, 2011, BEHAV NEUROSCI, V125, P282, DOI 10.1037/a0023165; Gao Y, 2006, NEUROSCIENCE, V141, P1139, DOI 10.1016/j.neuroscience.2006.04.066; Garcia-Caceres C, 2010, PSYCHONEUROENDOCRINO, V35, P1525, DOI 10.1016/j.psyneuen.2010.05.006; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Grillo CA, 2005, NEUROSCIENCE, V136, P477, DOI 10.1016/j.neuroscience.2005.08.019; Guest KA, 2010, SCHIZOPHR RES, V120, P229, DOI 10.1016/j.schres.2010.03.029; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI 10.1586/ERN.10.198; Ionescu IA, 2012, NEUROPSYCHOPHARMACOL; Larsen MH, 2008, EUR J PHARMACOL, V578, P114, DOI 10.1016/j.ejphar.2007.08.050; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; Liu W, 2011, PSYCHIAT RES-NEUROIM, V194, P385, DOI 10.1016/j.pscychresns.2011.02.007; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Martenyi F, 2006, EUR NEUROPSYCHOPHARM, V16, P340, DOI 10.1016/j.euroneuro.2005.10.007; Matrisciano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016447; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mehta D, 2012, NEUROPHARMACOLOGY, V62, P654, DOI 10.1016/j.neuropharm.2011.03.009; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; MOBLEY P, 1985, P NATL ACAD SCI USA, V82, P945, DOI 10.1073/pnas.82.3.945; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nowicka D, 2003, ACTA NEUROBIOL EXP, V63, P185; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pitman RK, 2006, ANN NY ACAD SCI, V1071, P242, DOI 10.1196/annals.1364.019; Qi C, 2010, GENES BRAIN BEHAV, V9, P974, DOI 10.1111/j.1601-183X.2010.00636.x; Rapp S, 2004, PHARMACOGENOMICS J, V4, P110, DOI 10.1038/sj.tpj.6500229; Reines A, 2008, NEUROPSYCHOPHARMACOL, V33, P1896, DOI 10.1038/sj.npp.1301596; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Schmidt U, 2011, DIS MARKERS, V30, P77, DOI [10.1155/2011/343616, 10.3233/DMA-2011-0749]; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; SIEGEL SJ, 1993, BRAIN RES, V619, P299, DOI 10.1016/0006-8993(93)91624-2; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Sterlemann V, 2010, HIPPOCAMPUS, V20, P540, DOI 10.1002/hipo.20655; Thome J, 2001, BIOL PSYCHIAT, V50, P809, DOI 10.1016/S0006-3223(01)01229-X; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wu LM, 2007, NEUROPSYCHOPHARMACOL, V32, P2500, DOI 10.1038/sj.npp.1301386; Yan J, 2010, BRAIN RES, V1347, P132, DOI 10.1016/j.brainres.2010.05.074; Yang C, 2009, BEHAV BRAIN RES, V205, P518, DOI 10.1016/j.bbr.2009.08.008; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zink M, 2010, NEUROPHARMACOLOGY, V58, P465, DOI 10.1016/j.neuropharm.2009.09.005	65	38	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42603	10.1371/journal.pone.0042603	http://dx.doi.org/10.1371/journal.pone.0042603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900032	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900048
J	Zach, GJ; Peneder, S; Strodl, MA; Schausberger, P				Zach, Gernot J.; Peneder, Stefan; Strodl, Markus A.; Schausberger, Peter			Social Familiarity Governs Prey Patch-Exploitation, - Leaving and Inter-Patch Distribution of the Group-Living Predatory Mite Phytoseiulus persimilis	PLOS ONE			English	Article							PRIOR ASSOCIATION; KIN RECOGNITION; ADULT FEMALES; DISPERSAL; CONSEQUENCES; BEHAVIOR; ACARI; CANNIBALISM; COMPETITION; TETRANYCHIDAE	Background: In group-living animals, social interactions and their effects on other life activities such as foraging are commonly determined by discrimination among group members. Accordingly, many group-living species evolved sophisticated social recognition abilities such as the ability to recognize familiar individuals, i.e. individuals encountered before. Social familiarity may affect within-group interactions and between-group movements. In environments with patchily distributed prey, group-living predators must repeatedly decide whether to stay with the group in a given prey patch or to leave and search for new prey patches and groups. Methodology/Principal Findings: Based on the assumption that in group-living animals social familiarity allows to optimize the performance in other tasks, as for example predicted by limited attention theory, we assessed the influence of social familiarity on prey patch exploitation, patch-leaving, and inter-patch distribution of the group-living, plant-inhabiting predatory mite Phytoseiulus persimilis. P. persimilis is highly specialized on herbivorous spider mite prey such as the two-spotted spider mite Tetranychus urticae, which is patchily distributed on its host plants. We conducted two experiments with (1) groups of juvenile P. persimilis under limited food on interconnected detached leaflets, and (2) groups of adult P. persimilis females under limited food on whole plants. Familiar individuals of both juvenile and adult predator groups were more exploratory and dispersed earlier from a given spider mite patch, occupied more leaves and depleted prey more quickly than individuals of unfamiliar groups. Moreover, familiar juvenile predators had higher survival chances than unfamiliar juveniles. Conclusions/Significance: We argue that patch-exploitation and -leaving, and inter-patch dispersion were more favorably coordinated in groups of familiar than unfamiliar predators, alleviating intraspecific competition and improving prey utilization and suppression.	[Zach, Gernot J.; Peneder, Stefan; Strodl, Markus A.; Schausberger, Peter] Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Zach, GJ (corresponding author), Univ Nat Resources & Life Sci, Grp Arthropod Ecol & Behav, Div Plant Protect, Dept Crop Sci, Vienna, Austria.	peter.schausberger@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P20743-B17]; Austrian Science Fund (FWF) [P 20743] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P20743-B17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELETSKY LD, 1989, P NATL ACAD SCI USA, V86, P7933, DOI 10.1073/pnas.86.20.7933; Bhat A, 2006, J FISH BIOL, V68, P759, DOI 10.1111/j.1095-8649.2006.00963.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chittenden AR, 2001, J ETHOL, V19, P55, DOI 10.1007/s101640170018; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; CRISTOL DA, 1995, ANIM BEHAV, V50, P151, DOI 10.1006/anbe.1995.0228; Dugatkin LA, 1997, BIOSCIENCE, V47, P355, DOI 10.2307/1313150; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; FELS D, 1995, BEHAVIOUR, V132, P49, DOI 10.1163/156853995X00270; FRETWELL S D, 1972, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Giraldeau Luc-Alain, 2008, P233; GODFRAY HCJ, 1988, NATURE, V331, P211, DOI 10.1038/331211a0; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; GRIGOR PN, 1995, APPL ANIM BEHAV SCI, V45, P97, DOI 10.1016/0168-1591(95)00596-K; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hojesjo J, 1998, BEHAV ECOL, V9, P445, DOI 10.1093/beheco/9.5.445; HOOGLAND JL, 1979, BEHAVIOUR, V69, P1, DOI 10.1163/156853979X00377; Jones RB, 2002, ANIM BEHAV, V63, P659, DOI 10.1006/anbe.2001.1943; KACELNIK A, 1992, TRENDS ECOL EVOL, V7, P50, DOI 10.1016/0169-5347(92)90106-L; KATZIR G, 1982, BEHAVIOUR, V81, P231, DOI 10.1163/156853982X00157; Koenig A, 2002, INT J PRIMATOL, V23, P759, DOI 10.1023/A:1015524931226; Krause J, 2002, LIVING GROUPS; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; LAWRENCE WS, 1987, BEHAV ECOL SOCIOBIOL, V21, P367, DOI 10.1007/BF00299931; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Liebgold EB, 2011, ANIM BEHAV, V82, P1059, DOI 10.1016/j.anbehav.2011.07.041; LINDSTROM A, 1989, AUK, V106, P225; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Madden JR, 2011, BEHAV ECOL SOCIOBIOL, V65, P1857, DOI 10.1007/s00265-011-1194-2; Mateo JM, 2009, ANIM BEHAV, V77, P115, DOI 10.1016/j.anbehav.2008.09.015; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Mayland H, 2000, ENTOMOL EXP APPL, V96, P245, DOI 10.1023/A:1004047722647; Milinski M, 1990, BEHAV ECOL, V1, P7, DOI 10.1093/beheco/1.1.7; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; NAGELKERKE CJ, 1994, AM NAT, V144, P262, DOI 10.1086/285674; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Ranta Esa, 1994, Ecoscience, V1, P99; Sabelis M.W., 1985, P141; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2005, BEHAV ECOL SOCIOBIOL, V58, P53, DOI 10.1007/s00265-004-0898-y; Schausberger P, 2004, ANIM BEHAV, V67, P1031, DOI 10.1016/j.anbehav.2003.10.006; Schausberger P, 2003, EXP APPL ACAROL, V29, P173, DOI 10.1023/A:1025839206394; Schausberger P, 2001, ANIM BEHAV, V61, P459, DOI 10.1006/anbe.2000.1611; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Seppa T, 2001, CAN J FISH AQUAT SCI, V58, P1380, DOI 10.1139/cjfas-58-7-1380; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Stephens D.W., 1986, pi; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; Vanas V, 2006, EXP APPL ACAROL, V39, P1, DOI 10.1007/s10493-006-0024-0; vanBaalen M, 1995, OIKOS, V74, P391, DOI 10.2307/3545984; Walzer A, 2006, J INSECT BEHAV, V19, P305, DOI 10.1007/s10905-006-9025-4; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Webster MM, 2007, ANIM BEHAV, V74, P253, DOI 10.1016/j.anbehav.2006.07.021; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; Zemek R, 1998, EXP APPL ACAROL, V22, P259, DOI 10.1023/A:1006022500205; ZHANG ZQ, 1992, ENVIRON ENTOMOL, V21, P799, DOI 10.1093/ee/21.4.799	69	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42889	10.1371/journal.pone.0042889	http://dx.doi.org/10.1371/journal.pone.0042889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900062	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900080
J	Qiao, T; Ma, RH; Luo, XB; Luo, ZL; Zheng, PM				Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming			Cholecystolithiasis Is Associated with Clonorchis sinensis Infection	PLOS ONE			English	Article							OPISTHORCHIS-VIVERRINI INFECTION; GALLSTONE; CHOLESTEROL; BILE; PREVALENCE; DISEASE; INTENSITY; COMMUNITY; RISK	Background: The objective of this study was to analyze gallbladder stones for direct evidence of a relationship between Clonorchis sinensis infection and gallbladder stones formation. Methodology: We investigated one hundred eighty-three gallbladder stones for the presence of Clonorchis sinensis eggs using microscopy, and analyzed their composition using Fourier transform infrared spectroscopy. We confirmed the presence of Clonorchis sinensis eggs in the gallbladder stones using real-time fluorescent PCR and scanning electron microscopy. Principal Findings: Clonorchis sinensis eggs were detected in 122 of 183 gallbladder stones based on morphologic characteristics and results from real-time fluorescent PCR. The proportion of pigment stones, cholesterol stones and mixed gallstones in the egg-positive stones was 79.5% (97/122), 3.3% (4/122) and 17.2% (21/122), respectively, while 29.5% (18/61), 31.1% (19/61) and 39.3% (24/61) in the egg-negative stones. The proportion of pigment stone in the Clonorchis sinensis egg-positive stones was higher than in egg-negative stones (P < 0.0001). In the 30 egg-positive stones examined by scanning electron microscopy, dozens or even hundreds of Clonorchis sinensis eggs were visible (x400) showing a distinct morphology. Many eggs were wrapped with surrounding particles, and in some, muskmelon wrinkles was seen on the surface of the eggs. Also visible were pieces of texture shed from some of the eggs. Some eggs were depressed or without operculum while most eggs were adhered to or wrapped with amorphous particles or mucoid matter (x3000). Conclusion: Clonorchis sinensis eggs were detected in the gallbladder stones which suggests an association between Clonorchis sinensis infection and gallbladder stones formation, especially pigment stones.	[Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming] Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China; [Qiao, Tie; Ma, Rui-hong; Luo, Xiao-bing; Luo, Zhen-liang; Zheng, Pei-ming] Second Peoples Hosp Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China		Qiao, T (corresponding author), Inst Gallbladder Dis Panyu, Lab Gallbladder Dis, Guangzhou, Guangdong, Peoples R China.	fqj1958@163.com						ABDUSSALAM M, 1995, WHO TECH REP SER, V849, P1; AKERLUND JE, 1991, GASTROENTEROLOGY, V100, P1046, DOI 10.1016/0016-5085(91)90281-O; Chen ZuZe, 1997, Chinese Journal of Parasitic Disease Control, V10, P31; Choi D, 2008, J GASTROEN HEPATOL, V23, pE399, DOI 10.1111/j.1440-1746.2007.05242.x; Coordinating Office of the National Survey on the Important Human Parasitic Diseases, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P332; Djessou PS, 2010, ANN BIOL CLIN-PARIS, V68, P39; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; Fang YueYi, 2008, Chinese Journal of Parasitology and Parasitic Diseases, V26, P99; FLAVELL DJ, 1981, T ROY SOC TROP MED H, V75, P814, DOI 10.1016/0035-9203(81)90419-3; HARINASUTA T, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1167; HOU MF, 1989, J TROP MED HYG, V92, P108; Jang Ji Sun, 2007, Korean Journal of Parasitology, V45, P301, DOI 10.3347/kjp.2007.45.4.301; JONGSUKSUNTIGUL P, 1996, J TROP MED PARASITOL, V19, P24; Joo KR, 2005, YONSEI MED J, V46, P794, DOI 10.3349/ymj.2005.46.6.794; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P2297, DOI 10.3748/wjg.14.2297; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; Kratzer W, 1999, J CLIN ULTRASOUND, V27, P1, DOI 10.1002/(SICI)1097-0096(199901)27:1<1::AID-JCU1>3.0.CO;2-H; Lee Soo-Ung, 2004, Korean Journal of Parasitology, V42, P145, DOI 10.3347/kjp.2004.42.3.145; Li XM, 2011, SE ASIAN J TROP MED, V42, P248; LIM JH, 1990, AM J ROENTGENOL, V155, P1001, DOI 10.2214/ajr.155.5.2120925; LIM JH, 1991, AM J ROENTGENOL, V157, P1; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mairiang E, 2003, ACTA TROP, V88, P221, DOI 10.1016/j.actatropica.2003.03.001; McManus DP, 2004, INT J PARASITOL, V34, P153, DOI 10.1016/j.ijpara.2003.11.003; Pae WK, 1968, J KOREAN SURG SOC, V10, P377; Park GM, 2007, PARASITOL RES, V100, P351, DOI 10.1007/s00436-006-0269-x; Pereira SP, 2003, ALIMENT PHARM THER, V17, P923, DOI 10.1046/j.1365-2036.2003.01529.x; Rahman SMM, 2011, PARASITOL RES, V109, P297, DOI 10.1007/s00436-011-2253-3; Rana Surinder Singh, 2007, Curr Gastroenterol Rep, V9, P156, DOI 10.1007/s11894-007-0011-6; Rim Han-Jong, 1996, Korean Journal of Parasitology, V34, P7, DOI 10.3347/kjp.1996.34.1.7; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Schirmer Bruce D, 2005, J Long Term Eff Med Implants, V15, P329, DOI 10.1615/JLongTermEffMedImplants.v15.i3.90; Shi JS, 2001, WORLD J GASTROENTERO, V7, P593; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Stewart L, 2006, AM J SURG, V192, P598, DOI 10.1016/j.amjsurg.2006.08.001; Stolk MFJ, 2001, DIGEST DIS SCI, V46, P1328, DOI 10.1023/A:1010635901414; STOLK MFJ, 1995, GASTROENTEROLOGY, V108, P1882, DOI 10.1016/0016-5085(95)90153-1; UPATHAM ES, 1984, B WORLD HEALTH ORGAN, V62, P451; UPATHAM ES, 1982, AM J TROP MED HYG, V31, P1156, DOI 10.4269/ajtmh.1982.31.1156; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; WETTER LA, 1994, LANCET, V343, P444, DOI 10.1016/S0140-6736(94)92691-3; Wu JP, 2000, HUANG JIASI SURG, P1226; Xie Qiong-Jun, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P106; Yoo EH, 2008, CLIN CHEM LAB MED, V46, P376, DOI 10.1515/CCLM.2008.074	44	32	46	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42471	10.1371/journal.pone.0042471	http://dx.doi.org/10.1371/journal.pone.0042471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905137	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100041
J	Aristieta, A; Azkona, G; Sagarduy, A; Miguelez, C; Ruiz-Ortega, JA; Sanchez-Pernaute, R; Ugedo, L				Aristieta, Asier; Azkona, Garikoitz; Sagarduy, Ainhoa; Miguelez, Cristina; Angel Ruiz-Ortega, Jose; Sanchez-Pernaute, Rosario; Ugedo, Luisa			The Role of the Subthalamic Nucleus in L-DOPA Induced Dyskinesia in 6-Hydroxydopamine Lesioned Rats	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ABNORMAL INVOLUNTARY MOVEMENTS; HIGH-FREQUENCY STIMULATION; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; BASAL GANGLIA; RECEPTOR ANTAGONIST; SUBSTANTIA-NIGRA; RODENT MODEL; MGLUR5 ANTAGONIST	L-DOPA is the most effective treatment for Parkinson's disease (PD), but prolonged use leads to disabling motor complications including dyskinesia. Strong evidence supports a role of the subthalamic nucleus (STN) in the pathophysiology of PD whereas its role in dyskinesia is a matter of controversy. Here, we investigated the involvement of STN in dyskinesia, using single-unit extracellular recording, behavioural and molecular approaches in hemi-parkinsonian rats rendered dyskinetic by chronic L-DOPA administration. Our results show that chronic L-DOPA treatment does not modify the abnormal STN activity induced by the 6-hydroxydopamine lesion of the nigrostriatal pathway in this model. Likewise, we observed a loss of STN responsiveness to a single L-DOPA dose both in lesioned and sham animals that received daily L-DOPA treatment. We did not find any correlation between the abnormal involuntary movement (AIM) scores and the electrophysiological parameters of STN neurons recorded 24 h or 20-120 min after the last L-DOPA injection, except for the axial subscores. Nonetheless, unilateral chemical ablation of the STN with ibotenic acid resulted in a reduction in global AIM scores and peak-severity of dyskinesia. In addition, STN lesion decreased the anti-dyskinetogenic effect of buspirone in a reciprocal manner. Striatal protein expression was altered in dyskinetic animals with increases in Delta FosB, phosphoDARPP-32, dopamine receptor (DR) D3 and DRD2/DRD1 ratio. The STN lesion attenuated the striatal molecular changes and normalized the DRD2/DRD1 ratio. Taken together, our results show that the STN plays a role, if modest, in the physiopathology of dyskinesias.	[Aristieta, Asier; Sagarduy, Ainhoa; Miguelez, Cristina; Angel Ruiz-Ortega, Jose; Ugedo, Luisa] Univ Basque Country, Dept Pharmacol, Fac Med & Dent, Leioa, Spain; [Azkona, Garikoitz; Sanchez-Pernaute, Rosario] Fdn Inbiomed, Lab Stem Cells & Neural Repair, San Sebastian, Spain	University of Basque Country	Aristieta, A (corresponding author), Univ Basque Country, Dept Pharmacol, Fac Med & Dent, Leioa, Spain.	rpernaute@inbiomed.org; LuisaUgedoluisa.ugedo@ehu.es	Azkona, Garikoitz/AAE-6205-2020; Azkona, Garikoitz/A-4789-2013; Ruiz-Ortega, Jose Angel/F-2465-2016; Sanchez-Pernaute, Rosario/AAZ-9566-2021; Ugedo, Luisa/H-4244-2015; Sanchez-Pernaute, Rosario/ABD-8661-2021; Miguelez, Cristina/I-6213-2015	Azkona, Garikoitz/0000-0002-5312-1207; Azkona, Garikoitz/0000-0002-5312-1207; Ruiz-Ortega, Jose Angel/0000-0003-2246-4378; Sanchez-Pernaute, Rosario/0000-0003-1144-9025; Ugedo, Luisa/0000-0001-5993-0606; Miguelez, Cristina/0000-0001-6624-2932	Spanish Ministry of Science [SAF 2009-08664]; department of Industry of the Basque Government [S-PE10UN24]; Kutxa Obra social; University of the Basque Country	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); department of Industry of the Basque Government; Kutxa Obra social; University of the Basque Country	This study was supported by grants from the Spanish Ministry of Science SAF 2009-08664 (LU), the department of Industry of the Basque Government S-PE10UN24 (LU and RSP) and Kutxa Obra social (RSP). AA and AS have a fellowship from the University of the Basque Country. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Apetauerova D, 2006, MOVEMENT DISORD, V21, P1277, DOI 10.1002/mds.20896; Armentero MT, 2006, NEUROBIOL DIS, V22, P1, DOI 10.1016/j.nbd.2005.09.010; Azkona G, 2010, GENES BRAIN BEHAV, V9, P160, DOI 10.1111/j.1601-183X.2009.00538.x; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BONIFATI V, 1994, CLIN NEUROPHARMACOL, V17, P73, DOI 10.1097/00002826-199402000-00008; BOUTHENET ML, 1987, NEUROSCIENCE, V20, P117, DOI 10.1016/0306-4522(87)90008-X; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Breit S, 2007, EXP NEUROL, V205, P36, DOI 10.1016/j.expneurol.2006.12.016; Breysse N, 2002, J NEUROSCI, V22, P5669; BROWN LL, 1979, SCIENCE, V206, P1416, DOI 10.1126/science.505015; BURBAUD P, 1995, EXP BRAIN RES, V105, P48; CANTERAS NS, 1990, BRAIN RES, V513, P43, DOI 10.1016/0006-8993(90)91087-W; Capus L, 2001, NEUROL SCI, V22, P57, DOI 10.1007/s100720170045; Carlsson T, 2005, BRAIN, V128, P559, DOI 10.1093/brain/awh374; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Cenci MA, 2007, CURR PROTOC NEUROSCI; Cesaro P, 2003, MALADIE PARKINSON; Dekundy A, 2007, BEHAV BRAIN RES, V179, P76, DOI 10.1016/j.bbr.2007.01.013; Eskow KL, 2007, PHARMACOL BIOCHEM BE, V87, P306, DOI 10.1016/j.pbb.2007.05.002; Flores G, 1999, NEUROSCIENCE, V91, P549, DOI 10.1016/S0306-4522(98)00633-2; Gerlach M, 2011, J NEURAL TRANSM, V118, P1727, DOI 10.1007/s00702-010-0570-9; Gill SS, 1997, LANCET, V350, P1224, DOI 10.1016/S0140-6736(05)63455-1; Gilmour TP, 2011, EXP NEUROL, V228, P53, DOI 10.1016/j.expneurol.2010.12.001; Guridi J, 2008, NEUROSURGERY, V62, P311, DOI 10.1227/01.neu.0000315998.58022.55; Murer MG, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00051; Hassani OK, 1996, NEUROSCIENCE, V72, P105, DOI 10.1016/0306-4522(95)00535-8; Hilker R, 2002, J NEURAL TRANSM, V109, P1257, DOI 10.1007/s00702-002-0696-5; HOLLERMAN JR, 1992, BRAIN RES, V590, P291, DOI 10.1016/0006-8993(92)91108-Q; JOHNSON AE, 1994, NEUROREPORT, V5, P1836, DOI 10.1097/00001756-199409080-00038; Johnston TH, 2010, J PHARMACOL EXP THER, V333, P865, DOI 10.1124/jpet.110.166629; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Katayama Y, 2006, STEREOT FUNCT NEUROS, V84, P176, DOI 10.1159/000094957; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; Kobylecki C, 2011, MOVEMENT DISORD, V26, P2354, DOI 10.1002/mds.23867; Kreiss DS, 1997, J NEUROSCI, V17, P6807; Kumar R, 2009, NEUROPHARMACOLOGY, V56, P956, DOI 10.1016/j.neuropharm.2009.01.019; Lacombe E, 2007, EUR J NEUROSCI, V26, P1670, DOI 10.1111/j.1460-9568.2007.05747.x; Levandis G, 2008, NEUROBIOL DIS, V29, P161, DOI 10.1016/j.nbd.2007.08.011; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; de Maturana RL, 2010, CNS NEUROL DISORD-DR, V9, P601, DOI 10.2174/187152710793361531; Lozano AM, 2000, ANN NEUROL, V47, pS141; Lundblad M, 2003, J NEUROCHEM, V84, P1398, DOI 10.1046/j.1471-4159.2003.01632.x; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Marin C, 2001, SYNAPSE, V42, P40, DOI 10.1002/syn.1097; Mela F, 2007, J NEUROCHEM, V101, P483, DOI 10.1111/j.1471-4159.2007.04456.x; Miguelez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024679; MITCHELL IJ, 1989, NEUROSCIENCE, V32, P213, DOI 10.1016/0306-4522(89)90120-6; Morera-Herreras T, 2008, NEUROSCIENCE, V151, P817, DOI 10.1016/j.neuroscience.2007.11.016; Morera-Herreras T, 2011, PSYCHOPHARMACOLOGY, V214, P379, DOI 10.1007/s00213-010-2043-0; Morera-Herreras T, 2010, SYNAPSE, V64, P20, DOI 10.1002/syn.20701; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Ni ZG, 2001, EUR J NEUROSCI, V14, P373, DOI 10.1046/j.0953-816x.2001.01644.x; Ni ZG, 2001, BRAIN RES, V899, P142, DOI 10.1016/S0006-8993(01)02219-3; Nimura T, 2005, J NEUROSURG, V103, P968, DOI 10.3171/jns.2005.103.6.0968; Nishikawa Y, 2010, NEUROL MED-CHIR, V50, P257, DOI 10.2176/nmc.50.257; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Oueslati A, 2007, J NEUROSCI, V27, P2377, DOI 10.1523/JNEUROSCI.2949-06.2007; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Piallat B, 1999, J NEURAL TRANSM-SUPP, P71; RINVIK E, 1993, J CHEM NEUROANAT, V6, P19, DOI 10.1016/0891-0618(93)90004-N; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Russmann H, 2004, NEUROLOGY, V63, P153, DOI 10.1212/01.WNL.0000131910.72829.9D; Rylander D, 2010, ANN NEUROL, V68, P619, DOI 10.1002/ana.22097; Rylander D, 2009, J PHARMACOL EXP THER, V330, P227, DOI 10.1124/jpet.108.150425; Sanchez-Pernaute R, 2008, NEUROIMAGE, V42, P248, DOI 10.1016/j.neuroimage.2008.04.170; Sanchez-Pernaute R, 2007, NEUROBIOL DIS, V27, P220, DOI 10.1016/j.nbd.2007.04.016; Shimo Y, 2009, EUR J NEUROSCI, V29, P104, DOI 10.1111/j.1460-9568.2008.06565.x; Shin E, 2012, NEUROBIOL DIS, V47, P393, DOI 10.1016/j.nbd.2012.03.038; Strafella AP, 2003, NEUROREPORT, V14, P1287, DOI 10.1097/00001756-200307010-00020; Thobois S, 2003, J NEUROL, V250, P1219, DOI 10.1007/s00415-003-0188-z; Vernon AC, 2007, J NEUROCHEM, V103, P1075, DOI 10.1111/j.1471-4159.2007.04860.x; Vila M, 2000, EUR J NEUROSCI, V12, P337, DOI 10.1046/j.1460-9568.2000.00901.x; Visanji NP, 2009, NEUROBIOL DIS, V35, P184, DOI 10.1016/j.nbd.2008.11.010; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Zheng Z, 2010, STEREOT FUNCT NEUROS, V88, P29, DOI 10.1159/000260077; Zhu ZT, 2002, BRAIN RES, V945, P31, DOI 10.1016/S0006-8993(02)02543-X	89	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42652	10.1371/journal.pone.0042652	http://dx.doi.org/10.1371/journal.pone.0042652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880070	Green Published, gold			2022-12-25	WOS:000307810000056
J	Chen, B; Tardell, C; Higgins, B; Packman, K; Boylan, JF; Niu, HF				Chen, Brenden; Tardell, Christine; Higgins, Brian; Packman, Kathryn; Boylan, John F.; Niu, Huifeng			BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; MAPK PATHWAY; CANCER-CELLS; BRAF GENE; INHIBITION; MEK; RAF; ACTIVATION; PHOSPHORYLATION; MUTATION	Cross-feedback activation of MAPK and AKT pathways is implicated as a resistance mechanism for cancer therapeutic agents targeting either RAF/MEK or PI3K/AKT/mTOR. It is thus important to have a better understanding of the molecular resistance mechanisms to improve patient survival benefit from these agents. Here we show that BRAFV600E is a negative regulator of the AKT pathway. Expression of BRAFV600E in NIH3T3 cells significantly suppresses MEK inhibitor (RG7167) or mTORC1 inhibitor (rapamycin) induced AKT phosphorylation (pAKT) and downstream signal activation. Treatment-induced pAKT elevation is found in BRAF wild type melanoma cells but not in a subset of melanoma cell lines harboring BRAFV600E. Knock-down of BRAFV600E in these melanoma cells elevates basal pAKT and downstream signals, whereas knock-down of CRAF, MEK1/2 or ERK1/2 or treatment with a BRAF inhibitor have no impact on pAKT. Mechanistically, we show that BRAFV600E interacts with rictor complex (mTORC2) and regulates pAKT through mTORC2. BRAFV600E is identified in mTORC2 after immunoprecipitation of rictor. Knock-down of rictor abrogates BRAFV600E depletion induced pAKT. Knockdown of BRAFV600E enhances cellular enzyme activity of mTORC2. Aberrant activation of AKT pathway by PTEN loss appears to override the negative impact of BRAFV600E on pAKT. Taken together, our findings suggest that in a subset of BRAFV600E melanoma cells, BRAFV600E negatively regulates AKT pathway in a rictor-dependent, MEK/ERK and BRAF kinase-independent manner. Our study reveals a novel molecular mechanism underlying the regulation of feedback loops between the MAPK and AKT pathways.	[Chen, Brenden; Tardell, Christine; Higgins, Brian; Packman, Kathryn; Boylan, John F.; Niu, Huifeng] Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ USA	Roche Holding	Chen, B (corresponding author), Hoffmann La Roche Inc, Discovery Oncol, Nutley, NJ USA.	huifeng.niu@roche.com			Roche Postdoc Fellowship Program	Roche Postdoc Fellowship Program	This work was partly supported by Roche Postdoc Fellowship Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Esteve-Puig R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004771; Falchook GS, 2011, ASCO M; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee L, 2009, CLIN CANCER RES, V15, P7368, DOI 10.1158/1078-0432.CCR-09-1696; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; McCubrey JA, 2008, CURR OPIN INVEST DR, V9, P614; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mielgo A, 2011, NAT MED, V17, P1641, DOI 10.1038/nm.2464; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	42	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42598	10.1371/journal.pone.0042598	http://dx.doi.org/10.1371/journal.pone.0042598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880048	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100138
J	Kryczka, J; Stasiak, M; Dziki, L; Mik, M; Dziki, A; Cierniewski, CS				Kryczka, Jakub; Stasiak, Marta; Dziki, Lukasz; Mik, Michal; Dziki, Adam; Cierniewski, Czeslaw S.			Matrix Metalloproteinase-2 Cleavage of the beta 1 Integrin Ectodomain Facilitates Colon Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; SURFACE ASSOCIATION; INTEGRIN EXPRESSION; TUMOR INVASION; GROWTH-FACTOR; ALPHA-V-BETA-3; MIGRATION; MATRIX-METALLOPROTEINASE-9; LOCALIZATION; INDUCTION	Cancer cell invasion is a key element in metastasis that requires integrins for adhesion/de-adhesion, as well as matrix metalloproteinases (MMPs) for focalized proteolysis. Herein we show that MMP-2 is up-regulated in resected colorectal tumors and degrades beta 1 integrins with the release of fragments containing the beta 1 I-domain. The beta 1 cleavage pattern is similar to that produced by digestion of alpha 5 beta 1 and alpha 2 beta 1 with MMP-2. Two such fragments, at 25 and 75 kDa, were identified after immunoprecipitation, with monoclonal antibody BD610468 reacting with the NH2-terminal I-like ectodomain followed by SDS-PAGE and microsequencing using electrospray (ISI-Q-TOF-Micromass) spectrometry. Cleavage of the beta 1 integrin can be abolished by inhibition of MMP-2 activity; it can be induced by up-regulation of MMP-2 expression, as exemplified by HT29 colon cancer cells transfected with pCMV6-XL5-MMP-2. Co-immunoprecipitation studies of colon cancer cells showed that the beta 1 integrin subunit is associated with MMP-2. The MMP-2-mediated shedding of the I-like domain from beta 1 integrins resulted in decreased adhesion of colon cancer cells to collagen and fibronectin, thus abolishing their receptivity. Furthermore, such cells showed enhanced motility as evaluated by a "wound healing-like" assay and time-lapse microscopy, indicating their increased invasiveness. Altogether, our data demonstrate that MMP-2 amplifies the motility of colon cancer cells, not only by digesting the extracellular matrix components in the vicinity of cancer cells but also by inactivating their major beta 1 integrin receptors.	[Kryczka, Jakub; Stasiak, Marta; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Dziki, Lukasz; Mik, Michal; Dziki, Adam] Med Univ Lodz, Dept Gen & Colorectal Surg, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-92215 Lodz, Poland	Medical University Lodz; Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl		Mik, Michal/0000-0001-6290-1806; Dziki, Adam/0000-0002-5439-6237; Kryczka, Jakub/0000-0002-5719-4139; Dziki, Lukasz/0000-0002-0390-0827	National Science Center, Krakow, Poland [2011/02/A/NZ3/00068]	National Science Center, Krakow, Poland	This work was supported by Project 2011/02/A/NZ3/00068 from the National Science Center, Krakow, Poland.	Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Choi WS, 2010, J THROMB HAEMOST, V8, P1364, DOI 10.1111/j.1538-7836.2010.03837.x; Cierniewski CS, 2010, ANN NY ACAD SCI, V1194, P60, DOI 10.1111/j.1749-6632.2010.05480.x; Cieslak M, 2002, J BIOL CHEM, V277, P6779, DOI 10.1074/jbc.M102325200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Hodgkinson CP, 2000, MOL PHARMACOL, V58, P976, DOI 10.1124/mol.58.5.976; Ise H, 2001, BIOCHEM BIOPH RES CO, V285, P172, DOI 10.1006/bbrc.2001.5139; Kanda S, 2000, ARTERIOSCL THROM VAS, V20, P998, DOI 10.1161/01.ATV.20.4.998; KawakamiKimura N, 1997, BRIT J CANCER, V75, P47, DOI 10.1038/bjc.1997.8; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Menon B, 2006, AM J PHYSIOL-CELL PH, V290, pC254, DOI 10.1152/ajpcell.00235.2005; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morozevich G, 2009, CELL CYCLE, V8, P2219, DOI 10.4161/cc.8.14.8980; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Niewiarowska J, 2009, CANCER GENE THER, V16, P713, DOI 10.1038/cgt.2009.13; Pawlowska Z, 2005, PROTEOMICS, V5, P1217, DOI 10.1002/pmic.200400983; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schaffert CS, 2001, ALCOHOL CLIN EXP RES, V25, P1749, DOI 10.1097/00000374-200112000-00010; SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389, DOI 10.1091/mbc.5.4.389; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Torimura T, 2001, J HEPATOL, V35, P245, DOI 10.1016/S0168-8278(01)00127-1; Toth M, 1997, CANCER RES, V57, P3159; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yu Q, 2000, GENE DEV, V14, P163; Yuan ST, 2000, WORLD J GASTROENTERO, V6, P231; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I	40	57	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36556	36566		10.1074/jbc.M112.384909	http://dx.doi.org/10.1074/jbc.M112.384909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898815	Green Published, hybrid			2022-12-25	WOS:000310364000076
J	Meriin, AB; Mense, M; Colbert, JD; Liang, F; Bihler, H; Zaarur, N; Rock, KL; Sherman, MY				Meriin, Anatoli B.; Mense, Martin; Colbert, Jeff D.; Liang, Feng; Bihler, Hermann; Zaarur, Nava; Rock, Kenneth L.; Sherman, Michael Y.			A Novel Approach to Recovery of Function of Mutant Proteins by Slowing Down Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURODEGENERATIVE DISEASES; AGGRESOME FORMATION; HEAT-SHOCK; AUTOPHAGY; DEGRADATION; F508DEL-CFTR; ASSOCIATION; CHAPERONES; HUNTINGTIN; TOXICITY	Protein homeostasis depends on a balance of translation, folding, and degradation. Here, we demonstrate that mild inhibition of translation results in a dramatic and disproportional reduction in production of misfolded polypeptides in mammalian cells, suggesting an improved folding of newly synthesized proteins. Indeed, inhibition of translation elongation, which slightly attenuated levels of a copepod GFP mutant protein, significantly enhanced its function. In contrast, inhibition of translation initiation had minimal effects on copepod GFP folding. On the other hand, mild suppression of either translation elongation or initiation corrected folding defects of the disease-associated cystic fibrosis transmembrane conductance regulator mutant F508del. We propose that modulation of translation can be used as a novel approach to improve overall proteostasis in mammalian cells, as well as functions of disease-associated mutant proteins with folding deficiencies.	[Meriin, Anatoli B.; Zaarur, Nava; Sherman, Michael Y.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Mense, Martin] Cyst Fibrosis Fdn Therapeut, Bethesda, MD 20814 USA; [Colbert, Jeff D.; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Liang, Feng; Bihler, Hermann] Flatley Discovery Lab, Charlestown, MA 02129 USA	Boston University; Cystic Fibrosis Foundation; University of Massachusetts System; University of Massachusetts Worcester	Sherman, MY (corresponding author), Boston Univ, Sch Med, Dept Biochem, K-323, Boston, MA 02118 USA.	sherma1@bu.edu		Bihler, Hermann/0000-0002-8167-1548; Meriin, Anatoli/0000-0003-0087-814X; Sherman, Michael/0000-0003-3345-073X	National Institutes of Health [R01 GM086890, R01 AI20248, DK32520, AI007272-25]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007272, R01AI020248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM086890 (to M. Y. S.), R01 AI20248 (to K. L. R.), and DK32520 (to the Diabetes Endocrinology Research Center) and Training Grant AI007272-25 (to J. D. C.).	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Meriin AB, 2012, J CELL SCI, V125, P2665, DOI 10.1242/jcs.098954; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Syntichaki P, 2007, ANN NY ACAD SCI, V1119, P289, DOI 10.1196/annals.1404.001; Thakerar A., 2009, PEDIAT PULMONOL, V44, P305; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Wigley WC, 1999, J CELL BIOL, V145, P481; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	29	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34264	34272		10.1074/jbc.M112.397307	http://dx.doi.org/10.1074/jbc.M112.397307			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902621	hybrid, Green Published			2022-12-25	WOS:000309654200031
J	Bermudez-Brito, M; Munoz-Quezada, S; Gomez-Llorente, C; Matencio, E; Bernal, MJ; Romero, F; Gil, A				Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Matencio, Esther; Bernal, Maria J.; Romero, Fernando; Gil, Angel			Human Intestinal Dendritic Cells Decrease Cytokine Release against Salmonella Infection in the Presence of Lactobacillus paracasei upon TLR Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; PROBIOTIC STRAINS; EPITHELIAL-CELLS; CACO-2 CELLS; KAPPA-B; EXPRESSION; GUT; INFLAMMATION	Probiotic bacteria have been shown to modulate immune responses and could have therapeutic effects in allergic and inflammatory disorders. However, little is known about the signalling pathways that are engaged by probiotics. Dendritic cells (DCs) are antigen-presenting cells that are involved in immunity and tolerance. Monocyte-derived dendritic cells (MoDCs) and murine DCs are different from human gut DCs; therefore, in this study, we used human DCs generated from CD34+ progenitor cells (hematopoietic stem cells) harvested from umbilical cord blood; those DCs exhibited surface antigens of dendritic Langerhans cells, similar to the lamina propria DCs in the gut. We report that both a novel probiotic strain isolated from faeces of exclusively breast-fed newborn infants, Lactobacillus paracasei CNCM I-4034, and its cell-free culture supernatant (CFS) decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with Salmonella. Interestingly, the supernatant was as effective as the bacteria in reducing pro-inflammatory cytokine expression. In contrast, the bacterium was a potent inducer of TGF-beta 2 secretion, whereas the supernatant increased the secretion of TGF-beta 1 in response to Salmonella. We also showed that both the bacteria and its supernatant enhanced innate immunity through the activation of Toll-like receptor (TLR) signalling. These treatments strongly induced the transcription of the TLR9 gene. In addition, upregulation of the CASP8 and TOLLIP genes was observed. This work demonstrates that L. paracasei CNCM I-4034 enhanced innate immune responses, as evidenced by the activation of TLR signalling and the downregulation of a broad array of pro-inflammatory cytokines. The use of supernatants like the one described in this paper could be an effective and safe alternative to using live bacteria in functional foods.	[Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain; [Matencio, Esther; Bernal, Maria J.; Romero, Fernando] Hero Spain, Hero Inst Infant Nutr, Murcia, Spain	University of Granada	Bermudez-Brito, M (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain.	agil@ugr.es	Gil, Angel/L-2275-2014; Gil, Angel/ABA-7621-2020; Llorente, Carolina Gomez/K-7484-2015	Gil, Angel/0000-0001-7663-0939; Gil, Angel/0000-0001-7663-0939; Llorente, Carolina Gomez/0000-0003-3948-1473; Bermudez Brito, Miriam/0000-0003-4156-143X	Hero Spain S.A. [3143]; Fundacion General Universidad de Granada Empresa; CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	Hero Spain S.A.; Fundacion General Universidad de Granada Empresa; CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	This work was funded by Hero Spain S.A. through the contract no 3143 signed with the Fundacion General Universidad de Granada Empresa and co-sponsored by the CDTI, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government. Carolina Gomez-Llorente received a postdoctoral fellowship from Plan Propio of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Bongaerts GPA, 2005, MED HYPOTHESES, V64, P1089, DOI 10.1016/j.mehy.2004.10.018; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Clarke JO, 2008, NUTR CLIN PRACT, V23, P49, DOI 10.1177/011542650802300149; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Hotel ACP., 2001, PREVENTION, V5, P1; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Huang Y, 2010, BRIT J NUTR, V103, P473, DOI 10.1017/S0007114509991991; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lomax AR, 2009, CURR PHARM DESIGN, V15, P1428, DOI 10.2174/138161209788168155; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Medellin-Pena MJ, 2007, APPL ENVIRON MICROB, V73, P4259, DOI 10.1128/AEM.00159-07; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Mesquita D, 2010, REV BRAS REUMATOL, V50, P566, DOI 10.1590/S0482-50042010000500008; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Munoz-Quezada S, 2013, Br. J. Nutr., V109, pS51, Patent No. 090006; Niess JH, 2005, CURR OPIN GASTROEN, V21, P687, DOI 10.1097/01.mog.0000181710.96904.58; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ouwehand AC, 2009, WORLD J GASTROENTERO, V15, P3261, DOI 10.3748/wjg.15.3261; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Villena J, 2012, CLIN VACCINE IMMUNOL; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Zhou C, 2008, WORLD J GASTROENTERO, V14, P5090, DOI 10.3748/wjg.14.5090	50	58	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43197	10.1371/journal.pone.0043197	http://dx.doi.org/10.1371/journal.pone.0043197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905233	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800060
J	Kitamura, K; Kishi-Itakura, C; Tsuboi, T; Sato, S; Kita, K; Ohta, N; Mizushima, N				Kitamura, Kei; Kishi-Itakura, Chieko; Tsuboi, Takafumi; Sato, Shigeharu; Kita, Kiyoshi; Ohta, Nobuo; Mizushima, Noboru			Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; ERYTHROCYTIC STAGES; ALGAL ORIGIN; MEMBRANE; PROTEINS; MITOCHONDRIA; APICOMPLEXAN; HOMOLOG; COMPLEX; SYSTEM	Autophagy is a membrane-mediated degradation process, which is governed by sequential functions of Atg proteins. Although Atg proteins are highly conserved in eukaryotes, protozoa possess only a partial set of Atg proteins. Nonetheless, almost all protozoa have the complete factors belonging to the Atg8 conjugation system, namely, Atg3, Atg4, Atg7, and Atg8. Here, we report the biochemical properties and subcellular localization of the Atg8 protein of the human malaria parasite Plasmodium falciparum (PfAtg8). PfAtg8 is expressed during intra-erythrocytic development and associates with membranes likely as a lipid-conjugated form. Fluorescence microscopy and immunoelectron microscopy show that PfAtg8 localizes to the apicoplast, a four membrane-bound non-photosynthetic plastid. Autophagosome-like structures are not observed in the erythrocytic stages. These data suggest that, although Plasmodium parasites have lost most Atg proteins during evolution, they use the Atg8 conjugation system for the unique organelle, the apicoplast.	[Kitamura, Kei; Kishi-Itakura, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo, Japan; [Kitamura, Kei; Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Tsuboi, Takafumi] Ehime Univ, Venture Business Lab, Matsuyama, Ehime, Japan; [Sato, Shigeharu] MRC Natl Inst Med Res, Div Parasitol, London, England; [Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Ehime University; Ehime University; MRC National Institute for Medical Research; University of Tokyo	Kitamura, K (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo, Japan.	matata.vip@tmd.ac.jp; nmizu.phy2@tmd.ac.jp	Tsuboi, Takafumi/AAK-6145-2021; Mizushima, Noboru/C-3635-2009; Sato, Shigeharu/K-9464-2013	Mizushima, Noboru/0000-0002-6258-6444; Sato, Shigeharu/0000-0003-2738-430X; Tsuboi, Takafumi/0000-0002-7415-1325; Sato, Shigeharu/0000-0001-9559-7580; Kita, Kiyoshi/0000-0002-0426-4308	Ministry of Education, Culture, Sports, Science and Technology [23117008]; British Medical Research Council [U117584270]; Creative Scientific Research Grant [18GS0314]; grant for Ministry of Health, Labor and Welfare [H23-Kokui-004]; Funding Program for Next Generation World-Leading Researchers; MRC [MC_U117532072] Funding Source: UKRI; Medical Research Council [MC_U117532072, U117584270] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Creative Scientific Research Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); grant for Ministry of Health, Labor and Welfare; Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (23117008) (to T.T.), the British Medical Research Council (U117584270) (to S. S.), Creative Scientific Research Grant 18GS0314 (to K. Kita), a grant for Ministry of Health, Labor and Welfare (H23-Kokui-004) (to N.O.) and the Funding Program for Next Generation World-Leading Researchers (to N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Cuervo AM, 2011, NAT REV MOL CELL BIO, V12, P535, DOI 10.1038/nrm3150; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi M, 2001, J BIOL CHEM, V276, P15249, DOI 10.1074/jbc.M011709200; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kageyama Shun, 2011, Mol Biol Cell, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kobayashi T, 2007, MITOCHONDRION, V7, P125, DOI 10.1016/j.mito.2006.11.021; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kovacs AL, 2007, AUTOPHAGY, V3, P655, DOI 10.4161/auto.4590; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lim L, 2009, TRENDS PARASITOL, V25, P197, DOI 10.1016/j.pt.2009.02.001; McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Picazarri K, 2008, INFECT IMMUN, V76, P278, DOI 10.1128/IAI.00636-07; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rigden DJ, 2009, AUTOPHAGY, V5, P784, DOI 10.4161/auto.8838; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sasaki N, 2009, FEBS LETT, V583, P1446, DOI 10.1016/j.febslet.2009.03.071; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL MICROBIOL, V61, P614, DOI 10.1111/j.1365-2958.2006.05244.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	72	59	59	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42977	10.1371/journal.pone.0042977	http://dx.doi.org/10.1371/journal.pone.0042977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900071	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900089
J	Shibata, K; Miura, M; Watanabe, Y; Saito, K; Nishimura, A; Furuta, K; Toyoshima, YY				Shibata, Keitaro; Miura, Michi; Watanabe, Yuta; Saito, Kei; Nishimura, Atsuko; Furuta, Ken'ya; Toyoshima, Yoko Y.			A Single Protofilament Is Sufficient to Support Unidirectional Walking of Dynein and Kinesin	PLOS ONE			English	Article							AAA PLUS RING; CYTOPLASMIC DYNEIN; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; MOTOR-PROTEIN; BETA-TUBULIN; DOMAIN; MICROTUBULES; MECHANISM; MOTILITY	Cytoplasmic dynein and kinesin are two-headed microtubule motor proteins that move in opposite directions on microtubules. It is known that kinesin steps by a 'hand-over-hand' mechanism, but it is unclear by which mechanism dynein steps. Because dynein has a completely different structure from that of kinesin and its head is massive, it is suspected that dynein uses multiple protofilaments of microtubules for walking. One way to test this is to ask whether dynein can step along a single protofilament. Here, we examined dynein and kinesin motility on zinc-induced tubulin sheets (zinc-sheets) which have only one protofilament available as a track for motor proteins. Single molecules of both dynein and kinesin moved at similar velocities on zinc-sheets compared to microtubules, clearly demonstrating that dynein and kinesin can walk on a single protofilament and multiple rows of parallel protofilaments are not essential for their motility. Considering the size and the motile properties of dynein, we suggest that dynein may step by an inchworm mechanism rather than a hand-over-hand mechanism.	[Shibata, Keitaro; Miura, Michi; Watanabe, Yuta; Saito, Kei; Nishimura, Atsuko; Furuta, Ken'ya; Toyoshima, Yoko Y.] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Shibata, K (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp		Miura, Michi/0000-0002-6943-3782	MEXT [20370057]; JST; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [10J10101] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B) (20370057) from MEXT and by the Strategic International Science and Technology Cooperation Program (http://www.jst.go.jp/inter/index.html) from JST to YYT. K. Shibata was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1978, J MOL BIOL, V123, P89, DOI 10.1016/0022-2836(78)90378-9; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; CROSS RA, 1995, J MUSCLE RES CELL M, V16, P91, DOI 10.1007/BF00122526; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HIROSE K, 1995, NATURE, V376, P277, DOI 10.1038/376277a0; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; KAMIMURA S, 1992, J CELL BIOL, V118, P865, DOI 10.1083/jcb.118.4.865; KIKKAWA M, 1995, NATURE, V376, P274, DOI 10.1038/376274a0; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Miura M, 2010, FEBS LETT, V584, P2351, DOI 10.1016/j.febslet.2010.04.016; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; RAY S, 1995, CELL MOTIL CYTOSKEL, V30, P146, DOI 10.1002/cm.970300206; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toba S, 2004, CELL MOTIL CYTOSKEL, V58, P281, DOI 10.1002/cm.20018; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373; WOLF SG, 1993, J STRUCT BIOL, V111, P190, DOI 10.1006/jsbi.1993.1049	43	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42990	10.1371/journal.pone.0042990	http://dx.doi.org/10.1371/journal.pone.0042990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900078	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900096
J	Frank, S; Lee, S; Preissl, H; Schultes, B; Birbaumer, N; Veit, R				Frank, Sabine; Lee, Sangkyun; Preissl, Hubert; Schultes, Bernd; Birbaumer, Niels; Veit, Ralf			The Obese Brain Athlete: Self-Regulation of the Anterior Insula in Adiposity	PLOS ONE			English	Article							NEURAL MECHANISMS; FOOD; FMRI; SATIATION	The anterior insular cortex (AIC) is involved in emotional processes and gustatory functions which can be examined by imaging techniques. Such imaging studies showed increased activation in the insula in response to food stimuli as well as a differential activation in lean and obese people. Additionally, studies investigating lean subjects established the voluntary regulation of the insula by a real-time functional magnetic resonance imaging-brain computer interface (rtfMRI-BCI) approach. In this exploratory study, 11 lean and 10 obese healthy, male participants were investigated in a rtfMRI-BCI protocol. During the training sessions, all obese participants were able to regulate the activity of the AIC voluntarily, while four lean participants were not able to regulate at all. In successful regulators, functional connectivity during regulation vs. relaxation between the AIC and all other regions of the brain was determined by a seed voxel approach. Lean in comparison to obese regulators showed stronger connectivity in cingular and temporal cortices during regulation. We conclude, that obese people possess an improved capacity to self-regulate the anterior insula, a brain system tightly related to bodily awareness and gustatory functions.	[Frank, Sabine; Preissl, Hubert; Veit, Ralf] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Frank, Sabine; Lee, Sangkyun; Birbaumer, Niels; Veit, Ralf] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Preissl, Hubert] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Schultes, Bernd] Cantonal Hosp St Gallen, Interdisciplinary Obes Ctr, CH-9400 Rorschach, Switzerland; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Kantonsspital St. Gallen	Frank, S (corresponding author), Univ Tubingen, MEG Ctr, Tubingen, Germany.	sabine.frank@med.uni-tuebingen.de	Frank-Podlech, Sabine/I-8986-2012; Veit, Ralf/F-8907-2012; Preißl, Hubert/E-9070-2012	Frank-Podlech, Sabine/0000-0002-9646-3987; Veit, Ralf/0000-0001-9860-642X; Preißl, Hubert/0000-0002-8859-4661; Birbaumer, Niels/0000-0002-6786-5127	Kompetenznetz Adipositas (Competence Network for Adiposity); German Federal Ministry of Education and Research (BMBF) [FKZ 01GI0837]; German Research Foundation (DFG) [PAK347]	Kompetenznetz Adipositas (Competence Network for Adiposity); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the "Kompetenznetz Adipositas (Competence Network for Adiposity)'' funded by the German Federal Ministry of Education and Research (BMBF FKZ 01GI0837) and by the German Research Foundation (DFG PAK347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijs IMT, 2007, APPETITE, V49, P38, DOI 10.1016/j.appet.2006.11.001; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; Pudel D, 1989, FRAGEBOGEN ESSVERHAL; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; World Health Organization, 2016, OB OV; Yokum S, 2011, OBESITY, V19, P1775, DOI 10.1038/oby.2011.168	27	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42570	10.1371/journal.pone.0042570	http://dx.doi.org/10.1371/journal.pone.0042570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905151	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100049
J	Sanseverino, AM; Bastviken, D; Sundh, I; Pickova, J; Enrich-Prast, A				Sanseverino, Angela M.; Bastviken, David; Sundh, Ingvar; Pickova, Jana; Enrich-Prast, Alex			Methane Carbon Supports Aquatic Food Webs to the Fish Level	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACIDS; STABLE-ISOTOPES; OXIDIZING BACTERIA; LIPID EXTRACTION; BIOGENIC METHANE; PETIT SAUT; GEN-NOV; LAKE; RIVER; COMMUNITY	Large amounts of the greenhouse gas methane (CH4) are produced by anaerobic mineralization of organic matter in lakes. In spite of extensive freshwater CH4 emissions, most of the CH4 is typically oxidized by methane oxidizing bacteria (MOB) before it can reach the lake surface and be emitted to the atmosphere. In turn, it has been shown that the CH4-derived biomass of MOB can provide the energy and carbon for zooplankton and macroinvertebrates. In this study, we demonstrate the presence of specific fatty acids synthesized by MOB in fish tissues having low carbon stable isotope ratios. Fish species, zooplankton, macroinvertebrates and the water hyacinth Eichhornia crassipes were collected from a shallow lake in Brazil and analyzed for fatty acids (FA) and carbon stable isotope ratios (delta C-13). The fatty acids 16:1 omega 8c, 16:1 omega 8t, 16:1 omega 6c, 16:1 omega 5t, 18:1 omega 8c and 18:1 omega 8t were used as signature for MOB. The delta C-13 ratios varied from -27.7 parts per thousand to -42.0 parts per thousand and the contribution of MOB FA ranged from 0.05% to 0.84% of total FA. Organisms with higher total content of MOB FAs presented lower delta C-13 values (i.e. they were more depleted in C-13), while organisms with lower content of MOB signature FAs showed higher delta C-13 values. An UPGMA cluster analysis was carried out to distinguish grouping of organisms in relation to their MOB FA contents. This combination of stable isotope and fatty acid tracers provides new evidence that assimilation of methane-derived carbon can be an important carbon source for the whole aquatic food web, up to the fish level.	[Sanseverino, Angela M.; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Sanseverino, Angela M.; Bastviken, David; Enrich-Prast, Alex] Linkoping Univ, Dept Themat Studies Water & Environm Studies, Linkoping, Sweden; [Sundh, Ingvar] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Pickova, Jana] Swedish Univ Agr Sci, Dept Food Sci, Uppsala BioCtr, Uppsala, Sweden	Universidade Federal do Rio de Janeiro; Linkoping University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Sanseverino, AM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	angelamsanseverino@gmail.com	Prast, Alex Enrich/AAL-4722-2021; Sanseverino, Angela/G-2809-2012; Enrich-Prast, Alex/H-5391-2012	Prast, Alex Enrich/0000-0003-3561-0936; Sanseverino, Angela/0000-0001-7133-257X; pickova, jana/0000-0002-3406-3435; Bastviken, David/0000-0003-0038-2152	Coordination for the Improvement of Higher Education Personnel CAPES; Brazilian Science Council CNPq; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ; Swedish Research Council VR	Coordination for the Improvement of Higher Education Personnel CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Science Council CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swedish Research Council VR(Swedish Research Council)	Financial support was contributed by Coordination for the Improvement of Higher Education Personnel CAPES (http://www.capes.gov.br), the Brazilian Science Council CNPq (http://www.cnpq.br), and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State FAPERJ (http://www.faperj.br) to AEP and AMS and by the Swedish Research Council VR (http://www.vr.se) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MP, 2003, STUD NEOTROP FAUNA E, V38, P33, DOI 10.1076/snfe.38.1.33.14033; AMARAL JA, 1995, FEMS MICROBIOL LETT, V126, P215, DOI 10.1111/j.1574-6968.1995.tb07421.x; APPELQVIST LA, 1968, ARK KEMI, V28, P551; Arcifa M. S., 2000, Revista Brasileira de Biologia, V60, P591, DOI 10.1590/S0034-71082000000400008; Arrington DA, 2006, J FISH BIOL, V68, P1347, DOI 10.1111/j.0022-1112.2006.00996.x; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Bastviken D., 2009, ENCY INLAND WATERS, P783, DOI [10.1016/b978-012370626-3.00117-4, DOI 10.1016/B978-012370626-3.00117-4]; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Bodelier PLE, 2009, ISME J, V3, P606, DOI 10.1038/ismej.2009.6; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borjesson G, 2004, FEMS MICROBIOL ECOL, V48, P305, DOI 10.1016/j.femsec.2004.02.006; Bowman J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P266, DOI 10.1007/0-387-30745-1_15; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; Calheiros DF, 2003, THESIS U SAO PAULO B; Chowdhury TR, 2011, NATURE PRECEDINGS; Coffman W.P., 1996, P635; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Conrad R, 2011, BIOGEOSCIENCES, V8, P795, DOI 10.5194/bg-8-795-2011; Correa CE, 2011, NEOTROP ICHTHYOL, V9, P637, DOI 10.1590/S1679-62252011000300017; Correa SB, 2005, THESIS U FLORIDA; de Oliveira ERN, 2003, BRAZ ARCH BIOL TECHN, V46, P105, DOI 10.1590/S1516-89132003000100015; Deines P, 2007, ENVIRON MICROBIOL, V9, P1126, DOI 10.1111/j.1462-2920.2006.01235.x; Dumestre JF, 1999, HYDROBIOLOGIA, V400, P75, DOI 10.1023/A:1003707129170; Dumestre JF, 2002, AQUAT MICROB ECOL, V26, P209, DOI 10.3354/ame026209; ESTEVES KE, 1995, ENVIRON BIOL FISH, V42, P375, DOI 10.1007/BF00001468; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Goedkoop W, 1998, FRESHWATER BIOL, V40, P135, DOI 10.1046/j.1365-2427.1998.00339.x; Grey J, 2000, OECOLOGIA, V123, P232, DOI 10.1007/s004420051010; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; Grey J, 2004, LIMNOL OCEANOGR, V49, P239, DOI 10.4319/lo.2004.49.1.0239; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harrod C, 2006, ARCH HYDROBIOL, V167, P281, DOI 10.1127/0003-9136/2006/0167-0281; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jones RI, 1998, P ROY SOC B-BIOL SCI, V265, P105, DOI 10.1098/rspb.1998.0270; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Junk W.J., 1993, WETL ECOL MANAG, V2, P231, DOI [10.1007/BF00188157, DOI 10.1007/BF00188157]; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; KING GM, 1992, ADV MICROB ECOL, V12, P431; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kiyashko SI, 2004, COMP BIOCHEM PHYS B, V139, P705, DOI 10.1016/j.cbpc.2004.08.013; Kiyashko SI, 2001, AQUAT MICROB ECOL, V24, P203, DOI 10.3354/ame024203; Lopes CA, 2009, BRAZ J BIOL, V69, P573, DOI 10.1590/S1519-69842009000300012; MERRITT R. W., 1996, INTRO AQUATIC INSECT; Molineri C, 2010, AQUAT INSECT, V32, P265, DOI 10.1080/01650424.2010.533131; NICHOLS PD, 1986, J MICROBIOL METH, V5, P49, DOI 10.1016/0167-7012(86)90023-0; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Pereira PR, 2007, NEOTROP ICHTHYOL, V5, P399, DOI 10.1590/S1679-62252007000300019; Pereira R.A.C., 1998, EMBRAPA BOL PESQ, V12, P1; Peretti D, 2008, BRAZ J BIOL, V68, P671, DOI 10.1590/S1519-69842008000300027; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Raghoebarsing AA, 2005, NATURE, V436, P1153, DOI 10.1038/nature03802; RAU G, 1978, SCIENCE, V201, P901, DOI 10.1126/science.201.4359.901; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Resende E. K., 2000, EMBRAPA BOL PESQ, V16, P1; Saether O.A., 1997, AQUATIC INSECTS N EU, P149; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Sohngen NL, 1906, ZENTRALBL BAKTERIOL, V15, P513; Steger K, 2011, LIMNOL OCEANOGR, V56, P725, DOI 10.4319/lo.2011.56.2.0725; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Sundh I, 2005, APPL ENVIRON MICROB, V71, P6746, DOI 10.1128/AEM.71.11.6746-6752.2005; Taipale S, 2009, FRESHWATER BIOL, V54, P90, DOI 10.1111/j.1365-2427.2008.02094.x; Trattner S, 2008, LIPIDS, V43, P999, DOI 10.1007/s11745-008-3229-7; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P1541, DOI 10.4319/lo.2009.54.5.1541; Vari R. P., 1992, SMITHSONIAN CONTRIBU, V529, P1, DOI DOI 10.5479/SI.00810282.529; Virtue P, 1996, J MICROBIOL METH, V25, P177, DOI 10.1016/0167-7012(95)00095-X; Wantzen KM, 2002, AQUAT SCI, V64, P239, DOI 10.1007/PL00013196; Wise MG, 2001, INT J SYST EVOL MICR, V51, P611, DOI 10.1099/00207713-51-2-611	70	56	58	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42723	10.1371/journal.pone.0042723	http://dx.doi.org/10.1371/journal.pone.0042723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880091	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000307437900051
J	Wichroski, MJ; Fang, J; Eggers, BJ; Rose, RE; Mazzucco, CE; Pokornowski, KA; Baldick, CJ; Anthony, MN; Dowling, CJ; Barber, LE; Leet, JE; Beno, BR; Gerritz, SW; Agler, ML; Cockett, MI; Tenney, DJ				Wichroski, Michael J.; Fang, Jie; Eggers, Betsy J.; Rose, Ronald E.; Mazzucco, Charles E.; Pokornowski, Kevin A.; Baldick, Carl J.; Anthony, Monique N.; Dowling, Craig J.; Barber, Lauren E.; Leet, John E.; Beno, Brett R.; Gerritz, Samuel W.; Agler, Michele L.; Cockett, Mark I.; Tenney, Daniel J.			High-Throughput Screening and Rapid Inhibitor Triage Using an Infectious Chimeric Hepatitis C Virus	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; CELL-CULTURE SYSTEMS; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; POTENT INHIBITORS; IN-VIVO; CLEAVAGE; MEMBRANE; PARTICLES; PROMOTES	The recent development of a Hepatitis C virus (HCV) infectious virus cell culture model system has facilitated the development of whole-virus screening assays which can be used to interrogate the entire virus life cycle. Here, we describe the development of an HCV growth assay capable of identifying inhibitors against all stages of the virus life cycle with assay throughput suitable for rapid screening of large-scale chemical libraries. Novel features include, 1) the use of an efficiently-spreading, full-length, intergenotypic chimeric reporter virus with genotype 1 structural proteins, 2) a homogenous assay format compatible with miniaturization and automated liquid-handling, and 3) flexible assay end-points using either chemiluminescence (high-throughput screening) or Cellomics ArrayScan (TM) technology (high-content screening). The assay was validated using known HCV antivirals and through a large-scale, high-throughput screening campaign that identified novel and selective entry, replication and late-stage inhibitors. Selection and characterization of resistant viruses provided information regarding inhibitor target and mechanism. Leveraging results from this robust whole-virus assay represents a critical first step towards identifying inhibitors of novel targets to broaden the spectrum of antivirals for the treatment of HCV.	[Wichroski, Michael J.; Fang, Jie; Eggers, Betsy J.; Rose, Ronald E.; Mazzucco, Charles E.; Pokornowski, Kevin A.; Baldick, Carl J.; Anthony, Monique N.; Dowling, Craig J.; Barber, Lauren E.; Leet, John E.; Beno, Brett R.; Gerritz, Samuel W.; Agler, Michele L.; Cockett, Mark I.; Tenney, Daniel J.] Bristol Myers Squibb Res & Dev, Wallingford, CT USA	Bristol-Myers Squibb	Wichroski, MJ (corresponding author), Bristol Myers Squibb Res & Dev, Wallingford, CT USA.	michael.wichroski@bms.com		Gerritz, Samuel/0000-0002-8378-0393				Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gentzsch J, 2011, ANTIVIR RES, V89, P136, DOI 10.1016/j.antiviral.2010.12.005; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2011, J VIROL, V85, P8913, DOI 10.1128/JVI.00049-11; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hope RG, 2006, J GEN VIROL, V87, P623, DOI 10.1099/vir.0.81371-0; Horscroft Nigel, 2005, Antiviral Chemistry & Chemotherapy, V16, P1; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kota S, 2009, J GEN VIROL, V90, P1319, DOI 10.1099/vir.0.008565-0; Kota S, 2009, ASSAY DRUG DEV TECHN; Laakso MM, 2007, PLOS PATHOG, V3, P1118, DOI 10.1371/journal.ppat.0030117; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ma HC, 2007, J BIOMED SCI, V14, P31, DOI 10.1007/s11373-006-9127-1; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mittapalli GK, 2011, BIOORG MED CHEM LETT; Ni F, 2011, BIOORG MED CHEM LETT, V21, P2198, DOI 10.1016/j.bmcl.2011.03.014; Nolan KM, 2009, J VIROL, V83, P3798, DOI 10.1128/JVI.01751-08; Nyanguile O, 2010, J VIROL, V84, P2923, DOI 10.1128/JVI.01980-09; O'Boyle DR, 2005, ANTIMICROB AGENTS CH, V49, P1346, DOI 10.1128/AAC.49.4.1346-1353.2005; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Seeff L B, 1997, Clin Liver Dis, V1, P587, DOI 10.1016/S1089-3261(05)70323-8; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97, DOI 10.7326/0003-4819-116-2-97; Strosberg AD, 2010, VIRUSES-BASEL, V2, P1734, DOI 10.3390/v2081734; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MinKyung, 2009, V510, P337, DOI 10.1007/978-1-59745-394-3_25; Yu XM, 2009, ANTIMICROB AGENTS CH, V53, P4311, DOI 10.1128/AAC.00495-09; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42609	10.1371/journal.pone.0042609	http://dx.doi.org/10.1371/journal.pone.0042609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880053	Green Submitted, gold, Green Published			2022-12-25	WOS:000307810000051
J	Qurei, L; Seto, D; Salah, Z; Azzeh, M				Qurei, Lina; Seto, Donald; Salah, Zaidoun; Azzeh, Maysa			A Molecular Epidemiology Survey of Respiratory Adenoviruses Circulating in Children Residing in Southern Palestine	PLOS ONE			English	Article							COMPUTATIONAL ANALYSIS; TRACT INFECTIONS; BUENOS-AIRES; 2 STRAINS; OUTBREAK; DISEASE; PNEUMONIA; TYPE-3; IDENTIFICATION; SEROTYPES	A molecular epidemiology survey was performed in order to establish and document the respiratory adenovirus pathogen profiles among children in Southern Palestine. Three hundred and thirty-eight hospitalized pediatric cases with adenovirus-associated respiratory tract infections were analyzed. Forty four cases out of the 338 were evaluated in more detail for the adenoviruses types present. All of the children resided in Southern Palestine, that is, in city, village and refugee camp environments within the districts of Hebron and Bethlehem. Human adenoviruses circulated throughout 2005-2010, with major outbreaks occurring in the spring months. A larger percent of the children diagnosed with adenoviral infections were male infants. DNA sequence analysis of the hexon genes from 44 samples revealed that several distinct adenovirus types circulated in the region; these were HAdV-C1, HAdV-C2, HAdV-B3 and HAdV-C5. However, not all of these types were detected within each year. This is the first study ever conducted in Palestine of the genetic epidemiology of respiratory adenovirus infections.	[Qurei, Lina; Salah, Zaidoun; Azzeh, Maysa] Al Quds Univ, Virol Res Lab, Med Res Ctr, E Jerusalem Abu Dies, Israel; [Seto, Donald] George Mason Univ, Sch Syst Biol, Manassas, VA USA	George Mason University	Qurei, L (corresponding author), Al Quds Univ, Virol Res Lab, Med Res Ctr, E Jerusalem Abu Dies, Israel.	mazzeh@med.alquds.edu			Virology Laboratory at the Medical Research Center	Virology Laboratory at the Medical Research Center	Support for this work came, in part, from the internal resources of the Virology Laboratory at the Medical Research Center. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; BRANDT CD, 1969, AM J EPIDEMIOL, V90, P484, DOI 10.1093/oxfordjournals.aje.a121094; Carballal Guadalupe, 2002, BMC Pediatr, V2, P6, DOI 10.1186/1471-2431-2-6; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; De Jong JC, 1999, J CLIN MICROBIOL, V37, P3940, DOI 10.1128/JCM.37.12.3940-3945.1999; DENNY FW, 1995, AM J RESP CRIT CARE, V152, pS4, DOI 10.1164/ajrccm/152.4_Pt_2.S4; Esposito DH, 2010, J INFECT DIS, V202, P214, DOI 10.1086/653498; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; FU WY, 1989, CHINESE MED J-PEKING, V102, P857; Ghanaiem H, 2011, PEDIATR INFECT DIS J, V30, P948, DOI 10.1097/INF.0b013e31822702fe; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Harley D, 2001, Commun Dis Intell, V25, P9; HEMMING VG, 1994, J PEDIATR-US, V124, pS13, DOI 10.1016/S0022-3476(94)70185-7; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Hsieh WY, 2009, J MICROBIOL IMMUNOL, V42, P371; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; JOHANSSON ME, 1993, J VIROL METHODS, V42, P193, DOI 10.1016/0166-0934(93)90032-M; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; KAJON AE, 1992, J MED VIROL, V36, P292, DOI 10.1002/jmv.1890360411; Kandel R, 2010, INFECT CONT HOSP EP, V31, P755, DOI 10.1086/653612; Landry ML, 2009, J MED VIROL, V81, P1380, DOI 10.1002/jmv.21539; Lautenbach Ebbing, 2010, LDI Issue Brief, V16, P1; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Lessa FC, 2009, J INFECT DIS, V200, P1759, DOI 10.1086/647987; Liu EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024491; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Mandelboim M, 2011, J CLIN MICROBIOL, V49, P597, DOI 10.1128/JCM.00979-10; MANTYJAR.R, 1966, ANN MED EXP BIOL FEN, VS 44, P7; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Mitchell LS, 2000, PEDIATR INFECT DIS J, V19, P996, DOI 10.1097/00006454-200010000-00011; Mizuta K, 2006, MICROBIOL IMMUNOL, V50, P553, DOI 10.1111/j.1348-0421.2006.tb03826.x; Munoz FM, 1998, CLIN INFECT DIS, V27, P1194, DOI 10.1086/514978; Palomino MA, 2000, PEDIATR INFECT DIS J, V19, P527, DOI 10.1097/00006454-200006000-00007; Palomino MA, 2004, PEDIATR INFECT DIS J, V23, P337, DOI 10.1097/00006454-200404000-00012; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; PIEDRA PA, 1962, INFECT IMMUNOCOMPOMI, P662; PINTO A, 1992, ARCH PATHOL LAB MED, V116, P95; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Rocholl C, 2004, PEDIATRICS, V113, pE51, DOI 10.1542/peds.113.1.e51; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; RUUSKANEN O, 1992, EUR J CLIN MICROBIOL, V11, P217, DOI 10.1007/BF02098083; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; SINGHNAZ N, 1993, PEDIATR INFECT DIS J, V12, P922, DOI 10.1097/00006454-199311000-00006; VANDERVEEN J, 1969, J HYG-CAMB, V67, P255, DOI 10.1017/S0022172400041668; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Wold WSM, 2007, FIELDS VIROLOGY, P2396; Wu E, 1990, Rev Chil Pediatr, V61, P177; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zhang QW, 2006, J GEN VIROL, V87, P1531, DOI 10.1099/vir.0.81515-0; Zheng X, 2008, J CLIN MICROBIOL, V46, P317, DOI 10.1128/JCM.01585-07; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	64	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42732	10.1371/journal.pone.0042732	http://dx.doi.org/10.1371/journal.pone.0042732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880092	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100163
J	Durand, E; Derrez, E; Audoly, G; Spinelli, S; Ortiz-Lombardia, M; Raoult, D; Cascales, E; Cambillau, C				Durand, Eric; Derrez, Estelle; Audoly, Gilles; Spinelli, Silvia; Ortiz-Lombardia, Miguel; Raoult, Didier; Cascales, Eric; Cambillau, Christian			Crystal Structure of the VgrG1 Actin Cross-linking Domain of the Vibrio cholerae Type VI Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RTX TOXIN; PROTEIN; HOST; IDENTIFICATION; MECHANISM; REQUIRES	Vibrio cholerae is the cause of the diarrheal disease cholera. V. cholerae produces RtxA, a large toxin of the MARTX family, which is targeted to the host cell cytosol, where its actin cross-linking domain (ACD) cross-links G-actin, leading to F-actin depolymerization, cytoskeleton rearrangements, and cell rounding. These effects on the cytoskeleton prevent phagocytosis and bacterial engulfment by macrophages, thus preventing V. cholerae clearance from the gut. The V. cholerae Type VI secretion-associated VgrG1 protein also contains a C-terminal ACD, which shares 61% identity with MARTX ACD and has been shown to covalently cross-link G-actin. Here, we purified the VgrG1 C-terminal domain and determined its crystal structure. The VgrG1 ACD exhibits a V-shaped three-dimensional structure, formed of 12 beta-strands and nine alpha-helices. Its active site comprises five residues that are conserved in MARTX ACD toxin, within a conserved area of similar to 10 angstrom radius. We showed that less than 100 ACD molecules are sufficient to depolymerize the actin filaments of a fibroblast cell in vivo. Mutagenesis studies confirmed that Glu-16 is critical for the F-actin depolymerization function. Co-crystals with divalent cations and ATP reveal the molecular mechanism of the MARTX/VgrG toxins and offer perspectives for their possible inhibition.	[Audoly, Gilles; Raoult, Didier] CNRS, Fac Med Timone, UMR 6236, IRD 198,Unite Rickettsies URMITE, F-13385 Marseille 05, France; [Cascales, Eric] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, UMR7255,Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Cambillau, Christian] Aix Marseille Univ, CNRS, UMR7257, AFMB, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cambillau, C (corresponding author), Aix Marseille Univ, CNRS, UMR7257, AFMB, 163 Ave Luminy,Case 932,Campus Luminy, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	RAOULT, Didier/A-8434-2008; Durand, Eric/E-6739-2017; CASCALES, ERIC/G-7420-2011	RAOULT, Didier/0000-0002-0633-5974; Durand, Eric/0000-0002-0577-8220; CASCALES, ERIC/0000-0003-0611-9179; Audoly, Gilles/0000-0001-8242-471X	Fondation pour la Recherche Medicale Postdoctoral Fellowship [SPF20101221116]; CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Universite de la Mediterranee; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]	Fondation pour la Recherche Medicale Postdoctoral Fellowship; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite de la Mediterranee; Marseille-Nice Genopole; IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	Supported by Fondation pour la Recherche Medicale Postdoctoral Fellowship SPF20101221116.; Work in the laboratory of this author was supported by CNRS and funded by Agence Nationale de la Recherche Grant ANR-10-JCJC-1303-03.; Work in the laboratory of this author was supported by CNRS, Universite de la Mediterranee, and grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (FRM DEQ2011-0421282). To whom correspondence should be addressed: AFMB, CNRS UMR7257, Aix-Marseille Universite, 163 Ave. de Luminy, Case 932, 13288 Marseille Cedex 09, France. Tel.: 33-491825590; Fax: 33-491266720; E-mail: cambillau@afmb.univ-mrs.fr.	Audoly G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026528; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Charles RC, 2011, CURR OPIN INFECT DIS, V24, P472, DOI 10.1097/QCO.0b013e32834a88af; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sanchez J, 2011, INDIAN J MED RES, V133, P153; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Satchell KJF, 2009, CELL HOST MICROBE, V5, P213, DOI 10.1016/j.chom.2009.03.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Weil AA, 2012, CURR INFECT DIS REP, V14, P1, DOI 10.1007/s11908-011-0221-9	43	47	49	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.390153	http://dx.doi.org/10.1074/jbc.M112.390153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22898822	hybrid, Green Published			2022-12-25	WOS:000310642200052
J	Greaves, J; Lemonidis, K; Gorleku, OA; Cruchaga, C; Grefen, C; Chamberlain, LH				Greaves, Jennifer; Lemonidis, Kimon; Gorleku, Oforiwa A.; Cruchaga, Carlos; Grefen, Christopher; Chamberlain, Luke H.			Palmitoylation-induced Aggregation of Cysteine-string Protein Mutants That Cause Neuronal Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA; CSP; THIOESTERASE; EXOCYTOSIS; HUNTINGTIN; NEURODEGENERATION; IDENTIFICATION; MUTATIONS; CHAPERONE; DISEASE	Recently, mutations in the DNAJC5 gene encoding cysteine-string protein alpha (CSP alpha) were identified to cause the neurodegenerative disorder adult-onset neuronal ceroid lipofuscinosis. The disease-causing mutations (L115R or Delta L116) occur within the cysteine-string domain, a region of the protein that is post-translationally modified by extensive palmitoylation. Here we demonstrate that L115R and Delta L116 mutant proteins are mistargeted in neuroendocrine cells and form SDS-resistant aggregates, concordant with the properties of other mutant proteins linked to neurodegenerative disorders. The mutant aggregates are membrane-associated and incorporate palmitate. Indeed, co-expression of palmitoyltransferase enzymes promoted the aggregation of the CSP alpha mutants, and chemical depalmitoylation solubilized the aggregates, demonstrating that aggregation is induced and maintained by palmitoylation. In agreement with these observations, SDS-resistant CSP alpha aggregates were present in brain samples from patients carrying the L115R mutation and were depleted by chemical depalmitoylation. In summary, this study identifies a novel interplay between genetic mutations and palmitoylation in driving aggregation of CSP alpha mutant proteins. We propose that this palmitoylation-induced aggregation of mutant CSP alpha proteins may underlie the development of adult-onset neuronal ceroid lipofuscinosis in affected families.	[Greaves, Jennifer; Lemonidis, Kimon; Gorleku, Oforiwa A.; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO 63130 USA; [Cruchaga, Carlos] Washington Univ, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO 63130 USA; [Grefen, Christopher] Univ Glasgow, Inst Mol Cell & Syst Biol, Lab Plant Physiol & Biophys, Glasgow G12 8QQ, Lanark, Scotland	University of Strathclyde; Washington University (WUSTL); Washington University (WUSTL); University of Glasgow	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	luke.chamberlain@strath.ac.uk	Grefen, Christopher/AAH-4512-2020; Cruchaga, Carlos/ABF-4065-2020	Grefen, Christopher/0000-0002-5820-4466; Cruchaga, Carlos/0000-0002-0276-2899; Greaves, Jennifer/0000-0001-8445-789X; Lemonidis, Kimon/0000-0003-1332-6002	Medical Research Council Senior Fellowship Award [G0601597]; National Institutes of Health [P50 AG05681]; Medical Research Council [G0601597] Funding Source: researchfish; MRC [G0601597] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	Medical Research Council Senior Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Medical Research Council Senior Fellowship Award Grant G0601597 and Wellcome Trust Grant 094184 (to L. H. C.). This work was also supported by National Institutes of Health Grant P50 AG05681.	Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026741; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Grefen Christopher, 2009, V479, P217, DOI 10.1007/978-1-59745-289-2_14; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Lu JY, 1996, P NATL ACAD SCI USA, V93, P10046, DOI 10.1073/pnas.93.19.10046; Rozas JL, 2012, NEURON, V74, P151, DOI 10.1016/j.neuron.2012.02.019; Millar T, 2007, J PATHOL, V213, P369, DOI 10.1002/path.2247; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	30	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37330	37339		10.1074/jbc.M112.389098	http://dx.doi.org/10.1074/jbc.M112.389098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22902780	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000310588500064
J	Li, J; Mo, HY; Xiong, G; Zhang, L; He, J; Huang, ZF; Liu, ZW; Chen, QY; Du, ZM; Zheng, LM; Qian, CN; Zeng, YX				Li, Jiang; Mo, Hao-Yuan; Xiong, Geng; Zhang, Lin; He, Jia; Huang, Zhou-Feng; Liu, Zhi-Wei; Chen, Qiu-Yan; Du, Zi-Ming; Zheng, Li-Min; Qian, Chao-Nan; Zeng, Yi-Xin			Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; TH17 CELLS; POOR-PROGNOSIS; FACTOR MIF; GENERATION; CANCER; INFLAMMATION; STAT3; DIFFERENTIATION; ANGIOGENESIS	The accumulation of an intratumoral CD4(+) interleukin-17-producing subset (Th17) of tumor-infiltrating lymphocytes (TILs) is a general characteristic in many cancers. The relationship between the percentage of Th17 cells and clinical prognosis differs among cancers. The mechanism responsible for the increasing percentage of such cells in NPC is still unknown, as is their biological function. Here, our data showed an increase of Th17 cells in tumor tissues relative to their numbers in normal nasopharynx tissues or in the matched peripheral blood of NPC patients. Th17 cells in tumor tissue produced more IFN gamma than did those in the peripheral blood of matched NPC patients and healthy controls. We observed high levels of CD154, G-CSF, CXCL1, IL-6, IL-8, and macrophage inhibitory factor (MIF) out of 36 cytokines examined in tumor tissue cultures. MIF promoted the generation and recruitment of Th17 cells mediated by NPC tumor cells in vitro; this promoting effect was mainly dependent on the mammalian target of rapamycin pathway and was mediated by the MIF-CXCR4 axis. Finally, the expression level of MIF in tumor cells and in TILs was positively correlated in NPC tumor tissues, and the frequency of MIF-positive TILs was positively correlated with NPC patient clinical outcomes. Taken together, our findings illustrate that tumor-derived MIF can affect patient prognosis, which might be related to the increase of Th17 cells in the NPC tumor microenvironment.	[Li, Jiang; Zhang, Lin; He, Jia; Zheng, Li-Min] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou 510060, Guangdong, Peoples R China; [Qian, Chao-Nan] Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI 49503 USA; [Li, Jiang; Xiong, Geng; Liu, Zhi-Wei; Du, Zi-Ming; Zheng, Li-Min; Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Mo, Hao-Yuan; Huang, Zhou-Feng; Chen, Qiu-Yan; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Van Andel Institute; Sun Yat Sen University; Sun Yat Sen University	Li, J (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, 651 Dongfeng E Rd, Guangzhou 510060, Guangdong, Peoples R China.	lijiang2@mail.sysu.edu.cn; qianchn@sysucc.org.cn	zheng, limin/HGB-2510-2022; Liu, Zhiwei/AAM-5300-2020; zhan, lin/AAP-5149-2020; ZHANG, LIN/GYD-9123-2022	Liu, Zhiwei/0000-0002-0136-651X; Zheng, Limin/0000-0002-8281-1450; li, jiang/0000-0001-5596-9159	National Natural Science Foundation of China [30872981, 81172164, 81030043]; Guangdong Province Natural Science Foundation [0151008901000156]; National High Technology Research and Development Program of China (863 Program) [20060102A4002]; Major State Basic Research Program (973 Project) of China [2006CB910104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Major State Basic Research Program (973 Project) of China(National Basic Research Program of China)	This work was supported by General Program Grants 30872981 and 81172164 (to J. L.), State Key Program Grant 81030043 (to C.-N. Q.) from the National Natural Science Foundation of China, Guangdong Province Natural Science Foundation Grant 0151008901000156 (to J. L.), National High Technology Research and Development Program of China (863 Program) Grant 20060102A4002 (to C.-N. Q.), and Major State Basic Research Program (973 Project) of China Grant 2006CB910104 (to Y. X. Z.).	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Bachand AM, 2010, CRIT REV TOXICOL, V40, P85, DOI 10.3109/10408440903341696; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; BRANN E, 1990, ARCH INTERN MED, V150, P2495; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Chuang CC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-50; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Durr C, 2010, CANCER RES, V70, P10170, DOI 10.1158/0008-5472.CAN-10-1943; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Gaber T, 2011, J IMMUNOL, V186, P764, DOI 10.4049/jimmunol.0903421; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Krockenberger M, 2010, J CANCER RES CLIN, V136, P651, DOI 10.1007/s00432-009-0702-5; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Liao B, 2010, J SURG ONCOL, V102, P844, DOI 10.1002/jso.21728; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Niedobitek G, 1996, SEMIN CANCER BIOL, V7, P165, DOI 10.1006/scbi.1996.0023; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Radojcic V, 2010, J IMMUNOL, V184, P764, DOI 10.4049/jimmunol.0903006; Ratajczak P, 2010, BLOOD, V116, P1165, DOI 10.1182/blood-2009-12-255810; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shen XH, 2010, J CANCER RES CLIN, V136, P1745, DOI 10.1007/s00432-010-0833-8; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Takahashi N, 1998, MOL MED, V4, P707, DOI 10.1007/BF03401765; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vasef MA, 1997, ANN OTO RHINOL LARYN, V106, P348, DOI 10.1177/000348949710600416; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; WEE A, 1994, J CLIN PATHOL, V47, P453, DOI 10.1136/jcp.47.5.453; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	53	58	61	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35484	35495		10.1074/jbc.M112.367532	http://dx.doi.org/10.1074/jbc.M112.367532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893706	Green Published, hybrid			2022-12-25	WOS:000309968000057
J	Gurung, P; Malireddi, RKS; Anand, PK; Demon, D; Vande Walle, L; Liu, ZP; Vogel, P; Lamkanfi, M; Kanneganti, TD				Gurung, Prajwal; Malireddi, R. K. Subbarao; Anand, Paras K.; Demon, Dieter; Vande Walle, Lieselotte; Liu, Zhiping; Vogel, Peter; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			Toll or Interleukin-1 Receptor (TIR) Domain-containing Adaptor Inducing Interferon-beta (TRIF)-mediated Caspase-11 Protease Production Integrates Toll-like Receptor 4 (TLR4) Protein- and Nlrp3 Inflammasome-mediated Host Defense against Enteropathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTTING EDGE; CITROBACTER-RODENTIUM; CRYOPYRIN INFLAMMASOME; PATTERN-RECOGNITION; SIGNALING PATHWAY; ACTIVATION; MICE; INNATE; INFECTION; IMMUNITY	Enteric pathogens represent a major cause of morbidity and mortality worldwide. Toll-like receptor (TLR) and inflammasome signaling are critical for host responses against these pathogens, but how these pathways are integrated remains unclear. Here, we show that TLR4 and the TLR adaptor TRIF are required for inflammasome activation in macrophages infected with the enteric pathogens Escherichia coli and Citrobacter rodentium. In contrast, TLR4 and TRIF were dispensable for Salmonella typhimurium-induced caspase-1 activation. TRIF regulated expression of caspase-11, a caspase-1-related protease that is critical for E. coli-and C. rodentium-induced inflammasome activation, but dispensable for inflammasome activation by S. typhimurium. Thus, TLR4- and TRIF-induced caspase-11 synthesis is critical for noncanonical Nlrp3 inflammasome activation in macrophages infected with enteric pathogens.	[Gurung, Prajwal; Malireddi, R. K. Subbarao; Anand, Paras K.; Liu, Zhiping; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Biochem, B-9000 Ghent, Belgium; [Demon, Dieter; Vande Walle, Lieselotte; Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Suite E7004, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Vogel, Peter/N-2490-2018; Kanneganti, Thirumala-Devi/Y-2503-2019; Liu, Zhiping/O-3510-2019; Kanneganti, Thirumala-Devi/M-9435-2018; Malireddi, RKSubbarao/C-5804-2013	Vogel, Peter/0000-0002-7535-0545; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Liu, Zhiping/0000-0002-5109-4153; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Malireddi, RKSubbarao/0000-0001-8855-9447; Anand, Paras/0000-0003-2503-3653; Gurung, Prajwal/0000-0002-7451-9433	National Institutes of Health [AR056296, AI101935, CA163507]; European Union [256432]; European Research Council [281600]; Fund for Scientific Research-Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101935, R37AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056296, AI101935, and CA163507 (to T.-D. K.). This work was also supported by Marie-Curie Grant 256432 from the European Union, European Research Council Grant 281600, and the Fund for Scientific Research-Flanders Grants G030212N, 1.2.201.10.N.00, and 1.5.122.11.N.00 (to M. L.), and by the American Lebanese Syrian Associated Charities (ALSAC) (to T.-D. K.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Malireddi RKS, 2010, J IMMUNOL, V185, P3127, DOI 10.4049/jimmunol.1001512; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	39	190	196	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34474	34483		10.1074/jbc.M112.401406	http://dx.doi.org/10.1074/jbc.M112.401406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22898816	Green Published, hybrid			2022-12-25	WOS:000309654200049
J	Keil, M; Bareth, B; Woellhaf, MW; Peleh, V; Prestele, M; Rehling, P; Herrmann, JM				Keil, Melanie; Bareth, Bettina; Woellhaf, Michael W.; Peleh, Valentina; Prestele, Martin; Rehling, Peter; Herrmann, Johannes M.			Oxa1-Ribosome Complexes Coordinate the Assembly of Cytochrome c Oxidase in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-BINDING; TERMINAL TAIL; TUNNEL EXIT; PROTEIN; YEAST; INSERTION; INTERACTS; EXPORT; SUBUNITS; OXA1	The terminal enzyme of the respiratory chain, cytochrome c oxidase, consists of a hydrophobic reaction center formed by three mitochondrially encoded subunits with which 9-10 nuclear encoded subunits are associated. The three core subunits are synthesized on mitochondrial ribosomes and inserted into the inner membrane in a co-translational reaction facilitated by the Oxa1 insertase. Oxa1 consists of an N-terminal insertase domain and a C-terminal ribosome-binding region. Mutants lacking the C-terminal region show specific defects in co-translational insertion, suggesting that the close contact of the ribosome with the insertase promotes co-translational insertion of nascent chains. In this study, we inserted flexible linkers of 100 or 200 amino acid residues between the insertase domain and ribosome-binding region of Oxa1 of Saccharomyces cerevisiae. In the absence of the ribosome receptor Mba1, these linkers caused a length-dependent decrease in mitochondrial respiratory activity caused by diminished levels of cytochrome c oxidase. Interestingly, considerable amounts of mitochondrial translation products were still integrated into the inner membrane in these linker mutants. However, they showed severe defects in later stages of the biogenesis process, presumably during assembly into functional complexes. Our observations suggest that the close proximity of Oxa1 to ribosomes is not only used to improve membrane insertion but is also critical for the productive assembly of the subunits of the cytochrome c oxidase. This points to a role for Oxa1 in the spatial coordination of the ribosome with assembly factors that are critical for enzyme biogenesis.	[Keil, Melanie; Woellhaf, Michael W.; Peleh, Valentina; Prestele, Martin; Herrmann, Johannes M.] Univ Kaiserslautern, Dept Cell Biol, D-67663 Kaiserslautern, Germany; [Bareth, Bettina; Rehling, Peter] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Kaiserslautern; University of Gottingen; Max Planck Society	Herrmann, JM (corresponding author), Univ Kaiserslautern, Dept Cell Biol, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	hannes.herrmann@biologie.uni-kl.de			Deutsche Forschungsgemeinschaft [FOR 967]; Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Max-Planck-Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz; Gottingen Graduate School for Neurosciences and Molecular Biosciences; Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR 967 (to J. M. H. and P. R.), the Landesschwerpunkt fur Membrantransport in Rheinland-Pfalz (to J. M. H.), the Gottingen Graduate School for Neurosciences and Molecular Biosciences (to B. B.), and the Max-Planck-Gesellschaft (to P. R.).	Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; ALTMANN K, 2007, MITOCHONDRIA PRACTIC, P81; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Brandner K, 2005, J BIOL CHEM, V280, P6215, DOI 10.1074/jbc.M412269200; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Elliott LE, 2012, GENETICS, V190, P559, DOI 10.1534/genetics.111.135665; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fujihira E, 2002, J BIOCHEM, V131, P145, DOI 10.1093/oxfordjournals.jbchem.a003069; Funes Soledad, 2007, Methods Mol Biol, V372, P255, DOI 10.1007/978-1-59745-365-3_18; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Giglione C, 2009, TRENDS BIOCHEM SCI, V34, P417, DOI 10.1016/j.tibs.2009.04.003; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Haque ME, 2010, J BIOL CHEM, V285, P34991, DOI 10.1074/jbc.M110.163808; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Herrmann JM, 2012, BIOCH BIOPH IN PRESS; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Khalimonchuk O, 2005, CURR GENET, V47, P223, DOI 10.1007/s00294-005-0569-1; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Wagner K, 2010, MOL BIOL CELL, V21, P1494, DOI 10.1091/mbc.E09-12-1023; WATSON K, 1972, J CELL BIOL, V55, P721, DOI 10.1083/jcb.55.3.721; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	55	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34484	34493		10.1074/jbc.M112.382630	http://dx.doi.org/10.1074/jbc.M112.382630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904327	Green Published, hybrid			2022-12-25	WOS:000309654200050
J	Wang, CY; Jenkitkasemwong, S; Duarte, S; Sparkman, BK; Shawki, A; Mackenzie, B; Knutson, MD				Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Sparkman, Brian K.; Shawki, Ali; Mackenzie, Bryan; Knutson, Mitchell D.			ZIP8 Is an Iron and Zinc Transporter Whose Cell-surface Expression Is Up-regulated by Cellular Iron Loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN-BOUND IRON; METAL-ION TRANSPORTER; FUNCTIONAL-PROPERTIES; RECEPTOR EXPRESSION; GENE ENCODES; RAT-LIVER; OVERLOAD; MOUSE; HEMOCHROMATOSIS; PROTEIN	ZIP8 (SLC39A8) belongs to the ZIP family of metal-ion transporters. Among the ZIP proteins, ZIP8 is most closely related to ZIP14, which can transport iron, zinc, manganese, and cadmium. Here we investigated the iron transport ability of ZIP8, its subcellular localization, pH dependence, and regulation by iron. Transfection of HEK 293T cells with ZIP8 cDNA enhanced the uptake of Fe-59 and Zn-65 by 200 and 40%, respectively, compared with controls. Excess iron inhibited the uptake of zinc and vice versa. In RNA-injected Xenopus oocytes, ZIP8-mediated Fe-55(2+) transport was saturable (K-0.5 of similar to 0.7 mu M) and inhibited by zinc. ZIP8 also mediated the uptake of Cd-109(2+), Co-57(2+), Zn-65(2+) > Mn-54(2+), but not Cu-64 (I or II). By using immunofluorescence analysis, we found that ZIP8 expressed in HEK 293T cells localized to the plasma membrane and partially in early endosomes. Iron loading increased total and cell-surface levels of ZIP8 in H4IIE rat hepatoma cells. We also determined by using site-directed mutagenesis that asparagine residues 40, 88, and 96 of rat ZIP8 are glycosylated and that N-glycosylation is not required for iron or zinc transport. Analysis of 20 different human tissues revealed abundant ZIP8 expression in lung and placenta and showed that its expression profile differs markedly from ZIP14, suggesting nonredundant functions. Suppression of endogenous ZIP8 expression in Be Wo cells, a placental cell line, reduced iron uptake by similar to 40%, suggesting that ZIP8 participates in placental iron transport. Collectively, these data identify ZIP8 as an iron transport protein that may function in iron metabolism.	[Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Sparkman, Brian K.; Shawki, Ali; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Shawki, Ali] Univ Cincinnati, Coll Med, Syst Biol & Physiol Program, Cincinnati, OH 45267 USA	State University System of Florida; University of Florida; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Knutson, MD (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, POB 110370, Gainesville, FL 32611 USA.	mknutson@ufl.edu	Wang, Chia-Yu/ABF-1758-2020	Wang, Chia-Yu/0000-0003-3679-6453; Shawki, Ali/0000-0002-6413-5313; Mackenzie, Bryan/0000-0002-9661-8838	National Institutes of Health from NIDDK [R01 DK080706, R01 DK080047]; National Cancer Institute [R24 CA086307]; University of Cincinnati; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080706, R01DK080047] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080706 (to M. D. K.) and R01 DK080047 (to B. M.) from NIDDK and Grant R24 CA086307 from the National Cancer Institute. This work was also supported by funds from the University of Cincinnati (to B. M.).	ADAMS PC, 1991, CLIN INVEST MED, V14, P16; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Begum NA, 2002, GENOMICS, V80, P630, DOI 10.1006/geno.2002.7000; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; BIERINGS MB, 1991, MOL CELL BIOCHEM, V100, P31, DOI 10.1007/BF00230807; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brissot P, 2002, ADV EXP MED BIOL, V509, P45; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Heaton SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1445, DOI 10.1152/ajpcell.00286.2008; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jarup L, 2002, NEPHROL DIAL TRANSPL, V17, P35, DOI 10.1093/ndt/17.suppl_2.35; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; LAUWERYS R, 1994, SCI TOTAL ENVIRON, V150, P1, DOI 10.1016/0048-9697(94)90125-2; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LU JP, 1989, ACTA PATHOL JAPON, V39, P759; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B., 1999, BIOMEMBRANE TRANSPOR, P327; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; McArdle HJ, 2011, NUTR REV, V69, pS17, DOI 10.1111/j.1753-4887.2011.00428.x; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; Nam H, 2012, BIOMETALS, V25, P115, DOI 10.1007/s10534-011-9487-5; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; PARKES JG, 1993, J LAB CLIN MED, V122, P36; Peters JL, 2007, GENESIS, V45, P339, DOI 10.1002/dvg.20297; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; Richardson DR, 1999, J LAB CLIN MED, V133, P144, DOI 10.1016/S0022-2143(99)90007-0; SCHADE SG, 1970, J LAB CLIN MED, V75, P435; Scheiber-Mojdehkar B, 2003, BIOCHEM PHARMACOL, V65, P1973, DOI 10.1016/S0006-2952(03)00181-3; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; VALBERG LS, 1969, GASTROENTEROLOGY, V56, P241; Vayenas DV, 1998, INT J CLIN LAB RES, V28, P183, DOI 10.1007/s005990050041; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Zhang Y, 2009, BIOMETALS, V22, P251, DOI 10.1007/s10534-008-9161-8; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	63	236	238	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34032	34043		10.1074/jbc.M112.367284	http://dx.doi.org/10.1074/jbc.M112.367284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22898811	Green Published, hybrid			2022-12-25	WOS:000309654200010
J	Wang, XH; Li, JP; Chiu, LL; Lan, JL; Chen, DY; Boomer, J; Tan, TH				Wang, Xiaohong; Li, Ju-Pi; Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan; Boomer, Jonathan; Tan, Tse-Hua			Attenuation of T Cell Receptor Signaling by Serine Phosphorylation-mediated Lysine 30 Ubiquitination of SLP-76 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR KINASE; N-TERMINAL KINASE; GERMINAL CENTER KINASE; ADAPTER PROTEINS; LINKER PROTEIN; KAPPA-B; PATHWAY; ACTIVATION; HPK1; LYMPHOCYTES	SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa) is an adaptor protein that is essential for T cell development and Tcell receptor (TCR) signaling activation. Previous studies have identified an important negative feedback regulation of SLP-76 by HPK1 (hematopoietic progenitor kinase 1; MAP4K1)-induced Ser-376 phosphorylation. Ser-376 phosphorylation of SLP-76 mediates 14-3-3 binding, resulting in the attenuation of SLP-76 activation and downstream signaling; however, the underlying mechanism of this action remains unknown. Here, we report that phosphorylated SLP-76 is ubiquitinated and targeted for proteasomal degradation during TCR signaling. SLP-76 ubiquitination is mediated by Ser-376 phosphorylation. Furthermore, Lys-30 is identified as a ubiquitination site of SLP-76. Loss of Lys-30 ubiquitination of SLP-76 results in enhanced anti-CD3 antibody-induced ERK and JNK activation. These results reveal a novel regulation mechanism of SLP-76 by ubiquitination and proteasomal degradation of activated SLP-76, which is mediated by Ser-376 phosphorylation, leading to down-regulation of TCR signaling.	[Li, Ju-Pi; Tan, Tse-Hua] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Wang, Xiaohong; Boomer, Jonathan; Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung 40705, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 11221, Taiwan	National Health Research Institutes - Taiwan; Baylor College of Medicine; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	ttan@bcm.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Li, Ju-Pi/AAS-8866-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Li, Ju-Pi/0000-0003-3406-4865	National Institutes of Health [R01 AI066895]; National Health Research Institute (Taiwan) [98A1-IMPP01-014]; Taichung Veterans General Hospital (Taiwan) [TCVGH-NHRI01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institute (Taiwan)(National Health Research Institutes - Taiwan); Taichung Veterans General Hospital (Taiwan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066895 (to T.-H. T.). This work was also supported by National Health Research Institute (Taiwan) Grant 98A1-IMPP01-014 (to T.-H. T.) and Taichung Veterans General Hospital (Taiwan) Grant TCVGH-NHRI01 (to J.-L. L.).	Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Fang N, 1996, J IMMUNOL, V157, P3769; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang XH, 2012, J BIOL CHEM, V287, P11037, DOI 10.1074/jbc.M111.310946; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	30	23	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34091	34100		10.1074/jbc.M112.371062	http://dx.doi.org/10.1074/jbc.M112.371062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902619	Green Published, hybrid			2022-12-25	WOS:000309654200015
J	Huang, CY; Shih, CM; Tsao, NW; Chen, YH; Li, CY; Chang, YJ; Chang, NC; Ou, KL; Lin, CY; Lin, YW; Nien, CH; Lin, FY				Huang, Chun-Yao; Shih, Chun-Ming; Tsao, Nai-Wen; Chen, Yung-Hsiang; Li, Chi-Yuan; Chang, Yu-Jia; Chang, Nen-Chung; Ou, Keng-Liang; Lin, Cheng-Yen; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen			GroEL1, from Chlamydia pneumoniae, Induces Vascular Adhesion Molecule 1 Expression by p37(AUF1) in Endothelial Cells and Hypercholesterolemic Rabbit	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AU-RICH ELEMENT; RANDOMIZED CONTROLLED-TRIALS; MESSENGER-RNA STABILITY; SMOOTH-MUSCLE-CELLS; HEAT-SHOCK PROTEINS; TNF-ALPHA; DIFFERENTIAL REGULATION; EARLY ATHEROSCLEROSIS; VCAM-1 EXPRESSION	The expression of vascular adhesion molecule-1 (VCAM-1) by endothelial cells may play a major role in atherogenesis. The actual mechanisms of chlamydia pneumoniae (C. pneumoniae) relate to atherogenesis are unclear. We investigate the influence of VCAM-1 expression in the GroEL1 from C. pneumoniae-administered human coronary artery endothelial cells (HCAECs) and hypercholesterolemic rabbits. In this study, we constructed the recombinant GroEL1 from C. pneumoniae. The HCAECs/THP-1 adhesion assay, tube formation assay, western blotting, enzyme-linked immunosorbent assay, actinomycin D chase experiment, luciferase reporter assay, and immunohistochemical stainings were performed. The results show that GroEL1 increased both VCAM-1expression and THP-1 cell adhesives, and impaired tube-formation capacity in the HCAECs. GroEL1 significantly increased the VCAM-1 mRNA stability and cytosolic AU-binding factor 1 (AUF1) level. Overexpression of the p37(AUF1) significantly increased VCAM-1 gene expression in GroEL1-induced bovine aortic endothelial cells (BAECs). GroEL1 prolonged the stability of VCAM-1 mRNA by increasing both p(37AUF1) and the regulation of the 5' untranslated region (UTR) of the VCAM-1 mRNA in BAECs. In hypercholesterolemic rabbits, GroEL1 administration enhanced fatty-streak and macrophage infiltration in atherosclerotic lesions, which may be mediated by elevated VCAM-1 expression. In conclusion, GroEL1 induces VCAM-1 expression by p37(AUF1) in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits.	[Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ, Dept Internal Med, Sch Med, Coll Med, Taipei, Taiwan; [Huang, Chun-Yao; Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Huang, Chun-Yao; Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Ming; Chang, Nen-Chung; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen] Taipei Med Univ Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chang, Nen-Chung; Lin, Yi-Wen; Nien, Chih-Hao; Lin, Feng-Yen] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan; [Lin, Cheng-Yen] Hung Kuang Univ, Dept Comp Sci & Informat Management, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei Medical University Hospital; Hungkuang University	Huang, CY (corresponding author), Taipei Med Univ, Dept Internal Med, Sch Med, Coll Med, Taipei, Taiwan.	g870905@tmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Li, Chi-Yuan/0000-0003-3390-7568; Chang, Yu-Jia/0000-0003-3978-3244	National Science Council [NSC 99-2314-B-038-030-MY2]; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan [DOH100-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan	This work was funded partial by the National Science Council (NSC 99-2314-B-038-030-MY2) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta J, 1999, AM J RESP CELL MOL, V20, P643, DOI 10.1165/ajrcmb.20.4.3265; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; BENNETT CF, 1994, J IMMUNOL, V152, P3530; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Borel N, 2008, ATHEROSCLEROSIS, V199, P154, DOI 10.1016/j.atherosclerosis.2007.09.026; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Croft D, 1999, AM J PATHOL, V154, P1149, DOI 10.1016/S0002-9440(10)65367-9; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hogdahl M, 2008, APMIS, V116, P1082, DOI 10.1111/j.1600-0463.2008.01145.x; Hortovanyi E, 2003, PATHOL ONCOL RES, V9, P42, DOI 10.1007/BF03033713; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Illoh KO, 2005, ATHEROSCLEROSIS, V179, P403, DOI 10.1016/j.atherosclerosis.2004.10.034; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P407, DOI 10.1006/mpat.1996.0071; Kohara K, 2002, STROKE, V33, P1474, DOI 10.1161/01.STR.0000018974.05768.FB; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Krull M, 1999, J IMMUNOL, V162, P4834; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lin FY, 2011, SHOCK, V36, P279, DOI 10.1097/SHK.0b013e3182236e7e; Lin FY, 2011, J IMMUNOL, V186, P4405, DOI 10.4049/jimmunol.1003116; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schumacher A, 2002, CLIN MICROBIOL INFEC, V8, P654, DOI 10.1046/j.1469-0691.2002.00439.x; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Tsai CS, 2009, SHOCK, V32, P40, DOI 10.1097/SHK.0b013e318199608d; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Volanen I, 2006, ARTERIOSCL THROM VAS, V26, P649, DOI 10.1161/01.ATV.0000202664.76816.bb; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Wells BJ, 2004, ARCH INTERN MED, V164, P2156, DOI 10.1001/archinte.164.19.2156; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Xu QB, 2003, CURR OPIN CARDIOL, V18, P245, DOI 10.1097/00001573-200307000-00001; Yu H, 2011, CYTOKINE, V56, P245, DOI 10.1016/j.cyto.2011.06.006; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	45	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42808	10.1371/journal.pone.0042808	http://dx.doi.org/10.1371/journal.pone.0042808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900050	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900068
J	Wang, YF; Zhu, S; Weisman, GA; Gitlin, JD; Petris, MJ				Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Gitlin, Jonathan D.; Petris, Michael J.			Conditional Knockout of the Menkes Disease Copper Transporter Demonstrates Its Critical Role in Embryogenesis	PLOS ONE			English	Article							P-TYPE ATPASE; MOUSE; ATP7A; GENE; MICE; HOMEOSTASIS; PROTEIN; ACTIVATION; EXPRESSION; RESISTANCE	The transition metal, copper (Cu), is an enzymatic cofactor required for a wide range of biochemical processes. Its essentiality is demonstrated by Menkes disease, an X-linked copper deficiency disorder characterized by defects in nervous-, cardiovascular-and skeletal systems, and is caused by mutations in the ATP7A copper transporter. Certain ATP7A mutations also cause X-linked Spinal Muscular Atrophy type 3 (SMAX3), which is characterized by neuromuscular defects absent an underlying systemic copper deficiency. While an understanding of these ATP7A-related disorders would clearly benefit from an animal model that permits tissue-specific deletion of the ATP7A gene, no such model currently exists. In this study, we generated a floxed mouse model allowing the conditional deletion of the Atp7a gene using Cre recombinase. Global deletion of Atp7a resulted in morphological and vascular defects in hemizygous male embryos and death in utero. Heterozygous deletion in females resulted in a 50% reduction in live births and a high postnatal lethality. These studies demonstrate the essential role of the Atp7a gene in mouse embryonic development and establish a powerful model for understanding the tissue-specific roles of ATP7A in copper metabolism and disease.	[Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Wang, Yanfang; Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Wang, Yanfang; Zhu, Sha; Weisman, Gary A.; Petris, Michael J.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Gitlin, Jonathan D.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Marine Biological Laboratory - Woods Hole	Wang, YF (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO USA.	petrism@missouri.edu	Johnson, Michael D. L./B-4352-2012		National Institutes of Health [DK59893, DK093386, DK44464]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044464, R01DK059893, R01DK093386, R01DK044464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK59893 and DK093386 to M.J.P., and DK44464 to J.D.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; Donsante A, 2011, MOL THERAPY J AM SOC; El Meskini R, 2007, MOL CELL NEUROSCI, V34, P409, DOI 10.1016/j.mcn.2006.11.018; GREEN MA, 1988, J NUCL MED, V29, P1549; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; Levinson B, 1997, NAT GENET, V16, P224, DOI 10.1038/ng0797-224; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; Mercer JFB, 1998, AM J CLIN NUTR, V67, p1022S, DOI 10.1093/ajcn/67.5.1022S; Mototani Y, 2006, GENOMICS, V87, P191, DOI 10.1016/j.ygeno.2005.09.011; Owatari S, 2007, CANCER RES, V67, P4860, DOI 10.1158/0008-5472.CAN-06-3096; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Prohaska JR, 2003, ARCH BIOCHEM BIOPHYS, V417, P227, DOI 10.1016/S0003-9861(03)00364-3; Qin ZY, 2010, J LIPID RES, V51, P1471, DOI 10.1194/jlr.M003426; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; VOLPINTESTA EJ, 1974, AM J DIS CHILD, V128, P244, DOI 10.1001/archpedi.1974.02110270118024; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	32	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43039	10.1371/journal.pone.0043039	http://dx.doi.org/10.1371/journal.pone.0043039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900086	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900104
J	Zhang, PD; Liu, SS; Ngan, HYS				Zhang, Pingde; Liu, Stephanie Si; Ngan, Hextan Yuen Sheung			TAp73-Mediated the Activation of C-Jun N-Terminal Kinase Enhances Cellular Chemosensitivity to Cisplatin in Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE; SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; P73; APOPTOSIS; STRESS; JNK; P53; GADD45A; PROTEIN	P73, one member of the tumor suppressor p53 family, shares highly structural and functional similarity to p53. Like p53, the transcriptionally active TAp73 can mediate cellular response to chemotherapeutic agents in human cancer cells by up-regulating the expressions of its pro-apoptotic target genes such as PUMA, Bax, NOXA. Here, we demonstrated a novel molecular mechanism for TAp73-mediated apoptosis in response to cisplatin in ovarian cancer cells, and that was irrespective of p53 status. We found that TAp73 acted as an activator of the c-Jun N-terminal kinase (JNK) signaling pathway by up-regulating the expression of its target growth arrest and DNA-damage-inducible protein GADD45 alpha (GADD45 alpha) and subsequently activating mitogen-activated protein kinase kinase-4 (MKK4). Inhibition of JNK activity by a specific inhibitor or small interfering RNA (siRNA) significantly abrogated TAp73-mediated apoptosis induced by cisplatin. Furthermore, inhibition of GADD45 alpha by siRNA inactivated MKK4/JNK activities and also blocked TAp73-mediated apoptosis induction by cisplatin. Our study has demonstrated that TAp73 activated the JNK apoptotic signaling pathway in response to cisplatin in ovarian cancer cells.	[Zhang, Pingde; Liu, Stephanie Si; Ngan, Hextan Yuen Sheung] Univ Hong Kong, Dept Obstet & Gynecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, PD (corresponding author), Univ Hong Kong, Dept Obstet & Gynecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	gyonc@hku.hk		Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation; Department of Obstetrics and Gynaecology, the University of Hong Kong	Wong Check She Charitable Foundation; Department of Obstetrics and Gynaecology, the University of Hong Kong(University of Hong Kong)	This research was jointly funded by the Wong Check She Charitable Foundation and the research fund from the Department of Obstetrics and Gynaecology, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Das S, 2005, CANCER GENE THER, V12, P417, DOI 10.1038/sj.cgt.7700803; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Gong JG, 1999, NATURE, V399, P806; Hildesheim J, 2002, CANCER RES, V62, P7305; Ibrahim N, 2010, CANCER RES, V70, P7155, DOI 10.1158/0008-5472.CAN-10-0668; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jones EV, 2007, BIOCHEM J, V405, P617, DOI 10.1042/BJ20061778; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tront JS, 2006, CANCER RES, V66, P8448, DOI 10.1158/0008-5472.CAN-06-2013; Wei N, 2009, MOL CANCER, V8, P1408; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang X, 2004, BRIT J CANCER, V91, P2042, DOI 10.1038/sj.bjc.6602254; Zhu JH, 2001, ONCOGENE, V20, P4050, DOI 10.1038/sj.onc.1204516; Zhu JH, 1998, CANCER RES, V58, P5061	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42985	10.1371/journal.pone.0042985	http://dx.doi.org/10.1371/journal.pone.0042985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900074	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900092
J	Lipski, R; Lippincott, DJ; Durden, BC; Kaplan, AR; Keiser, HE; Park, JH; Levesque, AA				Lipski, Robert; Lippincott, Daniel J.; Durden, Brittany C.; Kaplan, Anne R.; Keiser, Hilary E.; Park, Jung-Ho; Levesque, Aime A.			p53 Dimers Associate with a Head-to-Tail Response Element to Repress Cyclin B Transcription	PLOS ONE			English	Article							MAMMALIAN-CELL CYCLE; DNA-DAMAGE; IONIZING-RADIATION; PREMATURE MITOSIS; DEPENDENT KINASES; TUMOR-SUPPRESSOR; BINDING-SITE; CHECKPOINT; ARREST; ACTIVATION	DNA damage induced by the topoisomerase I inhibitor SN38 activates cell cycle checkpoints which promote cell cycle arrest. This arrest can be abrogated in p53-defective cells by the Chk1 inhibitor 7-hydroxystaurosporine (UCN-01). Previously, we compared p53 wild-type MCF10A cells with derivatives whose p53 function was inhibited by over-expression of the tetramerization domain (MCF10A/OD) or expression of shRNA against p53 (MCF10A/Delta p53). Treatment of SN38-arrested MCF10A/OD cells with UCN-01 abrogated S, but not G2 arrest, while the MCF10A/Delta p53 cells abrogated both S and G2 arrest. The MCF10A/OD cells had reduced levels of cyclin B, suggesting that tetramerization of p53 is not required for repression of cyclin B gene expression. In the present study, we analyzed p53 oligomerization status using glutaraldehyde cross-linking. Following SN38 treatment, MCF10A cells contained oligomeric forms of p53 with molecular weights approximating monomers, dimers, trimers, and tetramers. However, MCF10A/OD cells possessed only monomers and dimers suggesting that these complexes may be involved in repression of cyclin B. While genes transcriptionally activated by p53 contain a consensus sequence with elements repeated in a head-to-head orientation, the cyclin B promoter contains similar elements oriented head-to-tail. Chromatin immunoprecipitation (ChIP) assays revealed that p53 associates with this head-to-tail element in both MCF10A and MCF10A/OD. Electrophoretic mobility shift assays ( EMSA) using a biotin-labeled probe containing the head-to-tail element showed a shift in mobility consistent with the molecular weight of tetramers and dimers in MCF10A nuclear extract, but only the dimer in MCF10A/OD nuclear extract. Taken together, these results suggest a novel mechanism whereby p53 dimers associate with the head-to-tail element to repress cyclin B transcription.	[Lipski, Robert; Lippincott, Daniel J.; Durden, Brittany C.; Kaplan, Anne R.; Keiser, Hilary E.; Park, Jung-Ho; Levesque, Aime A.] Univ Hartford, Dept Biol, Hartford, CT 06117 USA	University of Hartford	Lipski, R (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	alevesque@hartford.edu	Levesque, Aime/GNM-9708-2022	Levesque, Aime/0000-0002-2907-229X	Young Investigator's Grant from the Breast Cancer Alliance; Women's Education and Leadership Fund; Legacy of the Hartford College for Women at the University of Hartford; Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford; Vincent B. Coffin grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Greenberg grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	Young Investigator's Grant from the Breast Cancer Alliance; Women's Education and Leadership Fund; Legacy of the Hartford College for Women at the University of Hartford; Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford; Vincent B. Coffin grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Greenberg grant from the College of Arts and Sciences Dean's Office at the University of Hartford; Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford	This work was supported, in part, by the Young Investigator's Grant from the Breast Cancer Alliance (AAL) (breastcanceralliance.org), a grant from the Women's Education and Leadership Fund, a Legacy of the Hartford College for Women at the University of Hartford (AAL) (http://www.hartford.edu/welfund/), a grant from the Dorothy Goodwin Summer Scholars Program from the Women's Education and Leadership Fund at the University of Hartford (AAL, BCD) (http://www.hartford.edu/welfund/) as well as the Vincent B. Coffin grant, Greenberg grant, and Faculty Research grants from the College of Arts and Sciences Dean's Office at the University of Hartford (AAL)(http://hartford.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Hoffmann TK, 2011, ANTICANCER RES, V31, P3151; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Menendez D, 2006, P NATL ACAD SCI USA, V103, P1406, DOI 10.1073/pnas.0508103103; Menendez D, 2007, MOL CELL BIOL, V27, P2590, DOI 10.1128/MCB.01742-06; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Shieh SY, 2000, GENE DEV, V14, P289; STENGER JE, 1992, MOL CARCINOGEN, V5, P102, DOI 10.1002/mc.2940050204; TAM SW, 1995, J CELL BIOCHEM, V59, P339, DOI 10.1002/jcb.240590306; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yan J, 2009, J BIOL CHEM, V284, P19280, DOI 10.1074/jbc.M109.013102; Yin XY, 2001, CANCER RES, V61, P6487; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42615	10.1371/journal.pone.0042615	http://dx.doi.org/10.1371/journal.pone.0042615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905155	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100052
J	Wu, T; Wang, YJ; Guo, DJ				Wu, Ting; Wang, Yejun; Guo, Dianjing			Investigation of Glandular Trichome Proteins in Artemisia annua L. Using Comparative Proteomics	PLOS ONE			English	Article							2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE; ISOPRENOID BIOSYNTHESIS; MOLECULAR-CLONING; STRESS; ENZYME; PLANTS; IDENTIFICATION; EXPRESSION; TOLERANCE; REDUCTASE	Glandular secreting trichomes (GSTs) are called biofactories because they are active in synthesizing, storing and secreting various types of plant secondary metabolites. As the most effective drug against malaria, artemisinin, a sesquiterpene lactone is derived from GSTs of Artemisia annua. However, low artemisinin content (0.001%similar to 1.54% of dry weight) has hindered its wide application. We investigate the GST-expressed proteins in Artemisia annua using a comparative proteomics approach, aiming for a better understanding of the trichome proteome and arteminisin metabolism. 2D-electrophoresis was employed to compare the protein profiles of GSTs and leaves. More than 700 spots were resolved for GSTs, of which similar to 93 non-redundant proteins were confidently identified by searching NCBI and Artemisia EST databases. Over 70% of these proteins were highly expressed in GTSs. Functional classification of these GSTs enriched proteins revealed that many of them participate in major plant metabolic processes such as electron transport, transcription and translation.	[Wu, Ting] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, State Kay Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, T (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	djguo@cuhk.edu.hk		Wu, Ting/0000-0003-4021-6298	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 4609647, CUHK 4610651]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project no. CUHK 4609647 and CUHK 4610651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amme S, 2005, PROTEOMICS, V5, P2508, DOI 10.1002/pmic.200401274; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Balbuena TS, 2011, J PROTEOME RES, V10, P2330, DOI 10.1021/pr101137q; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Brown GD, 2004, TETRAHEDRON, V60, P1139, DOI 10.1016/j.tet.2003.11.070; Brown GD, 2007, TETRAHEDRON, V63, P9548, DOI 10.1016/j.tet.2007.06.062; Brown GD, 2010, MOLECULES, V15, P7603, DOI 10.3390/molecules15117603; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Cushman JC, 2001, AM ZOOL, V41, P758, DOI 10.1668/0003-1569(2001)041[0758:OIPIFA]2.0.CO;2; FERREIRA JFS, 1995, INT J PLANT SCI, V156, P807, DOI 10.1086/297304; Ferreira JFS, 1998, PROGR NEW CROPS, P579; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Kim SM, 2006, PLANT CELL REP, V25, P829, DOI 10.1007/s00299-006-0136-3; Kjellsen TD, 2010, J PROTEOMICS, V73, P965, DOI 10.1016/j.jprot.2009.12.010; Lan P, 2011, PLANT SIGNAL BEHAV, V6, P528, DOI 10.4161/psb.6.4.14747; Laughlin JC, 1995, ACTA HORTIC, P67, DOI 10.17660/ActaHortic.1995.390.8; Mahmoud SS, 2002, TRENDS PLANT SCI, V7, P366, DOI 10.1016/S1360-1385(02)02303-8; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Musumeci MA, 2011, ADV PHOTOSYNTHESIS F, P540; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Pamela JW, 2006, IN VITRO CELL DEP PL, V42, P309; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Picaud S, ARCH BIOCH BIOPHYS, V448, P150; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Richard SB, 2002, J BIOL CHEM, V277, P8667, DOI 10.1074/jbc.C100739200; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Schilmiller AL, 2008, PLANT J, V54, P702, DOI 10.1111/j.1365-313X.2008.03432.x; Schramek N, 2010, PHYTOCHEMISTRY, V71, P179, DOI 10.1016/j.phytochem.2009.10.015; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wehrl W, 2000, J BACTERIOL, V182, P3870, DOI 10.1128/JB.182.13.3870-3873.2000; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	48	13	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41822	10.1371/journal.pone.0041822	http://dx.doi.org/10.1371/journal.pone.0041822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905110	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100020
J	Guo, K				Guo, Kun			Holistic Gaze Strategy to Categorize Facial Expression of Varying Intensities	PLOS ONE			English	Article							FACES; RECOGNITION; INFORMATION; DURATION; EMOTION	Using faces representing exaggerated emotional expressions, recent behaviour and eye-tracking studies have suggested a dominant role of individual facial features in transmitting diagnostic cues for decoding facial expressions. Considering that in everyday life we frequently view low-intensity expressive faces in which local facial cues are more ambiguous, we probably need to combine expressive cues from more than one facial feature to reliably decode naturalistic facial affects. In this study we applied a morphing technique to systematically vary intensities of six basic facial expressions of emotion, and employed a self-paced expression categorization task to measure participants' categorization performance and associated gaze patterns. The analysis of pooled data from all expressions showed that increasing expression intensity would improve categorization accuracy, shorten reaction time and reduce number of fixations directed at faces. The proportion of fixations and viewing time directed at internal facial features (eyes, nose and mouth region), however, was not affected by varying levels of intensity. Further comparison between individual facial expressions revealed that although proportional gaze allocation at individual facial features was quantitatively modulated by the viewed expressions, the overall gaze distribution in face viewing was qualitatively similar across different facial expressions and different intensities. It seems that we adopt a holistic viewing strategy to extract expressive cues from all internal facial features in processing of naturalistic facial expressions.	Lincoln Univ, Sch Psychol, Lincoln, England	University of Lincoln	Guo, K (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	kguo@lincoln.ac.uk		Guo, Kun/0000-0001-6765-1957	State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; Leverhulme Trust [RF/2/RFG/2009/0152]	State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; Leverhulme Trust(Leverhulme Trust)	This research was partly supported by Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning, P.R. China; The Leverhulme Trust Grant (RF/2/RFG/2009/0152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Clark US, 2010, NEUROPSYCHOLOGIA, V48, P1901, DOI 10.1016/j.neuropsychologia.2010.03.006; Du SC, 2011, J VISION, V11, DOI 10.1167/11.13.24; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Ekman P, 1978, FACIAL ACTION CODING; Ekman P., 1976, PICTURES FACIAL AFFE; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Guo K, 2003, EXP BRAIN RES, V150, P363, DOI 10.1007/s00221-003-1429-1; Guo K, 2006, EXP BRAIN RES, V171, P91, DOI 10.1007/s00221-005-0248-y; Guo K, 2007, EXP BRAIN RES, V181, P673, DOI 10.1007/s00221-007-1038-5; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; KIROUAC G, 1985, J NONVERBAL BEHAV, V9, P3, DOI 10.1007/BF00987555; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Lundqvist D., 1998, KAROLINSKA DIRECTED; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Rutishauser U, 2011, CURR BIOL, V21, P1654, DOI 10.1016/j.cub.2011.08.035; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11	27	56	57	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42585	10.1371/journal.pone.0042585	http://dx.doi.org/10.1371/journal.pone.0042585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985QT	22880043	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000307284100136
J	Jiao, J; Hindoyan, A; Wang, SY; Tran, LM; Goldstein, AS; Lawson, D; Chen, DH; Li, YF; Guo, CY; Zhang, BH; Fazli, L; Gleave, M; Witte, ON; Garraway, IP; Wu, H				Jiao, Jing; Hindoyan, Antreas; Wang, Shunyou; Tran, Linh M.; Goldstein, Andrew S.; Lawson, Devon; Chen, Donghui; Li, Yunfeng; Guo, Changyong; Zhang, Baohui; Fazli, Ladan; Gleave, Martin; Witte, Owen N.; Garraway, Isla P.; Wu, Hong			Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; ADHESION MOLECULE; MOUSE PROSTATE; PROGENITOR CELLS; BASAL-CELLS; IN-VITRO; MURINE; PTEN; EXPRESSION; SURVIVAL	New therapies for late stage and castration resistant prostate cancer (CRPC) depend on defining unique properties and pathways of cell sub-populations capable of sustaining the net growth of the cancer. One of the best enrichment schemes for isolating the putative stem/ progenitor cell from the murine prostate gland is Lin(-);Sca1(+);CD49f(hi) (LSChi), which results in a more than 10-fold enrichment for in vitro sphere-forming activity. We have shown previously that the LSChi subpopulation is both necessary and sufficient for cancer initiation in the Pten-null prostate cancer model. To further improve this enrichment scheme, we searched for cell surface molecules upregulated upon castration of murine prostate and identified CD166 as a candidate gene. CD166 encodes a cell surface molecule that can further enrich sphere-forming activity of WT LSChi and Pten null LSChi. Importantly, CD166 could enrich sphere-forming ability of benign primary human prostate cells in vitro and induce the formation of tubule-like structures in vivo. CD166 expression is upregulated in human prostate cancers, especially CRPC samples. Although genetic deletion of murine CD166 in the Pten null prostate cancer model does not interfere with sphere formation or block prostate cancer progression and CRPC development, the presence of CD166 on prostate stem/ progenitors and castration resistant sub-populations suggest that it is a cell surface molecule with the potential for targeted delivery of human prostate cancer therapeutics.	[Jiao, Jing; Hindoyan, Antreas; Wang, Shunyou; Tran, Linh M.; Lawson, Devon; Li, Yunfeng; Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Jiao, Jing; Hindoyan, Antreas; Tran, Linh M.; Li, Yunfeng; Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Goldstein, Andrew S.; Chen, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Goldstein, Andrew S.; Chen, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90024 USA; [Guo, Changyong; Zhang, Baohui; Garraway, Isla P.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Fazli, Ladan; Gleave, Martin] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Witte, Owen N.; Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of British Columbia; University of California System; University of California Los Angeles	Jiao, J (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	igarraway@mednet.ucla.edu; hwu@mednet.ucla.edu	Witte, Otto/P-4127-2018; Jiao, Jing/F-5354-2015	Witte, Otto/0000-0003-2101-4105; Goldstein, Andrew/0000-0003-0434-9149; Gleave, Martin/0000-0003-4235-0167	Prostate Cancer Foundation; Jean Perkins Foundation; Department of Defense; National Institutes of Health [R01 CA107166, RO1 CA121110]; NATIONAL CANCER INSTITUTE [R01CA121110, R01CA107166] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Jean Perkins Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by an award from the Prostate Cancer Foundation (to OW, IPG and HW), Jean Perkins Foundation and Department of Defense (to IPG) and a grant from the National Institutes of Health (R01 CA107166 and RO1 CA121110 to HW). ONW is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; De Marzo AM, 2010, NAT REV UROL, V7, P650, DOI 10.1038/nrurol.2010.188; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Ishigami S, 2011, J SURG ONCOL, V103, P57, DOI 10.1002/jso.21756; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; King JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-266; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001237; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Maitland NJ, 2005, BJU INT, V96, P1219, DOI 10.1111/j.1464-410X.2005.05744.x; McMenamin ME, 1999, CANCER RES, V59, P4291; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Moscatelli D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001445; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Sawhney M, 2009, INT J CANCER, V124, P2098, DOI 10.1002/ijc.24192; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor RA, 2010, ENDOCR-RELAT CANCER, V17, pR273, DOI 10.1677/ERC-10-0145; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang CH, 2011, NANOMED-NANOTECHNOL, V7, P69, DOI 10.1016/j.nano.2010.06.010; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Wiiger MT, 2010, CANCER IMMUNOL IMMUN, V59, P1665, DOI 10.1007/s00262-010-0892-3; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355	59	73	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42564	10.1371/journal.pone.0042564	http://dx.doi.org/10.1371/journal.pone.0042564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880034	Green Published, gold			2022-12-25	WOS:000307284100130
J	Mazurek, J; Ignatowicz, L; Kallenius, G; Svenson, SB; Pawlowski, A; Hamasur, B				Mazurek, Jolanta; Ignatowicz, Lech; Kallenius, Gunilla; Svenson, Stefan B.; Pawlowski, Andrzej; Hamasur, Beston			Divergent Effects of Mycobacterial Cell Wall Glycolipids on Maturation and Function of Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BACILLUS-CALMETTE-GUERIN; HUMAN ALVEOLAR MACROPHAGES; TUBERCULOSIS H37RV; MANNOSYLATED LIPOARABINOMANNANS; CYTOKINE PRODUCTION; DC-SIGN; ACTIVATION; STRAINS; ALPHA	Background: Mycobacterium tuberculosis (Mtb) is able to evade the immune defenses and may persist for years, decades and even lifelong in the infected host. Mtb cell wall components may contribute to such persistence by modulating several pivotal types of immune cells. Dendritic cells (DCs) are the most potent antigen-presenting cells and hence play a crucial role in the initial immune response to infections by connecting the innate with the adaptive immune system. Principal Findings: We investigated the effects of two of the major mycobacterial cell wall-associated types of glycolipids, mannose-capped lipoarabinomannan (ManLAM) and phosphatidylinositol mannosides (PIMs) purified from the Mtb strains H37Rv and Mycobacterium bovis, on the maturation and cytokine profiles of immature human monocyte-derived DCs. ManLAM from Mtb H37Rv stimulated the release of pro-inflammatory cytokines TNF, IL-12, and IL-6 and expression of costimulatory (CD80, CD86) and antigen-presenting molecules (MHC class II). ManLAM from M. bovis also induced TNF, IL-12 and IL-6 but at significantly lower levels. Importantly, while ManLAM was found to augment LPS-induced DC maturation and pro-inflammatory cytokine production, addition of PIMs from both Mtb H37Rv and M. bovis strongly reduced this stimulatory effect. Conclusions: These results indicate that the mycobacterial cell wall contains macromolecules of glycolipid nature which are able to induce strong and divergent effects on human DCs; i.e while ManLAM is immune-stimulatory, PIMs act as powerful inhibitors of DC cytokine responses. Thus PIMs may be important Mtb-associated virulence factors contributing to the pathogenesis of tuberculosis disease. These findings may also aid in the understanding of some earlier conflicting reports on the immunomodulatory effects exerted by different ManLAM preparations.	[Mazurek, Jolanta; Ignatowicz, Lech] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kallenius, Gunilla; Svenson, Stefan B.; Pawlowski, Andrzej; Hamasur, Beston] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Mazurek, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	beston.hamasur@ki.se	Källenius, Gunilla/AGZ-3956-2022	Pawlowski, Andrzej/0000-0003-4555-6048; Mazurek, Jolanta/0000-0001-5023-0398	European Commission [MEST-CT-2005-020872]; Swedish Research Council [K2007-58X-13027, K2010-79X-21374-01-3]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by European Commission Grant MEST-CT-2005-020872 (to J.M. and A.P), and by Swedish Research Council Grants K2007-58X-13027 (to G.K.) and K2010-79X-21374-01-3 (to A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1993, INFECT IMMUN, V61, P4173, DOI 10.1128/IAI.61.10.4173-4181.1993; Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; BARNES PF, 1992, J IMMUNOL, V149, P541; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; BRADBURY MG, 1993, CLIN EXP IMMUNOL, V94, P57; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1992, INFECT IMMUN, V60, P1249, DOI 10.1128/IAI.60.3.1249-1253.1992; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Dahl KE, 1996, INFECT IMMUN, V64, P399, DOI 10.1128/IAI.64.2.399-405.1996; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dulphy N, 2007, CELL MICROBIOL, V9, P1412, DOI 10.1111/j.1462-5822.2006.00881.x; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gilleron M, 2000, J BIOL CHEM, V275, P677, DOI 10.1074/jbc.275.1.677; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hamasur B, 1999, FEMS IMMUNOL MED MIC, V24, P11, DOI 10.1111/j.1574-695X.1999.tb01259.x; Henderson RA, 1997, J IMMUNOL, V159, P635; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hetland G, 1998, CLIN DIAGN LAB IMMUN, V5, P211, DOI 10.1128/CDLI.5.2.211-218.1998; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Holt PG, 2000, J AEROSOL MED, V13, P361, DOI 10.1089/jam.2000.13.361; Hope JC, 2004, VET IMMUNOL IMMUNOP, V100, P187, DOI 10.1016/j.vetimm.2004.04.007; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Kim KD, 1999, IMMUNOLOGY, V97, P626; Majumder N, 2008, MICROBES INFECT, V10, P349, DOI 10.1016/j.micinf.2007.12.013; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marshall BG, 2000, EUR RESPIR J, V15, P764, DOI 10.1034/j.1399-3003.2000.15d22.x; Mazurek J, 2012, EUR J IMMUNOL, V42, P1192, DOI 10.1002/eji.201142049; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; MOLLOY A, 1990, P NATL ACAD SCI USA, V87, P973, DOI 10.1073/pnas.87.3.973; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; MORENO C, 1988, CLIN EXP IMMUNOL, V74, P206; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; ROACH TIA, 1993, J IMMUNOL, V150, P1886; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; SIBLEY LD, 1990, CLIN EXP IMMUNOL, V80, P141; Takimoto H, 2006, CLIN EXP IMMUNOL, V144, P134, DOI 10.1111/j.1365-2249.2006.03043.x; Thurnher M, 1997, INT J CANCER, V70, P128; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Torrelles JB, 2011, J BIOL CHEM, V286, P35438, DOI 10.1074/jbc.M111.232587; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Wu TT, 2011, CELL IMMUNOL, V272, P94, DOI 10.1016/j.cellimm.2011.09.001; Yoshida A, 1997, INFECT IMMUN, V65, P1953, DOI 10.1128/IAI.65.5.1953-1955.1997	71	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42515	10.1371/journal.pone.0042515	http://dx.doi.org/10.1371/journal.pone.0042515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880012	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100115
J	Abhari, BA; Cristofanon, S; Kappler, R; von Schweinitz, D; Humphreys, R; Fulda, S				Abhari, B. A.; Cristofanon, S.; Kappler, R.; von Schweinitz, D.; Humphreys, R.; Fulda, S.			RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex	ONCOGENE			English	Article						apoptosis; IAP inhibitor; TRAIL; RIP1; neuroblastoma	NF-KAPPA-B; DRUG-INDUCED APOPTOSIS; TESTING STAGE 1; CANCER-CELLS; DNA-DAMAGE; RECEPTOR; ANTAGONISTS; NECROSIS; CIAP1; IDENTIFICATION	Inhibitor of apoptosis (IAP) proteins represent promising therapeutic targets due to their high expression in many cancers. Here, we report that small-molecule IAP inhibitors at subtoxic concentrations cooperate with monoclonal antibodies against TRAIL receptor 1 (Mapatumumab) or TRAIL-R2 (Lexatumumab) to induce apoptosis in neuroblastoma cells in a highly synergistic manner (combination index <0.1). Importantly, we identify receptor-activating protein 1 (RIP1) as a critical mediator of this synergism. RIP1 is required for the formation of a RIP1/FADD/caspase-8 complex that drives caspase-8 activation, cleavage of Bid into tBid, mitochondrial outer membrane permeabilization, full activation of caspase-3 and caspase-dependent apoptosis. Indeed, knockdown of RIP1 abolishes formation of the RIP1/FADD/caspase-8 complex, caspase activation and apoptosis upon combination treatment. Similarly, inhibition of RIP1 kinase activity by Necrostatin-1 inhibits IAP inhibitor- and TRAIL receptor-triggered apoptosis. In contrast, overexpression of the dominant-negative superrepressor I kappa B alpha-SR or addition of the tumor necrosis factor (TNF)alpha-blocking antibody Enbrel do not interfere with cotreatment-induced apoptosis, pointing to a nuclear factor-kappa B- and TNF alpha-independent mechanism. Of note, IAP inhibitor also sensitizes primary cultured neuroblastoma cells for TRAIL receptor-mediated loss of viability, underscoring the clinical relevance. By identifying RIP1 as a critical mediator of IAP inhibitor- mediated sensitization for Mapatumumab- or Lexatumumab-induced apoptosis, our findings provide new insights into the synergistic interaction of IAP inhibitors together with TRAIL receptor agonists.	[Abhari, B. A.; Cristofanon, S.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Kappler, R.; von Schweinitz, D.] Univ Munich, Dr von Haunerschen Childrens Hosp, Dept Pediat Surg, Munich, Germany; [Humphreys, R.] Human Genome Sci Inc, Oncol Res Dept, Rockville, MD USA	Goethe University Frankfurt; University of Munich; GlaxoSmithKline; Human Genome Sciences Inc	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417; Kappler, Roland/0000-0002-8581-2803	Deutsche Forschungsgemeinschaft; European Community (ApopTrain, APO-SYS); IAP6/18	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community (ApopTrain, APO-SYS)(European CommissionEuropean Commission Joint Research Centre); IAP6/18	We thank X Wang for providing RIP3 antibody and C Hugenberg for expert secretarial assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, European Community (ApopTrain, APO-SYS) and IAP6/18 (to SF).	Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bellail AC, 2010, J CELL MOL MED, V14, P1303, DOI 10.1111/j.1582-4934.2009.00777.x; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Chao B, 2006, inventors; Tetrapeptide analogs. United States patent, Patent No. PCT/US2005/024700; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2006, CANCER RES, V66, P10016, DOI 10.1158/0008-5472.CAN-05-4079; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P636, DOI 10.1002/pbc.23167; Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Naumann I, 2011, CLIN CANCER RES, V17, P3204, DOI 10.1158/1078-0432.CCR-10-2451; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Palacios C, 2010, CANCER LETT, V287, P207, DOI 10.1016/j.canlet.2009.06.012; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Smith MA, 2010, PEDIATR BLOOD CANCER, V54, P307, DOI 10.1002/pbc.22188; Stadel D, 2010, CLIN CANCER RES, V16, P5734, DOI 10.1158/1078-0432.CCR-10-0985; Straub CS, 2011, CURR TOP MED CHEM, V11, P291; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	41	51	51	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2013	32	27					3263	3273		10.1038/onc.2012.337	http://dx.doi.org/10.1038/onc.2012.337			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22890322				2022-12-25	WOS:000321301600006
J	Ly, P; Kim, SB; Kaisani, AA; Marian, G; Wright, WE; Shay, JW				Ly, P.; Kim, S. B.; Kaisani, A. A.; Marian, G.; Wright, W. E.; Shay, J. W.			Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation	ONCOGENE			English	Article						aneuploidy; EGFR; AICAR; chromosomal instability; trisomy	CHROMOSOMAL INSTABILITY; RECEPTOR; CANCER; UBIQUITINATION; TRISOMY; PROLIFERATION; POPULATIONS; METABOLISM; MUTATIONS; PROTEOME	Trisomy for chromosome 7 is frequently observed as an initiating event in sporadic colorectal cancer. Although unstable chromosome numbers and recurrent aneuploidies drive a large fraction of human cancers, targeted therapies selective to pre-neoplastic trisomic cells are non-existent. We have previously characterized a trisomy 7 cell line (1CT+7) spontaneously derived from normal diploid human colonic epithelial cells that aberrantly expresses the epidermal growth factor receptor (EGFR, chromosome 7p11). Recent studies identified AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) as a pharmacological inhibitor of aneuploid murine fibroblast proliferation. Here, we report that AICAR induces profound cytostatic and metabolic effects on 1CT+7 cells, but not on their isogenic diploid counterpart. Dose-response experiments indicate that 1CT+7 cells are fourfold preferentially sensitive to AICAR compared to diploid cells. Unexpectedly, treatment of 1CT+7 cells with AICAR led to a reversible 3.5-fold reduction (P = 0.0025) in EGFR overexpression. AICAR-induced depletion of EGFR protein can be abrogated through inhibition of the proteasome with MG132. AICAR also heavily promoted EGFR ubiquitination in cell-based immunoprecipitation assays, suggesting enhanced degradation of EGFR protein mediated by the proteasome. Moreover, treatment with AICAR reduced EGFR protein levels in a panel of human colorectal cancer cells in vitro and in xenograft tumors in vivo. Our data collectively support the pharmacological compound AICAR as a novel inhibitor of EGFR protein abundance and as a potential anticancer agent for aneuploidy-driven colorectal cancer.	[Ly, P.; Kim, S. B.; Kaisani, A. A.; Marian, G.; Wright, W. E.; Shay, J. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Shay, J. W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	University of Texas System; University of Texas Southwestern Medical Center Dallas; King Abdulaziz University	Shay, JW (corresponding author), Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Ly, Peter/B-3722-2012	Ly, Peter/0000-0001-8946-7069; Kim, Sang Bum/0000-0001-5965-3354	CPRIT [RP101496]; NASA [NNX09AU95G, NNX11AC15G, NNX11AC54G]; NCI [SPORE CA70907]; NATIONAL CANCER INSTITUTE [P30CA142543, P50CA070907] Funding Source: NIH RePORTER	CPRIT; NASA(National Aeronautics & Space Administration (NASA)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank RY Quach for figure artwork and U Eskiocak, G Stadler and AR Mullen (UT Southwestern) for technical assistance. We also express gratitude to YC Tang and A Amon (MIT) for providing xenograft tumors for IHC analysis and for critical reading of the manuscript. HA-tagged ubiquitin plasmids and anti-HA antibodies were a kind gift from LJ Huang (UT Southwestern). EGFR-V5 expression constructs and human bronchial epithelial cell-EGFR cell lines were provided by C Nirodi (UT Southwestern). This work was supported by CPRIT Training Grant RP101496 to PL, NASA Grants NNX09AU95G, NNX11AC15G, and NNX11AC54G and NCI SPORE CA70907 to JWS.	Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Briand P, 1996, CANCER RES, V56, P2039; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; GAREWAL H, 1990, DIGEST DIS SCI, V35, P1115, DOI 10.1007/BF01537584; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Lamprecht SA, 2002, CARCINOGENESIS, V23, P1777, DOI 10.1093/carcin/23.11.1777; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Ly P, 2011, NEOPLASIA, V13, P348, DOI 10.1593/neo.101580; Manchado E, 2011, CELL, V144, P465, DOI 10.1016/j.cell.2011.01.037; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; MELTZER SJ, 1994, CANCER RES, V54, P3379; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	36	14	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2013	32	26					3139	3146		10.1038/onc.2012.339	http://dx.doi.org/10.1038/onc.2012.339			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	172LL	22890317	Green Accepted			2022-12-25	WOS:000321004600004
J	Chung, KY; Kim, TH; Manglik, A; Alvares, R; Kobilka, BK; Prosser, RS				Chung, Ka Young; Kim, Tae Hun; Manglik, Aashish; Alvares, Rohan; Kobilka, Brian K.; Prosser, R. Scott			Role of Detergents in Conformational Exchange of a G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; KCSA POTASSIUM CHANNEL; MODEL-FREE APPROACH; MEMBRANE-PROTEINS; NMR; DYNAMICS; INSIGHTS; LIGAND; STATE; MACROMOLECULES	The G protein-coupled beta(2)-adrenoreceptor (beta(2)AR) signals through the heterotrimeric G proteins G(s) and G(i) and beta-arrestin. As such, the energy landscape of beta(2)AR-excited state conformers is expected to be complex. Upon tagging Cys-265 of beta(2)AR with a trifluoromethyl probe, F-19 NMR was used to assess conformations and possible equilibria between states. Here, we report key differences in beta(2)AR conformational dynamics associated with the detergents used to stabilize the receptor. In dodecyl maltoside (DDM) micelles, the spectra are well represented by a single Lorentzian line that shifts progressively downfield with activation by appropriate ligand. The results are consistent with interconversion between two or more states on a time scale faster than the greatest difference in ligand-dependent chemical shift (i.e. >100 Hz). Given that high detergent off-rates of DDM monomers may facilitate conformational exchange between functional states of beta(2)AR, we utilized the recently developed maltose-neopentyl glycol (MNG-3) diacyl detergent. In MNG-3 micelles, spectra indicated at least three distinct states, the relative populations of which depended on ligand, whereas no ligand-dependent shifts were observed, consistent with the slow exchange limit. Thus, detergent has a profound effect on the equilibrium kinetics between functional states. MNG-3, which has a critical micelle concentration in the nanomolar regime, exhibits an off-rate that is 4 orders of magnitude lower than that of DDM. High detergent off-rates are more likely to facilitate conformational exchange between distinct functional states associated with the G protein-coupled receptor.	[Prosser, R. Scott] Univ Toronto, Dept Chem, UTM, Mississauga, ON L5L 1C6, Canada; [Chung, Ka Young; Manglik, Aashish; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea	University of Toronto; University Toronto Mississauga; Stanford University; Sungkyunkwan University (SKKU)	Prosser, RS (corresponding author), Univ Toronto, Dept Chem, UTM, 3359 Mississauga Rd N, Mississauga, ON L5L 1C6, Canada.	scott.prosser@utoronto.ca	Chung, Ka Young/AAO-7984-2020	Chung, Ka Young/0000-0001-9038-9571; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NH028471]; Natural Sciences and Engineering Research Council of Canada (NSERC) [261980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NH028471 (to B. K. K.). This work was also supported by Research Discovery Award 261980 from the Natural Sciences and Engineering Research Council of Canada (NSERC; to R. S. P.).	Acosta EJ, 2004, J COLLOID INTERF SCI, V274, P652, DOI 10.1016/j.jcis.2004.03.037; ANIANSSON EA, 1974, J PHYS CHEM-US, V78, P1024, DOI 10.1021/j100603a016; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Catoire LJ, 2010, J AM CHEM SOC, V132, P9049, DOI 10.1021/ja101868c; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kang CB, 2011, CURR OPIN CHEM BIOL, V15, P560, DOI 10.1016/j.cbpa.2011.05.025; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Tamm LK, 2006, PROG NUCL MAG RES SP, V48, P201, DOI 10.1016/j.pnmrs.2006.05.005; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Thomas MJ, 1999, BBA-BIOMEMBRANES, V1417, P144, DOI 10.1016/S0005-2736(98)00254-5; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Tsamaloukas AD, 2009, LANGMUIR, V25, P4393, DOI 10.1021/la8033935; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	37	70	70	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36305	36311		10.1074/jbc.M112.406371	http://dx.doi.org/10.1074/jbc.M112.406371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22893704	hybrid, Green Published			2022-12-25	WOS:000310364000051
J	Enns, CA; Ahmed, R; Zhang, AS				Enns, Caroline A.; Ahmed, Riffat; Zhang, An-Sheng			Neogenin Interacts with Matriptase-2 to Facilitate Hemojuvelin Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1Q-LINKED JUVENILE HEMOCHROMATOSIS; REGULATES HEPCIDIN EXPRESSION; REPULSIVE GUIDANCE MOLECULE; SYSTEMIC IRON HOMEOSTASIS; SERINE-PROTEASE TMPRSS6; SOLUBLE HEMOJUVELIN; RECEPTOR NEOGENIN; DOWN-REGULATION; MEMBRANE; METABOLISM	Hemojuvelin (HJV) and matriptase-2 (MT2) are co-expressed in hepatocytes, and both are essential for systemic iron homeostasis. HJV is a glycosylphosphatidylinositol-linked membrane protein that acts as a co-receptor for bone morphogenetic proteins to induce hepcidin expression. MT2 regulates the levels of membrane-bound HJV in hepatocytes by binding to and cleaving HJV into an inactive soluble form that is released from cells. HJV also interacts with neogenin, a ubiquitously expressed transmembrane protein with multiple functions. In this study, we showed that neogenin interacted with MT2 as well as with HJV and facilitated the cleavage of HJV by MT2. In contrast, neogenin was not cleaved by MT2, indicating some degree of specificity by MT2. Down-regulation of neogenin with siRNA increased the amount of MT2 and HJV on the plasma membrane, suggesting a lack of neogenin involvement in their trafficking to the cell surface. The increase in MT2 and HJV upon neogenin knockdown was likely due to the inhibition of cell surface MT2 and HJV internalization. Analysis of the Asn-linked oligosaccharides showed that MT2 cleavage of cell surface HJV was coupled to a transition from high mannose oligosaccharides to complex oligosaccharides on HJV. These results suggest that neogenin forms a ternary complex with both MT2 and HJV at the plasma membrane. The complex facilitates HJV cleavage by MT2, and release of the cleaved HJV from the cell occurs after a retrograde trafficking through the TGN/Golgi compartments.	[Enns, Caroline A.; Ahmed, Riffat; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765, DK72166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054488, R01DK080765, R01DK072166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A. S. Z.) and DK72166 (to C. A. E.).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2011, SEMIN LIVER DIS, V31, P280, DOI 10.1055/s-0031-1286059; Bae GU, 2009, MOL BIOL CELL, V20, P4920, DOI 10.1091/mbc.E09-06-0491; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	53	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35104	35117		10.1074/jbc.M112.363937	http://dx.doi.org/10.1074/jbc.M112.363937			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893705	Green Published, hybrid			2022-12-25	WOS:000309968000021
J	Xiong, DP; Xiao, F; Liu, L; Hu, K; Tan, YP; He, SM; Gao, XP				Xiong, Dapeng; Xiao, Fen; Liu, Li; Hu, Kai; Tan, Yanping; He, Shunmin; Gao, Xieping			Towards a Better Detection of Horizontally Transferred Genes by Combining Unusual Properties Effectively	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; ESCHERICHIA-COLI; BACTERIAL; PREDICTION; ARCHAEAL	Background: Horizontal gene transfer (HGT) is one of the major mechanisms contributing to microbial genome diversification. A number of computational methods for finding horizontally transferred genes have been proposed in the past decades; however none of them has provided a reliable detector yet. In existing parametric approaches, only one single compositional property can participate in the detection process, or the results obtained through each single property are just simply combined. It's known that different properties may mean different information, so the single property can't sufficiently contain the information encoded by gene sequences. In addition, the class imbalance problem in the datasets, which also results in great errors for the gene detection, hasn't been considered by the published methods. Here we developed an effective classifier system (Hgtident) that used support vector machine (SVM) by combining unusual properties effectively for HGT detection. Results: Our approach Hgtident includes the introduction of more representative datasets, optimization of SVM model, feature selection, handling of imbalance problem in the datasets and extensive performance evaluation via systematic cross-validation methods. Through feature selection, we found that JS-DN and JS-CB have higher discriminating power for HGT detection, while GC1-GC3 and k-mer (k = 1, 2, ..., 7) make the least contribution. Extensive experiments indicated the new classifier could reduce Mean error dramatically, and also improve Recall by a certain level. For the testing genomes, compared with the existing popular multiple-threshold approach, on average, our Recall and Mean error was respectively improved by 2.81% and reduced by 26.32%, which means that numerous false positives were identified correctly. Conclusions: Hgtident introduced here is an effective approach for better detecting HGT. Combining multiple features of HGT is also essential for a wider range of HGT events detection.	[Xiong, Dapeng; Xiao, Fen; Hu, Kai; Tan, Yanping; Gao, Xieping] Xiangtan Univ, Minist Educ, Key Lab Intelligent Comp & Informat Proc, Xiangtan, Hunan, Peoples R China; [Liu, Li; He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Xiangtan University; Chinese Academy of Sciences; Institute of Zoology, CAS	Xiong, DP (corresponding author), Xiangtan Univ, Minist Educ, Key Lab Intelligent Comp & Informat Proc, Xiangtan, Hunan, Peoples R China.	heshunmin@gmail.com; xpgao@xtu.edu.cn	He, Shunmin/B-8037-2011; Gao, Xieping/G-1969-2016	He, Shunmin/0000-0002-7294-0865; 	National Natural Science Foundation of China [61172171]; Chinese Academy of Science Knowledge Innovation [KSCX2-EW-R-01-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science Knowledge Innovation	This work was supported by grants from the National Natural Science Foundation of China under Grant No. 61172171 and the Chinese Academy of Science Knowledge Innovation Project No. KSCX2-EW-R-01-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Azad RK, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr059; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Y, 2010, CHINESE J ELECTRON, V19, P86; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Faguy DM, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-13; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Hamady M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-476; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Ragan MA, 2001, FEMS MICROBIOL LETT, V201, P187, DOI 10.1111/j.1574-6968.2001.tb10755.x; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P3699, DOI 10.1093/nar/gki660; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Weiss G. M., 2004, SIGKDD EXPLORATIONS, V6, P7, DOI DOI 10.1145/1007730.1007734; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43126	10.1371/journal.pone.0043126	http://dx.doi.org/10.1371/journal.pone.0043126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905214	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800048
J	Andersen, LG; Baker, JL; Sorensen, TIA				Andersen, Lise Geisler; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Contributions of Incidence and Persistence to the Prevalence of Childhood Obesity during the Emerging Epidemic in Denmark	PLOS ONE			English	Article							BODY-MASS INDEX; YOUNG-CHILDREN; OVERWEIGHT; TRACKING; WEIGHT; COHORT; TRENDS; BIRTH; RISK; AGE	Background: Prevalence of obesity is the result of preceding incidence of newly developed obesity and persistence of obesity. We investigated whether increasing incidence and/or persistence during childhood drove the prevalence of childhood obesity during the emerging epidemic. Methods: Height and weight were measured at ages 7 and 13 years in 192,992 Danish school children born 1930-1969. Trends in the incidence (proportion obese at 13 years among those not obese at 7 years) and persistence (proportion obese at 13 years among those obese at 7 years) across birth cohort periods (1930-41 with low stable prevalence of obesity, 194-251 with increasing prevalence, 1952-69 with the higher, but stable prevalence) were investigated. Logistic regression was used to examine the associations between BMI at 7 years as a continuous trait, allowing interactions with the birth cohorts, and occurrence of obesity at 13 years. Results: The prevalence of obesity was similar at 7 and 13 years and increased across birth cohorts in boys from around 0.1% to 0.5% and in girls from around 0.3% to 0.7%. The incidence of obesity between ages 7 and 13 years increased from 0.15% to 0.35% in boys and from 0.20% to 0.44% in girls. The persistence increased from 28.6% to 41.4% in boys and from 16.4% to 31.0% in girls. Despite a decrease over time, the remission of obesity occurred in > 60% of obese children in the last birth cohort. However, the odds ratios of obesity at age 13 years in relation to the full range of BMI at 7 years remained unchanged across the birth cohort periods. Conclusions/Significance: The development of the obesity epidemic in children was due to an increase in both incidence and persistence of obesity. Contrary to prevailing expectations, a large, although declining, proportion of children obese at an early age underwent remission during childhood.	[Andersen, Lise Geisler; Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Copenhagen	Andersen, LG (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	lg@ipm.regionh.dk	Baker, Jennifer L./AAH-4693-2020; Bjerregaard, Lise Geisler/F-3818-2014; Baker, Jennifer/F-1917-2010	Baker, Jennifer L./0000-0002-9649-6615; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Baker, Jennifer/0000-0002-9649-6615	Danish Heart Foundation; Rosalie Petersen's Foundation; Aase and Ejner Danielsen's Foundation; Danish PhD School of Molecular Metabolism; University of Copenhagen; Novo Nordisk Foundation; Capital region of Denmark; Danish Council for Strategic Research [2101-06-0005]	Danish Heart Foundation; Rosalie Petersen's Foundation; Aase and Ejner Danielsen's Foundation; Danish PhD School of Molecular Metabolism; University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Capital region of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Heart Foundation; the Rosalie Petersen's Foundation; the Aase and Ejner Danielsen's Foundation; the Danish PhD School of Molecular Metabolism; University of Copenhagen; the Novo Nordisk Foundation; the Capital region of Denmark; and the Danish Council for Strategic Research (grant 2101-06-0005). The study is part of the activities in the Danish Obesity Research Centre (DanORC, see http://www.danorc.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; Armitage P, 2002, STAT METHODS MED RES, P503; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Eriksson M, 2005, ACTA PAEDIATR, V94, P1558, DOI 10.1080/08035250500274926; Evers S, 2007, J AM COLL NUTR, V26, P219, DOI 10.1080/07315724.2007.10719604; Fuentes RM, 2003, INT J OBESITY, V27, P716, DOI 10.1038/sj.ijo.0802271; Heitmann BL, 2004, PUBLIC HEALTH NUTR, V7, P453, DOI 10.1079/PHN2003542; Julia M, 2008, HORM RES, V69, P301, DOI 10.1159/000114862; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kim J, 2005, AM J PUBLIC HEALTH, V95, P1588, DOI 10.2105/AJPH.2004.054015; Kunesova M, 2011, OBES REV, V12, P483, DOI 10.1111/j.1467-789X.2011.00870.x; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; Pearson S, 2010, ACTA PAEDIATR, V99, P1675, DOI 10.1111/j.1651-2227.2010.01897.x; Robbins JM, 2007, ARCH PEDIAT ADOL MED, V161, P17, DOI 10.1001/archpedi.161.1.17; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Sorensen T I, 1988, Acta Med Scand Suppl, V723, P11; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Summerbell CD, 2003, COCHRANE DATABASE SY; Taveras EM, 2005, OBES RES, V13, P900, DOI 10.1038/oby.2005.104; The Danish Data Protection agency, 2011, COMP VERS ACT PROC P; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657; Williamson DA, 2011, OBESITY, V19, P667, DOI 10.1038/oby.2010.221; Zellner K, 2004, ECON HUM BIOL, V2, P281, DOI 10.1016/j.ehb.2004.04.006; Zimmerman MB, 2004, SWISS MED WKLY, V134, P523	42	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42521	10.1371/journal.pone.0042521	http://dx.doi.org/10.1371/journal.pone.0042521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900026	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900042
J	Le, DT; Nishiyama, R; Watanabe, Y; Vankova, R; Tanaka, M; Seki, M; Ham, LH; Yamaguchi-Shinozaki, K; Shinozaki, K; Tran, LSP				Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Vankova, Radomira; Tanaka, Maho; Seki, Motoaki; Le Huy Ham; Yamaguchi-Shinozaki, Kazuko; Shinozaki, Kazuo; Lam-Son Phan Tran			Identification and Expression Analysis of Cytokinin Metabolic Genes in Soybean under Normal and Drought Conditions in Relation to Cytokinin Levels	PLOS ONE			English	Article							ZEATIN-TYPE CYTOKININS; TRANSCRIPTIONAL REGULATORY NETWORKS; RESPONSIVE 2-COMPONENT SYSTEM; TRANSGENIC TOBACCO PLANTS; LIGAND-BINDING PROPERTIES; ABSCISIC-ACID; LEAF SENESCENCE; OXIDASE ACTIVITY; FACTOR FAMILY; CIS-ZEATIN	Cytokinins (CKs) mediate cellular responses to drought stress and targeted control of CK metabolism can be used to develop drought-tolerant plants. Aiming to manipulate CK levels to improve drought tolerance of soybean cultivars through genetic engineering of CK metabolic genes, we surveyed the soybean genome and identified 14 CK biosynthetic (isopentenyltransferase, GmIPT) and 17 CK degradative (CK dehydrogenase, GmCKX) genes. Comparative analyses of GmIPTs and GmCKXs with Arabidopsis counterparts revealed their similar architecture. The average numbers of abiotic stress-inducible cis-elements per promoter were 0.4 and 1.2 for GmIPT and GmCKX genes, respectively, suggesting that upregulation of GmCKXs, thereby reduction of CK levels, maybe the major events under abiotic stresses. Indeed, the expression of 12 GmCKX genes was upregulated by dehydration in R2 roots. Overall, the expressions of soybean CK metabolic genes in various tissues at various stages were highly responsive to drought. CK contents in various organs at the reproductive (R2) stage were also determined under well-watered and drought stress conditions. Although tRNA-type GmIPT genes were highly expressed in soybean, cis-zeatin and its derivatives were found at low concentrations. Moreover, reduction of total CK content in R2 leaves under drought was attributable to the decrease in dihydrozeatin levels, suggesting a role of this molecule in regulating soybean's responses to drought stress. Our systematic analysis of the GmIPT and GmCKX families has provided an insight into CK metabolism in soybean under drought stress and a solid foundation for in-depth characterization and future development of improved drought-tolerant soybean cultivars by manipulation of CK levels via biotechnological approach.	[Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell Biotechnol, Hanoi, Vietnam; [Vankova, Radomira] Acad Sci Czech Republ, Lab Hormonal Regulat Plants, Inst Expt Bot, Prague, Czech Republic; [Tanaka, Maho; Seki, Motoaki] RIKEN Plant Sci Ctr, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Yokohama, Kanagawa, Japan; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam	RIKEN; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; RIKEN; Japan International Research Center for Agricultural Sciences; RIKEN	Le, DT (corresponding author), RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tran@psc.riken.jp	Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/AAB-4945-2019; Vanková, Radomíra/G-6808-2014; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Shinozaki, Kazuo/G-4202-2013; Tran, Lam-Son P/A-1346-2009; Le, Dung Tien/A-7276-2008	Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Shinozaki, Kazuo/0000-0002-6317-9867; Tran, Lam-Son P/0000-0001-9883-9768; Le, Dung Tien/0000-0002-5117-3476	Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan); RIKEN Strategic Research Program for R D (Japan) [AP24-1-0076]	Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan); RIKEN Strategic Research Program for R D (Japan)	This work was supported by a Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (RIKEN) Foreign Postdoctoral Fellowship (Japan; http://www.riken.go.jp/engn/) to DTL and by a grant (No. AP24-1-0076) from the RIKEN Strategic Research Program for R & D (Japan; http://www.riken.go.jp/engn/) to L-SPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; Dobrev P, 2002, PLANT PHYSIOL BIOCH, V40, P333, DOI 10.1016/S0981-9428(02)01383-9; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; HEWELT A, 1994, PLANT J, V6, P879, DOI 10.1046/j.1365-313X.1994.6060879.x; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kudoyarova GR, 2007, J EXP BOT, V58, P161, DOI 10.1093/jxb/erl116; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; LI Y, 1992, DEV BIOL, V153, P386, DOI 10.1016/0012-1606(92)90123-X; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lomin SN, 2011, J EXP BOT, V62, P5149, DOI 10.1093/jxb/err220; Ma QH, 2008, CRIT REV BIOTECHNOL, V28, P213, DOI 10.1080/07388550802262205 ; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; MARTIN RC, 1989, PLANT PHYSIOL, V90, P1630, DOI 10.1104/pp.90.4.1630; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mochida K, 2010, DNA RES, V17, P303, DOI 10.1093/dnares/dsq021; Mok DWS, 1990, PLANT GROWTH SUBSTAN, P267; Motyka V, 2003, PHYSIOL PLANTARUM, V117, P11, DOI 10.1034/j.1399-3054.2003.1170102.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Synkova H, 1999, J PLANT PHYSIOL, V155, P173, DOI 10.1016/S0176-1617(99)80004-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang J, 1997, AUST J PLANT PHYSIOL, V24, P661, DOI 10.1071/PP96101; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490	63	87	91	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42411	10.1371/journal.pone.0042411	http://dx.doi.org/10.1371/journal.pone.0042411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900018	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900035
J	Mohibullah, M; Williams, M; Vandenbroucke, TRA; Sabbe, K; Zalasiewicz, JA				Mohibullah, Mohibullah; Williams, Mark; Vandenbroucke, Thijs R. A.; Sabbe, Koen; Zalasiewicz, Jan A.			Marine Ostracod Provinciality in the Late Ordovician of Palaeocontinental Laurentia and Its Environmental and Geographical Expression	PLOS ONE			English	Article							EASTERN UNITED-STATES; GIRVAN DISTRICT; SPECIATION; APARCHITIDAE; BIOGEOGRAPHY; LITHOFACIES; PATTERNS; ZONATION; BEARING	Background: We examine the environmental, climatic and geographical controls on tropical ostracod distribution in the marine Ordovician of North America. Methodology/Principal Findings: Analysis of the inter-regional distribution patterns of Ordovician Laurentian ostracods, focussing particularly on the diverse Late Ordovician Sandbian (ca 461 to 456 Ma) faunas, demonstrates strong endemicity at the species-level. Local endemism is very pronounced, ranging from 25% (e. g. Foxe basin) to 75% (e. g. Michigan basin) in each basin, a pattern that is also reflected in other benthic faunas such as brachiopods. Multivariate (ordination) analyses of the ostracod faunas allow demarcation of a Midcontinent Province and a southern Marginal Province in Laurentia. While these are most clearly differentiated at the stratigraphical level of the bicornis graptolite biozone, analyses of the entire dataset suggest that these provinces remain distinct throughout the Sandbian interval. Differences in species composition between the provinces appear to have been controlled by changes in physical parameters (e. g. temperature and salinity) related to water depth and latitude and a possible regional geographic barrier, and these differences persist into the Katian and possibly the Hirnantian. Local environmental parameters, perhaps operating at the microhabitat scale, may have been significant in driving local speciation events from ancestor species in each region. Conclusions/Significance: Our work establishes a refined methodology for assessing marine benthic arthropod micro-benthos provinciality for the Early Palaeozoic.	[Mohibullah, Mohibullah; Williams, Mark; Zalasiewicz, Jan A.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Mohibullah, Mohibullah] Univ Balochistan, Dept Geol, Quetta, Pakistan; [Vandenbroucke, Thijs R. A.] Univ Lille 1, Lille, France; [Sabbe, Koen] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	University of Leicester; University of Balochistan; Universite de Lille - ISITE; Universite de Lille; Ghent University	Mohibullah, M (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mk241@le.ac.uk	Vandenbroucke, Thijs R. A./B-7974-2009; Williams, Mark/B-7590-2009	Vandenbroucke, Thijs R. A./0000-0002-8182-3708; Williams, Mark/0000-0002-7987-6069	University of Balochistan, Quetta, Pakistan	University of Balochistan, Quetta, Pakistan	This study was supported by the University of Balochistan, Quetta, Pakistan (http://www.uob.edu.pk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAB A, 1989, J PALEONTOL, V63, P14, DOI 10.1017/S0022336000040907; Anstey RL, 2003, PALEOBIOLOGY, V29, P305, DOI 10.1666/0094-8373(2003)029<0305:POBETT>2.0.CO;2; Becker G, 1990, BRIT MICROPALAEONTOL, P422; Bennett Carys, 2008, Senckenbergiana Lethaea, V88, P37; Bennett CE, 2011, GEOLOGICAL IN PRESS; BERDAN JM, 1988, NEW MEXICO BUREAU MI, V44, P273; Bergstrom SM, 2009, LETHAIA, V42, P97, DOI 10.1111/j.1502-3931.2008.00136.x; Bergstrom S.M., 1986, Geological Society Special Publication, P61; Bergstrom SM, 2000, EPISODES, V23, P102; Bergstrom SM, 1973, ATLAS PALAEOBIGEOGRA, P45; BERGSTROM SM, 1998, P 6 INT GRAPT C GWG, V23, P148; Butlin RK, 2000, HYDROBIOLOGIA, V419, P1, DOI 10.1023/A:1003925705735; Cocks LRM, 2011, EARTH-SCI REV, V106, P1, DOI 10.1016/j.earscirev.2011.01.007; COCKS LRM, 1990, GEO SOC MEM, V12, P97, DOI 10.1144/GSL.MEM.1990.012.01.08; Cocks LRM, 2005, EARTH-SCI REV, V72, P39, DOI 10.1016/j.earscirev.2005.04.001; COOPER RA, 1991, LETHAIA, V24, P199, DOI 10.1111/j.1502-3931.1991.tb01468.x; Copeland M. J., 1965, Bulletin Geological Survey of Canada, V127, P1; Copeland M.J., 1977, Bulletin geol Surv Can, VNo. 269, P77; Copeland M.J., 1982, B GEOL SURV CAN, P1; Copeland MJ, 2000, B GEOLOGICAL SURVEY, V557, P217; Cronin T.M., 1988, Developments in Palaeontology and Stratigraphy, V11, P871; CRONIN TM, 1990, MAR MICROPALEONTOL, V16, P117, DOI 10.1016/0377-8398(90)90032-H; CRONIN TM, 1993, PALEOCEANOGRAPHY, V8, P161, DOI 10.1029/93PA00060; CRONIN TM, 1985, SCIENCE, V227, P60, DOI 10.1126/science.227.4682.60; Cronin TM, 1988, CAUSES EVOLUTION PAL, P210; Dowsett HJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P459; Dowsett H, 2010, STRATIGRAPHY, V7, P123; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Floyd JD, 1999, SCOT J GEOL, V35, P15, DOI 10.1144/sjg35010015; Fortey RA, 2003, EARTH-SCI REV, V61, P245, DOI 10.1016/S0012-8252(02)00115-0; Hansen J, 2010, B GEOSCI, V85, P497, DOI 10.3140/bull.geosci.1178; Harper DAT, 2008, EARTH ENV SCI T R SO, V98, P281, DOI 10.1017/S1755691007078450; Harris R. W., 1957, Bulletin of the Oklahoma Geological Survey, V75, P1; Harris R.W., 1931, OKLAHOMA GEOLOGICAL; Hart MB, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P235; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Ingham JK, 2000, GEOL SOC SPEC REPORT, P43; Jones TR, 1858, ANN MAGAZINE NATUR 3, V1, P241; Jongman RHG, 1995, DATA ANAL COMMUNITY; Salas MJ, 2007, J PALEONTOL, V81, P1384, DOI 10.1666/05-134.1; KAY G. MARSHALL, 1934, JOUR PALEONTOL, V8, P328; KAY G. MARSHALL, 1940, JOUR PALEONTOL, V14, P234; KESLING ROBERT V., 1960, CONTR MUS PALEONTOL UNIV MICHIGAN, V15, P349; KESLING ROBERT V., 1960, CONTR MUS PALEONTOL UNIV MICHIGAN, V15, P365; Kraft JC, 1962, MEMOIR GEOLOGICAL SO, V86; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; LEVINSON STUART A., 1961, MICROPALEONTOLOGY, V7, P359, DOI 10.2307/1484369; Liebau A, 2005, HYDROBIOLOGIA, V538, P115, DOI 10.1007/s10750-004-4943-7; Longman M.W., 1982, University of Kansas Paleontological Contributions Monograph, V1, P17; Loydell DK, 2012, GEOL MAG, V149, P124, DOI 10.1017/S0016756811000513; Meidla T, BIOGEOGRAPH IN PRESS; Meidla T, 1993, NEUES JB GEOLOGIE PA, V188, P289; Mohibullah M, 2010, GEOL MAG, V147, P919, DOI 10.1017/S0016756810000385; Mohibullah M, 2011, SCOT J GEOL, V47, P57, DOI 10.1144/0036-9276/01-428; Neckaja A.I, 1966, VSESOYUZNOGO NEFTYAN, V251, P1; Norford B. S, 1981, INT UNION GEOLOGICAL; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; POKORNY V., 1978, INTRO MARINE MICROPA, P109; POTTER AW, 1992, GLOBAL PERSPECTIVES ON ORDOVICIAN GEOLOGY, P307; Pour MG, 2011, ALCHERINGA, V35, P517, DOI 10.1080/03115518.2011.538909; Pruss SB, 2010, PALAIOS, V25, P73, DOI 10.2110/palo.2009.p09-101r; ROSS RJ, 1982, INT UNION GEOLOGICAL, V12; SCHALLREUTER REL, 1985, PALAEONTOLOGY, V28, P577; Schellenberg SA., 2007, ENCY QUATERNARY SCI, P2046, DOI [10.1016/B0-444-52747-8/00249-0, DOI 10.1016/B0-444-52747-8/00249-0]; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Siveter DJ, 2009, MICROPALEAEONTOLOGIC, P15; Siveter DJ, 1991, J MICROPALAEONTOL, V10, P51; Steusloff A., 1895, Z DTSCH GEOLOGISCHEN, V46, P775; SWAIN FM, 1962, J PALEONTOL, V36, P719; Swain FM, 1996, GEOL SOC SPEC PUBL, V102, P97, DOI 10.1144/GSL.SP.1996.001.01.07; SWAIN FM, 1961, J PALEONTOL, V35, P345; SWAIN FM, 1957, J PALEONTOL, V31, P528; Teichert C, 1937, ORDOVICIAN SILURIAN; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Tinn O, 2004, PALAEONTOLOGY, V47, P199, DOI 10.1111/j.0031-0239.2004.00369.x; TUCKEY ME, 1990, PALAEOGEOGR PALAEOCL, V77, P91, DOI 10.1016/0031-0182(90)90128-T; uLRICH E.O., 1894, MINNESOTA GEOLOGICAL, V3, P629, DOI [DOI 10.5962/BHL.TITLE.57281, 10.5962/bhl.title.57281]; Ulrich EO, 1889, CONTRIBUTIONS MICR 2, P48; Vandenbroucke TRA, 2010, P NATL ACAD SCI USA, V107, P14983, DOI 10.1073/pnas.1003220107; Vandenbroucke TRA, 2010, PALAEOGEOGR PALAEOCL, V294, P202, DOI 10.1016/j.palaeo.2009.11.026; Vandenbroucke TRA, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/0008PA001720; VANNIER JMC, 1989, PALAEONTOLOGY, V32, P163; WARsHAuER s.M., 1982, GEOLOGICAL SURVEY PR, DOI [10.3133/pp1066H, DOI 10.3133/PP1066H]; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Whately R.C., 1988, Developments in Palaeontology and Stratigraphy, V11, P1021; Williams M, 2004, SCOT J GEOL, V40, P97, DOI 10.1144/sjg40020097; Williams M, 2003, PALAEOGEOGR PALAEOCL, V195, P193, DOI 10.1016/S0031-0182(03)00308-0; Williams M, 2001, T ROY SOC EDIN-EARTH, V91, P499; Williams M, 2000, SCOT J GEOL, V36, P51, DOI 10.1144/sjg36010051; Williams M, 1996, J MICROPALAEONTOL, V15, P69, DOI 10.1144/jm.15.1.69; Williams M, 2001, GEOL MAG, V138, P589, DOI 10.1017/S0016756801005726; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11; Wood A.M., 1994, Holocene, V4, P174, DOI 10.1177/095968369400400207; Zalasiewicz JA, 2009, GEOL MAG, V146, P785, DOI 10.1017/S0016756809990434; Zhen YY, 2003, LETHAIA, V36, P357, DOI 10.1080/00241160310006402	96	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41682	10.1371/journal.pone.0041682	http://dx.doi.org/10.1371/journal.pone.0041682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900000	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900015
J	Rybakin, V; Gascoigne, NRJ				Rybakin, Vasily; Gascoigne, Nicholas R. J.			Negative Selection Assay Based on Stimulation of T Cell Receptor Transgenic Thymocytes with Peptide-MHC Tetramers	PLOS ONE			English	Article							POSITIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; FLOW-CYTOMETRY; APOPTOSIS; DEATH; THYMUS; REQUIREMENT; PATHWAYS; CULTURE; BINDING	Thymocyte negative selection is a requirement for the development of self tolerance. Although it is possible to assay the induction of cell death in thymocytes in vitro using antibody cross-linking, this stimulus is much stronger than the normal range of T cell receptor ligands that could be encountered during normal development. Signaling in thymocytes is finely balanced between positive and negative selection stimuli, where a negative selecting ligand can be only marginally higher affinity than a positive selecting ligand. We have therefore developed an assay for the induction of negative selection that can distinguish such cases, and that is amenable to high-throughput analysis. The assay is based on the induction of activated caspase 3 in thymocytes expressing a defined T cell receptor, after stimulation with MHC-peptide tetramers in vitro for 24 hours or less.	[Rybakin, Vasily; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Rybakin, V (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	vrybakin@scripps.edu; ngascoigne@scripps.edu	Rybakin, Vasily/J-6310-2019	Rybakin, Vasily/0000-0002-5093-1757	National Institutes of Health [AI073870, AI074074, GM065230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074074, R01AI073870, R56AI073870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI073870, AI074074 and GM065230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 1997, J EXP MED, V186, P1503, DOI 10.1084/jem.186.9.1503; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anderson G., 2007, CSH PROTOC; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Bogojevic D, 2012, LAB CHIP, V12, P627, DOI 10.1039/c2lc20893h; Brunelle JK, 2010, DRUG RESIST UPDATE, V13, P172, DOI 10.1016/j.drup.2010.09.001; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Einarsdottir T, 2009, INFECT IMMUN, V77, P4621, DOI 10.1128/IAI.00415-09; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; Garza AS, 2009, LEUKEMIA RES, V33, P717, DOI 10.1016/j.leukres.2008.10.006; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jiang D, 1999, CELL DEATH DIFFER, V6, P402, DOI 10.1038/sj.cdd.4400513; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Le Meur N, 2007, CYTOM PART A, V71A, P393, DOI 10.1002/cyto.a.20396; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Murakami K, 2010, EUR J IMMUNOL, V40, P3372, DOI 10.1002/eji.201040475; Ohta T, 1997, J BIOL CHEM, V272, P23111, DOI 10.1074/jbc.272.37.23111; PAGE DM, 1993, J IMMUNOL, V151, P1868; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43191	10.1371/journal.pone.0043191	http://dx.doi.org/10.1371/journal.pone.0043191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900100	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900118
J	Kutay, H; Klepper, C; Wang, B; Hsu, SH; Datta, J; Yu, LB; Zhang, XL; Majumder, S; Motiwala, T; Khan, N; Belury, M; McClain, C; Jacob, S; Ghoshal, K				Kutay, Huban; Klepper, Corie; Wang, Bo; Hsu, Shu-hao; Datta, Jharna; Yu, Lianbo; Zhang, Xiaoli; Majumder, Sarmila; Motiwala, Tasneem; Khan, Nuzhat; Belury, Martha; McClain, Craig; Jacob, Samson; Ghoshal, Kalpana			Reduced Susceptibility of DNA Methyltransferase 1 Hypomorphic (Dnmt1(N/+)) Mice to Hepatic Steatosis upon Feeding Liquid Alcohol Diet	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; MOLECULAR-MECHANISMS; FATTY LIVER; METHYLATION; CANCER; HYPOMETHYLATION; DNMT3B; SUPPRESSION	Background: Methylation at C-5 (5-mdC) of CpG base pairs, the most abundant epigenetic modification of DNA, is catalyzed by 3 essential DNA methyltransferases (Dnmt1, Dnmt3a and Dnmt3b). Aberrations in DNA methylation and Dnmts are linked to different diseases including cancer. However, their role in alcoholic liver disease (ALD) has not been elucidated. Methodology/Principal Findings: Dnmt1 wild type (Dnmt1(+/+)) and hypomorphic (Dnmt1(N/+)) male mice that express reduced level of Dnmt1 were fed Lieber-DeCarli liquid diet containing ethanol for 6 weeks. Control mice were pair-fed calorie-matched alcohol-free liquid diet, and Dnmtase activity, 5-mdC content, gene expression profile and liver histopathology were evaluated. Ethanol feeding caused pronounced decrease in hepatic Dnmtase activity in Dnmt1(+/+) mice due to decrease in Dnmt1 and Dnmt3b protein levels and upregulation of miR-148 and miR-152 that target both Dnmt1 and Dnmt3b. Microarray and qPCR analysis showed that the genes involved in lipid, xenobiotic and glutathione metabolism, mitochondrial function and cell proliferation were dysregulated in the wild type mice fed alcohol. Surprisingly, Dnmt1(N/+) mice were less susceptible to alcoholic steatosis compared to Dnmt1(+/+) mice. Expression of several key genes involved in alcohol (Aldh3b1), lipid (Ppara, Lepr, Vldlr, Agpat9) and xenobiotic (Cyp39a1) metabolism, and oxidative stress (Mt-1, Fmo3) were significantly (P<0.05) altered in Dnmt1(N/+) mice relative to the wild type mice fed alcohol diet. However, CpG islands encompassing the promoter regions of Agpat9, Lepr, Mt1 and Ppara were methylation-free in both genotypes irrespective of the diet, suggesting that promoter methylation does not regulate their expression. Similarly, 5-mdC content of the liver genome, as measured by LC-MS/MS analysis, was not affected by alcohol diet in the wild type or hypomorphic mice. Conclusions/Significance: Although feeding alcohol diet reduced Dnmtase activity, the loss of one copy of Dnmt1 protected mice from alcoholic hepatosteatosis by dysregulating genes involved in lipid metabolism and oxidative stress.	[Kutay, Huban; Wang, Bo; Hsu, Shu-hao; Majumder, Sarmila; Motiwala, Tasneem; Jacob, Samson; Ghoshal, Kalpana] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Klepper, Corie; Wang, Bo; Hsu, Shu-hao; Datta, Jharna; Khan, Nuzhat; Jacob, Samson] Ohio State Univ, Coll Med, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wang, Bo; Hsu, Shu-hao] Ohio State Univ, Coll Med, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Yu, Lianbo; Zhang, Xiaoli] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Belury, Martha] Ohio State Univ, Coll Med, Dept Nutr, Columbus, OH 43210 USA; [McClain, Craig] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex Louisville VAMC, Louisville, KY USA; [Jacob, Samson] Ohio State Univ, Coll Med, Expt Therapeut Program, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Louisville; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kutay, H (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	samson.jacob@osumc.edu; kalpana.ghoshal@osumc.edu	Motiwala, Tasneem/AAB-9067-2021; yu, lianbo/B-3472-2010	HSU, SHU-HAO/0000-0002-9444-4192; Wang, Bo/0000-0001-9234-035X	National Institutes of Health [AA016677, CA086978, DK088076]; Pelotonia predoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA086978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pelotonia predoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by grants AA016677, CA086978 and DK088076 from the National Institutes of Health. Bo Wang was supported, in part, by a Pelotonia predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Eads CA, 2002, CANCER RES, V62, P1296; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Irizarry MC, 2003, ANN NEUROL, V54, P7, DOI 10.1002/ana.10642; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kinney SRM, 2010, MOL CELL BIOL, V30, P4159, DOI 10.1128/MCB.00235-10; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Liu Z, 2009, ANAL BIOCHEM, V391, P106, DOI 10.1016/j.ab.2009.05.012; Majumder S, 2002, J BIOL CHEM, V277, P16048, DOI 10.1074/jbc.M111662200; Majumder S, 2006, J BIOL CHEM; McClain C, 2005, ALCOHOL CLIN EXP RES, V29, p180S, DOI 10.1097/01.alc.0000189276.34230.f5; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Okiyama W, 2009, J HEPATOL, V50, P1236, DOI 10.1016/j.jhep.2009.01.025; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Purohit V, 2007, AM J CLIN NUTR, V86, P14, DOI 10.1093/ajcn/86.1.14; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang B, 2009, HEPATOLOGY IN PRESS; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41949	10.1371/journal.pone.0041949	http://dx.doi.org/10.1371/journal.pone.0041949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905112	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100022
J	Chuang, CC; Hsiao, CH; Tan, HY; Ma, DHK; Lin, KK; Chang, CJ; Huang, YC				Chuang, Chih-Chun; Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo; Chang, Chee-Jen; Huang, Yhu-Chering			Staphylococcus aureus Ocular Infection: Methicillin-Resistance, Clinical Features, and Antibiotic Susceptibilities	PLOS ONE			English	Article							UNITED-STATES; ANTIMICROBIAL SUSCEPTIBILITY; REFRACTIVE SURGERY; NORTHERN TAIWAN; KERATITIS; SURVEILLANCE; BACTEREMIA; VANCOMYCIN; EYE; CONJUNCTIVITIS	Background: Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important public health issue. The study aimed to determine the prevalence of ocular infections caused by MRSA and to identify the clinical characteristics and antibiotic susceptibility of ocular MRSA infections by comparing those of ocular methicillin-sensitive S. aureus (MSSA) infections. Methodology/Principal Findings: The medical records of the patients (n = 519) with culture-proven S. aureus ocular infections seen between January 1, 1999 and December 31, 2008 in Chang Gung Memorial Hospital were retrospectively reviewed. Two hundred and seventy-four patients with MRSA and 245 with MSSA ocular infections were identified. The average rate of MRSA in S. aureus infections was 52.8% and the trend was stable over the ten years (P value for trend = 0.228). MRSA ocular infections were significantly more common among the patients with healthcare exposure (P = 0.024), but 66.1% (181/274) patients with MRSA ocular infections had no healthcare exposure. The most common clinical presentation for both MRSA and MSSA ocular infections was keratitis; MRSA and MSSA caused a similar disease spectrum except for lid infections. MRSA was significantly more resistant than MSSA to clindamycin, erythromycin and sulfamethoxazole/trimethoprim (all P < 0.001). Conclusions/significance: We demonstrated a paralleled trend of ocular MRSA infection in a highly prevalent MRSA country by hospital-based survey. Except for lid disorder, MRSA shared similar spectrum of ocular pathology with MSSA. Since S. aureus is a common ocular pathogen, our results raise clinician's attention to the existence of highly prevalent MRSA.	[Chuang, Chih-Chun; Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chuang, Chih-Chun] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chuang, Chih-Chun] Yuan Sheng Hosp, Dept Ophthalmol, Changhua, Taiwan; [Hsiao, Ching-Hsi; Tan, Hsin-Yuan; Ma, David Hui-Kang; Lin, Ken-Kuo; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Dept Pediat, Linkou, Taiwan	Chang Gung Memorial Hospital; Changhua Christian Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chuang, CC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	ychuang@adm.cgmh.org.tw		Chang, Chee Jen/0000-0002-7725-7555	Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG381511]	Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This work was supported in part by Chang Gung Memorial Hospital, Linkou, Taiwan, grant number CMRPG381511. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo A, 2011, GRAEF ARCH CLIN EXP, V249, P111, DOI 10.1007/s00417-010-1426-6; Asbell PA, 2008, AM J OPHTHALMOL, V145, P951, DOI 10.1016/j.ajo.2008.01.025; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Blomquist Preston Howard, 2006, Trans Am Ophthalmol Soc, V104, P322; Broekema NM, 2009, J CLIN MICROBIOL, V47, P217, DOI 10.1128/JCM.01506-08; Cavuoto K, 2008, OPHTHALMOLOGY, V115, P51, DOI 10.1016/j.ophtha.2007.03.076; Center for Disease Control (CDC), 1995, AM J HEALTH-SYST PH, V52, P1272; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Chen FJ, 2009, DIAGN MICR INFEC DIS, V65, P351, DOI 10.1016/j.diagmicrobio.2009.07.024; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Deramo VA, 2008, AM J OPHTHALMOL, V145, P413, DOI 10.1016/j.ajo.2007.10.020; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Donnenfeld ED, 2003, OPHTHALMOLOGY, V110, P743, DOI 10.1016/S0161-6420(02)01936-X; Force A-CT, 1999, QUAL CAR PUBL, V515; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Fukuda M, 2002, CORNEA, V21, pS86, DOI 10.1097/01.ico.0000263125.99262.42; Gordon YJ, 2001, AM J OPHTHALMOL, V131, P371, DOI 10.1016/S0002-9394(00)00955-7; Haas W, 2011, AM J OPHTHALMOL, V152, P567, DOI 10.1016/j.ajo.2011.03.010; Hawser SP, 2011, INT J ANTIMICROB AG, V37, P219, DOI 10.1016/j.ijantimicag.2010.10.029; Hsiao CH, 2012, OPHTHALMOLOGY, V119, P522, DOI 10.1016/j.ophtha.2011.08.038; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Kotlus BS, 2006, AM J OPHTHALMOL, V142, P726, DOI 10.1016/j.ajo.2006.06.030; Kotlus BS, 2005, OPHTHAL PLAST RECONS, V21, P371, DOI 10.1097/01.iop.0000175035.22953.71; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; Marangon FB, 2004, AM J OPHTHALMOL, V137, P453, DOI 10.1016/j.ajo.2003.10.026; McDonald LC, 2004, INT J ANTIMICROB AG, V23, P362, DOI 10.1016/j.ijantimicag.2003.09.021; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Rutar T, 2006, OPHTHALMOLOGY, V113, P1455, DOI 10.1016/j.ophtha.2006.03.031; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Skiest DJ, 2007, J INFECTION, V54, P427, DOI 10.1016/j.jinf.2006.09.012; Solomon R, 2007, AM J OPHTHALMOL, V143, P629, DOI 10.1016/j.ajo.2006.12.029; Solomon R, 2011, J CATARACT REFR SURG, V37, P1343, DOI 10.1016/j.jcrs.2011.05.006; Sotozono C, 2002, CORNEA, V21, pS94, DOI 10.1097/01.ico.0000263127.84015.3f; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	43	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42437	10.1371/journal.pone.0042437	http://dx.doi.org/10.1371/journal.pone.0042437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880135	gold, Green Submitted, Green Published			2022-12-25	WOS:000307437900040
J	Sun, Z; Tian, WD				Sun, Zheng; Tian, Weidong			SAP-A Sequence Mapping and Analyzing Program for Long Sequence Reads Alignment and Accurate Variants Discovery	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; ULTRAFAST; TOOL; DNA	The third-generation of sequencing technologies produces sequence reads of 1000 bp or more that may contain high polymorphism information. However, most currently available sequence analysis tools are developed specifically for analyzing short sequence reads. While the traditional Smith-Waterman (SW) algorithm can be used to map long sequence reads, its naive implementation is computationally infeasible. We have developed a new Sequence mapping and Analyzing Program (SAP) that implements a modified version of SW to speed up the alignment process. In benchmarks with simulated and real exon sequencing data and a real E. coli genome sequence data generated by the third-generation sequencing technologies, SAP outperforms currently available tools for mapping short and long sequence reads in both speed and proportion of captured reads. In addition, it achieves high accuracy in detecting SNPs and InDels in the simulated data. SAP is available at https://github.com/davidsun/SAP.	[Sun, Zheng; Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Sun, Z (corresponding author), Fudan Univ, Sch Life Sci, Inst Biostat, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn			National Basic Research Program of China [2012CB316505, 2010CB529505]; National Natural Science Foundation of China [30971643, 31071113]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Basic Research Program of China (Grant No. 2012CB316505, 2010CB529505), and the National Natural Science Foundation of China (Grant No. 30971643, 31071113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrows M., 1994, BLOCK SORTING LOSSLE; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lam TW, 2008, BIOINFORMATICS, V24, P791, DOI 10.1093/bioinformatics/btn032; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248	16	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42887	10.1371/journal.pone.0042887	http://dx.doi.org/10.1371/journal.pone.0042887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880129	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900059
J	Leen, WG; Willemsen, MA; Wevers, RA; Verbeek, MM				Leen, Wilhelmina G.; Willemsen, Michel A.; Wevers, Ron A.; Verbeek, Marcel M.			Cerebrospinal Fluid Glucose and Lactate: Age-Specific Reference Values and Implications for Clinical Practice	PLOS ONE			English	Article							PROTEIN-CONCENTRATION; BACTERIAL-MENINGITIS; CHILDREN; GLUT1; DEFICIENCY; DISORDERS; MUTATIONS; INFANTS; RATIO	Cerebrospinal fluid (CSF) analysis is an important tool in the diagnostic work-up of many neurological disorders, but reference ranges for CSF glucose, CSF/plasma glucose ratio and CSF lactate based on studies with large numbers of CSF samples are not available. Our aim was to define age-specific reference values. In 1993 The Nijmegen Observational CSF Study was started. Results of all CSF samples that were analyzed between 1993 and 2008 at our laboratory were systematically collected and stored in our computerized database. After exclusion of CSF samples with an unknown or elevated erythrocyte count, an elevated leucocyte count, elevated concentrations of bilirubin, free hemoglobin, or total protein 9,036 CSF samples were further studied for CSF glucose (n = 8,871), CSF/plasma glucose ratio (n = 4,516) and CSF lactate values (n = 7,614). CSF glucose, CSF/plasma glucose ratio and CSF lactate were age-, but not sex dependent. Age-specific reference ranges were defined as 5-95th percentile ranges. CSF glucose 5th percentile values ranged from 1.8 to 2.9 mmol/L and 95th percentile values from 3.8 to 5.6 mmol/L. CSF/plasma glucose ratio 5th percentile values ranged from 0.41 to 0.53 and 95th percentile values from 0.82 to 1.19. CSF lactate 5th percentile values ranged from 0.88 to 1.41 mmol/L and 95th percentile values from 2.00 to 2.71 mmol/L. Reference ranges for all three parameters were widest in neonates and narrowest in toddlers, with lower and upper limits increasing with age. These reference values allow a reliable interpretation of CSF results in everyday clinical practice. Furthermore, hypoglycemia was associated with an increased CSF/plasma glucose ratio, whereas hyperglycemia did not affect the CSF/plasma glucose ratio.	[Leen, Wilhelmina G.; Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands; [Willemsen, Michel A.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Wevers, Ron A.; Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Leen, WG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands.	w.leen@neuro.umcn.nl	Wevers, Ron A./H-8116-2014; Verbeek, Marcel M/D-1971-2010; Willemsen, Michel A.A.P./H-8119-2014	Wevers, Ron A./0000-0003-2278-9746; Verbeek, Marcel M/0000-0003-4635-7876; 	Netherlands Organization for Scientific Research (NWO) [92003529]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	W. G. Leen was supported by The Netherlands Organization for Scientific Research (Project number 92003529; NWO; www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1996, PEDIATR INFECT DIS J, V15, P298, DOI 10.1097/00006454-199604000-00004; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Benoist JF, 2003, CLIN CHEM, V49, P487, DOI 10.1373/49.3.487; Biou D, 2000, CLIN CHEM, V46, P399; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P589, DOI 10.1097/00006454-199207000-00015; Bruna J, 2009, CANCER-AM CANCER SOC, V115, P381, DOI 10.1002/cncr.24041; CALABRESE VP, 1991, EPILEPSIA, V32, P816, DOI 10.1111/j.1528-1157.1991.tb05538.x; CAMERON PD, 1993, J INFECTION, V26, P245, DOI 10.1016/0163-4453(93)95253-F; Chow SL, 2005, ARCH DIS CHILD, V90, P1188, DOI 10.1136/adc.2005.075317; Dohnal L, 2010, Prague Med Rep, V111, P42; Fernandez F, 1986, Pediatr Neurol, V2, P39, DOI 10.1016/0887-8994(86)90038-X; Fishman RA., 1992, CEREBROSPINAL FLUID; FISHMAN ROBERT A., 1963, TRANS AMER NEUROL ASSOC, V88, P114; HEMACHANDRA AH, 1999, PEDIAT REV, V20, P16, DOI DOI 10.1542/PIR.20-7-E16; Hoffmann GF, 1998, NEUROPEDIATRICS, V29, P59, DOI 10.1055/s-2007-973538; Holbrook I, 2007, ANN CLIN BIOCHEM, V44, P443, DOI 10.1258/000456307781646085; Hume R, 2005, EARLY HUM DEV, V81, P95, DOI 10.1016/j.earlhumdev.2004.10.005; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; LAMERS KJB, 1987, CLIN CHIM ACTA, V167, P135, DOI 10.1016/0009-8981(87)90366-4; Leen WG, 2010, BRAIN, V133, P655, DOI 10.1093/brain/awp336; Mullen SA, 2010, NEUROLOGY, V75, P432, DOI 10.1212/WNL.0b013e3181eb58b4; POWERS WJ, 1981, AM J MED, V71, P217, DOI 10.1016/0002-9343(81)90108-X; Shah SS, 2011, J HOSP MED, V6, P22, DOI 10.1002/jhm.711; Smith S V, 1994, Clin Lab Sci, V7, P32; Straus SE, 2006, JAMA-J AM MED ASSOC, V296, P2012, DOI 10.1001/jama.296.16.2012; Suls A, 2008, BRAIN, V131, P1831, DOI 10.1093/brain/awn113; Vamosi B, 1983, Arch Psychiatr Nervenkr (1970), V232, P521; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Willemsen MAAP, 2001, ANN NEUROL, V49, P685, DOI 10.1002/ana.1044.abs; Wong M, 2000, ARCH PEDIAT ADOL MED, V154, P827, DOI 10.1001/archpedi.154.8.827	30	83	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42745	10.1371/journal.pone.0042745	http://dx.doi.org/10.1371/journal.pone.0042745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880096	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000066
J	Ochi, N; Hotta, K; Takigawa, N; Oze, I; Fujiwara, Y; Ichihara, E; Hisamoto, A; Tabata, M; Tanimoto, M; Kiura, K				Ochi, Nobuaki; Hotta, Katsuyuki; Takigawa, Nagio; Oze, Isao; Fujiwara, Yoshiro; Ichihara, Eiki; Hisamoto, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki			Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INDUCED FEBRILE NEUTROPENIA; THORACIC RADIOTHERAPY; CHEMOTHERAPY; SURVIVAL; METAANALYSIS; CYCLOPHOSPHAMIDE; DOXORUBICIN; CISPLATIN; ETOPOSIDE	Introduction: Treatment-related death (TRD) remains a serious problem in small-cell lung cancer (SCLC), despite recent improvements in supportive care. However, few studies have formally assessed time trends in the proportion of TRD over the past two decades. The aim of this study was to determine the frequency and pattern of TRD over time. Methods: We examined phase 3 trials conducted between 1990 and 2010 to address the role of systemic treatment for SCLC. The time trend was assessed using linear regression analysis. Results: In total, 97 trials including nearly 25,000 enrolled patients were analyzed. The overall TRD proportion was 2.95%. Regarding the time trend, while it was not statistically significant, it tended to decrease, with a 0.138% decrease per year and 2.76% decrease per two decades. The most common cause of death was febrile neutropenia without any significant time trend in its incidence over the years examined (p = 0.139). However, deaths due to febrile neutropenia as well as all causes in patients treated with non-platinum chemotherapy increased significantly (p = 0.033). Conclusions: The overall TRD rate has been low, but not negligible, in phase III trials for SCLC over the past two decades.	[Ochi, Nobuaki; Hotta, Katsuyuki; Takigawa, Nagio; Oze, Isao; Fujiwara, Yoshiro; Ichihara, Eiki; Hisamoto, Akiko; Tabata, Masahiro; Tanimoto, Mitsune; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Resp Med, Okayama, Japan; [Ochi, Nobuaki; Takigawa, Nagio] Kawasaki Hosp, Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan	Okayama University; Kawasaki Medical School	Ochi, N (corresponding author), Okayama Univ Hosp, Dept Resp Med, Okayama, Japan.	khotta@md.okayama-u.ac.jp	Oze, Isao/E-8288-2018; KIURA, Katsuyuki/B-1991-2011	Oze, Isao/0000-0002-0762-1147; Kiura, Katsuyuki/0000-0002-9172-9379				Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Clark OAC, 2005, J CLIN ONCOL, V23, P4198, DOI 10.1200/JCO.2005.05.645; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; Fujiwara Y, 2011, ANN ONCOL, V22, P376, DOI 10.1093/annonc/mdq360; GOODMAN GE, 1990, J CLIN ONCOL, V8, P39, DOI 10.1200/JCO.1990.8.1.39; GREEN RA, 1969, AM J MED, V46, P516, DOI 10.1016/0002-9343(69)90071-0; Hanna N, 2006, J CLIN ONCOL, V24, P2038, DOI 10.1200/JCO.2005.04.8595; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Hotta K, 2004, J CLIN ONCOL, V22, P3860, DOI 10.1200/JCO.2004.01.153; Hotta K, 2009, ANN ONCOL, V20, P829, DOI 10.1093/annonc/mdp020; Hotta K, 2004, ANN ONCOL, V15, P1782, DOI 10.1093/annonc/mdh476; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Hotta K, 2007, CANCER-AM CANCER SOC, V109, P939, DOI 10.1002/cncr.22478; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Lebeau B, 1999, CANCER-AM CANCER SOC, V86, P1480, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1480::AID-CNCR14>3.0.CO;2-O; Murray N, 1999, J CLIN ONCOL, V17, P2300, DOI 10.1200/JCO.1999.17.8.2300; Noda W, 2002, NEW ENGL J MED, V346, P85, DOI 10.1056/NEJMoa003034; Ohe Y, 2001, EUR J CANCER, V37, P54, DOI 10.1016/S0959-8049(00)00350-6; Oze I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007835; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Thatcher N, 2000, J CLIN ONCOL, V18, P395, DOI 10.1200/JCO.2000.18.2.395; Timmer-Bonte JN, 2005, J CLIN ONCOL, V23, P7974, DOI 10.1200/JCO.2004.00.7955; Urban T, 1999, CANCER-AM CANCER SOC, V86, P2238, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2238::AID-CNCR10>3.3.CO;2-7; Urban T, 1999, LUNG CANCER-J IASLC, V25, P105, DOI 10.1016/S0169-5002(99)00050-1	29	12	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42798	10.1371/journal.pone.0042798	http://dx.doi.org/10.1371/journal.pone.0042798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880112	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000072
J	Qu, ZP; Adelson, DL				Qu, Zhipeng; Adelson, David L.			Bovine ncRNAs Are Abundant, Primarily Intergenic, Conserved and Associated with Regulatory Genes	PLOS ONE			English	Article							NONCODING RNAS; SEQUENCE; EXPRESSION; REVEALS; GENOME; TRANSCRIPTS; IDENTIFICATION; COMPLEXITY; ENRICHMENT; EVOLUTION	It is apparent that non-coding transcripts are a common feature of higher organisms and encode uncharacterized layers of genetic regulation and information. We used public bovine EST data from many developmental stages and tissues, and developed a pipeline for the genome wide identification and annotation of non-coding RNAs (ncRNAs). We have predicted 23,060 bovine ncRNAs, 99% of which are un-annotated, based on known ncRNA databases. Intergenic transcripts accounted for the majority (57%) of the predicted ncRNAs and the occurrence of ncRNAs and genes were only moderately correlated (r = 0.55, p-value<2.2e-16). Many of these intergenic non-coding RNAs mapped close to the 3' or 5' end of thousands of genes and many of these were transcribed from the opposite strand with respect to the closest gene, particularly regulatory-related genes. Conservation analyses showed that these ncRNAs were evolutionarily conserved, and many intergenic ncRNAs proximate to genes contained sequence-specific motifs. Correlation analysis of expression between these intergenic ncRNAs and protein-coding genes using RNA-seq data from a variety of tissues showed significant correlations with many transcripts. These results support the hypothesis that ncRNAs are common, transcribed in a regulated fashion and have regulatory functions.	[Qu, Zhipeng; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Qu, ZP (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Qu, Zhipeng/0000-0002-6841-0773	University of Adelaide; China Scholarship Council (CSC)	University of Adelaide; China Scholarship Council (CSC)(China Scholarship Council)	This study was funded by the University of Adelaide. ZQ thanks the China Scholarship Council (CSC) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Freyhult EK, 2007, GENOME RES, V17, P117, DOI 10.1101/gr.5890907; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2005, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1205s9; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Hancock JM, 2005, TRENDS GENET, V21, P591, DOI 10.1016/j.tig.2005.08.008; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mourier T, 2009, BRIEF FUNCT GENOMIC; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Rearick D, 2011, NUCL ACIDS RES; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Seemann SE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-316; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xue CH, 2008, CELL RES, V18, P695, DOI 10.1038/cr.2008.59	57	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42638	10.1371/journal.pone.0042638	http://dx.doi.org/10.1371/journal.pone.0042638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880061	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000054
J	Torrent, M; Nogues, MV; Andreu, D; Boix, E				Torrent, Marc; Victoria Nogues, M.; Andreu, David; Boix, Ester			The "CPC Clip Motif": A Conserved Structural Signature for Heparin-Binding Proteins	PLOS ONE			English	Article							C-CHEMOKINE LYMPHOTACTIN; X-RAY-STRUCTURE; GLYCOSAMINOGLYCAN INTERACTIONS; ALZHEIMERS-DISEASE; SULFATE; DOMAIN; IDENTIFICATION; RECOGNITION; PRECURSOR; GROWTH	Glycosaminoglycans (GAGs) are essential molecules that regulate diverse biological processes including cell adhesion, differentiation, signaling and growth, by interaction with a wide variety of proteins. However, despite the efforts committed to understand the molecular nature of the interactions in protein-GAG complexes, the answer to this question remains elusive. In the present study the interphases of 20 heparin-binding proteins have been analyzed searching for a conserved structural pattern. We have found that a structural motif encompassing one polar and two cationic residues (which has been named the CPC clip motif) is conserved among all the proteins deposited in the PDB. The distances between the alpha carbons and the side chain center of gravity of the residues composing this motif are also conserved. Furthermore, this pattern can be found in other proteins suggested to bind heparin for which no structural information is available. Hence we propose that the CPC clip motif, working like a staple, is a primary contributor to the attachment of heparin and other sulfated GAGs to heparin-binding proteins.	[Torrent, Marc; Victoria Nogues, M.; Boix, Ester] Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain; [Torrent, Marc; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Torrent, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain.	marc.torrent@uab.cat	Burgas, Marc Torrent/A-5171-2010; Andreu, David/I-4359-2014; Nogues, M. Victoria/H-6100-2015; Boix, Ester/B-9038-2012	Burgas, Marc Torrent/0000-0001-6567-3474; Andreu, David/0000-0002-6317-6666; Nogues, M. Victoria/0000-0002-7104-0961; Boix, Ester/0000-0003-1790-2142	Alianza Cuatro Universidades (Spain); European Union [HEALTH-F3-2008-223414]; Spanish Ministry of Science and Innovation [BIO2008-04487-CO3-02, BFU2009-09371]; Generalitat de Catalunya [SGR2009-494, SGR2009-795]	Alianza Cuatro Universidades (Spain); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	MT is the recipient of a postdoctoral grant from Alianza Cuatro Universidades (Spain). Work supported by the European Union (HEALTH-F3-2008-223414), the Spanish Ministry of Science and Innovation (BIO2008-04487-CO3-02, BFU2009-09371, FEDER funds) and the Generalitat de Catalunya (SGR2009-494, SGR2009-795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393; BAE JH, 1994, BIOCHEM J, V301, P121, DOI 10.1042/bj3010121; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Casu B, 2004, CURR PHARM DESIGN, V10, P939, DOI 10.2174/1381612043452794; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoover DM, 2000, J BIOL CHEM, V275, P23187, DOI 10.1074/jbc.M002584200; IUIS/WHO, 2001, J LEUKOC BIOL, V70, P465; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kovensky J, 2009, CURR MED CHEM, V16, P2338, DOI 10.2174/092986709788453096; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuloglu ES, 2001, BIOCHEMISTRY-US, V40, P12486, DOI 10.1021/bi011106p; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Madsen D, 2002, J APPL CRYSTALLOGR, V35, P137, DOI 10.1107/S0021889802000602; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Peplow PV, 2005, THROMB HAEMOSTASIS, V94, P4, DOI 10.1160/TH04-12-0812; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; SMALL DH, 1994, J NEUROSCI, V14, P2117; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Volkman BF, 2009, METHOD ENZYMOL, V461, P51, DOI 10.1016/S0076-6879(09)05403-2; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	40	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42692	10.1371/journal.pone.0042692	http://dx.doi.org/10.1371/journal.pone.0042692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880084	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000062
J	Angenieux, C; Waharte, F; Gidon, A; Signorino-Gelo, F; Wurtz, V; Hojeij, R; Proamer, F; Gachet, C; Van Dorsselaer, A; Hanau, D; Salamero, J; de la Salle, H				Angenieux, Catherine; Waharte, Francois; Gidon, Alexandre; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Van Dorsselaer, Alain; Hanau, Daniel; Salamero, Jean; de la Salle, Henri			Lysosomal-Associated Transmembrane Protein 5 (LAPTM5) Is a Molecular Partner of CD1e	PLOS ONE			English	Article							HEMATOPOIETIC-CELLS; MEMBRANE-PROTEIN; DENDRITIC CELLS; EXPRESSION; PATHWAY; DIFFERENTIATION; ACTIVATION; MELANOMA; COMPLEX	The CD1e protein participates in the presentation of lipid antigens in dendritic cells. Its transmembrane precursor is transported to lysosomes where it is cleaved into an active soluble form. In the presence of bafilomycin, which inhibits vacuolar ATPase and consequently the acidification of endosomal compartments, CD1e associates with a 27 kD protein. In this work, we identified this molecular partner as LAPTM5. The latter protein and CD1e colocalize in trans-Golgi and late endosomal compartments. The quantity of LAPTM5/CD1e complexes increases when the cells are treated with bafilomycin, probably due to the protection of LAPTM5 from lysosomal proteases. Moreover, we could demonstrate that LAPTM5/CD1e association occurs under physiological conditions. Although LAPTM5 was previously shown to act as a platform recruiting ubiquitin ligases and facilitating the transport of receptors to lysosomes, we found no evidence that LATPM5 controls either CD1e ubiquitination or the generation of soluble lysosomal CD1e proteins. Notwithstanding these last observations, the interaction of LAPTM5 with CD1e and their colocalization in antigen processing compartments both suggest that LAPTM5 might influence the role of CD1e in the presentation of lipid antigens.	[Angenieux, Catherine; Signorino-Gelo, Francois; Hojeij, Rim; Proamer, Fabienne; Hanau, Daniel; de la Salle, Henri] Inst Natl Sante & Rech Med, Unite Mixte Rech S725, Strasbourg, France; [Angenieux, Catherine; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Hanau, Daniel; de la Salle, Henri] Etab Francais Sang Alsace, Strasbourg, France; [Angenieux, Catherine; Signorino-Gelo, Francois; Wurtz, Virginie; Hojeij, Rim; Proamer, Fabienne; Gachet, Christian; Van Dorsselaer, Alain; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg, Strasbourg, France; [Waharte, Francois; Salamero, Jean] Inst Curie, CNRS, Cell & Tissue Imaging Facil, Unite Mixte Rech 144,Sect Rech, F-75231 Paris, France; [Wurtz, Virginie; Gachet, Christian] Inst Natl Sante & Rech Med, Unite Mixte Rech S949, Strasbourg, France; [Van Dorsselaer, Alain] Ctr Natl Rech Sci, Unite Mixte Rech 7178, F-67037 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Angenieux, C (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech S725, Strasbourg, France.	henri.delasalle@efs-alsace.fr	De La Salle, Henri/H-9353-2016; Gachet, Christian/H-9156-2016; Gidon, Alexandre/ABC-1477-2020; El-Daher, Francois/AAJ-8976-2021	De La Salle, Henri/0000-0001-5136-0776; salamero, jean/0000-0002-2610-5826; El-Daher, Francois/0000-0002-6676-3970; Gidon, Alexandre/0000-0001-9722-1253	Etablissement Franeais du Sang (EFS)-Alsace; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-05-MIME-006, ANR-MICAD-08-Biot-015-01]; Fondation pour la Recherche Medicale; EU [NMP4-SL-2009-228980]; Research and Technology Ministry grant	Etablissement Franeais du Sang (EFS)-Alsace; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EU(European Commission); Research and Technology Ministry grant	This work was supported by the Etablissement Franeais du Sang (EFS)-Alsace, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique and grants from the Agence Nationale de la Recherche (ANR-05-MIME-006; ANR-MICAD-08-Biot-015-01), the Fondation pour la Recherche Medicale (Call Grand Equipement 2008) and the EU funded CAMINEMS project (NMP4-SL-2009-228980). A. G. was a recipient of a Research and Technology Ministry grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Angenieux C, 2005, TRAFFIC, V6, P286, DOI 10.1111/j.1600-0854.2005.00272.x; Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; GUARINI L, 1989, CANCER IMMUNOL IMMUN, V30, P262, DOI 10.1007/BF01744892; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Ishihara T, 2011, J BIOL CHEM, V286, P44086, DOI 10.1074/jbc.M111.251694; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MACKENSEN A, 1993, CANCER RES, V53, P3569; Maitre B, 2008, TRAFFIC, V9, P431, DOI 10.1111/j.1600-0854.2008.00707.x; Maitre B, 2009, BIOCHEM J, V419, P661, DOI 10.1042/BJ20082204; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Origasa M, 2001, MOL BRAIN RES, V88, P1, DOI 10.1016/S0169-328X(01)00005-5; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	24	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42634	10.1371/journal.pone.0042634	http://dx.doi.org/10.1371/journal.pone.0042634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880058	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100145
J	Matsumoto, H; Shibasaki, K; Uchigashima, M; Koizumi, A; Kurachi, M; Moriwaki, Y; Misawa, H; Kawashima, K; Watanabe, M; Kishi, S; Ishizaki, Y				Matsumoto, Hidetaka; Shibasaki, Koji; Uchigashima, Motokazu; Koizumi, Amane; Kurachi, Masashi; Moriwaki, Yasuhiro; Misawa, Hidemi; Kawashima, Koichiro; Watanabe, Masahiko; Kishi, Shoji; Ishizaki, Yasuki			Localization of Acetylcholine-Related Molecules in the Retina: Implication of the Communication from Photoreceptor to Retinal Pigment Epithelium	PLOS ONE			English	Article							AFFINITY CHOLINE TRANSPORTER; CENTRAL-NERVOUS-SYSTEM; RABBIT RETINA; NONNEURONAL ACETYLCHOLINE; CLINICAL-ASPECTS; AMACRINE CELLS; OUTER SEGMENT; RECEPTORS; SLURP-1; IDENTIFICATION	It has been long speculated that specific signals are transmitted from photoreceptors to the retinal pigment epithelium (RPE). However, such signals have not been identified. In this study, we examined the retinal expression and localization of acetylcholine-related molecules as putative candidates for these signals. Previous reports revealed that alpha 7 nicotinic acetylcholine receptors (nAChRs) are present in the microvilli of RPE cells that envelope the tips of photoreceptor outer segments (OS). Secreted mammalian leukocyte antigen 6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) is a positive allosteric modulator of the alpha 7 nAChR. Therefore, we first focused on the expression of SLURP-1. SLURP-1 mRNA was expressed in the outer nuclear layer, which is comprised of photoreceptor cell bodies. SLURP-1 immunoreactivity co-localized with rhodopsin and S-opsin in photoreceptor OS, while choline acetyltransferase (ChAT) and high affinity choline transporter (CHT-1) were also expressed in photoreceptor OS. Immunoelectron microscopy identified that the majority of SLURP-1 was localized to the plasma membranes of photoreceptor OS. These results provide evidence that SLURP-1 is synthesized in photoreceptor cell bodies and transported to photoreceptor OS, where SLURP-1 may also be secreted. Our findings suggest that photoreceptor OS communicate via neurotransmitters such as ACh and SLURP-1, while RPE cells might receive these signals through alpha 7 nAChRs in their microvilli.	[Matsumoto, Hidetaka; Kishi, Shoji] Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma 371, Japan; [Shibasaki, Koji; Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 371, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Koizumi, Amane] Natl Inst Physiol Sci, Sect Correlat Physiol, Okazaki, Aichi 444, Japan; [Moriwaki, Yasuhiro; Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Minato Ku, Tokyo, Japan; [Kawashima, Koichiro] Kitasato Univ, Dept Mol Pharmacol, Sch Pharm, Minato Ku, Tokyo, Japan	Gunma University; Gunma University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Keio University; Kitasato University	Matsumoto, H (corresponding author), Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma 371, Japan.	hide-m@showa.gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; WATANABE, Masahiko/A-4055-2012; Shibasaki, Koji/U-8674-2018; Watanabe, Masahiko/S-3614-2019; Misawa, Hiroaki/A-4312-2012	WATANABE, Masahiko/0000-0001-5037-7138; Shibasaki, Koji/0000-0003-2330-1749; Watanabe, Masahiko/0000-0001-5037-7138; Misawa, Hiroaki/0000-0003-1070-387X; Moriwaki, Yasuhiro/0000-0001-9533-0421; Koizumi, Amane/0000-0003-1177-0185	Uehara Memorial Foundation, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan [21200012, 20399554, 24111507, 23650159]; Sumitomo Foundation	Uehara Memorial Foundation, Tokyo, Japan(Uehara Memorial Foundation); Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation	This work was supported by the Uehara Memorial Foundation, Tokyo, Japan (to YI), by a grant from Takeda Science Foundation, Tokyo, Japan (to YI), by a grant from Grants-in-Aid for Scientific Research (Project. 21200012, 20399554, 24111507 to KS, 23650159 to YI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Sumitomo Foundation (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Bchetnia Mbarka, 2010, J Med Case Rep, V4, P108, DOI 10.1186/1752-1947-4-108; BRANDON C, 1987, BRAIN RES, V401, P385, DOI 10.1016/0006-8993(87)91426-0; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Durmus M, 1999, RETINA-J RET VIT DIS, V19, P247, DOI 10.1097/00006982-199903000-00013; Fischer AJ, 1998, J COMP NEUROL, V392, P273; Fischer J, 2001, HUM MOL GENET, V10, P875, DOI 10.1093/hmg/10.8.875; FRIEDMAN Z, 1988, BRAIN RES, V446, P11, DOI 10.1016/0006-8993(88)91291-7; Fujii T, 2009, J NEUROSCI RES, V87, P3024, DOI 10.1002/jnr.22117; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Horiguchi K, 2009, J NEUROSCI RES, V87, P2740, DOI 10.1002/jnr.22102; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Maneu V, 2010, VISUAL NEUROSCI, V27, P139, DOI 10.1017/S0952523810000246; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P121, DOI 10.1098/rspb.1984.0086; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Matsumoto H, 2008, AM J OPHTHALMOL, V145, P162, DOI 10.1016/j.ajo.2007.08.024; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Misawa H, 2001, NEUROSCIENCE, V105, P87, DOI 10.1016/S0306-4522(01)00147-6; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moritoh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012917; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Narumoto O, 2010, BIOCHEM BIOPH RES CO, V398, P713, DOI 10.1016/j.bbrc.2010.07.006; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; OSBORNE NN, 1991, VISION RES, V31, P1119, DOI 10.1016/0042-6989(91)90038-7; Phan TCA, 2010, J PERIODONTAL RES, V45, P331, DOI 10.1111/j.1600-0765.2009.01240.x; Pons M, 2011, INVEST OPHTH VIS SCI, V52, P3842, DOI 10.1167/iovs.10-6254; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; USDIN TB, 1995, TRENDS NEUROSCI, V18, P218, DOI 10.1016/0166-2236(95)93906-E; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010	42	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42841	10.1371/journal.pone.0042841	http://dx.doi.org/10.1371/journal.pone.0042841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880119	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100175
J	Ozden, I; Dombeck, DA; Hoogland, TM; Tank, DW; Wang, SSH				Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.			Widespread State-Dependent Shifts in Cerebellar Activity in Locomoting Mice	PLOS ONE			English	Article							SINGLE OLIVOCEREBELLAR AXONS; HIPPOCAMPAL PLACE CELLS; COMPLEX SPIKE ACTIVITY; CLIMBING FIBER INPUT; NEURAL ACTIVITY; GRANULE CELLS; CELLULAR RESOLUTION; ANTERIOR LOBE; IN-VIVO; FUNCTIONAL-ORGANIZATION	Excitatory drive enters the cerebellum via mossy fibers, which activate granule cells, and climbing fibers, which activate Purkinje cell dendrites. Until now, the coordinated regulation of these pathways has gone unmonitored in spatially resolved neuronal ensembles, especially in awake animals. We imaged cerebellar activity using functional two-photon microscopy and extracellular recording in awake mice locomoting on an air-cushioned spherical treadmill. We recorded from putative granule cells, molecular layer interneurons, and Purkinje cell dendrites in zone A of lobule IV/V, representing sensation and movement from trunk and limbs. Locomotion was associated with widespread increased activity in granule cells and interneurons, consistent with an increase in mossy fiber drive. At the same time, dendrites of different Purkinje cells showed increased co-activation, reflecting increased synchrony of climbing fiber activity. In resting animals, aversive stimuli triggered increased activity in granule cells and interneurons, as well as increased Purkinje cell co-activation that was strongest for neighboring dendrites and decreased smoothly as a function of mediolateral distance. In contrast with anesthetized recordings, no 1-10 Hz oscillations in climbing fiber activity were evident. Once locomotion began, responses to external stimuli in all three cell types were strongly suppressed. Thus climbing and mossy fiber representations can shift together within a fraction of a second, reflecting in turn either movement-associated activity or external stimuli.	[Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ozden, Ilker; Dombeck, Daniel A.; Hoogland, Tycho M.; Tank, David W.; Wang, Samuel S-H.] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Lewis Sigler Ctr Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Ozden, I (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	sswang@princeton.edu	Ozden, Ilker/AAJ-3856-2020	Dombeck, Daniel/0000-0003-2576-5918; Hoogland, T.M./0000-0002-7444-9279	National Institute of Health [NS045193, NS068148]; Autism Speaks postdoctoral award; Robert Leet and Clara Guthrie Patterson Trust; W.M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148, R01NS045193] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks postdoctoral award; Robert Leet and Clara Guthrie Patterson Trust; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by (1) National Institute of Health grants NS045193 (SW) and NS068148 (DT, SW) http://www.nih.gov (2) Autism Speaks postdoctoral award (IO) http://autismspeaks.org (3) Robert Leet and Clara Guthrie Patterson Trust (DD) https://www.bankofamerica.com/philanthropic/foundation.action?fnId = 106 (4) W.M. Keck Foundation Distinguished Young Investigator (SW). http://wmkeck.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Apps R, 1999, PROG NEUROBIOL, V57, P537, DOI 10.1016/S0301-0082(98)00068-9; Apps R, 2000, PROG BRAIN RES, V124, P201; APPS R, 1995, J PHYSIOL-LONDON, V483, P687, DOI 10.1113/jphysiol.1995.sp020614; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; ARMSTRONG DL, 1987, BRAIN RES BULL, V19, P699, DOI 10.1016/0361-9230(87)90057-8; BELL CC, 1972, J NEUROPHYSIOL, V35, P155, DOI 10.1152/jn.1972.35.2.155; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Bloedel JR, 1998, ANAT REC, V253, P118; BLOEDEL JR, 1984, J PHYSIOL-LONDON, V352, P129, DOI 10.1113/jphysiol.1984.sp015282; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; BUISSERETDELMAS C, 1993, PROG NEUROBIOL, V40, P63, DOI 10.1016/0301-0082(93)90048-W; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Collman FC, 2010, THESIS PRINCETON U, Vvii; Courtemanche R, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.006.2009; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; ECCLES JC, 1968, EXP BRAIN RES, V6, P171, DOI 10.1007/BF00235123; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Gall D, 2005, J NEUROSCI, V25, P4813, DOI 10.1523/JNEUROSCI.0410-05.2005; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Hartmann MJ, 2001, J NEUROSCI, V21, P3549, DOI 10.1523/JNEUROSCI.21-10-03549.2001; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Horn KM, 1996, J NEUROPHYSIOL, V76, P4140, DOI 10.1152/jn.1996.76.6.4140; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2000, J PHYSIOL-LONDON, V522, P297, DOI 10.1111/j.1469-7793.2000.00297.x; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; KEATING JG, 1995, J NEUROPHYSIOL, V73, P1329, DOI 10.1152/jn.1995.73.4.1329; Lang EJ, 1999, J NEUROSCI, V19, P2728; LIDIERTH M, 1990, J PHYSIOL-LONDON, V430, P453, DOI 10.1113/jphysiol.1990.sp018301; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Llinas RR, 2009, NEUROSCIENCE, V162, P797, DOI 10.1016/j.neuroscience.2009.04.045; Long MA, 2002, J NEUROSCI, V22, P10898; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Miri A, 2011, J NEUROPHYSIOL, V105, P964, DOI 10.1152/jn.00702.2010; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Ozden I, 2008, J NEUROPHYSIOL, V100, P495, DOI 10.1152/jn.01310.2007; Ozden I, 2009, J NEUROSCI, V29, P10463, DOI 10.1523/JNEUROSCI.0967-09.2009; Palay SL, 1974, CEREBELLAR CORTEX CY, Vxii; Pardoe J, 2004, J NEUROSCI, V24, P2656, DOI 10.1523/JNEUROSCI.1659-03.2004; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Pijpers A, 2006, J NEUROSCI, V26, P12067, DOI 10.1523/JNEUROSCI.2905-06.2006; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; PROCHAZKA A, 1989, PROG NEUROBIOL, V33, P281, DOI 10.1016/0301-0082(89)90004-X; PROVINI L, 1968, EXP BRAIN RES, V6, P216; Pugh JR, 2008, J NEUROSCI, V28, P10549, DOI 10.1523/JNEUROSCI.2061-08.2008; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; Sawtell NB, 2010, NEURON, V66, P573, DOI 10.1016/j.neuron.2010.04.018; Schultz SR, 2009, J NEUROSCI, V29, P8005, DOI 10.1523/JNEUROSCI.4919-08.2009; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; Sugihara I, 2001, J NEUROSCI, V21, P7715, DOI 10.1523/JNEUROSCI.21-19-07715.2001; Sugihara I, 1999, J COMP NEUROL, V414, P131; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Szapiro G, 2007, NAT NEUROSCI, V10, P735, DOI 10.1038/nn1907; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704; WYLIE DR, 1995, J NEUROSCI, V15, P2875	78	72	72	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42650	10.1371/journal.pone.0042650	http://dx.doi.org/10.1371/journal.pone.0042650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880068	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100151
J	Yoshida, T; Ishikawa, M; Niitsu, T; Nakazato, M; Watanabe, H; Shiraishi, T; Shiina, A; Hashimoto, T; Kanahara, N; Hasegawa, T; Enohara, M; Kimura, A; Iyo, M; Hashimoto, K				Yoshida, Taisuke; Ishikawa, Masatomo; Niitsu, Tomihisa; Nakazato, Michiko; Watanabe, Hiroyuki; Shiraishi, Tetsuya; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Hasegawa, Tadashi; Enohara, Masayo; Kimura, Atsushi; Iyo, Masaomi; Hashimoto, Kenji			Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder	PLOS ONE			English	Article							MOOD DISORDERS; SCHIZOPHRENIA; COGNITION; METALLOPROTEINASES; RELIABILITY; IMPAIRMENT; BATTERY; ANXIETY; SCALE	Background: Meta-analyses have identified serum levels of brain-derived neurotrophic factor (BDNF) as a potential biomarker for major depressive disorder (MDD). However, at the time, commercially available human ELISA kits are unable to distinguish between proBDNF (precursor of BDNF) and mature BDNF because of limited BDNF antibody specificity. In this study, we examined whether serum levels of proBDNF, mature BDNF, and matrix metalloproteinase-9 (MMP-9), which converts proBDNF to mature BDNF, are altered in patients with MDD. Methodology/Principal Findings: Sixty-nine patients with MDD and 78 age-and gender-matched healthy subjects were enrolled. Patients were evaluated using 17 items on the Structured Interview Guide for the Hamilton Depression Rating Scale. Cognitive impairment was evaluated using the CogState battery. Serum levels of proBDNF, mature BDNF, and MMP-9 were measured using ELISA kits. Serum levels of mature BDNF in patients with MDD were significantly lower than those of normal controls. In contrast, there was no difference in the serum levels of proBDNF and MMP-9 between patients and normal controls. While neither proBDNF nor mature BDNF serum levels was associated with clinical variables, there were significant correlations between MMP-9 serum levels and the severity of depression, quality of life scores, and social function scores in patients. Conclusions/Significance: These findings suggest that mature BDNF may serve as a biomarker for MDD, and that MMP-9 may play a role in the pathophysiology of MDD. Further studies using larger sample sizes will be needed to investigate these results.	[Yoshida, Taisuke; Ishikawa, Masatomo; Iyo, Masaomi; Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan; [Yoshida, Taisuke; Ishikawa, Masatomo; Watanabe, Hiroyuki; Shiraishi, Tetsuya; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Hasegawa, Tadashi; Enohara, Masayo; Kimura, Atsushi; Iyo, Masaomi] Chiba Univ, Dept Psychiat, Grad Sch Med, Chiba, Japan; [Niitsu, Tomihisa; Nakazato, Michiko] Chiba Univ, Res Ctr Child Mental Dev, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University; Chiba University	Yoshida, T (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Comprehensive Research on Disability, Health and Welfare Research Grant, Japan; Health and Labor Sciences Research Grant, Japan; Japan Foundation for Neuroscience and Mental Health, Japan	Comprehensive Research on Disability, Health and Welfare Research Grant, Japan; Health and Labor Sciences Research Grant, Japan; Japan Foundation for Neuroscience and Mental Health, Japan	This study was supported by a grant (to KH) from Comprehensive Research on Disability, Health and Welfare, Health and Labor Sciences Research Grants, Japan, and a grant (to TY) from Japan Foundation for Neuroscience and Mental Health, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bosc M, 2000, COMPR PSYCHIAT, V41, P63, DOI 10.1016/S0010-440X(00)90133-0; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2007, BIOESSAYS, V29, P116, DOI 10.1002/bies.20534; Hashimoto Kenji, 2012, Clin Psychopharmacol Neurosci, V10, P59, DOI 10.9758/cpn.2012.10.1.59; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Hindmarch I, 2010, HUM PSYCHOPHARM CLIN, V25, P193, DOI 10.1002/hup.1106; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Johannsen A, 2007, J PERIODONTAL RES, V42, P546, DOI 10.1111/j.1600-0765.2007.00980.x; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; RYBAKOWSKI JK, 2009, CARDIOVASC PSYCHIAT; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Ueda N, 2011, PSYCHIAT CLIN NEUROS, V65, P624, DOI 10.1111/j.1440-1819.2011.02274.x; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020469	33	187	191	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42676	10.1371/journal.pone.0042676	http://dx.doi.org/10.1371/journal.pone.0042676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880079	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100155
J	Ma, J; Becker, C; Lowell, CA; Underhill, DM				Ma, Jun; Becker, Courtney; Lowell, Clifford A.; Underhill, David M.			Dectin-1-triggered Recruitment of Light Chain 3 Protein to Phagosomes Facilitates Major Histocompatibility Complex Class II Presentation of Fungal-derived Antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECOGNITION; DECTIN-1; MACROPHAGES; AUTOPHAGY; PHAGOCYTOSIS; RECEPTOR; CELLS; ACTIVATION; RESPONSES; YEAST	Dectin-1 is a pattern recognition receptor that is important for innate immune responses against fungi in humans and mice. Dectin-1 binds to beta-glucans in fungal cell walls and triggers phagocytosis, production of reactive oxygen by the NADPH oxidase, and inflammatory cytokine production which all contribute to host immune responses against fungi. Although the autophagy pathway was originally characterized for its role in the formation of double-membrane compartments engulfing cytosolic organelles and debris, recent studies have suggested that components of the autophagy pathway may also participate in traditional phagocytosis. In this study, we show that Dectin-1 signaling in macrophages and bone marrow-derived dendritic cells triggers formation of LC3II, a major component of the autophagy machinery. Further, Dectin-1 directs the recruitment of LC3II to phagosomes, and this requires Syk, activation of reactive oxygen production by the NADPH oxidase, and ATG5. Using LC3-deficient dendritic cells we show that whereas LC3 recruitment to phagosomes is not important for triggering phagocytosis, killing or Dectin-1-mediated inflammatory cytokine production, it facilitates recruitment of MHC class II molecules to phagosomes and promotes presentation of fungal-derived antigens to CD4 T cells.	[Underhill, David M.] Cedars Sinai Med Ctr, IBIRI, Los Angeles, CA 90048 USA; [Ma, Jun; Becker, Courtney; Underhill, David M.] Cedars Sinai Med Ctr, Div Immunol, Los Angeles, CA 90048 USA; [Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California San Francisco	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, IBIRI, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu	UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X	National Institutes of Health [AI071116, GM085796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071116, R01AI068150, R01AI065495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071116 and GM085796 (to D. M. U.).	Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shahnazari S, 2011, CURR OPIN MICROBIOL, V14, P68, DOI 10.1016/j.mib.2010.11.001; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	26	150	155	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34149	34156		10.1074/jbc.M112.382812	http://dx.doi.org/10.1074/jbc.M112.382812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902620	Green Published, hybrid			2022-12-25	WOS:000309654200020
J	Ren, T; Dong, W; Takahashi, Y; Xiang, D; Yuan, YS; Liu, X; Loughran, TP; Sun, SC; Wang, HG; Cheng, H				Ren, Tong; Dong, Wen; Takahashi, Yoshinori; Xiang, Di; Yuan, Yunsheng; Liu, Xin; Loughran, Thomas P., Jr.; Sun, Shao-Cong; Wang, Hong-Gang; Cheng, Hua			HTLV-2 Tax Immortalizes Human CD4(+) Memory T Lymphocytes by Oncogenic Activation and Dysregulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VIRUS TYPE-1 HTLV-1; CELL LEUKEMIA; MEDIATED ACTIVATION; IKK-ALPHA; KINASE; ONCOPROTEIN; INDUCTION; GENE; NF-KAPPA-B2/P100	Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2) are two closely related retroviruses with the former causing adult T cell leukemia. HTLV-2 infection is prevalent among intravenous drug users, and the viral genome encodes the viral transactivator Tax, which is highly homologous to the transforming protein Tax from HTLV-1. However, the link between HTLV-2 infection and leukemia has not been established. In the present study, we evaluated the activity of HTLV-2 Tax in promoting aberrant proliferation of human CD4 T lymphocytes. Tax2 efficiently immortalized CD4(+) memory T lymphocytes with a CD3/TCR alpha beta/CD4/CD25/CD45RO/CD69 immunophenotype, promoted constitutive activation of PI3K/Akt, I kappa B kinase/NF-kappa B, mitogen-activated protein kinase, and STAT3, and it also increased the level of Mcl-1. Disruption of these oncogenic pathways led to growth retardation and apoptotic cell death of the Tax2-established T cell lines. We further found that Tax2 induced autophagy by interacting with the autophagy molecule complex containing Beclin1 and PI3K class III to form the LC3(+) autophagosome. Tax2-mediated autophagy promoted survival and proliferation of the immortalized T cells. The present study demonstrated the oncogenic properties of Tax2 in human T cells and also implicated Tax2 in serving as a molecular tool to generate distinct T cell subtype lines.	[Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Yuan, Yunsheng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Ren, Tong; Dong, Wen; Takahashi, Yoshinori; Xiang, Di; Yuan, Yunsheng; Liu, Xin; Loughran, Thomas P., Jr.; Wang, Hong-Gang; Cheng, Hua] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Ren, Tong; Cheng, Hua] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St,S219, Baltimore, MD 21201 USA.	hcheng@ihv.umaryland.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA129682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health (to H. C.).	Arsov I, 2011, J IMMUNOL, V186, P2201, DOI 10.4049/jimmunol.1002223; Bellon M, 2010, BLOOD, V115, P2441, DOI 10.1182/blood-2009-08-241117; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; Chung HK, 2003, BLOOD, V102, P4130, DOI 10.1182/blood-2003-04-1043; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Huang JN, 2009, J BIOL CHEM, V284, P6208, DOI 10.1074/jbc.M806390200; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; KANNO T, 1994, P NATL ACAD SCI USA, V91, P12634, DOI 10.1073/pnas.91.26.12634; LANOIX J, 1994, ONCOGENE, V9, P841; Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 1999, J BIOL CHEM, V274, P34417, DOI 10.1074/jbc.274.48.34417; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; MALEFYT RD, 1990, J IMMUNOL, V145, P2297; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qing GL, 2007, CELL RES, V17, P520, DOI 10.1038/cr.2007.47; Richard V, 2001, AM J PATHOL, V158, P2219, DOI 10.1016/S0002-9440(10)64694-9; Sugahara K, 1997, INT J CANCER, V72, P128, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;128::AID-IJC18&gt;3.0.CO;2-F; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Uhlik M, 1998, J BIOL CHEM, V273, P21132, DOI 10.1074/jbc.273.33.21132; Waldele K, 2004, J VIROL, V78, P6081, DOI 10.1128/JVI.78.12.6081-6090.2004; Wang TG, 2000, AIDS RES HUM RETROV, V16, P1661, DOI 10.1089/08892220050193119; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805	47	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34683	34693		10.1074/jbc.M112.377143	http://dx.doi.org/10.1074/jbc.M112.377143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891252	Green Published, hybrid			2022-12-25	WOS:000309654200069
J	Blair, ME; Melnick, DJ				Blair, Mary E.; Melnick, Don J.			Scale-Dependent Effects of a Heterogeneous Landscape on Genetic Differentiation in the Central American Squirrel Monkey (Saimiri oerstedii)	PLOS ONE			English	Article							POPULATION-STRUCTURE; HABITAT FRAGMENTATION; MICROSATELLITE VARIATION; DISPERSAL PATTERNS; RECENT MIGRATION; CIRCUIT-THEORY; COSTA-RICA; FLOW; CONNECTIVITY; INFERENCE	Landscape genetic studies offer a fine-scale understanding of how habitat heterogeneity influences population genetic structure. We examined population genetic structure and conducted a landscape genetic analysis for the endangered Central American Squirrel Monkey (Saimiri oerstedii) that lives in the fragmented, human-modified habitats of the Central Pacific region of Costa Rica. We analyzed non-invasively collected fecal samples from 244 individuals from 14 groups for 16 microsatellite markers. We found two geographically separate genetic clusters in the Central Pacific region with evidence of recent gene flow among them. We also found significant differentiation among groups of S. o. citrinellus using pairwise FST comparisons. These groups are in fragments of secondary forest separated by unsuitable "matrix" habitats such as cattle pasture, commercial African oil palm plantations, and human residential areas. We used an individual-based landscape genetic approach to measure spatial patterns of genetic variance while taking into account landscape heterogeneity. We found that large, commercial oil palm plantations represent moderate barriers to gene flow between populations, but cattle pastures, rivers, and residential areas do not. However, the influence of oil palm plantations on genetic variance was diminished when we restricted analyses to within population pairs, suggesting that their effect is scale-dependent and manifests during longer dispersal events among populations. We show that when landscape genetic methods are applied rigorously and at the right scale, they are sensitive enough to track population processes even in species with long, overlapping generations such as primates. Thus landscape genetic approaches are extremely valuable for the conservation management of a diverse array of endangered species in heterogeneous, human-modified habitats. Our results also stress the importance of explicitly considering the heterogeneity of matrix habitats in landscape genetic studies, instead of assuming that all matrix habitats have a uniform effect on population genetic processes.	[Blair, Mary E.; Melnick, Don J.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Blair, Mary E.; Melnick, Don J.] New York Consortium Evolutionary Primatol, New York, NY USA	Columbia University	Blair, ME (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mblair1@amnh.org			National Science Foundation (NSF) [BCS-0847912]; American Association of University Women; Margot Marsh Biodiversity Foundation; Columbia University; International Primatological Society; American Society of Primatologists; Northwest Primate Conservation Society; NSF; New York Consortium in Evolutionary Primatology [DGE-0333415]	National Science Foundation (NSF)(National Science Foundation (NSF)); American Association of University Women; Margot Marsh Biodiversity Foundation; Columbia University; International Primatological Society; American Society of Primatologists; Northwest Primate Conservation Society; NSF(National Science Foundation (NSF)); New York Consortium in Evolutionary Primatology	This research was generously funded by National Science Foundation (NSF) Award No. BCS-0847912, the American Association of University Women, the Margot Marsh Biodiversity Foundation, Columbia University, the International Primatological Society, the American Society of Primatologists, and the Northwest Primate Conservation Society. MEB was supported during her graduate training by a NSF Integrative Graduate Education and Research Traineeship program, the New York Consortium in Evolutionary Primatology, Award No. DGE-0333415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Arauz J, 1993, ESTADO CONSERVACION; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Blair ME, 2012, AM J PRIMATOL, V74, P37, DOI 10.1002/ajp.21007; Blair ME, 2011, THESIS COLUMBIA U NE; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bohle UR, 2002, MOL ECOL NOTES, V2, P1; Boinski S, 1999, EVOL ANTHROPOL, V8, P101, DOI 10.1002/(SICI)1520-6505(1999)8:3<101::AID-EVAN5>3.0.CO;2-O; Boinski S, 2005, BEHAVIOUR, V142, P633, DOI 10.1163/1568539054352860; Boinski S, 1997, FOLIA PRIMATOL, V68, P181, DOI 10.1159/000157245; Boinski S, 1998, ORYX, V32, P45, DOI 10.1017/S0030605300029756; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bourgain C, 2004, GENETICS, V168, P2349, DOI 10.1534/genetics.104.031617; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Di Fiore A, 2004, MOL ECOL NOTES, V4, P246, DOI 10.1111/j.1471-8286.2004.00631.x; Dunford W, 2005, LANDSCAPE ECOL, V20, P497, DOI 10.1007/s10980-004-5650-5; EOSL CCT FONAFIFO, 2002, EST COB FOR COST RIC; Epperson BK, 2003, GEOGRAPHIC GENETICS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fogelqvist J, 2010, MOL ECOL RESOUR, V10, P314, DOI 10.1111/j.1755-0998.2009.02756.x; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Goncalves da Silva A, 2007, CAUSES SPATIAL GENET; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Grativol AD, 2001, CONSERV GENET, V2, P1, DOI 10.1023/A:1011543401239; Greenwald KR, 2009, BIOL CONSERV, V142, P2493, DOI 10.1016/j.biocon.2009.05.021; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Hokit DG, 2010, CONSERV GENET, V11, P149, DOI 10.1007/s10592-009-0014-y; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Jack K., 2007, PRIMATES PERSPECTIVE, P107; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jules ES, 2003, J VEG SCI, V14, P459, DOI 10.1111/j.1654-1103.2003.tb02172.x; Keyghobadi N, 1999, MOL ECOL, V8, P1481, DOI 10.1046/j.1365-294x.1999.00726.x; Kindlmann P, 2005, ECOL COMPLEX, V2, P150, DOI 10.1016/j.ecocom.2004.11.007; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Lada H, 2008, J APPL ECOL, V45, P1732, DOI 10.1111/j.1365-2664.2008.01563.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANTEL N, 1967, CANCER RES, V27, P209; Mattey J, 1992, COLONIZACION ESPONTA; McRae B., 2009, CIRCUITSCAPE USER GU; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Najera A, 2010, AGROFOREST SYST, V80, P203, DOI 10.1007/s10457-010-9278-y; Nievergelt CM, 1998, MOL ECOL, V7, P1432; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Perez-Sweeney BM, 2005, MOL ECOL NOTES, V5, P198, DOI 10.1111/j.1471-8286.2005.00875.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Roon DA, 2005, MOL ECOL, V14, P195, DOI 10.1111/j.1365-294X.2004.02385.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Sierra Claudine, 2003, Primate Conservation, V19, P5; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Tracey JA, 2006, CONNECTIVITY CONSERV, P343; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigilant L, 2002, EVOL ANTHROPOL, V11, P162, DOI 10.1002/evan.10082; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Watling JI, 2011, GLOBAL ECOL BIOGEOGR, V20, P209, DOI 10.1111/j.1466-8238.2010.00586.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson GA, 2003, GENETICS, V163, P1177; Wong G, 1990, USO HABITAT ESTIMACI; WRIGHT S, 1978, P580; Zaldivar ME, 2004, REV BIOL TROP, V52, P679; [No title captured]	108	27	28	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43027	10.1371/journal.pone.0043027	http://dx.doi.org/10.1371/journal.pone.0043027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905197	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600040
J	Gaubert, P; Bloch, C; Benyacoub, S; Abdelhamid, A; Pagani, P; Djagoun, CAMS; Couloux, A; Dufour, S				Gaubert, Philippe; Bloch, Cecile; Benyacoub, Slim; Abdelhamid, Adnan; Pagani, Paolo; Djagoun, Chabi Adeyemi Marc Sylvestre; Couloux, Arnaud; Dufour, Sylvain			Reviving the African Wolf Canis lupus lupaster in North and West Africa: A Mitochondrial Lineage Ranging More than 6,000 km Wide	PLOS ONE			English	Article							POPULATION-SIZE; SEQUENCES; PHYLOGEOGRAPHY; HYBRIDIZATION; DISPERSAL; EVOLUTION; HISTORY; CLIMATE; MAMMALS; REGION	The recent discovery of a lineage of gray wolf in North-East Africa suggests the presence of a cryptic canid on the continent, the African wolf Canis lupus lupaster. We analyzed the mtDNA diversity (cytochrome b and control region) of a series of African Canis including wolf-like animals from North and West Africa. Our objectives were to assess the actual range of C. l. lupaster, to further estimate the genetic characteristics and demographic history of its lineage, and to question its taxonomic delineation from the golden jackal C. aureus, with which it has been considered synonymous. We confirmed the existence of four distinct lineages within the gray wolf, including C. lupus/familiaris (Holarctic wolves and dogs), C. l. pallipes, C. l. chanco and C. l. lupaster. Taxonomic assignment procedures identified wolf-like individuals from Algeria, Mali and Senegal, as belonging to C. l. lupaster, expanding its known distribution c. 6,000 km to the west. We estimated that the African wolf lineage (i) had the highest level of genetic diversity within C. lupus, (ii) coalesced during the Late Pleistocene, contemporaneously with Holarctic wolves and dogs, and (iii) had an effective population size of c. 80,000 females. Our results suggest that the African wolf is a relatively ancient gray wolf lineage with a fairly large, past effective population size, as also suggested by the Pleistocene fossil record. Unique field observations in Senegal allowed us to provide a morphological and behavioral diagnosis of the African wolf that clearly distinguished it from the sympatric golden jackal. However, the detection of C. l. lupaster mtDNA haplotypes in C. aureus from Senegal brings the delineation between the African wolf and the golden jackal into question. In terms of conservation, it appears urgent to further characterize the status of the African wolf with regard to the African golden jackal.	[Gaubert, Philippe] Museum Natl Hist Nat, UMR BOREA IRD 207, F-75231 Paris, France; [Bloch, Cecile; Dufour, Sylvain] SYLVATROP, Nantes, France; [Benyacoub, Slim] Univ Annaba, Lab Ecol Syst Terr & Aquat, Fac Sci, Annaba, Algeria; [Abdelhamid, Adnan] Egyptian Environm Affairs Agcy, Nat Conservat Sect, Cairo, Egypt; [Pagani, Paolo] Dutch Wildlife Hlth Ctr, Utrecht, Netherlands; [Djagoun, Chabi Adeyemi Marc Sylvestre] Univ Abomey Calavi, Lab Ecol Appl, Fac Sci Agron, Cotonou, Benin; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universite Badji Mokhtar - Annaba; University of Abomey Calavi; CEA; UDICE-French Research Universities; Universite Paris Saclay	Gaubert, P (corresponding author), Museum Natl Hist Nat, UMR BOREA IRD 207, F-75231 Paris, France.	gaubert@mnhn.fr	Gaubert, Philippe/AGV-9979-2022	Couloux, Arnaud/0000-0003-2356-0062; Gaubert, Philippe/0000-0002-1375-9935	Action Transversale "Biodiversite actuelle et fossile"; Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle [CNRS - UMS 2700]	Action Transversale "Biodiversite actuelle et fossile"; Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France); Consortium National de Recherche en Genomique; Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS))	PG received funding for lab work and field surveys from Action Transversale "Biodiversite actuelle et fossile" and Societe des Amis du Museum National d'Histoire Naturelle et du Jardin des Plantes (MNHN, Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following persons for contributing to the sampling effort: Severin Tchibozo (Centre de Recherche pour la Gestion de la Biodiversite, Cotonou, Benin), Geraldine Veron and Raphael Cornette (Museum National d'Histoire Naturelle, Paris, France), and Gauthier Dobigny (Institut de Recherche pour le Developpement, Montpellier, France). We are grateful to Baba Sarr (Direction des eaux et forets et de la chasse) for giving permission to carry out fieldwork in Senegal, and to Lamine Gueye (Parc de Hann, Dakar) and Rene Bancal (Ranch de Bango, Saint-Louis) for providing logistical support. Laboratory work was supported by the Consortium National de Recherche en Genomique, and the Service de Systematique Moleculaire of the Museum National d'Histoire Naturelle (CNRS - UMS 2700). It is part of agreement 2005/67 between Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. We thank Joseph Brennan, Mike Hoffmann and three anonymous reviewers for their useful comments on an earlier draft of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Anderson J., 1902, ZOOLOGY EGYPT MAMMAL; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; DAYAN T, 1991, PALEOBIOLOGY, V17, P189, DOI 10.1017/S0094837300010484; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FERGUSON WW, 1981, MAMMALIA, V45, P459, DOI 10.1515/mamm.1981.45.4.459; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Geraads D, 2011, PALAEONTOLOGY, V54, P429, DOI 10.1111/j.1475-4983.2011.01039.x; GOTTELLI D, 1994, MOL ECOL, V3, P301, DOI 10.1111/j.1365-294X.1994.tb00070.x; Gray A.P., 1971, MAMMALIAN HYBRIDS CH; Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huxley T. H., 1880, Proceedings of the Zoological Society, P238; Jhala Y. V, 2008, CANIS AUREUS IUCN 20; JOLICOEUR P, 1959, EVOLUTION, V13, P283, DOI 10.1111/j.1558-5646.1959.tb03016.x; Kays R, 2010, BIOL LETTERS, V6, P89, DOI 10.1098/rsbl.2009.0575; Kingdon J, 1997, KINGDON FIELD GUIDE; Krystufek B., 1990, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V91, P7; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li QF, 2008, J GENET GENOMICS, V35, P335, DOI 10.1016/S1673-8527(08)60049-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAHAN BR, 1978, AM MIDL NAT, V100, P408, DOI 10.2307/2424840; MECH L D, 1974, Mammalian Species, V37, P1; Mech LD, 2008, CANIS LUPUS IUCN 201; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nassef M, 2003, THESIS U LEEDS LEEDS; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; Piganeau G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004396; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2008, TRACER VERSION 1 4 1; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; SIDIYENE EA, 1990, MAMMALIA, V54, P471, DOI 10.1515/mamm.1990.54.3.471; Sillero-Zubiri C., 2009, P352; Simeneh G., 2010, HABITAT USE DIET GOL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiwari J, 2004, CANID NEWS, V7, P5; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; WAYNE RK, 1989, J HERED, V80, P447, DOI 10.1093/oxfordjournals.jhered.a110896; WAYNE RK, 1992, CONSERV BIOL, V6, P590, DOI 10.1046/j.1523-1739.1992.06040590.x; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532	53	63	68	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42740	10.1371/journal.pone.0042740	http://dx.doi.org/10.1371/journal.pone.0042740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900047	gold, Green Published			2022-12-25	WOS:000307380900064
J	Zhang, ZS; Li, G; Gao, HY; Zhang, LT; Yang, C; Liu, P; Meng, QW				Zhang, Zishan; Li, Geng; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Liu, Peng; Meng, Qingwei			Characterization of Photosynthetic Performance during Senescence in Stay-Green and Quick-Leaf-Senescence Zea mays L. Inbred Lines	PLOS ONE			English	Article							CHLOROPHYLL-A; ELECTRON-TRANSPORT; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CO2 ASSIMILATION; PHOTOSYSTEM-I; BARLEY LEAVES; JIP-TEST; FLUORESCENCE; DEGRADATION; TEMPERATURE	The net photosynthetic rate, chlorophyll content, chlorophyll fluorescence and 820 nm transmission were investigated to explore the behavior of the photosynthetic apparatus, including light absorption, energy transformation and the photoactivities of photosystem II (PSII) and photosystem I (PSI) during senescence in the stay-green inbred line of maize (Zea mays) Q319 and the quick-leaf-senescence inbred line of maize HZ4. The relationship between the photosynthetic performance and the decrease in chlorophyll content in the two inbred lines was also studied. Both the field and laboratory data indicated that the chlorophyll content, net photosynthetic rate, and the photoactivities of PSII and PSI decreased later and slower in Q319 than in HZ4, indicating that Q319 is a functional stay-green inbred line. In order to avoid the influence of different development stages and environmental factors on senescence, age-matched detached leaf segments from the two inbred lines were treated with ethephon under controlled conditions to induce senescence. The net photosynthetic rate, light absorption, energy transformation, the activities of PSII acceptor side and donor side and the PSI activities decreased much slower in Q319 than in HZ4 during the ethephon-induced senescence. These results suggest that the retention of light absorption, energy transformation and activity of electron transfer contribute to the extended duration of active photosynthesis in Q319. Although the chlorophyll content decreased faster in HZ4, with decrease of chlorophyll content induced by ethephon, photosynthetic performance of Q319 deteriorated much more severely than that of HZ4, indicating that, compared with Q319, HZ4 has an advantage at maintaining higher photosynthetic activity with decrease of chlorophyll although HZ4 is a quick-leaf-senescence inbred line. We conclude that attention should be paid to two favorable characteristics in breeding long duration of active photosynthesis hybrids: 1) maintaining more chlorophyll content during senescence and 2) maintaining higher photosynthetic activity during the loss of chlorophyll.	[Zhang, Zishan; Li, Geng; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Liu, Peng; Meng, Qingwei] State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Zishan; Gao, Huiyuan; Zhang, Litao; Yang, Cheng; Meng, Qingwei] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Li, Geng; Liu, Peng] Shandong Agr Univ, Coll Agr, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhang, ZS (corresponding author), State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	gaohy@sdau.edu.cn	Zhang, zs/GXN-3521-2022; Meng, Q./GSI-6185-2022		State Key Basic Research and Development Plan of China [2009CB118500]; Specialized Research Fund for the Doctoral Program of Higher Education [20113702110008]; National Key Technologies R&D Program of China [2006BAD02A13-2-2, 2006CB101700]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	State Key Basic Research and Development Plan of China (2009CB118500), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20113702110008), the National Key Technologies R&D Program of China (2006BAD02A13-2-2, 2006CB101700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; [Anonymous], 1978, CHLOROPLAST DEV; BENDAVID H, 1983, PLANT PHYSIOL, V73, P507, DOI 10.1104/pp.73.2.507; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Chiba A, 2003, PLANT CELL PHYSIOL, V44, P914, DOI 10.1093/pcp/pcg118; Choi SM, 2002, PLANTA, V216, P315, DOI 10.1007/s00425-002-0852-z; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; DUJARDYN M, 1989, PLANT PHYSIOL, V91, P1562, DOI 10.1104/pp.91.4.1562; El-Lithy ME, 2005, J EXP BOT, V56, P1625, DOI 10.1093/jxb/eri157; EVANS JR, 1988, AUST J PLANT PHYSIOL, V15, P93, DOI 10.1071/PP9880093; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Guiamet JJ, 1996, PHYSIOL PLANTARUM, V96, P655, DOI 10.1111/j.1399-3054.1996.tb00239.x; Haldimann P, 1999, PHOTOSYNTH RES, V62, P67, DOI 10.1023/A:1006321126009; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; HOLT JS, 1993, ANNU REV PLANT PHYS, V44, P203, DOI 10.1146/annurev.pp.44.060193.001223; Ivanov AG, 1998, FEBS LETT, V430, P288, DOI 10.1016/S0014-5793(98)00681-4; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Jiang CD, 2006, PHOTOSYNTHETICA, V44, P454, DOI 10.1007/s11099-006-0050-5; Jiang HX, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-102; Jose A, 2010, J PHYSL, V167, P430; Li PM, 2007, PHOTOSYNTHETICA, V45, P496, DOI 10.1007/s11099-007-0086-1; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; Martinez DE, 2008, PLANT BIOLOGY, V10, P15, DOI 10.1111/j.1438-8677.2008.00089.x; Miersch I, 2000, PLANT BIOLOGY, V2, P618, DOI 10.1055/s-2000-16632; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; NELSON CJ, 1988, PLANT PHYSIOL BIOCH, V26, P543; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2003, FUNCT PLANT BIOL, V30, P785, DOI 10.1071/FP03032; Schansker G, 2008, PHOTOSYNTHESIS ENERG, P951; Schrader SM, 2004, PLANT CELL ENVIRON, V27, P725, DOI 10.1111/j.1365-3040.2004.01172.x; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; TOLLENAAR M, 1978, CAN J PLANT SCI, V58, P869, DOI 10.4141/cjps78-126; Toth SZ, 2005, J PLANT PHYSIOL, V162, P181, DOI 10.1016/j.jplph.2004.06.010; Toth SZ, 2007, BBA-BIOENERGETICS, V1767, P295, DOI 10.1016/j.bbabio.2007.02.019; Tsimilli-Michael M., 2008, MYCORRHIZA, DOI [DOI 10.1007/978-3-540-78826-3_32, 10.1007/978-3-540-78826-3_32, DOI 10.1007/978]; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; WOLFE DW, 1988, AGRON J, V80, P859, DOI 10.2134/agronj1988.00021962008000060004x; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Yordanov I, 2008, J PLANT PHYSIOL, V165, P1954, DOI 10.1016/j.jplph.2008.05.003; Zhang ZS, 2011, PLANTA, V234, P883, DOI 10.1007/s00425-011-1447-3	54	65	77	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42936	10.1371/journal.pone.0042936	http://dx.doi.org/10.1371/journal.pone.0042936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900069	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900087
J	Chong, HS; Campbell, L; Padula, MP; Hill, C; Harry, E; Li, SS; Wilkins, MR; Herbert, B; Carter, D				Chong, Hin Siong; Campbell, Leona; Padula, Matthew P.; Hill, Cameron; Harry, Elizabeth; Li, Simone S.; Wilkins, Marc R.; Herbert, Ben; Carter, Dee			Time-Course Proteome Analysis Reveals the Dynamic Response of Cryptococcus gattii Cells to Fluconazole	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; CANDIDA-ALBICANS; IN-VITRO; SACCHAROMYCES-CEREVISIAE; BENZODIAZEPINE-RECEPTOR; MITOCHONDRIAL HSP70; KARYOPHERIN KAP95; STATISTICAL-MODEL; GENE-EXPRESSION; 14-3-3 PROTEINS	Cryptococcus gattii is an encapsulated fungus capable of causing fatal disease in immunocompetent humans and animals. As current antifungal therapies are few and limited in efficacy, and resistance is an emerging issue, the development of new treatment strategies is urgently required. The current study undertook a time-course analysis of the proteome of C. gattii during treatment with fluconazole (FLC), which is used widely in prophylactic and maintenance therapies. The aims were to analyze the overall cellular response to FLC, and to find fungal proteins involved in this response that might be useful targets in therapies that augment the antifungal activity of FLC. During FLC treatment, an increase in stress response, ATP synthesis and mitochondrial respiratory chain proteins, and a decrease in most ribosomal proteins was observed, suggesting that ATP-dependent efflux pumps had been initiated for survival and that the maintenance of ribosome synthesis was differentially expressed. Two proteins involved in fungal specific pathways were responsive to FLC. An integrative network analysis revealed co-ordinated processes involved in drug response, and highlighted hubs in the network representing essential proteins that are required for cell viability. This work demonstrates the dynamic cellular response of a typical susceptible isolate of C. gattii to FLC, and identified a number of proteins and pathways that could be targeted to augment the activity of FLC.	[Chong, Hin Siong; Campbell, Leona; Carter, Dee] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew P.; Harry, Elizabeth] Univ Technol, Ithree Inst, Broadway, NSW, Australia; [Hill, Cameron; Herbert, Ben] Macquarie Univ, Sch Chem & Biomol Sci, N Ryde, NSW, Australia; [Li, Simone S.; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2033, Australia	University of Sydney; University of Technology Sydney; Macquarie University; University of New South Wales Sydney	Chong, HS (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	dee.carter@sydney.edu.au	Harry, Elizabeth/G-8123-2017; Carter, Dee/C-1331-2010; Harry, Liz/AAT-9396-2020; Padula, Matthew P/R-6150-2016	Carter, Dee/0000-0002-4638-0059; Padula, Matthew P/0000-0002-8283-0643; Harry, Elizabeth/0000-0003-0858-9473; Li, Simone S/0000-0002-0073-3656; herbert, ben/0000-0003-4697-8197	Australian National Health and Medical Research Council [971254]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian National Health and Medical Research Council grant # 971254 (to DC). Australian Government EIF Super Science Scheme (to MW). NSW State Government Science Leveraging Fund (to MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Biggins S, 2001, GENETICS, V159, P453; Bledi Yaniv, 2003, Briefings in Functional Genomics & Proteomics, V2, P254, DOI 10.1093/bfgp/2.3.254; BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brummer E, 1998, MED MYCOL, V36, P227, DOI 10.1080/02681219880000341; Bucci M, 1998, MOL BIOL CELL, V9, P2439, DOI 10.1091/mbc.9.9.2439; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Camasses A, 1998, MOL CELL BIOL, V18, P1956, DOI 10.1128/MCB.18.4.1956; Chong HS, 2010, J CLIN MICROBIOL, V48, P4115, DOI 10.1128/JCM.01271-10; Cognetti D, 2002, YEAST, V19, P55, DOI 10.1002/yea.804; Cohen-Gihon I, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035009; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; CRAIG EA, 1987, P NATL ACAD SCI USA, V84, P4156, DOI 10.1073/pnas.84.12.4156; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Gautam P, 2008, ANTIMICROB AGENTS CH, V52, P4220, DOI 10.1128/AAC.01431-07; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Ho E, 2008, J PROTEOME RES, V7, P104, DOI 10.1021/pr070274m; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Hsing M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-80; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Jobbins SE, 2010, J PROTEOME RES, V9, P3832, DOI 10.1021/pr100028t; Taberner FJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-47; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kawai A, 2001, J CELL SCI, V114, P3565; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Lepak A, 2006, ANTIMICROB AGENTS CH, V50, P1311, DOI 10.1128/AAC.50.4.1311-1319.2006; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Mahmud SA, 2010, J BIOSCI BIOENG, V109, P262, DOI 10.1016/j.jbiosc.2009.08.500; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Nailis H, 2010, RES MICROBIOL, V161, P284, DOI 10.1016/j.resmic.2010.02.004; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Palmer DA, 2006, J BIOL CHEM, V281, P32596, DOI 10.1074/jbc.M602768200; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PARKINSON T, 1995, ANTIMICROB AGENTS CH, V39, P1696, DOI 10.1128/AAC.39.8.1696; Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P251, DOI 10.1016/S0732-8893(97)00246-0; Roberts RL, 1997, CELL, V89, P1055, DOI 10.1016/S0092-8674(00)80293-7; Rogers PD, 2006, J ANTIMICROB CHEMOTH, V58, P434, DOI 10.1093/jac/dkl221; ROY J, 1995, MOL CELL BIOL, V15, P445, DOI 10.1128/MCB.15.1.445; Ryan KJ, 2007, MOL BIOL CELL, V18, P886, DOI 10.1091/mbc.E06-06-0525; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; SYNETOS D, 1992, J BIOL CHEM, V267, P3008; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Veen M, 2005, BIOCHEM SOC T, V33, P1178, DOI 10.1042/BST0331178; Voit EO, 2003, J THEOR BIOL, V223, P55, DOI 10.1016/S0022-5193(03)00072-9; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j; [No title captured]	76	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42835	10.1371/journal.pone.0042835	http://dx.doi.org/10.1371/journal.pone.0042835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880118	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000076
J	Hough, C; Radu, M; Dore, JJE				Hough, Chris; Radu, Maria; Dore, Jules J. E.			TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling	PLOS ONE			English	Article							MYC PROTEIN STABILITY; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MAP KINASE; SERINE 338; P21-ACTIVATED KINASE-2; II RECEPTOR; CROSS-TALK; ACTIVATION; RAS	The Transforming Growth Factor-Beta (TGF-beta) family is involved in regulating a variety of cellular processes such as apoptosis, differentiation, and proliferation. TGF-beta binding to a Serine/Threonine kinase receptor complex causes the recruitment and subsequent activation of transcription factors known as smad2 and smad3. These proteins subsequently translocate into the nucleus to negatively or positively regulate gene expression. In this study, we define a second signaling pathway leading to TGF-beta receptor activation of Extracellular Signal Regulated Kinase (Erk) in a cell-type dependent manner. TGF-beta induced Erk activation was found in phenotypically normal mesenchymal cells, but not normal epithelial cells. By activating phosphotidylinositol 3-kinase (PI3K), TGF-beta stimulates p21-activated kinase2 (Pak2) to phosphorylate c-Raf, ultimately resulting in Erk activation. Activation of Erk was necessary for TGF-beta induced fibroblast replication. In addition, Erk phosphorylated the linker region of nuclear localized smads, resulting in increased half-life of C-terminal phospho-smad 2 and 3 and increased duration of smad target gene transcription. Together, these data show that in mesenchymal cell types the TGF-beta/PI3K/Pak2/Raf/MEK/Erk pathway regulates smad signaling, is critical for TGF-beta-induced growth and is part of an integrated signaling web containing multiple interacting pathways rather than discrete smad/non-smad pathways.	[Hough, Chris; Dore, Jules J. E.] Mem Univ Newfoundland, St John, NF, Canada; [Radu, Maria] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Memorial University Newfoundland; Fox Chase Cancer Center	Hough, C (corresponding author), Mem Univ Newfoundland, St John, NF, Canada.	jdore@mun.ca			Canadian Institutes of Health Research/Regional Partnership Program [ROP-62277, ROP-82355]	Canadian Institutes of Health Research/Regional Partnership Program(Canadian Institutes of Health Research (CIHR))	This work was supported by funding through the Canadian Institutes of Health Research/Regional Partnership Program, ROP-62277 and ROP-82355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Burch ML, 2010, CELL MOL LIFE SCI, V67, P2077, DOI 10.1007/s00018-010-0315-9; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Inman Gareth J, 2005, Biochem J, V386, pe1; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Liu YD, 2007, J BIOL CHEM, V282, P8594, DOI 10.1074/jbc.M610230200; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MANNE V, 1995, DRUG DEVELOP RES, V34, P121, DOI 10.1002/ddr.430340205; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; WHARTON W, 1982, P NATL ACAD SCI-BIOL, V79, P5567, DOI 10.1073/pnas.79.18.5567; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	52	106	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42513	10.1371/journal.pone.0042513	http://dx.doi.org/10.1371/journal.pone.0042513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880011	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000307810000038
J	Bode, N; Massey, C; Gonzalez-Alegre, P				Bode, Nicole; Massey, Cory; Gonzalez-Alegre, Pedro			DYT1 Knock-In Mice Are Not Sensitized against Mitochondrial Complex-II Inhibition	PLOS ONE			English	Article							EARLY-ONSET DYSTONIA; PC12 CELLS; TORSION DYSTONIA; TRANSGENIC MICE; STRESS; EXPRESSION; TOXICITY; PROTEIN; MOUSE; MODEL	DYT1 is caused by a partly penetrant dominant mutation in TOR1A that leads to a glutamic acid deletion (Delta E) in torsinA. Identifying environmental factors that modulate disease pathogenesis and penetrance could help design therapeutic strategies for dystonia. Several cell-based studies suggest that expression of torsinA(Delta E) increases the susceptibility of neuronal cells to challenges to their oxidative/energy metabolism. Based on those reports, we hypothesized that mice expressing torsinA(Delta E) would be more susceptible than control littermates to the effects of oxidative stress and ATP deficits caused by disruption of the mitochondrial respiratory chain in neurons. To test this hypothesis, we administered 20 or 50 mg/kg/day of the irreversible complex-II inhibitor 3-nitropropionic acid (3-NP) intraperitoneally for 15 consecutive days to young heterozygote DYT1 knock-in (KI) mice and wild type littermates. Repeated phenotypic assessments were performed at baseline, during and after the injections. Animals were then sacrificed and their brains processed for protein analysis. The administration of 20 mg/kg 3-NP led to increased levels of torsinA in the striatum, the main target of 3-NP, but did not cause motor dysfunction in DYT1 KI or control mice. The administration of 50 mg/kg/day of 3-NP caused the death of similar to 40% of wild type animals. Interestingly, DYT1 KI animals showed significantly reduced mortality. Surviving animals exhibited abnormal motor behavior during and right after the injection period, but recovered by 4 weeks postinjection independent of genotype. In contrast to the findings reported in cultured cells, these studies suggest the DYT1 mutation does not sensitize central neurons against the toxic effects of oxidative stress and energy deficits.	[Bode, Nicole; Gonzalez-Alegre, Pedro] Univ Iowa, Dept Neurol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Massey, Cory; Gonzalez-Alegre, Pedro] Univ Iowa, Grad Program Neurosci, Iowa City, IA USA	University of Iowa; University of Iowa	Bode, N (corresponding author), Univ Iowa, Dept Neurol, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA.	pedro-gonzalez-alegre@uiowa.edu		Massey, Cory/0000-0003-1625-7292	Bachmann-Strauss Dystonia & Parkinson Foundation, Inc	Bachmann-Strauss Dystonia & Parkinson Foundation, Inc	This work was funded by Bachmann-Strauss Dystonia & Parkinson Foundation, Inc (http://www.dystonia-parkinsons.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Bao L, 2010, J NEUROCHEM, V114, P1781, DOI 10.1111/j.1471-4159.2010.06890.x; Bragg DC, 2011, NEUROBIOL DIS, V42, P136, DOI 10.1016/j.nbd.2010.11.015; Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chen XP, 2010, NEUROCHEM RES, V35, P1214, DOI 10.1007/s11064-010-0177-4; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1998, Adv Neurol, V78, P1; Gabrielson KL, 2001, AM J PATHOL, V159, P1507, DOI 10.1016/S0002-9440(10)62536-9; Gonzalez-Alegre P, 2007, SEMIN NEUROL, V27, P151, DOI 10.1055/s-2007-971170; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2010, EUR J NEUROL, V17, P81, DOI 10.1111/j.1468-1331.2010.03057.x; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Hickey MA, 2000, J NEUROCHEM, V75, P2163, DOI 10.1046/j.1471-4159.2000.0752163.x; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kuner R, 2004, NEUROSCI LETT, V355, P126, DOI 10.1016/j.neulet.2003.10.069; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Li XB, 2008, GOSPOD SUROWCAMI MIN, V24, P225; Martin JN, 2011, GENE THER, V18, P666, DOI 10.1038/gt.2011.10; Martin JN, 2009, NEUROSCIENCE; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Risch NJ, 2007, AM J HUM GENET, V80, P1188, DOI 10.1086/518427; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Tassone A, 2011, INT REV NEUROBIOL, V98, P551, DOI 10.1016/B978-0-12-381328-2.00020-1; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108; Zhao Y, 2008, NEUROSCIENCE, V155, P439, DOI 10.1016/j.neuroscience.2008.04.053; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42644	10.1371/journal.pone.0042644	http://dx.doi.org/10.1371/journal.pone.0042644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880064	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100148
J	Vartanian, AS; Paz, A; Fortgang, EA; Abramson, J; Dahlquist, FW				Vartanian, Armand S.; Paz, Aviv; Fortgang, Emily A.; Abramson, Jeff; Dahlquist, Frederick W.			Structure of Flagellar Motor Proteins in Complex Allows for Insights into Motor Structure and Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; CHARGED RESIDUES; TORQUE RING; FLIG; ROTOR; ROTATION; DRIVEN	The flagellar motor is one type of propulsion device of motile bacteria. The cytoplasmic ring (C-ring) of the motor interacts with the stator to generate torque in clockwise and counter-clockwise directions. The C-ring is composed of three proteins, FliM, FliN, and FliG. Together they form the "switch complex" and regulate switching and torque generation. Here we report the crystal structure of the middle domain of FliM in complex with the middle and C-terminal domains of FliG that shows the interaction surface and orientations of the proteins. In the complex, FliG assumes a compact conformation in which the middle and C-terminal domains (FliG(MC)) collapse and stack together similarly to the recently published structure of a mutant of FliGMC with a clockwise rotational bias. This intramolecular stacking of the domains is distinct from the intermolecular stacking seen in other structures of FliG. We fit the complex structure into the three-dimensional reconstructions of the motor and propose that the cytoplasmic ring is assembled from 34 FliG and FliM molecules in a 1:1 fashion.	[Vartanian, Armand S.; Fortgang, Emily A.; Dahlquist, Frederick W.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Paz, Aviv; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dahlquist, FW (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	Dahlquist@chem.ucsb.edu	Paz, Aviv/AAN-3966-2021					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Blair DF, 2003, FEBS LETT, V545, P86, DOI 10.1016/S0014-5793(03)00397-1; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Marykwas DL, 1996, J BACTERIOL, V178, P1289, DOI 10.1128/jb.178.5.1289-1294.1996; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Passmore SE, 2008, MICROBIOL-SGM, V154, P714, DOI 10.1099/mic.0.2007/014597-0; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Stock D, 2012, CURR OPIN BIOTECH, V23, P545, DOI 10.1016/j.copbio.2012.01.008; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Yakushi T, 2006, J BACTERIOL, V188, P1466, DOI 10.1128/JB.188.4.1466-1472.2006	30	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35779	35783		10.1074/jbc.C112.378380	http://dx.doi.org/10.1074/jbc.C112.378380			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896702	Green Published, hybrid			2022-12-25	WOS:000310364000001
J	Yoshioka, Y; Kosaka, N; Ochiya, T; Kato, T				Yoshioka, Yusuke; Kosaka, Nobuyoshi; Ochiya, Takahiro; Kato, Takashi			Micromanaging Iron Homeostasis HYPOXIA-INDUCIBLE MICRO-RNA-210 SUPPRESSES IRON HOMEOSTASIS-RELATED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR EXPRESSION; HYPOXIA; ACTIVATION; GENE; IDENTIFICATION; MICRORNAS; MECHANISM; TARGETS; CELLS; DIFFERENTIATION	Iron is fundamental for sustaining life for living organisms, and the iron metabolism is finely regulated at different levels. In cancer cells, deregulation of the iron metabolism induces oxidative stress and drives tumor progression and metastasis; however, the molecular mechanisms of iron homeostasis are not fully understood. Here we found that iron deficiency as well as hypoxia promoted microRNA-210 (miR-210) expression. A central mediator of miR-210 transcriptional activation is the hypoxia-inducible factor (HIF)-1 alpha, and the hypoxia-response element in the miR-210 promoter is confirmed experimentally. This is in agreement with the data from in vivo studies that have demonstrated the presence of miR-210-expressing cells at the chronic hypoxic regions of xeno-grafted tumors. Furthermore we found two essential molecules for iron homeostasis, iron-sulfur cluster scaffold protein (ISCU) and transferrin receptor 1 (TfR), are a direct target of miR-210. Transfection of miR-210 decreases the uptake of transferrin by inhibiting the expression of TfR. In addition, inhibition of miR-210 by anti-miR-210 up-regulates ISCU expression. These findings suggest that miR-210 works as an iron sensor and is involved in the maintenance of iron homeostasis by sustaining the TfR expression level to stimulate cell proliferation and promote cell survival in the hypoxic region within tumors.	[Yoshioka, Yusuke; Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Translat Res Grp, Chuo Ku, Tokyo 1040045, Japan; [Kato, Takashi] Waseda Univ, Dept Biol, Sch Educ, Shinjuku Ku, Tokyo 1628480, Japan; [Yoshioka, Yusuke; Kato, Takashi] Waseda Univ, Grad Sch Sci & Engn, Mol Physiol Unit Major Integrat Biosci & Biomed E, Shinjuku Ku, Tokyo 1628480, Japan	National Cancer Center - Japan; Waseda University; Waseda University	Kato, T (corresponding author), Waseda Univ, Dept Biol, Sch Educ, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan.	tkato@waseda.jp	Kato, Takashi/AFO-2557-2022; Ochiya, Takahiro/AAH-7585-2019	Kato, Takashi/0000-0003-0384-7971; 	Ministry of Education, Culture, Sports, Science, and Technology; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio); Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science; Council for Science and Technology Policy (CSTP)	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This work was supported in part by a grant-in-aid for the third-term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science, and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). This work was supported in part by a grant from the Japan Society for the Promotion of Science (to Y. Y.).	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campbell J A, 1940, Br Med J, V2, P275; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; CHITAMBAR CR, 1983, J CLIN INVEST, V72, P1314, DOI 10.1172/JCI111087; Clark SF, 2009, CURR OPIN GASTROEN, V25, P122, DOI 10.1097/MOG.0b013e32831ef1cd; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Laftah AH, 2005, ANN HEMATOL, V84, P177, DOI 10.1007/s00277-004-0945-9; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pau MYM, 2007, P NATL ACAD SCI USA, V104, P18355, DOI 10.1073/pnas.0704191104; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; RAJA KB, 1990, INT J EXP PATHOL, V71, P785; Raleigh JA, 1999, RADIAT RES, V151, P580, DOI 10.2307/3580034; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; VAUPEL P, 1989, CANCER RES, V49, P6449; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Ye Hong, 2010, Adv Hematol, V2010, DOI 10.1155/2010/329394	38	59	63	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34110	34119		10.1074/jbc.M112.356717	http://dx.doi.org/10.1074/jbc.M112.356717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896707	Green Published, hybrid			2022-12-25	WOS:000309654200017
J	Karimian, G; Buist-Homan, M; Faber, KN; Moshage, H				Karimian, Golnar; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han			Pertussis Toxin, an Inhibitor of G(alpha i) PCR, Inhibits Bile Acid- and Cytokine-Induced Apoptosis in Primary Rat Hepatocytes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ISLET-ACTIVATING PROTEIN; FARNESOID-X-RECEPTOR; SUBUNIT STRUCTURE; MEMBRANE-PROTEIN; ADP-RIBOSYLATION; DRUG DISCOVERY; GI-PROTEIN; CELL-DEATH; LIVER	Excessive hepatocyte apoptosis is a common event in acute and chronic liver diseases leading to loss of functional liver tissue. Approaches to prevent apoptosis have therefore high potential for the treatment of liver disease. G-protein coupled receptors (GPCR) play crucial roles in cell fate (proliferation, cell death) and act through heterotrimeric G-proteins. G(alpha i)PCRs have been shown to regulate lipoapoptosis in hepatocytes, but their role in inflammation- or bile acid-induced apoptosis is unknown. Here, we analyzed the effect of inhibiting G(alpha i)PCR function, using pertussis toxin (PT), on bile acid-and cytokine-induced apoptosis in hepatocytes. Primary rat hepatocytes, HepG2-rNtcp cells (human hepatocellular carcinoma cells) or H-4-II-E cells (rat hepatoma cells) were exposed to glycochenodeoxycholic acid (GCDCA) or tumor necrosis factor-alpha (TNF alpha)/actinomycin D (ActD). PT (50-200 nmol/L) was added 30 minutes prior to the apoptotic stimulus. Apoptosis (caspase-3 activity, acridine orange staining) and necrosis (sytox green staining) were assessed. PT significantly reduced GCDCA-and TNF alpha/ActD-induced apoptosis in rat hepatocytes (260%, p, 0.05) in a dose-dependent manner (with no shift to necrosis), but not in HepG2-rNtcp cells or rat H-4-II-E cells. The protective effect of pertussis toxin was independent of the activation of selected cell survival signal transduction pathways, including ERK, p38 MAPK, PI3K and PKC pathways, as specific protein kinase inhibitors did not reverse the protective effects of pertussis toxin in GCDCA-exposed hepatocytes. Conclusion: Pertussis toxin, an inhibitor of G(alpha i)PCRs, protects hepatocytes, but not hepatocellular carcinoma cells, against bile acid-and cytokine-induced apoptosis and has therapeutic potential as primary hepatoprotective drug, as well as adjuvant in anticancer therapy.	[Karimian, Golnar; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands	University of Groningen	Karimian, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	g.karimian01@umcg.nl		Moshage, Han/0000-0002-4764-0246				Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; BURNS DL, 1988, MICROBIOL SCI, V5, P285; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dent P, 2005, HEPATOLOGY, V42, P1291, DOI 10.1002/hep.20942; Gonzalez B, 2000, MOL CELL BIOCHEM, V207, P19, DOI 10.1023/A:1007021710825; Gonzalez-Maeso J, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-20; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; James ND, 2010, BJU INT, V106, P966, DOI 10.1111/j.1464-410X.2010.09638.x; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kramer L, 2004, WIEN KLIN WOCHENSCHR, V116, P67, DOI 10.1007/BF03040699; Kukkonen JP, 2011, CELL CALCIUM, V50, P9, DOI 10.1016/j.ceca.2011.04.005; Kullak-Ublick GA, 2000, CYTOTECHNOLOGY, V34, pB1, DOI 10.1023/A:1008152729133; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; Maiga A, 2011, TOXICON; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311; Muntane J, 2011, ANTI-CANCER AGENT ME, V11, P576, DOI 10.2174/187152011796011082; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Ros JE, 2001, HEPATOLOGY, V33, P1425, DOI 10.1053/jhep.2001.24667; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Schoemaker MH, 2004, CLIN SCI, V107, P13, DOI 10.1042/CS20040090; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Sola S, 2007, CURR ISSUES MOL BIOL, V9, P123; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang Kun, 2002, J Toxicol Sci, V27, P229, DOI 10.2131/jts.27.229; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Woudenberg-Vrenken TE, 2010, LIVER INT, V30, P1511, DOI 10.1111/j.1478-3231.2010.02325.x; YANG LJ, 1991, J BIOL CHEM, V266, P22451; YANG LJ, 1993, J BIOL CHEM, V268, P3739	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43156	10.1371/journal.pone.0043156	http://dx.doi.org/10.1371/journal.pone.0043156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900098	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900116
J	Wiens, JJ; Tiu, J				Wiens, John J.; Tiu, Jonathan			Highly Incomplete Taxa Can Rescue Phylogenetic Analyses from the Negative Impacts of Limited Taxon Sampling	PLOS ONE			English	Article							MISSING DATA; MAXIMUM-LIKELIHOOD; DATA SETS; ACCURACY; FOSSILS; PHYLOGENOMICS; IMPROVE; TREE; PERFORMANCE; CHARACTERS	Background: Phylogenies are essential to many areas of biology, but phylogenetic methods may give incorrect estimates under some conditions. A potentially common scenario of this type is when few taxa are sampled and terminal branches for the sampled taxa are relatively long. However, the best solution in such cases (i.e., sampling more taxa versus more characters) has been highly controversial. A widespread assumption in this debate is that added taxa must be complete (no missing data) in order to save analyses from the negative impacts of limited taxon sampling. Here, we evaluate whether incomplete taxa can also rescue analyses under these conditions (empirically testing predictions from an earlier simulation study). Methodology/Principal Findings: We utilize DNA sequence data from 16 vertebrate species with well-established phylogenetic relationships. In each replicate, we randomly sample 4 species, estimate their phylogeny (using Bayesian, likelihood, and parsimony methods), and then evaluate whether adding in the remaining 12 species (which have 50, 75, or 90% of their data replaced with missing data cells) can improve phylogenetic accuracy relative to analyzing the 4 complete taxa alone. We find that in those cases where sampling few taxa yields an incorrect estimate, adding taxa with 50% or 75% missing data can frequently (>75% of relevant replicates) rescue Bayesian and likelihood analyses, recovering accurate phylogenies for the original 4 taxa. Even taxa with 90% missing data can sometimes be beneficial. Conclusions: We show that adding taxa that are highly incomplete can improve phylogenetic accuracy in cases where analyses are misled by limited taxon sampling. These surprising empirical results confirm those from simulations, and show that the benefits of adding taxa may be obtained with unexpectedly small amounts of data. These findings have important implications for the debate on sampling taxa versus characters, and for studies attempting to resolve difficult phylogenetic problems.	[Wiens, John J.; Tiu, Jonathan] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wiens, JJ (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	wiensj@life.bio.sunysb.edu		Wiens, John/0000-0003-4243-1127				Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Cobbett A, 2007, SYST BIOL, V56, P753, DOI 10.1080/10635150701627296; DeBry RW, 2005, SYST BIOL, V54, P432, DOI 10.1080/10635150590946745; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Manos PS, 2007, SYST BIOL, V56, P412, DOI 10.1080/10635150701408523; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; Soltis DE, 1998, SYST BIOL, V47, P32, DOI 10.1080/106351598261012; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Wiens JJ, 1998, SYST BIOL, V47, P427, DOI 10.1080/106351598260806; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wiens JJ, 2009, SYST BIOL, V58, P87, DOI 10.1093/sysbio/syp012; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	47	120	120	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42925	10.1371/journal.pone.0042925	http://dx.doi.org/10.1371/journal.pone.0042925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900065	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900083
J	Lee, JH; Kim, DG; Bae, TJ; Rho, K; Kim, JT; Lee, JJ; Jang, Y; Kim, BC; Park, KM; Kim, S				Lee, Ji-Hyun; Kim, Dae Gyu; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Lee, Jong-Jun; Jang, Yeongjun; Kim, Byung Cheol; Park, Kyoung Mii; Kim, Sunghoon			CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANTICANCER DRUGS; KINASE INHIBITOR; ZD1839 IRESSA; DATABASE; EXPRESSION; RECEPTOR; APOPTOSIS; ESTROGEN; DISEASE	Background: Anticancer therapies that target single signal transduction pathways often fail to prevent proliferation of cancer cells because of overlapping functions and cross-talk between different signaling pathways. Recent research has identified that balanced multi-component therapies might be more efficacious than highly specific single component therapies in certain cases. Ideally, synergistic combinations can provide 1) increased efficacy of the therapeutic effect 2) reduced toxicity as a result of decreased dosage providing equivalent or increased efficacy 3) the avoidance or delayed onset of drug resistance. Therefore, the interest in combinatorial drug discovery based on systems-oriented approaches has been increasing steadily in recent years. Methodology: Here we describe the development of Combinatorial Drug Assembler (CDA), a genomics and bioinformatics system, whereby using gene expression profiling, multiple signaling pathways are targeted for combinatorial drug discovery. CDA performs expression pattern matching of signaling pathway components to compare genes expressed in an input cell line (or patient sample data), with expression patterns in cell lines treated with different small molecules. Then it detects best pattern matching combinatorial drug pairs across the input gene set-related signaling pathways to detect where gene expression patterns overlap and those predicted drug pairs could likely be applied as combination therapy. We carried out in vitro validations on non-small cell lung cancer cells and triple-negative breast cancer (TNBC) cells. We found two combinatorial drug pairs that showed synergistic effect on lung cancer cells. Furthermore, we also observed that halofantrine and vinblastine were synergistic on TNBC cells. Conclusions: CDA provides a new way for rational drug combination. Together with phExplorer, CDA also provides functional insights into combinatorial drugs. CDA is freely available at http://cda.i-pharm.org.	[Lee, Ji-Hyun; Kim, Dae Gyu; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Lee, Jong-Jun; Kim, Byung Cheol; Park, Kyoung Mii; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea; [Lee, Ji-Hyun; Bae, Tae Jeong; Rho, Kyoohyoung; Kim, Ji-Tae; Kim, Byung Cheol] Seoul Natl Univ, Informat Ctr Biopharmacol Network, Suwon, South Korea; [Jang, Yeongjun] KRIBB, Korean BioInformat Ctr KOBIC, Taejon, South Korea; [Kim, Sunghoon] Seoul Natl Univ, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020; Bae, Taejeong/AAW-6003-2021	Bae, Taejeong/0000-0002-4626-3725; kim, sunghoon/0000-0002-1570-3230; Jang, Yeongjun/0000-0002-7816-3278	Global Frontier [NRF-M1AXA002-2010-0029785]; Research Information Center Supporting Program [370C-20090004]; WCU project of the Ministry of Education, Science, and Technology and Korea Healthcare Technology [R31-2008-000-10103-0, A092255-0911-1110100]; Ministry of Health and Welfare Affairs; Gyonggi-do; EU project of the 7th framework programme (METOXIA); Korean Ministry of Education, Science and Technology (MEST) [20110002321]	Global Frontier; Research Information Center Supporting Program; WCU project of the Ministry of Education, Science, and Technology and Korea Healthcare Technology; Ministry of Health and Welfare Affairs; Gyonggi-do; EU project of the 7th framework programme (METOXIA); Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the grants of the Global Frontier (NRF-M1AXA002-2010-0029785) and the Research Information Center Supporting Program (370C-20090004) and the WCU project (R31-2008-000-10103-0) of the Ministry of Education, Science, and Technology and Korea Healthcare Technology (A092255-0911-1110100), the Ministry of Health and Welfare Affairs, and Gyonggi-do to Dr. Sunghoon Kim, an EU project of the 7th framework programme (METOXIA), and by the Korean Ministry of Education, Science and Technology (MEST) under grant number 20110002321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bange J, 2001, NAT MED, V7, P548, DOI 10.1038/87872; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bouchaud O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-289; Brazelle W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014335; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chatterjee MS, 2010, NAT BIOTECHNOL, V28, P727, DOI 10.1038/nbt.1642; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Croxtall JD, 2011, DRUGS, V71, P363, DOI 10.2165/11204810-000000000-00000; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gonzalez-Arenas A, 2008, BBA-MOL CELL RES, V1783, P253, DOI 10.1016/j.bbamcr.2007.11.014; Guo Y, 2008, ORAL ONCOL, V44, P23, DOI 10.1016/j.oraloncology.2006.11.020; Gupta Eric K, 2002, Heart Dis, V4, P124; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kubinyi H, 2003, NAT REV DRUG DISCOV, V2, P665, DOI 10.1038/nrd1156; Lahusen T, 2003, MOL CARCINOGEN, V36, P183, DOI 10.1002/mc.10114; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Marsh S, 2010, PHARMACOGENOMICS, V11, P1003, DOI [10.2217/pgs.10.95, 10.2217/PGS.10.95]; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Moulder SL, 2001, CANCER RES, V61, P8887; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Nelson HS, 2001, J ALLERGY CLIN IMMUN, V107, P397, DOI 10.1067/mai.2001.112939; Normanno N, 2002, ANN ONCOL, V13, P65, DOI 10.1093/annonc/mdf020; Oesterreich S, 2003, CANCER RES, V63, P5203; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tamm I, 1998, CANCER RES, V58, P5315; Thorn CF, 2010, PHARMACOGENOMICS, V11, P501, DOI 10.2217/PGS.10.15; Valabrega G, 2011, BREAST CANCER RES TR, V130, P29, DOI 10.1007/s10549-010-1281-5; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wu ZK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S7; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	57	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42573	10.1371/journal.pone.0042573	http://dx.doi.org/10.1371/journal.pone.0042573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905152	Green Published, gold			2022-12-25	WOS:000307331100050
J	Temunovic, M; Franjic, J; Satovic, Z; Grgurev, M; Frascaria-Lacoste, N; Fernandez-Manjarre, JF				Temunovic, Martina; Franjic, Jozo; Satovic, Zlatko; Grgurev, Marin; Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.			Environmental Heterogeneity Explains the Genetic Structure of Continental and Mediterranean Populations of Fraxinus angustifolia Vahl	PLOS ONE			English	Article							EXCELSIOR L.; CHLOROPLAST DNA; SPECIES DISTRIBUTIONS; NICHE CONSERVATISM; MOLECULAR ECOLOGY; GLACIAL REFUGIA; PHYLOGEOGRAPHY; LANDSCAPE; HISTORY; ASSOCIATION	Tree species with wide distributions often exhibit different levels of genetic structuring correlated to their environment. However, understanding how environmental heterogeneity influences genetic variation is difficult because the effects of gene flow, drift and selection are confounded. We investigated the genetic variation and its ecological correlates in a wind-pollinated Mediterranean tree species, Fraxinus angustifolia Vahl, within a recognised glacial refugium in Croatia. We sampled 11 populations from environmentally divergent habitats within the Continental and Mediterranean biogeographical regions. We combined genetic data analyses based on nuclear microsatellite loci, multivariate statistics on environmental data and ecological niche modelling (ENM). We identified a geographic structure with a high genetic diversity and low differentiation in the Continental region, which contrasted with the significantly lower genetic diversity and higher population divergence in the Mediterranean region. The positive and significant correlation between environmental and genetic distances after controlling for geographic distance suggests an important influence of ecological divergence of the sites in shaping genetic variation. The ENM provided support for niche differentiation between the populations from the Continental and Mediterranean regions, suggesting that contemporary populations may represent two divergent ecotypes. Ecotype differentiation was also supported by multivariate environmental and genetic distance analyses. Our results suggest that despite extensive gene flow in continental areas, long-term stability of heterogeneous environments have likely promoted genetic divergence of ashes in this region and can explain the present-day genetic variation patterns of these ancient populations.	[Temunovic, Martina; Franjic, Jozo] Univ Zagreb, Dept Forest Genet Dendrol & Bot, Fac Forestry, Zagreb 41000, Croatia; [Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Grgurev, Marin] State Inst Nat Protect, Zagreb, Croatia; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] AgroParisTech, Lab Ecol Systemat & Evolut, UMR 8079, Orsay, France; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] Univ Paris 11, UMR 8079, Orsay, France; [Frascaria-Lacoste, Nathalie; Fernandez-Manjarre, Juan F.] CNRS, UMR 8079, F-91405 Orsay, France	University of Zagreb; University of Zagreb; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Temunovic, M (corresponding author), Univ Zagreb, Dept Forest Genet Dendrol & Bot, Fac Forestry, Zagreb 41000, Croatia.	martina.temunovic@gmail.com	Šatović, Zlatko/AAA-9626-2020	Šatović, Zlatko/0000-0002-9848-1601; Frascaria-Lacoste, Nathalie/0000-0002-3425-7838	EU Network of Excellence EVOLTREE; bilateral project between Croatia and France within Cogito Programme of Hubert Curien Partnership (PHC) [25031UM]; Croatian Science Foundation doctoral fellowship [03.01/69]	EU Network of Excellence EVOLTREE; bilateral project between Croatia and France within Cogito Programme of Hubert Curien Partnership (PHC); Croatian Science Foundation doctoral fellowship	This study was supported by the EU Network of Excellence EVOLTREE (http://www.evoltree.eu) and by a bilateral project between Croatia and France (no. 25031UM) within Cogito Programme of Hubert Curien Partnership (PHC). M.T. was supported by a Croatian Science Foundation doctoral fellowship (03.01/69). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2011, MOL ECOL RESOUR, V11, P219, DOI 10.1111/j.1755-0998.2010.02944.x; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Bockelmann AC, 2003, MOL ECOL, V12, P505, DOI 10.1046/j.1365-294X.2003.01706.x; Bogdan S, 2007, PERIOD BIOL, V109, P1; Brachet S, 1999, MOL ECOL, V8, P160; Cavlovic J, 2010, PRVA NACIONALMA INVE; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fernandez-Manjarres JF, 2006, MOL ECOL, V15, P3245, DOI 10.1111/j.1365-294X.2006.02975.x; Ferrazzini D, 2007, ANN FOREST SCI, V64, P159, DOI 10.1051/forest:2006100; FRAXIGEN, 2005, ASH SPECIES IN EUROP, P128; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Fukarek P., 1983, SUMARSKA ENCIKLOPEDI; Gerard PR, 2006, MOL ECOL, V15, P3655, DOI 10.1111/j.1365-294X.2006.03032.x; Gonzalez-Martinez SC, 2010, MOL PHYLOGENET EVOL, V55, P805, DOI 10.1016/j.ympev.2010.03.001; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gram WK, 2001, ECOLOGY, V82, P2012, DOI 10.1890/0012-9658(2001)082[2012:ABEAGH]2.0.CO;2; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe A, 2003, MOL ECOL, V12, P3415, DOI 10.1046/j.1365-294X.2003.02006.x; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Heuertz M, 2006, MOL ECOL, V15, P2131, DOI 10.1111/j.1365-294X.2006.02897.x; Heuertz M, 2001, MOL ECOL, V10, P1615, DOI 10.1046/j.1365-294X.2001.01300.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Klimo E., 2008, FLOODPLAIN FORESTS T; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Lefort F, 1999, MOL ECOL, V8, P1088, DOI 10.1046/j.1365-294X.1999.00655_8.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Minch E, 1997, MICROSAT COMPUTER PR; Morand ME, 2002, MOL ECOL, V11, P377, DOI 10.1046/j.1365-294X.2002.01461.x; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; Stoffberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031946; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Surina B, 2011, J BIOGEOGR, V38, P1381, DOI 10.1111/j.1365-2699.2011.02493.x; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Tutin TG, 1972, FLORA EUROPAEA; Tzedakis PC, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P49; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WILLIS KJ, 1994, QUATERNARY SCI REV, V13, P769, DOI 10.1016/0277-3791(94)90104-X; Wright S, 1943, GENETICS, V28, P114; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	69	53	53	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42764	10.1371/journal.pone.0042764	http://dx.doi.org/10.1371/journal.pone.0042764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905171	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100064
J	Gao, ZX; Luo, W; Liu, H; Zeng, C; Liu, XL; Yi, SJ; Wang, WM				Gao, Zexia; Luo, Wei; Liu, Hong; Zeng, Cong; Liu, Xiaolian; Yi, Shaokui; Wang, Weimin			Transcriptome Analysis and SSR/SNP Markers Information of the Blunt Snout Bream (Megalobrama amblycephala)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANDIDATE GENES; SNP DISCOVERY; REVEALS; POLYMORPHISMS; GENERATION; SPECIATION; POPULATION; EVOLUTION; SELECTION	Background: Blunt snout bream (Megalobrama amblycephala) is an herbivorous freshwater fish species native to China and has been recognized as a main aquaculture species in the Chinese freshwater polyculture system with high economic value. Right now, only limited EST resources were available for M. amblycephala. Recent advances in large-scale RNA sequencing provide a fast, cost-effective, and reliable approach to generate large expression datasets for functional genomic analysis, which is especially suitable for non-model species with un-sequenced genomes. Methodology and Principal Findings: Using 454 pyrosequencing, a total of 1,409,706 high quality reads (total length 577 Mbp) were generated from the normalized cDNA of pooled M. amblycephala individuals. These sequences were assembled into 26,802 contigs and 73,675 singletons. After BLAST searches against the NCBI non-redundant (NR) and UniProt databases with an arbitrary expectation value of E-10, over 40,000 unigenes were functionally annotated and classified using the FunCat functional annotation scheme. A comparative genomics approach revealed a substantial proportion of genes expressed in M. amblycephala tanscriptome to be shared across the genomes of zebrafish, medaka, tetraodon, fugu, stickleback, human, mouse, and chicken, and identified a substantial number of potentially novel M. amblycephala genes. A total number of 4,952 SSRs were found and 116 polymorphic loci have been characterized. A significant number of SNPs (25,697) and indels (23,287) were identified based on specific filter criteria in the M. amblycephala. Conclusions: This study is the first comprehensive transcriptome analysis for a fish species belonging to the genus Megalobrama. These large EST resources are expected to be valuable for the development of molecular markers, construction of gene-based linkage map, and large-scale expression analysis of M. amblycephala, as well as comparative genome analysis for the genus Megalobrama fish species. The identified SSR and SNP markers will greatly benefit its breeding program and whole genome association studies.	[Gao, Zexia; Luo, Wei; Liu, Hong; Zeng, Cong; Liu, Xiaolian; Yi, Shaokui; Wang, Weimin] Huazhong Agr Univ, Key Lab Freshwater Anim Breeding, Key Lab Agr Anim Genet Breeding & Reprod, Coll Fisheries,Minist Agr,Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Gao, ZX (corresponding author), Huazhong Agr Univ, Key Lab Freshwater Anim Breeding, Key Lab Agr Anim Genet Breeding & Reprod, Coll Fisheries,Minist Agr,Minist Educ, Wuhan, Peoples R China.	wangwm@mail.hzau.edu.cn	YI, Shaokui/GZH-2932-2022; Yi, Shaokui/I-5726-2019; Zeng, Cong/J-4933-2014	YI, Shaokui/0000-0003-2325-0179; Zeng, Cong/0000-0003-1003-9382	Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System" [CARS-46-05]; Fundamental Research Funds for the Central Universities [2011PY023, 2011PY043, 52902-0900202146]	Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System"; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the grants from Modern Agroindustry Technology Research System entitled "Staple Freshwater Fishery Industry Technology System" (No. CARS-46-05), Fundamental Research Funds for the Central Universities (No. 2011PY023, 2011PY043 and 52902-0900202146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016368; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; *CAFS, 2001, FISH STAT DAT; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Du ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004837; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kim ES, 2009, ANIM GENET, V40, P300, DOI 10.1111/j.1365-2052.2008.01832.x; Klmer KR, 2010, MOL ECOL S1, V19, P197; Li HH, 2008, FRESHW FISHERIES, V38, P63; LI SF, 1993, AQUACULTURE, V111, P117, DOI 10.1016/0044-8486(93)90030-3; Li SF, 1996, J FISHERIES CHINA, V3, P1; Li Shao-wu, 2006, Journal of Fishery Sciences of China, V13, P187; Li WT, 2007, MOL ECOL NOTES, V7, P771, DOI 10.1111/j.1471-8286.2007.01689.x; Li Y, 2010, THESIS HUAZHONG AGR, DOI DOI 10.1093/bioinformatics/bts460; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; THURSTON MI, 2005, MSATFINDER DETECTION; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang WM, 2009, SCI FISH FARMING, V4, P44; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xu W, 2008, J HYDROECOL, V1, P7; ZHANG D, 2001, J CHINA 3 GORGES U, V3, P282	53	200	224	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42637	10.1371/journal.pone.0042637	http://dx.doi.org/10.1371/journal.pone.0042637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880060	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000053
J	Gaddi, PJ; Crane, MJ; Kamanaka, M; Flavell, RA; Yap, GS; Salazar-Mather, TP				Gaddi, Pamela J.; Crane, Meredith J.; Kamanaka, Masahito; Flavell, Richard A.; Yap, George S.; Salazar-Mather, Thais P.			IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection	PLOS ONE			English	Article							T-CELL RESPONSES; NATURAL-KILLER-CELLS; ANTIVIRAL DEFENSE; VIRUS-INFECTION; CYTOKINE PRODUCTION; VIRAL PERSISTENCE; IFN-GAMMA; IN-VIVO; EXPRESSION; HEPATITIS	Various cell types in both lymphoid and non-lymphoid tissues produce the anti-inflammatory cytokine interleukin (IL)-10 during murine cytomegalovirus (MCMV) infection. The functions of IL-10 in the liver during acute infection and the cells that generate this cytokine at this site have not been extensively investigated. In this study, we demonstrate that the production of IL-10 in the liver is elevated in C57BL/6 mice during late acute MCMV infection. Using IL-10 green fluorescence protein (GFP) reporter knock-in mice, designated IL-10-internal ribosomal entry site (IRES)-GFP-enhanced reporter (tiger), NK cells are identified as major IL-10 expressing cells in the liver after infection, along with T cells and other leukocytes. In the absence of IL-10, mice exhibit marked elevations in proinflammatory cytokines and in the numbers of mononuclear cells and lymphocytes infiltrating the liver during this infection. IL-10-deficiency also enhances liver injury without improving viral clearance from this site. Collectively, the results indicate that IL-10-producing cells in the liver provide protection from collateral injury by modulating the inflammatory response associated with MCMV infection.	[Gaddi, Pamela J.; Crane, Meredith J.; Salazar-Mather, Thais P.] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Gaddi, Pamela J.; Crane, Meredith J.; Salazar-Mather, Thais P.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Kamanaka, Masahito; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Yap, George S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Yap, George S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA	Brown University; Brown University; Yale University; Howard Hughes Medical Institute; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gaddi, PJ (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Thais_Mather@brown.edu			Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship [1F31AI075614-01]; National Institutes of Health [AI083405, AA018772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083405, R01AI083405, F31AI075614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018772] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ruth L. Kirschstein National Research Service Award Individual Pre-doctoral Fellowship, 1F31AI075614-01 (to PJG), and in part by National Institutes of Health Grants AI083405 (to GSY) and AA018772 (to TSM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039161; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Endharti AT, 2011, J IMMUNOL, V186, P41, DOI 10.4049/jimmunol.1000800; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Gold MC, 2002, J IMMUNOL, V169, P359, DOI 10.4049/jimmunol.169.1.359; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; KOSZINOWSKI UH, 1990, CURR TOP MICROBIOL, V154, P189; KOSZINOWSKI UH, 1991, CURR OPIN IMMUNOL, V3, P471, DOI 10.1016/0952-7915(91)90005-L; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Lin MT, 1998, VIROLOGY, V245, P270, DOI 10.1006/viro.1998.9170; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Mutnal MB, 2010, J NEUROIMMUNOL, V227, P101, DOI 10.1016/j.jneuroim.2010.06.020; Oakley OR, 2008, CLIN EXP IMMUNOL, V151, P155, DOI 10.1111/j.1365-2249.2007.03533.x; OLVER SD, 1994, CLIN EXP IMMUNOL, V98, P375; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Redpath S, 1999, J IMMUNOL, V162, P6701; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Schlub TE, 2011, J IMMUNOL, V187, P1385, DOI 10.4049/jimmunol.1100416; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Sharma S, 2011, P NATL ACAD SCI USA, V108, P19001, DOI 10.1073/pnas.1107087108; Sumaria N, 2009, IMMUNOL CELL BIOL, V87, P559, DOI 10.1038/icb.2009.41; Sun J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002173; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tang-Feldman YJ, 2011, INFLAMM RES, V60, P233, DOI 10.1007/s00011-010-0259-4; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037	66	24	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42850	10.1371/journal.pone.0042850	http://dx.doi.org/10.1371/journal.pone.0042850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880122	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100176
J	Qin, XH; Li, JP; Zhang, Y; Ma, W; Fan, FF; Wang, BY; Xing, HX; Tang, GF; Wang, XB; Xu, X; Xu, XP; Huo, Y				Qin, Xianhui; Li, Jianping; Zhang, Yan; Ma, Wei; Fan, Fangfang; Wang, Binyan; Xing, Houxun; Tang, Genfu; Wang, Xiaobin; Xu, Xin; Xu, Xiping; Huo, Yong			Prevalence and Associated Factors of Diabetes and Impaired Fasting Glucose in Chinese Hypertensive Adults Aged 45 to 75 Years	PLOS ONE			English	Article							RISK-FACTORS; METABOLIC SYNDROME; POPULATION; DISEASE; METAANALYSIS; MELLITUS; C677T; MEN; POLYMORPHISMS; HOMOCYSTEINE	Objective: This study examined the prevalence of impaired fasting glucose (IFG) and diabetes and their associated factors in 17,184 Chinese hypertensive adults aged 45-75 years. Methods: A cross-sectional investigation was carried out in a rural area of Lianyungang, China. Previously undiagnosed diabetes [fasting plasma glucose (FPG) >= 7.0mmol/l] and IFG (6.1-6.9mmol/l) were defined based on FPG concentration. Previously diagnosed diabetes was determined on the basis of self-report. Total diabetes included both previously diagnosed diabetes and previously undiagnosed diabetes. Results: The prevalence of previously diagnosed diabetes, undiagnosed diabetes, and IFG were 3.4%, 9.8%, and 14.1%, respectively. About 74.2% of the participants with diabetes had not previously been diagnosed. In the multivariable logistic-regression model, older age, men, antihypertensive treatment, obesity (BMI >= 25kg/m(2)), abdominal obesity (waist circumference >= 90cm for men and >= 80cm for women), non-current smoking, a family history of diabetes, higher heart rate, lower physical activity levels, and inland residence (versus coastal) were significantly associated with both total diabetes and previously undiagnosed diabetes. Furthermore, methylene-tetrahydrofolate reductase (MTHFR) 677 TT genotype was an independent associated factor for total diabetes, and current alcohol drinking was an independent associated factor for previously undiagnosed diabetes. At the same time, older age, men, abdominal obesity, non-current smoking, current alcohol drinking, a family history of diabetes, higher heart rate, and inland residence (versus coastal) were important independent associated factors for IFG. Conclusion: In conclusion, we found a high prevalence of diabetes in Chinese hypertensive adults. Furthermore, about three out of every four diabetic adults were undiagnosed. Our results suggest that population-level measures aimed at the prevention, identification (even if only based on the FPG evaluation), and treatment of diabetes should be urgently taken to overcome the diabetes epidemic in Chinese hypertensive adults.	[Qin, Xianhui; Wang, Binyan] Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; [Li, Jianping; Zhang, Yan; Ma, Wei; Fan, Fangfang; Huo, Yong] Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China; [Xing, Houxun] Lianyungang Ctr Adv Res Cardiovasc Dis, Lianyungang, Peoples R China; [Tang, Genfu] Anhui Med Univ, Sch Hlth Adm, Hefei, Peoples R China; [Wang, Xiaobin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Early Life Origins Dis, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Xu, Xin; Xu, Xiping] So Med Univ, Inst Nephrol, Guangzhou, Guangdong, Peoples R China	Anhui Medical University; Peking University; Anhui Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Southern Medical University - China	Qin, XH (corresponding author), Anhui Med Univ, Inst Biomed, Hefei, Peoples R China.	xipingxu18@gmail.com; huoyong@263.net.cn	Xu, Xin/A-1687-2016; Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022	Xu, Xin/0000-0002-6324-5211; Qin, Xianhui/0000-0001-7812-7982	Ministry of Science and Technology of the People's Republic of China [2012zx09101-105]; Major State Basic Research Development Program of China (973 program) [2012CB517703]; Department of Development and Reform, Shenzhen [(2010)1744]; Department of Science, Industry, Trade and Information Technology, Shenzhen	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Department of Development and Reform, Shenzhen; Department of Science, Industry, Trade and Information Technology, Shenzhen	The study was supported by The Ministry of Science and Technology of the People's Republic of China (2012zx09101-105); The Major State Basic Research Development Program of China (973 program, No.2012CB517703); Department of Development and Reform, Shenzhen (2010)1744; Department of Science, Industry, Trade and Information Technology, Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belalcazar LM, 2010, DIABETES CARE, V33, P197, DOI 10.2337/dc09-1235; Benes P, 2001, MOL GENET METAB, V73, P188, DOI 10.1006/mgme.2001.3188; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chang YH, 2011, CLIN BIOCHEM, V44, P1370, DOI 10.1016/j.clinbiochem.2011.09.020; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Iimura O, 1996, Hypertens Res, V19 Suppl 1, pS1, DOI 10.1291/hypres.19.SupplementI_S1; International Diabetes Federation, IDF CONS WORLDW DEF; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Movva S, 2011, GENET TEST MOL BIOMA, V15, P257, DOI 10.1089/gtmb.2010.0118; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Qin XH, 2012, PHARMACOGENET GENOM, V22, P421, DOI 10.1097/FPC.0b013e32834ac5e8; Qin XH, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-2; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi ZM, 2010, NEW ENGL J MED, V362, P2425, DOI 10.1056/NEJMc1004671; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Sun ZQ, 2009, ACTA CARDIOL, V64, P351, DOI 10.2143/AC.64.3.2038021; *WHO W PAC REG INT, 2000, AS PAC PERSP RED OB; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125; Zhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068	31	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42538	10.1371/journal.pone.0042538	http://dx.doi.org/10.1371/journal.pone.0042538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880024	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100124
J	Coneyworth, LJ; Jackson, KA; Tyson, J; Bosomworth, HJ; van der Hagen, E; Hann, GM; Ogo, OA; Swann, DC; Mathers, JC; Valentine, RA; Ford, D				Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Swann, Daniel C.; Mathers, John C.; Valentine, Ruth A.; Ford, Dianne			Identification of the Human Zinc Transcriptional Regulatory Element (ZTRE) A PALINDROMIC PROTEIN-BINDING DNA SEQUENCE RESPONSIBLE FOR ZINC-INDUCED TRANSCRIPTIONAL REPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIETARY ZINC; FACTOR MTF-1; NUCLEOTIDE-SEQUENCE; TRANSPORTERS; METAL; HOMEOSTASIS; DEFICIENCY; EXPRESSION; ZNT5; ACTIVATION	Many genes with crucial roles in zinc homeostasis in mammals respond to fluctuating zinc supply through unknown mechanisms, and uncovering these mechanisms is essential to understanding the process at cellular and systemic levels. We detected zinc-dependent binding of a zinc-induced protein to a specific sequence, the zinc transcriptional regulatory element (ZTRE), in the SLC30A5 (zinc transporter ZnT5) promoter and showed that substitution of the ZTRE abrogated the repression of a reporter gene in response to zinc. We identified the ZTRE in other genes, including (through an unbiased search) the CBWD genes and (through targeted analysis) in multiple members of the SLC30 family, including SLC30A10, which is repressed by zinc. The function of the CBWD genes is currently unknown, but roles for homologs in metal homeostasis are being uncovered in bacteria. We demonstrated that CBWD genes are repressed by zinc and that substitution of the ZTRE in SLC30A10 and CBWD promoter-reporter constructs abrogates this response. Other metals did not affect expression of the transcriptional regulator, binding to the ZTRE or promoter-driven reporter gene expression. These findings provide the basis for elucidating how regulation of a network of genes through this novel mechanism contributes to zinc homeostasis and how the cell orchestrates this response.	[Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Swann, Daniel C.; Valentine, Ruth A.; Ford, Dianne] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4NN, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Coneyworth, Lisa J.; Jackson, Kelly A.; Tyson, John; Bosomworth, Helen J.; van der Hagen, Eline; Hann, Georgia M.; Ogo, Ogo A.; Mathers, John C.; Valentine, Ruth A.; Ford, Dianne] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Bosomworth, Helen J.; Valentine, Ruth A.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Ford, D (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4NN, Tyne & Wear, England.	dianne.ford@ncl.ac.uk		Swan, Daniel/0000-0001-8978-8129; Mathers, John/0000-0003-3406-3002; tyson, John/0000-0002-1108-7602; Jackson, Kelly/0000-0001-9116-3769	Biotechnology and Biological Sciences Research Council [BB/F019637/1, BB/D01669X/2]; Medical Research Council; Tertiary Education Trust through Benue State University, Makurdi, Nigeria; Human Nutrition Research Centre, Newcastle University; BBSRC [BB/D01669X/2, BB/F019637/1, BB/D01669X/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D01669X/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tertiary Education Trust through Benue State University, Makurdi, Nigeria; Human Nutrition Research Centre, Newcastle University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council Research Grants BB/F019637/1 (to D. F.) and BB/D01669X/2 (to R. A. V.) plus a Ph.D. studentship supporting L. J. C. (awarded to D. F.); Medical Research Council Ph.D. studentships supporting K. A. J. (awarded to D. F.) and supporting H. J. B. (awarded to R. A. V.); the Tertiary Education Trust Fund through Benue State University, Makurdi, Nigeria (Ph.D. studentship supporting O. A. O.); and the Human Nutrition Research Centre, Newcastle University (vacation studentship supporting G. M. H.).	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Chowanadisai W, 2005, J NEUROCHEM, V94, P510, DOI 10.1111/j.1471-4159.2005.03246.x; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; CROUZET J, 1991, J BACTERIOL, V173, P6074, DOI 10.1128/jb.173.19.6074-6087.1991; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Ford D, 2011, P NUTR SOC, V70, P374, DOI 10.1017/S0029665111000851; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Helston RM, 2007, PLACENTA, V28, P437, DOI 10.1016/j.placenta.2006.07.002; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mendel RR, 2007, NAT PROD REP, V24, P963, DOI 10.1039/b703112m; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Radtke F, 1996, BIOL CHEM H-S, V377, P47, DOI 10.1515/bchm3.1996.377.1.47; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Thornton JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023878; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wong A, 2004, GENOMICS, V84, P239, DOI 10.1016/j.ygeno.2004.03.001; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	44	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36567	36581		10.1074/jbc.M112.397000	http://dx.doi.org/10.1074/jbc.M112.397000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22902622	Green Published, hybrid			2022-12-25	WOS:000310364000077
J	Fei, J; Chen, JJ				Fei, Jia; Chen, Junjie			KIAA1530 Protein Is Recruited by Cockayne Syndrome Complementation Group Protein A (CSA) to Participate in Transcription-coupled Repair (TCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UV-SENSITIVE SYNDROME; NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; NUCLEAR-MATRIX; IN-VIVO; DAMAGE; CHROMATIN; IRRADIATION; MUTATIONS	Transcription-coupled repair (TCR) is the major pathway involved in the removal of UV-induced photolesions from the transcribed strand of active genes. Two Cockayne syndrome (CS) complementation group proteins, CSA and CSB, are important for TCR repair. The molecular mechanisms by which CS proteins regulate TCR remain elusive. Here, we report the characterization of KIAA1530, an evolutionarily conserved protein that participates in this pathway through its interaction with CSA and the TFIIH complex. We found that UV irradiation led to the recruitment of KIAA1530 onto chromatin in a CSA-dependent manner. Cells lacking KIAA1530 were highly sensitive to UV irradiation and displayed deficiency in TCR. In addition, KIAA1530 depletion abrogated stability of the CSB protein following UV irradiation. More excitingly, we found that a unique CSA mutant (W361C), which was previously identified in a patient with (UVS)-S-s syndrome, showed defective KIAA1530 binding and resulted in a failure of recruiting KIAA1530 and stabilizing CSB after UV treatment. Together, our data not only reveal that KIAA1530 is an important player in TCR but also lead to a better understanding of the molecular mechanism underlying (UVS)-S-s syndrome.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Rm Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Fei, Jia/G-6866-2011; Fei, Jia/K-3287-2016	Fei, Jia/0000-0003-0612-6176	Swiss National Science Foundation [PBZHP3-135924]; Department of Defense [W81XWH-05-1-0470]; MD Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Department of Defense(United States Department of Defense); MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Postdoctoral Fellowship PBZHP3-135924 from the Swiss National Science Foundation.; Recipient of Era of Hope Scholar Award W81XWH-05-1-0470 from the Department of Defense and MD Anderson Cancer Center Support Grant CA016672. To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, Unit 66, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Rm. Y3.6006, Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5396; E-mail: jchen8@mdanderson.org.	Beerens N, 2005, J BIOL CHEM, V280, P4722, DOI 10.1074/jbc.M409147200; Bhatia PK, 1996, J BACTERIOL, V178, P5977, DOI 10.1128/jb.178.20.5977-5988.1996; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; FUJIWARA Y, 1981, J INVEST DERMATOL, V77, P256, DOI 10.1111/1523-1747.ep12482447; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; ITOH T, 1995, AM J HUM GENET, V56, P1267; ITOH T, 1994, MUTAT RES, V314, P233, DOI 10.1016/0921-8777(94)90068-X; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Koehler DR, 1996, NUCLEIC ACIDS RES, V24, P2877, DOI 10.1093/nar/24.15.2877; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; MITCHELL DL, 1990, J BIOL CHEM, V265, P5353; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	31	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35118	35126		10.1074/jbc.M112.398131	http://dx.doi.org/10.1074/jbc.M112.398131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902626	Green Published, hybrid			2022-12-25	WOS:000309968000022
J	Girault, EM; Alkemade, A; Foppen, E; Ackermans, MT; Fliers, E; Kalsbeek, A				Girault, Elodie M.; Alkemade, Anneke; Foppen, Ewout; Ackermans, Mariette T.; Fliers, Eric; Kalsbeek, Andries			Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; LIVER PLASMA-MEMBRANE; ATYPICAL ANTIPSYCHOTICS; IN-VIVO; RECEPTOR; RAT; SCHIZOPHRENIA; PHOSPHORYLATION; PREDOMINANCE; OCCUPANCY	Atypical antipsychotic drugs such as Olanzapine induce weight gain and metabolic changes associated with the development of type 2 diabetes. The mechanisms underlying the metabolic side-effects of these centrally acting drugs are still unknown to a large extent. We compared the effects of peripheral (intragastric; 3 mg/kg/h) versus central (intracerebroventricular; 30 mg/kg/h) administration of Olanzapine on glucose metabolism using the stable isotope dilution technique (Experiment 1) in combination with low and high hyperinsulinemic-euglycemic clamps (Experiments 2 and 3), in order to evaluate hepatic and extra-hepatic insulin sensitivity, in adult male Wistar rats. Blood glucose, plasma corticosterone and insulin levels were measured alongside endogenous glucose production and glucose disappearance. Livers were harvested to determine glycogen content. Under basal conditions peripheral administration of Olanzapine induced pronounced hyperglycemia without a significant increase in hepatic glucose production (Experiment 1). The clamp experiments revealed a clear insulin resistance both at hepatic (Experiment 2) and extra-hepatic levels (Experiment 3). The induction of insulin resistance in Experiments 2 and 3 was supported by decreased hepatic glycogen stores in Olanzapine-treated rats. Central administration of Olanzapine, however, did not result in any significant changes in blood glucose, plasma insulin or corticosterone concentrations nor in glucose production. In conclusion, acute intragastric administration of Olanzapine leads to hyperglycemia and insulin resistance in male rats. The metabolic side-effects of Olanzapine appear to be mediated primarily via a peripheral mechanism, and not to have a central origin.	[Girault, Elodie M.; Foppen, Ewout; Kalsbeek, Andries] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Alkemade, Anneke; Foppen, Ewout; Fliers, Eric; Kalsbeek, Andries] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Ackermans, Mariette T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Endocrinol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Girault, EM (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.girault@nin.knaw.nl	Kalsbeek, Andries/H-3076-2019	Kalsbeek, Andries/0000-0001-9606-8453; Fliers, Eric/0000-0001-8048-9050	Top Institute Pharma [T2-105]	Top Institute Pharma	This work was supported in part by a grant from Top Institute Pharma (project T2-105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Belanoff JK, 2011, EUR J PHARMACOL, V655, P117, DOI 10.1016/j.ejphar.2011.01.019; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Citrome L, 2004, POSTGRAD MED, V116, P49, DOI 10.3810/pgm.2004.10.1601; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; Hoiberg MP, 2006, NORD J PSYCHIAT, V60, P207, DOI 10.1080/08039480600636296; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; Huang XF, 2006, BEHAV BRAIN RES, V171, P355, DOI 10.1016/j.bbr.2006.03.040; IMOTO M, 1985, BIOCHEM BIOPH RES CO, V127, P885, DOI 10.1016/S0006-291X(85)80026-7; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KAWAI Y, 1986, J CLIN ENDOCR METAB, V62, P827, DOI 10.1210/jcem-62-5-827; Kirk SL, 2009, PSYCHOPHARMACOLOGY, V207, P119, DOI 10.1007/s00213-009-1639-8; Lee CT, 2002, J CLIN PSYCHIAT, V63, P569, DOI 10.4088/JCP.v63n0706; Lublin H, 2005, INT CLIN PSYCHOPHARM, V20, P183, DOI 10.1097/00004850-200507000-00001; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; NASSAR CF, 1986, GEN PHARMACOL, V17, P367, DOI 10.1016/0306-3623(86)90057-1; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; Ruddell RG, 2008, J HEPATOL, V48, P666, DOI 10.1016/j.jhep.2008.01.006; Sirota P, 2006, HUM PSYCHOPHARM CLIN, V21, P227, DOI 10.1002/hup.763; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; van Bruggen J, 2003, INT CLIN PSYCHOPHARM, V18, P341, DOI 10.1097/00004850-200311000-00005; VANDERVIES J, 1954, BIOCHEM J, V57, P410, DOI 10.1042/bj0570410; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Wetterling T, 2001, DRUG SAFETY, V24, P59, DOI 10.2165/00002018-200124010-00005	33	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43244	10.1371/journal.pone.0043244	http://dx.doi.org/10.1371/journal.pone.0043244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905238	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800063
J	M'Kada, H; Perazzo, H; Munteanu, M; Ngo, Y; Ramanujam, N; Fautrel, B; Imbert-Bismut, F; Ratziu, V; Schuppe-Koistinen, I; Leblond, V; Delattre, JY; Samson, Y; Caen, OL; Bricaire, F; Khayat, D; Pierrot-Deseilligny, C; Herson, S; Amoura, Z; Tilleul, P; Deckmyn, O; Coriat, P; Delpech, VN; Boulogne, P; Bonnefont-Rousselot, D; Poynard, T				M'Kada, Helmi; Perazzo, Hugo; Munteanu, Mona; Ngo, Yen; Ramanujam, Nittia; Fautrel, Bruno; Imbert-Bismut, Francoise; Ratziu, Vlad; Schuppe-Koistinen, Ina; Leblond, Veronique; Delattre, Jean Yves; Samson, Yves; Caen, Olivier Lyon; Bricaire, Francois; Khayat, David; Pierrot-Deseilligny, Charles; Herson, Serge; Amoura, Zahir; Tilleul, Patrick; Deckmyn, Olivier; Coriat, Pierre; Delpech, Vincent Nicolas; Boulogne, Philippe; Bonnefont-Rousselot, Dominique; Poynard, Thierry		DILI-GHPS Grp; SAFE-T Consortium	Real Time Identification of Drug-Induced Liver Injury (DILI) through Daily Screening of ALT Results: A Prospective Pilot Cohort Study	PLOS ONE			English	Article							ALANINE TRANSAMINASE-ACTIVITY; PREVALENCE; ADMISSIONS; BIOMARKER; EVENTS; VALUES	Objective: Identification of drug-induced liver disease (DILI) is difficult, even among hospitalized patients. The aim of this pilot study was to assess the impact of a specific strategy for DILI screening. Design: We prospectively compared the number of acute DILI cases identified in one week of a proactive strategy based on centralized elevated ALT values to those identified with a standard of care strategy for 24-week period based on referral cases to the hepatology unit. In the centralized strategy, a designated study biochemist identified patients with ALT greater than 3 times the upper limit of normal values (ULN) and notified the designated hepatologists, who then went to the patients' wards, analyzed the charts, and if necessary, interviewed the identified patients. During these two periods, patients with possible DILI were included after signing an informed consent in an ongoing European diagnostic study (SAFE-T consortium). Results: During the 24-week period of the standard strategy, 12 (0.04%) patients out of a total of 28,145 were identified as having possible DILI, and 11 of these accepted to be included in the protocol. During the one-week proactive period, 7 patients out of a total of 1407 inpatients (0.498%) [odds ratio vs. standard = 12.1 (95% CI, 3.9-32.3); P < 0.0001] were identified with possible DILI, and 5 were included in the protocol. Conclusion: A simple strategy based on the daily analysis of cases with ALT > 3 ULN by designated biochemists and hepatologists identified 12 times more acute cases of drug-induced liver disease than the standard strategy. This pilot cohort is registered on the number AP-HP P110201/1/08-03-2011 and AFSSAPS B110346-70.	[M'Kada, Helmi; Ramanujam, Nittia; Imbert-Bismut, Francoise; Ratziu, Vlad; Bonnefont-Rousselot, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75634 Paris, France; [M'Kada, Helmi; Perazzo, Hugo; Ramanujam, Nittia; Poynard, Thierry] Univ Paris 06, AP HP, Ctr Liver, Paris, France; [Munteanu, Mona; Ngo, Yen; Deckmyn, Olivier] Biopredictive, Paris, France; [Fautrel, Bruno] GHPS, Rheumatol Unit, Paris, France; [Schuppe-Koistinen, Ina] Astra Zeneca, Sodertalje, Sweden; [Leblond, Veronique] GHPS, Hematol Unit, Paris, France; [Delattre, Jean Yves] GHPS, Neurol Unit 2, Paris, France; [Samson, Yves] GHPS, Cerebral Vasc Emergency Unit, Paris, France; [Bricaire, Francois] GHPS, Infect Dis Unit, Paris, France; [Caen, Olivier Lyon] Neurol 4 GHPS, Paris, France; [Khayat, David] GHPS, Oncol Unit, Paris, France; [Pierrot-Deseilligny, Charles] Neurol 1 GHPS, Paris, France; [Herson, Serge] Internal Med 2 GHPS, Paris, France; [Amoura, Zahir] Internal Med 1 GHPS, Paris, France; [Tilleul, Patrick] GHPS, Pharmacol Unit, Paris, France; [Coriat, Pierre] Intens Care Anesthesiol GHPS, Paris, France; [Delpech, Vincent Nicolas] Adm Direct GHPS, Paris, France; [Boulogne, Philippe] GHPS, Informat Technol Unit, Paris, France; [Bonnefont-Rousselot, Dominique] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4466, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; AstraZeneca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	M'Kada, H (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75634 Paris, France.	tpoynard@teaser.fr	Rousselot, Bonnefont/U-7434-2019; samson, yves/C-5647-2013; Poynard, Thierry/C-1355-2010; AMOURA, Zahir/P-5324-2017; BACHET, Jean-Baptiste/N-6943-2017; Amoura, Zahir/P-5325-2017	Poynard, Thierry/0000-0002-3726-7230; AMOURA, Zahir/0000-0003-0292-9043; BACHET, Jean-Baptiste/0000-0003-4337-286X; Munteanu, Mona/0000-0003-4517-2757; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; delpech, valerie/0000-0002-9952-8109; Poynard, Thierry/0000-0002-2050-640X; Deckmyn, Olivier/0000-0002-1589-9368; samson, yves/0000-0002-8080-1427; Perazzo, Hugo/0000-0003-0931-6418; Schuppe-Koistinen, Ina/0000-0002-1423-3089	Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium	Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium	This study was supported by the Innovative Medicines Initiative Safer and Faster Evidence-based Translation (IMI-SAFE-T) consortium (FP-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader T, 2012, J HEPATOL, V56, P305, DOI 10.1016/j.jhep.2011.08.016; Bagheri H, 2000, BRIT J CLIN PHARMACO, V50, P479, DOI 10.1046/j.1365-2125.2000.00282.x; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BENICHOU C, 1993, J CLIN EPIDEMIOL, V46, P1331, DOI 10.1016/0895-4356(93)90102-7; Carey EJ, 2008, DIGEST DIS SCI, V53, P1977, DOI 10.1007/s10620-008-0250-x; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Devarbhavi H, 2010, AM J GASTROENTEROL, V105, P2396, DOI 10.1038/ajg.2010.287; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEWIS JH, 1989, HEPATOLOGY, V9, P679, DOI 10.1002/hep.1840090504; M'Kada H, 2011, REGUL TOXICOL PHARM, V60, P290, DOI 10.1016/j.yrtph.2011.04.002; Matheis K, 2011, DRUG DISCOV TODAY, V16, P600, DOI 10.1016/j.drudis.2011.04.011; Meier Y, 2005, EUR J CLIN PHARMACOL, V61, P135, DOI 10.1007/s00228-004-0888-z; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Nebeker JR, 2007, MED CARE, V45, pS81, DOI 10.1097/MLR.0b013e3180616c2c; Ozer JS, 2010, BIOMARK MED, V4, P475, DOI 10.2217/BMM.10.9; Ozer JS, 2010, REGUL TOXICOL PHARM, V56, P237, DOI 10.1016/j.yrtph.2009.11.001; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Stausberg J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-134; Verma S, 2009, GUT, V58, P1555, DOI 10.1136/gut.2008.163675; Watkins PB, 2008, HEPATOLOGY, V48, P1680, DOI 10.1002/hep.22633	21	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42418	10.1371/journal.pone.0042418	http://dx.doi.org/10.1371/journal.pone.0042418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905129	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800010
J	Pardee, TS				Pardee, Timothy S.			Overexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE RESPONSE; GROUP-B; MEDIATED TRANSCRIPTION; PROGNOSTIC-FACTORS; AML; CANCER; CYTOGENETICS; CONTRIBUTES; EXPRESSION	Background: The transcriptional co-activator MN1 confers a worse prognosis for patients with acute myeloid leukemia (AML) when highly expressed; however, the mechanisms involved are unknown. We sought to model the effects of high MN1 expression in AML models to explore the underlying mechanisms. Methodology/Principal Findings: We used cell lines and a genetically defined mouse model of AML to examine the effects of MN1 overexpression on prognosis and response to cytarabine and doxorubicin in vitro and in vivo. Murine AML that was engineered to overexpress MN1 became more aggressive in vivo, leading to shortened survival in both treated and control groups. In vitro murine AML cells that overexpressed MN1 became resistant to treatment with cytarabine and highly resistant to doxorubicin. This resistant phenotype was also seen in vivo, where treatment with the combination of cytarabine and doxorubicin selected for cells expressing MN1. When therapy-induced DNA damage levels were assessed by gamma H2AX foci, no reduction was seen in MN1 expressing cells arguing against a drug efflux mechanism. Despite no reduction in DNA damage, MN1-expressing cells showed less apoptosis as assessed by annexin V and propidium iodide staining. Following treatment, p53 and BIM induction were markedly reduced in cells expressing MN1. Pharmacologic inhibition of the p53 E3 ligase MDM2 resulted in increased p53 levels and improved response to doxorubicin in vitro. Conclusions/Significance: MN1 overexpression accelerates an already aggressive leukemia, confers resistance to chemotherapy, and suppresses p53 and BIM induction, resulting in decreased apoptosis. This provides a mechanistic explanation of the poor prognosis observed with high MN1 expression and suggests that therapies directed at increasing p53 function may be useful for these patients.	[Pardee, Timothy S.] Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27157 USA; [Pardee, Timothy S.] Wake Forest Sch Med, Dept Canc Biol, Ctr Comprehens Canc, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University	Pardee, TS (corresponding author), Wake Forest Univ Hlth Sci, Dept Internal Med, Sect Hematol & Oncol, Winston Salem, NC 27157 USA.	tspardee@wakehealth.edu		Pardee, Timothy/0000-0002-1186-6948	National Cancer Institute [P30CA012197]; Doug Coley Leukemia Research Foundation; MacKay Foundation for Cancer Research; Leight Endowed Research Fund; Frances P. Tutwiler Fund; NATIONAL CANCER INSTITUTE [P30CA012197, K08CA169809] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doug Coley Leukemia Research Foundation; MacKay Foundation for Cancer Research; Leight Endowed Research Fund; Frances P. Tutwiler Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the studies contained in the manuscript was obtained from: The Doug Coley Leukemia Research Foundation (http://dougcoleyfoundation.org/), The MacKay Foundation for Cancer Research (http://www.mackayfoundation.org/), The Leight Endowed Research Fund and the Frances P. Tutwiler Fund. Additional support provided by P30CA012197 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953; Boehrer S, 2009, ONCOGENE, V28, P2205, DOI 10.1038/onc.2009.69; BUIJS A, 1995, ONCOGENE, V10, P1511; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; CHEN W, 1989, LEUKEMIA, V3, P264; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Farag SS, 2006, BLOOD, V108, P63, DOI 10.1182/blood-2005-11-4354; Frohling S, 2006, BLOOD, V108, P3280, DOI 10.1182/blood-2006-04-014324; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Haferlach C, 2011, GENES CHROMOSOMES CA; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Ju JF, 1998, CLIN CANCER RES, V4, P1315; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kornblau SM, 2010, CLIN CANCER RES, V16, P1865, DOI 10.1158/1078-0432.CCR-09-2551; Langer C, 2009, J CLIN ONCOL, V27, P3198, DOI 10.1200/JCO.2008.20.6110; Lee BD, 2007, LEUKEMIA RES, V31, P1131, DOI 10.1016/j.leukres.2006.11.012; Lin Yunping, 1997, Leukemia (Basingstoke), V11, P324; Liu T, 2010, LEUKEMIA, V24, P601, DOI 10.1038/leu.2009.272; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Pardee TS, 2012, BLOOD, V119, P3561, DOI 10.1182/blood-2011-06-362442; Pardee TS, 2011, EXP HEMATOL; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Seedhouse CH, 2006, LEUKEMIA, V20, P2130, DOI 10.1038/sj.leu.2404439; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; Thepot S, 2011, CELL CYCLE, V10, P2323, DOI 10.4161/cc.10.14.16399; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walker A, 2011, HAEMATOL-HEMATOL J, V96, P640, DOI 10.3324/haematol.2011.042739; Yin B, 2006, EXP HEMATOL, V34, P631, DOI 10.1016/j.exphem.2006.01.015; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43185	10.1371/journal.pone.0043185	http://dx.doi.org/10.1371/journal.pone.0043185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905229	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800058
J	Wagenaar, BH; Christiansen-Lindquist, L; Khosropour, C; Salazar, LF; Benbow, N; Prachand, N; Sineath, RC; Stephenson, R; Sullivan, PS				Wagenaar, Bradley H.; Christiansen-Lindquist, Lauren; Khosropour, Christine; Salazar, Laura F.; Benbow, Nanette; Prachand, Nik; Sineath, R. Craig; Stephenson, Rob; Sullivan, Patrick S.			Willingness of US Men Who Have Sex with Men (MSM) to Participate in Couples HIV Voluntary Counseling and Testing (CVCT)	PLOS ONE			English	Article							DISCORDANT COUPLES; SEROCONVERSION; PARTNERS; EPIDEMIC; BEHAVIOR; RISK	Background: We evaluated willingness to participate in CVCT and associated factors among MSM in the United States. Methods: 5,980 MSM in the US, recruited through MySpace.com, completed an online survey March-April, 2009. A multivariable logistic regression model was built using being "willing'' or "unwilling'' to participate in CVCT in the next 12 months as the outcome. Results: Overall, 81.5% of respondents expressed willingness to participate in CVCT in the next year. Factors positively associated with willingness were: being of non-Hispanic Black (adjusted odds ratio [aOR]: 1.5, 95% confidence interval [Cl]: 1.2-1.8), Hispanic (aOR: 1.3, Cl: 1.1-1.6), or other (aOR: 1.4, Cl: 1.1-1.8) race/ethnicity compared to non-Hispanic White; being aged 18-24 (aOR: 2.5, Cl: 1.7-3.8), 25-29 (aOR: 2.3, Cl: 1.5-3.6), 30-34 (aOR: 1.9, Cl: 1.2-3.1), and 35-45 (aOR: 2.3, Cl: 1.4-3.7) years, all compared to those over 45 years of age; and having had a main male sex partner in the last 12 months (aOR: 1.9, Cl: 1.6-2.2). Factors negatively associated with willingness were: not knowing most recent male sex partner's HIV status (aOR: 0.81, Cl: 0.69-0.95) compared to knowing that the partner was HIV-negative; having had 4-7 (aOR: 0.75, Cl: 0.61-0.92) or > 7 male sex partners in the last 12 months (aOR: 0.62, Cl: 0.50-0.78) compared to 1 partner; and never testing for HIV (aOR: 0.38, Cl: 0.31-0.46), having been tested over 12 months ago (aOR: 0.63, Cl: 0.50-0.79), or not knowing when last HIV tested (aOR: 0.67, Cl: 0.51-0.89), all compared to having tested 0-6 months previously. Conclusions: Young MSM, men of color, and those with main sex partners expressed a high level of willingness to participate in couples HIV counseling and testing with a male partner in the next year. Given this willingness, it is likely feasible to scale up and evaluate CVCT interventions for US MSM.	[Wagenaar, Bradley H.; Christiansen-Lindquist, Lauren; Khosropour, Christine; Sineath, R. Craig; Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Salazar, Laura F.] Georgia State Univ, Inst Publ Hlth, Dept Hlth Promot & Behav, Atlanta, GA 30303 USA; [Benbow, Nanette; Prachand, Nik] Chicago Dept Publ Hlth, Chicago, IL USA; [Stephenson, Rob] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Chicago Department of Public Health; Emory University; Rollins School Public Health	Wagenaar, BH (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	pssulli@emory.edu	Stephenson, Rob/J-9876-2012; Khosropour, Christine M/J-5036-2013	Khosropour, Christine M/0000-0002-9743-0829; Sineath, Robert/0000-0002-7302-8640; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health [R34-MH086331]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [T32HD052460]; MAC AIDS Fund; Emory Center for AIDS Research [P30 AI050409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH086331] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MAC AIDS Fund; Emory Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from National Institute of Mental Health (R34-MH086331) the Eunice Kennedy Shriver National Institute of Child Health & Human Development (T32HD052460), the MAC AIDS Fund, and by the Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, BEST EV INT; Centers for Disease Control and Prevention, 2005, HITS SURV REP 2002; Centers for Disease Control and Prevention, 2007, COUPL HIV COUNS TEST; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; Davidovich U, 2001, AIDS, V15, P1303, DOI 10.1097/00002030-200107060-00013; Department of Health and Human Services, 2011, TECHN GUID COMB HIV; Ellingson JE, 1999, J APPL PSYCHOL, V84, P155, DOI 10.1037/0021-9010.84.2.155; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pew Internet & American Life Project, 2011, 65 ONL AD US SOC NET; Pew Internet & American Life Project, 2012, DIG DIFF; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Stephenson R, 2011, AIDS BEHAV, V15, pS80, DOI 10.1007/s10461-011-9893-2; Sullivan PS, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1797; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Zack M, 2010, COLLINEARITY DIAGNOS	23	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42953	10.1371/journal.pone.0042953	http://dx.doi.org/10.1371/journal.pone.0042953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OQ	22905191	gold, Green Submitted, Green Published			2022-12-25	WOS:000307500800033
J	Del Coso, J; Gonzalez-Millan, C; Salinero, JJ; Abian-Vicen, J; Soriano, L; Garde, S; Perez-Gonzalez, B				Del Coso, Juan; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Soriano, Lidon; Garde, Sergio; Perez-Gonzalez, Benito			Muscle Damage and Its Relationship with Muscle Fatigue During a Half-Iron Triathlon	PLOS ONE			English	Article							PROLONGED STRENUOUS EXERCISE; FLUID BALANCE; CARBOHYDRATE; HEMATURIA; DEHYDRATION; PERFORMANCE; INTENSITY; INGESTION; HYDRATION; FEEDINGS	Background: To investigate the cause/s of muscle fatigue experienced during a half-iron distance triathlon. Methodology/Principal Findings: We recruited 25 trained triathletes (36 +/- 7 yr; 75.1 +/- 9.8 kg) for the study. Before and just after the race, jump height and leg muscle power output were measured during a countermovement jump on a force platform to determine leg muscle fatigue. Body weight, handgrip maximal force and blood and urine samples were also obtained before and after the race. Blood myoglobin and creatine kinase concentrations were determined as markers of muscle damage. Results: Jump height (from 30.3 +/- 5.0 to 23.4 +/- 6.4 cm; P<0.05) and leg power output (from 25.6 +/- 2.9 to 20.7 +/- 4.6 W.kg (-1); P<0.05) were significantly reduced after the race. However, handgrip maximal force was unaffected by the race (430 +/- 59 to 430 +/- 62 N). Mean dehydration after the race was 2.3 +/- 1.2% with high inter-individual variability in the responses. Blood myoglobin and creatine kinase concentration increased to 516 +/- 248 mu g.L-1 and 442 +/- 204 U.L-1, respectively (P<0.05) after the race. Pre-to post-race jump change did not correlate with dehydration (r = 0.16; P>0.05) but significantly correlated with myoglobin concentration (r = 0.65; P<0.001) and creatine kinase concentration (r = 0.54; P<0.001). Conclusions/significance: During a half-iron distance triathlon, the capacity of leg muscles to produce force was notably diminished while arm muscle force output remained unaffected. Leg muscle fatigue was correlated with blood markers of muscle damage suggesting that muscle breakdown is one of the most relevant sources of muscle fatigue during a triathlon.	[Del Coso, Juan; Gonzalez-Millan, Cristina; Jose Salinero, Juan; Abian-Vicen, Javier; Soriano, Lidon; Garde, Sergio; Perez-Gonzalez, Benito] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Abián-Vicén, Javier/I-8509-2012; Salinero, Juan J./GLT-1243-2022; Pérez-González, Benito/AAF-7128-2021; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Abián-Vicén, Javier/0000-0001-9635-3289; Salinero, Juan J./0000-0003-4153-5100; Pérez-González, Benito/0000-0002-6191-2885; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Gonzalez-Millan, Cristina/0000-0002-3371-9420				ABARBANEL J, 1990, J UROLOGY, V143, P887, DOI 10.1016/S0022-5347(17)40125-X; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; COGGAN AR, 1987, J APPL PHYSIOL, V63, P2388, DOI 10.1152/jappl.1987.63.6.2388; Coso JD, 2011, EUR J SPORT SCI, V11; Coso JD, 2012, ANN C SPAN IN PRESS; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; Del Coso J, 2008, APPL PHYSIOL NUTR ME, V33, P290, DOI 10.1139/H07-188; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2011, EUR J APPL PHYSIOL, V111, P2173, DOI 10.1007/s00421-011-1847-x; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; GUR H, 1994, BRIT J SPORT MED, V28, P61, DOI 10.1136/bjsm.28.1.61; Jeukendrup A, 1997, INT J SPORTS MED, V18, P125, DOI 10.1055/s-2007-972607; Jeukendrup AE, 2000, SPORTS MED, V29, P407, DOI 10.2165/00007256-200029060-00004; Jeukendrup AE, 2005, SPORTS MED, V35, P163, DOI 10.2165/00007256-200535020-00005; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47; Knechtle B, 2010, RES Q EXERCISE SPORT, V81, P319; Knechtle Beat, 2008, Res Sports Med, V16, P97, DOI 10.1080/15438620701878881; Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426; Margaritis I, 1999, J SPORT MED PHYS FIT, V39, P133; McInnis MD, 1998, EUR J APPL PHYSIOL O, V79, P99; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Nybo L, 2003, MED SCI SPORT EXER, V35, P589, DOI 10.1249/01.MSS.0000058433.85789.66; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; REID RI, 1987, BRIT J UROL, V59, P133, DOI 10.1111/j.1464-410X.1987.tb04803.x; Saboisky J, 2003, EXP PHYSIOL, V88, P783, DOI 10.1113/eph8802611; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; SCHIFF HB, 1978, Q J MED, V47, P463; Smith JE, 2004, BRIT J SPORT MED, V38, P292, DOI 10.1136/bjsm.2002.002873; Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008; Speedy DB, 2000, CLIN J SPORT MED, V10, P272, DOI 10.1097/00042752-200010000-00009; Suzuki K, 2006, EUR J APPL PHYSIOL, V98, P525, DOI 10.1007/s00421-006-0296-4; Vrijens DMJ, 1999, J APPL PHYSIOL, V86, P1847, DOI 10.1152/jappl.1999.86.6.1847	34	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43280	10.1371/journal.pone.0043280	http://dx.doi.org/10.1371/journal.pone.0043280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900101	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900119
J	Avizienis, AV; Sillin, HO; Martin-Olmos, C; Shieh, HH; Aono, M; Stieg, AZ; Gimzewski, JK				Avizienis, Audrius V.; Sillin, Henry O.; Martin-Olmos, Cristina; Shieh, Hsien Hang; Aono, Masakazu; Stieg, Adam Z.; Gimzewski, James K.			Neuromorphic Atomic Switch Networks	PLOS ONE			English	Article							OBJECT RECOGNITION; DYNAMICAL-SYSTEMS; NEURAL-NETWORKS; BRAIN NETWORKS; 1/F NOISE; CIRCUITS; SILVER; DIFFUSION; MEMRISTOR; NANOSTRUCTURES	Efforts to emulate the formidable information processing capabilities of the brain through neuromorphic engineering have been bolstered by recent progress in the fabrication of nonlinear, nanoscale circuit elements that exhibit synapse-like operational characteristics. However, conventional fabrication techniques are unable to efficiently generate structures with the highly complex interconnectivity found in biological neuronal networks. Here we demonstrate the physical realization of a self-assembled neuromorphic device which implements basic concepts of systems neuroscience through a hardware-based platform comprised of over a billion interconnected atomic-switch inorganic synapses embedded in a complex network of silver nanowires. Observations of network activation and passive harmonic generation demonstrate a collective response to input stimulus in agreement with recent theoretical predictions. Further, emergent behaviors unique to the complex network of atomic switches and akin to brain function are observed, namely spatially distributed memory, recurrent dynamics and the activation of feedforward subnetworks. These devices display the functional characteristics required for implementing unconventional, biologically and neurally inspired computational methodologies in a synthetic experimental system.	[Avizienis, Audrius V.; Sillin, Henry O.; Martin-Olmos, Cristina; Gimzewski, James K.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Shieh, Hsien Hang; Stieg, Adam Z.; Gimzewski, James K.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA; [Aono, Masakazu; Stieg, Adam Z.; Gimzewski, James K.] Natl Inst Mat Sci, World Premier Int Ctr Mat Nanoarchitectond, Tsukuba, Ibaraki, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institute for Materials Science	Avizienis, AV (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	stieg@cnsi.ucla.edu	Martin-Olmos, Cristina/A-6489-2011; Stieg, Adam/C-5816-2009; Stieg, Adam/AAI-8505-2021	Martin-Olmos, Cristina/0000-0003-0688-484X; Stieg, Adam/0000-0001-7312-9364; Stieg, Adam/0000-0001-7312-9364; gimzewski, james/0000-0003-4333-6957	Defense Advanced Research Projects Agency (DARPA) [HR0011-10-1-0008]; WPI International Center for Materials Nanoarchitectonics (MANA)	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); WPI International Center for Materials Nanoarchitectonics (MANA)	This research was partially supported by the Defense Advanced Research Projects Agency (DARPA) "Physical Intelligence" program (contract number: HR0011-10-1-0008), and by the WPI International Center for Materials Nanoarchitectonics (MANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1991, CORTICONICS; ALLEN RL, 1959, J PHYS CHEM-US, V63, P223, DOI 10.1021/j150572a021; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Chung A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/412001; Cohen GZ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698153; Coombes S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021915; DOUGLAS R, 1995, ANNU REV NEUROSCI, V18, P255, DOI 10.1146/annurev.ne.18.030195.001351; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; FUNAHASHI K, 1993, NEURAL NETWORKS, V6, P801, DOI 10.1016/S0893-6080(05)80125-X; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GRIER BH, 1984, PHYS REV B, V29, P3810, DOI 10.1103/PhysRevB.29.3810; Hasegawa T, 2010, ADV MATER, V22, P1831, DOI 10.1002/adma.200903680; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ho R, 2001, P IEEE, V89, P490, DOI 10.1109/5.920580; Ielmini D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304167; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; KUHN A, 1995, J ELECTROANAL CHEM, V397, P93, DOI 10.1016/0022-0728(95)04157-X; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Kundu M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2199067; Likharev K, 2003, ANN NY ACAD SCI, V1006, P146, DOI 10.1196/annals.1292.010; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Lv S, 2009, SOLID STATE COMMUN, V149, P227, DOI 10.1016/j.ssc.2008.11.021; Martin-Olmos C, 2012, ADV FUNCT MATER, V22, P1482, DOI 10.1002/adfm.201102789; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Oskoee EN, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031105; RALLS KS, 1991, PHYS REV B, V44, P5800, DOI 10.1103/PhysRevB.44.5800; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rowland NC, 2008, J NEUROPHYSIOL, V99, P704, DOI 10.1152/jn.01100.2007; Roychowdhury VP, 1996, IEEE T ELECTRON DEV, V43, P1688, DOI 10.1109/16.536815; SEARLE JR, 1980, BEHAV BRAIN SCI, V3, P417, DOI 10.1017/S0140525X00006038; Segev R, 1998, PHYS LETT A, V237, P307, DOI 10.1016/S0375-9601(97)00870-0; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Stieg AZ, 2012, ADV MATER, V24, P286, DOI 10.1002/adma.201103053; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Teuscher C, 2008, IEEE INT SYMP CIRC S, P2785, DOI 10.1109/ISCAS.2008.4542035; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Torralba A, 2008, IEEE T PATTERN ANAL, V30, P1958, DOI 10.1109/TPAMI.2008.128; Tour JM, 2002, IEEE T NANOTECHNOL, V1, P100, DOI 10.1109/TNANO.2002.804744; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Wang Z, 2007, NANO LETT, V7, P2688, DOI 10.1021/nl0711054; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Wen XG, 2006, LANGMUIR, V22, P4836, DOI 10.1021/la060267x; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Xu Z, 2010, ACS NANO, V4, P2515, DOI 10.1021/nn100483a	59	106	106	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42772	10.1371/journal.pone.0042772	http://dx.doi.org/10.1371/journal.pone.0042772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880101	Green Submitted, gold, Green Published			2022-12-25	WOS:000307810000068
J	Hui, SK; Sharkey, L; Kidder, LS; Zhang, Y; Fairchild, G; Coghill, K; Xian, CJ; Yee, D				Hui, Susanta K.; Sharkey, Leslie; Kidder, Louis S.; Zhang, Yan; Fairchild, Greg; Coghill, Kayti; Xian, Cory J.; Yee, Douglas			The Influence of Therapeutic Radiation on the Patterns of Bone Marrow in Ovary-Intact and Ovariectomized Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE HEMATOLOGIC TOXICITY; TOTAL-BODY IRRADIATION; LONG-TERM BONE; STROMAL CELLS; FRACTURE RISK; FAT; OSTEOPOROSIS; OSTEOBLASTOGENESIS; MICROENVIRONMENT	Background: The functional components of bone marrow (i.e., the hematopoietic and stromal populations) and the adjacent bone have traditionally been evaluated incompletely as distinct entities rather than the integrated system. We perturbed this system in vivo using a medically relevant radiation model in the presence or absence of ovarian function to understand integrated tissue interaction. Methodology/Principal Findings: Ovary-intact and ovariectomized mice underwent either no radiation or single fractional 16 Gy radiation to the caudal skeleton (I +/- R, OVX +/- R). Marrow fat, hematopoietic cellularity, and cancellous bone volume fraction (BV/TV %) were assessed. Ovariectomy alone did not significantly reduce marrow cellularity in non-irradiated mice (OVX-R vs. I-R, p = 0.8445) after 30 days; however it impaired the hematopoietic recovery of marrow following radiation exposure (OVX+R vs. I+R, p = 0.0092). The combination of radiation and OVX dramatically increases marrow fat compared to either factor alone (p = 0.0062). The synergistic effect was also apparent in the reduction of hematopoietic marrow cellularity (p = 0.0661); however it was absent in BV/TV% changes (p = 0.2520). The expected inverse relationship between marrow adiposity vs. hematopoietic cellularity and bone volume was observed. Interestingly compared with OVX mice, intact mice demonstrated double the reduction in hematopoietic cellularity and a tenfold greater degree of bone loss for a given unit of expansion in marrow fat. Conclusions/Significance: Ovariectomy prior to delivery of a clinically-relevant focal radiation exposure in mice, exacerbated post-radiation adipose accumulation in the marrow space but blunted bone loss and hematopoietic suppression. In the normally coupled homeostatic relationship between the bone and marrow domains, OVX appears to alter feedback mechanisms. Confirmation of this non-linear phenomenon (presumably due to differential radiosensitivity) and demonstration of the mechanism of action is needed to provide strategies to diminish the effect of radiation on exposed tissues.	[Hui, Susanta K.; Fairchild, Greg; Coghill, Kayti] Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA; [Sharkey, Leslie] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Hui, Susanta K.; Sharkey, Leslie; Kidder, Louis S.; Zhang, Yan; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Yee, Douglas] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Xian, Cory J.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5001, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of South Australia	Hui, SK (corresponding author), Univ Minnesota, Sch Med, Dept Therapeut Radiol, Minneapolis, MN 55455 USA.	huixx019@umn.edu	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; Yee, Douglas/0000-0002-3387-4009	National Institutes of Health [1R01CA154491-01, 1R03AR055333-01A1, 1K12-HD055887-01]; PHS Cancer Center [P30 CA77398]; Minnesota Medical Foundation (MMF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077398, R01CA154491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS Cancer Center; Minnesota Medical Foundation (MMF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health grants (1R01CA154491-01, 1R03AR055333-01A1 and 1K12-HD055887-01). This work was also supported by PHS Cancer Center Support Grant P30 CA77398 and the Minnesota Medical Foundation (MMF). Susanta K. Hui is a scholar of the BIRCWH (Building Interdisciplinary Careers in Women's Health) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanei CM, 2012, STEM CELLS DEV, V21, P1604, DOI 10.1089/scd.2011.0390; Abdallah BM, 2012, BONE, V50, P540, DOI 10.1016/j.bone.2011.06.030; Ali Khalil, 2010, AM J OBSTET GYNECOLO, V203; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P323, DOI 10.1038/bmt.2011.102; Bianco P, 2011, ENDOCRINOLOGY, V152, P2957, DOI 10.1210/en.2011-0217; Blake GM, 2009, BONE, V44, P495, DOI 10.1016/j.bone.2008.11.003; BOYCE RW, 1990, J BONE MINER RES, V5, P947; Chen Z, 2005, ARCH INTERN MED, V165, P552, DOI 10.1001/archinte.165.5.552; Clavin NW, 2008, PLAST RECONSTR SURG, V122, P739, DOI 10.1097/PRS.0b013e318180edaa; Despars G, 2011, EXP HEMATOL, V39, P809, DOI 10.1016/j.exphem.2011.04.008; Elmore SA, 2006, TOXICOL PATHOL, V34, P666, DOI 10.1080/01926230600939971; Fowler JF, 2006, PHYS MED BIOL, V51, pR263, DOI 10.1088/0031-9155/51/13/R16; Greenberger JS, 2009, SEMIN RADIAT ONCOL, V19, P133, DOI 10.1016/j.semradonc.2008.11.006; Greenberger JS, 1996, LEUKEMIA, V10, P514; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Hui SK, 2012, CALCIFIED TISSUE INT, V90, P40, DOI 10.1007/s00223-011-9547-4; Imai Y, 2009, ANN NY ACAD SCI, V1173, pE31, DOI 10.1111/j.1749-6632.2009.04954.x; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Kim YY, 2010, MOL CELLS, V29, P277, DOI 10.1007/s10059-010-0027-x; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Liu SB, 2011, CELL BIOCHEM BIOPHYS, V61, P539, DOI 10.1007/s12013-011-9236-y; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; MARTIN RB, 1991, BONE, V12, P123, DOI 10.1016/8756-3282(91)90011-7; Mell LK, 2008, INT J RADIAT ONCOL, V70, P1431, DOI 10.1016/j.ijrobp.2007.08.074; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Rose BS, 2012, INT J RADIAT ONCOL, V83, P1185, DOI 10.1016/j.ijrobp.2011.09.048; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Tong XQ, 1998, ACTA RADIOL, V39, P620, DOI 10.3109/02841859809175486; Travlos GS, 2006, TOXICOL PATHOL, V34, P566, DOI 10.1080/01926230600964706; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Zhang H, 2011, CURR MOL MED, V11, P489, DOI 10.2174/156652411796268704; Zhu L, 2009, INT J EXP PATHOL, V90, P512, DOI 10.1111/j.1365-2613.2009.00661.x	43	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42668	10.1371/journal.pone.0042668	http://dx.doi.org/10.1371/journal.pone.0042668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880075	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000307810000059
J	Desgent, S; Duss, S; Sanon, NT; Lema, P; Levesque, M; Hebert, D; Rebillard, RM; Bibeau, K; Brochu, M; Carmant, L				Desgent, Sebastien; Duss, Sandra; Sanon, Nathalie T.; Lema, Pablo; Levesque, Maxime; Hebert, David; Rebillard, Rose-Marie; Bibeau, Karine; Brochu, Michele; Carmant, Lionel			Early-Life Stress Is Associated with Gender-Based Vulnerability to Epileptogenesis in Rat Pups	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PROLONGED FEBRILE SEIZURES; METHYL-D-ASPARTATE; LONG-TERM; PRENATAL STRESS; IMMATURE RAT; CEREBRAL MICROGYRIA; RECURRENT SEIZURES; PYRAMIDAL NEURONS; BRAIN-DEVELOPMENT	During development, the risk of developing mesial temporal lobe epilepsy (MTLE) increases when the developing brain is exposed to more than one insult in early life. Early life insults include abnormalities of cortical development, hypoxic-ischemic injury and prolonged febrile seizures. To study epileptogenesis, we have developed a two-hit model of MTLE characterized by two early-life insults: a freeze lesion-induced cortical malformation at post-natal day 1 (P1), and a prolonged hyperthermic seizure (HS) at P10. As early life stressors lead to sexual dimorphism in both acute response and long-term outcome, we hypothesized that our model could lead to gender-based differences in acute stress response and long-term risk of developing MTLE. Male and female pups underwent a freeze-lesion induced cortical microgyrus at P1 and were exposed to HS at P10. Animals were monitored by video-EEG from P90 to P120. Pre and post-procedure plasma corticosterone levels were used to measure stress response at P1 and P10. To confirm the role of sex steroids, androgenized female pups received daily testosterone injections to the mother pre-natally and post-natally for nine days while undergoing both insults. We demonstrated that after both insults females did not develop MTLE while all males did. This correlated with a rise in corticosterone levels at P1 following the lesion in males only. Interestingly, all androgenized females showed a similar rise in corticosterone at P1, and also developed MTLE. Moreover, we found that the cortical lesion significantly decreased the latency to generalized convulsion during hyperthermia at P10 in both genders. The cortical dysplasia volumes at adulthood were also similar between male and female individuals. Our data demonstrate sexual dimorphism in long-term vulnerability to develop epilepsy in the lesion + hyperthermia animal model of MTLE and suggest that the response to early-life stress at P1 contributes significantly to epileptogenesis in a gender-specific manner.	[Desgent, Sebastien; Duss, Sandra; Sanon, Nathalie T.; Lema, Pablo; Levesque, Maxime; Hebert, David; Rebillard, Rose-Marie; Bibeau, Karine; Brochu, Michele; Carmant, Lionel] Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Desgent, Sebastien; Brochu, Michele; Carmant, Lionel] Univ Montreal, Dept Physiol, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Desgent, S (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada.	sebastien.desgent@umontreal.ca; lionel.carmant@umontreal.ca			Epilepsy Canada,Toronto (Ontario) Canada; SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada; Foundation of the CHU Sainte-Justine Hospital; foundation of the stars, Montreal (Quebec) Canada; Steriade-SAVOY foundation; foundation of the stars scholarship, Montreal (Quebec) Canada	Epilepsy Canada,Toronto (Ontario) Canada; SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada; Foundation of the CHU Sainte-Justine Hospital; foundation of the stars, Montreal (Quebec) Canada; Steriade-SAVOY foundation; foundation of the stars scholarship, Montreal (Quebec) Canada	S. Desgent was supported by postdoctoral research awards from: Epilepsy Canada,Toronto (Ontario) Canada; the SAVOY epilepsy foundation, Saint-Jean-sur-Richelieu (Quebec) Canada and the Foundation of the CHU Sainte-Justine Hospital and the foundation of the stars, Montreal (Quebec) Canada. Fondation Savoy Epilepsy to LC. ML obtained the Steriade-SAVOY foundation award, Saint-Jean-sur-Richelieu (Quebec) Canada and the Foundation of the CHU Sainte-Justine Hospital and the foundation of the stars scholarship, Montreal (Quebec) Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2011, PSYCHOPHARMACOLOGY, V214, P155, DOI 10.1007/s00213-010-2125-z; BARAM TZ, 1991, DEV BRAIN RES, V61, P97, DOI 10.1016/0165-3806(91)90118-3; Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; Briellmann RS, 2000, NEUROLOGY, V55, P1479, DOI 10.1212/WNL.55.10.1479; Burnham W McIntyre, 2006, Adv Neurol, V97, P351; Carmant L, 2007, M S-MED SCI, V23, P929, DOI 10.1051/medsci/20072311929; Carrer HF, 2003, J NEUROSCI, V23, P6338; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; DVORAK K, 1977, ACTA NEUROPATHOL, V38, P203; Edwards HE, 2002, HORM BEHAV, V42, P437, DOI 10.1006/hbeh.2002.1839; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Frye CA, 1999, DEV PSYCHOBIOL, V34, P227; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Galanopoulou AS, 2003, EXP NEUROL, V183, P628, DOI 10.1016/S0014-4886(03)00213-9; GALLAGHER BB, 1984, EPILEPSIA, V25, P683, DOI 10.1111/j.1528-1157.1984.tb03477.x; Gibbs S, 2011, NEUROBIOL DIS, V43, P312, DOI 10.1016/j.nbd.2011.02.013; Gibbs SA, 2008, NEUROBIOL DIS, V32, P176, DOI 10.1016/j.nbd.2008.07.005; Giorgi FS, 2007, NEUROBIOL DIS, V25, P73, DOI 10.1016/j.nbd.2006.08.009; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamed SA, 2008, NEUROLOGIST, V14, P157, DOI 10.1097/NRL.0b013e3181618ada; Heida JG, 2005, EPILEPSIA, V46, P1906, DOI 10.1111/j.1528-1167.2005.00294.x; Herman AE, 1997, CEREB CORTEX, V7, P453, DOI 10.1093/cercor/7.5.453; Huang LT, 2002, EPILEPSIA, V43, P1141, DOI 10.1046/j.1528-1157.2002.14602.x; Janszky J, 2004, J NEUROL NEUROSUR PS, V75, P773, DOI 10.1136/jnnp.2003.020941; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Joels M, 2009, EPILEPSIA, V50, P586, DOI 10.1111/j.1528-1167.2008.01902.x; Jones NC, 2009, BEHAV BRAIN RES, V203, P81, DOI 10.1016/j.bbr.2009.04.023; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Koe AS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.024.2009; Kumar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024033; Lai Ming-Chi, 2008, Pediatr Neonatol, V49, P19, DOI 10.1016/S1875-9572(08)60006-6; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Mejias-Aponte CA, 2002, BRAIN RES, V944, P210, DOI 10.1016/S0006-8993(02)02691-4; Mouton P.R., 2002, PRINCIPLES PRACTICES, Vx; Mouton PR, 2011, UNBIAISED STEREOLOGY; Nunez JL, 2008, EXP NEUROL, V210, P699, DOI 10.1016/j.expneurol.2008.01.001; Ouardouz M, 2010, EUR J NEUROSCI, V31, P1252, DOI 10.1111/j.1460-9568.2010.07159.x; Paxinos G, 2009, COMPACT; Peternel S, 2009, PROG NEURO-PSYCHOPH, V33, P456, DOI 10.1016/j.pnpbp.2009.01.005; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roselli CE, 1998, ENDOCRINOLOGY, V139, P3193, DOI 10.1210/en.139.7.3193; ROSEN GD, 1992, J NEUROPATH EXP NEUR, V51, P601, DOI 10.1097/00005072-199211000-00005; Rosen GD, 1999, CEREB CORTEX, V9, P27, DOI 10.1093/cercor/9.1.27; ROSEN JB, 1994, NEUROSCI LETT, V174, P113, DOI 10.1016/0304-3940(94)90132-5; Rudick CN, 2001, J NEUROSCI, V21, P6532, DOI 10.1523/JNEUROSCI.21-17-06532.2001; Saberi M, 2001, EPILEPSY RES, V46, P45, DOI 10.1016/S0920-1211(01)00257-1; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; Sanon N, 2012, ATYPICAL FEBRILE SEI, V1, P9; Sawyer NT, 2010, J CLIN NEUROPHYSIOL, V27, P445, DOI 10.1097/WNP.0b013e3181fe0573; Scantlebury MH, 2005, ANN NEUROL, V58, P41, DOI 10.1002/ana.20512; Scantlebury MH, 2004, EPILEPSIA, V45, P592, DOI 10.1111/j.0013-9580.2004.51503.x; Scantlebury MH, 2010, EPILEPSY RES, V89, P27, DOI 10.1016/j.eplepsyres.2009.11.002; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zamani MR, 2004, NEUROSCIENCE, V129, P243, DOI 10.1016/j.neuroscience.2004.06.082	64	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42622	10.1371/journal.pone.0042622	http://dx.doi.org/10.1371/journal.pone.0042622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880055	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100144
J	Linger, RMA; Cohen, RA; Cummings, CT; Sather, S; Migdall-Wilson, J; Middleton, DHG; Lu, X; Baron, AE; Franklin, WA; Merrick, DT; Jedlicka, P; DeRyckere, D; Heasley, LE; Graham, DK				Linger, R. M. A.; Cohen, R. A.; Cummings, C. T.; Sather, S.; Migdall-Wilson, J.; Middleton, D. H. G.; Lu, X.; Baron, A. E.; Franklin, W. A.; Merrick, D. T.; Jedlicka, P.; DeRyckere, D.; Heasley, L. E.; Graham, D. K.			Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer	ONCOGENE			English	Article						targeted therapy; receptor tyrosine kinase; MerTK; signal transduction; xenograft; chemosensitivity	SYSTEMIC-LUPUS-ERYTHEMATOSUS; ELEMENT-BINDING PROTEIN; NF-KAPPA-B; GENE-EXPRESSION; BREAST-CANCER; TUMOR-GROWTH; THERAPEUTIC TARGETS; PROLONGS SURVIVAL; DISEASE-ACTIVITY; DRUG-RESISTANCE	Non-small cell lung cancer (NSCLC) is a prevalent and devastating disease that claims more lives than breast, prostate, colon and pancreatic cancers combined. Current research suggests that standard chemotherapy regimens have been optimized to maximal efficiency. Promising new treatment strategies involve novel agents targeting molecular aberrations present in subsets of NSCLC. We evaluated 88 human NSCLC tumors of diverse histology and identified Mer and Axl as receptor tyrosine kinases (RTKs) overexpressed in 69% and 93%, respectively, of tumors relative to surrounding normal lung tissue. Mer and Axl were also frequently overexpressed and activated in NSCLC cell lines. Ligand-dependent Mer or Axl activation stimulated MAPK, AKT and FAK signaling pathways indicating roles for these RTKs in multiple oncogenic processes. In addition, we identified a novel pro-survival pathway-involving AKT, CREB, Bcl-xL, survivin, and Bcl-2-downstream of Mer, which is differentially modulated by Axl signaling. We demonstrated that short hairpin RNA (shRNA) knockdown of Mer or Axl significantly reduced NSCLC colony formation and growth of subcutaneous xenografts in nude mice. Mer or Axl knockdown also improved in vitro NSCLC sensitivity to chemotherapeutic agents by promoting apoptosis. When comparing the effects of Mer and Axl knockdown, Mer inhibition exhibited more complete blockade of tumor growth while Axl knockdown more robustly improved chemosensitivity. These results indicate that Mer and Axl have complementary and overlapping roles in NSCLC and suggest that treatment strategies targeting both RTKs may be more effective than singly-targeted agents. Our findings validate Mer and Axl as potential therapeutic targets in NSCLC and provide justification for development of novel therapeutic compounds that selectively inhibit Mer and/or Axl.	[Linger, R. M. A.; Cohen, R. A.; Cummings, C. T.; Sather, S.; Migdall-Wilson, J.; DeRyckere, D.; Graham, D. K.] Univ Colorado, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, Aurora, CO 80045 USA; [Middleton, D. H. G.] Univ Colorado, Program Canc Biol, Aurora, CO 80045 USA; [Lu, X.; Baron, A. E.] Univ Colorado, Dept Biostat & Informat, Aurora, CO 80045 USA; [Franklin, W. A.; Merrick, D. T.; Jedlicka, P.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Merrick, D. T.] Denver VA Med Ctr, Dept Pathol, Denver, CO USA; [Heasley, L. E.] Denver VA Med Ctr, Dept Craniofacial Biol, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Graham, DK (corresponding author), Univ Colorado, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, Anschutz Med Campus,Mail Stop 8302,12800 East 19t, Aurora, CO 80045 USA.	doug.graham@ucdenver.edu		Maller, Justine/0000-0001-6930-7375; Cummings, Christopher/0000-0002-2978-2494	Uniting Against Lung Cancer: Elliot's Legacy (RMAL); Lung Cancer Research Foundation (RMAL); American Cancer Society [RSG-08-291-01-LIB]; National Institutes of Health [RO1CA137078]; University of Colorado Cancer Center SPORE in Lung Cancer [NIH 5P50CA058187]; Damon Runyon Cancer Research Foundation [CI-39-07]; NATIONAL CANCER INSTITUTE [P30CA046934, P50CA058187, R01CA127105, R01CA137078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	Uniting Against Lung Cancer: Elliot's Legacy (RMAL); Lung Cancer Research Foundation (RMAL); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center SPORE in Lung Cancer; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from Uniting Against Lung Cancer: Elliot's Legacy (RMAL), the Lung Cancer Research Foundation (RMAL), the American Cancer Society (RSG-08-291-01-LIB, DKG) and the National Institutes of Health (RO1CA137078, DKG). RMA Linger received a Career Development Award from the University of Colorado Cancer Center SPORE in Lung Cancer (NIH 5P50CA058187). DK Graham is the Damon Runyon-Novartis Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation (CI-39-07). The authors wish to thank Karen Helm, Christine Childs and Lester Acosta in the University of Colorado Cancer Center Flow Cytometry Core for their expert technical assistance, Randall Wong in the University of Colorado Denver Diabetes and Endocrinology Research Center Molecular Biology Core Facility (NIH P30 DK57516) for cell line authentication services, Patricia Lenhart for help optimizing Mer and Axl immunohistochemistry of human tissues, and Storey Wilson and Andrea Abeyta for technical assistance with the Aperio imaging system used to digitize stained tumor microarray slides.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Allen MP, 2002, J BIOL CHEM, V277, P38133, DOI 10.1074/jbc.M200826200; [Anonymous], 2011, SEER CANC STAT REV 1; Arriola EL, 1999, ONCOGENE, V18, P1457, DOI 10.1038/sj.onc.1202420; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Brandao Luis, 2011, Critical Reviews in Oncogenesis, V16, P47; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brose MS, 2002, CANCER RES, V62, P6997; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Ekman C, 2011, RHEUMATOLOGY, V50, P1064, DOI 10.1093/rheumatology/keq459; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Han ZY, 1996, CANCER RES, V56, P1621; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Janku F, 2011, J THORAC ONCOL, V6, P1601, DOI 10.1097/JTO.0b013e31822944b3; Jansen FH, 2012, J PROTEOME RES, V11, P728, DOI 10.1021/pr2006473; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Macleod K, 2005, CANCER RES, V65, P6789, DOI 10.1158/0008-5472.CAN-04-2684; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mudduluru G, 2011, BIOL CELL, V103, P21, DOI 10.1042/BC20100094; Nielsen-Preiss SM, 2007, ENDOCRINOLOGY, V148, P2806, DOI 10.1210/en.2007-0039; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Reeve JG, 1996, BRIT J CANCER, V73, P1193, DOI 10.1038/bjc.1996.230; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Shinoura N, 1999, CANCER RES, V59, P4119; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Society AC, 2012, CANC FACTS FIG 2012; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Wu J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3316; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	65	135	154	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 18	2013	32	29					3420	3431		10.1038/onc.2012.355	http://dx.doi.org/10.1038/onc.2012.355			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22890323	Green Accepted			2022-12-25	WOS:000322014900003
J	Deeraksa, A; Pan, J; Sha, Y; Liu, XD; Eissa, NT; Lin, SH; Yu-Lee, LY				Deeraksa, A.; Pan, J.; Sha, Y.; Liu, X-D; Eissa, N. T.; Lin, S-H; Yu-Lee, L-y			Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis	ONCOGENE			English	Article						Plk1; BI2536; mitotic catastrophe; necroptosis; autophagy; prostate cancer	POLO-LIKE KINASES; MITOTIC CATASTROPHE; DEATH PATHWAY; LNCAP MODEL; PHOSPHORYLATION; IDENTIFICATION; CYTOKINESIS; KINETOCHORE; PROGRESSION; INDUCTION	Castration-resistant prostate cancer (PCa) is refractory to hormone therapy and new strategies for treatment are urgently needed. We found that androgen-insensitive (AI) PCa cells, LNCaP-AI, are reprogrammed to upregulate the mitotic kinase Plk1 (Polo-like kinase 1) and other M-phase cell-cycle proteins, which may underlie AI PCa growth. In androgen-depleted media, LNCaP-AI cells showed exquisite sensitivity to growth inhibition by subnanomolar concentrations of a small molecule inhibitor of Plk1, BI2536, suggesting that these cells are dependent on Plk1 for growth. In contrast, the androgen-responsive parental LNCaP cells showed negligible responses to BI2536 treatment under the same condition. BI2536 treatment of LNCaP-AI cells resulted in an increase in cell death marker PARP-1 (polymerase-1) but did not activate caspase-3, an apoptosis marker, suggesting that the observed cell death was caspase-independent. BI2536-treated LNCaP-AI cells formed multinucleated giant cells that contain clusters of nuclear vesicles indicative of mitotic catastrophe. Live-cell time-lapse imaging revealed that BI2536-treated giant LNCaP-AI cells underwent necroptosis, as evidenced by 'explosive' cell death and partial reversal of cell death by a necroptosis inhibitor. Our studies suggest that LNCaP-AI cells underwent reprogramming in both their cell growth and cell death pathways, rendering them highly sensitive to Plk1 inhibition that induces necroptosis. Harnessing necroptosis through Plk1 inhibition may be explored for therapeutic intervention of castration-resistant PCa.	[Deeraksa, A.; Pan, J.; Yu-Lee, L-y] Dept Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Sha, Y.; Liu, X-D; Eissa, N. T.] Dept Med, Sect Pulm Crit Care & Sleep Med, Houston, TX 77030 USA; [Lin, S-H] UT Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX USA; [Yu-Lee, L-y] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Yu-Lee, LY (corresponding author), Dept Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA.	yulee@bcm.edu		Liu, xiande/0000-0002-9639-0458	NIH [T32-AI07495, T32-DK07696, HL080205, CA111479, DK53176, AI071130]; DOD [PC080847, PC093132]; Dan L Duncan Cancer Center; Alkek Award in Experimental Therapeutics; NATIONAL CANCER INSTITUTE [R01CA111479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053176, T32DK007696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Dan L Duncan Cancer Center; Alkek Award in Experimental Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Anna Ferrari of New York University for the LNCaP-AI cells and Ms Shenyan Zeng for FACS analysis. This work was supported by NIH training Grants T32-AI07495 and T32-DK07696 for AD and Grants from the NIH (HL080205 to NTE; CA111479 to S-HL; DK53176, AI071130 to L-yY-L), DOD (PC080847, PC093132 to S-HL), Dan L Duncan Cancer Center (L-yY-L and S-HL) and Alkek Award in Experimental Therapeutics (L-yY-L and S-HL).	Alano CC, 2006, TRENDS BIOCHEM SCI, V31, P309, DOI 10.1016/j.tibs.2006.04.006; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Brennan IM, 2007, P NATL ACAD SCI USA, V91, P5046; Caserta TM, 2003, VIROLOGY, V191, P589; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Guan R, 2005, CANCER RES, V65, P2698, DOI 10.1158/0008-5472.CAN-04-2131; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lenart P, 2007, CURR BIOL, V17, P1; Li J, 2010, J GENET GENOMICS, V37, P159, DOI 10.1016/S1673-8527(09)60034-5; Liu XS, 2010, PROTEIN CELL, V1, P999, DOI 10.1007/s13238-010-0131-x; Macy B, 2009, CELL CYCLE, V8, P35, DOI 10.4161/cc.8.1.7327; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Park JE, 2011, P NATL ACAD SCI USA, V108, P8200, DOI 10.1073/pnas.1102020108; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Schmit TL, 2009, J INVEST DERMATOL, V129, P2843, DOI 10.1038/jid.2009.172; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Speirs CK, 2011, AM J CANCER RES, V1, P43; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; THALMANN GN, 1994, CANCER RES, V54, P2577; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang LG, 2004, ONCOGENE, V23, P5175, DOI 10.1038/sj.onc.1207654; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	41	53	59	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2013	32	24					2973	2983		10.1038/onc.2012.309	http://dx.doi.org/10.1038/onc.2012.309			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WV	22890325	Green Accepted			2022-12-25	WOS:000320369700007
J	Ghosal, G; Leung, JWC; Nair, BC; Fong, KW; Chen, JJ				Ghosal, Gargi; Leung, Justin Wai-Chung; Nair, Binoj C.; Fong, Ka-Wing; Chen, Junjie			Proliferating Cell Nuclear Antigen (PCNA)-binding Protein C1orf124 Is a Regulator of Translesion Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE TOLERANCE; POSTREPLICATION REPAIR; GENOMIC INSTABILITY; STALLED REPLICATION; POLYMERASE SWITCH; REV1 PROTEIN; PCNA; UBIQUITIN; RAD18; STABILITY	DNA damage-induced proliferating cell nuclear antigen (PCNA) ubiquitination serves as the key event mediating post-replication repair. Post-replication repair involves either translesion synthesis (TLS) or damage avoidance via template switching. In this study, we have identified and characterized C1orf124 as a regulator of TLS. C1orf124 co-localizes and interacts with unmodified and mono-ubiquitinated PCNA at UV light-induced damage sites, which require the PIP box and UBZ domain of C1orf124. C1orf124 also binds to the AAA-ATPase valosin-containing protein via its SHP domain, and cellular resistance to UV radiation mediated by C1orf124 requires its interactions with valosin-containing protein and PCNA. Interestingly, C1orf124 binds to replicative DNA polymerase POLD3 and PDIP1 under normal conditions but preferentially associates with TLS polymerase eta (POLH) upon UV damage. Depletion of C1orf124 compromises PCNA monoubiquitination, RAD18 chromatin association, and RAD18 localization to UV damage sites. Thus, C1orf124 acts at multiple steps in TLS, stabilizes RAD18 and ubiquitinated PCNA at damage sites, and facilitates the switch from replicative to TLS polymerase to bypass DNA lesion.	[Ghosal, Gargi; Leung, Justin Wai-Chung; Nair, Binoj C.; Fong, Ka-Wing; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org		Ghosal, Gargi/0000-0001-8399-5354; Fong, Ka-wing/0000-0001-6995-0264; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA100109, P30CA016672, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of Era of Hope Scholar Award W81XWH-05-1-0470 from the United States Department of Defense and member of the MD Anderson Cancer Center (supported by National Institutes of Health Grant CA016672).	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gari K, 2009, CRIT REV BIOCHEM MOL, V44, P292, DOI 10.1080/10409230903154150; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Lee KY, 2008, MOL CELLS, V26, P5; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409	39	79	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34225	34233		10.1074/jbc.M112.400135	http://dx.doi.org/10.1074/jbc.M112.400135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902628	Green Published, hybrid			2022-12-25	WOS:000309654200027
J	Hegde, ML; Banerjee, S; Hegde, PM; Bellot, LJ; Hazra, TK; Boldogh, I; Mitra, S				Hegde, Muralidhar L.; Banerjee, Srijita; Hegde, Pavana M.; Bellot, Larry J.; Hazra, Tapas K.; Boldogh, Istvan; Mitra, Sankar			Enhancement of NEIL1 Protein-initiated Oxidized DNA Base Excision Repair by Heterogeneous Nuclear Ribonucleoprotein U (hnRNP-U) via Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AP-ENDONUCLEASE APE1/REF-1; RESISTANCE GENE MDR1; DOUBLE-STRAND BREAKS; GLYCOSYLASE NEIL1; OXIDATIVE STRESS; BINDING-PROTEIN; HUMAN-CELLS; SAF-A; DAMAGE; IDENTIFICATION	Repair of oxidized base lesions in the human genome, initiated by DNA glycosylases, occurs via the base excision repair pathway using conserved repair and some non-repair proteins. However, the functions of the latter noncanonical proteins in base excision repair are unclear. Here we elucidated the role of heterogeneous nuclear ribonucleoprotein-U (hnRNP-U), identified in the immunoprecipitate of human NEIL1, a major DNA glycosylase responsible for oxidized base repair. hnRNP-U directly interacts with NEIL1 in vitro via the NEIL1 common interacting C-terminal domain, which is dispensable for its enzymatic activity. Their in-cell association increases after oxidative stress. hnRNP-U stimulates the NEIL1 in vitro base excision activity for 5-hydroxyuracil in duplex, bubble, forked, or single-stranded DNA substrate, primarily by enhancing product release. Using eluates from FLAG-NEIL1 immunoprecipitates from human cells, we observed 3-fold enhancement in complete repair activity after oxidant treatment. The lack of such enhancement in hnRNP-U-depleted cells suggests its involvement in repairing enhanced base damage after oxidative stress. The NEIL1 disordered C-terminal region binds to hnRNP-U at equimolar ratio with high affinity (K-d = similar to 54 nM). The interacting regions in hnRNP-U, mapped to both termini, suggest their proximity in the native protein; these are also disordered, based on PONDR (Predictor of Naturally Disordered Regions) prediction and circular dichroism spectra. Finally, depletion of hnRNP-U and NEIL1 epistatically sensitized human cells at low oxidative genome damage, suggesting that the hnRNP-U protection of cells after oxidative stress is largely due to enhancement of NEIL1-mediated repair.	[Hegde, Muralidhar L.; Banerjee, Srijita; Hegde, Pavana M.; Bellot, Larry J.; Hazra, Tapas K.; Mitra, Sankar] UTMB, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hegde, Muralidhar L.] UTMB, Dept Neurol, Galveston, TX 77555 USA; [Hazra, Tapas K.] UTMB, Dept Internal Med, Galveston, TX 77555 USA; [Boldogh, Istvan] UTMB, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hazra, Tapas K.; Boldogh, Istvan; Mitra, Sankar] UTMB, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Mitra, S (corresponding author), MRB 6-136,301 Univ Blvd, Galveston, TX 77555 USA.	samitra@utmb.edu	Classen, Scott/AAY-8176-2020	Hegde, Muralidhar/0000-0001-7333-8123; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health through USPHS [R01 CA81063, P01 CA092584, R01 NS073976, ES018948]; NIEHS Center (National Institutes of Health) [P30 ES06676]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976] Funding Source: NIH RePORTER	National Institutes of Health through USPHS; NIEHS Center (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA81063 and P01 CA092584 (to S. M.), R01 NS073976 (to T. K. H.), and ES018948 (to I. B.) through the USPHS.; We thank Drs. D. W. Bolen and L. Holthauzen (Department of Biochemistry and Molecular Biology) for the use of the Biophysical Core Facility and Drs. M. Banadakoppa and C. Yallampalli (Department of Obstetrics and Gynecology) for fluorescence microscopy. We acknowledge the help of Dr. T. Wood of the NIEHS Center (National Institutes of Health), supported by Grant P30 ES06676 for large scale purification of pUC19CPD plasmid. We thank former Mitra laboratory members Drs. C. Theriot and A. Das for various help and Dr. D. Konkel for critically editing this manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; Bozner P, 1997, J NEUROPATH EXP NEUR, V56, P1356, DOI 10.1097/00005072-199712000-00010; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chatterjee M, 2012, J BIOL CHEM, V287, DOI [10.1074/jbc.M112.415067, 10.1074/jbc.M111.272179]; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Douki T, 2003, NUCLEIC ACIDS RES, V31, P3134, DOI 10.1093/nar/gkg408; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Hegde ML, 2010, CELL MOL LIFE SCI, V67, P3573, DOI 10.1007/s00018-010-0485-5; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Meyer TE, 1998, INT J CANCER, V77, P55, DOI 10.1002/(SICI)1097-0215(19980703)77:1<55::AID-IJC10>3.0.CO;2-8; Mukherjee SK, 1997, MOL CHEM NEUROPATHOL, V32, P59, DOI 10.1007/BF02815167; Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Spraggon L, 2007, ONCOGENE, V26, P1484, DOI 10.1038/sj.onc.1209922; Theriot CA, 2010, DNA REPAIR, V9, P643, DOI 10.1016/j.dnarep.2010.02.014; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; YANG JT, 1986, METHOD ENZYMOL, V130, P208	50	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34202	34211		10.1074/jbc.M112.384032	http://dx.doi.org/10.1074/jbc.M112.384032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22902625	Green Published, hybrid			2022-12-25	WOS:000309654200025
J	Kumar, NV; Rangarajan, PN				Kumar, Nallani Vijay; Rangarajan, Pundi N.			The Zinc Finger Proteins Mxr1p and Repressor of Phosphoenolpyruvate Carboxykinase (ROP) Have the Same DNA Binding Specificity but Regulate Methanol Metabolism Antagonistically in Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UTILIZATION PATHWAY; EXPRESSION; PROMOTER; IDENTIFICATION; GENES	The methanol-inducible alcohol oxidase I (AOXI) promoter of the methylotrophic yeast, Pichia pastoris, is used widely for the production of recombinant proteins. AOXI transcription is regulated by the zinc finger protein Mxr1p (methanol expression regulator 1). ROP (repressor of phosphoenolpyruvate carboxykinase, PEPCK) is a methanol- and biotin starvation-inducible zinc finger protein that acts as a negative regulator of PEPCK in P. pastoris cultured in biotin-deficient, glucose-ammonium medium. The function of ROP during methanol metabolism is not known. In this study, we demonstrate that ROP represses methanol-inducible expression of AOXI when P. pastoris is cultured in a nutrient-rich medium containing yeast extract, peptone, and methanol (YPM). Deletion of the gene encoding ROP results in enhanced expression of AOXI and growth promotion whereas overexpression of ROP results in repression of AOXI and growth retardation of P. pastoris cultured in YPM medium. Surprisingly, deletion or overexpression of ROP has no effect on AOXI gene expression and growth of P. pastoris cultured in a minimal medium containing yeast nitrogen base and methanol (YNBM). Subcellular localization studies indicate that ROP translocates from cytosol to nucleus of cells cultured in YPM but not YNBM. In vitro DNA binding studies indicate that AOXI promoter sequences containing 5' CYCCNY 3' motifs serve as binding sites for Mxr1p as well as ROP. Thus, Mxr1p and ROP exhibit the same DNA binding specificity but regulate methanol metabolism antagonistically in P. pastoris. This is the first report on the identification of a transcriptional repressor of methanol metabolism in any yeast species.	[Kumar, Nallani Vijay; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Department of Biotechnology, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, New Delhi, India.	Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; Koller A, 2000, YEAST, V16, P651, DOI 10.1002/(SICI)1097-0061(200005)16:7<651::AID-YEA580>3.3.CO;2-6; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Maniatis T., 1982, MOL CLONING LAB MANU; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	12	16	18	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34465	34473		10.1074/jbc.M112.365304	http://dx.doi.org/10.1074/jbc.M112.365304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888024	hybrid, Green Published			2022-12-25	WOS:000309654200048
J	Mitchell, DA; Hamel, LD; Ishizuka, K; Mitchell, G; Schaefer, LM; Deschenes, RJ				Mitchell, David A.; Hamel, Laura D.; Ishizuka, Kayoko; Mitchell, Gayatri; Schaefer, Logan M.; Deschenes, Robert J.			The Erf4 Subunit of the Yeast Ras Palmitoyl Acyltransferase Is Required for Stability of the Acyl-Erf2 Intermediate and Palmitoyl Transfer to a Ras2 Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; SACCHAROMYCES-CEREVISIAE; PROTEIN PALMITOYLATION; MENTAL-RETARDATION; UBIQUITIN LIGASE; GENE; DEGRADATION; EXPRESSION; FAMILY; PALMITOYLTRANSFERASE	Protein S-palmitoylation is a posttranslational modification in which a palmitoyl group is added to a protein via a thioester linkage on cysteine. Palmitoylation is a reversible modification involved in protein membrane targeting, receptor trafficking and signaling, vesicular biogenesis and trafficking, protein aggregation, and protein degradation. An example of the dynamic nature of this modification is the palmitoylation-depalmitoylation cycle that regulates the subcellular trafficking of Ras family GTPases. The Ras protein acyltransferase (PAT) consists of a complex of Erf2-Erf4 and DHHC9-GCP16 in yeast and mammalian cells, respectively. Both subunits are required for PAT activity, but the function of the Erf4 and Gcp16 subunits has not been established. This study elucidates the function of Erf4 and shows that one role of Erf4 is to regulate Erf2 stability through an ubiquitin-mediated pathway. In addition, Erf4 is required for the stable formation of the palmitoyl-Erf2 intermediate, the first step of palmitoyl transfer to protein substrates. In the absence of Erf4, the rate of hydrolysis of the active site palmitoyl thioester intermediate is increased, resulting in reduced palmitoyl transfer to a Ras2 substrate. This is the first demonstration of regulation of a DHHC PAT enzyme by an associated protein.	[Deschenes, Robert J.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Deschenes, RJ (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	rdeschen@health.usf.edu			National Institutes of Health [CA50211, GM73976]; NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50211 and GM73976 (to R. J. D.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; Chen WY, 2004, HUM MOL GENET, V13, P2991, DOI 10.1093/hmg/ddh322; Choi YW, 2007, INT J GYNECOL CANCER, V17, P687, DOI 10.1111/j.1525-1438.2007.00834.x; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; JUNG V, 1995, MOL CELL BIOL, V15, P1333; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohta E, 2003, J BIOL CHEM, V278, P51957, DOI 10.1074/jbc.M310014200; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	43	34	34	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34337	34348		10.1074/jbc.M112.379297	http://dx.doi.org/10.1074/jbc.M112.379297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904317	Green Published, hybrid			2022-12-25	WOS:000309654200037
J	Fayolle, A; Engelbrecht, B; Freycon, V; Mortier, F; Swaine, M; Rejou-Mechain, M; Doucet, JL; Fauvet, N; Cornu, G; Gourlet-Fleury, S				Fayolle, Adeline; Engelbrecht, Bettina; Freycon, Vincent; Mortier, Frederic; Swaine, Michael; Rejou-Mechain, Maxime; Doucet, Jean-Louis; Fauvet, Nicolas; Cornu, Guillaume; Gourlet-Fleury, Sylvie			Geological Substrates Shape Tree Species and Trait Distributions in African Moist Forests	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HABITAT ASSOCIATIONS; FUNCTIONAL TRAITS; PATTERNS; SPECIALIZATION; CONVERGENCE; PERFORMANCE; ENVIRONMENT; DIVERSITY; SEEDLINGS	Background: Understanding the factors that shape the distribution of tropical tree species at large scales is a central issue in ecology, conservation and forest management. The aims of this study were to (i) assess the importance of environmental factors relative to historical factors for tree species distributions in the semi-evergreen forests of the northern Congo basin; and to (ii) identify potential mechanisms explaining distribution patterns through a trait-based approach. Methodology/Principal Findings: We analyzed the distribution patterns of 31 common tree species in an area of more than 700,000 km(2) spanning the borders of Cameroon, the Central African Republic, and the Republic of Congo using forest inventory data from 56,445 0.5-ha plots. Spatial variation of environmental (climate, topography and geology) and historical factors (human disturbance) were quantified from maps and satellite records. Four key functional traits (leaf phenology, shade tolerance, wood density, and maximum growth rate) were extracted from the literature. The geological substrate was of major importance for the distribution of the focal species, while climate and past human disturbances had a significant but lesser impact. Species distribution patterns were significantly related to functional traits. Species associated with sandy soils typical of sandstone and alluvium were characterized by slow growth rates, shade tolerance, evergreen leaves, and high wood density, traits allowing persistence on resource-poor soils. In contrast, fast-growing pioneer species rarely occurred on sandy soils, except for Lophira alata. Conclusions/Significance: The results indicate strong environmental filtering due to differential soil resource availability across geological substrates. Additionally, long-term human disturbances in resource-rich areas may have accentuated the observed patterns of species and trait distributions. Trait differences across geological substrates imply pronounced differences in population and ecosystem processes, and call for different conservation and management strategies.	[Fayolle, Adeline; Freycon, Vincent; Mortier, Frederic; Fauvet, Nicolas; Cornu, Guillaume; Gourlet-Fleury, Sylvie] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Tropicaux BSE, Montpellier, France; [Fayolle, Adeline; Doucet, Jean-Louis] Univ Liege ULg, Gembloux Agrobio Tech GxABT, Unite Gest Ressources Forestieres & Milieux Nat G, Lab Foresterie Reg Trop & Subtrop FORTHOP, Gembloux, Belgium; [Engelbrecht, Bettina] Univ Bayreuth, Dept Plant Ecol, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany; [Engelbrecht, Bettina] Smithsonian Trop Res Inst STRI, Balboa, Ancon, Panama; [Swaine, Michael] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Rejou-Mechain, Maxime] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, F-31062 Toulouse, France	CIRAD; University of Bayreuth; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fayolle, A (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Tropicaux BSE, Montpellier, France.	adeline.fayolle@ulg.ac.be	Cornu, Guillaume/C-1607-2014	Cornu, Guillaume/0000-0002-7523-5176; FAYOLLE, Adeline/0000-0002-6770-0031; Mortier, Frederic/0000-0001-5473-709X; Rejou-Mechain, Maxime/0000-0003-2824-267X	National Research Agency (ANR); Natural Environment Research Council (NERC)	National Research Agency (ANR)(French National Research Agency (ANR)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of the ErA Net BiodivERsA CoForChange project, funded by the National Research Agency (ANR) and the Natural Environment Research Council (NERC), involving 16 European, African and international partners and a number of timber companies (see list on the website, http://www.coforchange.eu). AF was supported by ANR funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Anderson D.R., 2008, MODEL BASED INFERENC; Arbelaez MV, 2004, J VEG SCI, V15, P181, DOI 10.1111/j.1654-1103.2004.tb02253.x; Aubreville A., 1959, FLORE FORESTIERE COT; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Couteron P, 2003, FOREST ECOL MANAG, V172, P89, DOI 10.1016/S0378-1127(02)00310-9; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Furrer R., 2012, FIELDS TOOLS SPATIAL; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Givnish TJ, 2002, SILVA FENN, V36, P703, DOI 10.14214/sf.535; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; HILL MO, 1974, ROY STAT SOC C-APP, V23, P340; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lebrun J., 1954, CLASSIFICATION ECOLO; Lebrun J.-P, 1991, ENUMERATION PLANTES; Maharjan SK, 2011, BIOTROPICA, V43, P552, DOI 10.1111/j.1744-7429.2010.00747.x; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Rejou-Mechain M, 2008, J TROP ECOL, V24, P663, DOI 10.1017/S0266467408005506; Rejou-Mechain M, 2011, FOREST ECOL MANAG, V261, P187, DOI 10.1016/j.foreco.2010.10.003; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Swaine MD, 1996, J ECOL, V84, P419, DOI 10.2307/2261203; Ter Steege H, 2001, ECOLOGY, V82, P3197, DOI 10.1890/0012-9658(2001)082[3197:CCDADI]2.0.CO;2; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Veenendaal EM, 1996, FUNCT ECOL, V10, P501, DOI 10.2307/2389943; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Wright IJ, 2001, OECOLOGIA, V127, P21, DOI 10.1007/s004420000554; Wright S Joseph, 2010, Ecology, V91, P3664, DOI 10.1890/09-2335.1	65	66	67	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42381	10.1371/journal.pone.0042381	http://dx.doi.org/10.1371/journal.pone.0042381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905127	Green Published, gold			2022-12-25	WOS:000307823600012
J	Baldan, R; Testa, F; Lore, NI; Bragonzi, A; Cichero, P; Ossi, C; Biancardi, A; Nizzero, P; Moro, M; Cirillo, DM				Baldan, Rossella; Testa, Francesca; Lore, Nicola I.; Bragonzi, Alessandra; Cichero, Paola; Ossi, Cristina; Biancardi, Anna; Nizzero, Paola; Moro, Matteo; Cirillo, Daniela M.			Factors Contributing to Epidemic MRSA Clones Replacement in a Hospital Setting	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SURVEILLANCE; INFECTION; VIRULENCE; CELLS; EVOLUTION; BIOFILM; FITNESS; PERIOD; TOXIN	The mechanisms governing the epidemiology dynamics and success determinants of a specific healthcare-associated methicillin-resistant S. aureus (HA-MRSA) clone in hospital settings are still unclear. Important epidemiological changes have occurred in Europe since 2000 that have been related to the appearance of the ST22-IV clone. Between 2006 and 2010, we observed the establishment of the ST22-IV clone displacing the predominant Italian clone, ST228-I, in a large Italian university hospital. To investigate the factors associated with a successful spread of epidemic MRSA clones we studied the biofilm production, the competitive behavior in co-culture, the capacity of invasion of the A549 cells, and the susceptibility to infection in a murine model of acute pneumonia of the two major HA-MRSA clones, ST22-IV and ST228-I. We showed that persistence of ST22-IV is associated with its increased biofilm production and capacity to inhibit the growth of ST228-I in co-culture. Compared to ST228-I, ST22-IV had a significantly higher capacity to invade the A549 cells and a higher virulence in a murine model of acute lung infection causing severe inflammation and determining death in all the mice within 60 hours. On the contrary, ST228-I was associated with mice survival and clearance of the infection. ST22-IV, compared with ST228-I, caused a higher number of persistent, long lasting bacteremia. These data suggest that ST22-IV could have exploited its capacity to i) increase its biofilm production over time, ii) maintain its growth kinetics in the presence of a competitor and iii) be particularly invasive and virulent both in vitro and in vivo, to replace other well-established MRSA clones, becoming the predominant European clone.	[Baldan, Rossella; Testa, Francesca; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Lore, Nicola I.; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Cichero, Paola; Ossi, Cristina] Laboraf Diagnost & Res San Raffaele, Milan, Italy; [Biancardi, Anna; Nizzero, Paola; Moro, Matteo] Ist Sci San Raffaele, Chief Med Off, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Baldan, R (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	Cirillo, Daniela Maria/AAB-3646-2019; Lorè, Nicola Ivan/K-9285-2016; Bragonzi, Alessandra/AAC-6751-2022	Cirillo, Daniela Maria/0000-0001-6415-1535; Lorè, Nicola Ivan/0000-0001-9159-1632; moro, matteo/0000-0001-5398-6000; Bragonzi, Alessandra/0000-0002-5808-7669; Baldan, Rossella/0000-0002-4674-4326	Fondazione per la ricerca sulla Fibrosi Cistica [FFC 9/2010]	Fondazione per la ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This study was supported to DMC and A. Bragonzi by Fondazione per la ricerca sulla Fibrosi Cistica (project FFC#9/2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; CAMPANILE F, 2009, ANN CLIN MICROB ANTI, V24, P8; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DEMARIA TF, 1978, INFECT IMMUN, V21, P114, DOI 10.1128/IAI.21.1.114-123.1978; Denis O, 2004, ANTIMICROB AGENTS CH, V48, P3625, DOI 10.1128/AAC.48.9.3625-3629.2004; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Giese B, 2011, CELL MICROBIOL, V13, P316, DOI 10.1111/j.1462-5822.2010.01538.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Matthews TD, 2010, J BACTERIOL, V192, P6086, DOI 10.1128/JB.00649-10; Melter O, 2006, EUROSURVEILLANCE, V11; Moore CL, 2009, INT J ANTIMICROB AG, V34, P148, DOI 10.1016/j.ijantimicag.2009.03.004; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Perez-Roth E, 2004, J CLIN MICROBIOL, V42, P4649, DOI 10.1128/JCM.42.10.4649-4656.2004; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Skov RL, 2009, J HOSP INFECT, V73, P364, DOI 10.1016/j.jhin.2009.07.004; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Strommenger B, 2004, EUR J CLIN MICROBIOL, V23, P15, DOI 10.1007/s10096-003-1046-8; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672	36	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43153	10.1371/journal.pone.0043153	http://dx.doi.org/10.1371/journal.pone.0043153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905220	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800052
J	Canale, GR; Peres, CA; Guidorizzi, CE; Gatto, CAF; Kierulff, MCM				Canale, Gustavo R.; Peres, Carlos A.; Guidorizzi, Carlos E.; Ferreira Gatto, Cassiano A.; Kierulff, Maria Cecilia M.			Pervasive Defaunation of Forest Remnants in a Tropical Biodiversity Hotspot	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; AREA RELATIONSHIPS; PATCH SIZE; CONSERVATION; LANDSCAPE; FRAGMENTATION; EXTINCTIONS; ABUNDANCE; PROSPECTS	Tropical deforestation and forest fragmentation are among the most important biodiversity conservation issues worldwide, yet local extinctions of millions of animal and plant populations stranded in unprotected forest remnants remain poorly explained. Here, we report unprecedented rates of local extinctions of medium to large-bodied mammals in one of the world's most important tropical biodiversity hotspots. We scrutinized 8,846 person-years of local knowledge to derive patch occupancy data for 18 mammal species within 196 forest patches across a 252,669-km(2) study region of the Brazilian Atlantic Forest. We uncovered a staggering rate of local extinctions in the mammal fauna, with only 767 from a possible 3,528 populations still persisting. On average, forest patches retained 3.9 out of 18 potential species occupancies, and geographic ranges had contracted to 0-14.4% of their former distributions, including five large-bodied species that had been extirpated at a regional scale. Forest fragments were highly accessible to hunters and exposed to edge effects and fires, thereby severely diminishing the predictive power of species-area relationships, with the power model explaining only similar to 9% of the variation in species richness per patch. Hence, conventional species-area curves provided over-optimistic estimates of species persistence in that most forest fragments had lost species at a much faster rate than predicted by habitat loss alone.	[Canale, Gustavo R.] Univ Cambridge, Sch Anat, Wildlife Res Grp, Cambridge, England; [Canale, Gustavo R.] Univ Estado Mato Grosso UNEMAT, Dept Biol, Tangara Da Serra, Mato Grosso, Brazil; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Ctr Biodivers Res, Norwich NR4 7TJ, Norfolk, England; [Guidorizzi, Carlos E.] Brazilian Minist Environm ICMBIO, Inst Chico Mendes, Brasilia, DF, Brazil; [Ferreira Gatto, Cassiano A.] Inst Nacl Pesquisa Amazonia INPA, Manaus, Amazonas, Brazil; [Kierulff, Maria Cecilia M.] Inst Primatas Conservacao Biodiversidade, Belo Horizonte, MG, Brazil	University of Cambridge; Universidade do Estado de Mato Grosso; University of East Anglia; Institute Nacional de Pesquisas da Amazonia	Canale, GR (corresponding author), Univ Cambridge, Sch Anat, Wildlife Res Grp, Cambridge, England.	g.canale@cantab.net	Guidorizzi, Carlos Eduardo/AAG-2086-2020; Gatto, Cassiano/AAH-3409-2021; Peres, Carlos A./ABE-8361-2020; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./B-1276-2013	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Canale, Gustavo/0000-0002-3932-282X	Brazilian Ministry of Education/CAPES; Brazilian Ministry of Environment (PROBIO); Brazilian Ministry of Education (CAPES)	Brazilian Ministry of Education/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Environment (PROBIO); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Brazilian Ministry of Environment/Probio for supporting fieldwork and Brazilian Ministry of Education/CAPES for PhD studentship of G. Canale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brazilian Ministry of Environment (PROBIO) for funding the fieldwork, the Instituto de Estudos Socioambientais do Sul da Bahia (especially Gabriel Santos, Paulo Vila Nova and Alexandre Coelho) for logistical support; Leticia Castro for helping with data entry; and the Brazilian Ministry of Education (CAPES) for funding GRC's PhD studentship.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; da Silva AP, 2008, BIODIVERS CONSERV, V17, P1455, DOI 10.1007/s10531-008-9353-0; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dean Warren, 1995, BROADAX FIREBRAND DE; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Galindo-Leal C, 2003, STATE HOTS, P3; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gonzalez A, 2000, ECOL LETT, V3, P441, DOI 10.1046/j.1461-0248.2000.00171.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Laurance WF, 2001, CONSERV BIOL, V15, P1488, DOI 10.1046/j.1523-1739.2001.01088.x; MA, 2005, ECOSYSTEMS HUMAN WEL; Mendonca JR, 1993, HIST LAND CLEARING S; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norris D, 2008, MAMMALIA, V72, P15, DOI 10.1515/MAMM.2008.002; Norris D, 2010, J MAMMAL, V91, P551, DOI 10.1644/09-MAMM-A-199.1; Paglia AP, 2004, C BRAS UN CONS FUND, P39; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peres Carlos A., 2006, P105; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; STRIER KB, 1989, FOLIA PRIMATOL, V52, P70, DOI 10.1159/000156383; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z	33	159	166	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e41671	10.1371/journal.pone.0041671	http://dx.doi.org/10.1371/journal.pone.0041671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905103	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800006
J	Napoli, E; Ross-Inta, C; Wong, S; Hung, C; Fujisawa, Y; Sakaguchi, D; Angelastro, J; Omanska-Klusek, A; Schoenfeld, R; Giulivi, C				Napoli, Eleonora; Ross-Inta, Catherine; Wong, Sarah; Hung, Connie; Fujisawa, Yasuko; Sakaguchi, Danielle; Angelastro, James; Omanska-Klusek, Alicja; Schoenfeld, Robert; Giulivi, Cecilia			Mitochondrial Dysfunction in Pten Haplo-Insufficient Mice with Social Deficits and Repetitive Behavior: Interplay between Pten and p53	PLOS ONE			English	Article							C-OXIDASE DEFICIENCY; AUTISM SPECTRUM DISORDERS; LHERMITTE-DUCLOS-DISEASE; RILEY-RUVALCABA-SYNDROME; TUMOR-SUPPRESSOR GENE; FRAGILE-X-SYNDROME; COPY NUMBER; TRANSCRIPTION FACTOR; DNA-DAMAGE; ALZHEIMERS-DISEASE	Etiology of aberrant social behavior consistently points to a strong polygenetic component involved in fundamental developmental pathways, with the potential of being enhanced by defects in bioenergetics. To this end, the occurrence of social deficits and mitochondrial outcomes were evaluated in conditional Pten (Phosphatase and tensin homolog) haplo-insufficient mice, in which only one allele was selectively knocked-out in neural tissues. Pten mutations have been linked to Alzheimer's disease and syndromic autism spectrum disorders, among others. By 4-6 weeks of age, Pten insufficiency resulted in the increase of several mitochondrial Complex activities (II-III, IV and V) not accompanied by increases in mitochondrial mass, consistent with an activation of the PI3K/Akt pathway, of which Pten is a negative modulator. At 8-13 weeks of age, Pten haplo-insufficient mice did not show significant behavioral abnormalities or changes in mitochondrial outcomes, but by 20-29 weeks, they displayed aberrant social behavior (social avoidance, failure to recognize familiar mouse, and repetitive self-grooming), macrocephaly, increased oxidative stress, decreased cytochrome c oxidase (CCO) activity (50%) and increased mtDNA deletions in cerebellum and hippocampus. Mitochondrial dysfunction was the result of a downregulation of p53-signaling pathway evaluated by lower protein expression of p21 (65% of controls) and the CCO chaperone SCO2 (47% of controls), two p53-downstream targets. This mechanism was confirmed in Pten-deficient striatal neurons and, HCT 116 cells with different p53 gene dosage. These results suggest a unique pathogenic mechanism of the Pten-p53 axis in mice with aberrant social behavior: loss of Pten (via p53) impairs mitochondrial function elicited by an early defective assembly of CCO and later enhanced by the accumulation of mtDNA deletions. Consistent with our results, (i) SCO2 deficiency and/or CCO activity defects have been reported in patients with learning disabilities including autism and (ii) mutated proteins in ASD have been found associated with p53-signaling pathways.	[Napoli, Eleonora; Ross-Inta, Catherine; Wong, Sarah; Hung, Connie; Fujisawa, Yasuko; Sakaguchi, Danielle; Angelastro, James; Omanska-Klusek, Alicja; Schoenfeld, Robert; Giulivi, Cecilia] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Giulivi, Cecilia] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Napoli, E (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/AAV-6774-2021; Napoli, Eleonora/AAQ-6079-2021; Giulivi, Cecilia/ABB-7809-2020	Napoli, Eleonora/0000-0001-8808-4242; Giulivi, Cecilia/0000-0003-1033-7435	Autism Speaks Foundation [58739]; MIND Institute; Elsa U. Pardee Foundation; National Institute of Environmental Health Sciences [NIEHS R01-ES012691, NIEHS R01-ES020392]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012691, R01ES020392] Funding Source: NIH RePORTER	Autism Speaks Foundation; MIND Institute; Elsa U. Pardee Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funds provided by Autism Speaks Foundation (#58739); and, partially, by the MIND Institute, Elsa U. Pardee Foundation and National Institute of Environmental Health Sciences (NIEHS R01-ES012691 & NIEHS R01-ES020392). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chiu S, 2007, J DEV BEHAV PEDIATR, V28, P31, DOI 10.1097/01.DBP.0000257518.60083.2d; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Clay HB, 2011, INT J DEV NEUROSCI, V29, P311, DOI 10.1016/j.ijdevneu.2010.08.007; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Delatycki MB, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e92; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Drage MG, 2002, J NEUROCYTOL, V31, P681, DOI 10.1023/A:1025747813463; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elder LM, 2008, J AUTISM DEV DISORD, V38, P1104, DOI 10.1007/s10803-007-0495-9; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Goghari VM, 2007, CEREB CORTEX, V17, P415, DOI 10.1093/cercor/bhj158; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; HALTIA M, 1992, BRAIN PATHOL, V2, P133, DOI 10.1111/j.1750-3639.1992.tb00681.x; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hassel B, 1998, J NEUROCHEM, V71, P1511; Haukvik UK, 2009, J PSYCHIATR RES, V43, P1287, DOI 10.1016/j.jpsychires.2009.05.001; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Herman GE, 2007, AM J MED GENET A, V143A, P589, DOI 10.1002/ajmg.a.31619; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hirasawa M, 2001, NEUROSCI RES, V40, P125, DOI 10.1016/S0168-0102(01)00216-4; Howard R, 2000, AM J PSYCHIAT, V157, P172, DOI 10.1176/appi.ajp.157.2.172; Isaacs JS, 1997, CANCER RES, V57, P2986; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004; Kakiuchi C, 2005, INT J NEUROPSYCHOPH, V8, P515, DOI 10.1017/S1461145705005213; Kalkman HO, 2006, PHARMACOL THERAPEUT, V110, P117, DOI 10.1016/j.pharmthera.2005.10.014; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; Kerr F, 2006, FEBS LETT, V580, P3121, DOI 10.1016/j.febslet.2006.04.064; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lawrence YA, 2010, ACTA NEUROL SCAND, V121, P99, DOI 10.1111/j.1600-0404.2009.01234.x; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li YT, 2011, BLOOD, V117, P6702, DOI 10.1182/blood-2010-09-309864; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Meesters PD, 2012, AM J GERIAT PSYCHIAT, V20, P18, DOI 10.1097/JGP.0b013e3182011b7f; Merks JHM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e111; Moretti A, 2003, MOL PSYCHIATR, V8, P773, DOI 10.1038/sj.mp.4001353; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Noack H, 2006, BBA-GEN SUBJECTS, V1760, P141, DOI 10.1016/j.bbagen.2005.12.007; O'Roak B.J., 2012, NATURE; O'Roak BJ, 2012, NAT GENET, V44, P471, DOI 10.1038/ng0412-471; Ozonoff S, 2008, AUTISM RES, V1, P320, DOI 10.1002/aur.53; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pessah IN, 2008, NEUROTOXICOLOGY, V29, P532, DOI 10.1016/j.neuro.2008.02.006; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Rickle A, 2006, J NEUROSCI RES, V84, P596, DOI 10.1002/jnr.20970; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Santoro L, 2000, NEUROMUSCULAR DISORD, V10, P450, DOI 10.1016/S0960-8966(99)00122-4; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Torres M, 2004, INT J RADIAT ONCOL, V58, P479, DOI 10.1016/j.ijrobp.2003.09.062; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tulinius M, 2003, NEUROPEDIATRICS, V34, P87; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Wanka C, 2011, ONCOGENE; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; Wolfe A, 2008, J NEUROENDOCRINOL, V20, P909, DOI 10.1111/j.1365-2826.2008.01746.x; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.3.CO;2-F	119	81	83	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42504	10.1371/journal.pone.0042504	http://dx.doi.org/10.1371/journal.pone.0042504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900024	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900040
J	Strijk, JS; Noyes, RD; Strasberg, D; Cruaud, C; Gavory, F; Chase, MW; Abbott, RJ; Thebaud, C				Strijk, Joeri S.; Noyes, Richard D.; Strasberg, Dominique; Cruaud, Corinne; Gavory, Frederic; Chase, Mark W.; Abbott, Richard J.; Thebaud, Christophe			In and out of Madagascar: Dispersal to Peripheral Islands, Insular Speciation and Diversification of Indian Ocean Daisy Trees (Psiadia, Asteraceae)	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; LONG-DISTANCE DISPERSAL; DES-NEIGES VOLCANO; PHYLOGENETIC ANALYSIS; COLONIZATION HISTORY; MOLECULAR EVIDENCE; REUNION-ISLAND; BIODIVERSITY HOTSPOTS; ENDEMIC CLADES; EAST GONDWANA	Madagascar is surrounded by archipelagos varying widely in origin, age and structure. Although small and geologically young, these archipelagos have accumulated disproportionate numbers of unique lineages in comparison to Madagascar, highlighting the role of waif-dispersal and rapid in situ diversification processes in generating endemic biodiversity. We reconstruct the evolutionary and biogeographical history of the genus Psiadia (Asteraceae), a plant genus with near equal numbers of species in Madagascar and surrounding islands. Analyzing patterns and processes of diversification, we explain species accumulation on peripheral islands and aim to offer new insights on the origin and potential causes for diversification in the Madagascar and Indian Ocean Islands biodiversity hotspot. Our results provide support for an African origin of the group, with strong support for non-monophyly. Colonization of the Mascarenes took place by two evolutionary distinct lineages from Madagascar, via two independent dispersal events, each unique for their spatial and temporal properties. Significant shifts in diversification rate followed regional expansion, resulting in co-occurring and phenotypically convergent species on high-elevation volcanic slopes. Like other endemic island lineages, Psiadia have been highly successful in dispersing to and radiating on isolated oceanic islands, typified by high habitat diversity and dynamic ecosystems fuelled by continued geological activity. Results stress the important biogeographical role for Rodrigues in serving as an outlying stepping stone from which regional colonization took place. We discuss how isolated volcanic islands contribute to regional diversity by generating substantial numbers of endemic species on short temporal scales. Factors pertaining to the mode and tempo of archipelago formation and its geographical isolation strongly govern evolutionary pathways available for species diversification, and the potential for successful diversification of dispersed lineages, therefore, appears highly dependent on the timing of arrival, as habitat and resource properties change dramatically over the course of oceanic island evolution.	[Strijk, Joeri S.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Strijk, Joeri S.; Thebaud, Christophe] Univ Toulouse 3, Lab Evolut & Diversite Biol, UMR CNRS 5174, ENFA, F-31062 Toulouse, France; [Noyes, Richard D.] Univ Cent Arkansas, Dept Biol, Conway, AR USA; [Strasberg, Dominique] Univ La Reunion, UMR PVBMT, Fac Sci & Technol, St Denis, La Reunion, France; [Cruaud, Corinne; Gavory, Frederic] Ctr Natl Sequencage, CEA, Inst Genom, Genoscope, Evry, France; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Abbott, Richard J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); University of Central Arkansas; University of La Reunion; CEA; Royal Botanic Gardens, Kew; University of St Andrews	Strijk, JS (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	joeristrijk@xtbg.org.cn	Thébaud, Christophe/N-3916-2016; Chase, Mark W/A-6642-2011; Strijk, Joeri S./F-8220-2019	Thébaud, Christophe/0000-0002-8586-1234; Strijk, Joeri S./0000-0003-1109-7015; Cruaud, Corinne/0000-0002-4752-7278; Strasberg, Dominique/0000-0003-3012-252X; Gavory, Frederick/0000-0003-1534-5725	European Union's HOTSPOTS Training Network [MEST-2005-020561]; French National Research Agency [ANR-06-BDIV-002]; "Laboratoire d'Excellence" TULIP [ANR-10-LABX-41]	European Union's HOTSPOTS Training Network; French National Research Agency(French National Research Agency (ANR)); "Laboratoire d'Excellence" TULIP	This study was supported by the European Union's HOTSPOTS Training Network (MEST-2005-020561), the French National Research Agency's Biodiversity program (ANR-06-BDIV-002) and the "Laboratoire d'Excellence'' TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Antoine R, 1993, COMPOSEES, P80; Audru JC, 2006, CR GEOSCI, V338, P1240, DOI 10.1016/j.crte.2006.07.010; Austin JJ, 2004, MOL PHYLOGENET EVOL, V31, P109, DOI 10.1016/j.ympev.2003.07.011; Austin JJ, 2001, P ROY SOC B-BIOL SCI, V268, P2515, DOI 10.1098/rspb.2001.1825; BALDWIN BG, 1990, ANN MO BOT GARD, V77, P96, DOI 10.2307/2399629; Barreda V, 2012, REV PALAEOBOT PALYNO, V160, P102; Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Barreda VD, 2010, ANN BOT, V109, P127; Becker HF., 1969, PALAEONTOGR ABT B, V127, P1; Beentje H, 2002, COMPOSITAE, P514; Bergh NG, 2009, MOL PHYLOGENET EVOL, V51, P5, DOI 10.1016/j.ympev.2008.09.001; Bone RE, 2012, BOT J LINN SOC, V169, P284, DOI 10.1111/j.1095-8339.2012.01221.x; Bremer K, 1997, P NATL ACAD SCI USA, V94, P9188, DOI 10.1073/pnas.94.17.9188; BREMER K, 1992, NORD J BOT, V12, P141, DOI 10.1111/j.1756-1051.1992.tb01281.x; Bremer K., 1994, ASTERACEAE CLADISTIC; Bremer K, 1994, P INT COMP C, P1; Cadet LJT, 1977, VEG IL REUN; Carr GD, 2003, TARWEEDS SILVERSWORD, P229; CBOL-Kew, 2007, DNA BARC PHAS 2 PROT; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Collier JS, 2008, EARTH PLANET SC LETT, V272, P264, DOI 10.1016/j.epsl.2008.04.045; Couvreur TLP, 2008, BEAST PARTITIONING M; Cross EW, 2002, PLANT SYST EVOL, V235, P99, DOI 10.1007/s00606-002-0198-9; Cuenca A, 2008, MOL PHYLOGENET EVOL, V46, P760, DOI 10.1016/j.ympev.2007.10.010; DENIEL C, 1992, J VOLCANOL GEOTH RES, V51, P253, DOI 10.1016/0377-0273(92)90126-X; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyment J, 2003, INTERRIDGE S WORKSH; Eastwood A, 2004, BOT J LINN SOC, V144, P69, DOI 10.1111/j.0024-4074.2004.00238.x; Elsik William C., 2000, Palynology, V24, P177, DOI 10.2113/0240177; Francisco-Ortega J, 2008, BOT REV, V74, P112, DOI 10.1007/s12229-008-9008-6; Francisco-Ortega Javier, 1997, P407; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fretzdorff S, 2000, B VOLCANOL, V62, P266, DOI 10.1007/s004450000095; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Funk VA., 2005, BIOL SKRIFTER, V55, P343; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3538[1:ANSOEC]2.0.CO;2; Gradstein F.M., 2004, A; Graham, 1994, P INT COMPOSITAE C, P123; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hobohm C, 2000, FLORA, V195, P9; Humbert H, 1960, COMPOSEES, P267; Hume J., 2008, LOST LAND DODO; IUCN, 2019, IUCN RED LIST THREAT; JANSEN RK, 1990, EVOLUTION, V44, P2089, DOI 10.1111/j.1558-5646.1990.tb04314.x; JANSEN RK, 1996, COMPOSITAE SYSTEMATI, V1, P317; Janssen T, 2008, EVOLUTION, V62, P1876, DOI 10.1111/j.1558-5646.2008.00408.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KARIS PO, 1992, ANN MO BOT GARD, V79, P416, DOI 10.2307/2399778; KIEFFER G, 1993, CR ACAD SCI II, V317, P835; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; KIM KJ, 1992, ANN MO BOT GARD, V79, P428, DOI 10.2307/2399779; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Le Pechon T, 2009, TAXON, V58, P519; Lewis P. O, 2010, PHYCAS V1 2 0; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Malcomber ST, 2002, EVOLUTION, V56, P42, DOI 10.1111/j.0014-3820.2002.tb00848.x; MBG, 2011, MAD CAT CAT VASC PLA; MCDOUGAL.I, 1969, GEOL SOC AM BULL, V80, P1419, DOI 10.1130/0016-7606(1969)80[1419:IDAGPS]2.0.CO;2; MCDOUGALL I, 1965, NATURE, V206, P26, DOI 10.1038/206026a0; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; McMullen C.K., 1999, FLOWERING PLANTS GAL; MOORE BR, 2004, COMPU BIOL, V4, P487; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Mourer-Chauvire C, 1999, SM C PALEOB, P1; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Myers N, 2003, BIOSCIENCE, V53, P916; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Oehler JF, 2004, B VOLCANOL, V66, P585, DOI 10.1007/s00445-004-0341-2; Ott M, 2007, P 2007 ACM IEEE C SU, DOI DOI 10.1145/1362622.1362628; Panero JL, 1999, P NATL ACAD SCI USA, V96, P13886, DOI 10.1073/pnas.96.24.13886; Perroud B., 1982, ETUDE VOLCANO STRUCT; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pybus OG, 2002, BIOINFORMATICS, V18, P1404, DOI 10.1093/bioinformatics/18.10.1404; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Rambaut A, 2007, LOGCOMBINER MCMC SAM; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Rambaut A., 2002, PHYLOGEN PHYLOGENETI, V1.1; Rambaut A., 2007, TREEANNOTATOR V1 4 8; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Rambaut A., 2007, TRACE V1 4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; Renner SS, 2010, J BIOGEOGR, V37, P1227, DOI 10.1111/j.1365-2699.2010.02319.x; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Saddul P, 1995, MAURITIUS GEOMORPHOL; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, TRENDS PLANT SCI, V8, P374, DOI 10.1016/S1360-1385(03)00165-1; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schluter T, 2006, COMOROS GEOLOGICAL A; SCOTT A J, 1991, Kew Bulletin, V46, P339, DOI 10.2307/4110609; Scott L, 2006, REV PALAEOBOT PALYNO, V142, P47, DOI 10.1016/j.revpalbo.2006.07.010; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Sheldon FH, 2009, J BIOGEOGR, V36, P1070, DOI 10.1111/j.1365-2699.2009.02087.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; SLOWINSKI JB, 1989, SYST ZOOL, V38, P189, DOI 10.2307/2992389; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Song ZC, 1999, FOSSIL SPORES POLLEN, P749; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Sun XJ, 1981, TERTIARY PALACONTOLO; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thebaud C, 2009, ENCY ISLANDS, P612; Trenel P, 2007, MOL PHYLOGENET EVOL, V45, P272, DOI 10.1016/j.ympev.2007.03.018; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Walter KS, 1998, 1997 IUCN RED LIST T; Wang WM, 2004, BOT J LINN SOC, V145, P331, DOI 10.1111/j.1095-8339.2004.00287.x; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Warren BH, 2005, BIOL J LINN SOC, V85, P271, DOI 10.1111/j.1095-8312.2005.00492.x; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Yuan YM, 2005, SYST BIOL, V54, P21, DOI 10.1080/10635150590905867; ZHANG XP, 1993, PLANT SYST EVOL, V184, P259; [No title captured]	149	41	42	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42932	10.1371/journal.pone.0042932	http://dx.doi.org/10.1371/journal.pone.0042932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900068	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900086
J	Liu, SH; Rao, DD; Nemunaitis, J; Senzer, N; Zhou, GS; Dawson, D; Gingras, MC; Wang, ZH; Gibbs, R; Norman, M; Templeton, NS; DeMayo, FJ; O'Malley, B; Sanchez, R; Fisher, WE; Brunicardi, FC				Liu, Shi-He; Rao, Donald D.; Nemunaitis, John; Senzer, Neil; Zhou, Guisheng; Dawson, David; Gingras, Marie-Claude; Wang, Zhaohui; Gibbs, Richard; Norman, Michael; Templeton, Nancy S.; DeMayo, Francesco J.; O'Malley, Bert; Sanchez, Robbi; Fisher, William E.; Brunicardi, F. Charles			PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PDX-1; DUODENAL HOMEOBOX-1; IN-VIVO; GENE-EXPRESSION; CELLS; POLYPEPTIDE; DELIVERY; DIFFERENTIATION; INVOLVEMENT; ACTIVATION	Pancreatic and duodenal homeobox-1 (PDX-1) is a transcription factor that regulates insulin expression and islet maintenance in the adult pancreas. Our recent studies demonstrate that PDX-1 is an oncogene for pancreatic cancer and is overexpressed in pancreatic cancer. The purpose of this study was to demonstrate that PDX-1 is a therapeutic target for both hormonal symptoms and tumor volume in mouse models of pancreatic cancer, insulinoma and islet neoplasia. Immunohistochemistry of human pancreatic and islet neoplasia specimens revealed marked PDX-1 overexpression, suggesting PDX-1 as a "drugable" target within these diseases. To do so, a novel RNA interference effector platform, bifunctional shRNA(PDX-1), was developed and studied in mouse and human cell lines as well as in mouse models of pancreatic cancer, insulinoma and islet neoplasia. Systemic delivery of bi-shRNA(humanPDX-1) lipoplexes resulted in marked reduction of tumor volume and improved survival in a human pancreatic cancer xenograft mouse model. bi-shRNA(mousePDX-1) lipoplexes prevented death from hyperinsulinemia and hypoglycemia in an insulinoma mouse model. shRNA(mousePDX-1) lipoplexes reversed hyperinsulinemia and hypoglycemia in an immune-competent mouse model of islet neoplasia. PDX-1 was overexpressed in pancreatic neuroendocrine tumors and nesidioblastosis. These data demonstrate that PDX-1 RNAi therapy controls hormonal symptoms and tumor volume in mouse models of pancreatic cancer, insulinoma and islet neoplasia, therefore, PDX-1 is a potential therapeutic target for these pancreatic diseases.	[Liu, Shi-He; Zhou, Guisheng; Sanchez, Robbi; Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Dawson, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Liu, Shi-He; Zhou, Guisheng; Norman, Michael; Fisher, William E.; Brunicardi, F. Charles] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Fisher, William E.; Brunicardi, F. Charles] Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA; [DeMayo, Francesco J.; O'Malley, Bert] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gingras, Marie-Claude; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rao, Donald D.; Nemunaitis, John; Senzer, Neil; Wang, Zhaohui] Gradalis Inc, Dallas, TX USA; [Nemunaitis, John; Senzer, Neil] Mary Crowley Canc Res Ctr, Dallas, TX USA; [Nemunaitis, John; Senzer, Neil] Texas Oncol PA, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mary Crowley Cancer Research; Texas Oncology	Liu, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.	cbrunicardi@mednet.ucla.edu	DeMayo, Francesco/C-6255-2019; Dawson, David/I-5917-2014; Templeton, Nancy S/C-9565-2011	DeMayo, Francesco/0000-0002-9480-7336; 	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK46441]; National Cancer Institute [R01-CA095731]; Alkek Foundation; Vivian L. Smith Foundation; MD Anderson Foundation; Bill and Olivia Heintz family; NATIONAL CANCER INSTITUTE [R01CA095731] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046441] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alkek Foundation; Vivian L. Smith Foundation; MD Anderson Foundation; Bill and Olivia Heintz family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant R01-DK46441 from the National Institute of Diabetes and Digestive and Kidney Diseases; grant R01-CA095731 from the National Cancer Institute; the Alkek Foundation; the Vivian L. Smith Foundation; the MD Anderson Foundation; and the generosity of the Bill and Olivia Heintz family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa S, 2004, PANCREAS, V28, P109, DOI 10.1097/00006676-200403000-00001; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Feanny MA, 2008, J SURG RES, V144, P8, DOI 10.1016/j.jss.2007.04.018; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Jepeal LI, 2005, ENDOCRINOLOGY, V146, P383, DOI 10.1210/en.2004-0223; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; Koizumi M, 2005, SURGERY, V138, P125, DOI 10.1016/j.surg.2005.06.008; Koizumi M, 2003, SURGERY, V134, P260, DOI 10.1067/msy.2003.231; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Liu SH, CANCER, V117, P723; Liu SH, 2008, PANCREAS, V37, P210, DOI 10.1097/MPA.0b013e31816a4a33; Liu SH, 2007, J SURG RES, V137, P1, DOI 10.1016/j.jss.2006.04.039; Liu T, 2007, WORLD J GASTROENTERO, V13, P2615, DOI 10.3748/wjg.v13.i18.2615; Liu Tao, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P464; Lu C, 2010, J CLIN ONCOL S, V28, p15s; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Nemunaitis G, 2010, J GENE MED, V12, P403, DOI 10.1002/jgm.1450; Offield MF, 1996, DEVELOPMENT, V122, P983; Ramesh R, 2001, MOL THER, V3, P337, DOI 10.1006/mthe.2001.0266; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rao DD, CANC GENE THER, V17, P780; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Serup P, 1996, P NATL ACAD SCI USA, V93, P9015, DOI 10.1073/pnas.93.17.9015; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Taguchi M, 2002, J PATHOL, V197, P638, DOI 10.1002/path.1134; Templeton NS, 2002, BIOSCIENCE REP, V22, P283; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang XL, 2001, ENDOCRINOLOGY, V142, P1820, DOI 10.1210/en.142.5.1820; Wang XP, 2005, WORLD J SURG, V29, P334, DOI 10.1007/s00268-004-7823-4; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143	41	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40452	10.1371/journal.pone.0040452	http://dx.doi.org/10.1371/journal.pone.0040452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905092	Green Published, gold			2022-12-25	WOS:000307331100004
J	Wang, HM; Wu, JM; Liu, X; He, HB; Ding, FR; Yang, HJ; Cheng, L; Liu, WH; Zhong, JF; Dai, YP; Li, GP; He, CQ; Yu, L; Li, JB				Wang, Hongmei; Wu, Jianming; Liu, Xiao; He, Hongbin; Ding, Fangrong; Yang, Hongjun; Cheng, Lei; Liu, Wenhao; Zhong, Jifeng; Dai, Yunping; Li, Guangpeng; He, Chengqiang; Yu, Li; Li, Jianbin			Identification of Short Hairpin RNA Targeting Foot-And-Mouth Disease Virus with Transgenic Bovine Fetal Epithelium Cells	PLOS ONE			English	Article							CONSERVED REGIONS; INTERFERING RNA; SUCKLING MICE; GUINEA-PIGS; IN-VITRO; REPLICATION; INHIBITION; INFECTION; GENOME; GENE	Background: Although it is known that RNA interference (RNAi) targeting viral genes protects experimental animals, such as mice, from the challenge of Foot-and-mouth disease virus (FMDV), it has not been previously investigated whether shRNAs targeting FMDV in transgenic dairy cattle or primary transgenic bovine epithelium cells will confer resistance against FMDV challenge. Principal Finding: Here we constructed three recombinant lentiviral vectors containing shRNA against VP2 (RNAi-VP2), VP3 (RNAi-VP3), or VP4 (RNAi-VP4) of FMDV, and found that all of them strongly suppressed the transient expression of a FLAG-tagged viral gene fusion protein in 293T cells. In BHK-21 cells, RNAi-VP4 was found to be more potent in inhibition of viral replication than the others with over 98% inhibition of viral replication. Therefore, recombinant lentiviral vector RNAi-VP4 was transfected into bovine fetal fibroblast cells to generate transgenic nuclear donor cells. With subsequent somatic cell cloning, we generated forty transgenic blastocysts, and then transferred them to 20 synchronized recipient cows. Three transgenic bovine fetuses were obtained after pregnant period of 4 months, and integration into chromosome in cloned fetuses was confirmed by Southern hybridization. The primary tongue epithelium cells of transgenic fetuses were isolated and inoculated with 100 TCID50 of FMDV, and it was observed that shRNA significantly suppressed viral RNA synthesis and inhibited over 91% of viral replication after inoculation of FMDV for 48 h. Conclusion: RNAi-VP4 targeting viral VP4 gene appears to prevent primary epithelium cells of transgenic bovine fetus from FMDV infection, and it could be a candidate shRNA used for cultivation of transgenic cattle against FMDV.	[Wang, Hongmei; Wu, Jianming; Liu, Xiao; He, Hongbin; Yang, Hongjun; Liu, Wenhao; Zhong, Jifeng; Li, Jianbin] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Ding, Fangrong; Dai, Yunping] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cheng, Lei; Li, Guangpeng] Inner Mongolia Univ, Coll Life Sci, Hohhot, Peoples R China; [He, Chengqiang] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Yu, Li] Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Livestock Infect Dis, Harbin, Peoples R China	Shandong Academy of Agricultural Sciences; China Agricultural University; Inner Mongolia University; Shandong Normal University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, HM (corresponding author), Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China.	hongbinhe@yahoo.com; guangpengli@yahoo.com		Li, Jianbin/0000-0002-9587-2666	Taishan Scholar and Distinguished Experts from overseas; earmarked fund for China Agriculture Research System; State Major Project of Transgenic [2009ZX08007-006B, 2011ZX08007-002]; National Natural Science Fund of China [31072160]; Science and Technology Research Fund of Shandong Province [2009GG20002032]; University and Institute Independent Innovation Program of Jinan [201004027]; Opening Fund of State Key Laboratory of Veterinary Biotechnology [SKLVBF200806]	Taishan Scholar and Distinguished Experts from overseas; earmarked fund for China Agriculture Research System; State Major Project of Transgenic; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Fund of Shandong Province; University and Institute Independent Innovation Program of Jinan; Opening Fund of State Key Laboratory of Veterinary Biotechnology	This work was partially supported by grants from Taishan Scholar and Distinguished Experts from overseas (HH), the earmarked fund for China Agriculture Research System (HH), State Major Project of Transgenic (2009ZX08007-006B to JZ; 2011ZX08007-002 to GL), National Natural Science Fund of China (31072160 to HH), Science and Technology Research Fund of Shandong Province (2009GG20002032 to HH), University and Institute Independent Innovation Program of Jinan (201004027 to HH), and Opening Fund of State Key Laboratory of Veterinary Biotechnology (SKLVBF200806 to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-188; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; BROOKSBY JB, 1982, INTERVIROLOGY, V18, P1, DOI 10.1159/000149299; Chen FY, 2011, J GEN VIROL, V92, P945, DOI 10.1099/vir.0.027680-0; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cong W, 2010, VET RES COMMUN, V34, P335, DOI 10.1007/s11259-010-9360-y; Cong W, 2010, VET RES, V41, DOI 10.1051/vetres/2010002; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; Donovan DM, 2005, TRANSGENIC RES, V14, P563, DOI 10.1007/s11248-005-0670-8; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haydon DT, 2001, PREV VET MED, V51, P111, DOI 10.1016/S0167-5877(01)00210-0; He H, 2007, ONCOGENE, V26, P2707, DOI 10.1038/sj.onc.1210073; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Joyappa DH, 2009, VET RES COMMUN, V33, P263, DOI 10.1007/s11259-008-9174-3; Kahana R, 2004, J GEN VIROL, V85, P3213, DOI 10.1099/vir.0.80133-0; Kerr DE, 2003, J ANIM SCI, V81, P38; Kim SM, 2008, ANTIVIR RES, V80, P178, DOI 10.1016/j.antiviral.2008.06.001; Leforban Y, 1999, VACCINE, V17, P1755, DOI 10.1016/S0264-410X(98)00445-9; Leonard JN, 2006, GENE THER, V13, P532, DOI 10.1038/sj.gt.3302645; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Liu MQ, 2005, VIROLOGY, V336, P51, DOI 10.1016/j.virol.2005.01.051; Lv K, 2009, RES VET SCI, V86, P443, DOI 10.1016/j.rvsc.2008.10.011; Perrimon N, 2010, CSH PERSPECT BIOL, V2, P10; Santos TDL, 2005, VIROLOGY, V335, P222, DOI 10.1016/j.virol.2005.03.001; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Summerfield A, 2009, VET IMMUNOL IMMUNOP, V128, P205, DOI 10.1016/j.vetimm.2008.10.296; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang PY, 2010, ANTIVIR RES, V87, P265, DOI 10.1016/j.antiviral.2010.02.319; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4	34	15	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42356	10.1371/journal.pone.0042356	http://dx.doi.org/10.1371/journal.pone.0042356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905125	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100034
J	Wu, GS; Jiang, MS; Liu, YH; Nagaoka, Y; Rao, NA				Wu, Guey Shuang; Jiang, Meisheng; Liu, Yi-Hsin; Nagaoka, Yoshiko; Rao, Narsing A.			Phenotype of Transgenic Mice Overexpressed with Inducible Nitric Oxide Synthase in the Retina	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; ALPHA-A-CRYSTALLIN; CYTOCHROME-C; NITROSATIVE STRESS; ZYGOSITY DETERMINATION; UP-REGULATION; MITOCHONDRIA; EXPRESSION; APOPTOSIS; OPSIN	Background: Unlike its constitutive isoforms, including neuronal and endothelial nitric oxide synthase, inducible nitric oxide synthase (iNOS) along with a series of cytokines are generated in inflammatory pathologic conditions in retinal photoreceptors. In this study, we constructed transgenic mice overexpressing iNOS in the retina to evaluate the effect of sustained, intense iNOS generation in the photoreceptor damage. Methods: For construction of opsin/iNOS transgene in the CMVSport 6 expression vector, the 4.4 kb Acc65I/Xhol mouse rod opsin promoter was ligated upstream to a 4.1 kb fragment encoding the complete mouse cDNA of iNOS. From the four founders identified, two heterozygote lines and one homozygote line were established. The presence of iNOS in the retina was confirmed and the pathologic role of iNOS was assessed by detecting nitrotyrosine products and apoptosis. Commercial TUNEL kit was used to detect DNA strand breaks, a later step in a sequence of morphologic changes of apoptosis process. Results: The insertion and translation of iNOS gene were demonstrated by an intense single 130 kDa band in Western blot and specific immunolocalization at the photoreceptors of the retina. Cellular toxicity in the retinas of transgenic animals was detected by a post-translational modification product, tyrosine-nitrated protein, the most significant one of which was nitrated cytochrome c. Following the accumulation of nitrated mitochondrial proteins and cytochrome c release, marked apoptosis was detected in the photoreceptor cell nuclei of the retina. Conclusions: We have generated a pathologic phenotype with sustained iNOS overexpression and, therefore, high output of nitric oxide. Under basal conditions, such overexpression of iNOS causes marked mitochondrial cytochrome c nitration and release and subsequent photoreceptor apoptosis in the retina. Therefore, the modulation of pathways leading to iNOS generation or its effective neutralization can be of significant therapeutic benefit in the oxidative stress-mediated retinal degeneration, a leading cause of blindness.	[Wu, Guey Shuang; Liu, Yi-Hsin; Rao, Narsing A.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Jiang, Meisheng; Nagaoka, Yoshiko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Doheny Eye Institute; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, GS (corresponding author), Univ So Calif, Keck Sch Med, Dept Ophthalmol, Doheny Eye Inst, Los Angeles, CA 90033 USA.	nrao@usc.edu			National Institute of Health [EY017347]; NATIONAL EYE INSTITUTE [R01EY017347] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants EY017347 from National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; CAPALDI RA, 1982, FEBS LETT, V138, P1, DOI 10.1016/0014-5793(82)80382-7; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHANG CJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P880, DOI 10.1001/archopht.1995.01100070054025; Conner DA, 2005, CURR PROTOC MOL BIOL; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Godecke A, 2003, J BIOL CHEM, V278, P21761, DOI 10.1074/jbc.M302573200; Haurogne K, 2007, TRANSGENIC RES, V16, P127, DOI 10.1007/s11248-006-9024-4; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; Hickey MJ, 2001, ACTA PHYSIOL SCAND, V173, P119, DOI 10.1046/j.1365-201X.2001.00892.x; Hirst DG, 2010, CURR PHARM DESIGN, V16, P45, DOI 10.2174/138161210789941838; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; KIEDROWSKI L, 1991, NEUROPHARMACOLOGY, V30, P1241, DOI 10.1016/0028-3908(91)90171-7; Kubes P, 2000, GUT, V47, P6, DOI 10.1136/gut.47.1.6; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Mizuno K, 2001, INVEST OPHTH VIS SCI, V42, P688; Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pang JJ, 2010, J COMP NEUROL, V518, P2456, DOI 10.1002/cne.22347; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Quiambao AB, 1997, VISUAL NEUROSCI, V14, P617, DOI 10.1017/S095252380001258X; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Roebroek Anton J M, 2003, Methods Mol Biol, V209, P187; Sakurai T, 2008, TRANSGENIC RES, V17, P149, DOI 10.1007/s11248-007-9134-7; Saraswathy S, 2010, INVEST OPHTH VIS SCI, V51, P3680, DOI 10.1167/iovs.09-4575; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Tsutsui M, 2010, PHARMACOL THERAPEUT, V128, P499, DOI 10.1016/j.pharmthera.2010.08.010; Vorwerk CK, 1997, INVEST OPHTH VIS SCI, V38, P2038; Wang XD, 2001, GENE DEV, V15, P2922; Wu GS, 2005, INVEST OPHTH VIS SCI, V46, P2271, DOI 10.1167/iovs.04-1525; Wu GS, 2008, EXPERT REV OPHTHALMO, V3, P299, DOI 10.1586/17469899.3.3.299; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhu YL, 2006, EXP EYE RES, V82, P153, DOI 10.1016/j.exer.2005.06.005	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43089	10.1371/journal.pone.0043089	http://dx.doi.org/10.1371/journal.pone.0043089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905206	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100083
J	Bjordahl, RL; Gapin, L; Marrack, P; Refaeli, Y				Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef			iNKT Cells Suppress the CD8(+) T Cell Response to a Murine Burkitt's-Like B Cell Lymphoma	PLOS ONE			English	Article							V(ALPHA)14 NKT CELLS; TUMOR-IMMUNITY; ALPHA-GALACTOSYLCERAMIDE; AUTOIMMUNE-DISEASE; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; CUTTING EDGE; IFN-GAMMA; MICE; LYMPHOCYTES	The T cell response to B cell lymphomas differs from the majority of solid tumors in that the malignant cells themselves are derived from B lymphocytes, key players in immune response. B cell lymphomas are therefore well situated to manipulate their surrounding microenvironment to enhance tumor growth and minimize anti-tumor T cell responses. We analyzed the effect of T cells on the growth of a transplantable B cell lymphoma and found that iNKT cells suppressed the anti-tumor CD8(+) T cell response. Lymphoma cells transplanted into syngeneic wild type (WT) mice or Jalpha18(-/-) mice that specifically lack iNKT cells grew initially at the same rate, but only the mice lacking iNKT cells were able to reject the lymphoma. This effect was due to the enhanced activity of tumor-specific CD8(+) T cells in the absence of iNKT cells, and could be partially reversed by reconstitution of iNKT cells in Jalpha 18(-/-) mice. Treatment of tumor-bearing WT mice with alpha -galactosyl ceramide, an activating ligand for iNKT cells, reduced the number of tumor-specific CD8(+) T cells. In contrast, lymphoma growth in CD1d1(-/-) mice that lack both iNKT and type II NKT cells was similar to that in WT mice, suggesting that type II NKT cells are required for full activation of the anti-tumor immune response. This study reveals a tumor-promoting role for iNKT cells and suggests their capacity to inhibit the CD8(+) T cell response to B cell lymphoma by opposing the effects of type II NKT cells.	[Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Bjordahl, Ryan L.; Gapin, Laurent; Marrack, Philippa; Refaeli, Yosef] Univ Colorado, Denver, CO 80202 USA; [Marrack, Philippa] Howard Hughes Med Inst, Chevy Chase, MD USA; [Refaeli, Yosef] Univ Colorado, Sch Med, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO USA; [Refaeli, Yosef] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bjordahl, RL (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	Yosef.Refaeli@ucdenver.edu	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	United States Public Health Service, National Institutes of Health [R01 CA117802-06, P30 AR057212-02, P01 AI022295-24, R21 AI090450-01, R56 AI078246-01A1, AI-18785, AI-22295]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA117802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090450, R37AI018785, P01AI022295, R56AI078246, T32AI007405, R56AI018785, R01AI018785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by United States Public Health Service, National Institutes of Health grants R01 CA117802-06, P30 AR057212-02, and P01 AI022295-24 (to Y.R.), grants R21 AI090450-01 and R56 AI078246-01A1 (to L. G.), grants AI-18785 and AI-22295 (to P. M.), and the Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology Fellowship (to R. L. B.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Berzofsky JA, 2009, CURR MOL MED, V9, P667, DOI 10.2174/156652409788970706; Burdin N, 1998, J IMMUNOL, V161, P3271; Butcher BW, 2005, BONE MARROW TRANSPL, V36, P1, DOI 10.1038/sj.bmt.1705008; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Cuttner J, 2005, J RHEUMATOL, V32, P1884; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Grigg A, 2004, BIOL BLOOD MARROW TR, V10, P579, DOI 10.1016/j.bbmt.2004.05.008; Halder RC, 2007, J CLIN INVEST, V117, P2302, DOI 10.1172/JCI31602; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Liu K, 2005, J EXP MED, V202, P1507, DOI 10.1084/jem.20050956; Mallevaey T, 2007, INFECT IMMUN, V75, P2171, DOI 10.1128/IAI.01178-06; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Refaeli Y, 2005, P NATL ACAD SCI USA, V102, P4097, DOI 10.1073/pnas.0409832102; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Renukaradhya GJ, 2006, INT J CANCER, V118, P3045, DOI 10.1002/ijc.21764; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Smyth MJ, 2001, INT IMMUNOL, V13, P459, DOI 10.1093/intimm/13.4.459; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Terabe M, 2006, CANCER RES, V66, P3869, DOI 10.1158/0008-5472.CAN-05-3421; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Yang WH, 2011, INVEST OPHTH VIS SCI, V52, P3094, DOI 10.1167/iovs.10-7067; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42635	10.1371/journal.pone.0042635	http://dx.doi.org/10.1371/journal.pone.0042635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880059	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900047
J	Takaku, M; Tomita, S; Kurobe, H; Kihira, Y; Morimoto, A; Higashida, M; Ikeda, Y; Ushiyama, A; Hashimoto, I; Nakanishi, H; Tamaki, T				Takaku, Mitsuru; Tomita, Shuhei; Kurobe, Hirotsugu; Kihira, Yoshitaka; Morimoto, Atsushi; Higashida, Mayuko; Ikeda, Yasumasa; Ushiyama, Akira; Hashimoto, Ichiro; Nakanishi, Hideki; Tamaki, Toshiaki			Systemic Preconditioning by a Prolyl Hydroxylase Inhibitor Promotes Prevention of Skin Flap Necrosis via HIF-1-Induced Bone Marrow-Derived Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HIF-1-ALPHA GENE; ANGIOGENIC CELLS; RECRUITMENT; NEOVASCULARIZATION; MICE; REVASCULARIZATION; STABILIZATION; MOBILIZATION; CONTRIBUTES	Background: Local skin flaps often present with flap necrosis caused by critical disruption of the blood supply. Although animal studies demonstrate enhanced angiogenesis in ischemic tissue, no strategy for clinical application of this phenomenon has yet been defined. Hypoxia-inducible factor 1 (HIF-1) plays a pivotal role in ischemic vascular responses, and its expression is induced by the prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG). We assessed whether preoperative stabilization of HIF-1 by systemic introduction of DMOG improves skin flap survival. Methods and Results: Mice with ischemic skin flaps on the dorsum were treated intraperitoneally with DMOG 48 hr prior to surgery. The surviving area with neovascularization of the ischemic flaps was significantly greater in the DMOG-treated mice. Significantly fewer apoptotic cells were present in the ischemic flaps of DMOG-treated mice. Interestingly, marked increases in circulating endothelial progenitor cells (EPCs) and bone marrow proliferative progenitor cells were observed within 48 hr after DMOG treatment. Furthermore, heterozygous HIF-1 alpha-deficient mice exhibited smaller surviving flap areas, fewer circulating EPCs, and larger numbers of apoptotic cells than did wild-type mice, while DMOG pretreatment of the mutant mice completely restored these parameters. Finally, reconstitution of wild-type mice with the heterozygous deficient bone marrow cells significantly decreased skin flap survival. Conclusion: We demonstrated that transient activation of the HIF signaling pathway by a single systemic DMOG treatment upregulates not only anti-apoptotic pathways but also enhances neovascularization with concomitant increase in the numbers of bone marrow-derived progenitor cells.	[Takaku, Mitsuru; Morimoto, Atsushi; Hashimoto, Ichiro; Nakanishi, Hideki] Univ Tokushima, Grad Sch, Dept Plast & Reconstruct Surg, Tokushima 770, Japan; [Tomita, Shuhei; Kihira, Yoshitaka; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Tokushima 770, Japan; [Kurobe, Hirotsugu] Univ Tokushima, Grad Sch, Dept Cardiovasc Surg, Tokushima 770, Japan; [Higashida, Mayuko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan; [Ushiyama, Akira] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; National Institute of Public Health - Japan	Takaku, M (corresponding author), Univ Tokushima, Grad Sch, Dept Plast & Reconstruct Surg, Tokushima 770, Japan.	tomita@basic.med.tokushima-u.ac.jp	Ushiyama, Akira/AAT-5226-2020; KUROBE, Hirotsugu/ABC-8384-2021	KUROBE, Hirotsugu/0000-0002-5789-5402; Ikeda, Yasumasa/0000-0003-4318-7349	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21590335]; Grants for the Regional Innovation Cluster Program in Japan; Grants-in-Aid for Scientific Research [23790089, 24590381] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for the Regional Innovation Cluster Program in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-Aid for Scientific Research (C) (to ST, #21590335) and Grants for the Regional Innovation Cluster Program in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Fadini GP, 2010, CARDIOVASC RES, V87, P12, DOI 10.1093/cvr/cvq119; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Horrevoets AJG, 2009, AM J PATHOL, V174, P1594, DOI 10.2353/ajpath.2009.090198; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jiang M, 2008, INT J BIOCHEM CELL B, V40, P2284, DOI 10.1016/j.biocel.2008.03.012; Jiang M, 2008, J CELL BIOCHEM, V103, P321, DOI 10.1002/jcb.21416; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jones CP, 2009, STEM CELLS, V27, P3074, DOI 10.1002/stem.222; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Minet E, 2001, FREE RADICAL BIO MED, V31, P847, DOI 10.1016/S0891-5849(01)00657-8; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rey S, 2011, BLOOD, V117, P4988, DOI 10.1182/blood-2010-11-321190; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Ushiyama A, 2004, MICROVASC RES, V68, P147, DOI 10.1016/j.mvr.2004.05.004; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang XJ, 2010, WOUND REPAIR REGEN, V18, P193, DOI 10.1111/j.1524-475X.2010.00570.x	33	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42964	10.1371/journal.pone.0042964	http://dx.doi.org/10.1371/journal.pone.0042964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880134	Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900064
J	Lovas, A; Weidemann, A; Albrecht, D; Wiechert, L; Weih, D; Weih, F				Lovas, Agnes; Weidemann, Anja; Albrecht, Daniela; Wiechert, Lars; Weih, Debra; Weih, Falk			p100 Deficiency Is Insufficient for Full Activation of the Alternative NF-kappa B Pathway: TNF Cooperates with p52-RelB in Target Gene Transcription	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BREAST-CANCER; AUTOTAXIN EXPRESSION; LYMPHOTOXIN; IDENTIFICATION; CARCINOMA; PROMOTES; ALPHA; ROLES; RELB	Background: Constitutive activation of the alternative NF-kappa B pathway leads to marginal zone B cell expansion and disorganized spleen microarchitecture. Furthermore, uncontrolled alternative NF-kappa B signaling may result in the development and progression of cancer. Here, we focused on the question how does the constitutive alternative NF-kappa B signaling exert its effects in these malignant processes. Methodology/Principal Findings: To explore the consequences of unrestricted alternative NF-kappa B activation on genome-wide transcription, we compared gene expression profiles of wild-type and NF-kappa B2/p100-deficient (p100(-/-)) primary mouse embryonic fibroblasts (MEFs) and spleens. Microarray experiments revealed only 73 differentially regulated genes in p100(-/-) vs. wild-type MEFs. Chromatin immunoprecipitation (ChIP) assays showed in p100(-/-) MEFs direct binding of p52 and RelB to the promoter of the Enpp2 gene encoding ENPP2/Autotaxin, a protein with an important role in lymphocyte homing and cell migration. Gene ontology analysis revealed upregulation of genes with anti-apoptotic/proliferative activity (Enpp2/Atx, Serpina3g, Traf1, Rrad), chemotactic/locomotory activity (Enpp2/Atx, Ccl8), and lymphocyte homing activity (Enpp2/Atx, Cd34). Most importantly, biochemical and gene expression analyses of MEFs and spleen, respectively, indicated a marked crosstalk between classical and alternative NF-kappa B pathways. Conclusions/Significance: Our results show that p100 deficiency alone was insufficient for full induction of genes regulated by the alternative NF-kappa B pathway. Moreover, alternative NF-kappa B signaling strongly synergized both in vitro and in vivo with classical NF-kappa B activation, thereby extending the number of genes under the control of the p100 inhibitor of the alternative NF-kappa B signaling pathway.	[Lovas, Agnes; Weidemann, Anja; Wiechert, Lars; Weih, Debra; Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Res Grp Immunol, Jena, Germany; [Albrecht, Daniela] Biocontrol Jena GmbH, Jena, Germany; [Weih, Falk] Univ Jena, Fac Biol & Pharmacol, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Lovas, A (corresponding author), Heidelberg Univ, Dept Inner Med 4, Med Clin, Heidelberg, Germany.	fweih@fli-leibniz.de			Leibniz-Institute for Age Research - Fritz-Lipmann-Institute	Leibniz-Institute for Age Research - Fritz-Lipmann-Institute	This work was supported by funds from the Leibniz-Institute for Age Research - Fritz-Lipmann-Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Ciana P, 1997, ONCOGENE, V14, P1805, DOI 10.1038/sj.onc.1201015; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Corcoran DL, 2005, GENOME RES, V15, P840, DOI 10.1101/gr.2952005; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Euer N, 2002, ANTICANCER RES, V22, P733; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guo F, 2008, BLOOD, V112, P551, DOI 10.1182/blood-2007-11-125930; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Lovas A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-606; McCabe CD, 2005, NUCLEIC ACIDS RES, V33, P6782, DOI 10.1093/nar/gki979; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Tseng YH, 2001, CANCER RES, V61, P2071; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; WEIH F, 1994, ONCOGENE, V9, P3289; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Ying XY, 2005, AM J PATHOL, V166, P135, DOI 10.1016/S0002-9440(10)62239-0; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446	51	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42741	10.1371/journal.pone.0042741	http://dx.doi.org/10.1371/journal.pone.0042741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880094	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000065
J	Selvadurai, HJ; Mason, JO				Selvadurai, Hayden J.; Mason, John O.			Activation of Wnt/beta-Catenin Signalling Affects Differentiation of Cells Arising from the Cerebellar Ventricular Zone	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BETA-CATENIN; PRECURSOR PROLIFERATION; GABAERGIC INTERNEURONS; SPORADIC MEDULLOBLASTOMAS; NEURONAL DIFFERENTIATION; INT-1 PROTOONCOGENE; PURKINJE-CELLS; SONIC HEDGEHOG; WHITE-MATTER	Development of the cerebellum proceeds under the precise spatio-temporal control of several key developmental signalling pathways, including the Wnt/beta-catenin pathway. We recently reported the activity of Wnt/beta-catenin signalling in the perinatal cerebellar ventricular zone (VZ), a germinal centre in the developing cerebellum that gives rise to GABAergic and glial cells. In order to investigate the normal function of Wnt/beta-catenin signalling in the VZ and the cell lineages it gives rise to, we used a combination of ex vivo cerebellar slice culture and in vivo genetic manipulation to dysregulate its activity during late embryonic development. Activation of the pathway at the cerebellar ventricular zone led to a reduction in the number of cells expressing the glial lineage markers Sox9 and GFAP and the interneuron marker Pax2, but had no consistent effect on either proliferation or apoptosis. Our findings suggest that activation of the Wnt/beta-catenin pathway in the cerebellar ventricular zone causes a shift in the cell types produced, most likely due to disruption of normal differentiation. Thus, we propose that regulation of Wnt/beta-catenin signalling levels are required for normal development of cells arising from the cerebellar ventricular zone during late embryogenesis.	[Selvadurai, Hayden J.; Mason, John O.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Selvadurai, HJ (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Programme Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.mason@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400	Wellcome Trust [083209/Z/07/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by award number 083209/Z/07/A from the Wellcome Trust, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Baeza N, 2003, ONCOGENE, V22, P632, DOI 10.1038/sj.onc.1206156; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Benchabane H, 2009, ADV EXP MED BIOL, V656, P75, DOI 10.1007/978-1-4419-1145-2_7; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn Anjen, 2008, Organogenesis, V4, P76; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Gibson P, 2010, NATURE, V33; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hashimoto M, 2003, J NEUROSCI, V23, P11342; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Milosevic A, 2004, MOL CELL NEUROSCI, V26, P342, DOI 10.1016/j.mcn.2004.02.008; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; Mizuhara E, 2010, DEV BIOL, V338, P202, DOI 10.1016/j.ydbio.2009.11.032; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nolte C, 2001, GLIA, V33, P72; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Pei Y, 2012, DEVELOPMENT; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schwalbe EC, 2011, CLIN CANC RES OFFICI; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Yu TA, 2011, DEVELOPMENT, V138, P2957, DOI 10.1242/dev.063784; Yuasa S, 1996, ANAT EMBRYOL, V194, P223; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007; Zurawel RH, 1998, CANCER RES, V58, P896	63	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42572	10.1371/journal.pone.0042572	http://dx.doi.org/10.1371/journal.pone.0042572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880037	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100133
J	Chen, CC; Wang, KY; Shen, CKJ				Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James			The Mammalian de Novo DNA Methyltransferases DNMT3A and DNMT3B Are Also DNA 5-Hydroxymethylcytosine Dehydroxymethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TET PROTEINS; 5-METHYLCYTOSINE; DEMETHYLATION; METHYLATION; EXPRESSION; REPLICATION; MECHANISMS; CONVERSION; OXIDATION; GENOME	For cytosine (C) demethylation of vertebrate DNA, it is known that the TET proteins could convert 5-methyl C (5-mC) to 5-hydroxymethyl C (5-hmC). However, DNA dehydroxymethylase(s), or enzymes able to directly convert 5-hmC to C, have been elusive. We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases. Significantly, intactness of the C methylation catalytic sites of these de novo enzymes is also required for their 5-hmC dehydroxymethylation activity. That DNMT3A and DNMT3B function bidirectionally both as DNA methyltransferases and as dehydroxymethylases raises intriguing and new questions regarding the structural and functional aspects of these enzymes and their regulatory roles in the dynamic modifications of the vertebrate genomes during development, carcinogenesis, and gene regulation.	[Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Frontier of Science Award from the National Science Council (NSC); Academia Sinica (AS), Taipei, Taiwan	Frontier of Science Award from the National Science Council (NSC); Academia Sinica (AS), Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by the Frontier of Science Award from the National Science Council (NSC) and the Academia Sinica (AS), Taipei, Taiwan.	Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Castro GD, 1996, CHEM-BIOL INTERACT, V99, P289, DOI 10.1016/0009-2797(95)03680-6; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Haffner MC, 2011, ONCOTARGET, V2, P627; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Park SK, 2009, PLANT PHYSIOL, V150, P552, DOI 10.1104/pp.109.135426; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J, 2001, MOL CLONING LAB MANU; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	43	130	139	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33116	33121		10.1074/jbc.C112.406975	http://dx.doi.org/10.1074/jbc.C112.406975			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22898819	Green Published, hybrid			2022-12-25	WOS:000309602100003
J	Sharifmoghadam, MR; Curto, MA; Hoya, M; de Leon, N; Martin-Garcia, R; Doncel, C; Valdivieso, MH				Sharifmoghadam, Mohammad Reza; Curto, M-Angeles; Hoya, Marta; de Leon, Nagore; Martin-Garcia, Rebeca; Doncel, Cristina; Valdivieso, M-Henar			The Integrity of the Cytokinesis Machinery under Stress Conditions Requires the Glucan Synthase Bgs1p and Its Regulator Cfh3p	PLOS ONE			English	Article							FISSION-YEAST; CELL-DIVISION; CONTRACTILE RING; OSMOTIC-STRESS; PRIMARY SEPTUM; ACTOMYOSIN RING; KINASE PATHWAYS; PROTEIN-KINASE; POLO KINASE; TIP GROWTH	In yeast, cytokinesis requires coordination between nuclear division, acto-myosin ring contraction, and septum synthesis. We studied the role of the Schizosaccharomyces pombe Bgs1p and Cfh3p proteins during cytokinesis under stress conditions. Cfh3p formed a ring in the septal area that contracted during mitosis; Cfh3p colocalized and co-immunoprecipitated with Cdc15p, showing that Cfh3p interacted with the contractile acto-myosin ring. In a wild-type strain, a significant number of contractile rings collapsed under stress conditions and this number increased dramatically in the cfh3 Delta, bgs1cps1-191, and cfh3 Delta bgs1/cps1-191. Our results show that after osmotic shock Cfh3p is essential for the stability of the (1,3) glucan synthase Bgs1p in the septal area, but not at the cell poles. Finally, cells adapted to stress; they repaired their contractile rings and re-localized Bgs1p to the cell surface some time after osmotic shock. A detailed analysis of the cytokinesis machinery in the presence of KCl revealed that the actomyosin ring collapsed before Bgs1p was internalized, and that it was repaired before Bgs1p re-localized to the cell surface. In the cfh3 Delta, bgs1/cps1-191, and cfh3 Delta bgs1/cps1-191 mutants, which have reduced glucan synthesis, the damage produced to the ring had stronger consequences, suggesting that an intact primary septum contributes to ring stability. The results show that the contractile actomyosin ring is very sensitive to stress, and that cells have efficient mechanisms to remedy the damage produced in this structure.	[Sharifmoghadam, Mohammad Reza; Curto, M-Angeles; Hoya, Marta; de Leon, Nagore; Martin-Garcia, Rebeca; Doncel, Cristina; Valdivieso, M-Henar] Univ Salamanca, Dept Microbiol & Genet, Inst Biol Func & Genom, Consejo Super Invest Cient, E-37008 Salamanca, Spain; [Sharifmoghadam, Mohammad Reza] Univ Zabol, Fac Vet Med, Zabol, Iran	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Sharifmoghadam, MR (corresponding author), Univ Salamanca, Dept Microbiol & Genet, Inst Biol Func & Genom, Consejo Super Invest Cient, E-37008 Salamanca, Spain.	henar@usal.es	Angeles, Maria/HCH-1574-2022; Sharifmoghadam, Mohammad Reza/AAI-8210-2021; Valdivieso, M.-Henar/B-5199-2017; Martín-García, Rebeca/H-5547-2015	Sharifmoghadam, Mohammad Reza/0000-0002-3638-0653; Valdivieso, M.-Henar/0000-0002-6857-7493; Martín-García, Rebeca/0000-0001-8318-2898; Curto, Maria Angeles/0000-0002-0306-382X; Hoya, Marta/0000-0002-3186-2514; Doncel, Cristina/0000-0002-1592-3583	Fundacion Ramon Areces; Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program [BFU2007-61866]; Junta de Castilla y Leon; Formacion de Personal Investigador (FPU) fellowship; FPU fellowship from the Ministry of Science; Junta de Ampliacion de Estudios fellowship Ministry of Science; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Fundacion Ramon Areces; Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program; Junta de Castilla y Leon(Junta de Castilla y Leon); Formacion de Personal Investigador (FPU) fellowship(Spanish Government); FPU fellowship from the Ministry of Science; Junta de Ampliacion de Estudios fellowship Ministry of Science; Consejo Superior de Investigaciones Cientificas (CSIC), Spain	Financial support to the Instituto de Biologia Funcional y Genomica (IBFG) from the Fundacion Ramon Areces and to our group from the Comision Interministerial de Ciencia y Tecnologia (CICYT) (Spain)/European Union FEDER (Fondo Europeo de Desarrollo Regional) program (grant BFU2007-61866) made this work possible. Dr. Curto was supported by a contract for training in research and technological innovation by Junta de Castilla y Leon and by Formacion de Personal Investigador (FPU) fellowship. Dr. de Leon and Dr. Hoya were supported by FPU and Junta de Ampliacion de Estudios (JAE)-PREDOC fellowships from the Ministry of Science and Consejo Superior de Investigaciones Cientificas (CSIC), Spain, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; Balasubramanian MK, 2000, J CELL SCI, V113, P1503; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Duran A, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P269; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Feierbach B, 2001, CURR OPIN MICROBIOL, V4, P713, DOI 10.1016/S1369-5274(01)00273-9; Garcia I, 2005, BIOL CELL, V97, P569; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hales KG, 1999, CURR OPIN CELL BIOL, V11, P717, DOI 10.1016/S0955-0674(99)00042-3; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Kinnunen PKJ, 2000, CELL PHYSIOL BIOCHEM, V10, P243, DOI 10.1159/000016360; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; Martin-Garcia R, 2003, FEBS LETT, V549, P176, DOI 10.1016/S0014-5793(03)00812-3; Martin-Garcia R, 2006, J CELL SCI, V119, P2768, DOI 10.1242/jcs.02998; Matsuo Y, 2004, YEAST, V21, P1005, DOI 10.1002/yea.1145; Mishra M, 2008, CURR BIOL, V18, pR247, DOI 10.1016/j.cub.2008.01.029; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Paoletti A, 2000, MOL BIOL CELL, V11, P2757, DOI 10.1091/mbc.11.8.2757; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Robertson AM, 2008, J CELL SCI, V121, P4055, DOI 10.1242/jcs.034488; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmidt M, 2002, J CELL SCI, V115, P293; Sharifmoghadam MR, 2009, J BIOL CHEM, V284, P11070, DOI 10.1074/jbc.M808353200; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Wolfe BA, 2005, TRENDS CELL BIOL, V15, P10, DOI 10.1016/j.tcb.2004.11.006; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e42726	10.1371/journal.pone.0042726	http://dx.doi.org/10.1371/journal.pone.0042726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905165	gold, Green Submitted, Green Published			2022-12-25	WOS:000307823600025
J	Zupancic, ML; Cantarel, BL; Liu, ZQ; Drabek, EF; Ryan, KA; Cirimotich, S; Jones, C; Knight, R; Walters, WA; Knights, D; Mongodin, EF; Horenstein, RB; Mitchell, BD; Steinle, N; Snitker, S; Shuldiner, AR; Fraser, CM				Zupancic, Margaret L.; Cantarel, Brandi L.; Liu, Zhenqiu; Drabek, Elliott F.; Ryan, Kathleen A.; Cirimotich, Shana; Jones, Cheron; Knight, Rob; Walters, William A.; Knights, Daniel; Mongodin, Emmanuel F.; Horenstein, Richard B.; Mitchell, Braxton D.; Steinle, Nanette; Snitker, Soren; Shuldiner, Alan R.; Fraser, Claire M.			Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome	PLOS ONE			English	Article							OBESITY; PREVOTELLA	Obesity has been linked to the human gut microbiota; however, the contribution of gut bacterial species to the obese phenotype remains controversial because of conflicting results from studies in different populations. To explore the possible dysbiosis of gut microbiota in obesity and its metabolic complications, we studied men and women over a range of body mass indices from the Old Order Amish sect, a culturally homogeneous Caucasian population of Central European ancestry. We characterized the gut microbiota in 310 subjects by deep pyrosequencing of bar-coded PCR amplicons from the V1-V3 region of the 16S rRNA gene. Three communities of interacting bacteria were identified in the gut microbiota, analogous to previously identified gut enterotypes. Neither BMI nor any metabolic syndrome trait was associated with a particular gut community. Network analysis identified twenty-two bacterial species and four OTUs that were either positively or inversely correlated with metabolic syndrome traits, suggesting that certain members of the gut microbiota may play a role in these metabolic derangements.	[Zupancic, Margaret L.; Cantarel, Brandi L.; Drabek, Elliott F.; Cirimotich, Shana; Jones, Cheron; Mongodin, Emmanuel F.; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ryan, Kathleen A.; Horenstein, Richard B.; Mitchell, Braxton D.; Steinle, Nanette; Snitker, Soren; Shuldiner, Alan R.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Div Endocrinol Diabet & Nutr,Dept Med, Baltimore, MD 21201 USA; [Cantarel, Brandi L.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Liu, Zhenqiu] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Knight, Rob; Knights, Daniel] Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Walters, William A.; Steinle, Nanette] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Zupancic, ML (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	cmfraser@som.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Mongodin, Emmanuel/AAF-1850-2020; Knight, Rob/D-1299-2010; Cantarel, Brandi/ABF-5756-2020	Mongodin, Emmanuel/0000-0003-3833-7437; Cantarel, Brandi/0000-0003-4126-4478; Fraser, Claire/0000-0003-1462-2428; Knight, Rob/0000-0002-0975-9019; Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	National Institutes of Health [DK83982];  [U01 GM074518];  [P30 DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, UH2DK083982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work in this study was supported by UH2/UH3 award DK83982 from the National Institutes of Health to CMF-L and ARS, and U01 GM074518 and P30 DK072488 (Mid-Atlantic Nutrition and Obesity Research Center) to ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CROSS HE, 1976, NATURE, V262, P17, DOI 10.1038/262017a0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Desper R, 2006, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0603s15, DOI 10.1002/0471250953.BI0603S15]; Felsenstein J, PHYLIP PHYLOGENY INF; Ford PJ, 2006, ORAL MICROBIOL IMMUN, V21, P206, DOI 10.1111/j.1399-302X.2006.00276.x; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P238; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pollin TI, 2008, HUM HERED, V65, P91, DOI 10.1159/000108941; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uyeno Y, 2007, J APPL MICROBIOL, V103, P1995, DOI 10.1111/j.1365-2672.2007.03443.x; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	37	158	165	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43052	10.1371/journal.pone.0043052	http://dx.doi.org/10.1371/journal.pone.0043052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905200	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600044
J	Faircloth, BC; Glenn, TC				Faircloth, Brant C.; Glenn, Travis C.			Not All Sequence Tags Are Created Equal: Designing and Validating Sequence Identification Tags Robust to Indels	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; ERROR-CORRECTING CODES; DNA-POLYMERASE; SHORT-READ; LIBRARIES; FIDELITY; PRIMERS; OLIGONUCLEOTIDES; PERFORMANCE; LIGATION	Ligating adapters with unique synthetic oligonucleotide sequences (sequence tags) onto individual DNA samples before massively parallel sequencing is a popular and efficient way to obtain sequence data from many individual samples. Tag sequences should be numerous and sufficiently different to ensure sequencing, replication, and oligonucleotide synthesis errors do not cause tags to be unrecoverable or confused. However, many design approaches only protect against substitution errors during sequencing and extant tag sets contain too few tag sequences. We developed an open-source software package to validate sequence tags for conformance to two distance metrics and design sequence tags robust to indel and substitution errors. We use this software package to evaluate several commercial and non-commercial sequence tag sets, design several large sets (max(count) = 7,198) of edit metric sequence tags having different lengths and degrees of error correction, and integrate a subset of these edit metric tags to polymerase chain reaction (PCR) primers and sequencing adapters. We validate a subset of these edit metric tagged PCR primers and sequencing adapters by sequencing on several platforms and subsequent comparison to commercially available alternatives. We find that several commonly used sets of sequence tags or design methodologies used to produce sequence tags do not meet the minimum expectations of their underlying distance metric, and we find that PCR primers and sequencing adapters incorporating edit metric sequence tags designed by our software package perform as well as their commercial counterparts. We suggest that researchers evaluate sequence tags prior to use or evaluate tags that they have been using. The sequence tag sets we design improve on extant sets because they are large, valid across the set, and robust to the suite of substitution, insertion, and deletion errors affecting massively parallel sequencing workflows on all currently used platforms.	[Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	University of California System; University of California Los Angeles; University System of Georgia; University of Georgia	Faircloth, BC (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	brant@faircloth-lab.org	Glenn, Travis C/A-2390-2008; Faircloth, Brant C/Y-3978-2019	Glenn, Travis C/0000-0001-7725-3637; Faircloth, Brant/0000-0002-1943-0217	Smithsonian Scholarly Studies Grant; National Science Foundation (NSF) [DEB-1136626]; NSF [DEB-0614208]; Amazon Web Services Educational grant; Division Of Environmental Biology [1136626] Funding Source: National Science Foundation	Smithsonian Scholarly Studies Grant; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Amazon Web Services Educational grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Smithsonian Scholarly Studies Grant to Stephen P. Hubbell and BCF, National Science Foundation (NSF) grant DEB-1136626 to BCF and TCG, NSF grant DEB-0614208 to TCG, an Amazon Web Services Educational grant to BCF and TCG, and material (TruSeq-style adapters) and sequencing contributions (HiSeq lanes) from Integrated DNA Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Ashlock D, 2002, IEEE C EVOL COMPUTAT, P1296, DOI 10.1109/CEC.2002.1004430; Ashlock D, 2009, CIBCB: 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P38; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Blumenstiel Brendan, 2010, Curr Protoc Hum Genet, VChapter 18, DOI 10.1002/0471142905.hg1804s66; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Chen DH, 1999, NUCLEIC ACIDS RES, V27, P389, DOI 10.1093/nar/27.2.389; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cole R, 2004, P 36 ANN ACM S THEOR, V91; CONWAY JH, 1986, IEEE T INFORM THEORY, V32, P337, DOI 10.1109/TIT.1986.1057187; Cummings N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-641; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Eckert K A, 1991, PCR Methods Appl, V1, P17; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gusfield D., 1997, ALGORITHMS STRINGS T; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Housby JN, 1998, NUCLEIC ACIDS RES, V26, P4259, DOI 10.1093/nar/26.18.4259; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Pon RT, 1996, BIOTECHNIQUES, V21, P680; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Qiu F, 2003, PLANT PHYSIOL, V133, P475, DOI 10.1104/pp.103.025015; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Roche, 2009, ROCHE TECHNICAL B; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stephen G, 1994, STRING SEARCHING ALG; TEMSAMANI J, 1995, NUCLEIC ACIDS RES, V23, P1841, DOI 10.1093/nar/23.11.1841; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	56	189	202	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42543	10.1371/journal.pone.0042543	http://dx.doi.org/10.1371/journal.pone.0042543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900027	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900043
J	Kapoor, R; Kakkar, P				Kapoor, Radhika; Kakkar, Poonam			Protective Role of Morin, a Flavonoid, against High Glucose Induced Oxidative Stress Mediated Apoptosis in Primary Rat Hepatocytes	PLOS ONE			English	Article							HYPERGLYCEMIC CONDITIONS; MITOCHONDRIAL; CELLS; PATHWAYS; ACID; INVOLVEMENT; EXTRACT; INJURY	Apoptosis is an early event of liver damage in diabetes and oxidative stress has been linked to accelerate the apoptosis in hepatocytes. Therefore, the compounds that can scavenge ROS may confer regulatory effects on high-glucose induced apoptosis. In the present study, primary rat hepatocytes were exposed to high concentration (40 mM) of glucose. At this concentration decreased cell viability and enhanced ROS generation was observed. Depleted antioxidant status of hepatocytes under high glucose stress was also observed as evident from transcriptional level and activities of antioxidant enzymes. Further, mitochondrial depolarisation was accompanied by the loss of mitochondrial integrity and altered expression of Bax and Bcl-2. Increased translocation of apoptotic proteins like AIF (Apoptosis inducing factor) & Endo-G (endonuclease-G) from its resident place mitochondria to nucleus was also observed. Cyt-c residing in the inter-membrane space of mitochondria also translocated to cytoplasm. These apoptotic proteins initiated caspase activation, DNA fragmentation, chromatin condensation, increased apoptotic DNA content in glucose treated hepatocytes, suggesting mitochondria mediated apoptotic mode of cell death. Morin, a dietary flavonoid from Psidium guajava was effective in increasing the cell viability and decreasing the ROS level. It maintained mitochondrial integrity, inhibited release of apoptotic proteins from mitochondria, prevented DNA fragmentation, chromatin condensation and hypodiploid DNA upon exposure to high glucose. This study confirms the capacity of dietary flavonoid Morin in regulating apoptosis induced by high glucose via mitochondrial mediated pathway through intervention of oxidative stress.	[Kapoor, Radhika; Kakkar, Poonam] Indian Inst Toxicol Res, CSIR, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Kapoor, R (corresponding author), Indian Inst Toxicol Res, CSIR, Lucknow, Uttar Pradesh, India.	poonam_kakkar@yahoo.com			Indian Council of Medical Research, New Delhi; Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR)	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR)	This work was supported by Indian Council of Medical Research, New Delhi and Supra-Institutional Project-08 of Council of Scientific & Industrial Research (CSIR). The funding agencies approved the broad study design. They had no role in data collection and analysis, preparation of the manuscript or decision to publish.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; BarathManiKanth Selvaraj, 2010, Journal of Nanobiotechnology, V8, P16, DOI 10.1186/1477-3155-8-16; Bell David S H, 2007, Endocr Pract, V13, P300; Chandrasekaran K, 2010, TOXICOL IN VITRO, V24, P387, DOI 10.1016/j.tiv.2009.10.020; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Chu HL, 2011, FOOD CHEM, V129, P871, DOI 10.1016/j.foodchem.2011.05.037; Cloherty JP, 2012, MANUAL NEONATAL CARE, P22; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Das J, 2012, AMINO ACIDS, V43, P1509, DOI 10.1007/s00726-012-1225-y; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Han ZM, 2008, AM J PHYSIOL-ENDOC M, V295, pE798, DOI 10.1152/ajpendo.00683.2007; Hornick T, 2008, CLEV CLIN J MED, V75, P153, DOI 10.3949/ccjm.75.2.153; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kamboj SS, 2011, MITOCHONDRION, V11, P214, DOI 10.1016/j.mito.2010.09.014; Kandhare AD, 2012, FITOTERAPIA, V83, P650, DOI 10.1016/j.fitote.2012.01.010; Kapoor R, 2009, ENVIRON TOXICOL PHAR, V27, P62, DOI 10.1016/j.etap.2008.08.007; Kassab A, 2012, BIOCHIMIE; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; Leinninger GM, 2004, CELL DEATH DIFFER, V11, P885, DOI 10.1038/sj.cdd.4401429; Li AF, 2009, INVEST OPHTH VIS SCI, V50, P1400, DOI 10.1167/iovs.07-1519; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053; Meng LD, 2008, ARCH PHARM RES, V31, P357, DOI [10.1007/s12272-001-1164-y, 10.1007/s00000-001-1164-y]; Mokini Z, 2010, DIABETES RES CLIN PR, V87, P313, DOI 10.1016/j.diabres.2009.11.018; Mustapha NM, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/746978; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rattanachaikunsopon P, 2010, J MED PLANTS RES, V4, P393; Ricardo KFS, 2001, BRAZ ARCH BIOL TECHN, V44, P263, DOI 10.1590/S1516-89132001000300007; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Samadder A, 2011, EUR J PHARM SCI, V44, P207, DOI 10.1016/j.ejps.2011.07.012; Seglen PO, 1976, METHOD CELL BIOL, V19, P187; Singh BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034200; Sreedharan V, 2009, INVEST NEW DRUG, V27, P21, DOI 10.1007/s10637-008-9136-1; Sun LQ, 2012, NEUROCHEM RES, V37, P996, DOI 10.1007/s11064-011-0695-8; Taneda S, 2010, AM J PHYSIOL-RENAL, V299, pF1451, DOI 10.1152/ajprenal.00637.2009; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Tripathi M, 2010, TOXICOL IN VITRO, V24, P495, DOI 10.1016/j.tiv.2009.09.011; Varma S, 2005, AM J PHYSIOL-HEART C, V289, pH1744, DOI 10.1152/ajpheart.01088.2004; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173; Zhang Jie, 2009, Shengli Xuebao, V61, P379; Zhang R, 2011, BASIC CLIN PHARMACOL, V108, P63, DOI 10.1111/j.1742-7843.2010.00629.x; Zhang YL, 2011, EUR J PHARMACOL, V670, P325, DOI 10.1016/j.ejphar.2011.08.011	48	117	118	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41663	10.1371/journal.pone.0041663	http://dx.doi.org/10.1371/journal.pone.0041663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899998	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900013
J	Nawaz-Ul-Rehman, MS; Briddon, RW; Fauquet, CM				Nawaz-ul-Rehman, Muhammad Shah; Briddon, Rob W.; Fauquet, Claude M.			A Melting Pot of Old World Begomoviruses and Their Satellites Infecting a Collection of Gossypium Species in Pakistan	PLOS ONE			English	Article							LEAF CURL DISEASE; CASSAVA MOSAIC-VIRUS; YELLOW VEIN DISEASE; MOVEMENT PROTEIN NSP; STRANDED-DNA VIRUSES; MONOPARTITE BEGOMOVIRUSES; PHYLOGENETIC EVIDENCE; FAMILY GEMINIVIRIDAE; NUCLEOTIDE-SEQUENCES; NORTHWESTERN INDIA	CLCuD in southern Asia is caused by a complex of multiple begomoviruses (whitefly transmitted, single-stranded [ ss] DNA viruses) in association with a specific ssDNA satellite; Cotton leaf curl Multan betasatellite (CLCuMuB). A further single ssDNA molecule, for which the collective name alphasatellites has been proposed, is also frequently associated with begomovirus-betasatellite complexes. Multan is in the center of the cotton growing area of Pakistan and has seen some of the worst problems caused by CLCuD. An exhaustive analysis of the diversity of begomoviruses and their satellites occurring in 15 Gossypium species (including G. hirsutum, the mainstay of Pakistan's cotton production) that are maintained in an orchard in the vicinity of Multan has been conducted using phi 29 DNA polymerase-mediated rolling-circle amplification, cloning and sequence analysis. The non-cultivated Gossypium species, including non-symptomatic plants, were found to harbor a much greater diversity of begomoviruses and satellites than found in the cultivated G. hirsutum. Furthermore an African cassava mosaic virus (a virus previously only identified in Africa) DNA-A component and a Jatropha curcas mosaic virus (a virus occurring only in southern India) DNA-B component were identified. Consistent with earlier studies of cotton in southern Asia, only a single species of betasatellite, CLCuMuB, was identified. The diversity of alphasatellites was much greater, with many previously unknown species, in the non-cultivated cotton species than in G. hirsutum. Inoculation of newly identified components showed them to be competent for symptomatic infection of Nicotiana benthamiana plants. The significance of the findings with respect to our understanding of the role of host selection in virus diversity in crops and the geographical spread of viruses by human activity are discussed.	[Nawaz-ul-Rehman, Muhammad Shah; Fauquet, Claude M.] Danforth Plant Sci Ctr, St Louis, MO USA; [Briddon, Rob W.] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan	Donald Danforth Plant Science Center; Pakistan Institute of Engineering & Applied Science	Nawaz-Ul-Rehman, MS (corresponding author), Univ Agr Faisalabad, CABB, Mol Virol Lab, Faisalabad, Pakistan.	iltab@danforthcenter.org	Briddon, Rob W./I-5921-2012; Directorate of CABB, Muhammad Shah Nawaz-ul-Rehman - Associate Professor/AAF-3137-2021	Briddon, Rob W./0000-0001-8738-0365; 	Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program) [PGA-7251-05-007]; Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program	Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program); Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program	This project was supported by the Pak-US linkage program (Pakistan-US Science and Technology Cooperation Program) under the contract PGA-7251-05-007. Dr. Briddon is supported by the Higher Education Commission (Pakistan) under the Foreign Faculty Hiring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar KP, 2010, ANN APPL BIOL, V157, P135, DOI 10.1111/j.1744-7348.2010.00416.x; Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Amin I, 2006, ARCH VIROL, V151, P2055, DOI 10.1007/s00705-006-0773-4; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Arguello-Astorga GR, 2001, ARCH VIROL, V146, P1465, DOI 10.1007/s007050170072; Ariyo OA, 2006, J VIROL METHODS, V137, P43, DOI 10.1016/j.jviromet.2006.05.031; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2000, VIRUS GENES, V20, P19, DOI 10.1023/A:1008151921937; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Brown JK, 2011, VIRUS TAXONOMY, P351; CAMI B, 1978, NUCLEIC ACIDS RES, V5, P2381, DOI 10.1093/nar/5.7.2381; Carvalho MF, 2006, PLANT PHYSIOL, V140, P1317, DOI 10.1104/pp.105.075556; Carvalho MF, 2004, J VIROL, V78, P11161, DOI 10.1128/JVI.78.20.11161-11171.2004; Chatterjee A, 2007, VIRUS GENES, V35, P835, DOI 10.1007/s11262-007-0160-6; Chatterji A, 2000, VIROLOGY, V273, P341, DOI 10.1006/viro.2000.0434; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Das S, 2008, VIRUS GENES, V37, P414, DOI 10.1007/s11262-008-0287-0; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Duffy S, 2009, J GEN VIROL, V90, P1539, DOI 10.1099/vir.0.009266-0; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Fauquet CM, 2003, ARCH VIROL, V148, P405, DOI 10.1007/s00705-002-0957-5; Gao SQ, 2010, ARCH VIROL, V155, P607, DOI 10.1007/s00705-010-0625-0; Gilbertson RL, 2003, PLANT CELL, V15, P2578, DOI 10.1105/tpc.015057; Homs M, 2008, VIRUS RES, V136, P124, DOI 10.1016/j.virusres.2008.04.027; Hussain T., 1991, Pakistan Journal of Phytopathology, V3, P57; Idris AM, 2011, J GEN VIROL, V92, P706, DOI 10.1099/vir.0.025288-0; Idris AM, 2004, PHYTOPATHOLOGY, V94, P1068, DOI 10.1094/PHYTO.2004.94.10.1068; Ilyas M, 2010, J GEN VIROL, V91, P2091, DOI 10.1099/vir.0.020404-0; Kirthi N, 2004, ARCH VIROL, V149, P2047, DOI 10.1007/s00705-004-0352-5; Lefeuvre P, 2007, J GEN VIROL, V88, P3458, DOI 10.1099/vir.0.83252-0; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McGarry RC, 2003, PLANT CELL, V15, P1605, DOI 10.1105/tpc.012120; Moffat AS, 1999, SCIENCE, V286, P1835, DOI 10.1126/science.286.5446.1835; Monde G, 2010, ARCH VIROL, V155, P1865, DOI 10.1007/s00705-010-0772-3; Moulherat Christophe, 2002, Journal of Archaeological Science, V29, P1393, DOI 10.1006/jasc.2001.0779; Nahid N, 2008, ARCH VIROL, V153, P1441, DOI 10.1007/s00705-008-0133-7; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Nawaz-Ul-Rehman MS, 2009, J VIROL, V83, P9347, DOI 10.1128/JVI.00795-09; PADIDAM M, 1995, J GEN VIROL, V76, P25, DOI 10.1099/0022-1317-76-1-25; Paprotka T, 2010, VIROLOGY, V404, P148, DOI 10.1016/j.virol.2010.05.003; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Paul S, 2006, AUSTRALAS PLANT DIS, V1, P29, DOI 10.1071/DN06013; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Rahman M, 2005, PLANT PATHOL, V54, P764, DOI 10.1111/j.1365-3059.2005.01280.x; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; Saeed M, 2007, J GEN VIROL, V88, P2881, DOI 10.1099/vir.0.83049-0; Saunders K, 2004, VIROLOGY, V324, P37, DOI 10.1016/j.virol.2004.03.018; Saunders K, 2002, J GEN VIROL, V83, P907, DOI 10.1099/0022-1317-83-4-907; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Saunders K, 2001, VIROLOGY, V282, P38, DOI 10.1006/viro.2000.0832; Saunders K, 2008, J GEN VIROL, V89, P3165, DOI 10.1099/vir.0.2008/003848-0; Shahid MS, 2007, ARCH VIROL, V152, P2131, DOI 10.1007/s00705-007-1043-9; STANLEY J, 1983, NATURE, V305, P643, DOI 10.1038/305643a0; STANLEY J, 1983, NATURE, V301, P260, DOI 10.1038/301260a0; Tahir M, 2010, AUSTRALAS PLANT DIS, V5, P21, DOI 10.1071/DN10009; Tahir MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020366; TAMURA K., 2011, MOL BIO EVOL; Tao XR, 2008, J GEN VIROL, V89, P306, DOI 10.1099/vir.0.83388-0; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Wendel JF, 2009, EVOLUTION NATURAL HI, P1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zaffalon V, 2012, ARCH VIROL, V157, P483, DOI 10.1007/s00705-011-1201-y; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915	80	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40050	10.1371/journal.pone.0040050	http://dx.doi.org/10.1371/journal.pone.0040050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899988	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900003
J	Yang, GR; Jia, ZJ; Aoyagi, T; McClain, D; Mortensen, RM; Yang, TX				Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Mortensen, Richard M.; Yang, Tianxin			Systemic PPAR gamma Deletion Impairs Circadian Rhythms of Behavior and Metabolism	PLOS ONE			English	Article							REV-ERB-ALPHA; ACTIVATED RECEPTOR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SUPRACHIASMATIC NUCLEUS; ADIPOCYTE DETERMINATION; ESSENTIAL COMPONENTS; INSULIN-RESISTANCE; GENE-EXPRESSION; CLOCK; TRANSCRIPTION	Compelling evidence from both human and animal studies suggests a physiological link between the circadian rhythm and metabolism but the underlying mechanism is still incompletely understood. We examined the role of PPAR gamma, a key regulator of energy metabolism, in the control of physiological and behavioral rhythms by analyzing two strains of whole-body PPAR gamma null mouse models. Systemic inactivation of PPAR gamma was generated constitutively by using Mox2-Cre mice (MoxCre/flox) or inducibly by using the tamoxifen system (EsrCre/flox/TM). Circadian variations in oxygen consumption, CO2 production, food and water intake, locomotor activity, and cardiovascular parameters were all remarkably suppressed in MoxCre/flox mice. A similar phenotype was observed in EsrCre/flox/TM mice, accompanied by impaired rhythmicity of the canonical clock genes in adipose tissues and liver but not skeletal muscles or the kidney. PPAR gamma inactivation in isolated preadipocytes following exposure to tamoxifen led to a similar blockade of the rhythmicity of the clock gene expression. Together, these results support an essential role of PPAR gamma in the coordinated control of circadian clocks and metabolic pathways.	[Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Yang, Tianxin] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Yang, Guangrui; Jia, Zhanjun; Aoyagi, Toshinori; McClain, Donald; Yang, Tianxin] Salt Lake Vet Affairs Med Ctr, Salt Lake City, UT USA; [Mortensen, Richard M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Yang, Tianxin] Sun Yat Sen Univ, Sch Med, Inst Hypertens, Guangzhou 510275, Guangdong, Peoples R China	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Michigan System; University of Michigan; Sun Yat Sen University	Yang, GR (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	tianxin.yang@hsc.utah.edu	YANG, GUANGRUI/F-9693-2013	YANG, GUANGRUI/0000-0002-8310-8257; McClain, Don/0000-0002-3310-2359	VA Merit Review; National Basic Research Program of China 973 Program [2012CB517600, 2012CB517602]; National Institute of Diabetes and Digestive and Kidney Diseases [DK079162]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079162, P30DK020572] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the VA Merit Review, the National Basic Research Program of China 973 Program 2012CB517600 (No. 2012CB517602), and the National Institute of Diabetes and Digestive and Kidney Diseases DK079162. TY is an Established Investigator from the American Heart Association and Research Career Scientist in Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Jia ZJ, 2006, CIRC RES, V99, P1243, DOI 10.1161/01.RES.0000251306.40546.08; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kawada N, 2005, HYPERTENSION; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakahata Y, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-5; Pande V, 2005, BIOORG MED CHEM LETT, V15, P4057, DOI 10.1016/j.bmcl.2005.06.025; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 2000, GENE DEV, V14, P1293; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sanchez-Gomez FJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P150, DOI 10.1016/j.abb.2006.10.032; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shiraki T, 2006, BIOCHEM J, V393, P749, DOI 10.1042/BJ20050930; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Teboul M, 2009, J APPL PHYSIOL, V107, P1965, DOI 10.1152/japplphysiol.00515.2009; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2007, COLD SPRING HARB SYM, V72, P365, DOI 10.1101/sqb.2007.72.047; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	52	64	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e38117	10.1371/journal.pone.0038117	http://dx.doi.org/10.1371/journal.pone.0038117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899986	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900001
J	Zomer, A; Burghout, P; Bootsma, HJ; Hermans, PWM; van Hijum, SAFT				Zomer, Aldert; Burghout, Peter; Bootsma, Hester J.; Hermans, Peter W. M.; van Hijum, Sacha A. F. T.			ESSENTIALS: Software for Rapid Analysis of High Throughput Transposon Insertion Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CONDITIONALLY ESSENTIAL GENES; IDENTIFICATION; GENOME	High-throughput analysis of genome-wide random transposon mutant libraries is a powerful tool for (conditional) essential gene discovery. Recently, several next-generation sequencing approaches, e.g. Tn-seq/INseq, HITS and TraDIS, have been developed that accurately map the site of transposon insertions by mutant-specific amplification and sequence readout of DNA flanking the transposon insertions site, assigning a measure of essentiality based on the number of reads per insertion site flanking sequence or per gene. However, analysis of these large and complex datasets is hampered by the lack of an easy to use and automated tool for transposon insertion sequencing data. To fill this gap, we developed ESSENTIALS, an open source, web-based software tool for researchers in the genomics field utilizing transposon insertion sequencing analysis. It accurately predicts (conditionally) essential genes and offers the flexibility of using different sample normalization methods, genomic location bias correction, data preprocessing steps, appropriate statistical tests and various visualizations to examine the results, while requiring only a minimum of input and hands-on work from the researcher. We successfully applied ESSENTIALS to in-house and published Tn-seq, TraDIS and HITS datasets and we show that the various pre- and post-processing steps on the sequence reads and count data with ESSENTIALS considerably improve the sensitivity and specificity of predicted gene essentiality.	[Zomer, Aldert; Burghout, Peter; Bootsma, Hester J.; Hermans, Peter W. M.] Radboud Univ Nijmegen, Lab Pediat Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Zomer, Aldert; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.] Kluyver Ctr Genom Ind Fermentat, NIZO Food Res, Ede, Netherlands; [van Hijum, Sacha A. F. T.] TI Food & Nutr, Wageningen, Netherlands; [van Hijum, Sacha A. F. T.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; NIZO Food Research; Top Institute Food & Nutrition	Zomer, A (corresponding author), Radboud Univ Nijmegen, Lab Pediat Infect Dis, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	a.zomer@cukz.umcn.nl	van Hijum, Sacha/F-6445-2014; Fu, Lixia/B-7429-2009; Hermans, Peter W.M./H-8042-2014	van Hijum, Sacha/0000-0003-0741-2991; Zomer, Aldert/0000-0002-0758-5190	European Commission [274586]; Netherlands Genomics Initiative Horizon Breakthrough [93518023]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Genomics Initiative Horizon Breakthrough	This work was supported by the European Commission FP7 Marie Curie IEF Action [274586 to AZ] and by the Netherlands Genomics Initiative Horizon Breakthrough [93518023 to PB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brouwer RWW, 2009, BIOINFORMATICS, V25, P139, DOI 10.1093/bioinformatics/btn588; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Gallagher LA, 2011, MBIO, V2, DOI 10.1128/mBio.00315-10; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mobegi FM, IDENTIFICATION UNPUB; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]	26	92	92	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43012	10.1371/journal.pone.0043012	http://dx.doi.org/10.1371/journal.pone.0043012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900082	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900100
J	He, Q; Chen, HL; Huang, L; Dong, JJ; Guo, DG; Mao, MM; Kong, L; Li, Y; Wu, ZX; Lei, W				He, Qiang; Chen, Huiling; Huang, Li; Dong, Jingjing; Guo, Dagang; Mao, Mengmeng; Kong, Liang; Li, Yang; Wu, Zixiang; Lei, Wei			Porous Surface Modified Bioactive Bone Cement for Enhanced Bone Bonding	PLOS ONE			English	Article							HYDROXYAPATITE; POLYMETHYLMETHACRYLATE; PHOSPHATE; CHITOSAN; INGROWTH; CELLS; GLASS; DIFFERENTIATION; PARTICLES; ADHESION	Background: Polymethylmethacrylate bone cement cannot provide an adhesive chemical bonding to form a stable cement-bone interface. Bioactive bone cements show bone bonding ability, but their clinical application is limited because bone resorption is observed after implantation. Porous polymethylmethacrylate can be achieved with the addition of carboxymethylcellulose, alginate and gelatin microparticles to promote bone ingrowth, but the mechanical properties are too low to be used in orthopedic applications. Bone ingrowth into cement could decrease the possibility of bone resorption and promote the formation of a stable interface. However, scarce literature is reported on bioactive bone cements that allow bone ingrowth. In this paper, we reported a porous surface modified bioactive bone cement with desired mechanical properties, which could allow for bone ingrowth. Materials and Methods: The porous surface modified bioactive bone cement was evaluated to determine its handling characteristics, mechanical properties and behavior in a simulated body fluid. The in vitro cellular responses of the samples were also investigated in terms of cell attachment, proliferation, and osteoblastic differentiation. Furthermore, bone ingrowth was examined in a rabbit femoral condyle defect model by using micro-CT imaging and histological analysis. The strength of the implant-bone interface was also investigated by push-out tests. Results: The modified bone cement with a low content of bioactive fillers resulted in proper handling characteristics and adequate mechanical properties, but slightly affected its bioactivity. Moreover, the degree of attachment, proliferation and osteogenic differentiation of preosteoblast cells was also increased. The results of the push-out test revealed that higher interfacial bonding strength was achieved with the modified bone cement because of the formation of the apatite layer and the osseointegration after implantation in the bony defect. Conclusions: Our findings suggested a new bioactive bone cement for prosthetic fixation in total joint replacement.	[He, Qiang; Dong, Jingjing; Li, Yang; Wu, Zixiang; Lei, Wei] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Chen, Huiling] Fourth Mil Med Univ, Dept Hlth Serv, Sch Publ Hlth & Mil Prevent, Xian 710032, Shaanxi, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Dept Gen Dent, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China; [Guo, Dagang; Mao, Mengmeng] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Shaanxi, Peoples R China; [Kong, Liang] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University	He, Q (corresponding author), Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	wuzixiang@fmmu.edu.cn; fmmuleiwei@gmail.com	chen, hui/HDO-2955-2022	Lei, Wei/0000-0002-7346-6915; Guo, Dagang/0000-0001-8802-5453	Research Fund for the National Natural Science Foundation of China [31170913/C1002]	Research Fund for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Research Fund for the National Natural Science Foundation of China (No.31170913/C1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Samad H, 2011, BIO-MED MATER ENG, V21, P247, DOI 10.3233/BME-2011-0673; Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552; Bernards MT, 2008, J BIOMED MATER RES A, V86A, P779, DOI 10.1002/jbm.a.31650; Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5; FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489, DOI 10.1302/0301-620X.64B4.7096429; FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017; Fujita H, 2000, J BIOMED MATER RES, V49, P273, DOI 10.1002/(SICI)1097-4636(200002)49:2<273::AID-JBM17>3.0.CO;2-Y; GETTLEMAN L, 1980, J DENT RES, V59, P139, DOI 10.1177/00220345800590021001; Ginebra M. P., 1994, Clinical Materials, V17, P99, DOI 10.1016/0267-6605(94)90018-3; Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018; Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032; Heikkila JT, 1996, BIOMATERIALS, V17, P1755, DOI 10.1016/0142-9612(95)00326-6; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; HENNIG W, 1979, J BIOMED MATER RES, V13, P89, DOI 10.1002/jbm.820130110; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; *ISO, 1992, 5833 ISO; Ito Y, 2004, J BIOMED MATER RES A, V69A, P454, DOI 10.1002/jbm.a.30014; Itoh S, 2006, BIOMATERIALS, V27, P5572, DOI 10.1016/j.biomaterials.2006.07.007; JASTY M, 1990, J BONE JOINT SURG AM, V72A, P1220, DOI 10.2106/00004623-199072080-00015; Jeong JC, 2004, TOXICOL IN VITRO, V18, P829, DOI 10.1016/j.tiv.2004.05.002; Kawashita M, 2010, ACTA BIOMATER, V6, P3187, DOI 10.1016/j.actbio.2010.02.047; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C; Lye KW, 2011, CLIN ORAL IMPLAN RES, V8, P1; Markus DS, 2011, PLOS ONE, V6; MARTENS M, 1980, ARCH ORTHOP TRAUM SU, V97, P111, DOI 10.1007/BF00450933; Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6; Ohashi KL, 2000, J BIOMED MATER RES, V51, P172, DOI 10.1002/(SICI)1097-4636(200008)51:2<172::AID-JBM5>3.0.CO;2-Y; Qi XP, 2009, J BIOMED MATER RES A, V89A, P980, DOI 10.1002/jbm.a.32054; Ralf S, 1999, BIOMATERIALS, V21, P2137; RAMAKRISHNAN N, 1990, B MATER SCI, V13, P217, DOI 10.1007/BF02744949; Shi M, 2011, J CONTROL RELEASE, V152, P196, DOI 10.1016/j.jconrel.2011.01.029; Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036; Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F; Tsukeoka T, 2006, BIOMATERIALS, V27, P3897, DOI 10.1016/j.biomaterials.2006.03.002; Tunney MM, 2008, J MATER SCI-MATER M, V19, P1609, DOI 10.1007/s10856-008-3394-5; Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036; Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6	40	28	31	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42525	10.1371/journal.pone.0042525	http://dx.doi.org/10.1371/journal.pone.0042525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905143	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100046
J	Park, TS; Huo, JS; Peters, A; Talbot, CC; Verma, K; Zimmerlin, L; Kaplan, IM; Zambidis, ET				Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Talbot, C. Conover, Jr.; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.			Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORK; EMBRYONIC STEM; HEMATOPOIETIC STEM; TRANSCRIPTIONAL NETWORK; DIFFERENTIATED CELLS; SELF-RENEWAL; PLURIPOTENT; EXPRESSION; CHROMATIN; EFFICIENT	Nonviral conversion of skin or blood cells into clinically useful human induced pluripotent stem cells (hiPSC) occurs in only rare fractions (similar to 0.001%-0.5%) of donor cells transfected with non-integrating reprogramming factors. Pluripotency induction of developmentally immature stem-progenitors is generally more efficient than differentiated somatic cell targets. However, the nature of augmented progenitor reprogramming remains obscure, and its potential has not been fully explored for improving the extremely slow pace of non-integrated reprogramming. Here, we report highly optimized four-factor reprogramming of lineage-committed cord blood (CB) myeloid progenitors with bulk efficiencies of similar to 50% in purified episome-expressing cells. Lineage-committed CD33(+)CD45(+)CD34(-) myeloid cells and not primitive hematopoietic stem-progenitors were the main targets of a rapid and nearly complete non-integrated reprogramming. The efficient conversion of mature myeloid populations into NANOG(+)TRA-1-81(+) hiPSC was mediated by synergies between hematopoietic growth factor (GF), stromal activation signals, and episomal Yamanaka factor expression. Using a modular bioinformatics approach, we demonstrated that efficient myeloid reprogramming correlated not to increased proliferation or endogenous Core factor expressions, but to poised expression of GF-activated transcriptional circuits that commonly regulate plasticity in both hematopoietic progenitors and embryonic stem cells (ESC). Factor-driven conversion of myeloid progenitors to a high-fidelity pluripotent state was further accelerated by soluble and contact-dependent stromal signals that included an implied and unexpected role for Toll receptor-NF kappa B signaling. These data provide a paradigm for understanding the augmented reprogramming capacity of somatic progenitors, and reveal that efficient induced pluripotency in other cell types may also require extrinsic activation of a molecular framework that commonly regulates self-renewal and differentiation in both hematopoietic progenitors and ESC.	[Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Park, Tea Soon; Huo, Jeffrey S.; Peters, Ann; Verma, Karan; Zimmerlin, Ludovic; Kaplan, Ian M.; Zambidis, Elias T.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Pediat Oncol, Baltimore, MD USA; [Talbot, C. Conover, Jr.] Inst Basic Biomed Sci Johns Hopkins, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Park, TS (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	ezambid1@jhmi.edu		Huo, Jeffrey/0000-0002-0057-9118	National Institutes of Health (NIH) [1U01HL099775, U01HL100397]; National Cancer Institute (NCI) [CA60441]; Maryland Stem Cell Research Fund [2011-MS CRF II-0008-00, 2007-MSCRF II-0379-00]; NATIONAL CANCER INSTITUTE [T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL096220, U01HL100397, K08HL077595, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health (NIH) 1U01HL099775 and U01HL100397 (Dr. Zambidis), the National Cancer Institute (NCI) CA60441 (Dr. Huo), and grants from the Maryland Stem Cell Research Fund (2011-MS CRF II-0008-00 and 2007-MSCRF II-0379-00: Dr. Zambidis; MSCRF Postdoctoral Fellowship: Dr. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hasegawa Y, 2011, STEM CELLS, V29, P1196, DOI 10.1002/stem.673; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Koh SH, 2005, BIOCHEM BIOPH RES CO, V329, P1039, DOI 10.1016/j.bbrc.2005.02.077; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee J, 2012, ACTIVATION IN PRESS; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Murray LJ, 1999, EXP HEMATOL, V27, P1019, DOI 10.1016/S0301-472X(99)00031-4; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Peters A, 2012, SPRINGER PROTOCOLS H, DOI [10.1007/978-1-61779-267-0, DOI 10.1007/978-1-61779-267-0]; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Taylor T, 2010, STEM CELLS DEV, V19, P1333, DOI 10.1089/scd.2009.0484; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamaguchi M, 2001, EXP HEMATOL, V29, P174, DOI 10.1016/S0301-472X(00)00653-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522	56	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42838	10.1371/journal.pone.0042838	http://dx.doi.org/10.1371/journal.pone.0042838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905176	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100068
J	Vaca, RA; Golicher, DJ; Cayuela, L; Hewson, J; Steininger, M				Vaca, Raul Abel; Golicher, Duncan John; Cayuela, Luis; Hewson, Jenny; Steininger, Marc			Evidence of Incipient Forest Transition in Southern Mexico	PLOS ONE			English	Article							LAND-COVER CHANGE; TROPICAL FOREST; SELVA-LACANDONA; CENTRAL-AMERICA; OUT-MIGRATION; DEFORESTATION; CONSERVATION; DYNAMICS; CHIAPAS; CLASSIFICATION	Case studies of land use change have suggested that deforestation across Southern Mexico is accelerating. However, forest transition theory predicts that trajectories of change can be modified by economic factors, leading to spatial and temporal heterogeneity in rates of change that may take the form of the Environmental Kuznets Curve (EKC). This study aimed to assess the evidence regarding potential forest transition in Southern Mexico by classifying regional forest cover change using Landsat imagery from 1990 through to 2006. Patterns of forest cover change were found to be complex and nonlinear. When rates of forest loss were averaged over 342 municipalities using mixed-effects modelling the results showed a significant (p< 0.001) overall reduction of the mean rate of forest loss from 0.85% per year in the 1990-2000 period to 0.67% in the 2000-2006 period. The overall regional annual rate of deforestation has fallen from 0.33% to 0.28% from the 1990s to 2000s. A high proportion of the spatial variability in forest cover change cannot be explained statistically. However analysis using spline based general additive models detected underlying relationships between forest cover and income or population density of a form consistent with the EKC. The incipient forest transition has not, as yet, resulted in widespread reforestation. Forest recovery remains below 0.20% per year. Reforestation is mostly the result of passive processes associated with reductions in the intensity of land use. Deforestation continues to occur at high rates in some focal areas. A transition could be accelerated if there were a broader recognition among policy makers that the regional rate of forest loss has now begun to fall. The changing trajectory provides an opportunity to actively restore forest cover through stimulating afforestation and stimulating more sustainable land use practices. The results have clear implications for policy aimed at carbon sequestration through reducing deforestation and enhancing forest growth.	[Vaca, Raul Abel; Golicher, Duncan John] El Colegio Frontera Sur, Dept Ecol & Sistemat Terrestre, Div Conservac Biodiversidad, San Cristobal De La Casa, Chiapas, Mexico; [Golicher, Duncan John] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Cayuela, Luis] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Hewson, Jenny; Steininger, Marc] Conservat Int, Arlington, VA USA	El Colegio de la Frontera Sur (ECOSUR); Bournemouth University; Universidad Rey Juan Carlos; Conservation International	Vaca, RA (corresponding author), El Colegio Frontera Sur, Dept Ecol & Sistemat Terrestre, Div Conservac Biodiversidad, San Cristobal De La Casa, Chiapas, Mexico.	rgenuit@ecosur.mx	Cayuela, Luis/K-7255-2015; Golicher, Duncan/B-4240-2009; Vaca, Raúl/AAF-9324-2020	Cayuela, Luis/0000-0003-3562-2662; Vaca, Raúl/0000-0003-0500-1291	Critical Ecosystem Partnership Fund; Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America	Critical Ecosystem Partnership Fund; Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America	This work was financed by: (1) The Critical Ecosystem Partnership Fund (http://www.cepf.net/Pages/default.aspx); and (2) Project ReForLan (Restoration of Forest Landscapes for Biodiversity Conservation and Rural Development in the Drylands of Latin America (http://reforlan.bournemouth.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Montiel C., 2010, Tropical and Subtropical Agroecosystems, V12, P605; Alix-Garcia J, 2005, ASSESSMENT MEXICOS P; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; [Anonymous], 2 CONT POBL VIV; [Anonymous], 2002, SELLING FOREST ENV S; [Anonymous], 2011, STAT WORLDS FOR; Aranda Marcelo, 1996, Acta Zoologica Mexicana Nueva Serie, V68, P45; BOUMAN CA, 1994, IEEE T IMAGE PROCESS, V3, P162, DOI 10.1109/83.277898; Bray D. B., 2005, Environment and History, V11, P195, DOI 10.3197/096734005774434584; Bray DB, 2010, LANDSC SER, V10, P85, DOI 10.1007/978-1-4020-9656-3_5; Browder J.O., 1997, RAINFOREST CITIES UR; Castro-Soto G, 2009, WRM B, V144, P21; Castro-Soto G, 2009, PALMA AFRICANA MEXIC; Cayuela L, 2006, INT J REMOTE SENS, V27, P1951, DOI 10.1080/01431160500181788; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208, DOI 10.1016/j.foreco.2006.01.047; Challenger A, 1998, ZONA ECOLOGICA TROPI, P375; Challenger A, 1998, AMBIENTE FISICO ZONA, P269; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; Christie T, 2007, ORYX, V41, P539, DOI 10.1017/S0030605307000609; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Comision Nacional de A reas Naturales Protegidas ( CONANP) & Fondo Mundial Para la Conservacion de la Naturaleza A.C. (FMCN), 2008, SIST MON EV FOND AR; Corbera E, 2009, ECOL ECON, V68, P743, DOI 10.1016/j.ecolecon.2008.06.008; Cortina Sergio, 2006, DEFORESTACION ALTOS; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; De Jong BHJ, 2000, AMBIO, V29, P504, DOI 10.1639/0044-7447(2000)029[0504:CFAPOL]2.0.CO;2; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; Elbers C, 2002, ECONOMETRICA, V57, P1027; FAO-Food and Agriculture Organization of the United Nations, 1995, FOR RES ASS 1990 GLO; Flamenco-Sandoval A, 2007, BIOL CONSERV, V138, P131, DOI 10.1016/j.biocon.2007.04.022; GABRIELMORALES J, 2006, GACETA ECOLOGICA, V79, P53; Garcia-Barrios L, 2009, BIOSCIENCE, V59, P863, DOI 10.1525/bio.2009.59.10.8; Gobierno del estado de Tabasco, 2007, MUN HUIM; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; Guevara Sada S, 1999, DOCUMENTOS TRABAJO; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hecht SB, 2006, WORLD DEV, V34, P308, DOI 10.1016/j.worlddev.2005.09.005; Helmer EH, 2000, INT J REMOTE SENS, V21, P2163, DOI 10.1080/01431160050029495; Hernandez Tovilla, 2005, ECOFRONTERAS, V25, P5; INEGI (Instituto Nacional de Estadistica y Geografia), 2000, 12 CENS GEN POBL VIV; Instituto Nacional de Estadistica y Geografia (INEGI), 1990, 11 CENS GEN POBL VIV; Kaimowitz D, 2008, INT FOREST REV, V10, P485, DOI 10.1505/ifor.10.3.485; Kleinn C, 2002, ENVIRON MONIT ASSESS, V73, P17, DOI 10.1023/A:1012659129083; Klepeis P, 2003, ECON GEOGR, V79, P221; Klooster D, 2003, PROF GEOGR, V55, P227; Klooster D, 2000, GLOBAL ENVIRON CHANG, V10, P259, DOI 10.1016/S0959-3780(00)00033-9; Klooster D, 2010, FOREST TRANSITION MO; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Landell-Mills N, 2002, SILVER BULLET FOOLS; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Mas J. F., 2004, International Journal of Applied Earth Observation and Geoinformation, V5, P249, DOI 10.1016/j.jag.2004.06.002; MASERA O, 1992, CIENCIA, V43, P151; Masera OR, 1997, CLIMATIC CHANGE, V35, P265, DOI 10.1023/A:1005309908420; Mather AS, 2007, INT FOREST REV, V9, P491, DOI 10.1505/ifor.9.1.491; MATHER AS, 1992, AREA, V24, P367; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; MEDELLIN RA, 1994, CONSERV BIOL, V8, P780, DOI 10.1046/j.1523-1739.1994.08030780.x; Meyfroidt P, 2008, GLOBAL CHANGE BIOL, V14, P1319, DOI 10.1111/j.1365-2486.2008.01575.x; MYERS N, 1980, ENVIRON CONSERV, V7, P101, DOI 10.1017/S0376892900007098; MYERS N, 1991, CLIMATIC CHANGE, V19, P3, DOI 10.1007/BF00142209; NICHOLSON CF, 1995, J DAIRY SCI, V78, P719, DOI 10.3168/jds.S0022-0302(95)76684-X; Ochoa-Gaona S, 2000, APPL GEOGR, V20, P17, DOI 10.1016/S0143-6228(99)00017-X; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pasch R., 2006, TROPICAL CYCLONE REP; Pedroni L, 2003, INT J REMOTE SENS, V24, P91, DOI 10.1080/01431160304998; Perez Sanchez JM, 2011, DESARROLLO LOCAL TRO; Perz SG, 2007, PROF GEOGR, V59, P105, DOI 10.1111/j.1467-9272.2007.00594.x; Pinheiro J, 2009, R PACKAGE NLME LINEA; Puebla-Olivares Fernando, 2002, Ornitologia Neotropical, V13, P381; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Richter M, 2000, MT RES DEV, V20, P332, DOI 10.1659/0276-4741(2000)020[0332:TECICA]2.0.CO;2; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; Rudel T., 2005, TROPICAL FORESTS REG; Rudel TK, 2010, LAND USE POLICY, V27, P95, DOI 10.1016/j.landusepol.2009.09.021; Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Rzedowski J., 1978, VEGETACION MEXICO; SAYER JA, 1991, BIOL CONSERV, V55, P199, DOI 10.1016/0006-3207(91)90056-F; Secretaria de Agricultura y Recursos Hidraulicos (SARH), 1994, INV NAC FOR PER MEX; Sohn YS, 1999, PHOTOGRAMM ENG REM S, V65, P947; Stasinopoulos D.M., 2007, J STAT SOFTW, V23, P1, DOI [10.18637/jss.v023.i07, DOI 10.18637/JSS.V023.I07]; Steininger MK, 2001, ENVIRON CONSERV, V28, P127, DOI 10.1017/S0376892901000133; Toledo V. M., 1988, CIENCIA DESARROLLO, V81, P17; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Tucker CJ, 2004, PHOTOGRAMM ENG REM S, V70, P313, DOI 10.14358/PERS.70.3.313; Tucker CJ, 2000, INT J REMOTE SENS, V21, P1461, DOI 10.1080/014311600210263; Turner BL, 2010, LAND USE POLICY, V27, P170, DOI 10.1016/j.landusepol.2009.03.006; Vaca RA, 2011, APPL VEG SCI, V14, P388, DOI 10.1111/j.1654-109X.2011.01132.x; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; VELAZQUEZ A, 2002, UNASYLVA, P7; Vos Jan de, 2002, TIERRA SEMBRAR SUENO; World Wildlife Found & Conservation International, 2004, INT MAN CHIM WAT; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wright SJ, 2008, ECOL SOC, V13; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x; Xu Jianchu, 2007, Tropical Ecology, V48, P137; Zuur Alain F., 2009, P1	102	41	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42309	10.1371/journal.pone.0042309	http://dx.doi.org/10.1371/journal.pone.0042309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905123	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100032
J	Wu, YA; Wang, XT; Wu, FB; Huang, RL; Xue, FQ; Liang, GT; Tao, M; Cai, PW; Huang, Y				Wu, Yan'an; Wang, Xuetao; Wu, Fangbo; Huang, Ruolei; Xue, Fangqin; Liang, Guantao; Tao, Min; Cai, Pengwei; Huang, Yi			Transcriptome Profiling of the Cancer, Adjacent Non-Tumor and Distant Normal Tissues from a Colorectal Cancer Patient by Deep Sequencing	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENE-EXPRESSION; COLON-CANCER; INTEGRATIVE ANALYSIS; RNA-SEQ; TUMOR; EXON; MUTATIONS; FUSIONS; MATRIX	Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in the world. A genome-wide screening of transcriptome dysregulation between cancer and normal tissue would provide insight into the molecular basis of CRC initiation and progression. Compared with microarray technology, which is commonly used to identify transcriptional changes, the recently developed RNA-seq technique has the ability to detect other abnormal regulations in the cancer transcriptome, such as alternative splicing, novel transcripts or gene fusion. In this study, we performed high-throughput transcriptome sequencing at similar to 50x coverage on CRC, adjacent non-tumor and distant normal tissue. The results revealed cancer-specific, differentially expressed genes and differential alternative splicing, suggesting that the extracellular matrix and metabolic pathways are activated and the genes related to cell homeostasis are suppressed in CRC. In addition, one tumor-restricted gene fusion, PRTEN-NOTCH2, was also detected and experimentally confirmed. This study reveals some common features in tumor invasion and provides a comprehensive survey of the CRC transcriptome, which provides better insight into the complexity of regulatory changes during tumorigenesis.	[Wu, Yan'an; Wang, Xuetao; Wu, Fangbo; Liang, Guantao; Tao, Min; Cai, Pengwei; Huang, Yi] Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Clin Lab, Fuzhou, Peoples R China; [Huang, Ruolei; Xue, Fangqin] Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Tumor Surg, Fuzhou, Peoples R China	Fujian Medical University; Fujian Provincial Hospital; Fujian Medical University; Fujian Provincial Hospital	Wu, YA (corresponding author), Fujian Med Univ, Fujian Prov Clin Med Coll, Fujian Prov Hosp, Dept Clin Lab, Fuzhou, Peoples R China.	wya_sl@yahoo.com.cn			Medical Innovation Project of Fujian Province [2012-CXB-6]	Medical Innovation Project of Fujian Province	This work was supported by the Medical Innovation Project of Fujian Province (2012-CXB-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Chu D, 2009, ANN SURG ONCOL, V16, P3259, DOI 10.1245/s10434-009-0655-6; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Grade M, 2007, CANCER RES, V67, P1877; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim D, 2011, CSHL BIOL GEN C; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Ogino S, 2009, J CLIN ONCOL, V27, P4591, DOI 10.1200/JCO.2009.22.8858; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Skovbjerg H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-136; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	71	55	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41001	10.1371/journal.pone.0041001	http://dx.doi.org/10.1371/journal.pone.0041001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905095	Green Submitted, gold, Green Published			2022-12-25	WOS:000307331100007
J	Kramer, RSS; Jones, AL; Ward, R				Kramer, Robin S. S.; Jones, Alex L.; Ward, Robert			A Lack of Sexual Dimorphism in Width-to-Height Ratio in White European Faces Using 2D Photographs, 3D Scans, and Anthropometry	PLOS ONE			English	Article							FACIAL STRUCTURE; BODY; PREDICTS; CUES	Facial width-to-height ratio has received a great deal of attention in recent research. Evidence from human skulls suggests that males have a larger relative facial width than females, and that this sexual dimorphism is an honest signal of masculinity, aggression, and related traits. However, evidence that this measure is sexually dimorphic in faces, rather than skulls, is surprisingly weak. We therefore investigated facial width-to-height ratio in three White European samples using three different methods of measurement: 2D photographs, 3D scans, and anthropometry. By measuring the same individuals with multiple methods, we demonstrated high agreement across all measures. However, we found no evidence of sexual dimorphism in the face. In our third study, we also found a link between facial width-to-height ratio and body mass index for both males and females, although this relationship did not account for the lack of dimorphism in our sample. While we showed sufficient power to detect differences between male and female width-to-height ratio, our results failed to support the general hypothesis of sexual dimorphism in the face.	[Kramer, Robin S. S.; Jones, Alex L.; Ward, Robert] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Bangor University	Kramer, RSS (corresponding author), Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales.	r.ward@bangor.ac.uk	Jones, Alex L./J-2779-2019	Jones, Alex L./0000-0003-3600-3644; Kramer, Robin/0000-0001-8339-8832				Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; Dandajena TC, 2006, AM J ORTHOD DENTOFAC, V130, P196, DOI 10.1016/j.ajodo.2004.11.039; De Greef S, 2009, FORENSIC SCI MED PAT, V5, P60, DOI 10.1007/s12024-009-9085-9; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Domaracki M, 2006, J FORENSIC SCI, V51, P5, DOI 10.1111/j.1556-4029.2005.00009.x; Fink B, 2003, ANN HUM BIOL, V30, P728, DOI 10.1080/03014460310001620153; Geniole SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030366; Greil H, 2006, COLLEGIUM ANTROPOL, V30, P637; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Jones A, 2012, J EXP PSYCH IN PRESS; Kimmerle EH, 2008, J FORENSIC SCI, V53, P54, DOI 10.1111/j.1556-4029.2007.00627.x; Maynard SJ., 2003, ANIMAL SIGNALS; Ngeow W C, 2009, Indian J Dent Res, V20, P313, DOI 10.4103/0970-9290.57372; Ngeow WC, 2009, SINGAP MED J, V50, P525; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Simpson E, 2002, AM J PHYS ANTHROPOL, V33, P221; Stephan CN, 2005, J FORENSIC SCI, V50, P513; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; SUTTON PRN, 1969, AM J PHYS ANTHROPOL, V30, P303, DOI 10.1002/ajpa.1330300215; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838	27	55	58	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42705	10.1371/journal.pone.0042705	http://dx.doi.org/10.1371/journal.pone.0042705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	987SL	22880088	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900050
J	Li, SW; Yang, X; Shao, J; Shen, YQ				Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan			Structural Insights into the Assembly of CARMA1 and BCL10	PLOS ONE			English	Article							NF-KAPPA-B; ONCOGENIC CARD11 MUTATIONS; ANTIGEN RECEPTOR; CHROMOSOMAL TRANSLOCATION; LYMPHOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; ACTIVATION; PHOSPHORYLATION; PROTEIN; KINASE	The CBM complex (CARMA1, BCL10 and MALT1) plays a crucial role in B and T lymphocyte activation. CARMA1 serves as a scaffold for BCL10, MALT1 and other effector proteins and regulates various signaling pathways related to the immune response. The assembly of CARMA1 and BCL10 is mediated through a CARD-CARD interaction. Here, we report the crystal structure of the CARD domain of CARMA1 at a resolution of 1.75 angstrom. The structure consists of six helices, as previously determined for CARD domains. Structural and computational analysis identified the binding interface between CARMA1-CARD and BCL10-CARD, which consists of a basic patch in CARMA1 and an acidic patch in BCL10. Site-directed mutagenesis, co-immunoprecipitation and an NF-kappa B activation assay confirmed that the interface is necessary for association and downstream signaling. Our studies provide molecular insight into the assembly of CARMA1 and BCL10.	[Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Li, Siwei; Yang, Xue; Shao, Juan; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, SW (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Shen, Yuequan/C-8950-2013	Shen, Yuequan/0000-0002-3775-0900	973 Program [2012CB917201, 2009CB825504]; NSFC [31170684]; Fundamental Research Funds for the Central Universities [65020241]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the 973 Program (grants 2012CB917201 and 2009CB825504), NSFC (grant 31170684) and the Fundamental Research Funds for the Central Universities (grant 65020241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Lamason RL, 2010, BIOCHEMISTRY-US, V49, P8240, DOI 10.1021/bi101052d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNOL REV, V193, P93, DOI 10.1034/j.1600-065X.2003.00049.x; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shen LJ, 2003, BLOOD, V102, P1553, DOI 10.1182/blood-2003-04-1286; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yang X, 2009, J STRUCT BIOL, V168, P437, DOI 10.1016/j.jsb.2009.09.001	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42775	10.1371/journal.pone.0042775	http://dx.doi.org/10.1371/journal.pone.0042775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880103	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100168
J	Chang, Y; Al-Alwan, L; Risse, PA; Halayko, AJ; Martin, JG; Baglole, CJ; Eidelman, DH; Hamid, Q				Chang, Ying; Al-Alwan, Laila; Risse, Paul-Andre; Halayko, Andrew J.; Martin, James G.; Baglole, Carolyn J.; Eidelman, David H.; Hamid, Qutayba			Th17-associated cytokines promote human airway smooth muscle cell proliferation	FASEB JOURNAL			English	Article						asthma; apoptosis; ERK; NF-kappa B	INTERLEUKIN-17; ACTIVATION; RECEPTOR; GROWTH; ROLES; INFLAMMATION; RECRUITMENT; NEUTROPHIL; EXPRESSION; INDUCTION	Increased airway smooth muscle (ASM) mass is a hallmark of airway remodeling in severe asthma. Th17-associated cytokines, particularly IL-17A, IL-17F, and IL-22, have been postulated to play a role in the pathogenesis of asthma. To investigate the in vitro effect of Th17 cytokines on the proliferation and survival of airway smooth muscle cells (ASMCs), human ASMCs from asthmatic and nonasthmatic subjects were incubated with IL-17A, IL-17F, or IL-22. The aforementioned cytokines demonstrated an ability to promote proliferation and survival of ASMCs from asthmatic and nonasthmatic subjects, which were mediated by selective activation of their corresponding receptors on ASMCs, including IL-17RA, IL-17RC, or IL-22R1, respectively. IL-17A and IL-17F-induced proliferation of ASMCs was dependent on ERK1/2 MAPK pathway, while IL-22-induced proliferation involved both ERK1/2 MAPK and NF-kappa B pathways. The involvement of signaling pathways was further confirmed by the inhibition of proliferation by knockdown of ERK1/2 MAPK or NF-kappa B p65 expression with pathway-specific siRNA. Together, our results show that Th17-associated cytokines promote proliferation and reduce the apoptotic rate of human ASMCs, raising the possibility that Th17 cytokines may contribute to increasing airway smooth muscle mass and airway remodeling in asthma.-Chang, Y., Al-Alwan, L., Risse, P.-A., Halayko, A. J., Martin, J. G.. Baglole, C. J., Eidelman, D. H., Hamid, Q. Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J. 26, 5152-5160 (2012). www.fasebj.org	[Chang, Ying; Al-Alwan, Laila; Risse, Paul-Andre; Martin, James G.; Baglole, Carolyn J.; Eidelman, David H.; Hamid, Qutayba] McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; [Chang, Ying; Al-Alwan, Laila; Risse, Paul-Andre; Martin, James G.; Baglole, Carolyn J.; Eidelman, David H.; Hamid, Qutayba] McGill Univ, Dept Med, Div Resp, Montreal, PQ H2X 2P2, Canada; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Resp Hosp, Winnipeg, MB, Canada	McGill University; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 Rue St Urbain, Montreal, PQ H2X 2P2, Canada.	qutayba.hamid@mcgill.ca	Chang, Ying/I-1362-2012	Halayko, Andrew/0000-0002-7865-4552; Martin, James/0000-0001-7574-5363	Canadian Institutes of Health Research; Costello Memorial Fund; McGill University Health Centre-Research Institute of les Fonds de la Recherche en Sante Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Costello Memorial Fund; McGill University Health Centre-Research Institute of les Fonds de la Recherche en Sante Quebec	This work was supported by the Canadian Institutes of Health Research, the Costello Memorial Fund, and the McGill University Health Centre-Research Institute of les Fonds de la Recherche en Sante Quebec.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Allen LF, 2003, SEMIN ONCOL, V30, P105, DOI 10.1053/j.seminoncol.2003.08.012; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Brar SS, 2002, AM J PHYSIOL-LUNG C, V282, pL782, DOI 10.1152/ajplung.00206.2001; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Chang Y, 2011, J ALLERGY CLIN IMMUN, V127, P1046, DOI 10.1016/j.jaci.2010.12.1117; Dragon S, 2008, MOL IMMUNOL, V45, P160, DOI 10.1016/j.molimm.2007.04.027; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Gosens R, 2002, BRIT J PHARMACOL, V137, P459, DOI 10.1038/sj.bjp.0704889; Govindaraju V, 2006, AM J PHYSIOL-CELL PH, V291, pC957, DOI 10.1152/ajpcell.00451.2005; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hirota JA, 2011, AM J RESP CELL MOL, V45, P566, DOI 10.1165/rcmb.2010-0277OC; Hirst SJ, 1996, AM J PHYSIOL-LUNG C, V270, pL415, DOI 10.1152/ajplung.1996.270.3.L415; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Joubert P, 2005, J ALLERGY CLIN IMMUN, V116, P713, DOI 10.1016/j.jaci.2005.05.042; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kuma Y., 2005, J BIOL CHEM, V280, P19472; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lee JH, 2001, AM J PHYSIOL-LUNG C, V280, pL1019, DOI 10.1152/ajplung.2001.280.5.L1019; Linden A, 2006, PULM PHARMACOL THER, V19, P47, DOI 10.1016/j.pupt.2005.02.004; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; Lyss G, 1997, BIOL CHEM, V378, P951, DOI 10.1515/bchm.1997.378.9.951; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Robins S, 2011, AM J RESP CELL MOL, V45, P984, DOI 10.1165/rcmb.2010-0450OC; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Seidel P, 2009, AM J PHYSIOL-LUNG C, V297, pL326, DOI 10.1152/ajplung.90624.2008; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Silverpil E, 2011, INFLAMMATION, V34, P1, DOI 10.1007/s10753-010-9201-8; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Xie SP, 2007, AM J PHYSIOL-LUNG C, V293, pL245, DOI 10.1152/ajplung.00068.2007; Ying-Fang S, 2007, INDIAN J MED RES, V126, P139; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	40	92	99	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5152	5160		10.1096/fj.12-208033	http://dx.doi.org/10.1096/fj.12-208033			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22898922				2022-12-25	WOS:000311838300035
J	Dutta, T; Malhotra, A; Deutscher, MP				Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.			Exoribonuclease and Endoribonuclease Activities of RNase BN/RNase Z both Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRNASE-Z-FAMILY; ESCHERICHIA-COLI; ZINC PHOSPHODIESTERASE; PROCESSING ENZYME; PRECURSORS; BN; PROTEINS; MATURATION; MOLECULES; GROWTH	Escherichia coli RNase BN, a member of the RNase Z family of endoribonucleases, differs from other family members in that it also can act as an exoribonuclease in vitro. Here, we examine whether this activity of RNase BN also functions in vivo. Comparison of the x-ray structure of RNase BN with that of Bacillus subtilis RNase Z, which lacks exoribonuclease activity, revealed that RNase BN has a narrower and more rigid channel downstream of the catalytic site. We hypothesized that this difference in the putative RNA exit channel might be responsible for the acquisition of exoribonuclease activity by RNase BN. Accordingly, we generated several mutant RNase BN proteins in which residues within a loop in this channel were converted to the corresponding residues present in B. subtilis RNase Z, thus widening the channel and increasing its flexibility. The resulting mutant RNase BN proteins had reduced or were essentially devoid of exoribonuclease activity in vitro. Substitution of one mutant rbn gene (P142G) for wild type rbn in the E. coli chromosome revealed that the exoribonuclease activity of RNase BN is not required for maturation of phage T4 tRNA precursors, a known specific function of this RNase. On the other hand, removal of the exoribonuclease activity of RNase BN in a cell lacking other processing RNases leads to slower growth and affects maturation of multiple tRNA precursors. These findings help explain how RNase BN can act as both an exo- and an endoribonuclease and also demonstrate that its exoribonuclease activity is capable of functioning in vivo, thus widening the potential role of this enzyme in E. coli.	[Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021; Malhotra, Arun/A-3916-2008; Malhotra, Arun/Z-5140-2019	Malhotra, Arun/0000-0001-6656-7841; Malhotra, Arun/0000-0001-6656-7841	National Institutes of Health Grant [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M.P.D.).	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; DEUTSCHER MP, 1974, J BIOL CHEM, V249, P6696; Deutscher Murray P., 1995, P51; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Dutta T, 2010, J BIOL CHEM, V285, P22872, DOI 10.1074/jbc.M110.141101; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; MAISURIAN AN, 1973, MOL GEN GENET, V120, P227, DOI 10.1007/BF00267154; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, P NATL ACAD SCI USA, V72, P1491, DOI 10.1073/pnas.72.4.1491; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08	30	15	15	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35747	35755		10.1074/jbc.M112.407403	http://dx.doi.org/10.1074/jbc.M112.407403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893707	Green Published, hybrid			2022-12-25	WOS:000309968000085
J	Giral, H; Cranston, D; Lanzano, L; Caldas, Y; Sutherland, E; Rachelson, J; Dobrinskikh, E; Weinman, EJ; Doctor, RB; Gratton, E; Levi, M				Giral, Hector; Cranston, DeeAnn; Lanzano, Luca; Caldas, Yupanqui; Sutherland, Eileen; Rachelson, Joanna; Dobrinskikh, Evgenia; Weinman, Edward J.; Doctor, R. Brian; Gratton, Enrico; Levi, Moshe			NHE3 Regulatory Factor 1 (NHERF1) Modulates Intestinal Sodium-dependent Phosphate Transporter (NaPi-2b) Expression in Apical Microvilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; NA+-H+ EXCHANGER; IN-VITRO MODEL; PDZ PROTEINS; DIETARY PHOSPHATE; PROXIMAL TUBULES; RENAL ADAPTATION; CACO-2BBE CELLS; VITAMIN-D; COTRANSPORTER	P-i uptake in the small intestine occurs predominantly through the NaPi-2b (SLC34a2) co-transporter. NaPi-2b is regulated by changes in dietary P-i but the mechanisms underlying this regulation are largely undetermined. Sequence analyses show NaPi-2b has a PDZ binding motif at its C terminus. Immunofluorescence imaging shows NaPi-2b and two PDZ domain containing proteins, NHERF1 and PDZK1, are expressed in the apical microvillar domain of rat small intestine enterocytes. Co-immunoprecipitation studies in rat enterocytes show that NHERF1 associates with NaPi-2b but not PDZK1. In HEK co-expression studies, GFP-NaPi-2b co-precipitates with FLAG-NHERF1. This interaction is markedly diminished when the C-terminal four amino acids are truncated from NaPi-2b. FLIM-FRET analyses using tagged proteins in CACO-2(BBE) cells show a distinct phasor shift between NaPi-2b and NHERF1 but not between NaPi-2b and the PDZK1 pair. This shift demonstrates that NaPi-2b and NHERF1 reside within 10 nm of each other. NHERF1(-/-) mice, but not PDZK1(-/-) mice, had a diminished adaptation of NaPi-2b expression in response to a low Pi diet. Together these studies demonstrate that NHERF1 associates with NaPi-2b in enterocytes and regulates NaPi-2b adaptation.	[Levi, Moshe] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Giral, Hector; Cranston, DeeAnn; Caldas, Yupanqui; Sutherland, Eileen; Rachelson, Joanna; Dobrinskikh, Evgenia; Doctor, R. Brian; Levi, Moshe] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO 80045 USA; [Lanzano, Luca; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Levi, M (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, 12700 E 19th Ave,Res 2,Rm 7002,Box C281, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu		Lanzano', Luca/0000-0001-6539-394X; Levi, Moshe/0000-0002-6225-946X	National Institutes of Health [R01 DK066029-6, R01 DK-080769, 8P41GM103540, P50-GM076516]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080769, R01DK066029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103540, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK066029-6 (to M. L., E. G., H. G., Y. C., and L. L.), R01 DK-080769 (to B. D., D. C., J. R., and E. D.), 8P41GM103540 (to E. G. and L. L.), and P50-GM076516 (to E. G. and L. L.).	Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Biber J, 2005, J MEMBRANE BIOL, V203, P111, DOI 10.1007/s00232-005-0738-7; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Caldas YA, 2011, KIDNEY INT, V80, P535, DOI 10.1038/ki.2011.159; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Capuano P, 2005, AM J PHYSIOL-CELL PH, V288, pC429, DOI 10.1152/ajpcell.00331.2004; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dobrinskikh E, 2010, AM J PHYSIOL-CELL PH, V299, pC1324, DOI 10.1152/ajpcell.00183.2010; Donowitz M, 2010, PHYSIOL GENOMICS, V42A, P200, DOI 10.1152/physiolgenomics.00001.2010; Farrow EG, 2010, NAT REV NEPHROL, V6, P207, DOI 10.1038/nrneph.2010.17; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Fujiya M, 2011, INFLAMM BOWEL DIS, V17, P907, DOI 10.1002/ibd.21444; Giral H, 2011, J BIOL CHEM, V286, P15032, DOI 10.1074/jbc.M110.199752; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hattenhauer O, 1999, AM J PHYSIOL-GASTR L, V277, pG756, DOI 10.1152/ajpgi.1999.277.4.G756; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hoag HM, 1999, J CLIN INVEST, V104, P679, DOI 10.1172/JCI7103; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; KEMPSON SA, 1995, AM J PHYSIOL-RENAL, V268, pF784, DOI 10.1152/ajprenal.1995.268.4.F784; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Lanzano L, 2011, J BIOPHOTONICS, V4, P415, DOI 10.1002/jbio.201100002; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Marks J, 2006, EXP PHYSIOL, V91, P531, DOI 10.1113/expphysiol.2005.032516; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Musch MW, 2008, AM J PHYSIOL-GASTR L, V295, pG909, DOI 10.1152/ajpgi.90312.2008; Naderi ASA, 2010, NAT REV NEPHROL, V6, P657, DOI 10.1038/nrneph.2010.121; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ohkido I, 2003, PFLUG ARCH EUR J PHY, V446, P106, DOI 10.1007/s00424-003-1010-6; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; PETERSON MD, 1993, J CELL SCI, V105, P445; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Sugiura T, 2008, DRUG METAB DISPOS, V36, P1181, DOI 10.1124/dmd.107.020321; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641	57	32	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35047	35056		10.1074/jbc.M112.392415	http://dx.doi.org/10.1074/jbc.M112.392415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904329	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000309968000016
J	Litvinov, RI; Mekler, A; Shuman, H; Bennett, JS; Barsegov, V; Weisel, JW				Litvinov, Rustem I.; Mekler, Andrey; Shuman, Henry; Bennett, Joel S.; Barsegov, Valeri; Weisel, John W.			Resolving Two-dimensional Kinetics of the Integrin alpha IIb beta 3-Fibrinogen Interactions Using Binding-Unbinding Correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIGAND INTERACTIONS; HIGH-STRENGTH STATES; BETA(2) INTEGRIN; ICAM-1 BONDS; CATCH BONDS; ADHESION; FORCE; ACTIVATION; FIBRINOGEN; DISSOCIATION	Using a combined experimental and theoretical approach named binding-unbinding correlation spectroscopy (BUCS), we describe the two-dimensional kinetics of interactions between fibrinogen and the integrin alpha IIb beta 3, the ligand-receptor pair essential for platelet function during hemostasis and thrombosis. The methodology uses the optical trap to probe force-free association of individual surface-attached fibrinogen and alpha IIb beta 3 molecules and forced dissociation of an IIb beta 3-fibrinogen complex. This novel approach combines force clamp measurements of bond lifetimes with the binding mode to quantify the dependence of the binding probability on the interaction time. We found that fibrinogen-reactive alpha IIb beta 3 pre-exists in at least two states that differ in their zero force on-rates (k(on1) = 1.4 x 10(-4) and k(on2) x 2.3 x 10(-4) mu m(2)/s), off-rates (k(off1) = 2.42 and k(off2) = 0.60 s(-1)), and dissociation constants (K-d1 = 1.7 x 10(4) and K-d2 = 2.6 x 10(3) mu m(-2)). The integrin activator Mn2+ changed the on-rates and affinities (K-d1 = 5 x 10(4) and K-d2 = 0.3 x 10(3) mu m(-2)) but did not affect the off-rates. The strength of alpha IIb beta 3-fibrinogen interactions was time-dependent due to a progressive increase in the fraction of the high affinity state of the alpha IIb beta 3-fibrinogen complex characterized by a faster on-rate. Upon Mn2+-induced integrin activation, the force-dependent off-rates decrease while the complex undergoes a conformational transition from a lower to higher affinity state. The results obtained provide quantitative estimates of the two-dimensional kinetic rates for the low and high affinity alpha IIb beta 3 and fibrinogen interactions at the single molecule level and offer direct evidence for the time-and force-dependent changes in alpha IIb beta 3 conformation and ligand binding activity, underlying the dynamics of fibrinogen-mediated platelet adhesion and aggregation.	[Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA; [Litvinov, Rustem I.; Mekler, Andrey; Weisel, John W.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Shuman, Henry] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Bennett, Joel S.] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Lowell; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Barsegov, V (corresponding author), Univ Massachusetts, Dept Chem, 401B Olney Hall, Lowell, MA 01854 USA.	Valeri_Barsegov@uml.edu; weisel@mail.med.upenn.edu	Barsegov, Valeri/A-6203-2014; Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917	National Institutes of Health [HL030954/HL090774, HL40387/HL81012]; American Heart Association [09SDG2460023]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030954, R01HL090774, R56HL090774, P01HL040387, P50HL081012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL030954/HL090774 (to J.W.W.) and HL40387/HL81012 (to J.S.B.). This work was also supported by American Heart Association Grant 09SDG2460023 (to V.B.).	Agnihotri A, 2009, COLLOID SURFACE B, V71, P138, DOI 10.1016/j.colsurfb.2009.01.019; Barsegov V, 2006, J PHYS CHEM B, V110, P26403, DOI 10.1021/jp0653306; Barsegov V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168302; Barsegov V, 2006, BIOPHYS J, V90, P3827, DOI 10.1529/biophysj.105.075937; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bergmeier W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005132; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100; Chen W., 2011, PLOS COMPUT BIOL, V7; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Danilowicz C, 2005, ANAL CHEM, V77, P3023, DOI 10.1021/ac050057+; DICERA E, 1990, BIOPHYS CHEM, V37, P147, DOI 10.1016/0301-4622(90)88015-K; DICERA E, 1988, P NATL ACAD SCI USA, V85, P5077; Edwards LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00086; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9; Hantgan RR, 2006, PROTEIN SCI, V15, P1893, DOI 10.1110/ps.052049506; Huang J, 2012, MOL IMMUNOL, V52, P155, DOI 10.1016/j.molimm.2012.05.004; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kuroki K, 2011, METHODS MOL BIOL, V748, P83, DOI 10.1007/978-1-61779-139-0_6; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; Long M, 2006, CELL MOL IMMUNOL, V3, P79; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mukamel S., 1995, PRINCIPLES NONLINEAR; Rico F, 2011, METHODS MOL BIOL, V736, P331, DOI 10.1007/978-1-61779-105-5_20; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xiang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027946; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	46	28	28	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35275	35285		10.1074/jbc.M112.404848	http://dx.doi.org/10.1074/jbc.M112.404848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893701	Green Published, hybrid			2022-12-25	WOS:000309968000037
J	Nakaya, M; Chikura, S; Watari, K; Mizuno, N; Mochinaga, K; Mangmool, S; Koyanagi, S; Ohdo, S; Sato, Y; Ide, T; Nishida, M; Kurose, H				Nakaya, Michio; Chikura, Satsuki; Watari, Kenji; Mizuno, Natsumi; Mochinaga, Koji; Mangmool, Supachoke; Koyanagi, Satoru; Ohdo, Shigehiro; Sato, Yoji; Ide, Tomomi; Nishida, Motohiro; Kurose, Hitoshi			Induction of Cardiac Fibrosis by beta-Blocker in G Proteinin-dependent and G Protein-coupled Receptor Kinase 5/beta-Arrestin2-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; BIASED AGONISM; HEART-FAILURE; ARRESTIN; GRKS; PHOSPHORYLATION; TRAFFICKING; ACTIVATION	G-protein coupled receptors (GPCRs) have long been known as receptors that activate G protein-dependent cellular signaling pathways. In addition to the G protein-dependent pathways, recent reports have revealed that several ligands called "biased ligands" elicit G protein-independent and beta-arrestin-dependent signaling through GPCRs (biased agonism). Several beta-blockers are known as biased ligands. All beta-blockers inhibit the binding of agonists to the beta-adrenergic receptors. In addition to beta-blocking action, some beta-blockers are reported to induce cellular responses through G protein-independent and beta-arrestin-dependent signaling pathways. However, the physiological significance induced by the beta-arrestin-dependent pathway remains much to be clarified in vivo. Here, we demonstrate that metoprolol, a beta(1)-adrenergic receptor-selective blocker, could induce cardiac fibrosis through a G protein-independent and beta-arrestin2-dependent pathway. Metoprolol, a beta-blocker, increased the expression of fibrotic genes responsible for cardiac fibrosis in cardiomyocytes. Furthermore, metoprolol induced the interaction between beta(1)-adrenergic receptor and beta-arrestin2, but not beta-arrestin1. The interaction between beta(1)-adrenergic receptor and beta-arrestin2 by metoprolol was impaired in the G protein-coupled receptor kinase 5 (GRK5)knockdown cells. Metoprolol-induced cardiac fibrosis led to cardiac dysfunction. However, the metoprolol-induced fibrosis and cardiac dysfunction were not evoked in beta-arrestin2- or GRK5-knock-out mice. Thus, metoprolol is a biased ligand that selectively activates a G protein-independent and GRK5/beta-arrestin2-dependent pathway, and induces cardiac fibrosis. This study demonstrates the physiological importance of biased agonism, and suggests that G protein-independent and beta-arrestin-dependent signaling is a reason for the diversity of the effectiveness of beta-blockers.	[Nakaya, Michio; Chikura, Satsuki; Watari, Kenji; Mizuno, Natsumi; Mochinaga, Koji; Mangmool, Supachoke; Nishida, Motohiro; Kurose, Hitoshi] Kyushu Univ, Dept Pharmacol & Toxicol, Higashi Ku, Fukuoka 8128582, Japan; [Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut Sci, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 8128582, Japan; [Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan	Kyushu University; Kyushu University; Kyushu University; National Institute of Health Sciences - Japan	Kurose, H (corresponding author), Kyushu Univ, Dept Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kurose@phar.kyushu-u.ac.jp		Koyanagi, Satoru/0000-0003-4849-2377; Mizuno, Natsumi/0000-0001-7161-266X; Nishida, Motohiro/0000-0002-2587-5458	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Scientific Research on Priority Areas; Grants-in-Aid for Scientific Research [22136008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. Na, M. Ni, and H.K.), a Grant-in-aid for Scientific Research on Innovative Areas (to M. Ni), a Grant-in-aid for Scientific Research on Priority Areas (to H.K.), the Takeda Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M. Na).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRODDE OE, 1993, PHARMACOL THERAPEUT, V60, P405, DOI 10.1016/0163-7258(93)90030-H; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Cruickshank JM, 2007, INT J CARDIOL, V120, P10, DOI 10.1016/j.ijcard.2007.01.069; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gustafsson AB, 2000, MOL PHARMACOL, V58, P1470, DOI 10.1124/mol.58.6.1470; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hjalmarson A, 1999, LANCET, V353, P2001; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Mangmool S, 2006, J BIOL CHEM, V281, P31940, DOI 10.1074/jbc.M602832200; Metra M, 2004, HEART FAIL REV, V9, P123, DOI 10.1023/B:HREV.0000046367.99002.a4; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reiter MJ, 2004, PROG CARDIOVASC DIS, V47, P11, DOI 10.1016/j.pcad.2004.04.004; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P21028, DOI 10.1073/pnas.1004169107; Varma DR, 1999, BRIT J PHARMACOL, V127, P895, DOI 10.1038/sj.bjp.0702616; WAAGSTEIN F, 1989, CIRCULATION, V80, P551, DOI 10.1161/01.CIR.80.3.551; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yamamoto K, 2002, CARDIOVASC RES, V55, P76, DOI 10.1016/S0008-6363(02)00341-3; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	50	38	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35669	35677		10.1074/jbc.M112.357871	http://dx.doi.org/10.1074/jbc.M112.357871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22888001	hybrid, Green Published			2022-12-25	WOS:000309968000078
J	Sikorski, TW; Joo, YJ; Ficarro, SB; Askenazi, M; Buratowski, S; Marto, JA				Sikorski, Timothy W.; Joo, Yoo Jin; Ficarro, Scott B.; Askenazi, Manor; Buratowski, Stephen; Marto, Jarrod A.			Proteomic Analysis Demonstrates Activator- and Chromatin-specific Recruitment to Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; QUANTITATIVE PROTEOMICS; PREINITIATION COMPLEX; TRANSCRIPTION REINITIATION; IN-VIVO; MEDIATOR; QUANTIFICATION; IDENTIFICATION; MECHANISM; ENHANCER	In-depth characterization of RNA polymerase II preinitiation complexes remains an important and challenging goal. We used quantitative mass spectrometry to explore context-dependent Saccharomyces cerevisiae preinitiation complex formation at the HIS4 promoter reconstituted on naked and chromatinized DNA templates. The transcription activators Gal4-VP16 and Gal4-Gcn4 recruited a limited set of chromatin-related coactivator complexes, namely the chromatin remodeler Swi/Snf and histone acetyltransferases SAGA and NuA4, suggesting that transcription stimulation is mediated through these factors. Moreover, the two activators differentially recruited the coactivator complexes, consistent with specific activator-coactivator interactions. Chromatinized templates suppressed recruitment of basal transcription factors, thereby amplifying the effect of activators, compared with naked DNA templates. This system is sensitive, highly reproducible, and easily applicable to mapping the repertoire of proteins found at any promoter.	[Sikorski, Timothy W.; Joo, Yoo Jin; Ficarro, Scott B.; Askenazi, Manor; Buratowski, Stephen; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sikorski, Timothy W.; Ficarro, Scott B.; Askenazi, Manor; Marto, Jarrod A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Askenazi, Manor; Marto, Jarrod A.] Harvard Univ, Sch Med, Blais Prote Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu; jarrod_marto@dfci.harvard.edu	Joo, Yoo Jin/AAK-6614-2020	Askenazi, Manor/0000-0003-1646-833X	National Institutes of Health [GM46498]; Dana-Farber Strategic Research Initiative; National Defense Science and Engineering Graduate predoctoral fellowship; National Research Foundation of Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber Strategic Research Initiative; National Defense Science and Engineering Graduate predoctoral fellowship; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46498 (to S. B.). This work was also supported by the Dana-Farber Strategic Research Initiative (to J.A.M.).; Supported by a National Defense Science and Engineering Graduate predoctoral fellowship.; Supported by a National Research Foundation of Korea postdoctoral fellowship.	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Benaglia T, 2009, J STAT SOFTW, V32, P1; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Ficarro SB, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.011064; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Reeves WM, 2003, MOL CELL BIOL, V23, P349, DOI 10.1128/MCB.23.1.349-358.2003; Savitski MM, 2011, ANAL CHEM, V83, P8959, DOI 10.1021/ac201760x; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wenger CD, 2011, NAT METHODS, V8, P933, DOI [10.1038/NMETH.1716, 10.1038/nmeth.1716]; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhou F, 2011, ANAL CHEM, V83, P6996, DOI 10.1021/ac200639v; Zhou F, 2010, J PROTEOME RES, V9, P6242, DOI 10.1021/pr1004696	40	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35397	35408		10.1074/jbc.M112.391581	http://dx.doi.org/10.1074/jbc.M112.391581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22902623	Green Published, hybrid			2022-12-25	WOS:000309968000047
J	Yao, L; Li, WM; She, H; Dou, J; Jia, LL; He, YL; Yang, Q; Zhu, JQ; Capiro, NL; Walker, DI; Pennell, KD; Pang, YP; Liu, Y; Han, YF; Mao, ZX				Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Capiro, Natalie L.; Walker, Douglas I.; Pennell, Kurt D.; Pang, Yuanping; Liu, Yong; Han, Yifan; Mao, Zixu			Activation of Transcription Factor MEF2D by Bis(3)-cognitin Protects Dopaminergic Neurons and Ameliorates Parkinsonian Motor Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE-ENHANCER FACTOR-2; CEREBELLAR GRANULE NEURONS; D-ASPARTATE RECEPTORS; OXIDATIVE STRESS; DISEASE; SURVIVAL; APOPTOSIS; GROWTH; TARGETS; MPTP	Parkinson disease (PD) is characterized by the selective demise of dopaminergic (DA) neurons in the substantial nigra pars compacta. Dysregulation of transcriptional factor myocyte enhancer factor 2D (MEF2D) has been implicated in the pathogenic process in in vivo and in vitro models of PD. Here, we identified a small molecule bis(3)-cognitin (B3C) as a potent activator of MEF2D. We showed that B3C attenuated the toxic effects of neurotoxin 1-methyl-4-phenylpyridinium (MPP+) by activating MEF2D via multiple mechanisms. B3C significantly reduced MPP+-induced oxidative stress and potentiated Akt to down-regulate the activity of MEF2 inhibitor glycogen synthase kinase 3 beta (GSK3 beta) in a DA neuronal cell line SN4741. Furthermore, B3C effectively rescued MEF2D from MPP+-induced decline in both nucleic and mitochondrial compartments. B3C offered SN4741 cells potent protection against MPP+-induced apoptosis via MEF2D. Interestingly, B3C also protected SN4741 cells from wild type or mutant A53T alpha-synuclein-induced cytotoxicity. Using the in vivo PD model of C57BL/6 mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP), we showed that B3C maintained redox homeostasis, promoted Akt function activity, and restored MEF2D level in midbrain neurons. Moreover, B3C greatly prevented the loss of tyrosine hydroxylase signal in substantial nigra pars compacta DA neurons and ameliorated behavioral impairments in mice treated with MPTP. Collectedly, our studies identified B3C as a potent neuroprotective agent whose effectiveness relies on its ability to effectively up-regulate MEF2D in DA neurons against toxic stress in models of PD in vitro and in vivo.	[Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Yao, Lu; Li, Wenming; She, Hua; Dou, Juan; Jia, Leili; He, Yingli; Yang, Qian; Zhu, Jinqiu; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Yao, Lu; Liu, Yong] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol Environm & Genes Related Dis, Key Lab Educ Minist, Xian 710061, Shaanxi, Peoples R China; [Li, Wenming; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Chinese Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Capiro, Natalie L.; Walker, Douglas I.; Pennell, Kurt D.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Pang, Yuanping] Mayo Fdn Med Educ & Res, Rochester, MN 55905 USA	Emory University; Emory University; Xi'an Jiaotong University; Hong Kong Polytechnic University; Tufts University; Mayo Clinic	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Whitehead Bldg,Rm 505L,615 Michael St, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Pennell, Kurt D/F-6862-2010; Capiro, Natalie/G-5955-2010; zhu, jinqiu/F-5039-2015; Pennell, Kurt/ABD-8337-2020	Pennell, Kurt D/0000-0002-5788-6397; Capiro, Natalie/0000-0002-8125-1658; zhu, jinqiu/0000-0003-1090-2609; Han, Yifan/0000-0002-5833-069X; Pang, Yuan-Ping/0000-0003-0838-2560	National Institutes of Health [AG023695, NS048254, 1P50NS071669, ES015317, ES015317-002]; Michael J. Fox Foundation; Research Grants Council of Hong Kong [5609/09M, 5610/11M]; Hong Kong Polytechnic University [G-U952]; National Science Foundation [CHE-03200783]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048254, P50NS071669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG023695 and NS048254 (to Z. M.), 1P50NS071669 (to W. L.), and ES015317 and ES015317-002 (to Z. M.). This work was also supported in part by a grant from the Michael J. Fox Foundation (to Z. M.), in part by grants from the Research Grants Council of Hong Kong (5609/09M; 5610/11M) and the Hong Kong Polytechnic University (G-U952) (to Y. H.), and in part by National Science Foundation Grant CHE-03200783 (to K. D. P.).	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Chaturvedi RK, 2008, J NEUROCHEM, V106, P506, DOI 10.1111/j.1471-4159.2008.05388.x; Chu YP, 2011, NEUROBIOL DIS, V41, P71, DOI 10.1016/j.nbd.2010.08.022; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Luo JL, 2010, J BIOL CHEM, V285, P19947, DOI 10.1074/jbc.M110.111286; Mandel SA, 2008, CNS NEUROSCI THER, V14, P352, DOI 10.1111/j.1755-5949.2008.00060.x; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Pang YP, 1996, J BIOL CHEM, V271, P23646, DOI 10.1074/jbc.271.39.23646; Prasad KN, 1999, J AM COLL NUTR, V18, P413, DOI 10.1080/07315724.1999.10718878; Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714; Richter F, 2007, J NEUROSCI RES, V85, P681, DOI 10.1002/jnr.21159; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Schapira A, 2004, LANCET NEUROL, V3, P362, DOI 10.1016/S1474-4422(04)00769-0; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Sherer TB, 2002, J NEUROSCI, V22, P7006; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sun X, 2010, TOXICOLOGY, V271, P5, DOI 10.1016/j.tox.2010.01.001; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wang XM, 2004, GASTROENTEROLOGY, V127, P1174, DOI 10.1053/j.gastro.2004.07.007; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007	46	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34246	34255		10.1074/jbc.M112.367540	http://dx.doi.org/10.1074/jbc.M112.367540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891246	Green Published, hybrid			2022-12-25	WOS:000309654200029
J	Zhang, L; Iyer, J; Chowdhury, A; Ji, M; Xiao, L; Yang, SP; Chen, YH; Tsai, MY; Dong, JX				Zhang, Lin; Iyer, Jyoti; Chowdhury, Aparajita; Ji, Ming; Xiao, Ling; Yang, Shuping; Chen, Yuanhong; Tsai, Ming-Ying; Dong, Jixin			KIBRA Regulates Aurora Kinase Activity and Is Required for Precise Chromosome Alignment During Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN PHOSPHATASE 1; LYMPHOCYTIC-LEUKEMIA; EPISODIC MEMORY; DROSOPHILA; HIPPO; PHOSPHORYLATION; HOMOLOG; PATHWAY; TARGET	The Hippo pathway controls organ size and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. KIBRA was recently identified as a novel regulator of the Hippo pathway. Several of the components of the Hippo pathway are important regulators of mitosis-related cell cycle events. We recently reported that KIBRA is phosphorylated by the mitotic kinases Aurora-A and -B. However, the role KIBRA plays in mitosis has not been established. Here, we show that KIBRA activates the Aurora kinases and is required for full activation of Aurora kinases during mitosis. KIBRA also promotes the phosphorylation of large tumor suppressor 2 (Lats2) on Ser(83) by activating Aurora-A, which controls Lats2 centrosome localization. However, Aurora-A is not required for KIBRA to associate with Lats2. We also found that Lats2 inhibits the Aurora-mediated phosphorylation of KIBRA on Ser(539), probably via regulating protein phosphatase 1. Consistent with playing a role in mitosis, siRNA-mediated knockdown of KIBRA causes mitotic abnormalities, including defects of spindle and centrosome formation and chromosome misalignment. We propose that the KIBRA-Aurora-Lats2 protein complexes form a novel axis that regulates precise mitosis.	[Zhang, Lin; Iyer, Jyoti; Chowdhury, Aparajita; Ji, Ming; Xiao, Ling; Yang, Shuping; Chen, Yuanhong; Tsai, Ming-Ying; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Tsai, MY (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	mtsai@unmc.edu; dongj@unmc.edu	Iyer, Jyoti/AAM-5009-2020	Iyer, Jyoti/0000-0002-0942-6919	National Center for Research Resources, National Institutes of Health [5P20GM103489]; Nebraska Cancer and Smoking Disease Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Cancer and Smoking Disease Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 5P20GM103489 from the National Center for Research Resources, National Institutes of Health and a grant from the Nebraska Cancer and Smoking Disease Research Program (to J. D.).	Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Florindo C, 2012, J CELL SCI, V125, P3085, DOI 10.1242/jcs.097147; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hill VK, 2011, EPIGENETICS-US, V6, P326, DOI 10.4161/epi.6.3.14404; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Shimizu T, 2008, GENETICS, V178, P957, DOI 10.1534/genetics.107.081570; Shinawi T, 2012, EPIGENETICS-US, V7, P211, DOI 10.4161/epi.7.3.19222; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; XU TA, 1995, DEVELOPMENT, V121, P1053; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	47	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34069	34077		10.1074/jbc.M112.385518	http://dx.doi.org/10.1074/jbc.M112.385518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904328	Green Published, hybrid			2022-12-25	WOS:000309654200013
J	Xiao, L; Wang, BL; Li, Y; Wang, QQ; Liu, SH; Wang, Y; Liu, GY; Lu, J; Ye, XT; Zhang, LM				Xiao Liang; Wang Beilei; Li Ying; Wang Qianqian; Liu Sihua; Wang Yang; Liu Guoyan; Lu Jia; Ye Xuting; Zhang Liming			Cardiovascular Effect Is Independent of Hemolytic Toxicity of Tentacle-Only Extract from the Jellyfish Cyanea capillata	PLOS ONE			English	Article							NEMOPILEMA-NOMURAI SCYPHOZOA; PHYSALIA-PHYSALIS VENOM; CHIRONEX-FLECKERI VENOM; BOX-JELLYFISH; NEMATOCYST VENOM; CHIROPSALMUS-QUADRIGATUS; HABU-KURAGE; SEA WASP; NOZAKII KISHINOUYE; PROTEIN TOXIN	Our previous studies have confirmed that the crude tentacle-only extract (cTOE) from the jellyfish Cyanea capillata (Cyaneidae) exhibits hemolytic and cardiovascular toxicities simultaneously. So, it is quite difficult to discern the underlying active component responsible for heart injury caused by cTOE. The inactivation of the hemolytic toxicity from cTOE accompanied with a removal of plenty of precipitates would facilitate the separation of cardiovascular component and the investigation of its cardiovascular injury mechanism. In our research, after the treatment of one-step alkaline denaturation followed by twice dialysis, the protein concentration of the treated tentacle-only extract (tTOE) was about 1/3 of cTOE, and SDS-PAGE showed smaller numbers and lower density of protein bands in tTOE. The hemolytic toxicity of tTOE was completely lost while its cardiovascular toxicity was well retained. The observations of cardiac function, histopathology and ultrastructural pathology all support tTOE with significant cardiovascular toxicity. Blood gas indexes and electrolytes changed far less by tTOE than those by cTOE, though still with significant difference from normal. In summary, the cardiovascular toxicity of cTOE can exist independently of the hemolytic toxicity and tTOE can be employed as a better venom sample for further purification and mechanism research on the jellyfish cardiovascular toxic proteins.	[Xiao Liang; Wang Beilei; Wang Qianqian; Liu Sihua; Liu Guoyan; Lu Jia; Zhang Liming] Second Mil Med Univ, Fac Naval Med, Dept Chem Def Med, Shanghai, Peoples R China; [Li Ying] Second Mil Med Univ, Sch Nursing, Shanghai, Peoples R China; [Wang Yang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Ye Xuting] Second Mil Med Univ, Dept Biophys, Sch Basic Med Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University	Xiao, L (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Chem Def Med, Shanghai, Peoples R China.	lilly_wang@126.com; lmzhang1969@yahoo.com.cn			National Natural Science Foundation Young Scientists Fund [81000098]; Natural Science Foundation of Shanghai Municipal Government [10ZR1437900]; Foundation of the Key Discipline and Specialties of Nautical Medicine [2010ZL03]	National Natural Science Foundation Young Scientists Fund; Natural Science Foundation of Shanghai Municipal Government; Foundation of the Key Discipline and Specialties of Nautical Medicine	This research was funded by the National Natural Science Foundation Young Scientists Fund (81000098), the Natural Science Foundation of Shanghai Municipal Government (10ZR1437900) and the Foundation of the Key Discipline and Specialties of Nautical Medicine (2010ZL03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Beilei W, 2011, J CARDIOVASC PHARM; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; CURRIE B, 1994, TOXICON, V32, P1305, DOI 10.1016/0041-0101(94)90403-0; Edwards L, 2000, TOXICON, V38, P323, DOI 10.1016/S0041-0101(99)00156-7; Edwards LP, 2002, TOXICON, V40, P1299, DOI 10.1016/S0041-0101(02)00138-1; Feng JH, 2010, TOXICOL IN VITRO, V24, P1750, DOI 10.1016/j.tiv.2010.02.010; Feng JH, 2010, TOXICON, V55, P118, DOI 10.1016/j.toxicon.2009.07.008; Fenner PJ, 2010, J TRAVEL MED, V17, P133, DOI 10.1111/j.1708-8305.2009.00390.x; Helmholz H, 2008, J CHROMATOGR B, V871, P60, DOI 10.1016/j.jchromb.2008.06.040; Howarth FC, 2002, PFLUG ARCH EUR J PHY, V444, P446, DOI 10.1007/s00424-002-0830-0; Kang C, 2009, COMP BIOCHEM PHYS C, V150, P85, DOI 10.1016/j.cbpc.2009.03.003; Kim E, 2006, TOXICOL LETT, V167, P205, DOI 10.1016/j.toxlet.2006.09.009; Li R, 2011, TOXICOL LETT, V201, P221, DOI 10.1016/j.toxlet.2011.01.003; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; [聂菲 NIE Fei], 2008, [第二军医大学学报, Academic Journal of Second Military Medical University], V29, P83; Noguchi K, 2005, TOXICON, V45, P519, DOI 10.1016/j.toxicon.2004.12.015; Ramasamy S, 2005, TOXICOL LETT, V155, P219, DOI 10.1016/j.toxlet.2004.09.018; Ramasamy S, 2005, TOXICOL LETT, V155, P135, DOI 10.1016/j.toxlet.2004.09.004; Ramasamy S, 2004, TOXICON, V43, P685, DOI 10.1016/j.toxicon.2004.02.024; Sakanashi M, 2002, ANAESTH INTENS CARE, V30, P570, DOI 10.1177/0310057X0203000504; Sando JJ, 2010, J CLIN NURS, V19, P109, DOI 10.1111/j.1365-2702.2009.03034.x; Suput D, 2009, TOXICON, V54, P1190, DOI 10.1016/j.toxicon.2009.03.001; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P40, DOI 10.1177/0310057X9802600105; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Wang Q, 2011, EXP TOXICOL PATHOL; Winter KL, 2007, TOXICON, V49, P804, DOI 10.1016/j.toxicon.2006.11.031; Winter KL, 2007, TOXICOL LETT, V168, P13, DOI 10.1016/j.toxlet.2006.10.011; Xiao L, 2011, MAR DRUGS, V9, P526, DOI 10.3390/md9040526; Xiao LA, 2010, TOXICOL IN VITRO, V24, P1203, DOI 10.1016/j.tiv.2010.02.009; Xiao L, 2010, TOXICON, V55, P838, DOI 10.1016/j.toxicon.2009.11.022; Xiao L, 2009, TOXICON, V53, P146, DOI 10.1016/j.toxicon.2008.10.023	37	6	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43096	10.1371/journal.pone.0043096	http://dx.doi.org/10.1371/journal.pone.0043096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905209	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600047
J	Denison, FC; Semple, SI; Stock, SJ; Walker, J; Marshall, I; Norman, JE				Denison, Fiona C.; Semple, Scott I.; Stock, Sarah J.; Walker, Jane; Marshall, Ian; Norman, Jane E.			Novel Use of Proton Magnetic Resonance Spectroscopy (1HMRS) to Non-Invasively Assess Placental Metabolism	PLOS ONE			English	Article							IN-UTERO; FOOTPRINT; APOPTOSIS; FETUSES; BIRTH	Background: Placental insufficiency is a major cause of antepartum stillbirth and fetal growth restriction (FGR). In affected pregnancies, delivery is expedited when the risks of ongoing pregnancy outweigh those of prematurity. Current tests are unable to assess placental function and determine optimal timing for delivery. An accurate, non-invasive test that clearly defines the failing placenta would address a major unmet clinical need. Proton magnetic resonance spectroscopy (H-1 MRS) can be used to assess the metabolic profile of tissue in-vivo. In FGR pregnancies, a reduction in N-acetylaspartate (NAA)/choline ratio and detection of lactate methyl are emerging as biomarkers of impaired neuronal metabolism and fetal hypoxia, respectively. However, fetal brain hypoxia is a late and sometimes fatal event in placental compromise, limiting clinical utility of brain H-1 MRS to prevent stillbirth. We hypothesised that abnormal placental H-1 MRS may be an earlier biomarker of intrauterine hypoxia, affording the opportunity to optimise timing of delivery in at-risk fetuses. Methods and Findings: We recruited three women with severe placental insufficiency/FGR and three matched controls. Using a 3T MR system and a combination of phased-array coils, a 20x20x40 mm H-1 MRS voxel was selected along the 'long-axis' of the placenta with saturation bands placed around the voxel to prevent contaminant signals. A significant choline peak (choline/lipid ratio 1.35-1.79) was detected in all healthy placentae. In contrast, in pregnancies complicated by FGR, the choline/lipid ratio was <= 0.02 in all placentae, despite preservation of the lipid peak (p<0.001). Conclusions: This novel proof-of-concept study suggests that in severe placental insufficiency/FGR, the observed 60-fold reduction in the choline/lipid ratio by H-1 MRS may represent an early biomarker of critical placental insufficiency. Further studies will determine performance of this test and the potential role of 1H-MRS in the in-vivo assessment of placental function to inform timing of delivery.	[Denison, Fiona C.; Stock, Sarah J.; Norman, Jane E.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Lothian, Scotland; [Semple, Scott I.] Univ Edinburgh, Clin Res Imaging Ctr, Queens Med Res Inst, Edinburgh, Lothian, Scotland; [Walker, Jane] Royal Edinburgh Infirm, Simpson Ctr Reprod Hlth, Edinburgh, Lothian, Scotland; [Marshall, Ian] Univ Edinburgh, Sch Clin Sci, Edinburgh, Lothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Denison, FC (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Lothian, Scotland.	Fiona.Denison@ed.ac.uk		Norman, Jane/0000-0001-6031-6953; Denison, Fiona/0000-0003-0371-2014	Tommy's; Baby Charity; Action Medical Research; Albert McKern Trust; Medical Research Council [G0701127, G1002033] Funding Source: researchfish; Action Medical Research [1811] Funding Source: researchfish; MRC [G1002033, G0701127] Funding Source: UKRI	Tommy's; Baby Charity; Action Medical Research; Albert McKern Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank Tommy's, the Baby Charity, Action Medical Research and the Albert McKern Trust for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonel HM, 2010, RADIOLOGY, V257, P810, DOI 10.1148/radiol.10092283; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Brighina E, 2009, PEDIATR NEUROL, V40, P327, DOI 10.1016/j.pediatrneurol.2008.11.001; Brunelli R, 2010, PLACENTA, V31, P1051, DOI 10.1016/j.placenta.2010.09.004; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Cetin I, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.020; Chalubinski KM, 2011, ULTRASOUND OBSTET GY; Damodaram M, 2010, PLACENTA, V31, P491, DOI 10.1016/j.placenta.2010.03.001; Derwig IE, 2011, J MAGN RESON IMAGING, V34, P1125, DOI 10.1002/jmri.22794; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Hasegawa J, 2010, J PERINAT MED, V38, P29, DOI [10.1515/JPM.2010.003, 10.1515/jpm.2010.003]; Heazell AEP, 2008, PLACENTA, V29, P691, DOI 10.1016/j.placenta.2008.05.002; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Horgan RP, 2010, PLACENTA, V31, P893, DOI 10.1016/j.placenta.2010.07.002; Kakogawa J, 2010, AM J PERINAT, V27, P463, DOI 10.1055/s-0030-1247600; Kakogawa J, 2010, AM J PERINAT, V27, P25, DOI 10.1055/s-0029-1234038; KAZZI GM, 1983, AM J OBSTET GYNECOL, V145, P733, DOI 10.1016/0002-9378(83)90582-3; Lindskog M, 2005, CANCER LETT, V228, P247, DOI 10.1016/j.canlet.2004.12.055; Loughna P, 2009, ULTRASOUND, V17, P160, DOI 10.1179/174313409X448543; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Madazli R, 2003, PLACENTA, V24, P510, DOI 10.1053/plac.2002.0945; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; Sankaran S, 2009, BEST PRACT RES CL OB, V23, P765, DOI 10.1016/j.bpobgyn.2009.05.003; Schott J, J FAM HLTH CARE, V20, P116; Sebire NJ, 2008, J CLIN PATHOL, V61, P1276, DOI 10.1136/jcp.2008.055251; Semple SIK, 2001, MAGN RESON IMAGING, V19, P921, DOI 10.1016/S0730-725X(01)00421-0; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Story L, 2011, EUR J OBSTET GYN R B, V158, P3, DOI 10.1016/j.ejogrb.2010.03.003; Teo TH, 2009, CLIN RADIOL, V64, P511, DOI 10.1016/j.crad.2009.02.003; Wright C, 2011, PLACENTA, V32, P1010, DOI 10.1016/j.placenta.2011.07.008; Yin TT, 2009, PLACENTA, V30, P726, DOI 10.1016/j.placenta.2009.05.002	35	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42926	10.1371/journal.pone.0042926	http://dx.doi.org/10.1371/journal.pone.0042926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900066	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900084
J	Hjouj, M; Last, D; Guez, D; Daniels, D; Sharabi, S; Lavee, J; Rubinsky, B; Mardor, Y				Hjouj, Mohammad; Last, David; Guez, David; Daniels, Dianne; Sharabi, Shirley; Lavee, Jacob; Rubinsky, Boris; Mardor, Yael			MRI Study on Reversible and Irreversible Electroporation Induced Blood Brain Barrier Disruption	PLOS ONE			English	Article							MAGNETIC-RESONANCE; TISSUE ABLATION; DRUG-DELIVERY; ELECTROTRANSFER; CONTRAST; CELLS	Electroporation, is known to induce cell membrane permeabilization in the reversible (RE) mode and cell death in the irreversible (IRE) mode. Using an experimental system designed to produce a continuum of IRE followed by RE around a single electrode we used MRI to study the effects of electroporation on the brain. Fifty-four rats were injected with Gd-DOTA and treated with a G25 electrode implanted 5.5 mm deep into the striata. MRI was acquired immediately after treatment, 10 min, 20 min, 30 min, and up to three weeks following the treatment using: T1W, T2W, Gradient echo (GE), serial SPGR (DCE-MRI) with flip angles ranging over 5-25 degrees, and diffusion-weighted MRI (DWMRI). Blood brain barrier (BBB) disruption was depicted as clear enhancement on T1W images. The average signal intensity in the regions of T1-enhancement, representing BBB disruption, increased from 1887 +/- 83 (arbitrary units) immediately post treatment to 2246 +/- 94 20 min post treatment, then reached a plateau towards the 30 min scan where it reached 2289 +/- 87. DWMRI at 30 min showed no significant effects. Early treatment effects and late irreversible damage were clearly depicted on T2W. The enhancing volume on T2W has increased by an average of 2.27 +/- 0.27 in the first 24-48 hours post treatment, suggesting an inflammatory tissue response. The permanent tissue damage, depicted as an enhancing region on T2W, 3 weeks post treatment, decreased to an average of 50 +/- 10% of the T2W enhancing volumes on the day of the treatment which was 33 +/- 5% of the BBB disruption volume. Permanent tissue damage was significantly smaller than the volume of BBB disruption, suggesting, that BBB disruption is associated with RE while tissue damage with IRE. These results demonstrate the feasibility of applying reversible and irreversible electroporation for transient BBB disruption or permanent damage, respectively, and applying MRI for planning/monitoring disruption volume/ shape by optimizing electrode positions and treatment parameters.	[Hjouj, Mohammad] Hebrew Univ Jerusalem, Ctr Bioengn Serv Human & Soc, Sch Comp Sci & Engn, Jerusalem, Israel; [Last, David; Guez, David; Daniels, Dianne; Sharabi, Shirley; Mardor, Yael] Chaim Sheba Med Ctr, Adv Technol Ctr, Ramat Gan, Israel; [Mardor, Yael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Lavee, Jacob] Chaim Sheba Med Ctr, Cardiol Inst, Ramat Gan, Israel; [Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Hebrew University of Jerusalem; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; University of California System; University of California Berkeley	Hjouj, M (corresponding author), Hebrew Univ Jerusalem, Ctr Bioengn Serv Human & Soc, Sch Comp Sci & Engn, Jerusalem, Israel.	yael.mardor@sheba.health.gov.il		guez, david/0000-0002-9143-2575; sharabi, shirley/0000-0002-1561-7965; Daniels, Dianne/0000-0002-0912-8719; Hjouj, Mohammad/0000-0001-8002-3488; Lavee, Jacob/0000-0002-3641-1114				Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Aung W, 2009, GENE THER, V16, P830, DOI 10.1038/gt.2009.55; Bagla S, 2012, J VASC INTERV RADIOL, V23, P142, DOI 10.1016/j.jvir.2011.10.002; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669; Bureau MF, 2010, BBA-GEN SUBJECTS, V1800, P537, DOI 10.1016/j.bbagen.2010.02.003; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Dev SB, 2002, MAGN RESON IMAGING, V20, P389, DOI 10.1016/S0730-725X(02)00517-9; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Filippi M, 1998, J NEUROL NEUROSUR PS, V64, pS88; Garcia PA, 2010, J MEMBRANE BIOL, V236, P127, DOI 10.1007/s00232-010-9284-z; Ghosh N, 2011, J MAGN RESON IMAGING, V33, P772, DOI 10.1002/jmri.22488; Hannig J, 1999, P 1 JOINT BMES EMBS; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; Hjouj M, 2011, NEUROONCOL S3, V13; Hjouj M, 2010, J MEMBRANE BIOL, V236, P137, DOI 10.1007/s00232-010-9281-2; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Leroy-Willig A, 2005, GENE THER, V12, P1434, DOI 10.1038/sj.gt.3302541; Lopez-Quintero SV, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016005; Mahmood F, 2011, J MEMBRANE BIOL, V240, P131, DOI 10.1007/s00232-011-9351-0; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001035; Mardor Y, 2005, CANCER RES, V65, P6858, DOI 10.1158/0008-5472.CAN-05-0161; Mardor Y, 2001, CANCER RES, V61, P4971; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; Mikulis DJ, 2007, J MAGN RESON IMAGING, V26, P838, DOI 10.1002/jmri.21041; Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Pakhomov AG, 2010, ADV ELECTROPORATION; Phillips MA, 2012, BRIT J CANCER, V106, P490, DOI 10.1038/bjc.2011.582; Phillips M, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001882; Rosman Y, 2012, J APPL TOXICOL, V32, P409, DOI 10.1002/jat.1715; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; RUNGE VM, 1995, TOP MAGN RESON IMAG, V7, P158; Runge VM, 1898, RADIOGRAPHICS, V9, P929; Sersa G, 1998, ELECTRO MAGNETOBIOL, V17, P299; Silva GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S4; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Sinnecker T, 2012, ARCH NEUROL; Thomson K, 2010, HUMAN EXPERIENCE IRR; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Zhang Y, 2010, RADIOLOGY, V256, P424, DOI 10.1148/radiol.10091955	48	54	85	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42817	10.1371/journal.pone.0042817	http://dx.doi.org/10.1371/journal.pone.0042817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900052	Green Published, gold			2022-12-25	WOS:000307380900070
J	Yi, ZJ; Fu, YR; Ji, R; Li, RF; Guan, ZY				Yi, Zhengjun; Fu, Yurong; Ji, Rui; Li, Ruifang; Guan, Zhiyu			Altered microRNA Signatures in Sputum of Patients with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PROTEIN EXPRESSION; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; INFECTION; DISEASE; INNATE; INDUCTION; CHILDREN; SMOKERS	Role of microRNA (miRNA) has been highlighted in pathogen-host interactions recently. At present, their role in active pulmonary tuberculosis is unknown. The aim of the study was to delineate miRNA expression in sputum supernatant of patients with active pulmonary tuberculosis. Expression of miRNAs was evaluated by microarray analysis and differentially expressed miRNAs were validated by RT-qPCR. Secreted cytokines TNF-alpha and IL-6 were measured by ELISA. We found that 95 miRNAs were differentially expressed between tuberculosis group and controls. More miRNAs (52 out of 95 miRNAs) were underexpressed than overexpressed during tuberculosis infection. Overexpression of miR-3179, miR-147 and underexpression of miR-19b-2* in TB group compared with controls were confirmed in the validation cohort. TNF-alpha and IL-6 levels were not significantly altered between TB group and controls. For the first time, differential expression of miRNAs in sputum was found in active pulmonary tuberculosis. The study provides rationale for identifying the role of miRNAs in the pathogenesis of pulmonary tuberculosis and indicates potential for miRNA-based therapeutic strategies.	[Yi, Zhengjun] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Affiliated Hosp, Dept Lab Med,Clin Fac, Weifang, Peoples R China; [Fu, Yurong; Ji, Rui; Li, Ruifang; Guan, Zhiyu] Weifang Med Univ, Dept Med Microbiol, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University	Yi, ZJ (corresponding author), Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Affiliated Hosp, Dept Lab Med,Clin Fac, Weifang, Peoples R China.	yifuyurong@163.com			National Science Foundation of China [30972639]; Project of Shandong Province Higher Educational Science and Technology Program of China [J09LF20]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shandong Province Higher Educational Science and Technology Program of China	This work was supported by the grants of National Science Foundation of China (No. 30972639) and the Project of Shandong Province Higher Educational Science and Technology Program of China (No. J09LF20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casado B, 2007, J PROTEOME RES, V6, P4615, DOI 10.1021/pr070440q; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gershman NH, 1999, J ALLERGY CLIN IMMUN, V104, P322, DOI 10.1016/S0091-6749(99)70374-X; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Ma RM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-38; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Sloane AJ, 2005, AM J RESP CRIT CARE, V172, P1416, DOI 10.1164/rccm.200409-1215OC; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thunnissen FBJM, 2003, J CLIN PATHOL, V56, P805, DOI 10.1136/jcp.56.11.805; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie Y, 2010, LUNG CANCER, V67, P170, DOI 10.1016/j.lungcan.2009.04.004; Yu L, 2010, INT J CANCER, V127, P2870, DOI 10.1002/ijc.25289; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	31	80	96	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43184	10.1371/journal.pone.0043184	http://dx.doi.org/10.1371/journal.pone.0043184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900099	Green Published, gold			2022-12-25	WOS:000307380900117
J	Petridou, NI; Stylianou, P; Christodoulou, N; Rhoads, D; Guan, JL; Skourides, PA				Petridou, Nicoletta I.; Stylianou, Panayiota; Christodoulou, Neophytos; Rhoads, Daniel; Guan, Jun-Lin; Skourides, Paris A.			Activation of Endogenous FAK via Expression of Its Amino Terminal Domain in Xenopus Embryos	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-MATRIX ADHESIONS; SMOOTH-MUSCLE-CELLS; TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; FERM DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; INTEGRIN; LAEVIS; PAXILLIN	Background: The Focal Adhesion Kinase is a well studied tyrosine kinase involved in a wide number of cellular processes including cell adhesion and migration. It has also been shown to play important roles during embryonic development and targeted disruption of the FAK gene in mice results in embryonic lethality by day 8.5. Principal Findings: Here we examined the pattern of phosphorylation of FAK during Xenopus development and found that FAK is phosphorylated on all major tyrosine residues examined from early blastula stages well before any morphogenetic movements take place. We go on to show that FRNK fails to act as a dominant negative in the context of the early embryo and that the FERM domain has a major role in determining FAK's localization at the plasma membrane. Finally, we show that autonomous expression of the FERM domain leads to the activation of endogenous FAK in a tyrosine 397 dependent fashion. Conclusions: Overall, our data suggest an important role for the FERM domain in the activation of FAK and indicate that integrin signalling plays a limited role in the in vivo activation of FAK at least during the early stages of development.	[Petridou, Nicoletta I.; Stylianou, Panayiota; Christodoulou, Neophytos; Rhoads, Daniel; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Guan, Jun-Lin] Univ Michigan Med Sch, Dept Internal Med MMG, Ann Arbor, MI USA	University of Cyprus; University of Michigan System; University of Michigan	Petridou, NI (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	skourip@ucy.ac.cy	Christodoulou, Neophytos/AAB-7645-2019	Christodoulou, Neophytos/0000-0003-4338-5847; Petridou, Nicoletta/0000-0002-8451-1195; Skourides, Paris/0000-0003-3502-5729	Cyprus Research Promotion Foundation [YGammaEIA/BIOSigma/0609(BE)/14]	Cyprus Research Promotion Foundation	Funding was provided by the Cyprus Research Promotion Foundation (Y Gamma EIA/BIO Sigma/0609(BE)/14). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chatzizacharias NA, 2010, HISTOL HISTOPATHOL, V25, P1039, DOI 10.14670/HH-25.1039; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DANKER K, 1993, MECH DEVELOP, V44, P155, DOI 10.1016/0925-4773(93)90064-5; DEMETRIOU MC, 2007, BIOCHEM BIOPH RES CO, V3, P779; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Fesenko I, 2000, MECH DEVELOP, V96, P51, DOI 10.1016/S0925-4773(00)00368-3; FEY J, 1990, DIFFERENTIATION, V42, P144, DOI 10.1111/j.1432-0436.1990.tb00755.x; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Henry CA, 2001, DEV BIOL, V240, P474, DOI 10.1006/dbio.2001.0467; HENS MD, 1995, DEV BIOL, V170, P274, DOI 10.1006/dbio.1995.1214; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; JOOS TO, 1995, MECH DEVELOP, V50, P187, DOI 10.1016/0925-4773(94)00335-K; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Marsden M, 2001, DEVELOPMENT, V128, P3635; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peng X, 2011, CURR PROTEIN PEPT SC, V12, P52, DOI 10.2174/138920311795659452; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; RAFFERTY KA, 1969, CYTOGENETICS, V8, P427; Ramos JW, 1996, DEVELOPMENT, V122, P2873; Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sarrazin S, 2011, COLD SPRING HARB PER, P3; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Stylianou P, 2009, MECH DEVELOP, V126, P828, DOI 10.1016/j.mod.2009.07.008; Sundberg LJ, 2003, J BIOL CHEM, V278, P29783, DOI 10.1074/jbc.M303771200; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; UBBELS GA, 1983, J EMBRYOL EXP MORPH, V77, P15; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WINKLBAUER R, 1995, J CELL SCI, V108, P1575; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; ZHANG XA, 1995, GENE, V160, P219, DOI 10.1016/0378-1119(95)00153-W	71	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42577	10.1371/journal.pone.0042577	http://dx.doi.org/10.1371/journal.pone.0042577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880041	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000048
J	Song, L; Zhou, Q; Duan, P; Guo, P; Li, DW; Xu, Y; Li, ST; Luo, F; Zhang, ZH				Song, Lei; Zhou, Qiang; Duan, Ping; Guo, Ping; Li, Dianwei; Xu, Yuan; Li, Songtao; Luo, Fei; Zhang, Zehua			Successful Development of Small Diameter Tissue-Engineering Vascular Vessels by Our Novel Integrally Designed Pulsatile Perfusion-Based Bioreactor	PLOS ONE			English	Article							IN-VITRO; COLLAGEN; CULTURE; SYSTEM	Small-diameter (<4 mm) vascular constructs are urgently needed for patients requiring replacement of their peripheral vessels. However, successful development of constructs remains a significant challenge. In this study, we successfully developed small-diameter vascular constructs with high patency using our integrally designed computer-controlled bioreactor system. This computer-controlled bioreactor system can confer physiological mechanical stimuli and fluid flow similar to physiological stimuli to the cultured grafts. The medium circulating system optimizes the culture conditions by maintaining fixed concentration of O-2 and CO2 in the medium flow and constant delivery of nutrients and waste metabolites, as well as eliminates the complicated replacement of culture medium in traditional vascular tissue engineering. Biochemical and mechanical assay of newly developed grafts confirm the feasibility of the bioreactor system for small-diameter vascular engineering. Furthermore, the computer-controlled bioreactor is superior for cultured cell proliferation compared with the traditional non-computer-controlled bioreactor. Specifically, our novel bioreactor system may be a potential alternative for tissue engineering of large-scale small-diameter vascular vessels for clinical use.	[Song, Lei; Zhou, Qiang; Duan, Ping; Guo, Ping; Li, Dianwei; Xu, Yuan; Li, Songtao; Luo, Fei; Zhang, Zehua] Third Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China	Army Medical University	Song, L (corresponding author), Third Mil Med Univ, Affiliated Hosp 1, Dept Orthopaed, Chongqing, Peoples R China.	zqthl@yahoo.com.cn			National High Technology Research and Development Program (863) [2006AA02Z4E3]; National Natural Science Foundation of China [81027005]	National High Technology Research and Development Program (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National High Technology Research and Development Program (863) (No. 2006AA02Z4E3) and the National Natural Science Foundation of China (No. 81027005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO J, 1994, AM J PHYSIOL, V267, pC679, DOI 10.1152/ajpcell.1994.267.3.C679; Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015; Bordenave L, 2008, EXPERT REV MED DEVIC, V5, P337, DOI 10.1586/17434440.5.3.337; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed; Crapo PM, 2011, J BIOMED MATER RES A, V96A, P673, DOI 10.1002/jbm.a.33019; EVANS BK, 1992, N-S ARCH PHARMACOL, V346, P362; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kevil CG, 2001, ACTA PHYSIOL SCAND, V173, P151, DOI 10.1046/j.1365-201X.2001.00901.x; Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45; Lohn M, 2001, J APPL PHYSIOL, V91, P1350, DOI 10.1152/jappl.2001.91.3.1350; McCulloch AD, 2004, TISSUE ENG, V10, P565, DOI 10.1089/107632704323061924; McFetridge PS, 2007, ASAIO J, V53, P623, DOI 10.1097/MAT.0b013e31812f3b7e; Miyatake SI, 1999, STROKE, V30, P2431, DOI 10.1161/01.STR.30.11.2431; Naito Y, 2012, CELLS TISSUES ORGANS, V195, P60, DOI 10.1159/000331405; Narita Y, 2004, TISSUE ENG, V10, P1224, DOI 10.1089/ten.2004.10.1224; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Niklason LE, 2002, ANN NY ACAD SCI, V961, P220, DOI 10.1111/j.1749-6632.2002.tb03089.x; Ou WF, 2011, BIOMATERIALS, V32, P3178, DOI 10.1016/j.biomaterials.2011.01.031; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222; Stock UA, 2001, TISSUE ENG, V7, P1, DOI 10.1089/107632701300003241; Tanaka Yoshio, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P257, DOI 10.2174/1568016043356273; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; Thompson CA, 2002, TISSUE ENG, V8, P1083, DOI 10.1089/107632702320934173; Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086; Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536; Xia ZY, 2003, J THORAC CARDIOV SUR, V126, P1404, DOI 10.1016/S0022-5223(03)00970-X; Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876	33	27	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42569	10.1371/journal.pone.0042569	http://dx.doi.org/10.1371/journal.pone.0042569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880036	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100132
J	Visweswaraiah, J; Lee, SJ; Hinnebusch, AG; Sattlegger, E				Visweswaraiah, Jyothsna; Lee, Su Jung; Hinnebusch, Alan G.; Sattlegger, Evelyn			Overexpression of Eukaryotic Translation Elongation Factor 3 Impairs Gcn2 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EIF-2-ALPHA KINASE GCN2; UNCHARGED TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; YEAST; INITIATION; RIBOSOMES; GENE; PHOSPHORYLATION; PURIFICATION	In eukaryotes, phosphorylation of translation initiation factor 2 alpha (eIF2 alpha) by the kinase Gcn2 (general control nonderepressible 2) is a key response to amino acid starvation. Sensing starvation requires that Gcn2 directly contacts its effector protein Gcn1, and both must contact the ribosome. We have proposed that Gcn2 is activated by uncharged tRNA bound to the ribosomal decoding (A) site, in a manner facilitated by ribosome-bound Gcn1. Protein synthesis requires cyclical association of eukaryotic elongation factors (eEFs) with the ribosome. Gcn1 and Gcn2 are large proteins, raising the question of whether translation and monitoring amino acid availability can occur on the same ribosome. Part of the ribosome-binding domain in Gcn1 has homology to one of the ribosome-binding domains in eEF3, suggesting that these proteins utilize overlapping binding sites on the ribosome and consequently cannot function simultaneously on the same ribosome. Supporting this idea, we found that eEF3 overexpression in Saccharomyces cerevisiae diminished growth on amino acid starvation medium (Gcn(-) phenotype) and decreased eIF2 alpha phosphorylation, and that the growth defect associated with constitutively active Gcn2 was diminished by eEF3 overexpression. Overexpression of the eEF3 HEAT domain, or C terminus, was sufficient to confer a Gcn(-) phenotype, and both fragments have ribosome affinity. eEF3 overexpression did not significantly affect Gcn1-ribosome association, but it exacerbated the Gcn(-) phenotype of Gcn1-M7A that has reduced ribosome affinity. Together, this suggests that eEF3 blocks Gcn1 regulatory function on the ribosome. We propose that the Gcn1-Gcn2 complex only functions on ribosomes with A-site-bound uncharged tRNA, because eEF3 does not occupy these stalled complexes.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Auckland 0745, Albany, New Zealand; [Hinnebusch, Alan G.; Sattlegger, Evelyn] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Massey University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, POB 102 904, Auckland 0745, Albany, New Zealand.	e.sattlegger@massey.ac.nz			National Institutes of Health; Marsden Fund Council Grant [MAU0607]; Massey University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsden Fund Council Grant(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Intramural Research Program (to A. G. H.). This work was also supported by Marsden Fund Council Grant MAU0607 administered by the Royal Society of New Zealand, a Massey University Technicians Award (to E. S. for supporting S. J. L.), the Massey University Research Fund (to E. S.), and a Massey University Ph.D. Scholarship (to J. V.).	Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Cashel M, 1987, ESCHERICHIA COLI SAL, P1410; CASKEY CT, 1971, P NATL ACAD SCI USA, V68, P3163, DOI 10.1073/pnas.68.12.3163; DASMAHAPATRA B, 1981, J BIOL CHEM, V256, P9999; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elskaya AV, 1997, BIOCHEMISTRY-US, V36, P10492, DOI 10.1021/bi970631e; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDMAN E, 1990, MOL MICROBIOL, V4, P2035, DOI 10.1111/j.1365-2958.1990.tb00563.x; Gontarek RR, 1998, J BIOL CHEM, V273, P10249, DOI 10.1074/jbc.273.17.10249; HANNIG EM, 1990, GENETICS, V126, P549; HILTON JL, 1965, ARCH BIOCHEM BIOPHYS, V112, P544, DOI 10.1016/0003-9861(65)90093-7; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kambampati R, 1997, J BIOL CHEM, V272, P6377, DOI 10.1074/jbc.272.10.6377; Kambampati R, 1997, PROTEIN EXPRES PURIF, V10, P209, DOI 10.1006/prep.1997.0728; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kiel MC, 2001, EUR J BIOCHEM, V268, P278, DOI 10.1046/j.1432-1327.2001.01873.x; Kiel MC, 1999, BIOCHIMIE, V81, P1097, DOI 10.1016/S0300-9084(99)00352-1; LAROSSA RA, 1984, J BIOL CHEM, V259, P8753; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; MURCHIE MJ, 1978, BIOCHIM BIOPHYS ACTA, V520, P233, DOI 10.1016/0005-2787(78)90024-2; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.212, DOI 10.1038/PROTEX.2011.212]; SIKORSKI RS, 1989, GENETICS, V122, P19; SKOGERSON L, 1976, P NATL ACAD SCI USA, V73, P73, DOI 10.1073/pnas.73.1.73; Taylor DR, 2006, STRUCTURE FUNCTION E; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Visweswaraiah J, 2011, J BIOL CHEM, V286, P36568, DOI 10.1074/jbc.M111.248898; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Zaborske JM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-29; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	40	16	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.368266	http://dx.doi.org/10.1074/jbc.M112.368266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22888004	hybrid, Green Published			2022-12-25	WOS:000310642200015
J	Kim, JC; Crary, B; Chang, YC; Kwon-Chung, KJ; Kim, KJ				Kim, Jong-Chul; Crary, Benjamin; Chang, Yun C.; Kwon-Chung, Kyung J.; Kim, Kee J.			Cryptococcus neoformans Activates RhoGTPase Proteins Followed by Protein Kinase C, Focal Adhesion Kinase, and Ezrin to Promote Traversal across the Blood-Brain Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ESCHERICHIA-COLI K1; CENTRAL-NERVOUS-SYSTEM; RHO GTPASES; INVASION; MENINGITIS; INTERNALIZATION; TRANSLOCATION; CYTOSKELETON; STRATEGIES	Cryptococcus neoformans is an opportunistic fungal pathogen that causes meningoencephalitis. Previous studies have demonstrated that Cryptococcus binding and invasion of human brain microvascular endothelial cells (HBMEC) is a prerequisite for transmigration across the blood-brain barrier. However, the molecular mechanism involved in the cryptococcal blood-brain barrier traversal is poorly understood. In this study we examined the signaling events in HBMEC during interaction with C. neoformans. Analysis with inhibitors revealed that cryptococcal association, invasion, and transmigration require host actin cytoskeleton rearrangement. Rho pulldown assays revealed that Cryptococcus induces activation of three members of RhoGTPases, e.g. RhoA, Rac1, and Cdc42, and their activations are required for cryptococcal transmigration across the HBMEC monolayer. Western blot analysis showed that Cryptococcus also induces phosphorylation of focal adhesion kinase (FAK), ezrin, and protein kinase C alpha (PKC alpha), all of which are involved in the rearrangement of host actin cytoskeleton. Down-regulation of FAK, ezrin, or PKC alpha by shRNA knockdown, dominant-negative transfection, or inhibitors significantly reduces cryptococcal ability to traverse the HBMEC monolayer, indicating their positive role in cryptococcal transmigration. In addition, activation of RhoGTPases is the upstream event for phosphorylation of FAK, ezrin, and PKC alpha during C. neoformans-HBMEC interaction. Taken together, our findings demonstrate that C. neoformans activates RhoGTPases and subsequently FAK, ezrin, and PKC alpha to promote their traversal across the HBMEC monolayer, which is the critical step for cryptococcal brain infection and development of meningitis.	[Kim, Jong-Chul; Crary, Benjamin; Kim, Kee J.] Univ Kansas, Dept Microbiol Mol Genet & Immunol, Med Ctr, Kansas City, KS 66160 USA; [Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Lab Clin Infect Dis, Mol Microbiol Sect, NIH, Bethesda, MD 20892 USA	University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kim, KJ (corresponding author), Univ Kansas, Dept Microbiol Mol Genet & Immunol, Med Ctr, Kansas City, KS 66160 USA.	kkim@kumc.edu			National Institutes of Health [P20RR016443, R01DA027729]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR016443 and R01DA027729 (to K.J.K.) and NIAID intramural grants (to Y.C.C. and K.J.K.-C.).	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Badger JL, 1999, INFECT IMMUN, V67, P4208, DOI 10.1128/IAI.67.8.4208-4215.1999; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Casadevall A, 2010, J CLIN INVEST, V120, P1389, DOI 10.1172/JCI42949; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chung JW, 2003, J BIOL CHEM, V278, P16857, DOI 10.1074/jbc.M301028200; Eugene E, 2002, J CELL SCI, V115, P1231; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Jain SK, 2006, J INFECT DIS, V193, P1287, DOI 10.1086/502631; Jarvis WD, 1999, INVEST NEW DRUG, V17, P227, DOI 10.1023/A:1006328303451; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Khan NA, 2002, J BIOL CHEM, V277, P15607, DOI 10.1074/jbc.M112224200; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kwon-Chung KJ, 2000, MED MYCOL, V38, P205, DOI 10.1080/mmy.38.s1.205.213; Maruvada R., 2012, CELL MICROB IN PRESS; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Prasadarao NV, 1999, INFECT IMMUN, V67, P5775, DOI 10.1128/IAI.67.11.5775-5783.1999; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sheen TR, 2010, J MOL MED, V88, P633, DOI 10.1007/s00109-010-0630-5; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Sukumaran SK, 2002, J BIOL CHEM, V277, P12253, DOI 10.1074/jbc.M110740200; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Voelz K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015968; Wilson SL, 1998, J INFECT DIS, V178, P1658, DOI 10.1086/314490; Wu L, 2008, ONCOGENE, V27, P1439, DOI 10.1038/sj.onc.1210770; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	50	32	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36147	36157		10.1074/jbc.M112.389676	http://dx.doi.org/10.1074/jbc.M112.389676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898813	hybrid, Green Published			2022-12-25	WOS:000310364000036
J	Mitomi, Y; Nomura, T; Kurosawa, M; Nukina, N; Furukawa, Y				Mitomi, Yasushi; Nomura, Takao; Kurosawa, Masaru; Nukina, Nobuyuki; Furukawa, Yoshiaki			Post-aggregation Oxidation of Mutant Huntingtin Controls the Interactions between Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; METHIONINE OXIDATION; IN-VITRO; PRION PROTEIN; DISEASE; MICE; MUTATION; BETA; VIVO; DYSFUNCTION	Aggregation of protein molecules is a pathological hallmark of many neurodegenerative diseases. Abnormal modifications have often been observed in the aggregated proteins, supporting the aggregation mechanism regulated by post-translational modifications on proteins. Modifications are in general assumed to occur in soluble proteins before aggregation, but actually it remains quite obscure when proteins are modified in the course of the aggregation. Here we focus upon aggregation of huntingtin (HTT), which causes a neurodegenerative disorder, Huntington disease, and we show that oxidation of a methionine residue in HTT occurs in vitro and also in vivo. Copper ions as well as added hydrogen peroxide are found to oxidize the methionine residue, but notably, this oxidative modification occurs only in the aggregated HTT but not in the soluble state. Furthermore, the methionine oxidation creates additional interactions among HTT aggregates and alters overall morphologies of the aggregates. We thus reveal that protein aggregates can be a target of oxidative modifications and propose that such a "post-aggregation" modification is a relevant factor to regulate properties of protein aggregates.	[Furukawa, Yoshiaki] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111542, 22110004, 22770162]; CREST from Japan Science and Technology Agency; Research Committee for Ataxic Diseases from MHLW; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Research Committee for Ataxic Diseases from MHLW; Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid 24111542 (to Y. F.) and 22110004 (to N. N.) for Scientific Research on Innovative Areas and Grant-in-Aid 22770162 for Young Scientists (B) (to Y. F.) and Strategic Research Program for Brain Sciences (to N. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, funds from CREST from Japan Science and Technology Agency (to N. N.), a grant-in-aid from the Research Committee for Ataxic Diseases from MHLW (to N. N.), and a grant from the Naito Foundation (to Y. F.).	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diaz-Hernandez M, 2004, J NEUROSCI, V24, P9361, DOI 10.1523/JNEUROSCI.2365-04.2004; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ding F, 2012, J MOL BIOL, V421, P548, DOI 10.1016/j.jmb.2011.12.029; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Fox JH, 2011, J BIOL CHEM, V286, P18320, DOI 10.1074/jbc.M110.199448; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MEYER RA, 1975, BIOPHYS J, V15, P191, DOI 10.1016/S0006-3495(75)85811-5; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	51	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34764	34775		10.1074/jbc.M112.387035	http://dx.doi.org/10.1074/jbc.M112.387035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891249	Green Published, hybrid			2022-12-25	WOS:000309654200076
J	Wu, DD; Li, GM; Jin, W; Li, Y; Zhang, YP				Wu, Dong-Dong; Li, Gui-Mei; Jin, Wei; Li, Yan; Zhang, Ya-Ping			Positive Selection on the Osteoarthritis-Risk and Decreased-Height Associated Variants at the GDF5 Gene in East Asians	PLOS ONE			English	Article							HUMAN GENOME; POPULATION DIFFERENTIATION; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; NATURAL-SELECTION; BODY-SIZE; MUTATION; SUSCEPTIBILITY; SNP; POLYMORPHISM	GDF5 is a member of the bone morphogenetic protein (BMP) gene family, and plays an important role in the development of the skeletal system. Variants of the gene are associated with osteoarthritis and height in some human populations. Here, we resequenced the gene in individuals from four geographically separated human populations, and found that the evolution of the promoter region deviated from neutral expectations, with the sequence evolution driven by positive selection in the East Asian population, especially the haplotypes carrying the derived alleles of 5' UTR SNPs rs143384 and rs143383. The derived alleles of rs143384 and rs143383, which are associated with a risk of osteoarthritis and decreased height, have high frequencies in non-Africans and show strong extended haplotype homozygosity and high population differentiation in East Asian. It is concluded that positive selection has driven the rapid evolution of the two osteoarthritis osteoarthritis-risk and decreased height associated variants of the human GDF5 gene, and supports the suggestion that the reduction in body size during the terminal Pleistocene and Holocene period might have been an adaptive process influenced by genetic factors.	[Wu, Dong-Dong; Li, Yan; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Li, Gui-Mei; Jin, Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Wu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Wu, Dong-Dong/AAR-5615-2020		National Natural Science Foundation of China [31061160189]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31061160189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cann HM, 2002, SCIENCE, V296, P261; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chapman K, 2008, HUM MOL GENET, V17, P1497, DOI 10.1093/hmg/ddn038; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Egli RJ, 2009, ARTHRITIS RHEUM-US, V60, P2055, DOI 10.1002/art.24616; Faiyaz-Ul-Haque M, 2002, CLIN GENET, V61, P454, DOI 10.1034/j.1399-0004.2002.610610.x; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRISANCH.AR, 1973, AM J PHYS ANTHROPOL, V39, P255, DOI 10.1002/ajpa.1330390216; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Hawks J, 2011, ARXIV11025604V1; He F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002948; KIMURA M, 1973, GENETICS, V75, P199; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LEPPALUOTO J, 1991, ARCTIC, V44, P139; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; NEI M, 1995, P NATL ACAD SCI USA, V92, P6720, DOI 10.1073/pnas.92.15.6720; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P361; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stini WA, 1975, PHYSL MORPHOLOGICAL, P387; TAJIMA F, 1989, GENETICS, V123, P585; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wu DD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-16; Wu DD, 2010, HUM MOL GENET, V19, P2341, DOI 10.1093/hmg/ddq107; Wu DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010959; Wu DD, 2008, CHINESE SCI BULL, V53, P1457, DOI 10.1007/s11434-008-0202-z; Yang W, 2008, J HUM GENET, V53, P368, DOI 10.1007/s10038-008-0253-7	46	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42553	10.1371/journal.pone.0042553	http://dx.doi.org/10.1371/journal.pone.0042553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905146	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800015
J	Ott, IM; Alter, ML; von Websky, K; Kretschmer, A; Tsuprykov, O; Sharkovska, Y; Krause-Relle, K; Raila, J; Henze, A; Stasch, JP; Hocher, B				Ott, Ina M.; Alter, Markus L.; von Websky, Karoline; Kretschmer, Axel; Tsuprykov, Oleg; Sharkovska, Yuliya; Krause-Relle, Katharina; Raila, Jens; Henze, Andrea; Stasch, Johannes-Peter; Hocher, Berthold			Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ANTI-THY1 GLOMERULONEPHRITIS; CARDIOVASCULAR-DISEASE; GLOMERULAR-LESIONS; GENE POLYMORPHISM; HYPERTENSIVE-RATS; TELMISARTAN; FIBROSIS; RISK	The prevalence of diabetes mellitus and its complications, such as diabetic nephropathy (DN), is rising worldwide and prevention and treatment are therefore becoming increasingly important. Therapy of DN is particularly important for patients who do not adequately respond to angiotensin receptor blocker (ARB) treatment. Novel approaches include the stimulation of soluble guanylate cyclase (sGC) as it is reported to have beneficial effects on cardiac and renal damage. We aimed to investigate the effects of the sGC stimulator riociguat and ARB telmisartan on kidney function and structure in a hypertensive model of diabetic nephropathy. Seventy-six diabetic male eNOS knockout C57BL/6J mice were randomly divided after having received streptozotocin: telmisartan (1 mg/kg/d), riociguat (3 mg/kg/d), riociguat+telmisartan (3+1 mg/kg/d), and vehicle. Fourteen mice were used as non-diabetic controls. Treatment duration was 11 weeks. Glucose concentrations were increased and similar in all diabetic groups. Telmisartan insignificantly reduced blood pressure by 5.9 mmHg compared with diabetic controls (111.2 +/- 2.3 mmHg vs. 117.1 +/- 2.2 mmHg; p = 0.071). Treatment with riociguat both alone and in combination with telmisartan led to a significant reduction of blood pressure towards diabetic vehicle (105.2 +/- 2.5 mmHg and 105.0 +/- 3.2 mmHg, respectively, vs. 117.1 +/- 2.2 mmHg). Combined treatment also significantly decreased albuminuria compared with diabetic controls (47.3 +/- 9.6 mu g/24 h vs. 170.8 +/- 34.2 mu g/24 h; p = 0.002) reaching levels similar to those of non-diabetic controls (34.4 +/- 10.6 mu g/24 h), whereas the reduction by single treatment with either telmisartan (97.8 +/- 26.4 mu g/24 h) or riociguat (97.1 +/- 15.7 mu g/24 h) was not statistically significant. The combination treatment led to a significant (p < 0.01) decrease of tissue immunoreactivity of malondialdehyde, as consequence of reduced oxidative stress. In conclusion, stimulation of sGC significantly reduced urinary albumin excretion in diabetic eNOS knockout mice treated already with ARB. Thus, this new drug class on top of standard ARBs administration may offer a new therapeutic approach for patients resistant to ARB treatment.	[Ott, Ina M.; von Websky, Karoline; Tsuprykov, Oleg; Krause-Relle, Katharina; Raila, Jens; Henze, Andrea; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Ott, Ina M.; Alter, Markus L.; von Websky, Karoline; Tsuprykov, Oleg; Sharkovska, Yuliya; Krause-Relle, Katharina; Hocher, Berthold] Charite Campus Mitte, Cardiovasc Res Ctr, Berlin, Germany; [Alter, Markus L.] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Inst Pharm, Halle, Saale, Germany; [Kretschmer, Axel; Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany	University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Bayer AG; Bayer Healthcare Pharmaceuticals	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.	hocher@uni-potsdam.de	Henze, Andrea/A-9176-2019; Henze, Andrea/G-7214-2016; Hocher, Berthold/AAC-3510-2020	Henze, Andrea/0000-0002-5708-2989; Henze, Andrea/0000-0002-5708-2989; Hocher, Berthold/0000-0001-8143-0579	Bayer HealthCare AG, Wuppertal, Germany; Dr. Werner Jackstadt- Stiftung	Bayer HealthCare AG, Wuppertal, Germany(Bayer AGBayer Healthcare Pharmaceuticals); Dr. Werner Jackstadt- Stiftung	This study was supported by Bayer HealthCare AG, Wuppertal, Germany (http://www.wuppertal.bayer.de/). The work of Dr. Alter was supported by a grant from the Dr. Werner Jackstadt- Stiftung (http://www.jackstaedt-stiftung.de/). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Bayer HealthCare AG, Wuppertal, Germany, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Dr. Stasch and Dr. Kretschmer are employees of Bayer HealthCare AG, Wuppertal, Germany (http://www.wuppertal.bayer.de/). Bayer HealthCare AG holds the patent of riociguat (patent number: PIXXD2 WO 2003/095451). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. No further conflicts of interest.	Alexopoulos E, 2000, NEPHROL DIAL TRANSPL, V15, P1348, DOI 10.1093/ndt/15.9.1348; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Benz K, 2007, KIDNEY BLOOD PRESS R, V30, P224, DOI 10.1159/000104091; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen S, 2001, RENAL FAILURE, V23, P471, DOI 10.1081/JDI-100104730; Clausell N, 1999, CARDIOVASC PATHOL, V8, P145, DOI 10.1016/S1054-8807(98)00033-7; Conlon PJ, 1996, CLIN NEPHROL, V46, P170; Van Wijngaarden RAFD, 2006, J AM SOC NEPHROL, V17, P2264, DOI 10.1681/ASN.2005080870; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Ezzidi I, 2008, J DIABETES COMPLICAT, V22, P331, DOI 10.1016/j.jdiacomp.2007.11.011; Futrakul N, 2006, CLIN HEMORHEOL MICRO, V34, P373; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Gray SP, 2011, NAT REV NEPHROL, V7, P71, DOI 10.1038/nrneph.2010.176; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hocher B, 2000, J HYPERTENS, V18, P1807, DOI 10.1097/00004872-200018120-00015; Hohenstein B, 2005, AM J PHYSIOL-RENAL, V288, pF685, DOI 10.1152/ajprenal.00280.2004; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Jones ES, 2009, BMC PHARM S1, pP29; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kosugi T, 2010, AM J PATHOL, V176, P619, DOI 10.2353/ajpath.2010.090578; Ladeia AM, 2005, DIABETES CARE, V28, P2048, DOI 10.2337/diacare.28.8.2048; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Masuyama H, 2006, HYPERTENSION, V48, P972, DOI 10.1161/01.HYP.0000241087.12492.47; Masuyama H, 2009, HYPERTENS RES, V32, P597, DOI 10.1038/hr.2009.64; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Onozato ML, 2002, KIDNEY INT, V61, P186, DOI 10.1046/j.1523-1755.2002.00123.x; Peters H, 2004, KIDNEY INT, V66, P2224, DOI 10.1111/j.1523-1755.2004.66012.x; Peters H, 2003, KIDNEY INT, V64, P509, DOI 10.1046/j.1523-1755.2003.00112.x; Ritz E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-60; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schmieder RE, 2007, DIABETES CARE, V30, P1351, DOI 10.2337/dc06-1551; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Suzuki D, 1999, J AM SOC NEPHROL, V10, P822; Tomson C, 2007, NEPHROL DIAL TRANSPL, V22, P58, DOI 10.1093/ndt/gfm330; Tsukada T, 1998, BIOCHEM BIOPH RES CO, V245, P190, DOI 10.1006/bbrc.1998.8267; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Wang YR, 2005, KIDNEY INT, V68, P47, DOI 10.1111/j.1523-1755.2005.00380.x; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zanchi A, 2000, KIDNEY INT, V57, P405, DOI 10.1046/j.1523-1755.2000.00860.x; Zanfolin M, 2006, J CARDIOVASC PHARM, V47, P391; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	57	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42623	10.1371/journal.pone.0042623	http://dx.doi.org/10.1371/journal.pone.0042623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900035	Green Published, gold			2022-12-25	WOS:000307380900051
J	Cattaneo, ER; Pellon-Maison, M; Rabassa, ME; Lacunza, E; Coleman, RA; Gonzalez-Baro, MR				Cattaneo, Elizabeth R.; Pellon-Maison, Magali; Rabassa, Martin E.; Lacunza, Ezequiel; Coleman, Rosalind A.; Gonzalez-Baro, Maria R.			Glycerol-3-Phosphate Acyltransferase-2 Is Expressed in Spermatic Germ Cells and Incorporates Arachidonic Acid into Triacylglycerols	PLOS ONE			English	Article							SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; HORMONAL-REGULATION; FATTY-ACIDS; IDENTIFICATION; APOPTOSIS; CLONING; ENZYME; PHOSPHOLIPIDS; BIOSYNTHESIS	Background: De novo glycerolipid synthesis begins with the acylation of glycerol-3 phosphate catalyzed by glycerol-3-phosphate acyltransferase (GPAT). In mammals, at least four GPAT isoforms have been described, differing in their cell and tissue locations and sensitivity to sulfhydryl reagents. In this work we show that mitochondrial GPAT2 overexpression in CHO-K1 cells increased TAG content and both GPAT and AGPAT activities 2-fold with arachidonoyl-CoA as a substrate, indicating specificity for this fatty acid. Methods and Results: Incubation of GPAT2-transfected CHO-K1 cells with [1-C-14] arachidonate for 3 h increased incorporation of [C-14] arachidonate into TAG by 40%. Consistently, arachidonic acid was present in the TAG fraction of cells that overexpressed GPAT2, but not in control cells, corroborating GPAT2's role in synthesizing TAG that is rich in arachidonic acid. In rat and mouse testis, Gpat2 mRNA was expressed only in primary spermatocytes; the protein was also detected in late stages of spermatogenesis. During rat sexual maturation, both the testicular TAG content and the arachidonic acid content in the TAG fraction peaked at 30 d, matching the highest expression of Gpat2 mRNA and protein. Conclusions: These results strongly suggest that GPAT2 expression is linked to arachidonoyl-CoA incorporation into TAG in spermatogenic germ cells.	[Cattaneo, Elizabeth R.; Pellon-Maison, Magali; Gonzalez-Baro, Maria R.] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Rabassa, Martin E.; Lacunza, Ezequiel] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, Fac Ciencias Med, La Plata, Buenos Aires, Argentina; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; University of North Carolina; University of North Carolina Chapel Hill	Cattaneo, ER (corresponding author), Univ Nacl La Plata, Inst Invest Bioquim La Plata, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Med, La Plata, Buenos Aires, Argentina.	mgbaro@med.unlp.edu.ar	Rabassa, Martín/AAI-3447-2020	Rabassa, Martin Enrique/0000-0001-7195-2891; Pellon-Maison, Magali/0000-0002-7981-5258	National Institutes of Health [TW8698, DK56598]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; CONICET, Argentina [PIP0527]; ANPCyT, Argentina [PICT2246]; UNLP, Argentina [M137]; FOGARTY INTERNATIONAL CENTER [R03TW008698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT); UNLP, Argentina(National University of La Plata); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants TW8698 and DK56598, Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET PIP0527, ANPCyT PICT2246 and UNLP M137, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Bhat BG, 1999, BBA-MOL CELL BIOL L, V1439, P415, DOI 10.1016/S1388-1981(99)00103-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Fonteh AN, 2001, J BIOL CHEM, V276, P1439, DOI 10.1074/jbc.M006551200; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Lewin TM, 2004, J BIOL CHEM, V279, P13488, DOI 10.1074/jbc.M314032200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marty MS, 2003, BIRTH DEFECTS RES B, V68, P125, DOI 10.1002/bdrb.10015; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Pellon-Maison M, 2009, LIPIDS, V44, P337, DOI 10.1007/s11745-008-3275-1; Pellon-Maison M, 2006, ARCH BIOCHEM BIOPHYS, V450, P157, DOI 10.1016/j.abb.2006.03.009; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Qiu QM, 2009, ACTA BIOCH BIOPH SIN, V41, P668, DOI 10.1093/abbs/gmp055; Sambrook J, 2001, MOL CLONING LAB MANU; SCHLOSSMAN DM, 1977, ARCH BIOCHEM BIOPHYS, V182, P732, DOI 10.1016/0003-9861(77)90555-0; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Sukumaran S, 2009, J MOL ENDOCRINOL, V42, P469, DOI 10.1677/JME-09-0010; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wolf Leslie A., 1999, Cell Biochemistry and Biophysics, V30, P353, DOI 10.1007/BF02738119; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111	34	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42986	10.1371/journal.pone.0042986	http://dx.doi.org/10.1371/journal.pone.0042986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905194	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100079
J	Li, JC; Foighil, DO; Middelfart, P				Li, Jingchun; Foighil, Diarmaid O.; Middelfart, Peter			The Evolutionary Ecology of Biotic Association in a Megadiverse Bivalve Superfamily: Sponsorship Required for Permanent Residency in Sediment	PLOS ONE			English	Article							MYSELLA-CHARCOTI LAMY; CLAM MYA-ARENARIA; RED QUEEN; MACOMA-BALTHICA; BURYING DEPTH; SPECIES-DIVERSITY; PANOPEA-ABRUPTA; CHESAPEAKE BAY; FOSSIL RECORD; COURT JESTER	Background: Marine lineage diversification is shaped by the interaction of biotic and abiotic factors but our understanding of their relative roles is underdeveloped. The megadiverse bivalve superfamily Galeommatoidea represents a promising study system to address this issue. It is composed of small-bodied clams that are either free-living or have commensal associations with invertebrate hosts. To test if the evolution of this lifestyle dichotomy is correlated with specific ecologies, we have performed a statistical analysis on the lifestyle and habitat preference of 121 species based on 90 source documents. Methodology/Principal Findings: Galeommatoidea has significant diversity in the two primary benthic habitats: hard- and soft-bottoms. Hard-bottom dwellers are overwhelmingly free-living, typically hidden within crevices of rocks/coral heads/encrusting epifauna. In contrast, species in soft-bottom habitats are almost exclusively infaunal commensals. These infaunal biotic associations may involve direct attachment to a host, or clustering around its tube/burrow, but all commensals locate within the oxygenated sediment envelope produced by the host's bioturbation. Conclusions/Significance: The formation of commensal associations by galeommatoidean clams is robustly correlated with an abiotic environmental setting: living in sediments (P<0.001). Sediment-dwelling bivalves are exposed to intense predation pressure that drops markedly with depth of burial. Commensal galeommatoideans routinely attain depth refuges many times their body lengths, independent of siphonal investment, by virtue of their host's burrowing and bioturbation. In effect, they use their much larger hosts as giant auto-irrigating siphon substitutes. The evolution of biotic associations with infaunal bioturbating hosts may have been a prerequisite for the diversification of Galeommatoidea in sediments and has likely been a key factor in the success of this exceptionally diverse bivalve superfamily.	[Li, Jingchun; Foighil, Diarmaid O.] Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Middelfart, Peter] Australian Museum, Sydney, NSW 2000, Australia	University of Michigan System; University of Michigan; Australian Museum	Li, JC (corresponding author), Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jingchun@umich.edu		Li, Jingchun/0000-0001-7947-0950	Malacological Society of Australasia Molluscan Research Grant; National Science Foundation OCE award [0850625]	Malacological Society of Australasia Molluscan Research Grant; National Science Foundation OCE award	This study is supported by the Malacological Society of Australasia Molluscan Research Grant to JL and National Science Foundation OCE award 0850625 to DOF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aberhan M, 2006, PALEOBIOLOGY, V32, P259, DOI 10.1666/05028.1; Alejandrino A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-164; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Anker A, 2005, ZOOL STUD, V44, P157; Barber PH, 2009, J BIOGEOGR, V36, P1845, DOI 10.1111/j.1365-2699.2009.02198.x; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bertics VJ, 2010, MAR ECOL PROG SER, V409, P1, DOI 10.3354/meps08639; BLUNDON JA, 1982, J EXP MAR BIOL ECOL, V65, P67, DOI 10.1016/0022-0981(82)90176-9; Bottjer D.J., 2000, GSA TODAY, V10, P1; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; Bourne G, 1906, CEYLON PEARL OYSTER, P212; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Buschbaum C, 2009, HELGOLAND MAR RES, V63, P47, DOI 10.1007/s10152-008-0139-2; Campbell A, 2004, J SHELLFISH RES, V23, P661; Carpenter SM, 2005, NAUTILUS, V119, P105; Cledon M, 2010, MAR BIOL, V157, P737, DOI 10.1007/s00227-009-1357-0; Coan E. V., 2000, BIVALVE SEASHELLS W; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Cotton BC, 1938, VICTORIAN NAT, V55, P58; Cowles A, 2009, MAR ECOL PROG SER, V384, P175, DOI 10.3354/meps08038; Danovaro R, 2002, MAR ECOL PROG SER, V230, P159, DOI 10.3354/meps230159; de Goeij P, 2001, OECOLOGIA, V126, P500, DOI 10.1007/s004420000526; Domaneschi O, 2002, POLAR BIOL, V25, P538, DOI 10.1007/s00300-002-0379-6; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GAGE J, 1968, CAN J ZOOLOG, V46, P877, DOI 10.1139/z68-124; GAGE J, 1966, J MAR BIOL ASSOC UK, V46, P71, DOI 10.1017/S0025315400017550; GAGE JD, 1979, J MAR BIOL ASSOC UK, V59, P635, DOI 10.1017/S0025315400045653; GALLAGHER ED, 1983, ECOLOGY, V64, P1200, DOI 10.2307/1937829; Huber M., 2010, COMPENDIUM BIVALVES; Hultgren KM, 2010, MAR ECOL PROG SER, V407, P1, DOI 10.3354/meps08609; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Jespersen A, 2004, ZOOL ANZ, V243, P3, DOI 10.1016/j.jcz.2004.04.001; Jespersen A, 2006, ZOOMORPHOLOGY, V125, P157, DOI 10.1007/s00435-006-0020-2; Jespersen A, 2009, ACTA ZOOL-STOCKHOLM, V90, P51, DOI 10.1111/j.1463-6395.2008.00332.x; JONES NS, 1950, BIOL REV, V25, P283, DOI 10.1111/j.1469-185X.1950.tb01587.x; Judd W, 1971, J MOLLUS STUD, V39, P343; KAMERMANS P, 1994, J EXP MAR BIOL ECOL, V175, P59, DOI 10.1016/0022-0981(94)90176-7; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kelsey FW, 1902, NAUTILUS, V15, P144; Kerr G, 1998, MAR FRESHWATER RES, V49, P801, DOI 10.1071/MF97093; Kosnik MA, 2011, PALEOBIOLOGY, V37, P303, DOI 10.1666/10022.1; KRANTZBERG G, 1985, ENVIRON POLLUT A, V39, P99, DOI 10.1016/0143-1471(85)90009-1; Lanterbecq D, 2010, MOL PHYLOGENET EVOL, V54, P357, DOI 10.1016/j.ympev.2009.08.011; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lutzen J, 2005, ZOOL J LINN SOC-LOND, V144, P261, DOI 10.1111/j.1096-3642.2005.00168.x; Lutzen J, 2001, J ZOOL, V254, P429, DOI 10.1017/S0952836901000929; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; McInnes L, 2011, BIOL LETT; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; MIKKELSEN PM, 1992, MALACOLOGIA, V34, P1; MORTON B, 1989, Asian Marine Biology, V6, P129; MORTON B, 1973, J ZOOL, V170, P463; MORTON JE, 1960, J MAR BIOL ASSOC UK, V39, P5, DOI 10.1017/S0025315400013060; Nicell L, 1995, J NAT HIST, V29, P871; O'Foighil D, 1985, VELIGER, V27, P72; O'Foighil D, 1988, VELIGER, V31, P205; OCKELMANN KW, 1978, OPHELIA, V17, P1; Oliver PG, 2006, ZOOL J LINN SOC-LOND, V148, P237, DOI 10.1111/j.1096-3642.2006.00256.x; Oliver PG, 2011, J CONCHOL, V40, P365; Oliver PG, 1993, P 5 INT MAR BIOL WOR, P634; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Passos FD, 2006, POLAR BIOL, V29, P389, DOI 10.1007/s00300-005-0068-3; Passos FD, 2005, POLAR BIOL, V28, P372, DOI 10.1007/s00300-004-0702-5; Paulay Gustav, 2003, Micronesica, V35-36, P218; Pillay D, 2011, OCEANOGR MAR BIOL, V49, P137; Pillay D, 2010, MAR ECOL PROG SER, V409, P301, DOI 10.3354/meps08628; Ponder W.F., 1998, FAUNA AUSTR MOLLUSCA, P316; PONDER WF, 1965, T ROY SOC NZ ZOOL, V6, P75; Prevedelli D, 2001, J MAR BIOL ASSOC UK, V81, P897, DOI 10.1017/S0025315401004817; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; RUSS GR, 1980, J EXP MAR BIOL ECOL, V42, P55, DOI 10.1016/0022-0981(80)90166-5; SEILACHER A, 1984, PALAEONTOLOGY, V27, P207; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; SENDALL KA, 1995, CAN J ZOOL, V73, P509, DOI 10.1139/z95-058; Smith TE, 1999, J EXP MAR BIOL ECOL, V238, P185, DOI 10.1016/S0022-0981(98)00157-9; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Vadopalas B, 2010, MALACOLOGIA, V52, P169, DOI 10.4002/040.052.0111; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Vermeij GJ, 2008, PALAEOGEOGR PALAEOCL, V263, P3, DOI 10.1016/j.palaeo.2008.01.023; VIRNSTEIN RW, 1977, ECOLOGY, V58, P1199, DOI 10.2307/1935076; WEAR RG, 1966, BIOL BULL, V130, P141, DOI 10.2307/1539960; Whitlow WL, 2003, BIOL INVASIONS, V5, P23, DOI 10.1023/A:1024059025890; Zaklan SD, 1997, J EXP MAR BIOL ECOL, V215, P1, DOI 10.1016/S0022-0981(97)00021-X; ZWARTS L, 1989, MAR BIOL, V100, P227, DOI 10.1007/BF00391963; ZWARTS L, 1994, J EXP MAR BIOL ECOL, V183, P193, DOI 10.1016/0022-0981(94)90087-6	91	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42121	10.1371/journal.pone.0042121	http://dx.doi.org/10.1371/journal.pone.0042121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905116	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100026
J	Schlecht, U; St Onge, RP; Walther, T; Francois, JM; Davis, RW				Schlecht, Ulrich; St Onge, Robert P.; Walther, Thomas; Francois, Jean-Marie; Davis, Ronald W.			Cationic Amphiphilic Drugs Are Potent Inhibitors of Yeast Sporulation	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASES; TRANSCRIPTIONAL REGULATION; DELETION STRAINS; BUDDING YEAST; MEIOSIS; AUTOPHAGY; GENES; RECOMBINATION	Meiosis is a highly regulated developmental process that occurs in all eukaryotes that engage in sexual reproduction. Previous epidemiological work shows that male and female infertility is rising and environmental factors, including pollutants such as organic solvents, are thought to play a role in this phenomenon. To better understand how organic compounds interfere with meiotic development, the model organism Saccharomyces cerevisiae was exposed to 446 bioactive molecules while undergoing meiotic development, and sporulation efficiency was quantified employing two different high-throughput assays. 12 chemicals were identified that strongly inhibited spore formation but did not interfere with vegetative growth. Many of these chemicals are known to bind to monoamine-receptors in higher eukaryotes and are cationic amphiphilic drugs. A detailed analysis of one of these drugs, tripelennamine, revealed that it induces sporulation-specific cytotoxicity and a strong inhibition of meiotic M phase. The drug, however, only mildly interfered with pre-meiotic DNA synthesis and the early meiotic transcriptional program. Chemical-genomic screening identified genes involved in autophagy as hypersensitive to tripelennamine. In addition, we found that growing and sporulating yeast cells heterozygous for the aminophospholipid translocase, NEO1, are haploinsufficient in the presence of the drug.	[Schlecht, Ulrich; St Onge, Robert P.; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Walther, Thomas; Francois, Jean-Marie] Univ Toulouse, Lab Ingn Syst Biol & Proc, Toulouse, France	Stanford University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Schlecht, U (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	ulrich.schlecht@stanford.edu		Francois, Jean marie/0000-0001-9884-5535	Swiss National Foundation grant [PBBSA-118661]	Swiss National Foundation grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation grant no. PBBSA-118661 to US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; BETZ H, 1976, EUR J BIOCHEM, V70, P385, DOI 10.1111/j.1432-1033.1976.tb11028.x; Brachmann CB, 1998, YEAST, V14, P115; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; ESPOSITO RE, 1974, P NATL ACAD SCI USA, V71, P3172, DOI 10.1073/pnas.71.8.3172; Esposito RE, 2006, MEIOSIS SPORE DEV, P157; FAN QQ, 1995, MOL CELL BIOL, V15, P1679; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLAUMANN H, 1987, EXP MOL PATHOL, V47, P346, DOI 10.1016/0014-4800(87)90018-9; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Groussac E, 2000, ENZYME MICROB TECH, V26, P715, DOI 10.1016/S0141-0229(00)00163-0; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Mendola Pauline, 2008, Fertil Steril, V89, pe81, DOI 10.1016/j.fertnstert.2007.12.036; MILLER JJ, 1963, CAN J MICROBIOL, V9, P259, DOI 10.1139/m63-032; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Piekarska I, 2010, EUR J CELL BIOL, V89, P780, DOI 10.1016/j.ejcb.2010.06.009; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rose MD., 1990, METHODS YEAST GENETI; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447; Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; SORA S, 1983, MUTAT RES, V107, P249, DOI 10.1016/0027-5107(83)90167-7; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tenreiro S, 2000, YEAST, V16, P1469, DOI 10.1002/1097-0061(200012)16:16&lt;1469::AID-YEA640&gt;3.0.CO;2-A; Thonneau P, 1998, HUM REPROD, V13, P2122, DOI 10.1093/humrep/13.8.2122; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vershon AK, 2000, CURR OPIN CELL BIOL, V12, P334, DOI 10.1016/S0955-0674(00)00104-6; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004	60	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42853	10.1371/journal.pone.0042853	http://dx.doi.org/10.1371/journal.pone.0042853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905177	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100069
J	Arnan, X; Molowny-Horas, R; Rodrigo, A; Retana, J				Arnan, Xavier; Molowny-Horas, Roberto; Rodrigo, Anselm; Retana, Javier			Uncoupling the Effects of Seed Predation and Seed Dispersal by Granivorous Ants on Plant Population Dynamics	PLOS ONE			English	Article							HARVESTING ANTS; FORAGING BEHAVIOR; RECRUITMENT; SELECTION; PATTERNS; FRUIT; PROTECTION; RESOURCES; EVOLUTION; COMMUNITY	Secondary seed dispersal is an important plant-animal interaction, which is central to understanding plant population and community dynamics. Very little information is still available on the effects of dispersal on plant demography and, particularly, for ant-seed dispersal interactions. As many other interactions, seed dispersal by animals involves costs (seed predation) and benefits (seed dispersal), the balance of which determines the outcome of the interaction. Separate quantification of each of them is essential in order to understand the effects of this interaction. To address this issue, we have successfully separated and analyzed the costs and benefits of seed dispersal by seed-harvesting ants on the plant population dynamics of three shrub species with different traits. To that aim a stochastic, spatially-explicit individually-based simulation model has been implemented based on actual data sets. The results from our simulation model agree with theoretical models of plant response dependent on seed dispersal, for one plant species, and ant-mediated seed predation, for another one. In these cases, model predictions were close to the observed values at field. Nonetheless, these ecological processes did not affect in anyway a third species, for which the model predictions were far from the observed values. This indicates that the balance between costs and benefits associated to secondary seed dispersal is clearly related to specific traits. This study is one of the first works that analyze tradeoffs of secondary seed dispersal on plant population dynamics, by disentangling the effects of related costs and benefits. We suggest analyzing the effects of interactions on population dynamics as opposed to merely analyzing the partners and their interaction strength.	[Arnan, Xavier; Molowny-Horas, Roberto; Rodrigo, Anselm; Retana, Javier] Univ Autonoma Barcelona, Fac Biociencies, CREAF, Bellaterra, Catalonia, Spain; [Rodrigo, Anselm; Retana, Javier] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Anim Biol Vegetal & Ecol, Unitat Ecol, Bellaterra, Catalonia, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Arnan, X (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, CREAF, Bellaterra, Catalonia, Spain.	x.arnan@creaf.uab.es	Rodrigo, Anselm/AAH-1553-2022; Arnan, Xavier/N-7829-2013; Molowny-Horas, Roberto/D-1171-2014; Rodrigo, Anselm/AFL-9450-2022; Retana, Javier/L-1214-2014	Arnan, Xavier/0000-0002-9904-274X; Molowny-Horas, Roberto/0000-0003-2626-6379; Retana, Javier/0000-0002-7505-9467; Rodrigo, Anselm/0000-0001-6341-0363	CICYT project [REN2001-2500/GLO]; CONSOLIDER INGENIO project [CSD 2008-0040]	CICYT project(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); CONSOLIDER INGENIO project(Spanish Government)	This research was partly funded by CICYT project REN2001-2500/GLO and by the CONSOLIDER INGENIO project CSD 2008-0040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSEN AN, 1989, OECOLOGIA, V81, P310, DOI 10.1007/BF00377076; Arnan X, 2010, INSECT SOC, V57, P421, DOI 10.1007/s00040-010-0100-7; Arnan X, 2010, PLANT BIOLOGY, V12, P842, DOI 10.1111/j.1438-8677.2009.00294.x; Arnan X, 2007, ECOGRAPHY, V30, P161, DOI [10.1111/j.2006.0906-7590.04796.x, 10.1111/j.0906-7590.2007.04796.x]; Arnan X, 2011, OECOLOGIA, V167, P1027, DOI 10.1007/s00442-011-2034-9; Azcarate FM, 2005, FUNCT ECOL, V19, P273, DOI 10.1111/j.0269-8463.2005.00956.x; BEATTIE AJ, 1981, ECOLOGY, V62, P107, DOI 10.2307/1936674; Bernard F., 1968, FOURMIS HYMENOPTERA; Bernard F., 1983, FOURMIS LEUR MILIEU; Boulay R, 2007, P ROY SOC B-BIOL SCI, V274, P2515, DOI 10.1098/rspb.2007.0594; Brodie JF, 2009, ECOLOGY, V90, P688, DOI 10.1890/08-0111.1; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2001, AM ZOOL, V41, P825, DOI 10.1668/0003-1569(2001)041[0825:TCOM]2.0.CO;2; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Brown MJF, 1997, OECOLOGIA, V112, P237, DOI 10.1007/s004420050306; CERDA X, 1994, J APPL ENTOMOL, V117, P268, DOI 10.1111/j.1439-0418.1994.tb00735.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; CRIST TO, 1992, ECOLOGY, V73, P1768, DOI 10.2307/1940028; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; de Bolos O., 1993, FLORA MANUAL PAISOS; Dixon PM, 2002, ENCY ENVIRONMETRICS; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fehmi JS, 2001, J VEG SCI, V12, P467, DOI 10.2307/3236998; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Godinez-Alvarez H., 2007, Seed dispersal: theory and its application in a changing world, P391, DOI 10.1079/9781845931650.0391; Holland J.N., 2008, ENCY ECOLOGY 5 VOLUM, P2485, DOI DOI 10.1016/B978-008045405-4.00673-X; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Howe HF, 2004, BIOSCIENCE, V54, P651, DOI 10.1641/0006-3568(2004)054[0651:WSDM]2.0.CO;2; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; Jordano Pedro, 2002, P305, DOI 10.1079/9780851995250.0305; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; Liu JG, 1998, ECOL MODEL, V106, P177, DOI 10.1016/S0304-3800(97)00191-9; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; Manzaneda AJ, 2009, J EVOLUTION BIOL, V22, P1407, DOI 10.1111/j.1420-9101.2009.01752.x; Manzaneda AJ, 2007, BIOL J LINN SOC, V92, P135, DOI 10.1111/j.1095-8312.2007.00831.x; Mladenoff D. J., 1999, Spatial modeling of forest landscape change: approaches and applications. Papers presented at a symposium in Albuquerque, New Mexico, USA, 1977., P1; Ness JH, 2004, ECOLOGY, V85, P1244, DOI 10.1890/03-0364; Ordonez JL, 2006, ECOL MODEL, V197, P405, DOI 10.1016/j.ecolmodel.2006.03.027; PONS X., 2000, MIRAMON SISTEMA INFO; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Retana J, 2004, OIKOS, V105, P377, DOI 10.1111/j.0030-1299.2004.12854.x; Rey PJ, 2007, J ECOL, V95, P1381, DOI 10.1111/j.1365-2745.2007.01293.x; Rodriguez-Perez J, 2011, OECOLOGIA, V167, P97, DOI 10.1007/s00442-011-1964-6; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Stoyan D, 2000, STAT SCI, V15, P61; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Veech JA, 2001, BEHAV ECOL, V12, P467, DOI 10.1093/beheco/12.4.467; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zwolak R, 2012, OIKOS, V121, P20, DOI 10.1111/j.1600-0706.2011.19849.x	52	21	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42869	10.1371/journal.pone.0042869	http://dx.doi.org/10.1371/journal.pone.0042869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880125	gold, Green Published, Green Submitted			2022-12-25	WOS:000307437900056
J	Roier, S; Leitner, DR; Iwashkiw, J; Schild-Prufert, K; Feldman, MF; Krohne, G; Reidl, J; Schild, S				Roier, Sandro; Leitner, Deborah R.; Iwashkiw, Jeremy; Schild-Pruefert, Kristina; Feldman, Mario F.; Krohne, Georg; Reidl, Joachim; Schild, Stefan			Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice	PLOS ONE			English	Article							DNA-BINDING VESICLES; OTITIS-MEDIA; HEMOPHILUS-INFLUENZAE; VIBRIO-CHOLERAE; CONJUGATE VACCINE; DETOXIFIED LIPOOLIGOSACCHARIDE; NASOPHARYNGEAL COLONIZATION; FUNCTIONAL-CHARACTERIZATION; CHANGING EPIDEMIOLOGY; MUCOSAL IMMUNIZATION	Haemophilus influenzae is a Gram-negative human-restricted bacterium that can act as a commensal and a pathogen of the respiratory tract. Especially nontypeable H. influenzae (NTHi) is a major threat to public health and is responsible for several infectious diseases in humans, such as pneumonia, sinusitis, and otitis media. Additionally, NTHi strains are highly associated with exacerbations in patients suffering from chronic obstructive pulmonary disease. Currently, there is no licensed vaccine against NTHi commercially available. Thus, this study investigated the utilization of outer membrane vesicles (OMVs) as a potential vaccine candidate against NTHi infections. We analyzed the immunogenic and protective properties of OMVs derived from various NTHi strains by means of nasopharyngeal immunization and colonization studies with BALB/c mice. The results presented herein demonstrate that an intranasal immunization with NTHi OMVs results in a robust and complex humoral and mucosal immune response. Immunoprecipitation revealed the most important immunogenic proteins, such as the heme utilization protein, protective surface antigen D15, heme binding protein A, and the outer membrane proteins P1, P2, P5 and P6. The induced immune response conferred not only protection against colonization with a homologous NTHi strain, which served as an OMV donor for the immunization mixtures, but also against a heterologous NTHi strain, whose OMVs were not part of the immunization mixtures. These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.	[Roier, Sandro; Leitner, Deborah R.; Schild-Pruefert, Kristina; Reidl, Joachim; Schild, Stefan] Graz Univ, Inst Mol Biosci, Graz, Austria; [Iwashkiw, Jeremy; Feldman, Mario F.] Univ Alberta, Alberta Glyc Ctr, Dept Biol Sci, Edmonton, AB, Canada; [Krohne, Georg] Univ Wurzburg, Div Electron Microscopy, Bioctr, Wurzburg, Germany	University of Graz; University of Alberta; University of Wurzburg	Roier, S (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	stefan.schild@uni-graz.at	Reidl, Joachim/O-2107-2016; Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976; Schild, Kristina/0000-0002-0154-7310; Reidl, Joachim/0000-0001-5798-9524; Schild, Stefan/0000-0001-7842-0177	Austrian Science Fund (FWF) [W901-B12, I 662-B09]; Alberta Glycomics Centre; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Alberta Glycomics Centre; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF): grant W901-B12 (DK Molecular Enzymology) to SR and SS and grant I 662-B09 to JR. The authors acknowledge the Alberta Glycomics Centre for funding to MFF. MFF is a Canadian Institutes of Health Research (CIHR) new investigator and Alberta Heritage Foundation for Medical Research (AHFMR) scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, VACCINE, V28, P4073, DOI 10.1016/j.vaccine.2010.03.075; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; [Anonymous], 2008, WORLD HLTH STAT 2008; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; BARENKAMP SJ, 1982, INFECT IMMUN, V36, P535, DOI 10.1128/IAI.36.2.535-540.1982; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bertot GM, 2004, J INFECT DIS, V189, P1304, DOI 10.1086/382508; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Chang A, 2011, HUM VACCINES, V7, P102, DOI 10.4161/hv.7.1.13351; CONCINO MF, 1982, J BACTERIOL, V152, P441; Dalseg R, 1999, VACCINE, V17, P2336, DOI 10.1016/S0264-410X(99)00046-8; DEICH RA, 1982, J BACTERIOL, V152, P855; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Engskog MKR, 2011, CARBOHYD RES, V346, P1241, DOI 10.1016/j.carres.2011.04.030; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FADEN H, 1989, J INFECT DIS, V160, P999, DOI 10.1093/infdis/160.6.999; GANKEMA H, 1980, INFECT IMMUN, V29, P704; Gaucher SP, 2000, BIOCHEMISTRY-US, V39, P12406, DOI 10.1021/bi001181k; GROENEVELD K, 1988, J INFECT DIS, V158, P360, DOI 10.1093/infdis/158.2.360; GROENEVELD K, 1989, INFECT IMMUN, V57, P3038, DOI 10.1128/IAI.57.10.3038-3044.1989; Gu XX, 1996, INFECT IMMUN, V64, P4047, DOI 10.1128/IAI.64.10.4047-4053.1996; Gu XX, 2003, VACCINE, V21, P2107, DOI 10.1016/S0264-410X(02)00768-5; Gu XX, 1997, INFECT IMMUN, V65, P4488, DOI 10.1128/IAI.65.11.4488-4493.1997; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Hirano T, 2003, FEMS IMMUNOL MED MIC, V35, P1; Hirano T, 2006, IMMUNOL LETT, V107, P131, DOI 10.1016/j.imlet.2006.08.005; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Hong WZ, 2007, J BACTERIOL, V189, P8300, DOI 10.1128/JB.00532-07; Hong WZ, 2010, MICROBES INFECT, V12, P11, DOI 10.1016/j.micinf.2009.09.006; Hotomi M, 2005, VACCINE, V23, P1294, DOI 10.1016/j.vaccine.2004.08.042; Johnston JW, 2009, ENCY MICROBIOLOGY, P153; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; KESAVALU L, 1992, INFECT IMMUN, V60, P1455, DOI 10.1128/IAI.60.4.1455-1464.1992; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOOS BG, 1989, INFECT IMMUN, V57, P2751, DOI 10.1128/IAI.57.9.2751-2757.1989; Loosmore SM, 1997, INFECT IMMUN, V65, P3701, DOI 10.1128/IAI.65.9.3701-3707.1997; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2012, P NATL ACAD SCI USA, V109, P3623, DOI 10.1073/pnas.1121383109; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mason KW, 2004, VACCINE, V22, P3449, DOI 10.1016/j.vaccine.2004.02.027; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; MESTECKY J, 1992, ADV EXP MED BIOL, V327, P13; Michel LV, 2011, VACCINE, V29, P1624, DOI 10.1016/j.vaccine.2010.12.082; Morris SK, 2008, LANCET INFECT DIS, V8, P435, DOI 10.1016/S1473-3099(08)70152-X; Morton DJ, 2009, INT J MED MICROBIOL, V299, P479, DOI 10.1016/j.ijmm.2009.03.004; Morton DJ, 2004, MICROBIOL-SGM, V150, P3923, DOI 10.1099/mic.0.27238-0; Morton DJ, 2005, FEMS MICROBIOL LETT, V253, P193, DOI 10.1016/j.femsle.2005.09.016; MURPHY TF, 1985, INFECT IMMUN, V50, P15, DOI 10.1128/IAI.50.1.15-21.1985; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Murphy TF, 2006, INFECT IMMUN, V74, P5169, DOI 10.1128/IAI.00692-06; Murphy Timothy F, 2009, Curr Infect Dis Rep, V11, P177, DOI 10.1007/s11908-009-0027-1; Novotny LA, 2008, INFECT IMMUN, V76, P967, DOI 10.1128/IAI.01395-07; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; OGRA PL, 1974, J IMMUNOL, V112, P488; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Ostberg KL, 2009, MUCOSAL IMMUNOL, V2, P63, DOI 10.1038/mi.2008.70; Pang B, 2008, INFECT IMMUN, V76, P2037, DOI 10.1128/IAI.01716-07; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Rahman MM, 1999, GLYCOBIOLOGY, V9, P1371, DOI 10.1093/glycob/9.12.1371; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Saunders NB, 1999, INFECT IMMUN, V67, P113, DOI 10.1128/IAI.67.1.113-119.1999; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sexton Kerry, 2004, N Z Med J, V117, pU1015; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHURIN PA, 1980, J PEDIATR-US, V97, P364, DOI 10.1016/S0022-3476(80)80182-X; Singh B, 2010, J INFECT DIS, V201, P414, DOI 10.1086/649782; SLOYER JL, 1976, J CLIN MICROBIOL, V4, P306; SPINOLA SM, 1986, J INFECT DIS, V154, P100, DOI 10.1093/infdis/154.1.100; Tong HH, 2000, INFECT IMMUN, V68, P4593, DOI 10.1128/IAI.68.8.4593-4597.2000; Tsang RSW, 2007, CLIN INFECT DIS, V44, P1611, DOI 10.1086/518283; Ulanova M, 2009, INFECT GENET EVOL, V9, P594, DOI 10.1016/j.meegid.2009.03.001; vanAlphen L, 1997, MICROBIOL-SGM, V143, P1423, DOI 10.1099/00221287-143-4-1423; Vetvik H, 1998, J IMMUNOL METHODS, V215, P163, DOI 10.1016/S0022-1759(98)00089-1; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; WHITMIRE WM, 1993, INFECT IMMUN, V61, P1460, DOI 10.1128/IAI.61.4.1460-1467.1993; Wu TH, 2005, VACCINE, V23, P5177, DOI 10.1016/j.vaccine.2005.06.014	98	61	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42664	10.1371/journal.pone.0042664	http://dx.doi.org/10.1371/journal.pone.0042664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880074	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100153
J	Aldridge, C; Storm, A; Cline, K; Dabney-Smith, C				Aldridge, Cassie; Storm, Amanda; Cline, Kenneth; Dabney-Smith, Carole			The Chloroplast Twin Arginine Transport (Tat) Component, Tha4, Undergoes Conformational Changes Leading to Tat Protein Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI TATA; TRANSLOCATION SYSTEM; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; MONOVALENT STREPTAVIDIN; PRECURSOR PROTEINS; BACILLUS-SUBTILIS; SIGNAL PEPTIDE; BINDING-SITE; IN TOPOLOGY	Twin arginine transport (Tat) systems transport folded proteins using proton-motive force as sole energy source. The thylakoid Tat system comprises three membrane components. A complex composed of cpTatC and Hcf106 is the twin arginine signal peptide receptor. Signal peptide binding triggers assembly of Tha4 for the translocation step. Tha4 is thought to serve as the protein-conducting element, and the topology it adopts during transport produces the transmembrane passageway. We analyzed Tha4 topology and conformation in actively transporting translocases and compared that with Tha4 in nontransporting membranes. Using cysteine accessibility labeling techniques and diagnostic protease protection assays, we confirm an overall N-OUT-C-IN topology for Tha4 that is maintained under transport conditions. Significantly, the amphipathic helix (APH) and C-tail exhibited substantial changes in accessibility when actively engaged in protein transport. Compared with resting state, cysteines within the APH became less accessible to stromally applied modifying reagent. The APH proximal C-tail, although still accessible to Cys-directed reagents, was much less accessible to protease. We attribute these changes in accessibility to indicate the Tha4 conformation that is adopted in the translocase primed for translocation. We propose that in the primed translocase, the APH partitions more extensively and uniformly into the membrane interface and the C-tails pack closer together in a mesh-like network. Implications for the mode by which the substrate protein crosses the bilayer are discussed.	[Aldridge, Cassie; Cline, Kenneth] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Storm, Amanda; Dabney-Smith, Carole] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	State University System of Florida; University of Florida; University System of Ohio; Miami University	Dabney-Smith, C (corresponding author), 651 E High St, Oxford, OH USA.	adabney@MiamiOH.edu	Dabney-Smith, Carole/C-2432-2008; Storm, Amanda R/AAF-2600-2021	Dabney-Smith, Carole/0000-0003-1347-3870; Storm, Amanda R/0000-0002-3736-2043; Aldridge, Cassie/0000-0002-9162-3478	National Institutes of Health [R01 GM46951]; Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences [DE-FG02-10ER16138]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science Early Career Research Program through the Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM46951 (to K. C.) and Department of Energy Office of Science Early Career Research Program Grant DE-FG02-10ER16138 (to C. D. S.) through the Office of Basic Energy Sciences.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Calderone V, 2003, EMBO REP, V4, P900, DOI 10.1038/sj.embor.embor923; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Chan CS, 2011, BBA-BIOMEMBRANES, V1808, P2289, DOI 10.1016/j.bbamem.2011.05.024; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Grage SL, 2010, METHODS MOL BIOL, V618, P183, DOI 10.1007/978-1-60761-594-1_13; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jackson SA, 2010, BIOCHEMISTRY-US, V49, P2765, DOI 10.1021/bi100217h; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; Martin JR, 2009, PLANT J, V58, P831, DOI 10.1111/j.1365-313X.2009.03816.x; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Vilen H, 2009, J BACTERIOL, V191, P3339, DOI 10.1128/JB.01782-08; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s	38	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34752	34763		10.1074/jbc.M112.385666	http://dx.doi.org/10.1074/jbc.M112.385666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896708	Green Published, hybrid			2022-12-25	WOS:000309654200075
J	Shang, XW; Li, YP; Liu, AL; Zhang, Q; Hu, XQ; Du, SM; Ma, J; Xu, GF; Li, Y; Guo, HW; Du, L; Ma, GS				Shang, Xianwen; Li, Yanping; Liu, Ailing; Zhang, Qian; Hu, Xiaoqi; Du, Songming; Ma, Jun; Xu, Guifa; Li, Ying; Guo, Hongwei; Du, Lin; Ma, Guansheng			Dietary Pattern and Its Association with the Prevalence of Obesity and Related Cardiometabolic Risk Factors among Chinese Children	PLOS ONE			English	Article							MEDITERRANEAN-STYLE DIET; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NUTRITION TRANSITION; EATING PATTERNS; BLOOD-PRESSURE; DAIRY FOODS; LIFE-STYLE; OVERWEIGHT; CHILDHOOD	Background: The association of dietary pattern with chronic diseases has been investigated widely in western countries. However, information is quite limited among children in China. Our study is aimed to identify the dietary patterns of Chinese children and examine their association with obesity and related cardiometabolic risk factors. Methods: A total of 5267 children were selected using multistage random sampling from 30 primary schools of 5 provincial capital cities in China. Dietary intake was derived from 24 hour dietary recall for three consecutive days. Anthropometric measurements, glucose and lipid profiles were obtained. Factor analysis combined with cluster analysis was used for identifying major dietary patterns. The associations of dietary patterns with obesity and related cardiometabolic risk factors were examined by logistic regression analysis. Results: Three mutually exclusive dietary patterns were identified, which were labeled as the healthy dietary pattern, the transitive dietary pattern, and the Western dietary pattern. Compared with children of the healthy dietary pattern, the multiple-adjusted odds ratios (95% confidence interval (CI)) of obesity were 1.11 (0.89-1.38) for children with the transitive dietary pattern and 1.80 (1.15-2.81) for children with the Western dietary pattern, which was 1.31 (95% CI 1.09-1.56) and 1.71 (95% CI: 1.13-2.56), respectively, for abdominal obesity. The Western dietary pattern was associated with significantly higher concentrations of low-density lipoprotein cholesterol (P<. 001), triglycerides (P<.001), systolic blood pressure (P = 0.0435) and fasting glucose (P = 0.0082) and a lower concentration of high-density lipoprotein cholesterol (P = 0.0023), as compared with the healthy dietary pattern. Conclusions: The Western dietary pattern characterized by red meat, eggs, refined grain and products, was positively associated with odds of obesity, the levels of plasma glucose, low-density lipoprotein cholesterol and triglycerides, and was inversely associated with the level of high-density lipoprotein cholesterol.	[Shang, Xianwen; Li, Yanping; Liu, Ailing; Zhang, Qian; Hu, Xiaoqi; Du, Songming; Ma, Guansheng] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China; [Shang, Xianwen] Chinese Acad Med Sci, China Oxford Ctr Int Hlth Res, Cardiovasc Inst, Beijing 100730, Peoples R China; [Shang, Xianwen] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Shang, Xianwen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jun] Beijing Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Xu, Guifa] Shandong Univ, Jinan 250100, Shandong, Peoples R China; [Li, Ying] Haerbin Med Univ, Coll Publ Hlth, Haerbin, Heilongjiang, Peoples R China; [Guo, Hongwei] Fudan Univ, Shanghai 200433, Peoples R China; [Du, Lin] Guangzhou Ctr Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Shandong University; Harbin Medical University; Fudan University	Shang, XW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China.	mags@chinacdc.cn	Ma, Guansheng/AAD-6767-2020; Li, Yanping/H-6437-2011	Shang, Xianwen/0000-0001-6143-9349; Shang, Xianwen/0000-0002-2362-3222; Li, Yanping/0000-0002-0412-2748	China Ministry of Science Technology [2008BAI58B05]	China Ministry of Science Technology(Ministry of Science and Technology, China)	This project has been funded by China Ministry of Science & Technology as "Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period." Grant number: 2008BAI58B05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014126; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Balthazar Emilia A, 2011, BMC Res Notes, V4, P567, DOI 10.1186/1756-0500-4-567; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Botton J, 2007, METABOLISM, V56, P614, DOI 10.1016/j.metabol.2006.12.006; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Cary NC, 1999, SAS STAT US GUID VER, P1122; Cary NC, 1999, SAS STAT US GUID VER, P1194; Chen Chun-ming, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P95; Chinese Medical Association Professional Committee of Children's Health, 2007, CHIN J EVID BASED PE, V22, P69; Chivers P, 2010, INT J OBESITY, V34, P1169, DOI 10.1038/ijo.2010.61; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; de Lorgeril M, 2006, PUBLIC HEALTH NUTR, V9, P118, DOI 10.1079/PHN2005933; Denova-Gutierrez E, 2011, J NUTR, V141, P921, DOI 10.3945/jn.110.132332; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Esfahani A, 2011, J AM COLL NUTR, V30, P285, DOI 10.1080/07315724.2011.10719971; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; German JB, 2009, EUR J NUTR, V48, P191, DOI 10.1007/s00394-009-0002-5; Gibson RA, 2009, BRIT J NUTR, V102, P1267, DOI 10.1017/S0007114509371664; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hoffmann K, 2000, PUBLIC HEALTH NUTR, V5, P89; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Jason A, 2010, J AM DIET ASSOC, V110, P434; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kral TVE, 2010, PHYSIOL BEHAV, V100, P567, DOI 10.1016/j.physbeh.2010.04.031; Lebars MA, 2010, ARCH PEDIATRIE, V17, P1126, DOI 10.1016/j.arcped.2010.04.014; Lee SA, 2010, BRIT J NUTR, V104, P265, DOI 10.1017/S0007114510000383; Li YP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Lim JH, 2011, J KOREAN MED SCI, V26, P1201, DOI 10.3346/jkms.2011.26.9.1201; Liu Ai-Ling, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P901; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Melnik BC, 2009, MED HYPOTHESES, V72, P631, DOI 10.1016/j.mehy.2009.01.008; Menik BC, 2011, MED HYPOTHESES, V76, P553, DOI 10.1016/j.mehy.2010.12.017; Mercedes DO, 2007, DEV WHO GROWTH REFER; [米杰 MI Jie], 2010, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V5, P4; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Olinto MT, 2010, PUBLIC HEALTH NUTR, V25, P1; Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240; Paletas K, 2010, J AM COLL NUTR, V29, P41, DOI 10.1080/07315724.2010.10719815; Patro B, 2010, CURR OPIN CLIN NUTR, V13, P300, DOI 10.1097/MCO.0b013e32833681a2; Paul Z, 2007, LANCET, V369, P2059; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Power ML, 1999, AM J OBSTET GYNECOL, V181, P1560, DOI 10.1016/S0002-9378(99)70404-7; RAITAKARI OT, 1994, ACTA PAEDIATR, V83, P935, DOI 10.1111/j.1651-2227.1994.tb13176.x; Resnick L, 1999, PROG CARDIOVASC DIS, V42, P1, DOI 10.1016/S0033-0620(99)70006-X; Rezazadeh A, 2010, J NUTR SCI VITAMINOL, V56, P132, DOI 10.3177/jnsv.56.132; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Sabate J, 2010, AM J CLIN NUTR, V91, p1525S, DOI 10.3945/ajcn.2010.28701F; Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980; Schiel R, 2006, EUR J MED RES, V11, P97; SCHWERIN HS, 1982, AM J CLIN NUTR, V35, P1319, DOI 10.1093/ajcn/35.5.1319; Shi H, 2001, FASEB J, V15, P2751, DOI 10.1096/fj.01-0584fje; Steemburgo T, 2007, ARQ BRAS ENDOCRINOL, V51, P1425, DOI 10.1590/S0004-27302007000900004; Tan F, 2000, J Epidemiol, V10, P255; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Tseng, 2000, Ann Epidemiol, V10, P481, DOI 10.1016/S1047-2797(00)00088-0; Twisk JWR, 1999, J CARDIOVASC RISK, V6, P355; Vergnaud AC, 2012, AM J CLIN NUTR, V95, P184, DOI 10.3945/ajcn.111.019968; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Wosje KS, 2010, AM J CLIN NUTR, V92, P294, DOI 10.3945/ajcn.2009.28925; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x	74	86	89	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43183	10.1371/journal.pone.0043183	http://dx.doi.org/10.1371/journal.pone.0043183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905228	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800057
J	Morlan, JD; Qu, KB; Sinicropi, DV				Morlan, John D.; Qu, Kunbin; Sinicropi, Dominick V.			Selective Depletion of rRNA Enables Whole Transcriptome Profiling of Archival Fixed Tissue	PLOS ONE			English	Article							COPY-NUMBER; CELL; DNA	We report a method for Selective Depletion of abundant RNA (SDRNA) species from Human total RNA isolated from formalin-fixed, paraffin-embedded (FFPE) tissue, here demonstrating removal of ribosomal and mitochondrial transcripts from clinical FFPE tissue RNA archived up to 20 years. Importantly, SDRNA removes 98% of targeted RNAs while preserving relative abundance profiles of non-targeted RNAs, enabling routine whole transcriptome analysis of clinically valuable archival tissue specimens by Next-Generation Sequencing.	[Morlan, John D.; Qu, Kunbin; Sinicropi, Dominick V.] Genom Hlth Inc, Redwood City, CA USA	Genomic Health	Morlan, JD (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	jmorlan@genomichealth.com						Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	13	103	112	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42882	10.1371/journal.pone.0042882	http://dx.doi.org/10.1371/journal.pone.0042882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900061	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900079
J	Rana, VS; Singh, ST; Priya, NG; Kumar, J; Rajagopal, R				Rana, Vipin Singh; Singh, Shalini Thakur; Priya, Natarajan Gayatri; Kumar, Jitendra; Rajagopal, Raman			Arsenophonus GroEL Interacts with CLCuV and Is Localized in Midgut and Salivary Gland of Whitefly B. tabaci	PLOS ONE			English	Article							LEAF CURL VIRUS; BEMISIA-TABACI; CIRCULATIVE TRANSMISSION; ENDOSYMBIOTIC BACTERIA; COAT PROTEIN; SARDINIA-VIRUS; SPECIES LEVEL; VECTOR; APHIDS; ALEYRODIDAE	Cotton leaf curl virus (CLCuV) (Gemininiviridae: Begomovirus) is the causative agent of leaf curl disease in cotton plants (Gossypium hirsutum). CLCuV is exclusively transmitted by the whitefly species B. tabaci (Gennadius) (Hemiptera: Alerodidae). B. tabaci contains several biotypes which harbor dissimilar bacterial endo-symbiotic community. It is reported that these bacterial endosymbionts produce a 63 kDa chaperon GroEL protein which binds to geminivirus particles and protects them from rapid degradation in gut and haemolymph. In biotype B, GroEL protein of Hamiltonella has been shown to interact with Tomato yellow leaf curl virus (TYLCV). The present study was initiated to find out whether endosymbionts of B. tabaci are similarly involved in CLCuV transmission in Sriganganagar (Rajasthan), an area endemic with cotton leaf curl disease. Biotype and endosymbiont diversity of B. tabaci were identified using MtCO1 and 16S rDNA genes respectively. Analysis of our results indicated that the collected B. tabaci population belong to AsiaII genetic group and harbor the primary endosymbiont Portiera and the secondary endosymbiont Arsenophonus. The GroEL proteins of Portiera and Arsenophonus were purified and in-vitro interaction studies were carried out using pull down and co-immunoprecipitation assays. In-vivo interaction was confirmed using yeast two hybrid system. In both in-vitro and in-vivo studies, the GroEL protein of Arsenophonus was found to be interacting with the CLCuV coat protein. Further, we also localized the presence of Arsenophonus in the salivary glands and the midgut of B. tabaci besides the already reported bacteriocytes. These results suggest the involvement of Arsenophonus in the transmission of CLCuV in AsiaII genetic group of B. tabaci.	[Rana, Vipin Singh; Singh, Shalini Thakur; Priya, Natarajan Gayatri; Kumar, Jitendra; Rajagopal, Raman] Univ Delhi, Dept Zool, Delhi 110007, India	University of Delhi	Rana, VS (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	zoorajagopal@gmail.com	Rana, Vipin/ABB-5594-2021; Rana, Vipin Singh/AAE-6615-2021; KUMAR, JITENDRA/AFJ-9849-2022	Rana, Vipin/0000-0003-2673-7871; KUMAR, JITENDRA/0000-0003-4222-446X	University of Delhi Faculty Research Grant; National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research	University of Delhi Faculty Research Grant; National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research	This work has been funded by 1. University of Delhi Faculty Research Grant and 2. National Agricultural Innovation Project (NAIP) grant of the Indian Council for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmera B. D, 1994, NAT SEM COTT PROD CH; Baumann L, 2004, CURR MICROBIOL, V48, P77, DOI 10.1007/s00284-003-4132-3; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1993, ASM NEWS, V59, P21; Bouvaine S, 2011, J GEN VIROL, V92, P1467, DOI 10.1099/vir.0.029355-0; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Caciagli P, 2009, J VIROL, V83, P5784, DOI 10.1128/JVI.02267-08; Choudhury NR, 2006, NUCLEIC ACIDS RES, V34, P6362, DOI 10.1093/nar/gkl903; Cicero JM, 2011, ANN ENTOMOL SOC AM, V104, P261, DOI 10.1603/AN10075; Czosnek H, 2002, ANN APPL BIOL, V140, P215, DOI 10.1111/j.1744-7348.2002.tb00175.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Fauquet CM, 2005, ARCH VIROL, V150, P2151, DOI 10.1007/s00705-005-0583-0; Filichkin SA, 1997, J VIROL, V71, P569, DOI 10.1128/JVI.71.1.569-577.1997; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2007, TOMATO YELLOW LEAF C, P175; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hofer P, 1997, VIROLOGY, V236, P288, DOI 10.1006/viro.1997.8751; Hogenhout SA, 1998, J VIROL, V72, P358, DOI 10.1128/JVI.72.1.358-365.1998; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jiang Y. X., 2004, Spanish Journal of Agricultural Research, V2, P115; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu SJ, 2009, ARCH VIROL, V154, P469, DOI 10.1007/s00705-009-0327-7; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Medina V, 2006, J PLANT PATHOL, V88, P299; Monga D, 2011, 5 M AS COTT RES DEV; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; NARULA AM, 1999, J COTTON RES DEV, V0013, P00129; Noris E, 1998, J VIROL, V72, P10050, DOI 10.1128/JVI.72.12.10050-10057.1998; Ohnesorge S, 2009, INSECT MOL BIOL, V18, P693, DOI 10.1111/j.1365-2583.2009.00906.x; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	58	76	78	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42168	10.1371/journal.pone.0042168	http://dx.doi.org/10.1371/journal.pone.0042168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900008	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900023
J	Tian, TH; Song, JN				Tian, Tianhai; Song, Jiangning			Mathematical Modelling of the MAP Kinase Pathway Using Proteomic Datasets	PLOS ONE			English	Article							SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; SIGNAL-TRANSDUCTION; SYSTEMS BIOLOGY; PHOSPHORYLATION NETWORKS; ROBUSTNESS ANALYSIS; GENE-EXPRESSION; IN-VIVO; CASCADE; PHOSPHATASES	The advances in proteomics technologies offer an unprecedented opportunity and valuable resources to understand how living organisms execute necessary functions at systems levels. However, little work has been done up to date to utilize the highly accurate spatio-temporal dynamic proteome data generated by phosphoprotemics for mathematical modeling of complex cell signaling pathways. This work proposed a novel computational framework to develop mathematical models based on proteomic datasets. Using the MAP kinase pathway as the test system, we developed a mathematical model including the cytosolic and nuclear subsystems; and applied the genetic algorithm to infer unknown model parameters. Robustness property of the mathematical model was used as a criterion to select the appropriate rate constants from the estimated candidates. Quantitative information regarding the absolute protein concentrations was used to refine the mathematical model. We have demonstrated that the incorporation of more experimental data could significantly enhance both the simulation accuracy and robustness property of the proposed model. In addition, we used the MAP kinase pathway inhibited by phosphatases with different concentrations to predict the signal output influenced by different cellular conditions. Our predictions are in good agreement with the experimental observations when the MAP kinase pathway was inhibited by phosphatase PP2A and MKP3. The successful application of the proposed modeling framework to the MAP kinase pathway suggests that our method is very promising for developing accurate mathematical models and yielding insights into the regulatory mechanisms of complex cell signaling pathways.	[Tian, Tianhai] Monash Univ, Fac Sci, Sch Math Sci, Clayton, Vic, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University	Tian, TH (corresponding author), Monash Univ, Fac Sci, Sch Math Sci, Clayton, Vic, Australia.	tianhai.tian@monash.edu	Tian, Tianhai/AAU-2335-2021; Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Tian, Tianhai/0000-0001-6191-0209	Australian Research Council (ARC) [FT100100748]; National Health and Medical Research Council of Australia (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) (project number FT100100748) and the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Apri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009865; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Bates DG, 2011, IET SYST BIOL, V5, P229, DOI 10.1049/iet-syb.2010.0072; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bourret RB, 2008, MOL MICROBIOL, V69, P1336, DOI 10.1111/j.1365-2958.2008.06379.x; Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chipperfield A.J., 1994, P AD COMP ENG DES CO, P128; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kall L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002277; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Kersten B, 2009, PROTEOMICS, V9, P964, DOI 10.1002/pmic.200800548; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Kitano H, 2003, NATURE, V426, P125, DOI 10.1038/426125a; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Martin SF, 2011, J PROTEOME RES; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Mayya V, 2009, EXPERT REV PROTEOMIC, V6, P605, DOI 10.1586/EPR.09.84; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Raabe T, 2003, CURR BIOL, V13, pR635, DOI 10.1016/S0960-9822(03)00568-2; Rizk A, 2009, BIOINFORMATICS, V25, pI169, DOI 10.1093/bioinformatics/btp200; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schwacke JH, 2007, PROTEOMICS, V7, P890, DOI 10.1002/pmic.200600927; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stasyk T, 2011, TRENDS MOL MED; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Tasaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013926; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2007, BIOINFORMATICS, V23, P84, DOI 10.1093/bioinformatics/btl552; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Tian TH, 2010, BIOSYSTEMS, V99, P192, DOI 10.1016/j.biosystems.2009.11.002; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Wang JB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-36; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100	67	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42230	10.1371/journal.pone.0042230	http://dx.doi.org/10.1371/journal.pone.0042230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905119	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100028
J	van der Heide, T; Eklof, JS; van Nes, EH; van der Zee, EM; Donadi, S; Weerman, EJ; Olff, H; Eriksson, BK				van der Heide, Tjisse; Eklof, Johan S.; van Nes, Egbert H.; van der Zee, Els M.; Donadi, Serena; Weerman, Ellen J.; Olff, Han; Eriksson, Britas Klemens			Ecosystem Engineering by Seagrasses Interacts with Grazing to Shape an Intertidal Landscape	PLOS ONE			English	Article							SPATIAL VEGETATION PATTERNS; GEESE BRANTA-BERNICLA; BRENT GEESE; ARID ECOSYSTEMS; ZOSTERA-NOLTII; WADDEN SEA; DYNAMICS; ORGANISMS; DESERTIFICATION; EXPLOITATION	Self-facilitation through ecosystem engineering (i.e., organism modification of the abiotic environment) and consumer-resource interactions are both major determinants of spatial patchiness in ecosystems. However, interactive effects of these two mechanisms on spatial complexity have not been extensively studied. We investigated the mechanisms underlying a spatial mosaic of low-tide exposed hummocks and waterlogged hollows on an intertidal mudflat in the Wadden Sea dominated by the seagrass Zostera noltii. A combination of field measurements, an experiment and a spatially explicit model indicated that the mosaic resulted from localized sediment accretion by seagrass followed by selective waterfowl grazing. Hollows were bare in winter, but were rapidly colonized by seagrass during the growth season. Colonized hollows were heavily grazed by brent geese and widgeon in autumn, converting these patches to a bare state again and disrupting sediment accretion by seagrass. In contrast, hummocks were covered by seagrass throughout the year and were rarely grazed, most likely because the waterfowl were not able to employ their preferred but water requiring feeding strategy ('dabbling') here. Our study exemplifies that interactions between ecosystem engineering by a foundation species (seagrass) and consumption (waterfowl grazing) can increase spatial complexity at the landscape level.	[van der Heide, Tjisse; Weerman, Ellen J.; Olff, Han] Univ Groningen, Community & Conservat Ecol Grp, CEES, Groningen, Netherlands; [van Nes, Egbert H.] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [van der Zee, Els M.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands; [van der Zee, Els M.] Univ Groningen, Anim Ecol Grp, CEES, Groningen, Netherlands; [Eklof, Johan S.] Univ Gothenburg, Dept Biol & Environm Sci Kristineberg, Fiskebackskil, Sweden; [Eklof, Johan S.] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	University of Groningen; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; University of Gothenburg; Stockholm University	van der Heide, T (corresponding author), Univ Groningen, Community & Conservat Ecol Grp, CEES, Groningen, Netherlands.	T.van.der.Heide@rug.nl	Eklöf, Johan S/C-7722-2017; Donadi, Serena/I-5092-2019; Eriksson, Britas Klemens/D-8601-2015; van der Heide, Tjisse/M-3000-2013; van Nes, Egbert H/F-2681-2011; Olff, Han/A-8516-2008	Eklöf, Johan S/0000-0001-6936-0926; Donadi, Serena/0000-0002-8920-9630; Eriksson, Britas Klemens/0000-0003-4752-922X; Olff, Han/0000-0003-2154-3576; van Nes, Egbert/0000-0002-6345-104X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [2008-839]; ZKO program from the Netherlands Organization of Scientific Research (NWO) [839.08.310]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); ZKO program from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was financially supported by a post-doctoral grant from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) to JSE (grant no. 2008-839), and by a grant from the ZKO program from the Netherlands Organization of Scientific Research (NWO) to BKE, TVDH, EW, SD and EVDZ (grant no. 839.08.310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SS, 1999, ECOSYSTEMS, V2, P493, DOI 10.1007/s100219900097; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Eklof JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023229; Eklof JS, 2009, MAR FRESHWATER RES, V60, P1317, DOI 10.1071/MF09008; Eriksson BK, 2010, ECOSYSTEMS, V13, P752, DOI 10.1007/s10021-010-9352-3; Fonseca M, 2002, ECOL APPL, V12, P218, DOI 10.1890/1051-0761(2002)012[0218:MSLPAA]2.0.CO;2; Fox AD, 1996, BIRD STUDY, V43, P257, DOI 10.1080/00063659609461018; Ganter B, 2000, HELGOLAND MAR RES, V54, P63, DOI 10.1007/s101520050003; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; Lin Y, 2010, LANDSCAPE ECOL, V25, P1519, DOI 10.1007/s10980-010-9520-z; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; Moore KA, 2004, J COASTAL RES, P162, DOI 10.2112/SI45-162.1; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PATRIQUIN D G, 1975, Aquatic Botany, V1, P163, DOI 10.1016/0304-3770(75)90021-2; Percival SM, 1997, IBIS, V139, P121, DOI 10.1111/j.1474-919X.1997.tb04511.x; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; Pringle RM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000377; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; van der Heide T, 2010, ECOLOGY, V91, P362, DOI 10.1890/08-1567.1; van Wesenbeeck BK, 2007, OIKOS, V116, P742, DOI [10.1111/j.2007.0030-1299.15485.x, 10.1111/j.0030-1299.2007.15485.x]; VERMAAT JE, 1987, AQUAT BOT, V28, P287, DOI 10.1016/0304-3770(87)90006-4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weerman EJ, 2012, ECOLOGY, V93, P608, DOI 10.1890/11-0625.1; Weerman EJ, 2011, ECOLOGY, V92, P487, DOI 10.1890/10-0270.1; Zipperle AM, 2010, AQUAT BOT, V93, P202, DOI 10.1016/j.aquabot.2010.05.002	42	40	40	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42060	10.1371/journal.pone.0042060	http://dx.doi.org/10.1371/journal.pone.0042060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905115	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100025
J	Sun, W; Peng, CS; Zhao, YY; Li, ZY				Sun, Wei; Peng, Chongsheng; Zhao, Yunyu; Li, Zhiyong			Functional Gene-Guided Discovery of Type II Polyketides from Culturable Actinomycetes Associated with Soft Coral Scleronephthya sp	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MARINE MICROMONOSPORA; ACROPORA-DIGITIFERA; JADOMYCIN-B; SP-NOV.; BACTERIA; ACTINOBACTERIA; MUCUS; DEPSIPEPTIDE; THIOCORALINE	Compared with the actinomycetes in stone corals, the phylogenetic diversity of soft coral-associated culturable actinomycetes is essentially unexplored. Meanwhile, the knowledge of the natural products from coral-associated actinomycetes is very limited. In this study, thirty-two strains were isolated from the tissue of the soft coral Scleronephthya sp. in the East China Sea, which were grouped into eight genera by 16S rDNA phylogenetic analysis: Micromonospora, Gordonia, Mycobacterium, Nocardioides, Streptomyces, Cellulomonas, Dietzia and Rhodococcus. 6 Micromonospora strains and 4 Streptomyces strains were found to be with the potential for producing aromatic polyketides based on the analysis of KS alpha (ketoacyl-synthase) gene in the PKS II (type II polyketides synthase) gene cluster. Among the 6 Micromonospora strains, angucycline cyclase gene was amplified in 2 strains (A5-1 and A6-2), suggesting their potential in synthesizing angucyclines e. g. jadomycin. Under the guidance of functional gene prediction, one jadomycin B analogue (7b, 13-dihydro-7-O-methyl jadomycin B) was detected in the fermentation broth of Micromonospora sp. strain A5-1. This study highlights the phylogenetically diverse culturable actinomycetes associated with the tissue of soft coral Scleronephthya sp. and the potential of coral-derived actinomycetes especially Micromonospora in producing aromatic polyketides.	[Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China; [Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Peng, Chongsheng; Zhao, Yunyu] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, W (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Marine Biotechnol Lab, Shanghai 200030, Peoples R China.	zyli@sjtu.edu.cn			National Natural Science Foundation of China [81102417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81102417) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; Anzai K, 2008, J BIOSCI BIOENG, V106, P215, DOI 10.1263/jbb.106.215; Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Bull AT, 2007, TRENDS MICROBIOL, V15, P491, DOI 10.1016/j.tim.2007.10.004; Charan RD, 2004, J NAT PROD, V67, P1431, DOI 10.1021/np040042r; DOULL JL, 1994, J IND MICROBIOL, V13, P120, DOI 10.1007/BF01584109; Fiedler HP, 2008, J ANTIBIOT, V61, P158, DOI 10.1038/ja.2008.125; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Han L, 2010, BIOCHEM SYST ECOL, V38, P243, DOI 10.1016/j.bse.2009.12.030; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hirsch AM, 2010, SOIL BIOL BIOCHEM, V42, P536, DOI 10.1016/j.soilbio.2009.11.023; Izumi H, 2010, FEMS MICROBIOL LETT, V313, P33, DOI 10.1111/j.1574-6968.2010.02118.x; Jakeman DL, 2005, BIOORG MED CHEM LETT, V15, P1447, DOI 10.1016/j.bmcl.2004.12.082; Jiang SM, 2007, ANTON LEEUW INT J G, V92, P405, DOI 10.1007/s10482-007-9169-z; Khan ST, 2011, ENVIRON MICROBIOL, V13, P391, DOI 10.1111/j.1462-2920.2010.02337.x; Lampert Y, 2008, FEMS MICROBIOL ECOL, V64, P187, DOI 10.1111/j.1574-6941.2008.00458.x; Lampert Y, 2006, FEMS MICROBIOL ECOL, V58, P99, DOI 10.1111/j.1574-6941.2006.00136.x; Li K, 2011, MAR DRUGS, V9, P690, DOI 10.3390/md9050690; Li L, 2011, J NAT PROD, V74, P2089, DOI 10.1021/np2003325; LI XA, 1995, PHYTOPATHOLOGY, V85, P837, DOI 10.1094/Phyto-85-837; Macherla VR, 2007, J NAT PROD, V70, P1454, DOI 10.1021/np0702032; Martin GDA, 2007, J NAT PROD, V70, P1406, DOI 10.1021/np060621r; Metsa-Ketela M, 1999, FEMS MICROBIOL LETT, V180, P1; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Nithyanand P, 2011, FEMS MICROBIOL LETT, V314, P112, DOI 10.1111/j.1574-6968.2010.02149.x; Nithyanand P, 2010, CURR MICROBIOL, V60, P454, DOI 10.1007/s00284-009-9564-y; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Olson JB, 2007, INT J SYST EVOL MICR, V57, P1478, DOI 10.1099/ijs.0.64837-0; Ouyang YC, 2011, ANTON LEEUW INT J G, V99, P807, DOI 10.1007/s10482-011-9554-5; PADGITT PJ, 1987, INT J SYST BACTERIOL, V37, P186, DOI 10.1099/00207713-37-3-186; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Rix U, 2004, J AM CHEM SOC, V126, P4496, DOI 10.1021/ja031724o; Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734; Schneemann I, 2010, APPL ENVIRON MICROB, V76, P3702, DOI 10.1128/AEM.00780-10; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ward AC, 2006, CURR OPIN MICROBIOL, V9, P279, DOI 10.1016/j.mib.2006.04.004; Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Xiao J, 2011, INT J SYST EVOL MICR, V61, P16, DOI 10.1099/ijs.0.019976-0; Yan XH, 2007, TETRAHEDRON LETT, V48, P5313, DOI 10.1016/j.tetlet.2007.05.096; Yan XH, 2011, J NAT PROD, V74, P175, DOI 10.1021/np100562n; Zhang HT, 2008, ANTON LEEUW INT J G, V93, P241, DOI 10.1007/s10482-007-9196-9; Zhang HT, 2006, INT J SYST EVOL MICR, V56, P2309, DOI 10.1099/ijs.0.64217-0; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	47	33	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42847	10.1371/journal.pone.0042847	http://dx.doi.org/10.1371/journal.pone.0042847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880121	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900055
J	Ahmad, R; Wolber, W; Eckardt, S; Koch, P; Schmitt, J; Semechkin, R; Geis, C; Heckmann, M; Brustle, O; McLaughlin, JK; Siren, AL; Muller, AM				Ahmad, Ruhel; Wolber, Wanja; Eckardt, Sigrid; Koch, Philipp; Schmitt, Jessica; Semechkin, Ruslan; Geis, Christian; Heckmann, Manfred; Bruestle, Oliver; McLaughlin, John K.; Siren, Anna-Leena; Mueller, Albrecht M.			Functional Neuronal Cells Generated by Human Parthenogenetic Stem Cells	PLOS ONE			English	Article							IN-VITRO; BRAIN-DEVELOPMENT; LINES; DIFFERENTIATION; PLURIPOTENT; BLASTOCYSTS; DERIVATION; MICE; SPECIFICATION; METHYLATION	Parent of origin imprints on the genome have been implicated in the regulation of neural cell type differentiation. The ability of human parthenogenetic (PG) embryonic stem cells (hpESCs) to undergo neural lineage and cell type-specific differentiation is undefined. We determined the potential of hpESCs to differentiate into various neural subtypes. Concurrently, we examined DNA methylation and expression status of imprinted genes. Under culture conditions promoting neural differentiation, hpESC-derived neural stem cells (hpNSCs) gave rise to glia and neuron-like cells that expressed subtype-specific markers and generated action potentials. Analysis of imprinting in hpESCs and in hpNSCs revealed that maternal-specific gene expression patterns and imprinting marks were generally maintained in PG cells upon differentiation. Our results demonstrate that despite the lack of a paternal genome, hpESCs generate proliferating NSCs that are capable of differentiation into physiologically functional neuron-like cells and maintain allele-specific expression of imprinted genes. Thus, hpESCs can serve as a model to study the role of maternal and paternal genomes in neural development and to better understand imprinting-associated brain diseases.	[Ahmad, Ruhel; Schmitt, Jessica; Mueller, Albrecht M.] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Ctr Expt Mol Med ZEMM, Wurzburg, Germany; [Wolber, Wanja; Siren, Anna-Leena] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Eckardt, Sigrid; McLaughlin, John K.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Koch, Philipp; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, Bonn, Germany; [Koch, Philipp; Bruestle, Oliver] Hertie Fdn, Bonn, Germany; [Geis, Christian] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Dept Physiol, D-8700 Wurzburg, Germany; [Semechkin, Ruslan] Int Stem Cell Corp, Oceanside, CA USA	University of Wurzburg; University of Wurzburg; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Bonn; University of Wurzburg; University of Wurzburg	Ahmad, R (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Ctr Expt Mol Med ZEMM, Wurzburg, Germany.	albrecht.mueller@uni-wuerzburg.de	Koch, Philipp/M-1186-2016; Sirén, Anna-Leena/AAE-1374-2019; McLaughlin, Kenneth/E-3648-2011; Koch, Philipp/AAZ-3751-2020	Sirén, Anna-Leena/0000-0002-2217-0081; Koch, Philipp/0000-0003-3713-8786; Heckmann, Manfred/0000-0002-4874-1735	BMBF [01GN0825, 01GN1009B]; IZKF Wurzburg [D-103]; DFG [SFB-TR3 D2]; EU [222943]; Hertie Foundation; German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg	BMBF(Federal Ministry of Education & Research (BMBF)); IZKF Wurzburg; DFG(German Research Foundation (DFG)); EU(European Commission); Hertie Foundation; German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg	This work was supported by the BMBF-funded project 01GN0825 and 01GN1009B, the IZKF Wurzburg project D-103, the DFG (SFB-TR3 D2), the EU 7FP project Neurostemcell (#222943) and the Hertie Foundation. RA was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brevini TA, 2012, STEM CELL REV; Brevini TAL, 2009, STEM CELL REV REP, V5, P340, DOI 10.1007/s12015-009-9086-9; Chen Y, 2012, STEM CELLS DEV, V21, P143, DOI 10.1089/scd.2010.0585; Choi SW, 2010, INT J DEV BIOL, V54, P1755, DOI 10.1387/ijdb.103188sc; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dinger TC, 2008, STEM CELLS, V26, P1474, DOI 10.1634/stemcells.2007-0877; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Eckardt S, 2011, J CLIN INVEST, V121, P623, DOI 10.1172/JCI45377; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Harness JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014499; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Isaev DA, 2012, REGEN MED, V7, P37, DOI [10.2217/RME.11.110, 10.2217/rme.11.110]; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Khoureiry R, 2008, J MED GENET, V45, P583, DOI 10.1136/jmg.2008.057943; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lengerke C, 2007, ANN NY ACAD SCI, V1106, P209, DOI 10.1196/annals.1392.011; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lin G, 2007, CELL RES, V17, P999, DOI 10.1038/cr.2007.97; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Teramura T, 2009, J REPROD DEVELOP, V55, P283, DOI 10.1262/jrd.20146; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turovets N, 2012, CELL TRANSPLANT, V21, P217, DOI 10.3727/096368911X582723; Wilkins JF, 2011, PROG MOL BIOL TRANSL, V101, P401, DOI 10.1016/B978-0-12-387685-0.00013-5; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x	45	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42800	10.1371/journal.pone.0042800	http://dx.doi.org/10.1371/journal.pone.0042800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880113	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000073
J	Sant'Anna, MRV; Darby, AC; Brazil, RP; Montoya-Lerma, J; Dillon, VM; Bates, PA; Dillon, RJ				Sant'Anna, Mauricio R. V.; Darby, Alistair C.; Brazil, Reginaldo P.; Montoya-Lerma, James; Dillon, Viv M.; Bates, Paul A.; Dillon, Rod J.			Investigation of the Bacterial Communities Associated with Females of Lutzomyia Sand Fly Species from South America	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; VISCERAL LEISHMANIASIS; GUT BACTERIA; PHLEBOTOMUS-PAPATASI; SPOROGONIC DEVELOPMENT; PHYLOGENETIC ANALYSIS; MANAGEMENT REGIMENS; DIPTERA PSYCHODIDAE; NATURAL INFECTION; VECTOR COMPETENCE	Phlebotomine sand flies are vectors of Leishmania that are acquired by the female sand fly during blood feeding on an infected mammal. Leishmania parasites develop exclusively in the gut lumen during their residence in the insect before transmission to a suitable host during the next blood feed. Female phlebotomine sand flies are blood feeding insects but their life style of visiting plants as well as animals, and the propensity for larvae to feed on detritus including animal faeces means that the insect host and parasite are exposed to a range of microorganisms. Thus, the sand fly microbiota may interact with the developing Leishmania population in the gut. The aim of the study was to investigate and identify the bacterial diversity associated with wild adult female Lutzomyia sand flies from different geographical locations in the New World. The bacterial phylotypes recovered from 16S rRNA gene clone libraries obtained from wild caught adult female Lutzomyia sand flies were estimated from direct band sequencing after denaturing gradient gel electrophoresis of bacterial 16 rRNA gene fragments. These results confirm that the Lutzomyia sand flies contain a limited array of bacterial phylotypes across several divisions. Several potential plant-related bacterial sequences were detected including Erwinia sp. and putative Ralstonia sp. from two sand fly species sampled from 3 geographically separated regions in Brazil. Identification of putative human pathogens also demonstrated the potential for sand flies to act as vectors of bacterial pathogens of medical importance in addition to their role in Leishmania transmission.	[Sant'Anna, Mauricio R. V.; Bates, Paul A.; Dillon, Rod J.] Univ Lancaster, Sch Hlth & Med, Lancaster, England; [Darby, Alistair C.; Dillon, Viv M.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Brazil, Reginaldo P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil; [Montoya-Lerma, James] Univ Valle, Dept Biol, Cali, Valle, Colombia	Lancaster University; University of Liverpool; Fundacao Oswaldo Cruz; Universidad del Valle	Sant'Anna, MRV (corresponding author), Univ Lancaster, Sch Hlth & Med, Lancaster, England.	r.dillon@lancaster.ac.uk	Darby, Alistair/I-6485-2012; Brazil, Reginaldo Peçanha/AAF-6777-2019; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021	Darby, Alistair/0000-0002-3786-6209; Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Dillon, Rod/0000-0002-3551-0030; Bates, Paul/0000-0001-6861-5421; Montoya-Lerma, James/0000-0003-2122-1323	Wellcome Trust [073405]; Leverhulme Trust [F/00 808/C]	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust)	The work was supported by the Wellcome Trust http://www.wellcome.ac.uk (ref 073405) and the Leverhulme Trust http://www.leverhulme.ac.uk (ref F/00 808/C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; ALEXANDER B, 1994, ANN TROP MED PARASIT, V88, P543, DOI 10.1080/00034983.1994.11812902; Felipe IMA, 2011, MEM I OSWALDO CRUZ, V106, P207, DOI 10.1590/S0074-02762011000200015; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Bloch KC, 1997, MEDICINE, V76, P30, DOI 10.1097/00005792-199701000-00003; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; CAMERON MM, 1994, B ENTOMOL RES, V84, P461, DOI 10.1017/S0007485300032685; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; de Oliveira Sandra Maria Pereira, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P319, DOI 10.1590/S0037-86822000000300012; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2000, NATURE, V403, P851, DOI 10.1038/35002669; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Silva JGDE, 2007, CAD SAUDE PUBLICA, V23, P1715, DOI 10.1590/S0102-311X2007000700024; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FELSENSTEIN, 2005, PHYLIP PHYLOGENY INF; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Losada L, 2010, GENOME BIOL EVOL, V2, P102, DOI 10.1093/gbe/evq003; McCaig AE, 2001, APPL ENVIRON MICROB, V67, P4554, DOI 10.1128/AEM.67.10.4554-4559.2001; McCarthy CB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001304; MURPHY KM, 1994, APPL ENVIRON MICROB, V60, P2508, DOI 10.1128/AEM.60.7.2508-2517.1994; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oliveira S. M. P. de, 2001, Cadernos de Saude Publica, V17, P229, DOI 10.1590/S0102-311X2001000100024; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Ono M, 2001, J MED ENTOMOL, V38, P237, DOI 10.1603/0022-2585-38.2.237; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Schlein Y, 1999, MED VET ENTOMOL, V13, P65, DOI 10.1046/j.1365-2915.1999.00138.x; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; SCHLEIN Y, 1986, INSECT SCI APPL, V7, P231, DOI 10.1017/S1742758400009000; Schonfeld J, 2003, APPL ENVIRON MICROB, V69, P7248, DOI 10.1128/AEM.69.12.7248-7256.2003; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Tekerekoglu MS, 2003, MICROBIOLOGICA, V26, P57; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Webster G, 2002, APPL ENVIRON MICROB, V68, P20, DOI 10.1128/AEM.68.1.20-30.2002; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x	53	50	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42531	10.1371/journal.pone.0042531	http://dx.doi.org/10.1371/journal.pone.0042531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880020	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000307284100121
J	Fang, Y; Yu, YH; Hou, Q; Zheng, X; Zhang, M; Zhang, DY; Li, JX; Wu, XR; Huang, CS				Fang, Yong; Yu, Yonghui; Hou, Qi; Zheng, Xiao; Zhang, Min; Zhang, Dongyun; Li, Jingxia; Wu, Xue-Ru; Huang, Chuanshu			The Chinese Herb Isolate Isorhapontigenin Induces Apoptosis in Human Cancer Cells by Down-regulating Overexpression of Antiapoptotic Protein XIAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED INHIBITOR; TRAIL-MEDIATED APOPTOSIS; NUCLEAR-FACTOR; GENE PROMOTER; IN-VITRO; EXPRESSION; INDUCTION; ARSENITE; SP1; PROLIFERATION	Although the Chinese herb Gnetum cleistostachyum has been used as a remedy for cancers for hundred years, the active compounds and molecular mechanisms underlying its anti-cancer activity have not been explored. Recently a new derivative of stilbene compound, isorhapontigenin (ISO), was isolated from this Chinese herb. In the present study, we examined the potential of ISO in anti-cancer activity and the mechanisms involved in human cancer cell lines. We found that ISO exhibited significant inhibitory effects on human bladder cancer cell growth that was accompanied by marked apoptotic induction as well as down-regulation of the X-linked inhibitor of apoptosis protein (XIAP). Further studies have shown that ISO down-regulation of XIAP protein expression was only observed in endogenous XIAP, but not in constitutionally exogenously expressed XIAP in the same cells, excluding the possibility of ISO regulating XIAP expression at the level of protein degradation. We also identified that ISO down-regulated XIAP gene transcription via inhibition of Sp1 transactivation. There was no significant effect of ISO on apoptosis and colony formation of cells transfected with exogenous HA-tagged XIAP. Collectively, current studies, for the first time to the best of our knowledge, identify ISO as a major active compound for the anti-cancer activity of G. cleistostachyum by down-regulation of XIAP expression and induction of apoptosis through specific targeting of a SP1 pathway, and cast new light on the treatment of the cancer patients with XIAP overexpression.	[Fang, Yong; Yu, Yonghui; Zheng, Xiao; Zhang, Min; Zhang, Dongyun; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Fang, Yong] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310016, Zhejiang, Peoples R China; [Hou, Qi] Mat Med Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Hou, Qi] Peking Union Med Coll, Beijing 100050, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York University; New York University	Huang, CS (corresponding author), 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health from NCI [CA112557]; NIEHS [ES000260, ES010344]; National Science Foundation [NSFC81229002, NSFC30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from the NCI, ES000260 and ES010344 from the NIEHS, and National Science Foundation Grants NSFC81229002 and NSFC30971516.	Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cai T, 2011, CURR CANCER DRUG TAR, V11, P548, DOI 10.2174/156800911795656001; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, MOL CANCER THER, V8, P2762, DOI 10.1158/1535-7163.MCT-09-0509; Danson S, 2007, CURR CANCER DRUG TAR, V7, P785, DOI 10.2174/156800907783220471; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Holt SV, 2011, ONCOL REP, V25, P1177, DOI 10.3892/or.2011.1167; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Huang KS, 2002, PLANTA MED, V68, P916, DOI 10.1055/s-2002-34951; Huang KS, 2000, PHYTOCHEMISTRY, V54, P875, DOI 10.1016/S0031-9422(00)00151-5; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; Jiang C, 2011, MOL MED REP, V4, P667, DOI 10.3892/mmr.2011.472; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li HL, 2005, FREE RADICAL BIO MED, V38, P243, DOI 10.1016/j.freeradbiomed.2004.10.020; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Liu Y, 2011, J INT MED RES, V39, P1682, DOI 10.1177/147323001103900510; Liu YL, 2004, BIOCHEM PHARMACOL, V67, P777, DOI 10.1016/j.bcp.2003.09.025; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Rajput Sandeep, 2010, Front Biosci (Schol Ed), V2, P176; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; Shibata T, 2008, ANN SURG ONCOL, V15, P3579, DOI 10.1245/s10434-008-0062-4; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Song L, 2011, ONCOGENE, V30, P1360, DOI 10.1038/onc.2010.506; Wai PY, 2012, WORLD J CLIN ONCOL, V3, P15, DOI 10.5306/wjco.v3.i2.15; Wang SM, 2011, CURR TOP MICROBIOL, V348, P89, DOI 10.1007/82_2010_111; Wang ZH, 2011, INT J ONCOL, V39, P1123, DOI 10.3892/ijo.2011.1115; Yano K, 2011, INT J ONCOL, V38, P365, DOI 10.3892/ijo.2010.874; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002; Zhang LA, 2010, CLIN CANCER RES, V16, P4478, DOI 10.1158/1078-0432.CCR-10-0859	40	50	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35234	35243		10.1074/jbc.M112.389494	http://dx.doi.org/10.1074/jbc.M112.389494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896709	Green Published, hybrid			2022-12-25	WOS:000309968000033
J	Hanna, J; Waterman, D; Boselli, M; Finley, D				Hanna, John; Waterman, David; Boselli, Monica; Finley, Daniel			Spg5 Protein Regulates the Proteasome in Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; BUDDING YEAST; DEGRADATION; PARTICLE; GENE; IDENTIFICATION; STARVATION; COMPLEXES; AUTOPHAGY	The ubiquitin-proteasome system is the major pathway for selective protein degradation in eukaryotes. Despite extensive study of this system, the mechanisms by which proteasome function and cell growth are coordinated remain unclear. Here, we identify Spg5 as a novel component of the ubiquitin-proteasome system. Spg5 binds the regulatory particle of the proteasome and the base subassembly in particular, but it is excluded from mature proteasomes. The SPG5 gene is strongly induced in the stationary phase of budding yeast, and spg5 Delta mutants show a progressive loss of viability under these conditions. Accordingly, during logarithmic growth, Spg5 appears largely dispensable for proteasome function, but during stationary phase the proteasomes of spg5 Delta mutants show both structural and functional defects. This loss of proteasome function is reflected in the accumulation of oxidized proteins preferentially in stationary phase in spg5 Delta mutants. Thus, Spg5 is a positive regulator of the proteasome that is critical for survival of cells that have ceased to proliferate due to nutrient limitation.	[Hanna, John; Waterman, David; Boselli, Monica; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Hanna, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jwhanna@partners.org; Daniel_Finley@hms.harvard.edu			National Institutes of Health [R37GM043601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM043601 (to D. F.).	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2005, METHODS YEAST GENETI; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Devenish Rodney J, 2012, Front Biosci (Schol Ed), V4, P1354; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	34	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34400	34409		10.1074/jbc.M112.390294	http://dx.doi.org/10.1074/jbc.M112.390294			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904326	Green Published, hybrid			2022-12-25	WOS:000309654200042
J	Kang, WH; Seo, JK; Chung, BN; Kim, KH; Kang, BC				Kang, Won-Hee; Seo, Jang-Kyun; Chung, Bong Nam; Kim, Kook-Hyung; Kang, Byoung-Cheorl			Helicase Domain Encoded by Cucumber mosaic virus RNA1 Determines Systemic Infection of Cmr1 in Pepper	PLOS ONE			English	Article							TO-CELL MOVEMENT; LONG-DISTANCE MOVEMENT; SATELLITE RNA; COAT PROTEIN; 1A PROTEIN; METHYLTRANSFERASE DOMAIN; HYPERSENSITIVE RESPONSE; ZUCCHINI SQUASH; VIRAL SPREAD; 3A PROTEIN	The Cmr1 gene in peppers confers resistance to Cucumber mosaic virus isolate-P0 (CMV-P0). Cmr1 restricts the systemic spread of CMV strain-Fny (CMV-Fny), whereas this gene cannot block the spread of CMV isolate-P1 (CMV-P1) to the upper leaves, resulting in systemic infection. To identify the virulence determinant of CMV-P1, six reassortant viruses and six chimeric viruses derived from CMV-Fny and CMV-P1 cDNA clones were used. Our results demonstrate that the C-terminus of the helicase domain encoded by CMV-P1 RNA1 determines susceptibility to systemic infection, and that the helicase domain contains six different amino acid substitutions between CMV-Fny and CMV-P1. To identify the key amino acids of the helicase domain determining systemic infection with CMV-P1, we then constructed amino acid substitution mutants. Of the mutants tested, amino acid residues at positions 865, 896, 957, and 980 in the 1a protein sequence of CMV-P1 affected the systemic infection. Virus localization studies with GFP-tagged CMV clones and in situ localization of virus RNA revealed that these four amino acid residues together form the movement determinant for CMV-P1 movement from the epidermal cell layer to mesophyll cell layers. Quantitative real-time PCR revealed that CMV-P1 and a chimeric virus with four amino acid residues of CMV-P1 accumulated more genomic RNA in inoculated leaves than did CMV-Fny, indicating that those four amino acids are also involved in virus replication. These results demonstrate that the C-terminal region of the helicase domain is responsible for systemic infection by controlling virus replication and cell-to-cell movement. Whereas four amino acids are responsible for acquiring virulence in CMV-Fny, six amino acid (positions at 865, 896, 901, 957, 980 and 993) substitutions in CMV-P1 were required for complete loss of virulence in 'Bukang'.	[Kang, Won-Hee; Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Kang, Won-Hee; Kang, Byoung-Cheorl] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Seo, Jang-Kyun; Kim, Kook-Hyung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Chung, Bong Nam] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kang, WH (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019		Vegetable Breeding Research Center through Agriculture Research Center (ARC) from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [0636-20110005]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0005310]	Vegetable Breeding Research Center through Agriculture Research Center (ARC) from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant (code: 0636-20110005) from the Vegetable Breeding Research Center through Agriculture Research Center (ARC) program from Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea and by Basic Science Research Program though the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0005310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Chaim A, 2001, THEOR APPL GENET, V102, P1213, DOI 10.1007/s001220100581; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Canto T, 1997, VIROLOGY, V237, P237, DOI 10.1006/viro.1997.8804; Canto T, 2001, J VIROL, V75, P9114, DOI 10.1128/JVI.75.19.9114-9120.2001; Canto T, 1999, VIROLOGY, V265, P74, DOI 10.1006/viro.1999.0028; Caranta C, 1997, THEOR APPL GENET, V94, P431, DOI 10.1007/s001220050433; Caranta C, 2002, THEOR APPL GENET, V104, P586, DOI 10.1007/s001220100753; Chu MH, 1997, MOL PLANT MICROBE IN, V10, P472, DOI 10.1094/MPMI.1997.10.4.472; Ding SW, 1996, P NATL ACAD SCI USA, V93, P7470, DOI 10.1073/pnas.93.15.7470; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; DIVEKI Z, 2004, MOL PLANT MICROBE IN, V17, P837; DUFOUR O, 1989, CAN J BOT, V67, P655, DOI 10.1139/b89-088; Eggenberger AL, 2008, MOL PLANT MICROBE IN, V21, P931, DOI 10.1094/MPMI-21-7-0931; Feng JL, 2006, ACTA BIOCH BIOPH SIN, V38, P669, DOI [10.1111/j.1745-7270.2006.00216.x, 10.1111/J.1745-7270.2006.00216.x]; GALON A, 1994, VIROLOGY, V205, P280, DOI 10.1006/viro.1994.1644; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Grube RC, 2000, PLANT DIS, V84, P885, DOI 10.1094/PDIS.2000.84.8.885; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Havelda Z, 2000, PLANT CELL, V12, P1975, DOI 10.1105/tpc.12.10.1975; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; 이미연, 2006, The Plant Pathology Journal, V22, P265; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang WH, 2010, THEOR APPL GENET, V120, P1587, DOI 10.1007/s00122-010-1278-9; Kaplan IB, 1997, VIROLOGY, V230, P343, DOI 10.1006/viro.1997.8468; Karasawa A, 1999, PHYTOPATHOLOGY, V89, P1186, DOI 10.1094/PHYTO.1999.89.12.1186; Kim CH, 1997, EMBO J, V16, P4060, DOI 10.1093/emboj/16.13.4060; Kim MJ, 2008, J VIROL, V82, P4823, DOI 10.1128/JVI.02518-07; Kim MJ, 2006, J GEN VIROL, V87, P3425, DOI 10.1099/vir.0.82252-0; Kim MJ, 2006, BIOCHEM BIOPH RES CO, V340, P228, DOI 10.1016/j.bbrc.2005.11.178; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; LAKSHMAN DK, 1985, PHYTOPATHOLOGY, V75, P758, DOI 10.1094/Phyto-75-758; Lapidot M, 1997, PLANT DIS, V81, P185, DOI 10.1094/PDIS.1997.81.2.185; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; MCGARVEY P, 1995, J GEN VIROL, V76, P2257, DOI 10.1099/0022-1317-76-9-2257; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; Roossinck MJ, 1997, J VIROL, V71, P608, DOI 10.1128/JVI.71.1.608-612.1997; ROOSSINCK MJ, 1990, MOL PLANT MICROBE IN, V3, P188, DOI 10.1094/MPMI-3-188; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Ryu KH, 1998, MOL PLANT MICROBE IN, V11, P351, DOI 10.1094/MPMI.1998.11.5.351; Salanki K, 2007, VIROLOGY, V358, P109, DOI 10.1016/j.virol.2006.08.014; Seo JK, 2009, VIROLOGY, V383, P248, DOI 10.1016/j.virol.2008.10.033; Shi BJ, 2002, MOL PLANT MICROBE IN, V15, P947, DOI 10.1094/MPMI.2002.15.9.947; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Stamova BS, 2000, THEOR APPL GENET, V101, P527, DOI 10.1007/s001220051512; Takahashi Hideki, 2000, Journal of General Plant Pathology, V66, P335, DOI 10.1007/PL00012975; Takeshita M, 2004, VIROLOGY, V328, P45, DOI 10.1016/j.virol.2004.06.046; Takeshita M, 2001, ARCH VIROL, V146, P697, DOI 10.1007/s007050170140; Takeshita M, 2012, MOL PLANT MICROBE IN, V25, P18, DOI 10.1094/MPMI-06-11-0170; Takeshita M, 2009, VIROLOGY, V389, P59, DOI 10.1016/j.virol.2009.04.010; Valkonen JPT, 1999, THEOR APPL GENET, V99, P996, DOI 10.1007/s001220051407; Wong SM, 1999, MOL PLANT MICROBE IN, V12, P628, DOI 10.1094/MPMI.1999.12.7.628; Xu P, 2000, PLANT CELL, V12, P1079, DOI 10.1105/tpc.12.7.1079; Yamaguchi N, 2005, J GEN VIROL, V86, P2359, DOI 10.1099/vir.0.81059-0; Yeom SI, 2011, MOL PLANT MICROBE IN, V24, P671, DOI 10.1094/MPMI-08-10-0183; Ziebell H, 2007, J GEN VIROL, V88, P2862, DOI 10.1099/vir.0.83138-0	59	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43136	10.1371/journal.pone.0043136	http://dx.doi.org/10.1371/journal.pone.0043136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905216	gold, Green Submitted, Green Published			2022-12-25	WOS:000307823600050
J	Carbonara, S; Bruno, G; Di Ciaula, G; Pantaleo, AD; Angarano, G; Monno, L				Carbonara, Sergio; Bruno, Giuseppe; Di Ciaula, Giuseppe; Pantaleo, Anna Donata; Angarano, Gioacchino; Monno, Laura			Limiting Severe Outcomes and Impact on Intensive Care Units of Moderate-Intermediate 2009 Pandemic Influenza: Role of Infectious Diseases Units	PLOS ONE			English	Article							H1N1 INFLUENZA; RISK-FACTORS; BACTERIAL PNEUMONIA; A(H1N1) INFECTION; HOSPITALIZATION; VIRUS; CLARITHROMYCIN; MACROLIDES; DEATH	Purpose: The rate of severe outcomes of patients with 2009 pandemic (A/H1N1) influenza (2009pI) hospitalized in non-intensive care units (ICUs) has not been defined thus far. This study aims to assess the efficacy of the management of patients with influenza-like illness (ILI) of moderate intermediate severity in an infectious diseases unit (IDU) during the first wave of 2009pI and its influence on the burden of ICUs. Methods: All patients hospitalized from October 27, 2009, to February 5, 2010, with ILI were included in this prospective observational study. The IDU was organized and the staff was trained to provide intermediate care; patients were transferred to the ICU only if they required invasive ventilation, extracorporeal membrane oxygenation, or advanced cardiovascular support. Demographic data, clinical presentation, coexisting medical conditions, and laboratory and radiological findings were recorded and analyzed, as well as treatment and outcome data. Results: Overall, 108 patients (median age 36 years [IQR 27-54], 57.4% males) including 66.7% with >= 1 risk factor for severe influenza, 47.2% with confirmed 2009pI by RT-PCR and 63.9% with pneumonia, were enrolled in the study. All subjects received intravenous fluids and 83.3% were administered oseltamivir, 96.3% antibacterials, 19.4% oxygen therapy without ventilatory support, and 10.2% non-invasive ventilation. A total of 106 (98.1%) subjects were discharged after a 6-day median hospital stay [IQR 4-9]. Two patients (1.9%) were transferred to the ICU. There were no deaths. Conclusions: These results suggest that the aggressive treatment of patients with moderate intermediate severity 2009 pandemic ILI in non-ICU wards may result in a low rate of severe outcomes and brief hospitalization. IDUs, if properly organized for intermediate care, may efficiently provide correct disease management, in addition to complying with infection control requirements, thus reducing the burden of the pandemic on ICUs. Further studies are warranted to evaluate the outcome of patients with moderate intermediate 2009pI in different non-ICU settings.	[Carbonara, Sergio; Bruno, Giuseppe; Di Ciaula, Giuseppe; Pantaleo, Anna Donata; Angarano, Gioacchino; Monno, Laura] Univ Bari, Clin Infect Dis, Sch Med & Surg, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Carbonara, S (corresponding author), Univ Bari, Clin Infect Dis, Sch Med & Surg, Bari, Italy.	s_carbonara@yahoo.it	Carbonara, Sergio/AAE-7283-2022	Carbonara, Sergio/0000-0001-6757-2458; ANGARANO, Gioacchino/0000-0003-3207-7523; MONNO, Laura/0000-0002-2713-4258				Agenzia Italiana del Farmaco, 2008, GAZZETTA UFFICI 0331, V76, P68; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Bassetti M, 2011, CLIN MICROBIOL INFEC, V17, P247, DOI 10.1111/j.1469-0691.2010.03275.x; Baudouin S, 2002, THORAX, V57, P192; Bermejo-Martin JF, 2009, J INFECT DEV COUNTR, V3, P159, DOI 10.3855/jidc.18; British Thoracic Society Royal College of Physicians London Intensive Care Society, 2008, US NON VENT MAN PAT; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, UPD CDC EST 2009 H1N; Charles PGP, 2009, MED J AUSTRALIA, V191, P517, DOI 10.5694/j.1326-5377.2009.tb02922.x; ECDC, 2010, 2009 H1N1 PAND EUR R; European Centre for Disease Prevention and Control (ECDC), 2010, INFL SURV EUR 2008 0; Gilca R, 2011, INFLUENZA OTHER RESP, V5, P247, DOI 10.1111/j.1750-2659.2011.00204.x; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Leelarasamee Amorn, 2008, Journal of the Medical Association of Thailand, V91, P924; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Louie J., 2009, Morbidity and Mortality Weekly Report, V58, P1071; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mereckiene J, 2008, Euro Surveill, V13; Ministero del Lavoro della Salute e delle Politiche Sociali Dipartimento della prevenzione e della comunicazione Direzione generale della prevenzione sanitaria Ufficio V-Malattie Infettive e Profilassi Internazionale Roma, 2009, 0034102 MIN LAV SAL; Ministero della Salute, 2010, CIRC INFL 2010 2011; Miyamoto D, 2008, BIOL PHARM BULL, V31, P217, DOI 10.1248/bpb.31.217; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Ninomiya Keiko, 2003, Jpn J Antibiot, V56 Suppl A, P84; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10; Parnham Michael J, 2005, Curr Opin Infect Dis, V18, P125, DOI 10.1097/01.qco.0000160901.71813.fe; Poeppl W, 2011, INFECTION, V39, P341, DOI 10.1007/s15010-011-0121-9; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Sato K, 1998, AM J RESP CRIT CARE, V157, P853, DOI 10.1164/ajrccm.157.3.9703098; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; STAUDINGER T, 2010, WIEN KLIN WOCHENSCHR, V122, P3, DOI DOI 10.1007/S00508-010-1304-6; Tsigrelis C, 2010, INFECTION, V38, P237, DOI 10.1007/s15010-010-0009-0; Tsurita M, 2001, J PHARMACOL EXP THER, V298, P362; U. K. Department of Health (DH), 2009, PAND H1N1 2009 INFL; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; White DB, 2009, JAMA-J AM MED ASSOC, V302, P1905, DOI 10.1001/jama.2009.1539; World Health Organization, 2009, HUM INF PAND H1N1 20; World Health Organization, 2009, CLIN MAN HUM INF PAN; World Health Organization (2010), 2009, EV PAND H1N1 2009 AP; World Health Organization (WHO), GUID PHARM MAN PAN 1; Yang SG, 2012, PLOS ONE, V71; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42940	10.1371/journal.pone.0042940	http://dx.doi.org/10.1371/journal.pone.0042940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905188	Green Published, gold			2022-12-25	WOS:000307500800031
J	Dufresne, SF; Datta, K; Li, XM; Dadachova, E; Staab, JF; Patterson, TF; Feldmesser, M; Marr, KA				Dufresne, Simon F.; Datta, Kausik; Li, Xinming; Dadachova, Ekaterina; Staab, Janet F.; Patterson, Thomas F.; Feldmesser, Marta; Marr, Kieren A.			Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; LATEX AGGLUTINATION-TEST; ENZYME-IMMUNOASSAY; PULMONARY ASPERGILLOSIS; NEUTROPENIC PATIENTS; INFECTED-RABBITS; FUMIGATUS; SERUM; PCR; SAMPLES	Mortality associated with invasive aspergillosis (IA) remains high, partly because of delayed diagnosis. Detection of microbial exoantigens, released in serum and other body fluids during infection, may help timely diagnosis. In course of IA, Aspergillus galactomannan (GM), a well established polysaccharide biomarker, is released in body fluids including urine. Urine is an abundant, safely collected specimen, well-suited for point-of-care (POC) testing, which could play an increasing role in screening for early disease. Our main objective was to demonstrate GM antigenuria as a clinically relevant biological phenomenon in IA and establish proof-of-concept that it could be translated to POC diagnosis. Utilizing a novel IgM monoclonal antibody (MAb476) that recognizes GM-like antigens from Aspergillus and other molds, we demonstrated antigenuria in an experimental animal IA model (guinea pig), as well as in human patients. In addition, we investigated the chemical nature of the urinary excreted antigen in human samples, characterized antigen detection in urine by immunoassays, described a putative assay inhibitor in urine, and indicated means of alleviation of the inhibition. We also designed and used a lateral flow immunochromatographic assay to detect urinary excreted antigen in a limited number of IA patient urine samples. In this study, we establish that POC diagnosis of IA based on urinary GM detection is feasible. Prospective studies will be necessary to establish the performance characteristics of an optimized device and define its optimal clinical use.	[Dufresne, Simon F.; Datta, Kausik; Staab, Janet F.; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Marr, Kieren A.] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Li, Xinming; Dadachova, Ekaterina; Feldmesser, Marta] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Patterson, Thomas F.] S Texas Vet Healthcare Syst, San Antonio, TX USA; [Patterson, Thomas F.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Dufresne, Simon F.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Li, Xinming] China Med Univ, Shenyang, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Universite de Montreal; China Medical University	Dufresne, SF (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	kmarr4@jhmi.edu	Datta, Kausik/A-2879-2016; Dadachova, Ekaterina/I-7838-2013	Datta, Kausik/0000-0001-8666-143X; 	Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program; National Institutes of Health [AI065745, AI060507]; National Institute of Allergy and Infectious Disease [AI30041]; Hopital Maisonneuve-Rosemont and Universite de Montreal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065745, R56AI060507, R01AI060507] Funding Source: NIH RePORTER	Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hopital Maisonneuve-Rosemont and Universite de Montreal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Accelerated Translational Incubator Pilot (ATIP) program grant to JFS; National Institutes of Health [R21 grant AI065745 to MF, grant AI060507 to ED and National Institute of Allergy and Infectious Disease N01 Contract AI30041 to TFP]; and Hopital Maisonneuve-Rosemont and Universite de Montreal [fellowship grant to SFD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSORG R, 1994, EUR J CLIN MICROBIOL, V13, P582, DOI 10.1007/BF01971310; Antinori S, 2010, TRANSPL INFECT DIS, V12, P64, DOI 10.1111/j.1399-3062.2009.00460.x; Asgeirsson D, 2007, ACTA PHYSIOL, V191, P237, DOI 10.1111/j.1748-1716.2007.01733.x; Baddley JW, 2010, CLIN INFECT DIS, V50, P1559, DOI 10.1086/652768; BENNETT JE, 1987, J INFECT DIS, V155, P1005, DOI 10.1093/infdis/155.5.1005; CAPEDING MRZ, 1991, J CLIN MICROBIOL, V29, P1818, DOI 10.1128/JCM.29.9.1818-1821.1991; Dadachova E, 2003, P NATL ACAD SCI USA, V100, P10942, DOI 10.1073/pnas.1731272100; De Jesus M, 2010, EUKARYOT CELL, V9, P1018, DOI 10.1128/EC.00268-09; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dominguez J, 1999, EUR J CLIN MICROBIOL, V18, P896, DOI 10.1007/s100960050427; Dowell SF, 2001, CLIN INFECT DIS, V32, P824, DOI 10.1086/319205; DUPONT B, 1987, J INFECT DIS, V155, P1, DOI 10.1093/infdis/155.1.1; Gohda T, 2012, AM J PHYSL RENAL PHY; Hawk PB, 1918, URINE PHYSL CONSTITU, P369; HAYNES KA, 1990, J CLIN MICROBIOL, V28, P2040, DOI 10.1128/JCM.28.9.2040-2044.1990; Howard CP, 1926, J CLIN INVEST, V2, P587, DOI 10.1172/JCI100066; Ikuta K, 1997, BIOCHEM J, V323, P297, DOI 10.1042/bj3230297; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; KOHLER RB, 1981, ANN INTERN MED, V94, P601, DOI 10.7326/0003-4819-94-5-601; Labbe AC, 2007, BIOL BLOOD MARROW TR, V13, P1192, DOI 10.1016/j.bbmt.2007.06.013; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lay LDAR, 2003, CLIN DIAGN LAB IMMUN, V10, P492, DOI 10.1128/CDLI.10.3.492-494.2003; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; LEHMANN PF, 1978, INFECT IMMUN, V20, P570, DOI 10.1128/IAI.20.2.570-572.1978; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Lindsley MD, 2007, CLIN VACCINE IMMUNOL, V14, P700, DOI 10.1128/CVI.00083-07; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Mokaddas E, 2010, J MED MICROBIOL, V59, P1519, DOI 10.1099/jmm.0.023630-0; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Salas V, 2011, ANTIMICROB AGENTS CH, V55, P676, DOI 10.1128/AAC.00736-10; Salonen J, 2000, SCAND J INFECT DIS, V32, P485, DOI 10.1080/003655400458749; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Shimizu K, 2001, GENETICS, V157, P591; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Staab JF, 2009, J CLIN MICROBIOL, V47, P2079, DOI 10.1128/JCM.00551-09; Stephens-Romero SD, 2005, INFECT IMMUN, V73, P114, DOI 10.1128/IAI.73.1.114-125.2005; STYNEN D, 1995, J CLIN MICROBIOL, V33, P497, DOI 10.1128/JCM.33.2.497-500.1995; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; TEMSTET A, 1992, J CLIN MICROBIOL, V30, P2544, DOI 10.1128/JCM.30.10.2544-2550.1992; Vallor AC, 2008, ANTIMICROB AGENTS CH, V52, P2593, DOI 10.1128/AAC.00276-08; Varga J, 2005, ANTON LEEUW INT J G, V88, P141, DOI 10.1007/s10482-005-3870-6; VERWEIJ PE, 1995, J CLIN MICROBIOL, V33, P1912, DOI 10.1128/JCM.33.7.1912-1914.1995; VERWEIJ PE, 1995, J CLIN PATHOL, V48, P474, DOI 10.1136/jcp.48.5.474; Weber CJ, 1928, J BIOL CHEM, V78, P465; Wheat LJ, 2007, CLIN VACCINE IMMUNOL, V14, P638, DOI 10.1128/CVI.00479-06	52	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42736	10.1371/journal.pone.0042736	http://dx.doi.org/10.1371/journal.pone.0042736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900046	gold, Green Submitted, Green Published			2022-12-25	WOS:000307380900063
J	Gu, SH; Wang, SY; Zhang, XY; Ji, P; Liu, JT; Wang, GR; Wu, KM; Guo, YY; Zhou, JJ; Zhang, YJ				Gu, Shao-Hua; Wang, Song-Ying; Zhang, Xue-Ying; Ji, Ping; Liu, Jing-Tao; Wang, Gui-Rong; Wu, Kong-Ming; Guo, Yu-Yuan; Zhou, Jing-Jiang; Zhang, Yong-Jun			Functional Characterizations of Chemosensory Proteins of the Alfalfa Plant Bug Adelphocoris lineolatus Indicate Their Involvement in Host Recognition	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; MOLECULAR-CLONING; EXPRESSION PATTERN; REGENERATING LEGS; SILKWORM MOTH; VOLATILES; LOCALIZATION; IMMUNOLOCALIZATION; PURIFICATION; ATTRACTION	Insect chemosensory proteins (CSPs) have been proposed to capture and transport hydrophobic chemicals from air to olfactory receptors in the lymph of antennal chemosensilla. They may represent a new class of soluble carrier protein involved in insect chemoreception. However, their specific functional roles in insect chemoreception have not been fully elucidated. In this study, we report for the first time three novel CSP genes (AlinCSP1-3) of the alfalfa plant bug Adelphocoris lineolatus (Goeze) by screening the antennal cDNA library. The qRT-PCR examinations of the transcript levels revealed that all three genes (AlinCSP1-3) are mainly expressed in the antennae. Interestingly, these CSP genes AlinCSP1-3 are also highly expressed in the 5th instar nymphs, suggesting a proposed function of these CSP proteins (AlinCSP1-3) in the olfactory reception and in maintaining particular life activities into the adult stage. Using bacterial expression system, the three CSP proteins were expressed and purified. For the first time we characterized the types of sensilla in the antennae of the plant bug using scanning electron microscopy (SEM). Immunocytochemistry analysis indicated that the CSP proteins were expressed in the pheromone-sensitive sensilla trichodea and general odorant-sensitive sensilla basiconica, providing further evidence of their involvement in chemoreception. The antennal activity of 55 host-related semiochemicals and sex pheromone compounds in the host location and mate selection behavior of A. lineolatus was investigated using electroantennogram (EAG), and the binding affinities of these chemicals to the three CSPs (AlinCSP1-3) were measured using fluorescent binding assays. The results showed several host-related semiochemicals, (Z)-3-hexen-1-ol, (E)-2-hexen-1-al and valeraldehyde, have a high binding affinity with AlinCSP1-3 and can elicit significant high EAG responses of A. lineolatus antennae. Our studies indicate the three antennae-biased CSPs may mediate host recognition in the alfalfa plant bug A. lineolatus.	[Gu, Shao-Hua; Wang, Song-Ying; Zhang, Xue-Ying; Ji, Ping; Liu, Jing-Tao; Wang, Gui-Rong; Wu, Kong-Ming; Guo, Yu-Yuan; Zhang, Yong-Jun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Gu, SH (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	jing-jiang.zhou@rothamsted.ac.uk; yjzhang@ippcaas.cn			China National "973" Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858]; Royal Society, United Kingdom [31111130203]	China National "973" Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, United Kingdom(Royal Society of London)	This work was supported by the China National "973" Basic Research Program (2012CB114104), and the National Natural Science Foundation of China (31071694 and 31171858). JJ Zhou and YJ Zhang acknowledge financial support from the Royal Society, United Kingdom, for the international joint project between China and the United Kingdom (31111130203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Bai SX, 2001, THESIS CHINESE ACAD, P20; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blackmer JL, 2004, J CHEM ECOL, V30, P1547, DOI 10.1023/B:JOEC.0000042067.27698.30; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Campanacci V, 2003, P NATL ACAD SCI USA, V100, P5069, DOI 10.1073/pnas.0836654100; Chinta S, 1997, INT J INSECT MORPHOL, V26, P21, DOI 10.1016/S0020-7322(96)00022-0; CRAIG C. H., 1963, CANADIAN ENTOMOL, V95, P6; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; de Santis F, 2006, J CHEM ECOL, V32, P1703, DOI 10.1007/s10886-006-9103-2; Drukker B, 2000, PHYSIOL ENTOMOL, V25, P260, DOI 10.1046/j.1365-3032.2000.00190.x; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; GUELDNER RC, 1978, INSECT BIOCHEM, V8, P389, DOI 10.1016/0020-1790(78)90026-4; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Kaissling K.-E., 1971, Handbook of sensory physiology, Vol. IV, P351; Kendra PE, 2005, ENVIRON ENTOMOL, V34, P584, DOI 10.1603/0046-225X-34.3.584; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Millar JG, 2005, TOP CURR CHEM, V240, P37, DOI 10.1007/b98315; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Mosbah A, 2003, BIOCHEM J, V369, P39, DOI 10.1042/BJ20021217; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Plettner E, 2002, CURR MED CHEM, V9, P1075, DOI 10.2174/0929867024606669; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robert D, 2002, CURR OPIN NEUROBIOL, V12, P715, DOI 10.1016/S0959-4388(02)00378-1; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHNEIDER D, 1957, Z VERGL PHYSIOL, V40, P8, DOI 10.1007/BF00298148; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VISSER JH, 1979, ENTOMOL EXP APPL, V25, P86, DOI 10.1007/BF00421821; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wardle AR, 2003, J CHEM ECOL, V29, P931, DOI 10.1023/A:1022987901330; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Whitbey RM, 1999, ENVIRON ENTOMOL, V28, P201, DOI 10.1093/ee/28.2.201; Yu Hui-lin, 2007, Yingyong Shengtai Xuebao, V18, P859; Zhao N, 2010, PLANT PHYSIOL BIOCH, V48, P279, DOI 10.1016/j.plaphy.2010.01.023; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	72	96	113	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42871	10.1371/journal.pone.0042871	http://dx.doi.org/10.1371/journal.pone.0042871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900060	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900078
J	Hoover, WC; Zhang, WW; Xue, ZD; Gao, HL; Chernoff, J; Clapp, DW; Gunst, SJ; Tepper, RS				Hoover, Wyn C.; Zhang, Wenwu; Xue, Zhidong; Gao, Huanling; Chernoff, Jonathan; Clapp, D. Wade; Gunst, Susan J.; Tepper, Robert S.			Inhibition of p21 Activated Kinase (PAK) Reduces Airway Responsiveness In Vivo and In Vitro in Murine and Human Airways	PLOS ONE			English	Article							P21-ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE; CONTRACTION; MECHANISMS; PHOSPHORYLATION; TARGETS; CELLS; MAPK	The p21-activated protein kinases (Paks) have been implicated in the regulation of smooth muscle contractility, but the physiologic effects of Pak activation on airway reactivity in vivo are unknown. A mouse model with a genetic deletion of Pak1 (Pak1(-/-)) was used to determine the role of Pak in the response of the airways in vivo to challenge with inhaled or intravenous acetylcholine (ACh). Pulmonary resistance was measured in anesthetized mechanically ventilated Pak1(-/-) and wild type mice. Pak1(-/-) mice exhibited lower airway reactivity to ACh compared with wild type mice. Tracheal segments dissected from Pak1(-/-) mice and studied in vitro also exhibited reduced responsiveness to ACh compared with tracheas from wild type mice. Morphometric assessment and pulmonary function analysis revealed no differences in the structure of the airways or lung parenchyma, suggesting that that the reduced airway responsiveness did not result from structural abnormalities in the lungs or airways due to Pak1 deletion. Inhalation of the small molecule synthetic Pak1 inhibitor, IPA3, also significantly reduced in vivo airway responsiveness to ACh and 5-hydroxytryptamine (5-Ht) in wild type mice. IPA3 inhibited the contractility of isolated human bronchial tissues to ACh, confirming that this inhibitor is also effective in human airway smooth muscle tissue. The results demonstrate that Pak is a critical component of the contractile activation process in airway smooth muscle, and suggest that Pak inhibition could provide a novel strategy for reducing airway hyperresponsiveness.	[Hoover, Wyn C.; Xue, Zhidong; Gao, Huanling; Clapp, D. Wade; Tepper, Robert S.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA; [Hoover, Wyn C.; Xue, Zhidong; Gao, Huanling; Clapp, D. Wade; Tepper, Robert S.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Zhang, Wenwu; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Clapp, D. Wade] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Fox Chase Cancer Center; Indiana University System; Indiana University Bloomington	Hoover, WC (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46204 USA.	rtepper@iupui.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836; Gunst, Susan/0000-0001-9836-4782	American Asthma Foundation [08-0049];  [NIH-HL29289];  [HL074099]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074099, R01HL109629, R01HL029289, R23HL029289] Funding Source: NIH RePORTER	American Asthma Foundation; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH-HL29289, HL074099, and American Asthma Foundation 08-0049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dechert MA, 2001, AM J PHYSIOL-CELL PH, V281, pC123, DOI 10.1152/ajpcell.2001.281.1.C123; Foster DB, 2000, J BIOL CHEM, V275, P1959, DOI 10.1074/jbc.275.3.1959; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; McFawn PK, 2003, AM J PHYSIOL-LUNG C, V284, pL863, DOI 10.1152/ajplung.00068.2002; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Murthy KS, 2003, BIOCHEM J, V374, P1; Pacheco A, 2010, INT J BIOCHEM CELL B, V42, P13, DOI 10.1016/j.biocel.2009.09.006; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wirth A, 2003, J PHYSL, V549, P2; Xue Z, 2008, J APPL PHYSIOL, V104, P610, DOI 10.1152/japplphysiol.00241.2007; Xue Z, 2005, J APPL PHYSIOL, V99, P677, DOI 10.1152/japplphysiol.00165.2005; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	23	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42601	10.1371/journal.pone.0042601	http://dx.doi.org/10.1371/journal.pone.0042601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900031	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900047
J	Kumar, P; Lindberg, L; Thirkill, TL; Ji, JW; Martsching, L; Douglas, GC				Kumar, Priyadarsina; Lindberg, Louise; Thirkill, Twanda L.; Ji, Jennifer W.; Martsching, Lindsay; Douglas, Gordon C.			The MUC1 Extracellular Domain Subunit Is Found in Nuclear Speckles and Associates with Spliceosomes	PLOS ONE			English	Article							POLYMORPHIC EPITHELIAL MUCIN; CARCINOMA-ASSOCIATED PROTEIN; CELL-SURFACE RECEPTORS; GROWTH-FACTOR RECEPTOR; CYTOPLASMIC TAIL; BREAST-CARCINOMA; CANCER-CELLS; BETA-CATENIN; IN-SITU; SUBNUCLEAR LOCALIZATION	MUC1 is a large transmembrane glycoprotein and oncogene expressed by epithelial cells and overexpressed and underglycosylated in cancer cells. The MUC1 cytoplasmic subunit (MUC1-C) can translocate to the nucleus and regulate gene expression. It is frequently assumed that the MUC1 extracellular subunit (MUC1-N) does not enter the nucleus. Based on an unexpected observation that MUC1 extracellular domain antibody produced an apparently nucleus-associated staining pattern in trophoblasts, we have tested the hypothesis that MUC1-N is expressed inside the nucleus. Three different antibodies were used to identify MUC1-N in normal epithelial cells and tissues as well as in several cancer cell lines. The results of immunofluorescence and confocal microscopy analyses as well as subcellular fractionation, Western blotting, and siRNA/shRNA studies, confirm that MUC1-N is found within nuclei of all cell types examined. More detailed examination of its intranuclear distribution using a proximity ligation assay, subcellular fractionation, and immunoprecipitation suggests that MUC1-N is located in nuclear speckles (interchromatin granule clusters) and closely associates with the spliceosome protein U2AF65. Nuclear localization of MUC1-N was abolished when cells were treated with RNase A and nuclear localization was altered when cells were incubated with the transcription inhibitor 5,6-dichloro-1-b-d-ribofuranosylbenzimidazole (DRB). While MUC1-N predominantly associated with speckles, MUC1-C was present in the nuclear matrix, nucleoli, and the nuclear periphery. In some nuclei, confocal microscopic analysis suggest that MUC1-C staining is located close to, but only partially overlaps, MUC1-N in speckles. However, only MUC1-N was found in isolated speckles by Western blotting. Also, MUC1-C and MUC1-N distributed differently during mitosis. These results suggest that MUC1-N translocates to the nucleus where it is expressed in nuclear speckles and that MUC1-N and MUC1-C have dissimilar intranuclear distribution patterns.	[Kumar, Priyadarsina; Lindberg, Louise; Thirkill, Twanda L.; Ji, Jennifer W.; Martsching, Lindsay; Douglas, Gordon C.] Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Kumar, P (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA.	gcdouglas@ucdavis.edu			National Institutes of Health Grant [5R01HL068035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068035] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 5R01HL068035 (GCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1989, CANCER RES, V49, P2834; Agrawal B, 2005, INT IMMUNOL, V17, P391, DOI 10.1093/intimm/dxh219; Akporiaye ET, 2007, VACCINE, V25, P6965, DOI 10.1016/j.vaccine.2007.06.063; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Aplin JD, 2009, PLACENTA, V30, P293, DOI 10.1016/j.placenta.2008.12.001; Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Baruch A, 1999, CANCER RES, V59, P1552; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; BOSHELL M, 1992, BIOCHEM BIOPH RES CO, V185, P1, DOI 10.1016/S0006-291X(05)80946-5; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Cao Y, 1998, TUMOR BIOL, V19, P88, DOI 10.1159/000056509; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Chusainow J, 2005, RNA, V11, P1201, DOI 10.1261/rna.7277705; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; DOUGLAS GC, 1990, IN VITRO CELL DEV B, V26, P754; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; Gilles F, 2000, BLOOD, V95, P2930, DOI 10.1182/blood.V95.9.2930.009k39_2930_2936; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; HERLYN M, 1987, ADV CANCER RES, V49, P189, DOI 10.1016/S0065-230X(08)60798-8; Hiesberger T, 2006, J BIOL CHEM, V281, P34357, DOI 10.1074/jbc.M606740200; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; Hinojosa-Kurtzberg AM, 2003, AM J PHYSIOL-GASTR L, V284, pG853, DOI 10.1152/ajpgi.00326.2002; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501, DOI 10.1165/ajrcmb.17.4.2253; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Julian J, 2002, BIOCHEM BIOPH RES CO, V293, P1183, DOI 10.1016/S0006-291X(02)00352-2; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lallena MJ, 1997, J CELL SCI, V110, P239; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LIU XH, 1995, GLYCOCONJUGATE J, V12, P607, DOI 10.1007/BF00731254; Liu XL, 2008, BIOCHEM BIOPH RES CO, V376, P688, DOI 10.1016/j.bbrc.2008.09.065; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Marcos NT, 2003, J HISTOCHEM CYTOCHEM, V51, P761, DOI 10.1177/002215540305100607; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Massinen S, 2009, HUM MOL GENET, V18, P2802, DOI 10.1093/hmg/ddp215; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; PATTILLO RA, 1972, J CLIN ENDOCR METAB, V34, P59, DOI 10.1210/jcem-34-1-59; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Reddish MA, 1992, J TUMOR MARKER ONCOL, V7, P19; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Rino J, 2007, PLOS COMPUT BIOL, V3, P2019, DOI 10.1371/journal.pcbi.0030201; Rockel TD, 2002, J STRUCT BIOL, V140, P189; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schut IC, 2003, BJU INT, V91, P278, DOI 10.1046/j.1464-410X.2003.03062.x; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Shyu M-K, 2008, BIOL REPROD BIOLREPR, V108; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soghomonians A, 2002, BBA-MOL CELL RES, V1589, P233, DOI 10.1016/S0167-4889(02)00179-9; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Spector DL, 2011, COLD SPRING HARBOR P, P3; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Thirkill TL, 2007, BBA-MOL CELL RES, V1773, P1007, DOI 10.1016/j.bbamcr.2007.04.006; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Wang P, 2008, BIOL REPROD, V78, P290, DOI 10.1095/biolreprod.107.064584; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x	90	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42712	10.1371/journal.pone.0042712	http://dx.doi.org/10.1371/journal.pone.0042712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905162	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100058
J	Li, S; Kang, J; Yu, WD; Zhou, Y; Zhang, WL; Xin, Y; Ma, YF				Li, Shuang; Kang, Jian; Yu, Wendan; Zhou, Yan; Zhang, Wenli; Xin, Yi; Ma, Yufang			Identification of M-tuberculosis Rv3441c and M-smegmatis MSMEG_1556 and Essentiality of M-smegmatis MSMEG_1556	PLOS ONE			English	Article							ENCODING PHOSPHOGLUCOSAMINE MUTASE; DRUG-RESISTANT TUBERCULOSIS; ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GLUCOSAMINE-1-PHOSPHATE ACETYLTRANSFERASE; GLMM GENE; ENVELOPE; SEQUENCE; ARABINAN; GROWTH	The normal growth of mycobacteria attributes to the integrity of cell wall core which consists of peptidoglycan (PG), arabinogalactan (AG) and mycolic acids. N-acetyl glucosamine (GlcNAc) is an essential component in both PG and AG of mycobacterial cell wall. The biosynthetic pathway for UDP-N-acetylglucosamine (UDP-GlcNAc), as a sugar donor of GlcNAc, is different in prokaryotes and eukaryotes. The conversion of glucosamine-6-phosphate to glucosamine-1-phosphate, which is catalyzed by phosphoglucosamine mutase (GlmM), is unique to prokaryotes. Bioinformatic analysis showed that Msm MSMEG_1556 and Mtb Rv3441c are homologous to Ec GlmM. In this study, soluble Msm MSMEG_1556 protein and Mtb Rv3441c protein were expressed in E. coli BL21(DE3) and their phosphoglucosamine mutase activity were detected. In order to further investigate the essentiality of MSMEG_1556 for the growth of M. smegmatis, we generated a conditional MSMEG_1556 knockout mutant, which harbored thermo-sensitive rescue plasmid carrying Mtb Rv3441c. As the rescue plasmid was unable to complement MSMEG_1556 deficiency at 42 degrees C, MSMEG_1556 knockout mutant did not grow. The dramatic morphological changes of MSMEG_1556 knockout mutant after temperature shift from 30 degrees C to 42 degrees C have been observed by scanning electron microscope. These results demonstrated that MSMEG_1556 is essential for growth of M. smegmatis. This study provided evidence that GlmM enzyme could be as a potential target for developing anti-tuberculosis drugs.	[Li, Shuang; Kang, Jian; Yu, Wendan; Zhou, Yan; Zhang, Wenli; Ma, Yufang] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China; [Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Liaoning, Peoples R China; [Xin, Yi; Ma, Yufang] Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University	Li, S (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Dalian, Liaoning, Peoples R China.	yufang_ma@hotmail.com			National Basic Research Program of China [2012CB518803]; National Natural Science Foundation of China [30970067]; National Science and Technology Major Project [2012ZX10003003-006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This work was supported by the National Basic Research Program of China (2012CB518803; http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30970067; http://www.nsfc.gov.cn/Portal0/default166.htm), and the National Science and Technology Major Project (2012ZX10003003-006; http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeReuse H, 1997, J BACTERIOL, V179, P3488, DOI 10.1128/jb.179.11.3488-3493.1997; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Jolly L, 1997, J BACTERIOL, V179, P5321, DOI 10.1128/jb.179.17.5321-5325.1997; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Li W, 2006, BIOCHEM BIOPH RES CO, V342, P170, DOI 10.1016/j.bbrc.2006.01.130; Liu XD, 2009, ORAL MICROBIOL IMMUN, V24, P272, DOI 10.1111/j.1399-302X.2009.00503.x; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimazu K, 2008, FEMS IMMUNOL MED MIC, V53, P166, DOI 10.1111/j.1574-695X.2008.00410.x; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Tavares IM, 2000, J BACTERIOL, V182, P4453, DOI 10.1128/JB.182.16.4453-4457.2000; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003; Zhou Y, 2011, ARCH MICROBIOL, V193, P751, DOI 10.1007/s00203-011-0715-8	32	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42769	10.1371/journal.pone.0042769	http://dx.doi.org/10.1371/journal.pone.0042769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905172	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100065
J	Prasad, R; Vaid, M; Katiyar, SK				Prasad, Ram; Vaid, Mudit; Katiyar, Santosh K.			Grape Proanthocyanidin Inhibit Pancreatic Cancer Cell Growth In Vitro and In Vivo through Induction of Apoptosis and by Targeting the PI3K/Akt Pathway	PLOS ONE			English	Article							ACTIVATED AKT; CARCINOMA-CELLS; CYCLE CONTROL; BCL-2 FAMILY; EXPRESSION; PROTEIN; PHOSPHORYLATION; KINASES; MICE; SKIN	Pancreatic cancer is an aggressive malignancy that is frequently diagnosed at an advanced stage with poor prognosis. Here, we report the chemotherapeutic effects of bioactive proanthocyanidins from grape seeds (GSPs) as assessed using In Vitro and In Vivo models. Treatment of human pancreatic cancer cells (Miapaca-2, PANC-1 and AsPC-1) with GSPs In Vitro reduced cell viability and increased G2/M phase arrest of the cell cycle leading to induction of apoptosis in a dose- and time-dependent manner. The GSPs-induced apoptosis of pancreatic cancer cells was associated with a decrease in the levels of Bcl-2 and Bcl-xl and an increase in the levels of Bax and activated caspase-3. Treatment of Miapaca-2 and PANC-1 cells with GSPs also decreased the levels of phosphatidylinositol-3-kinase (PI3K) and phosphorylation of Akt at ser(473). siRNA knockdown of PI3K from pancreatic cancer cells also reduced the phosphorylation of Akt. Further, dietary administration of GSPs (0.5%, w/w) as a supplemented AIN76A control diet significantly inhibited the growth of Miapaca-2 pancreatic tumor xenografts grown subcutaneously in athymic nude mice, which was associated with: (i) inhibition of cell proliferation, (ii) induction of apoptosis of tumor cells, (iii) increased expression of Bax, reduced expression of anti-apoptotic proteins and activation of caspase-3-positive cells, and (iv) decreased expression of PI3K and p-Akt in tumor xenograft tissues. Together, these results suggest that GSPs may have a potential chemotherapeutic effect on pancreatic cancer cell growth.	[Prasad, Ram; Vaid, Mudit; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Prasad, R (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			Veterans Administration Merit Review Award	Veterans Administration Merit Review Award(US Department of Veterans Affairs)	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Bondar VM, 2002, MOL CANCER THER, V1, P989; Chadha KS, 2006, ANN SURG ONCOL, V13, P933, DOI 10.1245/ASO.2006.07.011; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Fahy BN, 2003, BRIT J CANCER, V89, P391, DOI 10.1038/sj.bjc.6601037; GRANA X, 1995, ONCOGENE, V11, P211; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Nandakumar V, 2008, CANC LETT, V375, P162; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	36	62	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43064	10.1371/journal.pone.0043064	http://dx.doi.org/10.1371/journal.pone.0043064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905202	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100082
J	Spanos, A; Theocharis, G; Karageorgopoulos, DE; Peppas, G; Fouskakis, D; Falagas, ME				Spanos, Alex; Theocharis, George; Karageorgopoulos, Drosos E.; Peppas, George; Fouskakis, Dimitris; Falagas, Matthew E.			Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece	PLOS ONE			English	Article							METEOROLOGICAL VARIABLES; INFLUENZA; ETIOLOGY	Background: The traditional Serfling-type approach for influenza-like illness surveillance requires long historical time-series. We retrospectively evaluated the use of recent, short, historical time-series for recognizing the onset of community outbreaks of respiratory tract infections (RTIs). Methods: The data used referred to the proportion of diagnoses for upper or lower RTIs to total diagnoses for house-call visits, performed by a private network of medical specialists (SOS Doctors) in the metropolitan area of Athens, Greece, between January 01, 2000 and October 12, 2008. The reference standard classification of the observations was obtained by generating epidemic thresholds after analyzing the full 9-year period. We evaluated two different alert generating methods [simple regression and cumulative sum (CUSUM), respectively], under a range of input parameters, using data for the previous running 4-6 week period. These methods were applied if the previous weeks contained non-aberrant observations. Results: We found that the CUSUM model with a specific set of parameters performed marginally better than simple regression for both groups. The best results (sensitivity, specificity) for simple regression and CUSUM models for upper RTIs were (1.00, 0.82) and (0.94, 0.93) respectively. Corresponding results for lower RTIs were (1.00, 0.80) and (0.93, 0.91) respectively. Conclusions: Short-term data for house-call visits can be used rather reliably to identify respiratory tract outbreaks in the community using simple regression and CUSUM methods. Such surveillance models could be particularly useful when a large historical database is either unavailable or inaccurate and, thus, traditional methods are not optimal.	[Spanos, Alex; Karageorgopoulos, Drosos E.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Theocharis, George; Peppas, George] SOS Doctors, Athens, Greece; [Fouskakis, Dimitris] Natl Tech Univ Athens, Dept Math, GR-15773 Athens, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; National Technical University of Athens; Henry Dunant Hospital; Tufts University	Spanos, A (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018; Fouskakis, Dimitris/AAG-3101-2021	Karageorgopoulos, Drosos/0000-0002-9959-9978; Fouskakis, Dimitris/0000-0001-8514-6911				Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Falagas ME, 2009, EUR J CLIN MICROBIOL, V28, P709, DOI 10.1007/s10096-008-0679-z; Falagas ME, 2008, RESP MED, V102, P733, DOI 10.1016/j.rmed.2007.12.010; Falagas ME, 2009, CAN MED ASSOC J, V181, P484, DOI 10.1503/cmaj.090694; Foldy Seth L, 2004, MMWR Suppl, V53, P12; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Gault G, 2009, J PUBLIC HEALTH-UK, V31, P286, DOI 10.1093/pubmed/fdp020; Han SW, 2010, QUAL RELIAB ENG INT, V26, P279, DOI 10.1002/qre.1056; Hawkins DM., 1998, STAT ENGN PHYS SCI, DOI 10.2307/2670188; Heisterkamp SH, 2006, STAT MED, V25, P4179, DOI 10.1002/sim.2674; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lenz HJ, 2001, FRONTIERS STAT QUALI, V9; Lu HM, 2010, IEEE T KNOWL DATA EN, V22, P565, DOI 10.1109/TKDE.2009.115; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Oakland JS, 2007, STAT PROCESS CONTROL, DOI 10.4324/9780080551739; Pelat C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-29; Peppas G, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-112; Pham H., 2006, SPRINGER HDB ENG STA; *R DEV COR TEAM, R LANG ENV STAT COMP; Rath TM, 2003, AUTOMATED DETECTION; Ryan TP., 2007, MODERN ENG STAT; Sebastiani P., 2006, STAT MED, V25, P1817; Sebastiani P, 2006, STAT MED, V25, P1803, DOI 10.1002/sim.2566; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Unkel S, 2010, STAT METHODS PROSPEC; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wagner MM., 2006, HDB BIOSURVEILLANCE; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	38	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e40310	10.1371/journal.pone.0040310	http://dx.doi.org/10.1371/journal.pone.0040310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905091	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100003
J	Hsu, WL; Tse, KP; Liang, SR; Chien, YC; Su, WH; Yu, KJ; Cheng, YJ; Tsang, NM; Hsu, MM; Chang, KP; Chen, IH; Chen, TI; Yang, CS; Goldstein, AM; Chen, CJ; Chang, YS; Hildesheim, A				Hsu, Wan-Lun; Tse, Ka-Po; Liang, Sharon; Chien, Yin-Chu; Su, Wen-Hui; Yu, Kelly J.; Cheng, Yu-Juen; Tsang, Ngan-Ming; Hsu, Mow-Ming; Chang, Kai-Ping; Chen, I-How; Chen, Tzu-I; Yang, Czau-Siung; Goldstein, Alisa M.; Chen, Chien-Jen; Chang, Yu-Sun; Hildesheim, Allan			Evaluation of Human Leukocyte Antigen-A (HLA-A), Other Non-HLA Markers on Chromosome 6p21 and Risk of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CLASS-I; SUSCEPTIBILITY; TAIWAN; ASSOCIATION; HAPLOTYPES; ALLELES	Background: The association between human leukocyte antigen (HLA) genes (located in the Major Histocompatibility Complex [MHC] region of chromosome 6p21) and NPC has been known for some time. Recently, two genome-wide association studies (GWAS) conducted in Taiwan and China confirmed that the strongest evidence for NPC association was mapped to the MHC region. It is still unclear, however, whether these findings reflect direct associations with Human Leukocyte Antigen (HLA) genes and/or to other genes in this gene-rich region. Methods: To better understand genetic associations for NPC within the MHC region of chromosome 6, we conducted an evaluation that pooled two previously conducted NPC case-control studies in Taiwan (N = 591 cases and N = 521 controls). PCR-based genotyping was performed for 12 significant SNPs identified within 6p21 in the Taiwan NPC GWAS and for the HLA-A gene (exons 2 and 3). Findings: After confirming homogeneity between the two studies, pooled odds ratios (OR) and 95% confidence intervals (CI) were estimated by logistic regression. We found that HLA-A (p-trend = 0.0006) and rs29232 (within the GABBR1 gene; p-trend = 0.005) were independent risk factors for NPC after adjustment for age, gender, study and each other. NPC risk was highest among individuals who were homozygous for the HLA-A*0207 risk allele and carriers of the rs29232 risk allele (A). Conclusion: Our study suggests that most of the SNPs significantly associated with NPC from GWAS reflect previously identified HLA-A associations. An independent effect of rs29232 (GABBR1), however, remained, suggesting that additional genes within this region might be associated with NPC risk.	[Hsu, Wan-Lun; Chen, Tzu-I; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Tse, Ka-Po; Chang, Yu-Sun] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Genome Med Core, Tao Yuan, Taiwan; [Liang, Sharon; Yu, Kelly J.; Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Liang, Sharon] US FDA, Rockville, MD 20857 USA; [Chien, Yin-Chu] China Med Univ Hosp, Mol & Genom Epidemiol Res Ctr, Taichung, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Mol Epidemiol Core, Tao Yuan, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Grad Inst Biomed Sci, Dept Biomed Sci, Tao Yuan, Taiwan; [Yu, Kelly J.] NCI, Canc Prevent Div, Rockville, MD USA; [Cheng, Yu-Juen; Chen, Chien-Jen] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hsu, Mow-Ming] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chang, Kai-Ping; Chen, I-How] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol, Tao Yuan, Taiwan; [Yang, Czau-Siung] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Taiwan University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; National Taiwan University	Hsu, WL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	ysc@mail.cgu.edu.tw	Hildesheim, Allan/B-9760-2015; Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Hildesheim, Allan/0000-0003-0257-2363; Chang, Yu-Sun/0000-0002-6457-3890; Su, Wen-Hui/0000-0003-1037-4615	National Institutes of Health, USA; Ministry of Education, Taiwan; NATIONAL CANCER INSTITUTE [ZIACP010210] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Taiwan(Ministry of Education, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the intramural funds from the National Institutes of Health, USA and The Top University Project of Ministry of Education, Taiwan (to Chang Gung University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, IARC MONOGRAPHS EVAL, V70, P47; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chien Y., 2003, CANC REV ASIA PAC, V01, P1, DOI [10.1142/s0219836303000074, DOI 10.1142/S0219836303000074]; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; GAVIOLI R, 1993, J VIROL, V67, P1572, DOI 10.1128/JVI.67.3.1572-1578.1993; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; Hildesheim A, 1997, J NATL CANCER I, V89, P1207, DOI 10.1093/jnci/89.16.1207; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014562; SANTAMARIA P, 1993, HUM IMMUNOL, V37, P39, DOI 10.1016/0198-8859(93)90141-M; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Tang M, 2010, GENES IMMUN, V11, P334, DOI 10.1038/gene.2009.109; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Xiong W, 2004, CANCER RES, V64, P1972, DOI 10.1158/0008-5472.CAN-03-3253; Yu KJ, 2009, HUM IMMUNOL, V70, P910, DOI 10.1016/j.humimm.2009.08.005	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42767	10.1371/journal.pone.0042767	http://dx.doi.org/10.1371/journal.pone.0042767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880099	Green Published, Green Submitted, gold			2022-12-25	WOS:000307437900053
J	Cherkis, KA; Temple, BRS; Chung, EH; Sondek, J; Dangl, JL				Cherkis, Karen A.; Temple, Brenda R. S.; Chung, Eui-Hwan; Sondek, John; Dangl, Jeffery L.			AvrRpm1 Missense Mutations Weakly Activate RPS2-Mediated Immune Response in Arabidopsis thaliana	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; III EFFECTOR; POLY(ADP-RIBOSE) POLYMERASE; CATALYTIC FRAGMENT; CRYSTAL-STRUCTURES; CELL-DEATH; PROTEIN; RIN4; VIRULENCE; TARGET	Plants recognize microbes via specific pattern recognition receptors that are activated by microbe-associated molecular patterns (MAMPs), resulting in MAMP-triggered immunity (MTI). Successful pathogens bypass MTI in genetically diverse hosts via deployment of effectors (virulence factors) that inhibit MTI responses, leading to pathogen proliferation. Plant pathogenic bacteria like Pseudomonas syringae utilize a type III secretion system to deliver effectors into cells. These effectors can contribute to pathogen virulence or elicit disease resistance, depending upon the host plant genotype. In disease resistant genotypes, intracellular immune receptors, typically belonging to the nucleotide binding leucine-rich repeat family of proteins, perceive bacterial effector(s) and initiate downstream defense responses (effector triggered immunity) that include the hypersensitive response, and transcriptional re-programming leading to various cellular outputs that collectively halt pathogen growth. Nucleotide binding leucine-rich repeat sensors can be indirectly activated via perturbation of a host protein acting as an effector target. AvrRpm1 is a P. syringae type III effector. Upon secretion into the host cell, AvrRpm1 is acylated by host enzymes and directed to the plasma membrane, where it contributes to virulence. This is correlated with phosphorylation of Arabidopsis RIN4 in vivo. RIN4 is a negative regulator of MAMP-triggered immunity, and its modification in the presence of four diverse type III effectors, including AvrRpm1, likely enhances this RIN4 regulatory function. The RPM1 nucleotide binding leucine-rich repeat sensor perceives RIN4 perturbation in disease resistant plants, leading to a successful immune response. Here, demonstrate that AvrRpm1 has a fold homologous to the catalytic domain of poly(ADP-ribosyl) polymerase. Site-directed mutagenesis of each residue in the putative catalytic triad, His63-Tyr122-Asp185 of AvrRpm1, results in loss of both AvrRpm1-dependent virulence and AvrRpm1-mediated activation of RPM1, but, surprisingly, causes a gain of function: the ability to activate the RPS2 nucleotide binding leucine-rich repeat sensor.	[Cherkis, Karen A.; Chung, Eui-Hwan; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC USA; [Cherkis, Karen A.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Temple, Brenda R. S.; Sondek, John] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Sondek, John] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cherkis, KA (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	dangl@email.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health (NIH) [GM057391, GM062299, GM081881]; National Science Foundation [IOS-0929410]; Department of Energy [DE-FG05-95ER20187]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081881, R01GM057391, R01GM062299] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0929410] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is supported by National Institutes of Health (NIH) grants GM057391 and GM062299, National Science Foundation Arabidopsis 2010 program grant IOS-0929410, and Department of Energy grant DE-FG05-95ER20187 (to JLD) and NIH grant GM081881 (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arnold DL, 2000, MOL PLANT PATHOL, V1, P195, DOI 10.1046/j.1364-3703.2000.00019.x; ASHFIELD T, 1995, GENETICS, V141, P1597; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jeong BR, 2011, J BIOL CHEM, V286, P43272, DOI 10.1074/jbc.M111.290122; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim MG, 2009, PLANT J, V57, P645, DOI 10.1111/j.1365-313X.2008.03716.x; Kinoshita T, 2004, FEBS LETT, V556, P43, DOI [10.1016/S0014-5793(03)01362-0, 10.5940/jcrsj.46.421]; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lim MTS, 2004, PLANT J, V40, P790, DOI 10.1111/j.1365-313X.2004.02251.x; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Qi YP, 2011, MOL PLANT PATHOL, V12, P702, DOI 10.1111/J.1364-3703.2010.00704.X; RAZZELL WE, 1959, J BIOL CHEM, V234, P2114; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wang H, 2011, PLANTA, V233, P1287, DOI 10.1007/s00425-011-1415-y; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	71	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42633	10.1371/journal.pone.0042633	http://dx.doi.org/10.1371/journal.pone.0042633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880057	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000052
J	Sato, Y; Nagata, S; Takiguchi, M				Sato, Yoshinori; Nagata, Sayaka; Takiguchi, Masafumi			Effective Elicitation of Human Effector CD8(+) T Cells in HLA-B*51:01 Transgenic Humanized Mice after Infection with HIV-1	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; MHC CLASS-I; RESTRICTED IMMUNE-RESPONSES; HEMATOPOIETIC STEM-CELLS; BLOOD CD34(+) CELLS; ALPHA-3 DOMAIN; MOUSE MODEL; PHENOTYPIC CLASSIFICATION; HOMEOSTATIC PROLIFERATION; SPECIES-SPECIFICITY	Humanized mice are expected to be useful as small animal models for in vivo studies on the pathogenesis of infectious diseases. However, it is well known that human CD8(+) T cells cannot differentiate into effector cells in immunodeficient mice transplanted with only human CD34(+) hematopoietic stem cells (HSCs), because human T cells are not educated by HLA in the mouse thymus. We here established HLA-B*51:01 transgenic humanized mice by transplanting human CD34(+) HSCs into HLA-B*51:01 transgenic NOD/SCID/Jak3(-/-) mice (hNOK/B51Tg mice) and investigated whether human effector CD8(+) T cells would be elicited in the mice or in those infected with HIV-1 NL4-3. There were no differences in the frequency of late effector memory and effector subsets (CD27(low)CD28(-)CD45RA(+/-)CCR7(-) and CD27(-)CD28(-)CD45RA(+/-)CCR7(-), respectively) among human CD8(+) T cells and in that of human CD8(+) T cells expressing CX3CR1 and/or CXCR1 between hNOK/B51Tg and hNOK mice. In contrast, the frequency of late effector memory and effector CD8(+) T cell subsets and of those expressing CX3CR1 and/or CXCR1 was significantly higher in HIV-1-infected hNOK/B51Tg mice than in uninfected ones, whereas there was no difference in that of these subsets between HIV-1-infected and uninfected hNOK mice. These results suggest that hNOK/B51Tg mice had CD8(+) T cells that were capable of differentiating into effector T cells after viral antigen stimulation and had a greater ability to elicit effector CD8(+) T cells than hNOK ones.	[Sato, Yoshinori; Nagata, Sayaka; Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	Kumamoto University	Sato, Y (corresponding author), Kumamoto Univ, Ctr AIDS Res, 2-2-1 Honjo, Kumamoto, Japan.	masafumi@kumamoto-u.ac.jp	Sato, Yoshinori/J-2497-2015; Takiguchi, Masafumi/E-7468-2013	Sato, Yoshinori/0000-0001-8250-6598; 	Global COE program "Global Education and Research Center Aiming at the Control of AIDS" [F-13]; Ministry of Education, Science, Sports, Culture and Technology, Japan [23700513]	Global COE program "Global Education and Research Center Aiming at the Control of AIDS"; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Global COE program "Global Education and Research Center Aiming at the Control of AIDS," (No. F-13) launched as a project commissioned by the Ministry of Education, Science, Sports, and Culture and Technology, Japan; and by a grant-in-aid (No. 23700513) for scientific research from the Ministry of Education, Science, Sports, Culture and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COMBADIERE B, 2003, 17 INT AIDS C MEX CI, V17, P1279, DOI DOI 10.1097/01.AIDS.0000060413.18106.9D; Denton PW, 2011, AIDS REV, V13, P135; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; Garcia S, 2012, IMMUNOL LETT; Gasser O, 2005, BLOOD, V106, P3718, DOI 10.1182/blood-2005-04-1366; Gorantla S, 2010, J IMMUNOL, V184, P7082, DOI 10.4049/jimmunol.1000438; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Pham HP, 2012, EUR J IMMUNOL, V42, P760, DOI 10.1002/eji.201141798; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Hess C, 2004, BLOOD, V104, P3463, DOI 10.1182/blood-2004-03-1067; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; KAMEYAMA Y, 1994, NEUROTOXICOLOGY, V15, P75; KARAKI S, 1993, IMMUNOGENETICS, V37, P139; LAFACE DM, 1995, J EXP MED, V182, P1315, DOI 10.1084/jem.182.5.1315; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; Melenhorst JJ, 2010, BLOOD, V116, P4700, DOI 10.1182/blood-2010-06-289991; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Nauta AJ, 2005, EXP HEMATOL, V33, P1249, DOI 10.1016/j.exphem.2005.06.019; Nesic D, 1998, J IMMUNOL, V160, P3705; NEWBERG MH, 1992, J IMMUNOL, V149, P136; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Okada R, 2008, INT IMMUNOL, V20, P1189, DOI 10.1093/intimm/dxn075; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013109; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takata H, 2004, J IMMUNOL, V173, P2231, DOI 10.4049/jimmunol.173.4.2231; Takata H, 2006, J IMMUNOL, V177, P4330, DOI 10.4049/jimmunol.177.7.4330; TEITELL M, 1993, J EXP MED, V178, P2139, DOI 10.1084/jem.178.6.2139; Tomiyama H, 2005, J IMMUNOL, V174, P36, DOI 10.4049/jimmunol.174.1.36; Tomiyama H, 2002, J VIROL, V76, P7535, DOI 10.1128/JVI.76.15.7535-7543.2002; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wils EJ, 2011, J IMMUNOL, V187, P2974, DOI 10.4049/jimmunol.1004209; Yahata T, 2002, J IMMUNOL, V169, P204, DOI 10.4049/jimmunol.169.1.204; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502	66	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42776	10.1371/journal.pone.0042776	http://dx.doi.org/10.1371/journal.pone.0042776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880104	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000069
J	Tullus, A; Kupper, P; Sellin, A; Parts, L; Sober, J; Tullus, T; Lohmus, K; Sober, A; Tullus, H				Tullus, Arvo; Kupper, Priit; Sellin, Arne; Parts, Leopold; Sober, Jaak; Tullus, Tea; Lohmus, Krista; Sober, Anu; Tullus, Hardi			Climate Change at Northern Latitudes: Rising Atmospheric Humidity Decreases Transpiration, N-Uptake and Growth Rate of Hybrid Aspen	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; LEAF WATER STATUS; ECOSYSTEM CARBON; NUTRIENT-UPTAKE; AIR HUMIDITY; TREE GROWTH; CO2; FOREST; PRODUCTIVITY; PLANTATIONS	At northern latitudes a rise in atmospheric humidity and precipitation is predicted as a consequence of global climate change. We studied several growth and functional traits of hybrid aspen (Populus tremula L. xP. tremuloides Michx.) in response to elevated atmospheric humidity (on average 7% over the ambient level) in a free air experimental facility during three growing seasons (2008-2010) in Estonia, which represents northern temperate climate (boreo-nemoral zone). Data were collected from three humidified (H) and three control (C) plots, and analysed using nested linear models. Elevated air humidity significantly reduced height, stem diameter and stem volume increments and transpiration of the trees whereas these effects remained highly significant also after considering the side effects from soil-related confounders within the 2.7 ha study area. Tree leaves were smaller, lighter and had lower leaf mass per area (LMA) in H plots. The magnitude and significance of the humidity treatment effect - inhibition of above-ground growth rate - was more pronounced in larger trees. The lower growth rate in the humidified plots can be partly explained by a decrease in transpiration-driven mass flow of NO3- in soil, resulting in a significant reduction in the measured uptake of N to foliage in the H plots. The results suggest that the potential growth improvement of fast-growing trees like aspens, due to increasing temperature and atmospheric CO2 concentration, might be smaller than expected at high latitudes if a rise in atmospheric humidity simultaneously takes place.	[Tullus, Arvo; Tullus, Tea; Tullus, Hardi] Estonian Univ Life Sci, Dept Silviculture, Inst Forestry & Rural Engn, Tartu, Estonia; [Tullus, Arvo; Kupper, Priit; Sellin, Arne; Sober, Jaak; Lohmus, Krista; Sober, Anu] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Parts, Leopold] Wellcome Trust Sanger Inst, Cambridge, England; [Parts, Leopold] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	Estonian University of Life Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Wellcome Trust Sanger Institute; University of Toronto	Tullus, A (corresponding author), Estonian Univ Life Sci, Dept Silviculture, Inst Forestry & Rural Engn, Tartu, Estonia.	arvo.tullus@emu.ee	Tullus, Arvo/A-8680-2010; Tullus, Hardi/H-3777-2012; Sellin, Arne/AAA-5134-2020; Tullus, Tea/G-9770-2012	Tullus, Arvo/0000-0002-5945-7967; Tullus, Tea/0000-0001-7927-0756; Parts, Leopold/0000-0002-2618-670X	EU [MJD 257]; Estonian Science Foundation [7298, 7736, 7792, 8333, 9186]; Estonian Ministry of Education and Research [SF0182732s06]; European Regional Development Fund (Centre of Excellence in Environmental Adaptation); Wellcome Trust [WT077192/Z/05/Z]	EU(European Commission); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund (Centre of Excellence in Environmental Adaptation); Wellcome Trust(Wellcome TrustEuropean Commission)	AT was supported by the EU through the European Social Fund (Mobilitas postdoctoral grant MJD 257). Data collection, field work and laboratory analyses costs were covered by the Estonian Science Foundation grants Nos. 7298 (HT, TT), 7736 (PK), 7792 (KL), 8333 (A. Sellin) and 9186 (A. Sober). The authors from the University of Tartu received additional support from the Estonian Ministry of Education and Research (project No SF0182732s06) and the European Regional Development Fund (Centre of Excellence in Environmental Adaptation). LP was supported by the Wellcome Trust (grant WT077192/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen H, 2004, METSATIETEEN AIKAKAU, V1, P102; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bovard BD, 2005, TREE PHYSIOL, V25, P31, DOI 10.1093/treephys/25.1.31; Burgess SSO, 2004, PLANT CELL ENVIRON, V27, P1023, DOI 10.1111/j.1365-3040.2004.01207.x; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Clifton-Brown JC, 1999, J EXP BOT, V50, P1393, DOI 10.1093/jexbot/50.337.1393; Cole CT, 2010, GLOBAL CHANGE BIOL, V16, P2186, DOI 10.1111/j.1365-2486.2009.02103.x; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; del Amor FM, 2005, ACTA HORTIC, P523, DOI 10.17660/ActaHortic.2005.697.68; DeLucia EH, 2000, GLOBAL CHANGE BIOL, V6, P587, DOI 10.1046/j.1365-2486.2000.00338.x; Dessler AE, 2008, GEOPHYS RES LETT, V35; Dessler AE, 2009, SCIENCE, V323, P1020, DOI 10.1126/science.1171264; EINSPAHR DW, 1978, TAPPI, V61, P49; FORD MA, 1974, ANN BOT-LONDON, V38, P441, DOI 10.1093/oxfordjournals.aob.a084827; Gerten D, 2008, GLOBAL CHANGE BIOL, V14, P2365, DOI 10.1111/j.1365-2486.2008.01651.x; Gilserod HR, 1990, HORTSCIENCE, V25, P524; Grant RF, 2006, AGR FOREST METEOROL, V140, P152, DOI 10.1016/j.agrformet.2006.01.012; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hedenas H, 2007, BIOL CONSERV, V135, P380, DOI 10.1016/j.biocon.2006.10.008; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Holscher D, 2005, TREES-STRUCT FUNCT, V19, P628, DOI 10.1007/s00468-005-0426-3; ISHIBASHI M, 1995, PLANT CELL ENVIRON, V18, P431, DOI 10.1111/j.1365-3040.1995.tb00377.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; Kerr G, 2003, CAN J FOREST RES, V33, P1196, DOI 10.1139/X03-041; Kont A, 2003, GLOBAL PLANET CHANGE, V36, P1, DOI 10.1016/S0921-8181(02)00149-2; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kupper P, 2011, ENVIRON EXP BOT, V72, P432, DOI 10.1016/j.envexpbot.2010.09.003; Lendzion J, 2008, FOREST ECOL MANAG, V256, P648, DOI 10.1016/j.foreco.2008.05.008; Leuschner C, 2002, FLORA, V197, P262, DOI 10.1078/0367-2530-00040; Liesebach M, 1999, FOREST ECOL MANAG, V121, P25, DOI 10.1016/S0378-1127(98)00554-4; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Liu N, 2006, CAN J BOT, V84, P294, DOI 10.1139/B05-171; Lohmus A, 2011, SCAND J FOREST RES, V26, P212, DOI 10.1080/02827581.2011.558850; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Messaoud Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014691; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Oren R, 2001, OECOLOGIA, V127, P549, DOI 10.1007/s004420000622; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pataki DE, 1998, TREE PHYSIOL, V18, P307; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Reinhardt K, 2008, OECOLOGIA, V158, P229, DOI 10.1007/s00442-008-1128-5; Rytter L, 2006, FOREST ECOL MANAG, V236, P422, DOI 10.1016/j.foreco.2006.09.055; Sellin A, 2005, OECOLOGIA, V142, P388, DOI 10.1007/s00442-004-1748-3; Sellin A, 2004, ANN FOREST SCI, V61, P419, DOI 10.1051/forest:2004035; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAYLOR G, 1986, NEW PHYTOL, V104, P347, DOI 10.1111/j.1469-8137.1986.tb02902.x; Trnka M, 2011, GLOBAL CHANGE BIOL, V17, P2298, DOI 10.1111/j.1365-2486.2011.02396.x; Tullus A, 2007, FOREST ECOL MANAG, V245, P118, DOI 10.1016/j.foreco.2007.04.006; Tullus A, 2012, SCAND J FOREST RES, V27, P10, DOI 10.1080/02827581.2011.628949; Tullus A, 2010, PLANT SOIL, V333, P129, DOI 10.1007/s11104-010-0330-5; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; WONG SC, 1993, VEGETATIO, V104, P211, DOI 10.1007/BF00048154; Wyckoff PH, 2005, CAN J FOREST RES, V35, P13, DOI 10.1139/x04-142; Xue QW, 2004, ENVIRON EXP BOT, V51, P167, DOI 10.1016/j.envexpbot.2003.09.003	64	56	56	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42648	10.1371/journal.pone.0042648	http://dx.doi.org/10.1371/journal.pone.0042648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880067	Green Published, Green Submitted, gold			2022-12-25	WOS:000307810000055
J	Grey, J; Jackson, MC				Grey, Jonathan; Jackson, Michelle C.			'Leaves and Eats Shoots': Direct Terrestrial Feeding Can Supplement Invasive Red Swamp Crayfish in Times of Need	PLOS ONE			English	Article							PROCAMBARUS-CLARKII; LAKE NAIVASHA; INTRODUCED CRAYFISH; STABLE-ISOTOPES; DECAPODA; KENYA; FRACTIONATION; BIODIVERSITY; CAMBARIDAE; DIVERSITY	We used stable isotope analyses to characterise the feeding dynamics of a population of red swamp crayfish in Lake Naivasha, Kenya, after the crash of submerged macrophytes and associated macroinvertebrates, and during a natural drawdown of the lake water level. We expected a heavy reliance upon a diet of detrital matter to sustain the population as a consequence, and indeed, for the majority of the crayfish population caught from the lake, we saw a concomitant shift in isotopic values reflecting a dietary change. However, we also caught individual crayfish that had occupied the footprints of hippopotamus and effectively extended their range beyond the lake up to 40 m into the riparian zone. Isotopic analysis confirmed limited nocturnal observations that these individuals were consuming living terrestrial plants in the vicinity of the footprints. These are the first empirical data to demonstrate direct use of terrestrial resources by an aquatic crayfish species and further highlight the traits that make red swamp crayfish such opportunistic and successful invaders.	[Grey, Jonathan] Max Planck Inst Limnol, Dept Physiol Ecol, D-2320 Plon, Schleswig Holst, Germany; [Grey, Jonathan; Jackson, Michelle C.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	Max Planck Society; University of London; Queen Mary University London	Grey, J (corresponding author), Max Planck Inst Limnol, Dept Physiol Ecol, D-2320 Plon, Schleswig Holst, Germany.	j.grey@qmul.ac.uk		Jackson, Michelle/0000-0003-2227-1111; Grey, Jonathan/0000-0001-9069-2271	Max Planck Society; Earthwatch Institute, Boston	Max Planck Society(Max Planck SocietyFoundation CELLEX); Earthwatch Institute, Boston	JG was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the National Council for Science and Technology, Kenya for research permission, and Dr. David Harper (Leicester University, England) of the 'Lakes of the Rift Valley' project funded by the Earthwatch Institute, Boston for logistical support. We also acknowledge the assistance of Velia Carn, Reuben Ngeete, numerous Earthwatch volunteers, and the late Joan Root. The comments of two very helpful reviewers greatly improved the manuscript.	Aquiloni L, 2011, BIOL INVASIONS, V13, P359, DOI 10.1007/s10530-010-9828-2; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barbaresi S, 2000, BIOL INVASIONS, V2, P259, DOI DOI 10.1023/A:1010009701606; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, BIOL INVASIONS, V12, P3439, DOI 10.1007/s10530-010-9742-7; Capinha C, 2011, ECOGRAPHY, V34, P448, DOI 10.1111/j.1600-0587.2010.06369.x; CHIEN YH, 1980, PROG FISH CULT, V42, P67, DOI 10.1577/1548-8659(1980)42[67:POCIRF]2.0.CO;2; CORREIA AM, 1995, J CRUSTACEAN BIOL, V15, P248, DOI 10.2307/1548953; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Cruz MJ, 2008, HERPETOL J, V18, P197; Cruz MJ, 2007, HYDROBIOLOGIA, V575, P191, DOI 10.1007/s10750-006-0376-9; Cumberlidge N, 2009, MONOGR BIOL, V89, P547; Foster John, 2007, V2, P91; Furse James M., 2004, Freshwater Crayfish, V14, P213; GAUDET J J, 1977, Aquatic Botany, V3, P1, DOI 10.1016/0304-3770(77)90002-X; Geiger W, 2005, BIOL INVASIONS, V7, P49, DOI 10.1007/s10530-004-9635-8; Gherardi F, 2010, ENCY INVASIVE INTRO, P129; Gherardi F, 2011, BIOL CONSERV, V144, P2585, DOI 10.1016/j.biocon.2011.07.020; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Grey J, 2002, ISOT ENVIRON HEALT S, V38, P245, DOI 10.1080/10256010208033269; Grey J, 2006, POL J ECOL, V54, P563; Gutierrez-Yurrita PJ, 1999, CRUSTACEAN ISS, V11, P161; Hickley P, 2002, MANAGEMENT ECOLOGY L; Hofkin BV, 1991, BIOL CONTROL, V1, P183, DOI 10.1016/1049-9644(91)90065-8; HUNER JV, 1995, AM ZOOL, V35, P12; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Larson ER, 2011, BIOL LETTERS, V7, P551, DOI 10.1098/rsbl.2011.0089; Larson ER, 2010, CONSERV BIOL, V24, P1099, DOI 10.1111/j.1523-1739.2010.01462.x; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; Lowe K, 2010, J COMP PHYSIOL B, V180, P653, DOI 10.1007/s00360-010-0445-2; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Rodriguez CF, 2005, BIOL INVASIONS, V7, P75, DOI 10.1007/s10530-004-9636-7; Rudnick D, 2005, FRESHWATER BIOL, V50, P1323, DOI 10.1111/j.1365-2427.2005.01398.x; Smart AC, 2002, HYDROBIOLOGIA, V488, P129, DOI 10.1023/A:1023326530914; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115	41	39	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42575	10.1371/journal.pone.0042575	http://dx.doi.org/10.1371/journal.pone.0042575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880039	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100134
J	Zou, L; Xu, HG; Ren, W; Jin, R; Wang, Y; Zhou, GP				Zou, Li; Xu, Hua-Guo; Ren, Wei; Jin, Rui; Wang, Yi; Zhou, Guo-Ping			Transcriptional Activation of the Human CD2AP Promoter by E2F1	PLOS ONE			English	Article							CD2-ASSOCIATED PROTEIN; NEPHROTIC SYNDROME; INDUCED APOPTOSIS; COMPLEX; FAMILY; PROLIFERATION; ENDOCYTOSIS; EXPRESSION; REPRESSION; MUTATION	CD2-associated protein (CD2AP) is an adaptor molecule involved in T cell receptor signaling and podocyte homeostasis. CD2AP-deficient mice develop nephritic syndrome and renal failure caused by glomerulosclerosis. Transcription factor E2F1 is a key regulator of cell proliferation and apoptosis. Here we report that E2F1 up-regulates the human CD2AP promoter and further increases the mRNA and protein levels of the human CD2AP in human embryonic kidney (HEK) 293 cells. By semi-quantitative RT-PCR and Western blot analysis we demonstrate that ectopic expression of E2F1 elevates the mRNA and protein levels of CD2AP. Consistently, transient transfection assays prove that overexpression of E2F1 transactivates the CD2AP promoter while knocking-down of endogenous E2F1 by a shRNA strategy results in reduction of the CD2AP promoter activity. Toward understanding the underlying mechanism of this regulation, we performed chromatin immunoprecipitation and mutations of the putative Sp1 binding sites, demonstrating that E2F1 can bind to Sp1 binding site and overexpression of E2F1 is capable of increasing the binding of E2F1 and decreasing the binding of Sp1 to Sp1 binding sites.	[Zou, Li; Xu, Hua-Guo; Ren, Wei; Jin, Rui; Wang, Yi; Zhou, Guo-Ping] Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xu, Hua-Guo] Nanjing Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zou, L (corresponding author), Nanjing Med Univ, Dept Pediat, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	gpzhou2003@126.com			National Natural Science Foundation of China [30570863, 30872804, 81170661]; Natural Science Foundation of Jiangsu Province of China [BK2007244]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234110010]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Academic Key Talent Program of Jiangsu Province in China [RC2007050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Academic Key Talent Program of Jiangsu Province in China	This work was supported by the National Natural Science Foundation of China (30570863, 30872804, 81170661), Natural Science Foundation of Jiangsu Province of China (BK2007244), Specialized Research Fund for the Doctoral Program of Higher Education (20113234110010), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Medical Academic Key Talent Program of Jiangsu Province in China (RC2007050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukur J, 2010, J BIOL CHEM, V285, P30419, DOI 10.1074/jbc.M109.094284; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; DeGregori J, 2006, CURR MOL MED, V6, P739; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Gubler MC, 2003, J AM SOC NEPHROL, V14, pS22, DOI 10.1097/01.ASN.0000067648.75923.68; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Lowik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Lu C, 2009, GENE, V433, P56, DOI 10.1016/j.gene.2008.11.015; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Ma YH, 2003, MOL CANCER THER, V2, P73; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smoyer WE, 1998, J MOL MED, V76, P172, DOI 10.1007/s001090050206; Su XM, 2009, AM J NEPHROL, V29, P203, DOI 10.1159/000155658; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Xu HG, 2012, MOL BIOL REP, V39, P1479, DOI 10.1007/s11033-011-0885-0; Xu HG, 2011, IMMUNOGENETICS, V63, P189, DOI 10.1007/s00251-010-0505-5; Xu HG, 2010, MOL BIOL REP, V37, P3073, DOI 10.1007/s11033-009-9880-0; Zhang HJ, 2009, J CELL BIOCHEM, V106, P464, DOI 10.1002/jcb.22033; Zhou DJ, 2005, GENE, V361, P89, DOI 10.1016/j.gene.2005.07.012	31	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42774	10.1371/journal.pone.0042774	http://dx.doi.org/10.1371/journal.pone.0042774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880102	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100167
J	Endo-Streeter, S; Tsui, MKM; Odom, AR; Block, J; York, JD				Endo-Streeter, Stuart; Tsui, Man-Kin Marco; Odom, Audrey R.; Block, Jeremy; York, John D.			Structural Studies and Protein Engineering of Inositol Phosphate Multikinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE 3-KINASE; STRUCTURE VALIDATION; ARGININE METABOLISM; CRYSTAL-STRUCTURE; C-BETA; BINDING; KINASE; SYMMETRY	Inositol phosphates (IPs) regulate vital processes in eukaryotes, and their production downstream of phospholipase C activation is controlled through a network of evolutionarily conserved kinases and phosphatases. Inositol phosphate multikinase (IPMK, also called Ipk2 and Arg82) accounts for phosphorylation of IP3 to IP5, as well as production of several other IP molecules. Here, we report the structure of Arabidopsis thaliana IPMK alpha at 2.9 angstrom and find it is similar to the yeast homolog Ipk2, despite 17% sequence identity, as well as the active site architecture of human IP3 3-kinase. Structural comparison and substrate modeling were used to identify a putative basis for IPMK selectivity. To test this model, we re-engineered binding site residues predicted to have restricted substrate specificity. Using steady-state kinetics and in vivo metabolic labeling studies in modified yeast strains, we observed that K117W and K117W:K121W mutants exhibited nearly normal 6-kinase function but harbored significantly reduced 3-kinase activity. These mutants complemented conditional nutritional growth defects observed in ipmk null yeast and, remarkably, suppressed lethality observed in ipmk null flies. Our data are consistent with the hypothesis that IPMK 6-kinase activity and production of Ins(1,4,5,6)P-4 are critical for cellular signaling. Overall, our studies provide new insights into the structure and function of IPMK and utilize a synthetic biological approach to redesign inositol phosphate signaling pathways.	[York, John D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, DUMC Box 3813, Durham, NC 27710 USA.	john.york@vanderbilt.edu	Tsui, Man-kin/E-9612-2010; John, Audrey Odom/AAF-1300-2019	John, Audrey Odom/0000-0001-8395-8537	Howard Hughes Medical Institute; National Institutes of Health [RO1 HL-55672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078031] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health Grant RO1 HL-55672 (both to J.D.Y.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chamberlain PP, 2005, BIOCHEMISTRY-US, V44, P14486, DOI 10.1021/bi051256q; Chang SC, 2006, BIOCHEM BIOPH RES CO, V339, P209, DOI 10.1016/j.bbrc.2005.10.201; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; DUBOIS E, 1994, MOL GEN GENET, V243, P315, DOI 10.1007/BF00301067; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; DUBOIS E, 1985, MOL GEN GENET, V198, P283, DOI 10.1007/BF00383008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ives EB, 2000, J BIOL CHEM, V275, P36575, DOI 10.1074/jbc.M007586200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MESSENGUY F, 1991, MOL CELL BIOL, V11, P2852, DOI 10.1128/MCB.11.5.2852; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; Seeds AM, 2004, J BIOL CHEM, V279, P47222, DOI 10.1074/jbc.M408295200; Sheldrick G. M., 1997, SHELX97 MANUAL; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Stolz LE, 1998, GENETICS, V148, P1715; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014	42	23	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35360	35369		10.1074/jbc.M112.365031	http://dx.doi.org/10.1074/jbc.M112.365031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896696	hybrid, Green Published			2022-12-25	WOS:000309968000045
J	Zhou, Y; Holmseth, S; Guo, CY; Hassel, B; Hofner, G; Huitfeldt, HS; Wanner, KT; Danbolt, NC				Zhou, Yun; Holmseth, Silvia; Guo, Caiying; Hassel, Bjornar; Hoefner, Georg; Huitfeldt, Henrik S.; Wanner, Klaus T.; Danbolt, Niels C.			Deletion of the gamma-Aminobutyric Acid Transporter 2 (GAT2 and SLC6A13) Gene in Mice Leads to Changes in Liver and Brain Taurine Contents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; PERFUSED-RAT-LIVER; GABA TRANSPORTERS; MOUSE-BRAIN; GLUTAMATE TRANSPORTERS; CEREBRAL-CORTEX; MOLECULAR CHARACTERIZATION; BETAINE/GABA TRANSPORTER	The GABA transporters (GAT1, GAT2, GAT3, and BGT1) have mostly been discussed in relation to their potential roles in controlling the action of transmitter GABA in the nervous system. We have generated the first mice lacking the GAT2 (slc6a13) gene. Deletion of GAT2(both mRNA and protein) neither affected growth, fertility, nor life span under nonchallenging rearing conditions. Immunocytochemistry showed that the GAT2 protein was predominantly expressed in the plasma membranes of periportal hepatocytes and in the basolateral membranes of proximal tubules in the renal cortex. This was validated by processing tissue from wild-type and knockout mice in parallel. Deletion of GAT2 reduced liver taurine levels by 50%, without affecting the expression of the taurine transporter TAUT. These results suggest an important role for GAT2 in taurine uptake from portal blood into liver. In support of this notion, GAT2-transfected HEK293 cells transported [H-3] taurine. Furthermore, most of the uptake of [H-3] GABA by cultured rat hepatocytes was due to GAT2, and this uptake was inhibited by taurine. GAT2 was not detected in brain parenchyma proper, excluding a role in GABA inactivation. It was, however, expressed in the leptomeninges and in a subpopulation of brain blood vessels. Deletion of GAT2 increased brain taurine levels by 20%, suggesting a taurine-exporting role for GAT2 in the brain.	[Zhou, Yun; Holmseth, Silvia; Danbolt, Niels C.] Univ Oslo, Inst Basic Med Sci, Dept Anat, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; [Guo, Caiying] HHMI, Ashburn, VA 20147 USA; [Hassel, Bjornar] Oslo Univ Hosp, Dept Neurohabilitat, N-0372 Oslo, Norway; [Hassel, Bjornar] Norwegian Def Res Estab, N-2027 Kjeller, Norway; [Hoefner, Georg; Wanner, Klaus T.] Univ Munich, Zentrum Pharmaforsch, Dept Pharm, D-81377 Munich, Germany; [Huitfeldt, Henrik S.] Univ Oslo, Oslo Univ Hosp, Dept Pathol, N-0372 Oslo, Norway	University of Oslo; Howard Hughes Medical Institute; University of Oslo; Norwegian Defence Research Establishment; University of Munich; University of Oslo	Danbolt, NC (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Ctr Mol Biol & Neurosci, POB 1105 Blindern, N-0317 Oslo, Norway.	n.c.danbolt@medisin.uio.no	Zhou, Yun/I-1840-2017; Danbolt, Niels Christian/A-1907-2014	Zhou, Yun/0000-0002-5682-0169; Danbolt, Niels Christian/0000-0003-4227-4520	Norwegian Research Council Grant [183727/S10]	Norwegian Research Council Grant(Research Council of Norway)	This work was supported by Norwegian Research Council Grant 183727/S10.	Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO;2-C; Beckstrom H, 2001, J NEUROCHEM, V78, P37; Bella DL, 2002, AMINO ACIDS, V23, P453, DOI 10.1007/s00726-002-0213-z; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BORDEN LA, 1995, J NEUROCHEM, V64, P977; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Burnham CE, 1996, BBA-BIOMEMBRANES, V1284, P4, DOI 10.1016/0005-2736(96)00118-6; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1999, J COMP NEUROL, V409, P482; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dominy J, 2004, J NEUROCHEM, V89, P1195, DOI 10.1111/j.1471-4159.2004.02410.x; Dominy J, 2004, NEUROCHEM RES, V29, P97, DOI 10.1023/B:NERE.0000010437.81860.d5; DURKIN MM, 1995, MOL BRAIN RES, V33, P7, DOI 10.1016/0169-328X(95)00101-W; Eulenburg V, 2010, BRAIN RES REV, V63, P103, DOI 10.1016/j.brainresrev.2010.01.003; Evans JE, 1996, J COMP NEUROL, V376, P431, DOI 10.1002/(SICI)1096-9861(19961216)376:3<431::AID-CNE6>3.0.CO;2-3; FERENCI P, 1988, GASTROENTEROLOGY, V95, P402, DOI 10.1016/0016-5085(88)90497-0; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; Gavish M, 1999, PHARMACOL REV, V51, P629; GOODYER PR, 1985, BIOCHIM BIOPHYS ACTA, V818, P45, DOI 10.1016/0005-2736(85)90136-1; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HARDISON WGM, 1980, BIOCHIM BIOPHYS ACTA, V598, P145, DOI 10.1016/0005-2736(80)90272-2; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Henjum S, 2007, NEUROCHEM INT, V50, P365, DOI 10.1016/j.neuint.2006.09.004; HESPE W, 1969, BRAIN RES, V14, P663, DOI 10.1016/0006-8993(69)90206-6; Holmseth S, 2006, ANAT EMBRYOL, V211, P257, DOI 10.1007/s00429-005-0077-6; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Holmseth S, 2012, J HISTOCHEM CYTOCHEM, V60, P174, DOI 10.1369/0022155411434828; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; INOUE M, 1988, J BIOCHEM-TOKYO, V104, P155, DOI 10.1093/oxfordjournals.jbchem.a122413; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Janzen JWG, 1987, J HISTOCHEM CYTOCHEM, V35, P49, DOI 10.1177/35.1.2878950; Jursky F, 1999, J NEUROSCI RES, V55, P394, DOI 10.1002/(SICI)1097-4547(19990201)55:3<394::AID-JNR14>3.0.CO;2-E; Kang YS, 2002, J NEUROCHEM, V83, P1188, DOI 10.1046/j.1471-4159.2002.01223.x; Kragler A, 2005, EUR J PHARMACOL, V519, P43, DOI 10.1016/j.ejphar.2005.06.053; Kragler A, 2008, EUR J MED CHEM, V43, P2404, DOI 10.1016/j.ejmech.2008.01.005; Kuroda E, 2000, MICROSC RES TECHNIQ, V48, P116, DOI 10.1002/(SICI)1097-0029(20000115)48:2<116::AID-JEMT7>3.3.CO;2-G; Lee NY, 2004, BRAIN RES, V1023, P141, DOI 10.1016/j.brainres.2004.07.033; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lehre AC, 2011, EPILEPSY RES, V95, P70, DOI 10.1016/j.eplepsyres.2011.02.014; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LEVY LM, 1993, FEBS LETT, V317, P79, DOI 10.1016/0014-5793(93)81495-L; Li Y., 2012, J HISTOCHEM IN PRESS, V60; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; Minelli A, 2003, DEV BRAIN RES, V142, P7, DOI 10.1016/S0165-3806(03)00007-5; MINUK GY, 1984, HEPATOLOGY, V4, P180, DOI 10.1002/hep.1840040203; Motulsky H., 2004, FITTING MODELS BIOL, P222; NIELSEN EB, 1991, EUR J PHARMACOL, V196, P257, DOI 10.1016/0014-2999(91)90438-V; Ohtsuki S, 2004, BIOL PHARM BULL, V27, P1489, DOI 10.1248/bpb.27.1489; Pabel J, 2012, CHEMMEDCHEM, V7, P1245, DOI 10.1002/cmdc.201200126; Parsons RB, 1998, J HEPATOL, V29, P595, DOI 10.1016/S0168-8278(98)80155-4; Phillips CL, 2004, J AM SOC NEPHROL, V15, P1744, DOI 10.1097/01.ASN.0000131520.07008.B3; Qume M, 1996, BIOCHEM PHARMACOL, V52, P1355, DOI 10.1016/S0006-2952(96)00454-6; Rasgado-Flores H, 2012, EXP NEUROL, V233, P457, DOI 10.1016/j.expneurol.2011.11.019; ROBERTS E, 1953, J BIOL CHEM, V201, P393; SAIKI H, 1992, J BIOL CHEM, V267, P192; SCHAFER DF, 1981, P SOC EXP BIOL MED, V167, P301; Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432; Sergeeva OA, 2003, J PHYSIOL-LONDON, V550, P911, DOI 10.1113/jphysiol.2003.045864; Skarpen E, 2000, MOL CARCINOGEN, V28, P84, DOI 10.1002/1098-2744(200006)28:2<84::AID-MC4>3.0.CO;2-X; SMITH KE, 1992, MOL PHARMACOL, V42, P563; Soudijn W, 2000, CURR MED CHEM, V7, P1063, DOI 10.2174/0929867003374363; STURMAN JA, 1978, J NUTR, V108, P1462, DOI 10.1093/jn/108.9.1462; Takanaga T, 2001, J CEREBR BLOOD F MET, V21, P1232, DOI 10.1097/00004647-200110000-00012; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; Vinnakota S, 1997, J NEUROCHEM, V69, P2238; Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WHITE HL, 1981, MOL CELL BIOCHEM, V39, P253, DOI 10.1007/BF00232578; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhang Y, 1998, BRAIN RES, V808, P1, DOI 10.1016/S0006-8993(98)00767-7; Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011	89	73	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35733	35746		10.1074/jbc.M112.368175	http://dx.doi.org/10.1074/jbc.M112.368175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22896705	hybrid, Green Published			2022-12-25	WOS:000309968000084
J	Song, JH; Lafont, A; Chen, JR; Wu, FM; Shirahige, K; Rankin, S				Song, Jianhua; Lafont, Andrea; Chen, Jingrong; Wu, Frank M.; Shirahige, Katsuhiko; Rankin, Susannah			Cohesin Acetylation Promotes Sister Chromatid Cohesion Only in Association with the Replication Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DNA-POLYMERASE-ALPHA; S-PHASE; SACCHAROMYCES-CEREVISIAE; ESTABLISHMENT; ACETYLTRANSFERASE; SORORIN; COMPLEX; ECO1; YEAST	Acetylation of the Smc3 subunit of cohesin is essential to establish functional cohesion between sister chromatids. Smc3 acetylation is catalyzed by members of the Eco family of acetyl-transferases, although the mechanism by which acetylation is regulated and how it promotes cohesion are largely unknown. In vertebrates, the cohesin complex binds to chromatin during mitotic exit and is converted to a functional form during or shortly after DNA replication. The conserved proliferating cell nuclear antigen-interacting protein box motif in yeast Eco1 is required for function, and cohesin is acetylated during the S phase. This has led to the notion that acetylation of cohesin is stimulated by interaction of Eco1 with the replication machinery. Here we show that in vertebrates Smc3 acetylation occurs independently of DNA replication. Smc3 is readily acetylated before replication is initiated and after DNA replication is complete. However, we also show that functional acetylation occurs only in association with the replication machinery: disruption of the interaction between XEco2 and proliferating cell nuclear antigen prevents cohesion establishment while having little impact on the overall levels of Smc3 acetylation. These results demonstrate that Smc3 acetylation can occur throughout interphase but that only acetylation in association with the replication fork promotes sister chromatid cohesion. These data reveal how the generation of cohesion is limited to the appropriate time and place during the cell cycle and provide insight into the mechanism by which acetylation ensures cohesion.	[Song, Jianhua; Lafont, Andrea; Chen, Jingrong; Rankin, Susannah] Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Wu, Frank M.; Rankin, Susannah] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Tokyo	Rankin, S (corresponding author), Oklahoma Med Res Fdn, Program Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	susannah-rankin@omrf.org		Rankin, Susannah/0000-0002-4056-6610	National Institutes of Health from the National Center for Research Resources [RR016478]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR016478 from the National Center for Research Resources.	Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Heidinger-Pauli JM, 2010, GENETICS, V185, P1249, DOI 10.1534/genetics.110.116871; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Higashi TL, 2012, CURR BIOL, V22, P977, DOI 10.1016/j.cub.2012.04.013; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; LUKE M, 1989, DEV BIOL, V136, P459, DOI 10.1016/0012-1606(89)90271-6; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Rankin S, 1997, CURR BIOL, V7, P451, DOI 10.1016/S0960-9822(06)00192-8; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Sarkaria JN, 1999, CANCER RES, V59, P4375; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Takagi M, 2008, FEBS J, V275, P6109, DOI 10.1111/j.1742-4658.2008.06736.x; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tutter Antonin V., 2006, V322, P121; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whelan G, 2012, EMBO J, V31, P71, DOI 10.1038/emboj.2011.381; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	41	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34325	34336		10.1074/jbc.M112.400192	http://dx.doi.org/10.1074/jbc.M112.400192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896698	Green Published, hybrid			2022-12-25	WOS:000309654200036
J	Wadsater, M; Laursen, T; Singha, A; Hatzakis, NS; Stamou, D; Barker, R; Mortensen, K; Feidenhans'l, R; Moller, BL; Cardenas, M				Wadsater, Maria; Laursen, Tomas; Singha, Aparajita; Hatzakis, Nikos S.; Stamou, Dimitrios; Barker, Robert; Mortensen, Kell; Feidenhans'l, Robert; Moller, Birger Lindberg; Cardenas, Marite			Monitoring Shifts in the Conformation Equilibrium of the Membrane Protein Cytochrome P450 Reductase (POR) in Nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; CYANOGENIC GLUCOSIDE DHURRIN; NANOSCALE LIPID-BILAYERS; FMN BINDING-SITE; ELECTRON-TRANSFER; SORGHUM-BICOLOR; NEUTRON REFLECTOMETRY; DIFLAVIN REDUCTASES; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEINS	Nanodiscs are self-assembled similar to 50-nm(2) patches of lipid bilayers stabilized by amphipathic belt proteins. We demonstrate that a well ordered dense film of nanodiscs serves for non-destructive, label-free studies of isolated membrane proteins in a native like environment using neutron reflectometry (NR). This method exceeds studies of membrane proteins in vesicle or supported lipid bilayer because membrane proteins can be selectively adsorbed with controlled orientation. As a proof of concept, the mechanism of action of the membrane-anchored cytochrome P450 reductase (POR) is studied here. This enzyme is responsible for catalyzing the transfer of electrons from NADPH to cytochrome P450s and thus is a key enzyme in the biosynthesis of numerous primary and secondary metabolites in plants. Neutron reflectometry shows a coexistence of two different POR conformations, a compact and an extended form with a thickness of 44 and 79 angstrom, respectively. Upon complete reduction by NADPH, the conformational equilibrium shifts toward the compact form protecting the reduced FMN cofactor from engaging in unspecific electron transfer reaction.	[Wadsater, Maria; Cardenas, Marite] Univ Copenhagen, Inst Chem, Fac Sci, DK-2100 Copenhagen, Denmark; [Wadsater, Maria; Cardenas, Marite] Univ Copenhagen, Nanosci Ctr, Fac Sci, DK-2100 Copenhagen, Denmark; [Laursen, Tomas; Moller, Birger Lindberg] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; [Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Nanosci Ctr,Dept Chem, Dept Neurosci & Pharmacol,Bionanotechnol Lab, DK-2100 Copenhagen, Denmark; [Barker, Robert] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Mortensen, Kell; Feidenhans'l, Robert] Niels Bohr Inst, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; Institut Laue-Langevin (ILL); University of Copenhagen; Niels Bohr Institute	Cardenas, M (corresponding author), Univ Copenhagen, Inst Chem, Fac Sci, Univ Pk 5, DK-2100 Copenhagen, Denmark.	cardenas@nano.ku.dk	Hatzakis, Nikos/P-3865-2019; Møller, Birger Lindberg/GQI-1792-2022; Stamou, Dimitrios/D-5042-2016; Barker, Robert D/E-6386-2012; Møller, Birger Lindberg/H-2657-2014; Mortensen, Kell/A-5066-2009; Cárdenas, Marité/O-4669-2014; Hatzakis, Nikos S/C-2715-2015; Cardenas, Marite/AAG-1793-2019; Singha, Aparajita/AAN-8356-2021	Hatzakis, Nikos/0000-0003-4202-0328; Møller, Birger Lindberg/0000-0002-3252-3119; Stamou, Dimitrios/0000-0001-8456-8995; Barker, Robert D/0000-0002-8645-5385; Møller, Birger Lindberg/0000-0002-3252-3119; Mortensen, Kell/0000-0002-8998-9390; Cárdenas, Marité/0000-0003-0392-3540; Hatzakis, Nikos S/0000-0003-4202-0328; Cardenas, Marite/0000-0003-0392-3540; Singha, Aparajita/0000-0001-6301-0394; Laursen, Tomas/0000-0002-6493-2259; Feidenhansl, Robert/0000-0002-7963-3649	Center for Synthetic Biology at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation; Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center; Danish government; Villum Research Center "Pro-Active Plants."	Center for Synthetic Biology at Copenhagen University; UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation; Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center; Danish government; Villum Research Center "Pro-Active Plants."	This work was supported by the Center for Synthetic Biology at Copenhagen University funded by the UNIK research initiative of the Danish Ministry of Science, Technology, and Innovation, the Danish Centre for the Use of Synchrotron X-ray and Neutron Faculties (DANSCATT) Center funded by the Danish government, and the Villum Research Center "Pro-Active Plants."	ABELES F, 1948, ANN PHYS-PARIS, V3, P504; Akesson A, 2012, SOFT MATTER, V8, P5658, DOI 10.1039/c2sm00013j; Aliverti A, 1999, METH MOL B, V131, P9; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bayburt TH, 2000, LANGMUIR, V16, P5993, DOI 10.1021/la991449c; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Campbell RA, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11107-8; Carlson JW, 1997, BIOPHYS J, V73, P1184, DOI 10.1016/S0006-3495(97)78150-5; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Das A, 2009, BIOCHEMISTRY-US, V48, P12104, DOI 10.1021/bi9011435; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hatzakis NS, 2012, J AM CHEM SOC, V134, P9296, DOI 10.1021/ja3011429; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ivanov AS, 2010, ACS CHEM BIOL, V5, P767, DOI 10.1021/cb100055v; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Jensen K, 2011, PHYTOCHEMISTRY, V72, P2113, DOI 10.1016/j.phytochem.2011.05.001; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Kent MS, 2008, BIOPHYS J, V94, P2115, DOI 10.1529/biophysj.107.113498; Kent MS, 2010, BIOPHYS J, V99, P1940, DOI 10.1016/j.bpj.2010.07.016; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Skar-Gislinge N, 2010, J AM CHEM SOC, V132, P13713, DOI 10.1021/ja1030613; Thomas RK, 2004, ANNU REV PHYS CHEM, V55, P391, DOI 10.1146/annurev.physchem.54.011002.103830; Wadsater M, 2011, LANGMUIR, V27, P15065, DOI 10.1021/la203100n; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587	50	52	55	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34596	34603		10.1074/jbc.M112.400085	http://dx.doi.org/10.1074/jbc.M112.400085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891242	hybrid, Green Published			2022-12-25	WOS:000309654200062
J	Zhang, HD; Lee, SJ; Kulczyk, AW; Zhu, B; Richardson, CC				Zhang, Huidong; Lee, Seung-Joo; Kulczyk, Arkadiusz W.; Zhu, Bin; Richardson, Charles C.			Heterohexamer of 56- and 63-kDa Gene 4 Helicase-Primase of Bacteriophage T7 in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; LAGGING-STRAND SYNTHESIS; NUCLEOTIDE-BINDING SITE; POLYMERASE-ACTIVITY; PRIMER SYNTHESIS; SINGLE-MOLECULE; DTTP HYDROLYSIS; LINKER REGION; PROTEIN; TEMPLATE	Bacteriophage T7 expresses two forms of gene 4 protein (gp4). The 63-kDa full-length gp4 contains both the helicase and primase domains. T7 phage also express a 56-kDa truncated gp4 lacking the zinc binding domain of the primase; the protein has helicase activity but no DNA-dependent primase activity. Although T7 phage grow better when both forms are present, the role of the 56-kDa gp4 is unknown. The two molecular weight forms oligomerize by virtue of the helicase domain to form heterohexamers. The 56-kDa gp4 and any mixture of 56- and 63-kDa gp4 show higher helicase activity in DNA unwinding and strand-displacement DNA synthesis than that observed for the 63-kDa gp4. However, single-molecule measurements show that heterohexamers have helicase activity similar to the 63-kDa gp4 hexamers. In oligomerization assays the 56-kDa gp4 and any mixture of the 56- and 63-kDa gp4 oligomerize to form more hexamers than does the 63-kDa gp4. The zinc binding domain of the 63-kDa gp4 interferes with hexamer formation, an inhibition that is relieved by the insertion of the 56-kDa species. Compared with the 63-kDa gp4, heterohexamers synthesize a reduced amount of oligoribonucleotides, mediated predominately by the 63-kDa subunits via a cis mode. During coordinated DNA synthesis 7% of the tetraribonucleotides synthesized are used as primers by both heterohexamers and hexamers of the 63-kDa gp4. Overall, an equimolar mixture of the two forms of gp4 shows the highest rate of DNA synthesis during coordinated DNA synthesis.	[Zhang, Huidong; Lee, Seung-Joo; Kulczyk, Arkadiusz W.; Zhu, Bin; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health Public Health Service [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant GM 54937 (to C.C.R.).	Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bianchi M, 2012, P NATL ACAD SCI USA, V109, P1713, DOI 10.1073/pnas.1121485109; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KIM YT, 1992, J BIOL CHEM, V267, P15032; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2009, J VIROL, V83, P8418, DOI 10.1128/JVI.00855-09; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Nakai H., 1988, DNA REPLICATION MUTA, P85; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107; Zhu B, 2009, J BIOL CHEM, V284, P23842, DOI 10.1074/jbc.M109.026104	49	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34273	34287		10.1074/jbc.M112.401158	http://dx.doi.org/10.1074/jbc.M112.401158			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22887996	hybrid, Green Published			2022-12-25	WOS:000309654200032
J	Dehnert, M; Fingerle, V; Klier, C; Talaska, T; Schlaud, M; Krause, G; Wilking, H; Poggensee, G				Dehnert, Manuel; Fingerle, Volker; Klier, Christiane; Talaska, Thomas; Schlaud, Martin; Krause, Gerard; Wilking, Hendrik; Poggensee, Gabriele			Seropositivity of Lyme Borreliosis and Associated Risk Factors: A Population-Based Study in Children and Adolescents in Germany (KiGGS)	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; BURGDORFERI INFECTION; FORESTRY WORKERS; DISEASE; SEROPREVALENCE; URBAN; PREVALENCE; ANTIBODIES; BITES; SURVEILLANCE	Background: Lyme borreliosis (LB) caused by spirochetes of the Borrelia burgdorferi sensu lato complex is the most common tick-borne disease in the northern hemisphere. Data on the distribution and on risk factors in Germany are sketchy. Methodology/Principal Findings: Blood samples of a nationwide population-based cross-sectional study from 2003-2006 in children and adolescents aged 1 to 17 years in Germany (KiGGS) were analysed (n = 12,614) to assess the seroprevalence of anti-Borrelia antibodies. Data from standardized interviews were used to assess potential risk factors. First, sera were screened for anti-Borrelia antibodies by ELISA. The overall prevalence was 4.8% (95% confidence interval (CI) 4.3-5.4%). Positive and borderline ELISA test results were confirmed by a line blot revealing a combined prevalence of 4.0% (95% CI 3.6-4.5%). Seroprevalence of ELISA was significantly higher in males (odds ratio (OR) = 1.37; CI 1.15-1.63) and in the southern part of Germany (OR = 1.41; CI 1.09-1.83), but significantly lower in children and adolescents with migration background (OR = 0.33; CI 0.24-0.44). Study participants from households with cats had a higher chance of seropositivity (OR = 6.7; CI 5.6-8.0). In a multivariable model the odds of seropositivity increases by 11% for every year of age for boys and 6% for girls. Conclusions/Significance: This survey is the first nationwide, representative seroprevalence survey of LB in children and young adolescents. The study shows that infections with Borrelia burgdorferi are endemic in all parts of Germany despite regional differences. Even at a young age children are exposed to tick bites including seropositivity. Encouraging a thorough check for ticks and promptly removal of ticks are the key public health strategies to reduce the risk of LB and other tick-borne diseases in children and adolescents. Further epidemiological studies are warranted to better understand the burden of disease related to LB.	[Dehnert, Manuel; Krause, Gerard; Wilking, Hendrik; Poggensee, Gabriele] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Fingerle, Volker; Klier, Christiane] Bavarian Food & Hlth Safety Author, Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Talaska, Thomas] Inst Tickborne Dis, Brieskow Finkenheerd, Germany; [Schlaud, Martin] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany	Robert Koch Institute; Bavarian Health & Food Safety Authority; Robert Koch Institute	Dehnert, M (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	WilkingH@rki.de		Wilking, Hendrik/0000-0002-8574-5831; Krause, Gerard/0000-0003-3328-8808; Fingerle, Volker/0000-0002-3835-5646	German Federal Ministry of Health	German Federal Ministry of Health	The study was funded by a grant from the German Federal Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2011, EUR J CLIN MICROBIOL, V30, P1027, DOI 10.1007/s10096-011-1157-6; Barker TL, 2001, AM J TROP MED HYG, V65, P804, DOI 10.4269/ajtmh.2001.65.804; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; BOHME M, 1992, BEITR INFUS, V30, P96; Carlsson SA, 1998, SCAND J INFECT DIS, V30, P501, DOI 10.1080/00365549850161520; Castiglia P, 2004, Ann Ig, V16, P103; CHRISTEN HJ, 1993, ACTA PAEDIATR, V82, P1, DOI 10.1111/j.1651-2227.1993.tb18082.x; Cinco M., 1993, Alpe Adria Microbiology Journal, V2, P91; Franz JK, 2003, BEST PRACT RES CL RH, V17, P241, DOI 10.1016/S1521-6942(02)00129-8; Fulop B, 2008, PARASITOL RES, V103, pS117, DOI 10.1007/s00436-008-1060-y; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; GUY EC, 1991, LANCET, V338, P253, DOI 10.1016/0140-6736(91)90392-3; HASSLER D, 1992, DEUT MED WOCHENSCHR, V117, P767, DOI 10.1055/s-2008-1062374; HEININGER U, 1993, MONATSSCHR KINDERH, V141, P874; Hristea A, 2001, EUR J EPIDEMIOL, V17, P891, DOI 10.1023/A:1015600729900; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Junttila T, 1999, J CLIN MICROBIOL, V37, P1361, DOI 10.1128/JCM.37.5.1361-1365.1999; Kaya AD, 2008, NEW MICROBIOL, V31, P203; KORENBERG EI, 1993, EUR J EPIDEMIOL, V9, P86, DOI 10.1007/BF00463095; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lange R, 1993, VEKTORBIOLOGISCHE IN, P31; Letrilliart L, 2005, EPIDEMIOL INFECT, V133, P935, DOI 10.1017/S0950268805004413; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Maetzel D, 2005, PARASITOL RES, V95, P5, DOI 10.1007/s00436-004-1240-3; MAGNARELLI LA, 1995, J CLIN MICROBIOL, V33, P541, DOI 10.1128/JCM.33.3.541-544.1995; Marangoni A, 2008, EUR J CLIN MICROBIOL, V27, P349, DOI 10.1007/s10096-007-0445-7; Matuschka FR, 1996, J INFECT DIS, V174, P1108, DOI 10.1093/infdis/174.5.1108; Muller I, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/595427; Oehme R, 2002, INT J MED MICROBIOL, V291, P22, DOI 10.1016/S1438-4221(02)80005-4; PAUL H, 1986, Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A, V263, P473; POKORNY P, 1990, Ceskoslovenska Epidemiologie Mikrobiologie Imunologie, V39, P32; Reimer B, 1999, S GENT WILDB KREUTH; RKI, 2001, EPID B, V21, P147; RKI, 2007, EPID B, V38, P351; Robert Koch-Institut, 2010, EPID B, V12, P101; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Skogman BH, 2010, ARCH DIS CHILD, V95, P1013, DOI 10.1136/adc.2010.183624; Smith R, 2000, EMERG INFECT DIS, V6, P404, DOI 10.3201/eid0604.000416; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Thorin C, 2008, MED MALADIES INFECT, V38, P533, DOI 10.1016/j.medmal.2008.06.008; Tomao P, 2005, EUR J CLIN MICROBIOL, V24, P457, DOI 10.1007/s10096-005-1348-0; WEILAND T, 1992, BEITR INFUS, V30, P92; Weisshaar E, 2006, J INVEST DERMATOL, V126, P584, DOI 10.1038/sj.jid.5700160; Zhioua E, 1997, EUR J EPIDEMIOL, V13, P959, DOI 10.1023/A:1007465305193	45	56	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e41321	10.1371/journal.pone.0041321	http://dx.doi.org/10.1371/journal.pone.0041321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905101	Green Published, gold			2022-12-25	WOS:000307823600005
J	Cauda, F; Torta, DME; Sacco, K; Geda, E; D'Agata, F; Costa, T; Duca, S; Geminiani, G; Amanzio, M				Cauda, Franco; Torta, Diana M-E.; Sacco, Katiuscia; Geda, Elisabetta; D'Agata, Federico; Costa, Tommaso; Duca, Sergio; Geminiani, Giuliano; Amanzio, Martina			Shared "Core" Areas between the Pain and Other Task-Related Networks	PLOS ONE			English	Article							EVOKED CUTANEOUS PAIN; HUMAN BRAIN; CINGULATE CORTEX; ANTERIOR INSULA; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; NEUROIMAGING DATA; ATTENTION; SYSTEM; DORSAL	The idea of a 'pain matrix' specifically devoted to the processing of nociceptive inputs has been challenged. Alternative views now propose that the activity of the primary and secondary somatosensory cortices (SI, SII), the insula and cingulate cortex may be related to a basic defensive system through which significant potentially dangerous events for the body's integrity are detected. By reviewing the role of the SI, SII, the cingulate and the insular cortices in the perception of nociceptive and tactile stimuli, in attentional, emotional and reward tasks, and in interoception and memory, we found that all these task-related networks overlap in the dorsal anterior cingulate cortex, the anterior insula and the dorsal medial thalamus. A thorough analysis revealed that the 'pain-related' network shares important functional similarities with both somatomotor-somatosensory networks and emotional-interoceptive ones. We suggest that these shared areas constitute the central part of an adaptive control system involved in the processing and integration of salient information coming both from external and internal sources. These areas are activated in almost all fMRI tasks and have been indicated to play a pivotal role in switching between externally directed and internally directed brain networks.	[Cauda, Franco; Sacco, Katiuscia; Geda, Elisabetta; D'Agata, Federico; Duca, Sergio; Geminiani, Giuliano] Koelliker Hosp, CCS FMRI, Turin, Italy; [Cauda, Franco; Torta, Diana M-E.; Sacco, Katiuscia; D'Agata, Federico; Costa, Tommaso; Geminiani, Giuliano; Amanzio, Martina] Univ Turin, Dept Psychol, Turin, Italy; [D'Agata, Federico] AOU San Giovanni Battista, Dept Neurosci, Turin, Italy; [Amanzio, Martina] Univ Turin, NIT, I-10124 Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Cauda, F (corresponding author), Koelliker Hosp, CCS FMRI, Turin, Italy.	franco.cauda@unito.it	Amanzio, Martina/A-9085-2010; D'Agata, Federico/ABG-8839-2021; Cauda, Franco/G-5021-2010; Sacco, Katiuscia/J-2133-2012	Amanzio, Martina/0000-0002-2504-032X; D'Agata, Federico/0000-0001-9432-0248; Cauda, Franco/0000-0003-1526-8475; Sacco, Katiuscia/0000-0002-9660-5236; Torta, Diana/0000-0002-3499-3982; BRISCHETTO COSTA, Tommaso/0000-0002-0822-862X	Regione Piemonte, bando ScienzeUmane e Sociali [4/2006]	Regione Piemonte, bando ScienzeUmane e Sociali(Regione Piemonte)	This work supported by Regione Piemonte, bando ScienzeUmane e Sociali 2008, L.R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian, 1999, Curr Rev Pain, V3, P308, DOI 10.1007/s11916-999-0047-4; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bilder Robert M, 2009, Cogn Neuropsychiatry, V14, P419, DOI 10.1080/13546800902787180; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Borsook D, 2009, NEURON, V61, P153, DOI 10.1016/j.neuron.2009.01.003; Buchsbaum MS, 2006, NEUROSCI LETT, V404, P282, DOI 10.1016/j.neulet.2006.05.063; Cauda F, 2012, NEUROIMAGE; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duerden EG, 2011, HUMAN BRAIN MAPPING; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; EDELMAN S, 1995, NEURAL COMPUT, V7, P408, DOI 10.1162/neco.1995.7.2.408; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Farmer M. A., 2012, NEUROSCI LETT; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Friebel U, 2011, NEUROIMAGE, V58, P1070, DOI 10.1016/j.neuroimage.2011.07.022; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; GREENSPAN JD, 1994, SOMATOSENS MOT RES, V11, P311, DOI 10.3109/08990229409028875; Greenspan JD, 1997, SOMATOSENS MOT RES, V14, P107, DOI 10.1080/08990229771105; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Isnard J, 2011, PAIN, V152, P946, DOI 10.1016/j.pain.2010.12.025; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kriegeskorte N, 2011, NEUROIMAGE, V56, P411, DOI 10.1016/j.neuroimage.2011.01.061; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Legrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020926; Legrain V, 2011, PAIN, V152, P453, DOI 10.1016/j.pain.2010.11.024; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Mazzola L, 2006, CEREB CORTEX, V16, P960, DOI 10.1093/cercor/bhj038; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Parker D S, 2009, Summit Transl Bioinform, V2009, P90; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Robinson JL, 2010, HUM BRAIN MAPP, V31, P173, DOI 10.1002/hbm.20854; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/nmeth.1635, 10.1038/NMETH.1635]	68	48	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41929	10.1371/journal.pone.0041929	http://dx.doi.org/10.1371/journal.pone.0041929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900003	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900018
J	Khan, MR; Hu, JY; Ali, GM				Khan, Muhammad Ramzan; Hu, Jinyong; Ali, Ghulam Muhammad			Reciprocal Loss of CArG-Boxes and Auxin Response Elements Drives Expression Divergence of MPF2-Like MADS-Box Genes Controlling Calyx Inflation	PLOS ONE			English	Article							MORPHOLOGICAL NOVELTY; ARABIDOPSIS-THALIANA; FLORAL ORGAN; DNA-BINDING; EVOLUTION; CIS; TRANSCRIPTION; AUX/IAA; MEMBERS	Expression divergence is thought to be a hallmark of functional diversification between homologs post duplication. Modification in regulatory elements has been invoked to explain expression divergence after duplication for several MADS-box genes, however, verification of reciprocal loss of cis-regulatory elements is lacking in plants. Here, we report that the evolution of MPF2-like genes has entailed degenerative mutations in a core promoter CArG-box and an auxin response factor (ARF) binding element in the large 1st intron in the coding region. Previously, MPF2-like genes were duplicated into MPF2-like-A and -B through genome duplication in Withania and Tubocapsicum (Withaninae). The calyx of Withania grows exorbitantly after pollination unlike Tubocapsicum, where it degenerates. Besides inflated calyx syndrome formation, MPF2-like transcription factors are implicated in functions both during the vegetative and reproductive development as well as in phase transition. MPF2-like-A of Withania (WSA206) is strongly expressed in sepals, while MPF2-like-B (WSB206) is not. Interestingly, their combined expression patterns seem to replicate the pattern of their closely related hypothetical progenitors from Vassobia and Physalis. Using phylogenetic shadowing, site-directed mutagenesis and motif swapping, we could show that the loss of a conserved CArG-box in MPF2-like-B of Withania is responsible for impeding its expression in sepals. Conversely, loss of an ARE in MPF2-like-A relaxed the constraint on expression in sepals. Thus, the ARE is an active suppressor of MPF2-like gene expression in sepals, which in contrast is activated via the CArG-box. The observed expression divergence in MPF2-like genes due to reciprocal loss of cis-regulatory elements has added to genetic and phenotypic variations in the Withaninae and enhanced the potential of natural selection for the adaptive evolution of ICS. Moreover, these results provide insight into the interplay of floral developmental and hormonal pathways during ICS development and add to the understanding of the importance of polyploidy in plants.	[Khan, Muhammad Ramzan; Ali, Ghulam Muhammad] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Hu, Jinyong] Max Planck Inst Plant Breeding Res, Dept Mol Plant Genet, Cologne, Germany	National Agricultural Research Council - Pakistan; Max Planck Society	Khan, MR (corresponding author), Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan.	khan@mpiz-koeln.mpg.de	Khan, Muhammad Ramzan/AAD-9958-2022		MPG (Max Planck Society); DAAD (German Academic Exchange Service); HEC (Higher Education Commission of Pakistan); NIGAB (National Institute for Genomics and Advanced Biotechnology)	MPG (Max Planck Society)(Max Planck Society); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); HEC (Higher Education Commission of Pakistan)(Higher Education Commission of Pakistan); NIGAB (National Institute for Genomics and Advanced Biotechnology)	Funding was provided by MPG (Max Planck Society), DAAD (German Academic Exchange Service), HEC (Higher Education Commission of Pakistan), and NIGAB (National Institute for Genomics and Advanced Biotechnology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000366; Aloni R, 2006, PLANTA, V223, P315, DOI 10.1007/s00425-005-0088-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; de Folter S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-47; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fang SC, 2002, PLANT PHYSIOL, V130, P78, DOI 10.1104/pp.004721; Force A, 1999, GENETICS, V151, P1531; Force AG, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P315; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hagen G, 2002, PLANT MOL BIOL, V15, P533; He CY, 2007, PLANT J, V49, P935, DOI 10.1111/j.1365-313X.2006.03008.x; He CY, 2010, PLANTA, V231, P767, DOI 10.1007/s00425-009-1087-z; He CY, 2005, P NATL ACAD SCI USA, V102, P5779, DOI 10.1073/pnas.0501877102; He CY, 2004, FEBS LETT, V567, P147, DOI 10.1016/j.febslet.2004.02.090; Hu JY, 2007, MOL BIOL EVOL, V24, P2443, DOI 10.1093/molbev/msm177; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Irish VF, 2006, ADV BOT RES, V44, P129, DOI 10.1016/S0065-2296(06)44003-9; Jarinova O, 2008, DEVELOPMENT, V135, P3543, DOI 10.1242/dev.025817; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Khan MR, 2009, MOL BIOL EVOL, V26, P2463, DOI 10.1093/molbev/msp159; Khan MR, 2012, J PLANT PHYSIOL, V169, P940, DOI 10.1016/j.jplph.2012.02.015; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schauer SE, 2009, PLANT J, V59, P987, DOI 10.1111/j.1365-313X.2009.03928.x; Sethupathy P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003137; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Tichopad A, 2006, COMPUT METH PROG BIO, V82, P44, DOI 10.1016/j.cmpb.2005.12.002; Tirosh Itay, 2009, J Biol, V8, P95, DOI 10.1186/jbiol204; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, P NATL ACAD SCI USA, V96, P5844; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	57	18	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42781	10.1371/journal.pone.0042781	http://dx.doi.org/10.1371/journal.pone.0042781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900049	gold, Green Published			2022-12-25	WOS:000307380900067
J	Kim, DW; Kilgore, PE; Kim, EJ; Kim, SA; Anh, DD; Dong, BQ; Kim, JS; Seki, M				Kim, Dong Wook; Kilgore, Paul E.; Kim, Eun Jin; Kim, Soon Ae; Anh, Dang Duc; Dong, Bai Qing; Kim, Jung Soo; Seki, Mitsuko			The Enhanced Pneumococcal LAMP Assay: A Clinical Tool for the Diagnosis of Meningitis Due to Streptococcus pneumoniae	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; BACTERIAL-MENINGITIS; LYTA GENE; DNA; INFECTIONS; PATHOGENS; CHILDREN; PRIMERS; CULTURE	Background: Streptococcus pneumoniae is a leading cause of invasive bacterial disease in developed and developing countries. We studied the loop-mediated isothermal amplification (LAMP) technique to assess its suitability for detecting S. pneumoniae nucleic acid in cerebrospinal fluid (CSF). Methodology/Principal Findings: We established an improved LAMP assay targeting the lytA gene (Streptococcus pneumoniae [Sp] LAMP). The analytical specificity of the primers was validated by using 32 reference strains (10 Streptococcus and seven non-Streptococcus species) plus 25 clinical alpha-hemolytic streptococcal strains, including four S. pneumoniae strains and 21 other strains (3 S. oralis, 17 S. mitis, and one Streptococcus species) harboring virulence factor-encoding genes (lytA or ply). Within 30 minutes, the assay could detect as few as 10 copies of both purified DNA and spiked CSF specimens with greater sensitivity than conventional polymerase chain reaction (PCR). The linear determination range for this assay is 10 to 1,000,000 microorganisms per reaction mixture using real-time turbidimetry. We evaluated the clinical sensitivity and specificity of the Sp LAMP assay using 106 randomly selected CSF specimens from children with suspected meningitis in Korea, China and Vietnam. For comparison, CSF specimens were also tested against conventional PCR and culture tests. The detection rate of the LAMP method was substantially higher than the rates of PCR and culture tests. In this small sample, relative to the LAMP assay, the clinical sensitivity of PCR and culture tests was 54.5% and 33.3%, respectively, while clinical specificity of the two tests was 100%. Conclusions/Significance: Compared to PCR, Sp LAMP detected S. pneumoniae with higher analytical and clinical sensitivity. This specific and sensitive LAMP method offers significant advantages for screening patients on a population basis and for diagnosis in clinical settings.	[Kim, Dong Wook; Kim, Eun Jin] Hanyang Univ, Dept Pharm, Coll Pharm, Ansan, South Korea; [Kim, Dong Wook; Kim, Eun Jin] Int Vaccine Inst, Mol Bacteriol Lab, Seoul, South Korea; [Kilgore, Paul E.; Kim, Soon Ae] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Kilgore, Paul E.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI USA; [Anh, Dang Duc] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Dong, Bai Qing] Ctr Dis Prevent & Control, Nanning, Guangxi, Peoples R China; [Kim, Jung Soo] Chonbuk Natl Univ, Sch Med, Jeonju, South Korea; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dent Res Ctr, Tokyo 101, Japan	Hanyang University; International Vaccine Institute; International Vaccine Institute; Wayne State University; National Institute of Hygiene & Epidemiology (NIHE); Jeonbuk National University; Nihon University; Nihon University	Kim, DW (corresponding author), Hanyang Univ, Dept Pharm, Coll Pharm, Ansan, South Korea.	seki-m@dent.nihon-u.ac.jp	Kilgore, Paul/AAD-2869-2019; Kilgore, Paul E/L-1462-2013; Kim, Dong Wook/H-8253-2015	Kilgore, Paul/0000-0003-3214-4482; Kilgore, Paul E/0000-0003-3214-4482; Kim, Dong Wook/0000-0001-5351-7597; Kim, Soon Ae/0000-0002-5945-2832	Ministry of Education, Culture, Sports, Science and Technology of Japan [10201004]; Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE) [RTI05-01-01]; Hanyang University [HY-2011-N]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE); Hanyang University	This investigation was supported by the Grant-in-Aid for Scientific Research (C) (No. 10201004) and a grant to promote multi-disciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology of Japan. DWK was supported by the grant RTI05-01-01 from the Regional Technology Innovation Program of the Ministry of Knowledge and Economy (MKE) and the research fund of Hanyang University (HY-2011-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Isenberg HD, 1998, ESSENTIAL PROCEDURES, P67; Jacoby GA, 1996, ANNU REV MED, V47, P169; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kennedy WA, 2007, EPIDEMIOL INFECT, V135, P1217, DOI 10.1017/S0950268806007734; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P915, DOI 10.1093/jac/48.6.915; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nandakumar R, 2008, ORAL SURG ORAL MED O, V106, P145, DOI 10.1016/j.tripleo.2008.01.036; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; SALO P, 1995, J INFECT DIS, V171, P479, DOI 10.1093/infdis/171.2.479; Seki M, 2005, J CLIN MICROBIOL, V43, P1581, DOI 10.1128/JCM.43.4.1581-1586.2005; Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Wester CW, 2002, DIAGN MICR INFEC DIS, V42, P263, DOI 10.1016/S0732-8893(01)00358-3; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000	23	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42954	10.1371/journal.pone.0042954	http://dx.doi.org/10.1371/journal.pone.0042954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900070	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900088
J	Popova, S; Lange, S; Burd, L; Rehm, J				Popova, Svetlana; Lange, Shannon; Burd, Larry; Rehm, Juergen			Health Care Burden and Cost Associated with Fetal Alcohol Syndrome: Based on Official Canadian Data	PLOS ONE			English	Article							ECONOMIC-IMPACT; SPECTRUM DISORDER; MORTALITY; FAS	Background: Fetal Alcohol Spectrum Disorder (FASD) is a group of disorders caused by prenatal alcohol exposure. From this group, Fetal Alcohol Syndrome (FAS) is the only disorder coded in the International Classification of Diseases, version 10 (ICD-10). This coding was used to gain an understanding on the health care utilization and the mortality rate for individuals diagnosed with FAS, as well as to estimate the associated health care costs in Canada for the most recent available fiscal year (2008-2009). Methods: Health care utilization data associated with a diagnosis of FAS were directly obtained from the Canadian Institute for Health Information (CIHI). Mortality data associated with a diagnosis of FAS were obtained from Statistics Canada. Results: The total direct health care cost of acute care, psychiatric care, day surgery, and emergency department services associated with FAS in Canada in 2008-2009, based on the official CIHI data, was about $6.7 million. The vast majority of the most responsible diagnoses, which account for the majority of a patient's length of stay in hospital, fall within the ICD-10 category Mental and Behavioural Disorders (F00-F99). It was evident that the burden and cost of acute care hospitalizations due to FAS is increasing -1.6 times greater in 2008-2009, compared to 2002-2003. The mortality data due to FAS, obtained from Statistics Canada (2000-2008), may be underreported, and are likely invalid. Discussion: The official data on the utilization of health care services by individuals diagnosed with FAS are likely to be underreported and therefore, the reported cost figures are most likely underestimated. The quantification of the health care costs associated with FAS is crucial for policy developers and decision makers alike, of the impact of prenatal alcohol exposure, with the ultimate goal of initiating preventive interventions to address FASD.	[Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada; [Popova, Svetlana; Lange, Shannon; Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, W Toronto, ON, Canada; [Burd, Larry] Univ N Dakota, Sch Med, Dept Pediat, Grand Forks, ND 58202 USA; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, D-01062 Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of North Dakota Grand Forks; Technische Universitat Dresden	Popova, S (corresponding author), Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada.	Lana.Popova@camh.ca			Public Health Agency of Canada [4500278412]; Ontario Ministry of Health and Long-Term Care	Public Health Agency of Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was supported by the Public Health Agency of Canada [contract #4500278412]. In addition, support to the Centre for Addiction and Mental Health for the salaries of scientists and infrastructure has been provided by the Ontario Ministry of Health and Long-Term Care. The views expressed in this manuscript do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E L, 1991, Recent Dev Alcohol, V9, P117; ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; ABEL EL, 1987, DRUG ALCOHOL DEPEN, V19, P51, DOI 10.1016/0376-8716(87)90087-1; Amendah DD, 2011, NEUROTOXICOL TERATOL, V33, P322, DOI 10.1016/j.ntt.2010.10.008; Astley SJ, 1995, DIAGNOSTIC GUIDE FET; Burd L, 2004, ADDICT BIOL, V9, P179, DOI 10.1080/13556210410001717088; Burd L, 2008, BIRTH DEFECTS RES A, V82, P217, DOI 10.1002/bdra.20445; Canadian Institute for Health Information (CIHI), 2010, HOSP RAT CAN CONT DE; Chudley AE, 2008, ARCH DIS CHILD, V93, P721, DOI 10.1136/adc.2008.137109; Crede S, 2011, DRUG ALCOHOL DEPEN, V115, P175, DOI 10.1016/j.drugalcdep.2010.10.019; Habbick BF, 1997, CAN J PUBLIC HEALTH, V88, P181, DOI 10.1007/BF03403884; Harwood H, 2003, EC COSTS FETAL ALCOH; Harwood H., 2000, NIH PUBLICATION; Harwood H. F., 1985, ALCOHOL HEALTH RES W, V10, P38; Harwood H.J., 1998, EC COSTS ALCOHOL DRU; Harwood H. J., 1984, EC COSTS SOC ALCOHOL; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Johansson P., 2006, SOCIAL COSTS ALCOHOL; Kloehn D, 1997, Minn Med, V80, P26; Klug MG, 2003, NEUROTOXICOL TERATOL, V25, P763, DOI 10.1016/j.ntt.2003.07.012; Lemoine P, 1968, OUEST MED, V21, P476; McDowell Group, 2005, EC COSTS ALC OTH DRU; Miller TR, 2006, J STUD ALCOHOL, V67, P519, DOI 10.15288/jsa.2006.67.519; Popova S., 2012, EC IMPACT FETAL ALCO; Popova S, 2012, J POPUL THER CLIN PH, V19, pE51; Popova S, 2011, ALCOHOL ALCOHOLISM, V46, P490, DOI 10.1093/alcalc/agr029; Popovici I, 2009, EC COSTS UNDERAGE DR; Public Health Agency of Canada (PHAC), 2003, FET ALC SPECTR DIS F; Public Health Agency of Canada (PHAC), 2003, FAS FAE INF TOOL KIT; Rice D, 1990, DHHS PUBLICATION, V(ADM) 90-1694; RICE DP, 1991, PUBLIC HEALTH REP, V106, P280; Rice RD, 1993, ALCOHOL HEALTH RES W, V17, P10; Roberts G, 2000, BEST PRACTICES FETAL; Rosen SM, 2008, ALCOHOL CLIN EXP RES, V32, P1925, DOI 10.1111/j.1530-0277.2008.00777.x; RUSSELL M, 1980, NEUROTOXICOL TERATOL, V2, P277; Stade B., 2006, J FETAL ALCOHOL SYND, V4, P1, DOI DOI 10.1093/PCH/9.SUPPL_A.41AA; Stade B, 2009, J POPUL THER CLIN PH, V16, pE91; Statistics Canada, 2011, TABL 051 0001 POP YE; Statistics Canada, 2011, TABL 102 0537 DEATHS; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Thanh NX, 2009, J POPUL THER CLIN PH, V16, pE80; Weeks M, 1989, COMMUNICATION   0217	42	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43024	10.1371/journal.pone.0043024	http://dx.doi.org/10.1371/journal.pone.0043024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900084	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900102
J	Rudick, CN; Jiang, MC; Yaggie, RE; Pavlov, VI; Done, J; Heckman, CJ; Whitfield, C; Schaeffer, AJ; Klumpp, DJ				Rudick, Charles N.; Jiang, Mingchen; Yaggie, Ryan E.; Pavlov, Vladimir I.; Done, Joseph; Heckman, Charles J.; Whitfield, Christopher; Schaeffer, Anthony J.; Klumpp, David J.			O-Antigen Modulates Infection-Induced Pain States	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT-INFECTION; TOXOPLASMA; LIPOPOLYSACCHARIDE; RECOGNITION; VIRULENCE; MENINGITIS; MECHANISMS; RECEPTORS; INDUCTION	The molecular initiators of infection-associated pain are not understood. We recently found that uropathogenic E. coli (UPEC) elicited acute pelvic pain in murine urinary tract infection (UTI). UTI pain was due to E. coli lipopolysaccharide (LPS) and its receptor, TLR4, but pain was not correlated with inflammation. LPS is known to drive inflammation by interactions between the acylated lipid A component and TLR4, but the function of the O-antigen polysaccharide in host responses is unknown. Here, we examined the role of O-antigen in pain using cutaneous hypersensitivity (allodynia) to quantify pelvic pain behavior and using sacral spinal cord excitability to quantify central nervous system manifestations in murine UTI. A UPEC mutant defective for O-antigen biosynthesis induced chronic allodynia that persisted long after clearance of transient infections, but wild type UPEC evoked only acute pain. E. coli strains lacking O-antigen gene clusters had a chronic pain phenotype, and expressing cloned O-antigen gene clusters altered the pain phenotype in a predictable manner. Chronic allodynia was abrogated in TLR4-deficient mice, but inflammatory responses in wild type mice were similar among E. coli strains spanning a wide range of pain phenotypes, suggesting that O-antigen modulates pain independent of inflammation. Spinal cords of mice with chronic allodynia exhibited increased spontaneous firing and compromised short-term depression, consistent with centralized pain. Taken together, these findings suggest that O-antigen functions as a rheostat to modulate LPS-associated pain. These observations have implications for an infectious etiology of chronic pain and evolutionary modification of pathogens to alter host behaviors.	[Rudick, Charles N.; Yaggie, Ryan E.; Pavlov, Vladimir I.; Done, Joseph; Schaeffer, Anthony J.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Jiang, Mingchen; Heckman, Charles J.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Heckman, Charles J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA; [Whitfield, Christopher] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Guelph	Rudick, CN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu		Heckman, CJ/0000-0002-1324-7278	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK066112, DK082342, DK042648, T32DK062716-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042648, T32DK062716, R37DK042648, R01DK066112, U01DK082342] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases awards DK066112 (DJK), DK082342 (DJK and AJS), and DK042648 (AJS and DJK) and T32DK062716-05 (CNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Billips BK, 2008, INFECT IMMUN, V76, P3891, DOI 10.1128/IAI.00069-08; Bjorling DE, 2008, J UROLOGY, V179, P759, DOI 10.1016/j.juro.2007.09.024; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clermont O, 2007, DIAGN MICR INFEC DIS, V57, P129, DOI 10.1016/j.diagmicrobio.2006.08.007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeBerry J, 2010, J PAIN, V11, P247, DOI 10.1016/j.jpain.2009.07.010; Eder K, 2009, BIOCHEM BIOPH RES CO, V389, P46, DOI 10.1016/j.bbrc.2009.08.082; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; GIBB AP, 1992, J INFECT DIS, V166, P1051, DOI 10.1093/infdis/166.5.1051; HOPKINS WJ, 1995, J INFECT DIS, V171, P462, DOI 10.1093/infdis/171.2.462; Jiang MC, 2006, J NEUROSCI METH, V156, P31, DOI 10.1016/j.jneumeth.2006.02.002; Jiang MC, 2009, J NEUROSCI, V29, P15031, DOI 10.1523/JNEUROSCI.0574-09.2009; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson JR, 2003, INFECT DIS CLIN N AM, V17, P261, DOI 10.1016/S0891-5520(03)00027-8; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nelson C, 1999, VITAL HLTH STAT, V13; NEUHARD J, 1976, J BACTERIOL, V126, P999, DOI 10.1128/JB.126.2.999-1001.1976; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Randich A, 2009, J UROLOGY, V182, P337, DOI 10.1016/j.juro.2009.02.107; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schaeffer EM, 2007, CAMPBELL WALSH UROLO, P223; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Svanborg C, 1996, ANN NY ACAD SCI, V797, P177, DOI 10.1111/j.1749-6632.1996.tb52959.x; Svanborg C, 1997, INFECT DIS CLIN N AM, V11, P513, DOI 10.1016/S0891-5520(05)70371-8; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Warren JW, 2008, UROLOGY, V71, P1085, DOI 10.1016/j.urology.2007.12.091; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Whitfield C, 2008, NAT STRUCT MOL BIOL, V15, P121, DOI 10.1038/nsmb0208-121; Witkin SS, 2002, AM J OBSTET GYNECOL, V187, P589, DOI 10.1067/mob.2002.125889; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41273	10.1371/journal.pone.0041273	http://dx.doi.org/10.1371/journal.pone.0041273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899994	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900009
J	Wang, YM; Zhou, P; Wang, LY; Li, ZH; Zhang, YN; Zhang, YX				Wang, Ya-Mei; Zhou, Ping; Wang, Li-Yong; Li, Zhen-Hua; Zhang, Yao-Nan; Zhang, Yu-Xiang			Correlation Between DNase I Hypersensitive Site Distribution and Gene Expression in HeLa S3 Cells	PLOS ONE			English	Article							REGULATORY ELEMENTS; ANTISENSE TRANSCRIPTION; NUCLEAR ARCHITECTURE; OPEN CHROMATIN; BINDING-SITES; HUMAN GENOME; CHIP; IDENTIFICATION; VIVO; PCR	Mapping DNase I hypersensitive sites (DHSs) within nuclear chromatin is a traditional and powerful method of identifying genetic regulatory elements. DHSs have been mapped by capturing the ends of long DNase I-cut fragments (> 100,000 bp), or 100-1200 bp DNase I-double cleavage fragments (also called double-hit fragments). But next generation sequencing requires a DNA library containing DNA fragments of 100-500 bp. Therefore, we used short DNA fragments released by DNase I digestion to generate DNA libraries for next generation sequencing. The short segments are 100-300 bp and can be directly cloned and used for high-throughput sequencing. We identified 83,897 DHSs in 2,343,479 tags across the human genome. Our results indicate that the DHSs identified by this DHS assay are consistent with those identified by longer fragments in previous studies. We also found: (1) the distribution of DHSs in promoter and other gene regions of similarly expressed genes differs among different chromosomes; (2) silenced genes had a more open chromatin structure than previously thought; (3) DHSs in 3'untranslated regions (3'UTRs) are negatively correlated with level of gene expression.	[Wang, Ya-Mei; Li, Zhen-Hua; Zhang, Yao-Nan; Zhang, Yu-Xiang] Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Zhou, Ping] Capital Med Univ, Sch Biomed Engn, Dept Bioinformat & Comp Sci, Beijing, Peoples R China; [Wang, Li-Yong] Capital Med Univ, Microarray Core Facil, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wang, YM (corresponding author), Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China.	yxzhang@ccmu.edu.cn			National Natural Science Foundation of China [30873033]; Major State Basic Research Development Programs of China [2009CB521800, 2010CB529400]; Beijing Municipal Natural Science Foundation [5122004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs of China(National Basic Research Program of China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by research grants from National Natural Science Foundation of China (30873033) and Major State Basic Research Development Programs of China (2009CB521800 and 2010CB529400;www.973.gov.cn), and a grant from Beijing Municipal Natural Science Foundation (5122004;www.bjnfc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Dey D, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/619583; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Fox JL, 2011, NAT BIOTECHNOL, V29, P375, DOI 10.1038/nbt0511-375a; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khitrinskaya IY, 2003, MOL BIOL+, V37, P325, DOI 10.1023/A:1024218806634; Kim TM, 2011, WIRES SYST BIOL MED, V3, P21, DOI 10.1002/wsbm.105; Klevebring D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009762; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Richardson P, 2010, GENES-BASEL, V1, P385, DOI 10.3390/genes1030385; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-92; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	52	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42414	10.1371/journal.pone.0042414	http://dx.doi.org/10.1371/journal.pone.0042414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900019	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900036
J	Golebiewska, U; Guo, YJ; Khalikaprasad, N; Zurawsky, C; Yerramilli, VS; Scarlata, S				Golebiewska, Urszula; Guo, Yuanjian; Khalikaprasad, Narindra; Zurawsky, Cassandra; Yerramilli, V. Siddhartha; Scarlata, Suzanne			gamma-Synuclein Interacts with Phospholipase C beta 2 to Modulate G Protein Activation	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BREAST-CANCER CELLS; G-BETA-GAMMA; C-BETA; ALPHA-SYNUCLEIN; MEMBRANE INTERACTIONS; SUBUNITS; BINDING; FLUORESCENCE; STIMULATION	Phospholipase C beta 2 (PLC beta 2) is activated by G proteins and generates calcium signals in cells. PLC beta 2 is absent in normal breast tissue, but is highly expressed in breast tumors where its expression is correlated with the progression and migration of the tumor. This pattern of expression parallels the expression of the breast cancer specific gene protein 1 which is also known as gamma-synuclein. The cellular function of gamma-synuclein and the role it plays in proliferation are unknown. Here, we determined whether gamma-synuclein can interact with PLC beta 2 and affect its activity. Using co-immunprecitation and co-immunofluorescence, we find that in both benign and aggressive breast cancer cell lines gamma-synuclein and PLC beta 2 are associated. In solution, purified gamma-synuclein binds to PLC beta 2 with high affinity as measured by fluorescence methods. Protease digestion and mass spectrometry studies show that gamma-synuclein binds to a site on the C-terminus of PLC beta 2 that overlaps with the G alpha q binding site. Additionally, gamma-synuclein competes for Gaq association, but not for activators that bind to the N-terminus (i.e. Rac1 and G beta gamma). Binding of gamma-synuclein reduces the catalytic activity of PLC beta 2 by mechanism that involves inhibition of product release without affecting membrane interactions. Since activated G alpha q binds more strongly to PLC beta 2 than gamma-synuclein, addition of G alpha q(GTP gamma S) to the gamma-synuclein -PLC beta 2 complex allows for relief of enzyme inhibition along with concomitant activation. We also find that G beta gamma can reverse gamma-synuclein inhibition without dissociating the gamma-synuclein- PLC beta 2-complex. These studies point to a role of gamma-synuclein in promoting a more robust G protein activation of PLC beta 2.	[Golebiewska, Urszula; Guo, Yuanjian; Khalikaprasad, Narindra; Zurawsky, Cassandra; Yerramilli, V. Siddhartha; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Golebiewska, Urszula] CUNY Queensborough Community Coll, Dept Biol Sci & Geol, Bayside, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System	Golebiewska, U (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@sunysb.edu			National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM053132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bertagnolo V, 2006, INT J ONCOL, V28, P863; Bertagnolo V, 2007, CARCINOGENESIS; BLANK JL, 1992, J BIOL CHEM, V267, P23069; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Feng JW, 2005, BIOCHEMISTRY-US, V44, P2577, DOI 10.1021/bi0482607; George JM, 2002, GENOME BIOL, V3; Guo YJ, 2012, CELL SIGNAL, V24, P1109, DOI 10.1016/j.cellsig.2012.01.007; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Inaba S, 2005, BREAST CANCER RES TR, V94, P25, DOI 10.1007/s10549-005-6938-0; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LEE SB, 1993, J BIOL CHEM, V268, P25952; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Narayanan V, 2005, BIOCHEMISTRY-US, V44, P462, DOI 10.1021/bi0487140; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Phillips F, 2006, SOCIAL CULTURE AND HIGH-TECH ECONOMIC DEVELOPMENT, P15; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Scarlata SF, 2004, REV FLUORESCENCE, V1, P75; Singh VK, 2007, CANCER RES, V67, P626, DOI 10.1158/0008-5472.CAN-06-1820; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Weinstein H, 2011, BBA-BIOMEMBRANES, V1808, P2940, DOI 10.1016/j.bbamem.2011.08.028	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41067	10.1371/journal.pone.0041067	http://dx.doi.org/10.1371/journal.pone.0041067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905097	Green Published, gold			2022-12-25	WOS:000307331100009
J	Longo, C; Pontassuglia, C; Corriero, G; Gaino, E				Longo, Caterina; Pontassuglia, Carmen; Corriero, Giuseppe; Gaino, Elda			Life-Cycle Traits of Paraleucilla magna, a Calcareous Sponge Invasive in a Coastal Mediterranean Basin	PLOS ONE			English	Article							SAN-FRANCISCO BAY; ATLANTIC-OCEAN; 2004 PORIFERA; POECILOSCLERIDA; REPRODUCTION; DEMOSPONGIAE; COMMUNITIES; CALIFORNIA; DISPERSAL; INCREASES	The calcareous sponge Paraleucilla magna, originally observed along the Brazilian coast (Atlantic Ocean), is the only allochthonous invasive species of Porifera reported in the Mediterranean Sea. A 1-year investigation of the population dynamics and life-cycle of this exotic species in the Mar Piccolo di Taranto (southern Italy, central Mediterranean Sea) has provided a good opportunity to test how environmental variations can influence its life-cycle and to ascertain what strategy can be adopted to successfully colonize a new environment. In the Mar Piccolo di Taranto, P. magna exhibits marked temporal changes in biomass. The studied specimens reproduce almost all year round, showing a seasonal pattern that peaks during warm months. This prolonged sexual activity allows P. magna to continuously produce young specimens, with repeated recruitment events taking place throughout the year, thus offsetting the seasonal mortality of adult specimens. This r-strategy enables the non-indigenous sponge to achieve a high degree of maintenance over relatively long periods (ten years at least).	[Longo, Caterina; Pontassuglia, Carmen; Corriero, Giuseppe] Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy; [Gaino, Elda] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy	Universita degli Studi di Bari Aldo Moro; University of Perugia	Longo, C (corresponding author), Univ Bari Aldo Moro, Dipartimento Biol, Bari, Italy.	caterina.longo@uniba.it	longo, caterina/J-4886-2013	LONGO, CATERINA/0000-0003-3123-1568; Corriero, Giuseppe/0000-0002-4076-5804	Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy)	Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy)	Funding for this work was provided by the Dipartimento di Biologia, Universita degli Studi di Bari "Aldo Moro'' (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Altman S, 2007, J EXP MAR BIOL ECOL, V342, P15, DOI 10.1016/j.jembe.2006.10.011; Amano S, 2001, BIOL BULL, V200, P20, DOI 10.2307/1543082; Avila E, 2009, BIOL INVASIONS, V11, P257, DOI 10.1007/s10530-008-9230-5; Azevedo F, 2007, ZOOTAXA, P1; Calcinai B, 2004, J MAR BIOL ASSOC UK, V84, P937, DOI 10.1017/S0025315404010227h; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Caroppo C., 1994, BIOL MARINA MEDITERR, V1, P201; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; COHEN AN, 1995, MAR BIOL, V122, P225; Coles SL, 2007, CORAL REEFS, V26, P911, DOI 10.1007/s00338-007-0295-x; Coles SL, 2002, 4 BIOL SURV BISH MUS; Corriero G, 2007, ITAL J ZOOL, V74, P21, DOI 10.1080/11250000601084100; Corriero Giuseppe, 2011, Fauna d'Italia, V46, P55; Crooks JA, 2011, BIOL INVASIONS, V13, P165, DOI 10.1007/s10530-010-9799-3; Duboscq O., 1944, ARCH ZOOL EXP ET GEN, V83, P445; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; ELVIN DW, 1976, BIOL BULL-US, V151, P108, DOI 10.2307/1540709; Ereskovsky AV, 2000, BIOL BULL, V198, P77, DOI 10.2307/1542805; Fell Paul E., 1993, P1; Floerl O, 2005, BIOL INVASIONS, V7, P459, DOI 10.1007/s10530-004-4863-5; Gaino E, 1996, ITAL J ZOOL, V63, P41, DOI 10.1080/11250009609356105; Gaino E, 2003, HYDROBIOLOGIA, V495, P127, DOI 10.1023/A:1025454506643; GAINO E, 1986, INT J INVER REP DEV, V10, P297, DOI 10.1080/01688170.1986.10510253; Gilis M, 2011, INVERTEBR BIOL, V130, P193, DOI 10.1111/j.1744-7410.2011.00239.x; Gravili C, 2010, CHEM ECOL, V26, P121, DOI 10.1080/02757541003627654; Guardiola M, 2012, HYDROBIOLOGIA, V687, P71, DOI 10.1007/s10750-011-0948-1; Henkel D, 2011, J MAR BIOL ASSOC UK, V91, P347, DOI 10.1017/S0025315410001487; ILAN M, 1993, OPHELIA, V38, P107, DOI 10.1080/00785326.1993.10429892; JOHNSON MF, 1978, MAR BIOL, V50, P73, DOI 10.1007/BF00390543; Klautau M, 2004, ZOOTAXA, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lanna E, 2010, ZOOMORPHOLOGY, V129, P249, DOI 10.1007/s00435-010-0117-5; Lanna Emilio, 2007, V28, P413; Levin PS, 2002, ECOLOGY, V83, P3182, DOI 10.2307/3071852; Leys SP, 2005, INTEGR COMP BIOL, V45, P171; Longo C, 2007, J MAR BIOL ASSOC UK, V87, P1749, DOI 10.1017/S0025315407057748; Luppi TA, 2002, CIENC MAR, V28, P319, DOI 10.7773/cm.v28i4.242; Maldonado M, 2008, MAR ECOL-EVOL PERSP, V29, P298, DOI 10.1111/j.1439-0485.2008.00244.x; Mastrototaro Francesco, 2004, Biogeographia, V25, P47; Meurer Bruno C., 2010, Marine Biodiversity Records, V3, pe62; Occhipinti-Ambrogi A, 2011, BIOL INVASIONS, V13, P215, DOI 10.1007/s10530-010-9803-y; Padua A, 2013, MAR ECOL-EVOL PERSP, V34, P56, DOI 10.1111/j.1439-0485.2012.00524.x; Pierri C, 2010, J MAR BIOL ASSOC UK, V90, P159, DOI 10.1017/S0025315409990798; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; PLUCERROSARIO G, 1987, CORAL REEFS, V5, P197, DOI 10.1007/BF00300963; Smith, 2001, 21 BISH MUS; Strusi A, 1975, OEBALIA, V1, P5; Zammit PP, 2009, MEDITERR MAR SCI, V10, P135, DOI 10.12681/mms.114; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	50	26	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42392	10.1371/journal.pone.0042392	http://dx.doi.org/10.1371/journal.pone.0042392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905128	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100036
J	Marin, MB; Ghenea, S; Spiridon, LN; Chiritoiu, GN; Petrescu, AJ; Petrescu, SM				Marin, Marioara B.; Ghenea, Simona; Spiridon, Laurentiu N.; Chiritoiu, Gabriela N.; Petrescu, Andrei-Jose; Petrescu, Stefana-Maria			Tyrosinase Degradation Is Prevented when EDEM1 Lacks the Intrinsically Disordered Region	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; PROTEIN-STRUCTURE PREDICTION; STRONGLY-DENATURED PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; MOLECULAR-DYNAMICS; N-GLYCOSYLATION; CALNEXIN; SERVER	EDEM1 is a mannosidase-like protein that recruits misfolded glycoproteins from the calnexin/calreticulin folding cycle to downstream endoplasmic reticulum associated degradation (ERAD) pathway. Here, we investigate the role of EDEM1 in the processing of tyrosinase, a tumour antigen overexpressed in melanoma cells. First, we analyzed and modeled EDEM1 major domains. The homology model raised on the crystal structures of human and Saccharomyces cerevisiae ER class I alpha 1,2-mannosidases reveals that the major mannosidase domain located between aminoacids 121-598 fits with high accuracy. We have further identified an N-terminal region located between aminoacids 40-119, predicted to be intrinsically disordered (ID) and susceptible to adopt multiple conformations, hence facilitating protein-protein interactions. To investigate these two domains we have constructed an EDEM1 deletion mutant lacking the ID region and a triple mutant disrupting the glycan-binding domain and analyzed their association with tyrosinase. Tyrosinase is a glycoprotein partly degraded endogenously by ERAD and the ubiquitin proteasomal system. We found that the degradation of wild type and misfolded tyrosinase was enhanced when EDEM1 was overexpressed. Glycosylated and non-glycosylated mutants co-immunoprecipitated with EDEM1 even in the absence of its intact mannosidase-like domain, but not when the ID region was deleted. In contrast, calnexin and SEL 1L associated with the deletion mutant. Our data suggest that the ID region identified in the N-terminal end of EDEM1 is involved in the binding of glycosylated and non-glycosylated misfolded proteins. Accelerating tyrosinase degradation by EDEM1 overexpression may lead to an efficient antigen presentation and enhanced elimination of melanoma cells.	[Marin, Marioara B.; Ghenea, Simona; Chiritoiu, Gabriela N.; Petrescu, Stefana-Maria] Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Bucharest, Romania; [Spiridon, Laurentiu N.; Petrescu, Andrei-Jose] Romanian Acad, Inst Biochem, Dept Bioinformat & Struct Biochem, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Marin, MB (corresponding author), Romanian Acad, Inst Biochem, Dept Mol Cell Biol, Bucharest, Romania.	ap@biochim.ro; stefana.petrescu@biochim.ro	Chiritoiu, Mari/Q-3983-2017; Petrescu, Andrei-Jose J/G-4576-2016; Spiridon, Laurentiu N/A-3352-2017; Chiritoiu, Gabriela N/C-8860-2017; Chiritoiu, Gabriela/ABC-9002-2020; Petrescu, Stefana M/I-9240-2012; Petrescu, Stefana/AAJ-9505-2021	Chiritoiu, Mari/0000-0003-2064-2003; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Spiridon, Laurentiu N/0000-0003-3080-1610; Chiritoiu, Gabriela/0000-0002-6321-6373; Petrescu, Stefana M/0000-0002-4047-0811; Petrescu, Stefana/0000-0002-4047-0811; Ghenea, Simona/0000-0002-5566-0335	Romanian Academy projects 1 and 3 of the Institute of Biochemistry; CNCSIS [1171 - 1018/2008, 3-0342 - 181/2011]; European Social Fund [POSDRU/89/1.5/S/60746]	Romanian Academy projects 1 and 3 of the Institute of Biochemistry; CNCSIS(Consiliul National al Cercetarii Stiintifice (CNCS)); European Social Fund(European Social Fund (ESF))	This work was supported by the Romanian Academy projects 1 and 3 of the Institute of Biochemistry(http://www.acad.ro) and CNCSIS Grants ID 1171 - 1018/2008 and ID 3-0342 - 181/2011 (http://www.uefiscdi.gov.ro). SG & LNS also acknowledges the postdoctoral program POSDRU/89/1.5/S/60746, from European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cioaca D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019979; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lobsanov YD, 2002, J BIOL CHEM, V277, P5620, DOI 10.1074/jbc.M110243200; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ostankovitch M, 2005, J IMMUNOL, V174, P2544, DOI 10.4049/jimmunol.174.5.2544; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Parodi AJ, 1999, BBA-GEN SUBJECTS, V1426, P287, DOI 10.1016/S0304-4165(98)00130-5; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrescu AJ, 1998, PROTEIN SCI, V7, P1396; Petrescu AJ, 1997, BIOPHYS J, V72, P335, DOI 10.1016/S0006-3495(97)78672-7; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Petrescu SM, 1997, J BIOL CHEM, V272, P15796, DOI 10.1074/jbc.272.25.15796; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Popescu CI, 2005, J BIOL CHEM, V280, P13833, DOI 10.1074/jbc.M413087200; Popescu CI, 2006, J BIOL CHEM, V281, P21682, DOI 10.1074/jbc.M603841200; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ron E, 2011, MOL BIOL CELL; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	51	30	33	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42998	10.1371/journal.pone.0042998	http://dx.doi.org/10.1371/journal.pone.0042998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905195	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100080
J	Wong, MHT; Holst, C; Astrup, A; Handjieva-Darlenska, T; Jebb, SA; Kafatos, A; Kunesova, M; Larsen, TM; Martinez, JA; Pfeiffer, AFH; van Baak, MA; Saris, WHM; McNicholas, PD; Mutch, DM				Wong, Monica H. T.; Holst, Claus; Astrup, Arne; Handjieva-Darlenska, Teodora; Jebb, Susan A.; Kafatos, Anthony; Kunesova, Marie; Larsen, Thomas M.; Alfredo Martinez, J.; Pfeiffer, Andreas F. H.; van Baak, Marleen A.; Saris, Wim H. M.; McNicholas, Paul D.; Mutch, David M.		DiOGenes	Caloric Restriction Induces Changes in Insulin and Body Weight Measurements That Are Inversely Associated with Subsequent Weight Regain	PLOS ONE			English	Article							LOSS MAINTENANCE; GLYCEMIC INDEX; LOW-PROTEIN; LONG-TERM; ENERGY; WOMEN; DIETS; PREDICTORS; RESISTANCE; MEN	Background: Successful weight maintenance following weight loss is challenging for many people. Identifying predictors of longer-term success will help target clinical resources more effectively. To date, focus has been predominantly on the identification of predictors of weight loss. The goal of the current study was to determine if changes in anthropometric and clinical parameters during acute weight loss are associated with subsequent weight regain. Methodology: The study consisted of an 8-week low calorie diet (LCD) followed by a 6-month weight maintenance phase. Anthropometric and clinical parameters were analyzed before and after the LCD in the 285 participants (112 men, 173 women) who regained weight during the weight maintenance phase. Mixed model ANOVA, Spearman correlation, and linear regression were used to study the relationships between clinical measurements and weight regain. Principal Findings: Gender differences were observed for body weight and several clinical parameters at both baseline and during the LCD-induced weight loss phase. LCD-induced changes in BMI (Spearman's rho = 0.22, p = 0.0002) were inversely associated with weight regain in both men and women. LCD-induced changes in fasting insulin (rho = 0.18, p = 0.0043) and HOMA-IR (rho = 0.19, p = 0.0023) were also associated independently with weight regain in both genders. The aforementioned associations remained statistically significant in regression models taking account of variables known to independently influence body weight. Conclusions/Significance: LCD-induced changes in BMI, fasting insulin, and HOMA-IR are inversely associated with weight regain in the 6-month period following weight loss.	[Wong, Monica H. T.; McNicholas, Paul D.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Holst, Claus] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Astrup, Arne; Larsen, Thomas M.] Univ Copenhagen, Dept Human Nutr, Copenhagen, Denmark; [Handjieva-Darlenska, Teodora] Natl Multiprofile Transport Hosp, Sofia, Bulgaria; [Jebb, Susan A.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Kafatos, Anthony] Univ Crete, Sch Med, Dept Social Med, Prevent Med & Nutr Clin, Iraklion, Crete, Greece; [Kunesova, Marie] Inst Endocrinol, Obes Management Ctr, Prague, Czech Republic; [Alfredo Martinez, J.] Univ Navarra, Dept Physiol & Nutr, E-31080 Pamplona, Spain; [Pfeiffer, Andreas F. H.] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Nuthetal, Germany; [van Baak, Marleen A.; Saris, Wim H. M.] Univ Maastricht, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht, Maastricht, Netherlands; [Mutch, David M.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Copenhagen; University of Copenhagen; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Crete; Institute of Endocrinology - Prague; University of Navarra; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Maastricht University; Maastricht University Medical Centre (MUMC); University of Guelph	Wong, MHT (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	dmutch@uoguelph.ca	Pfeiffer, Andreas F.H./AAJ-2311-2020; Martinez Hernandez, J Alfredo/K-8709-2014; Meinert Larsen, Thomas/D-4818-2015; Astrup, Arne/B-1407-2015	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Mutch, David/0000-0002-0908-7259; van Baak, Marleen/0000-0003-2592-6363; Martinez Hernandez, J Alfredo/0000-0001-5218-6941; McNicholas, Paul/0000-0002-2482-523X; Meinert Larsen, Thomas/0000-0001-7621-3131; Astrup, Arne/0000-0001-8968-8996; Jebb, Susan/0000-0001-9190-2920	European Community [FOOD-CT-2005-513946]; Medical Research Council [MC_U105960389] Funding Source: researchfish; MRC [MC_U105960389] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DIOGENES is the acronym of the project "Diet, Obesity and Genes" supported by the European Community (Contract no. FOOD-CT-2005-513946). The parties of the project are listed on the website of the project (http://www.diogenes-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2007, INT J OBESITY, V31, P488, DOI 10.1038/sj.ijo.0803423; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boule NG, 2008, DIABETES-METAB RES, V24, P123, DOI 10.1002/dmrr.768; Butryn ML, 2009, OBESITY, V17, P1101, DOI 10.1038/oby.2008.646; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Dye L, 1997, HUM REPROD, V12, P1142; Eckel R. H, 2003, OBESITY MECH CLIN MA; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Erez G, 2011, INT J OBESITY, V35, P785, DOI 10.1038/ijo.2010.217; Forrestal SG, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2010.00270.x; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Gripeteg L, 2010, OBESITY FACTS, V3, P159, DOI 10.1159/000314655; Handjieva-Darlenska T, 2011, CLIN OBES, V1, P62, DOI 10.1111/j.1758-8111.2011.00010.x; Handjieva-Darlenska T, 2010, EUR J CLIN NUTR, V64, P994, DOI 10.1038/ejcn.2010.110; Jeffery RW, 1998, J CONSULT CLIN PSYCH, V66, P641, DOI 10.1037/0022-006X.66.4.641; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Marquez-Quinones A, 2010, AM J CLIN NUTR, V92, P975, DOI 10.3945/ajcn.2010.29808; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Moore CS, 2010, OBES REV, V11, P67, DOI 10.1111/j.1467-789X.2009.00602.x; Mutch DM, 2011, AM J CLIN NUTR, V94, P1399, DOI 10.3945/ajcn.110.006858; Pannacciulli N, 2007, OBESITY, V15, P632, DOI 10.1038/oby.2007.572; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Raatz SK, 2005, J NUTR, V135, P2387, DOI 10.1093/jn/135.10.2387; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Rubio-Aliaga I, 2011, MOL NUTR FOOD RES, V55, P1603, DOI 10.1002/mnfr.201100081; Saris WHM, 2001, OBES RES, V9, p295S, DOI 10.1038/oby.2001.134; Saris WHM, 1998, INT J OBESITY, V22, pS15; Sartorio A, 2005, J ENDOCRINOL INVEST, V28, P494, DOI 10.1007/BF03347236; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Svetkey LP, 2011, OBESITY; Turk MW, 2009, J CARDIOVASC NURS, V24, P58, DOI 10.1097/01.JCN.0000317471.58048.32; Vogels N, 2005, AM J CLIN NUTR, V82, P740, DOI 10.1093/ajcn/82.4.740; Wang P, 2012, INT J OBESITY LONDON; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016773; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Yost T J, 1995, Obes Res, V3, P583	40	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42858	10.1371/journal.pone.0042858	http://dx.doi.org/10.1371/journal.pone.0042858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905179	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100071
J	Haege, S; Einer, C; Thiele, S; Mueller, W; Nietzsche, S; Lupp, A; Mackay, F; Schulz, S; Stumm, R				Haege, Sammy; Einer, Claudia; Thiele, Stefanie; Mueller, Wiebke; Nietzsche, Sandor; Lupp, Amelie; Mackay, Fabienne; Schulz, Stefan; Stumm, Ralf			CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney	PLOS ONE			English	Article							INTERNEURON MIGRATION; NEURONAL MIGRATION; ADULT BRAIN; CELLS; HEMATOPOIESIS; ACTIVATION; MICE; MORPHOGENESIS; CXCL12/SDF-1; PLASTICITY	Background: The CXCL12/CXCR4 axis is involved in kidney development by regulating formation of the glomerular tuft. Recently, a second CXCL12 receptor was identified and designated CXCR7. Although it is established that CXCR7 regulates heart and brain development in conjunction with CXCL12 and CXCR4, little is known about the influence of CXCR7 on CXCL12 dependent kidney development. Methodology/Principal Findings: We provided analysis of CXCR7 expression and function in the developing mouse kidney. Using in situ hybridization, we identified CXCR7 mRNA in epithelial cells including podocytes at all nephron stages up to the mature glomerulus. CXCL12 mRNA showed a striking overlap with CXCR7 mRNA in epithelial structures. In addition, CXCL12 was detected in stromal cells and the glomerular tuft. Expression of CXCR4 was complementary to that of CXCR7 as it occurred in mesenchymal cells, outgrowing ureteric buds and glomerular endothelial cells but not in podocytes. Kidney examination in CXCR7 null mice revealed ballooning of glomerular capillaries as described earlier for CXCR4 null mice. Moreover, we detected a severe reduction of CXCR4 protein but not CXCR4 mRNA within the glomerular tuft and in the condensed mesenchyme. Malformation of the glomerular tuft in CXCR7 null mice was associated with mesangial cell clumping. Conclusions/Significance: We established that there is a similar glomerular pathology in CXCR7 and CXCR4 null embryos. Based on the phenotype and the anatomical organization of the CXCL12/CXCR4/CXCR7 system in the forming glomerulus, we propose that CXCR7 fine-tunes CXCL12/CXCR4 mediated signalling between podocytes and glomerular capillaries.	[Haege, Sammy; Einer, Claudia; Thiele, Stefanie; Mueller, Wiebke; Lupp, Amelie; Schulz, Stefan; Stumm, Ralf] Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp Jena, D-6900 Jena, Germany; [Nietzsche, Sandor] Univ Jena, Electron Microscopy Ctr, Univ Hosp Jena, D-6900 Jena, Germany; [Mackay, Fabienne] Monash Univ, Dept Immunol, Cent Clin Sch, Alfred Med Res & Educ Precinct AMREP, Melbourne, Vic 3004, Australia	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Monash University	Haege, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp Jena, Lobderstr 1, D-6900 Jena, Germany.	sammy.haege@mti.uni-jena.de	Schulz, Stefan/A-6928-2017; Mackay, Fabienne/B-7440-2008	Schulz, Stefan/0000-0002-5997-8885; Mackay, Fabienne/0000-0002-6074-2693	Jena University; DFG [STUw295-5/1]	Jena University; DFG(German Research Foundation (DFG))	The study was supported by the Jena University grant program for young academics (to SH) and DFG grant STUw295-5/1 (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; D'Alterio C, 2010, CELL CYCLE, V9, P4492, DOI 10.4161/cc.9.22.13680; Ding M, 2006, NAT MED, V12, P1081, DOI 10.1038/nm1460; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Morishita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023267; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Stumm RK, 2003, J NEUROSCI, V23, P5123; Stumm RK, 2002, J NEUROSCI, V22, P5865; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Ueland J, 2009, DEV DYNAM, V238, P1083, DOI 10.1002/dvdy.21943; Vaughan MR, 2008, J AM SOC NEPHROL, V19, P24, DOI 10.1681/ASN.2007040471; Veith AM, 2006, GENOMICS, V88, P185, DOI 10.1016/j.ygeno.2006.01.003; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wehler TC, 2008, J ONCOL, V2008, DOI 10.1155/2008/626340; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	37	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42814	10.1371/journal.pone.0042814	http://dx.doi.org/10.1371/journal.pone.0042814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880115	Green Published, gold			2022-12-25	WOS:000307810000074
J	Steers, NJ; Ratto-Kim, S; de Souza, MS; Currier, JR; Kim, JH; Michael, NL; Alving, CR; Rao, M				Steers, Nicholas J.; Ratto-Kim, Silvia; de Souza, Mark S.; Currier, Jeffrey R.; Kim, Jerome H.; Michael, Nelson L.; Alving, Carl R.; Rao, Mangala			HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIGEN PRESENTATION; CLASS-II; INVARIANT CHAIN; DENDRITIC CELLS; IN-VIVO; PROTEIN; GLYCOSYLATION; DEGRADATION; GENERATION	Background: Antigen processing involves many proteolytic enzymes such as proteasomes and cathepsins. The processed antigen is then presented on the cell surface bound to either MHC class I or class II molecules and induces/interacts with antigen-specific CD8+ and CD4+ T-cells, respectively. Preliminary immunological data from the RV144 phase III trial indicated that the immune responses were biased towards the Env antigen with a dominant CD4+ T-cell response. Methods: In this study, we examined the susceptibility of HIV-1 Env-A244 gp120 protein, one of the protein boost subunits of the RV144 Phase III vaccine trial, to proteasomes and cathepsins and identified the generated peptide epitope repertoire by mass spectrometry. The peptide fragments were tested for cytokine production in CD4(+) T-cell lines derived from RV144 volunteers. Results: Env-A244 was resistant to proteasomes, thus diminishing the possibility of the generation of class I epitopes by the classical MHC class I pathway. However, Env-A244 was efficiently cleaved by cathepsins generating peptide arrays identified by mass spectrometry that contained both MHC class I and class II epitopes as reported in the Los Alamos database. Each of the cathepsins generated distinct degradation patterns containing regions of light and dense epitope clusters. The sequence DKKQKVHALF that is part of the V2 loop of gp120 produced by cathepsins induced a polyfunctional cytokine response including the generation of IFN-gamma from CD4(+) T-cell lines-derived from RV144 vaccinees. This sequence is significant since antibodies to the V1/V2-loop region correlated inversely with HIV-1 infection in the RV144 trial. Conclusions: Based on our results, the susceptibility of Env-A244 to cathepsins and not to proteasomes suggests a possible mechanism for the generation of Env-specific CD4(+)T cell and antibody responses in the RV144 vaccinees.	[Steers, Nicholas J.; Ratto-Kim, Silvia; Currier, Jeffrey R.; Kim, Jerome H.; Michael, Nelson L.; Alving, Carl R.; Rao, Mangala] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Steers, Nicholas J.; Ratto-Kim, Silvia; Currier, Jeffrey R.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Steers, NJ (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.	mrao@hivresearch.org		Ratto-Kim, Silvia/0000-0003-2025-6399	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense)	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; Creasy BM, 2011, CELL IMMUNOL, V267, P56, DOI 10.1016/j.cellimm.2010.11.004; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Karasavvas N, 2011, AIDS RES HUM RETROV, V27, pA29; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Ramachandra L, 2009, CURR OPIN IMMUNOL, V21, P98, DOI 10.1016/j.coi.2009.01.001; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; RATTO S, 1995, J INFECT DIS, V171, P1420, DOI 10.1093/infdis/171.6.1420; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roche PA, 2011, J IMMUNOL, V187, P3150; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sakamoto T, 2006, FEBS LETT, V580, P6543, DOI 10.1016/j.febslet.2006.10.075; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sharp ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021135; Steers NJ, 2011, J VIROL, V85, P1541, DOI 10.1128/JVI.01790-10; Steers NJ, 2009, J VIROL, V83, P7049, DOI 10.1128/JVI.00327-09; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Stove V, 2006, CURR HIV RES, V4, P57, DOI 10.2174/157016206775197583; Tenzer S, 2004, J IMMUNOL, V172, P1083, DOI 10.4049/jimmunol.172.2.1083; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; van Hall T, 2007, J IMMUNOL, V178, P657, DOI 10.4049/jimmunol.178.2.657; Verweij MC, 2011, MOL IMMUNOL, V48, P835, DOI 10.1016/j.molimm.2010.12.008; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zolla-Pazner S, 2011, AIDS RES HUM RETROV, V27, pA21	54	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42579	10.1371/journal.pone.0042579	http://dx.doi.org/10.1371/journal.pone.0042579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880042	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000049
J	Castelli, M; Pieroni, S; Brunacci, C; Piobbico, D; Bartoli, D; Bellet, MM; Colombo, E; Pelicci, PG; Della Fazia, MA; Servillo, G				Castelli, M.; Pieroni, S.; Brunacci, C.; Piobbico, D.; Bartoli, D.; Bellet, M. M.; Colombo, E.; Pelicci, P. G.; Della Fazia, M. A.; Servillo, G.			Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19(Arf) network	ONCOGENE			English	Article						nucleophosmin (NPM); p19(Arf); hepatocyte odd protein shuttling (HOPS); Tmub1; tumor suppressor gene	ACUTE MYELOID-LEUKEMIA; ARF TUMOR-SUPPRESSOR; ACUTE MYELOGENOUS LEUKEMIA; CYTOPLASMIC NUCLEOPHOSMIN; NORMAL KARYOTYPE; NPMC(+) AML; STABILITY; B23; TUMORIGENESIS; MUTATIONS	Nucleophosmin (NPM), a ubiquitously and abundantly expressed protein, occurs in the nucleolus, shuttling between the nucleoplasm and cytoplasm. The NPM gene is mutated in almost 30% of human acute myeloid leukemia cells. NPM interacts with p53 and p19(Arf), directs localization of p19(Arf) in the nucleolus and protects the latter from degradation. Hepatocyte odd protein shuttling (HOPS) is also a ubiquitously expressed protein that moves between the nucleus and cytoplasm. Within the nucleus of resting cells, HOPS overexpression causes cell cycle arrest in G0/G1. HOPS knockdown causes centrosome hyperamplification leading to multinucleated cells and the formation of micronuclei. We demonstrate a direct interaction of HOPS with NPM and p19(Arf), resulting in a functionally active trimeric complex. NPM appeared to regulate HOPS half-life, which, in turn, stabilized p19(Arf) and controlled its localization in the nucleolus. These findings suggest that HOPS acts as a functional bridge in the interaction between NPM and p19(Arf), providing new mechanistic insight into how NPM and p19(Arf) will oppose tumor cell proliferation.	[Castelli, M.; Pieroni, S.; Brunacci, C.; Piobbico, D.; Bartoli, D.; Bellet, M. M.; Della Fazia, M. A.; Servillo, G.] Univ Perugia, Dept Clin & Expt Med, I-06124 Perugia, Italy; [Colombo, E.; Pelicci, P. G.] Inst Europeo Oncol, Dept Expt Oncol, Milan, Italy	University of Perugia; IRCCS European Institute of Oncology (IEO)	Servillo, G (corresponding author), Univ Perugia, Dept Clin & Expt Med, Via E dal Pozzo,Pad AW, I-06124 Perugia, Italy.	giuseppe.servillo@unipg.it	Colombo, Emanuela/AAO-8113-2020; Colombo, Emanuela/AAO-7810-2020; Pelicci, Pier Giuseppe/AAL-6572-2020; Bellet, Marina Maria/K-7794-2016	Colombo, Emanuela/0000-0003-2079-7398; Bellet, Marina Maria/0000-0001-7604-0189; Della Fazia, Maria Agnese/0000-0002-5373-8477; Servillo, Giuseppe/0000-0001-7960-7689; Piobbico, Danilo/0000-0003-4240-1526	Associazione Umbra Contro il Cancro (AUCC); Fondazione Guido Berlucchi; Associazione Italiana Ricerca sul Cancro (AIRC); Only the Brave Foundation; Fondazione Cassa di Risparmio di Perugia; PRIN Project [2008BH7KA2_003]; AUCC fellowship program	Associazione Umbra Contro il Cancro (AUCC); Fondazione Guido Berlucchi; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Only the Brave Foundation; Fondazione Cassa di Risparmio di Perugia; PRIN Project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AUCC fellowship program	We thank Paolo Puccetti and Stefano Brancorsini for the critical reading of the manuscript, Silvano Pagnotta for technical assistance. This study was supported by grants from the Associazione Umbra Contro il Cancro (AUCC), Fondazione Guido Berlucchi, the Associazione Italiana Ricerca sul Cancro (AIRC), Only the Brave Foundation and Fondazione Cassa di Risparmio di Perugia. GS is recipient of a PRIN Project n. 2008BH7KA2_003. DB, CB and DP are recipient of the AUCC fellowship program.	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Braoudaki M, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-41; Brunacci C, 2010, LIVER INT, V30, P388, DOI 10.1111/j.1478-3231.2009.02174.x; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Chou WC, 2006, CANCER RES, V66, P3310, DOI 10.1158/0008-5472.CAN-05-4316; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; Coutts AS, 2007, CELL CYCLE, V6, P827, DOI 10.4161/cc.6.7.4086; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; den Besten W, 2005, CELL CYCLE, V4, P1593; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Gjerset RA, 2006, CELL CYCLE, V5, P686, DOI 10.4161/cc.5.7.2623; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Moulin S, 2008, ONCOGENE, V27, P2382, DOI 10.1038/sj.onc.1210887; Pasqualucci L, 2006, BLOOD, V108, P4146, DOI 10.1182/blood-2006-06-026716; Pieroni S, 2008, CELL CYCLE, V7, P1462, DOI 10.4161/cc.7.10.5882; Serrano M, 2000, CARCINOGENESIS, V21, P865, DOI 10.1093/carcin/21.5.865; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Szebeni A, 1999, PROTEIN SCI, V8, P905; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Zhang WD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011261	38	19	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 11	2013	32	28					3350	3358		10.1038/onc.2012.353	http://dx.doi.org/10.1038/onc.2012.353			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	180TM	22890319				2022-12-25	WOS:000321620200005
J	Li, HT; Hemann, C; Abdelghany, TM; El-Mahdy, MA; Zweier, JL				Li, Haitao; Hemann, Craig; Abdelghany, Tamer M.; El-Mahdy, Mohamed A.; Zweier, Jay L.			Characterization of the Mechanism and Magnitude of Cytoglobin-mediated Nitrite Reduction and Nitric Oxide Generation under Anaerobic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE-OXIDASE; BLOOD; NEUROGLOBIN; KINETICS; PROTEIN; OXYGEN; HEME; NO; DEOXYHEMOGLOBIN; HEMOGLOBIN	Cytoglobin (Cygb) is a recently discovered cytoplasmic heme-binding globin. Although multiple hemeproteins have been reported to function as nitrite reductases in mammalian cells, it is unknown whether Cygb can also reduce nitrite to nitric oxide (NO). The mechanism, magnitude, and quantitative importance of Cygb-mediated nitrite reduction in tissues have not been reported. To investigate this pathway and its quantitative importance, EPR spectroscopy, spectrophotometric measurements, and chemiluminescence NO analyzer studies were performed. Under anaerobic conditions, mixing nitrite with ferrous-Cygb triggered NO formation that was trapped and detected using EPR spin trapping. Spectrophotometric studies revealed that nitrite binding to ferrous-Cygb is followed by formation of ferric-Cygb and NO. The kinetics and magnitude of Cygb-mediated NO formation were characterized. It was observed that Cygb-mediated NO generation increased linearly with the increase of nitrite concentration under anaerobic conditions. This Cygb-mediated NO production greatly increased with acidosis and near-anoxia as occur in ischemic conditions. With the addition of nitrite, soluble guanylyl cyclase activation was significantly higher in normal smooth muscle cells compared with Cygb knocked down cells with Cygb accounting for similar to 40% of the activation in control cells and similar to 60% in cells subjected to hypoxia for 48 h. Overall, these studies show that Cygb-mediated nitrite reduction can play an important role in NO generation and soluble guanylyl cyclase activation under hypoxic conditions, with this process regulated by pH, oxygen tension, nitrite concentration, and the redox state of the cells.	Ohio State Univ, Coll Med, Ctr Biomed EPR Spect & Imaging, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zweier, JL (corresponding author), 611 Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	jay.zweier@osumc.edu	ABDELGHANY, Tamer/L-7347-2019; Abdelghany, Tamer/R-7026-2019	Abdelghany, Tamer/0000-0002-2568-9356; Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [HL63744, HL65608, HL38324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038324, P01HL065608, R01HL038324, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J. L. Z.).	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dezfulian C, 2007, CARDIOVASC RES, V75, P327, DOI 10.1016/j.cardiores.2007.05.001; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Joshi MS, 2002, P NATL ACAD SCI USA, V99, P10341, DOI 10.1073/pnas.152149699; KUPPUSAMY P, 1995, J MAGN RESON SER B, V107, P116, DOI 10.1006/jmrb.1995.1067; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2009, J BIOL CHEM, V284, P33850, DOI 10.1074/jbc.M109.019125; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Liu XP, 2007, J BIOL CHEM, V282, P8831, DOI 10.1074/jbc.M611684200; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; Ormerod JOM, 2011, CARDIOVASC RES, V89, P560, DOI 10.1093/cvr/cvq299; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; SERGEEV N S, 1985, Journal of Applied Biochemistry, V7, P86; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tornig J, 1999, J AM SOC NEPHROL, V10, P77; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; XIA Y, 1995, J BIOL CHEM, V270, P18797, DOI 10.1074/jbc.270.32.18797; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1994, J MAGN RESON SER B, V105, P52, DOI 10.1006/jmrb.1994.1099; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304	49	101	105	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					36623	36633		10.1074/jbc.M112.342378	http://dx.doi.org/10.1074/jbc.M112.342378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22896706	Green Published, hybrid			2022-12-25	WOS:000310364000082
J	Vigetti, D; Deleonibus, S; Moretto, P; Karousou, E; Viola, M; Bartolini, B; Hascall, VC; Tammi, M; De Luca, G; Passi, A				Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Karousou, Eugenia; Viola, Manuela; Bartolini, Barbara; Hascall, Vincent C.; Tammi, Markku; De Luca, Giancarlo; Passi, Alberto			Role of UDP-N-Acetylglucosamine (GlcNAc) and O-GlcNAcylation of Hyaluronan Synthase 2 in the Control of Chondroitin Sulfate and Hyaluronan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MOLECULAR-CLONING; DIABETIC COMPLICATIONS; INSULIN-RESISTANCE; HEPARAN-SULFATE; XENOPUS-LAEVIS; UP-REGULATION; TUNICA MEDIA; PROTEIN; GLUCOSE	Hyaluronan (HA) is a glycosaminoglycan present in most tissue microenvironments that can modulate many cell behaviors, including proliferation, migration, and adhesive proprieties. In contrast with other glycosaminoglycans, which are synthesized in the Golgi, HA is synthesized at the plasma membrane by one or more of the three HA synthases (HAS1-3), which use cytoplasmic UDP-glucuronic acid and UDP-N-acetylglucosamine as substrates. Previous studies revealed the importance of UDP-sugars for regulating HA synthesis. Therefore, we analyzed the effect of UDP-GlcNAc availability and protein glycosylation with O-linked N-acetylglucosamine (O-GlcNAcylation) on HA and chondroitin sulfate synthesis in primary human aortic smooth muscle cells. Glucosamine treatment, which increases UDP-GlcNAc availability and protein O-GlcNAcylation, increased synthesis of both HA and chondroitin sulfate. However, increasing O-GlcNAcylation by stimulation with O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate without a concomitant increase of UDP-GlcNAc increased only HA synthesis. We found that HAS2, the main synthase in aortic smooth muscle cells, can be O-GlcNAcylated on serine 221, which strongly increased its activity and its stability (t(1/2) > 5 h versus similar to 17 min without O-GlcNAcylation). S221A mutation prevented HAS2 O-GlcNAcylation, which maintained the rapid turnover rate even in the presence of GlcN and increased UDP-GlcNAc. These findings could explain the elevated matrix HA observed in diabetic vessels that, in turn, could mediate cell dedifferentiation processes critical in vascular pathologies.	[Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Karousou, Eugenia; Viola, Manuela; Bartolini, Barbara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Cleveland, OH 44195 USA; [Tammi, Markku] Univ Eastern Finland, Fac Hlth Sci, Sch Med, Inst Biomed, Kuopio 70211, Finland	University of Insubria; Cleveland Clinic Foundation; University of Eastern Finland	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Chirurg & Morfol, Via J H Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Tammi, Markku/AAQ-7878-2021; Vigetti, Davide/C-9861-2010; Viola, Manuela/B-7120-2011; passi, alberto g/A-1752-2018	Vigetti, Davide/0000-0002-6339-8453; Viola, Manuela/0000-0002-0634-6390; passi, alberto g/0000-0003-3328-3089	Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS); Fondo di Ateneo per la Ricerca (FAR); Centro Insubre di Biotecnologie per la Salute Umana young researcher award; School of Biological and Medical Science, University of Insubria, Varese, Italy; Sigrid Juselius Foundation; Cancer Center of Eastern Finland; Kuopio University Hospital EVO Funds	Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS); Fondo di Ateneo per la Ricerca (FAR); Centro Insubre di Biotecnologie per la Salute Umana young researcher award; School of Biological and Medical Science, University of Insubria, Varese, Italy; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Center of Eastern Finland; Kuopio University Hospital EVO Funds	This work was supported in part by the Fondazione Comunitaria del Varesotto-Organizzazione Non Lucrativa di Utilita Sociale (ONLUS), the Fondo di Ateneo per la Ricerca (FAR), and a Centro Insubre di Biotecnologie per la Salute Umana young researcher award (to D. V.).; Recipient of a Ph.D. fellowship from the School of Biological and Medical Science, University of Insubria, Varese, Italy.; Recipient of financial support from Sigrid Juselius Foundation, Cancer Center of Eastern Finland, and Kuopio University Hospital EVO Funds.	Badi I, 2009, FEBS LETT, V583, P2486, DOI 10.1016/j.febslet.2009.07.001; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chisalita SI, 2009, J MOL ENDOCRINOL, V43, P231, DOI 10.1677/JME-09-0021; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fujii N, 2007, CANCER RES, V67, P573, DOI 10.1158/0008-5472.CAN-06-2726; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardiville S, 2010, J BIOL CHEM, V285, P19205, DOI 10.1074/jbc.M109.080572; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HEICKENDORFF L, 1994, DIABETOLOGIA, V37, P286, DOI 10.1007/BF00398056; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Magee C, 2001, BIOCHEM J, V360, P667, DOI 10.1042/0264-6021:3600667; Marsh SA, 2011, CARDIOVASC RES, V89, P487, DOI 10.1093/cvr/cvq405; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xing DQ, 2008, AM J PHYSIOL-HEART C, V295, pH335, DOI 10.1152/ajpheart.01259.2007	61	96	96	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35544	35555		10.1074/jbc.M112.402347	http://dx.doi.org/10.1074/jbc.M112.402347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22887999	Green Published, hybrid			2022-12-25	WOS:000309968000067
J	Liu, NS; Du, XL; Lu, J; He, BP				Liu, Nicole Suyun; Du, Xiaoli; Lu, Jia; He, Bei Ping			Diva Reduces Cell Death in Response to Oxidative Stress and Cytotoxicity	PLOS ONE			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY-MEMBERS; BONE-MARROW-CELLS; BAX OLIGOMERIZATION; NEGATIVE REGULATOR; ISCHEMIC-INJURY; CYTOCHROME-C; BH3 DOMAINS; APOPTOSIS; EXPRESSION	Diva is a member of the Bcl2 family but its function in apoptosis remains largely unclear because of its specific expression found within limited adult tissues. Previous overexpression studies done on various cell lines yielded conflicting conclusions pertaining to its apoptotic function. Here, we discovered the expression of endogenous Diva in PC12 neuronal-like cell line and rat bone marrow mesenchymal stem cells (BMSCs), leading to their utilisation for the functional study of Diva. Through usage of recombinant Fas ligand, hydrogen peroxide, overexpression and knock down experiments, we discovered that Diva plays a crucial pro-survival role via the mitochondrial death pathway. In addition, immunoprecipitation studies also noted a decrease in Diva's interaction with Bcl2 and Bax following apoptosis induced by oxidative stress. By overexpressing Diva in BMSCs, we had observed an increase in the cells' capacity to survive under oxidative stress and microglial toxicity. The result obtained from our study gives us reason to believe that Diva plays an important role in controlling the survival of BMSCs. Through overexpression of Diva, the viability of these BMSCs may be boosted under adverse conditions.	[Liu, Nicole Suyun; Lu, Jia; He, Bei Ping] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Du, Xiaoli] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore	Liu, NS (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	anthebp@nus.edu.sg			Singapore National Research Foundation [NRF-CRP 002-082]	Singapore National Research Foundation(National Research Foundation, Singapore)	This work is supported by the Singapore National Research Foundation (NRF-CRP 002-082) under its Competitive Research Programme Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai S, 2007, MOL CANCER THER, V6, P101, DOI 10.1158/1535-7163.MCT-06-0367; Aouacheria A, 2001, ONCOGENE, V20, P5846, DOI 10.1038/sj.onc.1204740; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Carrio R, 1996, AM J PATHOL, V149, P2133; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; He BP, 2002, J NEUROIMMUNOL, V128, P31, DOI 10.1016/S0165-5728(02)00141-8; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Lee RM, 2001, BBA-GENE STRUCT EXPR, V1520, P187, DOI 10.1016/S0167-4781(01)00268-8; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Naumann U, 2001, FEBS LETT, V505, P23, DOI 10.1016/S0014-5793(01)02768-5; Ocker M, 2005, GUT, V54, P1298, DOI 10.1136/gut.2004.056192; Potten CS, 2004, APOPTOSIS LIFE DEATH, P165; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Russell HR, 2002, MOL CELL BIOL, V22, P6866, DOI 10.1128/MCB.22.19.6866-6870.2002; Sborgi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015575; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Vander Heiden MG, 1999, MOL CELL, V3, P159; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2000, GENE DEV, V14, P2060; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	43	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43180	10.1371/journal.pone.0043180	http://dx.doi.org/10.1371/journal.pone.0043180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905226	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600053
J	Sharma, R; Ghasparian, A; Robinson, JA; McCullough, KC				Sharma, Rajni; Ghasparian, Arin; Robinson, John A.; McCullough, Kenneth C.			Synthetic Virus-Like Particles Target Dendritic Cell Lipid Rafts for Rapid Endocytosis Primarily but Not Exclusively by Macropinocytosis	PLOS ONE			English	Article							VACCINE DELIVERY; ANTIGEN; NANOPARTICLES; SYSTEM; LYMPHOCYTES; MATURATION	DC employ several endocytic routes for processing antigens, driving forward adaptive immunity. Recent advances in synthetic biology have created small (20-30 nm) virus-like particles based on lipopeptides containing a virus-derived coiled coil sequence coupled to synthetic B- and T-cell epitope mimetics. These self-assembling SVLP efficiently induce adaptive immunity without requirement for adjuvant. We hypothesized that the characteristics of DC interaction with SVLP would elaborate on the roles of cell membrane and intracellular compartments in the handling of a virus-like entity known for its efficacy as a vaccine. DC rapidly bind SVLP within min, co-localised with CTB and CD9, but not caveolin-1. In contrast, internalisation is a relatively slow process, delivering SVLP into the cell periphery where they are maintained for a number of hrs in association with microtubules. Although there is early association with clathrin, this is no longer seen after 10 min. Association with EEA-1(+) early endosomes is also early, but proteolytic processing appears slow, the SVLP-vesicles remaining peripheral. Association with transferrin occurs rarely, and only in the periphery, possibly signifying translocation of some SVLP for delivery to B-lymphocytes. Most SVLP co-localise with high molecular weight dextran. Uptake of both is impaired with mature DC, but there remains a residual uptake of SVLP. These results imply that DC use multiple endocytic routes for SVLP uptake, dominated by caveolin-independent, lipid raft-mediated macropinocytosis. With most SVLP-containing vesicles being retained in the periphery, not always interacting with early endosomes, this relates to slow proteolytic degradation and antigen retention by DC. The present characterization allows for a definition of how DC handle virus-like particles showing efficacious immunogenicity, elements valuable for novel vaccine design in the future.	[Sharma, Rajni; McCullough, Kenneth C.] Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland; [Ghasparian, Arin; Robinson, John A.] Univ Zurich, Dept Chem, Zurich, Switzerland	University of Zurich	Sharma, R (corresponding author), Inst Virol & Immunoprophylaxis, Mittelhausern, Switzerland.	kmc.projects1@gmail.com		Sharma, Rajni/0000-0003-0051-2308	Swiss National Science Foundation, project NANOVACC [310000-1198828]	Swiss National Science Foundation, project NANOVACC	The work was funded by the Swiss National Science Foundation, project NANOVACC, project number 310000-1198828 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Borges O, 2005, INT J PHARMACEUT, V299, P155, DOI 10.1016/j.ijpharm.2005.04.037; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Ceppi M, 2005, J GENE MED, V7, P452, DOI 10.1002/jgm.685; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ghasparian A, 2011, CHEMBIOCHEM, V12, P100, DOI 10.1002/cbic.201000536; Guzylack-Piriou L, 2006, IMMUNOLOGY, V118, P78, DOI 10.1111/j.1365-2567.2006.02343.x; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johannes L, 2011, TRAFFIC, V12, P956, DOI 10.1111/j.1600-0854.2011.01200.x; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kiss AL, 2009, J CELL MOL MED, V13, P1228, DOI 10.1111/j.1582-4934.2009.00754.x; Kreuter J, 1996, J ANAT, V189, P503; Le Roux D, 2012, BLOOD, V119, P95, DOI 10.1182/blood-2011-02-336123; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; McCullough KC, 2008, DEV COMP IMMUNOL; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Perriman AW, 2010, SMALL, V6, P1191, DOI 10.1002/smll.200901186; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Riedel T, 2011, CHEMBIOCHEM, V12, P2829, DOI 10.1002/cbic.201100586; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wykes M, 1998, J IMMUNOL, V161, P1313; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	32	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43248	10.1371/journal.pone.0043248	http://dx.doi.org/10.1371/journal.pone.0043248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905240	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000307500800065
J	Jayaprakash, TP; Schellenberg, JJ; Hill, JE				Jayaprakash, Teenus Paramel; Schellenberg, John J.; Hill, Janet E.			Resolution and Characterization of Distinct cpn60-Based Subgroups of Gardnerella vaginalis in the Vaginal Microbiota	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIAL VAGINOSIS; CHAPERONIN-60 UNIVERSAL TARGET; SEQUENCE-BASED METHODS; HSP60 GENE-SEQUENCES; PREDICTING RELATEDNESS; SPECIES IDENTIFICATION; NONSPECIFIC VAGINITIS; PHYLOGENETIC ANALYSIS; COMMUNITY COMPOSITION; QUANTITATIVE PCR	Bacterial vaginosis (BV), characterized by a shift of the vaginal microbiota from a Lactobacillus-dominated community to a dense biofilm containing a complex mixture of organisms, is an important risk factor in poor reproductive health outcomes. The Nugent score, based on Gram stain, is used to diagnose BV and Gardnerella vaginalis abundance in the sample is one factor determining Nugent score. A high Nugent score is indicative of BV but does not always correspond to the presence of clinical symptoms. G. vaginalis is recognized as a heterogeneous group of organisms, which can also be part of the normal, healthy vaginal microbiome. In addition, asymptomatic BV and non-Gardnerella types of BV are being recognized. In an attempt to resolve the heterogeneous group of G. vaginalis, a phylogenetic tree of cpn60 universal target sequences from G. vaginalis isolates was constructed that indicates the existence of four subgroups of G. vaginalis. This subdivision, supported by whole genome similarity calculation of representative strains using JSpecies, demonstrates that these subgroups may represent different species. The cpn60 subgroupings did not correspond with the Piot biotyping scheme, but did show consistency with ARDRA genotyping and sialidase gene presence. Isolates from all four subgroups produced biofilm in vitro. We also investigated the distribution of G. vaginalis subgroups in vaginal samples from Kenyan women with Nugent scores consistent with BV, Intermediate and Normal microbiota (n = 44). All subgroups of G. vaginalis were detected in these women, with a significant difference (z = -3.372, n = 39, p = 0.001) in frequency of G. vaginalis subgroup B between BV and Normal groups. Establishment of a quantifiable relationship between G. vaginalis subgroup distribution and clinical status could have significant diagnostic implications.	[Jayaprakash, Teenus Paramel; Hill, Janet E.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Schellenberg, John J.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Saskatchewan; University of Manitoba	Jayaprakash, TP (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	janet.hill@usask.ca	Hill, Janet E./B-5001-2011	Hill, Janet E./0000-0002-2187-6277; Schellenberg, John/0000-0003-3970-1608	March of Dimes; Canadian Institutes for Health Research; University of Saskatchewan	March of Dimes(March of Dimes); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	This research was supported by the March of Dimes (www.marchofdimes.com) and the Canadian Institutes for Health Research (www.cihr.ca). TJP is supported by a scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], 1988, J APPL BACTERIOL, V64, P283; Aroutcheva AA, 2001, CLIN INFECT DIS, V33, P1022, DOI 10.1086/323030; BENITO R, 1986, J MED MICROBIOL, V21, P357, DOI 10.1099/00222615-21-4-357; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Cho JC, 2001, APPL ENVIRON MICROB, V67, P3677, DOI 10.1128/AEM.67.8.3677-3682.2001; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Demba E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-12; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Desai AR, 2009, VET MICROBIOL, V137, P120, DOI 10.1016/j.vetmic.2008.12.019; Dumonceaux TJ, 2006, CAN J MICROBIOL, V52, P494, DOI 10.1139/W05-160; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fernando WMU, 2010, BENEF MICROBES, V1, P197, DOI 10.3920/BM2009.0027; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gibbs RS, 2007, AM J OBSTET GYNECOL, V196, P495, DOI 10.1016/j.ajog.2007.04.001; Goh SH, 1996, J CLIN MICROBIOL, V34, P818, DOI 10.1128/JCM.34.4.818-823.1996; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Graham S, 2009, J MED MICROBIOL, V58, P1382, DOI 10.1099/jmm.0.007781-0; GREENWOOD JR, 1980, INT J SYST BACTERIOL, V30, P170, DOI 10.1099/00207713-30-1-170; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hill JE, 2002, APPL ENVIRON MICROB, V68, P3055, DOI 10.1128/AEM.68.6.3055-3066.2002; HILLIER SL, 1991, GENITOURIN MED, V67, P26; Holt J., 1994, BERGEYS MANUAL DETER; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hung WC, 2010, J CLIN MICROBIOL, V48, P3532, DOI 10.1128/JCM.00787-10; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ingianni A, 1997, FEMS IMMUNOL MED MIC, V18, P61, DOI 10.1111/j.1574-695X.1997.tb01028.x; Jian WY, 2001, INT J SYST EVOL MICR, V51, P1633, DOI 10.1099/00207713-51-5-1633; JOHNSON AP, 1987, EPIDEMIOL INFECT, V98, P131, DOI 10.1017/S0950268800061835; Kampan NC, 2011, SEX REPROD HEALTHC, V2, P1, DOI 10.1016/j.srhc.2010.11.002; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; LEOPOLD SIDNEY, 1953, U S ARMED FORCES MED JOUR, V4, P263; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Mastrobattista JM, 2000, OBSTET GYNECOL, V96, P504, DOI 10.1016/S0029-7844(00)00994-7; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Mikamo H., 1999, J Infect Chemother, V5, P82, DOI 10.1007/s101560050013; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Ness RB, 2004, OBSTET GYNECOL, V104, P761, DOI 10.1097/01.AOG.0000139512.37582.17; Numanovic F, 2008, BOSNIAN J BASIC MED, V8, P270, DOI 10.17305/bjbms.2008.2932; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P2984, DOI 10.1099/ijs.0.021154-0; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosun I, 2007, MIKROBIYOL BUL, V41, P21; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; Vermette CJ, 2010, MICROB ECOL, V59, P14, DOI 10.1007/s00248-009-9601-1; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0; ZINNEMANN K, 1963, J PATHOL BACTERIOL, V85, P213, DOI 10.1002/path.1700850120	67	55	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43009	10.1371/journal.pone.0043009	http://dx.doi.org/10.1371/journal.pone.0043009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900080	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900098
J	Le Sage, V; Banfield, BW				Le Sage, Valerie; Banfield, Bruce W.			Dysregulation of Autophagy in Murine Fibroblasts Resistant to HSV-1 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE PROTEOGLYCANS; CELL-SURFACE; GLYCOPROTEIN-B; PROTEIN-KINASE; GAMMA(1)34.5 PROTEIN; PSEUDORABIES VIRUS; GRO2C CELLS; IN-VIVO; TYPE-1	The mouse L cell mutant, gro29, was selected for its ability to survive infection by herpes simplex virus type 1 (HSV-1). gro29 cells are fully susceptible to HSV-1 infection, however, they produce 2000-fold less infectious virus than parental L cells despite their capacity to synthesize late viral gene products and assemble virions. Because productive HSV-1 infection is presumed to result in the death of the host cell, we questioned how gro29 cells might survive infection. Using time-lapse video microscopy, we demonstrated that a fraction of infected gro29 cells survived infection and divided. Electron microscopy of infected gro29 cells, revealed large membranous vesicles that contained virions as well as cytoplasmic constituents. These structures were reminiscent of autophagosomes. Autophagy is an ancient cellular process that, under nutrient deprivation conditions, results in the degradation and catabolism of cytoplasmic components and organelles. We hypothesized that enhanced autophagy, and resultant degradation of virions, might explain the ability of gro29 to survive HSV-1 infection. Here we demonstrate that gro29 cells have enhanced basal autophagy as compared to parental L cells. Moreover, treatment of gro29 cells with 3-methyladenine, an inhibitor of autophagy, failed to prevent the formation of autophagosome-like organelles in gro29 cells indicating that autophagy was dysregulated in these cells. Additionally, we observed robust co-localization of the virion structural component, VP26, with the autophagosomal marker, GFP-LC3, in infected gro29 cells that was not seen in infected parental L cells. Collectively, these data support a model whereby gro29 cells prevent the release of infectious virus by directing intracellular virions to an autophagosome-like compartment. Importantly, induction of autophagy in parental L cells did not prevent HSV-1 production, indicating that the relationship between autophagy, virus replication, and survival of HSV-1 infection by gro29 cells is complex.	[Le Sage, Valerie; Banfield, Bruce W.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Le Sage, V (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	bruce.banfield@queensu.ca			Canadian Institutes of Health Research [93804]; Canada Foundation for Innovation award [16389]; Violet E. Powell Research Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation award; Violet E. Powell Research Fund	This work was supported by the Canadian Institutes of Health Research operating grant 93804, Canada Foundation for Innovation award 16389, and an award from the Violet E. Powell Research Fund to BWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2008, AUTOPHAGY, V4, P101, DOI 10.4161/auto.5222; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; BANFIELD BW, 1990, J VIROL, V64, P5716, DOI 10.1128/JVI.64.12.5716-5729.1990; BANFIELD BW, 1995, VIROLOGY, V208, P531, DOI 10.1006/viro.1995.1184; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Ben-Porat T., 1985, HERPESVIRUSES, P105; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; Crump CA, 2007, J VIROL, V81, P7380, DOI 10.1128/JVI.00222-07; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dyer AP, 1997, J VIROL, V71, P191, DOI 10.1128/JVI.71.1.191-198.1997; Finnen RL, 2010, VIROLOGY, V397, P23, DOI 10.1016/j.virol.2009.11.012; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; GARCIN D, 1990, VIROLOGY, V179, P208, DOI 10.1016/0042-6822(90)90290-8; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HONESS RW, 1973, J VIROL, V12, P1347, DOI 10.1128/JVI.12.6.1347-1365.1973; Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jacquet A, 1998, VIRUS RES, V53, P197, DOI 10.1016/S0168-1702(97)00149-4; JOHNSON DC, 1982, J VIROL, V43, P1102, DOI 10.1128/JVI.43.3.1102-1112.1982; JONES F, 1988, J VIROL, V62, P2701, DOI 10.1128/JVI.62.8.2701-2711.1988; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KARGER A, 1995, J VIROL, V69, P3482, DOI 10.1128/JVI.69.6.3482-3489.1995; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; LIPPE R, 1993, J IMMUNOL, V150, P3170; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Mardberg K, 2002, J GEN VIROL, V83, P291, DOI 10.1099/0022-1317-83-2-291; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Mettenleiter TC, 2006, VET MICROBIOL, V113, P163, DOI 10.1016/j.vetmic.2005.11.040; MICHAELIS C, 1992, BIOCHEM CELL BIOL, V70, P1209, DOI 10.1139/o92-167; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Roizman B, 2001, FIELDS VIROLOGY, P2399; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; SANDVIG K, 1992, EXP CELL RES, V200, P253, DOI 10.1016/0014-4827(92)90171-4; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Suarez AL, 2011, J VIROL, V85, P6293, DOI 10.1128/JVI.00001-11; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; TUFARO F, 1987, J CELL BIOL, V105, P647, DOI 10.1083/jcb.105.2.647; Turcotte S, 2005, J VIROL, V79, P8847, DOI 10.1128/JVI.79.14.8847-8860.2005; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; WHEALY ME, 1992, J VIROL, V66, P3803, DOI 10.1128/JVI.66.6.3803-3810.1992; WHEALY ME, 1991, J VIROL, V65, P1066, DOI 10.1128/JVI.65.3.1066-1081.1991; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang QJ, 2000, J IMMUNOL, V164, P4513, DOI 10.4049/jimmunol.164.9.4513	79	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42636	10.1371/journal.pone.0042636	http://dx.doi.org/10.1371/journal.pone.0042636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900036	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900052
J	Oh, Y; Franck, WL; Han, SO; Shows, A; Gokce, E; Muddiman, DC; Dean, RA				Oh, Yeonyee; Franck, William L.; Han, Sang-Oh; Shows, Angela; Gokce, Emine; Muddiman, David C.; Dean, Ralph A.			Polyubiquitin Is Required for Growth, Development and Pathogenicity in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							INFECTION STRUCTURE FORMATION; UBIQUITIN LIGASE RSP5; APPRESSORIUM FORMATION; FUNCTIONAL-ANALYSIS; ANALYSIS REVEALS; GENE-EXPRESSION; HEAT-SHOCK; RESISTANCE; GRISEA; GENOME	Protein ubiquitination, which is highly selective, regulates many important biological processes including cellular differentiation and pathogenesis in eukaryotic cells. Here, we integrated pharmacological, molecular and proteomic approaches to explore the role of ubiquitination in Magnaporthe oryzae, the leading fungal disease of rice world-wide. Inhibition of ubiquitin-mediated proteolysis using the 26S proteasome inhibitor, Bortezomib, significantly attenuated conidia germination, appressorium formation and pathogenicity in M. oryzae. Gene expression analysis revealed that many genes associated with protein ubiquitination were developmentally regulated during conidia germination. Only a few, including a polyubiquitin encoding gene, MGG_01282, were more abundantly expressed during appressorium formation and under nitrogen starvation. Targeted gene deletion of MGG_01282, in addition to a significant reduction in protein ubiquitination as determined by immuno blot assays, resulted in pleiotropic effects on M. oryzae including reduced growth and sporulation, abnormal conidia morphology, reduced germination and appressorium formation, and the inability to cause disease. Mutants were also defective in sexual development and were female sterile. Using mass spectrometry, we identified 63 candidate polyubiquitinated proteins under nitrogen starvation, which included overrepresentation of proteins involved in translation, transport and protein modification. Our study suggests that ubiquitination of target proteins plays an important role in nutrient assimilation, development and pathogenicity of M. oryzae.	[Oh, Yeonyee; Franck, William L.; Shows, Angela; Dean, Ralph A.] N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Raleigh, NC 27695 USA; [Han, Sang-Oh] Duke Univ, Dept Med, Durham, NC USA; [Gokce, Emine; Muddiman, David C.] N Carolina State Univ, Dept Chem, WM Keck FT ICR Mass Spectrometry Lab, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Duke University; University of North Carolina; North Carolina State University	Oh, Y (corresponding author), N Carolina State Univ, Dept Plant Pathol, Ctr Integrated Fungal Res, Box 7616, Raleigh, NC 27695 USA.	radean2@ncsu.edu		Muddiman, David/0000-0003-2216-499X; Oh, Yeonyee/0000-0002-5571-3687	National Science Foundation [0918611, 0605017]	National Science Foundation(National Science Foundation (NSF))	This work was supported through National Science Foundation Award #0918611 and #0605017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FRASER J, 1991, CURR GENET, V20, P17, DOI 10.1007/BF00312760; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gokce E, 2011, J AM SOC MASS SPECTR, V22, P2199, DOI 10.1007/s13361-011-0237-2; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Liu XH, 2008, METHOD ENZYMOL, V451, P271, DOI 10.1016/S0076-6879(08)03219-9; Loser K, 1998, CURR GENET, V34, P404, DOI 10.1007/s002940050414; McCafferty HRK, 1998, CURR GENET, V33, P352, DOI 10.1007/s002940050347; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PIETERSE CMJ, 1991, PLANT MOL BIOL, V17, P799, DOI 10.1007/BF00037062; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; Takada K, 1996, BBA-GEN SUBJECTS, V1290, P282, DOI 10.1016/0304-4165(96)00032-3; TANAKA K, 1988, EMBO J, V7, P495, DOI 10.1002/j.1460-2075.1988.tb02837.x; VALENT B, 1991, GENETICS, V127, P87; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wang Y, 2011, PLANT PATHOLOGY J, V27, P225, DOI 10.5423/PPJ.2011.27.3.225; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	43	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42868	10.1371/journal.pone.0042868	http://dx.doi.org/10.1371/journal.pone.0042868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900059	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900077
J	Song, SM; Ji, BA; Ramachandran, V; Wang, HM; Hafley, M; Logsdon, C; Bresalier, RS				Song, Shumei; Ji, Baoan; Ramachandran, Vijaya; Wang, Huamin; Hafley, Margarete; Logsdon, Craig; Bresalier, Robert S.			Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling	PLOS ONE			English	Article							K-RAS; INTRAEPITHELIAL NEOPLASIA; EXPRESSION; ADENOCARCINOMA; CARCINOMAS; INCREASES; TUMORS	Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3-5%. Mutations in K-Ras are found in nearly all cases, but K-Ras mutations alone are not sufficient for the development of PDAC. Additional factors contribute to activation of Ras signaling and lead to tumor formation. Galectin-3 (Gal-3), a multifunctional beta-galactoside-binding protein, is highly expressed in PDAC. We therefore investigated the functional role of Gal-3 in pancreatic cancer progression and its relationship to Ras signaling. Expression of Gal-3 was determined by immunohistochemistry, Q-PCR and immunoblot. Functional studies were performed using pancreatic cell lines genetically engineered to express high or low levels of Gal-3. Ras activity was examined by Raf pull-down assays. Co-immunoprecipitation and immunofluorescence were used to assess protein-protein interactions. In this study, we demonstrate that Gal-3 was highly up-regulated in human tumors and in a mutant K-Ras mouse model of PDAC. Down-regulation of Gal-3 by lentivirus shRNA decreased PDAC cell proliferation and invasion in vitro and reduced tumor volume and size in an orthotopic mouse model. Gal-3 bound Ras and maintained Ras activity; down-regulation of Gal-3 decreased Ras activity as well as Ras down-stream signaling including phosphorylation of ERK and AKT and Ral A activity. Transfection of Gal-3 cDNA into PDAC cells with low-level Gal-3 augmented Ras activity and its down-stream signaling. These results suggest that Gal-3 contributes to pancreatic cancer progression, in part, by binding Ras and activating Ras signaling. Gal-3 may therefore be a potential novel target for this deadly disease.	[Song, Shumei; Hafley, Margarete; Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Ji, Baoan; Ramachandran, Vijaya; Logsdon, Craig] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Song, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	ssong@mdanderson.org		Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health/National Cancer Institute [R01CA69480]; American Gastroenterological Association; Public Health Service [DF56338]; NATIONAL CANCER INSTITUTE [R01CA069480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Gastroenterological Association; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institutes of Health/National Cancer Institute grant R01CA69480 (R.S.B), American Gastroenterological Association Research Scholar Award (S. Song), and Public Health Service Grant DF56338, which supports the Texas Medical Center Digestive Diseases Center (S. Song). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andea A, 2003, MODERN PATHOL, V16, P996, DOI 10.1097/01.MP.0000087422.24733.62; Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020859; Hebert E, 1996, CR ACAD SCI III-VIE, V319, P871; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Khayyata S, 2005, MODERN PATHOL, V18, P1504, DOI 10.1038/modpathol.3800460; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Levy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027490; Levy R, 2010, MOL CANCER THER, V9, P2208, DOI 10.1158/1535-7163.MCT-10-0262; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Ottenhof NA, 2009, ARCH PATHOL LAB MED, V133, P375, DOI 10.1043/1543-2165-133.3.375; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Song SM, 2009, CLIN CANCER RES, V15, P622, DOI 10.1158/1078-0432.CCR-08-0772; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; Takaori K, 2004, PANCREAS, V28, P257, DOI 10.1097/00006676-200404000-00008; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; van den Brule F, 2002, GLYCOCONJUGATE J, V19, P537, DOI 10.1023/B:GLYC.0000014083.48508.6a; Wang L, 2000, LAB INVEST, V80, P1233, DOI 10.1038/labinvest.3780131; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719	32	65	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42699	10.1371/journal.pone.0042699	http://dx.doi.org/10.1371/journal.pone.0042699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900040	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900057
J	Hoppitt, W; Samson, J; Laland, KN; Thornton, A				Hoppitt, Will; Samson, Jamie; Laland, Kevin N.; Thornton, Alex			Identification of Learning Mechanisms in a Wild Meerkat Population	PLOS ONE			English	Article							ANIMALS; TRADITIONS; IMITATION; ARBITRARY	Vigorous debates as to the evolutionary origins of culture remain unresolved due to an absence of methods for identifying learning mechanisms in natural populations. While laboratory experiments on captive animals have revealed evidence for a number of mechanisms, these may not necessarily reflect the processes typically operating in nature. We developed a novel method that allows social and asocial learning mechanisms to be determined in animal groups from the patterns of interaction with, and solving of, a task. We deployed it to analyse learning in groups of wild meerkats (Suricata suricatta) presented with a novel foraging apparatus. We identify nine separate learning processes underlying the meerkats' foraging behaviour, in each case precisely quantifying their strength and duration, including local enhancement, emulation, and a hitherto unrecognized form of social learning, which we term `observational perseverance'. Our analysis suggests a key factor underlying the stability of behavioural traditions is a high ratio of specific to generalized social learning effects. The approach has widespread potential as an ecologically valid tool to investigate learning mechanisms in natural groups of animals, including humans.	[Hoppitt, Will; Laland, Kevin N.] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Samson, Jamie] Kuruman River Reserve, Kalahari Meerkat Project, Van Zylsrus, Northern Cape, South Africa; [Thornton, Alex] Univ Cambridge, Dept Zool, Cambridge, England; [Thornton, Alex] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of St Andrews; University of Cambridge; University of Cambridge	Hoppitt, W (corresponding author), Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	wjeh1@st-andrews.ac.uk	Hoppitt, William/A-8216-2008	Hoppitt, William/0000-0003-0815-5720; Thornton, Alex/0000-0002-1607-2047; Laland, Kevin/0000-0002-2457-0900	Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/D015812/1]; Drapers' Company Fellowship from Pembroke College, Cambridge; David Phillips BBSRC Fellowship; BBSRC [BB/D015812/1, BB/C005430/1]; European Research Council (ERC) Advanced Grant [232823]; Biotechnology and Biological Sciences Research Council [BB/C005430/1, BB/D015812/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Drapers' Company Fellowship from Pembroke College, Cambridge; David Phillips BBSRC Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) Advanced Grant(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	W.H. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) grant (BB/D015812/1), A.T. was funded by a Drapers' Company Fellowship from Pembroke College, Cambridge and a David Phillips BBSRC Fellowship and K.N.L. by grants from the BBSRC (BB/C005430/1 and BB/D015812/1) and a European Research Council (ERC) Advanced Grant (EVOCULTURE, Ref. 232823) (http://www.bbsrc.ac.uk/, http://erc.europa.eu/, http://www.pem.cam.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, LEARNING INSTINCT AN; Bates D., 2008, LME4 LINEAR MIXED EF; Boyd R., 1985, CULTURE EVOLUTIONARY; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Gajdon GK, 2004, LEARN BEHAV, V32, P62; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; Galef BG, 2004, LEARN BEHAV, V32, P53; GALEF BG, 1995, ANIM BEHAV, V50, P705, DOI 10.1016/0003-3472(95)80131-6; Haccou P., 1992, STAT ANAL BEHAV DATA; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Heyes CM, 2000, ADV STUD BEHAV, V29, P215, DOI 10.1016/S0065-3454(08)60106-0; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kendal RL, 2007, INT J PSYCHOL PSYCHO, V7, P123; Lalalnd KN, 2009, QUESTION ANIMAL CULT; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; LALAND KN, 1991, ANIM BEHAV, V41, P997, DOI 10.1016/S0003-3472(05)80638-4; Laland KN, 1997, ANIM BEHAV, V53, P1161, DOI 10.1006/anbe.1996.0318; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; MCQUOID LM, 1992, J COMP PSYCHOL, V106, P137, DOI 10.1037/0735-7036.106.2.137; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Plummer M., 2015, PACKAGE CODA; Reader SM, 2010, LEARN BEHAV, V38, P265, DOI 10.3758/LB.38.3.265; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Sargent BL, 2009, QUESTION ANIMAL CULT, P152; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shipley B., 2000, CAUSE CORRELATIONS B; Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Team RDC, 2019, R LANG ENV STAT COMP; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Therneau T., 2009, COXME MIXED EFFECTS; Therneau TM, 2000, MODELING SURVIVAL DA; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; Tomasello M., 1990, P274, DOI 10.1017/CBO9780511665486.012; Tomasello M, 1994, QUESTION CHIMPANZEE, P301; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134	54	34	35	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42044	10.1371/journal.pone.0042044	http://dx.doi.org/10.1371/journal.pone.0042044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905113	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100023
J	Nocito, L; Zafra, D; Calbo, J; Dominguez, J; Guinovart, JJ				Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.			Tungstate Reduces the Expression of Gluconeogenic Enzymes in STZ Rats	PLOS ONE			English	Article							STREPTOZOTOCIN-DIABETIC RATS; GLYCOGEN-SYNTHASE KINASE-3; RABBIT SKELETAL-MUSCLE; SODIUM TUNGSTATE; SIGNAL-TRANSDUCTION; ANTIDIABETIC AGENT; PROTEIN-KINASE; ISOLATED HEPATOCYTES; METABOLIC PATHWAYS; S6 KINASE	Aims: Oral administration of sodium tungstate has shown hyperglycemia-reducing activity in several animal models diabetes. We present new insights into the mechanism of action of tungstate. Methods: We studied protein expression and phosphorylation in the liver of STZ rats, a type I diabetes model, treated with sodium tungstate in the drinking water (2 mg/ml) and in primary cultured-hepatocytes, through Western blot and Real Time PCR analysis. Results: Tungstate treatment reduces the expression of gluconeogenic enzymes (PEPCK, G6Pase, and FBPase) and also regulates transcription factors accountable for the control of hepatic metabolism (c-jun, c-fos and PGC1 alpha). Moreover, ERK, p90rsk and GSK3, upstream kinases regulating the expression of c-jun and c-fos, are phosphorylated in response to tungstate. Interestingly, PKB/Akt phosphorylation is not altered by the treatment. Several of these observations were reproduced in isolated rat hepatocytes cultured in the absence of insulin, thereby indicating that those effects of tungstate are insulin-independent. Conclusions: Here we show that treatment with tungstate restores the phosphorylation state of various signaling proteins and changes the expression pattern of metabolic enzymes.	[Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Nocito, Laura; Zafra, Delia; Calbo, Joaquim; Dominguez, Jorge; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Nocito, Laura; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Nocito, L (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	guinovart@irbbarcelona.org		Zafra, Delia/0000-0003-4143-0659	Ministerio de Educacion y Ciencia (Spain); Intra-European Fellowship from the Marie Curie Actions [FP7-PEOPLE-2009-IEF]; Ministry of Science and Innovation, Spain [BFU2008-00769, SAF2007-64722]; Autonomous Government of Catalonia [2009SGR-1176]; Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain)	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Intra-European Fellowship from the Marie Curie Actions; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion Marcelino Botin; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain)	L.N. was a recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (www.micinn.es, Spain). J.C. is a recipient of an Intra-European Fellowship from the Marie Curie Actions (FP7-PEOPLE-2009-IEF; http://ec.europa.eu/research/mariecurieactions/). This study was supported by grants BFU2008-00769 and SAF2007-64722 (Ministry of Science and Innovation, Spain), 2009SGR-1176 (Autonomous Government of Catalonia), a grant from the Fundacion Marcelino Botin to J.J.G. and by CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministry of Science and Innovation, Spain; www.ciberdem.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1986, BIOCHEM J, V239, P593, DOI 10.1042/bj2390593; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Amigo-Correig M, 2011, DIABETES OBES METAB, V13, P235, DOI 10.1111/j.1463-1326.2010.01339.x; Ballester J, 2005, J ANDROL, V26, P706, DOI 10.2164/jandrol.04156; BARBERA A, 1994, J BIOL CHEM, V269, P20047; Barbera A, 2001, DIABETOLOGIA, V44, P507, DOI 10.1007/s001250100479; Barbera A, 1998, DIABETOLOGIA, V41, pA236; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dominguez JE, 2003, J BIOL CHEM, V278, P42785, DOI 10.1074/jbc.M308334200; Ekladous D, 2008, CLIN EXP PHARMACOL P, V35, P971, DOI 10.1111/j.1440-1681.2008.04944.x; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fernandez-Alvarez J, 2004, DIABETOLOGIA, V47, P470, DOI 10.1007/s00125-004-1332-8; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Garcia CA, 2009, J IMMUNOL, V183, P4475, DOI 10.4049/jimmunol.0901283; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Giron MD, 2003, FEBS LETT, V542, P84, DOI 10.1016/S0014-5793(03)00352-1; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; He Q, 2010, AM J PHYSIOL-HEART C, V298, pH136, DOI 10.1152/ajpheart.00251.2009; JONES CG, 1993, BIOCHEM J, V289, P821, DOI 10.1042/bj2890821; Mage M, 2002, CAN J PHYSIOL PHARM, V80, P328, DOI 10.1139/Y02-024; MASSAGUE J, 1977, FEBS LETT, V82, P317, DOI 10.1016/0014-5793(77)80610-8; Miro-Queralt M, 2008, AM J PHYSIOL-GASTR L, V295, pG479, DOI 10.1152/ajpgi.00566.2007; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Munoz MC, 2001, DIABETES, V50, P131, DOI 10.2337/diabetes.50.1.131; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naito Z, 2003, EXP MOL PATHOL, V74, P23, DOI 10.1016/S0014-4800(03)80005-9; Oyadomari S, 2000, FEBS LETT, V478, P141, DOI 10.1016/S0014-5793(00)01840-8; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thirone ACP, 2002, DIABETES, V51, P2270, DOI 10.2337/diabetes.51.7.2270; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Yan SQ, 2001, CANCER RES, V61, P5016; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42305	10.1371/journal.pone.0042305	http://dx.doi.org/10.1371/journal.pone.0042305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905122	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100031
J	Wang, S; Fukuchi, M; Koch, C; Tsuchiya, N				Wang, Shuo; Fukuchi, Masaki; Koch, Christof; Tsuchiya, Naotsugu			Spatial Attention Is Attracted in a Sustained Fashion toward Singular Points in the Optic Flow	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; MOTION-IN-DEPTH; MST NEURONS; COLLISION-AVOIDANCE; VISUAL CONTROL; IMPENDING COLLISION; SENSITIVE NEURONS; NUCLEUS ROTUNDUS	While a single approaching object is known to attract spatial attention, it is unknown how attention is directed when the background looms towards the observer as s/he moves forward in a quasi-stationary environment. In Experiment 1, we used a cued speeded discrimination task to quantify where and how spatial attention is directed towards the target superimposed onto a cloud of moving dots. We found that when the motion was expansive, attention was attracted towards the singular point of the optic flow (the focus of expansion, FOE) in a sustained fashion. The effects were less pronounced when the motion was contractive. The more ecologically valid the motion features became (e.g., temporal expansion of each dot, spatial depth structure implied by distribution of the size of the dots), the stronger the attentional effects. Further, the attentional effects were sustained over 1000 ms. Experiment 2 quantified these attentional effects using a change detection paradigm by zooming into or out of photographs of natural scenes. Spatial attention was attracted in a sustained manner such that change detection was facilitated or delayed depending on the location of the FOE only when the motion was expansive. Our results suggest that focal attention is strongly attracted towards singular points that signal the direction of forward ego-motion.	[Wang, Shuo; Fukuchi, Masaki; Koch, Christof; Tsuchiya, Naotsugu] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Fukuchi, Masaki] Sony Corp, Syst & Software Platform, Shinagawa Ku, Tokyo, Japan; [Koch, Christof] Allen Inst Brain Sci, Seattle, WA USA; [Tsuchiya, Naotsugu] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Tsuchiya, Naotsugu] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Tsuchiya, Naotsugu] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia	California Institute of Technology; Sony Corporation; Allen Institute for Brain Science; Japan Science & Technology Agency (JST); RIKEN; Monash University	Wang, S (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	naotsugu.tsuchiya@monash.edu	Tsuchiya, Naotsugu/N-8153-2014	Tsuchiya, Naotsugu/0000-0003-4216-8701; Koch, Christof/0000-0001-6482-8067	Japan Society for the Promotion of Science; PRESTO award from Japan Science and Technology Agency; Office of Naval Research (via an award made through Johns Hopkins University); NeoVision program at DARPA; WCU program of the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-10008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO award from Japan Science and Technology Agency; Office of Naval Research (via an award made through Johns Hopkins University); NeoVision program at DARPA; WCU program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	NT was funded by the Japan Society for the Promotion of Science and PRESTO award from Japan Science and Technology Agency. The research reported here is supported by the Office of Naval Research (via an award made through Johns Hopkins University), by the NeoVision program at DARPA and by the WCU program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BOWER TGR, 1971, PERCEPT PSYCHOPHYS, V9, P193, DOI 10.3758/BF03212627; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Brosseau-Lachaine O, 2008, J VISION, V8, DOI 10.1167/8.4.5; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Efron B., 1994, CHAPMAN HALL CRC MON; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HAYES WN, 1967, ANIM BEHAV, V15, P102, DOI 10.1016/S0003-3472(67)80018-6; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hemmi JM, 2012, CURR OPIN NEUROBIOL, V22, P194, DOI 10.1016/j.conb.2011.11.012; Ingle DJ, 1985, BRAIN MECH SPATIAL V, P229; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappe M, 1998, J NEUROPHYSIOL, V79, P1461, DOI 10.1152/jn.1998.79.3.1461; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Laurent G, 1998, NAT NEUROSCI, V1, P261, DOI 10.1038/1071; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LEE DN, 1993, J EXP BIOL, V180, P85; Lin JY, 2008, PSYCHOL SCI, V19, P686, DOI 10.1111/j.1467-9280.2008.02143.x; Lin JY, 2009, CURR BIOL, V19, P1118, DOI 10.1016/j.cub.2009.05.021; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Morrone MC, 1999, CURR BIOL, V9, P763, DOI 10.1016/S0960-9822(99)80338-8; Nakagawa H, 2010, J NEUROPHYSIOL, V104, P2487, DOI 10.1152/jn.01055.2009; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Niemann T, 1999, VISION RES, V39, P1359, DOI 10.1016/S0042-6989(98)00236-3; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; REGAN D, 1978, VISION RES, V18, P209, DOI 10.1016/0042-6989(78)90188-8; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; SAITO H, 1986, J NEUROSCI, V6, P145; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Schrater PR, 2001, NATURE, V410, P816, DOI 10.1038/35071075; Sidaway B, 1989, ECOL PSYCHOL, V1, P253, DOI DOI 10.1207/S15326969EC00103_2; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Takeuchi T, 1997, VISION RES, V37, P2083, DOI 10.1016/S0042-6989(96)00225-8; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TRONICK E, 1967, J COMP PHYSIOL PSYCH, V64, P529, DOI 10.1037/h0025206; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; von Muhlenen A, 2007, J EXP PSYCHOL HUMAN, V33, P1297, DOI 10.1037/0096-1523.33.6.1297; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Yamamoto K, 2003, BRAIN BEHAV EVOLUT, V62, P201, DOI 10.1159/000073272; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YILMAZ EH, 1995, J EXP PSYCHOL HUMAN, V21, P996, DOI 10.1037/0096-1523.21.5.996; Zhang T, 2004, NEURON, V42, P993, DOI 10.1016/j.neuron.2004.06.008	73	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41040	10.1371/journal.pone.0041040	http://dx.doi.org/10.1371/journal.pone.0041040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905096	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000307331100008
J	Yang, HL; Liu, YJ; Wang, CL; Zeng, QY				Yang, Hai-Ling; Liu, Yan-Jing; Wang, Cai-Ling; Zeng, Qing-Yin			Molecular Evolution of Trehalose-6-Phosphate Synthase (TPS) Gene Family in Populus, Arabidopsis and Rice	PLOS ONE			English	Article							TREHALOSE METABOLISM; VEGETATIVE GROWTH; PROTEINS; ACCUMULATION; EXPRESSION; TOLERANCE; INSIGHTS; SEEDS	Trehalose-6-phosphate synthase (TPS) plays important roles in trehalose metabolism and signaling. Plant TPS proteins contain both a TPS and a trehalose-6-phosphate phosphatase (TPP) domain, which are coded by a multi-gene family. The plant TPS gene family has been divided into class I and class II. A previous study showed that the Populus, Arabidopsis, and rice genomes have seven class I and 27 class II TPS genes. In this study, we found that all class I TPS genes had 16 introns within the protein-coding region, whereas class II TPS genes had two introns. A significant sequence difference between the two classes of TPS proteins was observed by pairwise sequence comparisons of the 34 TPS proteins. A phylogenetic analysis revealed that at least seven TPS genes were present in the monocot-dicot common ancestor. Segmental duplications contributed significantly to the expansion of this gene family. At least five and three TPS genes were created by segmental duplication events in the Populus and rice genomes, respectively. Both the TPS and TPP domains of 34 TPS genes have evolved under purifying selection, but the selective constraint on the TPP domain was more relaxed than that on the TPS domain. Among 34 TPS genes from Populus, Arabidopsis, and rice, four class I TPS genes (AtTPS1, OsTPS1, PtTPS1, and PtTPS2) were under stronger purifying selection, whereas three Arabidopsis class I TPS genes (AtTPS2, 3, and 4) apparently evolved under relaxed selective constraint. Additionally, a reverse transcription polymerase chain reaction analysis showed the expression divergence of the TPS gene family in Populus, Arabidopsis, and rice under normal growth conditions and in response to stressors. Our findings provide new insights into the mechanisms of gene family expansion and functional evolution.	[Yang, Hai-Ling; Wang, Cai-Ling] Beijing Forestry Univ, Coll Life Sci & Biotechnol, Beijing, Peoples R China; [Liu, Yan-Jing; Zeng, Qing-Yin] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Yang, HL (corresponding author), Beijing Forestry Univ, Coll Life Sci & Biotechnol, Beijing, Peoples R China.	yhailing@yahoo.com.cn; qingyin.zeng@ibcas.ac.cn	刘, 妍婧/HCI-6701-2022	Zeng, Qing-Yin/0000-0002-5730-3016	National Basic Research Program of China [2009CB119104]; Natural Science Foundation of China [NSFC 30800873]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-1]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This study was supported by grants from the National Basic Research Program of China (2009CB119104), the Natural Science Foundation of China (NSFC 30800873), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Chary SN, 2008, PLANT PHYSIOL, V146, P97, DOI 10.1104/pp.107.107441; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Force A, 1999, GENETICS, V151, P1531; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Lunn JE, 2007, FUNCT PLANT BIOL, V34, P550, DOI 10.1071/FP06315; Ohno S., 1970, EVOLUTION GENE DUPLI; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zang BS, 2011, PLANT MOL BIOL, V76, P507, DOI 10.1007/s11103-011-9781-1	28	45	46	14	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42438	10.1371/journal.pone.0042438	http://dx.doi.org/10.1371/journal.pone.0042438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905132	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100038
J	Fu, MS; De Sordi, L; Muhlschlegel, FA				Fu, Man-Shun; De Sordi, Luisa; Muehlschlegel, Fritz A.			Functional Characterization of the Small Heat Shock Protein Hsp12p from Candida albicans	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; TRANSCRIPTIONAL RESPONSE; ADENYLYL-CYCLASE; STRESS-RESPONSE; YEAST-CELLS; KINASE; GROWTH; MORPHOGENESIS; RESISTANCE	Hsp12p is considered to be a small heat shock protein and conserved among fungal species. To investigate the expression of this heat shock protein in the fungal pathogen Candida albicans we developed an anti-CaHsp12p antibody. We show that this protein is induced during stationary phase growth and under stress conditions including heat shock, osmotic, oxidative and heavy metal stress. Furthermore, we find that CaHsp12p expression is influenced by the quorum sensing molecule farnesol, the change of CO2 concentration and pH. Notably we show that the key transcription factor Efg1p acts as a positive regulator of CaHsp12p in response to heat shock and oxidative stress and demonstrate that CaHsp12p expression is additionally modulated by Hog1p and the cAMP-PKA signaling pathway. To study the function of Hsp12p in C. albicans we generated a null mutant, in which all four CaHSP12 genes have been deleted. Phenotypic analysis of the strain shows that CaHSP12 is not essential for stress resistance, morphogenesis or virulence when tested in a Drosophila model of infection. However, when overexpressed, CaHSP12 significantly enhanced cell-cell adhesion, germ tube formation and susceptibility to azole antifungal agents whilst desensitizing C. albicans to the quorum sensing molecule farnesol.	[Fu, Man-Shun; De Sordi, Luisa; Muehlschlegel, Fritz A.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Muehlschlegel, Fritz A.] E Kent Hosp Univ NHS Fdn Trust, Clin Microbiol Serv, Ashford, Kent, England	University of Kent	Fu, MS (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	F.A.Muhlschlegel@kent.ac.uk	De Sordi, Luisa/ABC-2581-2021	De Sordi, Luisa/0000-0002-3785-550X	Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC); University of Kent; MRC [G0601049] Funding Source: UKRI; Medical Research Council [G0601049] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Kent; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (MRC)(http://www.mrc.ac.uk/index.htm); Biotechnology and Biological Sciences Research Council (BBSRC)(http://www.bbsrc.ac.uk/home/home.aspx); the University of Kent (http://www.kent.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY NJ, 1992, YEAST, V8, P95, DOI 10.1002/yea.320080204; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Brachmann CB, 1998, YEAST, V14, P115; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Carmelo V, 1997, FEMS MICROBIOL LETT, V149, P85, DOI 10.1016/S0378-1097(97)00059-1; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Cowen LE, 2002, P NATL ACAD SCI USA, V99, P9284, DOI 10.1073/pnas.102291099; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Eboigbodin KE, 2008, BIOMACROMOLECULES, V9, P686, DOI 10.1021/bm701043c; Eckert SE, 2007, FUNGAL GENET BIOL, V44, P368, DOI 10.1016/j.fgb.2006.12.006; El Barkani A, 2000, MOL CELL BIOL, V20, P4635, DOI 10.1128/MCB.20.13.4635-4647.2000; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2003, MOL BIOL CELL, V14, P1460, DOI 10.1091/mbc.E02-08-0546; FONZI WA, 1993, GENETICS, V134, P717; Garstel M., 1997, GUIDEBOOK MOL CHAPER, P269; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Hogan DA, 2011, CURR OPIN MICROBIOL, V14, P682, DOI 10.1016/j.mib.2011.09.014; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Hosking S, 1999, MOL FUNGAL BIOL, P322; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Krishnamurthy SS, 1999, FEMS MICROBIOL LETT, V173, P475, DOI 10.1111/j.1574-6968.1999.tb13541.x; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Motshwene P, 2004, BIOCHEM J, V377, P769, DOI 10.1042/bj20031301; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Nickerson KW, 2006, APPL ENVIRON MICROB, V72, P3805, DOI 10.1128/AEM.02765-05; PANARETOU B, 1992, EUR J BIOCHEM, V206, P635, DOI 10.1111/j.1432-1033.1992.tb16968.x; PETKO L, 1986, CELL, V45, P885, DOI 10.1016/0092-8674(86)90563-5; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Sheth CC, 2008, FUNGAL GENET BIOL, V45, P1075, DOI 10.1016/j.fgb.2008.04.004; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Wendland J, 2003, CURR GENET, V44, P115, DOI 10.1007/s00294-003-0436-x; Westwater C, 2005, EUKARYOT CELL, V4, P1654, DOI 10.1128/EC.4.10.1654-1661.2005; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	63	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42894	10.1371/journal.pone.0042894	http://dx.doi.org/10.1371/journal.pone.0042894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880130	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000307437900060
J	Liu, D; Shi, M; Zhang, H; Qian, L; Yu, M; Hu, MR; Zhang, RH; Wang, TY; Han, CL; Duan, HJ; Guo, N				Liu, Dan; Shi, Ming; Zhang, Hao; Qian, Lu; Yu, Ming; Hu, Meiru; Zhang, Ruihong; Wang, Tianyou; Han, Caili; Duan, Huijun; Guo, Ning			c-Myb Regulates Cell Cycle-Dependent Expression of Erbin: An Implication for a Novel Function of Erbin	PLOS ONE			English	Article							BASOLATERAL PDZ PROTEIN; HEMATOPOIETIC-CELLS; ACTIVATION; DOMAIN; DETERMINANTS; LOCALIZATION; COACTIVATOR; TRANSITION; INTERACTS; JUNCTIONS	In the present study, we demonstrated the cell cycle periodicity of Erbin expression with the maximal expression of Erbin in G2/M phase. A significant increase in Erbin promoter activity was observed in G2/M phase-synchronized cells. Sequence analysis revealed a c-Myb site in the core promoter region of Erbin. Mutagenesis of c-Myb consensus sequences abrogated the increased Erbin promoter activity in G2/M phase. ChIP and oligonucleotide pull-down assays validated that the recruitment of c-Myb to the consensus sequences was specific. The interaction of c-Myb with c-Myb site in the Erbin promoter was significantly enhanced in G2/M phase. Ectopic overexpression of c-Myb led to the up-regulation of Erbin promoter activity and c-Myb silencing by small interfering RNA significantly decreased Erbin protein level. Transfection of c-Myb rescued Erbin expression that was impaired by c-Myb knockdown. It proves that c-Myb and the c-Myb response element mediate the cell cycle-dependent expression of Erbin. Inactivation of Erbin causes an acceleration of the G1/S transition, the formation of multipolar spindles and abnormal chromosome congression. These results unravel a critical role of c-Myb in promoting Erbin transcription in G2/M phase and also predict an unappreciated function of Erbin in cell cycle progression.	[Liu, Dan; Zhang, Ruihong; Han, Caili; Duan, Huijun] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Shi, Ming; Zhang, Hao; Qian, Lu; Yu, Ming; Hu, Meiru; Guo, Ning] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing 100730, Peoples R China; [Wang, Tianyou] Capital Inst Pediat, Beijing, Peoples R China	Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Institute of Pediatrics (CIP)	Liu, D (corresponding author), Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China.	duanhj999@163.com; ningguo@nic.bmi.ac.cn	Zhang, Rui/GXN-3801-2022		National Basic Research Program of China (973 Program) [2010CB911904]; National Natural Science Foundation of China [30800582, 30972690]; Beijing National Natural Science Foundation [7122124]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing National Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Basic Research Program of China (973 Program, No. 2010CB911904), National Natural Science Foundation of China (No. 30800582 and 30972690) and Beijing National Natural Science Foundation (No. 7122124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bilder D, 2000, NAT CELL BIOL, V2, pE114, DOI 10.1038/35017119; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GOLAY J, 1991, BLOOD, V77, P149; HERNANDEZMUNAIN C, 1995, MOL CELL BIOL, V15, P3090; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Huang YZ, 2003, J BIOL CHEM, V278, P1108, DOI 10.1074/jbc.M205413200; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Izawa I, 2002, GENES CELLS, V7, P475, DOI 10.1046/j.1365-2443.2002.00533.x; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Kolch Walter, 2003, Sci STKE, V2003, ppe37; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lebeau S, 2005, BRIT J DERMATOL, V152, P1248, DOI 10.1111/j.1365-2133.2005.06687.x; Legouis R, 2000, NAT CELL BIOL, V2, P415, DOI 10.1038/35017046; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Mink S, 1996, MOL CELL BIOL, V16, P1316; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Ohno H, 2002, ONCOGENE, V21, P7042, DOI 10.1038/sj.onc.1205852; Quintana AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017362; Rangwala R, 2005, J BIOL CHEM, V280, P11790, DOI 10.1074/jbc.M414154200; Ress A, 2006, PROTEIN PEPTIDE LETT, V13, P877, DOI 10.2174/092986606778256126; Shi M, 2013, INT J CARDIOL, V167, P1570, DOI 10.1016/j.ijcard.2012.04.093; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Zhang H, 2008, PREP BIOCHEM BIOTECH, V38, P282, DOI 10.1080/10826060802165105	41	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42903	10.1371/journal.pone.0042903	http://dx.doi.org/10.1371/journal.pone.0042903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880131	Green Submitted, gold, Green Published			2022-12-25	WOS:000307437900061
J	Erb, PL; McShea, WJ; Guralnick, RP				Erb, Peter L.; McShea, William J.; Guralnick, Robert P.			Anthropogenic Influences on Macro-Level Mammal Occupancy in the Appalachian Trail Corridor	PLOS ONE			English	Article							FOXES VULPES-VULPES; WHITE-TAILED DEER; WILDLIFE RESPONSES; MESOPREDATOR RELEASE; SPECIES DISTRIBUTION; CITIZEN SCIENCE; BIODIVERSITY; RECREATION; PATTERNS; MODELS	Anthropogenic effects on wildlife are typically assessed at the local level, but it is often difficult to extrapolate to larger spatial extents. Macro-level occupancy studies are one way to assess impacts of multiple disturbance factors that might vary over different geographic extents. Here we assess anthropogenic effects on occupancy and distribution for several mammal species within the Appalachian Trail (AT), a forest corridor that extends across a broad section of the eastern United States. Utilizing camera traps and a large volunteer network of citizen scientists, we were able to sample 447 sites along a 1024 km section of the AT to assess the effects of available habitat, hunting, recreation, and roads on eight mammal species. Occupancy modeling revealed the importance of available forest to all species except opossums (Didelphis virginiana) and coyotes (Canis latrans). Hunting on adjoining lands was the second strongest predictor of occupancy for three mammal species, negatively influencing black bears (Ursus americanus) and bobcats (Lynx rufus), while positively influencing raccoons (Procyon lotor). Modeling also indicated an avoidance of high trail use areas by bears and proclivity towards high use areas by red fox (Vulpes vulpes). Roads had the lowest predictive power on species occupancy within the corridor and were only significant for deer. The occupancy models stress the importance of compounding direct and indirect anthropogenic influences operating at the regional level. Scientists and managers should consider these human impacts and their potential combined influence on wildlife persistence when assessing optimal habitat or considering management actions.	[Erb, Peter L.; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Erb, Peter L.; McShea, William J.] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Guralnick, Robert P.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Colorado System; University of Colorado Boulder	Erb, PL (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Peter.Erb@colorado.edu		McShea, William/0000-0002-8102-0200	Smithsonian Institution; University of Colorado Museum of Natural History; Department of Ecology and Evolutionary Biology at CU-Boulder; Appalachian Trail Conservancy	Smithsonian Institution(Smithsonian Institution); University of Colorado Museum of Natural History; Department of Ecology and Evolutionary Biology at CU-Boulder; Appalachian Trail Conservancy	Funding was provided by the Smithsonian Institution (www.si.edu), the University of Colorado Museum of Natural History (cumuseum.colorado.edu), the Department of Ecology and Evolutionary Biology at CU-Boulder (ebio.colorado.edu) and the Appalachian Trail Conservancy (www.appalachiantrail.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins CA, 1998, J ZOOL, V244, P335, DOI 10.1111/j.1469-7998.1998.tb00038.x; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; BERINGER JJ, 1990, INT C BEAR, V8, P85; BOYLE SA, 1985, WILDLIFE SOC B, V13, P110; Brown TL, 2000, WILDLIFE SOC B, V28, P797; Campbell Joseph, 2019, THESIS DURHAM U; CARBAUGH B, 1975, J WILDLIFE MANAGE, V39, P570, DOI 10.2307/3800400; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Darrah AJ, 2010, WATERBIRDS, V33, P367, DOI 10.1675/063.033.0314; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dufour C, 2008, APPALACHIAN TRAIL ME; Fahrig L, 2009, ECOL SOC, V14; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gehrt SD, 2003, WILDLIFE SOC B, V31, P836; George SL, 2006, BIOL CONSERV, V133, P107, DOI 10.1016/j.biocon.2006.05.024; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HARRIS S, 1986, J ANIM ECOL, V55, P605, DOI 10.2307/4742; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE., 2006, PRESENCESOFTWARE EST; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Johnson CJ, 2005, WILDLIFE MONOGR, P1; KASWORM WF, 1990, INT C BEAR, V8, P79; Kays Roland W., 2008, P110; Kelly MJ, 2008, NORTHEAST NAT, V15, P249, DOI 10.1656/1092-6194(2008)15[249:CTOCTS]2.0.CO;2; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kroll AJ, 2007, J WILDLIFE MANAGE, V71, P1089, DOI 10.2193/2006-037; Li S, 2010, BIODIVERS CONSERV, V19, P3195, DOI 10.1007/s10531-010-9886-x; Li S, 2010, IBIS, V152, P299, DOI 10.1111/j.1474-919X.2009.00989.x; Linkie M, 2007, BIOL CONSERV, V137, P20, DOI 10.1016/j.biocon.2007.01.016; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; MILLER S.D., 1990, INT C BEAR RES MANAG, V8, P357; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Potere D, 2007, PHOTOGRAMM ENG REM S, V73, P783, DOI 10.14358/PERS.73.7.783; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Ricketts T. H., 1999, TERRESTRIAL ECOREGIO; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROLLEY RE, 1985, J WILDLIFE MANAGE, V49, P283, DOI 10.2307/3801517; Smith MD, 2003, P SOC PHOTO-OPT INS, V5131, P31; Stephenson S.L., 1993, BIODIVERSITY SE US U, P255; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Williamson JF, 1983, URSUS, V5, P302	61	48	51	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42574	10.1371/journal.pone.0042574	http://dx.doi.org/10.1371/journal.pone.0042574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880038	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000047
J	Zhou, JB; Liu, C; Niu, WY; Xin, Z; Yu, M; Feng, JP; Yang, JK				Zhou, Jian-Bo; Liu, Chang; Niu, Wen-Yan; Xin, Zhong; Yu, Mei; Feng, Jian-Ping; Yang, Jin-Kui			Contributions of Renin-Angiotensin System-Related Gene Interactions to Obesity in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INDUCED WEIGHT-GAIN; BODY-MASS INDEX; ADULT OBESITY; FTO GENE; EPISTASIS; VARIANTS; RISK; ADIPOSITY; LOCI	Background: Gene-gene interactions may be partly responsible for complex traits such as obesity. Increasing evidence suggests that the renin-angiotensin system (RAS) contributes to the etiology of obesity. How the epistasis of genes in the RAS contributes to obesity is still under research. We aim to evaluate the contribution of RAS-related gene interactions to a predisposition of obesity in a Chinese population. Methodology and Principal Findings: We selected six single nucleotide polymorphisms (SNPs) located in angiotensin (AGT), angiotensin converting enzyme (ACE), angiotensin type 1 receptor (AGTR1), MAS1, nitric oxide synthase 3 (NOS3) and the bradykinin B2 receptor gene (BDKRB2), and genotyped them in 324 unrelated individuals with obesity (BMI >= 28 kg/m(2)) and 373 non-obese controls (BMI 18.5 to <24 kg/m(2)) from a large scale population-based cohort. We analyzed gene-gene interactions among 6 polymorphic loci using the Generalized Multifactor Dimensionality Reduction (GMDR) method, which has been shown to be effective for detecting gene-gene interactions in case-control studies with relatively small samples. Then we used logistic regression models to confirm the best combination of loci identified in the GMDR. It showed a significant gene-gene interaction between the rs220721 polymorphism in the MAS1 gene and the rs1799722 polymorphism in the gene BDKB2R. The best two-locus combination scored 9 for cross-validation consistency and 9 for sign test (p = 0.0107). This interaction showed the maximum consistency and minimum prediction error among all gene-gene interaction models evaluated. Moreover, the combination of the MAS1 rs220721 and the BDKRB2 rs1799722 was associated with a significantly increased risk of obesity (OR 1.82, CI 95%: 1.15-2.88, p = 0.0103). Conclusions and Significance: These results suggest that the SNPs from the RAS-related genes may contribute to the risk of obesity in an interactive manner in a Chinese population. The gene-gene interaction may serve as a novel area for obesity research.	[Zhou, Jian-Bo; Liu, Chang; Xin, Zhong; Yu, Mei; Feng, Jian-Ping; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China; [Niu, Wen-Yan] Tianjin Med Univ, Dept Immunol, Key Lab Immuno Microenvironm & Dis, Educ Minist China, Tianjin, Peoples R China	Capital Medical University; Tianjin Medical University	Zhou, JB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China.	jinkui.yang@gmail.com		Yang, Jin-Kui/0000-0002-5430-2149	Capital Medical Development Foundation [2009-Z-SQ03]; Expert Promotion Program of Beijing Health Systems [2009-3-34]; Tianjin Municipal Science and Technology Commission [09ZCZDSF04500]	Capital Medical Development Foundation; Expert Promotion Program of Beijing Health Systems; Tianjin Municipal Science and Technology Commission	This work was supported by the Capital Medical Development Foundation (No. 2009-Z-SQ03) and Expert Promotion Program of Beijing Health Systems (No. 2009-3-34) to Professor Jin-Kui Yang and by a grant to Wen-Yan Niu from the Tianjin Municipal Science and Technology Commission (No. 09ZCZDSF04500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin F, 2010, DNA CELL BIOL, V29, P207, DOI 10.1089/dna.2009.0934; Babu M, 2009, MOL BIOSYST, V5, P1439, DOI [10.1039/b907407d, 10.1039/B907407d]; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Braun A, 1996, IMMUNOPHARMACOLOGY, V33, P32, DOI 10.1016/0162-3109(96)00079-3; Cong ND, 1999, P SOC EXP BIOL MED, V220, P46; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; de Kloet AD, 2009, ENDOCRINOLOGY, V150, P4114, DOI 10.1210/en.2009-0065; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; Feitosa MF, 2009, OBESITY, V17, P2190, DOI 10.1038/oby.2009.181; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Jayasooriya AP, 2005, P NATL ACAD SCI USA, V102, P7133, DOI 10.1073/pnas.0502594102; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Lei HP, 2012, J RENIN ANGIOTENSIN; Li WD, 2005, J LIPID RES, V46, P432, DOI 10.1194/jlr.M400391-JLR200; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Maier LM, 2005, AM J HUM GENET, V76, P517, DOI 10.1086/428387; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Mehri S, 2012, MOL BIOL REP, V39, P4059, DOI 10.1007/s11033-011-1187-2; Mei Ling, 2007, BMC Proc, V1 Suppl 1, pS17; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Procopciuc LM, 2010, EUR J INTERN MED, V21, P414, DOI 10.1016/j.ejim.2010.06.001; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Thekkumkara TJ, 2003, BIOCHEM J, V370, P631, DOI 10.1042/BJ20020960; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Warden CH, 2004, NUTRITION, V20, P74, DOI 10.1016/j.nut.2003.09.013; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhou JB, 2010, MED SCI MONITOR, V16, pBR179; Zhou JB, 2010, MOL BIOL REP, V37, P67, DOI 10.1007/s11033-009-9648-6	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42881	10.1371/journal.pone.0042881	http://dx.doi.org/10.1371/journal.pone.0042881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880127	gold, Green Submitted, Green Published			2022-12-25	WOS:000307810000080
J	Won, YJ; Ono, F; Ikeda, SR				Won, Yu-Jin; Ono, Fumihito; Ikeda, Stephen R.			Characterization of Na+ and Ca2+ Channels in Zebrafish Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							ROHON-BEARD NEURONS; VOLTAGE-DEPENDENT MODULATION; PROGRAMMED CELL-DEATH; BETA-GAMMA-SUBUNITS; NERVE GROWTH-FACTOR; CALCIUM-CHANNELS; SENSORY NEURONS; ADULT-RAT; IN-VIVO; N-TYPE	Background: Dorsal root ganglia (DRG) somata from rodents have provided an excellent model system to study ion channel properties and modulation using electrophysiological investigation. As in other vertebrates, zebrafish (Danio rerio) DRG are organized segmentally and possess peripheral axons that bifurcate into each body segment. However, the electrical properties of zebrafish DRG sensory neurons, as compared with their mammalian counterparts, are relatively unexplored because a preparation suitable for electrophysiological studies has not been available. Methodology/Principal Findings: We show enzymatically dissociated DRG neurons from juvenile zebrafish expressing Isl2b-promoter driven EGFP were easily identified with fluorescence microscopy and amenable to conventional whole-cell patch-clamp studies. Two kinetically distinct TTX-sensitive Na+ currents (rapidly-and slowly-inactivating) were discovered. Rapidly-inactivating I-Na were preferentially expressed in relatively large neurons, while slowly-inactivating I-Na was more prevalent in smaller DRG neurons. RT-PCR analysis suggests zscn1aa/ab, zscn8aa/ab, zscn4ab and zscn5Laa are possible candidates for these I-Na components. Voltage-gated Ca2+ currents (I-Ca) were primarily (87%) comprised of a high-voltage activated component arising from v-conotoxin GVIA-sensitive Ca(V)2.2 (N-type) Ca2+ channels. A few DRG neurons (8%) displayed a miniscule low-voltage-activated component. I-Ca in zebrafish DRG neurons were modulated by neurotransmitters via either voltage-dependent or -independent G-protein signaling pathway with large cell-to-cell response variability. Conclusions/Significance: Our present results indicate that, as in higher vertebrates, zebrafish DRG neurons are heterogeneous being composed of functionally distinct subpopulations that may correlate with different sensory modalities. These findings provide the first comparison of zebrafish and rodent DRG neuron electrical properties and thus provide a basis for future studies.	[Won, Yu-Jin; Ikeda, Stephen R.] NIAAA, Sect Transmitter Signaling, Lab Mol Physiol, NIH, Bethesda, MD USA; [Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Won, YJ (corresponding author), NIAAA, Sect Transmitter Signaling, Lab Mol Physiol, NIH, Bethesda, MD USA.	sikeda@mail.nih.gov		ono, fumihito/0000-0001-7532-5262; Ikeda, Stephen/0000-0002-4088-9508	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430, ZIAAA000437] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural program at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chopra SS, 2010, CIRC RES, V106, P1342, DOI 10.1161/CIRCRESAHA.109.213132; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Honjo Y, 2011, J ANAT, V218, P271, DOI 10.1111/j.1469-7580.2010.01337.x; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ikeda Stephen R, 2004, Methods Mol Biol, V259, P167; Kim CJ, 1997, J NEUROPHYSIOL, V77, P1418, DOI 10.1152/jn.1997.77.3.1418; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; MENSE S, 1990, ANAT EMBRYOL, V181, P1; MINTZ IM, 1991, P NATL ACAD SCI USA, V88, P6628, DOI 10.1073/pnas.88.15.6628; MOISES HC, 1994, J NEUROSCI, V14, P5903; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Pineda RH, 2005, J NEUROPHYSIOL, V93, P3582, DOI 10.1152/jn.01070.2004; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Priestley JV, 2002, CAN J PHYSIOL PHARM, V80, P495, DOI 10.1139/y02-034; RANDALL A, 1995, J NEUROSCI, V15, P2995; Reyes R, 2004, DEV DYNAM, V229, P30, DOI 10.1002/dvdy.10488; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; WEIS JS, 1968, J EMBRYOL EXP MORPH, V19, P121; Widmark J, 2011, MOL BIOL EVOL, V28, P859, DOI 10.1093/molbev/msq257; Won YJ, 2011, J NEUROPHYSIOL, V105, P442, DOI 10.1152/jn.00625.2010; Wright MA, 2010, J NEUROSCI, V30, P14513, DOI 10.1523/JNEUROSCI.4025-10.2010; Wright MA, 2010, DEVELOPMENT, V137, P3047, DOI 10.1242/dev.052696	54	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42602	10.1371/journal.pone.0042602	http://dx.doi.org/10.1371/journal.pone.0042602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880050	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100140
J	Ann, EJ; Kim, HY; Seo, MS; Mo, JS; Kim, MY; Yoon, JH; Ahn, JS; Park, HS				Ann, Eun-Jung; Kim, Hwa-Young; Seo, Mi-Sun; Mo, Jung-Soon; Kim, Mi-Yeon; Yoon, Ji-Hye; Ahn, Ji-Seon; Park, Hee-Sae			Wnt5a Controls Notch1 Signaling through CaMKII-mediated Degradation of the SMRT Corepressor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GAMMA-SECRETASE; KINASE-II; INTRACELLULAR DOMAIN; RETINOIC ACID; BETA-APP; PRESENILIN; RECEPTOR; APH-1; EXPRESSION	Serine-threonine Ca2+/calmodulin-dependent protein kinase II (CaMKII) is the key component in noncanonical Wnt5a signaling and has been shown to regulate its signaling. In this study, we found that CaMKII induced by Wnt5a remarkably reduced the protein stability of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT), a co-repressor of Notch signaling, through proteasomal degradation. Wnt5a was found to enhance Notch1 intracellular domain (Notch1-IC) transcription activity, which could be inhibited by treatment with KN93, a CaMKII inhibitor. The kinase activity of CaMKII was essential for the activation of Notch signaling. We also determined that CaMKII could enhance the association between Notch1-IC and RBP-Jk. Furthermore, the physical association between RBP-Jk and SMRT was substantially suppressed by CaMKII. We demonstrated that CaMKII directly bound and phosphorylated SMRT at Ser-1407, thereby facilitating SMRT translocation from the nucleus to the cytoplasm and proteasome-dependent degradation. These results suggest that CaMKII down-regulated the protein stability of SMRT through proteasomal degradation.	[Ann, Eun-Jung; Kim, Hwa-Young; Seo, Mi-Sun; Mo, Jung-Soon; Kim, Mi-Yeon; Yoon, Ji-Hye; Ahn, Ji-Seon; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Chonnam National University	Park, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	proteome@jnu.ac.kr	Ahn, Ji-Seon/GRO-6218-2022	Ahn, Ji-Seon/0000-0001-9465-2517	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100455]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by Grant A100455 of the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	AbuIssa R, 1996, J NEUROGENET, V10, P239, DOI 10.3109/01677069609083465; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COUSO JP, 1994, CELL, V79, P259, DOI 10.1016/0092-8674(94)90195-3; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1996, DEVELOPMENT, V122, P2719; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; HING HK, 1994, MECH DEVELOP, V47, P261, DOI 10.1016/0925-4773(94)90044-2; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong SH, 1998, MOL ENDOCRINOL, V12, P1161, DOI 10.1210/me.12.8.1161; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim MY, 2010, CELL DEATH DIFFER, V17, P1728, DOI 10.1038/cdd.2010.50; Kim MY, 2007, MOL CELL BIOL, V27, P6506, DOI 10.1128/MCB.01515-06; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Koyanagi M, 2007, CIRC RES, V101, P1139, DOI 10.1161/CIRCRESAHA.107.151381; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leimeister C, 2000, MECH DEVELOP, V98, P175, DOI 10.1016/S0925-4773(00)00459-7; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mamaeva OA, 2009, J CELL BIOCHEM, V106, P25, DOI 10.1002/jcb.21973; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Mo JS, 2007, MOL CELL BIOL, V27, P5565, DOI 10.1128/MCB.02372-06; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Struewing IT, 2007, EXP CELL RES, V313, P3526, DOI 10.1016/j.yexcr.2007.07.012; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zhou YY, 2001, MOL CELL BIOCHEM, V220, P1, DOI 10.1023/A:1011087910699	78	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36814	36829		10.1074/jbc.M112.356048	http://dx.doi.org/10.1074/jbc.M112.356048			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22888005	Green Published, hybrid			2022-12-25	WOS:000310588500018
J	Liu, YC; Zhu, X; Nakamura, A; Orlando, R; Soll, D; Whitman, WB				Liu, Yuchen; Zhu, Xiang; Nakamura, Akiyoshi; Orlando, Ron; Soell, Dieter; Whitman, William B.			Biosynthesis of 4-Thiouridine in tRNA in the Methanogenic Archaeon Methanococcus maripaludis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI TRANSFER-RNA; NEAR-ULTRAVIOLET LIGHT; IN-VITRO BIOSYNTHESIS; ESCHERICHIA-COLI; GROWTH DELAY; POSTTRANSCRIPTIONAL MODIFICATION; SALMONELLA-TYPHIMURIUM; LIQUID-CHROMATOGRAPHY; CYSTEINE DESULFURASE; THIAZOLE MOIETY	4-Thiouridine (s(4)U) is a conserved modified nucleotide at position 8 of bacterial and archaeal tRNAs and plays a role in protecting cells from near-UV killing. Escherichia coli employs the following two enzymes for its synthesis: the cysteine desulfurase IscS, which forms a Cys persulfide enzyme adduct from free Cys; and ThiI, which adenylates U8 and transfers sulfur from IscS to form s(4)U. The C-terminal rhodanese-like domain (RLD) of ThiI is responsible for the sulfurtransferase activity. The mechanism of s(4)U biosynthesis in archaea is not known as many archaea lack cysteine desulfurase and an RLD of the putative ThiI. Using the methanogenic archaeon Methanococcus maripaludis, we show that deletion of ThiI (MMP1354) abolished the biosynthesis of s(4)U but not of thiamine. MMP1354 complements an Escherichia coli Delta thiI mutant for s(4)U formation, indicating that MMP1354 is sufficient for sulfur incorporation into s(4)U. In the absence of an RLD, MMP1354 uses Cys(265) and Cys(268) located in the PP-loop pyrophosphatase domain to generate persulfide and disulfide intermediates for sulfur transfer. In vitro assays suggest that S2- is a physiologically relevant sulfur donor for s(4)U formation catalyzed by MMP1354 (K-m for Na2S is similar to 1mM). Thus, methanogenic archaea developed a strategy for sulfur incorporation into s(4)U that differs from bacteria; this may be an adaptation to life in sulfide-rich environments.	[Liu, Yuchen; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Liu, Yuchen; Nakamura, Akiyoshi; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Chem, Athens, GA 30602 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	University System of Georgia; University of Georgia; Yale University; University System of Georgia; University of Georgia; Yale University	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	whitman@uga.edu	Nakamura, Akiyoshi/L-4928-2016; Whitman, William/AAC-5896-2020	Nakamura, Akiyoshi/0000-0003-2828-3033; Liu, Yuchen/0000-0003-0842-5882; Whitman, William/0000-0003-1229-0423	National Institutes of Health [GM22854, P41-RR-018502]; Department of Energy Office of Basic Energy Sciences [DE-FG02-05ER15709, DE-FG02-98ER20311]; University of Georgia Graduate School; Japan Society for the Promotion of Science; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022854, R01GM022854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); University of Georgia Graduate School; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM22854 (to D. S.) and P41-RR-018502 (to R. O.). This work was also supported by Department of Energy Office of Basic Energy Sciences Grants DE-FG02-05ER15709 (to W. W.) and DE-FG02-98ER20311.; Recipient of a doctoral dissertation completion award from the University of Georgia Graduate School.; Recipient of a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science.	ABRELL JW, 1971, J BIOL CHEM, V246, P294; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bender RA, 2011, J BACTERIOL, V193, P4574, DOI 10.1128/JB.05666-11; BEST AN, 1978, J BACTERIOL, V133, P240, DOI 10.1128/JB.133.1.240-250.1978; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; CARRE DS, 1974, BIOCHIMIE, V56, P1089, DOI 10.1016/S0300-9084(74)80097-0; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; EMILSSON V, 1992, NUCLEIC ACIDS RES, V20, P4499, DOI 10.1093/nar/20.17.4499; FAVRE A, 1969, BIOCHEM BIOPH RES CO, V37, P266, DOI 10.1016/0006-291X(69)90729-3; FAVRE A, 1971, J MOL BIOL, V58, P367, DOI 10.1016/0022-2836(71)90252-X; FAVRE A, 1985, BIOCHIMIE, V67, P335, DOI 10.1016/S0300-9084(85)80076-6; GERNHARDT P, 1990, MOL GEN GENET, V221, P273, DOI 10.1007/BF00261731; Gupta R., 1995, P119; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kambampati R, 1999, BIOCHEMISTRY-US, V38, P16561, DOI 10.1021/bi991119r; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KRAMER GF, 1988, J BACTERIOL, V170, P2344, DOI 10.1128/jb.170.5.2344-2351.1988; Lauhon CT, 2004, J BIOL CHEM, V279, P23022, DOI 10.1074/jbc.M401757200; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; LEIGH JA, 1983, APPL ENVIRON MICROB, V45, P800, DOI 10.1128/AEM.45.3.800-803.1983; Lin W, 2004, ARCH MICROBIOL, V181, P68, DOI 10.1007/s00203-003-0629-1; LIPSETT MN, 1978, J BACTERIOL, V135, P993, DOI 10.1128/JB.135.3.993-997.1978; Liu Y., 2012, ENVIRON MICROBIOL, V194, P4933; Liu YC, 2012, TRENDS MICROBIOL, V20, P251, DOI 10.1016/j.tim.2012.02.002; Liu YC, 2012, J BIOL CHEM, V287, P5426, DOI 10.1074/jbc.M111.313700; Liu YC, 2010, J BIOL CHEM, V285, P31923, DOI 10.1074/jbc.M110.152447; Martinez-Gomez NC, 2011, J BACTERIOL, V193, P4582, DOI 10.1128/JB.05325-11; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Mihara H, 2002, P NATL ACAD SCI USA, V99, P6679, DOI 10.1073/pnas.102176099; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; Mueller EG, 1998, NUCLEIC ACIDS RES, V26, P2606, DOI 10.1093/nar/26.11.2606; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Nilsson K, 2002, J BACTERIOL, V184, P6830, DOI 10.1128/JB.184.24.6830-6835.2002; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Phillips G, 2011, CURR OPIN MICROBIOL, V14, P335, DOI 10.1016/j.mib.2011.03.001; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Rajakovich L. J., 2012, J BACTERIOL; RAMABHADRAN TV, 1976, P NATL ACAD SCI USA, V73, P59, DOI 10.1073/pnas.73.1.59; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka Y, 2009, RNA, V15, P1498, DOI 10.1261/rna.1614709; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; THOMAS G, 1980, EUR J BIOCHEM, V113, P67; THOMAS G, 1975, BIOCHEM BIOPH RES CO, V66, P1454, DOI 10.1016/0006-291X(75)90522-7; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; Waterman DG, 2006, J MOL BIOL, V356, P97, DOI 10.1016/j.jmb.2005.11.013; Webb E, 1997, J BACTERIOL, V179, P4399, DOI 10.1128/jb.179.13.4399-4402.1997; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c; Wright CM, 2002, CHEM COMMUN, P2708, DOI 10.1039/b208626c; You DL, 2008, CHEMBIOCHEM, V9, P1879, DOI 10.1002/cbic.200800033; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	65	40	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36683	36692		10.1074/jbc.M112.405688	http://dx.doi.org/10.1074/jbc.M112.405688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22904325	Green Published, hybrid			2022-12-25	WOS:000310588500006
J	Tan, KW; Ong, TC; Gao, YF; Tiong, YS; Wong, KN; Chew, FT; Mok, YK				Tan, Kang Wei; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Mok, Yu Keung			NMR Structure and IgE Epitopes of Blo t 21, a Major Dust Mite Allergen from Blomia tropicalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTIVITY; CHEMICAL-SHIFT; P 5; IDENTIFICATION; RESONANCE; SYSTEM; C-13; RESTRAINTS; ASSIGNMENT; DATABASE	Blo t 21 is a paralogue of the group 5 allergen, Blo t 5, a major allergen from the dust mite Blomia tropicalis. Blo t 21 has moderate sequence identity (40.7%) to Blo t 5 and low to moderate cross-reactivity to Blo t 5. In B. tropicalis, the most prevalent and allergenic allergens are in the order of Blo t 21, Blo t 5, and Blo t 7. Here, we determined the NMR solution structure of Blo t 21, which represents the first structure of the group 21 dust mite allergen. The structure of Blo t 21 closely resembles the structures of Blo t 5 and Der p 5, comprising three anti-parallel alpha-helices arranged in a helical bundle. Using site-directed mutagenesis and specific IgE binding ELISA, Blo t 21 was found to contain both conserved and unique charged IgE epitope residues at the L2 loop region and on helix alpha 3. Cross-inhibition assays confirmed that Blo t 21 has a low to moderate cross-reactivity with Blo t 5 and Der p 5 and represents a novel group of major allergen in B. tropicalis. In addition to group 5 allergens, Blo t 21 has also a low to moderate cross-reactivity with group 21 allergens from Dermatophagoides mites, confirming that B. tropicalis is a major and distinct source of dust mite allergens.	[Tan, Kang Wei; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore	National University of Singapore	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Chew, Fook Tim/E-7259-2010; Mok, Yu Keung/H-8019-2012	Chew, Fook Tim/0000-0003-1337-5146; Mok, Yu Keung/0000-0002-2829-4878	Biomedical Research Council [04/1/21/19/315]; National Medical Research Council of Singapore [NMRC/1150/2008]; Ministry of Education [MOE 2011-T2-2-002]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Ministry of Education	This work was supported by Biomedical Research Council Grant 04/1/21/19/315, National Medical Research Council of Singapore Grant NMRC/1150/2008, and Ministry of Education Tier 2 Grant MOE 2011-T2-2-002.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caraballo L, 1998, INT ARCH ALLERGY IMM, V117, P38, DOI 10.1159/000023988; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Cheong N, 2003, ALLERGY, V58, P912, DOI 10.1034/j.1398-9995.2003.00215.x; Chew FT, 1999, ALLERGY, V54, P1150, DOI 10.1034/j.1398-9995.1999.00050.x; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Chua KY, 2007, PROTEIN PEPTIDE LETT, V14, P325; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W, 2002, PYMOL 0 99; Gao YF, 2007, J ALLERGY CLIN IMMUN, V120, P105, DOI 10.1016/j.jaci.2007.02.032; Goddard T. D., 2008, SPARKY 3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mueller GA, 2010, J BIOL CHEM, V285, P25394, DOI 10.1074/jbc.M110.128306; Naik MT, 2008, STRUCTURE, V16, P125, DOI 10.1016/j.str.2007.10.022; Naik MT, 2007, J BIOMOL NMR, V38, P189, DOI 10.1007/s10858-006-9113-y; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robaina JCG, 2003, INT ARCH ALLERGY IMM, V131, P182, DOI 10.1159/000071484; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Tsai WJ, 2003, J IMMUNOL METHODS, V276, P163, DOI 10.1016/S0022-1759(03)00105-4; Weghofer M, 2008, ALLERGY, V63, P758, DOI 10.1111/j.1398-9995.2008.01647.x; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yi Fong Cheng, 2006, Inflammation & Allergy Drug Targets, V5, P261	34	29	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34776	34785		10.1074/jbc.M112.348730	http://dx.doi.org/10.1074/jbc.M112.348730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22887997	Green Published, hybrid			2022-12-25	WOS:000309654200077
J	Ruan, XS; Crupper, SS; Schultz, BD; Robertson, DC; Zhang, WP				Ruan, Xiaosai; Crupper, Scott S.; Schultz, Bruce D.; Robertson, Donald C.; Zhang, Weiping			Escherichia coli Expressing EAST1 Toxin Did Not Cause an Increase of cAMP or cGMP Levels in Cells, and No Diarrhea in 5-Day Old Gnotobiotic Pigs	PLOS ONE			English	Article							HEAT-STABLE ENTEROTOXIN; VIRULENCE GENES; POSTWEANING DIARRHEA; LABILE ENTEROTOXIN; EDEMA DISEASE; BRUSH-BORDERS; WEANED PIGS; YOUNG-PIGS; OSAKA CITY; PREVALENCE	Background: Enterotoxigenic Escherichia coli (ETEC) strains are the leading bacterial cause of diarrhea to humans and farm animals. These ETEC strains produce heat-labile toxin (LT) and/or heat-stable toxins that include type I (STa), type II (STb), and enteroaggregative heat-stable toxin 1 (EAST1). LT, STa, and STb (in pigs) are proven the virulence determinants in ETEC diarrhea. However, significance of EAST1 in ETEC-associated diarrheal has not been determined, even though EAST1 is highly prevalent among ETEC strains. Methodology/Principal Findings: In this study, we constructed E. coli strains to express EAST1 toxin as the only toxin and studied them in cell lines and five-day old gnotobiotic piglets to determine significance of EAST1 toxin. Data from in vitro studies indicated that EAST1 did not stimulate an increase of intracellular cyclic AMP or GMP levels in T-84 cells or porcine cell line IPEC-J2, nor did it enhance LT or STa toxin of ETEC strains in stimulation of cAMP or cGMP in T-84 cells. In addition, 5-day old gnotobiotic pigs challenged with E. coli strains expressing EAST1 as the only toxin did not developed diarrhea or signs of clinical disease during 72 h post-inoculation. Conclusion/Significance: Results from this study indicated that EAST1 alone is not sufficient to cause diarrhea in five-day old gnotobiotic pigs, and suggest that EAST1 likely is not a virulence determinant in ETEC-associated diarrhea.	[Ruan, Xiaosai; Zhang, Weiping] S Dakota State Univ, Vet & Biomed Sci Dept, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA; [Crupper, Scott S.] Emporia State Univ, Dept Biol Sci, Emporia, KS 66801 USA; [Schultz, Bruce D.; Robertson, Donald C.] Kansas State Univ, Sch Vet Med, Manhattan, KS 66506 USA	South Dakota State University; Kansas State University	Ruan, XS (corresponding author), S Dakota State Univ, Vet & Biomed Sci Dept, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA.	weiping.zhang@sdstate.edu	Schultz, Bruce/F-8854-2013		National Institutes of Health [AI076871-01]; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI076871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by National Institutes of Health AI076871-01 (WZ) and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; BHAN MK, 1989, J INFECT DIS, V159, P1061, DOI 10.1093/infdis/159.6.1061; BIJLSMA IGW, 1982, INFECT IMMUN, V37, P891, DOI 10.1128/IAI.37.3.891-894.1982; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Choi C, 2001, J VET DIAGN INVEST, V13, P26, DOI 10.1177/104063870101300106; Choi C, 2001, VET MICROBIOL, V81, P65, DOI 10.1016/S0378-1135(01)00332-7; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; DOUGAN G, 1986, INFECT IMMUN, V52, P344, DOI 10.1128/IAI.52.1.344-347.1986; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; FRANCIS DH, 1991, AM J VET RES, V52, P1051; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Fujihara S, 2009, JPN J INFECT DIS, V62, P318; Gascon J, 1998, J INFECT DIS, V177, P1409, DOI 10.1086/517826; Gascon J, 2000, J CLIN MICROBIOL, V38, P4459; Greenberg DE, 2002, J INFECT DIS, V185, P944, DOI 10.1086/339617; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; HOWELL A, 1987, CANCER RES, V47, P296; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; KUNG M, 1980, CLIN RES PROC, V16, P429; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Ngeleka M, 2003, J VET DIAGN INVEST, V15, P242, DOI 10.1177/104063870301500305; Nishikawa Y, 1999, EMERG INFECT DIS, V5, P300, DOI 10.3201/eid0502.990220; Nishikawa Y, 2000, J CLIN MICROBIOL, V38, P2440; Noamani BN, 2003, VET MICROBIOL, V97, P87, DOI 10.1016/j.vetmic.2003.08.006; Osek J, 2003, VET MICROBIOL, V91, P65, DOI 10.1016/S0378-1135(02)00262-6; Piva IC, 2003, J CLIN MICROBIOL, V41, P1827, DOI 10.1128/JCM.41.5.1827-1832.2003; SACKETT DL, 1980, CAN J PUBLIC HEALTH, V71, P225; Savarino SJ, 1996, J INFECT DIS, V173, P1019, DOI 10.1093/infdis/173.4.1019; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; SELLWOOD R, 1975, J MED MICROBIOL, V8, P405, DOI 10.1099/00222615-8-3-405; SOM P, 1980, J NUCL MED, V21, P670; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; TZIPORI S, 1983, AM J TROP MED HYG, V32, P931, DOI 10.4269/ajtmh.1983.32.931; TZIPORI S, 1992, INFECT IMMUN, V60, P5302, DOI 10.1128/IAI.60.12.5302-5306.1992; USDA, 2002, USDA APHIS VS CEAH 2; Veilleux S, 2006, VET RES, V37, P3, DOI 10.1051/vetres:2005045; Veilleux S, 2008, COMP IMMUNOL MICROB, V31, P567, DOI 10.1016/j.cimid.2007.10.003; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Yamamoto T, 1997, FEMS MICROBIOL LETT, V147, P89, DOI 10.1016/S0378-1097(96)00509-5; Yamamoto T, 1997, J CLIN MICROBIOL, V35, P223, DOI 10.1128/JCM.35.1.223-227.1997; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Yamamoto T, 2000, FEBS LETT, V472, P22, DOI 10.1016/S0014-5793(00)01414-9; Zhang CX, 2010, CLIN VACCINE IMMUNOL, V17, P1859, DOI 10.1128/CVI.00251-10; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09	53	16	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43203	10.1371/journal.pone.0043203	http://dx.doi.org/10.1371/journal.pone.0043203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905235	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600059
J	Fernandez-Sanchez, L; Lax, P; Esquiva, G; Martin-Nieto, J; Pinilla, I; Cuenca, N				Fernandez-Sanchez, Laura; Lax, Pedro; Esquiva, Gema; Martin-Nieto, Jose; Pinilla, Isabel; Cuenca, Nicolas			Safranal, a Saffron Constituent, Attenuates Retinal Degeneration in P23H Rats	PLOS ONE			English	Article							CROCUS-SATIVUS L.; DOMINANT RETINITIS-PIGMENTOSA; PHOTORECEPTOR CELL-DEATH; INDUCED OXIDATIVE DAMAGE; ISCHEMIA-REPERFUSION; ACTIVE CONSTITUENTS; TRANSGENIC RAT; RHODOPSIN GENE; ANIMAL-MODEL; DNA-DAMAGE	Saffron, an extract from Crocus sativus, has been largely used in traditional medicine for its antiapoptotic and anticarcinogenic properties. In this work, we investigate the effects of safranal, a component of saffron stigmas, in attenuating retinal degeneration in the P23H rat model of autosomal dominant retinitis pigmentosa. We demonstrate that administration of safranal to homozygous P23H line-3 rats preserves both photoreceptor morphology and number. Electroretinographic recordings showed higher a- and b-wave amplitudes under both photopic and scotopic conditions in safranal-treated versus non-treated animals. Furthermore, the capillary network in safranal-treated animals was preserved, unlike that found in untreated animals. Our findings indicate that dietary supplementation with safranal slows photoreceptor cell degeneration and ameliorates the loss of retinal function and vascular network disruption in P23H rats. This work also suggests that safranal could be potentially useful to retard retinal degeneration in patients with retinitis pigmentosa.	[Fernandez-Sanchez, Laura; Lax, Pedro; Esquiva, Gema; Martin-Nieto, Jose; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Pinilla, Isabel] Univ Hosp Lozano Blesa, Dept Ophthalmol, Zaragoza, Spain	Universitat d'Alacant; Lozano Blesa University Clinical Hospital	Fernandez-Sanchez, L (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain.	cuenca@ua.es	MARTÍN-NIETO, JOSÉ/R-5428-2018; Esquiva, Gema/ABA-6317-2020; Cuenca, Nicolas/I-2007-2015; Fernandez-Sanchez, Laura/AAB-5663-2019; Lax, Pedro/M-9074-2014; Esquiva, Gema/AAE-5642-2020	MARTÍN-NIETO, JOSÉ/0000-0002-7815-6887; Cuenca, Nicolas/0000-0002-6767-5710; Fernandez-Sanchez, Laura/0000-0002-3629-0156; Lax, Pedro/0000-0001-6931-1008; Esquiva, Gema/0000-0002-3951-6464; Pinilla, Isabel/0000-0003-0349-9997	Spanish Government [BFU2009-07793/BFI, RETICS RD07/0062/0012]; Organizacion Nacional de Ciegos de Espana (ONCE); Fundacion Lucha contra la Ceguera (FUNDALUCE); Fundacion Medica Mutua Madrilena	Spanish Government(Spanish GovernmentEuropean Commission); Organizacion Nacional de Ciegos de Espana (ONCE); Fundacion Lucha contra la Ceguera (FUNDALUCE); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III)	This research was supported by grants from the Spanish Government (BFU2009-07793/BFI and RETICS RD07/0062/0012), Organizacion Nacional de Ciegos de Espana (ONCE), Fundacion Lucha contra la Ceguera (FUNDALUCE) and Fundacion Medica Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev FI, 2004, CANCER DETECT PREV, V28, P426, DOI 10.1016/j.cdp.2004.09.002; Abdullaev FI, 2002, EXP BIOL MED, V227, P20, DOI 10.1177/153537020222700104; Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749; Basti AA, 2007, PROG NEURO-PSYCHOPH, V31, P439, DOI 10.1016/j.pnpbp.2006.11.010; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Beutelspacher SC, 2011, GRAEF ARCH CLIN EXP, V249, P1855, DOI 10.1007/s00417-011-1757-y; Bharti S, 2011, EUR J NUTR; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Escribano J, 2000, PLANTA MED, V66, P157, DOI 10.1055/s-2000-11127; Escribano J, 1996, CANCER LETT, V100, P23, DOI 10.1016/0304-3835(95)04067-6; Falsini B, 2010, INVEST OPHTH VIS SCI, V51, P6118, DOI 10.1167/iovs.09-4995; Fatehi M, 2003, J ETHNOPHARMACOL, V84, P199, DOI 10.1016/S0378-8741(02)00299-4; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Garcia-Ayuso D, 2010, EXP EYE RES; Hariri AT, 2011, PHYTOMEDICINE, V18, P499, DOI 10.1016/j.phymed.2010.10.001; Haverkamp S, 2000, CELL TISSUE RES, V302, P11, DOI 10.1007/s004410000267; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P394; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P387; Hosseinzadeh H, 2005, FITOTERAPIA, V76, P722, DOI 10.1016/j.fitote.2005.07.008; Hosseinzadeh H, 2011, PHYTOTHER RES; Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767; Hosseinzadeh H, 2007, DNA CELL BIOL, V26, P841, DOI 10.1089/dna.2007.0631; Hosseinzadeh Hossein, 2002, BMC Pharmacol, V2, P7; Hosseinzadeh H, 2009, EVID-BASED COMPL ALT, V6, P343, DOI 10.1093/ecam/nem125; Hosseinzadeh H, 2009, PHYTOTHER RES, V23, P768, DOI 10.1002/ptr.2597; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Imenshahidi M, 2010, PHYTOTHER RES, V24, P990, DOI 10.1002/ptr.3044; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kanakis CD, 2009, J PHOTOCH PHOTOBIO B, V95, P204, DOI 10.1016/j.jphotobiol.2009.03.006; Kanakis CD, 2007, DNA CELL BIOL, V26, P63, DOI 10.1089/dna.2006.0529; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Karimi E, 2010, MOLECULES, V15, P6244, DOI 10.3390/molecules15096244; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Laabich A, 2006, INVEST OPHTH VIS SCI, V47, P3156, DOI 10.1167/iovs.05-1621; Lax P, 2011, J PINEAL RES, V50, P183, DOI 10.1111/j.1600-079X.2010.00827.x; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mehri S, 2012, CELL MOL NEUROBIOL, V32, P227, DOI 10.1007/s10571-011-9752-8; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; Moghaddasi MS, 2010, J MED PLANTS RES, V4, P427; Ochiai T, 2007, BBA-GEN SUBJECTS, V1770, P578, DOI 10.1016/j.bbagen.2006.11.012; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Penn JS, 2000, INVEST OPHTH VIS SCI, V41, P4007; Pinilla I, 2005, NEUROSCI LETT, V382, P16, DOI 10.1016/j.neulet.2005.02.055; Pinilla I, 2009, VISION RES, V49, P2067, DOI 10.1016/j.visres.2009.05.014; Pinilla I, 2007, EXP EYE RES, V85, P381, DOI 10.1016/j.exer.2007.06.002; Pitsikas N, 2008, PHYTOMEDICINE, V15, P1135, DOI 10.1016/j.phymed.2008.06.005; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Soeda S, 2001, LIFE SCI, V69, P2887, DOI 10.1016/S0024-3205(01)01357-1	57	67	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43074	10.1371/journal.pone.0043074	http://dx.doi.org/10.1371/journal.pone.0043074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900092	Green Published, gold			2022-12-25	WOS:000307380900110
J	McMullan, M; van Oosterhout, C				McMullan, Mark; van Oosterhout, Cock			Inference of Selection Based on Temporal Genetic Differentiation in the Study of Highly Polymorphic Multigene Families	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-IIB; FREQUENCY-DEPENDENT SELECTION; BALANCING SELECTION; ALLELE FREQUENCIES; WILD POPULATIONS; WATER VOLE; DIVERSITY; PATHOGENS; GUPPIES	The co-evolutionary arms race between host immune genes and parasite virulence genes is known as Red Queen dynamics. Temporal fluctuations in allele frequencies, or the 'turnover' of alleles at immune genes, are concordant with predictions of the Red Queen hypothesis. Such observations are often taken as evidence of host-parasite co-evolution. Here, we use computer simulations of the Major Histocompatibility Complex (MHC) of guppies (Poecilia reticulata) to study the turnover rate of alleles (temporal genetic differentiation, G'(ST)). Temporal fluctuations in MHC allele frequencies can be >=<= order of magnitude larger than changes observed at neutral loci. Although such large fluctuations in the MHC are consistent with Red Queen dynamics, simulations show that other demographic and population genetic processes can account for this observation, these include: (1) overdominant selection, (2) fluctuating population size within a metapopulation, and (3) the number of novel MHC alleles introduced by immigrants when there are multiple duplicated genes. Synergy between these forces combined with migration rate and the effective population size can drive the rapid turnover in MHC alleles. We posit that rapid allelic turnover is an inherent property of highly polymorphic multigene families and that it cannot be taken as evidence of Red Queen dynamics. Furthermore, combining temporal samples in spatial F-ST outlier analysis may obscure the signal of selection.	[McMullan, Mark; van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	McMullan, M (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	M.Mcmullan@uea.ac.uk		McMullan, Mark/0000-0002-0711-5666; van Oosterhout, Cock/0000-0002-5653-738X	Natural Environment Research Council [NE/E529241/1]; Earth and Life Systems Alliance (ELSA)	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Earth and Life Systems Alliance (ELSA)	Financial support was provided by a Natural Environment Research Council (http://www.nerc.ac.uk/) studentship to MM (NE/E529241/1) and the Earth and Life Systems Alliance (ELSA, http://www.elsa.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI [10.1139/f02-066, 10.1139/F02-066]; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bell G., 1982, MASTERPIECE NATURE E; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bryja J, 2007, MOL ECOL, V16, P5084, DOI 10.1111/j.1365-294X.2007.03584.x; Campos JL, 2010, MAMM BIOL, V76, P251; Charbonnel N, 2005, HEREDITY, V95, P377, DOI 10.1038/sj.hdy.6800735; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Ejsmond MJ, 2011, CONSERV GENET, V12, P129, DOI 10.1007/s10592-009-9998-6; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Fraser BA, 2009, J FISH BIOL, V75, P2299, DOI 10.1111/j.1095-8649.2009.02449.x; Fraser BA, 2010, EVOLUTION, V64, P2086, DOI 10.1111/j.1558-5646.2010.00965.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jensen LF, 2008, HEREDITY, V100, P79, DOI 10.1038/sj.hdy.6801067; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; KOJIMA KI, 1971, EVOLUTION, V25, P281, DOI [10.2307/2406919, 10.1111/j.1558-5646.1971.tb01881.x]; Llaurens V, 2012, MOL BIOL EVOL, V29, P1631, DOI 10.1093/molbev/mss012; Llaurens V, 2008, EVOLUTION, V62, P2545, DOI 10.1111/j.1558-5646.2008.00469.x; McMullan M, 2011, THESIS U HULL; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Muirhead CA, 2001, EVOLUTION, V55, P1532; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Schierup MH, 1998, GENETICS, V149, P1153; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stoeckel S, 2012, EVOLUTION, V66, P486, DOI 10.1111/j.1558-5646.2011.01457.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; van Oers K, 2010, J ORNITHOL, V151, P69, DOI 10.1007/s10336-009-0427-x; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; Westerdahl H, 2004, J EVOLUTION BIOL, V17, P485, DOI 10.1111/j.1420-9101.2004.00711.x; Westerdahl H, 2011, P ROYAL SOC B; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	54	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42119	10.1371/journal.pone.0042119	http://dx.doi.org/10.1371/journal.pone.0042119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900006	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000307380900021
J	Moffatt, S; Noble, E; White, M				Moffatt, Suzanne; Noble, Emma; White, Martin			Addressing the Financial Consequences of Cancer: Qualitative Evaluation of a Welfare Rights Advice Service	PLOS ONE			English	Article							OLDER; CARE; PERCEPTIONS; DISABILITY; BENEFITS; HEALTH; BREAST; LUNG	Background: The onset, treatment and trajectory of cancer is associated with financial stress among patients across a range of health and welfare systems and has been identified as a significant unmet need. Welfare rights advice can be delivered effectively in healthcare settings, has the potential to alleviate financial stress, but has not yet been evaluated. We present an evaluation of a welfare rights advice intervention designed to address the financial consequences of cancer. Methods: Descriptive study of welfare outcomes among 533 male and 641 female cancer patients and carers aged 4-95 (mean 62) years, who accessed the welfare rights advice service in North East England between April 2009 and March 2010; and qualitative interview study of a maximum variation sample of 35 patients and 9 carers. Results: Over two thirds of cancer patients and carers came from areas of high socio-economic deprivation. Welfare benefit claims were successful for 96% of claims made and resulted in a median increase in weekly income of 70.30 pound ($109.74, (sic)84.44). Thirty-four different types of benefits or grants were awarded. Additional resources were perceived to lessen the impact of lost earnings, help offset costs associated with cancer, reduce stress and anxiety and increase ability to maintain independence and capacity to engage in daily activities, all of which were perceived to impact positively on well-being and quality of life. Key barriers to accessing benefit entitlements were knowledge, system complexity, eligibility concerns and assumptions that health professionals would alert patients to entitlements. Conclusions: The intervention proved feasible, effectively increased income for cancer patients and was highly valued. Addressing the financial sequelae of cancer can have positive social and psychological consequences that could significantly enhance effective clinical management and suitable services should be routinely available. Further research is needed to evaluate health outcomes definitely and assess cost-effectiveness.	[Moffatt, Suzanne; Noble, Emma; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Moffatt, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	suzanne.moffatt@ncl.ac.uk		Moffatt, Suzanne/0000-0002-8553-249X; White, Martin/0000-0002-1861-6757	Macmillan Cancer Support; MRC [G0900686] Funding Source: UKRI; Medical Research Council [G0900686] Funding Source: researchfish	Macmillan Cancer Support; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Macmillan Cancer Support funded this study. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acheson D., 1998, INDEPENDENT INQUIRY; Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-81; [Anonymous], 2010, MARMOT REV; [Anonymous], 2007, INDICES DEPRIVATION; [Anonymous], 2009, STAT PACKAGE SOCIAL; Arber S., 1995, CONNECTING GENDER AG; Argyle E, 2001, DISABIL SOC, V16, P585, DOI 10.1080/09687590120059559; Association of Public Health Observatories and Department of Health, 2009, HLTH SUMM COUNT DURH; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Brennan Shannon, 2011, JURISTATE B, P1; Chapple A, 2004, BRIT J GEN PRACT, V54, P589; Clayman SE, 1995, SITUATED ORDER STUDI, P1; Cook K, 2010, HEALTH SERV RES, V45, P418, DOI 10.1111/j.1475-6773.2009.01049.x; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Denzin N., 1978, RES ACT, V2nd; Eikemo TA, 2008, J EPIDEMIOL COMMUN H, V62, P3, DOI 10.1136/jech.2007.066787; Francoeur RB, 2001, J PSYCHOSOC ONCOL, V19, P1, DOI 10.1300/J077v19n01_01; Francoeur RB, 2007, PATIENT EDUC COUNS, V69, P84, DOI 10.1016/j.pec.2007.07.005; Fraser of Allander Institute, 2003, IMP WELF SPEND GLASG; Glaser B, 1978, DISCOV GROUNDED THEO; Green J, 2009, QUALITATIVE METHODS; Hanratty B, 2007, PALLIATIVE MED, V21, P595, DOI 10.1177/0269216307082476; Himmelstein D.U., 2005, HLTH AFF, V24, pW5, DOI 10.1377/hlthaff.W5.63; Kogevinas M, 1997, IARC Sci Publ, P177; Lauzier S, 2008, J NATL CANCER I, V100, P321, DOI 10.1093/jnci/djn028; Macmillan Cancer Relief, 2004, UNCL MILL; Mayer DK, 2009, CLIN J ONCOL NURS, V13, P255, DOI 10.1188/09.CJON.255-256; McKee M, 2011, BMJ, P343; Men's Health Forum, 2009, CHALL CHOIC IMPR HLT; Moffatt S, 2008, AGEING SOC, V28, P875, DOI 10.1017/S0144686X08007253; Moffatt S, 2009, ETHNIC HEALTH, V14, P5, DOI 10.1080/13557850802056455; National Audit Office, 2005, DEP WORK PENS DEAL C; National Cancer Action Team, 2007, HOL COMM ASS SUPP PA; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR P; National League Against Cancer, 2021, PAT RESS CANC EXP PA; Northern and Yorkshire Cancer Registry and Information Service, 2008, COUNT DURH PCT FACTS; Nosowska G, 2004, HEALTH SOC CARE COMM, V12, P283, DOI 10.1111/j.1365-2524.2004.00496.x; PARIS JAG, 1993, BRIT MED J, V306, P1518, DOI 10.1136/bmj.306.6891.1518; Pearce S, 1999, J ADV NURS, V33, P317; QSR International, 2007, NVIVO 7 COMP ASS SOF; Quinn MJ, 2001, STUDIES MED POPULATI; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rosengren A, 2004, EUR J EPIDEMIOL, V19, P533, DOI 10.1023/B:EJEP.0000032370.56821.71; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; Silverman D., 2017, DOING QUALITATIVE RE; Singh GK, 2003, 035417 NAT CANC I; Smith AE, 2004, AGEING SOC, V24, P793, DOI 10.1017/S0144686X04002569; Soothill K, 2001, SUPPORT CARE CANCER, V9, P597, DOI 10.1007/s005200100278; Syse Astri, 2008, J Cancer Surviv, V2, P149, DOI 10.1007/s11764-008-0053-2; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; Wilson K, 2008, PSYCHO-ONCOLOGY, V17, P421, DOI 10.1002/pon.1265; Wintour P, 2011, GUARDIAN, P1; Wright EP, 2002, BRIT J CANCER, V87, P1099, DOI 10.1038/sj.bjc.6600642	55	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42979	10.1371/journal.pone.0042979	http://dx.doi.org/10.1371/journal.pone.0042979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986XO	22900073	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900091
J	Schumacher, A; Wafula, PO; Teles, A; El-Mousleh, T; Linzke, N; Zenclussen, ML; Langwisch, S; Heinze, K; Wollenberg, I; Casalis, PA; Volk, HD; Fest, S; Zenclussen, AC				Schumacher, Anne; Wafula, Paul Ojiambo; Teles, Ana; El-Mousleh, Tarek; Linzke, Nadja; Zenclussen, Maria Laura; Langwisch, Stefanie; Heinze, Kristina; Wollenberg, Ivonne; Casalis, Pablo Ariel; Volk, Hans-Dieter; Fest, Stefan; Zenclussen, Ana Claudia			Blockage of Heme Oxygenase-1 Abrogates the Protective Effect of Regulatory T Cells on Murine Pregnancy and Promotes the Maturation of Dendritic Cells	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; ALLOGENEIC PREGNANCY; SPONTANEOUS-ABORTION; ZINC-PROTOPORPHYRIN; PATERNAL ANTIGENS; FETAL REJECTION; CARBON-MONOXIDE; EXPRESSION; TOLERANCE; SUPPRESSION	Regulatory T cells (Treg) play an important role in fetal protection. They expand during normal pregnancy and protect fetal antigens from maternal effector cells. Their effect is associated with the up-regulation of tolerance-associated molecules at the fetal-maternal interface. Among these, Heme Oxygenase-1 (HO-1, coded by Hmox1) is of special importance as its blockage correlates with increased abortion rates and its up-regulation positively affects pregnancy outcome. Here, we aimed to investigate whether the protective effect of Treg is mediated by HO-1 in a mouse model. HO-1 blockage by Zinc Protoporhyrin (ZnPPIX) abrogated the protective effect of Treg transfer. We found that HO-1 is important in maintaining maternal dendritic cells (DCs) in an immature state, which contributes to the expansion of the peripheral Treg population. This brings to light one essential pathway through which Treg mediates the semi-allogeneic fetus tolerance.	[Schumacher, Anne; Teles, Ana; El-Mousleh, Tarek; Linzke, Nadja; Zenclussen, Maria Laura; Langwisch, Stefanie; Heinze, Kristina; Zenclussen, Ana Claudia] Univ Magdeburg, Dept Expt Obstet & Gynaecol, Fac Med, D-39106 Magdeburg, Germany; [Wafula, Paul Ojiambo; Wollenberg, Ivonne; Casalis, Pablo Ariel; Volk, Hans-Dieter; Zenclussen, Ana Claudia] Med Univ Berlin, Inst Med Immunol, Charite, Berlin, Germany; [Fest, Stefan] Univ Klinikum Leipzig, Leipzig, Germany	Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Schumacher, A (corresponding author), Univ Magdeburg, Dept Expt Obstet & Gynaecol, Fac Med, D-39106 Magdeburg, Germany.	ana.zenclussen@med.ovgu.de	Schumacher, Anne/AAG-6028-2021; Zenclussen, Ana/AAE-8760-2020; volk, hans-dieter/AAV-8053-2021; Zenclussen, Ana C/G-2186-2013	Zenclussen, Ana/0000-0003-3544-4552; volk, hans-dieter/0000-0002-7743-6668; Zenclussen, Ana C/0000-0003-3544-4552; Zenclussen, Maria Laura/0000-0003-2728-080X	German Research Association [DFG ZE-526/4-1, 526/5-1, DFG FE 914/2-1]; German Academic Exchange Program (DAAD); FCT foundation, Portugal	German Research Association(German Research Foundation (DFG)); German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); FCT foundation, Portugal	The present study was supported by grants from the German Research Association to ACZ (DFG ZE-526/4-1 and 526/5-1) and to SF (DFG FE 914/2-1). POW was funded by a PhD grant from the German Academic Exchange Program (DAAD) and Ana Teles is a grantee from the FCT foundation, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Biburger M, 2010, J LEUKOCYTE BIOL, V87, P192, DOI 10.1189/jlb.0508280; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Braudeau C, 2004, GENE THER, V11, P701, DOI 10.1038/sj.gt.3302208; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chaouat G, 2001, AM J REPROD IMMUNOL, V45, P108, DOI 10.1111/j.8755-8920.2001.450208.x; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; CLARK DA, 1980, CELL IMMUNOL, V52, P106, DOI 10.1016/0008-8749(80)90404-9; COULAM CB, 1991, AM J REPROD IMMUNOL, V26, P23, DOI 10.1111/j.1600-0897.1991.tb00697.x; Critchley WR, 2012, IMMUNOLOGY, V136, P123, DOI 10.1111/j.1365-2567.2012.03560.x; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Denschlag D, 2004, MOL HUM REPROD, V10, P211, DOI 10.1093/molehr/gah024; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hu CM, 2007, DIABETES, V56, P1240, DOI 10.2337/db06-0495; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Inoue S, 2001, HUM GENE THER, V12, P967, DOI 10.1089/104303401750195926; Josien R, 1998, J CLIN INVEST, V102, P1920, DOI 10.1172/JCI4221; Katori M, 2002, TRANSPLANTATION, V73, P287, DOI 10.1097/00007890-200201270-00023; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Labbe RF, 1999, CLIN CHEM, V45, P2060; Leber A, 2011, METHODS MOL BIOL, V677, P397, DOI 10.1007/978-1-60761-869-0_25; LIN H, 1993, J IMMUNOL, V151, P4562; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyall F, 2000, FASEB J, V14, P208, DOI 10.1096/fasebj.14.1.208; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Makrigiannakis A, 2003, BIOCHEM PHARMACOL, V65, P917, DOI 10.1016/S0006-2952(02)01547-2; Martins PNA, 2005, TRANSPL P, V37, P384, DOI 10.1016/j.transproceed.2005.01.004; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Moreau A, 2009, FASEB J, V23, P3070, DOI 10.1096/fj.08-128173; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Robillard PY, 2002, J REPROD IMMUNOL, V53, P279, DOI 10.1016/S0165-0378(01)00081-X; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; SAINTEMARIE G, 1962, J HISTOCHEM CYTOCHEM, V10, P250, DOI 10.1177/10.3.250; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Schumacher A, 2007, OBSTET GYNECOL, V110, P1137, DOI 10.1097/01.AOG.0000284625.10175.31; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Shojaeian J, 2007, J REPROD IMMUNOL, V75, P23, DOI 10.1016/j.jri.2007.02.006; Soares MP, 1999, IMMUNOL TODAY, V20, P434, DOI 10.1016/S0167-5699(99)01530-3; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P1; Sollwedel A, 2005, J IMMUNOL, V175, P4875, DOI 10.4049/jimmunol.175.8.4875; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Svensson L, 2001, J REPROD IMMUNOL, V51, P3, DOI 10.1016/S0165-0378(01)00065-1; Thuere C, 2007, AM J REPROD IMMUNOL, V58, P514, DOI 10.1111/j.1600-0897.2007.00538.x; Yamashita K, 2006, FASEB J, V20, P776, DOI 10.1096/fj.05-4791fje; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zenclussen AC, 2005, INT IMMUNOPHARMACOL, V5, P41, DOI 10.1016/j.intimp.2004.09.011; Zenclussen ML, 2012, AM J REPROD IMMUNOL, V67, P376, DOI 10.1111/j.1600-0897.2011.01096.x; Zenclussen ML, 2011, J PATHOL, V225, P293, DOI 10.1002/path.2946; Zenclussen ML, 2006, J REPROD IMMUNOL, V69, P35, DOI 10.1016/j.jri.2005.10.001; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012	66	70	73	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42301	10.1371/journal.pone.0042301	http://dx.doi.org/10.1371/journal.pone.0042301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900010	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900027
J	Takenaka, M; Tiriveedhi, V; Subramanian, V; Hoshinaga, K; Patterson, AG; Mohanakumar, T				Takenaka, Masashi; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Hoshinaga, Kiyotaka; Patterson, Alexander G.; Mohanakumar, Thalachallour			Antibodies to MHC Class II Molecules Induce Autoimmunity: Critical Role for Macrophages in the Immunopathogenesis of Obliterative Airway Disease	PLOS ONE			English	Article							LUNG ALLOGRAFT-REJECTION; REGULATORY T-CELLS; BRONCHIOLITIS OBLITERANS; TRANSPLANT RECIPIENTS; DENDRITIC CELLS; SELF-ANTIGEN; HLA; ACTIVATION; ALLORECOGNITION; PATHOGENESIS	Previous studies have shown that intrabronchial administration of antibodies (Abs) to MHC class I resulted in development of obliterative airway disease (OAD), a correlate of chronic human lung allograft rejection. Since development of Abs specific to mismatched donor HLA class II have also been associated with chronic human lung allograft rejection, we analyzed the role of Abs to MHC class II in inducing OAD. Administration of MHC class II Abs (M5/114) to C57BL/6 mice induced the classical features of OAD even though MHC class II expression is absent de novo on murine lung epithelial and endothelial cells. The induction of OAD was accompanied by enhanced cellular and humoral immune responses to self-antigens (Collagen V and K- alpha 1Tubulin). Further, lung-infiltrating macrophages demonstrated a switch in their phenotype predominance from M Phi 1 (F4/80(+)CD11c(+)) to M Phi 2 (F4/80(+)CD206(+)) following administration of Abs and prior to development of OAD. Passive administration of macrophages harvested from animals with OAD but not from naive animals induced OAD lesions. We conclude that MHC class II Abs induces a phenotype switch of lung infiltrating macrophages from M Phi 1 (F4/80(+)CD11c(+)) to M Phi 2 (F4/80(+)CD206(+)) resulting in the breakdown of self-tolerance along with an increase in autoimmune Th17 response leading to OAD.	[Takenaka, Masashi; Tiriveedhi, Venkataswarup; Subramanian, Vijay; Patterson, Alexander G.; Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Mohanakumar, Thalachallour] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Hoshinaga, Kiyotaka] Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 47011, Japan	Washington University (WUSTL); Washington University (WUSTL); Fujita Health University	Takenaka, M (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	kumart@wustl.edu			NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases) [HL092514-01A2]; Barnes-Jewish Children's Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092514] Funding Source: NIH RePORTER	NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases); Barnes-Jewish Children's Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI (National Heart, Lung, and Blood Institute)/NIAID (National Institute of Allergy and Infectious Diseases) HL092514-01A2 and the Barnes-Jewish Children's Hospital Foundation (TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL JD, 1986, J IMMUNOL, V136, P389; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Benichou G, 1996, Int Rev Immunol, V13, P231, DOI 10.3109/08830189609061750; Bharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x; Bharat A, 2008, ANN THORAC SURG, V86, P189, DOI 10.1016/j.athoracsur.2008.03.073; Bharat A, 2006, J IMMUNOL, V177, P5631, DOI 10.4049/jimmunol.177.8.5631; Boehler A, 2003, EUR RESPIR J, V22, P1007, DOI 10.1183/09031936.03.00039103; Boisgerault F, 2001, J IMMUNOL, V167, P1891, DOI 10.4049/jimmunol.167.4.1891; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Girnita AL, 2006, PEDIATR TRANSPLANT, V10, P146, DOI 10.1111/j.1399-3046.2005.00425.x; Hachem RR, 2009, CURR OPIN ORGAN TRAN, V14, P477, DOI 10.1097/MOT.0b013e32832fb981; Hachem Ramsey R, 2004, Semin Thorac Cardiovasc Surg, V16, P350, DOI 10.1053/j.semtcvs.2004.09.011; HALLORAN PF, 1992, TRANSPLANTATION, V53, P550, DOI 10.1097/00007890-199203000-00011; Haque MA, 2002, J IMMUNOL, V169, P1542, DOI 10.4049/jimmunol.169.3.1542; Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x; Hele DJ, 2001, RESPIR RES, V2, P169, DOI 10.1186/rr55; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Irmler I, 2007, Z RHEUMATOL, V66, P17; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jaramillo A, 1999, TRANSPLANT P, V31, P185, DOI 10.1016/S0041-1345(98)01495-X; Jaramillo A, 2003, HUM IMMUNOL, V64, P521, DOI 10.1016/S0198-8859(03)00038-7; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kreisel D, 2011, AM J TRANSPLANT, V11, P882, DOI 10.1111/j.1600-6143.2011.03483.x; Kreisel D, 2010, J IMMUNOL, V185, P3809, DOI 10.4049/jimmunol.1000971; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Lu KC, 2003, J HEART LUNG TRANSPL, V22, P35, DOI 10.1016/S1053-2498(02)00478-3; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Nath DS, 2011, TRANSPLANTATION, V91, P1036, DOI 10.1097/TP.0b013e318211d2f4; Nath DS, 2010, CURR OPIN ORGAN TRAN, V15, P16, DOI 10.1097/MOT.0b013e3283342780; Okazaki M, 2007, AM J TRANSPLANT, V7, P1672, DOI 10.1111/j.1600-6143.2007.01819.x; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Reznik SI, 2001, AM J TRANSPLANT, V1, P228, DOI 10.1034/j.1600-6143.2001.001003228.x; Saadi S, 2002, XENOTRANSPLANTATION, V9, P239, DOI 10.1034/j.1399-3089.2002.02042.x; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; Saini D, 2010, J HEART LUNG TRANSPL, V29, P1330, DOI 10.1016/j.healun.2010.05.036; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; Seetharam A, 2010, CURR OPIN ORGAN TRAN, V15, P531, DOI 10.1097/MOT.0b013e32833b31f4; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Smith MA, 1998, J THORAC CARDIOV SUR, V116, P812, DOI 10.1016/S0022-5223(98)00444-9; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Sundaresan S, 1998, TRANSPLANTATION, V65, P648, DOI 10.1097/00007890-199803150-00008; Tang JL, 2001, TRANSPLANTATION, V72, P348, DOI 10.1097/00007890-200107270-00035; Tiriveedhi V, 2012, CLIN EXP IMMUNOL, V167, P158, DOI 10.1111/j.1365-2249.2011.04486.x; Tiriveedhi V, 2010, DISCOV MED, V9, P229; Vos I H C, 2002, Transpl Infect Dis, V4, P152, DOI 10.1034/j.1399-3062.2002.t01-1-02002.x; Vos R, 2011, EUR RESPIR J, V37, P164, DOI 10.1183/09031936.00068310; Weber J., 2012, J HEART LUNG TRANSPL, V31, P419; Zamilpa R, 2011, AM J PHYSIOL-HEART C, V300, pH1418, DOI 10.1152/ajpheart.01002.2010; Zarkhin V, 2008, TRANSPLANTATION, V85, P1705, DOI 10.1097/TP.0b013e318177793e; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	56	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42370	10.1371/journal.pone.0042370	http://dx.doi.org/10.1371/journal.pone.0042370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900015	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900032
J	Kadowaki, K; Inouye, BD; Miller, TE				Kadowaki, Kohmei; Inouye, Brian D.; Miller, Thomas E.			Assembly-History Dynamics of a Pitcher-Plant Protozoan Community in Experimental Microcosms	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; BETA DIVERSITY; SUCCESSION; CONSEQUENCES; CONVERGENCE; FUNGI; WOOD	Background: History drives community assembly through differences both in density (density effects) and in the sequence in which species arrive (sequence effects). Density effects arise from predictable population dynamics, which are free of history, but sequence effects are due to a density-free mechanism, arising solely from the order and timing of immigration events. Few studies have determined how components of immigration history (timing, number of individuals, frequency) alter local dynamics to determine community assembly, beyond addressing when immigration history produces historically contingent assembly. Methods/Findings: We varied density and sequence effects independently in a two-way factorial design to follow community assembly in a three-species aquatic protozoan community. A superior competitor, Colpoda steinii, mediated alternative community states; early arrival or high introduction density allowed this species to outcompete or suppress the other competitors (Poterioochromonas malhamensis and Eimeriidae gen. sp.). Multivariate analysis showed that density effects caused greater variation in community states, whereas sequence effects altered the mean community composition. Conclusions: A significant interaction between density and sequence effects suggests that we should refine our understanding of priority effects. These results highlight a practical need to understand not only the "ingredients" (species) in ecological communities but their "recipes" as well.	[Kadowaki, Kohmei; Inouye, Brian D.; Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kadowaki, K (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	kadowaki.koumei.6w@kyoto-u.ac.jp	Kadowaki, Kohmei/K-8117-2019	Kadowaki, Kohmei/0000-0003-0512-1621	U.S. National Science Foundation [DEB-0816838, DEB-0716891]; Division Of Environmental Biology [0816838] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the U.S. National Science Foundation to BDI (DEB-0816838) and TEM (DEB-0716891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Collinge SK, 2009, ECOLOGY, V90, P3313, DOI 10.1890/08-2155.1; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Diamond J.M., 1975, P342; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; GROVER JP, 1994, J ANIM ECOL, V63, P484, DOI 10.2307/5565; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Houseman GR, 2008, ECOLOGY, V89, P2172, DOI 10.1890/07-1228.1; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2012, OECOLOGIA IN PRESS; Miller TE, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P122; MORRIS WF, 1989, ECOLOGY, V70, P697, DOI 10.2307/1940220; Oksanen J., 2016, R PACKAG; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; Petraitis PS, 2005, J EXP MAR BIOL ECOL, V326, P14, DOI 10.1016/j.jembe.2005.05.013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBINSON JV, 1987, ECOLOGY, V68, P587, DOI 10.2307/1938464; SCHAFFER WM, 1981, ECOL MONOGR, V51, P383, DOI 10.2307/2937321; SHORROCKS B, 1994, J ANIM ECOL, V63, P799, DOI 10.2307/5257; Shurin JB, 2004, J THEOR BIOL, V227, P359, DOI 10.1016/j.jtbi.2003.11.013; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]	33	11	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42651	10.1371/journal.pone.0042651	http://dx.doi.org/10.1371/journal.pone.0042651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880069	gold, Green Submitted, Green Published			2022-12-25	WOS:000307437900048
J	Haque, R; Chun, E; Howell, JC; Sengupta, T; Chen, D; Kim, H				Haque, Rashidul; Chun, Eugene; Howell, Jennifer C.; Sengupta, Trisha; Chen, Dan; Kim, Hana			MicroRNA-30b-Mediated Regulation of Catalase Expression in Human ARPE-19 Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; ARYLALKYLAMINE N-ACETYLTRANSFERASE; MITOCHONDRIAL-DNA DAMAGE; OXIDATIVE STRESS; GENE-EXPRESSION; MICROARRAY ANALYSIS; OCULAR NEOVASCULARIZATION; MACULAR DEGENERATION; MESSENGER-RNA; HUMAN RPE	Background: Oxidative injury to retinal pigment epithelium (RPE) and retinal photoreceptors has been linked to a number of retinal diseases, including age-related macular degeneration (AMD). Reactive oxygen species (ROS)-mediated gene expression has been extensively studied at transcriptional levels. Also, the post-transcriptional control of gene expression at the level of translational regulation has been recently reported. However, the microRNA (miRNA/miR)-mediated post-transcriptional regulation in human RPE cells has not been thoroughly looked at. Increasing evidence points to a potential role of miRNAs in diverse physiological processes. Methodology/Principal Findings: We demonstrated for the first time in a human retinal pigment epithelial cell line (ARPE-19) that the post-transcriptional control of gene expression via miRNA modulation regulates human catalase, an important and potent component of cell's antioxidant defensive network, which detoxifies hydrogen peroxide (H2O2) radicals. Exposure to several stress-inducing agents including H2O2 has been reported to alter miRNA expression profile. Here, we demonstrated that a sublethal dose of H2O2 (200 mu M) up-regulated the expression of miR-30b, a member of the miR-30 family, which inhibited the expression of endogenous catalase both at the transcript and protein levels. However, antisense (antagomirs) of miR-30b was not only found to suppress the miR-30b mimics-mediated inhibitions, but also to dramatically increase the expression of catalase even under an oxidant environment. Conclusions/Significance: We propose that a microRNA antisense approach could enhance cytoprotective mechanisms against oxidative stress by increasing the antioxidant defense system.	[Haque, Rashidul; Chun, Eugene; Howell, Jennifer C.; Sengupta, Trisha; Chen, Dan; Kim, Hana] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Emory University	Haque, R (corresponding author), Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA.	rhaque@emory.edu			Research to Prevent Blindnes (RPB) [R01EY004864, P30EY006360]; NATIONAL EYE INSTITUTE [R01EY004864, P30EY006360] Funding Source: NIH RePORTER	Research to Prevent Blindnes (RPB); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research to Prevent Blindnes (RPB), R01EY004864, P30EY006360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov JP, 2011, TOXICOL SCI, V120, P428, DOI 10.1093/toxsci/kfr007; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Alizadeh M, 2001, INVEST OPHTH VIS SCI, V42, P2706; Babizhayev MA, 2010, AM J THER, V22, P22; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Cai JY, 2000, PROG RETIN EYE RES, V19, P205, DOI 10.1016/S1350-9462(99)00009-9; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chaum E, 2009, J CELL BIOCHEM, V108, P1280, DOI 10.1002/jcb.22358; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; Delcourt C, 1999, OPHTHALMOLOGY, V106, P215, DOI 10.1016/S0161-6420(99)90059-3; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Girard A, 2006, NUTRITION, V22, P758, DOI 10.1016/j.nut.2006.05.006; Guy J, 1998, P NATL ACAD SCI USA, V95, P13847, DOI 10.1073/pnas.95.23.13847; Haque R, 2011, J NEUROCHEM, V119, P6, DOI 10.1111/j.1471-4159.2011.07397.x; Haque R, 2010, J NEUROCHEM, V113, P1296, DOI 10.1111/j.1471-4159.2010.06698.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kim Min-Ho, 2003, Korean J Ophthalmol, V17, P19; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MICELI MV, 1994, EXP CELL RES, V214, P242, DOI 10.1006/excr.1994.1254; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nenoi M, 2001, CANCER RES, V61, P5885; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Sarna T, 2003, EXP EYE RES, V76, P89, DOI 10.1016/S0014-4835(02)00247-6; Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; STINSON AM, 1991, EXP EYE RES, V52, P213, DOI 10.1016/0014-4835(91)90261-C; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; Winkler BS, 1999, MOL VIS, V5; Wu JM, 2006, SURV OPHTHALMOL, V51, P461, DOI 10.1016/j.survophthal.2006.06.009; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	62	75	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42542	10.1371/journal.pone.0042542	http://dx.doi.org/10.1371/journal.pone.0042542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880027	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000044
J	Xia, CW; Lin, XL; Liu, W; Lloyd, H; Zhang, YY				Xia, Canwei; Lin, Xuanlong; Liu, Wei; Lloyd, Huw; Zhang, Yanyun			Acoustic Identification of Individuals within Large Avian Populations: A Case Study of the Brownish-Flanked Bush Warbler, South-Central China	PLOS ONE			English	Article							PENGUINS; BEHAVIOR; BIRDS; CALL; SONG	Acoustic identification is increasingly being used as a non-invasive method for identifying individuals within avian populations. However, most previous studies have utilized small samples of individuals (<30). The feasibility of using acoustic identification of individuals in larger avian populations has never been seriously tested. In this paper, we assess the feasibility of using distinct acoustic signals to identify individuals in a large avian population (139 colour-banded individuals) of Brownish-flanked Bush Warbler (Cettia fortipes) in the Dongzhai National Nature Reserve, south-central China. Most spectro-temporal variables we measured show greater variation among individuals than within individual. Although there was slight decline in the correct rate of individual identification with increasing sample sizes, the total mean correct rate yielded by discriminant function analysis was satisfactory, with more than 98% of songs correctly recognized to the corresponding individuals. We also found that using a part of randomly selected measured variables was sufficient to obtain a high correct rate of individual identification. We believe that our work will increase confidence in the use of using acoustic recognition techniques for avian population monitoring programs.	[Xia, Canwei; Lin, Xuanlong; Zhang, Yanyun] Beijing Normal Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Lloyd, Huw] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England	Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Manchester Metropolitan University	Xia, CW (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Coll Life Sci, Beijing 100875, Peoples R China.	zhangyy@bnu.edu.cn			National Natural Science Foundation of China [31172098]; Foundation for Excellent Doctoral Dissertation of Beijing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Doctoral Dissertation of Beijing Normal University	This work was supported by the National Natural Science Foundation of China (No. 31172098) and the Foundation for Excellent Doctoral Dissertation of Beijing Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner P, 2010, J AVIAN BIOL, V41, P388, DOI 10.1111/j.1600-048X.2009.04967.x; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; Charrier I, 2003, MAR MAMMAL SCI, V19, P161, DOI 10.1111/j.1748-7692.2003.tb01099.x; Charrier I, 2001, POLAR BIOL, V24, P378, DOI 10.1007/s003000100231; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; DELHOYO A, 2006, HDB BIRDS WORLD, V11; Dixon A, 2011, VET REC, V169, P308, DOI 10.1136/vr.d5778; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Fox EJS, 2008, ANIM BEHAV, V75, P1187, DOI 10.1016/j.anbehav.2007.11.003; Klenova AV, 2009, J ETHOL, V27, P401, DOI 10.1007/s10164-008-0133-9; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Martens J, 1995, BONNER ZOOLOLOGISCHE, P38; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Park SR, 2000, AUK, V117, P228, DOI 10.1642/0004-8038(2000)117[0228:STFIII]2.0.CO;2; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Thomas RJ, 1999, ANIM BEHAV, V57, P277, DOI 10.1006/anbe.1998.0956; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Wegrzyn E, 2009, ORNIS FENNICA, V86, P61; Xia CW, 2010, CONDOR, V112, P591, DOI 10.1525/cond.2010.090021	21	22	23	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42528	10.1371/journal.pone.0042528	http://dx.doi.org/10.1371/journal.pone.0042528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880018	gold, Green Published, Green Submitted			2022-12-25	WOS:000307810000041
J	Gras, LM; Smid, JH; Wagenaar, JA; de Boer, AG; Havelaar, AH; Friesema, IHM; French, NP; Busani, L; van Pelt, W				Gras, Lapo Mughini; Smid, Joost H.; Wagenaar, Jaap A.; de Boer, Albert G.; Havelaar, Arie H.; Friesema, Ingrid H. M.; French, Nigel P.; Busani, Luca; van Pelt, Wilfrid			Risk Factors for Campylobacteriosis of Chicken, Ruminant, and Environmental Origin: A Combined Case-Control and Source Attribution Analysis	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; DISEASE BURDEN; JEJUNI CLONES; NETHERLANDS; INFECTIONS; COLI; HUMANS; IDENTIFICATION; ASSOCIATION; PREVALENCE	Background: Campylobacteriosis contributes strongly to the disease burden of food-borne pathogens. Case-control studies are limited in attributing human infections to the different reservoirs because they can only trace back to the points of exposure, which may not point to the original reservoirs because of cross-contamination. Human Campylobacter infections can be attributed to specific reservoirs by estimating the extent of subtype sharing between strains from humans and reservoirs using multilocus sequence typing (MLST). Methodology/Principal Findings: We investigated risk factors for human campylobacteriosis caused by Campylobacter strains attributed to different reservoirs. Sequence types (STs) were determined for 696 C. jejuni and 41 C. coli strains from endemic human cases included in a case-control study. The asymmetric island model, a population genetics approach for modeling Campylobacter evolution and transmission, attributed these cases to four putative animal reservoirs (chicken, cattle, sheep, pig) and to the environment (water, sand, wild birds) considered as a proxy for other unidentified reservoirs. Most cases were attributed to chicken (66%) and cattle (21%), identified as the main reservoirs in The Netherlands. Consuming chicken was a risk factor for campylobacteriosis caused by chicken-associated STs, whereas consuming beef and pork were protective. Risk factors for campylobacteriosis caused by ruminant-associated STs were contact with animals, barbecuing in non-urban areas, consumption of tripe, and never/seldom chicken consumption. Consuming game and swimming in a domestic swimming pool during springtime were risk factors for campylobacteriosis caused by environment-associated STs. Infections with chicken-and ruminant-associated STs were only partially explained by food-borne transmission; direct contact and environmental pathways were also important. Conclusion/Significance: This is the first case-control study in which risk factors for campylobacteriosis are investigated in relation to the attributed reservoirs based on MLST profiles. Combining epidemiological and source attribution data improved campylobacteriosis risk factor identification and characterization, generated hypotheses, and showed that genotype-based source attribution is epidemiologically sensible.	[Gras, Lapo Mughini; Busani, Luca] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Gras, Lapo Mughini; Smid, Joost H.; Havelaar, Arie H.; Friesema, Ingrid H. M.; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, RIVM, NL-3720 BA Bilthoven, Netherlands; [Gras, Lapo Mughini] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Wagenaar, Jaap A.; de Boer, Albert G.] Cent Vet Inst Wageningen UR, Dept Bacteriol, Lelystad, Netherlands; [Wagenaar, Jaap A.; de Boer, Albert G.] TSEs, Lelystad, Netherlands; [Wagenaar, Jaap A.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] World Hlth Org Collaborating Ctr Reference & Res, OIE Reference Lab Campylobacteriosis, Lelystad, Netherlands; [Havelaar, Arie H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [French, Nigel P.] Massey Univ, Infect Dis Res Ctr, Palmerston North, New Zealand	Istituto Superiore di Sanita (ISS); Netherlands National Institute for Public Health & the Environment; University of Bologna; Wageningen University & Research; Utrecht University; World Health Organization; Utrecht University; Massey University	Gras, LM (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	lapo.mughinigras2@unibo.it	Friesema, Ingrid HM/H-6601-2019; French, Nigel/F-5725-2011; Busani, Luca/J-9253-2012; Havelaar, Arie H./P-8495-2014	Friesema, Ingrid HM/0000-0001-9943-0518; French, Nigel/0000-0002-6334-0657; Busani, Luca/0000-0002-6081-2794; Havelaar, Arie H./0000-0002-6456-5460	Italian Ministry of Health - Centro di Controllo delle Malattie [9254]	Italian Ministry of Health - Centro di Controllo delle Malattie	LMG receives a PhD grant from the Italian Ministry of Health - Centro di Controllo delle Malattie "Stima di base dell'incidenza delle gastroenteriti acute in Italia e integrazione dei dati di notifica, ricovero e laboratorio per la valutazione dell'impatto sulla salute" (Grant no. 9254 Jan 14 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2006, VET REC, V158, P51, DOI 10.1136/vr.158.2.51; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; Ang CW, 2011, EPIDEMIOL INFECT, V139, P1361, DOI 10.1017/S0950268810002359; Bessell PR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-80; de Jong AEI, 2008, J APPL MICROBIOL, V105, P615, DOI 10.1111/j.1365-2672.2008.03778.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; European Food Safety Authority, 2011, EFSA Journal, V9, P2090; Fermer C, 1999, J CLIN MICROBIOL, V37, P3370; Fitch BR, 2005, J CLIN MICROBIOL, V43, P4221, DOI 10.1128/JCM.43.8.4221-4224.2005; French N, 2005, ENVIRON MICROBIOL, V7, P1116, DOI 10.1111/j.1462-2920.2005.00782.x; Friesema IHM, 2011, EPIDEMIOL INFECT, V139, P1081, DOI 10.1017/S0950268810002050; Friesema IHM, 2012, EMERG INFECT DIS, V18, P466, DOI 10.3201/eid1803.111024; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Jolliffe, 2002, PRINCIPAL COMPONENT; Jones K, 2001, J APPL MICROBIOL, V90, p68S, DOI 10.1046/j.1365-2672.2001.01355.x; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Mangen M. J. J., 2005, Acta Agricultura Scandinavica. Section C, Food Economics, V2, P35, DOI 10.1080/16507540510033451; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Rijksinstituut voor Volksgezondheid en Milieu, 2011, STAAT ZOON 2010; Rubin DB, 2004, MULTIPLE IMPUTATION; Ruiter H, 2004, CAMPYLOBACTER WATER; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Smid JH, 2009, 15 INT WORKSH CAMP H; Stafford RJ, 2007, EPIDEMIOL INFECT, V135, P978, DOI 10.1017/S0950268806007576; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Studahl A, 2000, EPIDEMIOL INFECT, V125, P269, DOI 10.1017/S0950268899004562; Sturmer T, 2001, EPIDEMIOLOGY, V12, P101; Swift L, 2004, EUR J EPIDEMIOL, V19, P219, DOI 10.1023/B:EJEP.0000020453.84296.f6; van Asselt ED, 2008, POULTRY SCI, V87, P2166, DOI 10.3382/ps.2007-00520; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	51	132	132	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42599	10.1371/journal.pone.0042599	http://dx.doi.org/10.1371/journal.pone.0042599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880049	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100139
J	Heng, TSP; Reiseger, JJ; Fletcher, AL; Leggatt, GR; White, OJ; Vlahos, K; Frazer, IH; Turner, SJ; Boyd, RL				Heng, Tracy S. P.; Reiseger, Jessica J.; Fletcher, Anne L.; Leggatt, Graham R.; White, Olivia J.; Vlahos, Katerina; Frazer, Ian H.; Turner, Stephen J.; Boyd, Richard L.			Impact of Sex Steroid Ablation on Viral, Tumour and Vaccine Responses in Aged Mice	PLOS ONE			English	Article							INFLUENZA; DIVERSITY; TRANSPLANTATION; REGENERATION; LYMPHOCYTES; GENERATION; INDUCTION; CELLS	Recent evidence suggests that the decline in resistance to viral infections with age occurs predominantly as a result of a gradual loss of naive antigen-specific T cells. As such, restoration of the naive T cell repertoire to levels seen in young healthy adults may improve defence against infection in the aged. We have previously shown that sex steroid ablation (SSA) rejuvenates the ageing thymus and increases thymic export of naive T cells, but it remains unclear whether T cell responses are improved. Using mouse models of clinically relevant diseases, we now demonstrate that SSA increases the number of naive T cells able to respond to antigen, thereby enhancing effector responses in aged mice. Specifically, aged mice exhibit a delay in clearing influenza A virus, which correlates with diminished specific cytotoxic activity. This is due to a decreased magnitude of response and not an intrinsic defect in effector T cell function. Upon SSA, aged mice exhibit increased T cell responsiveness that restores efficient viral clearance. We further demonstrate that SSA decreases the incidence of an inducible tumour in aged mice and can potentially increase their responsiveness to a low-dose human papillomavirus vaccine in clearing pre-formed tumours. As thymectomy abrogates the increase in T cell numbers and responsiveness following SSA, we propose that the T cell effects of SSA are dependent on thymic reactivation and subsequent replenishment of the peripheral T cell pool with newly emigrated naive T cells. These findings have important implications for strategies to improve protection from infection and responsiveness to vaccination in the aged.	[Heng, Tracy S. P.; Reiseger, Jessica J.; Fletcher, Anne L.; Vlahos, Katerina; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Fletcher, Anne L.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Leggatt, Graham R.; White, Olivia J.; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Woolloongabba, Qld, Australia; [Turner, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	Monash University; Harvard University; Dana-Farber Cancer Institute; University of Queensland; University of Melbourne	Heng, TSP (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia.	tracy.heng@monash.edu; richard.boyd@monash.edu	Turner, Stephen/GXM-4654-2022; Heng, Tracy/B-9847-2015; Leggatt, Graham/G-1924-2010; Heng, Tracy/AAR-5712-2021; Frazer, Ian/A-1137-2007	Heng, Tracy/0000-0003-4147-8986; Leggatt, Graham/0000-0002-4078-5653; Heng, Tracy/0000-0003-4147-8986; Turner, Stephen/0000-0002-1002-0000; Fletcher, Anne/0000-0003-1534-1142; Frazer, Ian/0000-0002-8002-4680	Australian National Health and Medical Research Council; Norwood Immunology Ltd; NHMRC RD Wright Fellowship; Pfizer Senior Research Fellowship; Queensland Government Smart State Fellowship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Norwood Immunology Ltd; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Senior Research Fellowship; Queensland Government Smart State Fellowship	This work was supported by program grants from the Australian National Health and Medical Research Council, Norwood Immunology Ltd, an NHMRC RD Wright Fellowship and Pfizer Senior Research Fellowship to ST, and a Queensland Government Smart State Fellowship to IF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN W, 1990, J IMMUNOL, V144, P3980; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; BENDER BS, 1991, IMMUNOLOGY, V72, P514; CASTRO JE, 1974, PROC R SOC SER B-BIO, V186, P387, DOI 10.1098/rspb.1974.0056; Dudakov JA, 2009, J IMMUNOL, V182, P6247, DOI 10.4049/jimmunol.0802446; Fernando GJP, 1998, J IMMUNOL, V161, P2421; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Lin KY, 1996, CANCER RES, V56, P21; Mbawuike Innocent N., 1993, Viral Immunology, V6, P55, DOI 10.1089/vim.1993.6.55; McElhaney JE, 2005, VACCINE, V23, P3294, DOI 10.1016/j.vaccine.2005.01.080; Po JLZ, 2002, MECH AGEING DEV, V123, P1167, DOI 10.1016/S0047-6374(02)00010-6; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Sutherland JS, 2008, CLIN CANCER RES, V14, P1138, DOI 10.1158/1078-0432.CCR-07-1784; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	28	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42677	10.1371/journal.pone.0042677	http://dx.doi.org/10.1371/journal.pone.0042677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880080	Green Published, gold			2022-12-25	WOS:000307284100156
J	Mills, RF; Peaston, KA; Runions, J; Williams, LE				Mills, Rebecca F.; Peaston, Kerry A.; Runions, John; Williams, Lorraine E.			HvHMA2, a P-1B-ATPase from Barley, Is Highly Conserved among Cereals and Functions in Zn and Cd Transport	PLOS ONE			English	Article							P-TYPE ATPASE; HEAVY-METAL TRANSPORT; ARABIDOPSIS-THALIANA; P-1B-TYPE ATPASE; THLASPI-CAERULESCENS; ZINC HOMEOSTASIS; BINDING SITES; CADMIUM; RICE; TRANSLOCATION	Manipulation of crops to improve their nutritional value (biofortification) and optimisation of plants for removal of toxic metals from contaminated soils (phytoremediation) are major goals. Identification of membrane transporters with roles in zinc and cadmium transport would be useful for both aspects. The P-1B-ATPases play important roles in heavy metal allocation and detoxification in Arabidopsis and it is now important to elucidate their roles in monocots. We identified nine P-1B-ATPases in barley and this study focuses on the functional characterization of HvHMA2, providing evidence for its role in heavy metal transport. HvHMA2 was cloned using information from EST analysis and 59 RACE. It possesses the conserved aspartate that is phosphorylated during the reaction cycle of P-type pumps and has motifs and key residues characteristic of P-1B-ATPases, falling into the P1B-2 subclass. Homologous sequences occur in three major sub-families of the Poaceae (Gramineae). Heterologous expression in Saccharomyces cerevisiae demonstrates that HvHMA2 functions as a Zn and Cd pump. Mutagenesis studies show that proposed cation coordination sites of the P1B-2 pumps are crucial for the metal responses conferred by HvHMA2 in yeast. HvHMA2 expression suppresses the Zn-deficient phenotype of the Arabidopsis hma2hma4 mutant indicating that HvHMA2 functions as a Zn pump in planta and could play a role in root to shoot Zn transport. When expressed in Arabidopsis, HvHMA2 localises predominantly to the plasma membrane.	[Mills, Rebecca F.; Peaston, Kerry A.; Williams, Lorraine E.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Runions, John] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England	University of Southampton; Oxford Brookes University	Mills, RF (corresponding author), Univ Southampton, Ctr Biol Sci, Highfield Campus, Southampton, Hants, England.	lew@soton.ac.uk			European Union [FOOD-CT-2006-016253]	European Union(European Commission)	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long-term, lowlevel mixed element exposure in susceptible population strata (PHIME) (contract no FOOD-CT-2006-016253); it reflects only the authors' views. The Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Clemens S, 2002, J BIOL CHEM, V277, P18215, DOI 10.1074/jbc.M201031200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Eren E, 2007, BIOCHEM, V46, P754; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Hall JL, 2003, J EXP BOT, V54, P2601, DOI 10.1093/jxb/erg303; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Kobayashi Y, 2008, PLANT PHYSIOL, V148, P969, DOI 10.1104/pp.108.119933; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee S, 2007, PLANT PHYSIOL, V145, P831, DOI 10.1104/pp.107.102236; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mills RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013388; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Nocito FF, 2011, PLANT CELL ENVIRON, V34, P994, DOI 10.1111/j.1365-3040.2011.02299.x; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Puig S, 2009, CURR OPIN PLANT BIOL, V12, P299, DOI 10.1016/j.pbi.2009.04.008; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Siemianowski O, 2011, PLANT BIOTECHNOL J, V9, P64, DOI 10.1111/j.1467-7652.2010.00531.x; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Talukdar S, 2008, PLANT SOIL, V306, P85, DOI 10.1007/s11104-007-9412-4; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; Ueno D, 2011, J EXP BOT, V62, P2265, DOI 10.1093/jxb/erq383; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Williams LE, 2010, PLANT CELL MONOGR, V17, P95, DOI 10.1007/978-3-642-10613-2_5; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x; Wu CC, 2004, BIOCHEM BIOPH RES CO, V324, P1034, DOI 10.1016/j.bbrc.2004.09.160	57	61	67	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42640	10.1371/journal.pone.0042640	http://dx.doi.org/10.1371/journal.pone.0042640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880063	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000307284100147
J	Valentin-Vargas, A; Toro-Labrador, G; Massol-Deya, AA				Valentin-Vargas, Alexis; Toro-Labrador, Gladys; Massol-Deya, Arturo A.			Bacterial Community Dynamics in Full-Scale Activated Sludge Bioreactors: Operational and Ecological Factors Driving Community Assembly and Performance	PLOS ONE			English	Article							WASTE-WATER TREATMENT; T-RFLP DATA; MICROBIAL COMMUNITY; TREATMENT-PLANT; POPULATION-DYNAMICS; TREATMENT SYSTEMS; DIVERSITY; REMOVAL; SOLIDS; TAXA	The assembling of bacterial communities in conventional activated sludge (CAS) bioreactors was thought, until recently, to be chaotic and mostly unpredictable. Studies done over the last decade have shown that specific, and often, predictable random and non-random factors could be responsible for that process. These studies have also motivated a "structure-function'' paradigm that is yet to be resolved. Thus, elucidating the factors that affect community assembly in the bioreactors is necessary for predicting fluctuations in community structure and function. For this study activated sludge samples were collected during a one-year period from two geographically distant CAS bioreactors of different size. Combining community fingerprinting analysis and operational parameters data with a robust statistical analysis, we aimed to identify relevant links between system performance and bacterial community diversity and dynamics. In addition to revealing a significant beta-diversity between the bioreactors' communities, results showed that the largest bioreactor had a less dynamic but more efficient and diverse bacterial community throughout the study. The statistical analysis also suggests that deterministic factors, as opposed to stochastic factors, may have a bigger impact on the community structure in the largest bioreactor. Furthermore, the community seems to rely mainly on mechanisms of resistance and functional redundancy to maintain functional stability. We suggest that the ecological theories behind the Island Biogeography model and the species-area relationship were appropriate to predict the assembly of bacterial communities in these CAS bioreactors. These results are of great importance for engineers and ecologists as they reveal critical aspects of CAS systems that could be applied towards improving bioreactor design and operation.	[Valentin-Vargas, Alexis; Toro-Labrador, Gladys; Massol-Deya, Arturo A.] Univ Puerto Rico Mayaguez, Dept Biol, Mayaguez, PR USA	University of Puerto Rico; University of Puerto Rico Mayaguez	Valentin-Vargas, A (corresponding author), Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA.	valentin.alexis@gmail.com						Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; APHA, 2005, STANDARD METHODS EXA, V21st; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; BALMER P, 1994, WATER SCI TECHNOL, V30, P7, DOI 10.2166/wst.1994.0147; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; BENEDICT RG, 1971, WATER RES, V5, P1023, DOI 10.1016/0043-1354(71)90036-4; Bitton G, 2011, WASTEWATER MICROBIOL; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Caro-Quintero A, 2009, THESIS U PUERTO RICO; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Curtis TP, 2003, ENVIRON SCI TECHNOL, V37, p64A, DOI 10.1021/es0323493; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; de los Reyes FL, 2010, WATER RES, V44, P4948, DOI 10.1016/j.watres.2010.07.038; DIAS FF, 1964, APPL MICROBIOL, V12, P412, DOI 10.1128/AEM.12.5.412-417.1964; Dollhopf SL, 2001, MICROB ECOL, V42, P495, DOI 10.1007/s00248-001-0027-7; Eschenhagen M, 2003, WATER RES, V37, P3224, DOI 10.1016/S0043-1354(03)00136-2; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Forney LJ, 2001, ECOTOX ENVIRON SAFE, V49, P40, DOI 10.1006/eesa.2001.2034; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Graham DW, 2004, FRONT ECOL ENVIRON, V2, P199, DOI 10.1890/1540-9295(2004)002[0199:DESAOE]2.0.CO;2; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han H, 2010, BIORESOURCE TECHNOL, V101, P3463, DOI 10.1016/j.biortech.2009.12.121; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hiraishi A, 2003, ENVIRON MICROBIOL, V5, P765, DOI 10.1046/j.1462-2920.2003.00473.x; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hoshino T, 2006, FEMS MICROBIOL ECOL, V55, P459, DOI 10.1111/j.1574-6941.2005.00047.x; Hubbell Stephen P., 2001, V32, pi; Jenkins D, 2008, WATER ENVIRON RES, V80, P677, DOI 10.2175/106143008X276679; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones PA, 2010, CHEM ENG J, V164, P16, DOI 10.1016/j.cej.2010.07.061; Kaewpipat K, 2002, WATER SCI TECHNOL, V46, P19, DOI 10.2166/wst.2002.0450; Kim YM, 2011, WATER RES, V45, P5785, DOI 10.1016/j.watres.2011.08.063; Kindt R, 2005, TREE DIVERSITY ANAL; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LIGHTHART B, 1969, J WATER POLLUT CON F, V41, pR267; Loy A, 2002, ENCY ENV MICROBIOLOG, P26; Manefield M, 2007, MICROB ECOL, V53, P348, DOI 10.1007/s00248-006-9167-0; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Matsuda M, 2010, WATER SCI TECHNOL, V61, P2843, DOI 10.2166/wst.2010.212; Mills AL, 2003, 2003012509 SAE INT; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Onuki M, 2000, WATER SCI TECHNOL, V42, P17, DOI 10.2166/wst.2000.0353; Padayachee P., 2006, Water SA, V32, P679; Palacios C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003853; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rodriguez-Martinez Enid M, 2006, Int J Environ Res Public Health, V3, P292, DOI 10.3390/ijerph2006030036; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Saikaly PE, 2004, MICROB ECOL, V48, P274, DOI 10.1007/s00248-003-1027-6; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1994, J VEG SCI, V5, P361, DOI 10.2307/3235860; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; VANVEEN WL, 1973, A VAN LEEUW J MICROB, V39, P189, DOI 10.1007/BF02578852; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520, DOI 10.1128/AEM.59.5.1520-1525.1993; Wagner M, 2002, ANTON LEEUW INT J G, V81, P665, DOI 10.1023/A:1020586312170; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Watanabe K, 1998, APPL ENVIRON MICROB, V64, P1203; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wilderer PA, 2002, WATER RES, V36, P370, DOI 10.1016/S0043-1354(01)00220-2; Wilson EO, 1967, THEORY ISLAND BIOGEO; Yuan Zhiguo, 2008, Reviews in Environmental Science and Bio/Technology, V7, P243, DOI 10.1007/s11157-008-9134-y	81	77	82	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42524	10.1371/journal.pone.0042524	http://dx.doi.org/10.1371/journal.pone.0042524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880016	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100118
J	Zhen, C; Chen, L; Zhao, Q; Liang, B; Gu, YX; Bai, ZF; Wang, K; Xu, X; Han, QY; Fang, DF; Wang, SX; Zhou, T; Xia, Q; Gong, WL; Wang, N; Li, HY; Jin, BF; Man, JH				Zhen, C.; Chen, L.; Zhao, Q.; Liang, B.; Gu, Y-X; Bai, Z-f; Wang, K.; Xu, X.; Han, Q-y; Fang, D-f; Wang, S-x; Zhou, T.; Xia, Q.; Gong, W-l; Wang, N.; Li, H-Y; Jin, B-F; Man, J-h			Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity	ONCOGENE			English	Article						Gankyrin; Rac; RhoA; adhesion; metastasis	GROWTH-FACTOR RECEPTOR; RHO-GTPASES; MIGRATION; ADHESION; OVEREXPRESSION; DEGRADATION; ONCOPROTEIN; INVASION; INACTIVATION; ACTIVATION	Tumor metastasis is responsible for most cancer patients' deaths. Understanding the mechanism of metastasis is crucial for improving the cure rate for cancer. Here, we report that Gankyrin, a chaperone of ubiquitin-proteasome, has an essential role in breast cancer metastasis. We find that Gankyrin is highly overexpressed in human breast cancers and the expression correlates strongly with lymph node metastasis. Knocking down Gankyrin expression in highly metastatic human breast cancer cells significantly decreases cancer cell migration and invasion. Furthermore, we demonstrate that depletion of Gankyrin inhibits intrinsic Rac1 activity and induces large focal adhesions. Overexpression of Gankyrin accelerates focal adhesion turnover and increases cell migration. Notably, reduction of Gankyrin expression in mouse mammary tumor cell significantly decreases tumor metastasis to lung in animal models. Therefore, our findings suggest that Gankyrin is crucial for breast cancer metastasis and highlight the potential of Gankyrin as a therapeutic target for tumor metastasis.	[Zhen, C.; Chen, L.; Zhao, Q.; Liang, B.; Gu, Y-X; Bai, Z-f; Wang, K.; Xu, X.; Han, Q-y; Fang, D-f; Wang, S-x; Zhou, T.; Xia, Q.; Gong, W-l; Wang, N.; Li, H-Y; Jin, B-F; Man, J-h] Natl Ctr Biomed Anal, Beijing 100850, Peoples R China		Jin, BF (corresponding author), Natl Ctr Biomed Anal, 27 Tai Ping Rd, Beijing 100850, Peoples R China.	jinbaofeng73@hotmail.com; jianghong_man@hotmail.com	FANG, DIFENG/G-7796-2018	FANG, DIFENG/0000-0003-2105-6743	Major Research Plan of the National Natural Science Foundation of China [91029733]; National Basic Research Program of China [2012CB910700]; China National Natural Science Foundation [81001174, 81171918]; Beijing Municipal Science and Technology Commission [2010B040]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the Major Research Plan of the National Natural Science Foundation of China (No. 91029733), National Basic Research Program of China (2012CB910700), China National Natural Science Foundation (No. 81001174 and No. 81171918), Beijing Municipal Science and Technology Commission (2010B040).	Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Jin BF, 2006, J PROTEOME RES, V5, P2815, DOI 10.1021/pr060283f; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Man JH, 2010, J CLIN INVEST, V120, P2829, DOI 10.1172/JCI42542; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Ortiz CM, 2008, INT J CANCER, V122, P325, DOI 10.1002/ijc.23106; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ridley AJ, 2001, J CELL SCI, V114, P2713; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun W, 2011, HEPATOLOGY, V54, P1259, DOI 10.1002/hep.24530; Tang SH, 2010, CANCER BIOL THER, V9, P88, DOI 10.4161/cbt.9.2.10283; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019	38	48	50	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 18	2013	32	29					3452	3460		10.1038/onc.2012.356	http://dx.doi.org/10.1038/onc.2012.356			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22890318				2022-12-25	WOS:000322014900006
J	Carpenter, MA; Li, M; Rathore, A; Lackey, L; Law, EK; Land, AM; Leonard, B; Shandilya, SMD; Bohn, MF; Schiffer, CA; Brown, WL; Harris, RS				Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Shandilya, Shivender M. D.; Bohn, Markus-Frederik; Schiffer, Celia A.; Brown, William L.; Harris, Reuben S.			Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AID/APOBEC FAMILY; TET PROTEINS; AID; EXCISION; HYPERMUTATION; TISSUES; 5-METHYLCYTOSINE; DEMETHYLATION; RECOGNITION; METHYLATION	Multiple studies have indicated that the TET oxidases and, more controversially, the activation-induced cytidine deaminase/APOBEC deaminases have the capacity to convert genomic DNA5-methylcytosine (MeC) into altered nucleobases that provoke excision repair and culminate in the replacement of the original MeC with a normal cytosine (C). We show that human APOBEC3A (A3A) efficiently deaminates both MeC to thymine (T) and normal C to uracil (U) in single-stranded DNA substrates. In comparison, the related enzyme APOBEC3G (A3G) has undetectable MeC to T activity and 10-fold less C to U activity. Upon 100-fold induction of endogenous A3A by interferon, the MeC status of bulk chromosomal DNA is unaltered, whereas both MeC and C nucleobases in transfected plasmid DNA substrates are highly susceptible to editing. Knockdown experiments show that endogenous A3A is the source of both of these cellular DNA deaminase activities. This is the first evidence for nonchromosomal DNA MeC to T editing in human cells. These biochemical and cellular data combine to suggest a model in which the expanded substrate versatility of A3A may be an evolutionary adaptation that occurred to fortify its innate immune function in foreign DNA clearance by myeloid lineage cell types.	[Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Minneapolis, MN 55455 USA; [Carpenter, Michael A.; Li, Ming; Rathore, Anurag; Lackey, Lela; Law, Emily K.; Land, Allison M.; Leonard, Brandon; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Shandilya, Shivender M. D.; Bohn, Markus-Frederik; Schiffer, Celia A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu	Shandilya, Shivender/D-8451-2013; Brown, William/GXN-2777-2022	Shandilya, Shivender/0000-0002-2479-2087; Bohn, Markus-Frederik/0000-0002-0369-1922; Carpenter, Michael/0000-0001-9524-5323; Lackey, Lela/0000-0003-2163-4005	National Institutes of Health [R01 AI064046, P01 GM091743, T32 AI083196]; University of Minnesota Academic Health Center [11.54]; Institutes of Health [T32 DE07288]; National Science Foundation; Canadian Institute of Health;  [F32 GM095219]; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, F32GM095219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Institutes of Health(National Health Research Institutes - Taiwan); National Science Foundation(National Science Foundation (NSF)); Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064046 and P01 GM091743. This work was also supported by Seed Grant 11.54 from the University of Minnesota Academic Health Center.; Supported by Institutes of Health Grant T32 DE07288 and subsequently Grant F32 GM095219.; Supported in part by an National Science Foundation predoctoral fellowship and a position with the Molecular Virology Training Grant T32 AI083196 from the National Institutes of Health.; Supported by a Canadian Institute of Health Research Postdoctoral Fellowship.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Wijesinghe P., 2012, NUCL ACIDS IN PRESS; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	49	101	106	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34801	34808		10.1074/jbc.M112.385161	http://dx.doi.org/10.1074/jbc.M112.385161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896697	Green Published, hybrid			2022-12-25	WOS:000309654200079
J	Ikeda, Y; Aihara, K; Yoshida, S; Iwase, T; Tajima, S; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Tomita, S; Tsuchiya, K; Sata, M; Akaike, M; Kato, S; Matsumoto, T; Tamaki, T				Ikeda, Yasumasa; Aihara, Ken-ichi; Yoshida, Sumiko; Iwase, Takashi; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Tomita, Shuhei; Tsuchiya, Koichiro; Sata, Masataka; Akaike, Masashi; Kato, Shigeaki; Matsumoto, Toshio; Tamaki, Toshiaki			Heparin Cofactor II, a Serine Protease Inhibitor, Promotes Angiogenesis via Activation of the AMP-activated Protein Kinase-Endothelial Nitric-oxide Synthase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-INDUCED ANGIOGENESIS; PERIPHERAL ARTERIAL-DISEASE; PROTECTIVE FACTOR; DERMATAN SULFATE; DEFICIENT MICE; THROMBIN; CELLS; PHOSPHORYLATION; ADIPONECTIN; PLASMA	We previously clarified that heparin cofactor II (HCII), a serine proteinase inhibitor, exerts various protective actions on cardiovascular diseases in both experimental and clinical studies. In the present study, we aimed to clarify whether HCII participates in the regulation of angiogenesis. Male heterozygous HCII-deficient (HCII+/-) mice and male littermate wild-type (HCII+/+) mice at the age of 12-16 weeks were subjected to unilateral hindlimb ligation surgery. Laser speckle blood flow analysis showed that blood flow recovery in response to hindlimb ischemia was delayed in HCII+/- mice compared with that in HCII+/+ mice. Capillary number, arteriole number, and endothelial nitric-oxide synthase (eNOS), AMP-activated protein kinase (AMPK), and liver kinase B1 (LKB1) phosphorylation in ischemic muscles were decreased in HCII+/- mice. Human purified HCII (h-HCII) administration almost restored blood flow recovery, capillary density, and arteriole number as well as phosphorylation levels of eNOS, AMPK, and LKB1 in ischemic muscles of HCII+/- mice. Although treatment with h-HCII increased phosphorylation levels of eNOS, AMPK, and LKB1 in human aortic endothelial cells (HAECs), the h-HCII-induced eNOS phosphorylation was abolished by compound C, an AMPK inhibitor, and by AMPK siRNA. In a similar fashion, tube formation, proliferation, and migration of HAECs were also promoted by h-HCII treatment and were abrogated by pretreatment with compound C. HCII potentiates the activation of vascular endothelial cells and the promotion of angiogenesis in response to hindlimb ischemia via an AMPK-eNOS signaling pathway. These findings suggest that HCII is a novel therapeutic target for treatment of patients with peripheral circulation insufficiency.	[Aihara, Ken-ichi; Yoshida, Sumiko; Matsumoto, Toshio] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan; [Ikeda, Yasumasa; Tajima, Soichiro; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tomita, Shuhei; Tamaki, Toshiaki] Univ Tokushima, Grad Sch Hlth Biosci, Dept Pharmacol, Tokushima 7708503, Japan; [Iwase, Takashi; Sata, Masataka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med Pharmacol, Tokushima 7708503, Japan; [Akaike, Masashi] Univ Tokushima, Grad Sch Hlth Biosci, Dept Med Educ, Tokushima 7708503, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University; University of Tokyo	Aihara, K (corresponding author), Univ Tokushima, Grad Sch Hlth Biosci, Dept Med & Bioregulatory Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	aihara@tokushima-u.ac.jp	Aihara, Ken-ichi/AEE-8245-2022	Aihara, Ken-ichi/0000-0001-8906-0920; Ikeda, Yasumasa/0000-0003-4318-7349	Grants-in-Aid for Scientific Research [22390159, 23790089, 24590381] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; Aihara K, 2007, J CLIN INVEST, V117, P1514, DOI 10.1172/JCI27095; Aihara K, 2009, J ATHEROSCLER THROMB, V16, P127, DOI 10.5551/jat.E695; Brevetti G, 2008, ATHEROSCLEROSIS, V197, P1, DOI 10.1016/j.atherosclerosis.2007.11.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Derian CK, 2002, BIOCHEMISTRY-MOSCOW+, V67, P56, DOI 10.1023/A:1013900130415; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084; Harris MB, 2004, AM J PHYSIOL-HEART C, V287, pH560, DOI 10.1152/ajpheart.00214.2004; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang PH, 2007, INT J CARDIOL, V114, P152, DOI 10.1016/j.ijcard.2005.12.009; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Ise T, 2011, HYPERTENS RES, V34, P225, DOI 10.1038/hr.2010.211; Izumi Y, 2009, HYPERTENS RES, V32, P675, DOI 10.1038/hr.2009.77; Kanagawa Y, 2001, THROMB HAEMOSTASIS, V85, P101, DOI 10.1055/s-0037-1612911; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li P, 2010, AM J PHYSIOL-ENDOC M, V299, pE560, DOI 10.1152/ajpendo.00284.2010; Mees B, 2007, ARTERIOSCL THROM VAS, V27, P1926, DOI 10.1161/ATVBAHA.107.145375; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Ohkawara H, 2010, CARDIOVASC RES, V88, P492, DOI 10.1093/cvr/cvq221; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; PARKER KA, 1985, J BIOL CHEM, V260, P3501; Schillinger M, 2004, THROMB HAEMOSTASIS, V92, P1108, DOI 10.1160/TH04-05-031; Shirk RA, 2000, J BIOL CHEM, V275, P18085, DOI 10.1074/jbc.M001659200; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sumitomo-Ueda Y, 2010, HYPERTENSION, V56, P430, DOI 10.1161/HYPERTENSIONAHA.110.152207; Takamori N, 2004, CIRCULATION, V109, P481, DOI 10.1161/01.CIR.0000109695.39671.37; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; TOLLEFSEN DM, 1982, J BIOL CHEM, V257, P2162; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Tollefsen DM, 2007, ARTERIOSCL THROM VAS, V27, P454, DOI 10.1161/01.ATV.0000256471.22437.88; Vicente CP, 2007, BLOOD, V110, P4261, DOI 10.1182/blood-2007-04-086611; Watts VL, 2009, EXP BIOL MED, V234, P132, DOI 10.3181/0807-RM-233; Yamanaga K, 2000, THROMB RES, V98, P95, DOI 10.1016/S0049-3848(99)00201-7	43	27	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34256	34263		10.1074/jbc.M112.353532	http://dx.doi.org/10.1074/jbc.M112.353532			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904320	Green Published, hybrid			2022-12-25	WOS:000309654200030
J	Mertens, HDT; Kjaergaard, M; Mysling, S; Gardsvoll, H; Jorgensen, TJD; Svergun, DI; Ploug, M				Mertens, Haydyn D. T.; Kjaergaard, Magnus; Mysling, Simon; Gardsvoll, Henrik; Jorgensen, Thomas J. D.; Svergun, Dmitri I.; Ploug, Michael			A Flexible Multidomain Structure Drives the Function of the Urokinase-type Plasminogen Activator Receptor (uPAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPPED-MONOCLONAL-ANTIBODIES; CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; TUMOR-GROWTH; CANCER; VITRONECTIN; SCATTERING; INVASION; BINDING; EPITOPE	The urokinase-type plasminogen activator receptor (uPAR) provides a rendezvous between proteolytic degradation of the extracellular matrix and integrin-mediated adhesion to vitronectin. These processes are, however, tightly linked because the high affinity binding of urokinase regulates the binding of uPAR to matrix-embedded vitronectin. Although crystal structures exist to define the corresponding static bi- and trimolecular receptor complexes, it is evident that the dynamic property of uPAR plays a decisive role in its function. In the present study, we combine small angle x-ray scattering, hydrogen-deuterium exchange, and surface plasmon resonance to develop a structural model describing the allosteric regulation of uPAR. We show that the flexibility of its N-terminal domain provides the key for understanding this allosteric mechanism. Importantly, our model has direct implications for understanding uPAR-assisted cell adhesion and migration as well as for translational research, including targeted intervention therapy and non-invasive tumor imaging in vivo.	[Gardsvoll, Henrik; Ploug, Michael] Rigshosp, Finsen Lab, DK-2200 Copenhagen N, Denmark; [Gardsvoll, Henrik; Ploug, Michael] Copenhagen Bioctr, BRIC, DK-2200 Copenhagen N, Denmark; [Mertens, Haydyn D. T.; Svergun, Dmitri I.] DESY, European Mol Biol Lab EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [Kjaergaard, Magnus] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark; [Mysling, Simon; Jorgensen, Thomas J. D.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Rigshospitalet; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Copenhagen; University of Southern Denmark	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk	Kjaergaard, Magnus/AAD-7717-2019	Kjaergaard, Magnus/0000-0002-7020-9366; Svergun, Dmitri/0000-0003-0830-5696; Jorgensen, Thomas J.D./0000-0002-7149-316X; Ploug, Michael/0000-0003-2215-4265; Mertens, Haydyn/0000-0002-5664-744X; Mysling, Simon/0000-0003-4221-6320	EMBL Interdisciplinary Postdocs program (EIPOD); Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer); National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	EMBL Interdisciplinary Postdocs program (EIPOD); Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer)(Danmarks Grundforskningsfond); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a fellowship from the EMBL Interdisciplinary Postdocs program (EIPOD) (to H. D. T. M.) and a grant from the Danish National Research Foundation (Danish-Chinese Centre for Proteases and Cancer) (to M. P. and H. G.).; We thank Gitte Juhl-Funch, Haldis Egholm Monsted, and John Post for excellent technical assistance. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081). All plots were created using the software package GRACE.	Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Ellis V, 1996, J BIOL CHEM, V271, P14779, DOI 10.1074/jbc.271.25.14779; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Khanna M, 2011, ACS CHEM BIOL, V6, P1232, DOI 10.1021/cb200180m; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kriegbaum M. C., 2011, CURR DRUG TARGETS, V27, P27; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Li ZB, 2008, CLIN CANCER RES, V14, P4758, DOI 10.1158/1078-0432.CCR-07-4434; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Luther T, 1997, AM J PATHOL, V150, P1231; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Persson M, 2012, J NUCL MED, V53, P138, DOI 10.2967/jnumed.110.083386; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; PLOUG M, 1991, J BIOL CHEM, V266, P1926; PLOUG M, 1992, BLOOD, V79, P1447; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schmiedeberg N, 2002, J MED CHEM, V45, P4984, DOI 10.1021/jm020254q; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Serrati S, 2011, ARTHRITIS RHEUM-US, V63, P2584, DOI 10.1002/art.30439; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058	56	39	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34304	34315		10.1074/jbc.M112.398404	http://dx.doi.org/10.1074/jbc.M112.398404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22896701	hybrid, Green Published			2022-12-25	WOS:000309654200034
J	Tanveer, R; Gowran, A; Noonan, J; Keating, SE; Bowie, AG; Campbell, VA				Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Keating, Sinead E.; Bowie, Andrew G.; Campbell, Veronica A.			The Endocannabinoid, Anandamide, Augments Notch-1 Signaling in Cultured Cortical Neurons Exposed to Amyloid-beta and in the Cortex of Aged Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX FACTORS; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CELL FATE; NICASTRIN; ACTIVATION; PRESENILIN; NUMB; TRANSDUCTION	Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although A beta(1-42) increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of gamma-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of A beta(1-42). AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate A beta(1-40). Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.	[Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Campbell, Veronica A.] Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland; [Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Campbell, Veronica A.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Keating, Sinead E.; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Campbell, VA (corresponding author), Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland.	vacmpbll@tcd.ie	Gowran, Aoife/K-6671-2016	Bowie, Andrew/0000-0001-5316-4373	Health Research Board Ireland	Health Research Board Ireland	This work is supported by Health Research Board Ireland.	Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boland B, 2003, NEUROBIOL AGING, V24, P179, DOI 10.1016/S0197-4580(02)00060-X; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Brijbassi S, 2007, NEUROBIOL DIS, V25, P291, DOI 10.1016/j.nbd.2006.09.013; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Chan SL, 2002, NEUROMOL MED, V1, P55; Checler F, 2010, NEURODEGENER DIS, V7, P50, DOI 10.1159/000283483; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Dale TC, 1998, BIOCHEM J, V329, P209; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; Frampton G, 2010, EXP CELL RES, V316, P1465, DOI 10.1016/j.yexcr.2010.03.017; Franberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009772; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Harrison H, 2010, CANCER RES, V70, P8973, DOI 10.1158/0008-5472.CAN-10-1559; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Kim SY, 2007, BBA-MOL CELL RES, V1773, P736, DOI 10.1016/j.bbamcr.2007.02.001; Kodam A, 2008, NEUROBIOL AGING, V29, P724, DOI 10.1016/j.neurobiolaging.2006.12.005; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Mackie K, 2006, INT J OBESITY, V30, pS19, DOI 10.1038/sj.ijo.0803273; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murphy Niamh, 2012, J Neuroinflammation, V9, P79, DOI 10.1186/1742-2094-9-79; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Nguyen V, 2006, BRAIN RES, V1086, P76, DOI 10.1016/j.brainres.2006.02.122; Noonan J, 2010, J BIOL CHEM, V285, P38543, DOI 10.1074/jbc.M110.162040; Pamren A, 2011, J BIOL CHEM, V286, P31153, DOI 10.1074/jbc.C111.235267; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Woo HN, 2009, BIOCHEM BIOPH RES CO, V390, P1093, DOI 10.1016/j.bbrc.2009.10.093; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	62	41	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34709	34721		10.1074/jbc.M112.350678	http://dx.doi.org/10.1074/jbc.M112.350678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891244	hybrid, Green Published			2022-12-25	WOS:000309654200071
J	Ukpabi, G; Takayama, SJ; Mauk, AG; Murphy, MEP				Ukpabi, Georgia; Takayama, Shin-ichi J.; Mauk, A. Grant; Murphy, Michael E. P.			Inactivation of the Heme Degrading Enzyme IsdI by an Active Site Substitution That Diminishes Heme Ruffling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA HEME; STAPHYLOCOCCUS-AUREUS; CORYNEBACTERIUM-DIPHTHERIAE; STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURES; HYDROXIDE COMPLEX; CATALYTIC SITE; CYTOCHROMES-B; OXYGENASE; PORPHYRINS	IsdG and IsdI are paralogous heme degrading enzymes from the bacterium Staphylococcus aureus. Heme bound by these enzymes is extensively ruffled such that the meso-carbons at the sites of oxidation are distorted toward bound oxygen. In contrast, the canonical heme oxygenase family degrades heme that is bound with minimal distortion. Trp-66 is a conserved heme pocket residue in IsdI implicated in heme ruffling. IsdI variants with Trp-66 replaced with residues having less bulky aromatic and alkyl side chains were characterized with respect to catalytic activity, heme ruffling, and electrochemical properties. The heme degradation activity of the W66Y and W66F variants was approximately half that of the wild-type enzyme, whereas the W66L and W66A variants were inactive. A crystal structure and NMR spectroscopic analysis of the W66Y variant reveals that heme binds to this enzyme with less heme ruffling than observed for wild-type IsdI. The reduction potential of this variant (-96 +/- 7 mV versus standard hydrogen electrode) is similar to that of wild-type IsdI (-89 +/- 7 mV), so we attribute the diminished activity of this variant to the diminished heme ruffling observed for heme bound to this enzyme and conclude that Trp-66 is required for optimal catalytic activity.	[Ukpabi, Georgia; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Takayama, Shin-ichi J.; Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Takayama, Shin-ichi J.; Mauk, A. Grant] Univ British Columbia, UBC Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Grant.Mauk@ubc.ca; Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014	Uehara Memorial Foundation; Canada Research Chair; Canadian Institutes of Health Research (CIHR) [MOP-49597]; Canadian Blood Services-CIHR; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Uehara Memorial Foundation(Uehara Memorial Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services-CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by a postdoctoral fellowship from the Uehara Memorial Foundation (to S. J. T.), a Canada Research Chair (to A. G. M.), Canadian Institutes of Health Research (CIHR) Operating Grant MOP-49597 (M. E. P. M.), a Canadian Blood Services-CIHR partnership grant (to A. G. M.), and the Canadian Foundation for Innovation (to A. G. M. and M. E. P. M.).; We thank Professor Lawrence McIntosh for use of the NMR spectrometer. Research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Cai S, 2006, INORG CHEM, V45, P3519, DOI 10.1021/ic0515352; Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960; Caignan GA, 2003, J AM CHEM SOC, V125, P11842, DOI 10.1021/ja036147i; Chu GC, 1999, J BIOL CHEM, V274, P24490, DOI 10.1074/jbc.274.35.24490; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1545, DOI 10.1021/bi00458a028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh A, 1999, J PHYS CHEM B, V103, P1363, DOI 10.1021/jp9830124; Gorst CM, 1998, J AM CHEM SOC, V120, P8875, DOI 10.1021/ja9815475; Haddad RE, 2003, J AM CHEM SOC, V125, P1253, DOI 10.1021/ja0280933; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Ma JG, 1998, BIOCHEMISTRY-US, V37, P12431, DOI 10.1021/bi981189i; Ma LH, 2006, J AM CHEM SOC, V128, P6657, DOI 10.1021/ja0584626; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 2006, COORDIN CHEM REV, V250, P2271, DOI 10.1016/j.ccr.2006.03.001; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; Ryeng H, 2002, J AM CHEM SOC, V124, P8099, DOI 10.1021/ja0202659; SAFO MK, 1992, J AM CHEM SOC, V114, P7066, DOI 10.1021/ja00044a017; Sato H, 2007, J INORG BIOCHEM, V101, P1394, DOI 10.1016/j.jinorgbio.2007.05.016; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walker FA, 1996, J AM CHEM SOC, V118, P12109, DOI 10.1021/ja961971a; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YAMAMOTO Y, 1993, BIOCHIM BIOPHYS ACTA, V1203, P267, DOI 10.1016/0167-4838(93)90093-7; Yang F, 2009, J BIOL INORG CHEM, V14, P1077, DOI 10.1007/s00775-009-0551-3; Yatsunyk LA, 2005, INORG CHEM, V44, P2848, DOI 10.1021/ic049089q; Zeng YH, 2005, J AM CHEM SOC, V127, P9794, DOI 10.1021/ja0425987; Zhou ZC, 2010, ORG LETT, V12, P1780, DOI 10.1021/ol100434w	46	30	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34179	34188		10.1074/jbc.M112.393249	http://dx.doi.org/10.1074/jbc.M112.393249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22891243	Green Published, hybrid			2022-12-25	WOS:000309654200023
J	Aldridge, K; Wang, L; Harms, MP; Moffitt, AJ; Cole, KK; Csernansky, JG; Selemon, LD				Aldridge, Kristina; Wang, Lei; Harms, Michael P.; Moffitt, Amanda J.; Cole, Kimberly K.; Csernansky, John G.; Selemon, Lynn D.			A Longitudinal Analysis of Regional Brain Volumes in Macaques Exposed to X-Irradiation in Early Gestation	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; LATERAL GENICULATE-NUCLEUS; PRIMATE VISUAL-CORTEX; PRENATAL EXPOSURE; CEREBRAL-CORTEX; RHESUS-MONKEY; SCHIZOPHRENIA; RISK; MRI; NEURONS	Background: Early gestation represents a period of vulnerability to environmental insult that has been associated with adult psychiatric disease. However, little is known about how prenatal perturbation translates into adult brain dysfunction. Here, we use a longitudinal study design to examine the effects of disruption of early gestational neurogenesis on brain volume in the non-human primate. Methods and Principal Findings: Five Rhesus macaques were exposed to x-irradiation in early gestation (E30-E41), and four control monkeys were sham-irradiated at comparable ages. Whole brain magnetic resonance imaging was performed at 6 months, 12 months, and 3 and 5 years of age. Volumes of whole cerebrum, cortical gray matter, caudate, putamen, and thalamus were estimated using semi-automated segmentation methods and high dimensional brain mapping. Volume reductions spanning all ages were observed in irradiated monkeys in the putamen (15-24%, p = 0.01) and in cortical gray matter (6-15%, p = 0.01). Upon covarying for whole cerebral volume, group differences were reduced to trend levels (putamen: p = 0.07; cortical gray matter: p = 0.08). No group-by-age effects were significant. Conclusions: Due to the small number of observations, the conclusions drawn from this study must be viewed as tentative. Early gestational irradiation may result in non-uniform reduction of gray matter, mainly affecting the putamen and cerebral cortex. This may be relevant to understanding how early prenatal environmental insult could lead to brain morphological differences in neurodevelopmental diseases.	[Aldridge, Kristina; Moffitt, Amanda J.; Cole, Kimberly K.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Wang, Lei; Csernansky, John G.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Wang, Lei; Csernansky, John G.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Harms, Michael P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Selemon, Lynn D.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Yale University	Aldridge, K (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	aldridgek@missouri.edu	Wang, Lei/I-7552-2013	Wang, Lei/0000-0003-3870-3388; Aldridge, Kristina/0000-0003-3924-761X; Harms, Michael/0000-0001-7945-036X	National Institutes of Health [P50-MH071616, RO1-MH59329, P50-MH44866, T32MH17104]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059329, P50MH071616, P50MH044866, T32MH017104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health grant numbers P50-MH071616, RO1-MH59329, P50-MH44866, T32MH17104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Algan O, 1997, J COMP NEUROL, V381, P335, DOI 10.1002/(SICI)1096-9861(19970512)381:3<335::AID-CNE6>3.0.CO;2-3; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; BRAND S, 1979, NEUROSCIENCE, V4, P767, DOI 10.1016/0306-4522(79)90005-8; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Brown AS, 2011, FRONT PSYCHIATRY, V2, P1; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; EIDELBERG D, 1982, ARCH NEUROL-CHICAGO, V39, P325, DOI 10.1001/archneur.1982.00510180003001; Friedman HR, 2010, BIOL PSYCHIAT, V68, P108, DOI 10.1016/j.biopsych.2010.02.021; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hollister JM, 1996, ARCH GEN PSYCHIAT, V53, P19; Insel BJ, 2008, ARCH GEN PSYCHIAT, V65, P1136, DOI 10.1001/archpsyc.65.10.1136; Insel BJ, 2005, SCHIZOPHR RES, V80, P331, DOI 10.1016/j.schres.2005.06.005; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kohn L, 1992, ELECT IMAGING HUMAN, P114; Kruggel F, 2010, NEUROIMAGE, V49, P2123, DOI 10.1016/j.neuroimage.2009.11.006; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lovanovsky K, 2008, J NEUROPSYCHIATRY CL, V20, P274; Maldova L, 2006, EUR J NEUROSCI, V24, P3204; MATHALON DH, 1993, PSYCHIAT RES-NEUROIM, V50, P121, DOI 10.1016/0925-4927(93)90016-B; O'Leary CM, 2010, ADDICTION, V105, P74, DOI 10.1111/j.1360-0443.2009.02756.x; OGREN MP, 1981, ANAT EMBRYOL, V162, P1, DOI 10.1007/BF00318090; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Paxinos G., 2000, RHESUS MONKEY BRAIN; Penner Justin D, 2007, Expert Rev Neurother, V7, P797, DOI 10.1586/14737175.7.7.797; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; RAKIC P, 1977, J COMP NEUROL, V176, P23, DOI 10.1002/cne.901760103; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 1976, NATURE, V176, P23; Rakic P, 1974, SCIENCE, V183, P170; Reig S, 2009, HUM BRAIN MAPP, V30, P355, DOI 10.1002/hbm.20511; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Schindler MK, 2002, BIOL PSYCHIAT, V51, P827, DOI 10.1016/S0006-3223(01)01341-5; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Selemon LD, 2005, BIOL PSYCHIAT, V57, P83, DOI 10.1016/j.biopsych.2004.10.014; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Suner I, 1996, VISUAL NEUROSCI, V13, P585, DOI 10.1017/S0952523800008269; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037	49	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43109	10.1371/journal.pone.0043109	http://dx.doi.org/10.1371/journal.pone.0043109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905212	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800046
J	Arriero, MD; Ramis, JM; Perello, J; Monjo, M				del Mar Arriero, Maria; Ramis, Joana M.; Perello, Joan; Monjo, Marta			Inositol Hexakisphosphate Inhibits Osteoclastogenesis on RAW 264.7 Cells and Human Primary Osteoclasts	PLOS ONE			English	Article							KAPPA-B LIGAND; RENAL STONE FORMATION; IN-VITRO; RECEPTOR ACTIVATOR; BONE-RESORPTION; MYOINOSITOL HEXAKISPHOSPHATE; BIOLOGICAL-ACTIVITIES; HUMAN OSTEOBLASTS; DIETARY PHYTATE; GIANT-CELLS	Background: Inoxitol hexakisphosphate (IP6) has been found to have an important role in biomineralization and a direct effect inhibiting mineralization of osteoblasts in vitro without impairing extracellular matrix production and expression of alkaline phosphatase. IP6 has been proposed to exhibit similar effects to those of bisphosphonates on bone resorption, however, its direct effect on osteoclasts (OCL) is presently unknown. Methodology/Principal Findings: The aim of the present study was to investigate the effect of IP6 on the RAW 264.7 monocyte/macrophage mouse cell line and on human primary osteoclasts. On one hand, we show that IP6 decreases the osteoclastogenesis in RAW 264.7 cells induced by RANKL, without affecting cell proliferation or cell viability. The number of TRAP positive cells and mRNA levels of osteoclast markers such as TRAP, calcitonin receptor, cathepsin K and MMP-9 was decreased by IP6 on RANKL-treated cells. On the contrary, when giving IP6 to mature osteoclasts after RANKL treatment, a significant increase of bone resorption activity and TRAP mRNA levels was found. On the other hand, we show that 1 mu M of IP6 inhibits osteoclastogenesis of human peripheral blood mononuclear cells (PBMNC) and their resorption activity both, when given to undifferentiated and to mature osteoclasts. Conclusions/Significance: Our results demonstrate that IP6 inhibits osteoclastogenesis on human PBMNC and on the RAW264.7 cell line. Thus, IP6 may represent a novel type of selective inhibitor of osteoclasts and prove useful for the treatment of osteoporosis.	[del Mar Arriero, Maria; Ramis, Joana M.; Monjo, Marta] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Spain; [Perello, Joan] ParcBIT, Lab Sanifit, Palma de Mallorca, Spain	Universitat de les Illes Balears	Arriero, MD (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Spain.	marta.monjo@uib.es	Perello, Joan/A-7387-2019; Ramis, Joana Maria/AAF-4892-2020; Monjo, Marta/GVS-7077-2022	Perello, Joan/0000-0003-2671-3386; Ramis, Joana Maria/0000-0001-9109-8362; Monjo, Marta/0000-0002-2731-9527	INVEST IN SPAIN [C2_10_32]; European Regional Development Fund (ERDF) from the European Union; Eureka-Eurostars Project Application NewBone [E! 5069]; Centre for the Development of Industrial Technology (CDTI) [CIIP20101024]; Ministry of Science and Innovation of Spain (Torres Quevedo contract); Ministry of Science and Innovation of Spain (Ramon y Cajal contract)	INVEST IN SPAIN; European Regional Development Fund (ERDF) from the European Union; Eureka-Eurostars Project Application NewBone; Centre for the Development of Industrial Technology (CDTI); Ministry of Science and Innovation of Spain (Torres Quevedo contract); Ministry of Science and Innovation of Spain (Ramon y Cajal contract)	This work was supported by INVEST IN SPAIN (C2_10_32), European Regional Development Fund (ERDF) from the European Union, Eureka-Eurostars Project Application E! 5069 NewBone, Interempresas Internacional Program (CIIP20101024) from the Centre for the Development of Industrial Technology (CDTI) and the Ministry of Science and Innovation of Spain (Torres Quevedo contract to J.M. Ramis, and Ramon y Cajal contract to M. Monjo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2010, BONE, V46, P1100, DOI 10.1016/j.bone.2010.01.367; Blair HC, 2004, J BONE MINER RES, V19, P1329, DOI 10.1359/JBMR.040403; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; Chakraborty A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001958; Conte A, 1999, Arch Esp Urol, V52, P305; Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7; Giuliani N, 1998, SCAND J RHEUMATOL, V27, P38; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2004, LIFE SCI, V75, P11, DOI 10.1016/j.lfs.2003.11.030; Grases F, 2009, J PERIODONTAL RES, V44, P616, DOI 10.1111/j.1600-0765.2008.01168.x; Grases F, 1998, SCAND J UROL NEPHROL, V32, P261; Grases F, 1999, ANTICANCER RES, V19, P3717; Grases F, 2001, J NUTR BIOCHEM, V12, P595, DOI 10.1016/S0955-2863(01)00178-4; Grases F, 2001, BRIT J NUTR, V86, P225, DOI 10.1079/BJN2001389; Grases F, 2000, UROL RES, V28, P136, DOI 10.1007/s002400050152; Grases F, 2000, BIOFACTORS, V11, P171, DOI 10.1002/biof.5520110303; GRASES F, 1994, BRIT J UROL, V74, P298, DOI 10.1111/j.1464-410X.1994.tb16614.x; Grases F, 2008, CARDIOVASC PATHOL, V17, P139, DOI 10.1016/j.carpath.2007.08.005; Grases F, 2007, CIRC J, V71, P1152, DOI 10.1253/circj.71.1152; Grases F, 2007, FRONT BIOSCI-LANDMRK, V12, P2580, DOI 10.2741/2256; Grases F, 2010, J MED FOOD, V13, P1301, DOI 10.1089/jmf.2009.0152; Grases F, 2008, J NEPHROL, V21, P768; Greiner S, 2007, J BIOMED MATER RES A, V80A, P769, DOI 10.1002/jbm.a.30950; Greiner S, 2007, J BIOMED MATER RES A, V83A, P1184, DOI 10.1002/jbm.a.31444; HAWKINS PT, 1993, BIOCHEM J, V294, P929, DOI 10.1042/bj2940929; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Irvine RF, 2005, J PHYSIOL-LONDON, V566, P295, DOI 10.1113/jphysiol.2005.087387; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Lopez-Gonzalez AA, 2008, J MED FOOD, V11, P747, DOI 10.1089/jmf.2008.0087; Lopez-Gonzalez Angel A, 2010, Front Biosci (Elite Ed), V2, P1093; MAGRILL DS, 1973, J DENT RES, V52, P1342, DOI 10.1177/00220345730520063401; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Reinholz GG, 2000, CANCER RES, V60, P6001; Reszka AA, 2004, MINI-REV MED CHEM, V4, P711; Rodan G, 2004, CURR MED RES OPIN, V20, P1291, DOI 10.1185/030079904125004475; Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; SASAKAWA N, 1995, BIOCHEM PHARMACOL, V50, P137, DOI 10.1016/0006-2952(95)00059-9; SHADDUCK RK, 1993, EXP HEMATOL, V21, P515; Shamsuddin AM, 1999, ANTICANCER RES, V19, P3733; Shamsuddin AM, 1997, LIFE SCI, V61, P343, DOI 10.1016/S0024-3205(97)00092-1; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Susa Mira, 2004, J Transl Med, V2, P6, DOI 10.1186/1479-5876-2-6; Toro EJ, 2012, J BIOL CHEM; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; Van Beek ER, 2002, BONE, V30, P64, DOI 10.1016/S8756-3282(01)00655-X; Viereck V, 2002, BIOCHEM BIOPH RES CO, V291, P680, DOI 10.1006/bbrc.2002.6510; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wittrant Y, 2004, EXP CELL RES, V293, P292, DOI 10.1016/j.yexcr.2003.10.016; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	67	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43187	10.1371/journal.pone.0043187	http://dx.doi.org/10.1371/journal.pone.0043187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905230	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800059
J	Feng, P; Zhao, H; Chai, JH; Huang, LQ; Wang, H				Feng, Pu; Zhao, Hang; Chai, Jinghua; Huang, Liquan; Wang, Hong			Expression and Secretion of TNF-alpha in Mouse Taste Buds: A Novel Function of a Specific Subset of Type II Taste Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SIGNALING PATHWAYS; MAMMALIAN SWEET; INNATE IMMUNITY; RECEPTORS; LIPOPOLYSACCHARIDE; INFLAMMATION; GUSTDUCIN; APOPTOSIS; PROTEINS	Taste buds are chemosensory structures widely distributed on the surface of the oral cavity and larynx. Taste cells, exposed to the oral environment, face great challenges in defense against potential pathogens. While immune cells, such as T-cells and macrophages, are rarely found in taste buds, high levels of expression of some immune-response-associated molecules are observed in taste buds. Yet, the cellular origins of these immune molecules such as cytokines in taste buds remain to be determined. Here, we show that a specific subset of taste cells selectively expresses high levels of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Based on immuno-colocalization experiments using taste-cell-type markers, the TNF-alpha-producing cells are predominantly type II taste cells expressing the taste receptor T1R3. These cells can rapidly increase TNF-alpha production and secretion upon inflammatory challenges, both in vivo and in vitro. The lipopolysaccharide (LPS)-induced TNF-alpha expression in taste cells was completely eliminated in TLR2(-/-)/TLR4(-/-) double-gene-knockout mice, which confirms that the induction of TNF-alpha in taste buds by LPS is mediated through TLR signaling pathways. The taste-cell-produced TNF-alpha may contribute to local immune surveillance, as well as regulate taste sensation under normal and pathological conditions.	[Feng, Pu; Chai, Jinghua; Huang, Liquan; Wang, Hong] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Zhao, Hang] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Zhao, Hang] Harvard Univ, Sch Med, Boston, MA USA	Monell Chemical Senses Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Feng, P (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pfeng@monell.org; hwang@monell.org		Wang, Hong/0000-0003-4130-8741	National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants [DC010012, DC007487, P30 DC011735]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007487, R01DC010012, P30DC011735] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by National Institutes of Health/National Institute of Deafness and Other Communication Disorders grants DC010012 (H.W.), DC007487 (L.H.), and P30 DC011735 and by a grant from the National Science Foundation DBJ-0216310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cannon JG, 2000, NEWS PHYSIOL SCI, V15, P298, DOI 10.1152/physiologyonline.2000.15.6.298; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cohn ZJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-72; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Feng P, 2010, CHEM SENSES, V35, P501, DOI 10.1093/chemse/bjq040; Feng P, 2009, BRAIN BEHAV IMMUN, V23, P760, DOI 10.1016/j.bbi.2009.02.016; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Ghallab NA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/847632; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hoshino K, 1999, J IMMUNOL, V162, P3749; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; JONES GJ, 1986, CANCER, V57, P1709, DOI 10.1002/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035588; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Moen K, 2005, ORAL SURG ORAL MED O, V100, P433, DOI 10.1016/j.tripleo.2005.05.060; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niu YL, 2009, CYTOKINE, V47, P23, DOI 10.1016/j.cyto.2009.04.003; Phillips LM, 1996, AM J PHYSIOL-REG I, V271, pR857, DOI 10.1152/ajpregu.1996.271.4.R857; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Shi LQ, 2012, J NEUROSCI RES, V90, P816, DOI 10.1002/jnr.22798; Sklavounou A, 2000, J ORAL PATHOL MED, V29, P370, DOI 10.1034/j.1600-0714.2000.290802.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tomonari H, 2012, CHEM SENSES, V37, P241, DOI 10.1093/chemse/bjr098; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; Wang H, 2009, ANN NY ACAD SCI, V1170, P596, DOI 10.1111/j.1749-6632.2009.04480.x; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	43	28	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43140	10.1371/journal.pone.0043140	http://dx.doi.org/10.1371/journal.pone.0043140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905218	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800051
J	Nassini, R; Pedretti, P; Moretto, N; Fusi, C; Carnini, C; Facchinetti, F; Viscomi, AR; Pisano, AR; Stokesberry, S; Brunmark, C; Svitacheva, N; McGarvey, L; Patacchini, R; Damholt, AB; Geppetti, P; Materazzi, S				Nassini, Romina; Pedretti, Pamela; Moretto, Nadia; Fusi, Camilla; Carnini, Chiara; Facchinetti, Fabrizio; Viscomi, Arturo Roberto; Pisano, Anna Rita; Stokesberry, Susan; Brunmark, Charlott; Svitacheva, Naila; McGarvey, Lorcan; Patacchini, Riccardo; Damholt, Anders B.; Geppetti, Pierangelo; Materazzi, Serena			Transient Receptor Potential Ankyrin 1 Channel Localized to Non-Neuronal Airway Cells Promotes Non-Neurogenic Inflammation	PLOS ONE			English	Article							CIGARETTE-SMOKE; ALPHA,BETA-UNSATURATED ALDEHYDES; ION-CHANNEL; CAPSAICIN RECEPTOR; TRPA1; ANTAGONIST; PAIN; ACTIVATION; RELEASE; A1	Background: The transient receptor potential ankyrin 1 (TRPA1) channel, localized to airway sensory nerves, has been proposed to mediate airway inflammation evoked by allergen and cigarette smoke (CS) in rodents, via a neurogenic mechanism. However the limited clinical evidence for the role of neurogenic inflammation in asthma or chronic obstructive pulmonary disease raises an alternative possibility that airway inflammation is promoted by non-neuronal TRPA1. Methodology/Principal Findings: By using Real-Time PCR and calcium imaging, we found that cultured human airway cells, including fibroblasts, epithelial and smooth muscle cells express functional TRPA1 channels. By using immunohistochemistry, TRPA1 staining was observed in airway epithelial and smooth muscle cells in sections taken from human airways and lung, and from airways and lung of wild-type, but not TRPA1-deficient mice. In cultured human airway epithelial and smooth muscle cells and fibroblasts, acrolein and CS extract evoked IL-8 release, a response selectively reduced by TRPA1 antagonists. Capsaicin, agonist of the transient receptor potential vanilloid 1 (TRPV1), a channel co-expressed with TRPA1 by airway sensory nerves, and acrolein or CS (TRPA1 agonists), or the neuropeptide substance P (SP), which is released from sensory nerve terminals by capsaicin, acrolein or CS), produced neurogenic inflammation in mouse airways. However, only acrolein and CS, but not capsaicin or SP, released the keratinocyte chemoattractant (CXCL-1/KC, IL-8 analogue) in bronchoalveolar lavage (BAL) fluid of wild-type mice. This effect of TRPA1 agonists was attenuated by TRPA1 antagonism or in TRPA1-deficient mice, but not by pharmacological ablation of sensory nerves. Conclusions: Our results demonstrate that, although either TRPV1 or TRPA1 activation causes airway neurogenic inflammation, solely TRPA1 activation orchestrates an additional inflammatory response which is not neurogenic. This finding suggests that non-neuronal TRPA1 in the airways is functional and potentially capable of contributing to inflammatory airway diseases.	[Nassini, Romina; Pedretti, Pamela; Fusi, Camilla; Geppetti, Pierangelo; Materazzi, Serena] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Pedretti, Pamela; Moretto, Nadia; Carnini, Chiara; Facchinetti, Fabrizio; Pisano, Anna Rita; Patacchini, Riccardo] Chiesi Farmaceutici SpA, Dept Pharmacol, Parma, Italy; [Viscomi, Arturo Roberto] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Stokesberry, Susan; McGarvey, Lorcan] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Brunmark, Charlott; Svitacheva, Naila; Damholt, Anders B.] AstraZeneca Res & Dev Innovat Med Resp Inflammat, Molndal, Sweden; [Brunmark, Charlott] Truly Translat Sweden AB, Lund, Sweden; [Svitacheva, Naila] Dis Pharmacol LEO Pharma AS, Ballerup, Denmark; [Damholt, Anders B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Geppetti, Pierangelo] Univ Florence, Headache Ctr, Florence, Italy	University of Florence; Chiesi Pharmaceuticals Inc; University of Parma; Queens University Belfast; AstraZeneca; University of Copenhagen; University of Florence	Nassini, R (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy.	geppetti@unifi.it	Nassini, Romina/AAC-5051-2022; Geppetti, Pierangelo/AHA-7897-2022	Nassini, Romina/0000-0002-9223-8395; 	Regione Toscana: "Regional Health Research Program"; FABER - POR CREO [FESR 2007-2013 1.1.C.]; Italian Institute of Technology; Ente Cassa di Risparmio di Firenze; AstraZenca	Regione Toscana: "Regional Health Research Program"(Regione Toscana); FABER - POR CREO; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); AstraZenca	This work was supported by grants from Regione Toscana: "Regional Health Research Program 2009" and "FABER - POR CREO, FESR 2007-2013 1.1.C." and the Italian Institute of Technology, "Project SEED", and Ente Cassa di Risparmio di Firenze. The work was also funded by AstraZenca; this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andre E, 2009, BRIT J PHARMACOL, V158, P1621, DOI 10.1111/j.1476-5381.2009.00438.x; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Belvisi MG, 2011, CHEST, V140, P1040, DOI 10.1378/chest.10-3327; Bertrand C, 1996, TRENDS PHARMACOL SCI, V17, P255, DOI 10.1016/S0165-6147(96)10027-4; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Boot JD, 2007, AM J RESP CRIT CARE, V175, P450, DOI 10.1164/rccm.200608-1186OC; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; DELAYGOYET P, 1991, EUR J PHARMACOL, V203, P157, DOI 10.1016/0014-2999(91)90808-4; Dykewicz MS, 2009, J ALLERGY CLIN IMMUN, V123, P519, DOI 10.1016/j.jaci.2009.01.061; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P879, DOI 10.1164/ajrccm.152.3.7663799; GEPPETTI P, 1995, CAN J PHYSIOL PHARM, V73, P843, DOI 10.1139/y95-115; Geppetti P, 1996, NEUROGENIC INFLAMMAT, P1; Hens G, 2011, AM J RESP CELL MOL, V44, P517, DOI 10.1165/rcmb.2009-0425OC; Hsieh YL, 2008, J NEUROPATH EXP NEUR, V67, P93, DOI 10.1097/nen.0b013e3181630bb8; Joos Guy F., 2001, Current Opinion in Pharmacology, V1, P235, DOI 10.1016/S1471-4892(01)00042-X; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kishimoto E, 2011, AM J PHYSIOL-GASTR L, V301, pG230, DOI 10.1152/ajpgi.00436.2009; LUNDBERG JM, 1983, NATURE, V302, P251, DOI 10.1038/302251a0; Malo JL, 2009, AM J RESP CRIT CARE, V179, P923, DOI 10.1164/rccm.200810-1550OC; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Mukhopadhyay I, 2011, J RECEPT SIG TRANSD, V31, P350, DOI 10.3109/10799893.2011.602413; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; STEDMAN RL, 1968, CHEM REV, V68, P153, DOI 10.1021/cr60252a002; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Talavera K, 2009, NAT NEUROSCI, V12, P1293, DOI 10.1038/nn.2379; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Taylor-Clark TE, 2009, J PHYSL, V588, P423; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Tigyi G, 2012, NAT CHEM BIOL, V8, P22, DOI 10.1038/nchembio.738; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104	58	169	173	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42454	10.1371/journal.pone.0042454	http://dx.doi.org/10.1371/journal.pone.0042454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905134	Green Submitted, Green Published, gold			2022-12-25	WOS:000307500800011
J	Shafiq, MI; Steinbrecher, T; Schmid, R				Shafiq, Muhammad Imtiaz; Steinbrecher, Thomas; Schmid, Ralf			FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; DEPENDENT KINASE INHIBITOR; LYMPHOCYTIC-LEUKEMIA CLL; FLAVOPIRIDOL ALVOCIDIB; SELECTIVE INHIBITORS; PROTEIN-LIGAND; CELL-CYCLE; NONNUCLEOSIDE INHIBITORS; BIOMOLECULAR SIMULATIONS; CDK4-SPECIFIC INHIBITORS	Cyclin-dependent kinases (CDKs) play a key role in the cell cycle and are important anti-cancer drug targets. The natural product fascaplysin inhibits CDK4 with surprising selectivity (IC50 = 0.4 mu M) compared to the close homolog CDK2 (IC50 = 500 mu M). Free energy calculations of the positively charged fascaplysin and an uncharged iso-electronic derivative in the CDK2 and CDK4 inhibitor complexes indicate that the positive charge of fascaplysin is crucial for selectivity. This finding will guide further improvements in the design of fascaplysin-based selective inhibitors for CDK4.	[Shafiq, Muhammad Imtiaz; Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Shafiq, Muhammad Imtiaz] Univ Punjab, Inst Chem, Lahore, Pakistan; [Steinbrecher, Thomas] Univ Karlsruhe, Inst Phys Chem, Abt Theoret Chem Biol, Karlsruher Inst Technol, Karlsruhe, Germany	University of Leicester; University of Punjab; Helmholtz Association; Karlsruhe Institute of Technology	Shafiq, MI (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	thomas.steinbrecher@kit.edu; R.Schmid@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023	Higher Education Commission (HEC) Pakistan; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	MIS was supported by a PhD studentship provided by the Higher Education Commission (commonly known as HEC) Pakistan (www.hec.gov.pk/). The authors acknowledge support for open access publishing by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; au>Hypercube Inc, 2008, HYPERCHEM TM PROF 8; Aubry C, 2006, ORG BIOMOL CHEM, V4, P787, DOI 10.1039/b518019h; Aubry C, 2004, CHEM COMMUN, P1696, DOI 10.1039/b406076h; Aubry C, 2009, BIOORGAN MED CHEM, V17, P6073, DOI 10.1016/j.bmc.2009.06.070; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Buolamwini JK, 2000, CURR PHARM DESIGN, V6, P379, DOI 10.2174/1381612003400948; Carvajal RD, 2009, PANCREATOLOGY, V9, P404, DOI 10.1159/000187135; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chipot C, 2005, J COMPUT AID MOL DES, V19, P765, DOI 10.1007/s10822-005-9021-3; Darden T, 1998, J CHEM PHYS, V109, P10921, DOI 10.1063/1.477788; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Finn RS, 2011, J CLIN ONCOL S, V29; Foloppe N, 2006, CURR MED CHEM, V13, P3583, DOI 10.2174/092986706779026165; Frisch M., 2016, GAUSSIAN 16 REVISION; Fry DW, 2004, MOL CANCER THER, V3, P1427; Garcia MD, 2006, ORG BIOMOL CHEM, V4, P4478, DOI 10.1039/b613861f; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Grillo M, 2006, BREAST CANCER RES TR, V95, P185, DOI 10.1007/s10549-005-9066-y; Grossfield A, 2003, J AM CHEM SOC, V125, P15671, DOI 10.1021/ja037005r; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Horiuchi T, 2009, BIOORGAN MED CHEM, V17, P7850, DOI 10.1016/j.bmc.2009.10.039; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jenkins PR, 2008, BIOORGAN MED CHEM, V16, P7728, DOI 10.1016/j.bmc.2008.07.002; Jiang YJ, 2005, J MOL MODEL, V11, P509, DOI 10.1007/s00894-005-0263-8; Jorgensen WL, 2008, J CHEM THEORY COMPUT, V4, P869, DOI 10.1021/ct800011m; Jorgensen WL, 2006, BIOORG MED CHEM LETT, V16, P663, DOI 10.1016/j.bmcl.2005.10.038; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kim JT, 2006, J AM CHEM SOC, V128, P15372, DOI 10.1021/ja066472g; Lacrima K, 2005, ANN ONCOL, V16, P1169, DOI 10.1093/annonc/mdi217; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lazaridis T, 2002, CURR ORG CHEM, V6, P1319, DOI 10.2174/1385272023373491; Li AX, 2008, J MOL STRUC-THEOCHEM, V849, P62, DOI 10.1016/j.theochem.2007.10.015; Lin TS, 2007, BLOOD, V110, p913A, DOI 10.1182/blood.V110.11.3104.3104; Lin TS, 2008, BLOOD, V112, P23; Mahale S, 2006, BIOORG CHEM, V34, P287, DOI 10.1016/j.bioorg.2006.06.004; Mahale S, 2006, BIOORG MED CHEM LETT, V16, P4272, DOI 10.1016/j.bmcl.2006.05.065; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2006, CANCER CELL, V9, P2, DOI 10.1016/j.ccr.2005.12.026; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mascarenhas NM, 2008, J CHEM INF MODEL, V48, P1325, DOI 10.1021/ci8000343; Mascarenhas NM, 2010, J MOL GRAPH MODEL, V28, P695, DOI 10.1016/j.jmgm.2010.01.008; McInnes C, 2004, CHEM BIOL, V11, P525, DOI 10.1016/j.chembiol.2004.03.022; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Ortega S., 2002, Current Genomics, V3, P245, DOI 10.2174/1389202023350444; Park H, 2004, CHEMBIOCHEM, V5, P1662, DOI 10.1002/cbic.200400214; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Reddy MR, 2000, REV COMP CH, V16, P217, DOI 10.1002/9780470125939.ch4; ROLL DM, 1988, J ORG CHEM, V53, P3276, DOI 10.1021/jo00249a025; Rossi KA, 2005, J COMPUT AID MOL DES, V19, P111, DOI 10.1007/s10822-005-1778-x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Simonson T, 2002, ACCOUNTS CHEM RES, V35, P430, DOI 10.1021/ar010030m; Steinbrecher T, 2006, J MED CHEM, V49, P1837, DOI 10.1021/jm0505720; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Steinbrecher T, 2011, J COMPUT CHEM, V32, P3253, DOI 10.1002/jcc.21909; Steinbrecher T, 2010, CURR MED CHEM, V17, P767, DOI 10.2174/092986710790514453; Stembrecher T, 2008, BIOORGAN MED CHEM, V16, P2385, DOI 10.1016/j.bmc.2007.11.070; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tsou HR, 2008, J MED CHEM, V51, P3507, DOI 10.1021/jm800072z; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wesierska-Gadek J, 2011, J CELL PHYSIOL, V226, P341, DOI 10.1002/jcp.22426; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zeevaart JG, 2008, J AM CHEM SOC, V130, P9492, DOI 10.1021/ja8019214	86	37	39	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42612	10.1371/journal.pone.0042612	http://dx.doi.org/10.1371/journal.pone.0042612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905154	Green Published, gold			2022-12-25	WOS:000307500800018
J	Wang, YJ; Rao, VK; Kok, WK; Roy, DN; Sethi, S; Ling, BMT; Lee, MBH; Taneja, R				Wang, Yaju; Rao, Vinay Kumar; Kok, Wai Kay; Roy, Dijendra Nath; Sethi, Sumita; Ling, Belinda Mei Tze; Lee, Martin Beng Huat; Taneja, Reshma			SUMO Modification of Stra13 Is Required for Repression of Cyclin D1 Expression and Cellular Growth Arrest	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DEC1; HISTONE DEACETYLASES; INDUCED APOPTOSIS; GENE-EXPRESSION; DIFFERENTIATION; ACTIVATION; HYPOXIA; CANCER; SUMOYLATION; OVEREXPRESSION	Stra13, a basic helix-loop-helix (bHLH) transcription factor is involved in myriad biological functions including cellular growth arrest, differentiation and senescence. However, the mechanisms by which its transcriptional activity and function are regulated remain unclear. In this study, we provide evidence that post-translational modification of Stra13 by Small Ubiquitin-like Modifier (SUMO) dramatically potentiates its ability to transcriptionally repress cyclin D1 and mediate G(1) cell cycle arrest in fibroblast cells. Mutation of SUMO acceptor lysines 159 and 279 located in the C-terminal repression domain has no impact on nuclear localization; however, it abrogates association with the co-repressor histone deacetylase 1 (HDAC1), attenuates repression of cyclin D1, and prevents Stra13-mediated growth suppression. HDAC1, which promotes cellular proliferation and cell cycle progression, antagonizes Stra13 sumoylation-dependent growth arrest. Our results uncover an unidentified regulatory axis between Stra13 and HDAC1 in progression through the G(1)/S phase of the cell cycle, and provide new mechanistic insights into regulation of Stra13-mediated transcriptional repression by sumoylation.	[Wang, Yaju; Rao, Vinay Kumar; Kok, Wai Kay; Roy, Dijendra Nath; Sethi, Sumita; Ling, Belinda Mei Tze; Taneja, Reshma] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Lee, Martin Beng Huat] Natl Univ Hlth Syst, Div Nephrol, Singapore, Singapore	National University of Singapore; National University of Singapore	Wang, YJ (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	phsrt@nus.edu.sg	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Lee, Martin/0000-0002-4809-3088; Reshma, Taneja/0000-0001-6214-6177; SETHI, SUMITA/0000-0002-6663-8010	National Medical Research Foundation	National Medical Research Foundation	This work was supported by funds from the National Medical Research Foundation (R.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2001, ONCOGENE, V20, P1771, DOI 10.1038/sj.onc.1204212; Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Fujimoto K, 2007, INT J MOL MED, V19, P925; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Hayakawa F, 2008, J BIOL CHEM, V283, P24420, DOI 10.1074/jbc.M802217200; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hong YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023046; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova A, 2005, J MED GENET, V42, P565, DOI 10.1136/jmg.2004.029835; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Liu JJ, 2010, FEBS LETT, V584, P619, DOI 10.1016/j.febslet.2009.12.011; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Miyazaki K, 2010, J IMMUNOL, V185, P7330, DOI 10.4049/jimmunol.1001381; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Sun Hong, 2007, Transl Oncogenomics, V2, P107; Thin TH, 2007, EMBO REP, V8, P401, DOI 10.1038/sj.embor.7400912; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43137	10.1371/journal.pone.0043137	http://dx.doi.org/10.1371/journal.pone.0043137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905217	Green Published, gold, Green Submitted			2022-12-25	WOS:000307500800050
J	Dai, JP; Li, WZ; Zhao, XF; Wang, GF; Yang, JC; Zhang, L; Chen, XX; Xu, YX; Li, KS				Dai, Jian-Ping; Li, Wei-Zhong; Zhao, Xiang-Feng; Wang, Ge-Fei; Yang, Jia-Cai; Zhang, Lin; Chen, Xiao-Xuan; Xu, Yan-Xuan; Li, Kang-Sheng			A Drug Screening Method Based on the Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus	PLOS ONE			English	Article							CELL-GROWTH; ASSAY; REPLICATION; COMPLEXES; H5N1; ACTIVATION; INHIBITORS; INDUCTION; APOPTOSIS; DEATH	In this research, we have established a drug screening method based on the autophagy signal pathway using the bimolecular fluorescence complementation - fluorescence resonance energy transfer (BiFC-FRET) technique to develop novel anti-influenza A virus (IAV) drugs. We selected Evodia rutaecarpa Benth out of 83 examples of traditional Chinese medicine and explored the mechanisms of evodiamine, the major active component of Evodia rutaecarpa Benth, on anti-IAV activity. Our results showed that evodiamine could significantly inhibit IAV replication, as determined by a plaque inhibition assay, an IAV vRNA promoter luciferase reporter assay and the Sulforhodamine B method using cytopathic effect (CPE) reduction. Additionally, evodiamine could significantly inhibit the accumulation of LC3-II and p62, and the dot-like aggregation of EGFP-LC3. This compound also inhibited the formation of the Atg5-Atg12/Atg16 heterotrimer, the expressions of Atg5, Atg7 and Atg12, and the cytokine release of TNF-alpha, IL-1 beta, IL-6 and IL-8 after IAV infection. Evodiamine inhibited IAV-induced autophagy was also dependent on its action on the AMPK/TSC2/mTOR signal pathway. In conclusion, we have established a new drug screening method, and selected evodiamine as a promising anti-IAV compound.	[Dai, Jian-Ping; Zhao, Xiang-Feng; Wang, Ge-Fei; Yang, Jia-Cai; Zhang, Lin; Chen, Xiao-Xuan; Xu, Yan-Xuan; Li, Kang-Sheng] Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China; [Li, Wei-Zhong] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dai, JP (corresponding author), Shantou Univ Med Coll, Dept Microbiol & Immunol, Shantou, Guangdong, Peoples R China.	ksli@stu.edu.cn	Wang, Gefei/A-1206-2013	Li, Kangsheng/0000-0002-6981-9263; Li, Weizhong/0000-0002-8602-8375	The National Natural Science Foundation of China [30972766, 31170852, 81001322, 81172795]; Guangdong Natural Science Foundation [9451503102003499]; Doctoral Program Foundation of Institutions of Higher Education of China [20094402110004]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from The National Natural Science Foundation of China (30972766, 31170852, 81001322, 81172795), Guangdong Natural Science Foundation (9451503102003499), and Doctoral Program Foundation of Institutions of Higher Education of China (20094402110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GR, 2009, BIOCHEM BIOPH RES CO, V390, P897, DOI 10.1016/j.bbrc.2009.10.071; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Dai JP, 2009, J ORAL PATHOL MED, V38, P276, DOI 10.1111/j.1600-0714.2008.00738.x; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; GIFFIN K, 1995, FEBS LETT, V357, P269, DOI 10.1016/0014-5793(94)01369-C; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hoelscher M, 2008, EXPERT OPIN DRUG DEL, V5, P1139, DOI 10.1517/17425247.5.10.1139 ; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Itakura E, 2009, AUTOPHAGY, V5, P534, DOI 10.4161/auto.5.4.8062; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Lee H, 2010, BIOCONJUGATE CHEM, V21, P289, DOI 10.1021/bc900342p; Lei H, 2011, CLIN VACCINE IMMUNOL, V18, P1046, DOI 10.1128/CVI.00050-11; Li WZ, 2010, CELL MOL IMMUNOL, V7, P235, DOI 10.1038/cmi.2010.6; Liu AL, 2005, SCI CHINA SER C, V48, P1, DOI 10.1360/062004-69; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Maddry JA, 2011, J BIOMOL SCREEN, V16, P73, DOI 10.1177/1087057110384613; Matarrese P, 2011, J CELL PHYSIOL, V226, P3368, DOI 10.1002/jcp.22696; Meng S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019863; Mueller Barbara, 2009, V189, P1, DOI 10.1007/978-3-540-79086-0_1; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Noah JW, 2007, ANTIVIR RES, V73, P50, DOI 10.1016/j.antiviral.2006.07.006; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Shih SR, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-13; Su CY, 2010, P NATL ACAD SCI USA, V107, P19151, DOI 10.1073/pnas.1013592107; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	39	42	47	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42706	10.1371/journal.pone.0042706	http://dx.doi.org/10.1371/journal.pone.0042706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900043	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900060
J	Oeggerli, M; Tian, YM; Ruiz, C; Wijker, B; Sauter, G; Obermann, E; Guth, U; Zlobec, I; Sausbier, M; Kunzelmann, K; Bubendorf, L				Oeggerli, Martin; Tian, Yuemin; Ruiz, Christian; Wijker, Barbara; Sauter, Guido; Obermann, Ellen; Gueth, Uwe; Zlobec, Inti; Sausbier, Matthias; Kunzelmann, Karl; Bubendorf, Lukas			Role of KCNMA1 in Breast Cancer	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNELS; ANDROGEN RECEPTOR; BK CHANNEL; TISSUE MICROARRAYS; CELL-PROLIFERATION; EXPRESSION; GENE; ACTIVATION	KCNMA1 encodes the a-subunit of the large conductance, voltage and Ca2+-activated (BK) potassium channel and has been reported as a target gene of genomic amplification at 10q22 in prostate cancer. To investigate the prevalence of the amplification in other human cancers, the copy number of KCNMA1 was analyzed by fluorescence-in-situ-hybridization (FISH) in 2,445 tumors across 118 different tumor types. Amplification of KCNMA1 was restricted to a small but distinct fraction of breast, ovarian and endometrial cancer with the highest prevalence in invasive ductal breast cancers and serous carcinoma of ovary and endometrium (3-7%). We performed an extensive analysis on breast cancer tissue microarrays (TMA) of 1,200 tumors linked to prognosis. KCNMA1 amplification was significantly associated with high tumor stage, high grade, high tumor cell proliferation, and poor prognosis. Immunofluorescence revealed moderate or strong KCNMA1 protein expression in 8 out of 9 human breast cancers and in the breast cancer cell line MFM223. KCNMA1-function in breast cancer cell lines was confirmed by whole-cell patch clamp recordings and proliferation assays, using siRNA-knockdown, BK channel activators such as 17 beta-estradiol and the BK-channel blocker paxilline. Our findings revealed that enhanced expression of KCNMA1 correlates with and contributes to high proliferation rate and malignancy of breast cancer.	[Oeggerli, Martin; Ruiz, Christian; Wijker, Barbara; Obermann, Ellen; Bubendorf, Lukas] Univ Basel, Inst Pathol, Basel, Switzerland; [Tian, Yuemin; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Regensburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Gueth, Uwe] Univ Basel Hosp, Dept Gynecol & Obstet, CH-4031 Basel, Switzerland; [Zlobec, Inti] Univ Bern, Inst Pathol, Bern, Switzerland; [Sausbier, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany	University of Basel; University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Bern; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Oeggerli, M (corresponding author), Univ Basel, Inst Pathol, Basel, Switzerland.	oeggerlim@uhbs.ch	Obermann, Ellen/E-2656-2013; Bubendorf, Lukas/G-5299-2015; Tian, Yuemin/AAE-8827-2021; Bubendorfl, Lukas/H-5880-2011	Bubendorf, Lukas/0000-0001-5970-1803; Zlobec, Inti/0000-0001-6741-3000; Kunzelmann, Karl/0000-0002-4583-7037	Swiss National Science Foundation [31003A_125181]; Deutsche Krebshilfe [109438]; Cancer League of Basel/Baselland [14-2010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer League of Basel/Baselland	The work was supported by grants from the Swiss National Science Foundation (31003A_125181), Deutsche Krebshilfe (Projekt 109438), and from the Cancer League of Basel/Baselland (14-2010). http://www.snf.ch; http://www.krebshilfe.de; http://www.krebsliga-basel.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basrai D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Buchanan G, 2005, CANCER RES, V65, P8487, DOI 10.1158/0008-5472.CAN-04-3077; Chen Lie, 2008, V491, P35, DOI 10.1007/978-1-59745-526-8_3; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; HACKENBERG R, 1991, CANCER RES, V51, P5722; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kraft R, 2003, PFLUG ARCH EUR J PHY, V446, P248, DOI 10.1007/s00424-003-1012-4; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magklara A, 2002, INT J CANCER, V100, P507, DOI 10.1002/ijc.10520; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Ousingsawat J, 2008, PFLUG ARCH EUR J PHY, V456, P847, DOI 10.1007/s00424-008-0451-3; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Qian X, 2002, J GEN PHYSIOL, V120, P829, DOI 10.1085/jgp.20028692; Ramirez-Rosas MB, 2011, STEROIDS, V76, P409, DOI 10.1016/j.steroids.2010.12.012; Roger S, 2004, BBA-BIOMEMBRANES, V1667, P190, DOI 10.1016/j.bbamem.2004.10.002; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174; Zhu N, 2005, FEBS LETT, V579, P4856, DOI 10.1016/j.febslet.2005.07.069	40	68	70	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e41664	10.1371/journal.pone.0041664	http://dx.doi.org/10.1371/journal.pone.0041664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899999	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900014
J	Buschmann, AH; Tomova, A; Lopez, A; Maldonado, MA; Henriquez, LA; Ivanova, L; Moy, F; Godfrey, HP; Cabello, FC				Buschmann, Alejandro H.; Tomova, Alexandra; Lopez, Alejandra; Maldonado, Miguel A.; Henriquez, Luis A.; Ivanova, Larisa; Moy, Fred; Godfrey, Henry P.; Cabello, Felipe C.			Salmon Aquaculture and Antimicrobial Resistance in the Marine Environment	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; ANTIBIOTIC-RESISTANCE; OXOLINIC ACID; OXYTETRACYCLINE RESISTANCE; GROWTH PROMOTERS; WILD FISH; TETRACYCLINE; DETERMINANTS; SEDIMENTS; RESIDUES	Antimicrobials used in salmon aquaculture pass into the marine environment. This could have negative impacts on marine environmental biodiversity, and on terrestrial animal and human health as a result of selection for bacteria containing antimicrobial resistance genes. We therefore measured the numbers of culturable bacteria and antimicrobial-resistant bacteria in marine sediments in the Calbuco Archipelago, Chile, over 12-month period at a salmon aquaculture site approximately 20 m from a salmon farm and at a control site 8 km distant without observable aquaculture activities. Three antimicrobials extensively used in Chilean salmon aquaculture (oxytetracycline, oxolinic acid, and florfenicol) were studied. Although none of these antimicrobials was detected in sediments from either site, traces of flumequine, a fluoroquinolone antimicrobial also widely used in Chile, were present in sediments from both sites during this period. There were significant increases in bacterial numbers and antimicrobial-resistant fractions to oxytetracycline, oxolinic acid, and florfenicol in sediments from the aquaculture site compared to those from the control site. Interestingly, there were similar numbers of presumably plasmid-mediated resistance genes for oxytetracycline, oxolinic acid and florfenicol in unselected marine bacteria isolated from both aquaculture and control sites. These preliminary findings in one location may suggest that the current use of large amounts of antimicrobials in Chilean aquaculture has the potential to select for antimicrobial-resistant bacteria in marine sediments.	[Buschmann, Alejandro H.; Lopez, Alejandra; Maldonado, Miguel A.; Henriquez, Luis A.] Univ Los Lagos, Ctr i Mar, Puerto Montt, Chile; [Tomova, Alexandra; Ivanova, Larisa; Cabello, Felipe C.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Moy, Fred; Godfrey, Henry P.] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA	Universidad de Los Lagos; New York Medical College; New York Medical College	Buschmann, AH (corresponding author), Univ Los Lagos, Ctr i Mar, Puerto Montt, Chile.	cabello@nymc.edu	Buschmann, Alejandro H./B-4770-2012	Buschmann, Alejandro H./0000-0003-3246-681X; Godfrey, Henry/0000-0002-7195-6363	Lenfest Ocean Program/Pew Charitable Trusts	Lenfest Ocean Program/Pew Charitable Trusts	This research was supported by a grant from the Lenfest Ocean Program/Pew Charitable Trusts to F.C.C. and A.H.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503; Akinbowale AL, 2007, INT J ANTIMICROB AG, V30, P177, DOI 10.1016/j.ijantimicag.2007.03.012; Asche Frank, 2008, P271, DOI 10.1007/978-1-4020-6810-2_9; Baquero F, 2009, CLIN MICROBIOL INFEC, V15, P5, DOI 10.1111/j.1469-0691.2008.02677.x; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; BARNES E. M., 1958, British Veterinary Journal, V114, P333; Barrientos M, 2006, THESIS U AUSTRAL CHI; Barton JR, 2010, GLOBAL ENVIRON CHANG, V20, P739, DOI 10.1016/j.gloenvcha.2010.04.001; Bey BS, 2010, BIOTECHNIQUES, V49, P631, DOI 10.2144/000113486; Bissett A, 2006, FEMS MICROBIOL ECOL, V55, P48, DOI 10.1111/j.1574-6941.2005.00012.x; BJORKLUND H, 1990, AQUACULTURE, V86, P359, DOI 10.1016/0044-8486(90)90324-G; Bolton LF, 1999, J CLIN MICROBIOL, V37, P1348, DOI 10.1128/JCM.37.5.1348-1351.1999; Bravo S, 2007, AQUACULTURE, V270, P36, DOI 10.1016/j.aquaculture.2007.06.017; Burridge L, 2010, AQUACULTURE, V306, P7, DOI 10.1016/j.aquaculture.2010.05.020; Buschmann AH, 2006, ICES J MAR SCI, V63, P1338, DOI 10.1016/j.icesjms.2006.04.021; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Bustos PA, 2011, AQUACULTURE, V310, P281, DOI 10.1016/j.aquaculture.2010.11.001; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Capone DG, 1996, AQUACULTURE, V145, P55, DOI 10.1016/S0044-8486(96)01330-0; Carroll ML, 2003, AQUACULTURE, V226, P165, DOI 10.1016/S0044-8486(03)00475-7; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cattoir V, 2007, ANTIMICROB AGENTS CH, V51, P2650, DOI 10.1128/AAC.00070-07; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Costa-Pierce BA, 2010, MAR TECHNOL SOC J, V44, P88, DOI 10.4031/MTSJ.44.3.3; Coyne R, 2001, MARINE ENV HLTH SERI, V3, P28; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DEPAOLA A, 1995, APPL ENVIRON MICROB, V61, P2335, DOI 10.1128/AEM.61.6.2335-2340.1995; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Fortt A, 2007, REV CHIL INFECTOL, V24, P14; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; GRUMBLES LC, 1948, SCIENCE, V107, P196, DOI 10.1126/science.107.2773.196; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; HEKTOEN H, 1995, AQUACULTURE, V133, P175, DOI 10.1016/0044-8486(94)00310-K; Herwig RP, 1997, AQUACULTURE, V149, P263, DOI 10.1016/S0044-8486(96)01455-X; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Holten Lutzhoft H-C, 1999, ARCH ENV CONTAM TOXI, V436, P1171; Jacobs L, 2007, INT J FOOD MICROBIOL, V114, P295, DOI 10.1016/j.ijfoodmicro.2006.09.030; JUKES TH, 1950, ARCH BIOCHEM, V26, P324; KAPETANAKI M, 1995, AQUACULTURE, V134, P227, DOI 10.1016/0044-8486(95)00062-7; Kerry J, 1996, AQUACULTURE, V145, P31, DOI 10.1016/S0044-8486(96)01353-1; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Millanao A, 2002, THESIS U AUSTRAL CHI; Millanao A, 2011, REV MED CHILE, V139, P107, DOI /S0034-98872011000100015; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Miller RA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0017-2017; Minarini LAR, 2008, J ANTIMICROB CHEMOTH, V62, P474, DOI 10.1093/jac/dkn237; Miranda CD, 2003, ANTIMICROB AGENTS CH, V47, P883, DOI 10.1128/AAC.47.3.883-888.2003; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; MOORE PR, 1946, J BIOL CHEM, V165, P437; National Research Council, 2010, PREVENTION TREATMENT; Navarro N, 2008, MAR ECOL PROG SER, V361, P47, DOI 10.3354/meps07357; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pan JC, 2008, ANTIMICROB AGENTS CH, V52, P3829, DOI 10.1128/AAC.00375-08; Pepe MS, 2003, OXFORD STAT SCI SERI, V28, P318; Pouliquen H, 1997, J CHROMATOGR B, V702, P157, DOI 10.1016/S0378-4347(97)00373-3; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Saga T, 2005, ANTIMICROB AGENTS CH, V49, P2144, DOI 10.1128/AAC.49.5.2144-2145.2005; SAMUELSEN OB, 1992, DIS AQUAT ORGAN, V12, P111, DOI 10.3354/dao012111; SAMUELSEN OB, 1992, SCI TOTAL ENVIRON, V114, P25, DOI 10.1016/0048-9697(92)90411-K; Schmidt AS, 2000, APPL ENVIRON MICROB, V66, P4908, DOI 10.1128/AEM.66.11.4908-4915.2000; Schmidt AS, 2001, APPL ENVIRON MICROB, V67, P5675, DOI 10.1128/AEM.67.12.5675-5682.2001; SILVA J, 1987, Revista Latinoamericana de Microbiologia, V29, P165; Singer RS, 2004, ANTIMICROB AGENTS CH, V48, P4047, DOI 10.1128/AAC.48.10.4047-4049.2004; Smith P, 2008, REV SCI TECH OIE, V27, P243, DOI 10.20506/rst.27.1.1799; Smith P, 1996, AQUACULTURE, V146, P157, DOI 10.1016/S0044-8486(96)01382-8; Smith Peter, 1994, Annual Review of Fish Diseases, V4, P273, DOI 10.1016/0959-8030(94)90032-9; Sorensen LK, 2001, J LIQ CHROMATOGR R T, V24, P2469, DOI 10.1081/JLC-100105952; Sorum H, 2003, ANTIMICROB AGENTS CH, V47, P1285, DOI 10.1128/AAC.47.4.1285-1290.2003; Soto D, 2004, J APPL ICHTHYOL, V20, P493, DOI 10.1111/j.1439-0426.2004.00602.x; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tett Paul, 2008, P1, DOI 10.1007/978-1-4020-6810-2_1; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Weston DP, 2000, USE CHEM AQUACULTURE, P20; Xu H, 2007, J BACTERIOL, V189, P6276, DOI 10.1128/JB.00348-07	88	123	129	3	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42724	10.1371/journal.pone.0042724	http://dx.doi.org/10.1371/journal.pone.0042724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905164	Green Published, gold			2022-12-25	WOS:000307331100060
J	Hsieh, TH; Tsai, CF; Hsu, CY; Kuo, PL; Hsi, E; Suen, JL; Hung, CH; Lee, JN; Chai, CY; Wang, SC; Tsai, EM				Hsieh, Tsung-Hua; Tsai, Cheng-Fang; Hsu, Chia-Yi; Kuo, Po-Lin; Hsi, Edward; Suen, Jau-Ling; Hung, Chih-Hsing; Lee, Jau-Nan; Chai, Chee-Yin; Wang, Shao-Chun; Tsai, Eing-Mei			n-Butyl Benzyl Phthalate Promotes Breast Cancer Progression by Inducing Expression of Lymphoid Enhancer Factor 1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; STEM-LIKE CELLS; ESTROGEN-RECEPTOR; BETA-CATENIN; SIGNALING PATHWAY; WNT PATHWAY; IN-VITRO; ANGIOGENESIS; INVASION	Environmental hormones play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk; however, their precise role in human breast cancer cells during cancer progression remains unclear. To elucidate the effect of the most widely used industrial phthalate, n-butyl benzyl phthalate (BBP), on cancer progression, we evaluated the results of BBP treatment using a whole human genome cDNA microarray and MetaCore software and selected candidate genes whose expression was changed by more than ten-fold by BBP compared with controls to analyze the signaling pathways in human breast cancer initiating cells (R2d). A total of 473 genes were upregulated, and 468 were downregulated. Most of these genes are involved in proliferation, epithelial-mesenchymal transition, and angiogenesis signaling. BBP induced the viability, invasion and migration, and tube formation in vitro, and Matrigel plug angiogenesis in vivo of R2d and MCF-7. Furthermore, the viability and invasion and migration of these cell lines following BBP treatment was reduced by transfection with a small interfering RNA targeting the mRNA for lymphoid enhancer-binding factor 1; notably, the altered expression of this gene consistently differentiated tumors expressing genes involved in proliferation, epithelial-mesenchymal transition, and angiogenesis. These findings contribute to our understanding of the molecular impact of the environmental hormone BBP and suggest possible strategies for preventing and treating human breast cancer.	[Hsieh, Tsung-Hua; Tsai, Cheng-Fang; Hsu, Chia-Yi; Hsi, Edward; Suen, Jau-Ling; Tsai, Eing-Mei] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Kuo, Po-Lin; Lee, Jau-Nan; Chai, Chee-Yin; Tsai, Eing-Mei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Hung, Chih-Hsing] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Wang, Shao-Chun] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Lee, Jau-Nan; Tsai, Eing-Mei] Kaohsiung Med Univ, Dept Obstet & Gynecol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University System of Ohio; University of Cincinnati; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hsieh, TH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	tsaieing@yahoo.com	Wang, Shao-Chun/P-9904-2019; Hsi, Edward/A-1356-2013; Hsieh, Tsung-Hua/B-2132-2013; Suen, Jan-Ling/C-7293-2009	Wang, Shao-Chun/0000-0002-5477-1682; Hsi, Edward/0000-0002-8272-6707; Hsu, ChiaYi/0000-0001-6809-2165; Chai, Chee-Yin/0000-0003-0486-9742; Suen, Jau-Ling/0000-0002-5146-8354	National Science Council, Taiwan [99-2628-B-037-009-MY3]; Ministry of Education, Taiwan [KMU-EM-99-3]; Kaohsiung Medical University (Hospital) Research Fund [KMUH 97-7R08, KMUH 98-8R19, KMUH 99-9I04, KMUH 99-9R30, KMUER-004]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Kaohsiung Medical University (Hospital) Research Fund	This work was supported in part by the National Science Council, Taiwan [99-2628-B-037-009-MY3]; the Ministry of Education, Taiwan [KMU-EM-99-3]; and the Kaohsiung Medical University (Hospital) Research Fund [KMUH 97-7R08, KMUH 98-8R19, KMUH 99-9I04, KMUH 99-9R30, and KMUER-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alfranca A, 2008, BLOOD, V112, P1120, DOI 10.1182/blood-2007-09-112268; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Barbieri F, 2012, EXP CELL RES, V318, P847, DOI 10.1016/j.yexcr.2012.02.008; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Buteau-Lozano H, 2008, J ENDOCRINOL, V196, P399, DOI 10.1677/JOE-07-0198; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Hsieh TH, 2011, FASEB J; Hsieh TH, 2012, TOXICOL SCI; Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015; Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kang KS, 1998, MOL CARCINOGEN, V21, P225, DOI 10.1002/(SICI)1098-2744(199804)21:4<225::AID-MC1>3.0.CO;2-J; Kim IY, 2004, J TOXICOL ENV HEAL A, V67, P2025, DOI 10.1080/15287390490514750; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Konno H, 2003, CANCER SCI, V94, P735, DOI 10.1111/j.1349-7006.2003.tb01511.x; Leushacke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023381; Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marchenko ND, 2004, INT J BIOCHEM CELL B, V36, P942, DOI 10.1016/j.biocel.2003.12.007; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Mei JM, 2000, FASEB J, V14, P1188, DOI 10.1096/fasebj.14.9.1188; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Nguyen A, 2005, INT J ONCOL, V27, P949; Obermair A, 1997, INT J CANCER, V74, P455, DOI 10.1002/(SICI)1097-0215(19970822)74:4<455::AID-IJC17>3.0.CO;2-8; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Strizzi Luigi, 2008, Breast Dis, V29, P91; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Wang KH, 2010, BIOL CELL, V102, P159, DOI 10.1042/BC20090132; Wang SH, 2009, BIOCHEM BIOPH RES CO, V388, P67, DOI 10.1016/j.bbrc.2009.07.117; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	51	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42750	10.1371/journal.pone.0042750	http://dx.doi.org/10.1371/journal.pone.0042750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905168	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100061
J	Capo-Ramos, DE; Gao, Y; Lubin, JH; Check, DP; Goldin, LR; Pesatori, AC; Consonni, D; Bertazzi, PA; Saxon, AJ; Bergen, AW; Caporaso, NE; Landi, MT				Capo-Ramos, David E.; Gao, Ying; Lubin, Jay H.; Check, David P.; Goldin, Lynn R.; Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto; Saxon, Andrew J.; Bergen, Andrew W.; Caporaso, Neil E.; Landi, Maria Teresa			Mood Disorders and Risk of Lung Cancer in the EAGLE Case-Control Study and in the US Veterans Affairs Inpatient Cohort	PLOS ONE			English	Article							BIPOLAR DISORDER; MAJOR DEPRESSION; RECORD-LINKAGE; SEROTONIN; GENETICS; SMOKING; ANTIDEPRESSANTS; SCHIZOPHRENIA; ENVIRONMENT; POPULATION	Background: Mood disorders may affect lung cancer risk. We evaluated this hypothesis in two large studies. Methodology/Principal Findings: We examined 1,939 lung cancer cases and 2,102 controls from the Environment And Genetics in Lung cancer Etiology (EAGLE) case-control study conducted in Italy (2002-2005), and 82,945 inpatients with a lung cancer diagnosis and 3,586,299 person-years without a lung cancer diagnosis in the U. S. Veterans Affairs Inpatient Cohort (VA study), composed of veterans with a VA hospital admission (1969-1996). In EAGLE, we calculated odds ratios (ORs) and 95% confidence intervals (CI), with extensive adjustment for tobacco smoking and multiple lifestyle factors. In the VA study, we estimated lung cancer relative risks (RRs) and 95% CIs with time-dependent Poisson regression, adjusting for attained age, calendar year, hospital visits, time within the study, and related previous medical diagnoses. In EAGLE, we found decreased lung cancer risk in subjects with a personal history of mood disorders (OR: 0.59, 95% CI: 0.44-0.79, based on 121 lung cancer incident cases and 192 controls) and family history of mood disorders (OR: 0.62, 95% CI: 0.50-0.77, based on 223 lung cancer cases and 345 controls). The VA study analyses yielded similar results (RR: 0.74, 95% CI: 0.71-0.77, based on 2,304 incident lung cancer cases and 177,267 non-cancer person-years) in men with discharge diagnoses for mood disorders. History of mood disorders was associated with nicotine dependence, alcohol and substance use and psychometric scales of depressive and anxiety symptoms in controls for these studies. Conclusions/Significance: The consistent finding of a relationship between mood disorders and lung cancer risk across two large studies calls for further research into the complex interplay of risk factors associated with these two widespread and debilitating diseases. Although we adjusted for smoking effects in EAGLE, residual confounding of the results by smoking cannot be ruled out.	[Capo-Ramos, David E.; Gao, Ying; Lubin, Jay H.; Check, David P.; Goldin, Lynn R.; Caporaso, Neil E.; Landi, Maria Teresa] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto] Univ Milan, Epidemiol Res Ctr, EPOCA, Milan, Italy; [Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy; [Saxon, Andrew J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Saxon, Andrew J.] Addict Psychiat Residency Program, Seattle, WA USA; [Saxon, Andrew J.] Univ Washington, Seattle, WA 98195 USA; [Bergen, Andrew W.] SRI Int, Ctr Hlth Sci, Mol Genet Program, Menlo Pk, CA 94025 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; SRI International	Capo-Ramos, DE (corresponding author), Ctr Dis Control & Prevent, Off Anal & Epidemiol, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA.	landim@mail.nih.gov	bertazzi, pietro alberto/D-5039-2017; Consonni, Dario/K-7943-2016; Consonni, Dario/AAM-2947-2020; Check, David P/J-7184-2015; pesatori, angela/K-5742-2016	bertazzi, pietro alberto/0000-0003-3475-2449; Consonni, Dario/0000-0002-8935-3843; Consonni, Dario/0000-0002-8935-3843; Check, David P/0000-0003-3887-0493; pesatori, angela/0000-0002-0261-3252; Bergen, Andrew/0000-0002-1237-7644	National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics); Region of Lombardy, Milan, Italy (Environmental Epidemiology Program); Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System; NIH [U01DA020830, RC2DA028793]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033813, RC2DA028793, U01DA020830] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Region of Lombardy, Milan, Italy (Environmental Epidemiology Program); Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (Division of Cancer Epidemiology and Genetics) and by the Region of Lombardy, Milan, Italy (Environmental Epidemiology Program). Dr. Saxon is supported by the Center of Excellence in Substance Abuse Treatment and Education at VA Puget Sound Health Care System. Dr. Bergen is supported by NIH grants U01DA020830 and RC2DA028793. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P161, DOI 10.1001/archpsyc.55.2.161; Breslow N E, 1987, IARC Sci Publ, P1; Brewer JK, 2008, J MOL NEUROSCI, V35, P307, DOI 10.1007/s12031-008-9078-2; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Dalton SO, 2002, AM J EPIDEMIOL, V155, P1088, DOI 10.1093/aje/155.12.1088; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P4934, DOI 10.1002/cncr.24533; FAWCETT J, 1987, AM J PSYCHIAT, V144, P35; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; Fitzgerald Paul J, 2010, Clin Epidemiol, V2, P1; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Goldacre MJ, 2007, SOC PSYCH PSYCH EPID, V42, P683, DOI 10.1007/s00127-007-0211-2; Gross AL, 2010, CANCER CAUSE CONTROL, V21, P191, DOI 10.1007/s10552-009-9449-1; Guo K, 2009, ONCOL REP, V22, P825, DOI 10.3892/or_00000505; Haukka J, 2010, INT J CANCER, V126, P285, DOI 10.1002/ijc.24537; Hippisley-Cox J, 2007, ARCH GEN PSYCHIAT, V64, P1368, DOI 10.1001/archpsyc.64.12.1368; Hooper TI, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-15; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; KAPLAN GA, 1988, J BEHAV MED, V11, P1, DOI 10.1007/BF00846165; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36; Kessing LV, 1998, EUR PSYCHIAT, V13, P342, DOI 10.1016/S0924-9338(99)80700-7; Knekt P, 1996, AM J EPIDEMIOL, V144, P1096, DOI 10.1093/oxfordjournals.aje.a008887; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Lau JYF, 2010, ANNU REV CLIN PSYCHO, V6, P313, DOI 10.1146/annurev.clinpsy.121208.131308; Lieb JL, 2007, MED HYPOTHESES, V69, P684, DOI 10.1016/j.mehy.2007.01.036; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Oerlemans Marjolein Ej, 2007, Clin Pract Epidemiol Ment Health, V3, P29, DOI 10.1186/1745-0179-3-29; Penninx BWJH, 1998, J NATL CANCER I, V90, P1888, DOI 10.1093/jnci/90.24.1888; Pratesi G, 1996, ANTICANCER RES, V16, P3615; Rao ML, 1998, NEUROPSYCHOBIOLOGY, V38, P84, DOI 10.1159/000026522; RICHARDSON C, 2003, VETERANS 2000 CENSUS; Sharma U, 1996, DRUG METAB DISPOS, V24, P669; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Taioli E, 2008, CARCINOGENESIS, V29, P1467, DOI 10.1093/carcin/bgn062; Toh S, 2007, CANCER CAUSE CONTROL, V18, P1055, DOI 10.1007/s10552-007-9045-1; Van Dam NT, 2010, PSYCHIAT RES; Vicaut E, 2000, ANN MED, V32, P187, DOI 10.3109/07853890008998826; Walker AJ, 2011, BRIT J CANCER, V104, P193, DOI 10.1038/sj.bjc.6605996	44	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42945	10.1371/journal.pone.0042945	http://dx.doi.org/10.1371/journal.pone.0042945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880133	Green Submitted, Green Published, gold			2022-12-25	WOS:000307437900063
J	Rey-Giraud, F; Hafner, M; Ries, CH				Rey-Giraud, Flora; Hafner, Mathias; Ries, Carola H.			In Vitro Generation of Monocyte-Derived Macrophages under Serum-Free Conditions Improves Their Tumor Promoting Functions	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; M2 MACROPHAGES; INTERFERON-GAMMA; IRON HOMEOSTASIS; POLARIZATION; ACTIVATION; DIFFERENTIATION; PROGRESSION; RECEPTORS	The tumor promoting role of M2 macrophages has been described in in vivo models and the presence of macrophages in certain tumor types has been linked to a poor clinical outcome. In light of burgeoning activities to clinically develop new therapies targeting tumor-associated macrophages (TAMs), reliable in vitro models faithfully mimicking the tumor promoting functions of TAMs are required. Generation and activation of human monocyte-derived macrophages (MDM) in vitro, described as M1 or M2 macrophages attributed with tumoricidal or tumor-promoting functions, respectively, has been widely reported using mainly serum containing culture methods. In this study, we compared the properties of macrophages originating from monocytes cultured either in media containing serum together with M-CSF for M2 and GM-CSF for M1 macrophages or in serum-free media supplemented with M-CSF or GM-CSF and cytokines such as IL-4, IL-10 to induce activated M2 or LPS together with IFN-gamma to generate activated M1 phenotype. We observed differences in cell morphology as well as increased surface receptor expression levels in serum-containing culture whereas similar or higher cytokine production levels were detected under serum-free culture conditions. More importantly, MDM differentiated under serum-free conditions displayed enhanced tumoricidal activity for M1 and tumor promoting property for M2 macrophages in contrast to MDM differentiated in the presence of serum. Moreover, evaluation of MDM phagocytic activity in serum free condition resulted in greater phagocytic properties of M2 compared to M1. Our data therefore confirm the tumor promoting properties of M2 macrophages in vitro and encourage the targeting of TAMs for cancer therapy.	[Rey-Giraud, Flora; Ries, Carola H.] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Rey-Giraud, Flora; Hafner, Mathias] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany	Roche Holding	Rey-Giraud, F (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany.	carola.ries@roche.com						Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; BECKER S, 1990, CELL IMMUNOL, V129, P351, DOI 10.1016/0008-8749(90)90211-9; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cairo G, 2010, HAEMATOL-HEMATOL J, V95, P1801, DOI 10.3324/haematol.2010.030239; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, CANCER IMMUNOL IMMUN, V41, P46, DOI 10.1007/s002620050198; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Palucka KA, 1998, J IMMUNOL, V160, P4587; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2010, EUR J IMMUNOL, V40, P2131, DOI 10.1002/eji.201040736; Smith W, 1998, EUR J IMMUNOL, V28, P2498, DOI 10.1002/(SICI)1521-4141(199808)28:08<2498::AID-IMMU2498>3.0.CO;2-Q; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689	34	161	172	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42656	10.1371/journal.pone.0042656	http://dx.doi.org/10.1371/journal.pone.0042656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880072	Green Submitted, Green Published, gold			2022-12-25	WOS:000307810000057
J	Choi, MY; Wang, Y; Wong, LLY; Lu, BT; Chen, WY; Huang, JD; Tanner, JA; Watt, RM				Choi, Mei Y.; Wang, Ying; Wong, Leo L. Y.; Lu, Bing-tai; Chen, Wen-yang; Huang, Jian-Dong; Tanner, Julian A.; Watt, Rory M.			The Two PPX-GppA Homologues from Mycobacterium tuberculosis Have Distinct Biochemical Activities	PLOS ONE			English	Article							ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; STRINGENT RESPONSE; PENTAPHOSPHATE PHOSPHOHYDROLASE; EXOPOLYPHOSPHATASE PPX; KINASE; VIRULENCE; (P)PPGPP; PERSISTENCE; PPGPP	Inorganic polyphosphate (poly-P), guanosine pentaphosphate (pppGpp) and guanosine tetraphosphate (ppGpp) are ubiquitous in bacteria. These molecules play a variety of important physiological roles associated with stress resistance, persistence, and virulence. In the bacterial pathogen Mycobacterium tuberculosis, the identities of the proteins responsible for the metabolism of polyphosphate and (p) ppGpp remain to be fully established. M. tuberculosis encodes two PPX-GppA homologues, Rv0496 (MTB-PPX1) and Rv1026, which share significant sequence similarity with bacterial exopolyphosphatase (PPX) and guanosine pentaphosphate 5'-phosphohydrolase (GPP) proteins. Here we delineate the respective biochemical activities of the Rv0496 and Rv1026 proteins and benchmark these against the activities of the PPX and GPP proteins from Escherichia coli. We demonstrate that Rv0496 functions as an exopolyphosphatase, showing a distinct preference for relatively short-chain poly-P substrates. In contrast, Rv1026 has no detectable exopolyphosphatase activities. Analogous to the E. coli PPX and GPP enzymes, the exopolyphosphatase activities of Rv0496 are inhibited by pppGpp and, to a lesser extent, by ppGpp alarmones, which are produced during the bacterial stringent response. However, neither Rv0496 nor Rv1026 have the ability to hydrolyze pppGpp to ppGpp; a reaction catalyzed by E. coli PPX and GPP. Both the Rv0496 and Rv1026 proteins have modest ATPase and to a lesser extent ADPase activities. pppGpp alarmones inhibit the ATPase activities of Rv1026 and, to a lesser extent, the ATPase activities of Rv0496. We conclude that PPX-GppA family proteins may not possess all the catalytic activities implied by their name and may play distinct biochemical roles involved in polyphosphate and (p) ppGpp metabolic pathways.	[Choi, Mei Y.; Lu, Bing-tai; Chen, Wen-yang; Watt, Rory M.] Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Wuhan, Hubei Province, Peoples R China; [Wong, Leo L. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Huang, Jian-Dong; Tanner, Julian A.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Choi, MY (corresponding author), Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China.	rmwatt@hku.hk	Watt, Rory M./B-2177-2009; Tanner, Julian A./C-4412-2009; /C-4277-2009	Watt, Rory M./0000-0002-8718-1988; Tanner, Julian A./0000-0002-5459-1526; /0000-0001-7531-2816; Chen, Wenyang/0000-0002-2480-6282	Infection and Immunology Strategic Research Theme of the University of Hong Kong; Research Grants Council of Hong Kong through a General Research Fund (GRF) [705007]	Infection and Immunology Strategic Research Theme of the University of Hong Kong; Research Grants Council of Hong Kong through a General Research Fund (GRF)	RMW acknowledges financial support from the Infection and Immunology Strategic Research Theme of the University of Hong Kong and the Research Grants Council of Hong Kong through a General Research Fund (GRF) award [#705007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; [Anonymous], 2004, BIOCH INORGANIC POLY; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bolesch DG, 2000, J BIOL CHEM, V275, P33814, DOI 10.1074/jbc.M002039200; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CLARK JE, 1987, ANAL BIOCHEM, V161, P280, DOI 10.1016/0003-2697(87)90452-0; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Gottesman S, 2001, SCIENCE, V293, P614, DOI 10.1126/science.1063371; HARA A, 1983, J BIOL CHEM, V258, P1678; Hardiman T, 2008, ANAL BIOCHEM, V383, P337, DOI 10.1016/j.ab.2008.07.042; Hsieh PC, 1996, BIOCHEMISTRY-US, V35, P9772, DOI 10.1021/bi9528659; Jagannathan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014336; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; KROHN M, 1995, ANAL BIOCHEM, V225, P188, DOI 10.1006/abio.1995.1138; Kulaev I, 2000, ANNU REV MICROBIOL, V54, P709, DOI 10.1146/annurev.micro.54.1.709; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lindner SN, 2009, APPL ENVIRON MICROB, V75, P3161, DOI 10.1128/AEM.02705-08; Manganelli R, 2007, MOL MICROBIOL, V65, P258, DOI 10.1111/j.1365-2958.2007.05819.x; McGrath JW, 2003, ADV APPL MICROBIOL, V52, P75, DOI 10.1016/S0065-2164(03)01003-7; Mittal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027398; OKI T, 1975, BIOCHIM BIOPHYS ACTA, V410, P262, DOI 10.1016/0005-2744(75)90228-4; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; REIZER J, 1993, TRENDS BIOCHEM SCI, V18, P247, DOI 10.1016/0968-0004(93)90172-J; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shi TY, 2011, CURR MICROBIOL, V63, P470, DOI 10.1007/s00284-011-0004-4; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shum KT, 2011, BIOCHEMISTRY-US, V50, P3261, DOI 10.1021/bi2001455; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; SUZUKI H, 1972, BIOCHIM BIOPHYS ACTA, V268, P381, DOI 10.1016/0005-2744(72)90333-6; Thayil SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028076; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393	51	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42561	10.1371/journal.pone.0042561	http://dx.doi.org/10.1371/journal.pone.0042561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880033	Green Submitted, gold, Green Published			2022-12-25	WOS:000307284100129
J	Coleman, MD; O'Neil, JD; Woehrling, EK; Ndunge, OBA; Hill, EJ; Menache, A; Reiss, CJ				Coleman, Michael D.; O'Neil, John D.; Woehrling, Elizabeth K.; Ndunge, Oscar Bate Akide; Hill, Eric J.; Menache, Andre; Reiss, Claude J.			A Preliminary Investigation into the Impact of a Pesticide Combination on Human Neuronal and Glial Cell Lines In Vitro	PLOS ONE			English	Article							FIELD APPLICATION; APOPTOSIS; RESIDUES; GRAPES; WINE; TRIMETHYLTIN; FLUDIOXONIL; CYPRODINIL; ASTROCYTES; TOXICITY	Many pesticides are used increasingly in combinations during crop protection and their stability ensures the presence of such combinations in foodstuffs. The effects of three fungicides, pyrimethanil, cyprodinil and fludioxonil, were investigated together and separately on U251 and SH-SY5Y cells, which can be representative of human CNS glial and neuronal cells respectively. Over 48h, all three agents showed significant reductions in cellular ATP, at concentrations that were more than tenfold lower than those which significantly impaired cellular viability. The effects on energy metabolism were reflected in their marked toxic effects on mitochondrial membrane potential. In addition, evidence of oxidative stress was seen in terms of a fall in cellular thiols coupled with increases in the expression of enzymes associated with reactive species formation, such as GSH peroxidase and superoxide dismutase. The glial cell line showed significant responsiveness to the toxin challenge in terms of changes in antioxidant gene expression, although the neuronal SH-SY5Y line exhibited greater vulnerability to toxicity, which was reflected in significant increases in caspase-3 expression, which is indicative of the initiation of apoptosis. Cyprodinil was the most toxic agent individually, although oxidative stress-related enzyme gene expression increases appeared to demonstrate some degree of synergy in the presence of the combination of agents. This report suggests that the impact of some pesticides, both individually and in combinations, merits further study in terms of their impact on human cellular health.	[Coleman, Michael D.; O'Neil, John D.; Woehrling, Elizabeth K.; Ndunge, Oscar Bate Akide; Hill, Eric J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Menache, Andre; Reiss, Claude J.] Antidote Europe, Perpignan, France	Aston University	Coleman, MD (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.d.coleman@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Hill, Eric/0000-0002-9419-1500; Coleman, MIchael D/0000-0002-5510-6852	Marchig Animal Welfare Trust Edinburgh, United Kingdom; Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Belgium)	Marchig Animal Welfare Trust Edinburgh, United Kingdom; Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Belgium)	This study received financial support from The Marchig Animal Welfare Trust Edinburgh, United Kingdom (www.marchigtrust.org), as well as the Union Belge pour l'Abolition de l'Experimentation sur Animaux Vivants (UBAEAV, Rue H. van Zuylen 21, 1180 Bruxelles Tel: 02/376 82 83 Bruxelles, Belgium. In addition, Generations Futures, Paris, France (http://www.mdrgf.org) also contributed to the funding of the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anli E, 2007, J I BREWING, V113, P213, DOI 10.1002/j.2050-0416.2007.tb00278.x; Band PR, 2011, PROSTATE, V71, P168, DOI 10.1002/pros.21232; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; Cabras P, 1997, J AGR FOOD CHEM, V45, P2708, DOI 10.1021/jf960939x; Caceres TP, 2011, ECOTOXICOLOGY, V20, P20, DOI 10.1007/s10646-010-0552-6; Coleman MD, 2000, BIOCHEM PHARMACOL, V60, P1409, DOI 10.1016/S0006-2952(00)00333-6; Coleman MD, 2008, BASIC CLIN PHARMACOL, V102, P25, DOI 10.1111/j.1742-7843.2007.00148.x; Cus F, 2010, FOOD CONTROL, V21, P1512, DOI 10.1016/j.foodcont.2010.04.024; DANIELS A, 1995, PESTIC SCI, V45, P33, DOI 10.1002/ps.2780450106; Engelmeier D, 2006, ADV PHYTOMED, V3, P423; Ensminger M, 2008, ENVIRON MONIT ASSESS, V4, P573; European Food Safety Authority, 2009, 231 EFSA, P1; FAO-WHO, 2005, JOINT M FAO PAN EXP; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Figiel I, 2002, NEUROTOXICOLOGY, V23, P77, DOI 10.1016/S0161-813X(02)00006-2; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Fritz R, 1997, PESTIC SCI, V49, P40, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;40::AID-PS470&gt;3.0.CO;2-Y; Gabryel B, 2002, NEUROTOXICOLOGY, V23, P19, DOI 10.1016/S0161-813X(02)00004-9; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Gradish AE, 2010, PEST MANAG SCI, V66, P142, DOI 10.1002/ps.1846; Holden LJ, 2008, ENVIRON TOXICOL PHAR, V26, P290, DOI 10.1016/j.etap.2008.05.009; Holden LJ, 2007, TOXICOLOGY, V241, P75, DOI 10.1016/j.tox.2007.08.083; Jaworska-Feil L, 2010, NEUROPEPTIDES, V44, P495, DOI 10.1016/j.npep.2010.08.004; Jimenez JJ, 2007, FOOD CHEM, V104, P216, DOI 10.1016/j.foodchem.2006.11.027; Karadag H, 2010, ASIAN J CHEM, V22, P8147; Kimura H, 2010, TOXIN REV, V29, P43, DOI 10.3109/15569543.2010.483533; Koprivica V, 2011, EUR J PHARMACOL, V651, P73, DOI 10.1016/j.ejphar.2010.10.064; Li WJ, 2011, J ZHEJIANG UNIV-SC B, V12, P226, DOI 10.1631/jzus.B0900264; Likas DT, 2011, FOOD ADDIT CONTAM A, V28, P189, DOI 10.1080/19440049.2010.542184; Liu CY, 2011, ENVIRON MONIT ASSESS, V179, P209, DOI 10.1007/s10661-010-1730-y; Lo Curto R, 2004, FOOD CHEM, V84, P71, DOI 10.1016/S0308-8146(03)00168-7; Lorenzin M, 2007, J ENVIRON SCI HEAL B, V42, P823, DOI 10.1080/03601230701555021; Gonzalez-Rodriguez RM, 2009, J CHROMATOGR A, V1216, P6033, DOI 10.1016/j.chroma.2009.06.046; Marin A, 2003, J AGR FOOD CHEM, V51, P4708, DOI 10.1021/jf021222e; Marini AM, 2000, J NEUROSCI RES, V62, P814, DOI 10.1002/1097-4547(20001215)62:6<814::AID-JNR8>3.3.CO;2-6; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Oliva J, 2007, J ENVIRON SCI HEAL B, V42, P775, DOI 10.1080/03601230701550964; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Pose-Juan E, 2011, J HAZARD MATER, V193, P288, DOI 10.1016/j.jhazmat.2011.07.074; RAGAN CI, 1987, CURR TOP BIOENERG, V15, P1; Raicevic N, 2005, NEUROPHARMACOLOGY, V48, P720, DOI 10.1016/j.neuropharm.2004.12.003; Ravelo-Perez LM, 2007, ELECTROPHORESIS, V28, P4072, DOI 10.1002/elps.200700251; Ravelo-Perez LM, 2007, ELECTROPHORESIS, V28, P1805, DOI 10.1002/elps.200600526; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; Reus J, 2002, AGR ECOSYST ENVIRON, V90, P177, DOI 10.1016/S0167-8809(01)00197-9; ROSS RA, 1983, J NATL CANCER I, V71, P741; Rosslenbroich HJ, 2008, J PLANT DIS PROTECT, V115, P208; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Sidiropoulou E, 2011, TOXICOL LETT, V201, P86, DOI 10.1016/j.toxlet.2010.12.009; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Thrupp L. A., 1990, International Journal of Environmental Studies, V36, P173, DOI 10.1080/00207239008710594; Tsiropoulos NG, 2005, J AGR FOOD CHEM, V53, P10091, DOI 10.1021/jf052162q; Tuzmen MN, 2007, TOXICOL MECH METHOD, V17, P535, DOI 10.1080/15376510701380463; U.S. Environmental Protection Agency, 1998, PEST FACT SHEET CYPR; Wang W, 2011, J NEUROSURG, V114, P689, DOI 10.3171/2010.2.JNS09719; WIKSTRAND CJ, 1981, J NEUROIMMUNOL, V1, P249, DOI 10.1016/0165-5728(81)90029-1; Wing KD, 2000, CROP PROT, V19, P537, DOI 10.1016/S0261-2194(00)00070-3; Yang W, 2010, TOXICOL LETT, V199, P239, DOI 10.1016/j.toxlet.2010.09.005; Zhao Q, 2011, BIRTH DEFECTS RES B, V92, P1, DOI 10.1002/bdrb.20277; Zou DJ, 2011, PHARMAZIE, V66, P44, DOI 10.1692/ph.2011.0618	62	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42768	10.1371/journal.pone.0042768	http://dx.doi.org/10.1371/journal.pone.0042768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880100	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000307284100166
J	Schmickl, R; Paule, J; Klein, J; Marhold, K; Koch, MA				Schmickl, Roswitha; Paule, Juraj; Klein, Johannes; Marhold, Karol; Koch, Marcus A.			The Evolutionary History of the Arabidopsis arenosa Complex: Diverse Tetraploids Mask the Western Carpathian Center of Species and Genetic Diversity	PLOS ONE			English	Article							CHLOROPLAST DNA; EASTERN ALPS; RELATIVES; ORIGIN; COLONIZATION; BRASSICACEAE; POPULATIONS; REFUGIA; DIFFERENTIATION; SPECIATION	The Arabidopsis arenosa complex is closely related to the model plant Arabidopsis thaliana. Species and subspecies in the complex are mainly biennial, predominantly outcrossing, herbaceous, and with a distribution range covering most parts of latitudes and the eastern reaches of Europe. In this study we present the first comprehensive evolutionary history of the A. arenosa species complex, covering its natural range, by using chromosome counts, nuclear AFLP data, and a maternally inherited marker from the chloroplast genome [trnL intron (trnL) and trnL/F intergenic spacer (trnL/F-IGS) of tRNA(Leu) and tRNA(Phe), respectively]. We unravel the broad-scale cytogeographic and phylogeographic patterns of diploids and tetraploids. Diploid cytotypes were exclusively found on the Balkan Peninsula and in the Carpathians while tetraploid cytotypes were found throughout the remaining distribution range of the A. arenosa complex. Three centers of genetic diversity were identified: the Balkan Peninsula, the Carpathians, and the unglaciated Eastern and Southeastern Alps. All three could have served as long-term refugia during Pleistocene climate oscillations. We hypothesize that the Western Carpathians were and still are the cradle of speciation within the A. arenosa complex due to the high species number and genetic diversity and the concurrence of both cytotypes there.	[Schmickl, Roswitha; Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany; [Paule, Juraj] Senckenberg Res Inst, Frankfurt, Germany; [Klein, Johannes] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, Mainz, Germany; [Marhold, Karol] Inst Bot SAS, Dept Vasc Plant Taxon, Bratislava, Slovakia	Ruprecht Karls University Heidelberg; Senckenberg Gesellschaft fur Naturforschung (SGN); Johannes Gutenberg University of Mainz; Slovak Academy of Sciences	Schmickl, R (corresponding author), Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany.	marcus.koch@cos.uni-heidelberg.de	Schmickl, Roswitha/H-1624-2014; Klein, Johannes T/D-7141-2013; Marhold, Karol/B-4699-2011; Paule, Juraj/A-2998-2017; Koch, Marcus A/A-4924-2011	Schmickl, Roswitha/0000-0002-0632-5143; Klein, Johannes T/0000-0003-2736-8094; Marhold, Karol/0000-0002-7658-0844; Paule, Juraj/0000-0001-5375-7689; Koch, Marcus A/0000-0002-1693-6829	DFG [KO 2302/5-2]	DFG(German Research Foundation (DFG))	This research was supported by DFG grant KO 2302/5-2 (to MAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 1999, NOVON, V9, P296, DOI 10.2307/3391724; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; [Anonymous], 2009, LANG ENV STAT COMP; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Cieslak E, 2007, TAXON, V56, P112; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Ehlers J., 2004, QUATERNARY GLACIATIO; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fer T, 2007, PRESLIA, V79, P367; Frenzel B, 1964, VERHANDLUNGEN ZOOLOG, V103, P110; GREGORIUS HR, 1978, MATH BIOSCI, V41, P253, DOI 10.1016/0025-5564(78)90040-8; Hayek Av, 1908, FLORA STEIERMARK, V1-2; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Koch M, 2003, PLANT SYST EVOL, V242, P137, DOI 10.1007/s00606-003-0048-4; Koch MA, 2005, MOL BIOL EVOL, V22, P1032, DOI 10.1093/molbev/msi092; Koch MA, 2008, TAXON, V57, P933, DOI 10.1002/tax.573021; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Kolnik M, 2007, CHROMOSOME NUMBER SU, P94; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mesiek J, 1998, ZOZNAM NIZSICH VYSSI, P395; Mesiek J, 1970, PRESLIA, V42, P225; Meusel H., 1965, VERGLEICHENDE CHOROL; Nei M., 1987, MOL EVOLUTIONARY GEN; Niklfeld H, 1972, JB VEREINS SCHUTZE A, V37, P1; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; PAWLOWSKI B, 1970, Vegetatio, V21, P181; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Ronikier M, 2008, MOL ECOL, V17, P1763, DOI 10.1111/j.1365-294X.2008.03664.x; Sall T, 2003, J EVOLUTION BIOL, V16, P1019, DOI 10.1046/j.1420-9101.2003.00554.x; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Schmickl R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-98; Schonswetter P, 2007, J PLANT RES, V120, P721, DOI 10.1007/s10265-007-0108-x; Schonswetter P, 2003, MOL ECOL, V12, P3373, DOI 10.1046/j.1365-294X.2003.01984.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Stuessy TF, 2004, AM J BOT, V91, P889, DOI 10.3732/ajb.91.6.889; TEMPLETON AR, 1992, GENETICS, V132, P619; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Willis KJ, 1996, ENDEAVOUR, V20, P110, DOI 10.1016/0160-9327(96)10019-3; Zimmermann A, 1972, DISS BOT, V18, P1	56	39	43	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42691	10.1371/journal.pone.0042691	http://dx.doi.org/10.1371/journal.pone.0042691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880083	Green Submitted, Green Published, gold			2022-12-25	WOS:000307284100158
J	Sully, K; Akinduro, O; Philpott, MP; Naeem, AS; Harwood, CA; Reeve, VE; O'Shaughnessy, RF; Byrne, C				Sully, K.; Akinduro, O.; Philpott, M. P.; Naeem, A. S.; Harwood, C. A.; Reeve, V. E.; O'Shaughnessy, R. F.; Byrne, C.			The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKB alpha isoform signaling	ONCOGENE			English	Article						mTOR; rapamycin; epidermis; Akt/PKB; squamous cell carcinoma; ultraviolet radiation	INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE B; SKIN-CANCER; KERATINOCYTE DIFFERENTIATION; TRANSPLANT RECIPIENTS; 3-KINASE/AKT PATHWAY; MAMMALIAN TARGET; GROWTH-FACTOR; MOUSE SKIN; AKT	Epidermal squamous cell carcinoma (SCC) is the most aggressive non-melanoma skin cancer and is dramatically increased in patients undergoing immunosuppression following solid organ transplantation, contributing substantially to morbidity and mortality. Recent clinical studies show that use of the mammalian target of rapamycin (mTOR) inhibitor rapamycin as a post-transplantation immunosuppressive significantly reduces SCC occurrence compared with other immunosuppressives, though the mechanism is not fully understood. We show that rapamycin selectively upregulates epidermal Akt1, while failing to upregulate epidermal Akt2. Rapamycin increases epidermal Akt1 phosphorylation via inhibition of the mTOR complex 1-dependent regulation of insulin receptor substrate-1. Epidermal Akt1 is commonly downregulated in SCC while Akt2 is upregulated. We now demonstrate similar Akt1 downregulation and Akt2 upregulation by ultraviolet (UV) radiation, the most important skin carcinogen. Hence, rapamycin's upregulation of Akt1 signaling could potentially oppose the effects of UV radiation and/or tumor-associated changes on Akt1 signaling. We show in skin culture that rapamycin does enhance restoration of Akt1 phosphorylation in skin recovering from UV radiation, suggesting a mechanism for rapamycin's antitumor activity in epidermis in spite of its efficient immunosuppressive properties.	[Sully, K.; Akinduro, O.; Philpott, M. P.; Harwood, C. A.; Byrne, C.] Queen Mary Univ London, Blizard Inst, Ctr Cutaneous Res, Barts & London Sch Med & Dent, London E1 2AT, England; [Naeem, A. S.; O'Shaughnessy, R. F.] UCL, Inst Child Hlth, London, England; [Reeve, V. E.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of London; Queen Mary University London; University of London; University College London; University of Sydney	Byrne, C (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Cutaneous Res, Barts & London Sch Med & Dent, London E1 2AT, England.	c.r.byrne@qmul.ac.uk		Harwood, Catherine/0000-0002-1375-0965; Nevin, Katherine/0000-0003-4710-2592; O'Shaughnessy, Ryan/0000-0002-3701-0267; Philpott, Michael/0000-0002-1255-4612	British Skin Foundation [941S]; Medical Research Council DTA studentship; Royal Society International Outgoing Short Visit [VO0872438]; Cancer Research UK [13044] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1039, W0907] Funding Source: researchfish	British Skin Foundation; Medical Research Council DTA studentship; Royal Society International Outgoing Short Visit; Cancer Research UK(Cancer Research UK); Great Ormond Street Hospital Childrens Charity	This work was supported by the British Skin Foundation 941S, a Medical Research Council DTA studentship for OA and a Royal Society International Outgoing Short Visit VO0872438.	Alberu J, 2011, TRANSPLANTATION, V92, P303, DOI 10.1097/TP.0b013e3182247ae2; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, P26; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Cao C, 2009, J CELL PHYSIOL, V220, P277, DOI 10.1002/jcp.21780; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; de Gruijl FR, 2010, INT J CANCER, V8, P8; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Geissler EK, 2010, NAT REV NEPHROL, V6, P639, DOI 10.1038/nrneph.2010.130; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Haratake A, 1997, J INVEST DERMATOL, V108, P769, DOI 10.1111/1523-1747.ep12292163; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Kim MA, 2009, ONCOGENE, V19, P19; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Meeran SM, 2009, NEOPLASIA, V11, P846, DOI 10.1593/neo.09528; Mitchell C, 2010, AM J TRANSPLANT, V10, P1343, DOI 10.1111/j.1600-6143.2010.03133.x; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; O'Shaughnessy RFL, 2007, CANCER RES, V67, P8207, DOI 10.1158/0008-5472.CAN-07-0755; O'Shaughnessy RFL, 2007, J BIOL CHEM, V282, P17297, DOI 10.1074/jbc.M610386200; O'Shaughnessy RFL, 2009, DEVELOPMENT, V136, P3423, DOI 10.1242/dev.037010; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Reeve VE, 2006, PHOTOCHEM PHOTOBIOL, V82, P406, DOI 10.1562/2005-09-29-RA-703; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Sadagurski M, 2007, J CELL PHYSIOL, V213, P519, DOI 10.1002/jcp.21131; Salgo R, 2010, AM J TRANSPLANT, V10, P1385, DOI 10.1111/j.1600-6143.2009.02997.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wulff BC, 2008, J INVEST DERMATOL, V128, P2467, DOI 10.1038/jid.2008.121; YAMAMOTO A, 1991, ARCH DERMATOL RES, V283, P219, DOI 10.1007/BF01106105; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	63	20	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 4	2013	32	27					3254	3262		10.1038/onc.2012.338	http://dx.doi.org/10.1038/onc.2012.338			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	176JZ	22890326				2022-12-25	WOS:000321301600005
J	Mo, M; Erdelyi, I; Szigeti-Buck, K; Benbow, JH; Ehrlich, BE				Mo, Michelle; Erdelyi, Ildiko; Szigeti-Buck, Klara; Benbow, Jennifer H.; Ehrlich, Barbara E.			Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment	FASEB JOURNAL			English	Article						neuronal calcium sensor-1; inositol; 1,4,5 trisphosphate receptor; intracellular calcium signaling; ibudilast	NEURONAL CALCIUM SENSOR-1; ORAL GLUTAMINE; RAT MODELS; CANCER; RECEPTOR; TAXOL; THERAPY; GLUTATHIONE; HOMEOSTASIS; INHIBITION	Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect that occurs in many patients undergoing chemotherapy. It is often irreversible and frequently leads to early termination of treatment. In this study, we have identified two compounds, lithium and ibudilast, that when administered as a single prophylactic injection prior to paclitaxel treatment, prevent the development of CIPN in mice at the sensory-motor and cellular level. The prevention of neuropathy was not observed in paclitaxel-treated mice that were only prophylactically treated with a vehicle injection. The coadministration of lithium with paclitaxel also allows for administration of higher doses of paclitaxel (survival increases by 60%), protects against paclitaxel-induced cardiac abnormalities, and, notably, does not interfere with the antitumor effects of paclitaxel. Moreover, we have determined a mechanism by which CIPN develops and have discovered that lithium and ibudilast inhibit development of peripheral neuropathy by disrupting the interaction between paclitaxel, neuronal calcium sensor 1 (NCS-1), and the inositol 1,4,5-trisphosphate receptor (InsP3R) to prevent treatment-induced decreases in intracellular calcium signaling. This study shows that lithium and ibudilast are candidate therapeutics for the prevention of paclitaxel-induced neuropathy and could enable patients to tolerate more aggressive treatment regimens.-Mo, M., Erdelyi, I., Szigeti-Buck, K., Benbow, J. H., Ehrlich, B. E. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J. 26, 4696-4709 (2012). www.fasebj.org	[Mo, Michelle; Benbow, Jennifer H.; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Erdelyi, Ildiko] Yale Univ, Dept Comparat Med, New Haven, CT 06520 USA; [Szigeti-Buck, Klara] Yale Univ, Dept Obstet & Gynecol, New Haven, CT 06520 USA; [Benbow, Jennifer H.; Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704	U.S. Department of Defense [W81XWH-10-1-0033]; U.S. National Institutes of Health [DK 57751, DK61747]; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK061747] Funding Source: NIH RePORTER	U.S. Department of Defense(United States Department of Defense); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the U.S. Department of Defense (W81XWH-10-1-0033) and the U.S. National Institutes of Health (DK 57751 and DK61747) and a National Science Foundation predoctoral fellowship. The authors are grateful for the insightful conversations regarding this study with Ivana Kuo, Colleen Feriod, Brenda DeGray, and Ed Kaftan. The authors thank Gordon Terwilliger and Caroline Zeiss for their help and expertise in histological processing and analysis; Nikki Mikkush and Kerry Russell for their assistance and knowledge in performing and analyzing echocardiograms; and Jiang Zaoli and Tommy Cheng for their expertise and assistance in creating a xenograft mouse model.	Agam G, 2009, BIOCHEM SOC T, V37, P1121, DOI 10.1042/BST0371121; Amara S, 2008, ANN PHARMACOTHER, V42, P1481, DOI 10.1345/aph.1L179; Baird RD, 2010, NAT REV CLIN ONCOL, V7, P575, DOI 10.1038/nrclinonc.2010.120; Benbow JH, 2011, J BIOL CHEM, V286, P34575, DOI 10.1074/jbc.M111.265751; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Chang A. Y., 1995, SEMIN ONCOL, V22, P70; CHANG AY, 1995, SEMIN ONCOL, V22, P66; COLOMBO N, 1995, INT J GYNECOL CANCER, V5, P81, DOI 10.1046/j.1525-1438.1995.05020081.x; Costa R, 2011, BRIT J PHARMACOL, V164, P681, DOI 10.1111/j.1476-5381.2011.01408.x; Fernyhough P, 2010, CELL CALCIUM, V47, P130, DOI 10.1016/j.ceca.2009.11.008; Fishman P, 2004, ONCOGENE, V23, P2465, DOI 10.1038/sj.onc.1207355; Grothey A, 2011, J CLIN ONCOL, V29, P421, DOI 10.1200/JCO.2010.31.5911; Hama AT, 2012, J NEUROTRAUM, V29, P600, DOI 10.1089/neu.2011.1863; Johenning FW, 2002, J NEUROSCI, V22, P5344; Johenning FW, 2004, BIOCHEM J, V382, P687, DOI 10.1042/BJ20040418; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; LEE M, 1980, AM J HOSP PHARM, V37, P1066, DOI 10.1093/ajhp/37.8.1066; Lema MJ, 2010, ONCOLOGIST, V15, P3, DOI 10.1634/theoncologist.2009-S505; Lersch Christian, 2002, Clin Colorectal Cancer, V2, P54, DOI 10.3816/CCC.2002.n.011; LYMAN GH, 1981, AM J MED, V70, P1222, DOI 10.1016/0002-9343(81)90831-7; LYMAN GH, 1980, NEW ENGL J MED, V302, P257, DOI 10.1056/NEJM198001313020503; Makoukji J, 2012, P NATL ACAD SCI USA, V109, P3973, DOI 10.1073/pnas.1121367109; Naderi S, 2004, J CELL SCI, V117, P3769, DOI 10.1242/jcs.01210; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pourmohammadi N, 2012, BASIC CLIN PHARMACOL, V110, P231, DOI 10.1111/j.1742-7843.2011.00795.x; Rahn EJ, 2008, J PHARMACOL EXP THER, V327, P584, DOI 10.1124/jpet.108.141994; Rousset M, 2003, J BIOL CHEM, V278, P7019, DOI 10.1074/jbc.M209537200; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; Saha L, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/143579; Sarosy GA, 2010, CANCER-AM CANCER SOC, V116, P1476, DOI 10.1002/cncr.24861; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; SHARMA A, 1994, PHARMACEUT RES, V11, P889, DOI 10.1023/A:1018994111594; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Siau C, 2006, ANESTH ANALG, V102, P1485, DOI 10.1213/01.ane.0000204318.35194.ed; Smyth JF, 1997, ANN ONCOL, V8, P569, DOI 10.1023/A:1008211226339; STEINHERZ LJ, 1995, MED PEDIATR ONCOL, V24, P352, DOI 10.1002/mpo.2950240604; Wada A, 2009, FRONT BIOSCI-LANDMRK, V14, P1558, DOI 10.2741/3324; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; Wang WS, 2007, ONCOLOGIST, V12, P312, DOI 10.1634/theoncologist.12-3-312; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; WOOD AJ, 1986, NEUROPHARMACOLOGY, V25, P1285, DOI 10.1016/0028-3908(86)90149-8; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhang K, 2010, J MOL CELL CARDIOL, V49, P829, DOI 10.1016/j.yjmcc.2010.08.018	50	52	54	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2012	26	11					4696	4709		10.1096/fj.12-214643	http://dx.doi.org/10.1096/fj.12-214643			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	030MG	22889832	Green Published			2022-12-25	WOS:000310574200030
J	Delphin, C; Bouvier, D; Seggio, M; Couriol, E; Saoudi, Y; Denarier, E; Bosc, C; Valiron, O; Bisbal, M; Arnal, I; Andrieux, A				Delphin, Christian; Bouvier, Denis; Seggio, Maxime; Couriol, Emilie; Saoudi, Yasmina; Denarier, Eric; Bosc, Christophe; Valiron, Odile; Bisbal, Mariano; Arnal, Isabelle; Andrieux, Annie			MAP6-F Is a Temperature Sensor That Directly Binds to and Protects Microtubules from Cold-induced Depolymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOP PROTEINS; ANTARCTIC FISHES; BETA-STRUCTURE; DAILY TORPOR; ENDS; TUBULINS; STABILIZATION; DOUBLECORTIN; HIBERNATION; STABILITY	Microtubules are dynamic structures that present the peculiar characteristic to be ice-cold labile in vitro. In vivo, microtubules are protected from ice-cold induced depolymerization by the widely expressed MAP6/STOP family of proteins. However, the mechanism by which MAP6 stabilizes microtubules at 4 degrees C has not been identified. Moreover, the microtubule cold sensitivity and therefore the needs for microtubule stabilization in the wide range of temperatures between 4 and 37 degrees C are unknown. This is of importance as body temperatures of animals can drop during hibernation or torpor covering a large range of temperatures. Here, we show that in the absence of MAP6, microtubules in cells below 20 degrees C rapidly depolymerize in a temperature-dependent manner whereas they are stabilized in the presence of MAP6. We further show that in cells, MAP6-F binding to and stabilization of microtubules is temperature-dependent and very dynamic, suggesting a direct effect of the temperature on the formation of microtubule/MAP6 complex. We also demonstrate using purified proteins that MAP6-F binds directly to microtubules through its Mc domain. This binding is temperature-dependent and coincides with progressive conformational changes of the Mc domain as revealed by circular dichroism. Thus, MAP6 might serve as a temperature sensor adapting its conformation according to the temperature to maintain the cellular microtubule network in organisms exposed to temperature decrease.	[Delphin, Christian; Seggio, Maxime; Couriol, Emilie; Saoudi, Yasmina; Denarier, Eric; Bosc, Christophe; Valiron, Odile; Bisbal, Mariano; Andrieux, Annie] Inst Natl Sante & Rech Med, Commissariat Energie Atom, Team Physiopathol Cytoskeleton 1, GIN iRTSV GPC U836, F-38042 Grenoble 9, France; [Bouvier, Denis] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Arnal, Isabelle] Inst Natl Sante & Rech Med, Team Dynam & Struct Regulat Cytoskeleton 13, GIN U836, F-38042 Grenoble 9, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm)	Delphin, C (corresponding author), Univ Grenoble 1, Inserm U836, Equipe 1, Batiment Edmond J Safra,Site Sante La Tronche,BP, F-38042 Grenoble 9, France.	christian.delphin@ujf-grenoble.fr	Denarier, Eric/X-6137-2019; saoudi, yasmina/AAW-7354-2020; Bosc, Christophe/P-3401-2017; Arnal, Isabelle/X-6559-2019; Bisbal, Mariano/AAE-9308-2021; Denarier, Eric/H-3555-2017; Bosc, Christophe/Q-8877-2019; ANDRIEUX, ANNIE/B-2134-2017; Christian, Delphin/P-9284-2017	Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Bisbal, Mariano/0000-0002-3870-6151; Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Christian, Delphin/0000-0003-3240-8695; Arnal, Isabelle/0000-0001-6149-8189	INSERM; CEA; University Joseph Fourier; French National Research Agency [2010Blan120201 CBioS]; Roche Pharmaceutic RPF program	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); University Joseph Fourier; French National Research Agency(French National Research Agency (ANR)); Roche Pharmaceutic RPF program	This work was supported by INSERM, CEA, University Joseph Fourier, and French National Research Agency Awards 2010Blan120201 CBioS (to A. A.).; Recipient of the Roche Pharmaceutic RPF program (AA team and F Hoffmann-La Roche Ltd, Basel, Switzerland).	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Detrich HW, 1997, COMP BIOCHEM PHYS A, V118, P501, DOI 10.1016/S0300-9629(97)00012-1; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Letournel F, 2003, J NEUROPATH EXP NEUR, V62, P1211, DOI 10.1093/jnen/62.12.1211; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Modig C, 2000, BIOCHEM BIOPH RES CO, V269, P787, DOI 10.1006/bbrc.2000.2362; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; OLMSTED JB, 1975, BIOCHEMISTRY-US, V14, P2996, DOI 10.1021/bi00684a032; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; REGULA CS, 1981, J CELL BIOL, V89, P45, DOI 10.1083/jcb.89.1.45; SCHILSTRA MJ, 1991, BIOCHEM J, V277, P839, DOI 10.1042/bj2770839; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; VERA JC, 1988, FEBS LETT, V232, P159, DOI 10.1016/0014-5793(88)80408-3; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5	36	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35127	35138		10.1074/jbc.M112.398339	http://dx.doi.org/10.1074/jbc.M112.398339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22904321	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000309968000023
J	Huck, B; Kemkemer, R; Franz-Wachtel, M; Macek, B; Hausser, A; Olayioye, MA				Huck, Bettina; Kemkemer, Ralf; Franz-Wachtel, Mirita; Macek, Boris; Hausser, Angelika; Olayioye, Monilola A.			GIT1 Phosphorylation on Serine 46 by PKD3 Regulates Paxillin Trafficking and Cellular Protrusive Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; P21-ACTIVATED KINASE; MASS-SPECTROMETRY; SIGNALING COMPLEX; FOCAL ADHESIONS; LEADING-EDGE; ACTIN; MIGRATION; ACTIVATION; TRANSPORT	The continuous assembly and disassembly of focal adhesions is required for efficient cell spreading and migration. The G-protein-coupled receptor kinase-interacting protein 1 (GIT1) is a multidomain protein whose dynamic localization to sites of cytoskeletal remodeling is critically involved in the regulation of these processes. Here we provide evidence that the subcellular localization of GIT1 is regulated by protein kinase D3 (PKD3) through direct phosphorylation on serine 46. GIT1 phosphorylation on serine 46 was abrograted by PKD3 depletion, thereby identifying GIT1 as the first specific substrate for this kinase. A GIT1 S46D phosphomimetic mutant localized to motile, paxillin-positive cytoplasmic complexes, whereas the phosphorylation-deficient GIT1 S46A was enriched in focal adhesions. We propose that phosphorylation of GIT1 on serine 46 by PKD3 represents a molecular switch by which GIT1 localization, paxillin trafficking, and cellular protrusive activity are regulated.	[Huck, Bettina; Hausser, Angelika; Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr Tuebingen, D-72076 Tubingen, Germany	University of Stuttgart; Max Planck Society; Eberhard Karls University of Tubingen	Olayioye, MA (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	monilola.olayioye@izi.uni-stuttgart.de	Macek, Boris/N-1442-2015; Hausser, Angelika/AAC-4531-2021	Macek, Boris/0000-0002-1206-2458; 	German Cancer Aid [109583]; Landesgraduiertenforderung; DFG	German Cancer Aid(Deutsche Krebshilfe); Landesgraduiertenforderung; DFG(German Research Foundation (DFG))	This work was funded by the German Cancer Aid 109583.; Supported by a fellowship from the Landesgraduiertenforderung.; Supported by the DFG Heisenberg program. To whom correspondence should be addressed: University of Stuttgart, Institute of Cell Biology and Immunology, Allmandring 31, 70569 Stuttgart, Germany. Tel.: 49-711-685-69301; Fax: 49-711-685-66774; E-mail: monilola.olayioye@izi.uni-stuttgart.de.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Manabe R, 2002, J CELL SCI, V115, P1497; Matafora V, 2001, J CELL SCI, V114, P4509; Mayhew MW, 2006, J PROTEOME RES, V5, P2417, DOI 10.1021/pr060140t; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Olsen Jesper V., 2009, V492, P131, DOI 10.1007/978-1-59745-493-3_7; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ren YX, 2012, MOL CELL BIOCHEM, V365, P109, DOI 10.1007/s11010-012-1249-3; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34604	34613		10.1074/jbc.M112.374652	http://dx.doi.org/10.1074/jbc.M112.374652			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22893698	hybrid, Green Published			2022-12-25	WOS:000309654200063
J	Majumdar, R; Railkar, R; Dighe, RR				Majumdar, Ritankar; Railkar, Reema; Dighe, Rajan R.			The Antibodies against the Computationally Designed Mimic of the Glycoprotein Hormone Receptor Transmembrane Domain Provide Insights into Receptor Activation and Suppress the Constitutively Activated Receptor Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-STIMULATING HORMONE; THYROTROPIN RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; LIGAND-BINDING; HINGE REGION; LUTROPIN RECEPTOR; ALPHA-SUBUNIT; LOOP; ECTODOMAIN	The exoloops of glycoprotein hormone receptors (GpHRs) transduce the signal generated by the ligand-ectodomain interactions to the transmembrane helices either through direct hormonal contact and/or by modulating the interdomain interactions between the hinge region (HinR) and the transmembrane domain (TMD). The ligand-induced conformational alterations in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormone receptor/thyroid stimulating hormone receptor were mapped using exoloop-specific antibodies generated against a mini-TMD protein designed to mimic the native exoloop conformations that were created by joining the thyroid stimulating hormone receptor exoloops constrained through helical tethers and library-derived linkers. The antibody against the mini-TMD specifically recognized all three GpHRs and inhibited the basal and hormone-stimulated cAMP production without affecting hormone binding. Interestingly, binding of the antibody to all three receptors was abolished by prior incubation of the receptors with the respective hormones, suggesting that the exoloops are buried in the hormone-receptor complexes. The antibody also suppressed the high basal activities of gain-of-function mutations in the HinRs, exoloops, and TMDs such as those involved in precocious puberty and thyroid toxic adenomas. Using the antibody and point/deletion/chimeric receptor mutants, we demonstrate that changes in the HinR-exoloop interactions play an important role in receptor activation. Computational analysis suggests that the mini-TMD antibodies act by conformationally locking the transmembrane helices by means of restraining the exoloops and the juxta-membrane regions. Using GpHRs as a model, we describe a novel computational approach of generating soluble TMD mimics that can be used to explain the role of exoloops during receptor activation and their interplay with TMDs.	[Majumdar, Ritankar; Railkar, Reema; Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Dighe, RR (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in	Railkar, Reema/AAE-7258-2022; Majumdar, Ritankar/AAE-7249-2022	Majumdar, Ritankar/0000-0001-6624-0187; Railkar, Reema/0000-0002-6808-7814	Department of Biotechnology, Government of India, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India, New Delhi.; Recipient of a Council of Scientific and Industrial Research, New Delhi, fellowship.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; Dupakuntla M, 2010, MOL CELL ENDOCRINOL, V315, P131, DOI 10.1016/j.mce.2009.10.002; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Gadkari RA, 2007, MOL CELL ENDOCRINOL, V260, P23, DOI 10.1016/j.mce.2006.07.006; GUSTAVSSON B, 1994, BIOCHEM BIOPH RES CO, V199, P612, DOI 10.1006/bbrc.1994.1272; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Heymann B, 2001, BIOPHYS J, V81, P1295, DOI 10.1016/S0006-3495(01)75787-6; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; KANESHIGE M, 1995, HORM METAB RES, V27, P267, DOI 10.1055/s-2007-979956; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kosugi S, 1997, FEBS LETT, V406, P139, DOI 10.1016/S0014-5793(97)00256-1; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Majumdar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040291; Majumdar R, 2012, FEBS LETT, V586, P810, DOI 10.1016/j.febslet.2012.01.052; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; MOYLE WR, 1995, J BIOL CHEM, V270, P20020, DOI 10.1074/jbc.270.34.20020; Mueller S, 2010, TRENDS ENDOCRIN MET, V21, P111, DOI 10.1016/j.tem.2009.09.001; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; Neumann S, 2001, MOL ENDOCRINOL, V15, P1294, DOI 10.1210/me.15.8.1294; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Saha S, 2010, METALLOMICS, V2, P754, DOI 10.1039/c0mt00028k; Shinozaki H, 2001, MOL ENDOCRINOL, V15, P972, DOI 10.1210/me.15.6.972; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wonerow P, 2001, J MOL MED, V79, P707, DOI 10.1007/s001090100279; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Yeagle PL, 1997, BIOCHEMISTRY-US, V36, P9649, DOI 10.1021/bi970908a; YOO JK, 1993, J BIOL CHEM, V268, P13034; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	52	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34514	34532		10.1074/jbc.M112.355032	http://dx.doi.org/10.1074/jbc.M112.355032			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22904318	Green Published, hybrid			2022-12-25	WOS:000309654200056
J	Wanka, C; Steinbach, JP; Rieger, J				Wanka, Christina; Steinbach, Joachim P.; Rieger, Johannes			Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE METABOLITES; TUMOR HYPOXIA; CANCER CELLS; TKTL1; P53; EXPRESSION; GROWTH; MUTATIONS; RECEPTOR; KINASE	Altered metabolism in tumor cells is increasingly recognized as a core component of the neoplastic phenotype. Because p53 has emerged as a master metabolic regulator, we hypothesized that the presence of wild-type p53 in glioblastoma cells could confer a selective advantage to these cells under the adverse conditions of the glioma microenvironment. Here, we report on the effects of the p53-dependent effector Tp53-induced glycolysis and apoptosis regulator (TIGAR) on hypoxia-induced cell death. We demonstrate that TIGAR is overexpressed in glioblastomas and that ectopic expression of TIGAR reduces cell death induced by glucose and oxygen restriction. Metabolic analyses revealed that TIGAR inhibits glycolysis and promotes respiration. Further, generation of reactive oxygen species (ROS) levels was reduced whereas levels of reduced glutathione were elevated in TIGAR-expressing cells. Finally, inhibiting the transketolase isoenzyme transketolase-like 1 (TKTL1) by siRNA reversed theses effects of TIGAR. These findings suggest that glioma cells benefit from TIGAR expression by (i) improving energy yield from glucose via increased respiration and (ii) enhancing defense mechanisms against ROS. Targeting metabolic regulators such as TIGAR may therefore be a valuable strategy to enhance glioma cell sensitivity toward spontaneously occurring or therapy-induced starvation conditions or ROS-inducing-therapeutic approaches.	[Wanka, Christina; Steinbach, Joachim P.; Rieger, Johannes] Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60528 Frankfurt, Germany	Goethe University Frankfurt	Steinbach, JP (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	joachim.steinbach@med.uni-frankfurt.de		Rieger, Johannes/0000-0002-7918-1777	Deutsche Forschungsgemeinschaft (DFG) [GRK 1302/1, RI2175/1-1]; Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt"; interdisciplinary center for neuroscience Frankfurt	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt"; interdisciplinary center for neuroscience Frankfurt	This work was supported by Grant GRK 1302/1 from the Deutsche Forschungsgemeinschaft (DFG) (to J. P. S.), DFG grant RI2175/1-1 (to J. P. S. and J. R.), and a Frankfurt Initiative for Neurooncology research grant from the "Prasidium der Goethe-Universitat Frankfurt" and the interdisciplinary center for neuroscience Frankfurt (to J. P. S. and J. R.).	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Campbell JA, 1925, J PHYSIOL-LONDON, V60, P20, DOI 10.1113/jphysiol.1925.sp002217; Comin-Anduix B, 2001, EUR J BIOCHEM, V268, P4177, DOI 10.1046/j.1432-1327.2001.02329.x; Coy JF, 2005, CLIN LAB, V51, P257; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Foldi M, 2007, ONCOL REP, V17, P841; Goldschmidt-Clermont PJ, 1999, GENE EXPRESSION, V7, P255; Griendling KK, 1999, CIRC RES, V85, P562, DOI 10.1161/01.RES.85.6.562; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; JAMIESON D, 1964, NATURE, V201, P1227, DOI 10.1038/2011227a0; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kayser G, 2011, PATHOLOGY, V43, P719, DOI 10.1097/PAT.0b013e32834c352b; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Krockenberger M, 2007, INT J GYNECOL CANCER, V17, P101, DOI 10.1111/j.1525-1438.2007.00799.x; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; OLINSKI R, 1992, ARCH BIOCHEM BIOPHYS, V297, P139, DOI 10.1016/0003-9861(92)90651-C; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Pistollato F, 2010, BIOCHEM PHARMACOL, V80, P1517, DOI 10.1016/j.bcp.2010.08.003; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sattler UGA, 2010, RADIOTHER ONCOL, V94, P102, DOI 10.1016/j.radonc.2009.11.007; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SRIDHAR KS, 1983, CANCER RES, V43, P4629; Steinbach JP, 2004, CANCER RES, V64, P1575, DOI 10.1158/0008-5472.CAN-03-3775; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Steinbach JP, 2002, BRAIN PATHOL, V12, P12; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tabatabaei P, 2008, J NEURO-ONCOL, V90, P35, DOI 10.1007/s11060-008-9625-2; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Volker HU, 2008, AM J CLIN PATHOL, V130, P50, DOI 10.1309/6H9844AMMET82DBJ; Walenta S, 2002, BIOMOL ENG, V18, P249, DOI 10.1016/S1389-0344(01)00107-1; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wibom C, 2010, J PROTEOME RES, V9, P2909, DOI 10.1021/pr901088r; Wischhusen J, 2004, CELL DEATH DIFFER, V11, P1150, DOI 10.1038/sj.cdd.4401477; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Yaromina A, 2009, INT J RADIAT BIOL, V85, P972, DOI 10.3109/09553000903232868; Yuan WJ, 2010, CANCER BIOL THER, V9, P710, DOI 10.4161/cbt.9.9.11431	68	120	127	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33436	33446		10.1074/jbc.M112.384578	http://dx.doi.org/10.1074/jbc.M112.384578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22887998	hybrid, Green Published			2022-12-25	WOS:000309602100030
J	Angle, MR; Schaefer, AT				Angle, Matthew R.; Schaefer, Andreas T.			Neuronal Recordings with Solid-Conductor Intracellular Nanoelectrodes (SCINEs)	PLOS ONE			English	Article							FOCUSED ION-BEAM; WHOLE-CELL PATCH; DENDRITIC INTEGRATION; MEMBRANE-PROPERTIES; ACTION-POTENTIALS; MICROELECTRODE; PRECURSOR; EXCHANGE; CURRENTS	Direct electrical recording of the neuronal transmembrane potential has been crucial to our understanding of the biophysical mechanisms subserving neuronal computation. Existing intracellular recording techniques, however, limit the accuracy and duration of such measurements by changing intracellular biochemistry and/or by damaging the plasma membrane. Here we demonstrate that nanoengineered electrodes can be used to record neuronal transmembrane potentials in brain tissue without causing these physiological perturbations. Using focused ion beam milling, we have fabricated Solid-Conductor Intracellular NanoElectrodes (SCINEs), from conventional tungsten microelectrodes. SCINEs have tips that are <300 nm in diameter for several micrometers, but can be easily handled and can be inserted into brain tissue. Performing simultaneous whole-cell patch recordings, we show that SCINEs can record action potentials (APs) as well as slower, subthreshold neuronal potentials without altering cellular properties. These results show a key role for nanotechnology in the development of new electrical recording techniques in neuroscience.	[Angle, Matthew R.; Schaefer, Andreas T.] Max Planck Inst Med Res, Heidelberg, Germany	Max Planck Society	Angle, MR (corresponding author), Max Planck Inst Med Res, Heidelberg, Germany.	schaefer@mpimf-heidelberg.mpg.de		Schaefer, Andreas/0000-0002-4677-8788; Angle, Matthew/0000-0002-2601-7631	Max Planck Society, University of Heidelberg; Medical Research Council [MC_UP_1202/5] Funding Source: researchfish; MRC [MC_UP_1202/5] Funding Source: UKRI	Max Planck Society, University of Heidelberg; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Max Planck Society, University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD S, 1995, J NEUROSCI, V15, P7528; Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BELLES B, 1988, PFLUG ARCH EUR J PHY, V411, P353, DOI 10.1007/BF00587713; Brown KT, 1986, ADV MICROPIPETTE TEC; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; Chorev E, 2009, CURR OPIN NEUROBIOL, V19, P513, DOI 10.1016/j.conb.2009.08.005; de Asis ED, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3247885; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; DOWBEN RM, 1953, SCIENCE, V118, P22, DOI 10.1126/science.118.3053.22; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Edinger K, 1998, J VAC SCI TECHNOL B, V16, P3311, DOI 10.1116/1.590497; Ferguson JE, 2012, NANOMEDICINE, V8, P427; Forscher P, 1985, BIOPHYS J, V45, P181; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; GRAHAM J, 1946, J CELL COMPAR PHYSL, V28, P99, DOI 10.1002/jcp.1030280106; Grundfest H, 1942, J NEUROPHYSIOL, V5, P275, DOI 10.1152/jn.1942.5.4.275; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han SW, 2005, BIOCHEM BIOPH RES CO, V332, P633, DOI 10.1016/j.bbrc.2005.04.059; Hanein Y., 2002, SENSORS UPDATE, V10, P47; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; INCE C, 1986, BIOPHYS J, V50, P1203, DOI 10.1016/S0006-3495(86)83563-9; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; Li H, 2006, FRONTIERS BIOCHIP TE; Li WC, 2004, J NEUROPHYSIOL, V92, P380, DOI 10.1152/jn.01238.2003; LING G, 1949, J CELL COMPAR PHYSL, V34, P383, DOI 10.1002/jcp.1030340304; Lipp S, 1996, J VAC SCI TECHNOL B, V14, P3920, DOI 10.1116/1.588695; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Marty A, 1995, SINGLE CHANNNEL RECO; Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007; MCADAMS ET, 1995, BIOSENS BIOELECTRON, V10, P67, DOI 10.1016/0956-5663(95)96795-Z; MELMED AJ, 1991, J VAC SCI TECHNOL B, V9, P601, DOI 10.1116/1.585467; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Ogden D, 1994, MICROELECTRODE TECHN; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PENNER R, 1987, BIOSCIENCE REP, V7, P313, DOI 10.1007/BF01121453; PONGRACZ F, 1991, J NEUROPHYSIOL, V65, P747, DOI 10.1152/jn.1991.65.3.747; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Qiao Y, 2005, NANOTECHNOLOGY, V16, P1598, DOI 10.1088/0957-4484/16/9/032; Reccius CH, 2004, LANGMUIR, V20, P11175, DOI 10.1021/la048233h; ROBBLEE LS, 1983, J ELECTROCHEM SOC, V130, P731, DOI 10.1149/1.2119793; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Sarantopoulos Constantine, 2007, V38, P253; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svirskis G, 1997, J NEUROPHYSIOL, V77, P579, DOI 10.1152/jn.1997.77.2.579; Swandulla D, 1992, PRACTICAL ELECTROPHY; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Zhang RW, 2010, J PHYSIOL-LONDON, V588, P2557, DOI 10.1113/jphysiol.2010.187088; Zybill CE, 1997, J ORGANOMET CHEM, V547, P167	60	28	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43194	10.1371/journal.pone.0043194	http://dx.doi.org/10.1371/journal.pone.0043194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905231	Green Published, gold, Green Submitted			2022-12-25	WOS:000307823600056
J	Hatzios, SK; Ringgaard, S; Davis, BM; Waldor, MK				Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.			Studies of Dynamic Protein-Protein Interactions in Bacteria Using Renilla Luciferase Complementation Are Undermined by Nonspecific Enzyme Inhibition	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VIVO; VIBRIO-CHOLERAE; FIREFLY LUCIFERASE; SPLIT-LUCIFERASE; SUICIDE VECTOR; LIVING CELLS; CHEMOTAXIS; CONSTRUCTION; REPORTERS	The luciferase protein fragment complementation assay is a powerful tool for studying protein-protein interactions. Two inactive fragments of luciferase are genetically fused to interacting proteins, and when these two proteins interact, the luciferase fragments can reversibly associate and reconstitute enzyme activity. Though this technology has been used extensively in live eukaryotic cells, split luciferase complementation has not yet been applied to studies of dynamic protein-protein interactions in live bacteria. As proof of concept and to develop a new tool for studies of bacterial chemotaxis, fragments of Renilla luciferase (Rluc) were fused to the chemotaxis-associated response regulator CheY3 and its phosphatase CheZ in the enteric pathogen Vibrio cholerae. Luciferase activity was dependent on the presence of both CheY3 and CheZ fusion proteins, demonstrating the specificity of the assay. Furthermore, enzyme activity was markedly reduced in V. cholerae chemotaxis mutants, suggesting that this approach can measure defects in chemotactic signaling. However, attempts to measure changes in dynamic CheY3-CheZ interactions in response to various chemoeffectors were undermined by nonspecific inhibition of the full-length luciferase. These observations reveal an unexpected limitation of split Rluc complementation that may have implications for existing data and highlight the need for great caution when evaluating small molecule effects on dynamic protein-protein interactions using the split luciferase technology.	[Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Hatzios, Stavroula K.; Ringgaard, Simon; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hatzios, SK (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu		Hatzios, Stavroula/0000-0001-8658-8949; Ringgaard, Simon/0000-0002-4980-5964; Waldor, Matthew/0000-0003-1843-7000	National Institutes of Health [NIH R37 AI-42347]; Howard Hughes Medical Institute; Villum Kann Rasmussen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Villum Kann Rasmussen Foundation(Villum Fonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institutes of Health (NIH R37 AI-42347) and the Howard Hughes Medical Institute (www.hhmi.org). S. R. was funded by a post-doctoral fellowship from the Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Barak R, 2006, J MOL BIOL, V359, P251, DOI 10.1016/j.jmb.2006.03.033; Boin MA, 2004, FEMS MICROBIOL LETT, V239, P1, DOI 10.1016/j.femsle.2004.08.039; Bouveret E, 2012, METHODS MOL BIOL, V804, P15, DOI 10.1007/978-1-61779-361-5_2; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Ciruela F, 2008, CURR OPIN BIOTECH, V19, P338, DOI 10.1016/j.copbio.2008.06.003; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; FRETER R, 1981, INFECT IMMUN, V34, P215, DOI 10.1128/IAI.34.1.215-221.1981; Herbst KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005642; Jawhara S, 2004, ANTIMICROB AGENTS CH, V48, P3436, DOI 10.1128/AAC.48.9.3436-3441.2004; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Lee SH, 2001, P NATL ACAD SCI USA, V98, P6889, DOI 10.1073/pnas.111581598; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Shimizu TS, 2006, P NATL ACAD SCI USA, V103, P2093, DOI 10.1073/pnas.0510958103; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; TSO WW, 1974, J BACTERIOL, V118, P560, DOI 10.1128/JB.118.2.560-576.1974; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; WOOD KV, 1987, ANAL BIOCHEM, V161, P501, DOI 10.1016/0003-2697(87)90480-5	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43175	10.1371/journal.pone.0043175	http://dx.doi.org/10.1371/journal.pone.0043175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905225	Green Published, Green Submitted, gold			2022-12-25	WOS:000307823600052
J	Xu, GL; Kuster, TM; Gunthardt-Goerg, MS; Dobbertin, M; Li, MH				Xu, Guo-Liang; Kuster, Thomas M.; Guenthardt-Goerg, Madeleine S.; Dobbertin, Matthias; Li, Mai-He			Seasonal Exposure to Drought and Air Warming Affects Soil Collembola and Mites	PLOS ONE			English	Article							BODY-SIZE; FOREST SOIL; LONG-TERM; FOOD WEBS; CLIMATE-CHANGE; ECOSYSTEM; COMMUNITY; DYNAMICS; BIOMASS; GROWTH	Global environmental changes affect not only the aboveground but also the belowground components of ecosystems. The effects of seasonal drought and air warming on the genus level richness of Collembola, and on the abundance and biomass of the community of Collembola and mites were studied in an acidic and a calcareous forest soil in a model oak-ecosystem experiment (the Querco experiment) at the Swiss Federal Research Institute WSL in Birmensdorf. The experiment included four climate treatments: control, drought with a 60% reduction in rainfall, air warming with a seasonal temperature increase of 1.4 degrees C, and air warming + drought. Soil water content was greatly reduced by drought. Soil surface temperature was slightly increased by both the air warming and the drought treatment. Soil mesofauna samples were taken at the end of the first experimental year. Drought was found to increase the abundance of the microarthropod fauna, but reduce the biomass of the community. The percentage of small mites (body length <= 0.20 mm) increased, but the percentage of large mites (body length >0.40 mm) decreased under drought. Air warming had only minor effects on the fauna. All climate treatments significantly reduced the richness of Collembola and the biomass of Collembola and mites in acidic soil, but not in calcareous soil. Drought appeared to have a negative impact on soil microarthropod fauna, but the effects of climate change on soil fauna may vary with the soil type.	[Xu, Guo-Liang] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Kuster, Thomas M.; Guenthardt-Goerg, Madeleine S.; Dobbertin, Matthias; Li, Mai-He] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	Chinese Academy of Sciences; South China Botanical Garden, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Xu, GL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	xugl@scbg.ac.cn	Li, Mai-He/L-6390-2013; Günthardt-Goerg, Madeleine S./L-6461-2013	Li, Mai-He/0000-0002-7029-2841; 	Chinese Academy of Sciences [KSCX2-EW-J-28]; National Natural Science Foundation of China [40801096]; Sino-Swiss Science and Technology Cooperation Program [EG07-092009]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Science and Technology Cooperation Program	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-28) and the National Natural Science Foundation of China (no. 40801096). G. L. Xu's research stay in Switzerland was supported by Sino-Swiss Science and Technology Cooperation Program (project No. EG07-092009) which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez T., 1999, Agricultural and Forest Entomology, V1, P243, DOI 10.1046/j.1461-9563.1999.00032.x; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; BAATH E, 1982, SOIL BIOL BIOCHEM, V14, P353, DOI 10.1016/0038-0717(82)90005-0; BADEJO MA, 1990, BIOTROPICA, V22, P382, DOI 10.2307/2388555; Badejo MA, 2006, EXP APPL ACAROL, V40, P145, DOI 10.1007/s10493-006-9029-y; Blanchard JL, 2011, OIKOS, V120, P481, DOI 10.1111/j.1600-0706.2010.19564.x; BOYCE MS, 1978, OECOLOGIA, V36, P1, DOI 10.1007/BF00344567; BRADY J, 1969, J APPL ECOL, V6, P391, DOI 10.2307/2401506; Bretfeld G, 1999, SYNOPSES PALAEARCTIC, V2; Brussaard L, 1997, AMBIO, V26, P563; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; CH2011, 2011, TECHNICAL REPORT, DOI [10.3929/ethz-a-006720559, DOI 10.3929/ETHZ-A-006720559]; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Chen PY, 2005, STAT SOFTWARE TUTORI; Coulson SJ, 1996, POLAR BIOL, V16, P147; Dallinger R, 1996, COMP BIOCHEM PHYS C, V113, P125, DOI 10.1016/0742-8413(95)02078-0; DANTHANARAYANA W, 1975, AUST J ZOOL, V23, P439, DOI 10.1071/ZO9750439; Digel C, 2011, OIKOS, V120, P503, DOI 10.1111/j.1600-0706.2010.18862.x; Dollery R, 2006, ECOGRAPHY, V29, P111, DOI 10.1111/j.2006.0906-7590.04366.x; DOUCE GK, 1976, OIKOS, V27, P324, DOI 10.2307/3543914; Freckman DW, 1997, AMBIO, V26, P556; Hagvar S, 1998, PEDOBIOLOGIA, V42, P358; Hagvar S, 2009, GLOBAL CHANGE BIOL, V15, P2972, DOI 10.1111/j.1365-2486.2009.01926.x; Haimi J, 2005, APPL SOIL ECOL, V30, P104, DOI 10.1016/j.apsoil.2005.02.006; Harte J, 1996, SOIL BIOL BIOCHEM, V28, P313, DOI 10.1016/0038-0717(95)00139-5; Hodar JA, 1996, ACTA OECOL, V17, P421; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Huhta V, 2001, PEDOBIOLOGIA, V45, P279, DOI 10.1078/0031-4056-00085; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Janssens F, 2007, CHECKLIST COLLEMBOLA; Johnston D.E., 1982, P111; JONES G, 1987, IBIS, V129, P274, DOI 10.1111/j.1474-919X.1987.tb03208.x; Jucevica E, 2006, PEDOBIOLOGIA, V50, P177, DOI 10.1016/j.pedobi.2005.10.006; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Kuster TM, 2013, PLANT BIOLOGY, V15, P138, DOI 10.1111/j.1438-8677.2011.00552.x; Laakso J, 1999, OIKOS, V87, P57, DOI 10.2307/3546996; Lindberg N, 2002, J APPL ECOL, V39, P924, DOI 10.1046/j.1365-2664.2002.00769.x; Lindberg N., 2003, THESIS SWEDISH U AGR; Maraun M, 1998, PEDOBIOLOGIA, V42, P232; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Mcgeoch MA, 2006, AUSTRAL ECOL, V31, P719, DOI 10.1111/j.1442-9993.2006.01614.x; Moron-Rios A, 2010, EUR J SOIL BIOL, V46, P91, DOI 10.1016/j.ejsobi.2009.12.008; Norby RJ, 2000, NEW PHYTOL, V147, P3, DOI 10.1046/j.1469-8137.2000.00676.x; Petchey OL, 2010, BIOL LETTERS, V6, P434, DOI 10.1098/rsbl.2010.0240; Pflug A, 2001, EUR J SOIL BIOL, V37, P305, DOI 10.1016/S1164-5563(01)01101-3; Pigino G, 2006, ECOTOX ENVIRON SAFE, V64, P257, DOI 10.1016/j.ecoenv.2005.12.012; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Potapov M, 2001, ISOTOMIDAE SYNOPSES, V3; Rhind SG, 2002, WILDLIFE RES, V29, P235, DOI 10.1071/WR01014; Rusek J, 1998, BIODIVERS CONSERV, V7, P1207, DOI 10.1023/A:1008887817883; Sinclair BJ, 2006, SOIL BIOL BIOCHEM, V38, P3158, DOI 10.1016/j.soilbio.2005.11.035; Sjursen H, 2005, APPL SOIL ECOL, V30, P148, DOI 10.1016/j.apsoil.2005.02.013; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Tsiafouli MA, 2005, APPL SOIL ECOL, V29, P17, DOI 10.1016/j.apsoil.2004.10.002; VERHOEF HA, 1983, HOLARCTIC ECOL, V6, P387; WALLWORK JA, 1983, ANNU REV ENTOMOL, V28, P109, DOI 10.1146/annurev.en.28.010183.000545; WIDDEN P, 1986, CAN J BOT, V64, P1424, DOI 10.1139/b86-194; Wolters V, 1998, APPL SOIL ECOL, V9, P221, DOI 10.1016/S0929-1393(98)00079-1; Xu GL, 2009, ENVIRON POLLUT, V157, P2030, DOI 10.1016/j.envpol.2009.02.026	60	33	40	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43102	10.1371/journal.pone.0043102	http://dx.doi.org/10.1371/journal.pone.0043102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905210	Green Published, gold			2022-12-25	WOS:000307823600048
J	Ba, Q; Zhou, NY; Duan, J; Chen, T; Hao, M; Yang, XY; Li, JY; Yin, J; Chu, RA; Wang, H				Ba, Qian; Zhou, Naiyuan; Duan, Juan; Chen, Tao; Hao, Miao; Yang, Xinying; Li, Junyang; Yin, Jun; Chu, Ruiai; Wang, Hui			Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1	PLOS ONE			English	Article							CANCER-CELLS; ARTEMISININ; APOPTOSIS; GROWTH; DERIVATIVES; ACTIVATION; MECHANISMS; EXPRESSION; TRANSPORT; METABOLISM	Artemisinin and its main active metabolite dihydroartemisinin, clinically used antimalarial agents with low host toxicity, have recently shown potent anticancer activities in a variety of human cancer models. Although iron mediated oxidative damage is involved, the mechanisms underlying these activities remain unclear. In the current study, we found that dihydroartemisinin caused cellular iron depletion in time- and concentration-dependent manners. It decreased iron uptake and disturbed iron homeostasis in cancer cells, which were independent of oxidative damage. Moreover, dihydroartemisinin reduced the level of transferrin receptor-1 associated with cell membrane. The regulation of dihydroartemisinin to transferrin receptor-1 could be reversed by nystatin, a cholesterol-sequestering agent but not the inhibitor of clathrin-dependent endocytosis. Dihydroartemisinin also induced transferrin receptor-1 palmitoylation and colocalization with caveolin-1, suggesting a lipid rafts mediated internalization pathway was involved in the process. Also, nystatin reversed the influences of dihydroartemisinin on cell cycle and apoptosis related genes and the siRNA induced downregulation of transferrin receptor-1 decreased the sensitivity to dihydroartemisinin efficiently in the cells. These results indicate that dihydroartemisinin can counteract cancer through regulating cell-surface transferrin receptor-1 in a non-classical endocytic pathway, which may be a new action mechanism of DHA independently of oxidative damage.	[Ba, Qian; Duan, Juan; Chen, Tao; Hao, Miao; Yang, Xinying; Li, Junyang; Yin, Jun; Chu, Ruiai; Wang, Hui] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Zhou, Naiyuan] China Natl Ctr Biotechnol Dev, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ba, Q (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	Ba, Qian/AAZ-2623-2021; hao, miao/HII-4487-2022	Ba, Qian/0000-0002-7253-7566; 	One Hundred Talents Program of the Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715]; Science and Technology Commission of Shanghai Municipality [10391902100]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001]; Xuhui Central Hospital [CRC2010002, CRC2011001, CRC2011004]; Director Foundation [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Xuhui District of Shanghai Municipality; Xuhui Central Hospital; Director Foundation; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	This study was supported by grants from the One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation (30870513, 31070680 and 91029715), the Science and Technology Commission of Shanghai Municipality (10391902100), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001), and Xuhui Central Hospital (CRC2010002, CRC2011001 and CRC2011004), Director Foundation (20090101) and the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of the Institute of Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba Q, 2011, CLIN CANCER RES, V17, P7625, DOI 10.1158/1078-0432.CCR-10-3099; Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Firestone GL, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001239; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; He Y, 2011, RHEUMATOL INT, V31, P53, DOI 10.1007/s00296-009-1218-7; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lu JJ, 2008, CANCER BIOL THER, V7, P1017, DOI 10.4161/cbt.7.7.6035; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Miller LH, 2011, CELL, V146, P855, DOI 10.1016/j.cell.2011.08.024; Morrissey C, 2010, ANTI-CANCER DRUG, V21, P423, DOI 10.1097/CAD.0b013e328336f57b; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SHTERMAN N, 1991, PATHOBIOLOGY, V59, P19, DOI 10.1159/000163611; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wartenberg M, 2003, LAB INVEST, V83, P1647, DOI 10.1097/01.LAB.0000098424.38003.FF	33	60	69	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42703	10.1371/journal.pone.0042703	http://dx.doi.org/10.1371/journal.pone.0042703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900042	Green Published, gold			2022-12-25	WOS:000307380900059
J	Boss, D; Hoffmann, A; Rappaz, B; Depeursinge, C; Magistretti, PJ; Van de Ville, D; Marquet, P				Boss, Daniel; Hoffmann, Annick; Rappaz, Benjamin; Depeursinge, Christian; Magistretti, Pierre J.; Van de Ville, Dimitri; Marquet, Pierre			Spatially-Resolved Eigenmode Decomposition of Red Blood Cells Membrane Fluctuations Questions the Role of ATP in Flickering	PLOS ONE			English	Article							DIGITAL HOLOGRAPHIC MICROSCOPY; ERYTHROCYTE-MEMBRANE; BIOLOGICAL-MEMBRANES; LIPID BILAYERS; ELASTICITY; SHAPE; MECHANICS; CURVATURE; SPECTRIN; SKELETON	Red blood cells (RBCs) present unique reversible shape deformability, essential for both function and survival, resulting notably in cell membrane fluctuations (CMF). These CMF have been subject of many studies in order to obtain a better understanding of these remarkable biomechanical membrane properties altered in some pathological states including blood diseases. In particular the discussion over the thermal or metabolic origin of the CMF has led in the past to a large number of investigations and modeling. However, the origin of the CMF is still debated. In this article, we present an analysis of the CMF of RBCs by combining digital holographic microscopy (DHM) with an orthogonal subspace decomposition of the imaging data. These subspace components can be reliably identified and quantified as the eigenmode basis of CMF that minimizes the deformation energy of the RBC structure. By fitting the observed fluctuation modes with a theoretical dynamic model, we find that the CMF are mainly governed by the bending elasticity of the membrane and that shear and tension elasticities have only a marginal influence on the membrane fluctations of the discocyte RBC. Further, our experiments show that the role of ATP as a driving force of CMF is questionable. ATP, however, seems to be required to maintain the unique biomechanical properties of the RBC membrane that lead to thermally excited CMF.	[Boss, Daniel; Hoffmann, Annick; Rappaz, Benjamin; Magistretti, Pierre J.; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland; [Depeursinge, Christian] Ecole Polytech Fed Lausanne, Adv Photon Lab, Lausanne, Vaud, Switzerland; [Magistretti, Pierre J.; Marquet, Pierre] DP CHUV, Dept Psychiat, Ctr Neurosci Psychiat, Prilly, Vaud, Switzerland; [Van de Ville, Dimitri] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Vaud, Switzerland; [Van de Ville, Dimitri] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Boss, D (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Vaud, Switzerland.	daniel.boss@a3.epfl.ch	Van De Ville, Dimitri/A-5364-2008; Rappaz, Benjamin/C-1881-2014	Van De Ville, Dimitri/0000-0002-2879-3861; Rappaz, Benjamin/0000-0002-8744-600X; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation [CR32I3132993, PP00P2123438]; Swiss Commission for Technology and Innovation [9389.1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission for Technology and Innovation	Funders are in part the Swiss National Science Foundation, grants #CR32I3132993 and #PP00P2123438, URL: http://www.snf.ch; and in part the Swiss Commission for Technology and Innovation, grant #9389.1, URL: http://www.kti.admin.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auth T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051910; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; BROCHARD F, 1975, J PHYS-PARIS, V36, P1035, DOI 10.1051/jphys:0197500360110103500; Colomb T, 2006, J OPT SOC AM A, V23, P3177, DOI 10.1364/JOSAA.23.003177; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; Evans J, 2008, BIOPHYS J, V94, P4134, DOI 10.1529/biophysj.107.117952; FEO C, 1977, NATURE, V265, P166, DOI 10.1038/265166a0; FISCHER TM, 1992, BIOPHYS J, V63, P1328, DOI 10.1016/S0006-3495(92)81710-1; Gov N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.228101; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Hale JP, 2009, SOFT MATTER, V5, P3603, DOI 10.1039/b910422d; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; LEVIN S, 1991, BIOPHYS J, V60, P733, DOI 10.1016/S0006-3495(91)82104-X; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Manno S, 2005, J BIOL CHEM, V280, P7581, DOI 10.1074/jbc.M410650200; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Manno S, 2010, J BIOL CHEM, V285, P33923, DOI 10.1074/jbc.M110.126896; Mark AP, 1992, J PHYS II, V2, P1273; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Mikirova N, 2005, ORTHOMOLECULAR MED, V20, P50; Park Y, 2010, P NATL ACAD SCI US; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; PETERSON MA, 1992, PHYS REV A, V45, P4116, DOI 10.1103/PhysRevA.45.4116; PETERSON MA, 1985, J MATH PHYS, V26, P711, DOI 10.1063/1.526612; Popescu G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218101; Rappaz B, 2008, CYTOM PART A, V73A, P895, DOI 10.1002/cyto.a.20605; Rappaz B, 2009, BLOOD CELL MOL DIS, V42, P228, DOI 10.1016/j.bcmd.2009.01.018; SEIFERT U, 1993, EUROPHYS LETT, V23, P71, DOI 10.1209/0295-5075/23/1/012; SEIFERT U, 1991, PHYS REV A, V44, P1182, DOI 10.1103/PhysRevA.44.1182; SHEETZ MP, 1977, J CELL BIOL, V73, P638, DOI 10.1083/jcb.73.3.638; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; STREY H, 1995, BIOPHYS J, V69, P478, DOI 10.1016/S0006-3495(95)79921-0; Szekely D, 2009, EUR BIOPHYS J BIOPHY, V38, P923, DOI 10.1007/s00249-009-0473-6; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tuvia S, 1998, J CELL BIOL, V141, P1551, DOI 10.1083/jcb.141.7.1551; ZEMAN K, 1990, EUR BIOPHYS J, V18, P203, DOI 10.1007/BF00183373; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900; ZILKER A, 1992, PHYS REV A, V46, P7998, DOI 10.1103/PhysRevA.46.7998	40	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40667	10.1371/journal.pone.0040667	http://dx.doi.org/10.1371/journal.pone.0040667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899990	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900005
J	McNutt, P; Lyman, M; Swartz, A; Tuznik, K; Kniffin, D; Whitten, K; Milhorn, D; Hamilton, T				McNutt, Patrick; Lyman, Megan; Swartz, Adam; Tuznik, Kaylie; Kniffin, Denise; Whitten, Kim; Milhorn, Denise; Hamilton, Tracey			Architectural and Biochemical Expressions of Mustard Gas Keratopathy: Preclinical Indicators and Pathogenic Mechanisms	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; SULFUR MUSTARD; CONFOCAL MICROSCOPY; EPITHELIAL INGROWTH; INJURY; KERATOCYTE; RABBITS; CORNEA; APOPTOSIS; SYSTEM	A subset of victims of ocular sulfur mustard (SM) exposure develops an irreversible, idiotypic keratitis with associated secondary pathologies, collectively referred to as mustard gas keratopathy (MGK). MGK involves a progressive corneal degeneration resulting in chronic ocular discomfort and impaired vision for which clinical interventions have typically had poor outcomes. Using a rabbit corneal vapor exposure model, we previously demonstrated a clinical progression with acute and chronic sequelae similar to that observed in human casualties. However, a better understanding of the temporal changes that occur during the biphasic SM injury is crucial to mechanistic understanding and therapeutic development. Here we evaluate the histopathologic, biochemical and ultrastructural expressions of pathogenesis of the chronic SM injury over eight weeks. We confirm that MGK onset exhibits a biphasic trajectory involving corneal surface regeneration over the first two weeks, followed by the rapid development and progressive degeneration of corneal structure. Preclinical markers of corneal dysfunction were identified, including destabilization of the basal corneal epithelium, basement membrane zone abnormalities and stromal deformation. Clinical sequelae of MGK appeared abruptly three weeks after exposure, and included profound anterior edema, recurring corneal erosions, basement membrane disorganization, basal cell necrosis and stromal degeneration. Unlike resolved corneas, MGK corneas exhibited frustrated corneal wound repair, with significantly elevated histopathology scores. Increased lacrimation, disruption of the basement membrane and accumulation of pro-inflammatory mediators in the aqueous humor provide several mechanisms for corneal degeneration. These data suggest that the chronic injury is fundamentally distinct from the acute lesion, involving injury mechanisms that operate on different time scales and in different corneal tissues. Corneal edema appears to be the principal pathology of MGK, in part resulting from persistent necrosis of the basal corneal epithelium and deterioration of the basement membrane. The findings also provide a potential explanation as to why administration of anti-inflammatories transiently delays, but does not prevent, the development of MGK sequelae.	[McNutt, Patrick; Lyman, Megan; Swartz, Adam; Tuznik, Kaylie; Kniffin, Denise; Whitten, Kim; Hamilton, Tracey] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA; [Milhorn, Denise] USA, Med Res & Mat Command, Ft Detrick, MD USA	Research Institute of Chemical Defense - China	McNutt, P (corresponding author), USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA.	patrick.mcnutt@us.army.mil	McNutt, Patrick/AAS-8535-2020	McNutt, Patrick/0000-0002-5703-4565	DTRA - Joint Science and Technology Office, Medical ST Division [2.F0012_08_RC_C, CBM.CUTOC.01.10.RC.003]	DTRA - Joint Science and Technology Office, Medical ST Division	This research was supported by the DTRA - Joint Science and Technology Office, Medical S&T Division (http://www.dtra.mil/Home.aspx), grants 2.F0012_08_RC_C and CBM.CUTOC.01.10.RC.003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; ABRAMS KL, 1990, AM J VET RES, V51, P1912; Alomar TS, 2011, INVEST OPHTH VIS SCI, V52, P8193, DOI 10.1167/iovs.11-8047; Amir A, 2000, J APPL TOXICOL, V21, pS109; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; AXELROD DJ, 1947, AM J PATHOL, V23, P389; Babin MC, 2004, J TOXICOL-CUTAN OCUL, V23, P65, DOI 10.1081/CUS-120027483; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Eagle Jr. RC, 1989, T AM OPHTHAL SOC, V87, P119; Eagle R C Jr, 1989, Trans Am Ophthalmol Soc, V87, P107; Feister AJ., 1991, MED DEFENSE MUSTARD; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Fini ME, 1996, AM J PATHOL, V149, P1287; Foley PL, 2001, COMPARATIVE MED, V51, P239; Fournie PR, 2010, ARCH OPHTHALMOL-CHIC, V128, P426, DOI 10.1001/archophthalmol.2010.23; Graham John S, 2005, J Burns Wounds, V4, pe1; Jain S, 1996, CORNEA, V15, P248, DOI 10.1097/00003226-199605000-00005; Javadi MA, 2005, OPHTHALMOLOGY, V112, P617, DOI 10.1016/j.ophtha.2004.09.027; Kadar T, 2009, TOXICOLOGY, V263, P59, DOI 10.1016/j.tox.2008.10.026; KATAKAMI C, 1991, INVEST OPHTH VIS SCI, V32, P1837; Latkany RA, 2004, J CATARACT REFR SURG, V30, P929, DOI 10.1016/j.jcrs.2003.07.017; Mann I, 1944, P R SOC MED, V35, P229; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; McNutt P, 2012, CORNEA, V31, P280, DOI 10.1097/ICO.0B013E31823D02CD; Milhorn D, 2010, ANN NY ACAD SCI, V1194, P72, DOI 10.1111/j.1749-6632.2010.05491.x; Mohan RR, 2000, INVEST OPHTH VIS SCI, V41, P1327; Mousavi B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-2; Naderi M, 2010, CUTAN OCUL TOXICOL, V29, P234, DOI 10.3109/15569527.2010.491102; Ollivier FJ, 2007, VET OPHTHALMOL, V10, P199, DOI 10.1111/j.1463-5224.2007.00546.x; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Pleyer U, 1999, AM J OPHTHALMOL, V128, P506, DOI 10.1016/S0002-9394(99)00178-6; Safarinejad MR, 2001, MIL MED, V166, P67, DOI 10.1093/milmed/166.1.67; Solberg Y, 1997, SURV OPHTHALMOL, V41, P461, DOI 10.1016/S0039-6257(97)00021-0; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 1996, INVEST OPHTH VIS SCI, V37, P1582; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	38	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42837	10.1371/journal.pone.0042837	http://dx.doi.org/10.1371/journal.pone.0042837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900056	Green Published, gold			2022-12-25	WOS:000307380900074
J	Peruquetti, RL; De Mateo, S; Sassone-Corsi, P				Peruquetti, Rita L.; De Mateo, Sara; Sassone-Corsi, Paolo			Circadian Proteins CLOCK and BMAL1 in the Chromatoid Body, a RNA Processing Granule of Male Germ Cells	PLOS ONE			English	Article							SPERMATOGENESIS; MOUSE; EXPRESSION; RHYTHMS; BODIES; METABOLISM; ORGANELLES; FERTILITY; HOMOLOG; OBESITY	Spermatogenesis is a complex differentiation process that involves genetic and epigenetic regulation, sophisticated hormonal control, and extensive structural changes in male germ cells. RNA nuclear and cytoplasmic bodies appear to be critical for the progress of spermatogenesis. The chromatoid body (CB) is a cytoplasmic organelle playing an important role in RNA post-transcriptional and translation regulation during the late steps of germ cell differentiation. The CB is also important for fertility determination since mutations of genes encoding its components cause infertility by spermatogenesis arrest. Targeted ablation of the Bmal1 and Clock genes, which encode central regulators of the circadian clock also result in fertility defects caused by problems other than spermatogenesis alterations. We show that the circadian proteins CLOCK and BMAL1 are localized in the CB in a stage-specific manner of germ cells. Both BMAL1 and CLOCK proteins physically interact with the ATP-dependent DEAD-box RNA helicase MVH (mouse VASA homolog), a hallmark component of the CB. BMAL1 is differentially expressed during the spermatogenic cycle of seminiferous tubules, and Bmal1 and Clock deficient mice display significant CB morphological alterations due to BMAL1 ablation or low expression. These findings suggest that both BMAL1 and CLOCK contribute to CB assembly and physiology, raising questions on the role of the circadian clock in reproduction and on the molecular function that CLOCK and BMAL1 could potentially have in the CB assembly and physiology.	[Peruquetti, Rita L.; De Mateo, Sara; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA	University of California System; University of California Irvine	Peruquetti, RL (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA.	psc@uci.edu	de Mateo Lopez, Sara/L-1870-2017	de Mateo Lopez, Sara/0000-0003-4754-6599; Peruquetti, Rita/0000-0003-3153-6599	Sao Paulo State Research Foundation (FAPESP) [2009/14090-6]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	RLP was a postdoctoral fellow supported by Sao Paulo State Research Foundation (FAPESP), grant number 2009/14090-6. http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Beyret E, 2011, DEV BIOL, V355, P215, DOI 10.1016/j.ydbio.2011.04.021; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; CROWLEY WF, 1991, RECENT PROG HORM RES, V47, P27; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Haraguchi CM, 2005, J HISTOCHEM CYTOCHEM, V53, P455, DOI 10.1369/jhc.4A6520.2005; Hess RA, 1999, ENCY REPROD, V4, P1; Kalamvoki M, 2010, P NATL ACAD SCI USA, V107, P17721, DOI 10.1073/pnas.1012991107; Kelly WG, 2007, CHROMOSOME RES, V15, P633, DOI 10.1007/s10577-007-1143-0; Kennaway DJ, 2012, MOL CELL ENDOCRINOL, V349, P56, DOI 10.1016/j.mce.2011.08.013; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kleene KC, 2011, REPRODUCTION, V142, P383, DOI 10.1530/REP-11-0113; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee DW, 2003, GENETICS, V164, P821; Lopes SMCDS, 2010, HISTOL HISTOPATHOL, V25, P267, DOI 10.14670/HH-25.267; Morse D, 2003, MOL ENDOCRINOL, V17, P141, DOI 10.1210/me.2002-0184; Nagamori I, 2011, J CELL SCI, V124, P4346, DOI 10.1242/jcs.096461; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pek JW, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-6; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Tanaka SS, 2000, GENE DEV, V14, P841; Yokota S, 2008, ACTA HISTOCHEM CYTOC, V41, P65, DOI 10.1267/ahc.08010; Zar JH., 1999, BIOSTATISCICAL ANAL	37	14	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42695	10.1371/journal.pone.0042695	http://dx.doi.org/10.1371/journal.pone.0042695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900038	Green Published, gold			2022-12-25	WOS:000307380900055
J	Valigurova, A				Valigurova, Andrea			Sophisticated Adaptations of Gregarina cuneata (Apicomplexa) Feeding Stages for Epicellular Parasitism	PLOS ONE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; TENEBRIO-MOLITOR LARVAE; MARINE GREGARINES; HOST EPITHELIUM; FINE-STRUCTURE; BLABERAE; CRYPTOSPORIDIUM; POLYMORPHA; EPIMERITE; MYOSIN	Background: Gregarines represent a very diverse group of early emerging apicomplexans, parasitising numerous invertebrates and urochordates, and are considered of little practical significance. Recently, they have gained more attention since some analyses showed that cryptosporidia are more closely related to the gregarines than to coccidia. Methodology/Principal Findings: Using a combined microscopic approach, this study points out the spectacular strategy of Gregarina cuneata for attachment to host tissue and nutrient acquisition while parasitising the intestine of yellow mealworm larvae, and reveals the unusual dynamics of cellular interactions between the host epithelium and parasite feeding stages. Trophozoites of G. cuneata develop epicellularly, attached to the luminal side of the host epithelial cell by an epimerite exhibiting a high degree of morphological variability. The presence of contractile elements in the apical region of feeding stages indicates that trophozoite detachment from host tissue is an active process self-regulated by the parasite. A detailed discussion is provided on the possibility of reversible retraction and protraction of the eugregarine apical end, facilitating eventual reattachment to another host cell in better physiological conditions. The gamonts, found in contact with host tissue via a modified protomerite top, indicate further adaptation of parasite for nutrient acquisition via epicellular parasitism while keeping their host healthy. The presence of eugregarines in mealworm larvae even seems to increase the host growth rate and to reduce the death rate despite often heavy parasitisation. Conclusions/Significance: Improved knowledge about the formation of host-parasite interactions in deep-branching apicomplexans, including gregarines, would offer significant insights into the fascinating biology and evolutionary strategy of Apicomplexa. Gregarines exhibit an enormous diversity in cell architecture and dimensions, depending on their parasitic strategy and the surrounding environment. They seem to be a perfect example of a coevolution between a group of parasites and their hosts.	Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic	Masaryk University Brno	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.	andreav@sci.muni.cz	Valigurová, Andrea/B-4522-2012	Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [GPP506/10/P372]; Ministry of Education, Youth and Sports [MEB021127]; Department of Botany and Zoology, Faculty of Science, Masaryk University	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Department of Botany and Zoology, Faculty of Science, Masaryk University	Financial support was provided by grants from the Czech Science Foundation (GPP506/10/P372). Travel expenses were partially supported by the Ministry of Education, Youth and Sports (MEB021127). The author acknowledges support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDOIN J, 1969, Protistologica, V5, P431; Carreno RA, 1999, PARASITOL RES, V85, P899, DOI 10.1007/s004360050655; Cook TJP, 2001, J PARASITOL, V87, P988, DOI 10.2307/3285220; DESPORTES I, 1986, PROTISTOLOGICA, V22, P47; Devauchelle G., 1968, Protistologica, V4, P313; Dyakin Andrey Yu., 2005, Protistology, V4, P97; Dykstra MJ, 1993, MANUAL APPL TECHNIQU; GHAZALI M, 1993, J EUKARYOT MICROBIOL, V40, P345, DOI 10.1111/j.1550-7408.1993.tb04927.x; GHAZALI M, 1989, BIOL CELL, V67, P173, DOI 10.1016/0248-4900(89)90052-X; HARRY OG, 1967, J PROTOZOOL, V14, P539, DOI 10.1111/j.1550-7408.1967.tb02039.x; HARRY OG, 1970, NATURE, V225, P964, DOI 10.1038/225964a0; HARRY OG, 1965, J PROTOZOOL, V12, P296, DOI 10.1111/j.1550-7408.1965.tb01856.x; Heintzelman MB, 2008, J PARASITOL, V94, P158, DOI 10.1645/GE-1339.1; Heintzelman MB, 2004, CELL MOTIL CYTOSKEL, V58, P83, DOI 10.1002/cm.10178; HENRY JE, 1981, ANNU REV ENTOMOL, V26, P49, DOI 10.1146/annurev.en.26.010181.000405; HILDEBRAND HF, 1976, Z PARASITENKD, V49, P193, DOI 10.1007/BF00380590; Kaya, 1993, INSECT PATHOLOGY; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; LIPA JERZY J., 1967, ACTA PROTOZOOL, V5, P97; Lucarotti CJ, 2000, J INVERTEBR PATHOL, V75, P117, DOI 10.1006/jipa.1999.4911; MACMILLAN WG, 1973, PARASITOLOGY, V66, P207, DOI 10.1017/S0031182000044553; ORMIERES R, 1977, Z PARASITENKD, V53, P13, DOI 10.1007/BF00383110; Perkins F. O., 2000, ILLUSTRATED GUIDE PR, V1, P190; RUHNKE TR, 1989, J PROTOZOOL, V36, P428, DOI 10.1111/j.1550-7408.1989.tb05541.x; RUHNKE TR, 1990, J PARASITOL, V76, P519, DOI 10.2307/3282832; SCHREVEL J, 1972, J MICROSC-PARIS, V15, P21; Schrevel J., 1966, Protistologica, V2, P17; SCHREVEL J, 1983, J CELL SCI, V61, P151; Schrevel Joseph, 1993, P133; Sumner R, 1932, SCIENCE, V78, P1; Talluri M.V., 1983, B ZOOL, V50, P247; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; THOMAS D, 1973, J INSECT PHYSIOL, V19, P515, DOI 10.1016/0022-1910(73)90062-0; TRONCHIN G, 1986, PROTISTOLOGICA, V22, P127; TRONCHIN G, 1977, J PROTOZOOL, V24, P67, DOI 10.1111/j.1550-7408.1977.tb05282.x; Valigurova A, 2005, EUR J PROTISTOL, V41, P209, DOI 10.1016/j.ejop.2005.05.005; Valigurova A, 2008, EUR J PROTISTOL, V44, P197, DOI 10.1016/j.ejop.2007.11.006; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Valigurova A, 2007, J EUKARYOT MICROBIOL, V54, P495, DOI 10.1111/j.1550-7408.2007.00291.x; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; VIVIER E, 1970, Protistologica, V6, P127	42	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42606	10.1371/journal.pone.0042606	http://dx.doi.org/10.1371/journal.pone.0042606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900033	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900049
J	Zhou, Y; Pei, ZQ; Su, JQ; Zhang, JL; Zheng, YR; Ni, J; Xiao, CW; Wang, RZ				Zhou, Yong; Pei, Zhiqin; Su, Jiaqi; Zhang, Jingli; Zheng, Yuanrun; Ni, Jian; Xiao, Chunwang; Wang, Renzhong			Comparing Soil Organic Carbon Dynamics in Perennial Grasses and Shrubs in a Saline-Alkaline Arid Region, Northwestern China	PLOS ONE			English	Article							PLANT LITTER DECOMPOSITION; MICROBIAL BIOMASS DYNAMICS; FINE-ROOT DYNAMICS; PATAGONIAN MONTE; NITROGEN; ECOSYSTEMS; PATTERNS; CLIMATE; COMMUNITY; TURNOVER	Background: Although semi-arid and arid regions account for about 40% of terrestrial surface of the Earth and contain approximately 10% of the global soil organic carbon stock, our understanding of soil organic carbon dynamics in these regions is limited. Methodology/Principal Findings: A field experiment was conducted to compare soil organic carbon dynamics between a perennial grass community dominated by Cleistogenes squarrosa and an adjacent shrub community co-dominated by Reaumuria soongorica and Haloxylon ammodendron, two typical plant life forms in arid ecosystems of saline-alkaline arid regions in northwestern China during the growing season 2010. We found that both fine root biomass and necromass in two life forms varied greatly during the growing season. Annual fine root production in the perennial grasses was 45.6% significantly higher than in the shrubs, and fine root turnover rates were 2.52 and 2.17 yr(-1) for the perennial grasses and the shrubs, respectively. Floor mass was significantly higher in the perennial grasses than in the shrubs due to the decomposition rate of leaf litter in the perennial grasses was 61.8% lower than in the shrubs even though no significance was detected in litterfall production. Soil microbial biomass and activity demonstrated a strong seasonal variation with larger values in May and September and minimum values in the dry month of July. Observed higher soil organic carbon stocks in the perennial grasses (1.32 Kg C m(-2)) than in the shrubs (1.12 Kg C m(-2)) might be attributed to both greater inputs of poor quality litter that is relatively resistant to decay and the lower ability of microorganism to decompose these organic matter. Conclusions/Significance: Our results suggest that the perennial grasses might accumulate more soil organic carbon with time than the shrubs because of larger amounts of inputs from litter and slower return of carbon through decomposition.	[Zhou, Yong; Pei, Zhiqin; Su, Jiaqi; Zhang, Jingli; Zheng, Yuanrun; Ni, Jian; Xiao, Chunwang; Wang, Renzhong] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhou, Yong; Su, Jiaqi; Zhang, Jingli] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Y (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	cwxiao@ibcas.ac.cn; wangrz@ibcas.ac.cn	Zhou, Yong/H-9048-2019; Ni, Jian/I-7067-2012; Zhou, Yong/B-9795-2017	Zhou, Yong/0000-0003-2546-8462; Ni, Jian/0000-0001-5411-7050; Zhou, Yong/0000-0003-2546-8462	National Research Program of China (973 Program) [2009CB825103]	National Research Program of China (973 Program)(National Basic Research Program of China)	This study was financially supported by the National Research Program of China (973 Program, no. 2009CB825103). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Alvarez JA, 2009, PLANT ECOL, V205, P295, DOI 10.1007/s11258-009-9618-z; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bao S.-D., 1999, AGR SOIL CHEM ANAL; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Campanella MV, 2008, J VEG SCI, V19, P75, DOI 10.3170/2007-8-18333; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chuyong CB, 2000, NEW PHYTOL, V148, P493, DOI 10.1046/j.1469-8137.2000.00774.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Descheemaeker K, 2006, FOREST ECOL MANAG, V233, P21, DOI 10.1016/j.foreco.2006.05.061; Fairley R. I., 1985, Ecological interactions in soil: plants, microbes and animals, P37; FAO-UNESCO, 1988, SOIL MAP WORLD; Feng Q, 2002, GEODERMA, V106, P21, DOI 10.1016/S0016-7061(01)00099-4; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Griffiths RI, 2003, APPL ENVIRON MICROB, V69, P6961, DOI 10.1128/AEM.69.12.6961-6968.2003; Hendricks JJ, 2006, J ECOL, V94, P40, DOI 10.1111/j.1365-2745.2005.01067.x; Hipondoka MHT, 2003, J ARID ENVIRON, V54, P319, DOI 10.1006/jare.2002.1093; HOLMES WE, 1994, SOIL SCI SOC AM J, V58, P238, DOI 10.2136/sssaj1994.03615995005800010036x; Hu S, 1997, MICROBIAL ECOL, V33, P134, DOI 10.1007/s002489900015; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jha P, 2010, PLANT SOIL, V326, P481, DOI 10.1007/s11104-009-0027-9; KINSBURSKY RS, 1989, OECOLOGIA, V80, P498, DOI 10.1007/BF00380072; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Liao JD, 2008, SOIL BIOL BIOCHEM, V40, P1207, DOI 10.1016/j.soilbio.2007.12.018; Liu S, 1996, ARID ZONE RES, V13, P36; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Maya Y, 1996, J ARID ENVIRON, V34, P23, DOI 10.1006/jare.1996.0090; Mlambo D, 2008, PLANT ECOL, V196, P101, DOI 10.1007/s11258-007-9337-2; Moore TC, 1979, BIOCH PHYSL PLANT HO; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pavon NP, 2005, J ARID ENVIRON, V60, P1, DOI 10.1016/j.jaridenv.2004.03.004; Phillips DL, 2006, GLOBAL CHANGE BIOL, V12, P61, DOI 10.1111/j.1365-2486.2005.01085.x; Rodriguez MV, 2007, PLANT SOIL, V300, P281, DOI 10.1007/s11104-007-9415-1; SALA OE, 1989, OECOLOGIA, V81, P501, DOI 10.1007/BF00378959; SCHAEFER D, 1985, OECOLOGIA, V65, P382, DOI 10.1007/BF00378913; [盛晋华 Sheng Jinhua], 2004, [草地学报, Acta agrestia sinica], V12, P91; Stone R, 2008, SCIENCE, V320, P1409, DOI 10.1126/science.320.5882.1409; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vargas DN, 2006, SOIL BIOL BIOCHEM, V38, P2401, DOI 10.1016/j.soilbio.2006.03.006; [汪诗平 Wang Shiping], 2003, [植物生态学报, Acta Phytoecologica Sinica], V27, P337; Wardle DA, 1995, SOIL BIOL BIOCHEM, V27, P1601, DOI 10.1016/0038-0717(95)00093-T; Weatherly HE, 2003, GLOBAL CHANGE BIOL, V9, P1223, DOI 10.1046/j.1365-2486.2003.00653.x; White DA, 2009, GEODERMA, V150, P214, DOI 10.1016/j.geoderma.2009.02.011; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Wilcox CS, 2004, J ARID ENVIRON, V56, P129, DOI 10.1016/S0140-1963(02)00324-5; Wu Z.Y., 1995, VEGETATION CHINA; Xu Hao, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P1309; [许皓 XU Hao], 2007, [生态学报, Acta Ecologica Sinica], V27, P5019; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9	59	14	17	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42927	10.1371/journal.pone.0042927	http://dx.doi.org/10.1371/journal.pone.0042927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900067	Green Submitted, gold, Green Published			2022-12-25	WOS:000307380900085
J	Maruta, C; Saito, Y; Hata, S; Gotoh, N; Suzuki, T; Yamamoto, T				Maruta, Chiaki; Saito, Yuhki; Hata, Saori; Gotoh, Naoya; Suzuki, Toshiharu; Yamamoto, Tohru			Constitutive Cleavage of the Single-Pass Transmembrane Protein Alcadein alpha Prevents Aberrant Peripheral Retention of Kinesin-1	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL-TRANSPORT; BINDING PARTNERS; MEMBRANE; CELLS; APP; CALSYNTENIN-1; ABNORMALITIES; SUFFICIENT; METABOLISM	Various membrane proteins are shed by proteinases, constitutively and/or when stimulated by external signals. While the physiological significance of external signal-induced cleavages has been intensely investigated, relatively little is known about the function of constitutive cleavages. Alcadeina (Alc alpha; also called Calsyntenin-1) is an evolutionarily conserved type I single-pass transmembrane protein that binds to kinesin-1 light chain (KLC) to activate kinesin-1's transport of Alc alpha-containing vesicles. We found that Alca was constitutively and efficiently cleaved to liberate its ectodomain into the extracellular space, and that full-length Alca protein was rarely detected on the cell surface. The secretion efficiency of the ectodomain was unaltered by a mutation that both abolished Alc alpha's KLC-binding activity and attenuated its peripheral transport, suggesting that Alc alpha's cleavage occurred, at least partly, en route to the cell surface. We further demonstrated that uncleavable mutant Alca proteins readily accumulated on the cell surface and induced aberrant peripheral recruitment of KLC1 and kinesin heavy chain. Our observations suggest that Alca is efficiently processed in part to minimize the inappropriate peripheral retention of kinesin-1. This role might exemplify the functional relevance of the constitutive cleavage of single-pass transmembrane proteins.	[Maruta, Chiaki; Saito, Yuhki; Hata, Saori; Gotoh, Naoya; Suzuki, Toshiharu; Yamamoto, Tohru] Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Sapporo, Hokkaido 060, Japan	Hokkaido University	Maruta, C (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Neurosci, Kita 12, Sapporo, Hokkaido 060, Japan.	tsuzuki@pharm.hokudai.ac.jp; yamamoto@pharm.hokudai.ac.jp	Yamamoto, Tohru/A-3801-2012; Hata, Saori/AAP-9634-2020; Hata, Saori/A-3829-2012; Suzuki, Toshiharu/B-5342-2013	Yamamoto, Tohru/0000-0002-1652-0233; 	Ministry of Education, Science, Culture, Sports, and Technology, Japan [20200011, 21113501];  [22590055];  [20390018];  [22659011]; Grants-in-Aid for Scientific Research [23390017, 22590055] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research 22590055 (T Y), 20390018 (TS), 22659011 (TS) and Grant-in-Aid for Scientific Research on Innovative Areas 20200011 (TY), 21113501 (TS) from the Ministry of Education, Science, Culture, Sports, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fujimura Y, 2006, BRAIN RES, V1101, P12, DOI 10.1016/j.brainres.2006.05.030; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kawano T, 2012, TRAFFIC, V13, P834, DOI 10.1111/j.1600-0854.2012.01350.x; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kitamura M, 2011, METHOD ENZYMOL, V490, P93, DOI 10.1016/B978-0-12-385114-7.00005-2; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; PAPPOLLA MA, 1995, NEUROSCI LETT, V192, P105, DOI 10.1016/0304-3940(95)11627-9; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e43058	10.1371/journal.pone.0043058	http://dx.doi.org/10.1371/journal.pone.0043058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905201	Green Published, gold			2022-12-25	WOS:000307331100081
J	Robles, P; Micol, JL; Quesada, V				Robles, Pedro; Micol, Jose Luis; Quesada, Victor			Arabidopsis MDA1, a Nuclear-Encoded Protein, Functions in Chloroplast Development and Abiotic Stress Responses	PLOS ONE			English	Article							CHELATASE H-SUBUNIT; GENE-EXPRESSION; ABSCISIC-ACID; RNA-POLYMERASES; TRANSCRIPTION; SUGAR; TERMINATION; ABA; GENOME; FAMILY	Most chloroplast and mitochondrial proteins are encoded by nuclear genes, whose functions remain largely unknown because mutant alleles are lacking. A reverse genetics screen for mutations affecting the mitochondrial transcription termination factor (mTERF) family in Arabidopsis thaliana allowed us to identify 75 lines carrying T-DNA insertions. Two of them were homozygous for insertions in the At4g14605 gene, which we dubbed MDA1 (MTERF DEFECTIVE IN Arabidopsis1). The mda1 mutants exhibited altered chloroplast morphology and plant growth, and reduced pigmentation of cotyledons, leaves, stems and sepals. The mda1 mutations enhanced salt and osmotic stress tolerance and altered sugar responses during seedling establishment, possibly as a result of reduced ABA sensitivity. Loss of MDA1 function caused up-regulation of the RpoTp/SCA3 nuclear gene encoding a plastid RNA polymerase and modified the steady-state levels of chloroplast gene transcripts. Double mutant analyses indicated that MDA1 and the previously described mTERF genes SOLDAT10 and RUG2 act in different pathways. Our findings reveal a new role for mTERF proteins in the response to abiotic stress, probably through perturbed ABA retrograde signalling resulting from a disruption in chloroplast homeostasis.	[Robles, Pedro; Micol, Jose Luis; Quesada, Victor] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Robles, P (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	vquesada@umh.es	Robles, Pedro/L-5104-2014; Micol, José Luis/B-4832-2010	Robles, Pedro/0000-0002-4539-5435; Micol, José Luis/0000-0002-0396-1750; quesada, victor/0000-0002-0965-8680	Conselleria d'Educacio of the Generalitat Valenciana [GV/2009/058]; Bancaja-UMH	Conselleria d'Educacio of the Generalitat Valenciana; Bancaja-UMH	This work has been supported by grants from the Conselleria d'Educacio of the Generalitat Valenciana (GV/2009/058) and Bancaja-UMH to V.Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baba K, 2004, PLANT J, V38, P38, DOI 10.1111/j.1365-313X.2004.02022.x; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Berna G, 1999, GENETICS, V152, P729; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chan KX, 2010, PLANT SIGNAL BEHAV, V5, P1575, DOI 10.4161/psb.5.12.13758; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Dhaubhadel S, 2008, J PLANT GROWTH REGUL, V27, P297, DOI 10.1007/s00344-008-9056-5; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Emanuel C, 2004, PLANT J, V38, P460, DOI 10.1111/j.0960-7412.2004.02060.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Gazzarrini S, 2001, CURR OPIN PLANT BIOL, V4, P387, DOI 10.1016/S1369-5266(00)00190-4; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Hyvarinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676; Inan G, 2007, PLANT MOL BIOL, V65, P295, DOI 10.1007/s11103-007-9219-y; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim C, 2009, P NATL ACAD SCI USA, V106, P9920, DOI 10.1073/pnas.0901315106; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Narsai R, 2011, PLANT PHYSIOL, V157, P1342, DOI 10.1104/pp.111.183129; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Quesada V, 1999, FEBS LETT, V461, P101, DOI 10.1016/S0014-5793(99)01426-X; Quesada V, 2000, GENETICS, V154, P421; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robles P, 2012, MOL PLANT, V5, P294, DOI 10.1093/mp/sss016; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu FQ, 2009, PLANT PHYSIOL, V150, P1940, DOI 10.1104/pp.109.140731; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	57	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42924	10.1371/journal.pone.0042924	http://dx.doi.org/10.1371/journal.pone.0042924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905186	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100075
J	ter Horst, AC; Cole, J; van Lier, R; Steenbergen, B				ter Horst, Arjan C.; Cole, Jonathan; van Lier, Rob; Steenbergen, Bert			The Effect of Chronic Deafferentation on Mental Imagery: A Case Study	PLOS ONE			English	Article							MOTOR IMAGERY; CORTICOSPINAL EXCITABILITY; HAND RECOGNITION; VISUO-MOTOR; ROTATION; ANESTHESIA; POSTURE; REPRESENTATIONS; INTEGRATION; STRATEGIES	Visual- and motor imagery rely primarily on perceptual and motor processes, respectively. In healthy controls, the type of imagery used to solve a task depends on personal preference, task instruction, and task properties. But how does the chronic loss of proprioceptive and tactile sensory inputs from the body periphery influence mental imagery? In a unique case study, we investigated the imagery capabilities of the chronically deafferented patient IW when he was performing a mental rotation task. We found that IW's motor imagery processes were impaired and that visual imagery processes were enhanced compared to controls. These results suggest that kinaesthetic afferent signals from the body periphery play a crucial role in enabling and maintaining central sensorimotor representations and hence the ability to incorporate kinaesthetic information into the imagery processes.	[ter Horst, Arjan C.; van Lier, Rob; Steenbergen, Bert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [ter Horst, Arjan C.; Steenbergen, Bert] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Cole, Jonathan] Bournemouth Univ, Poole Hosp, Poole BH12 5BB, Dorset, England	Radboud University Nijmegen; Radboud University Nijmegen; Bournemouth University; Poole Hospital	ter Horst, AC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.terhorst@donders.ru.nl	van Lier, Rob/E-1654-2012	van Lier, Rob/0000-0002-4705-5725; Steenbergen, Bert/0000-0001-8863-2624				Bosbach S, 2005, NAT NEUROSCI, V8, P1295, DOI 10.1038/nn1535; Bosbach S, 2006, NEUROPSYCHOLOGIA, V44, P2950, DOI 10.1016/j.neuropsychologia.2006.06.018; Cole C, 1998, BODY SELF; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Curtze C, 2009, EXP BRAIN RES; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Funk M, 2008, J INT NEUROPSYCH SOC, V14, P81, DOI 10.1017/S1355617708080041; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Guillot A., 2010, NEUROPHYSIOLOGICAL F; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karadi K, 2001, PERCEPT MOTOR SKILL, V93, P333, DOI 10.2466/PMS.93.5.333-337; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Martucci KT, 2011, ANESTHESIOLOGY, V114, P21, DOI 10.1097/ALN.0b013e3182016521; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miall RC, 2007, EXP BRAIN RES, V176, P432, DOI 10.1007/s00221-006-0626-0; Miall RC, 1995, EXP BRAIN RES, V107, P267; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson CJ, 2010, SCAND J MED SCI SPOR, V20, P711, DOI 10.1111/j.1600-0838.2010.01101.x; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Silva S, 2011, ANESTHESIOLOGY, V114, P126, DOI 10.1097/ALN.0b013e31820164f1; ter Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI 10.1111/j.1469-8986.2011.01322.x; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Ziemann U, 1998, J NEUROSCI, V18, P1115	43	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42742	10.1371/journal.pone.0042742	http://dx.doi.org/10.1371/journal.pone.0042742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880095	Green Published, gold, Green Accepted			2022-12-25	WOS:000307437900052
J	Henke, A; Grace, OC; Ashley, GR; Stewart, GD; Riddick, ACP; Yeun, H; O'Donnell, M; Anderson, RA; Thomson, AA				Henke, Alexander; Grace, O. Cathal; Ashley, George R.; Stewart, Grant D.; Riddick, Antony C. P.; Yeun, Henry; O'Donnell, Marie; Anderson, Richard A.; Thomson, Axel A.			Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; BRANCHING MORPHOGENESIS; REACTIVE STROMA; RECEPTOR; INHIBITION; FIBROBLASTS; DIFFERENTIATION; PROGRESSION; MESENCHYME	Background and Aim: During prostate development, mesenchymal-epithelial interactions regulate organ growth and differentiation. In adult prostate, stromal-epithelial interactions are important for tissue homeostasis and also play a significant role in prostate cancer. In this study we have identified molecules that show a mesenchymal expression pattern in the developing prostate, and one of these showed reduced expression in prostate cancer stroma. Methodology and Principal Findings: Five candidate molecules identified by transcript profiling of developmental prostate mesenchyme were selected using a wholemount in situ hybridisation screen and studied Decorin (Dcn), Semaphorin6D (Sema6D), SPARC/Osteonectin (SPARC), Sprouty1 (Spry-1) and Tsukushi (Tsku). Expression in rat tissues was evaluated using wholemount in situ hybridisation (postnatal day (P) 0.5) and immunohistochemistry (embryonic day (E) E17.5, E19.5; P0.5; P6; 28 & adult). Four candidates (Decorin, SPARC, Spry-1, Tsukushi) were immunolocalised in human foetal prostate (weeks 14, 16, 19) and expression of Decorin was evaluated on a human prostate cancer tissue microarray. In embryonic and perinatal rats Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi were expressed with varying distribution patterns throughout the mesenchyme at E17.5, E19.5, P0.5 and P6.5. In P28 and adult prostates there was either a decrease in the expression (Semaphorin6D) or a switch to epithelial expression of SPARC, and Spry-1, whereas Decorin and Tsukushi were specific to mesenchyme/stroma at all ages. Expression of Decorin, SPARC, Spry-1 and Tsukushi in human foetal prostates paralleled that in rat. Decorin showed mesenchymal and stromal-specific expression at all ages and was further examined in prostate cancer, where stromal expression was significantly reduced compared with non-malignant prostate. Conclusion and Significance: We describe the spatio-temporal expression of Decorin, Semaphorin6D, SPARC, Spry-1 and Tsukushi in developing prostate and observed similar mesenchymal expression patterns in rat and human. Additionally, Decorin showed reduced expression in prostate cancer stroma compared to non-malignant prostate stroma.	[Henke, Alexander; Grace, O. Cathal; Ashley, George R.; Anderson, Richard A.; Thomson, Axel A.] Queenss Med Res Inst, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland; [Stewart, Grant D.; Riddick, Antony C. P.; Yeun, Henry; O'Donnell, Marie] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh Urol Canc Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh	Henke, A (corresponding author), Univ Clin Cologne, Lab Immunotherapy, Cologne, Germany.	dr.a.henke@gmail.com; axelthomson@gmail.com	Thomson, Axel/A-7893-2013	Stewart, Grant D./0000-0003-3188-9140	Medical Research Council [WBSe 1276.00.003.00004.01]; Prostate Cancer Charity; MRC [MC_U127684421, G1100357, G1002033, G1002118] Funding Source: UKRI; Medical Research Council [G1100357, G1002033, G1002118, MC_U127684421] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Prostate Cancer Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council (WBSe 1276.00.003.00004.01) and the Prostate Cancer Charity (http://www.prostate-cancer.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Ashley GR, 2010, DIFFERENTIATION, V80, P89, DOI 10.1016/j.diff.2010.06.003; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Caruana G, 2006, GENE EXPR PATTERNS, V6, P807, DOI 10.1016/j.modgep.2006.02.001; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Coulson-Thomas VJ, 2010, EXP CELL RES, V316, P3207, DOI 10.1016/j.yexcr.2010.08.005; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; CUNHA GR, 1983, J CELL BIOL, V96, P1662, DOI 10.1083/jcb.96.6.1662; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Francisco IFS, 2004, INT J CANCER, V112, P213, DOI 10.1002/ijc.20388; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Gerdes MJ, 2004, PROSTATE, V58, P299, DOI 10.1002/pros.10327; Gorlov IP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-599; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HAYASHI N, 1991, CANCER RES, V51, P4924; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Ito A, 2010, BIOCHEM BIOPH RES CO, V402, P813, DOI 10.1016/j.bbrc.2010.10.127; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kuriyama S, 2006, DEVELOPMENT, V133, P75, DOI 10.1242/dev.02178; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; MCNEAL JE, 1978, INVEST UROL, V15, P340; Morris SA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001004; Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014; Ohta K, 2006, DEVELOPMENT, V133, P3777, DOI 10.1242/dev.02579; Olumi AF, 1999, CANCER RES, V59, P5002; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Orr B, 2010, PROSTATE; Orr B, 2009, ENDOCRINOLOGY, V150, P463, DOI 10.1210/en.2008-0383; Prins GS, 1996, DEV GENET, V18, P99; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Ricciardelli C, 1998, CLIN CANCER RES, V4, P963; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Steer DL, 2004, DEV BIOL, V272, P310, DOI 10.1016/j.ydbio.2004.04.029; Stock C, 2011, J CELL PHYSIOL, V226, P2641, DOI 10.1002/jcp.22612; STRANDJORD TP, 1995, AM J RESP CELL MOL, V13, P279, DOI 10.1165/ajrcmb.13.3.7654384; SUGIMURA Y, 1986, PROSTATE, V9, P217, DOI 10.1002/pros.2990090302; Thomson AA, 2001, REPRODUCTION, V121, P187, DOI 10.1530/rep.0.1210187; Timms BG, 2008, DIFFERENTIATION, V76, P565, DOI 10.1111/j.1432-0436.2008.00278.x; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P4292, DOI 10.1210/en.2004-0526; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Trevino V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016492; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Vanpoucke G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r213; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhao JS, 1999, AM J PHYSIOL-LUNG C, V277, pL412, DOI 10.1152/ajplung.1999.277.2.L412	61	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42516	10.1371/journal.pone.0042516	http://dx.doi.org/10.1371/journal.pone.0042516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880013	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100116
J	Vaara, M; Itkonen, H; Hillukkala, T; Liu, Z; Nasheuer, HP; Schaarschmidt, D; Pospiech, H; Syvaoja, JE				Vaara, Markku; Itkonen, Harri; Hillukkala, Tomi; Liu, Zhe; Nasheuer, Heinz-Peter; Schaarschmidt, Daniel; Pospiech, Helmut; Syvaoja, Juhani E.			Segregation of Replicative DNA Polymerases during S Phase DNA POLYMERASE is an element of, BUT NOT DNA POLYMERASES alpha/delta, ARE ASSOCIATED WITH LAMINS THROUGHOUT S PHASE IN HUMAN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; EUKARYOTIC CELLS; MCM2-7 HELICASE; ALPHA-PRIMASE; GINS COMPLEX; EPSILON; CDC45; FORK; ORIGIN; DELTA	DNA polymerases (Pol) alpha, delta, and is an element of replicate the bulk of chromosomal DNA in eukaryotic cells, Pol is an element of being the main leading strand and Pol delta the lagging strand DNA polymerase. By applying chromatin immunoprecipitation (ChIP) and quantitative PCR we found that at G(1)/S arrest, all three DNA polymerases were enriched with DNA containing the early firing lamin B2 origin of replication and, 2 h after release from the block, with DNA containing the origin at the upstream promoter region of the MCM4 gene. Pol alpha, delta, and is an element of were released from these origins upon firing. All three DNA polymerases, Mcm3 and Cdc45, but not Orc2, still formed complexes in late S phase. Reciprocal ChIP of the three DNA polymerases revealed that at G(1)/S arrest and early in S phase, Pol alpha, delta, and is an element of were associated with the same nucleoprotein complexes, whereas in late S phase Pol is an element of and Pol alpha/delta were largely associated with distinct complexes. At G(1)/S arrest, the replicative DNA polymerases were associated with lamins, but in late S phase only Pol is an element of, not Pol alpha/delta, remained associated with lamins. Consistently, Pol is an element of, but not Pol delta, was found in nuclear matrix fraction throughout the cell cycle. Therefore, Pol is an element of and Pol alpha/delta seem to pursue their functions at least in part independently in late S phase, either by physical uncoupling of lagging strand maturation from the fork progression, or by recruitment of Pol delta, but not Pol is an element of, to post-replicative processes such as translesion synthesis or post-replicative repair.	[Vaara, Markku; Itkonen, Harri; Liu, Zhe] Univ Eastern Finland, Dept Biol, FI-80101 Joensuu, Finland; [Hillukkala, Tomi; Pospiech, Helmut] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Nasheuer, Heinz-Peter] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Schaarschmidt, Daniel] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Pospiech, Helmut] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, FI-70211 Kuopio, Finland	University of Eastern Finland; Finland National Institute for Health & Welfare; University of Oulu; Ollscoil na Gaillimhe-University of Galway; University of Konstanz; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Eastern Finland	Syvaoja, JE (corresponding author), POB 1627, FI-70211 Kuopio, Finland.	juhani.syvaoja@uef.fi	Nasheuer, Heinz P./B-9025-2008; Pospiech, Helmut/J-8598-2015	Nasheuer, Heinz Peter/0000-0002-9218-9079; Itkonen, Harri/0000-0002-5194-7064	Academy of Finland Grants [106986, 123082]	Academy of Finland Grants(Academy of Finland)	This work was supported by Academy of Finland Grants 106986 (to H.P.) and 123082 (to J.E.S.).	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2010, FEBS LETT, V584, P2596, DOI 10.1016/j.febslet.2010.04.003; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson R. T., 1993, CELL CYCLE PRACTICAL, P1; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Nasheuer HP, 2002, PROG NUCLEIC ACID RE, V72, P41, DOI 10.1016/S0079-6603(02)72067-9; NASHEUER HP, 1988, J BIOL CHEM, V263, P8981; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pavlov YI, 2001, GENETICS, V159, P47; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pospiech H, 1999, NUCLEIC ACIDS RES, V27, P3799, DOI 10.1093/nar/27.19.3799; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rytkonen AK, 2006, FEBS J, V273, P5535, DOI 10.1111/j.1742-4658.2006.05544.x; Rytkonen AK, 2006, FEBS J, V273, P2984, DOI 10.1111/j.1742-4658.2006.05310.x; Schaarschmidt D, 2002, NUCLEIC ACIDS RES, V30, P4176, DOI 10.1093/nar/gkf532; Shikata Koh, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-21; STADLBAUER F, 1994, EUR J BIOCHEM, V222, P781, DOI 10.1111/j.1432-1033.1994.tb18925.x; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; TENHAGEN KG, 1993, NUCLEIC ACIDS RES, V21, P2139, DOI 10.1093/nar/21.9.2139; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; UITTO L, 1995, NUCLEIC ACIDS RES, V23, P244, DOI 10.1093/nar/23.2.244; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x	51	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2012	287	40					33327	33338		10.1074/jbc.M112.357996	http://dx.doi.org/10.1074/jbc.M112.357996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	017PG	22887995	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000309602100021
J	Guo, XP; Li, XL; Duan, XW; Shen, YY; Xing, Y; Cao, QQ; Qin, L				Guo, Xian-Ping; Li, Xing-Liang; Duan, Xu-Wei; Shen, Yuan-Yue; Xing, Yu; Cao, Qing-Qin; Qin, Ling			Characterization of sck1, a Novel Castanea mollissima Mutant with the Extreme Short Catkins and Decreased Gibberellin	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; THINNING CATKINS; BIOSYNTHESIS; ENCODES; METABOLISM; EXPRESSION; MUTATIONS; INDUCTION; OXIDASE; GENES	A novel Chinese chestnut (Castanea mollissima Bl.) mutant with extreme short catkins, here was named sck1 and has been characterized in the present study. This sck1 caused 6-fold shorter than wild-type catkins. Endogenous gibberellic acids markedly decreased in the mutant, and application of exogenous GA(3) could partially restore the sck1 phenotype to the wild-type phenotype. Paclobutrazol (PP333), an antagonist of GAs biosynthesis, could significantly inhibit the wild-type catkins growth, and lead to a short catkins phenotype similar to the sck1. In addition, compared to the wild-type catkins, the mRNA expression level of ent-kaurenoic acid oxidase (KAO), a gibberellin biosynthsis key gene, was significantly down-regulated (P<0.01) in the sck1. Importantly, transient over-expression of a normal CmKAO gene in short catkins also could partially restore the wild-type phenotype. Real-time PCR and semi-quantitative analysis showed that the mRNA expression level of KAO was significantly up-regulated. In addition, transient RNA interference of CmKAO in wild-type catkins led the mRNA expression level of KAO decrease significantly and inhibited the wild-type catkins elongation strongly. Taken together, our results suggest that the lower gibberellic acids content that is due to decreased CmKAO expression level may contribute to the generation of the extreme short male catkins, sck1.	[Guo, Xian-Ping; Li, Xing-Liang; Duan, Xu-Wei; Shen, Yuan-Yue; Xing, Yu; Qin, Ling] Beijing Agr Univ, Coll Plant Sci & Technol, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China; [Cao, Qing-Qin] Beijing Agr Univ, Coll Biotechnol, Beijing 100094, Peoples R China; [Guo, Xian-Ping] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Xinjiang Agricultural University	Guo, XP (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Key Lab New Technol Agr Applicat Beijing, Beijing 100094, Peoples R China.	qinling@bac.edu.cn	cao, qingqin/W-5009-2019	Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [30872039]; Beijing Municipal Natural Science Foundation [6092003, 6082004]; Beijing New-Star Program of Science and Technology [2007B031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing New-Star Program of Science and Technology	This work was provided by the National Natural Science Foundation of China (grant no. 30872039) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Beijing Municipal Natural Science Foundation (grant no. 6092003 and 6082004) (http://www.bjnsf.org/), the Beijing New-Star Program of Science and Technology (grant no. 2007B031) (http://www.bjkw.gov.cn/n8785584/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade GM, 2009, PLANT CELL REP, V28, P1385, DOI 10.1007/s00299-009-0738-7; Baluska F, 2001, DEV BIOL, V236, P478, DOI 10.1006/dbio.2001.0333; Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; CECCONI F, 2002, HELIA, V36, P161; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; Davidson Sandra E., 2006, Phytochemistry Reviews, V5, P405, DOI 10.1007/s11101-006-9005-5; Davidson SE, 2003, PLANT PHYSIOL, V131, P335, DOI 10.1104/pp.012963; De Schepper S, 2001, ACTA HORTIC, V552, P143; Feng YQ, 2011, SCI HORTIC-AMSTERDAM, V130, P431, DOI 10.1016/j.scienta.2011.07.014; Feng YQ, 2005, J BEIJING AGR COLL, V20, P1; Feng Z.Q., 1995, CHINESE FRUIT; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Freinkel S., 2009, AM CHESTNUT LIFE DEA; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Han XY, 2008, SCI HORTIC-AMSTERDAM, V115, P261, DOI 10.1016/j.scienta.2007.09.003; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; HEDDEN P, 1985, J PLANT GROWTH REGUL, V4, P111, DOI 10.1007/BF02266949; Hedden P, 1999, J EXP BOT, V50, P553, DOI 10.1093/jexbot/50.334.553; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Helliwell CA, 2000, AUST J PLANT PHYSIOL, V27, P1141, DOI 10.1071/PP00079; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; KOORNNEEF M, 1990, THEOR APPL GENET, V80, P852, DOI 10.1007/BF00224204; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Li XingLiang, 2011, Acta Horticulturae Sinica, V38, P1251; Liu K, 1999, ACTA HORTIC, P191, DOI 10.17660/ActaHortic.1999.494.28; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margis-Pinheiro M, 2005, PLANT CELL REP, V23, P819, DOI 10.1007/s00299-004-0896-6; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PHILLIPS AL, 1995, PLANT PHYSIOL, V108, P1049, DOI 10.1104/pp.108.3.1049; Qin L, 2011, SCI SILVAE SINICAE, V47, P197; Qing Ling, 2011, Scientia Silvae Sinicae, V47, P194; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sawada Y, 2008, J EXP BOT, V59, P3383, DOI 10.1093/jxb/ern192; Seabra RC, 1998, PLANT CELL REP, V17, P177, DOI 10.1007/s002990050374; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Swain SM, 2005, TRENDS PLANT SCI, V10, P123, DOI 10.1016/j.tplants.2005.01.007; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamaguchi Shinjiro, 2006, Phytochemistry Reviews, V5, P39, DOI 10.1007/s11101-005-4248-0; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Zhang Ling, 2007, Journal of Beijing Forestry University, V29, P99; Zhao ZY, 2009, ACTA HORTIC, V844, P457	49	3	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2012	7	8							e43181	10.1371/journal.pone.0043181	http://dx.doi.org/10.1371/journal.pone.0043181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	993AG	22905227	Green Submitted, Green Published, gold			2022-12-25	WOS:000307823600054
J	Kohl, C; Lesnik, R; Brinkmann, A; Ebinger, A; Radonic, A; Nitsche, A; Muhldorfer, K; Wibbelt, G; Kurth, A				Kohl, Claudia; Lesnik, Rene; Brinkmann, Annika; Ebinger, Arnt; Radonic, Aleksandar; Nitsche, Andreas; Muehldorfer, Kristin; Wibbelt, Gudrun; Kurth, Andreas			Isolation and Characterization of Three Mammalian Orthoreoviruses from European Bats	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; POPULATION BIOLOGY; GENOME SEGMENTS; REOVIRUS; SEQUENCE; VIRUS; PATHOGENS; HUMANS; ORIGIN; FAMILY	In recent years novel human respiratory disease agents have been described in South East Asia and Australia. The causative pathogens were classified as pteropine orthoreoviruses with strong phylogenetic relationship to orthoreoviruses of flying foxes inhabiting these regions. Subsequently, a zoonotic bat-to-human transmission has been assumed. We report the isolation of three novel mammalian orthoreoviruses (MRVs) from European bats, comprising bat-borne orthoreovirus outside of South East Asia and Australia and moreover detected in insectivorous bats (Microchiroptera). MRVs are well known to infect a broad range of mammals including man. Although they are associated with rather mild and clinically unapparent infections in their hosts, there is growing evidence of their ability to also induce more severe illness in dogs and man. In this study, eight out of 120 vespertilionid bats proved to be infected with one out of three novel MRV isolates, with a distinct organ tropism for the intestine. One isolate was analyzed by 454 genome sequencing. The obtained strain T3/Bat/Germany/342/08 had closest phylogenetic relationship to MRV strain T3D/04, isolated from a dog. These novel reoviruses provide a rare chance of gaining insight into possible transmission events and of tracing the evolution of bat viruses.	[Kohl, Claudia; Lesnik, Rene; Brinkmann, Annika; Ebinger, Arnt; Radonic, Aleksandar; Nitsche, Andreas; Kurth, Andreas] Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany; [Muehldorfer, Kristin; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Robert Koch Institute; Leibniz Institut fur Zoo und Wildtierforschung	Kohl, C (corresponding author), Robert Koch Inst, Ctr Biol Secur 1, Berlin, Germany.	KohlC@rki.de	Radonić, Aleksandar/AAP-2612-2020	kohl, claudia/0000-0002-1480-8911; Radonic, Aleksandar/0000-0001-6200-9607; Nitsche, Andreas/0000-0001-8185-3176	Konrad Adenauer Foundation; Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung	Konrad Adenauer Foundation; Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung	This study was partially financed by grants provided by the Konrad Adenauer Foundation (fellowship to Dr. Kohl) and by the Adolf and Hildegard Isler-Stiftung, Klara Samariter-Stiftung and FAZIT-Stiftung (Dr. Muhldorfer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2001, BIOCHEM BIOPH RES CO, V287, P583, DOI 10.1006/bbrc.2001.5612; Breun LA, 2001, VIROLOGY, V287, P333, DOI 10.1006/viro.2001.1052; Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025434; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Coombs KM, 2006, CURR TOP MICROBIOL, V309, P117; Cutler SJ, 2010, EMERG INFECT DIS, V16, P1, DOI 10.3201/eid1601.081467; Day JM, 2007, VIRUS GENES, V35, P235, DOI 10.1007/s11262-006-0044-1; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Decaro N, 2005, VET MICROBIOL, V109, P19, DOI 10.1016/j.vetmic.2005.05.014; DERMODY TS, 1990, J VIROL, V64, P4842, DOI 10.1128/JVI.64.10.4842-4850.1990; Dermody TS, 2010, REOVIRUSES ORBIVIRUS; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; HRDY DB, 1979, J VIROL, V31, P104, DOI 10.1128/JVI.31.1.104-111.1979; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang J, 2006, VIRUS GENES, V33, P193, DOI 10.1007/s11262-005-0046-4; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Muhldorfer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029773; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Song LH, 2008, VIRUS GENES, V37, P392, DOI 10.1007/s11262-008-0283-4; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; URBANO P, 1994, COMP IMMUNOL MICROB, V17, P151, DOI 10.1016/0147-9571(94)90040-X; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wellehan JFX, 2009, VET MICROBIOL, V133, P34, DOI 10.1016/j.vetmic.2008.06.011; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9	35	62	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43106	10.1371/journal.pone.0043106	http://dx.doi.org/10.1371/journal.pone.0043106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905211	Green Published, gold			2022-12-25	WOS:000307500800045
J	Li, LZ; Ben, YY; Zhu, ZQ; Li, WH; Xu, JQ; Zhang, XY				Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Li, Weihua; Xu, Jianqing; Zhang, Xiaoyan			Minocycline Down-Regulates Topical Mucosal Inflammation during the Application of Microbicide Candidates	PLOS ONE			English	Article							HIV-INFECTION; MACROLIDE ANTIBIOTICS; MOUSE MODEL; BIOMARKERS; TOXICITY; SAFETY	An effective anti-human immunodeficiency virus-1 (HIV-1) microbicide should exert its action in the absence of causing aberrant activation of topical immunity that will increase the risk of HIV acquisition. In the present study, we demonstrated that the vaginal application of cellulose sulfate (CS) gel induced topical mucosal inflammatory responses; the addition of minocycline to CS gel could significantly attenuate the inflammation in a mice model. The combined gel of CS plus minocycline not only reduced the production of inflammatory cytokines in cervicovaginal lavages (CVLs), also downregulated the activation of CD4+ T cells and the recruitment of other immune cells including HIV target cells into vaginal tissues. Furthermore, an In vitro HIV-1 pseudovirus infection inhibition assay showed that the combined gel decreased the infection efficacy of different subtypes of HIV-1 pseudoviruses compared with that of CS gel alone. These results implicate that minocycline could be integrated into microbicide formulation to suppress the aberrant activation of topical mucosal immunity and enhance the safety profile during the application of microbicides.	[Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Li, Liangzhu; Ben, Yinyin; Zhu, Zhaoqin; Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xu, Jianqing; Zhang, Xiaoyan] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Xu, Jianqing; Zhang, Xiaoyan] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Weihua] World Hlth Org Collaborating Ctr Res Human Reprod, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; World Health Organization	Li, LZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhang_xycn2002@yahoo.com.cn			National Ministry of Science and Technology of China [2012CB519000]; National Grand Program on Key Infectious Disease Control [2012ZX10001-007-008]; Natural Science Foundation of China [81102282, 81171553]	National Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Grand Program on Key Infectious Disease Control; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Ministry of Science and Technology of China (2012CB519000), National Grand Program on Key Infectious Disease Control (2012ZX10001-007-008), and Natural Science Foundation of China (81102282 and 81171553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg J, 2011, RESPIRATION, V81, P67, DOI 10.1159/000320319; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; BOBBIE RJ, 1980, APPL ENVIRON MICROB, V39, P1212, DOI 10.1128/AEM.39.6.1212-1222.1980; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cohen PR, 2004, SOUTH MED J, V97, P70, DOI 10.1097/01.SMJ.0000083857.98870.98; Copeland KFT, 2010, J INFECT DIS, V201, P1115, DOI 10.1086/651278; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Doh AS, 2007, CONTRACEPTION, V76, P245, DOI 10.1016/j.contraception.2007.05.083; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fux R, 2008, Dtsch Med Wochenschr, V133, pF4, DOI 10.1055/s-0028-1082824; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2006, AM J REPROD IMMUNOL, V56, P356, DOI 10.1111/j.1600-0897.2006.00436.x; Li LZ, 2010, CHINESE MED J-PEKING, V123, P3381, DOI 10.3760/cma.j.issn.0366-6999.2010.23.002; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Maffeis L, 2010, GIORN ITAL DERMAT V, V145, P425; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; ORIEL JD, 1975, J CLIN PATHOL, V28, P403, DOI 10.1136/jcp.28.5.403; Qiu Chao, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P394; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Tauber S C, 2008, Curr Mol Pharmacol, V1, P68; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Utari A, 2010, AJIDD-AM J INTELLECT, V115, P433, DOI 10.1352/1944-7558-115.5.433; Wormser GP, 2005, CLIN INFECT DIS, V41, P1368	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43211	10.1371/journal.pone.0043211	http://dx.doi.org/10.1371/journal.pone.0043211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905236	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500800061
J	Alkuwaity, K; Taylor, A; Heckels, JE; Doran, KS; Christodoulides, M				Alkuwaity, Khalil; Taylor, Alexander; Heckels, John E.; Doran, Kelly S.; Christodoulides, Myron			Group B Streptococcus Interactions with Human Meningeal Cells and Astrocytes In Vitro	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; LUNG EPITHELIAL-CELLS; BETA-HEMOLYSIN/CYTOLYSIN; NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; UNITED-STATES; CAPSULAR POLYSACCHARIDE; INFLAMMATORY RESPONSES; NEONATAL MENINGITIS	Background: Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of life-threatening neonatal meningitis and survivors often suffer permanent neurological damage. How this organism interacts with the meninges and subsequently with astrocytes that constitute the underlying cortical glia limitans superficialis is not known. Methodology/Principal Findings: In this paper, we demonstrate dose-dependent adherence of GBS over time to human meningioma cells and fetal astrocytes in vitro, which was not influenced by expression of either beta-haemolysin/cytolysin (beta-h/c) toxin, different capsule serotypes or by absence of capsule (p > 0.05). Internalization of GBS by both cell types was, however, a slow and an infrequent event (only 0.02-0.4% of associated bacteria were internalised by 9 h). Expression of beta-h/c toxin did not play a role in invasion (p > 0.05), whereas capsule expression lead to a reduction (p < 0.05) in the numbers of intracellular bacteria recovered. GBS strains induced cytotoxicity as demonstrated by the measurement of lactate dehydrogenase (LDH) enzyme release by 9 h and by viable staining. Increasing levels of meningioma cell death correlated with bacterial growth and the phenotype of beta-h/c toxin production, i.e. from weakly, to normo- to hyper-haemolytic. However, cytotoxicity was significantly greater (p < 0.05) towards astrocytes, and infection with initial MOI >= 0.003 induced 70-100% LDH release. By comparing wild-type (beta-h/c(+)) and mutant (Delta cylE beta-h/c(-)) strains and beta-h/c toxin extracts and by using the surfactant dipalmitoylphosphatidylcholine in cytotoxicity inhibition experiments, beta-h/c toxin was demonstrated as principally responsible for cell death. Conclusions/Significance: This study has described key events in the interactions of GBS with meningeal cells and astrocytes in vitro and a major virulence role for beta-h/c toxin. Understanding the mechanisms involved will help to identify potential therapies for improving patient survival and for reducing the incidence and severity of neurological sequelae.	[Alkuwaity, Khalil; Taylor, Alexander; Heckels, John E.; Christodoulides, Myron] Univ Southampton, Fac Med, Southampton Gen Hosp, Neisseria Res Grp,Sir Henry Wellcome Labs, Southampton SO9 5NH, Hants, England; [Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Southampton; California State University System; San Diego State University	Alkuwaity, K (corresponding author), King Abdulaziz Univ, Dept Lab Med, Fac Appl Med Sci, Jeddah 21413, Saudi Arabia.	mc4@soton.ac.uk	Christodoulides, Myron/C-6699-2011	Christodoulides, Myron/0000-0002-9663-4731	Ministry of Higher Education, Saudi Arabia; Hope (Wessex Medical Trust); National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS051247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	Ministry of Higher Education, Saudi Arabia; Hope (Wessex Medical Trust); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	K. Alkuwaity was a PhD student sponsored by the Ministry of Higher Education, Saudi Arabia. The study was supported by an award to M. Christodoulides and J. Heckels from Hope (Wessex Medical Trust) and grant R01NS051247 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to K. Doran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Bifrare YD, 2003, HIPPOCAMPUS, V13, P481, DOI 10.1002/hipo.10142; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; Cheng Q, 2002, INFECT IMMUN, V70, P3309; Christodoulides M, 2000, MOL MICROBIOL, V35, P32, DOI 10.1046/j.1365-2958.2000.01694.x; Christodoulides M, 2002, INFECT IMMUN, V70, P4035, DOI 10.1128/IAI.70.8.4035-4044.2002; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; ELSINGHORST EA, 1994, BACT PATH B, V236, P405; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; FEURER DJ, 1991, NEUROPATH APPL NEURO, V17, P391, DOI 10.1111/j.1365-2990.1991.tb00739.x; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; Fowler MI, 2004, CELL MICROBIOL, V6, P555, DOI 10.1111/j.1462-5822.2004.00382.x; GIBSON RL, 1993, INFECT IMMUN, V61, P478, DOI 10.1128/IAI.61.2.478-485.1993; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hardy SJ, 2000, MOL MICROBIOL, V36, P817, DOI 10.1046/j.1365-2958.2000.01923.x; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Hensler ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002446; HULSE ML, 1993, INFECT IMMUN, V61, P4835, DOI 10.1128/IAI.61.11.4835-4841.1993; HUTCHINGS M, 1986, J NEUROSURG, V65, P316, DOI 10.3171/jns.1986.65.3.0316; Iijima S, 2007, PEDIATR INT, V49, P1000, DOI 10.1111/j.1442-200X.2007.02474.x; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kleihues P., 1997, PATHOLOGY GENETICS T; Koedel U, 1999, INFECT DIS CLIN N AM, V13, P549, DOI 10.1016/S0891-5520(05)70094-5; LANCEFIELD RC, 1975, J EXP MED, V142, P165, DOI 10.1084/jem.142.1.165; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; MADOFF LC, 1991, INFECT IMMUN, V59, P204, DOI 10.1128/IAI.59.1.204-210.1991; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; MARCHLEWICZ BA, 1980, INFECT IMMUN, V30, P805; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Maruvada R, 2011, INFECT IMMUN, V79, P4088, DOI 10.1128/IAI.05506-11; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MCLONE DG, 1980, CHILD BRAIN, V6, P113; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; NOWICKI B, 1986, MICROB PATHOGENESIS, V1, P335, DOI 10.1016/0882-4010(86)90066-5; ODA Y, 1984, J COMP NEUROL, V225, P448, DOI 10.1002/cne.902250310; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PLATT MW, 1995, CURR MICROBIOL, V31, P5, DOI 10.1007/BF00294625; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Reiss A, 2011, J INFECT DIS, V203, P393, DOI 10.1093/infdis/jiq047; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Shet A, 2004, INDIAN J MED RES, V120, P141; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; Shin S, 2006, BIOCHEM BIOPH RES CO, V345, P538, DOI 10.1016/j.bbrc.2006.04.130; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; TAMURA GS, 1994, INFECT IMMUN, V62, P2450, DOI 10.1128/IAI.62.6.2450-2458.1994; Tazi A, 2012, CURR OPIN MICROBIOL, V15, P44, DOI 10.1016/j.mib.2011.12.002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; TETI G, 1987, INFECT IMMUN, V55, P3057, DOI 10.1128/IAI.55.12.3057-3064.1987; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Truemper E J, 1987, J Perinatol, V7, P267; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; WELLER RO, 1995, GRAYS ANATOMY, P1202; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; Wennekamp J, 2008, IMMUNOL REV, V225, P114, DOI 10.1111/j.1600-065X.2008.00673.x; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; WILLIAMS PA, 1993, J PEDIATR-US, V123, P292, DOI 10.1016/S0022-3476(05)81706-8; Winram SB, 1998, INFECT IMMUN, V66, P4932, DOI 10.1128/IAI.66.10.4932-4941.1998; Yim HH, 1997, ADV EXP MED BIOL, V418, P995; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	73	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42660	10.1371/journal.pone.0042660	http://dx.doi.org/10.1371/journal.pone.0042660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900037	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000307380900054
J	Freemantle, E; Lalovic, A; Mechawar, N; Turecki, G				Freemantle, Erika; Lalovic, Aleksandra; Mechawar, Naguib; Turecki, Gustavo			Age and Haplotype Variations within FADS1 Interact and Associate with Alterations in Fatty Acid Composition in Human Male Cortical Brain Tissue	PLOS ONE			English	Article							GENE-CLUSTER; DESATURASE ACTIVITIES; DOCOSAHEXAENOIC ACID; GENOMIC STRUCTURE; CDNA CLONING; METABOLISM; VARIANTS; POLYMORPHISMS; EXPRESSION; OMEGA-6	Fatty acids (FA) play an integral role in brain function and alterations have been implicated in a variety of complex neurological disorders. Several recent genomic studies have highlighted genetic variability in the fatty acid desaturase (FADS1/2/3) gene cluster as an important contributor to FA alterations in serum lipids as well as measures of FA desaturase index estimated by ratios of relevant FAs. The contribution to alterations of FAs within the brain by local synthesis is still a matter of debate. Thus, the impact of genetic variants in FADS genes on gene expression and brain FA levels is an important avenue to investigate. Methods: Analyses were performed on brain tissue from prefrontal cortex Brodmann area 47 (BA47) of 61 male subjects of French Canadian ancestry ranging in age from young adulthood to middle age (18-58 years old), with the exception of one teenager (15 years old). Haplotype tagging SNPs were selected using the publicly available HapMap genotyping dataset in conjunction with Haploview. DNA sequencing was performed by the Sanger method and gene expression was measured by quantitative real-time PCR. FAs in brain tissue were analysed by gas chromatography. Variants in the FADS1 gene region were sequenced and analyzed for their influence on both FADS gene expression and FAs in brain tissue. Results: Our results suggest an association of the minor haplotype with alteration in estimated fatty acid desaturase activity. Analysis of the impact of DNA variants on expression and alternative transcripts of FADS1 and FADS2, however, showed no differences. Furthermore, there was a significant interaction between haplotype and age on certain brain FA levels. Discussion: This study suggests that genetic variability in the FADS genes cluster, previously shown to be implicated in alterations in peripheral FA levels, may also affect FA composition in brain tissue, but not likely by local synthesis.	[Freemantle, Erika; Turecki, Gustavo] McGill Univ, Dept Genet, Montreal, PQ, Canada; [Mechawar, Naguib; Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Freemantle, Erika; Lalovic, Aleksandra; Mechawar, Naguib; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Freemantle, E (corresponding author), McGill Univ, Dept Genet, Montreal, PQ, Canada.	Gustavo.Turecki@McGill.ca	Turecki, Gustavo/K-5100-2015	Turecki, Gustavo/0000-0003-4075-2736	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide; Canadian Institute of Health Research (CIHR) [MOP 53321]; FRSQ	Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	The Quebec Suicide Brain Bank is supported in part by the Fonds de la Recherche en Sante du Quebec (FRSQ) through the Reseau Quebecois de Recherche sur le Suicide. This work was supported in part by the Canadian Institute of Health Research (CIHR) MOP 53321 to GT. EF received a scholarship from FRSQ. NM and GT are both FRSQ chercheur boursier. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basselin M, 2011, BRAIN RES B; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brenna JT, 2010, PROSTAG LEUKOTR ESS, V82, P281, DOI 10.1016/j.plefa.2010.02.011; Conklin SM, 2007, PSYCHOSOM MED, V69, P932, DOI 10.1097/PSY.0b013e31815aaa42; Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006; Conklin SM, 2010, PROSTAG LEUKOTR ESS, V82, P111, DOI 10.1016/j.plefa.2009.12.002; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; FOLCH J, 1951, J BIOL CHEM, V191, P833; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Haiman Christopher A., 2008, V141, P37; Hsieh AT, 2009, PROSTAG LEUKOTR ESS, V81, P105, DOI 10.1016/j.plefa.2009.05.012; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lalovic A, 2007, J PSYCHIATR NEUROSCI, V32, P363; Lassek William D, 2011, Front Evol Neurosci, V3, P5, DOI 10.3389/fnevo.2011.00005; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Lattka E, 2011, AM J CLIN NUTR, V93, P382, DOI 10.3945/ajcn.110.004515; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Liu YH, 2009, SCHIZOPHR RES, V109, P113, DOI 10.1016/j.schres.2008.12.027; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; McNamara RK, 2008, PROSTAG LEUKOTR ESS, V78, P293, DOI 10.1016/j.plefa.2008.04.001; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578; Nakamura MT, 2002, BIOCHEM SOC T, V30, P1076, DOI 10.1042/BST0301076; Park W.J., 2012, J LIPID RES; Park WJ, 2010, MOL BIOL REP, V37, P2403, DOI 10.1007/s11033-009-9750-9; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Reardon HT, 2011, J LIPID RES, V52, P2279, DOI 10.1194/jlr.M019653; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Standl M, 2012, ALLERGY, V67, P83, DOI 10.1111/j.1398-9995.2011.02708.x; Standl M, 2011, CLIN EXP ALLERGY, V41, P1757, DOI 10.1111/j.1365-2222.2011.03833.x; Stohr H, 2000, CYTOGENET CELL GENET, V88, P211, DOI 10.1159/000015552; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Tang B, 2012, PSYCHIAT RES, V196, P201, DOI 10.1016/j.psychres.2011.09.026; Umeda-Sawada R, 2006, BIOSCI BIOTECH BIOCH, V70, P2121, DOI 10.1271/bbb.60057; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42696	10.1371/journal.pone.0042696	http://dx.doi.org/10.1371/journal.pone.0042696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900039	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900056
J	Ito, E; Otsuka, E; Hama, N; Aonuma, H; Okada, R; Hatakeyama, D; Fujito, Y; Kobayashi, S				Ito, Etsuro; Otsuka, Emi; Hama, Noriyuki; Aonuma, Hitoshi; Okada, Ryuichi; Hatakeyama, Dai; Fujito, Yutaka; Kobayashi, Suguru			Memory Trace in Feeding Neural Circuitry Underlying Conditioned Taste Aversion in Lymnaea	PLOS ONE			English	Article							POND SNAIL LYMNAEA; CENTRAL PATTERN GENERATOR; CEREBRAL GIANT-CELLS; SYNAPTIC ENHANCEMENT; TENTACLE NERVES; STAGNALIS; SYSTEM; INTERNEURONS; LIP; EXPRESSION	Background: The pond snail Lymnaea stagnalis can maintain a conditioned taste aversion (CTA) as a long-term memory. Previous studies have shown that the inhibitory postsynaptic potential (IPSP) evoked in the neuron 1 medial (N1M) cell by activation of the cerebral giant cell (CGC) in taste aversion-trained snails was larger and lasted longer than that in control snails. The N1M cell is one of the interneurons in the feeding central pattern generator (CPG), and the CGC is a key regulatory neuron for the feeding CPG. Methodology/Principle Findings: Previous studies have suggested that the neural circuit between the CGC and the N1M cell consists of two synaptic connections: (1) the excitatory connection from the CGC to the neuron 3 tonic (N3t) cell and (2) the inhibitory connection from the N3t cell to the N1M cell. However, because the N3t cell is too small to access consistently by electrophysiological methods, in the present study the synaptic inputs from the CGC to the N3t cell and those from the N3t cell to the N1M cell were monitored as the monosynaptic excitatory postsynaptic potential (EPSP) recorded in the large B1 and B3 motor neurons, respectively. The evoked monosynaptic EPSPs of the B1 motor neurons in the brains isolated from the taste aversion-trained snails were identical to those in the control snails, whereas the spontaneous monosynaptic EPSPs of the B3 motor neurons were significantly enlarged. Conclusion/Significance: These results suggest that, after taste aversion training, the monosynaptic inputs from the N3t cell to the following neurons including the N1M cell are specifically facilitated. That is, one of the memory traces for taste aversion remains as an increase in neurotransmitter released from the N3t cell. We thus conclude that the N3t cell suppresses the N1M cell in the feeding CPG, in response to the conditioned stimulus in Lymnaea CTA.	[Ito, Etsuro; Otsuka, Emi; Okada, Ryuichi; Hatakeyama, Dai; Kobayashi, Suguru] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki, Japan; [Hama, Noriyuki] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido, Japan; [Aonuma, Hitoshi] Hokkaido Univ, Res Inst Elect Sci, Complex Syst Res Grp, Sapporo, Hokkaido, Japan; [Fujito, Yutaka] Sapporo Med Univ, Sch Med, Dept Syst Neurosci, Sapporo, Hokkaido, Japan	Tokushima Bunri University; Hokkaido University; Hokkaido University; Sapporo Medical University	Ito, E (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Lab Funct Biol, Sanuki, Japan.	eito@kph.bunri-u.ac.jp	ハタケヤマ, ダイ/HHS-5095-2022; Kobayashi, Suguru/AAN-9001-2021; Aonuma, Hitoshi/D-6540-2012	ハタケヤマ, ダイ/0000-0001-6047-7124; Aonuma, Hitoshi/0000-0001-8380-1820	KAKENHI from Japan Socienty for the Promotion of Science [24657055]	KAKENHI from Japan Socienty for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly funded by KAKENHI from Japan Socienty for the Promotion of Science to EI (24657055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benjamin PR, 2008, FRONT BIOSCI, V13, P4051, DOI 10.2741/2993; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Bernstein IL, 1999, NUTRITION, V15, P229, DOI 10.1016/S0899-9007(98)00192-0; Brierley MJ, 1997, J NEUROPHYSIOL, V78, P3396, DOI 10.1152/jn.1997.78.6.3396; ELLIOTT CJH, 1992, PHILOS T ROY SOC B, V336, P167, DOI 10.1098/rstb.1992.0054; ELLIOTT CJH, 1985, J NEUROPHYSIOL, V54, P1396, DOI 10.1152/jn.1985.54.6.1396; Ito E, 1999, ZOOL SCI, V16, P711, DOI 10.2108/zsj.16.711; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; Kawai R, 2011, ZOOL SCI, V28, P517, DOI 10.2108/zsj.28.517; Kemenes I, 2006, CURR BIOL, V16, P1269, DOI 10.1016/j.cub.2006.05.049; Kita S, 2011, BIOL BULL-US, V220, P71, DOI 10.1086/BBLv220n1p71; Kojima S, 1997, NEUROSCI LETT, V230, P179, DOI 10.1016/S0304-3940(97)00507-7; Kojima S, 1996, ZOOL SCI, V13, P803, DOI 10.2108/zsj.13.803; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; Lukowiak K, 2008, J EXP BIOL, V211, P1747, DOI 10.1242/jeb.014886; Marra V, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00161; MCCROHAN CR, 1980, J EXP BIOL, V85, P169; Nakamura H, 1999, NEUROSCI RES, V33, P291, DOI 10.1016/S0168-0102(99)00020-6; Nakamura H, 1999, NEUROSCI RES, V33, P127, DOI 10.1016/S0168-0102(98)00121-7; Nakamura H, 1999, ZOOL SCI, V16, P387, DOI 10.2108/zsj.16.387; ROSE RM, 1979, J EXP BIOL, V80, P137; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Sadamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020285; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Sakakibara M, 2006, BIOL BULL-US, V210, P298, DOI 10.2307/4134566; Silverman-Gavrila LB, 2011, NEUROSCIENCE, V186, P94, DOI 10.1016/j.neuroscience.2011.04.027; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Staras K, 1999, J NEUROPHYSIOL, V81, P1261, DOI 10.1152/jn.1999.81.3.1261; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; Sugai R, 2006, J EXP BIOL, V209, P826, DOI 10.1242/jeb.02069; Sugai R, 2007, J EXP BIOL, V210, P1225, DOI 10.1242/jeb.02735; Vavoulis DV, 2007, EUR J NEUROSCI, V25, P2805, DOI 10.1111/j.1460-9568.2007.05517.x; Wagatsuma A, 2004, ACTA BIOL HUNG, V55, P149, DOI 10.1556/ABiol.55.2004.1-4.18; Wagatsuma A, 2005, J EXP BIOL, V208, P2389, DOI 10.1242/jeb.01625; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012; Whelan HA, 1996, J MOLLUS STUD, V62, P483, DOI 10.1093/mollus/62.4.483; Yeoman MS, 1996, J NEUROPHYSIOL, V75, P11, DOI 10.1152/jn.1996.75.1.11	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43151	10.1371/journal.pone.0043151	http://dx.doi.org/10.1371/journal.pone.0043151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900097	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900115
J	Mekhanikova, IV; Andreev, DS; Belozerova, OY; Mikhlin, YL; Lipko, SV; Klimenkov, IV; Akimov, VV; Kargin, VF; Mazurova, YV; Tauson, VL; Likhoshway, YV				Mekhanikova, Irina V.; Andreev, Dmitry S.; Belozerova, Olga Yu.; Mikhlin, Yuri L.; Lipko, Sergey V.; Klimenkov, Igor V.; Akimov, Vladlen V.; Kargin, Valeriy F.; Mazurova, Yelena V.; Tauson, Vladimir L.; Likhoshway, Yelena V.			Specific Features of Mandible Structure and Elemental Composition in the Polyphagous Amphipod Acanthogammarus grewingkii Endemic to Lake Baikal	PLOS ONE			English	Article							ZINC; CUTICLE; HARDNESS; JAWS	Background: In crustaceans, several mechanisms provide for the mechanical strength of the cuticular "tools" (dactyli, claws, jaws), which serve to catch and crush food objects. Studies on the mandibles of the endemic Baikal amphipod Acanthogammarus grewingkii by means of electron microscopy and elemental analysis have revealed specific structural features of these mouthparts. Methodology: The fine structure of the mandible has been studied by means of SEM, TEM, and AFM; methods used to analyze its elemental and phase composition include XEPMA, XPS, SEM-EDS analysis, and XRD. Conclusion: Functional adaptations of the mandible in A. grewingkii provide for the optimum combination of mechanical hardness and fracture resistance, which is achieved due to a complex structure and composition of its cutting parts. Teeth of the mandible are covered by a thin layer of silica (10-20 mu m). Their epicuticle is characterized by a high density, consists of three layers, and increases in thickness toward the tooth apex. The epicuticle is enriched with Br, while the concentrations of Ca and P reach the peak values in the softer internal tissues of the teeth. These data broaden the view of the diversity of adaptation mechanisms providing for the strengthening of cuticular "tools" in crustaceans.	[Mekhanikova, Irina V.; Andreev, Dmitry S.; Klimenkov, Igor V.; Likhoshway, Yelena V.] Russian Acad Sci, Limnol Inst, Siberian Branch, Irkutsk 664003, Russia; [Belozerova, Olga Yu.; Lipko, Sergey V.; Akimov, Vladlen V.; Tauson, Vladimir L.] Russian Acad Sci, AP Vinogradov Inst Geochem, Siberian Branch, Irkutsk 664003, Russia; [Mikhlin, Yuri L.; Kargin, Valeriy F.; Mazurova, Yelena V.] Russian Acad Sci, Inst Chem & Chem Technol, Siberian Branch, Krasnoyarsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; A.P. Vinogradov Institute of Geochemistry of the Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Institute of Chemistry & Chemical Technology, Siberian Branch, Russian Academy of Sciences	Mekhanikova, IV (corresponding author), Russian Acad Sci, Limnol Inst, Siberian Branch, Irkutsk 664003, Russia.	irinam@lin.irk.ru; yel@lin.irk.ru	Akimov, Vladlen/O-5124-2015; Klimenkov, Klimen/C-6969-2015; Likhoshway, Yelena V./J-4496-2018; Mikhlin, Yuri/D-6591-2011; Akimov, Vladlen/W-6219-2018	Akimov, Vladlen/0000-0001-6799-6349; Likhoshway, Yelena V./0000-0002-2432-9260; Mikhlin, Yuri/0000-0003-1801-0947; Likhoshway, Yelena/0000-0001-5745-6891; Tauson, Vladimir/0000-0001-8704-6105; Klimenkov, Igor/0000-0002-4732-1501	SB RAS [95]; Russian Foundation for Basic Research [09-05-00511-a]	SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the Integration Project of SB RAS No. 95 "Study of Co-Adaptation in the Producer-Consumer System Using the Example of Diatoms and Their Consumers in Freshwater Ecosystems"; additional support was provided by a Russian Foundation for Basic Research grant no. 09-05-00511-a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bazikalova A.Y., 1945, P BAIKAL LIMNOLOGICA, V11, P1, DOI DOI 10.1016/J.JIP.2016.12.006; Bazikalova AYa, 1954, P BAIKAL LIMNOLOGICA, V14, P312; Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Cribb BW, 2010, ACTA BIOMATER, V6, P3152, DOI 10.1016/j.actbio.2010.02.009; Currey JD, 1999, J EXP BIOL, V202, P3285; DENNELL R., 1960, PHYSIOL CRUSTACEA, V1, P449, DOI DOI 10.1016/B978-0-12-395628-6.50020-8; FALKNER KK, 1991, LIMNOL OCEANOGR, V36, P413, DOI 10.4319/lo.1991.36.3.0413; GOLDBERG WM, 1994, COMP BIOCHEM PHYS B, V107, P633, DOI 10.1016/0305-0491(94)90197-X; Grachev M. A., 2002, CURRENT STATE LAKE B; HALCROW K, 1985, J CRUSTACEAN BIOL, V5, P606, DOI 10.2307/1548238; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; HILLERTON JE, 1982, J EXP BIOL, V101, P333; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Lupton R, 1993, STAT THEORY PRACTICE; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Mekhanikova I.V., 2008, Zoologiya Bespozvonochnykh, V5, P17; Mekhanikova IV, 2010, CRUSTACEANA, V83, P865, DOI 10.1163/001121610X504289; MILLER CB, 1990, MAR BIOL, V106, P91, DOI 10.1007/BF02114678; Neues F, 2007, CRYSTENGCOMM, V9, P1245, DOI 10.1039/b710789g; Phedorin MA, 2008, J PALEOLIMNOL, V40, P445, DOI 10.1007/s10933-007-9172-4; Pontin MG, 2007, P NATL ACAD SCI USA, V104, P13559, DOI 10.1073/pnas.0702034104; POPOVSKAYA GI, 2002, DIATOMS PLANKTON LAK; Pryor MGM, 1962, COMP BIOCH, P371; ROER R, 1984, AM ZOOL, V24, P893; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; Schofield RMS, 2001, SCORPION BIOLOGY AND RESEARCH, P234; Schofield RMS, 2009, J STRUCT BIOL, V166, P272, DOI 10.1016/j.jsb.2009.01.007; Vetrov VA., 1997, TRACE ELEMENTS NATUR; Vinogradov AP, 2001, ELEMENTAL CHEM COMPO; Votintsev KK, 1961, P BAIKAL LIMNOL ST, V20, P1; Warner GF, 1977, BIOL CRABS	36	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e43073	10.1371/journal.pone.0043073	http://dx.doi.org/10.1371/journal.pone.0043073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900091	Green Published, gold			2022-12-25	WOS:000307380900109
J	Miyagawa, M; Nishio, S; Usami, S				Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi			Prevalence and Clinical Features of Hearing Loss Patients with CDH23 Mutations: A Large Cohort Study	PLOS ONE			English	Article							USHER-SYNDROME; DEAFNESS; JAPANESE; FREQUENCIES; GENES; CADHERINS; MICE; 1D	Screening for gene mutations in CDH23, which has many exons, has lagged even though it is likely to be an important cause for hearing loss patients. To assess the importance of CDH23 mutations in non-syndromic hearing loss, two-step screening was applied and clinical characteristics of the patients with CDH23 mutations were examined in this study. As a first screening, we performed Sanger sequencing using 304 probands compatible with recessive inheritance to find the pathologic mutations. Twenty-six possible mutations were detected to be pathologic in the first screening. For the second screening, using the probes for these 26 mutations, a large cohort of probands (n = 1396) was screened using Taqman amplification-based mutation analysis followed by Sanger sequencing. The hearing loss in a total of 52 families (10 homozygous, 13 compound heterogygous, and 29 heterozygous) was found to be caused by the CDH23 mutations. The majority of the patients showed congenital, high frequency involved, progressive hearing loss. Interestingly, some particular mutations cause late onset moderate hearing loss. The present study is the first to demonstrate the prevalence of CDH23 mutations among non-syndromic hearing loss patients and indicated that mutations of the CDH23 gene are an important cause of non-syndromic hearing loss.	[Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan	Shinshu University	Miyagawa, M (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (SU), by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (SU), by a Health and Labour Sciences Research Grant for Research on Specific Diseases (Vestibular Disorders) from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (SU), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Angst BD, 2001, J CELL SCI, V114, P629; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rowlands TM, 2000, REV REPROD, V5, P53; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 2010, AUDIOLOGICAL MED, V8, P28; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Zheng QY, 2005, HUM MOL GENET, V14, P103, DOI 10.1093/hmg/ddi010	22	49	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e40366	10.1371/journal.pone.0040366	http://dx.doi.org/10.1371/journal.pone.0040366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899989	Green Published, gold, Green Submitted			2022-12-25	WOS:000307380900004
J	Yang, JY; Lan, HT; Huang, XB; Liu, BY; Tong, Y				Yang, Jiyun; Lan, Haitao; Huang, Xiaobing; Liu, Baoyu; Tong, Yu			MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							MIR-126; SUPPRESSOR; CARCINOMA; INVASION; GENES	Background: It is controversial whether microRNA-126 is a tumor suppressive or oncogenic miRNA. More experiments are needed to determine whether microRNA-126 is associated with non-small cell lung cancer risk and prognosis. Methods: Over-expression of microRNA-126 was performed to evaluate the cell invasion and tumor growth in non-small cell lung cancer (NSCLC) cell lines and nude mouse xenograft model. Gain-of-function experiments and luciferase assays were performed to reveal the relationship between microRNA-126 and PI3K-Akt signal pathway in A549 cells. We analyzed the associations of the microRNA-126 expression between genetic variants within microRNA-126 and clinical information including smoking status, sex, age, and histological type and the tumor stage. Results: Over-expression of microRNA-126 in NSCLC cell lines decreased cell proliferation in vitro and tumor growth in the nude mouse xenograft model. And microRNA-126 repressed the activity of PI3K-Akt pathway by targeting binding sites in the 3'-untranslated region of PI3KR2 mRNA. The expression level of microRNA-126 was decreased in NSCLC lines and tumor tissues. The patients with low microRNA-126 expression had significantly poorer survival time than those with high microRNA-126 expression (means for survival time (month): 24.392 +/- 1.055 vs. 29.282 +/- 1.140, P = 0.005). However, there was no significant difference in the genotype and allele frequencies of the microRNA-126 variant (G>A, rs4636297) between cases and controls (P = 0.366). In addition, there was no association between SNP rs4636297 and survival time in NSCLC patients (P = 0.992). And microRNA-126 expression had no significant difference among the three genotype groups (P = 0.972). Conclusions: Our data indicate that microRNA-126 is a tumor-suppressor gene in NSCLC and low microRNA-126 expression is a unfavorable prognostic factor in NSCLC patients. However, the regulatory mechanism of microRNA-126 remains to be elucidated in different normal and malignant tissues. Therefore, further research is needed to explore the tumor suppressive functions of microRNA-126 in NSCLC.	[Yang, Jiyun] Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China; [Yang, Jiyun; Lan, Haitao; Huang, Xiaobing] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Jiyun] Sichuan Acad Med Sci, Key Lab Human Dis Gene Study Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Tong, Yu] Sichuan Univ, Lab Early Dev & Injuries, W China Inst Woman & Childrens Hlth, Chengdu 610064, Sichuan, Peoples R China; [Tong, Yu] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Minist Educ, W China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Lan, Haitao] Sichuan Acad Med Sci, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Huang, Xiaobing] Sichuan Acad Med Sci, Dept Hematol, Chengdu, Sichuan, Peoples R China; [Liu, Baoyu] Chengdu Army Gen Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Yang, JY (corresponding author), Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Inst Lab Med, Chengdu, Sichuan, Peoples R China.	toyuer@gmail.com	Yang, Jiyun/AAS-3937-2020		National Natural Science Foundation of China [30800633]; Sichuan Province Science and Technology Foundation for Youths [09ZQ026-034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Foundation for Youths	This work was supported by National Natural Science Foundation of China (grant number 30800633) and Sichuan Province Science and Technology Foundation for Youths (grant number 09ZQ026-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2009, EXPERT REV MOL DIAGN, V9, P773, DOI [10.1586/erm.09.57, 10.1586/ERM.09.57]; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Feng R, 2011, CANC LETT, V298, P50; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hansen TF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-83; Harnprasopwat R, 2010, BIOCHEM BIOPH RES CO, V399, P117, DOI 10.1016/j.bbrc.2010.07.009; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Harris TA, 2010, ARTERIOSCL THROM VAS, V30, P1990, DOI 10.1161/ATVBAHA.110.211706; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Lu Y, 2012, CARCINOGENESIS, DOI [10.1093/carcin/bgs1100, DOI 10.1093/CARCIN/BGS1100]; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sun YQ, 2010, BIOCHEM BIOPH RES CO, V391, P1483, DOI 10.1016/j.bbrc.2009.12.098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Toyooka S, 2011, GEN THORAC CARDIOVAS, V59, P527, DOI 10.1007/s11748-010-0743-3; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yang RX, 2011, BREAST CANCER RES TR, V127, P549, DOI 10.1007/s10549-010-1244-x; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	39	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42978	10.1371/journal.pone.0042978	http://dx.doi.org/10.1371/journal.pone.0042978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900072	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900090
J	Binkowski, TA; Marino, SR; Joachimiak, A				Binkowski, T. Andrew; Marino, Susana R.; Joachimiak, Andrzej			Predicting HLA Class I Non-Permissive Amino Acid Residues Substitutions	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL EPITOPES; MHC CLASS-I; VERSUS-HOST-DISEASE; PEPTIDE-BINDING; STRUCTURAL PREDICTION; COMPUTATIONAL SYSTEM; MOLECULAR-MECHANISM; SIDE-CHAINS; LIGANDS	Prediction of peptide binding to human leukocyte antigen (HLA) molecules is essential to a wide range of clinical entities from vaccine design to stem cell transplant compatibility. Here we present a new structure-based methodology that applies robust computational tools to model peptide-HLA (p-HLA) binding interactions. The method leverages the structural conservation observed in p-HLA complexes to significantly reduce the search space and calculate the system's binding free energy. This approach is benchmarked against existing p-HLA complexes and the prediction performance is measured against a library of experimentally validated peptides. The effect on binding activity across a large set of high-affinity peptides is used to investigate amino acid mismatches reported as high-risk factors in hematopoietic stem cell transplantation.	[Binkowski, T. Andrew; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Binkowski, T. Andrew; Joachimiak, Andrzej] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Marino, Susana R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Binkowski, TA (corresponding author), Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Marino, Susana G./0000-0003-4369-018X	Office of Science of the U.S. Department of Energy [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]; National Institutes of Health [GM094585]; University of Chicago Comprehensive Cancer Center, Chicago, Illinois [5-31333]; U.S. Department of Energy Office of Biological and Environmental Research [DEAC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center, Chicago, Illinois; U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-06CH11357. We would like to acknowledge Drs. Devleena Shivakumar, Wei Jiang and Benoit Roux for valuable discussions and support on computational method development and implementation. The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.; This work was supported by National Institutes of Health grant GM094585, University of Chicago Comprehensive Cancer Center, Chicago, Illinois (Fund 5-31333) and by the U.S. Department of Energy Office of Biological and Environmental Research contract DEAC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; ALTUVIA Y, 1995, J MOL BIOL, V249, P244, DOI 10.1006/jmbi.1995.0293; Ball P, 2008, NATURE, V452, P291, DOI 10.1038/452291a; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2006, PROTEINS, V63, P43, DOI 10.1002/prot.20870; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui J, 2006, IMMUNOGENETICS, V58, P607, DOI 10.1007/s00251-006-0117-2; DAVENPORT MP, 1995, IMMUNOGENETICS, V42, P392; Doytchinova IA, 2004, METHODS, V34, P444, DOI 10.1016/j.ymeth.2004.06.007; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Ferrara GB, 2001, BLOOD, V98, P3150, DOI 10.1182/blood.V98.10.3150; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia-Sosa AT, 2010, MOL INFORM, V29, P589, DOI 10.1002/minf.201000007; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Hattotuwagama Channa K., 2007, V409, P227, DOI 10.1007/978-1-60327-118-9_16; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Jacob L, 2008, BIOINFORMATICS, V24, P358, DOI 10.1093/bioinformatics/btm611; Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kawase T, 2009, BLOOD, V113, P2851, DOI 10.1182/blood-2008-08-171934; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumar N, 2007, NUCLEIC ACIDS RES, V35, pW549, DOI 10.1093/nar/gkm266; Kumar N, 2010, MOL BIOSYST, V6, P2508, DOI 10.1039/c0mb00013b; Liao WWP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025055; Liao WWP, 2011, AUTOIMMUN REV, V10, P469, DOI 10.1016/j.autrev.2011.02.003; Lim JS, 1996, MOL IMMUNOL, V33, P221, DOI 10.1016/0161-5890(95)00065-8; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Logean A, 2002, J COMPUT AID MOL DES, V16, P229, DOI 10.1023/A:1020244329512; Luo WJ, 2010, J MOL MODEL, V16, P903, DOI 10.1007/s00894-009-0598-7; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; Marino SR, 2012, BONE MARROW TRANSPL, V47, P217, DOI 10.1038/bmt.2011.56; Michielin O, 2002, J MOL BIOL, V324, P547, DOI 10.1016/S0022-2836(02)00880-X; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Paczesny S, 2010, BONE MARROW TRANSPL, V45, P1, DOI 10.1038/bmt.2009.328; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang GL, 2007, J IMMUNOL METHODS, V320, P143, DOI 10.1016/j.jim.2006.12.011; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19; Zoete V, 2010, J MOL RECOGNIT, V23, P142, DOI 10.1002/jmr.1005	54	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e41710	10.1371/journal.pone.0041710	http://dx.doi.org/10.1371/journal.pone.0041710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905104	Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100015
J	Ip, CW; Kroner, A; Groh, J; Huber, M; Klein, D; Spahn, I; Diem, R; Williams, SK; Nave, KA; Edgar, JM; Martini, R				Ip, Chi Wang; Kroner, Antje; Groh, Janos; Huber, Marianne; Klein, Dennis; Spahn, Irene; Diem, Ricarda; Williams, Sarah K.; Nave, Klaus-Armin; Edgar, Julia M.; Martini, Rudolf			Neuroinflammation by Cytotoxic T-Lymphocytes Impairs Retrograde Axonal Transport in an Oligodendrocyte Mutant Mouse	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROTEOLIPID PROTEIN GENE; RETINAL GANGLION-CELLS; GRANZYME-B; MULTIPLE-SCLEROSIS; MYELIN DEGENERATION; AXONOPATHIC CHANGES; NEURONAL APOPTOSIS; NERVOUS-SYSTEM; MOTOR FUNCTION	Mice overexpressing proteolipid protein (PLP) develop a leukodystrophy-like disease involving cytotoxic, CD8+ T-lymphocytes. Here we show that these cytotoxic T-lymphocytes perturb retrograde axonal transport. Using fluorogold stereotactically injected into the colliculus superior, we found that PLP overexpression in oligodendrocytes led to significantly reduced retrograde axonal transport in retina ganglion cell axons. We also observed an accumulation of mitochondria in the juxtaparanodal axonal swellings, indicative for a disturbed axonal transport. PLP overexpression in the absence of T-lymphocytes rescued retrograde axonal transport defects and abolished axonal swellings. Bone marrow transfer from wildtype mice, but not from perforin- or granzyme B-deficient mutants, into lymphocyte-deficient PLP mutant mice led again to impaired axonal transport and the formation of axonal swellings, which are predominantly located at the juxtaparanodal region. This demonstrates that the adaptive immune system, including cytotoxic T-lymphocytes which release perforin and granzyme B, are necessary to perturb axonal integrity in the PLP-transgenic disease model. Based on our observations, so far not attended molecular and cellular players belonging to the immune system should be considered to understand pathogenesis in inherited myelin disorders with progressive axonal damage.	[Ip, Chi Wang; Kroner, Antje; Groh, Janos; Huber, Marianne; Klein, Dennis; Spahn, Irene; Martini, Rudolf] Univ Wurzburg, Dept Neurol, Sect Dev Neurobiol, D-8700 Wurzburg, Germany; [Diem, Ricarda; Williams, Sarah K.] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany; [Edgar, Julia M.] Univ Glasgow, Appl Neurobiol Grp, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Wurzburg; Ruprecht Karls University Heidelberg; Max Planck Society; University of Glasgow	Ip, CW (corresponding author), Univ Wurzburg, Dept Neurol, Sect Dev Neurobiol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	rudolf.martini@uni-wuerzburg.de	Ip, Chi Wang/HCH-3822-2022; Edgar, Julia M/U-8456-2019	Ip, Chi Wang/0000-0003-0484-385X; Edgar, Julia M/0000-0002-3869-0962; Groh, Janos/0000-0002-7628-0163; Klein, Dennis/0000-0002-0476-445X; Martini, Rudolf/0000-0002-5463-5592	Gemeinnutzige Hertie Stiftung [1.01.1/07/12]; Fritz-Thyssen Foundation [10.07.2.152]; German Research Council [SFB581, TP A3]; University of Wuerzburg (IZKF) [A168]; Roman, Marga and Mareille Sobek Foundation; National Contest for Life (NCL, Hamburg)	Gemeinnutzige Hertie Stiftung; Fritz-Thyssen Foundation; German Research Council(German Research Foundation (DFG)); University of Wuerzburg (IZKF); Roman, Marga and Mareille Sobek Foundation; National Contest for Life (NCL, Hamburg)	This study was funded by the Gemeinnutzige Hertie Stiftung (1.01.1/07/12), Fritz-Thyssen Foundation (10.07.2.152), German Research Council (SFB581, TP A3), local funds of the University of Wuerzburg (IZKF; A168) and by the Roman, Marga and Mareille Sobek Foundation. Other projects of the laboratory of RM are supported by the National Contest for Life (NCL, Hamburg). The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; Deb C, 2009, J NEUROPATH EXP NEUR, V68, P1037, DOI 10.1097/NEN.0b013e3181b5417e; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Edgar JM, 2010, EMBO MOL MED, V2, P42, DOI 10.1002/emmm.200900057; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gobel K, 2010, GLIA, V58, P469, DOI 10.1002/glia.20938; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Haile Y, 2011, J IMMUNOL, V187, P4861, DOI 10.4049/jimmunol.1100943; Hawkes C, 2003, J COMP NEUROL, V458, P113, DOI 10.1002/cne.10578; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Ip CW, 2007, NEUROBIOL DIS, V25, P105, DOI 10.1016/j.nbd.2006.08.023; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Kroner A, 2010, AM J PATHOL, V176, P549, DOI 10.2353/ajpath.2010.090722; Kroner A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004405; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Melzer N, 2009, FASEB J, V23, P3659, DOI 10.1096/fj.09-136200; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Morfini G, 2007, P NATL ACAD SCI USA, V104, P2442, DOI 10.1073/pnas.0611231104; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Muller M, 2007, EXP NEUROL, V203, P55, DOI 10.1016/j.expneurol.2006.07.018; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; SMITH RS, 1980, J NEUROCYTOL, V9, P39, DOI 10.1007/BF01205226; Sobottka B, 2009, AM J PATHOL, V175, P1160, DOI 10.2353/ajpath.2009.090340; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Williams SK, 2011, AM J PATHOL, V178, P2823, DOI 10.1016/j.ajpath.2011.02.046; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	44	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42554	10.1371/journal.pone.0042554	http://dx.doi.org/10.1371/journal.pone.0042554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905147	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000307331100048
J	Liss, M; Daubert, D; Brunner, K; Kliche, K; Hammes, U; Leiherer, A; Wagner, R				Liss, Michael; Daubert, Daniela; Brunner, Kathrin; Kliche, Kristina; Hammes, Ulrich; Leiherer, Andreas; Wagner, Ralf			Embedding Permanent Watermarks in Synthetic Genes	PLOS ONE			English	Article							OPTIMIZATION; CELLS	As synthetic biology advances, labeling of genes or organisms, like other high-value products, will become important not only to pinpoint their identity, origin, or spread, but also for intellectual property, classification, bio-security or legal reasons. Ideally information should be inseparably interlaced into expressed genes. We describe a method for embedding messages within open reading frames of synthetic genes by adapting steganographic algorithms typically used for watermarking digital media files. Text messages are first translated into a binary string, and then represented in the reading frame by synonymous codon choice. To aim for good expression of the labeled gene in its host as well as retain a high degree of codon assignment flexibility for gene optimization, codon usage tables of the target organism are taken into account. Preferably amino acids with 4 or 6 synonymous codons are used to comprise binary digits. Several different messages were embedded into open reading frames of T7 RNA polymerase, GFP, human EMG1 and HIV gag, variously optimized for bacterial, yeast, mammalian or plant expression, without affecting their protein expression or function. We also introduced Vigenere polyalphabetic substitution to cipher text messages, and developed an identifier as a key to deciphering codon usage ranking stored for a specific organism within a sequence of 35 nucleotides.	[Liss, Michael; Daubert, Daniela; Brunner, Kathrin; Kliche, Kristina; Wagner, Ralf] Life Technol Geneart AG, Regensburg, Germany; [Hammes, Ulrich] Univ Regensburg, Dept Cell Biol & Plant Physiol, Regensburg, Germany; [Leiherer, Andreas; Wagner, Ralf] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany	Thermo Fisher Scientific; University of Regensburg; University of Regensburg	Liss, M (corresponding author), Life Technol Geneart AG, Regensburg, Germany.	michael.liss@lifetech.com	Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Hammes, Ulrich/0000-0002-3663-4908	Bundesministerium fuer Bildung und Forschung [0313687]; Deutsche Forschungsgemeinschaft [HA3468/4-1]	Bundesministerium fuer Bildung und Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Assessment of HIV-1 infectivity and long-term replication kinetics was funded by the Bundesministerium fuer Bildung und Forschung, grant 0313687. Tobacco leaf transfection and analysis was funded by the Deutsche Forschungsgemeinschaft, grant HA3468/4-1. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2004, BIOTECHNOL PROGR, V20, P1605, DOI 10.1021/bp049917i; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Heider D, 2009, BMC RES NOTES, V2, pe125; Heider D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-40; Heider D, 2008, BIOINFORMATICS, V24, P1961, DOI 10.1093/bioinformatics/btn342; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Shimanovsky B, 2003, LECT NOTES COMPUT SC, V2578, P373; Wong PC, 2003, COMMUN ACM, V46, P95, DOI 10.1145/602421.602426	17	46	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42465	10.1371/journal.pone.0042465	http://dx.doi.org/10.1371/journal.pone.0042465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905136	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100040
J	Natalello, A; Ami, D; Collini, M; D'Alfonso, L; Chirico, G; Tonon, G; Scaramuzza, S; Schrepfer, R; Doglia, SM				Natalello, Antonino; Ami, Diletta; Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe; Tonon, Giancarlo; Scaramuzza, Silvia; Schrepfer, Rodolfo; Doglia, Silvia Maria			Biophysical Characterization of Met-G-CSF: Effects of Different Site-Specific Mono-Pegylations on Protein Stability and Aggregation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TRANSFORM INFRARED-SPECTROSCOPY; CONFORMATIONAL STABILITY; CIRCULAR-DICHROISM; FLUORESCENCE; CONJUGATION; FILGRASTIM; DYNAMICS; PEG	The limited stability of proteins in vitro and in vivo reduces their conversion into effective biopharmaceuticals. To overcome this problem several strategies can be exploited, as the conjugation of the protein of interest with polyethylene glycol, in most cases, improves its stability and pharmacokinetics. In this work, we report a biophysical characterization of the non-pegylated and of two different site-specific mono-pegylated forms of recombinant human methionyl-granulocyte colony stimulating factor (Met-G-CSF), a protein used in chemotherapy and bone marrow transplantation. In particular, we found that the two mono-pegylations of Met-G-CSF at the N-terminal methionine and at glutamine 135 increase the protein thermal stability, reduce the aggregation propensity, preventing also protein precipitation, as revealed by circular dichroism (CD), Fourier transform infrared (FTIR), intrinsic fluorescence spectroscopies and dynamic light scattering (DLS). Interestingly, the two pegylation strategies were found to drastically reduce the polydispersity of Met-G-CSF, when incubated under conditions favouring protein aggregation, as indicated by DLS measurements. Our in vitro results are in agreement with preclinical studies, underlining that preliminary biophysical analyses, performed in the early stages of the development of new biopharmaceutical variants, might offer a useful tool for the identification of protein variants with improved therapeutic values.	[Natalello, Antonino; Ami, Diletta; Doglia, Silvia Maria] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Natalello, Antonino; Ami, Diletta; Doglia, Silvia Maria] UdR Milano Bicocca, Consorzio Nazl Interuniv Sci Fis Mat CNISM, Milan, Italy; [Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe] Univ Milano Bicocca, Dept Phys, Milan, Italy; [Tonon, Giancarlo] IRCSS Multimed, Milan, Italy; [Scaramuzza, Silvia; Schrepfer, Rodolfo] Bioker Srl, Pula, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Natalello, A (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	diletta.ami@unimib.it	Natalello, Antonino/B-9659-2012; D'Alfonso, Laura/J-4193-2012	Natalello, Antonino/0000-0002-1489-272X; D'Alfonso, Laura/0000-0002-7378-4462; CHIRICO, Giuseppe/0000-0001-6578-6460; Ami, Diletta/0000-0003-4549-8300	FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy); University of Milano-Bicocca	FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy); University of Milano-Bicocca	SMD and GC acknowledge the financial support of the FAR (Fondo di Ateneo per la Ricerca) of the University of Milano-Bicocca (Italy). DA acknowledges a postdoctoral fellowship of the University of Milano-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bloomfield VA, 1985, DYNAMIC LIGHT SCATTE, P363; Chirico G, 1999, J CHEM PHYS, V110, P2297, DOI 10.1063/1.477883; FRAMPTON JE, 1994, DRUGS, V48, P731, DOI 10.2165/00003495-199448050-00007; Garidel Patrick, 2008, Biotechnology Journal, V3, P1201, DOI 10.1002/biot.200800091; Hao Y, 2006, BIODRUGS, V20, P357, DOI 10.2165/00063030-200620060-00006; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Kazakov AS, 2009, BIOPHYS CHEM, V145, P79, DOI 10.1016/j.bpc.2009.09.003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; PERMYAKOV EA, 1984, BIOPHYS CHEM, V19, P265, DOI 10.1016/0301-4622(84)87009-X; Pozzuolo S, 2008, PROTEIN EXPRES PURIF, V59, P334, DOI 10.1016/j.pep.2008.02.018; Rajan RS, 2006, PROTEIN SCI, V15, P1063, DOI 10.1110/ps.052004006; Salmaso S, 2009, BIOCONJUGATE CHEM, V20, P1179, DOI 10.1021/bc9000432; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; SHIRAFUJI N, 1989, EXP HEMATOL, V17, P116; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Thirumangalathu R, 2006, J PHARM SCI-US, V95, P1480, DOI 10.1002/jps.20619; Vazquez E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-60; Veronese FM, 2007, BIOCONJUGATE CHEM, V18, P1824, DOI 10.1021/bc070123+; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; ZINK T, 1994, BIOCHEMISTRY-US, V33, P8453, DOI 10.1021/bi00194a009	32	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42511	10.1371/journal.pone.0042511	http://dx.doi.org/10.1371/journal.pone.0042511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905140	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100044
J	Pelullo, CP; Di Giuseppe, G; Angelillo, IF				Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.			Human Papillomavirus Infection: Knowledge, Attitudes, and Behaviors among Lesbian, Gay Men, and Bisexual in Italy	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ANAL HPV INFECTION; PARENTAL ACCEPTANCE; VACCINATION; SEX; WOMEN; ADOLESCENTS; PREVENTION; CANCER; RISK	Background: This cross-sectional study assess knowledge, attitudes, and behavior towards the human papillomavirus (HPV) and the vaccination among a random sample of 1000 lesbian, gay men, and bisexual women and men. Methods: A face-to-face interview sought information about: socio-demographic characteristics, knowledge about HPV infection, perception of risk towards HPV infection and/or cervical, anal, and oropharyngeal cancers, perception of the benefits of a vaccination to prevent cervical, anal, and oropharyngeal cancers, sexual behaviors, health-promoting behaviors, and willingness to receive the HPV vaccine. Results: Only 60.6% had heard about the HPV infection and this knowledge was significantly higher in female, in those being a member of a homosexual association, in those having had the first sexual experience at a younger age, in those having received information about the HPV infection from physicians, and in those having no need of information about HPV infection. A higher perceived risk of contracting HPV infection has been observed in those younger, lesbian and gay men, who have heard of HPV infection and knew the risk factors and its related diseases, who have received information about HPV infection from physicians, and who need information about HPV infection. Only 1.7% have undergone HPV immunization and 73.3% professed intent to obtain it in the future. The significant predictors of the willingness to receive this vaccine were belief that the vaccination is useful, perception to be at higher risk of contracting HPV infection, and perception to be at higher risk of developing cervical, anal, and oropharyngeal cancers. Conclusions: Information and interventions are strongly needed in order to overcome the lack of knowledge about HPV infection and its vaccination. Inclusion of boys in the national vaccination program and initiate a catch-up program for men who have sex with men up to 26 years may reduce their burden of HPV-related disease.	[Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Pelullo, CP (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683	Second University of Naples (Naples, Italy)	Second University of Naples (Naples, Italy)	This study was supported by a research grant from the Second University of Naples (Naples, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer NT, 2010, J BEHAV MED, V33, P274, DOI 10.1007/s10865-010-9251-2; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Davis KC, 2012, HLTH ED BEH IN PRESS; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Dietz CA, 2011, J AM OSTEOPATH ASSOC, V111, pS19; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gilbert PA, 2011, J LOW GENIT TRACT DI, V15, P83, DOI 10.1097/LGT.0b013e3181f1a960; Gold J, 2011, SEX HEALTH, V8, P234, DOI 10.1071/SH10082; Heck JE, 2010, INT J EPIDEMIOL, V39, P166, DOI 10.1093/ije/dyp350; Heiligenberg M, 2010, SEX TRANSM DIS, V37, P672, DOI 10.1097/OLQ.0b013e3181e71069; Helme DW, 2011, HEALTH COMMUN, V26, P366, DOI 10.1080/10410236.2010.551582; IARC Human papillomaviruses, 2011, IARC MONOGR EVAL C B, V100, P1; Jaspers L, 2011, VACCINE, V29, P7785, DOI 10.1016/j.vaccine.2011.07.107; Kahn JA, 2009, CANCER EPIDEM BIOMAR, V18, P2325, DOI 10.1158/1055-9965.EPI-09-0184; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; McNair R, 2009, AUST NZ J PUBL HEAL, V33, P87, DOI 10.1111/j.1753-6405.2009.00345.x; Miksis S, 2008, JOGNN-J OBST GYN NEO, V37, P329, DOI 10.1111/j.1552-6909.2008.00236.x; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Pitts MK, 2007, SEX TRANSM DIS, V34, P170, DOI 10.1097/01.olq.0000230436.83029.ce; Reiter PL, 2010, SEX TRANSM DIS, V37, P197, DOI 10.1097/OLQ.0b013e3181bf542c; Sam IC, 2009, J ADOLESCENT HEALTH, V44, P610, DOI 10.1016/j.jadohealth.2008.11.014; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trani F, 2006, J INFECTION, V52, P269, DOI 10.1016/j.jinf.2005.06.010; Trani F, 2005, J PAEDIATR CHILD H, V41, P260, DOI 10.1111/j.1440-1754.2005.00607.x; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006; Weiss TW, 2010, J ADOLESCENT HEALTH, V47, P3, DOI 10.1016/j.jadohealth.2010.03.003; Wheldon CW, 2011, VACCINE, V29, P8060, DOI 10.1016/j.vaccine.2011.08.045; Wilson DP, 2010, CLIN TRIALS, V7, P36, DOI 10.1177/1740774509355177; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	36	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42856	10.1371/journal.pone.0042856	http://dx.doi.org/10.1371/journal.pone.0042856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986GX	22905178	Green Published, gold, Green Submitted			2022-12-25	WOS:000307331100070
J	Simon-Areces, J; Dietrich, MO; Hermes, G; Garcia-Segura, LM; Arevalo, MA; Horvath, TL				Simon-Areces, Julia; Dietrich, Marcelo O.; Hermes, Gretchen; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles; Horvath, Tamas L.			Ucp2 Induced by Natural Birth Regulates Neuronal Differentiation of the Hippocampus and Related Adult Behavior	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 PROTECTS; MECHANISM; SUPEROXIDE; BRAIN; MOUSE; DEATH	Mitochondrial uncoupling protein 2 (UCP2) is induced by cellular stress and is involved in regulation of fuel utilization, mitochondrial bioenergetics, cell proliferation, neuroprotection and synaptogenesis in the adult brain. Here we show that natural birth in mice triggers UCP2 expression in hippocampal neurons. Chemical inhibition or genetic ablation of UCP2 lead to diminished neuronal number and size, dendritic growth and synaptogenezis in vitro and impaired complex behaviors in the adult. These data reveal a critical role for Ucp2 expression in the development of hippocampal neurons and circuits and hippocampus-related adult behaviors.	[Simon-Areces, Julia; Miguel Garcia-Segura, Luis; Arevalo, Maria-Angeles] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Dietrich, Marcelo O.; Hermes, Gretchen; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06510 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Yale University; Universidade Federal do Rio Grande do Sul; Yale University; Yale University	Simon-Areces, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	tamas.horvath@yale.edu	Garcia-Segura, Luis M/U-3711-2017; Arevalo, Maria-Angeles/J-7000-2014; Dietrich, Marcelo/A-9928-2009	Garcia-Segura, Luis M/0000-0002-2450-2916; Arevalo, Maria-Angeles/0000-0002-4303-9576; Dietrich, Marcelo/0000-0001-9781-2221	NIH Director's Pioneer Award [DP1OD006850]; NIH [DK080000, DK 060711]; ADA [7-08-MN-25]; Ministerio de Ciencia e Innovacion, Spain [BFU2008-02950-C03-01]; Comunidad de Madrid [CCG08-CSIC/SAL-3617]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711, R01DK080000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge support from the NIH Director's Pioneer Award (DP1OD006850), NIH grants DK080000, DK 060711 and ADA 7-08-MN-25 to T.L.H; the Ministerio de Ciencia e Innovacion, Spain (BFU2008-02950-C03-01) and from Comunidad de Madrid (CCG08-CSIC/SAL-3617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Deierborg T, 2008, J CEREBR BLOOD F MET, V28, P1186, DOI 10.1038/jcbfm.2008.8; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Horvath B, 2002, BIOCHEM PHARMACOL, V64, P369, DOI 10.1016/S0006-2952(02)01167-X; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	20	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42911	10.1371/journal.pone.0042911	http://dx.doi.org/10.1371/journal.pone.0042911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905184	gold, Green Submitted, Green Published			2022-12-25	WOS:000307331100074
J	Saito, T; Okada, S; Nohara, A; Tagaya, Y; Osaki, A; Oh-i, S; Takahashi, H; Tsuchiya, T; Hashimoto, K; Satoh, T; Yamada, M; Pessin, JE; Mori, M				Saito, Tsugumichi; Okada, Shuichi; Nohara, Atsushi; Tagaya, Yuko; Osaki, Aya; Oh-i, Shinsuke; Takahashi, Hiroki; Tsuchiya, Takafumi; Hashimoto, Koshi; Satoh, Tetsurou; Yamada, Masanobu; Pessin, Jeffrey E.; Mori, Masatomo			Syntaxin4 Interacting Protein (Synip) Binds Phosphatidylinositol (3,4,5) Triphosphate	PLOS ONE			English	Article							STIMULATED GLUCOSE-TRANSPORT; WW DOMAIN; KINASE-C; GLUT4-CONTAINING VESICLES; INSULIN ACTION; ADIPOCYTES; GLUT4; COMPARTMENTALIZATION; PHOSPHOSERINE; MECHANISM	The insulin responsive Glut4 transport vesicles contain the v-SNARE protein Vamp2 that associate with the plasma membrane t-SNARE protein Syntaxin 4 to drive insulin-stimulated Glut4 translocation in skeletal muscle and adipocytes. The syntaxin 4 interacting protein (Synip) binds to syntaxin 4 in the basal state and dissociates in the insulin-stimulated state allowing for the subsequent binding of Vamp2 containing Glut4 vesicles and fusion with the plasma membrane. In this study, we have found that Synip binds phosphatidylinositol 3,4,5-triphosphate (PIP3), but not phosphatidylinositol 3 phosphate (PIP) or phosphatidylinositol 3,4-biphosphate (PIP2) through the Synip WW domain as deletion of this domain (Synip Delta WW) failed to bind PIP3. Over-expressed Synip Delta WW in 3T3L1 adipocytes reduced the basal levels of Glut4 at the plasma membrane with no effect on the binding to syntaxin 4 in vitro. Subcellular fractionation demonstrated that the amount of Synip Delta WW at the PM was decreased in response to insulin in 3T3L1 adipocytes whereas the amount of Synip WT increased. These data suggest that in the presence of insulin, the dissociated Synip remains anchored to the plasma membrane by binding to PIP3.	[Saito, Tsugumichi; Okada, Shuichi; Nohara, Atsushi; Tagaya, Yuko; Osaki, Aya; Oh-i, Shinsuke; Takahashi, Hiroki; Tsuchiya, Takafumi; Hashimoto, Koshi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10467 USA	Gunma University; Yeshiva University; Albert Einstein College of Medicine	Saito, T (corresponding author), Gunma Univ, Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 371, Japan.	tsaito@med.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	National Institutes of Health [DK082694, DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK082694, P30DK020541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK082694 and DK020541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; FARESE RV, 1984, DIABETES, V33, P648, DOI 10.2337/diabetes.33.7.648; Farese RV, 2005, EXP BIOL MED, V230, P593; He J, 2008, J LIPID RES, V49, P1807, DOI 10.1194/jlr.M800150-JLR200; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Lauritzen HPMM, 2008, DIABETES, V57, P13, DOI 10.2337/db07-0516; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; SANDRA A, 1982, HORM METAB RES, V14, P638, DOI 10.1055/s-2007-1019106; SANDRA A, 1985, ENDOCR RES, V11, P95, DOI 10.3109/07435808509035428; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Siddle Kenneth, 1992, Progress in Growth Factor Research, V4, P301, DOI 10.1016/0955-2235(92)90013-8; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Watson RT, 2001, EXP CELL RES, V271, P75, DOI 10.1006/excr.2001.5375; WHITE MF, 1994, J BIOL CHEM, V269, P1; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42782	10.1371/journal.pone.0042782	http://dx.doi.org/10.1371/journal.pone.0042782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880106	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100170
J	Vega, CG; Bok, M; Vlasova, AN; Chattha, KS; Fernandez, FM; Wigdorovitz, A; Parreno, VG; Saif, LJ				Vega, Celina G.; Bok, Marina; Vlasova, Anastasia N.; Chattha, Kuldeep S.; Fernandez, Fernando M.; Wigdorovitz, Andres; Parreno, Viviana G.; Saif, Linda J.			IgY Antibodies Protect against Human Rotavirus Induced Diarrhea in the Neonatal Gnotobiotic Piglet Disease Model	PLOS ONE			English	Article							EGG-YOLK IMMUNOGLOBULIN; SECRETING CELL RESPONSES; VIRUS-LIKE PARTICLES; WA HUMAN ROTAVIRUS; IMMUNE-RESPONSES; BOVINE ROTAVIRUS; MATERNAL ANTIBODIES; NASAL IMMUNIZATION; CLINICAL-TRIAL; NEWBORN CALVES	Group A Rotaviruses are the most common cause of severe, dehydrating diarrhea in children worldwide. The aim of the present work was to evaluate protection against rotavirus (RV) diarrhea conferred by the prophylactic administration of specific IgY antibodies (Ab) to gnotobiotic piglets experimentally inoculated with virulent Wa G1P[8] human rotavirus (HRV). Chicken egg yolk IgY Ab generated from Wa HRV hyperimmunized hens specifically recognized (ELISA) and neutralized Wa HRV in vitro. Supplementation of the RV Ab free cow milk diet with Wa HRV-specific egg yolk IgY Ab at a final ELISA Ab titer of 4096 (virus neutralization -VN- titer = 256) for 9 days conferred full protection against Wa HRV associated diarrhea and significantly reduced virus shedding. This protection was dose-dependent. The oral administration of semi-purified passive IgY Abs from chickens did not affect the isotype profile of the pig Ab secreting cell (ASC) responses to Wa HRV infection, but it was associated with significantly fewer numbers of HRV-specific IgA ASC in the duodenum. We further analyzed the pigs immune responses to the passive IgY treatment. The oral administration of IgY Abs induced IgG Ab responses to chicken IgY in serum and local IgA and IgG Ab responses to IgY in the intestinal contents of neonatal piglets in a dose dependent manner. To our knowledge, this is the first study to show that IgY Abs administered orally as a milk supplement passively protect neonatal pigs against an enteric viral pathogen (HRV). Piglets are an animal model with a gastrointestinal physiology and an immune system that closely mimic human infants. This strategy can be scaled-up to inexpensively produce large amounts of polyclonal IgY Abs from egg yolks to be applied as a preventive and therapeutic passive Ab treatment to control RV diarrhea.	[Vega, Celina G.; Bok, Marina; Fernandez, Fernando M.; Wigdorovitz, Andres; Parreno, Viviana G.] CICV & A INTA Castelar, Inst Virol, Buenos Aires, DF, Argentina; [Vlasova, Anastasia N.; Chattha, Kuldeep S.; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	Instituto Nacional de Tecnologia Agropecuaria (INTA); University System of Ohio; Ohio State University	Vega, CG (corresponding author), CICV & A INTA Castelar, Inst Virol, Buenos Aires, DF, Argentina.	vparreno@cnia.inta.gov.ar; saif.2@osu.edu	Saif, Linda/E-4005-2011; Vlasova, Anastasia N/C-2062-2016	Vlasova, Anastasia N/0000-0002-1447-6283; parreno, viviana/0000-0003-0385-5592; Vega, Celina/0000-0002-0644-7263; Bok, Marina/0000-0003-4309-8629	International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB) [R03]; Fogarty Foundation; National Institutes of Health, USA; FIRCA [60014561]	International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by an International Research Collaboration - Basic Biomedical-Fogarty International Research Collaboration - Basic Biomedical (FIRCA-BB) (R03); the Fogarty Foundation, National Institutes of Health, USA; and FIRCA grant no. 60014561, PI to LJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita EM, 1999, FOOD AGR IMMUNOL, V11, P191, DOI 10.1080/09540109999861; Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; BERNHISELBROADBENT J, 1991, PEDIATRICS, V87, P208; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cornaglia E, 1989, REV LATINOAM MICROBI, P59; Coste A, 2000, J VIROL, V74, P8966, DOI 10.1128/JVI.74.19.8966-8971.2000; Coste A, 2001, VACCINE, V19, P4167, DOI 10.1016/S0264-410X(01)00164-5; Dean KL, 2000, ALTERNATIVE COMPLEME, P118; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Desselberger U, 2011, J INFECT DIS, V203, P188, DOI 10.1093/infdis/jiq031; Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x; El-Merhibi A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/396232; Estes M. K., 2001, FIELDS VIROLOGY; Fernandez FM, 1998, VACCINE, V16, P507, DOI 10.1016/S0264-410X(97)80004-7; Fleming FE, 2007, ARCH VIROL, V152, P1087, DOI 10.1007/s00705-007-0937-x; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Franco MA, 2000, TRENDS MICROBIOL, V8, P50, DOI 10.1016/S0966-842X(99)01682-0; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; HATTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1077, DOI 10.1271/bbb.57.1077; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; Inagaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P680, DOI 10.1271/bbb.90862; Iosef C, 2002, VACCINE, V20, P1741, DOI 10.1016/S0264-410X(02)00031-2; Jacoby H. I., 2001, Journal of Nutraceuticals, Functional & Medical Foods, V3, P47, DOI 10.1300/J133v03n02_05; Jensen AR, 2001, J NUTR, V131, P3259, DOI 10.1093/jn/131.12.3259; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Littell RC, 1998, J ANIM SCI, V76, P1216; LOSONSKY GA, 1986, J CLIN MICROBIOL, V24, P1041, DOI 10.1128/JCM.24.6.1041-1044.1986; MEYER RC, 1964, APPL MICROBIOL, V12, P295, DOI 10.1128/AEM.12.4.295-300.1964; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Nelson R, 2007, FOOD AGR IMMUNOL, V18, P1, DOI 10.1080/09540100601178623; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parreno V, 2010, VET IMMUNOL IMMUNOP, V136, P12, DOI 10.1016/j.vetimm.2010.01.003; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Patel NC, 2010, NEW ENGL J MED, V362, P314, DOI 10.1056/NEJMoa0904485; Rahman S, 2012, VACCINE, V30, P4661, DOI 10.1016/j.vaccine.2012.04.091; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Sarker SA, 2007, J HEALTH POPUL NUTR, V25, P465; Schade K, 2005, ATLA-ALTERN LAB ANIM, V33, P129, DOI 10.1177/026119290503300208; SCHADE R, 1996, ALTEX, V13, P80; SCHADE R, 1996, ALTEX S, V13, P5; Schade Rudiger, 1994, ALTEX, V11, P75; Sesarman A, 2008, BRIT J DERMATOL, V158, P463, DOI 10.1111/j.1365-2133.2007.08388.x; Stupka JA, 2009, INFECT GENET EVOL, V9, P1225, DOI 10.1016/j.meegid.2009.07.002; Tini M, 2002, COMP BIOCHEM PHYS A, V131, P569, DOI 10.1016/S1095-6433(01)00508-6; Torche AM, 2006, VET IMMUNOL IMMUNOP, V109, P209, DOI 10.1016/j.vetimm.2005.08.016; TOSSER G, 1994, VIROLOGY, V204, P8, DOI 10.1006/viro.1994.1505; Vega C, 2011, VET IMMUNOL IMMUNOP, V142, P156, DOI 10.1016/j.vetimm.2011.05.003; Westfall PH, 1999, MULTIPLE COMP MULTIP; Wolfinger R., 1998, COMP SAS GLM MIXED P; Xu YP, 2006, CELL MOL IMMUNOL, V3, P67; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6	63	45	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42788	10.1371/journal.pone.0042788	http://dx.doi.org/10.1371/journal.pone.0042788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880110	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100173
J	Zhang, DQ; Belenky, MA; Sollars, PJ; Pickard, GE; McMahon, DG				Zhang, Dao-Qi; Belenky, Michael A.; Sollars, Patricia J.; Pickard, Gary E.; McMahon, Douglas G.			Melanopsin Mediates Retrograde Visual Signaling in the Retina	PLOS ONE			English	Article							INNER PLEXIFORM LAYER; GANGLION-CELLS; DOPAMINERGIC-NEURONS; BIPOLAR CELLS; MOUSE RETINA; AXON COLLATERALS; DENDRITES; SYNAPSES; VISION; INPUT	The canonical flow of visual signals proceeds from outer to inner retina (photoreceptors -> bipolar cells -> ganglion cells). However, melanopsin-expressing ganglion cells are photosensitive and functional sustained light signaling to retinal dopaminergic interneurons persists in the absence of rods and cones. Here we show that the sustained-type light response of retinal dopamine neurons requires melanopsin and that the response is mediated by AMPA-type glutamate receptors, defining a retrograde retinal visual signaling pathway that fully reverses the usual flow of light signals in retinal circuits.	[Zhang, Dao-Qi] Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA; [Belenky, Michael A.] Hebrew Univ Jerusalem, Dept Cell & Anim Biol, Jerusalem, Israel; [Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Pickard, Gary E.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA; [McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Oakland University; Hebrew University of Jerusalem; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; Vanderbilt University	Zhang, DQ (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA.	zhang@oakland.edu; douglas.g.mcmahon@vanderbilt.edu			NIH [R01 EY09256, R01 EY017809]; Vanderbilt Vision Core Grant [P30 EY008126]; Oakland University Research Excellent Fund; Midwest Eye Bank Research Grant Award; NATIONAL EYE INSTITUTE [R01EY017809, P30EY008126, R01EY009256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Vision Core Grant; Oakland University Research Excellent Fund; Midwest Eye Bank Research Grant Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by NIH R01 EY09256 to DGM, the Vanderbilt Vision Core Grant P30 EY008126, NIH R01 EY017809 to PJS and GEP, Oakland University Research Excellent Fund and Midwest Eye Bank Research Grant Award to D-QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Contini M, 2010, J COMP NEUROL, V518, P2035, DOI 10.1002/cne.22320; DACEY DM, 1985, J COMP NEUROL, V242, P247, DOI 10.1002/cne.902420207; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; DOWLING JE, 1978, PROC R SOC SER B-BIO, V201, P7, DOI 10.1098/rspb.1978.0030; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Grimes WN, 2012, VISUAL NEUROSCI, V29, P41, DOI 10.1017/S0952523811000241; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Peterson BB, 1998, VISUAL NEUROSCI, V15, P377, DOI 10.1017/S0952523898152161; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; SAKAI HM, 1986, NATURE, V319, P495, DOI 10.1038/319495a0; Thoreson WB, 2012, PROGR RETINAL EYE RE, P1; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41	22	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42647	10.1371/journal.pone.0042647	http://dx.doi.org/10.1371/journal.pone.0042647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880066	Green Published, gold			2022-12-25	WOS:000307284100150
J	Chan, ME; Adler, BJ; Green, DE; Rubin, CT				Chan, M. Ete; Adler, Benjamin J.; Green, Danielle E.; Rubin, Clinton T.			Bone structure and B-cell populations, crippled by obesity, are partially rescued by brief daily exposure to low-magnitude mechanical signals	FASEB JOURNAL			English	Article						adiposity; diabetes	RESISTANT ACID-PHOSPHATASE; HIGH-FREQUENCY; POSTMENOPAUSAL WOMEN; VISCERAL ADIPOSITY; RISK-FACTORS; DIET; FAT; MASS; OSTEOCLASTOGENESIS; EXERCISE	Deterioration of the immune and skeletal systems, each of which parallel obesity, reflects a fragile interrelationship between adiposity and osteo-immunology. Using a murine model of diet-induced obesity, this study investigated the ability of mechanical signals to protect the skeletal-immune systems at the tissue, cellular, and molecular level. A long-term (7 mo) high-fat diet increased total adiposity (+62%), accelerated age-related loss of trabecular bone (-61%), and markedly reduced B-cell number in the marrow (-52%) and blood (-36%) compared to mice fed a regular diet. In the final 4 mo of the protocol, the application of low-magnitude mechanical signals (0.2 g at 90 Hz, 15 min/d, 5 d/wk) restored both bone structure and B cells to those levels measured in control mice fed a regular diet. These phenotypic outcomes were achieved, in part, by reductions in osteoclastic activity and a biasing of hematopoietic stem cell differentiation toward the lymphoid B-cell lineage and away from a myeloid fate. These results emphasize that obesity undermines both the skeletal and immune systems, yet brief exposure to mechanical signals, perhaps as a surrogate to the salutary influence of exercise, diminishes the consequences of diabetes and obesity, restoring bone structure and normalizing B-cell populations by biasing of the fate of stem cells through mechanosensitive pathways.-Chan, M. E., Adler, B. J., Green, D. E., Rubin, C. T. Bone structure and B-cell populations, crippled by obesity, are partially rescued by brief daily exposure to low-magnitude mechanical signals. FASEB J. 26, 4855-4863 (2012). www.fasebj.org	[Chan, M. Ete; Adler, Benjamin J.; Green, Danielle E.; Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	clinton.rubin@sunysb.edu			U.S. National Institutes of Health through National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR043498]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043498] Funding Source: NIH RePORTER	U.S. National Institutes of Health through National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health through National Institute of Arthritis and Musculoskeletal and Skin Diseases grant AR043498. The authors are grateful for the help from Gunes Uzer, Ada Tsoi, Mario Botros, Elizabeth Fievisohn, Michelle Cheung, Kim Kawatra, and Engin Ozcivici for their technical assistance related to this project. Conflict of interest: C. T. R. is a founder of Marodyne Medical, Inc. (Lakeland, FL, USA) and has a U. S. Patent and Trademark Office application under review for the ability of mechanical signals to control metabolic disorders. The other authors declare no conflicts of interest.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Barbeau P, 2007, OBESITY, V15, P2077, DOI 10.1038/oby.2007.247; Blair HC, 1998, BIOESSAYS, V20, P837, DOI 10.1002/(SICI)1521-1878(199810)20:10<837::AID-BIES9>3.0.CO;2-D; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; CREVEL RWR, 1992, BRIT J NUTR, V67, P17, DOI 10.1079/BJN19920005; DILSEN G, 1989, Clinical Rheumatology, V8, P70, DOI 10.1007/BF02207238; DODDS RA, 1995, J BONE MINER RES, V10, P1666; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Ferguson V L, 1999, Biomed Sci Instrum, V35, P85; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gutin B, 2008, OBESITY, V16, P2193, DOI 10.1038/oby.2008.348; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Haffner SM, 2007, AM J MED, V120, P16; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hollberg K, 2002, EXP CELL RES, V279, P227, DOI 10.1006/excr.2002.5612; Horowitz MC, 2004, J IMMUNOL, V173, P6583, DOI 10.4049/jimmunol.173.11.6583; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Judex S, 2010, J MUSCULOSKEL NEURON, V10, P3; Judex S, 2010, METHODS, V50, P14, DOI 10.1016/j.ymeth.2009.05.017; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; LINDUNGER A, 1990, BONE MINER, V10, P109, DOI 10.1016/0169-6009(90)90086-U; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; Lublinsky S, 2009, J DIGIT IMAGING, V22, P222, DOI 10.1007/s10278-008-9152-x; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Rourke RW, 2005, OBES SURG, V15, P1463, DOI 10.1381/096089205774859308; Ominsky MS, 2011, BONE, V49, P162, DOI 10.1016/j.bone.2011.04.001; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Pan X, 1995, Zhonghua Nei Ke Za Zhi, V34, P108; Patsch JM, 2011, METABOLISM, V60, P243, DOI 10.1016/j.metabol.2009.11.023; Premaor MO, 2011, J CLIN ENDOCR METAB, V96, P2414, DOI 10.1210/jc.2011-0076; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rosen CJ, 2009, AM J MED, V122, P409, DOI 10.1016/j.amjmed.2008.11.027; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Russell M, 2010, J CLIN ENDOCR METAB, V95, P1247, DOI 10.1210/jc.2009-1475; Sato-Mito N, 2009, J NUTR HEALTH AGING, V13, P602, DOI 10.1007/s12603-009-0170-2; Sen B, 2011, STEM CELLS, V29, P1829, DOI 10.1002/stem.732; Slatkovska L., 2011, ANN INTERN MED, V155, pW205; Slatkovska L, 2011, ANN INTERN MED, V155, P668, DOI 10.7326/0003-4819-155-10-201111150-00005; Song I, 2009, FEBS LETT, V583, P2435, DOI 10.1016/j.febslet.2009.06.047; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Thivel D, 2011, PHYSIOL BEHAV, V102, P132, DOI 10.1016/j.physbeh.2010.10.011; Tolomio S, 2010, J WOMEN AGING, V22, P241, DOI 10.1080/08952841.2010.518866; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Zhou QD, 2011, P NATL ACAD SCI USA, V108, P2867, DOI 10.1073/pnas.1019270108	59	46	49	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					4855	4863		10.1096/fj.12-209841	http://dx.doi.org/10.1096/fj.12-209841			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22898923	Green Published			2022-12-25	WOS:000311838300009
J	Proffitt, KD; Virshup, DM				Proffitt, Kyle D.; Virshup, David M.			Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL DERMAL HYPOPLASIA; POLARITY GENE PORCUPINE; TRANSMEMBRANE PROTEIN; PORCN MUTATIONS; P24 PROTEINS; SECRETION; PATHWAY; GASTRULATION; CANCER; CELLS	Gradients of diverse Wnt proteins regulate development, renewal, and differentiation. Porcupine (PORCN) is a membrane-bound O-acyltransferase that is required for post-translational modification of all Wnts to enable their transport, secretion, and activity. Mutations in PORCN are associated with focal dermal hypoplasia (FDH), whereas gene deletion causes embryonic lethality in mice. To study the protein in more detail, zinc finger nucleases were used to edit the PORCN genomic locus, establishing two HT1080 fibrosarcoma clones null for PORCN activity that facilitate the study of PORCN structure and function. We establish that PORCN is a key non-redundant node for the regulation of global Wnt signaling because PORCN null cells are completely incapable of autocrine Wnt signaling. The strength of Wnt signaling is exquisitely sensitive to PORCN expression, with a dynamic range of at least 3 orders of magnitude, suggesting that PORCN activity is a key modulator of all Wnt ligand activity. Consistent with this, we find that multiple FDH-associated mutants have only subtle alterations in enzyme activity yet are associated with a severe FDH phenotype. These studies support an essential regulatory role of PORCN in shaping Wnt signaling gradients.	[Proffitt, Kyle D.; Virshup, David M.] Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, Singapore 169857, Singapore; [Virshup, David M.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Virshup, David M.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27705 USA	National University of Singapore; National University of Singapore; Duke University	Virshup, DM (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	Duke-NUS Signature Research Program; Agency for Science, Technology, and Research, Singapore; Ministry of Health, Singapore; Singapore Translational Research Investigator Award; National Research Foundation; National Medical Research Council	Duke-NUS Signature Research Program; Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); Singapore Translational Research Investigator Award; National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Duke-NUS Signature Research Program funded by the Agency for Science, Technology, and Research, Singapore, and the Ministry of Health, Singapore, and a Singapore Translational Research Investigator Award (to D. M. V.) funded by the National Research Foundation and the National Medical Research Council.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Bornholdt D, 2009, HUM MUTAT, V30, pE618, DOI 10.1002/humu.20992; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen QH, 2012, J CELL SCI, V125, P2224, DOI 10.1242/jcs.098368; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chen Z, 2008, ONCOGENE, V27, P3483, DOI 10.1038/sj.onc.1211006; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Fernandes PH, 2010, GENET TEST MOL BIOMA, V14, P709, DOI 10.1089/gtmb.2010.0089; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Harmsen MB, 2009, EUR J HUM GENET, V17, P1207, DOI 10.1038/ejhg.2009.40; Harterink M, 2012, ACTA PHYSIOL, V204, P8, DOI 10.1111/j.1748-1716.2011.02287.x; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032331; Lombardi MP, 2011, HUM MUTAT, V32, P723, DOI 10.1002/humu.21505; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vijayakumar S, 2011, CANCER CELL, V19, P601, DOI 10.1016/j.ccr.2011.03.010; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	51	82	87	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34167	34178		10.1074/jbc.M112.381970	http://dx.doi.org/10.1074/jbc.M112.381970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888000	Green Published, hybrid			2022-12-25	WOS:000309654200022
J	Yoon, YD; Zhang, XQ; Cho, WH				Yoon, Youngdae; Zhang, Xiuqi; Cho, Wonhwa			Phosphatidylinositol 4,5-Bisphosphate (PtdIns(4,5)P-2) Specifically Induces Membrane Penetration and Deformation by Bin/Amphiphysin/Rvs (BAR) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; DIFFERENTIAL SUBCELLULAR-LOCALIZATION; CYTOSOLIC PHOSPHOLIPASE A(2); MISSING-IN-METASTASIS; KINASE-C-ALPHA; PLASMA-MEMBRANE; STRUCTURAL BASIS; ACTIN CYTOSKELETON; INTERFACIAL CATALYSIS; ACTIVATION MECHANISMS	Cellular proteins containing Bin/amphiphysin/Rvs (BAR) domains play a key role in clathrin-mediated endocytosis. Despite extensive structural and functional studies of BAR domains, it is still unknown how exactly these domains interact with the plasma membrane containing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) and whether they function by a universal mechanism or by different mechanisms. Here we report that PtdIns(4,5)P-2 specifically induces partial membrane penetration of the N-terminal amphiphilic alpha-helix (H-0) of two representative N-BAR domains from Drosophila amphiphysin (dAmp-BAR) and rat endophilin A1 (EndoA1-BAR). Our quantitative fluorescence imaging analysis shows that PtdIns(4,5) P-2-dependent membrane penetration of H-0 is important for self-association of membrane-bound dAmp-BAR and EndoA1-BAR and their membrane deformation activity. EndoA1-BAR behaves differently from dAmp-BAR because the former has an additional amphiphilic alpha-helix that penetrates the membrane in a PtdIns(4,5)P-2-independent manner. Depletion of PtdIns(4,5)P-2 from the plasma membrane of HEK293 cells abrogated the membrane deforming activity of EndoA1-BAR and dAmp-BAR. Collectively, these studies suggest that the local PtdIns(4,5)P-2 concentration in the plasma membrane may regulate the membrane interaction and deformation by N-BAR domain-containing proteins during clathrin-mediated endocytosis.	[Yoon, Youngdae; Zhang, Xiuqi; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, WH (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			National Institutes of Health [GM68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Heath RJW, 2008, J CELL SCI, V121, P1951, DOI 10.1242/jcs.023895; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Lee BI, 1996, BIOCHEMISTRY-US, V35, P4231, DOI 10.1021/bi9524777; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yoon Y, 2011, NAT CHEM, V3, P868, DOI [10.1038/NCHEM.1163, 10.1038/nchem.1163]; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	71	32	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2012	287	41					34078	34090		10.1074/jbc.M112.372789	http://dx.doi.org/10.1074/jbc.M112.372789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	018IS	22888025	Green Published, hybrid			2022-12-25	WOS:000309654200014
J	Rusine, J; Jurriaans, S; van de Wijgert, J; Cornelissen, M; Kateera, B; Boer, K; Karita, E; Mukabayire, O; de Jong, M; Ondoa, P				Rusine, John; Jurriaans, Suzanne; van de Wijgert, Janneke; Cornelissen, Marion; Kateera, Brenda; Boer, Kimberly; Karita, Etienne; Mukabayire, Odette; de Jong, Menno; Ondoa, Pascale			Molecular and Phylogeographic Analysis of Human Immuno-deficiency Virus Type 1 Strains Infecting Treatment-naive Patients from Kigali, Rwanda	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; SUBTYPE C; GENETIC-ANALYSIS; HIV-INFECTIONS; AVIDITY INDEX; DIVERSITY; FITNESS; AFRICA; INDIVIDUALS; MUTATIONS	This study aimed at describing the genetic subtype distribution of HIV-1 strains circulating in Kigali and their epidemiological link with the HIV-1 strains from the five countries surrounding Rwanda. One hundred and thirty eight pol (RT and PR) sequences from 116 chronically-and 22 recently-infected antiretroviral therapy (ART)-naive patients from Kigali were generated and subjected to HIV drug resistance (HIV-DR), phylogenetic and recombinant analyses in connection with 366 reference pol sequences from Rwanda, Burundi, Kenya, Democratic Republic of Congo, Tanzania and Uganda (Los Alamos database). Among the Rwandan samples, subtype A1 predominated (71.7%), followed by A1/C recombinants (18.1%), subtype C (5.8%), subtype D (2.9%), one A1/D recombinant (0.7%) and one unknown subtype (0.7%). Thirteen unique and three multiple A1/C recombinant forms were identified. No evidence for direct transmission events was found within the Rwandan strains. Molecular characteristics of HIV-1 were similar between chronically and recently-infected individuals and were not significantly associated with demographic or social factors. Our report suggests that the HIV-1 epidemic in Kigali is characterized by the emergence of A1/C recombinants and is not phylogenetically connected with the HIV-1 epidemic in the five neighboring countries. The relatively low level of transmitted HIV-DR mutations (2.9%) reported here indicates the good performance of the ART programme in Rwanda. However, the importance of promoting couples' counseling, testing and disclosure during HIV prevention strategies is highlighted.	[Rusine, John; Mukabayire, Odette] Natl Reference Lab, Kigali, Rwanda; [Jurriaans, Suzanne; Cornelissen, Marion; de Jong, Menno] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Virol,AIGHD, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke; Kateera, Brenda; Boer, Kimberly; Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, NL-1105 AZ Amsterdam, Netherlands; [Kateera, Brenda; Boer, Kimberly] Infect Dis Network Treatment & Res Africa INTERAC, Kigali, Rwanda; [Kateera, Brenda; Boer, Kimberly] AIGHD, Epidemiol Unit, Royal Trop Inst KIT, Amsterdam, Netherlands; [Karita, Etienne] Projet San Francisco, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rusine, J (corresponding author), Natl Reference Lab, Kigali, Rwanda.	p.ondoa@aighd.org	Asiimwe-Kateera, Brenda/H-3378-2019	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) [W 07.05.201.00]; EuropAid [SANTE/2006/105-316]; International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_33070_001]	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP); EuropAid; International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP)	The Side Effect and Reproductive Health in a cohort on HAART (SEARCH) study was conducted in the frame of the Infectious diseases Network for Treatment and Research in Africa (INTERACT) program supported by the the Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP grant W 07.05.201.00) and EuropAid (grant SANTE/2006/105-316). Additional funding for the cross-sectional and prospective cohorts of high-risk women at Projet Ubuzima was provided by the International Partnership for Microbicides, Inc. and the European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled: "Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems" (CT_ct_05_33070_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HIV AIDS HLTH PROF R; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bennet DE, 2008, ANTIVIR THER S, V13, P26; Bennett DE, 2008, ANTIVIR THER, V13, P1; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Braunstein L, 2011, PLOS ONE, V6; Brown AJL, 1997, VIROLOGY, V235, P166, DOI 10.1006/viro.1997.8656; Bujingo G, 1988, REV MED RWANDAISE, V20, P37; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Collinson-Streng AN, 2009, AIDS RES HUM RETROV, V25, P1045, DOI 10.1089/aid.2009.0127; Des Forges A., 1999, LEAVE NO ONE TELL ST; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Iweriebor BC, 2011, AIDS RES HUM RETROV, V27, P911, DOI [10.1089/aid.2010.0286, 10.1089/AID.2010.0286]; Kayirangwa E, 2006, SEX TRANSM INFECT, V82, pI27, DOI 10.1136/sti.2006.019588; Kelley AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019573; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Lukashov VV, 1996, AIDS RES HUM RETROV, V12, P1179, DOI 10.1089/aid.1996.12.1179; Ministry of finance and economic planning national census service, 2003, 3 GEN CENS POP HOUS; Ministry of Health, 2003, GUID PRIS CHARG PERS; Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Ndiaye HD, 2009, JAIDS-J ACQ IMM DEF, V52, P249, DOI 10.1097/QAI.0b013e3181af70a4; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P655, DOI 10.1089/aid.2007.0282; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Prunier G, 1997, RWANDA CRISIS HIST G; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Rodriguez MA, 2009, VIROLOGY, V385, P416, DOI 10.1016/j.virol.2008.12.025; Rwanda Ministry of Health, 2008, TRAC REP EV CLIN IMM; Rwanda Ministry of Local Government, 2010, REP REF REP; Servais J, 2004, AIDS RES HUM RETROV, V20, P279, DOI 10.1089/088922204322996518; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Stanford University, HIV 1 DRUG RES DAT W; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; VANDEPERRE P, 1984, LANCET, V2, P62; VANDEPERRE P, 1989, LANCET, V1, P941; Veldhuijzen NJ, 2010, AIDS, V24, P2289, DOI 10.1097/QAD.0b013e32833cbb71; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; World Bank Global HIV/AIDS Program, 2008, HIV EP HIV RESP AN G; Yirrell DL, 2004, INT J STD AIDS, V15, P103, DOI 10.1258/095646204322764299	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e42557	10.1371/journal.pone.0042557	http://dx.doi.org/10.1371/journal.pone.0042557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	22905148	gold, Green Published, Green Submitted			2022-12-25	WOS:000307500800016
J	Canard, E; Mouquet, N; Marescot, L; Gaston, KJ; Gravel, D; Mouillot, D				Canard, Elsa; Mouquet, Nicolas; Marescot, Lucile; Gaston, Kevin J.; Gravel, Dominique; Mouillot, David			Emergence of Structural Patterns in Neutral Trophic Networks	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; ANIMAL MUTUALISTIC NETWORKS; ECOLOGICAL NETWORKS; COMMUNITY ECOLOGY; PHYLOGENETIC CONSTRAINTS; SPECIES ABUNDANCE; NESTEDNESS; NICHE; MODEL; SPECIALIZATION	Interaction networks are central elements of ecological systems and have very complex structures. Historically, much effort has focused on niche-mediated processes to explain these structures, while an emerging consensus posits that both niche and neutral mechanisms simultaneously shape many features of ecological communities. However, the study of interaction networks still lacks a comprehensive neutral theory. Here we present a neutral model of predator-prey interactions and analyze the structural characteristics of the simulated networks. We find that connectance values (complexity) and complexity-diversity relationships of neutral networks are close to those observed in empirical bipartite networks. High nestedness and low modularity values observed in neutral networks fall in the range of those from empirical antagonist bipartite networks. Our results suggest that, as an alternative to niche-mediated processes that induce incompatibility between species ("niche forbidden links"), neutral processes create "neutral forbidden links" due to uneven species abundance distributions and the low probability of interaction between rare species. Neutral trophic networks must be seen as the missing endpoint of a continuum from niche to purely stochastic approaches of community organization.	[Canard, Elsa; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [Marescot, Lucile] CNRS, Ctr Ecol Fonct & Evolut, F-34033 Montpellier, France; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Exeter; University of Quebec	Canard, E (corresponding author), Univ Montpellier 2, Inst Sci Evolut, Montpellier, France.	elsa.canard@univ-montp2.fr	MOUQUET, Nicolas/AAL-1440-2021	Mouquet, Nicolas/0000-0003-1840-6984; Gaston, Kevin J./0000-0002-7235-7928	Ministry of Higher Education and Research of France; CNRS; NSERC; Canada Research Chair program; French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage); European Research Council under the European Union's Seventh Framework Programme [268504]; Marie Curie International Outgoing Fellowship (FISHECO) [IOF-GA-2009-236316]; FRB project BIODIVMED; ANR project BIODIVNEK	Ministry of Higher Education and Research of France; CNRS(Centre National de la Recherche Scientifique (CNRS)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Marie Curie International Outgoing Fellowship (FISHECO)(European Commission); FRB project BIODIVMED; ANR project BIODIVNEK(French National Research Agency (ANR))	Dr. Canard was supported by a MENRT grant from Ministry of Higher Education and Research of France. Dr. Mouquet was supported by the CNRS. Dr. Gravel was supported by NSERC and the Canada Research Chair program. Dr. Marescot was supported by a grant from the French National Game and Wildlife Agency (Office National de la Chasse et de la Faune Sauvage). Dr. Gaston was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504. Dr. Mouillot was supported by Marie Curie International Outgoing Fellowship (FISHECO) IOF-GA-2009-236316. This study was partially funded by the FRB project BIODIVMED and by the ANR project BIODIVNEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, PHILOS T R SOC B, V364, P1781, DOI 10.1098/rstb.2008.0226; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bersier LF, 2008, ECOL COMPLEX, V5, P132, DOI 10.1016/j.ecocom.2007.06.013; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Dunne JA, 2006, NETWORK STRUCTURE FO; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Gotelli NJ, 2006, ECOGRAPHY, V29, P793, DOI 10.1111/j.2006.0906-7590.04714.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Guill C, 2008, J THEOR BIOL, V251, P108, DOI 10.1016/j.jtbi.2007.11.017; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Hubbell Stephen P., 2001, V32, pi; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1992, AM NAT, V139, P1208, DOI 10.1086/285382; May R. M., 1973, STABILITY COMPLEXITY; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rossberg AG, 2010, THEOR ECOL-NETH, V3, P13, DOI 10.1007/s12080-009-0049-1; Schmid-Araya JM, 2002, J ANIM ECOL, V71, P1056, DOI 10.1046/j.1365-2656.2002.00668.x; SCHOENLY K, 1991, ECOL MONOGR, V61, P267, DOI 10.2307/2937109; Sole RV, 2002, PHILOS T R SOC B, V357, P667, DOI 10.1098/rstb.2001.0992; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Team RDC, 2009, R LANG ENV STAT COMP; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007	57	53	54	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e38295	10.1371/journal.pone.0038295	http://dx.doi.org/10.1371/journal.pone.0038295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22899987	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900002
J	Ishikawa, HO; Xu, AG; Ogura, E; Manning, G; Irvine, KD				Ishikawa, Hiroyuki O.; Xu, Aiguo; Ogura, Eri; Manning, Gerard; Irvine, Kenneth D.			The Raine Syndrome Protein FAM20C Is a Golgi Kinase That Phosphorylates Bio-Mineralization Proteins	PLOS ONE			English	Article							OSTEOSCLEROTIC BONE DYSPLASIA; CASEIN KINASE; GENE-EXPRESSION; MAMMARY-GLAND; POSTTRANSLATIONAL MODIFICATIONS; OSTEOPONTIN; BIOMINERALIZATION; INHIBITION; APPARATUS; BINDING	Raine syndrome is caused by mutations in FAM20C, which had been reported to encode a secreted component of bone and teeth. We found that FAM20C encodes a Golgi-localized protein kinase, distantly related to the Golgi-localized kinase Fourjointed. Drosophila also encode a Golgi-localized protein kinase closely related to FAM20C. We show that FAM20C can phosphorylate secreted phosphoproteins, including both Casein and members of the SIBLING protein family, which modulate biomineralization, and we find that FAM20C phosphorylates a biologically active peptide at amino acids essential for inhibition of biomineralization. We also identify autophosphorylation of FAM20C, and characterize parameters of FAM20C's kinase activity, including its Km, pH and cation dependence, and substrate specificity. The biochemical properties of FAM20C match those of an enzymatic activity known as Golgi casein kinase. Introduction of point mutations identified in Raine syndrome patients into recombinant FAM20C impairs its normal localization and kinase activity. Our results identify FAM20C as a kinase for secreted phosphoproteins and establish a biochemical basis for Raine syndrome.	[Ishikawa, Hiroyuki O.; Ogura, Eri] Chiba Univ, Grad Sch Sci, Chiba, Japan; [Ishikawa, Hiroyuki O.; Xu, Aiguo; Irvine, Kenneth D.] Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ USA; [Ishikawa, Hiroyuki O.; Xu, Aiguo; Irvine, Kenneth D.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Chiba University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Salk Institute	Ishikawa, HO (corresponding author), Chiba Univ, Grad Sch Sci, Chiba, Japan.	irvine@waksman.rutgers.edu	Manning, Gerard/C-8308-2009	Manning, Gerard/0000-0002-5087-9151	Howard Hughes Medical Institute; NHGRI [HG004164]; Special Coordination Funds for Promoting Science and Technology; Japanese Ministry of Education, Culture, Sports and Science; Grants-in-Aid for Scientific Research [23770139] Funding Source: KAKEN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Howard Hughes Medical Institute (KDI), NHGRI grant HG004164 (GM), and by Special Coordination Funds for Promoting Science and Technology and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports and Science (HOI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BINGHAM EW, 1979, J BIOL CHEM, V254, P4510; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Buckles GR, 2001, DEVELOPMENT, V128, P3533; BURNETT G, 1954, J BIOL CHEM, V211, P969; Deshpande AS, 2011, BIOMACROMOLECULES, V12, P2933, DOI 10.1021/bm2005214; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fradin M, 2011, CLIN GENET, V80, P177, DOI 10.1111/j.1399-0004.2010.01516.x; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Hardie DG, 2000, METH MOL B, V99, P191; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hulskamp G, 2003, CLIN DYSMORPHOL, V12, P153, DOI 10.1097/01.mcd.0000080413.95344.60; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Rejjal A, 1998, AM J MED GENET, V78, P382, DOI 10.1002/(SICI)1096-8628(19980724)78:4<382::AID-AJMG17>3.0.CO;2-E; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wheeler SR, 2006, DEV BIOL, V294, P509, DOI 10.1016/j.ydbio.2006.03.016; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	47	116	124	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42988	10.1371/journal.pone.0042988	http://dx.doi.org/10.1371/journal.pone.0042988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900076	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900094
J	Liao, XL; Lu, SY; Zhuo, Y; Winter, C; Xu, WF; Wang, YX				Liao, Xiaoling; Lu, Shaoying; Zhuo, Yue; Winter, Christina; Xu, Wenfeng; Wang, Yingxiao			Visualization of Src and FAK Activity during the Differentiation Process from HMSCs to Osteoblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FOCAL ADHESION KINASE; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; BONE-FORMATION; ACTIVATION; EXPRESSION; DEXAMETHASONE; MEMBRANE	Non-receptor protein kinases FAK and Src play crucial roles in regulating cellular adhesions, growth, migration and differentiation. However, it remains unclear how the activity of FAK and Src is regulated during the differentiation process from mesenchymal stem cells (MSCs) to bone cells. In this study, we used genetically encoded FAK and Src biosensors based on fluorescence resonance energy transfer (FRET) to monitor the FAK and Src activity in live cells during the differentiation process. The results revealed that the FAK activity increased after the induction of differentiation, which peaked around 20-27 days after induction. Meanwhile, the Src activity decreased continuously for 27 days after induction. Therefore, the results showed significant and differential changes of FAK and Src activity upon induction. This opposite trend between FAK and Src activation suggests novel and un-coupled Src/FAK functions during the osteoblastic differentiation process. These results should provide important information for the biochemical signals during the differentiation process of stem cells toward bone cells, which will advance our understanding of bone repair and tissue engineering.	[Liao, Xiaoling; Xu, Wenfeng] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Sch Met & Mat Engn, Chongqing, Peoples R China; [Lu, Shaoying; Zhuo, Yue; Winter, Christina; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Biophys & Computat Biol, Inst Genom Biol,Dept Integrat & Mol Physiol, Urbana, IL 61801 USA	Chongqing University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liao, XL (corresponding author), Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Sch Met & Mat Engn, Chongqing, Peoples R China.	yingxiao@uiuc.edu	Zhuo, Yue/I-5526-2017	Zhuo, Yue/0000-0002-5739-1896	NIH [HL098472, NS063405]; NSF [CBET0846429]; Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China [CSTC2012JJB0097]; Research Foundation of Chongqing University of Science Technology [CK2010B18, CK2011Z03]; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China; Research Foundation of Chongqing University of Science Technology; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NIH HL098472, NS063405, NSF CBET0846429 (Y.W., S.L. and C.W.), Research Foundation of University of Illinois (S.L.) and the Natural Science Key Foundation Project of CQ in China (CSTC2012JJB0097), and Research Foundation of Chongqing University of Science & Technology (CK2010B18, CK2011Z03) (X.L., W.X.). Y.Z. was supported by the Beckman Graduate Fellowship.	Aicher WK, 2011, ADV DRUG DELIVER REV, V63, P342, DOI 10.1016/j.addr.2010.12.004; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Hong D, 2009, J STEROID BIOCHEM, V116, P86, DOI 10.1016/j.jsbmb.2009.05.007; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Seong J, 2011, CELL MOL BIOENG, V4, P138, DOI 10.1007/s12195-011-0161-3; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Sheyn D, 2010, TISSUE ENG PT A, V16, P3679, DOI [10.1089/ten.tea.2009.0786, 10.1089/ten.TEA.2009.0786]; Sheyn D, 2010, ADV DRUG DELIVER REV, V62, P683, DOI 10.1016/j.addr.2010.01.002; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42709	10.1371/journal.pone.0042709	http://dx.doi.org/10.1371/journal.pone.0042709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900044	Green Published, Green Submitted, gold			2022-12-25	WOS:000307380900061
J	Conway, ML; Thomas, J; Subramanian, A				Conway, Miriam L.; Thomas, Jennifer; Subramanian, Ahalya			Is the Aligning Prism Measured with the Mallett Unit Correlated with Fusional Vergence Reserves?	PLOS ONE			English	Article							FIXATION DISPARITY; BINOCULAR VISION; VISUAL-ACUITY; HETEROPHORIA; SYMPTOMS; LOCK; ILLUMINATION; DISTANCE; PHORIA	Background: The Mallett Unit is a clinical test designed to detect the fixation disparity that is most likely to occur in the presence of a decompensated heterophoria. It measures the associated phoria, which is the "aligning prism" needed to nullify the subjective disparity. The technique has gained widespread acceptance within professions such as optometry, for investigating suspected cases of decompensating heterophoria; it is, however, rarely used by orthoptists and ophthalmologists. The aim of this study was to investigate whether fusional vergence reserves, measured routinely by both orthoptists and ophthalmologists to detect heterophoria decompensation, were correlated with aligning prism (associated phoria) in a normal clinical population. Methodology/Principal Findings: Aligning prism (using the Mallett Unit) and fusional vergence reserves (using a prism bar) were measured in 500 participants (mean 41.63 years; standard deviation 11.86 years) at 40 cm and 6 m. At 40 cm a strong correlation (p<0.001) between base in aligning prism (Exo FD) and positive fusional reserves was found. Of the participants with zero aligning prism 30% had reduced fusional reserves. At 6 m a weak correlation between base out aligning prism (Eso FD) and negative fusional reserves was found to break (p = 0.01) and to recovery (p = 0.048). Of the participants with zero aligning prism 12% reported reduced fusional reserves. Conclusions/Significance: For near vision testing, the strong inverse correlation between base in aligning prism (Exo FD) and fusional vergence reserves supports the notion that both measures are indicators of decompensation of heterophoria. For distance vision testing and for those patients reporting zero aligning prism further research is required to determine why the relationship appears to be weak/non-existent?	[Conway, Miriam L.; Thomas, Jennifer; Subramanian, Ahalya] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England	City University London	Conway, ML (corresponding author), City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England.	miriam.conway.1@city.ac.uk		Subramanian, Ahalya/0000-0001-8104-5312				Anson AM, 2001, DIAGNOSIS MANAGEMENT; Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Brautaset RL, 1999, OPHTHAL PHYSL OPT, V19, P347, DOI 10.1046/j.1475-1313.1999.00448.x; Evans BJW, 2010, OPTOMETRY TODAY, P40; Evans BJW, 2007, PICKWELLS BINOCULAR; HERAVIANSHANDIZ J, 1993, OPHTHAL PHYSL OPT, V13, P295, DOI 10.1111/j.1475-1313.1993.tb00472.x; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; JENKINS TCA, 1995, OPHTHAL PHYSL OPT, V15, P53, DOI 10.1016/0275-5408(95)92793-E; JENKINS TCA, 1994, OPHTHAL PHYSL OPT, V14, P129, DOI 10.1111/j.1475-1313.1994.tb00100.x; Karania R, 2006, OPHTHAL PHYSL OPT, V26, P507, DOI 10.1111/j.1475-1313.2006.00385.x; Methling D, 1996, OPHTHAL PHYSL OPT, V16, P211, DOI 10.1016/0275-5408(95)00045-3; Millodot M., 2017, DICT OPTOMETRY VISIO; O'Leary CI, 2006, OPHTHAL PHYSL OPT, V26, P555, DOI 10.1111/j.1475-1313.2006.00400.x; Percival AS, 1928, FAULTY TENDENCIES DE; PICKWELL LD, 1991, OPHTHAL PHYSL OPT, V11, P291, DOI 10.1111/j.1475-1313.1991.tb00227.x; PICKWELL LD, 1987, AM J OPTOM PHYS OPT, V64, P513; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Rowe F, 2012, CLIN ORTHOPTICS; SALADIN JJ, 1983, AM J OPTOM PHYS OPT, V60, P933; Sheard C., 1930, AM J OPTOM, V7, P9, DOI [10.1097/00006324-193001000-00001, DOI 10.1097/00006324-193001000-00001]; SHEEDY JE, 1980, J AM OPTOM ASSOC, V51, P1079; SHEEDY JE, 1978, AM J OPTOM PHYS OPT, V55, P670; SHEEDY JE, 1977, AM J OPTOM PHYS OPT, V54, P474; Ukwade MT, 2000, OPTOMETRY VISION SCI, V77, P309, DOI 10.1097/00006324-200006000-00011; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; WILDSOET CF, 1985, OPHTHAL PHYSL OPT, V5, P171, DOI 10.1111/j.1475-1313.1985.tb00653.x; Yekta A, 1986, CLIN EXP OPTOM, V69, P228; YEKTA AA, 1987, OPHTHAL PHYSL OPT, V7, P349, DOI 10.1111/j.1475-1313.1987.tb00759.x	28	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42832	10.1371/journal.pone.0042832	http://dx.doi.org/10.1371/journal.pone.0042832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905174	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000307331100066
J	Whelan, NV; Johnson, PD; Harris, PM				Whelan, Nathan V.; Johnson, Paul D.; Harris, Phil M.			Rediscovery of Leptoxis compacta (Anthony, 1854) (Gastropoda: Cerithioidea: Pleuroceridae)	PLOS ONE			English	Article							RIVER; REINTRODUCTION	The Mobile River Basin is a hotspot of molluscan endemism, but anthropogenic activities have caused at least 47 molluscan extinctions, 37 of which were gastropods, in the last century. Nine of these suspected extinctions were in the freshwater gastropod genus Leptoxis (Cerithioidea: Pleuroceridae). Leptoxis compacta, a Cahaba River endemic, has not been collected for > 70 years and was formally declared extinct in 2000. Such gastropod extinctions underscore the imperilment of freshwater resources and the current biodiversity crisis in the Mobile River Basin. During a May 2011 gastropod survey of the Cahaba River in central Alabama, USA, L. compacta was rediscovered. The identification of snails collected was confirmed through conchological comparisons to the L. compacta lectotype, museum records, and radulae morphology of historically collected L. compacta. Through observations of L. compacta in captivity, we document for the first time that the species lays eggs in short, single lines. Leptoxis compacta is restricted to a single location in the Cahaba River, and is highly susceptible to a single catastrophic extinction event. As such, the species deserves immediate conservation attention. Artificial propagation and reintroduction of L. compacta into its native range may be a viable recovery strategy to prevent extinction from a single perturbation event.	[Whelan, Nathan V.; Harris, Phil M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Johnson, Paul D.] Alabama Dept Conservat & Nat Resources, Alabama Aquat Biodivers Ctr, Marion, AL USA	University of Alabama System; University of Alabama Tuscaloosa	Whelan, NV (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	nwhelan@crimson.ua.edu		Whelan, Nathan/0000-0002-3542-2102; Harris, Phillip/0000-0003-3215-2167	University of Alabama Department of Biological Sciences and Conchologists of America	University of Alabama Department of Biological Sciences and Conchologists of America	Culturing of L. compacta was done under a State Wildlife Grant Agreement with the U.S. Fish and Wildlife Service and the Alabama Department of Conservation and Natural Resources. The University of Alabama Department of Biological Sciences and Conchologists of America provided grants to N.V. Whelan for fieldwork and SEM work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEM, 2009, FIN TOT MAX DAIL LOA; AHLSTEDT SA, 1991, AM MALACOL BULL, V8, P139; Anthony JG, 1854, ANN LYCEUM NATURAL H, V6, P122; Bogan AE, 2000, IUCN 2011 RED LIST T; Bogan AE, 1993, SURVEY AQUATIC UNPUB; Burch J. B., 1980, WALKERANA, V3, P1; Fukuda H, 2008, ZOOSYMPOSIA, V1, P15, DOI 10.11646/zoosymposia.1.1.5; George AL, 2009, FISHERIES, V34, P529, DOI 10.1577/1548-8446-34.11.529; Goodrich C., 1941, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, VNo. 428, P1; Goodrich C, 1922, U MICHIGAN MUSEUM ZO, V7, P63; GRAF DL, 2001, WALKERANA, V12, P1; Holznagel WE, 1998, AM MALACOL BULL, V14, P181; Howard HS, 2002, CAHABA RUVER BIOL WA; Huryn AD, 1997, FUNCT ECOL, V11, P472, DOI 10.1046/j.1365-2435.1997.00116.x; IUCN, 1998, IUCN GUID REINTR; IUCN, 2019, IUCN RED LIST THREAT; Johnson PD, 2010, INTERIM REPORT UNPUB; Johnson PD, 2001, STATUS LEPTOXI UNPUB; Johnson PD, 2006, INVENTORY FRES UNPUB; Johnson PD, 2010, PROPOSED REINT UNPUB; Johnson PD, 2012, FISHERIES IN PRESS; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; Lysne SJ, 2008, J N AM BENTHOL SOC, V27, P463, DOI 10.1899/07-061.1; Minton RL, 2003, P BIOL SOC WASH, V116, P531; Minton RL, 2002, NAUTILUS, V116, P39; MRB Mollusc Recovery Committee, 2010, PLAN POP REST CONS I; NEVES RJ, 1997, AQUATIC FAUNA PERIL; O Foighil Diarmaid, 2011, PLoS One, V6, pe20496, DOI 10.1371/journal.pone.0020496; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Roberts DL, 2010, CONSERV BIOL, V24, P189, DOI 10.1111/j.1523-1739.2009.01292.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Shepard Thomas E., 1994, Geological Survey of Alabama Bulletin, V160, P1; Tolley-Jordan LR, 2008, BIOL PLEUROCERIDAE G; Turgeon D.D., 1998, COMMON SCI NAMES AQU; USFWS, 2010, FED REGISTER, V75, P67512; USFWS, 1998, FED REGISTER, V63, P57610; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Whelan NV, 2012, J MOLLUS STUD, V78, P231, DOI 10.1093/mollus/eys005; Williams JD., 2008, FRESHWATER MUSSELS A	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42499	10.1371/journal.pone.0042499	http://dx.doi.org/10.1371/journal.pone.0042499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905139	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100043
J	Togo, T				Togo, Tatsuru			Cell Membrane Disruption Stimulates NO/PKG Signaling and Potentiates Cell Membrane Repair in Neighboring Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; LONG-TERM POTENTIATION; PLASMA-MEMBRANE; CA2+-REGULATED EXOCYTOSIS; REGULATED EXOCYTOSIS; NITRIC-OXIDE; RELEASE; EXPRESSION; MECHANISM	Resealing of a disrupted plasma membrane at the micron-diameter range requires Ca2+-regulated exocytosis. Repeated membrane disruptions reseal more quickly than the initial wound, and this potentiation of membrane resealing persists for at least 24 hours after the initial wound. Long-term potentiation of membrane resealing requires CREB-dependent gene expression, which is activated by the PKC- and p38 MAPK-dependent pathway in a wounded cell. The present study demonstrates that membrane resealing is potentiated in both wounded and neighboring cells in MDCK cells. Wounding of cells expressing CREB133, a mutant variant of CREB, does not show the potentiated response of cell membrane resealing in either wounded or neighboring cells. Furthermore, wounding of cells induces CREB phosphorylation, not only in wounded cells, but also in neighboring cells. Inhibition of the nitric oxide/PKG signaling pathway suppresses CREB phosphorylation in neighboring cells, but not in wounded cells. The potentiation of membrane resealing in neighboring cells is suppressed if the nitric oxide/PKG pathway is inhibited during the initial wound. Together, these results suggest that the nitric oxide/PKG pathway stimulates CREB phosphorylation in neighboring cells so that subsequent cell membrane disruptions of the neighboring cells reseal more quickly.	St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan	Saint Marianna University	Togo, T (corresponding author), St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan.	togot@marianna-u.ac.jp	Togo, Tatsuru/D-5365-2011	Togo, Tatsuru/0000-0003-3015-6367	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grembowicz KP, 1999, MOL BIOL CELL, V10, P1247, DOI 10.1091/mbc.10.4.1247; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KITA Y, 1994, EUR J PHARMACOL, V257, P123, DOI 10.1016/0014-2999(94)90703-X; McNeil PL, 2000, J CELL SCI, V113, P1891; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Sammak PJ, 1997, J CELL SCI, V110, P465; Shen SS, 2005, CURR EYE RES, V30, P543, DOI 10.1080/02713680590968574; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 2006, J CELL SCI, V119, P2780, DOI 10.1242/jcs.03006; Togo T, 2004, J BIOL CHEM, V279, P44996, DOI 10.1074/jbc.M406327200; Togo T, 2004, MOL BIOL CELL, V15, P688, DOI 10.1091/mbc.E03-06-0430; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2012	7	8							e42885	10.1371/journal.pone.0042885	http://dx.doi.org/10.1371/journal.pone.0042885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	987SL	22880128	gold, Green Submitted, Green Published			2022-12-25	WOS:000307437900058
J	Buskohl, PR; Sun, ML; Thompson, RP; Butcher, JT				Buskohl, Philip R.; Sun, Michelle L.; Thompson, Robert P.; Butcher, Jonathan T.			Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular Valves	PLOS ONE			English	Article							MESENCHYMAL CELL-TRANSFORMATION; CRANIAL NEURAL CREST; FACTOR-BETA; INTERSTITIAL-CELLS; HEART DEVELOPMENT; CARDIAC MORPHOGENESIS; VASOACTIVE AGENTS; PROGENITOR CELLS; MOUSE EMBRYO; CHICK-EMBRYO	Embryonic heart valve primordia (cushions) maintain unidirectional blood flow during development despite an increasingly demanding mechanical environment. Recent studies demonstrate that atrioventricular (AV) cushions stiffen over gestation, but the molecular mechanisms of this process are unknown. Transforming growth factor-beta (TGF beta) and serotonin (5-HT) signaling modulate tissue biomechanics of postnatal valves, but less is known of their role in the biomechanical remodeling of embryonic valves. In this study, we demonstrate that exogenous TGF beta 3 increases AV cushion biomechanical stiffness and residual stress, but paradoxically reduces matrix compaction. We then show that TGF beta 3 induces contractile gene expression (RhoA, aSMA) and extracellular matrix expression (col1 alpha 2) in cushion mesenchyme, while simultaneously stimulating a twofold increase in proliferation. Local compaction increased due to an elevated contractile phenotype, but global compaction appeared reduced due to proliferation and ECM synthesis. Blockade of TGF beta type I receptors via SB431542 inhibited the TGF beta 3 effects. We next showed that exogenous 5-HT does not influence cushion stiffness by itself, but synergistically increases cushion stiffness with TGF beta 3 co-treatment. 5-HT increased TGF beta 3 gene expression and also potentiated TGF beta 3 induced gene expression in a dose-dependent manner. Blockade of the 5HT2b receptor, but not 5-HT2a receptor or serotonin transporter (SERT), resulted in complete cessation of TGF beta 3 induced mechanical strengthening. Finally, systemic 5-HT administration in ovo induced cushion remodeling related defects, including thinned/atretic AV valves, ventricular septal defects, and outflow rotation defects. Elevated 5-HT in ovo resulted in elevated remodeling gene expression and increased TGF beta signaling activity, supporting our ex-vivo findings. Collectively, these results highlight TGF beta/5-HT signaling as a potent mechanism for control of biomechanical remodeling of AV cushions during development.	[Buskohl, Philip R.] Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Sun, Michelle L.; Butcher, Jonathan T.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Thompson, Robert P.] Med Univ S Carolina, Dept Cell Biol & Regenerat Med, Charleston, SC 29425 USA	Cornell University; Cornell University; Medical University of South Carolina	Buskohl, PR (corresponding author), Cornell Univ, Dept Mech & Aerosp Engn, Ithaca, NY 14853 USA.	jtb47@cornell.edu	Butcher, Jonathan/AAE-8239-2020; Butcher, Jonathan T/D-2280-2012	Butcher, Jonathan/0000-0002-9309-6296; Butcher, Jonathan T/0000-0002-9309-6296	American Heart Association [0830384N]; National Institutes of Health [HL110328, HL91452]; Hartwell Foundation; National Science Foundation [CBET-0955172, DGE0841291]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110328, R21HL091452] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded by the American Heart Association (0830384N, JTB; www.heart.org), National Institutes of Health (HL110328, JTB; HL91452, RPT; www.NIH.gov), The Hartwell Foundation (JTB; www.thehartwellfoundation.org) and the National Science Foundation (CBET-0955172, JTB; DGE0841291, PRB; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Azhar M, 2011, DEV DYNAM, V240, P2127, DOI 10.1002/dvdy.22702; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Balachandran K, 2011, CARDIOVASC PATHOL; Bartram U, 2001, CIRCULATION, V103, P2745; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Buskohl PR, 2012, J BIOMECH, V45, P895, DOI 10.1016/j.jbiomech.2011.11.032; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Chiu YN, 2010, TISSUE ENG PT A, V16, P3375, DOI 10.1089/ten.tea.2010.0027; Choi DS, 1997, DEVELOPMENT, V124, P1745; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Disatian S, 2009, J HEART VALVE DIS, V18, P44; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Elangbam CS, 2008, EXP TOXICOL PATHOL, V60, P253, DOI 10.1016/j.etp.2008.03.005; Fukumoto T, 2005, DEV NEUROSCI-BASEL, V27, P349, DOI 10.1159/000088451; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48; Hafizi S, 2000, J HEART VALVE DIS, V9, P454; Hauso O, 2007, REGUL PEPTIDES, V143, P39, DOI 10.1016/j.regpep.2007.02.009; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6; KELLER BB, 1991, CIRC RES, V68, P226, DOI 10.1161/01.RES.68.1.226; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0; LAUDER JM, 1988, PROG BRAIN RES, V73, P365; Levin M, 2006, DEV NEUROSCI-BASEL, V28, P171, DOI 10.1159/000091915; Liu YL, 2011, AM J RESP CELL MOL, V44, P548, DOI 10.1165/rcmb.2010-0078OC; Massague J, 2000, GENE DEV, V14, P627; Mekontso-Dessap A, 2006, CIRCULATION, V113, P81, DOI 10.1161/CIRCULATIONAHA.105.554667; Merlob P, 2009, BIRTH DEFECTS RES A, V85, P837, DOI 10.1002/bdra.20615; Merryman WD, 2007, CARDIOVASC PATHOL, V16, P268, DOI 10.1016/j.carpath.2007.03.006; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Miller CE, 2005, MICROSC MICROANAL, V11, P216, DOI 10.1017/S1431927605050464; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; Monassier L, 2010, PHARMACOL THERAPEUT, V128, P559, DOI 10.1016/j.pharmthera.2010.08.004; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2009, DEV DYNAM, V238, P1052, DOI 10.1002/dvdy.21933; Oyama MA, 2010, J VET INTERN MED, V24, P27, DOI 10.1111/j.1939-1676.2009.0411.x; Pavone LM, 2009, J MOL CELL CARDIOL, V47, P691, DOI 10.1016/j.yjmcc.2009.07.021; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; POTTS JD, 1992, DEV DYNAM, V193, P340, DOI 10.1002/aja.1001930407; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Warnock JN, 2010, J HEART VALVE DIS, V19, P86; Watts SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005682; Xu J, 2002, AM J PATHOL, V161, P2209, DOI 10.1016/S0002-9440(10)64497-5; Yabanoglu S, 2009, J MOL CELL CARDIOL, V46, P518, DOI 10.1016/j.yjmcc.2008.12.019; Yalcin HC, 2010, AM J PHYSL HEART CIR; Yalcin HC, 2011, DEV DYNAM, V240, P23, DOI 10.1002/dvdy.22512; YAVARONE MS, 1993, TERATOLOGY, V47, P573, DOI 10.1002/tera.1420470609; Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004	74	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42527	10.1371/journal.pone.0042527	http://dx.doi.org/10.1371/journal.pone.0042527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880017	Green Published, gold, Green Submitted			2022-12-25	WOS:000307810000040
J	Poethko-Muller, C; Mankertz, A				Poethko-Mueller, Christina; Mankertz, Annette			Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; VACCINATION COVERAGE; VIRUS-ANTIBODIES; MMR VACCINATION; LARGE OUTBREAK; BORN CHILDREN; POPULATION; SEROEPIDEMIOLOGY; IMMUNITY; TITERS	We have undertaken a seroprevalence study with more than 13,000 children, who had been included in the German KIGGS survey, a representative sample of children and adolescents 0-17 years of age. The IgG titres against measles, mumps and rubella were determined in 1 to 17 year olds While 88.8% of the children were MMR-vaccinated at least once, 76.8% of children aged 1 to 17 years showed prevalence of antibodies to MMR. The highest seronegativity was seen with respect to mumps. Gender differences were most pronounced with regard to rubella IgG titres: girls aged 14 to 17 years were best protected, although seronegativity in 6.8% of this vulnerable group still shows the need of improvement. Search for predictors of missing seroprevalence identified young age to be the most important predictor. Children living in the former West and children born outside of Germany had a higher risk of lacking protection against measles and rubella, while children with a migration background but born in Germany were less often seronegative to measles antibodies than their German contemporaries. An association of seronegativity and early vaccination was seen for measles but not for mumps and rubella. A high maternal educational level was associated with seronegativity to measles and rubella. In vaccinated children, seronegativity was highest for mumps and lowest for rubella. For mumps, high differences were observed for seronegativity after one-dose and two-dose vaccination, respectively. Seronegativity increases as time since last vaccination passes thus indicating significant waning effects for all three components of MMR.	[Poethko-Mueller, Christina] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, Div Viral Infect, Natl Reference Ctr, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, RRL WHO EURO, Berlin, Germany; [Mankertz, Annette] Robert Koch Inst, MMR, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Poethko-Muller, C (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Berlin, Germany.	poethko-muellerc@rki.de		Mankertz, Annette/0000-0002-0131-5739	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	The KiGGS study was funded by the German Federal Ministry of Health (http://www.bmg.bund.de/), the Ministry of Education and Research (http://www.bmbf.de) and the Federal Ministry of Food, Agriculture and Consumer Protection (http://www.bmelv.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P51; Borras E, 2007, VACCINE, V25, P3240, DOI 10.1016/j.vaccine.2007.01.026; BRISS PA, 1994, J INFECT DIS, V169, P77, DOI 10.1093/infdis/169.1.77; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; CHEEK JE, 1995, ARCH PEDIAT ADOL MED, V149, P774, DOI 10.1001/archpedi.1995.02170200064010; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Chu SY, 2004, AM J PUBLIC HEALTH, V94, P973, DOI 10.2105/AJPH.94.6.973; Cohen BJ, 2006, J VIROL METHODS, V131, P209, DOI 10.1016/j.jviromet.2005.08.001; Cortese MM, 2011, J INFECT DIS, V204, P1413, DOI 10.1093/infdis/jir526; Date AA, 2008, J INFECT DIS, V197, P1662, DOI 10.1086/588197; DAVIDKIN I, 1995, VACCINE, V13, P1617, DOI 10.1016/0264-410X(95)00064-8; Davidkin I, 1998, VACCINE, V16, P2052, DOI 10.1016/S0264-410X(98)00081-4; Deeks SL, 2011, CAN MED ASSOC J, V183, P1014, DOI 10.1503/cmaj.101371; ENDERS G, 1988, LANCET, V1, P1445; Galazka AM, 1999, B WORLD HEALTH ORGAN, V77, P3; Gonzalez PP, 2011, ATEN PRIMARIA; Hanna-Wakim R, 2008, J INFECT DIS, V197, P1669, DOI 10.1086/588195; HERSH BS, 1991, J PEDIATR-US, V119, P187, DOI 10.1016/S0022-3476(05)80726-7; Johnson CE, 1996, PEDIATR INFECT DIS J, V15, P687, DOI 10.1097/00006454-199608000-00010; Kalies H, 2006, EUR J PEDIATR, V165, P30, DOI 10.1007/s00431-005-1758-0; Kalies H, 2006, PEDIATR INFECT DIS J, V25, P507, DOI 10.1097/01.inf.0000222413.47344.23; Koch-Institut: R, 2012, SURVSTAT; Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Kutty PK, 2010, J INFECT DIS, V202, P667, DOI 10.1086/655394; Lee MS, 2001, VACCINE, V19, P4644, DOI 10.1016/S0264-410X(01)00239-0; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; Mauldin J, 2005, J CLIN MICROBIOL, V43, P4847, DOI 10.1128/JCM.43.9.4847-4851.2005; MILLER E, 1982, LANCET, V2, P781; Mitchell LA, 1998, CAN J PUBLIC HEALTH, V89, P325, DOI 10.1007/BF03404484; MOSSONG J, 2009, EURO SURVEILL, V14; Muhsen K, 2011, VACCINE, V29, P3878, DOI 10.1016/j.vaccine.2011.03.047; Nardone A, 2003, EPIDEMIOL INFECT, V131, P691, DOI 10.1017/S0950268803008768; Otto W, 2010, EURO SURVEILL, V15; Pebody RG, 2002, VACCINE, V20, P1134, DOI 10.1016/S0264-410X(01)00435-2; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poethko-Mueller C, 2007, BUNDESGESUNDHEITSBLA, V50, P851, DOI 10.1007/s00103-007-0248-0; Poethko-Muller C, 2011, VACCINE, V29, P7949, DOI 10.1016/j.vaccine.2011.08.081; Poethko-Muller C, 2009, VACCINE, V27, P2563, DOI 10.1016/j.vaccine.2009.02.009; Quinlisk MP, 2010, J INFECT DIS, V202, P655, DOI 10.1086/655395; Ramsay M, 1999, 010105 EURICDCMDS; Schmid D, 2006, EUROSURVEILLANCE, V11; Siedler A, 2006, Euro Surveill, V11, P131; SULLIVAN KM, 1985, AM J DIS CHILD, V139, P909, DOI 10.1001/archpedi.1985.02140110063030; Sun WY, 1998, PUBLIC HEALTH, V112, P405, DOI 10.1016/S0033-3506(98)00287-X; Theeten H, 2011, EPIDEMIOL INFECT, V139, P494, DOI 10.1017/S0950268810001536; Vaidya SR, 2010, J VIROL METHODS, V163, P153, DOI 10.1016/j.jviromet.2009.09.006; van der Wal MF, 2005, ARCH DIS CHILD, V90, P36, DOI 10.1136/adc.2003.047126; Vandermeulen C, 2004, VACCINE, V22, P2713, DOI 10.1016/j.vaccine.2004.02.001; Vandermeulen C, 2007, VACCINE, V25, P6672, DOI 10.1016/j.vaccine.2007.07.008; Waldhoer T, 1997, EUR J EPIDEMIOL, V13, P145, DOI 10.1023/A:1007359632218; WHARTON M, 1988, J INFECT DIS, V158, P1253, DOI 10.1093/infdis/158.6.1253; Whelan J, 2010, EURO SURVEILL, V15; Whyte D, 2009, EURO SURVEILL, V14	58	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2012	7	8							e42867	10.1371/journal.pone.0042867	http://dx.doi.org/10.1371/journal.pone.0042867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992WD	22880124	gold, Green Published			2022-12-25	WOS:000307810000079
J	Boleij, H; Salomons, AR; van Sprundel, M; Arndt, SS; Ohl, F				Boleij, Hetty; Salomons, Amber R.; van Sprundel, Mariska; Arndt, Saskia S.; Ohl, Frauke			Not All Mice Are Equal: Welfare Implications of Behavioural Habituation Profiles in Four 129 Mouse Substrains	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; ANXIETY-LIKE BEHAVIOR; COGNITIVE PERFORMANCE; PATHOLOGICAL ANXIETY; ANIMAL-WELFARE; STRAINS; TRAIT; ENVIRONMENT; KNOCKOUT; C57BL/6	Safeguarding the welfare of animals is an important aim when defining housing and management standards in animal based, experimental research. While such standards are usually defined per animal species, it is known that considerable differences between laboratory mouse strains exist, for example with regard to their emotional traits. Following earlier experiments, in which we found that 129P3 mice show a lack of habituation of anxiety related behaviour after repeated exposure to an initially novel environment (non-adaptive profile), we here investigated four other 129 inbred mouse substrains (129S2/SvPas, 129S2/SvHsd (exp 1); 129P2 and 129X1 (exp 2)) on habituation of anxiety related behaviour. Male mice of each strain were repeatedly placed in the modified hole board test, measuring anxiety-related behaviour, exploratory and locomotor behaviour. The results reveal that all four substrains show a lack of habituation behaviour throughout the period of testing. Although not in all of the substrains a possible confounding effect of general activity can be excluded, our findings suggest that the genetic background of the 129 substrains may increase their vulnerability to cope with environmental challenges, such as exposure to novelty. This vulnerability might negatively affect the welfare of these mice under standard laboratory conditions when compared with other strains. Based on our findings we suggest to consider (sub) strain-specific guidelines and protocols, taking the (subs) train-specific adaptive capabilities into account.	[Boleij, Hetty; Salomons, Amber R.; van Sprundel, Mariska; Arndt, Saskia S.; Ohl, Frauke] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Anim Welf & Lab Anim Sci, Utrecht, Netherlands; [Boleij, Hetty; Salomons, Amber R.; Arndt, Saskia S.; Ohl, Frauke] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Boleij, H (corresponding author), Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Anim Welf & Lab Anim Sci, Utrecht, Netherlands.	h.boleij@uu.nl			Faculty of Veterinary Medicine, Utrecht University	Faculty of Veterinary Medicine, Utrecht University	The work was financially supported by the Faculty of Veterinary Medicine, Utrecht University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov U, 2008, NEUROSCI LETT, V443, P223, DOI 10.1016/j.neulet.2008.07.075; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bolivar VJ, 2009, NEUROBIOL LEARN MEM, V92, P206, DOI 10.1016/j.nlm.2009.02.002; Bothe GWM, 2005, COMPARATIVE MED, V55, P326; Bothe GWM, 2004, GENES BRAIN BEHAV, V3, P149, DOI 10.1111/j.1601-183x.2004.00064.x; Bracke MBM, 2006, J AGR ENVIRON ETHIC, V19, P77, DOI 10.1007/s10806-005-4493-7; Brambell F.W.R, 1965, REPORT TECHNICAL COM; Camp M, 2009, GENES BRAIN BEHAV, V8, P744, DOI 10.1111/j.1601-183X.2009.00519.x; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; Clement Y, 2009, PLOS ONE, V4, pA74, DOI 10.1371/journal.pone.0007745; Cook MN, 2002, BEHAV NEUROSCI, V116, P600, DOI 10.1037//0735-7044.116.4.600; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Eisenstein EM, 2006, REV NEUROSCIENCE, V17, P533; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Jensen P, 2010, ANIM WELFARE, V19, P7; Kim D, 2005, GENES BRAIN BEHAV, V4, P302, DOI 10.1111/j.1601-183X.2005.00133.x; Knierim U, 2009, ANIM WELFARE, V18, P451; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; Laarakker MC, 2008, BEHAV GENET, V38, P159, DOI 10.1007/s10519-007-9188-6; Livesey PJ, 1986, LEARNING EMOTION BIO; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; National Research Counci, 2010, GUIDE CARE USE LAB A; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; Ohl F, 2012, VET J, V192, P13, DOI 10.1016/j.tvjl.2011.05.019; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Ohl F, 2002, BEHAV NEUROSCI, V116, P464, DOI 10.1037//0735-7044.116.3.464; Ohl F, 2001, J PSYCHIAT RES, V35, P147, DOI 10.1016/S0022-3956(01)00017-6; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Pratte M, 2009, BEHAV BRAIN RES, V203, P54, DOI 10.1016/j.bbr.2009.04.011; Salomons AR, 2010, GENES BRAIN BEHAV, V9, P1, DOI 10.1111/j.1601-183X.2009.00527.x; Salomons AR, 2012, COGN AFFECT BEHAV NE, V12, P794, DOI 10.3758/s13415-012-0109-7; Salomons AR, 2010, BEHAV BRAIN RES, V215, P95, DOI 10.1016/j.bbr.2010.06.035; Salomons AR, 2010, BEHAV BRAIN RES, V209, P241, DOI 10.1016/j.bbr.2010.01.050; Salomons AR, 2009, SCAND J LAB ANIM SCI, V36, P37; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Tang XD, 2005, PHYSIOL BEHAV, V84, P105, DOI 10.1016/j.physbeh.2004.10.017; van der Staay FJ, 2010, GENES BRAIN BEHAV, V9, P849, DOI 10.1111/j.1601-183X.2010.00628.x; Webster A.J.F, 1994, ANIMAL WELFARE COOL; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	47	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42544	10.1371/journal.pone.0042544	http://dx.doi.org/10.1371/journal.pone.0042544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880028	Green Published, gold, Green Submitted			2022-12-25	WOS:000307284100126
J	Guenin, S; Mouallif, M; Deplus, R; Lampe, X; Krusy, N; Calonne, E; Delbecque, K; Kridelka, F; Fuks, F; Ennaji, MM; Delvenne, P				Guenin, Samuel; Mouallif, Mustapha; Deplus, Rachel; Lampe, Xavier; Krusy, Nathalie; Calonne, Emilie; Delbecque, Katty; Kridelka, Frederic; Fuks, Francois; Ennaji, My Mustapha; Delvenne, Philippe			Aberrant Promoter Methylation and Expression of UTF1 during Cervical Carcinogenesis	PLOS ONE			English	Article							CHROMATIN-ASSOCIATED PROTEIN; DNA-METHYLATION; OCT4 EXPRESSION; STEM-CELLS; CANCER; CARCINOMA; GENES; DIFFERENTIATION; MARKERS; HYPERMETHYLATION	Promoter methylation profiles are proposed as potential prognosis and/or diagnosis biomarkers in cervical cancer. Up to now, little is known about the promoter methylation profile and expression pattern of stem cell (SC) markers during tumor development. In this study, we were interested to identify SC genes methylation profiles during cervical carcinogenesis. A genome-wide promoter methylation screening revealed a strong hypermethylation of Undifferentiated cell Transcription Factor 1 (UTF1) promoter in cervical cancer in comparison with normal ectocervix. By direct bisulfite pyrosequencing of DNA isolated from liquid-based cytological samples, we showed that UTF1 promoter methylation increases with lesion severity, the highest level of methylation being found in carcinoma. This hypermethylation was associated with increased UTF1 mRNA and protein expression. By using quantitative RT-PCR and Western Blot, we showed that both UTF1 mRNA and protein are present in epithelial cancer cell lines, even in the absence of its two main described regulators Oct4A and Sox2. Moreover, by immunofluorescence, we confirmed the nuclear localisation of UTF1 in cell lines. Surprisingly, direct bisulfite pyrosequencing revealed that the inhibition of DNA methyltransferase by 5-aza-29-deoxycytidine was associated with decreased UTF1 gene methylation and expression in two cervical cancer cell lines of the four tested. These findings strongly suggest that UTF1 promoter methylation profile might be a useful biomarker for cervical cancer diagnosis and raise the questions of its role during epithelial carcinogenesis and of the mechanisms regulating its expression.	[Guenin, Samuel; Mouallif, Mustapha; Krusy, Nathalie; Delvenne, Philippe] Univ Liege, Lab Expt Pathol, Grp Interdisciplinaire Genoprote Appl GIGA Canc, Liege, Belgium; [Mouallif, Mustapha; Ennaji, My Mustapha] Univ Hassan II Mohammedia, Lab Virol & Hyg & Microbiol, Mohammadia, Morocco; [Deplus, Rachel; Lampe, Xavier; Calonne, Emilie; Fuks, Francois] Free Univ Brussels, Lab Canc Epigenet, Brussels, Belgium; [Delbecque, Katty] CHU Sart Tilman, Dept Pathol, B-4000 Liege, Belgium; [Kridelka, Frederic] CHU Sart Tilman, Dept Obstet & Gynecol, B-4000 Liege, Belgium	University of Liege; Hassan II University of Casablanca; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; University of Liege	Guenin, S (corresponding author), Univ Liege, Lab Expt Pathol, Grp Interdisciplinaire Genoprote Appl GIGA Canc, Liege, Belgium.	samuel.guenin@gmail.com	Ennaji, Moulay Mustapha/AAE-7386-2020; Ennaji, Moulay Mustapha/AAF-1514-2020	Ennaji, Moulay Mustapha/0000-0001-5809-0270	Program of the Walloon Region [616476]; Belgian Fund for Medical Scientific Research (FNRS); Neoangio; Averroes Program of the European Commission; F.R.S-FNRS	Program of the Walloon Region; Belgian Fund for Medical Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Neoangio; Averroes Program of the European Commission; F.R.S-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Program of the Walloon Region (Neoangio No 616476) and the Belgian Fund for Medical Scientific Research (FNRS). Samuel Guenin and Xavier Lampe are supported by Neoangio. Mustapha Mouallif is supported by a grant from the Averroes Program of the European Commission and by a Televie grant from the F.R.S-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Arafa M, 2008, APPL IMMUNOHISTO M M, V16, P422, DOI 10.1097/PAI.0b013e318166fd42; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Chik F, 2012, ADV EXP MED BIOL, V720, P91, DOI 10.1007/978-1-4614-0254-1_8; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Cox GS, 1998, BBA-GENE STRUCT EXPR, V1396, P67, DOI 10.1016/S0167-4781(97)00175-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dehan P, 2009, EXPERT REV MOL DIAGN, V9, P651, DOI 10.1586/ERM.09.53; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forte A, 2009, MOL MED, V15, P392, DOI 10.2119/molmed.2009.00068; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Hall S, 1996, GYNECOL ONCOL, V62, P353, DOI 10.1006/gyno.1996.0248; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Jackson K, 2011, DIGEST DIS SCI, V56, P125, DOI 10.1007/s10620-010-1422-z; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kim JH, 2010, GYNECOL ONCOL, V116, P99, DOI 10.1016/j.ygyno.2009.09.032; Kim TW, 2010, INT J ONCOL, V36, P1105, DOI 10.3892/ijo_00000592; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Kooistra SM, 2009, STEM CELL RES, V2, P211, DOI 10.1016/j.scr.2009.02.001; Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010; Lim EH, 2010, GYNECOL ONCOL, V119, P225, DOI 10.1016/j.ygyno.2010.07.028; Liu DB, 2011, TUMOR BIOL, V32, P941, DOI 10.1007/s13277-011-0196-z; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Melone MAB, 2009, CANCER BIOL THER, V8, P1300, DOI 10.4161/cbt.8.13.8890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller T, 2009, CELL MOL LIFE SCI, V66, P495, DOI 10.1007/s00018-008-8623-z; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Pellacani D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-94; Reinisch CM, 2007, J CUTAN PATHOL, V34, P174, DOI 10.1111/j.1600-0560.2006.00587.x; Reinisch CM, 2011, INT J EXP PATHOL, V92, P326, DOI 10.1111/j.1365-2613.2011.00769.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Takahashi Y, 2012, BREAST CANCER-TOKYO, V19, P242, DOI 10.1007/s12282-011-0272-7; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wang P, 2010, AM J CLIN PATHOL, V134, P604, DOI 10.1309/AJCPB44HBKINJNYU; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Zhao SD, 2011, J PATHOL, V223, P672, DOI 10.1002/path.2827; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	60	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42704	10.1371/journal.pone.0042704	http://dx.doi.org/10.1371/journal.pone.0042704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880087	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100161
J	Hansen, JJ; Huang, Y; Peterson, DA; Goeser, L; Fan, TJ; Chang, EB; Sartor, RB				Hansen, Jonathan J.; Huang, Yong; Peterson, Daniel A.; Goeser, Laura; Fan, Ting-Jia; Chang, Eugene B.; Sartor, R. Balfour			The Colitis-Associated Transcriptional Profile of Commensal Bacteroides thetaiotaomicron Enhances Adaptive Immune Responses to a Bacterial Antigen	PLOS ONE			English	Article							CROHNS-DISEASE; HIGH PREVALENCE; MOUSE MODEL; MICROBIOTA; SUSCEPTIBILITY; GASTRITIS; HLA-B27	Background: Inflammatory bowel diseases (IBD) may be caused in part by aberrant immune responses to commensal intestinal microbes including the well-characterized anaerobic gut commensal Bacteroides thetaiotaomicron (B. theta). Healthy, germ-free HLA-B27 transgenic (Tg) rats develop chronic colitis when colonized with complex gut commensal bacteria whereas non-transgenic (nTg) rats remain disease-free. However, the role of B. theta in causing disease in Tg rats is unknown nor is much known about how gut microbes respond to host inflammation. Methods: Tg and nTg rats were monoassociated with a human isolate of B. theta. Colonic inflammation was assessed by histologic scoring and tissue pro-inflammatory cytokine measurement. Whole genome transcriptional profiling of B. theta recovered from ceca was performed using custom GeneChips and data analyzed using dChip, Significance Analysis of Microarrays, and Gene Set Enrichment Analysis (GSEA) software. Western Blots were used to determine adaptive immune responses to a differentially expressed B. theta gene. Results: B. theta monoassociated Tg rats, but not nTg or germ-free controls, developed chronic colitis. Transcriptional profiles of cecal B. theta were significantly different in Tg vs. nTg rats. GSEA revealed that genes in KEGG canonical pathways involved in bacterial growth and metabolism were downregulated in B. theta from Tg rats with colitis though luminal bacterial concentrations were unaffected. Bacterial genes in the Gene Ontology molecular function "receptor activity", most of which encode nutrient binding proteins, were significantly upregulated in B. theta from Tg rats and include a SusC homolog that induces adaptive immune responses in Tg rats. Conclusions: B. theta induces colitis in HLA-B27 Tg rats, which is associated with regulation of bacterial genes in metabolic and nutrient binding pathways that may affect host immune responses. These studies of the host-microbial dialogue may lead to the identification of novel microbial targets for IBD therapies.	[Hansen, Jonathan J.; Goeser, Laura; Fan, Ting-Jia; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Hansen, Jonathan J.; Sartor, R. Balfour] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Huang, Yong; Chang, Eugene B.] Univ Chicago, Dept Med, Gastroenterol Sect, Med Ctr, Chicago, IL 60637 USA; [Peterson, Daniel A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; University of Chicago Medical Center; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Hansen, JJ (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	jjhansen@med.unc.edu			NIH [K08 DK087896]; Crohn's and Colitis Foundation of America [2662]; Center for Gastrointestinal Biology and Disease [NIH P30 DK34987, NIH R01 DK53347, NIH P40 RR18803]; Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility; University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center [NIH DK42086]; Helmsley Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK042086, K08DK087896, R01DK053347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Center for Gastrointestinal Biology and Disease; Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility; University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center; Helmsley Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K08 DK087896 (J.J.H.), a Career Development Award from the Crohn's and Colitis Foundation of America 2662 (J.J.H.), Center for Gastrointestinal Biology and Disease grant NIH P30 DK34987 (Robert S. Sandler, PI), NIH R01 DK53347 (R. B. S.), NIH P40 RR18803 (R. B. S.), Crohn's and Colitis Foundation of America Gnotobiotic Animal Facility (R. B. S.), University of Chicago Host-Microbe Core of the Digestive Disease Research Core Center (NIH DK42086, E. B. C.), and Helmsley Foundation (E. B. C., R. B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2009, ALIMENT PHARM THER, V29, P75, DOI 10.1111/j.1365-2036.2008.03860.x; Ashorn S, 2009, INFLAMM BOWEL DIS, V15, P199, DOI 10.1002/ibd.20535; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Carroll IM, 2007, AM J PHYSIOL-GASTR L, V293, pG729, DOI 10.1152/ajpgi.00132.2007; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Edwards LA, 2011, INFLAMM BOWEL DIS, V17, P1201, DOI 10.1002/ibd.21501; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hansen JJ, 2007, INFLAMM BOWEL DIS, P19; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patwa LG, 2011, GASTROENTEROLOGY, V141, P1842, DOI 10.1053/j.gastro.2011.06.064; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vine CE, 2011, FEMS MICROBIOL LETT; Wang YW, 2010, APPL MICROBIOL BIOT, V88, P1333, DOI 10.1007/s00253-010-2921-8; Wei B, 2001, INFECT IMMUN, V69, P6044, DOI 10.1128/IAI.69.10.6044-6054.2001; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	43	30	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42645	10.1371/journal.pone.0042645	http://dx.doi.org/10.1371/journal.pone.0042645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880065	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100149
J	Tarroux, A; Bety, J; Gauthier, G; Berteaux, D				Tarroux, Arnaud; Bety, Joel; Gauthier, Gilles; Berteaux, Dominique			The Marine Side of a Terrestrial Carnivore: Intra-Population Variation in Use of Allochthonous Resources by Arctic Foxes	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; TROPHIC NICHE WIDTH; ALOPEX-LAGOPUS; FOOD-WEB; INDIVIDUAL SPECIALIZATION; LIPID EXTRACTION; CYCLIC DYNAMICS; CARBON ISOTOPES; LEMMING CYCLES; CLIMATE-CHANGE	Inter-individual variation in diet within generalist animal populations is thought to be a widespread phenomenon but its potential causes are poorly known. Inter-individual variation can be amplified by the availability and use of allochthonous resources, i.e., resources coming from spatially distinct ecosystems. Using a wild population of arctic fox as a study model, we tested hypotheses that could explain variation in both population and individual isotopic niches, used here as proxy for the trophic niche. The arctic fox is an opportunistic forager, dwelling in terrestrial and marine environments characterized by strong spatial (arctic-nesting birds) and temporal (cyclic lemmings) fluctuations in resource abundance. First, we tested the hypothesis that generalist foraging habits, in association with temporal variation in prey accessibility, should induce temporal changes in isotopic niche width and diet. Second, we investigated whether within-population variation in the isotopic niche could be explained by individual characteristics (sex and breeding status) and environmental factors (spatiotemporal variation in prey availability). We addressed these questions using isotopic analysis and Bayesian mixing models in conjunction with linear mixed-effects models. We found that: i) arctic fox populations can simultaneously undergo short-term (i.e., within a few months) reduction in both isotopic niche width and inter-individual variability in isotopic ratios, ii) individual isotopic ratios were higher and more representative of a marine-based diet for non-breeding than breeding foxes early in spring, and iii) lemming population cycles did not appear to directly influence the diet of individual foxes after taking their breeding status into account. However, lemming abundance was correlated to proportion of breeding foxes, and could thus indirectly affect the diet at the population scale.	[Tarroux, Arnaud; Bety, Joel; Berteaux, Dominique] Univ Quebec, Chaire Rech Canada Conservat Ecosyst Nord, Rimouski, PQ G5L 3A1, Canada; [Tarroux, Arnaud; Bety, Joel; Berteaux, Dominique] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Gauthier, Gilles] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles] Univ Laval, Ctr Etud, Quebec City, PQ, Canada	University of Quebec; University of Quebec; Laval University; Laval University	Tarroux, A (corresponding author), Univ Quebec, Chaire Rech Canada Conservat Ecosyst Nord, Rimouski, PQ G5L 3A1, Canada.	arnaud.tarroux@gmail.com; dominique_berteaux@uqar.qc.ca	Berteaux, Dominique/J-3276-2016; Tarroux, Arnaud/AAE-5173-2021	Berteaux, Dominique/0000-0003-2728-5985; Tarroux, Arnaud/0000-0001-8306-6694; Bety, Joel/0000-0002-8775-6411	National Sciences & Engineering Research Council Northern Research Internship; Canada Foundation for Innovation; Canada Research Chairs; Centre d'Etudes Nordiques; Environment Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies; Indian and Northern Affairs Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); Networks of Centres of Excellence of Canada ArcticNet; Nunavut Wildlife Management Board; Parks Canada; Polar Continental Shelf Program; Universite du Quebec a Rimouski (UQAR); Universite Laval	National Sciences & Engineering Research Council Northern Research Internship; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Centre d'Etudes Nordiques; Environment Canada(CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Indian and Northern Affairs Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Networks of Centres of Excellence of Canada ArcticNet; Nunavut Wildlife Management Board; Parks Canada; Polar Continental Shelf Program; Universite du Quebec a Rimouski (UQAR); Universite Laval	This study was partly funded by an National Sciences & Engineering Research Council Northern Research Internship to A. Tarroux. This study was also supported by (alphabetical order): Canada Foundation for Innovation, Canada Research Chairs, Centre d'Etudes Nordiques, Environment Canada, Fonds Quebecois de la Recherche sur la Nature et les Technologies, Indian and Northern Affairs Canada, Natural Sciences and Engineering Research Council of Canada (NSERC), Networks of Centres of Excellence of Canada ArcticNet, Nunavut Wildlife Management Board, Parks Canada, Polar Continental Shelf Program, Universite du Quebec a Rimouski (UQAR), and Universite Laval. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; ANGERBJORN A, 1994, OECOLOGIA, V99, P226, DOI 10.1007/BF00627734; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Audet Alexandra M., 2002, Mammalian Species, V713, P1, DOI 10.1644/1545-1410(2002)713<0001:AL>2.0.CO;2; Bates D., 2010, LINEAR FIXED EFFECTS; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bety J, 2001, OIKOS, V93, P388, DOI 10.1034/j.1600-0706.2001.930304.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cadieux M. - C., 2008, MONITORING ENV ECOLO; Careau V, 2008, ECOSCIENCE, V15, P268, DOI 10.2980/15-2-3097; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dalerum F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032071; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Dehn LA, 2006, SCI TOTAL ENVIRON, V362, P103, DOI 10.1016/j.scitotenv.2005.11.012; Duchesne D, 2011, OECOLOGIA, V167, P967, DOI 10.1007/s00442-011-2045-6; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Gagnon CA, 2009, ECOL SOC, V14; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; GRANT PR, 1976, P NATL ACAD SCI USA, V73, P257, DOI 10.1073/pnas.73.1.257; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Huxel GR, 2002, ECOL RES, V17, P419, DOI 10.1046/j.1440-1703.2002.00501.x; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Jardine TD, 2005, OECOLOGIA, V144, P528, DOI 10.1007/s00442-005-0013-8; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Krebs CJ, 2002, CAN J ZOOL, V80, P1323, DOI 10.1139/Z02-120; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Legagneux P., 2012, ECOLOGY IN PRESS, DOI [10.1890/11-1973.1, DOI 10.1890/11-1973.1]; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Pamperin NJ, 2008, POLAR BIOL, V31, P1421, DOI 10.1007/s00300-008-0481-5; Parnell A, 2010, SIAR STABLE ISOTOPE; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; POND CM, 1995, J ZOOL, V236, P593, DOI 10.1111/j.1469-7998.1995.tb02734.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed A, 2002, PATTERNS DISTRIBUTIO, P53; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SMITH TG, 1976, CAN J ZOOL, V54, P1610, DOI 10.1139/z76-188; Stapp P, 2003, OECOLOGIA, V134, P496, DOI 10.1007/s00442-002-1146-7; Svanback R, 2005, EVOL ECOL RES, V7, P993; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Szepanski MM, 1999, OECOLOGIA, V120, P327, DOI 10.1007/s004420050866; Szor G, 2008, POLAR BIOL, V31, P351, DOI 10.1007/s00300-007-0364-1; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Tarroux A, 2010, POLAR BIOL, V33, P1021, DOI 10.1007/s00300-010-0780-5; Therrien JF, 2011, J AVIAN BIOL, V42, P363, DOI 10.1111/j.1600-048X.2011.05330.x; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Urton EJM, 2005, OECOLOGIA, V145, P317, DOI 10.1007/s00442-005-0124-2; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Willson JD, 2010, OIKOS, V119, P1161, DOI 10.1111/j.1600-0706.2009.17939.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	82	33	33	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42427	10.1371/journal.pone.0042427	http://dx.doi.org/10.1371/journal.pone.0042427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22900021	Green Published, Green Submitted, gold			2022-12-25	WOS:000307284100089
J	Tian, XL; Wang, SY; Zhang, Z; Lv, DC				Tian, Xiliang; Wang, Shouyu; Zhang, Zhen; Lv, Decheng			Rat Bone Marrow-Derived Schwann-Like Cells Differentiated by the Optimal Inducers Combination on Microfluidic Chip and Their Functional Performance	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION; STROMAL CELLS; IN-VITRO; NEUROTROPHIC FACTOR; MYELINATION; TRANSPLANTATION; PHENOTYPE; OUTGROWTH; LINEAGE	Numerous researches demonstrated the possibility of derivation of Schwann-like (SC-like) cells in vitro from bone marrow stromal cells (BMSCs). However, the concentration of the induce factors were different in those studies, especially for the critical factors forskolin (FSK) and beta-heregulin (HRG). Here, we used a new and useful method to build an integrated microfluidic chip for rapid analyses of the optimal combination between the induce factors FSK and HRG. The microfluidic device was mainly composed of an upstream concentration gradient generator (CGG) and a downstream cell culture module. Rat BMSCs were cultured in the cell chambers for 11 days at the different concentrations of induce factors generated by CGG. The result of immunofluorescence staining on-chip showed that the group of 4.00 mu M FSK and 250.00 ng/ml HRG presented an optimal effect to promote the derivation of SC-like cells. Moreover, the optimal SC-like cells obtained on-chip were further tested using DRG co-culture and ELISA to detect their functional performance. Our findings demonstrate that SC-like cells could be obtained with high efficiency and functional performance in the optimal inducers combination.	[Tian, Xiliang; Wang, Shouyu; Zhang, Zhen; Lv, Decheng] Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China	Dalian Medical University	Wang, SY (corresponding author), Dalian Med Univ, Dept Orthoped, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.	wangshouyu666.student@sina.com; lvdecheng88@sina.com			National Nature Science Foundation of China [30901950]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Nature Science Foundation of China (30901950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Bunge RP, 1994, J NEUROL S1, V242, pS19; Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; De Groot DM, 2006, MOL ENDOCRINOL, V20, P2987, DOI 10.1210/me.2006-0168; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Dezawa M, 2000, PROG RETIN EYE RES, V19, P171, DOI 10.1016/S1350-9462(99)00010-5; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Hou SY, 2006, NEUROSCIENCE, V140, P101, DOI 10.1016/j.neuroscience.2006.01.066; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Kim C, 2011, LAB CHIP, V11, P874, DOI [10.1039/c0lc00516a, 10.1039/c01c00516a]; Kim HA, 2001, J NEUROSCI, V21, P1110; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Liu L, 2010, BIOMED MICRODEVICES, V12, P505, DOI 10.1007/s10544-010-9407-4; Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013; Mahay D, 2008, BIOTECHNOL APPL BIOC, V51, P167, DOI 10.1042/BA20070212; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Peng JA, 2011, BRAIN RES BULL, V84, P235, DOI 10.1016/j.brainresbull.2010.12.013; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Todd KJ, 2007, EUR J NEUROSCI, V25, P1287, DOI 10.1111/j.1460-9568.2007.05385.x; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Tourovskaia A, 2006, NAT PROTOC, V1, P1092, DOI 10.1038/nprot.2006.123; Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Zhao FQ, 2005, BIOMED ENVIRON SCI, V18, P326; Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025	38	7	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42804	10.1371/journal.pone.0042804	http://dx.doi.org/10.1371/journal.pone.0042804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880114	gold, Green Published, Green Submitted			2022-12-25	WOS:000307284100174
J	Zimin, AV; Kelley, DR; Roberts, M; Marcais, G; Salzberg, SL; Yorke, JA				Zimin, Aleksey V.; Kelley, David R.; Roberts, Michael; Marcais, Guillaume; Salzberg, Steven L.; Yorke, James A.			Mis-Assembled "Segmental Duplications" in Two Versions of the Bos taurus Genome	PLOS ONE			English	Article								We analyzed the whole genome sequence coverage in two versions of the Bos taurus genome and identified all regions longer than five kilobases (Kbp) that are duplicated within chromosomes with >99% sequence fidelity in both copies. We call these regions High Fidelity Duplications (HFDs). The two assemblies were Btau 4.2, produced by the Human Genome Sequencing Center at Baylor College of Medicine, and UMD Bos taurus 3.1 (UMD 3.1), produced by our group at the University of Maryland. We found that Btau 4.2 has a far greater number of HFDs, 3111 versus only 69 in UMD 3.1. Read coverage analysis shows that 39 million base pairs (Mbp) of sequence in HFDs in Btau 4.2 appear to be a result of a mis-assembly and therefore cannot be qualified as segmental duplications. UMD 3.1 has only 0.41 Mbp of sequence in HFDs that are due to a mis-assembly.	[Zimin, Aleksey V.; Kelley, David R.; Roberts, Michael; Marcais, Guillaume; Yorke, James A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Salzberg, Steven L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University	Zimin, AV (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	alekseyz@ipst.umd.edu	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432	NSF [DMS0616585]; NIH [R01HG0294501]; USDA [CSREES 2008-04049]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006102, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported under NSF grant DMS0616585, NIH Grant R01HG0294501 and USDA grant CSREES 2008-04049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	6	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2012	7	8							e42680	10.1371/journal.pone.0042680	http://dx.doi.org/10.1371/journal.pone.0042680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985QT	22880081	gold, Green Submitted, Green Published			2022-12-25	WOS:000307284100157
J	Chanthaphavong, RS; Loughran, PA; Lee, TYS; Scott, MJ; Billiar, TR				Chanthaphavong, R. Savanh; Loughran, Patricia A.; Lee, Tiffany Y. S.; Scott, Melanie J.; Billiar, Timothy R.			A Role for cGMP in Inducible Nitric-oxide Synthase (iNOS)-induced Tumor Necrosis Factor (TNF) alpha-converting Enzyme (TACE/ADAM17) Activation, Translocation, and TNF Receptor 1 (TNFR1) Shedding in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; HEPATOCELLULAR APOPTOSIS; ORGAN MORPHOGENESIS; SIGNAL-TRANSDUCTION; PROTEIN-KINASES; POTENTIAL ROLE; ADAM PROTEASE; SEPTIC SHOCK; GENE FAMILY; CYCLIC-GMP	We and others have previously shown that the inducible nitric-oxide synthase (iNOS) and nitric oxide (NO) are hepatoprotective in a number of circumstances, including endotoxemia. In vitro, hepatocytes are protected from tumor necrosis factor (TNF) alpha-induced apoptosis via cGMP-dependent and cGMP-independent mechanisms. We have shown that the cGMP-dependent protective mechanisms involve the inhibition of death-inducing signaling complex formation. We show here that LPS-induced iNOS expression leads to rapid TNF receptor shedding from the surface of hepatocytes via NO/cGMP/protein kinase G-dependent activation and surface translocation of TNF alpha-converting enzyme (TACE/ADAM17). The activation of TACE is associated with the up-regulation of iRhom2 as well as the interaction and phosphorylation of TACE and iRhom2, which are also NO/cGMP/protein kinase G-dependent. These findings suggest that one mechanism of iNOS/NO-mediated protection of hepatocytes involves the rapid shedding of TNF receptor 1 to limit TNF alpha signaling.	[Chanthaphavong, R. Savanh; Loughran, Patricia A.; Lee, Tiffany Y. S.; Scott, Melanie J.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu	Loughran, Patricia/AAB-1184-2021		National Institutes of Health [R37-GM-044100, R01-GM-050441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441, R37GM044100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM-044100 and R01-GM-050441.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; BILLIAR TR, 1990, J LEUKOCYTE BIOL, V48, P565, DOI 10.1002/jlb.48.6.565; BILLIAR TR, 1992, AM J PHYSIOL, V262, pC1077, DOI 10.1152/ajpcell.1992.262.4.C1077; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Costelli P, 2003, CELL DEATH DIFFER, V10, P997, DOI 10.1038/sj.cdd.4401281; Dada LA, 2011, J CLIN INVEST, V121, P1683, DOI 10.1172/JCI57748; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Eum HA, 2011, AM J PATHOL, V179, P1221, DOI 10.1016/j.ajpath.2011.05.046; Eum HA, 2011, ADV EXP MED BIOL, V691, P617, DOI 10.1007/978-1-4419-6612-4_65; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Iglesias J, 2003, AM J KIDNEY DIS, V41, P62, DOI 10.1053/ajkd.2003.50024; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; Kim PKM, 2002, J BIOL CHEM, V277, P38855, DOI 10.1074/jbc.M203484200; Kim YM, 2000, HEPATOLOGY, V32, P770, DOI 10.1053/jhep.2000.18291; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kubota Y, 2006, DEVELOPMENT, V133, P263, DOI 10.1242/dev.02195; LEIST M, 1995, AM J PATHOL, V146, P1220; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Li JR, 2000, J BIOL CHEM, V275, P13026, DOI 10.1074/jbc.275.17.13026; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nishiwaki K, 2004, NAT CELL BIOL, V6, P31, DOI 10.1038/ncb1079; Oberholzer A, 2001, J ENDOTOXIN RES, V7, P375, DOI 10.1177/09680519010070050501; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Podbilewicz B, 2004, NAT CELL BIOL, V6, P9, DOI 10.1038/ncb0104-9; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rangaswami H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001423; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Refsum SE, 1996, J PEDIATR SURG, V31, P928, DOI 10.1016/S0022-3468(96)90413-3; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Santos D O, 1999, Nihon Hansenbyo Gakkai Zasshi, V68, P185; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; SEGLEN PO, 1977, ACTA BIOL MED GER, V36, P1789; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Takada Y, 2003, J BIOL CHEM, V278, P23390, DOI 10.1074/jbc.M213237200; TRACEY KJ, 1988, ANN INST PASTEUR IMM, V139, P311, DOI 10.1016/0769-2625(88)90148-1; TRACEY KJ, 1991, CIRC SHOCK, V35, P123; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; Wang Y, 2006, APOPTOSIS, V11, P441, DOI 10.1007/s10495-005-4293-6; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Zamora R, 2001, J BIOL CHEM, V276, P46887, DOI 10.1074/jbc.M101865200; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200	73	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2012	287	43					35887	35898		10.1074/jbc.M112.365171	http://dx.doi.org/10.1074/jbc.M112.365171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	027PA	22898814	Green Published, hybrid			2022-12-25	WOS:000310364000011
J	Alvarez, Y; Rodriguez, M; Municio, C; Hugo, E; Alonso, S; Ibarrola, N; Fernandez, N; Crespo, MS				Alvarez, Yolanda; Rodriguez, Mario; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Ibarrola, Nieves; Fernandez, Nieves; Sanchez Crespo, Mariano			Sirtuin 1 Is a Key Regulator of the Interleukin-12 p70/Interleukin-23 Balance in Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEPENDENT GENE-EXPRESSION; HISTONE H3; AUTOIMMUNE INFLAMMATION; DIFFERENTIAL REGULATION; PROTEIN SIR2; IFN-GAMMA; C-REL; IL-12; ACETYLATION	Stimulation of human dendritic cells with the fungal surrogate zymosan produces IL-23 and a low amount of IL-12 p70. Trans-repression of il12a transcription, which encodes IL-12 p35 chain, by proteins of the Notch family and lysine deacetylation reactions have been reported as the underlying mechanisms, but a number of questions remain to be addressed. Zymosan produced the location of sirtuin 1 (SIRT1) to the nucleus, enhanced its association with the il12a promoter, increased the nuclear concentration of the SIRT1 co-substrate NAD(+), and decreased chromatin accessibility in the nucleosome-1 of il12a, which contains a kappa B-site. The involvement of deacetylation reactions in the inhibition of il12a transcription was supported by the absence of Ac-Lys-14-histone H3 in dendritic cells treated with zymosan upon coimmunoprecipitation of transducin-like enhancer of split. In contrast, we did not obtain evidence of a possible effect of SIRT1 through the deacetylation of c-Rel, the central element of the NF-kappa B family involved in il12a regulation. These data indicate that an enhancement of SIRT1 activity in response to phagocytic stimuli may reduce the accessibility of c-Rel to the il12a promoter and its transcriptional activation, thus regulating the IL-12 p70/ IL-23 balance and modulating the ongoing immune response.	[Alvarez, Yolanda; Rodriguez, Mario; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Sanchez Crespo, Mariano] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Ibarrola, Nieves] Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Fernandez, Nieves] Univ Valladolid, Dept Bioquim & Biol Mol, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Universidad de Valladolid	Crespo, MS (corresponding author), CSIC, Inst Biol & Genet Mol, C Sanzy Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Municio, Cristina/D-2916-2019; Alvarez, Yolanda/AAD-4964-2021; Fernández, Nieves/N-5426-2018; Rodríguez, Mario/AAE-9602-2020	Municio, Cristina/0000-0002-8552-8183; Fernández, Nieves/0000-0002-9141-3956; Rodríguez, Mario/0000-0002-4587-3863; Alvarez, Yolanda/0000-0002-4851-8277; Sanchez Crespo, Mariano/0000-0002-6149-154X	Plan Nacional de Salud y Farmacia [SAF2007-60446, SAF2010-15070]; Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon Grant [CSI003A11-2]	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon Grant(Junta de Castilla y Leon)	This work was supported by Plan Nacional de Salud y Farmacia Grants SAF2007-60446 and SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular, and Junta de Castilla y Leon Grant CSI003A11-2.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; FISHER TL, 1973, J BIOL CHEM, V248, P4293; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Goriely S, 2003, BLOOD, V101, P4894, DOI 10.1182/blood-2002-09-2851; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Hassan AH, 2006, J BIOL CHEM, V281, P18126, DOI 10.1074/jbc.M602851200; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kollet JI, 2006, MOL IMMUNOL, V43, P623, DOI 10.1016/j.molimm.2005.04.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Legutko A, 2011, J IMMUNOL, V187, P4517, DOI 10.4049/jimmunol.1101493; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PALMERE RM, 1970, J ORG CHEM, V35, P2703, DOI 10.1021/jo00833a049; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Purushotham A, 2012, FASEB J, V26, P656, DOI 10.1096/fj.11-195172; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	66	23	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2012	287	42					35689	35701		10.1074/jbc.M112.391839	http://dx.doi.org/10.1074/jbc.M112.391839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	022OF	22893703	hybrid, Green Published			2022-12-25	WOS:000309968000080
J	Challa, AA; Vukmirovic, M; Blackmon, J; Stefanovic, B				Challa, Azariyas A.; Vukmirovic, Milica; Blackmon, John; Stefanovic, Branko			Withaferin-A Reduces Type I Collagen Expression In Vitro and Inhibits Development of Myocardial Fibrosis In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HYPERTENSIVE HEART-DISEASE; HEPATIC STELLATE CELLS; NF-KAPPA-B; LIVER FIBROSIS; MESSENGER-RNA; TGF-BETA; THERAPEUTIC TARGETS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS	Type I collagen is the most abundant protein in the human body. Its excessive synthesis results in fibrosis of various organs. Fibrosis is a major medical problem without an existing cure. Excessive synthesis of type I collagen in fibrosis is primarily due to stabilization of collagen mRNAs. We recently reported that intermediate filaments composed of vimentin regulate collagen synthesis by stabilizing collagen mRNAs. Vimentin is a primary target of Withaferin-A (WF-A). Therefore, we hypothesized that WF-A may reduce type I collagen production by disrupting vimentin filaments and decreasing the stability of collagen mRNAs. This study is to determine if WF-A exhibits anti-fibrotic properties in vitro and in vivo and to elucidate the molecular mechanisms of its action. In lung, skin and heart fibroblasts WF-A disrupted vimentin filaments at concentrations of 0.5-1.5 mu M and reduced 3 fold the half-lives of collagen alpha 1(I) and alpha 2(I) mRNAs and protein expression. In addition, WF-A inhibited TGF-beta 1 induced phosphorylation of TGF-beta 1 receptor I, Smad3 phosphorylation and transcription of collagen genes. WF-A also inhibited in vitro activation of primary hepatic stellate cells and decreased their type I collagen expression. In mice, administration of 4 mg/kg WF-A daily for 2 weeks reduced isoproterenol-induced myocardial fibrosis by 50%. Our findings provide strong evidence that Withaferin-A could act as an anti-fibrotic compound against fibroproliferative diseases, including, but not limited to, cardiac interstitial fibrosis.	[Challa, Azariyas A.; Vukmirovic, Milica; Blackmon, John; Stefanovic, Branko] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Challa, AA (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu			National Institutes of Health [5R01DK059466-08]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant 5R01DK059466-08 to BS and an American Heart Association grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Agocha AE, 1997, MOL CELL BIOCHEM, V172, P195, DOI 10.1023/A:1006848512174; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bauer M, 2001, FEBS LETT, V502, P1, DOI 10.1016/S0014-5793(01)02655-2; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuspidi C, 2006, NEPHROL DIAL TRANSPL, V21, P20, DOI 10.1093/ndt/gfi237; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Diez Javier, 2008, Circ J, V72 Suppl A, pA8, DOI 10.1253/circj.CJ-07-1067; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Fritz D, 2011, CURR MED CHEM, V18, P3410, DOI 10.2174/092986711796504691; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Gonzalez A, 2005, CURR OPIN NEPHROL HY, V14, P428, DOI 10.1097/01.mnh.0000174143.30045.bd; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Holwell TA, 1997, J CELL SCI, V110, P1947; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Maitra R, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-15; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Oh JH, 2008, EUR J PHARMACOL, V599, P11, DOI 10.1016/j.ejphar.2008.09.017; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; PICK R, 1989, AM J PATHOL, V134, P365; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Sharada AC, 1996, ACTA ONCOL, V35, P95, DOI 10.3109/02841869609098486; Smaldone S, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-8; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Thaiparambil JT, 2011, INT J CANC; Thompson Alexander James, 2010, Curr Gastroenterol Rep, V12, P23, DOI 10.1007/s11894-009-0080-9; Trojanowska M, 2009, CURR OPIN RHEUMATOL, V21, P623, DOI 10.1097/BOR.0b013e32833038ce; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamada NA, 2003, MUTAGENESIS, V18, P277, DOI 10.1093/mutage/18.3.277; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	68	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42989	10.1371/journal.pone.0042989	http://dx.doi.org/10.1371/journal.pone.0042989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900077	Green Submitted, Green Published, gold			2022-12-25	WOS:000307380900095
J	Lu, HR; Hallstrom, TC				Lu, Huarui; Hallstrom, Timothy C.			Sensitivity to TOP2 Targeting Chemotherapeutics Is Regulated by Oct1 and FILIP1L	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; LUNG-CANCER; DNA; FILAMIN; GENE; ANTICANCER; EXPRESSION; ENDOSTATIN; MUTATIONS; FAMILY	Topoisomerase II (TOP2) targeting drugs like doxorubicin and etoposide are frontline chemotherapeutics for a wide variety of solid and hematological malignancies, including breast and ovarian adenocarcinomas, lung cancers, soft tissue sarcomas, leukemias and lymphomas. These agents cause a block in DNA replication leading to a pronounced DNA damage response and initiation of apoptotic programs. Resistance to these agents is common, however, and elucidation of the mechanisms causing resistance to therapy could shed light on strategies to reduce the frequency of ineffective treatments. To explore these mechanisms, we utilized an unbiased shRNA screen to identify genes that regulate cell death in response to doxorubicin treatment. We identified the Filamin A interacting protein 1-like (FILIP1L) gene as a crucial mediator of apoptosis triggered by doxorubicin. FILIP1L shares significant similarity with bacterial SbcC, an ATPase involved in DNA repair. FILIP1L was originally described as DOC1, or "down-regulated in ovarian cancer" and has since been shown to be down-regulated in a wide variety of human tumors. FILIP1L levels increase markedly through transcriptional mechanisms following treatment with doxorubicin and other TOP2 poisons, including etoposide and mitoxantrone, but not by the TOP2 catalytic inhibitors merbarone or dexrazoxane (ICRF187), or by UV irradiation. This induction requires the action of the OCT1 transcription factor, which relocalizes to the FILIP1L promoter and facilitates its expression following doxorubicin treatment. Our findings suggest that the FILIP1L expression status in tumors may influence the response to anti-TOP2 chemotherapeutics.	[Lu, Huarui; Hallstrom, Timothy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lu, HR (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	halls026@umn.edu			Children's Cancer Research Fund, Minneapolis, MN	Children's Cancer Research Fund, Minneapolis, MN	This work was supported by Children's Cancer Research Fund, Minneapolis, MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Burton ER, 2011, MOL CANCER RES, V9, P1126, DOI 10.1158/1541-7786.MCR-11-0162; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Duncan MB, 2004, BBA-GEN SUBJECTS, V1671, P34, DOI 10.1016/j.bbagen.2003.12.010; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon M, 2008, CANCER RES, V68, P7332, DOI 10.1158/0008-5472.CAN-08-1087; Liu FJ, 2007, CANCER SCI, V98, P1381, DOI 10.1111/j.1349-7006.2007.00542.x; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mao Y, 1999, BIOCHEMISTRY-US, V38, P10793, DOI 10.1021/bi9909804; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Martin SA, 2010, CLIN CANCER RES, V16, P5107, DOI 10.1158/1078-0432.CCR-10-0821; Mazzanti CM, 2004, GENOME RES, V14, P1585, DOI 10.1101/gr.2552804; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Tandle AT, 2005, CYTOKINE, V30, P347, DOI 10.1016/j.cyto.2005.01.020; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Tissier A, 2010, DNA REPAIR, V9, P922, DOI 10.1016/j.dnarep.2010.04.010; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42921	10.1371/journal.pone.0042921	http://dx.doi.org/10.1371/journal.pone.0042921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900064	gold, Green Published, Green Submitted			2022-12-25	WOS:000307380900082
J	Vigelius, M; Meyer, B				Vigelius, Matthias; Meyer, Bernd			Stochastic Simulations of Pattern Formation in Excitable Media	PLOS ONE			English	Article							REACTION-DIFFUSION; CHEMICAL-SYSTEMS; CALCIUM OSCILLATIONS; COHERENCE RESONANCE; TRAVELING-WAVES; SPIRAL WAVES; NOISE; DYNAMICS; BEHAVIOR; MODEL	We present a method for mesoscopic, dynamic Monte Carlo simulations of pattern formation in excitable reaction-diffusion systems. Using a two-level parallelization approach, our simulations cover the whole range of the parameter space, from the noise-dominated low-particle number regime to the quasi-deterministic high-particle number limit. Three qualitatively different case studies are performed that stand exemplary for the wide variety of excitable systems. We present mesoscopic stochastic simulations of the Gray-Scott model, of a simplified model for intracellular Ca2+ oscillations and, for the first time, of the Oregonator model. We achieve simulations with up to 10(10) particles. The software and the model files are freely available and researchers can use the models to reproduce our results or adapt and refine them for further exploration.	[Vigelius, Matthias; Meyer, Bernd] Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia	Monash University	Vigelius, M (corresponding author), Monash Univ, FIT Ctr Res Intelligent Syst, Clayton, Vic, Australia.	Matthias.Vigelius@monash.edu			Australian Research Council [ARC DP0879239]	Australian Research Council(Australian Research Council)	This research is funded by the Australian Research Council (http://www.arc.gov.au/) under ARC DP0879239, providing salary support for MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066107; Alonso S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.078302; Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; Atzberger PJ, 2010, J COMPUT PHYS, V229, P3474, DOI 10.1016/j.jcp.2010.01.012; Bar M, 1994, CHAOS, V4, P499, DOI 10.1063/1.166028; BARKLEY D, 1991, PHYSICA D, V49, P61, DOI 10.1016/0167-2789(91)90194-E; Belousov B, 1985, OSCILLATIONS TRAVELI; Bernstein D, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biancalani T, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046215; Boon JP, 1996, PHYS REP, V273, P55, DOI 10.1016/0370-1573(95)00080-1; CHOPARD B, 1994, INT J MOD PHYS C, V5, P47, DOI 10.1142/S0129183194000052; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dupont G, 2003, LECT NOTES PHYS, V623, P131; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; Erban R., 2007, ARXIV07041908; Falcke M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/396; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Falcke M, 2009, CHAOS, V19, DOI 10.1063/1.3234259; FIELD RJ, 1974, J CHEM PHYS, V60, P1877, DOI 10.1063/1.1681288; FIELD RJ, 1972, J AM CHEM SOC, V94, P8649, DOI 10.1021/ja00780a001; Fu ZP, 2008, CHINESE PHYS LETT, V25, P1220, DOI 10.1088/0256-307X/25/4/016; Garcia-Ojalvo J, 1999, EUROPHYS LETT, V47, P298, DOI 10.1209/epl/i1999-00388-9; Gardiner C, 2009, SPRINGER SERIES SYNE; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glatt E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026206; Gong YB, 2011, PHYSICA A, V390, P3662, DOI 10.1016/j.physa.2011.05.038; Gosak M, 2007, BIOPHYS CHEM, V128, P210, DOI 10.1016/j.bpc.2007.04.007; GRAY P, 1985, J PHYS CHEM-US, V89, P22, DOI 10.1021/j100247a009; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; Hempel H, 1999, PHYS REV LETT, V82, P3713, DOI 10.1103/PhysRevLett.82.3713; Hochberg D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1900092; Izhikevich E.M, 2005, DYNAMICAL SYSTEMS NE; JAHNKE W, 1989, J PHYS CHEM-US, V93, P740, DOI 10.1021/j100339a047; JUNG P, 1995, CHAOS, V5, P458, DOI 10.1063/1.166117; Jung P, 1997, PHYS REV LETT, V78, P1723, DOI 10.1103/PhysRevLett.78.1723; Kadar S, 1998, NATURE, V391, P770, DOI 10.1038/35814; Kapral R, 2004, REV COMP CH, V20, P219, DOI 10.1002/0471678856.ch4; Kapral R, 1996, J PHYS CHEM-US, V100, P18976, DOI 10.1021/jp961247e; Keener J., 2009, INTERDISCIPLINARY AP, V8/I; Keener JP, 2006, MATH MED BIOL, V23, P1, DOI 10.1093/imammb/dql002; Klingbeil G, 2011, BIOINFORMATICS, V27, P1170, DOI 10.1093/bioinformatics/btr068; Koumoutsakos P, 2011, MATH MOD METH APPL S, V21, P955, DOI 10.1142/S021820251100543X; KUHNERT L, 1986, NATURE, V319, P393, DOI 10.1038/319393a0; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Lampoudi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3074302; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lechleiter JD, 1998, BIOPHYS CHEM, V72, P123, DOI 10.1016/S0301-4622(98)00128-8; Li H, 2010, INT J HIGH PERFORM C, V24, P107, DOI 10.1177/1094342009106066; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lis M, 2009, BIOINFORMATICS, V25, P2289, DOI 10.1093/bioinformatics/btp387; Ma J, 2008, CHINESE PHYS LETT, V25, P4325, DOI 10.1088/0256-307X/25/12/039; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Mazin W, 1996, MATH COMPUT SIMULAT, V40, P371, DOI 10.1016/0378-4754(95)00044-5; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Mott DR, 2001, 20041068 USGS; Muratov CB, 1999, PHYS REV E, V60, P242, DOI 10.1103/PhysRevE.60.242; Muratov CB, 2007, P NATL ACAD SCI USA, V104, P702, DOI 10.1073/pnas.0607433104; Murray JD, 2003, MATH BIOL, V3; Nakata S, 2011, J PHYS CHEM A, V115, P7406, DOI 10.1021/jp2012057; Ouyang Q, 2000, PHYS REV LETT, V84, P1047, DOI 10.1103/PhysRevLett.84.1047; PEARSON JE, 1993, SCIENCE, V261, P189, DOI 10.1126/science.261.5118.189; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Rodriguez JV, 2006, BIOINFORMATICS, V22, P1895, DOI 10.1093/bioinformatics/btl271; Sagues F, 2003, DALTON T, P1201, DOI 10.1039/b210932h; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Schlesner J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015003; Scott SK, 2004, OSCILLATIONS WAVES C; Sendina-Nadal I, 2000, PHYS REV LETT, V84, P2734, DOI 10.1103/PhysRevLett.84.2734; Si FN, 2007, EUR PHYS J B, V60, P507, DOI 10.1140/epjb/e2008-00009-1; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Solovey G, 2010, PHILOS T R SOC A, V368, P5597, DOI 10.1098/rsta.2010.0273; Stundzia AB, 1996, J COMPUT PHYS, V127, P196, DOI 10.1006/jcph.1996.0168; Swillens S, 1998, CELL CALCIUM, V23, P291, DOI 10.1016/S0143-4160(98)90025-2; TANG YH, 1995, P NATL ACAD SCI USA, V92, P7869, DOI 10.1073/pnas.92.17.7869; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Ullner E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.180601; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vigelius M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033384; Vigelius M, 2011, BIOINFORMATICS, V27, P288, DOI 10.1093/bioinformatics/btq622; Wang HL, 2007, J PHYS CHEM A, V111, P1265, DOI 10.1021/jp0674064; Wang JC, 1999, PHYS REV LETT, V82, P855, DOI 10.1103/PhysRevLett.82.855; Wang WM, 2011, COMMUN NONLINEAR SCI, V16, P2016, DOI 10.1016/j.cnsns.2010.09.002; Winfree Arthur T., 1991, Chaos, V1, P303, DOI 10.1063/1.165844; Woolley TE, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051914; Woolley TE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046216; Yamasaki-Mann M, 2010, J BIOL CHEM, V285, P25053, DOI 10.1074/jbc.M109.095257; Yang JZ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148302; Yuan GY, 2011, CHAOS SOLITON FRACT, V44, P728, DOI 10.1016/j.chaos.2011.06.013; ZHABOTINSKY AM, 1985, OSCILLATIONS TRAVELL; Zhou LQ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138301; Zhu CL, 2007, BIOPHYS CHEM, V125, P201, DOI 10.1016/j.bpc.2006.08.001	100	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2012	7	8							e42508	10.1371/journal.pone.0042508	http://dx.doi.org/10.1371/journal.pone.0042508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986XO	22900025	gold, Green Published			2022-12-25	WOS:000307380900041
J	Kumar, R; Bose, A; Mallick, BN				Kumar, Rupesh; Bose, Amitabha; Mallick, Birendra Nath			A Mathematical Model towards Understanding the Mechanism of Neuronal Regulation of Wake-NREMS-REMS States	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; BASAL FOREBRAIN STIMULATION; LOCUS-COERULEUS NEURONS; MESENCEPHALIC RETICULAR-FORMATION; ASCENDING AROUSAL SYSTEM; MEDIAL PREOPTIC AREA; FREELY MOVING CATS; BRAIN-STEM; HYPOCRETIN OREXIN; SUPRACHIASMATIC NUCLEUS	In this study we have constructed a mathematical model of a recently proposed functional model known to be responsible for inducing waking, NREMS and REMS. Simulation studies using this model reproduced sleep-wake patterns as reported in normal animals. The model helps to explain neural mechanism(s) that underlie the transitions between wake, NREMS and REMS as well as how both the homeostatic sleep-drive and the circadian rhythm shape the duration of each of these episodes. In particular, this mathematical model demonstrates and confirms that an underlying mechanism for REMS generation is pre-synaptic inhibition from substantia nigra onto the REM-off terminals that project on REM-on neurons, as has been recently proposed. The importance of orexinergic neurons in stabilizing the wake-sleep cycle is demonstrated by showing how even small changes in inputs to or from those neurons can have a large impact on the ensuing dynamics. The results from this model allow us to make predictions of the neural mechanisms of regulation and patho-physiology of REMS.	[Kumar, Rupesh; Mallick, Birendra Nath] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Bose, Amitabha] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India; [Bose, Amitabha] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Kumar, Rupesh] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; New Jersey Institute of Technology; Jawaharlal Nehru University, New Delhi	Kumar, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	remsbnm@yahoo.com	Chillale, Rupesh/GYU-9179-2022; Nath, Mallick Birendra/AAF-1781-2020	Kumar, Rupesh/0000-0002-0858-9660; Bose, Amitabha/0000-0002-4812-119X	Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology; UGC Capacity build-up funds; JC Bose Fellowship; Fulbright-Nehru Program; National Science Foundation, USA [DMS-1122291]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); UGC Capacity build-up funds; JC Bose Fellowship(Department of Science & Technology (India)); Fulbright-Nehru Program; National Science Foundation, USA(National Science Foundation (NSF))	Financial supports from the Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology; UGC Capacity build-up funds and JC Bose Fellowship to BNM are acknowledged. Financial support from the Fulbright-Nehru Program and from the National Science Foundation DMS-1122291, USA to AB is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; AKERSTEDT T, 1986, ELECTROEN CLIN NEURO, V64, P119, DOI 10.1016/0013-4694(86)90106-9; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Behn CGD, 2010, J NEUROPHYSIOL, V103, P1937, DOI 10.1152/jn.00795.2009; BENINGTON JH, 1994, PROG NEUROBIOL, V44, P433, DOI 10.1016/0301-0082(94)90005-1; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bourgin P, 2000, J NEUROSCI, V20, P7760; BREMER F, 1975, BRAIN RES, V96, P71, DOI 10.1016/0006-8993(75)90573-9; BREMER F, 1970, BRAIN RES, V21, P132, DOI 10.1016/0006-8993(70)90028-4; BREMER F, 1973, ARCH ITAL BIOL, V111, P85; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; CHU N, 1973, SCIENCE, V179, P908, DOI 10.1126/science.179.4076.908; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DEARMOND SJ, 1971, EXP NEUROL, V33, P653, DOI 10.1016/0014-4886(71)90134-8; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Espana RA, 2006, CONTEMPORARY CLIN NE, P189; Espana RA, 2001, NEUROSCIENCE, V106, P699, DOI 10.1016/S0306-4522(01)00319-0; EVERSON CA, 1989, SLEEP, V12, P60; Favale E, 1961, ARCH ITAL BIOL, V99, P1; Fleshner M, 2011, PHILOS T R SOC A, V369, P3855, DOI 10.1098/rsta.2011.0085; GILLILAND MA, 1989, SLEEP, V12, P53, DOI 10.1093/sleep/12.1.53; Guzman-Marin R, 2000, BRAIN RES, V875, P23, DOI 10.1016/S0006-8993(00)02561-0; Gvilia I, 2006, J NEUROSCI, V26, P3037, DOI 10.1523/JNEUROSCI.4827-05.2006; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hernandez Peon R, 1963, ELECTROENCEPHALO S24, V24, P188; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; JACOBS BL, 1986, PROG NEUROBIOL, V27, P183, DOI 10.1016/0301-0082(86)90008-0; Kaur S, 2004, BEHAV BRAIN RES, V151, P185, DOI 10.1016/j.bbr.2003.08.011; Kaur S, 2001, SYNAPSE, V42, P141, DOI 10.1002/syn.1109; KUMAR VM, 1985, EXP NEUROL, V89, P304, DOI 10.1016/0014-4886(85)90091-3; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Magnes J., 1961, ARCH ITAL BIOL, V99, P33; Magni F., 1959, ARCH ITAL BIOL, V97, P33; Mallick B. N., 2011, RAPID EYE MOVEMENT S; Mallick BN, 2011, SLEEP MED REV, V15, P165, DOI 10.1016/j.smrv.2010.11.001; Mallick BN, 2012, PROG NEUROBIOL, V97, P259, DOI 10.1016/j.pneurobio.2012.04.001; Mallick BN, 2005, BEHAV BRAIN RES, V158, P9, DOI 10.1016/j.bbr.2004.08.004; Mallick BN, 2004, J NEUROSCI RES, V75, P133, DOI 10.1002/jnr.10827; MALLICK BN, 1984, BRAIN RES BULL, V13, P353, DOI 10.1016/0361-9230(84)90084-4; Mallick BN, 2004, SYNAPSE, V51, P59, DOI 10.1002/syn.10283; MALLICK BN, 1986, BRAIN RES BULL, V16, P121, DOI 10.1016/0361-9230(86)90019-5; Mallick BN, 2001, NEUROSCIENCE, V104, P467, DOI 10.1016/S0306-4522(01)00062-8; MALLICK BN, 1983, EXP NEUROL, V81, P586, DOI 10.1016/0014-4886(83)90328-X; Mallick BN, 1999, RAPID EYE MOVEMENT S; MANCIA M, 1971, BRAIN RES, V33, P491, DOI 10.1016/0006-8993(71)90123-5; MANCIA M, 1974, BRAIN RES, V80, P41, DOI 10.1016/0006-8993(74)90722-7; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; MCGINTY D, 1990, TRENDS NEUROSCI, V13, P480, DOI 10.1016/0166-2236(90)90081-K; Methippara MM, 2000, NEUROREPORT, V11, P3423, DOI 10.1097/00001756-200011090-00004; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Nishino S, 2006, OREXIN HYPOCRETIN SY; Nishino S, 2007, J CLIN PSYCHIAT, V68, P9; Nishino S, 2007, SLEEP MED, V8, P373, DOI 10.1016/j.sleep.2007.03.008; OKUDZHAVA VM, 1985, ZH VYSSH NERV DEYAT+, V35, P891; Pal D, 2009, NEUROSCIENCE, V164, P404, DOI 10.1016/j.neuroscience.2009.08.025; Pal Dinesh, 2005, Shengli Xuebao, V57, P401; Pal D, 2006, NEUROPHARMACOLOGY, V51, P1, DOI 10.1016/j.neuropharm.2006.02.006; Peyron C, 1998, J NEUROSCI, V18, P9996; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; ROSINA A, 1966, ELECTROEN CLIN NEURO, V21, P157, DOI 10.1016/0013-4694(66)90123-4; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sherin JE, 1998, J NEUROSCI, V18, P4705; Singh S, 1996, NEUROSCI RES, V24, P227, DOI 10.1016/0168-0102(95)00998-1; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Steriade M. M., 2005, BRAIN CONTROL WAKEFU; STERMAN MB, 1962, EXP NEUROL, V6, P91, DOI 10.1016/0014-4886(62)90080-8; STERMAN MB, 1962, EXP NEUROL, V6, P103, DOI 10.1016/0014-4886(62)90081-X; Suntsova N, 2002, J PHYSIOL-LONDON, V543, P665, DOI 10.1113/jphysiol.2002.023085; SZYMUSIAK R, 1989, BRAIN RES, V498, P355, DOI 10.1016/0006-8993(89)91116-5; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; Thankachan S, 2001, BRAIN RES BULL, V55, P43, DOI 10.1016/S0361-9230(01)00486-5; TRACHSEL L, 1986, AM J PHYSIOL, V251, pR1037, DOI 10.1152/ajpregu.1986.251.6.R1037; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859	95	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42059	10.1371/journal.pone.0042059	http://dx.doi.org/10.1371/journal.pone.0042059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905114	Green Submitted, Green Published, gold			2022-12-25	WOS:000307331100024
J	Thornton, E; Vink, R				Thornton, Emma; Vink, Robert			Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease	PLOS ONE			English	Article							NEUROKININ-3 RECEPTORS; BASAL GANGLIA; IN-VIVO; MICROGLIAL ACTIVATION; FUNCTIONAL DEFICITS; OXIDATIVE STRESS; DOPAMINE; DEGENERATION; ASTROCYTES; NIGRA	Neuroinflammation and blood brain barrier (BBB) dysfunction have been implicated in the pathogenesis of Parkinson's disease (PD). The neuropeptide substance P (SP) is an important mediator of both neuroinflammation and BBB dysfunction through its NK1 receptor in a process known as neurogenic inflammation. Increased SP content has previously been reported following 6-OHDA treatment in vitro, with the levels of SP correlating with cell death. The present study used an in vivo 6-OHDA lesion model to determine if dopaminergic degeneration was associated with increased SP in the substantia nigra and whether this degeneration could be prevented by using a SP, NK1 receptor antagonist Unilateral, intrastriatal 6-OHDA lesions were induced and SP (10 mu g/2 mu L) or the NK1 receptor antagonists, N-acetyl-L-tryptophan (2 mu L at 50 nM) or L-333,060 (2 mu L at 100 nM), administered immediately after the neurotoxin. Nigral SP content was then determined using immunohistochemical and ELISA methods, neuroinflammation and barrier integrity was assessed using Iba-1, ED-1, GFAP and albumin immunohistochemistry, while dopaminergic cell loss was assessed with tyrosine hydroxylase immunohistochemistry. Motor function in all animals was assessed using the rotarod task. Intrastriatal 6-OHDA lesioning produced an early and sustained increase in ipsilateral nigral SP content, along with a breakdown of the BBB and activation of microglia and astrocytes. Further exacerbation of SP levels accelerated disease progression, whereas NK1 receptor antagonist treatment protected dopaminergic neurons, preserved barrier integrity, reduced neuroinflammation and significantly improved motor function. We propose that neurogenic inflammation contributes to dopaminergic degeneration in early experimental PD and demonstrate that an NK1 receptor antagonist may represent a novel neuroprotective therapy.	[Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia	University of Adelaide	Thornton, E (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Emery, Kitty/B-5850-2011; Speller, Camilla/D-2830-2014	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Emery, Kitty/0000-0002-4031-1968; Speller, Camilla/0000-0001-7128-9903	Neurosurgical Research Foundation, Adelaide, Australia	Neurosurgical Research Foundation, Adelaide, Australia	This study was funded, in part, by the Neurosurgical Research Foundation, Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; BANNON MJ, 1995, BRAIN RES, V695, P19, DOI 10.1016/0006-8993(95)00791-N; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Bevan MD, 1996, NEUROSCIENCE, V75, P5, DOI 10.1016/0306-4522(96)00377-6; Bishop C, 2004, BRAIN RES, V1023, P126, DOI 10.1016/j.brainres.2004.07.039; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chen LW, 2004, CURR DRUG TARGETS, V5, P197, DOI 10.2174/1389450043490596; Chung YC, 2010, BMB REP, V43, P225, DOI 10.5483/BMBRep.2010.43.4.225; De Ceballos ML, 1999, PEPTIDES, V20, P249, DOI 10.1016/S0196-9781(98)00177-6; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FERNANDEZ A, 1994, NEUROSCIENCE, V61, P73, DOI 10.1016/0306-4522(94)90061-2; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hirsch EC, 2000, J NEUROL, V247, P58, DOI 10.1007/PL00007762; Ionov ID, 2008, INT J NEUROSCI, V118, P1763, DOI 10.1080/00207450802330561; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Lee CS, 1996, NEUROSCIENCE, V72, P641, DOI 10.1016/0306-4522(95)00571-4; Levesque M, 2007, NEUROSCI RES, V57, P362, DOI 10.1016/j.neures.2006.11.002; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512000-00074; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MANTYH PW, 1989, P NATL ACAD SCI USA, V86, P5193, DOI 10.1073/pnas.86.13.5193; Marriott I, 2004, FRONT BIOSCI-LANDMRK, V9, P2153, DOI 10.2741/1377; Marti M, 2005, J NEUROCHEM, V93, P195, DOI 10.1111/j.1471-4159.2005.03015.x; MAUBORGNE A, 1983, BRAIN RES, V268, P167, DOI 10.1016/0006-8993(83)90403-1; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NISBET AP, 1995, NEUROSCIENCE, V66, P361, DOI 10.1016/0306-4522(94)00606-6; Ogura T, 2005, NEUROSCI RES, V51, P299, DOI 10.1016/j.neures.2004.12.006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; REID MS, 1990, EXP BRAIN RES, V82, P293; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Shults CW, 2004, MITOCHONDRION, V4, P641, DOI 10.1016/j.mito.2004.07.028; SIVAM SP, 1991, NEUROPEPTIDES, V18, P201, DOI 10.1016/0143-4179(91)90148-C; Takagi S, 2007, J NEURAL TRANSM, V114, P1553, DOI 10.1007/s00702-007-0790-9; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; TENOVUO O, 1984, BRAIN RES, V303, P113, DOI 10.1016/0006-8993(84)90217-8; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; UKAI M, 1995, PHARMACOL BIOCHEM BE, V51, P705, DOI 10.1016/0091-3057(95)00010-T; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wojtera M, 2005, FOLIA NEUROPATHOL, V43, P311	56	67	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2012	7	4							e34138	10.1371/journal.pone.0034138	http://dx.doi.org/10.1371/journal.pone.0034138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952GU	22905156	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000304780500034
J	Prinja, S; Bahuguna, P; Pinto, AD; Sharma, A; Bharaj, G; Kumar, V; Tripathy, JP; Kaur, M; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Pinto, Andrew D.; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh			The Cost of Universal Health Care in India: A Model Based Estimate	PLOS ONE			English	Article							POOR	Introduction: As high out-of-pocket healthcare expenses pose heavy financial burden on the families, Government of India is considering a variety of financing and delivery options to universalize health care services. Hence, an estimate of the cost of delivering universal health care services is needed. Methods: We developed a model to estimate recurrent and annual costs for providing health services through a mix of public and private providers in Chandigarh located in northern India. Necessary health services required to deliver good quality care were defined by the Indian Public Health Standards. National Sample Survey data was utilized to estimate disease burden. In addition, morbidity and treatment data was collected from two secondary and two tertiary care hospitals. The unit cost of treatment was estimated from the published literature. For diseases where data on treatment cost was not available, we collected data on standard treatment protocols and cost of care from local health providers. Results: We estimate that the cost of universal health care delivery through the existing mix of public and private health institutions would be INR 1713 (USD 38, 95% CI USD 18-73) per person per annum in India. This cost would be 24% higher, if branded drugs are used. Extrapolation of these costs to entire country indicates that Indian government needs to spend 3.8% (2.1%-6.8%) of the GDP for universalizing health care services. Conclusion: The cost of universal health care delivered through a combination of public and private providers is estimated to be INR 1713 per capita per year in India. Important issues such as delivery strategy for ensuring quality, reducing inequities in access, and managing the growth of health care demand need be explored.	[Prinja, Shankar; Bahuguna, Pankaj; Sharma, Atul; Bharaj, Gursimer; Kumar, Vishal; Tripathy, Jaya Prasad; Kaur, Manmeet; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Pinto, Andrew D.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Pinto, Andrew D.] St Michaels Hosp, Ctr Res Inner City Hlth, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	dr.rajeshkumar@gmail.com		Pinto, Ameet/0000-0003-1089-5664; Pinto, Andrew/0000-0003-1841-9347; Tripathy, Jaya Prasad/0000-0002-2626-5977; Bahuguna, Pankaj/0000-0001-9952-6077				*AFMC, 2007, STAND TREATM GUID ME; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bank W, 2010, WORLD DEV IND; Berman P, 2010, 59886 WORLD BANK HUM, P59886; Chollet D, 1997, PRIVATE INSURANCE PR; Dror DM, 2008, INDIAN J MED RES, V127, P347; Frenk J., 2011, NEW VISION HLTH SYST; Gupta I., 2000, WORLD HLTH POPULATIO, V3; Gupta M, 2010, RATE CONTRACT CONSUM; Hammer J., 2007, Economic and Political Weekly, V42, P4049; Health Do, 2010, SURG CARE PACKAGE; Hotchkiss DR, 1999, HEALTH POLICY, V46, P195, DOI 10.1016/S0168-8510(98)00063-3; Le Grand J., 2003, MOTIVATION AGENCY PU; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Mahal A, 2011, ACHIEVING UNIVERSAL; Mathur Neeta, 2010, Indian J Community Med, V35, P153, DOI 10.4103/0970-0218.62585; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; MOF, 2009, FISC CHALL; MOHFW, 2005, NAT HLTH ACC IND; MOHFW, 2005, NAT COMM MACR HLTH; MOHFW, 2009, NAT HLTH BILL 2009; MOHFW, 2005, BACKGR PAP BURD DIS; MOHFW, 2006, REP WORK GROUP HLTH; MOHFW, 2007, IND PUBL HLTH STAND; MOHFW, 2005, NAT RUR HLTH MISS IM; Moody A, 2011, EC TIMES; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; Palacios R, 2010, NEW APPR PROV HLTH I; Peters D, 2002, BETTER HLTH SYSTEMS, P233; Prinja S, 2011, INDIAN J ME IN PRESS; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rane W, 1996, EC POLITICAL WE 0824, V24, P2331; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Sengupta A, 2005, BMJ-BRIT MED J, V331, P1157, DOI 10.1136/bmj.331.7526.1157; Singh M, 2006, NEUROL INDIA, V54, P78; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Sur D, 2009, J HEALTH POPUL NUTR, V27, P725; Suryanarayana M, 2011, IN ADJ HUM DEV IND I; Tancharoensathien V, 2006, ACHIEVING UNIVERSAL; UNDP, 2011, HUM DEV REP 2010; van Doorslaer E, 2005, PAYING OUT OF POCKET; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; WHO, 2010, WOR HEALT REP, P1; WHO, 2005, CHOOSING INT AR COST	46	106	108	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30362	10.1371/journal.pone.0030362	http://dx.doi.org/10.1371/journal.pone.0030362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22905208	gold, Green Published, Green Submitted			2022-12-25	WOS:000301704200015
J	Zhang, X; Mao, Y; Huang, ZX; Qu, M; Chen, J; Ding, SX; Hong, JN; Sun, TT				Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian			Transcriptome Analysis of the Octopus vulgaris Central Nervous System	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-PERFORMANCE; ENDOTHELIAL-CELLS; MOLECULAR ANATOMY; TISSUES; IDENTIFICATION; SYNAPTOTAGMIN; LOCALIZATION; PERMEABILITY; MICROVESSELS	Background: Cephalopoda are a class of Mollusca species found in all the world's oceans. They are an important model organism in neurobiology. Unfortunately, the lack of neuronal molecular sequences, such as ESTs, transcriptomic or genomic information, has limited the development of molecular neurobiology research in this unique model organism. Results: With high-throughput Illumina Solexa sequencing technology, we have generated 59,859 high quality sequences from 12,918,391 paired-end reads. Using BLASTx/BLASTn, 12,227 contigs have blast hits in the Swissprot, NR protein database and NT nucleotide database with E-value cutoff 1e(-5). The comparison between the Octopus vulgaris central nervous system (CNS) library and the Aplysia californica/Lymnaea stagnalis CNS ESTs library yielded 5.93%/13.45% of O. vulgaris sequences with significant matches (1e(-5)) using BLASTn/tBLASTx. Meanwhile the hit percentage of the recently published Schistocerca gregaria, Tilapia or Hirudo medicinalis CNS library to the O. vulgaris CNS library is 21.03%-46.19%. We constructed the Phylogenetic tree using two genes related to CNS function, Synaptotagmin-7 and Synaptophysin. Lastly, we demonstrated that O. vulgaris may have a vertebrate-like Blood-Brain Barrier based on bioinformatic analysis. Conclusion: This study provides a mass of molecular information that will contribute to further molecular biology research on O. vulgaris. In our presentation of the first CNS transcriptome analysis of O. vulgaris, we hope to accelerate the study of functional molecular neurobiology and comparative evolutionary biology.	[Chen, Jun; Ding, Shaoxiong] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Xiang; Qu, Meng; Ding, Shaoxiong] Xiamen Univ, Lab Marine Biodivers & Global Change, Xiamen, Peoples R China; [Zhang, Xiang; Mao, Yong; Huang, Zixia; Qu, Meng; Chen, Jun; Ding, Shaoxiong; Hong, Jingni; Sun, Tiantian] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zhang, X (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	sxding@xmu.edu.cn	Huang, Zixia/AAO-6936-2021; Ding, SX/G-4137-2010; zhang, menghui/Q-3752-2016; Xu, Jia/GSD-6115-2022	Li, Xiaoying/0000-0002-9383-5757; zhang, menghui/0000-0002-9274-487X; Huang, Zixia/0000-0002-1298-0486; Zhang, Xu/0000-0003-2406-9478; Xu, Jia/0000-0002-3341-7668	National fund for oceanography research in Public Interest [201005013]; National Key Technology RD Program [2011BAD13]	National fund for oceanography research in Public Interest; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National fund for oceanography research in Public Interest (201005013) and the National Key Technology R&D Program (2011BAD13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VR, 1987, J BIOL CHEM, V262, P9404; Begley DJ, 1996, J PHARM PHARMACOL, V48, P136, DOI 10.1111/j.2042-7158.1996.tb07112.x; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cha SH, 2001, MOL PHARMACOL, V59, P1277, DOI 10.1124/mol.59.5.1277; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Feng ZP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-451; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hormiga JA, 2010, J BIOTECHNOL, V149, P209, DOI 10.1016/j.jbiotec.2009.12.008; KALARIA RN, 1987, J NEUROCHEM, V49, P856, DOI 10.1111/j.1471-4159.1987.tb00973.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Monteiro A, 2011, HARMFUL ALGAE, V10, P732, DOI 10.1016/j.hal.2011.06.004; Morita T, 2010, MAR POLLUT BULL, V60, P1193, DOI 10.1016/j.marpolbul.2010.03.031; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Perales-Raya C, 2010, FISH RES, V106, P171, DOI 10.1016/j.fishres.2010.05.003; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prato E, 2010, AQUACULTURE, V309, P203, DOI 10.1016/j.aquaculture.2010.09.036; Quintana D, 2008, AQUACULTURE, V280, P161, DOI 10.1016/j.aquaculture.2008.04.017; Raimundo J, 2010, CHEMOSPHERE, V81, P1314, DOI 10.1016/j.chemosphere.2010.08.029; Raimundo J, 2010, COMP BIOCHEM PHYS C, V152, P139, DOI 10.1016/j.cbpc.2010.03.009; Raimundo J, 2010, ECOTOX ENVIRON SAFE, V73, P1543, DOI 10.1016/j.ecoenv.2010.07.034; Raimundo J, 2010, ENVIRON POLLUT, V158, P2094, DOI 10.1016/j.envpol.2010.03.005; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seixas P, 2008, AQUACULTURE, V283, P83, DOI 10.1016/j.aquaculture.2008.06.019; Seixas P, 2010, AQUACULTURE, V300, P156, DOI 10.1016/j.aquaculture.2009.12.021; Shih JC, 2004, CURR MED CHEM, V11, P1995, DOI 10.2174/0929867043364757; Shomrat T, 2010, NEUROSCIENCE, V169, P52, DOI 10.1016/j.neuroscience.2010.04.050; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; Sobrino I, 2011, FISH RES, V108, P283, DOI 10.1016/j.fishres.2010.12.022; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ueno M, 2007, CURR MED CHEM, V14, P1199, DOI 10.2174/092986707780597943; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vargas-Yanez M, 2009, FISH RES, V99, P159, DOI 10.1016/j.fishres.2009.05.013; Vazquez-Rowe I, 2012, MAR POLICY, V36, P180, DOI 10.1016/j.marpol.2011.05.002; Villanueva R, 2009, AQUACULTURE, V286, P277, DOI 10.1016/j.aquaculture.2008.09.032; Vorbrodt AW, 2008, BRAIN CELL BIOL, V36, P203, DOI 10.1007/s11068-008-9038-3; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; Weksler BB, 2005, FASEB J; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2011, PLOS ONE, V6; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	59	285	298	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40320	10.1371/journal.pone.0040320	http://dx.doi.org/10.1371/journal.pone.0040320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768275	Green Submitted, Green Published, gold			2022-12-25	WOS:000305892100249
J	Cheng, J; Khan, MA; Qiu, WM; Li, J; Zhou, H; Zhang, QO; Guo, WW; Zhu, TT; Peng, JH; Sun, FJ; Li, SH; Korban, SS; Han, YP				Cheng, Jun; Khan, Muhammad Awais; Qiu, Wen-Ming; Li, Jing; Zhou, Hui; Zhang, Qiong; Guo, Wenwu; Zhu, Tingting; Peng, Junhua; Sun, Fengjie; Li, Shaohua; Korban, Schuyler S.; Han, Yuepeng			Diversification of Genes Encoding Granule-Bound Starch Synthase in Monocots and Dicots Is Marked by Multiple Genome-Wide Duplication Events	PLOS ONE			English	Article							MALUS X DOMESTICA; PROCESSED PSEUDOGENES; AMYLOPECTIN BIOSYNTHESIS; DEBRANCHING ENZYMES; RICE ENDOSPERM; WAXY LOCUS; 2 ISOFORMS; APPLE; ISOAMYLASE; EXPRESSION	Starch is one of the major components of cereals, tubers, and fruits. Genes encoding granule-bound starch synthase (GBSS), which is responsible for amylose synthesis, have been extensively studied in cereals but little is known about them in fruits. Due to their low copy gene number, GBSS genes have been used to study plant phylogenetic and evolutionary relationships. In this study, GBSS genes have been isolated and characterized in three fruit trees, including apple, peach, and orange. Moreover, a comprehensive evolutionary study of GBSS genes has also been conducted between both monocots and eudicots. Results have revealed that genomic structures of GBSS genes in plants are conserved, suggesting they all have evolved from a common ancestor. In addition, the GBSS gene in an ancestral angiosperm must have undergone genome duplication similar to 251 million years ago (MYA) to generate two families, GBSSI and GBSSII. Both GBSSI and GBSSII are found in monocots; however, GBSSI is absent in eudicots. The ancestral GBSSII must have undergone further divergence when monocots and eudicots split similar to 165 MYA. This is consistent with expression profiles of GBSS genes, wherein these profiles are more similar to those of GBSSII in eudicots than to those of GBSSI genes in monocots. In dicots, GBSSII must have undergone further divergence when rosids and asterids split from each other similar to 126 MYA. Taken together, these findings suggest that it is GBSSII rather than GBSSI of monocots that have orthologous relationships with GBSS genes of eudicots. Moreover, diversification of GBSS genes is mainly associated with genome-wide duplication events throughout the evolutionary course of history of monocots and eudicots.	[Cheng, Jun; Li, Jing; Zhou, Hui; Zhang, Qiong; Zhu, Tingting; Peng, Junhua; Li, Shaohua; Han, Yuepeng] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Khan, Muhammad Awais; Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Qiu, Wen-Ming; Guo, Wenwu] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China; [Sun, Fengjie] Georgia Gwinnett Coll, Sch Sci & Technol, Lawrenceville, GA USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; University of Illinois System; University of Illinois Urbana-Champaign; Huazhong Agricultural University; University System of Georgia; Georgia Gwinnett College	Cheng, J (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	korban@illinois.edu; yphan@wbgcas.cn	Peng, Junhua/HHZ-2344-2022; Zhu, Tingting/T-9997-2019; Zhu, Tingting/O-6989-2017	Peng, Junhua/0000-0002-8428-3137; Zhu, Tingting/0000-0003-3141-1884; Zhu, Tingting/0000-0003-3141-1884; Leung, Peter/0000-0003-3152-3800; Cheng, Jung-Chien/0000-0002-5399-9327; Khan, Muhammad Awais/0000-0002-0424-7727	National Program on Key Basic Research Project of China (973 Program) [2011CB100600]; CAS [XDA01020304]; Ministry of Agriculture of China	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This research was jointly supported by National Program on Key Basic Research Project of China (973 Program, grant no. 2011CB100600), the CAS Strategic Priority Research Program (grant no. XDA01020304), and the National 948 Project from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Carrin ME, 2004, FOOD CHEM, V87, P173, DOI 10.1016/j.foodchem.2003.10.032; Denyer K, 1997, PLANT CELL ENVIRON, V20, P1566, DOI 10.1046/j.1365-3040.1997.d01-48.x; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DRY I, 1992, PLANT J, V2, P193; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards A, 2002, PLANT CELL, V14, P1767, DOI 10.1105/tpc.002907; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; Evans RC, 2000, MOL PHYLOGENET EVOL, V17, P388, DOI 10.1006/mpev.2000.0828; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; GRAUR D, 1989, J MOL EVOL, V28, P279, DOI 10.1007/BF02103423; Han YP, 2007, PLANTA, V226, P1265, DOI 10.1007/s00425-007-0555-6; Han Y, 2007, MOL PHYLOGENET EVOL, V43, P852, DOI 10.1016/j.ympev.2006.09.001; Han YP, 2011, J EXP BOT, V62, P5117, DOI 10.1093/jxb/err215; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hylton CM, 1996, PLANTA, V198, P230, DOI 10.1007/BF00206248; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kelebek H, 2011, J SCI FOOD AGR, V91, P1855, DOI 10.1002/jsfa.4396; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Korban Schuyler S., 2009, V6, P85, DOI 10.1007/978-0-387-77491-6_5; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Magein H., 2000, ACTA HORTIC, V517, P487; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; McIntyre CL, 2008, GENOME, V51, P524, DOI 10.1139/G08-035; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Noda T, 2003, CEREAL CHEM, V80, P193, DOI 10.1094/CCHEM.2003.80.2.193; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Rambaut A, 2011, TRACER V1 5 COMPUTER; Sattler SE, 2009, MOL BREEDING, V24, P349, DOI 10.1007/s11032-009-9296-5; Stevenson DG, 2006, CARBOHYD POLYM, V63, P432, DOI 10.1016/j.carbpol.2005.10.009; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WOLFE J A, 1988, Aliso, V12, P177; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	49	43	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e30088	10.1371/journal.pone.0030088	http://dx.doi.org/10.1371/journal.pone.0030088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291904	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600014
J	Thomas, MA; Klaper, RD				Thomas, Michael A.; Klaper, Rebecca D.			Psychoactive Pharmaceuticals Induce Fish Gene Expression Profiles Associated with Human Idiopathic Autism	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; SEWAGE-TREATMENT PLANTS; COPY NUMBER VARIATION; WASTE-WATER; PRENATAL EXPOSURE; BIPOLAR DISORDER; SURFACE WATERS; ANTIDEPRESSANTS; BEHAVIOR; DRUGS	Idiopathic autism, caused by genetic susceptibility interacting with unknown environmental triggers, has increased dramatically in the past 25 years. Identifying environmental triggers has been difficult due to poorly understood pathophysiology and subjective definitions of autism. The use of antidepressants by pregnant women has been associated with autism. These and other unmetabolized psychoactive pharmaceuticals (UPPs) have also been found in drinking water from surface sources, providing another possible exposure route and raising questions about human health consequences. Here, we examined gene expression patterns of fathead minnows treated with a mixture of three psychoactive pharmaceuticals (fluoxetine, venlafaxine & carbamazepine) in dosages intended to be similar to the highest observed conservative estimates of environmental concentrations. We conducted microarray experiments examining brain tissue of fish exposed to individual pharmaceuticals and a mixture of all three. We used gene-class analysis to test for enrichment of gene sets involved with ten human neurological disorders. Only sets associated with idiopathic autism were unambiguously enriched. We found that UPPs induce autism-like gene expression patterns in fish. Our findings suggest a new potential trigger for idiopathic autism in genetically susceptible individuals involving an overlooked source of environmental contamination.	[Thomas, Michael A.] Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA; [Klaper, Rebecca D.] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Idaho; Idaho State University; University of Wisconsin System; University of Wisconsin Milwaukee	Thomas, MA (corresponding author), Idaho State Univ Sch, Dept Biol Sci, Pocatello, ID 83204 USA.	mthomas@isu.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Klaper, Rebecca/0000-0002-9239-6916; Suh, Mina/0000-0002-9557-4933; harris, mark/0000-0002-9007-1587	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources [P20 RR016454]; University Research Committee of Idaho State University [URC-FY2010-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER	PhRMA Foundation Sabbatical Fellowship grant; National Institutes of Health from the INBRE Program of the National Center for Research Resources; University Research Committee of Idaho State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MAT was supported by a PhRMA Foundation Sabbatical Fellowship grant, National Institutes of Health Grant Number P20 RR016454 from the INBRE Program of the National Center for Research Resources, and grant number URC-FY2010-05 from the University Research Committee of Idaho State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2006, PROG NEURO-PSYCHOPH, V30, P865, DOI 10.1016/j.pnpbp.2006.01.010; Batt AL, 2008, ANAL CHEM, V80, P5021, DOI 10.1021/ac800066n; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley RL, 2009, CURR OPIN NEUROL, V22, P162, DOI 10.1097/WCO.0b013e3283292401; Bruce GM, 2010, ENVIRON SCI TECHNOL, V44, P5619, DOI 10.1021/es1004895; Camacho-Munoz MD, 2010, J HAZARD MATER, V177, P1159, DOI 10.1016/j.jhazmat.2010.01.030; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Celiz MD, 2009, ENVIRON TOXICOL CHEM, V28, P2473, DOI 10.1897/09-173.1; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chen M, 2006, WATER QUAL RES J CAN, V41, P351, DOI 10.2166/wqrj.2006.039; Christensen AM, 2009, CHEMOSPHERE, V77, P351, DOI 10.1016/j.chemosphere.2009.07.018; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Croen LA, 2011, ARCH GEN PSYCHIAT AR; Cunningham VL, 2009, REGUL TOXICOL PHARM, V53, P39, DOI 10.1016/j.yrtph.2008.10.006; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; DasBanerjee T, 2008, AM J MED GENET B, V147B, P1554, DOI 10.1002/ajmg.b.30877; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Dufour-Rainfray D, 2010, NEUROSCI LETT, V470, P55, DOI 10.1016/j.neulet.2009.12.054; Favreliere S, 2010, ENCEPHALE, V36, pD133, DOI 10.1016/j.encep.2009.06.005; Gentile S, 2010, DEPRESS ANXIETY, V27, P675, DOI 10.1002/da.20706; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Alonso SG, 2010, ENVIRON INT, V36, P195, DOI 10.1016/j.envint.2009.11.004; Gros M, 2010, ENVIRON INT, V36, P15, DOI 10.1016/j.envint.2009.09.002; Hadjikhani N, 2010, MED HYPOTHESES, V74, P880, DOI 10.1016/j.mehy.2009.11.015; Hallmayer J, 2011, ARCH GEN PSYCHIAT AR; Hollander E, 2009, PSYCHIAT RES, V170, P43, DOI 10.1016/j.psychres.2008.07.014; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Madureira TV, 2010, SCI TOTAL ENVIRON, V408, P5513, DOI 10.1016/j.scitotenv.2010.07.069; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P110, DOI 10.3109/15622970903490626; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; McDonald ME, 2010, ENVIRON SCI TECHNOL, V44, P2112, DOI 10.1021/es902057k; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; McNamara IM, 2008, BRAIN RES, V1189, P203, DOI 10.1016/j.brainres.2007.10.063; Mennigen JA, 2010, AQUAT TOXICOL, V100, P128, DOI 10.1016/j.aquatox.2010.07.022; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Nakamura K, 2011, PROG NEURO-PSYCHOPH, V35, P454, DOI 10.1016/j.pnpbp.2010.11.033; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Olver JS, 2004, HUM PSYCHOPHARM CLIN, V19, P9, DOI 10.1002/hup.551; Painter MM, 2009, ENVIRON TOXICOL CHEM, V28, P2677, DOI 10.1897/08-556.1; Pedersen LH, 2010, PEDIATRICS, V125, pE600, DOI 10.1542/peds.2008-3655; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rice C, 2010, DISABIL HEALTH J, V3, P186, DOI 10.1016/j.dhjo.2009.10.008; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Schultzt MM, 2008, ANAL CHEM, V80, P1756, DOI 10.1021/ac702154e; Schwab BW, 2005, REGUL TOXICOL PHARM, V42, P296, DOI 10.1016/j.yrtph.2005.05.005; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Thomas MA, 2012, COMP BIOCHEM PHYS C, V155, P109, DOI 10.1016/j.cbpc.2011.05.014; Thomas MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-66; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	72	39	39	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2012	7	6							e32917	10.1371/journal.pone.0032917	http://dx.doi.org/10.1371/journal.pone.0032917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WK	22905163	Green Submitted, Green Published, gold			2022-12-25	WOS:000305348400001
J	Shen, HN; Lu, CL; Li, CY				Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi			Dementia Increases the Risks of Acute Organ Dysfunction, Severe Sepsis and Mortality in Hospitalized Older Patients: A National Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; END; PREVALENCE; TAIWAN; STATES; TREND; LIFE	Background: Dementia increases the risk of death in older patients hospitalized for acute illnesses. However, the effect of dementia on the risks of developing acute organ dysfunction and severe sepsis as well as on the risk of hospital mortality in hospitalized older patients remains unknown, especially when treatments for these life-threatening situations are considered. Methods: In this population-based cohort study, we analyzed 41,672 older (>= 65 years) patients, including 3,487 (8.4%) with dementia, from the first-time admission claim data between 2005 and 2007 for a nationally representative sample of one million beneficiaries enrolled in the Taiwan National Health Insurance Research Database. Outcomes included acute organ dysfunction, severe sepsis, and hospital mortality. The effect of dementia on outcomes was assessed using multivariable logistic regression. Results: Dementia was associated with a 32% higher risk of acute organ dysfunction (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.19-1.46), a 50% higher risk of severe sepsis (aOR 1.50, 95% CI 1.32-1.69) and a 28% higher risk of hospital mortality (aOR 1.28, 95% CI 1.10-1.48) after controlling age, sex, surgical condition, comorbidity, principal diagnosis, infection status, hospital level, and length of hospital stay. However, the significant adverse effect of dementia on hospital mortality disappeared when life-support treatments, including vasopressor use, hemodialysis, mechanical ventilation, and intensive care, were also controlled. Conclusions: In hospitalized older patients, the presence of dementia increased the risks of acute organ dysfunction, severe sepsis and hospital mortality. However, after intervention using life-support treatments, dementia only exhibited a minor role on short-term mortality.	[Shen, Hsiu-Nien] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Li, Chung-Yi] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital; China Medical University Taiwan	Shen, HN (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	hsiunian@gmail.com	Shen, Hsiu-Nien/H-2803-2019; LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908; Lu, Chin-Li/0000-0002-0818-4823	Chi Mei Medical Center [CMFHR9855]	Chi Mei Medical Center	The study was performed in Chi Mei Medical Center and supported by grant CMFHR9855 from the hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien IC, 2008, J GERIATR PSYCH NEUR, V21, P142, DOI 10.1177/0891988708316859; Demond DW, 2002, NEUROLOGY, V59, P537, DOI 10.1212/WNL.59.4.537; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Foreman MG, 2003, CHEST, V124, P1016, DOI 10.1378/chest.124.3.1016; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Kimata T, 2008, INT HEART J, V49, P533, DOI 10.1536/ihj.49.533; Laditka James N, 2005, Am J Alzheimers Dis Other Demen, V20, P27, DOI 10.1177/153331750502000109; Marengoni A, 2011, INT J GERIATR PSYCH, V26, P930, DOI 10.1002/gps.2627; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Pisani MA, 2005, CRIT CARE MED, V33, P1371, DOI 10.1097/01.CCM.0000165558.83676.48; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shah SM, 2012, AGE AGEING, V41, P64, DOI 10.1093/ageing/afr135; Shen HN, 2011, PSYCHOSOM MED, V73, P620, DOI 10.1097/PSY.0b013e3182280016; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Stevenson CG, 2001, CAN MED ASSOC J, V164, P1413; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	27	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42751	10.1371/journal.pone.0042751	http://dx.doi.org/10.1371/journal.pone.0042751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905169	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100062
J	Lichius, A; Yanez-Gutierrez, ME; Read, ND; Castro-Longoria, E				Lichius, Alexander; Yanez-Gutierrez, Mario E.; Read, Nick D.; Castro-Longoria, Ernestina			Comparative Live-Cell Imaging Analyses of SPA-2, BUD-6 and BNI-1 in Neurospora crassa Reveal Novel Features of the Filamentous Fungal Polarisome	PLOS ONE			English	Article							PENICILLIUM-CHRYSOGENUM HYPHAE; CANDIDA-ALBICANS HYPHAE; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; SEPTAL PORES; ACTIN CYTOSKELETON; POLARIZED GROWTH; FISSION YEAST; FUNCTIONAL-CHARACTERIZATION; ASHBYA-GOSSYPII	A key multiprotein complex involved in regulating the actin cytoskeleton and secretory machinery required for polarized growth in fungi, is the polarisome. Recognized core constituents in budding yeast are the proteins Spa2, Pea2, Aip3/Bud6, and the key effector Bni1. Multicellular fungi display a more complex polarized morphogenesis than yeasts, suggesting that the filamentous fungal polarisome might fulfill additional functions. In this study, we compared the subcellular organization and dynamics of the putative polarisome components BUD-6 and BNI-1 with those of the bona fide polarisome marker SPA-2 at various developmental stages of Neurospora crassa. All three proteins exhibited a yeast-like polarisome configuration during polarized germ tube growth, cell fusion, septal pore plugging and tip repolarization. However, the localization patterns of all three proteins showed spatiotemporally distinct characteristics during the establishment of new polar axes, septum formation and cytokinesis, and maintained hyphal tip growth. Most notably, in vegetative hyphal tips BUD-6 accumulated as a subapical cloud excluded from the Spitzenkorper (Spk), whereas BNI-1 and SPA-2 partially colocalized with the Spk and the tip apex. Novel roles during septal plugging and cytokinesis, connected to the reinitiation of tip growth upon physical injury and conidial maturation, were identified for BUD-6 and BNI-1, respectively. Phenotypic analyses of gene deletion mutants revealed additional functions for BUD-6 and BNI-1 in cell fusion regulation, and the maintenance of Spk integrity. Considered together, our findings reveal novel polarisome-independent functions of BUD-6 and BNI-1 in Neurospora, but also suggest that all three proteins cooperate at plugged septal pores, and their complex arrangement within the apical dome of mature hypha might represent a novel aspect of filamentous fungal polarisome architecture.	[Lichius, Alexander; Yanez-Gutierrez, Mario E.; Castro-Longoria, Ernestina] Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Lichius, Alexander; Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Edinburgh	Lichius, A (corresponding author), Ctr Sci Res & Higher Educ Ensenada CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	Castro-Longoria, Ernestina/GYV-4776-2022; Lichius, Alexander/M-3808-2017	Lichius, Alexander/0000-0002-2971-9604; Read, Nick/0000-0002-2286-2862; Jeffree, Christopher/0000-0002-3838-8720; Lord, Kathryn/0000-0002-2144-6269	SEP-CONACyT [CB-2006-1-61524]; Biotechnology and Biological Sciences Research Council [BB/E010741/1]; CONACyT; BBSRC [BB/E010741/1] Funding Source: UKRI	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this project was provided by a SEP-CONACyT (www.conacyt.mx) grant (CB-2006-1-61524) to EC-L and a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) grant (# BB/E010741/1) to NDR. We thank CONACyT for a grant to MEY-G., and a postdoctoral fellowship to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Araujo-Palomares CL, 2009, FUNGAL GENET BIOL, V46, P551, DOI 10.1016/j.fgb.2009.02.009; Beltran-Aguilar A, 2006, CARACTERIZACION MACR; Berepiki A, 2011, NATURE REV IN PRESS; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Buller A.H.R., 1933, RES FUNGI; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Carbo N, 2008, FUNGAL GENET BIOL, V45, P1315, DOI 10.1016/j.fgb.2008.06.010; Chapa-Y-Lazo B, 2011, FUNGAL BIOL-UK, V115, P547, DOI 10.1016/j.funbio.2011.02.001; CHENEVERT J, 1994, GENETICS, V136, P1287; COLLINGE AJ, 1987, FEMS MICROBIOL LETT, V40, P165; COLLINGE AJ, 1985, EXP MYCOL, V9, P80, DOI 10.1016/0147-5975(85)90051-9; Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Davis RH, 2000, NEUROSPORA CONTRIBUT, P333; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Delgehyr N, 2008, J CELL SCI, V121, P3803, DOI 10.1242/jcs.036269; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221; Gammie AE, 1998, MOL BIOL CELL, V9, P1395, DOI 10.1091/mbc.9.6.1395; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852; Leeder AC, 2008, FUNGAL GENET BIOL, V45, P897, DOI 10.1016/j.fgb.2007.12.001; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lichius A., 2010, FUNGAL GENET, V57, P8, DOI [10.4148/1941-4765.1070, DOI 10.4148/1941-4765.1070]; Lichius A, 2010, CELL FUSION NEUROSPO; Lichius A., 2010, DISTINGUISH CONIDIAL, P1; Lichius A, 2011, EUKARYOTIC CEL UNPUB; Lichius A, 2011, FUNGAL BIOL-UK, V115, P518, DOI 10.1016/j.funbio.2011.02.014; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; MARKHAM P, 1987, FEMS MICROBIOL LETT, V46, P1; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; Martin R, 2005, EUKARYOT CELL, V4, P1712, DOI 10.1128/EC.4.10.1712-1724.2005; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nolan S, 2006, MOL BIOL CELL, V17, P2439, DOI 10.1091/mbc.E05-11-1015; Ozaki-Kuroda K, 2011, MOL CELL BIOL, V21, P827; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Rasmussen CG, 2007, EUKARYOT CELL, V6, P1097, DOI 10.1128/EC.00050-07; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; RAYNER ADM, 1991, MYCOLOGIA, V83, P48, DOI 10.2307/3759832; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roca M. G., 2010, ANAL QUANTIFY CONIDI, P1; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356; Shaw BD, 2011, FUNGAL BIOL-UK, V115, P541, DOI 10.1016/j.funbio.2011.02.010; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Tcheperegine SE, 2005, MOL CELL BIOL, V25, P8567, DOI 10.1128/MCB.25.19.8567-8580.2005; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; TRINCI APJ, 1973, ARCH MIKROBIOL, V91, P113, DOI 10.1007/BF00424755; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; van Drogen F, 2002, CURR BIOL, V12, P1698, DOI 10.1016/S0960-9822(02)01186-7; Verdin J, 2009, MOL MICROBIOL, V74, P1044, DOI 10.1111/j.1365-2958.2009.06917.x; Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wedlich-Soldner R, 2008, SEMIN CELL DEV BIOL, V19, P224, DOI 10.1016/j.semcdb.2008.01.003	94	42	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30372	10.1371/journal.pone.0030372	http://dx.doi.org/10.1371/journal.pone.0030372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22900028	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600018
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-25	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400077
